FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Zhang, J
   Li, YP
   Wang, BY
   Luo, Y
   Shi, JP
   Zhao, BY
AF Zhang, Jing
   Li, Yanpeng
   Wang, Bingyuan
   Luo, Yan
   Shi, Junping
   Zhao, Baiyun
TI The p66shc-mediated Regulation of Hepatocyte Senescence Influences
   Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Cell Aging; Fatty Liver; Shc Signaling Adaptor Proteins
ID OXIDATIVE STRESS; CELLULAR SENESCENCE; LIFE-SPAN; PROGRESSION; P66SHC;
   MARKER; DAMAGE; P21; STEATOHEPATITIS; CONTRIBUTES
AB Background: Recent studies have suggested that hepatocyte senescence could contribute to hepatic steatosis and its progression in nonalcoholic fatty liver disease (NAFLD). However, the underlying mechanism causing hepatocyte senescence in this pathological condition is still unclear. A thorough understanding of the mechanism could provide a new target for therapeutic intervention. The purpose of this study was to investigate the role of p66shc in hepatocyte senescence and hepatocyte damage in NAFLD progression.
   Material/Methods: We examined the expression levels of hepatic p66shc and senescence markers in rats and humans with NAFLD, and we assessed the effect of p66shc knockdown or overexpression on senescence and steatosis in human liver cells.
   Results: In this study, we showed that increased hepatic p66shc expression was consistent with upregulated expression of the following senescence markers in NAFLD rats: heterochromatin protein-1-beta (HP1 beta), p16, p21, and p53. Furthermore, senescence and steatosis could be induced in hepatoblastoma cell line (HepG2) cells when cells were stimulated with a low concentration of H2O2, and this effect was significantly alleviated by knockdown of p66shc. However, overexpression of p66shc could promote senescence and steatosis in L02 cells. Finally, increased hepatic p66shc protein levels correlated with enhanced expression of the senescence marker p21 and mirrored the degree of disease severity in NAFLD patients.
   Conclusions: Our findings indicated that the increase in hepatocyte senescence and steatosis in NAFLD may be caused by the upregulation of p66shc expression, implying that strategies for p66shc-mediated regulation of hepatocyte senescence may provide new therapeutic tools for NAFLD.
C1 [Zhang, Jing] Jining Med Univ, Dept Gastroenterol, Affiliated Hosp, Jining, Shandong, Peoples R China.
   [Li, Yanpeng] Jining Med Univ, Dept Spine Surg, Affiliated Hosp, Jining, Shandong, Peoples R China.
   [Wang, Bingyuan] China Med Univ, Dept Elderly Gastroenterol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.
   [Luo, Yan] Hangzhou Normal Univ, Ctr Translat Med, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China.
   [Shi, Junping] Hangzhou Normal Univ, Dept Liver Dis, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China.
   [Zhao, Baiyun] Hangzhou Normal Univ, Affiliated Hosp, Drug Clin Trial Inst, Hangzhou, Zhejiang, Peoples R China.
C3 Jining Medical University; Jining Medical University; China Medical
   University; Hangzhou Normal University; Hangzhou Normal University;
   Hangzhou Normal University
RP Shi, JP (corresponding author), Hangzhou Normal Univ, Dept Liver Dis, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China.; Zhao, BY (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Drug Clin Trial Inst, Hangzhou, Zhejiang, Peoples R China.
EM shijpliver@163.com; gcp_ec@163.com
OI Zhang, Jing/0000-0003-2502-3156
FU National Natural Science Foundation of China [81570524]; Natural Science
   Foundation of Zhejiang Province [LQ16H290003]; Scientific Research
   Support Fund for Teachers of Jining Medical College [JYFC2018FKJ147]
FX This work was supported by grants from the National Natural Science
   Foundation of China (81570524), Natural Science Foundation of Zhejiang
   Province (LQ16H290003) and Scientific Research Support Fund for Teachers
   of Jining Medical College (JYFC2018FKJ147)
CR Arauz J, 2016, ANN HEPATOL, V15, P160, DOI 10.5604/16652681.1193701
   Aravinthan A, 2015, EXP CELL RES, V331, P38, DOI 10.1016/j.yexcr.2014.09.025
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   Boengler K, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00733
   Bozaykut P, 2016, MECH AGEING DEV, V157, P17, DOI 10.1016/j.mad.2016.07.001
   Brunt EM, 2007, LIVER INT, V27, P662, DOI 10.1111/j.1478-3231.2007.01470.x
   Carney Ellen F, 2016, Nat Rev Nephrol, V12, P442, DOI 10.1038/nrneph.2016.89
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Granatiero V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06363-0
   Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018
   Hu XN, 2018, PEERJ, V6, DOI 10.7717/peerj.5145
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44
   Kondo Y, 2016, GERIATR GERONTOL INT, V16, P4, DOI 10.1111/ggi.12722
   Kumar S, 2017, P NATL ACAD SCI USA, V114, P1714, DOI 10.1073/pnas.1614112114
   Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008
   Li QX, 2016, ARTERIOSCL THROM VAS, V36, P2394, DOI 10.1161/ATVBAHA.116.308321
   Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Miller B, 2016, J CLIN INVEST, V126, P2533, DOI 10.1172/JCI75079
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3
   Perrini S, 2015, AM J PHYSIOL-GASTR L, V309, pG826, DOI 10.1152/ajpgi.00041.2015
   Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591
   Seto WK, 2017, J GASTROENTEROL, V52, P164, DOI 10.1007/s00535-016-1264-3
   Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013
   Wang MJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.167
   Wright KD, 2018, AM J PHYSIOL-RENAL, V314, pF143, DOI 10.1152/ajprenal.00414.2017
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang WJ, 2017, ENVIRON TOXICOL PHAR, V56, P68, DOI 10.1016/j.etap.2017.08.028
   Zhao Y, 2019, THERANOSTICS, V9, P1510, DOI 10.7150/thno.29620
NR 40
TC 13
Z9 15
U1 1
U2 18
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD MAR 19
PY 2020
VL 26
AR e921887
DI 10.12659/MSM.921887
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA KW4MV
UT WOS:000521141000001
PM 32191680
OA Green Published
DA 2024-02-19
ER

PT J
AU Wijayasiri, P
   Astbury, S
   Kaye, P
   Oakley, F
   Alexander, GJ
   Kendall, TJ
   Aravinthan, AD
AF Wijayasiri, Pramudi
   Astbury, Stuart
   Kaye, Philip
   Oakley, Fiona
   Alexander, Graeme J.
   Kendall, Timothy J.
   Aravinthan, Aloysious D.
TI Role of Hepatocyte Senescence in the Activation of Hepatic Stellate
   Cells and Liver Fibrosis Progression
SO CELLS
LA English
DT Article
DE hepatocyte senescence; senescence-associated secretory phenotype (SASP)
   factors; hepatic stellate cells; smooth muscle alpha-actin (alpha SMA)
ID CELLULAR SENESCENCE; SECRETORY PHENOTYPE; RESISTANCE; RAPAMYCIN;
   SURVIVAL
AB Hepatocyte senescence is associated with liver fibrosis. However, the possibility of a direct, causal relation between hepatocyte senescence and hepatic stellate cell (HSC) activation was the subject of this study. Liver biopsy specimens obtained from 50 patients with non-alcoholic fatty liver disease and a spectrum of liver fibrosis stages were stained for p16, alpha SMA, and picrosirius red (PSR). Primary human HSCs were cultured in conditioned media derived from senescent or control HepG2 cells. Expression of inflammatory and fibrogenic genes in HSCs cultured in conditioned media were studied using RT-PCR. ELISAs were undertaken to measure factors known to activate HSCs in the conditioned media from senescent and control HepG2 cells and serum samples from healthy volunteers or patients with biopsy-proven cirrhosis. There was a strong association between proportion of senescent hepatocytes and hepatic stellate cell activation. Both proportion of hepatocyte senescence and hepatic stellate cell activation were closely associated with fibrosis stage. Inflammatory and fibrogenic genes were up-regulated significantly in HSCs cultured in conditioned media from senescent HepG2 cells compared with control HepG2 cells. PDGF levels were significantly higher in the conditioned media from senescent hepatocytes than control HepG2-conditioned media, and in serum samples from patients with cirrhosis than healthy volunteers. In conclusion, this 'proof of concept' study revealed activation of human HSCs by media from senescent HepG2 cells, indicating direct involvement of factors secreted by senescent hepatocytes in liver fibrosis.
C1 [Wijayasiri, Pramudi; Astbury, Stuart; Aravinthan, Aloysious D.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham NG7 2UH, England.
   [Wijayasiri, Pramudi; Astbury, Stuart; Aravinthan, Aloysious D.] Univ Nottingham, Nottingham NG7 2UH, England.
   [Wijayasiri, Pramudi; Astbury, Stuart; Aravinthan, Aloysious D.] Univ Nottingham, Nottingham Digest Dis Ctr, Sch Med, Nottingham NG7 2UH, England.
   [Kaye, Philip] Nottingham Univ Hosp NHS Trust, Dept Pathol, Nottingham NG7 2UH, England.
   [Oakley, Fiona] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Alexander, Graeme J.] UCL Inst Liver & Digest Hlth, Div Med, Royal Free Campus, London NW3 2PF, England.
   [Kendall, Timothy J.] Univ Edinburgh, Ctr Inflammat Res, Inst Regenerat & Repair, Edinburgh EH16 4TJ, Midlothian, Scotland.
C3 Nottingham University Hospital NHS Trust; University of Nottingham;
   University of Nottingham; Nottingham University Hospital NHS Trust;
   Newcastle University - UK; University of London; University College
   London; University of Edinburgh
RP Aravinthan, AD (corresponding author), Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham NG7 2UH, England.; Aravinthan, AD (corresponding author), Univ Nottingham, Nottingham NG7 2UH, England.; Aravinthan, AD (corresponding author), Univ Nottingham, Nottingham Digest Dis Ctr, Sch Med, Nottingham NG7 2UH, England.
EM pramudi.wijayasiri@nottingham.ac.uk; stuart.astbury@nottingham.ac.uk;
   philip.kaye@nuh.nhs.uk; fiona.oakley@newcastle.ac.uk;
   g.alexander@ucl.ac.uk; tim.kendall@ed.ac.uk;
   aloysious.aravinthan@nottingham.ac.uk
RI Aravinthan, Aloysious D/I-2557-2019; Kendall, Tim/H-2698-2019
OI Aravinthan, Aloysious D/0000-0003-0527-5137; Kendall,
   Tim/0000-0002-4174-2786; Astbury, Stuart/0000-0002-1919-3952; Oakley,
   Fiona/0000-0001-8692-1836
FU Sir Halley Stewart Trust, London; Nottingham Hospitals Charity,
   Nottingham
FX The study was partly supported by research grants from Sir Halley
   Stewart Trust, London and Nottingham Hospitals Charity, Nottingham.
CR Aravinthan A, 2015, HUM CELL, V28, P51, DOI 10.1007/s13577-015-0110-x
   Aravinthan A, 2015, EXP CELL RES, V331, P38, DOI 10.1016/j.yexcr.2014.09.025
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Aravinthan AD, 2015, J HEPATOL, V63, P532, DOI 10.1016/j.jhep.2015.03.031
   Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Deevska G, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10061278
   Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hillel AT, 2015, ONCOTARGET, V6, P15722, DOI 10.18632/oncotarget.4652
   Hoare M, 2011, SEMIN CANCER BIOL, V21, P397, DOI 10.1016/j.semcancer.2011.09.004
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   McKee C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08812
   Mela M, 2020, COPD-J COPD FDN, V7, P151, DOI 10.15326/jcopdf.7.3.2019.0158
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030
   Sabater L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78776-3
   Sakaida I, 1999, AM J GASTROENTEROL, V94, P489, DOI 10.1111/j.1572-0241.1999.884_m.x
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Shah M, 2015, ALIMENT PHARM THER, V41, P379, DOI 10.1111/apt.13049
   Tachtatzis PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127511
   Donato MT, 2015, METHODS MOL BIOL, V1250, P77, DOI 10.1007/978-1-4939-2074-7_5
   Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X
   Wang AS, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00247
   Wang WJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083908, 10.1371/journal.pone.0084654]
NR 38
TC 7
Z9 7
U1 0
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JUL
PY 2022
VL 11
IS 14
AR 2221
DI 10.3390/cells11142221
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 3K0RF
UT WOS:000833792700001
PM 35883664
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yu, HY
   Jiang, X
   Dong, FY
   Zhang, F
   Ji, XY
   Xue, MJ
   Yang, F
   Chen, J
   Hu, XN
   Bao, ZJ
AF Yu, Huiyuan
   Jiang, Xin
   Dong, Fangyuan
   Zhang, Fan
   Ji, Xueying
   Xue, Mengjuan
   Yang, Fan
   Chen, Jie
   Hu, Xiaona
   Bao, Zhijun
TI Lipid accumulation-induced hepatocyte senescence regulates the
   activation of hepatic stellate cells through the Nrf2-antioxidant
   response element pathway
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article; Early Access
DE Non-alcoholic fatty liver disease; Aging; Oxidative stress; Nrf2;
   Hepatic fibrosis
ID FATTY LIVER-DISEASE; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS;
   TARGET; PREVALENCE; METABOLISM; MECHANISMS
AB Non-alcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease globally. Elderly individuals are at a higher risk of developing NAFLD with severe clinical outcomes. Although NAFLD is closely related to liver aging, the role of hepatocyte senescence in the progression of NAFLD, especially in the development of fibrosis, is still unclear. The early stage of NAFLD is mainly characterized by lipid accumulation in hepatocytes, which could lead to severe oxidative stress, causing cellular senescence. In the present study, hepatocytes cultured in the presence of free fatty acids to induce lipid deposition were used as a hepatocyte senescence model in vitro. Senescent hepatocytes significantly increased the activation of co-cultured primary hepatic stellate cells (HSCs) and the expression of pro-fibrosis molecules. Moreover, the antioxidant regulator nuclear factor erythroid 2-related factor 2 (Nrf2) that was upregulated in senescent hepatocytes was found to be related to the activation of co-cultured HSCs. The Nrf2 agonist sulforaphane, which upregulated the transcriptional activity of the Nrf2-antioxidant response element (ARE) pathway, remarkably inhibited hepatocyte senescence and its activation effect on HSCs. However, the liver tissue obtained from non-alcoholic steatohepatitis (NASH) mice with Nrf2 knockdown showed decreased antioxidation and significant liver senescence and fibrosis. In conclusion, this study confirmed that lipid accumulation induces hepatocyte senescence, which leads to HSC activation and development of hepatic fibrosis. Increasing the activity of the Nrf2-ARE antioxidant pathway in senescent hepatocytes elicited the opposite effect, suggesting that targeting Nrf2 may prevent or delay the progression of aging-related liver fibrosis in NASH.
C1 [Yu, Huiyuan; Dong, Fangyuan; Chen, Jie; Hu, Xiaona; Bao, Zhijun] Fudan Univ, Huadong Hosp, Shanghai Med Coll, Dept Gastroenterol, 221 Yanan West Rd, Shanghai 200040, Peoples R China.
   [Jiang, Xin; Zhang, Fan; Ji, Xueying; Xue, Mengjuan; Yang, Fan; Hu, Xiaona; Bao, Zhijun] Fudan Univ, Huadong Hosp, Shanghai Med Coll, Dept Gerontol, Shanghai, Peoples R China.
   [Yu, Huiyuan; Jiang, Xin; Dong, Fangyuan; Zhang, Fan; Ji, Xueying; Xue, Mengjuan; Yang, Fan; Chen, Jie; Hu, Xiaona; Bao, Zhijun] Shanghai Key Lab Clin Geriatr Med, Shanghai, Peoples R China.
   [Yu, Huiyuan; Jiang, Xin; Dong, Fangyuan; Zhang, Fan; Ji, Xueying; Xue, Mengjuan; Yang, Fan; Chen, Jie; Hu, Xiaona; Bao, Zhijun] Fudan Univ, Res Ctr Aging & Med, Shanghai, Peoples R China.
C3 Fudan University; Fudan University; Fudan University
RP Chen, J; Hu, XN; Bao, ZJ (corresponding author), Fudan Univ, Huadong Hosp, Shanghai Med Coll, Dept Gastroenterol, 221 Yanan West Rd, Shanghai 200040, Peoples R China.
EM laughchen@126.com; huxn06@163.com; zhijunbao@fudan.edu.cn
RI Ji, Xueying/HRA-8284-2023
FU National Key Research and Development Program of China [2018YFC2002000];
   National Natural Science Foundation of China [81701374]; Young Excellent
   Medical Talents Training Program of Health Department of Shanghai
   Municipal Government [2018YQ58]
FX This work was supported by grants from the National Key Research and
   Development Program of China (2018YFC2002000), National Natural Science
   Foundation of China (81701374) and Young Excellent Medical Talents
   Training Program of Health Department of Shanghai Municipal Government
   (2018YQ58).
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bai XP, 2016, DRUG METAB REV, V48, P541, DOI 10.1080/03602532.2016.1197239
   Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774
   Buendia I, 2016, PHARMACOL THERAPEUT, V157, P84, DOI 10.1016/j.pharmthera.2015.11.003
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   Golabi P, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0972-6
   Hayes JD, 2015, BIOCHEM SOC T, V43, P611, DOI 10.1042/BST20150011
   Hellerbrand C, 1996, HEPATOLOGY, V24, P670
   Hernández A, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165857
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Lu MC, 2016, MED RES REV, V36, P924, DOI 10.1002/med.21396
   Luo J, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100982
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P519, DOI 10.1089/ars.2016.6776
   Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005
   Ye Q, 2020, LANCET GASTROENTEROL, V5, P739, DOI 10.1016/S2468-1253(20)30077-7
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033
   Zhang DL, 2018, THERANOSTICS, V8, P1340, DOI 10.7150/thno.22806
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001
NR 39
TC 14
Z9 15
U1 1
U2 30
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD 2021 AUG 15
PY 2021
VL 405
IS 2
AR 112689
DI 10.1016/j.yexcr.2021.112689
EA JUN 2021
PG 12
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA TS0HE
UT WOS:000679336700021
PM 34107274
DA 2024-02-19
ER

PT J
AU Mela, M
   Smeeton, W
   Davies, SE
   Miranda, E
   Scarpini, C
   Coleman, N
   Alexander, GJM
AF Mela, Marianna
   Smeeton, Wendy
   Davies, Susan E.
   Miranda, Elena
   Scarpini, Cinzia
   Coleman, Nick
   Alexander, Graeme J. M.
TI The Alpha-1 Antitrypsin Polymer Load Correlates With Hepatocyte
   Senescence, Fibrosis Stage and Liver-Related Mortality
SO CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION
LA English
DT Article
DE alpha-1 antitrypsin; polymers; polymer load; liver fibrosis; senescence
ID ALPHA(1)-ANTITRYPSIN DEFICIENCY; HEPATITIS-C; DISEASE; RISK; ADULTS;
   CIRRHOSIS; ARREST; PIZZ
AB Background: Alpha-1 antitrypsin deficiency (AATD) is an important, inherited cause of chronic liver disease. Marked variation in fibrosis stages in patients with homozygous deficiency and those factors that determine whether heterozygous carriers develop liver fibrosis, remain unexplained. Murine studies implicate polymerized alpha-1 antitrypsin (AAT) within hepatocytes as pathogenic.
   Aims and Methods: The relationship between the quantity of polymerized AAT within hepatocytes (polymer load), stage of hepatic fibrosis and liver-related clinical outcomes (death, evolution to hepatocellular carcinoma, or need for liver transplantation) were investigated using liver tissue from 92 patients at first presentation with either homozygous or heterozygous AATD. Further tissue-based studies were undertaken to determine if polymerized AAT was associated with failure of cell cycle progression, accelerated aging or hepatocyte senescence by immunohistochemical analysis.
   Results: The AAT polymer load correlated closely with hepatic fibrosis stage and long-term clinical outcome, independent of homozygous or heterozygous status. AAT polymers within hepatocytes correlated closely with failure of cell cycle progression assessed using cell cycle phase markers, accelerated aging manifest as shortened telomeres and other markers consistent with hepatocyte senescence manifest as the presence of nuclear p21 expression and enlarged nuclei. The proportion of p21 positive hepatocytes or hepatocytes with enlarged nuclei correlated with hepatic fibrosis stage and the long-term clinical outcome.
   Conclusion: These data suggest that accumulation of AAT polymers within hepatocytes drives senescence. Quantitation of both the AAT polymer load or hepatocyte senescence markers correlated with hepatic fibrosis stage and the long-term clinical outcome. Either or both could be considered markers of disease severity and treatment response in clinical trials.
C1 [Mela, Marianna; Smeeton, Wendy] Addenbrookes Hosp, Univ Dept Med, Div Gastroenterol & Hepatol, Cambridge, England.
   [Davies, Susan E.] Addenbrookes Hosp, Dept Histopathol, Cambridge, England.
   [Miranda, Elena] Sapienza Univ Rome, Charles Darwin & Pasteur Inst, Dept Biol & Biotechnol, Cenci Bolognetti Fdn, Rome, Italy.
   [Scarpini, Cinzia; Coleman, Nick] Univ Cambridge, Dept Pathol, Cambridge, England.
   [Alexander, Graeme J. M.] Royal Free Hosp, UCL Inst Liver & Digest Hlth, London, England.
C3 Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's
   Hospital; University of Cambridge; University of Cambridge; Cambridge
   University Hospitals NHS Foundation Trust; Addenbrooke's Hospital;
   Sapienza University Rome; Fondazione Cenci Bolognetti; University of
   Cambridge; University of London; University College London; Royal Free
   London NHS Foundation Trust; UCL Medical School
RP Alexander, GJM (corresponding author), Royal Free Hosp, UCL Inst Liver & Digest Hlth, London, England.
EM g.alexander@ucl.ac.uk
FU Alpha-1 Foundation; Pasteur Institute Cenci-Bolognetti Foundation;
   Sapienza Research Grants
FX M. is funded by the Alpha-1 Foundation, the Pasteur Institute
   Cenci-Bolognetti Foundation and by Sapienza Research Grants.
CR Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641
   Cacciottolo TM, 2014, EUR J GASTROEN HEPAT, V26, P412, DOI 10.1097/MEG.0000000000000061
   COX DW, 1983, AM J MED, V74, P221, DOI 10.1016/0002-9343(83)90615-0
   Dawwas MF, 2013, AM J RESP CRIT CARE, V187, P502, DOI 10.1164/rccm.201204-0739OC
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018
   Elzouki A N, 1999, Saudi J Gastroenterol, V5, P1
   Elzouki AN, 1996, EUR J GASTROEN HEPAT, V8, P989, DOI 10.1097/00042737-199610000-00010
   ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202
   ESQUIVEL CO, 1987, TRANSPLANT P, V19, P3798
   Goltz D, 2014, VIRCHOWS ARCH, V465, P539, DOI 10.1007/s00428-014-1633-3
   Graziadei IW, 1998, HEPATOLOGY, V28, P1058, DOI 10.1002/hep.510280421
   Hamesch K, 2019, GASTROENTEROLOGY, V157, P705, DOI 10.1053/j.gastro.2019.05.013
   Janciauskiene SM, 2011, RESP MED, V105, P1129, DOI 10.1016/j.rmed.2011.02.002
   Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760
   Ranes J, 2005, SEMIN RESP CRIT CARE, V26, P154, DOI 10.1055/s-2005-869536
   Rudnick DA, 2004, HEPATOLOGY, V39, P1048, DOI 10.1002/hep.20118
   Schaefer B, 2018, LIVER TRANSPLANT, V24, P744, DOI 10.1002/lt.25057
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Strnad P, 2019, GUT, V68, P1099, DOI 10.1136/gutjnl-2018-316228
   SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404
   Tachtatzis PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127511
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
NR 27
TC 9
Z9 9
U1 0
U2 4
PU COPD FOUNDATION
PI DENVER
PA COPD FOUNDATION, DENVER, CO 00000 USA
SN 2372-952X
J9 COPD-J COPD FDN
JI Chronic Obstr. Pulm. Dis.
PY 2020
VL 7
IS 3
BP 151
EP 162
DI 10.15326/jcopdf.7.3.2019.0158
PG 12
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA MV7QB
UT WOS:000556546400004
PM 32726073
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Luo, XY
   Jiang, XK
   Li, J
   Bai, YQ
   Li, Z
   Wei, PR
   Sun, SF
   Liang, Y
   Han, SY
   Li, XL
   Zhang, BY
AF Luo, Xiaoying
   Jiang, Xiaoke
   Li, Jun
   Bai, Yangqiu
   Li, Zhen
   Wei, Peiru
   Sun, Suofeng
   Liang, Yuan
   Han, Shuangyin
   Li, Xiuling
   Zhang, Bingyong
TI Insulin-like growth factor-1 attenuates oxidative stress-induced
   hepatocyte premature senescence in liver fibrogenesis via regulating
   nuclear p53-progerin interaction
SO CELL DEATH & DISEASE
LA English
DT Article
ID MOLECULAR-MECHANISMS; STELLATE CELLS; LAMIN A/C; CIRRHOSIS; AXIS; RATS
AB Stress-induced premature senescence (SIPS), a state of cell growth arrest due to various stimuli, is implicated in the pathogeneses of hepatic fibrogenesis. Progerin, a permanently farnesylated mutant lamin A protein, likely leads to premature senescence to influent liver diseases. The previous reports showed that activation of insulin-like growth factor-1 (IGF-1) signaling could enhance cell longevity and attenuate liver fibrosis. However, the underlying mechanisms about hepatocyte premature senility in liver fibrosis, and how IGF-1 regulates cell premature aging and fibrogenesis, remain poorly understood. In the present study, we found the augment of hepatocyte oxidation and premature aging, along with the decrease of plasm IGF-1 level in patients with liver fibrosis and CCl4-induced liver injury rat models. Nevertheless, IGF-1 gene transfer to CCl4 rats to overexpress intrahepatic IGF-1 relieved hepatocyte oxidative stress and premature senescence, which was likely mediated by the p53/progerin pathway, to improve hepatic steatosis and fibrogenesis. In vitro, H2O2 caused abnormal accumulation of progerin in nuclear and activation of nuclear p53-progerin interaction to trigger primary rat hepatocyte premature senescence through the p21-independent pathway; while these effects were rescued by prolonged exogenous IGF-1 or the IGF-1 adenovirus vector. Furthermore, the IGF-1 adenovirus vector, transfected to H2O2-treated hepatocytes, reversed oxidative stress-induced premature senescence via enhancing cytoplasmic AKT1-p53 interaction and subsequently inhibiting nuclear p53-progerin interaction. Consequently, our data illuminate a novel role of IGF-1 in regulating stress-induced hepatocyte premature senescence in liver fibrosis: prolonged IGF-1 relieves oxidative stress-initiated hepatocyte premature senescence via inhibition of nuclear p53-progerin interaction to ameliorate hepatic steatosis and fibrogenesis.
C1 [Luo, Xiaoying; Jiang, Xiaoke; Li, Jun; Bai, Yangqiu; Wei, Peiru; Sun, Suofeng; Liang, Yuan; Han, Shuangyin; Li, Xiuling; Zhang, Bingyong] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China.
   [Luo, Xiaoying; Sun, Suofeng] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Miaobiome Lab, Zhengzhou, Henan, Peoples R China.
   [Li, Zhen] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Pathol, Zhengzhou, Henan, Peoples R China.
C3 Zhengzhou University; Zhengzhou University; Zhengzhou University
RP Zhang, BY (corresponding author), Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China.
EM zhbingyong@sina.com
RI Wang, Jing/IQW-3496-2023; liu, xiao/HKE-9880-2023; WANG,
   YANG/JFA-8821-2023; wang, wenjuan/JGD-0428-2023; li, xiu/GXV-1745-2022
OI Wang, Jing/0000-0002-8296-2961; wang, wenjuan/0000-0002-4220-8817; 
FU WBE Liver Fibrosis Foundation [CFHPC2019008]; National Natural Science
   Foundation of China [81800551]; Scientific and Technological Project of
   Henan Province [182102310210]
FX This study was sponsored by WBE Liver Fibrosis Foundation (Grant no.
   CFHPC2019008), the National Natural Science Foundation of China (No.
   81800551), and the Scientific and Technological Project of Henan
   Province (No. 182102310210). The authors are much grateful to Prof. Deyu
   Li, Dr. Di Lu, Dr. Zhiyu Yang, Dr. Yonghui Dong, Dr. Shanjun Gao, Dr.
   Shasha Bian, Dr. Zhen Li, Mr. Xiulei Zhang, and Miss Huiping Liu for
   essential helps in this study.
CR Adamek A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051308
   Akram KM, 2014, INT J CLIN EXP PATHO, V7, P552
   Anchelin M, 2013, DIS MODEL MECH, V6, P1101, DOI 10.1242/dmm.011635
   Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021
   Candelario J, 2008, AGING CELL, V7, P355, DOI 10.1111/j.1474-9726.2008.00393.x
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1180, DOI 10.1053/gast.1997.v113.pm9322513
   Conchillo M, 2005, J HEPATOL, V43, P630, DOI 10.1016/j.jhep.2005.03.025
   de Ostrovich KK, 2008, AM J PATHOL, V173, P824, DOI 10.2353/ajpath.2008.071005
   Tran D, 2014, AGING CELL, V13, P669, DOI 10.1111/acel.12219
   Gibbs-Seymour I, 2015, AGING CELL, V14, P162, DOI 10.1111/acel.12258
   Hakeem A, 2007, MED SCI MONITOR, V13, pCS61
   Kasprzak A, 2017, MUTAT RES-REV MUTAT, V772, P78, DOI 10.1016/j.mrrev.2016.08.007
   Kasprzak A, 2012, INT J ONCOL, V41, P1919, DOI 10.3892/ijo.2012.1666
   Koshimizu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017688
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Liu BH, 2008, HISTOL HISTOPATHOL, V23, P747, DOI 10.14670/HH-23.747
   Liu YL, 2016, POULTRY SCI, V95, P1396, DOI 10.3382/ps/pew043
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019
   Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7
   Reddy S, 2012, EXP CELL RES, V318, P1, DOI 10.1016/j.yexcr.2011.08.009
   Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280
   Rotwein P, 2010, PEDIATR NEPHROL, V25, P651, DOI 10.1007/s00467-009-1258-y
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245
   Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412
   Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Vera M, 2007, GENE THER, V14, P203, DOI 10.1038/sj.gt.3302858
   Wu DY, 2018, CELL DEATH DIFFER, V25, P169, DOI 10.1038/cdd.2017.187
NR 33
TC 30
Z9 33
U1 2
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUN 6
PY 2019
VL 10
AR 451
DI 10.1038/s41419-019-1670-6
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA IC4LI
UT WOS:000470936800006
PM 31171766
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, C
   Chen, WJ
   Wu, YF
   You, P
   Zheng, SY
   Liu, CC
   Xiang, D
   Wang, MJ
   Cai, YC
   Zhao, QH
   Borjigin, U
   Liu, W
   Xiong, WJ
   Wangensteen, KJ
   Wang, X
   Liu, ZM
   He, ZY
AF Wang, Chao
   Chen, Wen-Jian
   Wu, Ying-Fu
   You, Pu
   Zheng, Shang-Yong
   Liu, Chang-Cheng
   Xiang, Dao
   Wang, Min-Jun
   Cai, Yong-Chao
   Zhao, Qing-Hui
   Borjigin, Uyunbilig
   Liu, Wei
   Xiong, Wu-Jun
   Wangensteen, Kirk J.
   Wang, Xin
   Liu, Zhong-Min
   He, Zhi-Ying
TI The extent of liver injury determines hepatocyte fate toward senescence
   or cancer
SO CELL DEATH & DISEASE
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; TYROSINEMIA TYPE-I; CELLULAR SENESCENCE;
   HEPATOCELLULAR-CARCINOMA; FUMARYLACETOACETATE HYDROLASE;
   HEPATIC-DYSFUNCTION; STEM-CELLS; PATHWAY; CLASSIFICATION; HETEROGENEITY
AB It is well known that induction of hepatocyte senescence could inhibit the development of hepatocellular carcinoma (HCC). Until now, it is still unclear how the degree of liver injury dictates hepatocyte senescence and carcinogenesis. In this study, we investigated whether the severity of injury determines cell fate decisions between hepatocyte senescence and carcinogenesis. After testing of different degrees of liver injury, we found that hepatocyte senescence is strongly induced in the setting of severe acute liver injury. Longer-term, moderate liver injury, on the contrary did not result into hepatocyte senescence, but led to a significant incidence of HCC instead. In addition, carcinogenesis was significantly reduced by the induction of severe acute injury after chronic moderate liver injury. Meanwhile, immune surveillance, especially the activations of macrophages, was activated after re-induction of senescence by severe acute liver injury. We conclude that severe acute liver injury leads to hepatocyte senescence along with activating immune surveillance and a low incidence of HCC, whereas chronic moderate injury allows hepatocytes to proliferate rather than to enter into senescence, and correlates with a high incidence of HCC. This study improves our understanding in hepatocyte cell fate decisions and suggests a potential clinical strategy to induce senescence to treat HCC.
C1 [Wang, Chao; Chen, Wen-Jian; Wu, Ying-Fu; Wang, Min-Jun; He, Zhi-Ying] Second Mil Med Univ, Dept Cell Biol, Ctr Stem Cell & Med, Shanghai 200433, Peoples R China.
   [Wang, Chao; Liu, Chang-Cheng; Cai, Yong-Chao; Zhao, Qing-Hui; Liu, Wei; Liu, Zhong-Min; He, Zhi-Ying] Tongji Univ, Shanghai East Hosp, Inst Regenerat Med, Sch Life Sci & Technol, Shanghai 200123, Peoples R China.
   [You, Pu] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China.
   [Zheng, Shang-Yong] Yunnan Univ, Sch Med, Kunming 650091, Yunnan, Peoples R China.
   [Xiang, Dao] Second Mil Med Univ, Naval Med Res Inst, Shanghai 200433, Peoples R China.
   [Borjigin, Uyunbilig; Wang, Xin] Inner Mongolia Univ, Natl Educ Minist Mammalian Reprod Biol & Biotechn, Key Lab, Hohhot 010070, Peoples R China.
   [Xiong, Wu-Jun] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Hepatol, Shanghai 200120, Peoples R China.
   [Wangensteen, Kirk J.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.
   [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.
   [Wang, Xin] Hepatoscience Inc, 725 San Aleso Ave, Sunnyvale, CA 94085 USA.
C3 Naval Medical University; Tongji University; Tongji University; Yunnan
   University; Naval Medical University; Inner Mongolia University; Tongji
   University; University of Pennsylvania; University of Minnesota System;
   University of Minnesota Twin Cities
RP He, ZY (corresponding author), Second Mil Med Univ, Dept Cell Biol, Ctr Stem Cell & Med, Shanghai 200433, Peoples R China.; Liu, ZM; He, ZY (corresponding author), Tongji Univ, Shanghai East Hosp, Inst Regenerat Med, Sch Life Sci & Technol, Shanghai 200123, Peoples R China.
EM liu.zhongmin@tongji.edu.cn; zyhe@tongji.edu.cn
RI wang, chao/JJE-1212-2023; Li, Wei/JLL-4365-2023; yang,
   qing/JBR-8440-2023
OI Wangensteen, Kirk/0000-0001-6042-6490; he, zhiying/0000-0002-0087-2277
FU National Natural Science Foundation of China [81772954, 81471948,
   31271474]; Shanghai Pujiang Program [17PJD045]; Science and Technology
   Development Fund of Shanghai Pudong New Area [PKJ2017-Y16]; Key
   Specialty Construction Project of Pudong Health and Family Planning
   Commission of Shanghai [PWZz2013-05]
FX This work was funded by National Natural Science Foundation of China
   (81772954, 81471948, and 31271474), Shanghai Pujiang Program (17PJD045),
   the Science and Technology Development Fund of Shanghai Pudong New Area
   (PKJ2017-Y16), and Key Specialty Construction Project of Pudong Health
   and Family Planning Commission of Shanghai (PWZz2013-05).
CR Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Agarwal R, 2017, CANCER GENET-NY, V216, P37, DOI 10.1016/j.cancergen.2017.06.002
   [Anonymous], 2018, PREPRINT
   [Anonymous], MED IMMUNOLOGY
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Beier F, 2015, J HEPATOL, V63, P446, DOI 10.1016/j.jhep.2015.03.022
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Buitrago-Molina LE, 2013, HEPATOLOGY, V58, P1143, DOI 10.1002/hep.26412
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Endig J, 2016, CANCER CELL, V30, P308, DOI 10.1016/j.ccell.2016.06.009
   Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]
   GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298
   GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003
   Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Larochelle J, 2012, MOL GENET METAB, V107, P49, DOI 10.1016/j.ymgme.2012.05.022
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042
   Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098
   Orejuela D, 2008, J HEPATOL, V48, P308, DOI 10.1016/j.jhep.2007.09.014
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302
   Stocker E, 1971, Beitr Pathol, V144, P400
   Stuart GR, 2000, GENETICS, V155, P1359
   TANGUAY RM, 1990, AM J HUM GENET, V47, P308
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   van Spronsen FJ, 2005, J PEDIATR GASTR NUTR, V40, P90, DOI 10.1097/00005176-200501000-00017
   VANSPRONSEN FJ, 1994, HEPATOLOGY, V20, P1187, DOI 10.1002/hep.1840200513
   Vogel A, 2004, HEPATOLOGY, V39, P433, DOI 10.1002/hep.20077
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Wangensteen KJ, 2008, HEPATOLOGY, V47, P1714, DOI 10.1002/hep.22195
   Wangensteen KJ, 2018, HEPATOLOGY, V68, P663, DOI 10.1002/hep.29626
   Willenbring H, 2008, CANCER CELL, V14, P59, DOI 10.1016/j.ccr.2008.05.004
   Xiang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.230
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017
NR 46
TC 21
Z9 21
U1 0
U2 22
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAY 14
PY 2018
VL 9
AR 575
DI 10.1038/s41419-018-0622-x
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GH0KG
UT WOS:000433090300004
PM 29760381
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Aravinthan, A
   Scarpini, C
   Tachtatzis, P
   Verma, S
   Penrhyn-Lowe, S
   Harvey, R
   Davies, SE
   Allison, M
   Coleman, N
   Alexander, G
AF Aravinthan, Aloysious
   Scarpini, Cinzia
   Tachtatzis, Phaedra
   Verma, Suman
   Penrhyn-Lowe, Sue
   Harvey, Rebecca
   Davies, Susan E.
   Allison, Michael
   Coleman, Nick
   Alexander, Graeme
TI Hepatocyte senescence predicts progression in non-alcohol-related fatty
   liver disease
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Senescence; Cell cycle arrest; Telomere; Non-alcohol-related fatty liver
   disease
ID DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; OXIDATIVE STRESS; NONALCOHOLIC
   STEATOHEPATITIS; PRIMARY NONFUNCTION; TELOMERES; CELLS; INFILTRATION;
   REGENERATION; CIRRHOSIS
AB Background & Aims: Models of non-alcohol-related fatty liver disease (NAFLD) reveal features of accelerated ageing, such as impaired regeneration, and an increased risk of hepatocellular carcinoma. The relation between accelerated ageing, disease progression and clinical outcome has not been previously investigated and is the subject of the current study.
   Methods: Liver sections from 70 patients with NAFLD (105 biopsies) and 60 controls were studied for telomere length, nuclear area, DNA damage and cell cycle phase markers, using quantitative fluorescent in situ hybridization and immunohistochemistry.
   Results: Hepatocyte telomeres were shorter in NAFLD than controls (p <0.0001). Hepatocytes in NAFLD demonstrated lack of cell cycle progression beyond G1/S phase and high-level expression of p21, the universal cell cycle inhibitor (p = 0.001). gamma-H(2)AX expression increased with steatosis (p = 0.01), indicating DNA damage, and was associated with shorter hepatocyte telomeres (p <0.0001). Hepatocyte p21 expression correlated with fibrosis stage and diabetes mellitus, independently (p <0.001 and p = 0.002, respectively). Further analysis revealed that an adverse liver-related outcome was strongly associated with higher hepatocyte p21 expression and greater hepatocyte nuclear area (p = 0.02 and p = 0.006), but not with telomere length. In paired biopsies, changes in hepatocyte p21 expression and nuclear area mirrored changes in fibrosis stage (p = 0.01 and p = 0.006, respectively).
   Conclusions: These findings are consistent with hepatocyte senescence and permanent cell cycle arrest in NAFLD. Hepatocyte senescence correlated closely with fibrosis stage, diabetes mellitus, and clinical outcome. Hepatocyte p21 expression could be used as a prognostic marker and for stratification in clinical studies. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Aravinthan, Aloysious; Scarpini, Cinzia; Tachtatzis, Phaedra; Verma, Suman; Penrhyn-Lowe, Sue; Harvey, Rebecca; Davies, Susan E.; Allison, Michael; Coleman, Nick; Alexander, Graeme] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 0QQ, England.
C3 University of Cambridge
RP Alexander, G (corresponding author), Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge Univ Hosp, Box 157,Hills Rd, Cambridge CB2 0QQ, England.
EM gja1000@doctors.org.uk
RI Aravinthan, Aloysious D/I-2557-2019
OI Aravinthan, Aloysious D/0000-0003-0527-5137; Allison,
   Michael/0000-0003-3677-3294; Scarpini, Cinzia G./0000-0003-4730-5197
FU Hepatology Endowment Fund, Addenbrooke's Liver Transplant Association,
   Cambridge University Hospitals NHS Trust; MRC [MC_U105359875] Funding
   Source: UKRI; Medical Research Council [MC_U105359875] Funding Source:
   researchfish
FX Hepatology Endowment Fund, Addenbrooke's Liver Transplant Association,
   Cambridge University Hospitals NHS Trust.
CR ABDELMALEK M, 1995, J CLIN GASTROENTEROL, V20, P127, DOI 10.1097/00004836-199503000-00011
   Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V282, P356, DOI 10.1006/bbrc.2001.4533
   Behrns K E, 1998, J Gastrointest Surg, V2, P292, DOI 10.1016/S1091-255X(98)80025-5
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Borel F, 2002, J CELL SCI, V115, P2829
   Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   DALESSANDRO AM, 1991, TRANSPLANTATION, V51, P157, DOI 10.1097/00007890-199101000-00024
   de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   GONZALEZREIMERS E, 1988, DRUG ALCOHOL DEPEN, V22, P195, DOI 10.1016/0376-8716(88)90018-X
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047
   Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193
   Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g
   Ourliac-Garnier I, 2011, METHODS MOL BIOL, V735, P21, DOI 10.1007/978-1-61779-092-8_3
   Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734
   POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087
   Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004
   TODO S, 1989, TRANSPLANTATION, V47, P903, DOI 10.1097/00007890-198905000-00034
   Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3
   Verma S, 2012, HEPATOLOGY
   Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 38
TC 192
Z9 205
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
J9 J HEPATOL
JI J. Hepatol.
PD MAR
PY 2013
VL 58
IS 3
BP 549
EP 556
DI 10.1016/j.jhep.2012.10.031
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 106TK
UT WOS:000316167400022
PM 23142622
DA 2024-02-19
ER

PT J
AU Fujita, T
   Shirasawa, T
   Inoue, H
   Kitamura, T
   Maruyama, N
AF Fujita, T
   Shirasawa, T
   Inoue, H
   Kitamura, T
   Maruyama, N
TI Hepatic and renal expression of senescence marker protein-30 and its
   biological significance
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Proceedings Paper
CT 4th Annual Meeting of the Japanese-Hepatic-Cells-Research-Society
CY JUN 06-07, 1997
CL JUNTENDO UNIV, TOKYO, JAPAN
SP Japanese Hepat Cells Res Soc
HO JUNTENDO UNIV
DE ageing; calcium-binding protein; calcium homeostasis; hepatocyte; HepG2;
   kidney; liver; plasma membrane Ca2+-pumping ATPase; senescence marker
   protein-30
ID PLASMA-MEMBRANE; GENE-EXPRESSION; RAT-LIVER; CALCIUM; SMP30;
   PURIFICATION; PUMP; LYMPHOCYTES; THYMOCYTES; AGE
AB A novel rat hepatic protein was detected and isolated, the amount of which is downregulated in an androgen-independent manner with ageing. This protein was designated as senescence marker protein-30 (SMP30). Senescence marker protein-30 turned out to be identical to a hepatic calcium-binding protein called regucalcin (RC). This review gives an overview of SMP30 in its structure, expression and possible physiological function(s). A hypothetical role of SMP30 in ageing and calcium homeostasis is also discussed.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 173, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Genet, Itabashi Ku, Tokyo 173, Japan.
   Kyorin Univ, Sch Med, Dept Internal Med 1, Tokyo, Japan.
   Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan
   Institute of Gerontology; Kyorin University; Juntendo University
RP Fujita, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 173, Japan.
EM tofujita@tmig.or.jp
CR AMMENDOLA R, 1992, J BIOL CHEM, V267, P17994
   APERIA A, 1979, ACTA PHYSIOL SCAND, V105, P11, DOI 10.1111/j.1748-1716.1979.tb06310.x
   CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7
   DOWD DR, 1992, MOL ENDOCRINOL, V6, P1843, DOI 10.1210/me.6.11.1843
   DOWD DR, 1991, J BIOL CHEM, V266, P18423
   ENYEDI A, 1994, J BIOL CHEM, V269, P41
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   FURUKAWA KI, 1988, J BIOL CHEM, V263, P8058
   GAIDO ML, 1991, J BIOL CHEM, V266, P18580
   IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078
   Kanungo M., 1995, MOL BASIS AGING, P183
   KESSLER F, 1990, J BIOL CHEM, V265, P16012
   KITAMURA T, 1991, HEPATOLOGY, V14, P640, DOI 10.1016/0270-9139(91)90051-V
   KITANI K, 1990, LIVER AGING 1990
   Kitano S, 1996, BIOCHEM BIOPH RES CO, V225, P122, DOI 10.1006/bbrc.1996.1140
   LARSSON L, 1980, KIDNEY INT, V18, P29, DOI 10.1038/ki.1980.107
   MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7
   MONTEITH GR, 1995, CELL CALCIUM, V18, P459, DOI 10.1016/0143-4160(95)90009-8
   Papaconstantinou John, 1996, P150
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SETOOHSHIMA A, 1988, LANCET, V1, P1252
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VARGHESE S, 1988, J BIOL CHEM, V263, P9776
   VARGHESE S, 1987, ANAL BIOCHEM, V165, P183, DOI 10.1016/0003-2697(87)90218-1
   Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G
   YAMAKUNI T, 1985, FEBS LETT, V188, P124
NR 32
TC 9
Z9 13
U1 0
U2 0
PU BLACKWELL SCIENCE
PI CARLTON
PA 54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA
SN 0815-9319
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD SEP
PY 1998
VL 13
SU S
BP S124
EP S131
PG 8
WC Gastroenterology & Hepatology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 128VR
UT WOS:000076429500020
PM 9792046
DA 2024-02-19
ER

PT J
AU Wu, RM
   Wang, XQ
   Shao, YY
   Jiang, YM
   Zhou, Y
   Lu, CF
AF Wu, Ruoman
   Wang, Xinqi
   Shao, Yunyun
   Jiang, Yiming
   Zhou, Ying
   Lu, Chunfeng
TI NFATc4 mediates ethanol-triggered hepatocyte senescence
SO TOXICOLOGY LETTERS
LA English
DT Article; Early Access
DE Alcoholic liver disease; Hepatocyte; Senescence; NFATc4; PPAR
ID STEATOSIS; LIVER; STEATOHEPATITIS; INFLAMMATION; PHENOTYPE; FIBROSIS;
   MODEL
AB Background: Hepatocyte senescence is a core event that mediates the occurrence and development of alcoholic liver disease. Nuclear factor of activated T-cells 4 (NFATc4) is a key driver of nonalcoholic steatohepatitis. However, little was known about the implication of NFATc4 for alcoholic liver disease. This study was aimed to investigate the role of NFATc4 in hepatocyte senescence and further elucidate the underlying mechanism.
   Methods: Real-time PCR, Western blot, immunofluorescence staining, and enzyme-linked immunosorbent assay were performed to explore the role of NFATc4 in hepatocyte senescence.
   Results: NFATc4 was induced in ethanol-incubated hepatocytes. NFATc4 knockdown recovered cell viability and reduced the release of aspartate transaminase, alanine transaminase, and lactic dehydrogenase from ethanol-incubated hepatocytes. NFATc4 knockdown protected mice from alcoholic liver injury and inflammation. NFATc4 knockdown counteracted ethanol-induced hepatocyte senescence, evidenced by decreased senescence-associated beta-galactosidase positivity and reduced p16, p21, HMGA1, and -gamma H2AX, which was validated in in vivo studies. Peroxisome proliferator-activated receptor (PPAR)gamma was inhibited by NFATc4 in ethanol-treated hepatocytes. PPAR gamma deficiency abrogated the inhibitory effects of NFATc4 knockdown on hepatocyte senescence, oxidative stress, and hepatic steatosis in mice with alcoholic liver disease.
   Conclusions: This work discovered that ethanol enhanced NFATc4 expression, which further triggered hepatocyte senescence via repression of PPAR-gamma. (C) 2021 Elsevier B.V. All rights reserved.
C1 [Wu, Ruoman; Wang, Xinqi; Shao, Yunyun; Jiang, Yiming; Zhou, Ying; Lu, Chunfeng] Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
C3 Nantong University
RP Lu, CF (corresponding author), Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM ntdxlcf@ntu.edu.cn
RI li, xiao/HKV-8405-2023; liu, junyang/IXD-1252-2023; Lu,
   Xiaomei/IUQ-2139-2023; cheng, shu/IZE-4788-2023; liu,
   junyang/IXD-1201-2023; lin, qing/JED-5250-2023; liang, YU/IYT-4334-2023
OI liang, YU/0009-0007-3922-3454
FU National Natural Science Foundation of China [81803606]; Science and
   Technology Project of Jiangsu Provincial Administration of Traditional
   Chinese Medicine [YB201847]; Nantong Science and Technology Project
   [MS12018051]; Scientific Research Startup Foundation for Talents of
   Nantong University, and Innovation and Entrepreneurship Training Program
   for Undergraduates of Nantong University [2020207]
FX This work was supported by the National Natural Science Foundation of
   China (81803606) , Science and Technology Project of Jiangsu Provincial
   Administration of Traditional Chinese Medicine (YB201847) , Nantong
   Science and Technology Project (MS12018051) , Scientific Research
   Startup Foundation for Talents of Nantong University, and Innovation and
   Entrepreneurship Training Program for Undergraduates of Nantong
   University (2020207) .
CR Ali SS, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13145
   Bosc C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17882-2
   Briganti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104045
   Briganti S, 2013, EXP DERMATOL, V22, P41, DOI 10.1111/exd.12066
   Dong RC, 2021, EUR J PHARMACOL, V890, DOI 10.1016/j.ejphar.2020.173653
   Du M, 2020, J HEPATOL, V73, P1333, DOI 10.1016/j.jhep.2020.07.030
   Flores-Costa R, 2020, P NATL ACAD SCI USA, V117, P28263, DOI 10.1073/pnas.2000466117
   Habiballa L, 2019, FREE RADICAL BIO MED, V132, P3, DOI 10.1016/j.freeradbiomed.2018.10.417
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12431
   Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09
   Kurokawa K, 2014, J NEUROCHEM, V131, P836, DOI 10.1111/jnc.12945
   Liu X, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01459
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Lu CF, 2017, IUBMB LIFE, V69, P540, DOI 10.1002/iub.1639
   Lu CF, 2017, TOXICOL SCI, V155, P432, DOI 10.1093/toxsci/kfw228
   Lu CF, 2016, MOL PHARMACEUT, V13, P4043, DOI 10.1021/acs.molpharmaceut.6b00562
   Lu XL, 2004, WORLD J GASTROENTERO, V10, P2423
   Luo XY, 2013, AM J PHYSIOL-GASTR L, V305, pG891, DOI 10.1152/ajpgi.00193.2013
   Luo XY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12991
   Manda KR, 2016, ONCOGENE, V35, P3282, DOI 10.1038/onc.2015.389
   Martinez-Chantar ML, 2020, J HEPATOL, V73, P1313, DOI 10.1016/j.jhep.2020.08.034
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Seitz HK, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0014-7
   Shih CT, 2017, AGING CELL, V16, P797, DOI 10.1111/acel.12607
   Shipley LC, 2020, TRANSL GASTROENT HEP, V5, DOI 10.21037/tgh.2019.11.17
   Thangaraj A, 2021, REDOX BIOL, V40, DOI 10.1016/j.redox.2020.101843
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129
   Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002
   Zhuang Y, 2020, GUT, V69, P133, DOI 10.1136/gutjnl-2019-318215
NR 33
TC 6
Z9 6
U1 1
U2 16
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD 2021 OCT 10
PY 2021
VL 350
BP 10
EP 21
DI 10.1016/j.toxlet.2021.06.018
EA JUL 2021
PG 12
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA UJ3XP
UT WOS:000691222600002
PM 34192554
DA 2024-02-19
ER

PT J
AU Jung, SY
   Yun, HH
   Lim, JH
   Lee, DH
   Bin Seo, S
   Baek, JY
   Lee, J
   Yoo, K
   Kim, H
   Kim, HL
   Lee, JH
AF Jung, Soon-Young
   Yun, Hye Hyeon
   Lim, Ji Hee
   Lee, Dong-Hyung
   Bin Seo, Sung
   Baek, Ji-Ye
   Lee, Jeehan
   Yoo, Kyunghyun
   Kim, Hyungmin
   Kim, Hong Lim
   Lee, Jeong-Hwa
TI Hepatocyte-specific deletion of<i> Bis</i> causes senescence in the
   liver without deteriorating hepatic function
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Bcl-2-interacting cell death suppressor; Hepatocyte-specific knockout;
   Senescence; p27; BAG3; Liver
ID CELLULAR SENESCENCE; OXIDATIVE STRESS; UBIQUITIN LIGASE; CANCER;
   DEGRADATION; INHIBITION; AUTOPHAGY; P27(KIP1); MYOPATHY; BCL-2
AB Bcl-2-interacting cell death suppressor (BIS), also called as BAG3, regulates numerous physiological processes, such as apoptosis, protein quality control, and senescence. Whole-body Bis-knockout (KO) mice exhibit early lethality following cardiac and skeletal muscle dysfunction. The first attempt to generate organ-specific knockout mice resulted in constitutive or inducible heart-specific Bis-knockout mice, which exhibited cardiac dilation and underwent premature death. Here, we generated hepatocyte-specific Bis-knockout (Bis-HKO) mice and found no abnormalities in metabolic function and survival. However, depletion of HSPB8 and accumulation of p62 indicated impaired autophagy in Bis-HKO livers. Interestingly, the number of peroxisomes wrapped by phagophore membranes increased as evidenced by transmission electron microscopy analysis, indicating defects in the progression of pexophagy. In addition, increased dihydroethidine intensities and histone H3 K9me3-positive nuclei indicated increased oxidative stress and senescence induction in Bis-HKO livers. Mechanistically, p27 was upregulated in Bis-HKO livers. In SNU368 hepatocellular carcinoma cells, BIS depletion led to p27 upregulation, and increase in histone H3 K9me3 levels and senescence-associated beta-galactosidase staining; therefore, reproducing the in vivo senescence phenotype. Despite the observation of no metabolic abnormalities, BIS depletion led to defective autophagy, increased oxidative stress, and senescence in Bis- HKO livers. Collectively, our results suggest a role for BIS in maintaining liver regeneration potential under pathological conditions. (C) 2022 Elsevier Inc. All rights reserved.
C1 [Jung, Soon-Young; Yun, Hye Hyeon; Lee, Dong-Hyung; Bin Seo, Sung; Baek, Ji-Ye; Lee, Jeehan; Yoo, Kyunghyun; Kim, Hyungmin; Lee, Jeong-Hwa] Catholic Univ Korea, Coll Med, Dept Biochem, Seoul 06591, South Korea.
   [Jung, Soon-Young; Yun, Hye Hyeon; Bin Seo, Sung; Baek, Ji-Ye; Lee, Jeehan; Yoo, Kyunghyun; Kim, Hyungmin; Lee, Jeong-Hwa] Catholic Univ Korea, Inst Aging & Metab Dis, Coll Med, Seoul 06591, South Korea.
   [Lim, Ji Hee] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Nephrol, Seoul 06591, South Korea.
   [Kim, Hong Lim] Catholic Univ Korea, Coll Med, Integrat Res Support Ctr, Lab Electron Microscope, Seoul 06591, South Korea.
   [Lee, Jeong-Hwa] Catholic Univ Korea, Coll Med, Dept Biochem, 222 Banpo Daero, Seoul 06591, South Korea.
C3 Catholic University of Korea; Catholic University of Korea; Catholic
   University of Korea; Catholic University of Korea; Catholic University
   of Korea
RP Lee, JH (corresponding author), Catholic Univ Korea, Coll Med, Dept Biochem, 222 Banpo Daero, Seoul 06591, South Korea.
EM leejh@catholic.ac.kr
RI Lee, Jeonghwa/JFA-4725-2023; Lee, Jung-Hye/F-6974-2013
OI Jung, Soon-Young/0000-0003-2693-9377
FU Basic Science Research Programs through the National Research Foundation
   of Korea (NRF) - Minister of Education, Science and Technology
   [2019R1A2C1086949, 2018R1D1A1B07048315]
FX This research was supported by Basic Science Research Programs through
   the National Research Foundation of Korea (NRF) , funded by the Minister
   of Education, Science and Technology (2019R1A2C1086949 and
   2018R1D1A1B07048315) .
CR Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937
   Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330
   Cai Z, 2020, SEMIN CANCER BIOL, V67, P16, DOI 10.1016/j.semcancer.2020.01.013
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Choi HH, 2015, ONCOTARGET, V6, P19721, DOI 10.18632/oncotarget.3821
   De Marco M, 2022, J CELL BIOCHEM, V123, P91, DOI 10.1002/jcb.30171
   De Marco M, 2018, SEMIN CELL DEV BIOL, V78, P85, DOI 10.1016/j.semcdb.2017.08.049
   Ezaki J, 2009, METHOD ENZYMOL, V452, P215, DOI 10.1016/S0076-6879(08)03614-8
   Fang X, 2017, J CLIN INVEST, V127, P3189, DOI 10.1172/JCI94310
   Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033
   Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250
   Huda N, 2022, CELL MOL GASTROENTER, V14, P333, DOI 10.1016/j.jcmgh.2022.04.003
   Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200
   Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194
   Khambu B, 2018, J CLIN INVEST, V128, P2419, DOI 10.1172/JCI91814
   Konersman CG, 2015, NEUROMUSCULAR DISORD, V25, P418, DOI 10.1016/j.nmd.2015.01.009
   Lee JJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.501
   Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043
   Lim JH, 2014, DIABETOLOGIA, V57, P214, DOI 10.1007/s00125-013-3064-0
   Lin H, 2022, J CELL BIOCHEM, V123, P4, DOI 10.1002/jcb.29952
   Flores JM, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29147
   Monastyrska Iryna, 2006, Molecular Aspects of Medicine, V27, P483, DOI 10.1016/j.mam.2006.08.004
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Narita M, 2007, BRIT J CANCER, V96, P686, DOI 10.1038/sj.bjc.6603636
   Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004
   Tian Y, 2015, CELL DEATH DIFFER, V22, P1025, DOI 10.1038/cdd.2014.201
   Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268
   Yan J, 2017, BBA-MOL CELL RES, V1864, P1668, DOI 10.1016/j.bbamcr.2017.06.004
   Youn DY, 2008, AM J PHYSIOL-ENDOC M, V295, pE1349, DOI 10.1152/ajpendo.90704.2008
   Yun HH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031343
   Yun HH, 2020, BIOCHEM BIOPH RES CO, V524, P643, DOI 10.1016/j.bbrc.2020.01.154
   Zhang NJ, 2022, REDOX BIOL, V50, DOI 10.1016/j.redox.2022.102238
NR 32
TC 1
Z9 1
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 3
PY 2022
VL 619
BP 42
EP 48
DI 10.1016/j.bbrc.2022.06.046
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 3E8WB
UT WOS:000830257800007
PM 35732079
DA 2024-02-19
ER

PT J
AU Wiemann, SU
   Satyanarayana, A
   Tsahuridu, M
   Tillmann, HL
   Zender, L
   Klempnauer, J
   Flemming, P
   Franco, S
   Blasco, MA
   Manns, MP
   Rudolph, KL
AF Wiemann, SU
   Satyanarayana, A
   Tsahuridu, M
   Tillmann, HL
   Zender, L
   Klempnauer, J
   Flemming, P
   Franco, S
   Blasco, MA
   Manns, MP
   Rudolph, KL
TI Hepatocyte telomere shortening and senescence are general markers of
   human liver cirrhosis
SO FASEB JOURNAL
LA English
DT Article
DE telomerase; regeneration; chronic disease; fibrosis; stellate cell
   activation
ID IN-VIVO; HEPATOCELLULAR CARCINOMAS; REPLICATIVE SENESCENCE;
   PROLIFERATIVE ACTIVITY; HEPATIC REGENERATION; MICE; CARCINOGENESIS;
   TUMORIGENESIS; DYSFUNCTION; FIBROBLASTS
AB Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lymphocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte-specific telomere shortening correlated with senescence-associated beta-galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type-specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.
C1 Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.
   Hannover Med Sch, Dept Visceral Surg, D-30625 Hannover, Germany.
   Hannover Med Sch, Dept Pathol, D-30625 Hannover, Germany.
   CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain.
C3 Hannover Medical School; Hannover Medical School; Hannover Medical
   School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC -
   Centro Nacional de Biotecnologia (CNB)
RP Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Rudolph.Lenhard@MH-Hannover.de
RI Blasco, Maria A./M-1694-2014
OI Blasco, Maria A./0000-0002-4211-233X; Rudolph, Karl
   Lenhard/0000-0002-4839-2862
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311
   Alcolado R, 1997, CLIN SCI, V92, P103, DOI 10.1042/cs0920103
   ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306
   Ball SE, 1998, BLOOD, V91, P3582
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Bond J, 1996, ONCOGENE, V13, P2097
   Boultwood J, 2000, BLOOD, V96, P358, DOI 10.1182/blood.V96.1.358.013k16_358_361
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   Delhaye M, 1996, HEPATOLOGY, V23, P1003, DOI 10.1002/hep.510230510
   Delhaye M, 1999, J HEPATOL, V30, P461, DOI 10.1016/S0168-8278(99)80106-8
   DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Effros RB, 2000, MICROBES INFECT, V2, P69, DOI 10.1016/S1286-4579(00)00283-5
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   González-Suárez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089
   Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Kaita KDE, 1997, LIVER, V17, P13
   Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   LIVNI N, 1995, CANCER, V75, P2420, DOI 10.1002/1097-0142(19950515)75:10<2420::AID-CNCR2820751006>3.0.CO;2-6
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   POON SSS, 2001, CURRENT PROTOCOLS CE
   RUDI J, 1995, J HEPATOL, V22, P43, DOI 10.1016/0168-8278(95)80258-4
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871
   RUDOLPH KL, 2001, LIVER BIOL PATHOBIOL, P1000
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Urabe Y, 1996, LIVER, V16, P293
   Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X
   Williams EJ, 1998, POSTGRAD MED J, V74, P193, DOI 10.1136/pgmj.74.870.193
NR 35
TC 404
Z9 467
U1 2
U2 26
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JUL
PY 2002
VL 16
IS 9
BP 935
EP 942
DI 10.1096/fj.01-0977com
PG 8
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 590HH
UT WOS:000177813100024
PM 12087054
DA 2024-02-19
ER

PT J
AU Li, FM
   Huangyang, PW
   Burrows, M
   Guo, K
   Riscal, R
   Godfrey, J
   Lee, KE
   Lin, N
   Lee, P
   Blair, IA
   Keith, B
   Li, B
   Simon, MC
AF Li, Fuming
   Huangyang, Peiwei
   Burrows, Michelle
   Guo, Kathy
   Riscal, Romain
   Godfrey, Jason
   Lee, Kyoung Eun
   Lin, Nan
   Lee, Pearl
   Blair, Ian A.
   Keith, Brian
   Li, Bo
   Simon, M. Celeste
TI FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a
   hepatic stellate cell senescence secretome
SO NATURE CELL BIOLOGY
LA English
DT Article; Early Access
ID TUMOR SUPPRESSION; CANCER; FIBROSIS; IDENTIFICATION; SURVEILLANCE;
   CHEMOTHERAPY; PROGRESSION; HEPATOCYTES; HOMEOSTASIS; ENRICHMENT
AB The crosstalk between deregulated hepatocyte metabolism and cells within the tumour microenvironment, as well as the consequent effects on liver tumorigenesis, are not completely understood. We show here that hepatocyte-specific loss of the gluconeogenic enzyme fructose 1,6-bisphosphatase 1 (FBP1) disrupts liver metabolic homeostasis and promotes tumour progression. FBP1 is universally silenced in both human and murine liver tumours. Hepatocyte-specific Fbp1 deletion results in steatosis, concomitant with activation and senescence of hepatic stellate cells (HSCs), exhibiting a senescence-associated secretory phenotype. Depleting senescent HSCs by 'senolytic' treatment with dasatinib/quercetin or ABT-263 inhibits tumour progression. We further demonstrate that FBP1-deficient hepatocytes promote HSC activation by releasing HMGB1; blocking its release with the small molecule inflachromene limits FBP1-dependent HSC activation, the subsequent development of the senescence-associated secretory phenotype and tumour progression. Collectively, these findings provide genetic evidence for FBP1 as a metabolic tumour suppressor in liver cancer and establish a critical crosstalk between hepatocyte metabolism and HSC senescence that promotes tumour growth.
   Li et al. show that hepatocyte-specific loss of Fbp1 in mice leads to steatosis and senescence in hepatic stellate cells, thereby disrupting metabolism and facilitating liver tumorigenesis.
C1 [Li, Fuming; Huangyang, Peiwei; Burrows, Michelle; Guo, Kathy; Riscal, Romain; Godfrey, Jason; Lee, Kyoung Eun; Lin, Nan; Lee, Pearl; Keith, Brian; Simon, M. Celeste] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.
   [Li, Fuming; Huangyang, Peiwei; Burrows, Michelle; Guo, Kathy; Riscal, Romain; Godfrey, Jason; Lee, Kyoung Eun; Lin, Nan; Lee, Pearl; Keith, Brian] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.
   [Blair, Ian A.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Keith, Brian] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Li, Bo] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Peoples R China.
   [Li, Bo] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, RNA Biomed Inst, Guangzhou, Peoples R China.
   [Simon, M. Celeste] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
   [Huangyang, Peiwei] UCSF, Helen Diller Canc Ctr, San Francisco, CA USA.
   [Guo, Kathy] Temple Univ, Kornberg Sch Dent, Philadelphia, PA 19122 USA.
   [Lee, Kyoung Eun] Univ Michigan, Dept Pharmacol, Med Sch, Ann Arbor, MI 48109 USA.
   [Lin, Nan] Trinity Partners LLC, Waltham, MA USA.
C3 University of Pennsylvania; University of Pennsylvania; University of
   Pennsylvania; The Wistar Institute; Sun Yat Sen University; Sun Yat Sen
   University; University of Pennsylvania; University of California System;
   University of California San Francisco; UCSF Medical Center; UCSF Helen
   Diller Family Comprehensive Cancer Center; Pennsylvania Commonwealth
   System of Higher Education (PCSHE); Temple University; University of
   Michigan System; University of Michigan
RP Simon, MC (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.; Li, B (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Peoples R China.; Li, B (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, RNA Biomed Inst, Guangzhou, Peoples R China.; Simon, MC (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
EM libo47@mail.sysu.edu.cn; celeste2@pennmedicine.upenn.edu
RI Li, Bo/M-2192-2013; HUANG, YANGPEIWEI/AAS-7683-2021; Simon,
   Celeste/AAG-3941-2021; Lin, Nan/AAL-6413-2021; Li, Bo/Y-2835-2019;
   Huangyang, Peiwei/AAS-8905-2021
OI Li, Bo/0000-0002-7979-8339; HUANG, YANGPEIWEI/0000-0002-9131-3891; Li,
   Bo/0000-0002-7979-8339; Lee, Pearl/0000-0002-1274-2891; Blair,
   Ian/0000-0003-0366-8658; Riscal, Romain/0000-0001-8969-224X; Lee, Kyoung
   Eun/0000-0002-3955-7389; Lin, Nan/0000-0002-9031-8252
FU National Key Research and Development Program [2016YFA0502600]; National
   Cancer Institute (NCI) [P01CA104838, R35CA197602, P30CA016520]
FX We thank the members of the Simon laboratory for their helpful
   discussions and insights on the manuscript. We also thank S. Berger for
   critical reading of the manuscript and K. E. Wellen for providing the
   D37 cells. H.-Y. Tang assisted in hepatocyte secretome profiling and
   data analysis. C. Mesaros and L. Weng assisted in lipid profiling and
   data analysis. We are grateful to J. Tobias for help with processing the
   human TCGA and mouse RNA-seq data, and A. Durham for histopathologic
   examination. We also thank W. Quinn III, A. J. Merrell, H. Xie and H.
   Weinstein for their technical assistance. This work was supported by the
   National Key Research and Development Program (grant no. 2016YFA0502600)
   of China (to B.L.) and National Cancer Institute (NCI) grant nos
   P01CA104838, R35CA197602 and P30CA016520 (to M.C.S.).
CR Affo S, 2017, ANNU REV PATHOL-MECH, V12, P153, DOI 10.1146/annurev-pathol-052016-100322
   [Anonymous], 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617
   Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
   Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005
   Cao YY, 2017, CHEM MATER, V29, P718, DOI 10.1021/acs.chemmater.6b04405
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen RC, 2013, MOL MED, V19, P357, DOI 10.2119/molmed.2013.00099
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Febbraio MA, 2019, CELL METAB, V29, P18, DOI 10.1016/j.cmet.2018.10.012
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Ge XD, 2018, HEPATOLOGY, V68, P2380, DOI 10.1002/hep.30093
   GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5
   Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Greten TF, 2015, GUT, V64, P842, DOI 10.1136/gutjnl-2014-307990
   Guièze R, 2019, CANCER CELL, V36, P369, DOI 10.1016/j.ccell.2019.08.005
   He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031
   Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282
   Hernandez C, 2018, J CLIN INVEST, V128, P2436, DOI 10.1172/JCI91786
   Hirata H, 2016, CANCER RES, V76, P3265, DOI 10.1158/0008-5472.CAN-15-2601
   Huangyang PW, 2020, CELL METAB, V31, P174, DOI 10.1016/j.cmet.2019.10.012
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009
   Khambu B, 2018, J CLIN INVEST, V128, P2419, DOI 10.1172/JCI91814
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee S, 2014, NAT CHEM BIOL, V10, P1055, DOI 10.1038/nchembio.1669
   Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2
   Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557
   Liu FY, 2016, ONCOTARGET, V7, P83907, DOI 10.18632/oncotarget.13438
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995
   Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350
   Ringelhan M, 2018, NAT IMMUNOL, V19, P222, DOI 10.1038/s41590-018-0044-z
   Riscal R, 2016, MOL CELL, V62, P890, DOI 10.1016/j.molcel.2016.04.033
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI [10.3322/caac.20006, 10.3322/caac.21387, 10.3322/caac.21601, 10.3322/caac.20073, 10.3322/caac.21654, 10.3322/caac.21332, 10.3322/caac.21551, 10.3322/caac.21254]
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051
   Tsuchida T, 2018, J HEPATOL, V69, P385, DOI 10.1016/j.jhep.2018.03.011
   Wang C, 2019, NATURE, V574, P268, DOI 10.1038/s41586-019-1607-3
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 68
TC 92
Z9 98
U1 4
U2 59
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD 2020 JUN
PY 2020
VL 22
IS 6
BP 728
EP +
DI 10.1038/s41556-020-0511-2
EA MAY 2020
PG 33
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA LX9HG
UT WOS:000530285800001
PM 32367049
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Wan, JH
   Benkdane, M
   Alons, E
   Lotersztajn, S
   Pavoine, C
AF Wan, Jinghong
   Benkdane, Merieme
   Alons, Elizabeth
   Lotersztajn, Sophie
   Pavoine, Catherine
TI M2 Kupffer Cells Promote Hepatocyte Senescence <i>An
   IL</i>-<i>6</i>-<i>Dependent Protective Mechanism against Alcoholic
   Liver Disease</i>
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID FATTY LIVER-DISEASE; REPLICATIVE SENESCENCE; OXIDATIVE STRESS;
   NONALCOHOLIC STEATOHEPATITIS; CELLULAR SENESCENCE; INSULIN-RESISTANCE;
   HEPATIC STEATOSIS; STELLATE CELLS; MICE; INFLAMMATION
AB Alcoholic Liver disease is a predominant cause of liver-related mortality in Western countries. The early steps of alcohol-induced steatosis and Liver injury involve several mechanisms, including inflammation and oxidative stress. The inflammatory process is initiated by polarization of Kupffer cells toward a proinflammatory M1 phenotype, and we recently found that promoting anti-inflammatory M2 Kupffer cell polarization protects against alcohol-induced hepatocyte steatosis and apoptosis. Alcohol-induced oxidative stress is a potential trigger of senescence, and senescent cells exhibit characteristic functional resistance to apoptosis. We sought to evaluate induction of hepatocyte senescence as an early protective mechanism against alcoholic Liver disease. Combining in vivo and in vitro studies, we show that M2 macrophages trigger hepatocyte senescence and enhance alcohol-induced hepatocyte senescence, as indicated by increased D-galactosidase activity, elevated CDKN1A mRNA expression, and induction of nuclear p21. We identify IL-6 as the mediator of M2-induced hepatocyte senescence. Senescent hepatocytes display characteristic resistance to apoptosis but also to steatosis, thus arguing for an early protective effect against alcoholic liver disease. These findings further suggest that pharmacologic interventions targeting M2 polarization during the early stages of alcoholic liver disease may represent an attractive strategy for the Limitation of inflammation, hepatocyte apoptosis, and steatosis.
C1 [Wan, Jinghong; Benkdane, Merieme; Alons, Elizabeth; Lotersztajn, Sophie; Pavoine, Catherine] Univ Paris Est Creteil, INSERM, Creteil, France.
   [Wan, Jinghong; Benkdane, Merieme; Alons, Elizabeth; Lotersztajn, Sophie; Pavoine, Catherine] Univ Paris Est Creteil, U955, Team 17, Creteil, France.
   [Wan, Jinghong; Benkdane, Merieme; Alons, Elizabeth; Lotersztajn, Sophie; Pavoine, Catherine] Univ Paris Est Creteil, UMR S955, Creteil, France.
   [Lotersztajn, Sophie] Hop H Mondor A Chenevier, AP HP, Dept Gastroenterol & Hepatol, Creteil, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Henri-Mondor - APHP; Universite
   Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital
   Universitaire Paul-Brousse - APHP
RP Pavoine, C (corresponding author), Univ Paris 04, INSERM UMR ICAN S1166, Inst Cardiometab & Nutr, Pitie Salpetriere Hosp,ICAN,Team 2,UPMC, F-75013 Paris, France.
EM catherine.pavoine@inserm.fr
RI Lotersztajn, Sophie/K-9160-2017; Pavoine, Catherine/N-4405-2018
OI Pavoine, Catherine/0000-0002-0598-5545; lotersztajn,
   Sophie/0000-0002-0053-7807
FU INSERM; Universite Paris-Est; Agence Nationale de la Recherche
   [R06402JS, R09072JS, R06403JS]
FX Supported by INSERM, the Universite Paris-Est, and grants (R06403JS to
   C.P. and R06402JS and R09072JS to S.L.) from the Agence Nationale de la
   Recherche.
CR ABDELMALEK M, 1995, J CLIN GASTROENTEROL, V20, P127, DOI 10.1097/00004836-199503000-00011
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009
   de la Monte S, 2012, J GASTROEN HEPATOL, V27, P33, DOI 10.1111/j.1440-1746.2011.07023.x
   Defer N, 2009, FASEB J, V23, P2120, DOI 10.1096/fj.09-129478
   Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205
   Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lieber CS, 2008, J HEPATOL, V48, P318, DOI 10.1016/j.jhep.2007.09.016
   Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524
   Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786
   McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063
   Miller AM, 2011, HEPATOLOGY, V54, P846, DOI 10.1002/hep.24517
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0
   Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268
   Szabo G, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000341126
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421
   Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9
   Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607
   White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909
NR 40
TC 46
Z9 54
U1 1
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JUN
PY 2014
VL 184
IS 6
BP 1763
EP 1772
DI 10.1016/j.ajpath.2014.02.014
PG 10
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA AI5ZE
UT WOS:000336948700014
PM 24713392
OA Bronze
DA 2024-02-19
ER

PT J
AU Toshima, T
   Shirabe, K
   Fukuhara, T
   Ikegami, T
   Yoshizumi, T
   Soejima, Y
   Ikeda, T
   Okano, S
   Maehara, Y
AF Toshima, Takeo
   Shirabe, Ken
   Fukuhara, Takasuke
   Ikegami, Toru
   Yoshizumi, Tomoharu
   Soejima, Yuji
   Ikeda, Tetsuo
   Okano, Shinji
   Maehara, Yoshihiko
TI Suppression of Autophagy During Liver Regeneration Impairs Energy Charge
   and Hepatocyte Senescence in Mice
SO HEPATOLOGY
LA English
DT Article
ID HEPATIC LIPID-METABOLISM; SECRETORY PHENOTYPE; PROLIFERATION; RECEPTOR;
   DNA; MITOCHONDRIA; HEPATECTOMY; INHIBITION; DELETION; PROMOTES
AB Autophagy is a homeostatic mechanism that regulates protein and organelle turnover and uses the amino acids from degraded proteins to produce adenosine 5'-triphosphate (ATP). We investigated the activity of autophagy-associated pathways in liver regeneration after partial hepatectomy (PHx) in liver-specific autophagy-related gene 5 (Atg5) knockout (KO) mice. Liver regeneration was severely impaired by 70% PHx, with a reduction in postoperative mitosis, but a compensating increase in hepatocyte size. PHx induced intracellular adenosine triphosphate and beta-oxidation reduction as well as injured cellular mitochondria. Furthermore, PHx in Atg5 KO mice enhanced hepatic accumulation of p62 and ubiquitinated proteins. These results indicated that reorganization of intracellular proteins and organelles during autophagy was impaired in the regenerating liver of these mice. Up-regulation of p21 was associated with hepatocyte senescence, senescence-associated beta-galactosidase expression, irreversible growth arrest, and secretion of senescence-associated molecules, including interleukin (IL)-6 and IL-8. Conclusion: These findings indicate that autophagy plays a critical role in liver regeneration and in the preservation of cellular quality, preventing hepatocytes from becoming fully senescent and hypertrophic.
C1 [Toshima, Takeo; Shirabe, Ken; Ikegami, Toru; Yoshizumi, Tomoharu; Soejima, Yuji; Ikeda, Tetsuo; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Sci, Grad Sch Med, Fukuoka 8128582, Japan.
   [Fukuhara, Takasuke] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Osaka, Japan.
   [Okano, Shinji] Kyushu Univ, Div Pathophysiol & Expt Pathol, Dept Pathol, Grad Sch Med Sci, Fukuoka 8128582, Japan.
C3 Kyushu University; Osaka University; Kyushu University
RP Shirabe, K (corresponding author), Kyushu Univ, Dept Surg & Sci, Grad Sch Med, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
EM kshirabe@surg2.med.kyushu-u.ac.jp
RI Ikegami, Toru/GRI-9889-2022
OI fei, Jiang/0009-0001-0212-9030
FU Grants-in-Aid for Scientific Research [23591989, 26670583, 26861083,
   24791433] Funding Source: KAKEN
CR Alexander E, 2013, J CELL SCI, V126, P3738, DOI 10.1242/jcs.128835
   Baker DJ, 2013, J CELL BIOL, V202, P11, DOI 10.1083/jcb.201305155
   Barde I, 2013, SCIENCE, V340, P350, DOI 10.1126/science.1232398
   Borude P, 2012, HEPATOLOGY, V56, P2344, DOI 10.1002/hep.25918
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158
   Coutant A, 2002, HEPATOLOGY, V36, P1079, DOI 10.1053/jhep.2002.36160
   Deffieu M, 2013, J CELL SCI, V126, P415, DOI 10.1242/jcs.103713
   Diehl AM, 2013, J CLIN INVEST, V123, P1858, DOI 10.1172/JCI69966
   Dong SX, 2013, CELL METAB, V18, P380, DOI 10.1016/j.cmet.2013.08.012
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312
   Gao LL, 2013, HEPATOLOGY, V57, P1992, DOI 10.1002/hep.26235
   Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583
   Haines DD, 2013, J CELL MOL MED, V17, P936, DOI 10.1111/jcmm.12074
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Hu W, 2014, HEPATOLOGY, V59, P651, DOI 10.1002/hep.26584
   Huang JS, 2013, HEPATOLOGY, V57, P1742, DOI 10.1002/hep.26206
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125
   Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376
   Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156
   Lehmann K, 2012, GASTROENTEROLOGY, V143, P1609, DOI 10.1053/j.gastro.2012.08.043
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Lin T, 2013, HEPATOLOGY, V58, P2176, DOI 10.1002/hep.26600
   Merlen G, 2014, J HEPATOL, V60, P152, DOI 10.1016/j.jhep.2013.08.025
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   O'Rourke EJ, 2013, NAT CELL BIOL, V15, P668, DOI 10.1038/ncb2741
   PARTIN JC, 1971, NEW ENGL J MED, V285, P1339, DOI 10.1056/NEJM197112092852402
   Peng KY, 2011, METABOLISM, V60, P888, DOI 10.1016/j.metabol.2010.08.009
   Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   von Meyenn F, 2013, CELL METAB, V17, P436, DOI 10.1016/j.cmet.2013.01.014
   Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984
NR 42
TC 80
Z9 90
U1 2
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUL
PY 2014
VL 60
IS 1
BP 290
EP 300
DI 10.1002/hep.27140
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AJ8PQ
UT WOS:000337969000033
PM 24668739
OA Bronze
DA 2024-02-19
ER

PT J
AU Ogrodnik, M
   Miwa, S
   Tchkonia, T
   Tiniakos, D
   Wilson, CL
   Lahat, A
   Day, CP
   Burt, A
   Palmer, A
   Anstee, QM
   Grellscheid, SN
   Hoeijmakers, JHJ
   Barnhoorn, S
   Mann, DA
   Bird, TG
   Vermeij, WP
   Kirkland, JL
   Passos, JF
   von Zglinicki, T
   Jurk, D
AF Ogrodnik, Mikolaj
   Miwa, Satomi
   Tchkonia, Tamar
   Tiniakos, Dina
   Wilson, Caroline L.
   Lahat, Albert
   Day, Christopher P.
   Burt, Alastair
   Palmer, Allyson
   Anstee, Quentin M.
   Grellscheid, Sushma Nagaraja
   Hoeijmakers, Jan H. J.
   Barnhoorn, Sander
   Mann, Derek A.
   Bird, Thomas G.
   Vermeij, Wilbert P.
   Kirkland, James L.
   Passos, Joao F.
   von Zglinicki, Thomas
   Jurk, Diana
TI Cellular senescence drives age-dependent hepatic steatosis
SO NATURE COMMUNICATIONS
LA English
DT Article
ID DNA-DAMAGE RESPONSE; HEPATOCYTE SENESCENCE; OXIDATIVE STRESS; SCORING
   SYSTEM; LIVER-CANCER; CELLS; MITOCHONDRIA; DYSFUNCTION; PROGRESSION;
   TISSUE
AB The incidence of non-alcoholic fatty liver disease (NAFLD) increases with age. Cellular senescence refers to a state of irreversible cell-cycle arrest combined with the secretion of proinflammatory cytokines and mitochondrial dysfunction. Senescent cells contribute to age-related tissue degeneration. Here we show that the accumulation of senescent cells promotes hepatic fat accumulation and steatosis. We report a close correlation between hepatic fat accumulation and markers of hepatocyte senescence. The elimination of senescent cells by suicide gene-meditated ablation of p16Ink4a-expressing senescent cells in INK-ATTAC mice or by treatment with a combination of the senolytic drugs dasatinib and quercetin (D + Q) reduces overall hepatic steatosis. Conversely, inducing hepatocyte senescence promotes fat accumulation in vitro and in vivo. Mechanistically, we show that mitochondria in senescent cells lose the ability to metabolize fatty acids efficiently. Our study demonstrates that cellular senescence drives hepatic steatosis and elimination of senescent cells may be a novel therapeutic strategy to reduce steatosis.
C1 [Ogrodnik, Mikolaj; Miwa, Satomi; Passos, Joao F.; von Zglinicki, Thomas; Jurk, Diana] Newcastle Univ, Inst Ageing, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Tchkonia, Tamar; Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, 200 First St SW, Rochester, MN 55905 USA.
   [Tiniakos, Dina; Wilson, Caroline L.; Day, Christopher P.; Burt, Alastair; Anstee, Quentin M.; Mann, Derek A.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Tiniakos, Dina] Univ Athens, Med Sch, Dept Pathol, Aretaieio Hosp, Athens 11528, Greece.
   [Lahat, Albert; Grellscheid, Sushma Nagaraja] Univ Durham, Dept Biosci, Durham DH1 3LE, England.
   [Day, Christopher P.] Newcastle Upon Tyne Hosp NHS Trust, Freeman Hosp, Liver Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.
   [Burt, Alastair] Univ Adelaide, Fac Hlth Sci, North Terrace, Adelaide, SA 5005, Australia.
   [Hoeijmakers, Jan H. J.; Barnhoorn, Sander; Vermeij, Wilbert P.] Erasmus Univ, Dept Mol Genet, Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands.
   [Hoeijmakers, Jan H. J.] Univ Cologne, CECAD Forschungszentrum, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.
   [Bird, Thomas G.] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland.
   [Bird, Thomas G.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.
C3 Newcastle University - UK; Mayo Clinic; Newcastle University - UK;
   National & Kapodistrian University of Athens; Durham University;
   Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Freeman
   Hospital; University of Adelaide; Erasmus University Rotterdam; Erasmus
   MC; University of Cologne; University of Edinburgh; Beatson Institute
RP Jurk, D (corresponding author), Newcastle Univ, Inst Ageing, Inst Cell & Mol Biosci, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM diana.jurk1@ncl.ac.uk
RI Kirkland, James/F-9159-2016; Anstee, Quentin M./L-2981-2013; Burt,
   Alastair D/D-3634-2013; Tiniakos, Dina G/AAA-5708-2020; Day,
   Christopher/Z-3305-2019; Hoeijmakers, Jan/AAX-6972-2021; Palmer,
   Allyson/ABA-5926-2020; Lahat, Albert/L-2014-2017; Mann, Derek
   A/E-4765-2011; Ogrodnik, Mikolaj/GSI-9480-2022; Bird, Tom/H-3840-2019
OI Anstee, Quentin M./0000-0002-9518-0088; Burt, Alastair
   D/0000-0002-3011-7774; Lahat, Albert/0000-0001-5648-3011; Bird,
   Tom/0000-0002-6120-1581; Vermeij, Wilbert/0000-0002-9690-1385; ,
   Caroline/0000-0002-9016-6025; Jurk, Diana/0000-0003-4486-0857; Mann,
   Derek/0000-0003-0950-243X; Ogrodnik, Mikolaj/0000-0003-3137-2037; Miwa,
   Satomi/0000-0002-1239-1198; Tchkonia, Tamar/0000-0003-4623-7145; Passos,
   Joao/0000-0001-8765-1890; Palmer, Allyson/0000-0001-7505-3455; von
   Zglinicki, Thomas/0000-0002-5939-0248
FU Newcastle University Faculty of Medical Sciences Fellowship; National
   Institute for Health Research; David Phillips BBSRC fellowship
   [BB/H022384/1]; BBSRC [BB/K017314/1, BB/ C008200/1, BB/I020748/1]; NIH
   [R37 AG013925]; Connor Group; Noaber Foundation; Centre for Ageing
   Vitality [MR/M501700, MK/K001949/1, MRC G0700890]; Wellcome Trust
   [WT107492]; NUIA; Newcastle Biomedical Research Centre; National
   Institute of Health (NIH)/National Institute of Ageing (NIA) [PO1
   AG017242]; European Research Council; KWO Dutch Cancer Society [5030];
   Royal Academy of Arts and Sciences of the Netherlands;  [SFB628];
   Wellcome Trust [107492/Z/15/Z] Funding Source: Wellcome Trust; BBSRC
   [BB/F010966/1, BB/I020748/1, BB/H022384/1, BB/K017314/1] Funding Source:
   UKRI; MRC [MR/K001949/1, MR/L016354/1] Funding Source: UKRI;
   Biotechnology and Biological Sciences Research Council [BB/F010966/1,
   1369828, BB/I020748/1, BB/K017314/1, BB/H022384/1] Funding Source:
   researchfish; Cancer Research UK [22311, 24009] Funding Source:
   researchfish; Medical Research Council [MR/L016354/1, MR/K001949/1]
   Funding Source: researchfish; Wellcome Trust [107492/Z/15/Z] Funding
   Source: researchfish
FX D.J. is funded by a Newcastle University Faculty of Medical Sciences
   Fellowship. C.P.D. is supported by the the National Institute for Health
   Research. J.F.P. is funded by a David Phillips BBSRC fellowship
   BB/H022384/1 and BBSRC grant BB/K017314/1. T.T., A.P. and J.L.K. were
   supported by NIH grant R37 AG013925 (J.L.K.), the Connor Group and the
   Noaber Foundation. D.A.M. is funded by Centre for Ageing & Vitality
   MR/M501700, MK/K001949/1 and MRC G0700890. T.G.B. is funded by a
   Wellcome Trust Intermediate Clinical Fellowship (WT107492). The study
   was supported by BBSRC (grants BB/ C008200/1 and BB/I020748/1 to T.v.Z.)
   and grants from NUIA (D.J.) and the Newcastle Biomedical Research Centre
   (T.v.Z.). Financial support for J.H.J.H. was obtained from the National
   Institute of Health (NIH)/National Institute of Ageing (NIA) (PO1
   AG017242), European Research Council Advanced Grant DamAge and Proof of
   Concept Grant Dementia, the KWO Dutch Cancer Society (5030), SFB628 and
   the Royal Academy of Arts and Sciences of the Netherlands (academia
   professorship to J.H.J.H.). We thank Dr Kerry Cameron for support with
   the mouse experiments, Professor Fiona Oakley for helpful comments and
   the Histology Services at the CRUK Beatson Institute for assistance with
   p21 immunohistochemistry.
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80
   Burt AD, 2015, SEMIN LIVER DIS, V35, P207, DOI 10.1055/s-0035-1562942
   Cameron Kerry M, 2012, Longev Healthspan, V1, P3, DOI 10.1186/2046-2395-1-3
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Dalle Pezze Piero, 2014, PLoS Comput Biol, V10, pe1003728, DOI 10.1371/journal.pcbi.1003728
   Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   González-Rodríguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162
   Hardy T, 2016, ANNU REV PATHOL-MECH, V11, P451, DOI 10.1146/annurev-pathol-012615-044224
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Kumar A, 2013, J CLIN EXP HEPATOL, V3, P12, DOI 10.1016/j.jceh.2012.10.009
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177
   Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078
   Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pospelova TV, 2012, CELL CYCLE, V11, P2402, DOI 10.4161/cc.20882
   Reeves HL, 2016, DIGEST DIS SCI, V61, P1234, DOI 10.1007/s10620-016-4085-6
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Swanson EC, 2013, J CELL BIOL, V203, P929, DOI 10.1083/jcb.201306073
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177
   Trak-Smayra V, 2011, INT J EXP PATHOL, V92, P413, DOI 10.1111/j.1365-2613.2011.00793.x
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   van Dongen S. M., 2000, THESIS
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wilson CL, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms7818, 10.1038/ncomms9901]
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 59
TC 575
Z9 609
U1 10
U2 99
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 13
PY 2017
VL 8
AR 15691
DI 10.1038/ncomms15691
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EX3OX
UT WOS:000403142800001
PM 28608850
OA Green Published, Green Accepted, gold
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Zhang, MF
   Serna-Salas, S
   Damba, T
   Borghesan, M
   Demaria, M
   Moshage, H
AF Zhang, Mengfan
   Serna-Salas, Sandra
   Damba, Turtushikh
   Borghesan, Michaela
   Demaria, Marco
   Moshage, Han
TI Hepatic stellate cell senescence in liver fibrosis: Characteristics,
   mechanisms and perspectives
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Early Access
DE Liver fibrosis; Hepatic stellate cells; Senescence; Oxidative stress
ID NF-KAPPA-B; PROTEIN-KINASE-C; CHAPERONE-MEDIATED AUTOPHAGY; DNA-DAMAGE
   RESPONSE; SECRETORY PHENOTYPE; GENE-EXPRESSION; REPLICATIVE SENESCENCE;
   SELECTIVE AUTOPHAGY; BETA-GALACTOSIDASE; CANCER-CELLS
AB Myofibroblasts play an important role in fibrogenesis. Hepatic stellate cells are the main precursors of myofibroblasts. Cellular senescence is the terminal cell fate in which proliferating cells undergo irreversible cell cycle arrest. Senescent hepatic stellate cells were identified in liver fibrosis. Senescent hepatic stellate cells display decreased collagen production and proliferation. Therefore, induction of senescence could be a protective mechanism against progression of liver fibrosis and the concept of therapy-induced senescence has been proposed to treat liver fibrosis. In this review, characteristics of senescent hepatic stellate cells and the essential signaling pathways involved in senescence are reviewed. Furthermore, the potential impact of senescent hepatic stellate cells on other liver cell types are discussed. Senescent cells are cleared by the immune system. The persistence of senescent cells can remodel the microenvironment and interact with inflammatory cells to induce aging-related dysfunction. Therefore, senolytics, a class of compounds that selectively induce death of senescent cells, were introduced as treatment to remove senescent cells and consequently decrease the disadvantageous effects of persisting senescent cells. The effects of senescent hepatic stellate cells in liver fibrosis need further investigation.
C1 [Zhang, Mengfan; Serna-Salas, Sandra; Damba, Turtushikh; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.
   [Damba, Turtushikh] Mongolian Natl Univ Med Sci, Sch Pharm, Ulaanbaatar, Mongolia.
   [Borghesan, Michaela; Demaria, Marco] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Aging ERIBA, Groningen, Netherlands.
C3 University of Groningen; Mongolian National University of Medical
   Sciences; University of Groningen
RP Moshage, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.
EM a.j.moshage@umcg.nl
RI Damba, Turtushikh/ABD-9709-2020
OI Damba, Turtushikh/0000-0003-3141-249X; Zhang,
   Mengfan/0000-0002-2587-9395; Serna Salas, Sandra A./0000-0002-7116-5844;
   Moshage, Han/0000-0002-4764-0246; Demaria, Marco/0000-0002-8429-4813
CR Abutaleb A, 2021, J CLIN EXP HEPATOL, V11, P195, DOI 10.1016/j.jceh.2020.08.001
   Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Serna-Salas SA, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4706976
   Alisi A, 2004, J CELL PHYSIOL, V201, P259, DOI 10.1002/jcp.20060
   Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bent EH, 2016, GENE DEV, V30, P1811, DOI 10.1101/gad.284851.116
   Bernal GM, 2014, AGING-US, V6, P931, DOI 10.18632/aging.100702
   Bielak-Zmijewska A, 2018, MECH AGEING DEV, V170, P13, DOI 10.1016/j.mad.2017.08.004
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015
   Boichuck M, 2019, AGING-US, V11, P2889, DOI 10.18632/aging.101961
   Borodkina AV, 2016, AGING-US, V8, P3400, DOI 10.18632/aging.101130
   BURCH RM, 1986, P NATL ACAD SCI USA, V83, P7201, DOI 10.1073/pnas.83.19.7201
   Campos-Murguía A, 2021, DIGEST LIVER DIS, V53, P525, DOI 10.1016/j.dld.2021.01.019
   Carroll B, 2017, J CELL BIOL, V216, P1949, DOI 10.1083/jcb.201610113
   Chan ASL, 2019, GENE DEV, V33, P127, DOI 10.1101/gad.320937.118
   Chang YC, 2018, J FOOD DRUG ANAL, V26, P1066, DOI 10.1016/j.jfda.2018.01.006
   Chen QQ, 2019, FREE RADICAL BIO MED, V130, P48, DOI 10.1016/j.freeradbiomed.2018.10.419
   Chen Y, 2010, INVEST OPHTH VIS SCI, V51, P5314, DOI 10.1167/iovs.10-5280
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200
   Corsello T, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7100129
   Damba T, 2019, NITRIC OXIDE-BIOL CH, V92, P26, DOI 10.1016/j.niox.2019.08.004
   Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Detjen KM, 2000, J CELL SCI, V113, P3025
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050
   Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548
   Ehedego H, 2015, CANCER RES, V75, P1144, DOI 10.1158/0008-5472.CAN-14-1356
   Endicott SJ, 2021, AUTOPHAGY, V17, P612, DOI 10.1080/15548627.2020.1725378
   Faggioli F, 2018, HEPATOLOGY, V67, P1970, DOI 10.1002/hep.29636
   Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z
   Gonzalez LC, 2016, BIOGERONTOLOGY, V17, P71, DOI 10.1007/s10522-015-9593-9
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Guo YN, 2019, AGING CELL, V18, DOI 10.1111/acel.13013
   HAN C, 1990, MOL PHARMACOL, V37, P903
   Hari P, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0254
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He JJ, 2017, ONCOL LETT, V14, P3846, DOI 10.3892/ol.2017.6653
   Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001
   Hizli AA, 2006, J BIOL CHEM, V281, P14596, DOI 10.1074/jbc.M601959200
   Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445
   Huang YH, 2018, MOL MED REP, V17, P5700, DOI 10.3892/mmr.2018.8592
   Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028
   Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006
   Inoue C, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0011-1
   Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548
   Ito M, 2017, OSTEOARTHR CARTILAGE, V25, P2134, DOI 10.1016/j.joca.2017.08.019
   Ito S, 2015, AUTOPHAGY, V11, P547, DOI 10.1080/15548627.2015.1017190
   Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110
   Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Jiang Y, 2021, THERANOSTICS, V11, P361, DOI 10.7150/thno.46360
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, CELL SIGNAL, V33, P79, DOI 10.1016/j.cellsig.2017.02.006
   Jing H, 2014, MOL CELLS, V37, P189
   Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611
   Jung SH, 2019, ONCOGENE, V38, P1639, DOI 10.1038/s41388-018-0521-8
   Kahl CR, 2004, MOL BIOL CELL, V15, P1833, DOI 10.1091/mbc.E03-10-0730
   Kandhaya-Pillai R, 2017, AGING-US, V9, P2411, DOI 10.18632/aging.101328
   Kang C, 2016, AUTOPHAGY, V12, P898, DOI 10.1080/15548627.2015.1121361
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028
   Katakura Y, 2009, J BIOCHEM, V146, P87, DOI 10.1093/jb/mvp046
   Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6
   Khosla S, 2020, NAT REV ENDOCRINOL, V16, P263, DOI 10.1038/s41574-020-0335-y
   Kim S, 2021, MOL CELLS, V44, P136, DOI 10.14348/molcells.2021.2239
   Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639
   Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5
   Kojima Hirotada, 2013, JAKSTAT, V2, pe25763, DOI 10.4161/jkst.25763
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Kowald A, 2020, AGING CELL, V19, DOI 10.1111/acel.13270
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029
   Lan AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025921
   Lau L, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00586-18
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee HJ, 2018, GEROSCIENCE, V40, P163, DOI 10.1007/s11357-018-0018-y
   Leontieva OV, 2017, ONCOTARGET, V8, P109848, DOI 10.18632/oncotarget.17827
   Liang Q, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.571847
   Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106
   Lipton JO, 2015, CELL, V161, P1138, DOI 10.1016/j.cell.2015.04.002
   Liu J, 2014, CELL SIGNAL, V26, P110, DOI 10.1016/j.cellsig.2013.10.002
   Liu JY, 1997, BIOCHEM MOL BIOL INT, V43, P355
   Liu X, 2020, GASTROENTEROLOGY, V158, P1728, DOI 10.1053/j.gastro.2020.01.027
   Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Malaquin N, 2016, EXP GERONTOL, V82, P39, DOI 10.1016/j.exger.2016.05.010
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   Mason JM, 2004, GENETICS, V168, P1353, DOI 10.1534/genetics.104.030676
   McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x
   Montoya A, 2019, BIOMED J, V42, P155, DOI 10.1016/j.bj.2019.02.003
   Moon AM, 2020, CLIN GASTROENTEROL H, V18, P2650, DOI 10.1016/j.cgh.2019.07.060
   Moreno-Blas D, 2018, AGEING RES REV, V41, P34, DOI 10.1016/j.arr.2017.11.001
   Moreno-Gonzalez M, 2021, CANCERS, V13, DOI 10.3390/cancers13102330
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Nacarelli T, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120343
   Naim A, 2017, J CLIN EXP HEPATOL, V7, P367, DOI 10.1016/j.jceh.2017.09.004
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nassour J, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1190885
   Nguyen-Jackson HT, 2012, J LEUKOCYTE BIOL, V92, P1215, DOI 10.1189/jlb.0312126
   NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0
   Niso-Santano M, 2013, AUTOPHAGY, V9, P415, DOI 10.4161/auto.22910
   Oben JA, 2004, GUT, V53, P438, DOI 10.1136/gut.2003.026658
   Oben JA, 2003, BIOCHEM BIOPH RES CO, V302, P685, DOI 10.1016/S0006-291X(03)00232-8
   Odagiri N, 2019, MOL CELL BIOCHEM, V455, P7, DOI 10.1007/s11010-018-3466-x
   Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034
   Ogrodnik M, 2017, CELL STRESS, V1, P70, DOI 10.15698/cst2017.10.108
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7
   Pajares M, 2018, AUTOPHAGY, V14, P1310, DOI 10.1080/15548627.2018.1474992
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   PANG JH, 1994, J CELL PHYSIOL, V160, P531, DOI 10.1002/jcp.1041600316
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Park C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7823
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Parsanathan R, 2018, FREE RADICAL RES, V52, P288, DOI 10.1080/10715762.2018.1431626
   Nguyen PT, 2020, J CANCER RES CLIN, V146, P3255, DOI 10.1007/s00432-020-03374-9
   Pignolo RJ, 2020, TRENDS MOL MED, V26, P630, DOI 10.1016/j.molmed.2020.03.005
   Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224
   Rachmawati H, 2007, DRUG METAB DISPOS, V35, P814, DOI 10.1124/dmd.106.013490
   RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Robert S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153118
   Rössig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200
   Saile B, 2002, AM J PHYSIOL-GASTR L, V283, pG435, DOI 10.1152/ajpgi.00441.2001
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310
   Schreiber KH, 2015, AGING CELL, V14, P265, DOI 10.1111/acel.12313
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Siddiqui MS, 2015, MUTAT RES-REV MUTAT, V766, P1, DOI 10.1016/j.mrrev.2015.07.001
   Sierra-Ramirez A, 2020, AGING-US, V12, P11337, DOI 10.18632/aging.103607
   Sigala B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072928
   Simon T.G., J HEPATOL, P2021
   Slobodnyuk K, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1607-0
   STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802
   Sugihara H, 2018, AGING-US, V10, P747, DOI 10.18632/aging.101425
   Summer R, 2019, AM J PHYSIOL-LUNG C, V316, pL1049, DOI 10.1152/ajplung.00244.2018
   Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52
   SUZUKI E, 1990, MOL PHARMACOL, V38, P725
   Tai HR, 2017, AUTOPHAGY, V13, P99, DOI 10.1080/15548627.2016.1247143
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Tan P, 2016, MOL CELL BIOCHEM, V422, P1, DOI 10.1007/s11010-016-2796-9
   Tang BL, 2016, MOL CELLS, V39, P87, DOI 10.14348/molcells.2016.2318
   Tian YQ, 2019, AGING CELL, V18, DOI 10.1111/acel.12858
   Tibudan SS, 2002, J INVEST DERMATOL, V119, P1282, DOI 10.1046/j.1523-1747.2002.19625.x
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011
   Trougakos IP, 2006, MECH AGEING DEV, V127, P88, DOI 10.1016/j.mad.2005.08.009
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315
   Venkatachalam G, 2017, NUCLEIC ACIDS RES, V45, P10564, DOI 10.1093/nar/gkx684
   VILE GF, 1995, PHOTOCHEM PHOTOBIOL, V62, P463, DOI 10.1111/j.1751-1097.1995.tb02369.x
   Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wakita M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15719-6
   Wan JH, 2014, AM J PATHOL, V184, P1763, DOI 10.1016/j.ajpath.2014.02.014
   Wang R, 2017, AGING CELL, V16, P564, DOI 10.1111/acel.12587
   Waters DW, 2019, AM J RESP CELL MOL, V61, P61, DOI 10.1165/rcmb.2018-0328OC
   WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0
   Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551
   White RR, 2016, MOL CELL, V63, P729, DOI 10.1016/j.molcel.2016.08.004
   Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792
   WILSON KM, 1990, J BIOL CHEM, V265, P17601
   Wu W, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5707830
   Xie ZZ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6043038
   Xu CY, 2020, NAT CELL BIOL, V22, P1170, DOI 10.1038/s41556-020-00579-5
   Xu W, 2018, CELL PHYSIOL BIOCHEM, V48, P1793, DOI 10.1159/000492352
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016
   Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645
   Yang JF, 2019, J CELL PHYSIOL, V234, P7587, DOI 10.1002/jcp.27521
   Yang S, 2019, CELL SIGNAL, V53, P327, DOI 10.1016/j.cellsig.2018.10.021
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu H., EXP CELL RES, V405
   Zhang H, 2000, EXP CELL RES, V259, P284, DOI 10.1006/excr.2000.4965
   Zhang HL, 2016, TRENDS MOL MED, V22, P671, DOI 10.1016/j.molmed.2016.06.001
   Zheng K, 2019, THERANOSTICS, V9, P104, DOI 10.7150/thno.30308
   Zhou J, 2017, AGING-US, V9, P583, DOI 10.18632/aging.101181
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zoubek ME, 2017, BEST PRACT RES CL GA, V31, P129, DOI 10.1016/j.bpg.2017.04.005
NR 222
TC 30
Z9 32
U1 17
U2 59
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD 2021 OCT
PY 2021
VL 199
AR 111572
DI 10.1016/j.mad.2021.111572
EA SEP 2021
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA WC8TX
UT WOS:000704526000007
PM 34536446
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Dumeus, S
   Shibu, MA
   Lin, WT
   Wang, MF
   Lai, CH
   Shen, CY
   Lin, YM
   Viswanadha, VP
   Kuo, WW
   Huang, CY
AF Dumeus, Stanley
   Shibu, Marthandam Asokan
   Lin, Wan-Teng
   Wang, Ming-Fu
   Lai, Chao-Hung
   Shen, Chia-Yao
   Lin, Yueh-Min
   Viswanadha, Vijaya Padma
   Kuo, Wei-Wen
   Huang, Chih-Yang
TI Bioactive Peptide Improves Diet-Induced Hepatic Fat Deposition and
   Hepatocyte Proinflammatory Response in SAMP8 Ageing Mice
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Aging; SAMP8; Hepatosteatosis; NAFLD; Proinflammatory mediators; HFD;
   Potato protein hydrolysate; Bioactive peptide
ID LIVER-DISEASE; LIPID-ACCUMULATION; NONALCOHOLIC STEATOHEPATITIS; MATRIX
   METALLOPROTEINASES; INFLAMMATION; REACTIVATION; ACTIVATION; STEATOSIS;
   INCREASES; APOPTOSIS
AB Background/Aims: High-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) poses therapeutic challenges in elderly subjects. Due to lack of efficient drug therapy, plantbased bioactive peptides have been studied as alternative strategy in NAFLD and for less toxicity in elderly. To mimic fatty liver in aging conditions, researchers highly commended the genetically engineered strains SAMP8 (senescence-accelerated mice prone 8). However, there is a paucity of reports about the anti-steatosis effects of bioactive peptides against fatty liver development under a combined action of high-fat diet exposure and aging process. This study was conducted to evaluate the activity of DIKTNKPVIF peptide synthesized from alcalase-generated potato protein hydrolysate (PH), on reducing HFD-driven and steatosisassociated proinflammatory reaction in ageing model. Methods: Five groups of six-month-old SAMP8 mice (n=4, each) were fed either a normal chow (NC group) for 14 weeks upon sacrifice, or induced with a 6-week HFD feeding, then treated without (HCO group) or with an 8-week simultaneous administration of peptide (HPEP group), protein (HPH group) or probucol (HRX group). Liver organs were harvested from each group for histological analysis and immunoblot assay. Results: In contrast to NC, extensive fat accumulation was visualized in the liver slides of HCO. Following the trends of orally administered PH, intraperitoneally injected peptide reduces hepatic fat deposition and causes at protein level, a significant decrease in HFD-induced proinflammatory mediators p-p38 MAPK, FGF-2, TNF-alpha, IL-6 with concomitant reactivation of AMPK. However, p-Foxo1 and PPAR-alpha levels were slightly changed. Conclusion: Oral supplementation of PH and intraperitoneal injection of derived bioactive peptide alleviate proinflammatory reaction associated with hepatosteatosis development in elderly subjects, through activation of AMPK. (C) 2018 The Author(s) Published by S. Karger AG, Basel.
C1 [Dumeus, Stanley; Shibu, Marthandam Asokan; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.
   [Dumeus, Stanley] State Univ Haiti, Fac Med & Pharm, Dept Med, Port Au Prince, Haiti.
   [Lin, Wan-Teng] Tunghai Univ, Dept Hospitality Management, Taichung, Taiwan.
   [Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
   [Lai, Chao-Hung] Armed Force Taichung Gen Hosp, Div Cardiol, Taichung, Taiwan.
   [Shen, Chia-Yao] MeiHo Univ, Dept Nursing, Pingtung, Taiwan.
   [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan.
   [Lin, Yueh-Min] Jen Teh Jr Coll Med, Nursing & Management Coll, Dept Med Technol, Taipei, Taiwan.
   [Viswanadha, Vijaya Padma] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India.
   [Kuo, Wei-Wen] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan.
   [Huang, Chih-Yang] Guangzhou Med Univ, Qingyuan Peoples Hosp, Affiliated Hosp 6, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China.
   [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.
C3 China Medical University Taiwan; Tunghai University; Providence
   University - Taiwan; Changhua Christian Hospital; Mackay Junior College
   of Medicine, Nursing & Management; Bharathiar University; China Medical
   University Taiwan; Guangzhou Medical University; Asia University Taiwan
RP Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.
EM cyhuang@mail.cmu.edu.tw
RI M. A., Shibu/F-6137-2018; Viswanadha, Vijaya Padma/ABG-4936-2020; wang,
   ming/HPC-6329-2023; wang, ming/ITV-5378-2023
OI M. A., Shibu/0000-0001-6381-3525; Viswanadha, Vijaya
   Padma/0000-0001-9154-027X; Lin, Wan-Teng/0000-0001-7700-3398; Huang,
   Chih-Yang/0000-0003-2347-0411
FU Ministry of Science and Technology of Taiwan
   [MOST-104-2410-H-029-033-MY2, MOST-106-2410-H-029-047-MY2]; Taiwan
   Department of Health, Clinical Trial and Research Center of Excellence
   [MOHW106-TDU- B-212- 113004]; Taiwan Ministry of Foreign Affairs (MOFA)
   Scholarship Program for the Republic of Haiti
FX This study was financially supported in part by grants
   (MOST-104-2410-H-029-033-MY2 and MOST-106-2410-H-029-047-MY2) from the
   Ministry of Science and Technology of Taiwan and (MOHW106-TDU- B-212-
   113004) Taiwan Department of Health, Clinical Trial and Research Center
   of Excellence. We thank Higie Tamar Dumeus BIEN-AIME for Englishediting
   assistance. We express our gratitude to Taiwan Ministry of Foreign
   Affairs (MOFA) Scholarship Program for the Republic of Haiti, through
   which SD (Faculte de Medecine et de Pharmacie, Universite Etat Haiti)
   was supported.
CR Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008
   Cheng KC, 2016, BIOMEDICINE-TAIWAN, V6, DOI 10.7603/s40681-016-0016-2
   Chiang WD, 2016, FOOD NUTR RES, V60, DOI [10.3402/fnr.v60.30511, 10.3402/fnr.v60.31417]
   Chiang WD, 2014, J FUNCT FOODS, V11, P482, DOI 10.1016/j.jff.2014.08.003
   Choi Y, 2016, J NUTR BIOCHEM, V38, P70, DOI 10.1016/j.jnutbio.2016.08.013
   Daliri EBM, 2017, FOODS, V6, DOI 10.3390/foods6050032
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Guo XC, 2003, J BIOL CHEM, V278, P22237, DOI 10.1074/jbc.M300847200
   Hijona E, 2010, MEDIAT INFLAMM, V2010, P7
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Hsu CS, 2017, EXPERT REV GASTROENT, V11, P759, DOI 10.1080/17474124.2017.1342535
   Hu WS, 2015, INT J MOL SCI, V16, P10158, DOI 10.3390/ijms160510158
   Ishiguro K, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00201
   Jang EH, 2008, INT J OBESITY, V32, P1161, DOI 10.1038/ijo.2008.60
   Jung EJ, 2011, J LIPID RES, V52, P1617, DOI 10.1194/jlr.M015263
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Le NTV, 2007, FRONT BIOSCI, V12, P1475, DOI 10.2741/2161
   Liang Yu-Chia, 2017, Biomedicine (Taipei), V7, P18, DOI 10.1051/bmdcn/2017070318
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   McKee C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08812
   Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3
   Nakamura I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092273
   Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418
   Schumacher JD, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8323747
   Singh S, 2017, WORLD J GASTROENTERO, V23, P6549, DOI 10.3748/wjg.v23.i36.6549
   Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tokushige K, 2007, HEPATOL RES, V37, P872, DOI 10.1111/j.1872-034X.2007.00128.x
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   Visvanathan R, 2016, J SCI FOOD AGR, V96, P4850, DOI 10.1002/jsfa.7848
   Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73
   Wu GY, 2017, CELL PHYSIOL BIOCHEM, V44, P1651, DOI 10.1159/000485765
   Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
NR 35
TC 25
Z9 25
U1 3
U2 14
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2018
VL 48
IS 5
BP 1942
EP 1952
DI 10.1159/000492518
PG 11
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA GS5WQ
UT WOS:000443744900011
PM 30092591
OA gold
DA 2024-02-19
ER

PT J
AU Jin, HH
   Lian, NQ
   Bian, ML
   Zhang, CX
   Chen, XR
   Shao, JJ
   Wu, L
   Chen, AP
   Guo, QL
   Zhang, F
   Zheng, SZ
AF Jin, Huanhuan
   Lian, Naqi
   Bian, Mianli
   Zhang, Chenxi
   Chen, Xingran
   Shao, Jiangjuan
   Wu, Li
   Chen, Anping
   Guo, Qinglong
   Zhang, Feng
   Zheng, Shizhong
TI Oroxylin A inhibits ethanol-induced hepatocyte senescence <i>via</i>YAP
   pathway
SO CELL PROLIFERATION
LA English
DT Article
ID ALCOHOLIC LIVER-INJURY; CELLULAR SENESCENCE; OXIDATIVE STRESS; TELOMERE
   LENGTH; STELLATE CELLS; FIBROSIS; ACTIVATION; REGENERATION; HEPATITIS;
   APOPTOSIS
AB ObjectivesOroxylin A, a natural flavonoid isolated from Scutellaria baicalensis, has been reported to have anti-hepatic injury effects. However, the effects of oroxylin A on alcoholic liver disease (ALD) remains unclear. The aim of this study was to elucidate the effects of oroxylin A on ALD and the potential mechanisms.
   Materials and methodsMale ICR mice and human hepatocyte cell line LO2 were used. Yes-associated protein (YAP) overexpression and knockdown were achieved using plasmid and siRNA technique. Cellular senescence was assessed by analyses of the senescence-associated -galactosidase (SA--gal), senescence marker p16, p21, Hmga1, cell cycle and telomerase activity.
   ResultsOroxylin A alleviated ethanol-induced hepatocyte damage by suppressing activities of supernatant marker enzymes. We found that oroxylin A inhibited ethanol-induced hepatocyte senescence by decreasing the number of SA--gal-positive LO2 cells and reducing the expression of senescence markers p16, p21 and Hmga1 in vitro. Moreover, oroxylin A affected the cell cycle and telomerase activity. Of importance, we revealed that YAP pharmacological inhibitor verteporfin or YAP siRNA eliminated the effect of oroxylin A on ethanol-induced hepatocyte senescence in vitro, and this was further supported by the evidence in vivo experiments.
   ConclusionTherefore, these aggregated data suggested that oroxylin A relieved alcoholic liver injury possibly by inhibiting the senescence of hepatocyte, which was dependent on its activation of YAP in hepatocytes.
C1 [Jin, Huanhuan; Lian, Naqi; Bian, Mianli; Zhang, Chenxi; Chen, Xingran; Wu, Li; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Jiangsu, Peoples R China.
   [Shao, Jiangjuan; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Therapeut Mat Chinese Med, Nanjing, Jiangsu, Peoples R China.
   [Shao, Jiangjuan; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, State Key Lab Cultivat Base TCM Qual & Efficacy, Nanjing, Jiangsu, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.
   [Guo, Qinglong] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing, Jiangsu, Peoples R China.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Nanjing University of Chinese Medicine; Saint Louis
   University; China Pharmaceutical University
RP Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.
EM nytws@163.com
RI WANG, YANG/JFA-8821-2023
OI Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [31571455, 31401210,
   31600653, 81600483, 81270514]; Natural Science Foundation of Jiangsu
   Province [BK20140955]; Open Project Program of Jiangsu Key Laboratory
   for Pharmacology and Safety Evaluation of Chinese Materia Medica [JKLPSE
   201502]; Project of the Priority Academic Program Development of Jiangsu
   Higher Education Institutions
FX the National Natural Science Foundation of China, Grant/Award Number:
   31571455, 31401210, 31600653, 81600483 and 81270514; the Natural Science
   Foundation of Jiangsu Province, Grant/Award Number: BK20140955; the Open
   Project Program of Jiangsu Key Laboratory for Pharmacology and Safety
   Evaluation of Chinese Materia Medica, Grant/Award Number: JKLPSE 201502;
   the Project of the Priority Academic Program Development of Jiangsu
   Higher Education Institutions, Grant/Award Number: PAPD
CR Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657
   Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035
   Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cardin R, 2002, ALCOHOL ALCOHOLISM, V37, P43, DOI 10.1093/alcalc/37.1.43
   Cheng B, 2010, LIVER INT, V30, P319, DOI 10.1111/j.1478-3231.2009.02167.x
   Dai QS, 2013, INT J BIOCHEM CELL B, V45, P1468, DOI 10.1016/j.biocel.2013.04.015
   Deaciuc IV, 2001, HEPATOL RES, V19, P306, DOI 10.1016/S1386-6346(00)00112-1
   Grijalva JL, 2014, AM J PHYSIOL-GASTR L, V307, pG196, DOI 10.1152/ajpgi.00077.2014
   Han QH, 2017, NAT PROD RES, V31, P1339, DOI 10.1080/14786419.2016.1244193
   Hu Y, 2006, BIOCHEM BIOPH RES CO, V351, P521, DOI 10.1016/j.bbrc.2006.10.064
   Huang HY, 2015, J SURG RES, V195, P522, DOI 10.1016/j.jss.2015.01.047
   Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523
   Kim Moon Young, 2017, Korean J Gastroenterol, V69, P341, DOI 10.4166/kjg.2017.69.6.341
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kwon BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155784
   Li JH, 2016, INT IMMUNOPHARMACOL, V40, P524, DOI 10.1016/j.intimp.2016.10.011
   Lu CF, 2017, TOXICOL SCI, V155, P432, DOI 10.1093/toxsci/kfw228
   Lu CF, 2016, MOL PHARMACEUT, V13, P4043, DOI 10.1021/acs.molpharmaceut.6b00562
   Lu CF, 2015, LIFE SCI, V141, P119, DOI 10.1016/j.lfs.2015.08.018
   Machado MV, 2015, J HEPATOL, V63, P962, DOI 10.1016/j.jhep.2015.05.031
   Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Serrano M, 2010, NATURE, V464, P363, DOI 10.1038/464363a
   Shen L, 2017, ONCOTARGET, V8, P49395, DOI 10.18632/oncotarget.17218
   Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
   vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0
   von Figura G, 2009, J MOL MED, V87, P1165, DOI 10.1007/s00109-009-0509-5
   Wang HF, 2016, CELL PHYSIOL BIOCHEM, V39, P1129, DOI 10.1159/000447820
   Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793
   Xu WX, 2017, TOXICOL APPL PHARM, V315, P23, DOI 10.1016/j.taap.2016.12.001
   Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008
   Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286
   Zhang P, 2007, NEUROSCIENCE, V145, P1439, DOI 10.1016/j.neuroscience.2006.11.052
   Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408
   Zhu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071612
   Zou MJ, 2012, CELL SIGNAL, V24, P1722, DOI 10.1016/j.cellsig.2012.04.009
NR 48
TC 31
Z9 34
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7722
EI 1365-2184
J9 CELL PROLIFERAT
JI Cell Prolif.
PD JUN
PY 2018
VL 51
IS 3
AR e12431
DI 10.1111/cpr.12431
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GI0OQ
UT WOS:000434069700008
PM 29318697
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Wang, MJ
   Chen, F
   Li, JX
   Liu, CC
   Zhang, HB
   Xia, Y
   Yu, B
   You, P
   Xiang, D
   Lu, L
   Yao, H
   Borjigin, U
   Yang, GS
   Wangensteen, KJ
   He, ZY
   Wang, X
   Hu, YP
AF Wang, Min-Jun
   Chen, Fei
   Li, Jian-Xiu
   Liu, Chang-Cheng
   Zhang, Hai-Bin
   Xia, Yong
   Yu, Bing
   You, Pu
   Xiang, Dao
   Lu, Lian
   Yao, Hao
   Borjigin, Uyunbilig
   Yang, Guang-Shun
   Wangensteen, Kirk J.
   He, Zhi-Ying
   Wang, Xin
   Hu, Yi-Ping
TI Reversal of Hepatocyte Senescence After Continuous <i>In Vivo</i> Cell
   Proliferation
SO HEPATOLOGY
LA English
DT Article
ID STEM-CELLS; SERIAL TRANSPLANTATION; AUTOIMMUNE HEPATITIS; PROGENITOR
   CELLS; LIVER; MICE; REPOPULATION; POLYPLOIDY; CAPACITY; STRESS
AB A better understanding of hepatocyte senescence could be used to treat age-dependent disease processes of the liver. Whether continuously proliferating hepatocytes could avoid or reverse senescence has not yet been fully elucidated. We confirmed that the livers of aged mice accumulated senescent and polyploid hepatocytes, which is associated with accumulation of DNA damage and activation of p53-p21 and p16(ink4a)-pRB pathways. Induction of multiple rounds continuous cell division is hard to apply in any animal model. Taking advantage of serial hepatocyte transplantation assays in the fumarylacetoacetate hydrolase-deficient (Fah(-/-)) mouse, we studied the senescence of hepatocytes that had undergone continuous cell proliferation over a long time period, up to 12 rounds of serial transplantations. We demonstrated that the continuously proliferating hepatocytes avoided senescence and always maintained a youthful state. The reactivation of telomerase in hepatocytes after serial transplantation correlated with reversal of senescence. Moreover, senescent hepatocytes harvested from aged mice became rejuvenated upon serial transplantation, with full restoration of proliferative capacity. The same findings were also true for human hepatocytes. After serial transplantation, the high initial proportion of octoploid hepatocytes decreased to match the low level of youthful liver. Conclusion: These findings suggest that the hepatocyte "ploidy conveyer" is regulated differently during aging and regeneration. The findings of reversal of hepatocyte senescence could enable future studies on liver aging and cell therapy.
C1 [Wang, Min-Jun; Chen, Fei; Li, Jian-Xiu; Liu, Chang-Cheng; Yu, Bing; You, Pu; Xiang, Dao; Lu, Lian; Yao, Hao; He, Zhi-Ying; Hu, Yi-Ping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China.
   [Wang, Min-Jun; Chen, Fei; Li, Jian-Xiu; Liu, Chang-Cheng; Yu, Bing; You, Pu; Xiang, Dao; Lu, Lian; Yao, Hao; He, Zhi-Ying; Hu, Yi-Ping] Second Mil Med Univ, Grad Sch, Ctr Stem Cell & Med, Shanghai, Peoples R China.
   [Zhang, Hai-Bin; Xia, Yong; Yang, Guang-Shun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.
   [Borjigin, Uyunbilig; Wang, Xin] Inner Mongolia Univ, Key Lab Natl Educ Minist Mammalian Reprod Biol &, Hohhot, Peoples R China.
   [Wangensteen, Kirk J.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.
   [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.
   [Wang, Xin] Hepatoscience Inc, Palo Alto, CA USA.
C3 Naval Medical University; Naval Medical University; Naval Medical
   University; Inner Mongolia University; University of Pennsylvania;
   University of Minnesota System; University of Minnesota Twin Cities
RP He, ZY (corresponding author), Second Mil Med Univ, Dept Cell Biol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.
EM yphu@smmu.edu.cn; wangxin_cn@imu.edu.cn
RI Yu, Bing/GSD-3362-2022; Li, Wei/JLL-4365-2023; wang, yi/HOF-6668-2023;
   yang, qing/JBR-8440-2023
OI yao, hao/0000-0002-2942-0004; he, zhiying/0000-0002-0087-2277;
   Wangensteen, Kirk/0000-0001-6042-6490
FU National Key Basic Research and Development Program of China
   [2011CB966200, 2010CB945600]; National Natural Science Foundation of
   China [31271474, 31171309, 30971462, 31271469, 31271042, 31100996]
FX Funded by National Key Basic Research and Development Program of China
   (2011CB966200, 2010CB945600), National Natural Science Foundation of
   China (31271474, 31171309, 30971462, 31271469, 31271042, and 31100996).
CR Al-Chalabi T, 2006, J HEPATOL, V45, P575, DOI 10.1016/j.jhep.2006.04.007
   Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Celton-Morizur S, 2010, CELL CYCLE, V9, P460, DOI 10.4161/cc.9.3.10542
   Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Czaja AJ, 2006, HEPATOLOGY, V43, P532, DOI 10.1002/hep.21074
   Duncan AW, 2012, J CLIN INVEST, V122, P3307, DOI 10.1172/JCI64026
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111
   Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042
   Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815
   Menthena A, 2011, GASTROENTEROLOGY, V140, P1009, DOI 10.1053/j.gastro.2010.12.003
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242
   Stuart GR, 2000, GENETICS, V155, P1359
   Toyoda H, 2005, GUT, V54, P297, DOI 10.1136/gut.2004.043893
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   von Figura G, 2009, J MOL MED, V87, P1165, DOI 10.1007/s00109-009-0509-5
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3
   Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
NR 38
TC 71
Z9 79
U1 2
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUL
PY 2014
VL 60
IS 1
BP 349
EP 361
DI 10.1002/hep.27094
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AJ8PQ
UT WOS:000337969000038
PM 24711261
DA 2024-02-19
ER

PT J
AU Aravinthan, A
   Shannon, N
   Heaney, J
   Hoare, M
   Marshall, A
   Alexander, GJM
AF Aravinthan, Aloysious
   Shannon, Nicholas
   Heaney, Judith
   Hoare, Matthew
   Marshall, Aileen
   Alexander, Graeme J. M.
TI The senescent hepatocyte gene signature in chronic liver disease
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Chronic liver disease; Hepatocyte senescence; Senescence gene signature
ID HUMAN DERMAL FIBROBLASTS; HEPATIC STELLATE CELLS; CELLULAR SENESCENCE;
   REPLICATIVE SENESCENCE; HETEROCHROMATIN FORMATION; HYDROGEN-PEROXIDE;
   DUCTULAR REACTION; EXPRESSION; CIRRHOSIS; FIBROSIS
AB Hepatocyte senescence is associated closely with fibrosis stage and an adverse outcome in chronic liver disease, but it is uncertain whether there is a causal relation with clinical manifestations of chronic liver disease, which was the subject of this study of the senescent hepatocyte gene signature. Senescence was induced in HepG2 cells using sub-lethal concentrations of H2O2. Gene expression of control and senescent HepG2 cells were studied. Comparison was made with patients with cirrhosis and three public microarray datasets. H2O2-treated HepG2 cells demonstrated characteristic cellular senescence. There was differential expression of 354 genes in senescence. Up-regulated genes in HepG2 senescence were also up regulated in patients with cirrhosis. The senescent hepatocyte gene signature distinguished liver disease from normal by unsupervised clustering in the public chronic liver disease microarray datasets, with enrichment of the senescence gene signature in all three datasets. The senescent hepatocyte gene signature included changes in cell cycle regulation, morphology, inflammation, signal transduction, metabolism and stellate cell activation, which alongside impaired synthetic function in senescence in vitro were consistent with manifestations of clinical liver disease, suggesting a close relation between hepatocyte senescence and manifestations of chronic liver disease including fibrosis and impaired synthetic function. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Aravinthan, Aloysious; Heaney, Judith; Hoare, Matthew; Marshall, Aileen; Alexander, Graeme J. M.] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 0QQ, England.
   [Shannon, Nicholas; Hoare, Matthew] Canc Res UK Cambridge Inst, Cambridge, England.
   [Heaney, Judith] Fdn Liver Res, Inst Hepatol, London, England.
   [Marshall, Aileen] Royal Free London NHS Fdn Trust, London, England.
C3 University of Cambridge; Cancer Research UK; CRUK Cambridge Institute;
   University of London; University College London; University of London;
   University College London; Royal Free London NHS Foundation Trust
RP Alexander, GJM (corresponding author), Univ Cambridge, Dept Med, Box 156,Hills Rd, Cambridge CB2 0QQ, England.
EM gja1000@doctors.org.uk
RI Aravinthan, Aloysious D/I-2557-2019
OI Aravinthan, Aloysious D/0000-0003-0527-5137; Shannon, Nicholas
   Brian/0000-0001-8742-8285; Hoare, Matthew/0000-0001-5990-9604
FU Hepatology Endowment Fund, Addenbrooke's Charitable Trust, Cambridge, UK
   [CB2 0QQ]
FX Hepatology Endowment Fund, Addenbrooke's Charitable Trust, Cambridge CB2
   0QQ, UK.
CR Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750
   BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973
   Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chen QM, 2000, ANN NY ACAD SCI, V908, P111
   Chen QM, 2000, J CELL SCI, V113, P4087
   Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   D'Arienzo A, 1998, SCAND J GASTROENTERO, V33, P1213
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
   Dekker P, 2012, MECH AGEING DEV, V133, P498, DOI 10.1016/j.mad.2012.06.002
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200
   GONZALEZREIMERS E, 1988, DRUG ALCOHOL DEPEN, V22, P195, DOI 10.1016/0376-8716(88)90018-X
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kim JS, 2011, EXP GERONTOL, V46, P500, DOI 10.1016/j.exger.2011.02.012
   Kinnman N, 2000, LAB INVEST, V80, P697, DOI 10.1038/labinvest.3780073
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Lener T, 2006, EXP GERONTOL, V41, P387, DOI 10.1016/j.exger.2006.01.012
   Liu DH, 2012, J CARDIOVASC PHARM, V59, P222, DOI 10.1097/FJC.0b013e31823c1d34
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Mehta IS, 2007, ANN NY ACAD SCI, V1100, P250, DOI 10.1196/annals.1395.027
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Narita M, 2007, BRIT J CANCER, V96, P686, DOI 10.1038/sj.bjc.6603636
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   NOLTE W, 1995, EXP CLIN ENDOCR DIAB, V103, P63, DOI 10.1055/s-0029-1211331
   Picardi A, 2006, DIABETES-METAB RES, V22, P274, DOI 10.1002/dmrr.636
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706
   Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002
NR 48
TC 32
Z9 35
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2014
VL 60
BP 37
EP 45
DI 10.1016/j.exger.2014.09.011
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AW1RW
UT WOS:000346068300005
PM 25240687
DA 2024-02-19
ER

PT J
AU Serra, MP
   Marongiu, F
   Sini, M
   Laconi, E
AF Serra, Maria Paola
   Marongiu, Fabio
   Sini, Marcella
   Laconi, Ezio
TI Hepatocyte senescence in vivo following preconditioning for liver
   repopulation
SO HEPATOLOGY
LA English
DT Article
ID CELL-CYCLE; HEPATOCELLULAR INJURY; PARTIAL-HEPATECTOMY; MOUSE-LIVER;
   RETRORSINE; RATS; GROWTH; TRANSPLANTATION; REPLACEMENT; MODEL
AB In the retrorsine (RS)-based model of massive liver repopulation, preexposure to this naturally occurring alkaloid is sufficient to prime normal host parenchymal cells to be slowly replaced by transplanted normal hepatocytes. The basis for this striking effect is yet to be fully elucidated. In the present studies the possible involvement of cell senescence was investigated. Fischer 344 rats were treated according to the RS-based protocol for hepatocyte transplantation, i.e., two doses of RS, 2 weeks apart, and were killed at 4 or 8 weeks after treatment. Control groups were given saline. Expression of senescence-associated beta-galactosidase was greatly induced in hepatocytes exposed to RS. In addition, several other changes that have been related to cell senescence were observed: these included markers of persistent activation of a DNA damage response, an increased expression of mammalian target of rapamycin, and positive regulators of the cell cycle, together with the induction of p21 and p27 cyclin-dependent kinase inhibitors. Furthermore, RS treatment increased levels of interleukin-6 in the liver, consistent with the activation of a senescence-associated secretory phenotype. Conclusion: These findings indicate that RS induces hepatocyte senescence in vivo. We propose that cell senescence and the associated secretory phenotype can contribute to the selective growth of transplanted hepatocytes in this system. (HEPATOLOGY 2012)
C1 [Laconi, Ezio] Univ Cagliari, Sch Med, Dept Biomed Sci, Unit Expt Med, I-09124 Cagliari, Italy.
C3 University of Cagliari
RP Laconi, E (corresponding author), Univ Cagliari, Sch Med, Dept Biomed Sci, Unit Expt Med, Via Porcell 4,3rd Floor, I-09124 Cagliari, Italy.
EM elaconi@unica.it
RI Marongiu, Fabio/E-6294-2016
OI Marongiu, Fabio/0000-0001-5860-4227
FU AIRC (Italian Association for Cancer Research) [IG 10604]
FX Supported by AIRC (Italian Association for Cancer Research, Grant No. IG
   10604).
CR Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728
   Best DH, 2010, EXP MOL PATHOL, V88, P7, DOI 10.1016/j.yexmp.2009.10.009
   Coleman W.B., 2005, Hepatology, V41, P1173, DOI [10.1002/hep.20685, DOI 10.1002/HEP.20685]
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Gordon GJ, 2000, HEPATOLOGY, V32, P312, DOI 10.1053/jhep.2000.9144
   Gordon GJ, 2000, AM J PATHOL, V156, P607, DOI 10.1016/S0002-9440(10)64765-7
   HINCKS JR, 1991, TOXICOL APPL PHARM, V111, P90, DOI 10.1016/0041-008X(91)90137-4
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   JAGO MV, 1969, AM J PATHOL, V56, P405
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   LACONI E, 1995, CARCINOGENESIS, V16, P139, DOI 10.1093/carcin/16.1.139
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   Laconi E, 2000, AM J PATHOL, V156, P389, DOI 10.1016/S0002-9440(10)64741-4
   Laconi S, 2001, P NATL ACAD SCI USA, V98, P7806, DOI 10.1073/pnas.131210498
   Laconi S, 2001, AM J PATHOL, V158, P771, DOI 10.1016/S0002-9440(10)64019-9
   Laconi S, 1999, J HEPATOL, V31, P1069, DOI 10.1016/S0168-8278(99)80320-1
   Laconi S, 2008, CELL TRANSPLANT, V17, P1415, DOI 10.3727/096368908787648128
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584
   MCLEAN E K, 1970, Pharmacological Reviews, V22, P429
   Menthena A, 2011, GASTROENTEROLOGY, V140, P1009, DOI 10.1053/j.gastro.2010.12.003
   Mignon A, 1998, NAT MED, V4, P1185, DOI 10.1038/2681
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   Pani G, 2011, CELL CYCLE, V10, P2450, DOI 10.4161/cc.10.15.16886
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   PETERSON JE, 1965, J PATHOL BACTERIOL, V89, P153, DOI 10.1002/path.1700890117
   Pichard V, 2008, J HEPATOL, V48, P368, DOI 10.1016/j.jhep.2007.11.001
   Pitzalis S, 2005, J HEPATOL, V43, P485, DOI 10.1016/j.jhep.2005.03.029
   RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010
   Tschaharganeh DF, 2010, LIVER TRANSPLANT, V16, P23, DOI 10.1002/lt.21962
   Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22
NR 43
TC 19
Z9 20
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD AUG
PY 2012
VL 56
IS 2
BP 760
EP 768
DI 10.1002/hep.25698
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 979GF
UT WOS:000306804500039
PM 22392699
OA Bronze
DA 2024-02-19
ER

PT J
AU Aravinthan, A
   Challis, B
   Shannon, N
   Hoare, M
   Heaney, J
   Alexander, GJM
AF Aravinthan, Aloysious
   Challis, Benjamin
   Shannon, Nicholas
   Hoare, Matthew
   Heaney, Judith
   Alexander, Graeme J. M.
TI Selective insulin resistance in hepatocyte senescence
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE Chronic liver disease; Hepatocyte senescence; Selective insulin
   resistance
ID FOXO TRANSCRIPTION FACTORS; DIABETES-MELLITUS; SIGNALING PATHWAYS;
   LIVER-CIRRHOSIS; HEPATITIS; GENE; REGENERATION; ASSOCIATION;
   PROGRESSION; INHIBITION
AB Insulin resistance has been described in association with chronic liver disease for decades. Hepatocyte senescence has been demonstrated in chronic liver disease and as many as 80% of hepatocytes show a senescent phenotype in advanced liver disease. The aim of this study was to understand the role of hepatocyte senescence in the development of insulin resistance. Senescence was induced in HepG2 cells via oxidative stress. The insulin metabolic pathway was studied in control and senescent cells following insulin stimulation. GLUT2 and GLUT4 expressions were studied in HepG2 cells and human liver tissue. Further, GLUT2 and GLUT4 expressions were studied in three independent chronic liver disease cohorts. Signalling impairment distal to Ala in phosphorylation of AS160 and FoxO1 was evident in senescent HepG2 cells. Persistent nuclear localisation of FoxO1 was demonstrated in senescent cells despite insulin stimulation. Increased GLUT4 and decreased GLUT2 expressions were evident in senescent cells, human cirrhotic liver tissue and publically available liver disease datasets. Changes in GLUT expressions were associated with a poor clinical prognosis. In conclusion, selective insulin resistance is evident in senescent HepG2 cells and changes in GLUT expressions can be used as surrogate markers of hepatocyte senescence. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Aravinthan, Aloysious; Hoare, Matthew; Heaney, Judith; Alexander, Graeme J. M.] Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England.
   [Challis, Benjamin] Univ Cambridge, Inst Metab Sci, Cambridge CB2 2QQ, England.
   [Shannon, Nicholas; Hoare, Matthew] Canc Res UK Cambridge Inst, Cambridge, England.
   [Heaney, Judith] Fdn Liver Res, Inst Hepatol, London, England.
C3 University of Cambridge; University of Cambridge; CRUK Cambridge
   Institute; Cancer Research UK; University of London; University College
   London
RP Alexander, GJM (corresponding author), Univ Cambridge, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England.
EM gja1000@doctors.org.uk
RI Aravinthan, Aloysious D/I-2557-2019
OI Aravinthan, Aloysious D/0000-0003-0527-5137; Shannon, Nicholas
   Brian/0000-0001-8742-8285; Hoare, Matthew/0000-0001-5990-9604
FU Hepatology Endowment Fund, Addenbrooke's Charitable Trust, Cambridge
   [CB2 0QQ UK]; NIHR & Translational Medicine and Therapeutics Clinical
   Lectureship; Cancer Research UK [19556] Funding Source: researchfish;
   National Institute for Health Research [CL-2010-14-006] Funding Source:
   researchfish
FX Hepatology Endowment Fund, Addenbrooke's Charitable Trust, Cambridge CB2
   0QQ UK.; B.C. is supported by a NIHR & Translational Medicine and
   Therapeutics Clinical Lectureship.
CR Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641
   BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198
   Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222
   BLEI AT, 1982, GASTROENTEROLOGY, V83, P1191
   BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Caronia S, 1999, HEPATOLOGY, V30, P1059, DOI 10.1002/hep.510300416
   CAVALLOPERIN P, 1985, J CLIN INVEST, V75, P1659, DOI 10.1172/JCI111873
   Creutzfeldt W, 1970, Prog Liver Dis, V3, P371
   Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902
   Giovannini C, 2012, AM J PATHOL, V181, P413, DOI 10.1016/j.ajpath.2012.04.019
   Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108
   GRECO AV, 1980, HORM METAB RES, V12, P577, DOI 10.1055/s-2007-999204
   Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x
   Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222
   Ikeda H, 2009, HUM PATHOL, V40, P1774, DOI 10.1016/j.humpath.2009.06.009
   Kim YM, 2010, ANN NY ACAD SCI, V1201, P65, DOI 10.1111/j.1749-6632.2010.05617.x
   Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003
   Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009
   Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   McIntyre N., 1991, OXFORD TXB CLIN HEPA
   MEGYESI C, 1967, LANCET, V2, P1051, DOI 10.1016/S0140-6736(67)90334-0
   Naïmi M, 2007, ENDOCRINOLOGY, V148, P2424, DOI 10.1210/en.2006-1411
   Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Naunyn B., DIABETES MELLITUS SP, P526
   Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259
   Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   RIGGIO O, 1982, METABOLISM, V31, P627, DOI 10.1016/0026-0495(82)90103-2
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432
   Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
NR 44
TC 35
Z9 38
U1 0
U2 25
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD FEB 1
PY 2015
VL 331
IS 1
BP 38
EP 45
DI 10.1016/j.yexcr.2014.09.025
PG 8
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA CA0UK
UT WOS:000348631600004
PM 25263463
DA 2024-02-19
ER

PT J
AU Aravinthan, A
   Pietrosi, G
   Hoare, M
   Jupp, J
   Marshall, A
   Verrill, C
   Davies, S
   Bateman, A
   Sheron, N
   Allison, M
   Alexander, GJM
AF Aravinthan, Aloysious
   Pietrosi, Giada
   Hoare, Matthew
   Jupp, James
   Marshall, Aileen
   Verrill, Clare
   Davies, Susan
   Bateman, Adrian
   Sheron, Nick
   Allison, Michael
   Alexander, Graeme J. M.
TI Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis
   and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease
SO PLOS ONE
LA English
DT Article
ID CELLULAR SENESCENCE; DNA-DAMAGE; CELLS; PROGRESSION
AB Background and Aim: Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD.
   Methods: Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively.
   Results: In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation.
   Conclusions: The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD.
C1 [Aravinthan, Aloysious; Pietrosi, Giada; Hoare, Matthew; Marshall, Aileen; Allison, Michael; Alexander, Graeme J. M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.
   [Hoare, Matthew] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.
   [Jupp, James; Verrill, Clare; Sheron, Nick] Southampton Univ Hosp, Dept Hepatol, Southampton, Hants, England.
   [Davies, Susan] Cambridge Univ Hosp, Dept Histopathol, Cambridge, England.
   [Bateman, Adrian] Southampton Univ Hosp, Dept Histopathol, Southampton, Hants, England.
C3 University of Cambridge; University of Cambridge; CRUK Cambridge
   Institute; Cancer Research UK; University of Southampton; University of
   Cambridge; University of Southampton
RP Alexander, GJM (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.
EM gja1000@doctors.org.uk
RI Aravinthan, Aloysious D/I-2557-2019; Pietrosi, Giada/R-5493-2016
OI Aravinthan, Aloysious D/0000-0003-0527-5137; Bateman,
   Adrian/0000-0003-2222-4104; Sheron, Nick/0000-0001-5232-8292; Sheron,
   Nick/0000-0002-6156-8367; Allison, Michael/0000-0003-3677-3294; Hoare,
   Matthew/0000-0001-5990-9604; Pietrosi, Giada/0000-0002-2299-7118;
   Verrill, Clare/0000-0002-4905-8233
FU Hepatology Endowment Fund; Addenbrooke's Charitable Fund
FX This work received support from the Hepatology Endowment Fund and
   Addenbrooke's Charitable Fund. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bell H, 2004, SCAND J GASTROENTERO, V39, P858, DOI 10.1080/00365520410006350
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Borel F, 2002, J CELL SCI, V115, P2829
   Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   GONZALEZREIMERS E, 1988, DRUG ALCOHOL DEPEN, V22, P195, DOI 10.1016/0376-8716(88)90018-X
   Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786
   Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004
   Michalopoulos George K, 2012, Hepatology, V55, P2024, DOI 10.1002/hep.25703
   O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258
   Ozen A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0357-y
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013
NR 18
TC 70
Z9 80
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 23
PY 2013
VL 8
IS 9
AR e72904
DI 10.1371/journal.pone.0072904
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 246EK
UT WOS:000326520200004
PM 24086266
OA Green Accepted, Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Kim, KH
   Chen, CC
   Monzon, RI
   Lau, LF
AF Kim, Ki-Hyun
   Chen, Chih-Chiun
   Monzon, Ricardo I.
   Lau, Lester F.
TI Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through
   Induction of Cellular Senescence in Hepatic Myofibroblasts
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID TISSUE GROWTH-FACTOR; STELLATE CELLS; INTEGRIN ALPHA(6)BETA(1); CYR61;
   APOPTOSIS; BETA; PROLIFERATION; RESOLUTION; PHENOTYPE; CIRRHOSIS
AB Liver fibrosis occurs as a wound-healing response to chronic hepatic injuries irrespective of the underlying etiology and may progress to life-threatening cirrhosis. Here we show that CCN1, a matricellular protein of the CCN (CYR61/CTGF/NOV) family, is accumulated in hepatocytes of human cirrhotic livers. CCN1 is not required for liver development or regeneration, since these processes are normal in mice with hepatocyte-specific Ccn1 deletion. However, Ccn1 expression is upregulated upon liver injuries and functions to inhibit liver fibrogenesis induced by either carbon tetrachloride intoxication or bile duct ligation and promote fibrosis regression. CCN1 acts by triggering cellular senescence in activated hepatic stellate cells and portal fibroblasts by engaging integrin alpha(6)beta(1) to induce reactive oxygen species accumulation through the RAC1-NADPH oxidase 1 enzyme complex, whereupon the senescent cells express an antifibrosis genetic program. Mice with hepatocyte-specific Ccn1 deletion suffer exacerbated fibrosis with a concomitant deficit in cellular senescence, whereas overexpression of hepatic Ccn1 reduces liver fibrosis with enhanced senescence. Furthermore, tail vein delivery of purified CCN1 protein accelerates fibrosis regression in mice with established fibrosis. These findings reveal a novel integrin-dependent mechanism of fibrosis resolution in chronic liver injury and identify the CCN1 signaling pathway as a potential target for therapeutic intervention.
C1 [Kim, Ki-Hyun; Chen, Chih-Chiun; Monzon, Ricardo I.; Lau, Lester F.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.
EM lflau@uic.edu
OI Lau, Lester/0000-0002-4364-2914; Kim, Ki-Hyun/0000-0001-8265-6609
FU National Institutes of Health [GM78492, AR61791]
FX This work was supported by grants from the National Institutes of Health
   (GM78492 and AR61791).
CR Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938
   Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200
   Baertschiger RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006657
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Brigstock DR, 2009, J CELL COMMUN SIGNAL, V3, P5, DOI 10.1007/s12079-009-0043-9
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200
   Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200
   Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596
   Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200
   Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200
   Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196
   Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Constandinou C, 2005, METH MOLEC MED, V117, P237
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465
   De Minicis S, 2008, J GASTROEN HEPATOL, V23, pS98, DOI 10.1111/j.1440-1746.2007.05277.x
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006
   Huang GC, 2012, FRONT BIOSCI-LANDMRK, V17, P2495, DOI 10.2741/4067
   Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007
   Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09
   Kireeva ML, 1996, MOL CELL BIOL, V16, P1326
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Leu SJ, 2004, J BIOL CHEM, V279, P44177, DOI 10.1074/jbc.M407850200
   Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200
   Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792
   Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947
   Mathijs K, 2009, DRUG METAB DISPOS, V37, P1305, DOI 10.1124/dmd.108.025775
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89
   Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002
   Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396
   Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010
NR 56
TC 187
Z9 212
U1 0
U2 35
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD MAY
PY 2013
VL 33
IS 10
BP 2078
EP 2090
DI 10.1128/MCB.00049-13
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 130ZN
UT WOS:000317959900017
PM 23508104
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Hu, XN
   Wang, JF
   Huang, YQ
   Wang, Z
   Dong, FY
   Ma, HF
   Bao, ZJ
AF Hu, Xiao-na
   Wang, Jiao-feng
   Huang, Yi-qin
   Wang, Zheng
   Dong, Fang-yuan
   Ma, Hai-fen
   Bao, Zhi-jun
TI Huperzine A attenuates nonalcoholic fatty liver disease by regulating
   hepatocyte senescence and apoptosis: an in vitro study
SO PEERJ
LA English
DT Article
DE Huperzine A; Hepatocyte senescence; Nonalcoholic fatty liver disease;
   Apoptosis
ID NF-KAPPA-B; CELLULAR SENESCENCE; OXIDATIVE STRESS; ACETYLCHOLINESTERASE
   INHIBITORS; HEPG2 CELLS; DNA-DAMAGE; L-02 CELLS; PREVALENCE; STEATOSIS;
   MODEL
AB Objective: This study was undertaken to detect if free fatty acids (FFA) induce hepatocyte senescence in L-02 cells and if huperzine A has an anti-aging effect in fatty liver cells.
   Methods: L-02 cells were treated with a FFA mixture (oleate/palmitate, at 3:0, 2:1, 1:1, 1:2 and 0:3 ratios) at different concentrations. Cell viability and fat accumulation rate were assessed by a Cell Counting Kit 8 and Nile Red staining, respectively. The mixture with the highest cell viability and fat accumulation rate was selected to continue with the following experiment. The L-02 cells were divided into five groups, including the control group, FFA group, FFA + 0.1 mu mol/L huperzine A (LH) group, FFA + 1.0 mu mol/L huperzine A (MH) group and FFA + 10 mu mol/L huperzine A (HH) group, and were cultured for 24 h. The expression of senescence-associated beta-galactosidase (SA-beta-gal) was detected by an SA-beta-gal staining kit. The expression levels of aging genes were measured by qRT-PCR. The expression levels of apoptosis proteins were detected by a Western blot. ELISA kits were used to detect inflammatory factors and oxidative stress products. The expression of nuclear factor (NF-kappa B) and I kappa B alpha were detected by immunofluorescence.
   Results: The FFA mixture (oleate/palmitate, at a 2:1 ratio) of 0.5 mmol/L had the highest cell viability and fat accumulation rate, which was preferable for establishing an in vitro fatty liver model. The expression of inflammatory factors (TNF-alpha and IL-6) and oxidants Malonaldehyde (MDA), 4-hydroxynonenal (HNE) and reactive oxygen species (ROS) also increased in the L-02 fatty liver cells. The expression levels of aging markers and aging genes, such as SA-beta-gal, p16, p21, p53 and pRb, increased more in the L-02 fatty liver cells than in the L-02 cells. The total levels of the apoptosis-associated proteins Bcl2, Bax, Bax/Bcl-2, CyCt and cleaved caspase 9 were also upregulated in the L-02 fatty liver cells. All of the above genes and proteins were downregulated in the huperzine A and FFA co-treatment group. In the L-02 fatty liver cells, the expression of I kappa B alpha decreased, while the expression of NF-kappa B increased. After the huperzine A and FFA co-treatment, the expression of I kappa B alpha increased, while the expression of NF-kappa B decreased.
   Conclusion: Fatty liver cells showed an obvious senescence and apoptosis phenomenon. Huperzine A suppressed hepatocyte senescence, and it might exert its anti-aging effect via the NF-kappa B pathway.
C1 [Hu, Xiao-na; Huang, Yi-qin; Bao, Zhi-jun] Fudan Univ, Huadong Hosp, Dept Gastroenterol, Shanghai, Peoples R China.
   [Hu, Xiao-na; Wang, Jiao-feng; Huang, Yi-qin; Wang, Zheng; Dong, Fang-yuan; Ma, Hai-fen; Bao, Zhi-jun] Shanghai Key Lab Clin Geriatr Med, Shanghai, Peoples R China.
   [Hu, Xiao-na; Wang, Jiao-feng; Wang, Zheng; Dong, Fang-yuan; Bao, Zhi-jun] Fudan Univ, Huadong Hosp, Dept Geriatr, Shanghai, Peoples R China.
C3 Fudan University; Fudan University
RP Bao, ZJ (corresponding author), Fudan Univ, Huadong Hosp, Dept Gastroenterol, Shanghai, Peoples R China.; Bao, ZJ (corresponding author), Shanghai Key Lab Clin Geriatr Med, Shanghai, Peoples R China.; Bao, ZJ (corresponding author), Fudan Univ, Huadong Hosp, Dept Geriatr, Shanghai, Peoples R China.
EM zhijunbao@fudan.edu.cn
FU National Natural Science Foundation of China [81701374]; Shanghai
   Municipal Commission of Health and Family Planning, Key developing
   disciplines [2015ZB0501]; Shanghai sailing program [17YF1405200];
   Shanghai Municipal Commission of Health and Family Planning research
   program [20154Y0002, 201440550]
FX This work was supported by the National Natural Science Foundation of
   China (81701374), the Shanghai Municipal Commission of Health and Family
   Planning, Key developing disciplines (2015ZB0501), the Shanghai sailing
   program (No. 17YF1405200), the Shanghai Municipal Commission of Health
   and Family Planning research program (Youth Project, 20154Y0002), and
   the Shanghai Municipal Commission of Health and Family Planning research
   program (Surface project, 201440550). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bai JX, 2006, J PHARMACOL EXP THER, V319, P1435, DOI 10.1124/jpet.106.110007
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774
   Brenner T, 2008, J NEUROIMMUNOL, V201, P121, DOI 10.1016/j.jneuroim.2008.05.022
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Brunt EM, 2007, LIVER INT, V27, P662, DOI 10.1111/j.1478-3231.2007.01470.x
   Caballería L, 2010, EUR J GASTROEN HEPAT, V22, P24, DOI 10.1097/MEG.0b013e32832fcdf0
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chu JH, 2011, WORLD J GASTROENTERO, V17, P2379, DOI 10.3748/wjg.v17.i19.2379
   Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334
   Fahham N, 2009, CANCER INFORM, V7, P1
   Fumagalli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110969
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x
   Gómez-Lechón MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004
   Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8
   Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86
   Hu XN, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-123
   Iannetti A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004642
   Inoue T, 2009, CANCER SCI, V100, P1275, DOI 10.1111/j.1349-7006.2009.01166.x
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Le Saux S, 2012, ANN NY ACAD SCI, V1247, P69, DOI 10.1111/j.1749-6632.2011.06297.x
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Marshall CB, 2006, NEPHRON EXP NEPHROL, V102, P39, DOI 10.1159/000088400
   McMillian MK, 2001, IN VITRO MOL TOXICOL, V14, P177, DOI 10.1089/109793301753407948
   Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083
   Ping F, 2017, J DIABETES INVEST, V8, P174, DOI 10.1111/jdi.12555
   Pollak Y, 2005, ANN NEUROL, V57, P741, DOI 10.1002/ana.20454
   Qin SM, 2016, LIPIDS, V51, P797, DOI 10.1007/s11745-016-4160-y
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257
   Seto WK, 2017, J GASTROENTEROL, V52, P164, DOI 10.1007/s00535-016-1264-3
   Sfikas A, 2012, CELL SIGNAL, V24, P2007, DOI 10.1016/j.cellsig.2012.06.010
   Shi DM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-173
   Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009
   Tabet N, 2006, AGE AGEING, V35, P336, DOI 10.1093/ageing/afl027
   Tachtatzis PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127511
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   Vaughan S, 2011, AGING-US, V3, P913, DOI 10.18632/aging.100390
   Venkatachalam G, 2017, NUCLEIC ACIDS RES, V45, P10564, DOI 10.1093/nar/gkx684
   Wang SZ, 2013, EUR ARCH OTO-RHINO-L, V270, P1329, DOI 10.1007/s00405-012-2136-y
   Wang ZF, 2008, J NEUROCHEM, V106, P1594, DOI 10.1111/j.1471-4159.2008.05504.x
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Yang GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074916
   Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
NR 52
TC 3
Z9 4
U1 0
U2 9
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JUN 26
PY 2018
VL 6
AR e5145
DI 10.7717/peerj.5145
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GK6YK
UT WOS:000436339100007
PM 29967757
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Aravinthan, A
   Verma, S
   Coleman, N
   Davies, S
   Allison, M
   Alexander, G
AF Aravinthan, Aloysious
   Verma, Suman
   Coleman, Nick
   Davies, Susan
   Allison, Michael
   Alexander, Graeme
TI Vacuolation in hepatocyte nuclei is a marker of senescence
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID CELLULAR SENESCENCE; LIVER; OBESITY; DISEASE; CELLS; SIZE
AB Hepatocyte nuclear vacuolation is considered benign and associated with non-alcohol-related fatty liver disease. Vacuolated hepatocyte nuclei were compared with non-vacuolated hepatocyte nuclei in eight patients with advanced fibrosis and a spectrum of liver disease to explore the hypothesis that such nuclei represent senescence. Age- and sex-matched liver donors served as normal tissue. In normal liver <0.01% hepatocytes showed nuclear vacuolation. In contrast, nuclear vacuolation was present in all patients with liver disease, ranging from 0.1% to 11.7% hepatocytes, irrespective of the aetiology of liver disease and independent of insulin resistance. There was a close association between nuclear vacuolation and increased nuclear area, p21 expression, gamma H(2)AX expression and the absence of Mcm-2, consistent with senescence and cell cycle arrest. Nuclear vacuolation in hepatocytes is a marker of senescence and likely to be a consequence of liver injury, unrelated to insulin resistance.
C1 [Aravinthan, Aloysious; Verma, Suman; Allison, Michael; Alexander, Graeme] Cambridge Univ Hosp, Div Gastroenterol & Hepatol, Univ Dept Med, Cambridge CB2 0QQ, England.
   [Coleman, Nick] Hutchison MRC Canc Res Cell Unit, Cambridge, England.
   [Davies, Susan] Cambridge Univ Hosp, Dept Pathol, Cambridge CB2 0QQ, England.
C3 University of Cambridge; University of Cambridge
RP Alexander, G (corresponding author), Cambridge Univ Hosp, Div Gastroenterol & Hepatol, Univ Dept Med, Box 157,Hills Rd, Cambridge CB2 0QQ, England.
EM gja1000@doctors.org.uk
RI Aravinthan, Aloysious D/I-2557-2019
OI Aravinthan, Aloysious D/0000-0003-0527-5137; Allison,
   Michael/0000-0003-3677-3294
FU Cambridge University Hospitals NHS Trust; Medical Research Council
   [MC_U105359875] Funding Source: researchfish; MRC [MC_U105359875]
   Funding Source: UKRI
FX The study was supported by the Hepatology Endowment Fund of Cambridge
   University Hospitals NHS Trust.
CR ABRAHAM S, 1994, HUM PATHOL, V25, P1063, DOI 10.1016/0046-8177(94)90066-3
   [Anonymous], 2006, LIVER BIOPSY INTERPR
   [Anonymous], 1883, Z KLIN MED
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chipps HD, 1942, AM J PATHOL, V18, P645
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Kim YM, 2010, ANN NY ACAD SCI, V1201, P65, DOI 10.1111/j.1749-6632.2010.05617.x
   Levene AP, 2010, HISTOPATHOLOGY, V56, P426, DOI 10.1111/j.1365-2559.2010.03501.x
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x
   STROMEYER FW, 1980, AM J CLIN PATHOL, V73, P12
   Suriawinata A, 2004, SEMIN LIVER DIS, V24, P363, DOI 10.1055/s-2004-860865
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
NR 14
TC 26
Z9 29
U1 1
U2 6
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD JUN
PY 2012
VL 65
IS 6
BP 557
EP 560
DI 10.1136/jclinpath-2011-200641
PG 4
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 949XE
UT WOS:000304609900015
PM 22447919
DA 2024-02-19
ER

PT J
AU Fujisawa, K
   Terai, S
   Hirose, Y
   Takami, T
   Yamamoto, N
   Sakaida, I
AF Fujisawa, Koichi
   Terai, Shuji
   Hirose, Yoshikazu
   Takami, Taro
   Yamamoto, Naoki
   Sakaida, Isao
TI Senescence marker protein 30 (SMP30)/regucalcin (RGN) expression
   decreases with aging, acute liver injuries and tumors in zebrafish
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zebrafish; Liver tumors; Aging; Senescence marker protein 30 (SMP30);
   Regucalcin
ID HEPATOMA H4-II-E CELLS; REGUCALCIN MESSENGER-RNA; RAT-LIVER;
   GENE-EXPRESSION; MODEL; OVEREXPRESSION; PROLIFERATION; REGENERATION;
   CARCINOMA; GROWTH
AB Senescence marker protein 30 (SMP30)/regucalcin (RGN) is known to be related to aging, hepatocyte proliferation and tumorigenesis. However, expression and function of non-mammalian SMP30/RGN is poorly understood. We found that zebrafish SMP30/RGN mRNA expression decreases with aging, partial hepatectomy and thioacetamide-induced acute liver injury. SMP30/RGN expression was also greatly decreased in a zebrafish liver cell line. In addition, we induced liver tumors in adult zebrafish by administering diethylnitrosamine. Decreased expression was observed in foci, hepatocellular carcinomas, cholangiocellular carcinomas and mixed tumors as compared to the surrounding area. We thus showed the importance of SMP30/RGN in liver proliferation and tumorigenesis. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Terai, Shuji; Hirose, Yoshikazu; Yamamoto, Naoki; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 7558505, Japan.
   [Fujisawa, Koichi; Sakaida, Isao] Yamaguchi Univ, Sch Med, Ctr Reparat Med, Ube, Yamaguchi 7558505, Japan.
   [Takami, Taro] Yamaguchi Univ, Div Lab, Ube, Yamaguchi 7558505, Japan.
C3 Yamaguchi University; Yamaguchi University; Yamaguchi University
RP Terai, S (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.
EM terais@yamaguchi-u.ac.jp
RI fujisawa, koichi/AAC-1392-2022
OI Terai, Shuji/0000-0002-5439-635X
FU Japan Society for the Promotion of Science [22390150, 22659148,
   23659398]; Grants-in-Aid for Scientific Research [22659148, 23659398,
   22390150] Funding Source: KAKEN
FX We thank Dr. M. Furutani-Seiki for technical advices and Ms. M. Yamada,
   Ms. I. Fujimoto and Ms. Y. Fukusumi for their technical assistance. This
   study was supported by Grants-in-Aid for Scientific Research (22390150)
   and a Grant-in-Aid for Challenging Exploratory Research (22659148,
   23659398) from the Japan Society for the Promotion of Science.
CR Arai M, 2003, J BIOL CHEM, V278, P29813, DOI 10.1074/jbc.M212648200
   Chen TM, 2008, INT J EXP PATHOL, V89, P223, DOI 10.1111/j.1365-2613.2008.00576.x
   Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560
   Goessling W, 2007, J CLIN ONCOL, V25, P2473, DOI 10.1200/JCO.2006.08.9821
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   Izumi T, 2004, J CELL BIOCHEM, V92, P296, DOI 10.1002/jcb.20056
   Katsumata T, 1998, J CELL BIOCHEM, V71, P569, DOI 10.1002/(SICI)1097-4644(19981215)71:4<569::AID-JCB11>3.0.CO;2-Z
   Kim W, 2003, CLIN CANCER RES, V9, P5493
   Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kuwashiro S, 2011, CELL TISSUE RES, V344, P125, DOI 10.1007/s00441-011-1132-7
   Maia C, 2009, J CELL BIOCHEM, V107, P667, DOI 10.1002/jcb.22158
   Makino R, 1996, MOL CELL BIOCHEM, V155, P85, DOI 10.1007/BF00714337
   Matsumoto T, 2010, DIS MODEL MECH, V3, P431, DOI 10.1242/dmm.002311
   Nikapitiya C, 2008, COMP BIOCHEM PHYS B, V150, P117, DOI 10.1016/j.cbpb.2008.02.004
   Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Suzuki S, 2004, CARCINOGENESIS, V25, P439, DOI 10.1093/carcin/bgh030
   Takahashi H, 1999, J CELL BIOCHEM, V74, P663, DOI 10.1002/(SICI)1097-4644(19990915)74:4<663::AID-JCB15>3.0.CO;2-2
   Terai S, 2010, HEPATOL RES, V40, P111, DOI 10.1111/j.1872-034X.2009.00621.x
   Tsurusaki Y, 2003, J CELL BIOCHEM, V90, P619, DOI 10.1002/jcb.10652
   Wu YD, 2008, B ENVIRON CONTAM TOX, V80, P482, DOI 10.1007/s00128-008-9395-8
   Yamaguchi M, 2005, J CELL BIOCHEM, V95, P1169, DOI 10.1002/jcb.20490
   YAMAGUCHI M, 1993, MOL CELL BIOCHEM, V122, P65, DOI 10.1007/BF00925738
NR 28
TC 22
Z9 26
U1 3
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 22
PY 2011
VL 414
IS 2
BP 331
EP 336
DI 10.1016/j.bbrc.2011.09.067
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 839YG
UT WOS:000296404800011
PM 21951853
DA 2024-02-19
ER

PT J
AU Serra, MP
   Marongiu, F
   Sini, M
   Marongiu, M
   Contini, A
   Wolff, H
   Rave-Frank, M
   Krause, P
   Laconi, E
   Koenig, S
AF Serra, Maria Paola
   Marongiu, Fabio
   Sini, Marcella
   Marongiu, Michela
   Contini, Antonella
   Wolff, Hendrik
   Rave-Frank, Margret
   Krause, Petra
   Laconi, Ezio
   Koenig, Sarah
TI Hepatocyte senescence induced by radiation and partial hepatectomy in
   rat liver
SO INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
LA English
DT Article
DE Cell senescence; radiation; regenerative medicine; liver repopulation;
   hepatocyte transplantation
ID SECRETORY PHENOTYPE; IN-VIVO; CELL TRANSPLANTATION; PREPARATIVE REGIMEN;
   GENE-EXPRESSION; MOUSE-LIVER; RETRORSINE; REGENERATION; REPOPULATION;
   REPLACEMENT
AB Purpose: Exposure to radiation primes the liver for extensive replacement of the resident parenchymal cells by transplanted hepatocytes. The mechanisms underlying this repopulation remain to be clarified. In these studies, we examined the possible occurrence of cell senescence in vivo following radiationassociated preconditioning of the host liver.
   Materials and methods: Fischer 344 rats underwent externalbeam, computed-tomography-based partial liver irradiation. A single dose of 25 Gy was delivered to the right liver lobes (40% of liver mass). An additional group of animals received a 1/3 partial hepatectomy (removal of the left anterior lobe) four days after irradiation. Non-irradiated groups served as controls. All rats were sacrificed four weeks after the initial treatment.
   Results: The irradiated livers displayed several markers of cell senescence, including expression of senescence-associatedp-galactosidase (SA-I3-gal), increase in cell size, and up-regulation of cyclin-dependent kinase inhibitors (CDK-I) p16 and p21. Furthermore, quantitative reverse-transcriptase polyrnerase chain reaction (qRT-PCR) analysis revealed activation of the senescence-associated secretory phenotype (SAW), including the cytokines interleukin 6 (IL6) and le (ILla). The senescencerelated changes were more prominent in rats undergoing partial hepatectomy (PH) following irradiation (IR).
   Conclusions: We conclude that priming with radiation for liver repopulation results in the induction of cell senescence and the up-regulation of a senescence-associated secretory phenotype. The latter can contribute to the extensive growth of transplanted cells in this system.
C1 [Serra, Maria Paola; Marongiu, Fabio; Sini, Marcella; Marongiu, Michela; Contini, Antonella; Laconi, Ezio] Univ Cagliari, Dept Biomed Sci, I-09124 Cagliari, Italy.
   [Wolff, Hendrik; Rave-Frank, Margret] Univ Med Ctr Goettingen, Dept Radiotherapy, Gottingen, Germany.
   [Krause, Petra; Koenig, Sarah] Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany.
C3 University of Cagliari; University of Gottingen; University of Gottingen
RP Laconi, E (corresponding author), Univ Cagliari, Sch Med, Dept Biomed Sci, Unit Expt Med, Via Porcell 4,3rd Floor, I-09124 Cagliari, Italy.
EM elaconi@unica.it
RI Koenig, Sarah/HSE-8443-2023; Marongiu, Fabio/E-6294-2016
OI Marongiu, Fabio/0000-0001-5860-4227
FU AIRC (Italian Association for Cancer Research) [IG 10604]; Sardinian
   Regional Government (RAS); Fondazione Banco di Sardegna; Deutsche
   Forschungsgemeinschaft (DFG) [KO 2218/5-1]
FX This work was supported by AIRC (Italian Association for Cancer
   Research, grant No. IG 10604), Sardinian Regional Government (RAS) and
   Fondazione Banco di Sardegna (to EL); and by the Deutsche
   Forschungsgemeinschaft (DFG, Grant KO 2218/5-1, to SK).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   Christiansen H, 2007, RADIOLOGY, V242, P189, DOI 10.1148/radiol.2421060083
   Christiansen H, 2006, INT J RADIAT ONCOL, V65, P509, DOI 10.1016/j.ijrobp.2006.01.040
   Citrin DE, 2013, JNCI-J NATL CANCER I, V105, P1474, DOI 10.1093/jnci/djt212
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Guha C, 1999, CANCER RES, V59, P5871
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Karnezis AN, 2001, J CLIN INVEST, V108, P383, DOI 10.1172/JCI200111933
   Koenig S, 2008, INT J RADIAT BIOL, V84, P285, DOI 10.1080/09553000801953359
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laberge RM, 2012, AGING CELL, V11, P569, DOI 10.1111/j.1474-9726.2012.00818.x
   LACONI E, 1995, CARCINOGENESIS, V16, P139, DOI 10.1093/carcin/16.1.139
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   Laconi S, 2001, AM J PATHOL, V158, P771, DOI 10.1016/S0002-9440(10)64019-9
   Laconi S, 1999, J HEPATOL, V31, P1069, DOI 10.1016/S0168-8278(99)80320-1
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Malhi H, 2002, P NATL ACAD SCI USA, V99, P13114, DOI 10.1073/pnas.192365499
   Mignon A, 1998, NAT MED, V4, P1185, DOI 10.1038/2681
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6
   Seol MA, 2012, J VET SCI, V13, P331, DOI 10.4142/jvs.2012.13.4.331
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309
   Suzuki M, 2008, J RADIAT RES, V49, P105, DOI 10.1269/jrr.07081
   Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418
   Wang Y, 2011, INT J RADIAT ONCOL, V81, P839, DOI 10.1016/j.ijrobp.2010.09.048
   Witek RP, 2005, CELL TRANSPLANT, V14, P41, DOI 10.3727/000000005783983278
NR 40
TC 12
Z9 13
U1 0
U2 5
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0955-3002
EI 1362-3095
J9 INT J RADIAT BIOL
JI Int. J. Radiat. Biol.
PD OCT
PY 2014
VL 90
IS 10
BP 876
EP 883
DI 10.3109/09553002.2014.922714
PG 8
WC Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Nuclear Science &
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA AQ7MF
UT WOS:000343001200006
PM 24827852
DA 2024-02-19
ER

PT J
AU Yuan, P
   Qi, XY
   Song, AP
   Ma, MY
   Zhang, XB
   Lu, CF
   Bian, MAL
   Lian, NQ
   He, JL
   Zheng, SG
   Jin, HH
AF Yuan, Ping
   Qi, Xiaoyu
   Song, Anping
   Ma, Mingyue
   Zhang, Xinbei
   Lu, Chunfeng
   Bian, Mianli
   Lian, Naqi
   He, Jianling
   Zheng, Shuguo
   Jin, Huanhuan
TI LncRNA MAYA promotes iron overload and hepatocyte senescence through
   inhibition of YAP in non-alcoholic fatty liver disease
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article; Early Access
DE cellular senescence; iron overload; MAYA; non-alcoholic fatty liver
   disease; Yes-associated protein
ID CELLS
AB Although recent evidence has shown that hepatocyte senescence plays a crucial role in the pathogenesis and development of non-alcoholic fatty liver disease (NAFLD), the mechanism is still not clear. The purpose of this study was to investigate the signal transduction pathways involved in the senescence of hepatocyte, in order to provide a potential strategy for blocking the process of NAFLD. The results confirmed that hepatocyte senescence occurred in HFD-fed Golden hamsters and PA-treated LO2 cells as manifested by increased levels of senescence marker SA-beta-gal, p16 and p21, heterochromatin marker H3K9me3, DNA damage marker gamma-H2AX and decreased activity of telomerase. Further studies demonstrated that iron overload could promote the senescence of hepatocyte, whereas the overexpression of Yes-associated protein (YAP) could blunt iron overload and alleviate the senescence of hepatocyte. Of importance, depression of lncRNA MAYA (MAYA) reduced iron overload and cellular senescence via promotion of YAP in PA-treated hepatocytes. These effects were further supported by in vivo experiments. In conclusion, these data suggested that inhibition of MAYA could up-regulate YAP, which might repress hepatocyte senescence through modulating iron overload. In addition, these findings provided a promising option for heading off the development of NAFLD by abrogating hepatocyte senescence.
C1 [Yuan, Ping; Qi, Xiaoyu; Song, Anping; Ma, Mingyue; Zhang, Xinbei; Zheng, Shuguo; Jin, Huanhuan] Wannan Med Coll, Sch Pharm, Dept Pharmacol, 22 Wenchang West Rd, Wuhu, Anhui, Peoples R China.
   [Lu, Chunfeng] Nantong Univ, Sch Pharm, Nantong, Peoples R China.
   [Bian, Mianli; Lian, Naqi] Nanjing Univ Chinese Med, Nanjing, Peoples R China.
   [He, Jianling] Minist Nat Resources, Inst Oceanog 3, Xiamen, Peoples R China.
C3 Wannan Medical College; Nantong University; Nanjing University of
   Chinese Medicine; Third Institute of Oceanography, Ministry of Natural
   Resources; Ministry of Natural Resources of the People's Republic of
   China
RP Zheng, SG; Jin, HH (corresponding author), Wannan Med Coll, Sch Pharm, Dept Pharmacol, 22 Wenchang West Rd, Wuhu, Anhui, Peoples R China.
EM zhengsg2000@163.com; jhhwnmc@163.com
OI Ma, mingyue/0000-0002-2394-1300
FU key Project of Natural Science Research Projects of Anhui Higher
   Education Institutions [KJ2019A0428]; National Natural Science
   Foundation of China [81900531, 81803606]
FX the key Project of Natural Science Research Projects of Anhui Higher
   Education Institutions, Grant/Award Number: KJ2019A0428; the National
   Natural Science Foundation of China, Grant/Award Number: 81900531 and
   81803606
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Atanasovska B, 2017, HEPATOLOGY, V66, P794, DOI 10.1002/hep.29034
   Bell RJA, 2016, MOL CANCER RES, V14, P315, DOI 10.1158/1541-7786.MCR-16-0003
   Coluzzi E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010019
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Fu LN, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000201
   Guan YF, 2020, ONCOGENE, V39, P2408, DOI 10.1038/s41388-020-1158-y
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6
   Ji DG, 2019, BIOCHEM BIOPH RES CO, V513, P669, DOI 10.1016/j.bbrc.2019.04.012
   Jia Y, 2020, J CELL MOL MED, V24, P5304, DOI 10.1111/jcmm.15186
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12431
   Kida Y, 2016, CAN J CARDIOL, V32, P634, DOI 10.1016/j.cjca.2015.11.022
   Kovatcheva M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00540-5
   Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706
   Li J, 2019, LANCET GASTROENTEROL, V4, P389, DOI 10.1016/S2468-1253(19)30039-1
   Lim CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01313-w
   Lu HM, 2019, NUCLEIC ACIDS RES, V47, P9467, DOI 10.1093/nar/gkz694
   Fernández-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8
   Martin N, 2021, HEPATOLOGY, V73, P853, DOI 10.1002/hep.31556
   Martinez-Zamudio Ricardo Ivan, 2017, Cell, V170, P816, DOI 10.1016/j.cell.2017.07.049
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakamura T, 2019, BBA-GEN SUBJECTS, V1863, P1398, DOI 10.1016/j.bbagen.2019.06.010
   Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Regulski MJ, 2017, WOUNDS, V29, P168
   Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902
   Ruivard M, 2016, HEPATOLOGY, V63, P1737, DOI 10.1002/hep.28296
   Santinon G, 2018, EMBO J, V37, DOI 10.15252/embj.201797780
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Shin C, 2017, BRIT J NUTR, V117, P1693, DOI 10.1017/S0007114517001696
   Shoeb M, 2020, ENVIRON RES, V180, DOI 10.1016/j.envres.2019.108900
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Talos F, 2010, CELL DEATH DIFFER, V17, P1816, DOI 10.1038/cdd.2010.131
   Veverka P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133186
   Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793
   Xu XX, 2020, AGING-US, V12, P18501, DOI 10.18632/aging.103819
   Yang F, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12422
   Yang F, 2016, CELL PHYSIOL BIOCHEM, V39, P1369, DOI 10.1159/000447841
   Zhang XQ, 2010, HEPATOLOGY, V51, P1190, DOI 10.1002/hep.23486
   Zhao XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05383-2
   Zhuo W, 2017, NAT CELL BIOL, V19, P81, DOI 10.1038/ncb3467
NR 44
TC 18
Z9 20
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-1838
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD 2021 AUG
PY 2021
VL 25
IS 15
BP 7354
EP 7366
DI 10.1111/jcmm.16764
EA JUN 2021
PG 13
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA TU3TW
UT WOS:000668186800001
PM 34190396
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bonomini, F
   Rodella, LF
   Moghadasian, M
   Lonati, C
   Rezzani, R
AF Bonomini, F.
   Rodella, L. F.
   Moghadasian, M.
   Lonati, C.
   Rezzani, R.
TI Apolipoprotein E deficiency and a mouse model of accelerated liver aging
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Apolipoprotein E; Oxidative stress; Liver
ID E-KNOCKOUT MICE; OXIDATIVE STRESS; CELLULAR SENESCENCE; NUCLEAR SIZE;
   DNA-DAMAGE; HUMAN SIR2; P53; EXPRESSION; DISEASE; AGE
AB The liver is the central metabolic organ which regulates several key aspects of lipid metabolism. The liver changes with age leading to an impaired ability to respond to hepatic insults and an increased incidence of liver disease in the elderly. Apolipoprotein E (ApoE) null mice have proved to be a very popular model to study spontaneous atherosclerosis, but recently it has been demonstrated that in ApoE-/- mice liver there are enzymatic and structural alterations, normally linked to the age. The purpose of this study was to consider ApoE-/- mice as a model for oxidative stress induced hepatic disease and to clarify how ApoE inactivation accelerates the aging process and causes liver disease.We used ApoE null mice and control mice at different ages (6 weeks and 15 months).Liver morphological damage as well as proteins involved in oxidative stress and liver ageing were all analyzed.Our study showed that ApoE null mice develop important age-related changes including oxidative stress, pseudocapillarization, increased polyploidy, decreased hepatocyte number and increased nuclear size. Our findings provide evidence that hypercholesterolemic ApoE-/- mice are more likely to develop severe liver injury, suggesting that in addition to vascular disease, increased cholesterol products and oxidative stress may also play a role in accelerating the progression of aging in the liver.
C1 [Bonomini, F.; Rodella, L. F.; Lonati, C.; Rezzani, R.] Univ Brescia, Dept Clin & Expt Sci, I-25123 Brescia, Italy.
   [Moghadasian, M.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada.
C3 University of Brescia; University of Manitoba
RP Bonomini, F (corresponding author), Univ Brescia, Dept Clin & Expt Sci, Viale Europa 11, I-25123 Brescia, Italy.
EM bonomini@med.unibs.it
RI Rodella, Luigi Fabrizio/F-1079-2010
OI Bonomini, Francesca/0000-0001-7210-0308; Rodella, Luigi
   Fabrizio/0000-0002-9497-4708
CR Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Bond J, 1996, ONCOGENE, V13, P2097
   Bonomini F, 2010, EXP GERONTOL, V45, P149, DOI 10.1016/j.exger.2009.11.006
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   Chen WY, 2010, BIOCHEM BIOPH RES CO, V397, P459, DOI 10.1016/j.bbrc.2010.05.129
   Erusalimsky J D, 2006, Handb Exp Pharmacol, P213
   Escames G, 2006, EXP GERONTOL, V41, P1165, DOI 10.1016/j.exger.2006.09.002
   Folkmann JK, 2007, MUTAGENESIS, V22, P105, DOI 10.1093/mutage/gel059
   Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Helmy MM, 2012, PHARMACOL REP, V64, P698, DOI 10.1016/S1734-1140(12)70864-2
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hofker MH, 1998, ATHEROSCLEROSIS, V137, P1, DOI 10.1016/S0021-9150(97)00266-9
   Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036
   Kumar Pardeep, 2011, J Aging Res, V2011, P580245, DOI 10.4061/2011/580245
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   Laurent A, 2004, HEPATOLOGY, V39, P1277, DOI 10.1002/hep.20177
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101
   Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4
   Melov S, 2002, INT J BIOCHEM CELL B, V34, P1395, DOI 10.1016/S1357-2725(02)00086-9
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Miyoshi N, 2006, P NATL ACAD SCI USA, V103, P1727, DOI 10.1073/pnas.0510346103
   Mocali A, 2005, J GERONTOL A-BIOL, V60, P695, DOI 10.1093/gerona/60.6.695
   Moghadasian MH, 1997, ARTERIOSCL THROM VAS, V17, P119, DOI 10.1161/01.ATV.17.1.119
   Müller AM, 2002, EXP GERONTOL, V37, P713, DOI 10.1016/S0531-5565(02)00010-4
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   Osada J, 2000, CURR OPIN LIPIDOL, V11, P25, DOI 10.1097/00041433-200002000-00004
   Pacana T, 2012, CLIN LIVER DIS, V16, P599, DOI 10.1016/j.cld.2012.05.008
   PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G
   Rizzoni D, 2006, J CLIN ENDOCR METAB, V91, P2638, DOI 10.1210/jc.2006-0101
   Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Semsei I, 2000, MECH AGEING DEV, V117, P93, DOI 10.1016/S0047-6374(00)00147-0
   Sersté T, 2006, ACTA GASTRO-ENT BELG, V69, P296
   Smith JS, 2002, TRENDS CELL BIOL, V12, P404, DOI 10.1016/S0962-8924(02)02342-5
   Stachowicz A, 2012, J PROTEOMICS, V77, P167, DOI 10.1016/j.jprot.2012.08.015
   Tonini CL, 2013, INT J MOL SCI, V14, P3325, DOI 10.3390/ijms14023325
   Tous M, 2005, MOL CELL BIOCHEM, V268, P53, DOI 10.1007/s11010-005-2997-0
   VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914
   Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285
   Wang Y, 2004, EXP CELL RES, V298, P188, DOI 10.1016/j.yexcr.2004.04.012
   Yang LJ, 2012, ONCOL LETT, V3, P1159, DOI 10.3892/ol.2012.634
   Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397
NR 49
TC 15
Z9 15
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD APR
PY 2013
VL 14
IS 2
BP 209
EP 220
DI 10.1007/s10522-013-9424-9
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 147KV
UT WOS:000319166600010
PM 23595262
DA 2024-02-19
ER

PT J
AU Yao, T
   Chen, JM
   Shen, LE
   Yu, YS
   Tang, ZH
   Zang, GQ
   Zhang, Y
   Chen, XH
AF Yao, Ting
   Jin-Mei Chen
   Le-Er Shen
   Yong-Sheng Yu
   Zheng-Hao Tang
   Guo-Qing Zang
   Zhang, Yi
   Xiao-Hua Chen
TI Astragalus polysaccharide alleviated hepatocyte senescence via autophagy
   pathway
SO KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
LA English
DT Article; Early Access
DE AMPK; Astragalus polysaccharide; autophagy; cell death; hepatocyte
   senescence
ID AMPK ACTIVATION; APOPTOSIS; DISEASE; DEATH; CELLS
AB Aging is characterized by inevitable organ function decline over time, with consequent body deterioration and increased susceptibility to death. Astragalus polysaccharide (APS) has been reported to have anti-oxidative, anti-apoptotic, and anti-inflammatory properties. We investigated the potential protective effects of APS on hydrogen peroxide (H2O2) induced hepatocyte senescence and identified related mechanisms in L02, Huh7, and LM3 cell lines. Aged female C57BL/6 mice were given APS for 1 week by intraperitoneal injection, and APS provided the strongest protective effect against H2O2-induced damage at 100 mu M. APS reduced the expression of cell senescence markers and alleviated pathological damage in aged mouse liver. APS treatment decreased oxidative stress, apoptosis, NOD-like receptor protein-3-mediated pyroptosis, and maintained mitochondrial homeostasis. Notably, the protective effect of APS was weakened in the presence of chloroquine. APS might enrich autophagy by activating AMP-activated protein kinase (AMPK) and inhibiting mammalian target of rapamycin (mTOR). In conclusion, APS reduced reactive oxygen species levels, inhibited apoptosis and pyroptosis, and promoted mitophagy via AMPK/mTOR pathway to alleviate hepatocyte senescence in vitro and in vivo.
C1 [Yao, Ting; Jin-Mei Chen; Le-Er Shen; Yong-Sheng Yu; Zheng-Hao Tang; Guo-Qing Zang; Zhang, Yi; Xiao-Hua Chen] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Infect Dis, 600 Yishan Rd, Shanghai 200233, Peoples R China.
C3 Shanghai Jiao Tong University
RP Zhang, Y; Chen, XH (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Infect Dis, 600 Yishan Rd, Shanghai 200233, Peoples R China.
EM zhangyi198068@163.com; chenxiaohua2000@163.com
RI YU, Yongsheng/O-6211-2015; wang, xi/JNT-5162-2023
OI YU, Yongsheng/0000-0001-5139-3439; 
FU National Natural Science Foundation of China [81770589]
FX National Natural Science Foundation of China, Grant/Award Number:
   81770589
CR Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008
   Alessio N, 2019, AGING-US, V11, P5817, DOI 10.18632/aging.102172
   Barth E, 2019, AGING-US, V11, P8556, DOI 10.18632/aging.102345
   Bi JB, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6946037
   Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010
   Fivenson EM, 2017, NEUROCHEM INT, V109, P202, DOI 10.1016/j.neuint.2017.02.007
   Goodall ML, 2016, DEV CELL, V37, P337, DOI 10.1016/j.devcel.2016.04.018
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Hui L, 2015, ARCH GERONTOL GERIAT, V60, P178, DOI 10.1016/j.archger.2014.11.002
   Jiang CT, 2018, TOXICOLOGY, V410, P26, DOI 10.1016/j.tox.2018.09.002
   Li MY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1728-5
   Li WF, 2020, INT J BIOL MACROMOL, V145, P985, DOI 10.1016/j.ijbiomac.2019.09.189
   Liu TL, 2019, INT J BIOL MACROMOL, V126, P179, DOI 10.1016/j.ijbiomac.2018.12.207
   Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Saleh T, 2019, BIOCHEM PHARMACOL, V162, P202, DOI 10.1016/j.bcp.2018.12.013
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013
   Tan YY, 2020, INT J BIOL MACROMOL, V153, P349, DOI 10.1016/j.ijbiomac.2020.02.282
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wang JY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02777-3
   Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685
   Whitley BN, 2019, MITOCHONDRION, V49, P269, DOI 10.1016/j.mito.2019.06.002
   Wu JL, 2019, AGING DIS, V10, P1094, DOI 10.14336/AD.2019.0116
   Xu FM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103606
   Yang XF, 2020, THERANOSTICS, V10, P1415, DOI 10.7150/thno.40857
   Zhang CM, 2020, MED SCI MONIT BASIC, V26, DOI 10.12659/MSMBR.923391
   Zhang RX, 2018, MOLECULES, V23, DOI 10.3390/molecules23102711
   Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127
   Zhang ZY, 2020, AUTOPHAGY, V16, P1506, DOI 10.1080/15548627.2019.1688488
NR 34
TC 7
Z9 7
U1 14
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1607-551X
EI 2410-8650
J9 KAOHSIUNG J MED SCI
JI Kaohsiung J. Med. Sci.
PD 2022 MAY
PY 2022
VL 38
IS 5
BP 457
EP 468
DI 10.1002/kjm2.12495
EA DEC 2021
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 0R8CG
UT WOS:000734989300001
PM 34962345
OA gold
DA 2024-02-19
ER

PT J
AU Aini, W
   Miyagawa-Hayashino, A
   Ozeki, M
   Adeeb, S
   Hirata, M
   Tamaki, K
   Uemoto, S
   Haga, H
AF Aini, Wulamujiang
   Miyagawa-Hayashino, Aya
   Ozeki, Munetaka
   Adeeb, Salah
   Hirata, Masahiro
   Tamaki, Keiji
   Uemoto, Shinji
   Haga, Hironori
TI Accelerated telomere reduction and hepatocyte senescence in tolerated
   human liver allografts
SO TRANSPLANT IMMUNOLOGY
LA English
DT Article
DE Tolerance; Liver transplantation; Real-time PCR; Cyclin-dependent kinase
   inhibitor p21; Hepatocyte nuclear area
ID CELLULAR SENESCENCE; OPERATIONAL TOLERANCE; TRANSPLANT RECIPIENTS;
   INJURY; AGE; IMMUNOSUPPRESSION; CIRRHOSIS; DISEASE; MARKERS; TISSUES
AB Background: In living donor liver transplantation, the biological organ age of the donated allograft is unknown in young patients who receive grafts from older donors. Few studies have focused on the effects of aging on allografts in the state of tolerance. The purpose of this study was to assess the biological organ age of liver grafts.
   Methods: In 20 tolerated allografts over a 10-year post-transplant follow-up period, the relative telomere lengths were measured by multiplex quantitative polymerase chain reaction, and hepatocyte nuclear size and cell cycle phase markers were determined by immunohistochemistry. The results were compared with the same measurements that had been obtained prior to transplantation in the recipients' pre-implantation donor livers. Tolerance was defined strictly as a condition in which the allograft functioned normally and showed normal histology without any histological signs of rejection, fibrosis or inflammation in the absence of immunosuppression.
   Results: First, telomere length correlated with chronological donor age (n = 41). Accelerated telomere reduction was seen in tolerated grafts compared with the predicted telomere length of each allograft calculated from the regression line of donor livers. Tolerated grafts were associated with higher hepatocyte p21 expression and greater nuclear area than in the donor livers prior to transplantation.
   Conclusions: These findings suggest that allografts age more rapidly than in the normal population, and that grafts may reach the limit of proliferative capacity even in the state of tolerance. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Aini, Wulamujiang; Miyagawa-Hayashino, Aya; Adeeb, Salah; Hirata, Masahiro; Haga, Hironori] Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, Kyoto 6068517, Japan.
   [Ozeki, Munetaka; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Kyoto, Japan.
   [Uemoto, Shinji] Kyoto Univ Hosp, Dept Hepatobiliary Pancreat Surg & Transplantat, Kyoto 6068517, Japan.
C3 Kyoto University; Kyoto University; Kyoto University
RP Miyagawa-Hayashino, A (corresponding author), Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068517, Japan.
EM ayam@kuhp.kyoto-u.ac.jp
RI Hirata, Masahiro/JVO-6179-2024
OI Hirata, Masahiro/0000-0001-9211-0511; Haga, Hironori/0000-0003-4322-9561
FU Japan Society for the Promotion of Science [23590424]; Grants-in-Aid for
   Scientific Research [23590424] Funding Source: KAKEN
FX This work was supported by a Grant-in-Aid from the Japan Society for the
   Promotion of Science (23590424) to AM-H.
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Aini W, 2012, TRANSPL INT, V25, P956, DOI 10.1111/j.1432-2277.2012.01523.x
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Eguchi S, 2011, DIGEST DIS SCI, V56, P1542, DOI 10.1007/s10620-010-1445-5
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Ferlicot S, 2003, HUM PATHOL, V34, P924, DOI 10.1016/S0046-8177(03)00340-X
   Fouquet V, 2005, LIVER TRANSPLANT, V11, P152, DOI 10.1002/lt.20358
   Funabashi KS, 2012, PATHOL RES PRACT, V208, P584, DOI 10.1016/j.prp.2012.07.001
   de la Garza RG, 2013, LIVER TRANSPLANT, V19, P937, DOI 10.1002/lt.23686
   Gorla GR, 2001, J CELL SCI, V114, P2943
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hori T, 2013, ANN TRANSPL, V18, P299, DOI 10.12659/AOT.883955
   Joosten SA, 2003, AM J PATHOL, V162, P1305, DOI 10.1016/S0002-9440(10)63926-0
   Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x
   Koshiba T, 2007, TRANSPL IMMUNOL, V17, P94, DOI 10.1016/j.trim.2006.10.004
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lunz JG, 2005, HEPATOLOGY, V41, P1262, DOI 10.1002/hep.20709
   Martínez-Llordella M, 2007, AM J TRANSPLANT, V7, P309, DOI 10.1111/j.1600-6143.2006.01621.x
   Martínez-Llordella M, 2008, J CLIN INVEST, V118, P2845, DOI 10.1172/JCI35342
   McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x
   Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9
   Melk A, 2009, AM J TRANSPLANT, V9, P114, DOI 10.1111/j.1600-6143.2008.02500.x
   Miyagawa-Hayashino A, 2012, LIVER TRANSPLANT, V18, P1333, DOI 10.1002/lt.23534
   Moon JI, 2010, LIVER TRANSPLANT, V16, P864, DOI 10.1002/lt.22094
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Orlando G, 2009, J HEPATOL, V50, P1247, DOI 10.1016/j.jhep.2009.03.006
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Westhoff JH, 2010, J AM SOC NEPHROL, V21, P327, DOI 10.1681/ASN.2009010072
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yoshitomi M, 2009, TRANSPLANTATION, V87, P606, DOI 10.1097/TP.0b013e318195a7cb
NR 36
TC 15
Z9 21
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0966-3274
EI 2210-3384
J9 TRANSPL IMMUNOL
JI Transpl. Immunol.
PD AUG
PY 2014
VL 31
IS 2
BP 55
EP 59
DI 10.1016/j.trim.2014.06.008
PG 5
WC Immunology; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Transplantation
GA AP2KL
UT WOS:000341901000001
PM 24993398
OA Green Published
DA 2024-02-19
ER

PT J
AU Qi, XY
   Song, AP
   Ma, MY
   Wang, PP
   Zhang, XB
   Lu, CF
   Zhang, JX
   Zheng, SG
   Jin, HH
AF Qi, Xiaoyu
   Song, Anping
   Ma, Mingyue
   Wang, Peipei
   Zhang, Xinbei
   Lu, Chunfeng
   Zhang, Junxiu
   Zheng, Shuguo
   Jin, Huanhuan
TI Curcumol inhibits ferritinophagy to restrain hepatocyte senescence
   through YAP/NCOA4 in non-alcoholic fatty liver disease
SO CELL PROLIFERATION
LA English
DT Article; Early Access
DE cellular senescence; curcumol; ferritinophagy; iron overload;
   non-alcoholic fatty liver disease; nuclear receptor coactivator 4;
   Yes-associated protein
ID IRON; FIBROSIS; PROGRESSION; MECHANISMS; CELLS
AB Objectives In recent years, cellular senescence has attracted a lot of interest in researchers due to its involvement in non-alcoholic fatty liver disease (NAFLD). However, the mechanism of cellular senescence is not clear. The purpose of this study was to investigate the effect of curcumol on hepatocyte senescence in NAFLD and the molecular mechanisms implicated. Materials and methods LVG Golden Syrian hamsters, C57BL/6J mice and human hepatocyte cell line LO2 were used. Cellular senescence was assessed by analyses of senescence marker SA-beta-gal, p16 and p21, H3K9me3, gamma-H2AX and telomerase activity. Results The results showed that curcumol could inhibit hepatocyte senescence in both in vivo and in vitro NAFLD models, and the mechanism might be related to its regulation of ferritinophagy and subsequent alleviation of iron overload. Moreover, overexpression of nuclear receptor coactivator 4 (NCOA4) weakened the effect of curcumol on ferritinophagy-mediated iron overload and cellular senescence. Furthermore, we demonstrated that curcumol reduced the expression of NCOA4 by Yes-associated protein (YAP). In addition, depression of YAP could impair the effect of curcumol on iron overload and cellular senescence. Conclusion Our results clarified the mechanism of curcumol inhibition of hepatocyte senescence through YAP/NCOA4 regulation of ferritinophagy in NAFLD. These findings provided a promising option of curcumol to regulate cellular senescence by target YAP/NCOA4 for the treatment of NAFLD.
C1 [Qi, Xiaoyu; Song, Anping; Ma, Mingyue; Wang, Peipei; Zhang, Xinbei; Zhang, Junxiu; Zheng, Shuguo; Jin, Huanhuan] Wannan Med Coll, Sch Pharm, Dept Pharmacol, 22 Wenchang West Rd, Wuhu 241000, Anhui, Peoples R China.
   [Lu, Chunfeng] Nantong Univ, Sch Pharm, Nantong, Peoples R China.
C3 Wannan Medical College; Nantong University
RP Zheng, SG; Jin, HH (corresponding author), Wannan Med Coll, Sch Pharm, Dept Pharmacol, 22 Wenchang West Rd, Wuhu 241000, Anhui, Peoples R China.
EM zhengsg2000@163.com; jhhwnmc@163.com
RI Wang, Peipei/AAL-4045-2021
FU key Project of Natural Science Research Projects of Anhui Higher
   Education Institutions [KJ2019A0428]; National Natural Science
   Foundation of China [81900531, 81803606]
FX the key Project of Natural Science Research Projects of Anhui Higher
   Education Institutions, Grant/Award Number: KJ2019A0428; National
   Natural Science Foundation of China, Grant/Award Number: 81900531 and
   81803606
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   Fu LN, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000201
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Jia Y, 2018, REDOX BIOL, V19, P375, DOI 10.1016/j.redox.2018.09.007
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12431
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Kim CH, 2021, CRIT REV ONCOL HEMAT, V163, DOI 10.1016/j.critrevonc.2021.103367
   Lin JG, 2014, NUCLEIC ACIDS RES, V42, P2493, DOI 10.1093/nar/gkt1132
   Lunova M, 2014, J HEPATOL, V61, P633, DOI 10.1016/j.jhep.2014.04.034
   Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308
   Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148
   Maras JS, 2015, HEPATOLOGY, V61, P1306, DOI 10.1002/hep.27636
   Mehta KJ, 2019, WORLD J GASTROENTERO, V25, P521, DOI 10.3748/wjg.v25.i5.521
   Nakamura T, 2019, BBA-GEN SUBJECTS, V1863, P1398, DOI 10.1016/j.bbagen.2019.06.010
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pasricha SR, 2021, LANCET, V397, P233, DOI 10.1016/S0140-6736(20)32594-0
   Pavel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05388-x
   Philpott CC, 2020, BLOOD, V136, P2604, DOI 10.1182/blood.2020007971
   Roake CM, 2020, NAT REV MOL CELL BIO, V21, P384, DOI 10.1038/s41580-020-0234-z
   Santana-Codina N, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040114
   Santinon G, 2018, EMBO J, V37, DOI 10.15252/embj.201797780
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014
   Tian NN, 2021, J ETHNOPHARMACOL, V280, DOI 10.1016/j.jep.2021.114413
   Totaro A, 2019, P NATL ACAD SCI USA, V116, P17848, DOI 10.1073/pnas.1908228116
   Wei W, 2019, INT J BIOL SCI, V15, P1600, DOI 10.7150/ijbs.34716
   Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793
   Yang F, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12422
   Yang X, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12762
   Zhou F, 2019, HEPATOLOGY, V70, P1119, DOI 10.1002/hep.30702
NR 34
TC 25
Z9 27
U1 2
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7722
EI 1365-2184
J9 CELL PROLIFERAT
JI Cell Prolif.
PD 2021 SEP
PY 2021
VL 54
IS 9
AR e13107
DI 10.1111/cpr.13107
EA AUG 2021
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA US0BM
UT WOS:000680752900001
PM 34346124
OA Green Published
DA 2024-02-19
ER

PT J
AU Guo, DH
   Shen, Y
   Li, W
   Li, QJ
   Miao, Y
   Zhong, Y
AF Guo, Donghao
   Shen, Yun
   Li, Wei
   Li, Qinjie
   Miao, Ya
   Zhong, Yuan
TI Upregulation of flavin-containing monooxygenase 3 mimics calorie
   restriction to retard liver aging by inducing autophagy
SO AGING-US
LA English
DT Article
DE Flavin-containing monooxygenase 3 (FMO3); calorie restriction (CR);
   anti-aging; autophagy; mammalian target of rapamycin (mTOR)
ID LIPID-METABOLISM; INFLAMMATION; ACTIVATION; MTOR; SIGNATURE; PROTEIN;
   STRESS; HEALTH; TARGET; SEX
AB Flavin-containing monooxygenase 3 (FMO3) gene expression is often upregulated in long-lived murine models. However, the specific relationship between FMO3 and aging remains unknown. Here, we show that 40% calorie restriction (CR), which is considered to be one of the most robust interventions to delay aging progression, markedly upregulates FMO3. Most importantly, upregulation of hepatocyte FMO3 in murine models prevented or reversed hepatic aging. Accordingly, the upregulation of FMO3 mimicked the effects of CR: reduced serum levels of pro-inflammatory cytokine interleukin-6 and fasting insulin; relief of oxidative stress, with lower hepatic malondialdehyde levels and higher superoxide dismutase activity; reduced serum and hepatic levels of total cholesterol and triglyceride, as well as reduced lipid deposition in the liver; and diminished levels of aging-related markers beta-gal and p16. There were also synergistic effects between FMO3 upregulation and CR. Inhibition of autophagy blocked the anti-aging effects of upregulation of hepatocyte FMO3, including reversing the amelioration of the serum and hepatic parameters related to inflammation, oxidative stress, lipid metabolism, liver function, and hepatocyte senescence. Our results suggest that the upregulation of FMO3 mimics CR to prevent or reverse hepatic aging by promoting autophagy.
C1 [Guo, Donghao; Shen, Yun; Li, Wei; Li, Qinjie; Miao, Ya; Zhong, Yuan] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Geriatr, Shanghai, Peoples R China.
   [Guo, Donghao] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Peoples R China.
C3 Shanghai Jiao Tong University; Chinese University of Hong Kong
RP Miao, Y; Zhong, Y (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Geriatr, Shanghai, Peoples R China.
EM nning-my@163.com; zhongyuan_zhy@163.com
RI Guo, Donghao/AAB-5671-2020
OI Guo, Donghao/0000-0002-8300-8176; Zhong, Yuan/0000-0002-3241-4924
FU Natural Science Foundation of Shanghai [19ZR1438800]; National Natural
   Science Foundation of China [81300933]
FX This work was supported by grants from the Natural Science Foundation of
   Shanghai (No. 19ZR1438800) and the National Natural Science Foundation
   of China (No. 81300933).
CR Bullone M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122612
   Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726
   Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009
   DAYNES RA, 1993, J IMMUNOL, V150, P5219
   Derous D, 2017, AGING-US, V9, P1770, DOI 10.18632/aging.101269
   Donati A, 2008, J GERONTOL A-BIOL, V63, P550, DOI 10.1093/gerona/63.6.550
   Du W, 2016, AGING CELL, V15, P766, DOI 10.1111/acel.12488
   Escobar KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12876
   Flores-Toro JA, 2016, ARCH PHARM RES, V39, P1050, DOI 10.1007/s12272-016-0807-8
   Fu ZD, 2014, TOXICOL APPL PHARM, V274, P137, DOI 10.1016/j.taap.2013.11.003
   Gokarn R, 2018, J GERONTOL A-BIOL, V73, P446, DOI 10.1093/gerona/glx186
   Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523
   He J, 2018, POULTRY SCI, V97, P2005, DOI 10.3382/ps/pey077
   He LQ, 2013, ACTA PHARMACOL SIN, V34, P605, DOI 10.1038/aps.2012.188
   Jimenez AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195832
   Jové M, 2014, AGING CELL, V13, P828, DOI 10.1111/acel.12241
   Kennedy BK, 2014, TRANSL RES, V163, P456, DOI 10.1016/j.trsl.2013.11.007
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376
   Leiser SF, 2015, SCIENCE, V350, P1375, DOI 10.1126/science.aac9257
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   Mao SA, 2014, TRANSL RES, V163, P352, DOI 10.1016/j.trsl.2014.01.005
   Marasco MR, 2018, ENDOCRINOLOGY, V159, P2127, DOI 10.1210/en.2017-03273
   Medvedev R, 2017, CELL BIOL TOXICOL, V33, P211, DOI 10.1007/s10565-016-9376-3
   Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Nacarelli T, 2015, EXP GERONTOL, V68, P66, DOI 10.1016/j.exger.2014.11.004
   Niedernhofer LJ, 2017, AGEING RES REV, V35, P241, DOI 10.1016/j.arr.2016.09.012
   Nurmi K, 2017, J INNATE IMMUN, V9, P65, DOI 10.1159/000448894
   Pazoki-Toroudi H, 2016, AGEING RES REV, V31, P55, DOI 10.1016/j.arr.2016.07.004
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Shih DM, 2015, J LIPID RES, V56, P22, DOI 10.1194/jlr.M051680
   Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012
   Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Wahl D, 2018, CELL REP, V25, P2234, DOI 10.1016/j.celrep.2018.10.070
   Warrier M, 2015, CELL REP, V10, P326, DOI 10.1016/j.celrep.2014.12.036
   Xu LF, 2016, BBA-MOL CELL RES, V1863, P1894, DOI 10.1016/j.bbamcr.2016.01.003
   Xu MJ, 2017, J PHARMACOL EXP THER, V363, P265, DOI 10.1124/jpet.117.243113
   Yew WW, 2018, ANTIMICROB AGENTS CH
   Zhang YM, 2018, NAT REV ENDOCRINOL, V14, P356, DOI 10.1038/s41574-018-0009-1
NR 43
TC 9
Z9 9
U1 0
U2 20
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JAN 15
PY 2020
VL 12
IS 1
BP 931
EP 944
DI 10.18632/aging.102666
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA KC5QX
UT WOS:000507233100054
PM 31927537
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yan, Y
   Qin, D
   Hu, B
   Zhang, CJ
   Liu, SH
   Wu, DD
   Huang, WD
   Huang, XX
   Wang, LQ
   Chen, XM
   Zhang, LS
AF Yan, Yi
   Qin, Dan
   Hu, Bian
   Zhang, Chunjing
   Liu, Shenghui
   Wu, Dongde
   Huang, Wendong
   Huang, Xingxu
   Wang, Liqiang
   Chen, Xiangmei
   Zhang, Lisheng
TI Deletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse
   Model of Cholestasis
SO MOLECULAR THERAPY-NUCLEIC ACIDS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HEPATOCELLULAR-CARCINOMA; SENESCENCE; LIVER;
   MICRORNAS; AGE; ATHEROSCLEROSIS; PROLIFERATION; TELOMERES; VERSICAN
AB MicroRNAs (miRNAs) act as regulators of aging at the tissue or organism level or as regulators of cellular senescence. Targeted deletion of miR-126 in mice causes partial embryonic lethality, but its biological function in the liver is still largely unknown. Here, we deleted miR-126a, using the CRISPR/Cas9 system in vitro and in vivo. miR-126a was reduced in the aging livers, and disruption of miR-126a in bone mesenchymal stem cells (BMSCs) induced age-associated telomere shortening, DNA damage responses, and proinflammatory cytokines. Moreover, disruption of miR-126a in mice caused hepatocyte senescence, inflammation, and metabolism deficiency. In addition, disruption of miR-126a via BMSC transplantation aggravated the severity of liver defects induced by cholestasis compared with that in the functional miR-126a BMSC group. Mechanistically, we identified versican (VCAN) as a novel direct miR-126a-5p target that induces telomere shortening, BMSC senescence, and nuclear factor kappa B (NF-kappa B) pathway activation. This study identified aging-related reduced expression of miR-126a and promotion of its target VCAN as a key mechanism in the regulation of hepatic metabolic function during aging and hepatic damage by inducing NF-kappa B pathway activation, DNA repair function disorder, and telomere attrition. The findings indicate that miR-126a may be a drug target for the treatment of hepatic failure.
C1 [Yan, Yi; Qin, Dan; Zhang, Chunjing; Liu, Shenghui; Zhang, Lisheng] Huazhong Agr Univ, Coll Vet Med, Biomed Ctr, Wuhan 430070, Hubei, Peoples R China.
   [Hu, Bian; Huang, Xingxu] Shanghai Tech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.
   [Wu, Dongde] Wuhan Univ, Hubei Canc Hosp, Canc Hosp, Dept Hepatobiliary & Pancreat Surg, Wuhan 430079, Hubei, Peoples R China.
   [Huang, Wendong] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Beckman Res Inst, Dept Diabet Complicat & Metab, Duarte, CA 91010 USA.
   [Wang, Liqiang; Chen, Xiangmei] Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Inst Nephrol, Dept Nephrol, State Key Lab Kidney Dis,Natl Clin Res Ctr Kidney, 28th Fuzing Rd, Beijing 100853, Peoples R China.
C3 Huazhong Agricultural University; ShanghaiTech University; Wuhan
   University; City of Hope; Beckman Research Institute of City of Hope;
   Chinese People's Liberation Army General Hospital
RP Zhang, LS (corresponding author), Huazhong Agr Univ, Coll Vet Med, Biomed Ctr, Wuhan 430070, Hubei, Peoples R China.
EM lishengzhang@mail.hzau.edu.cn
RI Hu, Bian/AAZ-7494-2020; Wang, Liqiang/JGD-1752-2023
OI Wang, Liqiang/0000-0002-1718-0453; wang, liqiang/0000-0002-6066-076X;
   huang, xingxu/0000-0001-8934-1247
FU National Key RD Plan [2017YFA0103202, 2017YFA0103200]; Fundamental
   Research Funds for the Central Universities [2662017PY106, 2662016PY087,
   2662019YJ008]; Huazhong Agricultural University Startup funds; Youth
   1000 Plan Project
FX This work was supported by National Key R&D Plan no. 2017YFA0103202 and
   no. 2017YFA0103200, the Fundamental Research Funds for the Central
   Universities (2662017PY106, 2662016PY087, and 2662019YJ008), the Youth
   1000 Plan Project and Huazhong Agricultural University Startup funds to
   L.Z.
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596
   Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390
   Chen YC, 2015, CELL RES, V25, P262, DOI 10.1038/cr.2014.167
   Cheng YJ, 2017, MOL THER-NUCL ACIDS, V9, P195, DOI 10.1016/j.omtn.2017.09.008
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Epstein Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00485-9
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004
   Fiedler J, 2017, EXP DERMATOL, V26, P284, DOI 10.1111/exd.13173
   He C, 2016, GUT, V65, P1938, DOI 10.1136/gutjnl-2015-309389
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kunisada M, 2011, AM J PATHOL, V179, P3056, DOI 10.1016/j.ajpath.2011.08.042
   Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028
   Li CX, 2017, NAT MATER, V16, P379, DOI [10.1038/NMAT4780, 10.1038/nmat4780]
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Rainov NG, 1999, HUM GENE THER, V10, P311, DOI 10.1089/10430349950019093
   Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46
   Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200
   Tang ST, 2017, VASC PHARMACOL, V88, P48, DOI 10.1016/j.vph.2016.12.002
   Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450
   Valdmanis PN, 2016, NAT MED, V22, P557, DOI 10.1038/nm.4079
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002
   Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51
   Xia LM, 2014, HEPATOLOGY, V59, P958, DOI 10.1002/hep.26735
   Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003
   Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586
   Zhang LS, 2013, HEPATOLOGY, V57, P1919, DOI 10.1002/hep.26162
   Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282
   Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690
NR 41
TC 18
Z9 19
U1 3
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2162-2531
J9 MOL THER-NUCL ACIDS
JI Mol. Ther.-Nucl. Acids
PD JUN 7
PY 2019
VL 16
BP 494
EP 504
DI 10.1016/j.omtn.2019.04.002
PG 11
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA IB4OC
UT WOS:000470250900044
PM 31051334
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Moustakas, II
   Katsarou, A
   Legaki, AI
   Pyrina, I
   Ntostoglou, K
   Papatheodoridi, AM
   Gercken, B
   Pateras, IS
   Gorgoulis, VG
   Koutsilieris, M
   Chavakis, T
   Chatzigeorgiou, A
AF Moustakas, Ioannis I.
   Katsarou, Angeliki
   Legaki, Aigli-Ioanna
   Pyrina, Iryna
   Ntostoglou, Konstantinos
   Papatheodoridi, Alkistis-Maria
   Gercken, Bettina
   Pateras, Ioannis S.
   Gorgoulis, Vassilis G.
   Koutsilieris, Michael
   Chavakis, Triantafyllos
   Chatzigeorgiou, Antonios
TI Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice
   Independently of Obesity
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE NAFLD; age; hepatocyte; replicative senescence; stress-induced
   senescence; obesity
AB Senescence is considered to be a cardinal player in several chronic inflammatory and metabolic pathologies. The two dominant mechanisms of senescence include replicative senescence, predominantly depending on age-induced telomere shortening, and stress-induced senescence, triggered by external or intracellular harmful stimuli. Recent data indicate that hepatocyte senescence is involved in the development of nonalcoholic fatty liver disease (NAFLD). However, previous studies have mainly focused on age-related senescence during NAFLD, in the presence or absence of obesity, while information about whether the phenomenon is characterized by replicative or stress-induced senescence, especially in non-aged organisms, is scarce. Herein, we subjected young mice to two different diet-induced NAFLD models which differed in the presence of obesity. In both models, liver fat accumulation and increased hepatic mRNA expression of steatosis-related genes were accompanied by hepatic senescence, indicated by the increased expression of senescence-associated genes and the presence of a robust hybrid histo-/immunochemical senescence-specific staining in the liver. Surprisingly, telomere length and global DNA methylation did not differ between the steatotic and the control livers, while malondialdehyde, a marker of oxidative stress, was upregulated in the mouse NAFLD livers. These findings suggest that senescence accompanies NAFLD emergence, even in non-aged organisms, and highlight the role of stress-induced senescence during steatosis development independently of obesity.
C1 [Moustakas, Ioannis I.; Katsarou, Angeliki; Legaki, Aigli-Ioanna; Papatheodoridi, Alkistis-Maria; Koutsilieris, Michael; Chatzigeorgiou, Antonios] Natl & Kapodistrian Univ Athens, Med Sch, Dept Expt Physiol, Athens 11527, Greece.
   [Pyrina, Iryna; Gercken, Bettina; Chavakis, Triantafyllos; Chatzigeorgiou, Antonios] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Inst Clin Chem & Lab Med, D-01307 Dresden, Germany.
   [Ntostoglou, Konstantinos; Pateras, Ioannis S.; Gorgoulis, Vassilis G.] Natl & Kapodistrian Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, Athens 11527, Greece.
   [Gorgoulis, Vassilis G.] Acad Athens, Biomed Res Fdn, Athens 11527, Greece.
   [Gorgoulis, Vassilis G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Canc Res Ctr, Mol & Clin Canc Sci, Manchester M20 4GJ, Lancs, England.
   [Gorgoulis, Vassilis G.] Natl & Kapodistrian Univ Athens, Ctr New Biotechnol & Precis Med, Med Sch, Athens 11527, Greece.
C3 National & Kapodistrian University of Athens; Technische Universitat
   Dresden; Carl Gustav Carus University Hospital; National & Kapodistrian
   University of Athens; Athens Medical School; Academy of Athens;
   University of Manchester; National & Kapodistrian University of Athens
RP Chatzigeorgiou, A (corresponding author), Natl & Kapodistrian Univ Athens, Med Sch, Dept Expt Physiol, Athens 11527, Greece.; Chatzigeorgiou, A (corresponding author), Tech Univ Dresden, Univ Clin Carl Gustav Carus, Inst Clin Chem & Lab Med, D-01307 Dresden, Germany.
EM ioamoustakas@med.uoa.gr; angelikikat@med.uoa.gr; elinalegaki@med.uoa.gr;
   Iryna.Pyrina@uniklinikum-dresden.de; kostasntostoglou@gmail.com;
   alkistispapath@gmail.com; Bettina.Gercken@uniklinikum-dresden.de;
   ipateras@med.uoa.gr; vgorg@med.uoa.gr; mkoutsil@med.uoa.gr;
   Triantafyllos.Chavakis@uniklinikum-dresden.de; achatzig@med.uoa.gr
RI Chatzigeorgiou, Antonios/G-1581-2010; Gorgoulis, Vassilis/AAD-3630-2019
OI Chatzigeorgiou, Antonios/0000-0002-7039-4223; Gorgoulis,
   Vassilis/0000-0001-9001-4112; Pyrina, Iryna/0000-0002-9849-6408;
   Ntostoglou, Konstantinos/0000-0001-9030-7169; Moustakas,
   Ioannis/0000-0002-6113-9255
FU German Research Foundation (Deutsche Forschungsgemeinschaft) [1862/3-1,
   CH279/5-1]; European Research Council (DEMETINL); Hellenic Association
   for the Study of the Liver; Hellenic Foundation for Research and
   Innovation
FX This research was funded by the German Research Foundation (Deutsche
   Forschungsgemeinschaft, Grant No. 1862/3-1 to A.C. and CH279/5-1 to
   T.C.), the European Research Council (DEMETINL to T.C.), the Hellenic
   Association for the Study of the Liver, and the Hellenic Foundation for
   Research and Innovation (both to A.C.).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Alves-Paiva RM, 2018, LIVER INT, V38, P144, DOI 10.1111/liv.13529
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0
   Chatzigeorgiou A, 2014, OBES REV, V15, P487, DOI 10.1111/obr.12163
   Chatzigeorgiou A, 2014, HEPATOLOGY, V60, P1196, DOI 10.1002/hep.27233
   Chmelar J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00524
   Chrysavgis L, 2020, WORLD J GASTROENTERO, V26, DOI 10.3748/wjg.v26.i42.6514
   Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008
   Evangelou K, 2017, AGING CELL, V16, P192, DOI 10.1111/acel.12545
   Fox JG, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   García-Martín R, 2016, MOL CELL BIOL, V36, P376, DOI 10.1128/MCB.00430-15
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guarasci F, 2018, MECH AGEING DEV, V174, P47, DOI 10.1016/j.mad.2018.02.001
   Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6
   Katsarou A, 2020, WORLD J GASTROENTERO, V26, P1993, DOI 10.3748/wjg.v26.i17.1993
   Kim D, 2018, CLIN LIVER DIS, V22, P133, DOI 10.1016/j.cld.2017.08.010
   Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028
   Kondo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065698
   Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127
   Lai ZW, 2020, OBESITY, V28, P197, DOI 10.1002/oby.22667
   Lee YH, 2016, ONCOTARGET, V7, P46959, DOI 10.18632/oncotarget.10506
   Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lonardo A, 2018, LIVER INT, V38, P1730, DOI 10.1111/liv.13935
   Lyall MJ, 2020, EPIGENETICS-US, V15, P61, DOI 10.1080/15592294.2019.1649527
   Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ore A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55020026
   Palmer AK, 2015, DIABETES, V64, P2289, DOI 10.2337/db14-1820
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263
   Nguyen P, 2018, CELL REP, V24, P1597, DOI 10.1016/j.celrep.2018.07.014
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Spruss A, 2012, MOL MED, V18, P1346, DOI 10.2119/molmed.2012.00223
   Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Thangapandi VR, 2021, GUT, V70, P940, DOI 10.1136/gutjnl-2020-320853
   Troullinaki M, 2020, FASEB J, V34, P3336, DOI 10.1096/fj.201900125RR
   Wang LJ, 2014, J NUTR BIOCHEM, V25, P329, DOI 10.1016/j.jnutbio.2013.11.007
   Ye Q, 2020, LANCET GASTROENTEROL, V5, P739, DOI 10.1016/S2468-1253(20)30077-7
   Zhang XY, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0595-5
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
NR 45
TC 14
Z9 14
U1 2
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2021
VL 22
IS 7
AR 3446
DI 10.3390/ijms22073446
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA RK9YB
UT WOS:000638641000001
PM 33810566
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, CY
   Tan, XH
   Yang, HH
   Jin, L
   Hong, JR
   Zhou, Y
   Huang, XT
AF Zhang, Chen-Yu
   Tan, Xiao-Hua
   Yang, Hui-Hui
   Jin, Ling
   Hong, Jie-Ru
   Zhou, Yong
   Huang, Xiao-Ting
TI COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice
   by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE non-alcoholic fatty liver disease; COX-2; sEH dual inhibitor;
   senescence; autophagy
ID FATTY LIVER-DISEASE; ENDOTHELIAL DYSFUNCTION; CELLULAR SENESCENCE;
   FIBROSIS; ACIDS; INFLAMMATION; ACTIVATION; EXPRESSION; INJURY
AB We previously found that the disorder of soluble epoxide hydrolase (sEH)/cyclooxygenase-2 (COX-2)-mediated arachidonic acid (ARA) metabolism contributes to the pathogenesis of the non-alcoholic fatty liver disease (NAFLD) in mice. However, the exact mechanism has not been elucidated. Accumulating evidence points to the essential role of cellular senescence in NAFLD. Herein, we investigated whether restoring the balance of sEH/COX-2-mediated ARA metabolism attenuated NAFLD via hepatocyte senescence. A promised dual inhibitor of sEH and COX-2, PTUPB, was used in our study to restore the balance of sEH/COX-2-mediated ARA metabolism. In vivo, NAFLD was induced by a high-fat diet (HFD) using C57BL/6J mice. In vitro, mouse hepatocytes (AML12) and mouse hepatic astrocytes (JS1) were used to investigate the effects of PTUPB on palmitic acid (PA)-induced hepatocyte senescence and its mechanism. PTUPB alleviated liver injury, decreased collagen and lipid accumulation, restored glucose tolerance, and reduced hepatic triglyceride levels in HFD-induced NAFLD mice. Importantly, PTUPB significantly reduced the expression of liver senescence-related molecules p16, p53, and p21 in HFD mice. In vitro, the protein levels of gamma H2AX, p53, p21, COX-2, and sEH were increased in AML12 hepatocytes treated with PA, while Ki67 and PCNA were significantly decreased. PTUPB decreased the lipid content, the number of beta-gal positive cells, and the expression of p53, p21, and gamma H2AX proteins in AML12 cells. Meanwhile, PTUPB reduced the activation of hepatic astrocytes JS1 by slowing the senescence of AML12 cells in a co-culture system. It was further observed that PTUPB enhanced the ratio of autophagy-related protein LC3II/I in AML12 cells, up-regulated the expression of Fundc1 protein, reduced p62 protein, and suppressed hepatocyte senescence. In addition, PTUPB enhanced hepatocyte autophagy by inhibiting the PI3K/AKT/mTOR pathway through Sirt1, contributing to the suppression of senescence. PTUPB inhibits the PI3K/AKT/mTOR pathway through Sirt1, improves autophagy, slows down the senescence of hepatocytes, and alleviates NAFLD.
C1 [Zhang, Chen-Yu; Yang, Hui-Hui; Jin, Ling; Hong, Jie-Ru; Zhou, Yong] Cent South Univ, Sch Basic Med Sci, Dept Physiol, Changsha 410078, Peoples R China.
   [Tan, Xiao-Hua] Cent South Univ, Expt Ctr Med Morphol, Sch Basic Med Sci, Changsha 410078, Peoples R China.
   [Huang, Xiao-Ting] Cent South Univ, Xiangya Nursing Sch, Changsha 410078, Peoples R China.
C3 Central South University; Central South University; Central South
   University
RP Huang, XT (corresponding author), Cent South Univ, Xiangya Nursing Sch, Changsha 410078, Peoples R China.
EM zhangchenyu@csu.edu.cn; 213131@csu.edu.cn; enzezeen@163.com;
   xyjinling@126.com; hongjieru2020@163.com; zhouyong421@csu.edu.cn;
   huangxiaoting@csu.edu.cn
RI Zhou, Yong/O-9481-2018
OI Zhou, Yong/0000-0002-7348-2376; Zhang, Chen-Yu/0000-0001-8904-789X
FU National Natural Science Foundation of China [91949110, 82170096,
   82100084, 82170853]; Health Commission Fund of Hunan Province
   [202202015232]; Fundamental Research Funds for the Central Universities
   of Central South University [2021zzts0314]
FX This study was supported by the National Natural Science Foundation of
   China (91949110 to Cha-Xiang Guan, 82170096 to Cha-Xiang Guan, 82100084
   to Xiao-Ting Huang, and 82170853 to Si-Yuan Tang), Health Commission
   Fund of Hunan Province (202202015232 to Jun Zhang), and Fundamental
   Research Funds for the Central Universities of Central South University
   (2021zzts0314 to Chen-Yu Zhang).
CR Abdelmalek MF, 2021, NAT REV GASTRO HEPAT, V18, P85, DOI 10.1038/s41575-020-00406-0
   Bellaver B, 2017, MOL NEUROBIOL, V54, P2969, DOI 10.1007/s12035-016-9880-8
   Domínguez-González M, 2018, EXP GERONTOL, V111, P218, DOI 10.1016/j.exger.2018.07.023
   Engelmann C, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020652
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Francque S, 2021, NAT REV GASTRO HEPAT, V18, P24, DOI 10.1038/s41575-020-00366-5
   Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871
   González-Rodríguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162
   Guan XX, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910714
   Harris TR, 2013, GENE, V526, P61, DOI 10.1016/j.gene.2013.05.008
   Huang JQ, 2019, FASEB J, V33, P11194, DOI 10.1096/fj.201900756R
   Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013
   Hwang SH, 2011, J MED CHEM, V54, P3037, DOI 10.1021/jm2001376
   Kaushik S, 2021, AGEING RES REV, V72, DOI 10.1016/j.arr.2021.101468
   Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120
   Lee DH, 2021, AUTOPHAGY, V17, P2415, DOI 10.1080/15548627.2020.1827779
   Lee SH, 2019, BMB REP, V52, P24, DOI 10.5483/BMBRep.2019.52.1.290
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Liu T, 2019, WORLD J GASTROENTERO, V25, P5451, DOI 10.3748/wjg.v25.i36.5451
   Lu HW, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04157-x
   Luo XQ, 2020, J CELL PHYSIOL, V235, P9910, DOI 10.1002/jcp.29806
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   Moustakas II, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073446
   Narumiya S, 2007, P JPN ACAD B-PHYS, V83, P296, DOI [10.2183/pjab.83.296, 10.2183/pjab/83.296]
   Niranjan R, 2018, MOL NEUROBIOL, V55, P8038, DOI 10.1007/s12035-018-0950-y
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Samokhvalov V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00242
   Singh BK, 2020, AGING-US, V12, P13958, DOI 10.18632/aging.103740
   Sun CC, 2020, BIOCHEM BIOPH RES CO, V523, P1020, DOI 10.1016/j.bbrc.2019.12.131
   Sun CP, 2021, FOOD CHEM TOXICOL, V156, DOI 10.1016/j.fct.2021.112516
   Sun CX, 2016, J MOL CELL CARDIOL, V94, P180, DOI 10.1016/j.yjmcc.2016.03.019
   Sun J, 2022, AGING CELL, V21, DOI 10.1111/acel.13532
   Sun L, 2015, AM J PHYSIOL-ENDOC M, V309, pE925, DOI 10.1152/ajpendo.00294.2015
   Sun T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8215
   Tanwar S, 2020, WORLD J GASTROENTERO, V26, P109, DOI 10.3748/wjg.v26.i2.109
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wagner K, 2011, PROSTAG OTH LIPID M, V96, P76, DOI 10.1016/j.prostaglandins.2011.08.001
   Wang LY, 2021, J MOL CELL CARDIOL, V154, P80, DOI 10.1016/j.yjmcc.2020.12.013
   Wils J, 2018, ATHEROSCLEROSIS, V275, P239, DOI 10.1016/j.atherosclerosis.2018.06.865
   Wu DD, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.585860
   Yang HH, 2020, THERANOSTICS, V10, P4749, DOI 10.7150/thno.43108
   Yu HY, 2021, EXP CELL RES, V405, DOI 10.1016/j.yexcr.2021.112689
   Zhang CY, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/5759626
   Zhang CY, 2020, FEBS J, V287, P1666, DOI 10.1111/febs.15105
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
   Zhang YF, 2020, BIOMED PHARMACOTHER, V126, DOI 10.1016/j.biopha.2020.109907
   Zhang YM, 2018, PHARMACOL THERAPEUT, V191, P1, DOI 10.1016/j.pharmthera.2018.06.004
   Zhong WJ, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107045
   Zhou C, 2018, FREE RADICAL BIO MED, V117, P168, DOI 10.1016/j.freeradbiomed.2018.02.009
NR 52
TC 11
Z9 11
U1 3
U2 26
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2022
VL 23
IS 15
AR 8267
DI 10.3390/ijms23158267
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 3T4EN
UT WOS:000840229700001
PM 35897843
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wood, MJ
   Gadd, VL
   Powell, LW
   Ramm, GA
   Clouston, AD
AF Wood, Marnie J.
   Gadd, Victoria L.
   Powell, Lawrie W.
   Ramm, Grant A.
   Clouston, Andrew D.
TI Ductular Reaction in Hereditary Hemochromatosis: The Link Between
   Hepatocyte Senescence and Fibrosis Progression
SO HEPATOLOGY
LA English
DT Article
ID CHRONIC HEPATITIS-C; GENETIC HEMOCHROMATOSIS; LIVER-INJURY; CELL
   ACTIVATION; IRON OVERLOAD; CIRRHOSIS; REGENERATION; ASSOCIATION;
   STEATOSIS; PATHOLOGY
AB The development of portal fibrosis following the iron loading of hepatocytes is the first stage of fibrogenesis in hereditary hemochromatosis. In other chronic liver diseases it has been shown that a ductular reaction (DR) appears early, correlates with fibrosis progression, and is a consequence of activation of an alternative pathway of hepatocyte replication. This study was designed to investigate the presence of the DR in hemochromatosis and describe its associations. Liver biopsies from 63 C282Y homozygous patients were assessed for hepatic iron concentration (HIC) and graded for iron loading, fibrosis stage, steatosis, and inflammation. Immunostaining allowed quantification of the DR, hepatocyte senescence and proliferation, and analysis incorporated clinical data. Hepatocyte senescence was positively correlated with HIC, serum ferritin, and oxidative stress. A DR was demonstrated and occurred prior to histological fibrosis. HIC, age, hepatocyte senescence and proliferation, portal inflammation, and excessive alcohol consumption all had significant associations with the extent of the DR. In multivariate analysis, iron loading, hepatocyte replicative arrest, and portal inflammation remained independently and significantly associated with the DR. Of factors associated with fibrosis progression, the DR (odds ratio [OR] 10.86 P<0.0001) and the presence of portal inflammation (OR 4.31, P=0.028) remained significant after adjustment for cofactors. The extent of the DR regressed following therapeutic venesection. Conclusion: Iron loading of hepatocytes leads to impaired replication, stimulating the development of the DR in hemochromatosis and this correlates strongly with hepatic fibrosis. Portal inflammation occurs in hemochromatosis and is independently associated with the DR and fibrosis, and thus its role in this disease should be evaluated further. (Hepatology 2014;59:848-857)
C1 [Wood, Marnie J.; Ramm, Grant A.] QIMR Berghofer Med Res Inst, Hepat Fibrosis Grp, Brisbane, Qld 4029, Australia.
   [Wood, Marnie J.; Gadd, Victoria L.; Powell, Lawrie W.; Ramm, Grant A.; Clouston, Andrew D.] Univ Queensland, Fac Hlth Sci, Brisbane, Qld, Australia.
   [Wood, Marnie J.] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia.
   [Powell, Lawrie W.] Royal Brisbane & Womens Hosp, Ctr Adv Clin Res, Brisbane, Qld, Australia.
   [Powell, Lawrie W.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.
   [Clouston, Andrew D.] Envoi Specialist Pathologists, Brisbane, Qld, Australia.
C3 QIMR Berghofer Medical Research Institute; University of Queensland;
   Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital;
   University of Queensland
RP Ramm, GA (corresponding author), QIMR Berghofer Med Res Inst, Hepat Fibrosis Grp, PO Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia.
EM Grant.Ramm@qimr.edu.au
RI Wood, Marnie J/B-8838-2015; Clouston, Andrew D/E-7199-2011; Ramm, Grant
   A/G-2669-2013
OI Clouston, Andrew D/0000-0002-9601-7952; Ramm, Grant
   A/0000-0001-7058-6201; Gadd, Victoria/0000-0003-1819-8660
FU NHMRC; Royal Brisbane & Women's Hospital Research Foundation; National
   Health and Medical Research Council (NHMRC); NHMRC [552409]
FX M.J.W. is supported by an NHMRC Medical Postgraduate Scholarship and the
   Royal Brisbane & Women's Hospital Research Foundation. G. A. R. and L.
   W. P. are supported by the National Health and Medical Research Council
   (NHMRC). G. A. R. is also supported by an NHMRC Senior Research
   Fellowship (#552409).
CR Adams PC, 2001, AM J GASTROENTEROL, V96, P567
   BEDOSSA P, 1994, HEPATOLOGY, V20, P15
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Bridle KR, 2003, J HEPATOL, V38, P426, DOI 10.1016/S0168-8278(02)00444-0
   Brunt EM, 2010, J PEDIATR GASTR NUTR, V51, P626, DOI 10.1097/MPG.0b013e3181e7ff55
   Chobert MN, 2012, LAB INVEST, V92, P135, DOI 10.1038/labinvest.2011.143
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R
   Fletcher LM, 2002, GASTROENTEROLOGY, V122, P281, DOI 10.1053/gast.2002.30992
   Gadd VL, 2013, LIVER INT, V33, P569, DOI 10.1111/liv.12050
   Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Kuramitsu K, 2013, AM J PATHOL, V183, P182, DOI 10.1016/j.ajpath.2013.03.018
   Lemoinne S, 2013, BBA-MOL BASIS DIS, V1832, P948, DOI 10.1016/j.bbadis.2013.02.019
   Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345
   Majhail NS, 2008, BONE MARROW TRANSPL, V41, P997, DOI 10.1038/bmt.2008.99
   Melino M, 2012, WORLD J GASTROENTERO, V18, P1732, DOI 10.3748/wjg.v18.i15.1732
   Powell EE, 2005, GASTROENTEROLOGY, V129, P1937, DOI 10.1053/j.gastro.2005.09.015
   Powell L W, 1975, Pathobiol Annu, V5, P317
   Powell LW, 2006, ARCH INTERN MED, V166, P294, DOI 10.1001/archinte.166.3.294
   Ramm GA, 1997, J HEPATOL, V26, P584, DOI 10.1016/S0168-8278(97)80424-2
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107
   STAL P, 1995, HEPATOLOGY, V21, P1308, DOI 10.1016/0270-9139(95)90052-7
   Svegliati-Baroni G, 2011, GUT, V60, P108, DOI 10.1136/gut.2010.219741
   Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820
   Wood MJ, 2008, BLOOD, V111, P4456, DOI 10.1182/blood-2007-11-122374
   Zhou HC, 2007, HEPATOLOGY, V45, P716, DOI 10.1002/hep.21557
NR 29
TC 58
Z9 59
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD MAR
PY 2014
VL 59
IS 3
BP 848
EP 857
DI 10.1002/hep.26706
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AB4VH
UT WOS:000331787500017
PM 24037895
OA Bronze
DA 2024-02-19
ER

PT J
AU Lu, CF
   Ge, T
   Shao, YY
   Cui, WQ
   Li, Z
   Xu, WX
   Bao, XF
AF Lu, Chunfeng
   Ge, Ting
   Shao, Yunyun
   Cui, Wenqian
   Li, Zhe
   Xu, Wenxuan
   Bao, Xiaofeng
TI ZNF281 drives hepatocyte senescence in alcoholic liver disease by
   reducing HK2-stabilized PINK1/Parkin-mediated mitophagy
SO CELL PROLIFERATION
LA English
DT Article; Early Access
ID CELLS
AB We investigated the role of zinc-finger protein 281 (ZNF281), a novel molecule, in ethanol-induced hepatocyte senescence and uncovered the potential mechanism. Real-time PCR, Western blot, immunofluorescence staining, and enzyme-linked immunosorbent assay were performed to explore the role of ZNF281 in hepatocyte senescence. ZNF281 expression was upregulated in both alcohol-fed mice livers and ethanol-treated hepatocytes. Silence of ZNF281 in hepatocytes using siRNA mitigated ethanol-caused decrease in cell viability and increased release of aspartate aminotransferase, alanine transaminase, and lactate dehydrogenase. ZNF281 siRNA reduced senescence-associated beta-galactosidase-positive cells under ethanol exposure, abolished cell cycle arrest at G0/G1 phase, and diminished senescence-associated secretory phenotype and proinflammatory cytokines (IL-1 beta and IL-6) release. At molecular level, ZNF281 deficiency altered the expression profile of senescence-associated proteins including p53, p21, p16, high mobility group AT-hook 1, and phospho-histone H2A.X and telomerase-associated regulatory factors including telomerase reverse transcriptase, telomeric repeat binding factor 1 (TRF1), and TRF2. ZNF281 knockdown promoted hepatocyte recovery from ethanol-induced mitochondrial dysfunction and ROS production, which was correlated with rescuing HK2-PINK1/Parkin signalling-mediated mitophagy. Mechanistically, ZNF281 directly bound to 5 '-GGCGGCGGGCGG-3 ' motif within HK2 promoter region and transcriptionally repressed HK2 expression. Systematic ZNF281 knockdown by adeno-associated virus encoding ZNF281 shRNA protected mice from alcohol feeding-caused hepatocyte injury and senescence. This study provides a novel factor ZNF281 as a driver of hepatocyte senescence during alcoholic liver disease.
C1 [Lu, Chunfeng; Ge, Ting; Shao, Yunyun; Cui, Wenqian; Li, Zhe; Bao, Xiaofeng] Nantong Univ, Sch Pharm, Nantong, Peoples R China.
   [Xu, Wenxuan] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Peoples R China.
   [Xu, Wenxuan] China Pharmaceut Univ, Sch Life Sci & Technol, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China.
   [Bao, Xiaofeng] Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
C3 Nantong University; China Pharmaceutical University; China
   Pharmaceutical University; Nantong University
RP Xu, WX (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China.; Bao, XF (corresponding author), Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM xwx8991@163.com; baoxi@ntu.edu.cn
OI Xu, Wenxuan/0000-0001-6878-0822; Lu, Chunfeng/0000-0003-3775-604X
FU National Natural Science Foundation of China [81803606]; Natural Science
   Research Project of Jiangsu Higher Education Institutions [22KJB360015];
   Scientific Research Project of Jiangsu Commission of Health [Z2021007];
   Science and Technology Project Fund of Nantong City [JC22022043]; Sixth
   226 High Level Talent Training Project of Nantong City; Innovation and
   Entrepreneurship Training Program for Undergraduates of Nantong
   University [2022233]
FX National Natural Science Foundation of China, Grant/Award Number:
   81803606; Natural Science Research Project of Jiangsu Higher Education
   Institutions, Grant/Award Number: 22KJB360015; Scientific Research
   Project of Jiangsu Commission of Health, Grant/Award Number: Z2021007;
   The Science and Technology Project Fund of Nantong City, Grant/Award
   Number: JC22022043; The Sixth 226 High Level Talent Training Project of
   Nantong City; Innovation and Entrepreneurship Training Program for
   Undergraduates of Nantong University, Grant/Award Number: 2022233
CR Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Dang K, 2020, AM J GASTROENTEROL, V115, P96, DOI 10.14309/ajg.0000000000000380
   Garaycoechea JI, 2018, NATURE, V553, P171, DOI 10.1038/nature25154
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guan LH, 2022, AGEING RES REV, V78, DOI 10.1016/j.arr.2022.101634
   Hahn S, 2013, EMBO J, V32, P3079, DOI 10.1038/emboj.2013.236
   Heo JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay4624
   Ji W, 2020, MOL THER-NUCL ACIDS, V21, P98, DOI 10.1016/j.omtn.2020.05.020
   Jiang YM, 2023, CELL BIOL TOXICOL, V39, P729, DOI 10.1007/s10565-021-09635-8
   Lee SJ, 2022, BIOLOGY-BASEL, V11, DOI 10.3390/biology11081108
   Liu LM, 2022, CLIN EXP PHARMACOL P, V49, P1042, DOI 10.1111/1440-1681.13696
   Lu CF, 2015, LIFE SCI, V141, P119, DOI 10.1016/j.lfs.2015.08.018
   Maciejowski J, 2017, NAT REV MOL CELL BIO, V18, P175, DOI 10.1038/nrm.2016.171
   Martínez-Cué C, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00016
   McCoy MK, 2014, HUM MOL GENET, V23, P145, DOI 10.1093/hmg/ddt407
   Nicolai S, 2020, ONCOGENE, V39, P754, DOI 10.1038/s41388-019-1028-7
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pieraccioli M, 2016, ONCOGENE, V35, P2592, DOI 10.1038/onc.2015.320
   Pieraccioli M, 2018, P NATL ACAD SCI USA, V115, P7356, DOI 10.1073/pnas.1801435115
   Qi XY, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.912825
   Seo KW, 2013, CELL TRANSPLANT, V22, P29, DOI 10.3727/096368912X654948
   Shao YY, 2021, TOXICOLOGY, V461, DOI 10.1016/j.tox.2021.152923
   Smolarz M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23084169
   Starzynska A, 2021, CANCERS, V13, DOI 10.3390/cancers13112661
   Tan VP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1965-7
   Uysal F, 2021, J ASSIST REPROD GEN, V38, P429, DOI 10.1007/s10815-020-01932-1
   Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014
   Wang J, 2020, ACTA PHARM SIN B, V10, P1866, DOI 10.1016/j.apsb.2020.03.004
   Wang J, 2020, PHARMACOL RES, V156, DOI 10.1016/j.phrs.2020.104771
   Wang J, 2020, ANGIOGENESIS, V23, P299, DOI 10.1007/s10456-020-09720-2
   Wang Y, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31211-9
   Wei WQ, 2018, J CELL PHYSIOL, V233, P9121, DOI 10.1002/jcp.26956
   Wu RM, 2021, TOXICOL LETT, V350, P10, DOI 10.1016/j.toxlet.2021.06.018
   Xian ZY, 2020, ONCOTARGETS THER, V13, P7571, DOI 10.2147/OTT.S258727
   Xie YD, 2019, CHINESE MED J-PEKING, V132, P420, DOI [10.1097/CM9.0000000000000067, 10.1097/cm9.0000000000000067]
   Yu W, 2022, J CELL MOL MED, V26, P2119, DOI 10.1111/jcmm.17235
   Zhang CY, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23158267
   Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286
   Zhang MY, 2022, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.759421
   Zhang ZB, 2020, CANCER BIOTHER RADIO, V35, P137, DOI 10.1089/cbr.2019.3008
   Zhou H, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101250
   Zhou H, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0094-1
   Zhou Y, 2022, CELL PROLIFERAT, V55, DOI 10.1111/cpr.13193
   Zhou Y, 2022, FREE RADICAL BIO MED, V179, P301, DOI 10.1016/j.freeradbiomed.2021.11.008
NR 44
TC 2
Z9 2
U1 6
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7722
EI 1365-2184
J9 CELL PROLIFERAT
JI Cell Prolif.
PD 2023 MAR
PY 2023
VL 56
IS 3
DI 10.1111/cpr.13378
EA DEC 2022
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 9M0UI
UT WOS:000898027100001
PM 36514923
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Qi, XY
   Zheng, SG
   Ma, MY
   Lian, NQ
   Wang, HT
   Chen, LR
   Song, AP
   Lu, CF
   Zheng, SZ
   Jin, HH
AF Qi, Xiaoyu
   Zheng, Shuguo
   Ma, Mingyue
   Lian, Naqi
   Wang, Hongting
   Chen, Lerong
   Song, Anping
   Lu, Chunfeng
   Zheng, Shizhong
   Jin, Huanhuan
TI Curcumol Suppresses CCF-Mediated Hepatocyte Senescence Through Blocking
   LC3B-Lamin B1 Interaction in Alcoholic Fatty Liver Disease
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE curcumol; cellular senescence; cytoplasmic chromatin fragments;
   alcoholic fatty liver disease; LC3B-lamin B1
ID CYTOSOLIC CHROMATIN FRAGMENTS; OXIDATIVE DNA-DAMAGE; CYCLIC GMP-AMP;
   CANCER; INFLAMMATION; STEATOHEPATITIS; DEGRADATION; EXPRESSION;
   RADIATION
AB Recent studies indicated that hepatocyte senescence plays an important role in the development of alcoholic fatty liver disease (AFLD), suggesting that inhibition of hepatocyte senescence might be a potential strategy for AFLD treatment. The present study investigated the effect of curcumol, a component from the root of Rhizoma Curcumae, on hepatocyte senescence in AFLD and the underlying mechanisms implicated. The results showed that curcumol was able to reduce lipid deposition and injury in livers of ethanol liquid diet-fed mice and in ethanol-treated LO2 cells. Both in vivo and in vitro studies indicated that supplementation with curcumol effectively alleviated ethanol-induced cellular senescence as manifested by a decrease in senescence-associated beta-galactosidase (SA-beta-gal) activity, a downregulated expression of senescence-related markers p16 and p21, and dysfunction of the telomere and telomerase system. Consistently, treatment with curcumol led to a marked suppression of ethanol-induced formation of cytoplasmic chromatin fragments (CCF) and subsequent activation of cGAS-STING, resulting in a significant reduction in senescence-associated secretory phenotype (SASP)-related inflammatory factors' secretion. Further studies indicated that curcumol's inhibition of CCF formation might be derived from blocking the interaction of LC3B with lamin B1 and maintaining nuclear membrane integrity. Taken together, these results indicated that curcumol was capable of ameliorating AFLD through inhibition of hepatocyte senescence, which might be attributed to its blocking of LC3B and lamin B1 interaction and subsequent inactivation of the CCF-cGAS-STING pathway. These findings suggest a promising use of curcumol in the treatment of AFLD.
C1 [Qi, Xiaoyu; Zheng, Shuguo; Ma, Mingyue; Wang, Hongting; Chen, Lerong; Song, Anping; Jin, Huanhuan] Wannan Med Coll, Sch Pharm, Dept Pharmacol, Wuhu, Peoples R China.
   [Lian, Naqi] Nanjing Univ Chinese Med, Sch Med & Holist Integrat Med, Nanjing, Peoples R China.
   [Lu, Chunfeng] Nantong Univ, Sch Pharm, Nantong, Peoples R China.
   [Zheng, Shizhong] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing, Peoples R China.
C3 Wannan Medical College; Nanjing University of Chinese Medicine; Nantong
   University; Nanjing University of Chinese Medicine
RP Jin, HH (corresponding author), Wannan Med Coll, Sch Pharm, Dept Pharmacol, Wuhu, Peoples R China.; Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing, Peoples R China.
EM szhengnucm@163.com; nytws@163.com
RI Wang, Hongting/GWM-3941-2022
OI Wang, Hongting/0000-0002-8211-3935; Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [81900531, 81803606]; Key
   Project of Natural Science Research Projects of Anhui Higher Education
   Institutions [KJ 2020A0621]; National College Students Innovation and
   Entrepreneurship Training Program [202110368050]
FX Funding This study was supported by the National Natural Science
   Foundation of China (81900531 and 81803606), the Key Project of Natural
   Science Research Projects of Anhui Higher Education Institutions (KJ
   2020A0621), and the National College Students Innovation and
   Entrepreneurship Training Program (202110368050).
CR Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V65, P1238, DOI 10.1016/j.freeradbiomed.2013.09.009
   Addolorato G, 2016, J HEPATOL, V65, P618, DOI 10.1016/j.jhep.2016.04.029
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Avila MA, 2020, GUT, V69, P764, DOI 10.1136/gutjnl-2019-319720
   Azarm K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17133-4
   Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304
   Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921
   Bauer ME, 2016, MECH AGEING DEV, V158, P27, DOI 10.1016/j.mad.2016.01.001
   Bhatia S, 2019, BIRTH DEFECTS RES, V111, P714, DOI 10.1002/bdr2.1509
   Caputo F, 2019, HEPATOLOGY, V70, P410, DOI 10.1002/hep.30358
   Chen CH, 2011, ALCOHOL CLIN EXP RES, V35, P338, DOI 10.1111/j.1530-0277.2010.01349.x
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050
   Dou ZX, 2016, AUTOPHAGY, V12, P1416, DOI 10.1080/15548627.2015.1127465
   Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548
   Galluzzi L, 2016, TRENDS CELL BIOL, V26, P1, DOI 10.1016/j.tcb.2015.11.001
   Gao DQ, 2004, AM J PHYSIOL-GASTR L, V287, pG1070, DOI 10.1152/ajpgi.00228.2004
   Glück S, 2019, CURR OPIN IMMUNOL, V56, P31, DOI 10.1016/j.coi.2018.09.013
   Glück S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586
   Guo XH, 2019, MUTAT RES-REV MUTAT, V779, P1, DOI 10.1016/j.mrrev.2018.11.001
   Han XJ, 2020, J BIOL CHEM, V295, P4451, DOI 10.1074/jbc.RA119.010734
   Hashem S, 2021, NUTR CANCER, V73, P181, DOI 10.1080/01635581.2020.1749676
   Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Huang YH, 2014, AUTOPHAGY, V10, P1212, DOI 10.4161/auto.28772
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110
   Jia Y, 2018, REDOX BIOL, V19, P375, DOI 10.1016/j.redox.2018.09.007
   Jiang YM, 2023, CELL BIOL TOXICOL, V39, P729, DOI 10.1007/s10565-021-09635-8
   Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523
   Kim DH, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110891
   Koelmel JP, 2022, HEPATOL COMMUN, V6, P513, DOI 10.1002/hep4.1825
   Kong LN, 2021, PHYTOMEDICINE, V90, DOI 10.1016/j.phymed.2021.153629
   Krupina K, 2021, CURR OPIN CELL BIOL, V70, P91, DOI 10.1016/j.ceb.2021.01.004
   Kumar S, 2019, AGING-US, V11, P4145, DOI 10.18632/aging.102043
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Leidal AM, 2015, DEV CELL, V35, P529, DOI 10.1016/j.devcel.2015.11.016
   Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266
   Malaquin N, 2016, EXP GERONTOL, V82, P39, DOI 10.1016/j.exger.2016.05.010
   Ogrodnik M, 2017, CELL STRESS, V1, P70, DOI 10.15698/cst2017.10.108
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Panyod S, 2016, J AGR FOOD CHEM, V64, P7104, DOI 10.1021/acs.jafc.6b02763
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Petitpas F, 2013, EXP TOXICOL PATHOL, V65, P263, DOI 10.1016/j.etp.2011.09.001
   Phelan T, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2020.113831
   Postberg J, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110940
   Seitz HK, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0014-7
   Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113
   Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111
   Shimizu R, 2015, J HEPATO-BIL-PAN SCI, V22, P675, DOI 10.1002/jhbp.256
   Singh BK, 2020, AGING-US, V12, P13958, DOI 10.18632/aging.103740
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Sun Y, 2018, TRENDS MOL MED, V24, P871, DOI 10.1016/j.molmed.2018.08.002
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004
   Tête A, 2020, FOOD CHEM TOXICOL, V146, DOI 10.1016/j.fct.2020.111798
   Wang H, 2020, AGING-US, V12, P9240, DOI 10.18632/aging.103200
   Wei W, 2019, INT J BIOL SCI, V15, P1600, DOI 10.7150/ijbs.34716
   Wen BJ, 2021, PHARMACOL THERAPEUT, V222, DOI 10.1016/j.pharmthera.2020.107752
   Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963
   Wu RM, 2021, TOXICOL LETT, V350, P10, DOI 10.1016/j.toxlet.2021.06.018
   Zhao JM, 2019, CELL CYCLE, V18, P3378, DOI 10.1080/15384101.2019.1677074
NR 64
TC 8
Z9 8
U1 3
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUN 28
PY 2022
VL 13
AR 912825
DI 10.3389/fphar.2022.912825
PG 16
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 2V9IE
UT WOS:000824149500001
PM 35837283
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kolosova, NG
   Aidagulova, SV
   Nepomnyashchikh, GI
   Shabalina, IG
   Shalubueva, NI
AF Kolosova, NG
   Aidagulova, SV
   Nepomnyashchikh, GI
   Shabalina, IG
   Shalubueva, NI
TI Dynamics of structural and functional changes in hepatocyte mitochondria
   of senescence-accelerated OXYS rats
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE OXYS rats; hepatocyte mitochondria; electron microscopy; energy
   metabolism of liver mitochondria
ID OXIDATIVE STRESS
AB Electron microscopy showed signs of degenerative dystrophic changes in hepatocytes and structural decompensation of mitochondria in senescence-accelerated OXYS rats in comparison with Wistar rats. These signs were detected in the presence of liver mitochondria dysfunction in OXYS rats: reduced oxygen consumption rate in all metabolic states, respiratory control volume, ADP/O ratio. transmembrane potential, and phosphorylation rate. The revealed disorders in mitochondrial structure and function are the key factors in the pathogenesis of accelerated aging in OXYS rats and visceropathies characteristic of these animals.
C1 Russian Acad Med Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk, Russia.
   Russian Acad Med Sci, Siberian Div, Inst Reg Pathol & Pathomorphol, Novosibirsk, Russia.
   Russian Acad Med Sci, Inst Biochem, Siberian Div, Novosibirsk, Russia.
   Russian Acad Med Sci, Inst Physiol, Siberian Div, Novosibirsk, Russia.
C3 Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB
   RAS; Russian Academy of Medical Sciences; Russian Academy of Medical
   Sciences; Russian Academy of Sciences; Russian Academy of Medical
   Sciences; Russian Academy of Sciences; Research Institute for
   Neurosciences & Medicine; Russian Academy of Sciences; Russian Academy
   of Medical Sciences
RI Shabalina, Irina G/A-4225-2011; Shabalina, Irina/AAC-3720-2019;
   Kolosova, Nataliya G/AAR-7409-2020; Aidagulova, Svetlana/AAU-1682-2021;
   Aidagulova, Svetlana/H-4573-2013; Kolosova, Nataliya G/P-3178-2015
OI Shabalina, Irina G/0000-0002-2915-6450; Shabalina,
   Irina/0000-0002-2915-6450; Kolosova, Nataliya G/0000-0003-2398-8544;
   Aidagulova, Svetlana/0000-0001-7124-1969; Aidagulova,
   Svetlana/0000-0001-7124-1969; Kolosova, Nataliya G/0000-0003-2398-8544
CR BORODIN PM, 1977, RAT NEWS LETT, P50
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   KOLOSOVA NG, 1991, BIOFIZIKA+, V36, P802
   LOSKUTOVA LV, 2000, B EKSP BIOL MED, V130, P155
   MENSHCHIKOVA EB, 2000, B SO ROSSIISK AKAD M, P43
   NEPOMNYASHEHIKH LM, 1995, MORPHOLOGY GENETICAL
   Nohl H, 1997, EXP GERONTOL, V32, P485, DOI 10.1016/S0531-5565(96)00169-6
   Salganik R. I., 1995, Byulleten' Eksperimental'noi Biologii i Meditsiny, V119, P628
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V205, P180, DOI 10.1006/bbrc.1994.2647
   Sastre J, 1998, FREE RADICAL BIO MED, V24, P298, DOI 10.1016/S0891-5849(97)00228-1
   Shabalina I G, 1995, Biokhimiia, V60, P2045
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOLOVEVA NA, 1975, GENETIKA+, V11, P63
   1996, RAT GENOME, V2, P52
NR 16
TC 20
Z9 22
U1 0
U2 7
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD AUG
PY 2001
VL 132
IS 2
BP 814
EP 819
DI 10.1023/A:1013014919721
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 518XJ
UT WOS:000173693100030
PM 11713575
DA 2024-02-19
ER

PT J
AU Jiang, YM
   Zhou, Y
   Xu, WX
   Wang, XQ
   Jin, HH
   Bao, XF
   Lu, CF
AF Jiang, Yiming
   Zhou, Ying
   Xu, Wenxuan
   Wang, Xinqi
   Jin, Huanhuan
   Bao, Xiaofeng
   Lu, Chunfeng
TI Induction of Sestrin2 by pterostilbene suppresses ethanol-triggered
   hepatocyte senescence by degrading CCN1 via p62-dependent selective
   autophagy
SO CELL BIOLOGY AND TOXICOLOGY
LA English
DT Article; Early Access
DE Alcoholic liver disease; Pterostilbene; Hepatocyte; Senescence;
   Autophagy; CCN1; Sestrin2
ID INDUCED LIVER-INJURY; OXIDATIVE STRESS; LIPOCYTE PHENOTYPE; NRF2
   ACTIVATION; LIGUSTRAZINE; CURCUMIN; CELLS
AB Hepatocyte senescence is a key event participating in the progression of alcoholic liver disease. Autophagy is a critical biological process that controls cell fates by affecting cell behaviors like senescence. Pterostilbene is a natural compound with hepatoprotective potential; however, its implication for alcoholic liver disease was not understood. This study was aimed to investigate the therapeutic effect of pterostilbene on alcoholic liver disease and elucidate the potential mechanism. Our results showed that pterostilbene alleviated ethanol-triggered hepatocyte damage and senescence. Intriguingly, pterostilbene decreased the protein abundance of cellular communication network factor 1 (CCN1) in ethanol-exposed hepatocytes, which was essential for pterostilbene to execute its anti-senescent function. In vivo studies verified the anti-senescent effect of pterostilbene on hepatocytes of alcohol-intoxicated mice. Pterostilbene also relieved senescence-associated secretory phenotype (SASP), redox imbalance, and steatosis by suppressing hepatic CCN1 expression. Mechanistically, pterostilbene-forced CCN1 reduction was dependent on posttranscriptional regulation via autophagy machinery but not transcriptional regulation. To be specific, pterostilbene restored autophagic flux in damaged hepatocytes and activated p62-mediated selective autophagy to recognize and lead CCN1 to autolysosomes for degradation. The protein abundance of Sestrin2 (SESN2), a core upstream modulator of autophagy pathway, was decreased in ethanol-administrated hepatocytes but rescued by co-treatment with pterostilbene. Induction of SESN2 protein by pterostilbene rescued ethanol-triggered autophagic dysfunction in hepatocytes, which then reduced senescence-associated markers, postponed hepatocyte senescence, and relieved alcohol-caused liver injury and inflammation. In conclusion, this work discovered a novel compound pterostilbene with therapeutic implications for alcoholic liver disease and uncover its underlying mechanism.
C1 [Jiang, Yiming; Zhou, Ying; Wang, Xinqi; Bao, Xiaofeng; Lu, Chunfeng] Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
   [Xu, Wenxuan] Nanjing Univ Chinese Med, Sch Pharm, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
   [Jin, Huanhuan] Wannan Med Coll, Sch Pharm, Dept Pharmacol, 22 West Wenchang Rd, Wuhu 241002, Anhui, Peoples R China.
C3 Nantong University; Nanjing University of Chinese Medicine; Wannan
   Medical College
RP Lu, CF (corresponding author), Nantong Univ, Sch Pharm, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM ntdxlcf@ntu.edu.cn
RI Lu, Xiaomei/IUQ-2139-2023; li, xiao/HKV-8405-2023; cheng,
   shu/IZE-4788-2023; lin, qing/JED-5250-2023; liu, junyang/IXD-1201-2023;
   li, yang/IQV-3559-2023; liu, junyang/IXD-1252-2023; liang,
   YU/IYT-4334-2023
OI liang, YU/0009-0007-3922-3454; Lu, Chunfeng/0000-0003-3775-604X
FU National Natural Science Foundation of China (China) [81803606,
   81900531]; Science and Technology Project of Jiangsu Provincial
   Administration of Traditional Chinese Medicine (China) [YB201847];
   Nantong Science and Technology Project (China) [MS12018051]; Innovation
   and Entrepreneurship Training Program for Undergraduates of Nantong
   University (China) [2020207]; Scientific Research Startup Foundation for
   Talents of Nantong University (China)
FX This work was supported by the National Natural Science Foundation of
   China (No. 81803606 and No. 81900531, China), The Science and Technology
   Project of Jiangsu Provincial Administration of Traditional Chinese
   Medicine (No. YB201847, China), Nantong Science and Technology Project
   (No. MS12018051, China), Innovation and Entrepreneurship Training
   Program for Undergraduates of Nantong University (No. 2020207, China),
   and Scientific Research Startup Foundation for Talents of Nantong
   University (China).
CR Babuta M, 2019, HEPATOLOGY, V70, P2123, DOI 10.1002/hep.30766
   Bian ZL, 2013, J LIPID RES, V54, P44, DOI 10.1194/jlr.M026013
   Chen JW, 2021, AGING-US, V13, P6025, DOI 10.18632/aging.202536
   Chen YN, 2020, POULTRY SCI, V99, P3158, DOI 10.1016/j.psj.2020.01.021
   Ding WX, 2011, EXP BIOL MED, V236, P546, DOI 10.1258/ebm.2011.010360
   Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041
   Dong RC, 2021, EUR J PHARMACOL, V890, DOI 10.1016/j.ejphar.2020.173653
   Feng M, 2020, BONE, V139, DOI 10.1016/j.bone.2020.115522
   Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530
   Gómez-Zorita S, 2021, CURR MED CHEM, V28, P238, DOI 10.2174/0929867326666191029112626
   Gorojod RM, 2015, FREE RADICAL BIO MED, V87, P237, DOI 10.1016/j.freeradbiomed.2015.06.034
   Habiballa L, 2019, FREE RADICAL BIO MED, V132, P3, DOI 10.1016/j.freeradbiomed.2018.10.417
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Huang XQ, 2021, ACTA BIOMATER, V121, P605, DOI 10.1016/j.actbio.2020.11.036
   Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603
   Jin HH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12431
   Kang KY, 2019, FOOD CHEM TOXICOL, V123, P536, DOI 10.1016/j.fct.2018.12.012
   Liu XJ, 2017, INT IMMUNOPHARMACOL, V49, P50, DOI 10.1016/j.intimp.2017.05.022
   Liu ZY, 2021, INFLAMMATION, V44, P526, DOI 10.1007/s10753-020-01349-z
   Lu CF, 2017, BIOMED PHARMACOTHER, V95, P1, DOI 10.1016/j.biopha.2017.08.037
   Lu CF, 2017, INT IMMUNOPHARMACOL, V49, P203, DOI 10.1016/j.intimp.2017.06.001
   Lu CF, 2017, TOXICOL SCI, V155, P432, DOI 10.1093/toxsci/kfw228
   Lu CF, 2016, MOL PHARMACEUT, V13, P4043, DOI 10.1021/acs.molpharmaceut.6b00562
   Lu CF, 2016, TOXICOLOGY, V365, P35, DOI 10.1016/j.tox.2016.07.018
   Ogrodnik M, 2017, CELL STRESS, V1, P70, DOI 10.15698/cst2017.10.108
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044
   Salazar G, 2020, AUTOPHAGY, V16, P1092, DOI 10.1080/15548627.2019.1659612
   Shao ZX, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12975
   Su, 2020, CANCERS, V12, P1
   Tai HR, 2017, AUTOPHAGY, V13, P99, DOI 10.1080/15548627.2016.1247143
   Tsou PS, 2019, ARTHRITIS RHEUMATOL, V71, P1350, DOI 10.1002/art.40890
   Wang Y, 2013, HEPATOLOGY, V58, P995, DOI 10.1002/hep.26394
   Wang YJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00436
   Wu JY, 2019, FOOD FUNCT, V10, P7308, DOI 10.1039/c9fo01405e
   Wu RM, 2021, TOXICOL LETT, V350, P10, DOI 10.1016/j.toxlet.2021.06.018
   Yao RQ, 2021, AUTOPHAGY, V17, P385, DOI 10.1080/15548627.2020.1725377
   Yu CL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1639-5
   Zhang H, 2021, NUTRITION, V81, DOI 10.1016/j.nut.2020.110940
   Zhang LL, 2021, CAN J PHYSIOL PHARM, V99, P900, DOI 10.1139/cjpp-2020-0583
   Zhou Y, 2019, TOXICOL IN VITRO, V57, P226, DOI 10.1016/j.tiv.2019.03.008
NR 42
TC 17
Z9 17
U1 4
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0742-2091
EI 1573-6822
J9 CELL BIOL TOXICOL
JI Cell Biol. Toxicol.
PD 2023 JUN
PY 2023
VL 39
IS 3
BP 729
EP 749
DI 10.1007/s10565-021-09635-8
EA AUG 2021
PG 21
WC Cell Biology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Toxicology
GA O5QG3
UT WOS:000685603300001
PM 34405320
DA 2024-02-19
ER

PT J
AU Baboota, RK
   Spinelli, R
   Erlandsson, MC
   Brandao, BB
   Lino, M
   Yang, H
   Mardinoglu, A
   Bokarewa, MI
   Boucher, J
   Kahn, CR
   Smith, U
AF Baboota, Ritesh K.
   Spinelli, Rosa
   Erlandsson, Malin C.
   Brandao, Bruna B.
   Lino, Marsel
   Yang, Hong
   Mardinoglu, Adil
   Bokarewa, Maria I.
   Boucher, Jeremie
   Kahn, C. Ronald
   Smith, Ulf
TI Chronic hyperinsulinemia promotes human hepatocyte senescence
SO MOLECULAR METABOLISM
LA English
DT Article; Early Access
DE Keywords Hyperinsulinemia; Senescence; Hepatocytes; NAFLD; Dasatinib;
   Quercetin
ID SELECTIVE INSULIN-RESISTANCE; CELLULAR SENESCENCE; HUMAN-CELLS;
   MECHANISMS; DISEASE; LEADS
AB Objective: Cellular senescence, an irreversible proliferative cell arrest, is caused by excessive intracellular or extracellular stress/damage. Increased senescent cells have been identified in multiple tissues in different metabolic and other aging-related diseases. Recently, several human and mouse studies emphasized the involvement of senescence in development and progression of NAFLD. Hyperinsulinemia, seen in obesity, metabolic syndrome, and other conditions of insulin resistance, has been linked to senescence in adipocytes and neurons. Here, we investigate the possible direct role of chronic hyperinsulinemia in the development of senescence in human hepatocytes.Methods: Using fluorescence microscopy, immunoblotting, and gene expression, we tested senescence markers in human hepatocytes subjected to chronic hyperinsulinemia in vitro and validated the data in vivo by using liver-specific insulin receptor knockout (LIRKO) mice. The consequences of hyperinsulinemia were also studied in senescent hepatocytes following doxorubicin as a model of stress-induced senescence. Furthermore, the effects of senolytic agents in insulin- and doxorubicin-treated cells were analyzed.Results: Results showed that exposing the hepatocytes to prolonged hyperinsulinemia promotes the onset of senescence by increasing the expression of p53 and p21. It also further enhanced the senescent phenotype in already senescent hepatocytes. Addition of insulin signaling pathway inhibitors prevented the increase in cell senescence, supporting the direct contribution of insulin. Furthermore, LIRKO mice, in which insulin signaling in the liver is abolished due to deletion of the insulin receptor gene, showed no differences in senescence compared to their wildtype counterparts despite having marked hyperinsulinemia indicating these are receptor-mediated effects. In contrast, the persistent hyperinsulinemia in LIRKO mice enhanced senescence in white adipose tissue. In vitro, senolytic agents dasatinib and quercetin reduced the prosenescent effects of hyperinsulinemia in hepatocytes.Conclusion: Our findings demonstrate a direct link between chronic hyperinsulinemia and hepatocyte senescence. This effect can be blocked by reducing the levels of insulin receptors or administration of senolytic drugs, such as dasatinib and quercetin.(c) 2022 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Baboota, Ritesh K.; Spinelli, Rosa; Boucher, Jeremie; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.
   [Spinelli, Rosa] Federico II Univ Naples, Dept Translat Med Sci, Naples, Italy.
   [Spinelli, Rosa] CNR, Inst Expt Endocrinol & Oncol, URT Genom Diabet, Naples, Italy.
   [Erlandsson, Malin C.; Bokarewa, Maria I.] Univ Gothenburg, Inst Med, Dept Rheumatol & flammat Res, Gothenburg, Sweden.
   [Erlandsson, Malin C.; Bokarewa, Maria I.] Sahlgrens Univ Hosp, Rheumatol Clin, Gothenburg, Sweden.
   [Brandao, Bruna B.; Kahn, C. Ronald] Joslin Diabet Ctr, One Joslin Pl, Boston, MA USA.
   [Brandao, Bruna B.; Kahn, C. Ronald] Harvard Med Sch, One Joslin Pl, Boston, MA USA.
   [Yang, Hong; Mardinoglu, Adil] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.
   [Boucher, Jeremie] Evotec Int GmbH, Metab Dis, Gottingen, Germany.
   [Smith, Ulf] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Bla Straket 5, SE-41345 Gothenburg, Sweden.
C3 University of Gothenburg; University of Naples Federico II; Consiglio
   Nazionale delle Ricerche (CNR); University of Gothenburg; Sahlgrenska
   University Hospital; Harvard University; Joslin Diabetes Center, Inc.;
   Harvard University; Harvard Medical School; Royal Institute of
   Technology; Evotec; Sahlgrenska University Hospital
RP Smith, U (corresponding author), Sahlgrens Univ Hosp, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Bla Straket 5, SE-41345 Gothenburg, Sweden.
EM ulf.smith@medic.gu.se
RI Lino, Marsel/HHN-1235-2022
OI Lino, Marsel/0000-0001-9662-6339; Smith, Ulf/0000-0002-1439-4608
FU Knut and Alice Wallenberg Foundation; Swedish Research Council; Novo
   Nordisk Foundation; Heart and Lung Foundation; Swedish Diabetes Research
   Foundation; National Institutes of Health [R01DK031036]
FX We acknowledge financial support from the Knut and Alice Wallenberg
   Foundation, the Swedish Research Council, the Novo Nordisk Foundation,
   the Heart and Lung Foundation, and the Swedish Diabetes Research
   Foundation. C.R.K. was supported by a grant from the National Institutes
   of Health (R01DK031036)
CR Alqahtani SA, 2021, CLIN INTERV AGING, V16, P1633, DOI 10.2147/CIA.S295524
   Aravinthan A, 2015, EXP CELL RES, V331, P38, DOI 10.1016/j.yexcr.2014.09.025
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Astle MV, 2012, ONCOGENE, V31, P1949, DOI 10.1038/onc.2011.394
   Bent EH, 2016, GENE DEV, V30, P1811, DOI 10.1101/gad.284851.116
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chow HM, 2019, NAT NEUROSCI, V22, P1806, DOI 10.1038/s41593-019-0505-1
   Cook JR, 2015, J BIOL CHEM, V290, P13972, DOI 10.1074/jbc.M115.638197
   Engelmann C, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020652
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Gonzalez E, 2011, P NATL ACAD SCI USA, V108, P10162, DOI 10.1073/pnas.1019268108
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Govaere O, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba4448
   Gustafson B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10688-x
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Li Q, 2021, NAT MED, V27, P1941, DOI 10.1038/s41591-021-01501-8
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Neurohr GE, 2019, CELL, V176, P1083, DOI 10.1016/j.cell.2019.01.018
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919
   Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Spinelli R, 2022, AGING CELL, V21, DOI 10.1111/acel.13557
   Wang MJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.167
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
NR 33
TC 12
Z9 12
U1 2
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-8778
J9 MOL METAB
JI Mol. Metab.
PD 2022 OCT
PY 2022
VL 64
AR 101558
DI 10.1016/j.molmet.2022.101558
EA AUG 2022
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 3Z0DV
UT WOS:000844092400003
PM 35872305
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Guo, QL
   Chen, MH
   Chen, QD
   Xiao, GT
   Chen, ZX
   Wang, XZ
   Huang, YH
AF Guo, Qilan
   Chen, Minghua
   Chen, Qingduo
   Xiao, Guitao
   Chen, Zhixin
   Wang, Xiaozhong
   Huang, Yuehong
TI Silencing p53 inhibits interleukin 10-induced activated hepatic stellate
   cell senescence and fibrotic degradation in vivo
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Interleukin 10; gene therapy; p53; hepatic stellate cells; senescence;
   liver fibrosis
AB Activated hepatic stellate cells are reported to play a significant role in liver fibrogenesis. Beside the phenotype reversion and apoptosis of activated hepatic stellate cells, the senescence of activated hepatic stellate cells limits liver fibrosis. Our previous researches have demonstrated that interleukin-10 could promote hepatic stellate cells senescence via p53 signaling pathway in vitro. However, the relationship between expression of p53 and senescence of activated hepatic stellate cells induced by interleukin-10 in fibrotic liver is unclear. The purpose of present study was to explore whether p53 plays a crucial role in the senescence of activated hepatic stellate cells and degradation of collagen mediated by interleukin-10. Hepatic fibrosis animal model was induced by carbon tetrachloride through intraperitoneal injection and transfection of interleukin-10 gene to liver was performed by hydrodynamic-based transfer system. Depletions of p53 in vivo and in vitro were carried out by adenovirus-based short hairpin RNA against p53. Regression of fibrosis was assessed by liver biopsy and collagen staining. Cellular senescence in the liver was observed by senescence-associated beta-galactosidase (SA-beta-Gal) staining. Immunohistochemistry, immunofluorescence double staining, and Western blot analysis were used to evaluate the senescent cell and senescence-related protein expression. Our data showed that interleukin-10 gene treatment could lighten hepatic fibrosis induced by carbon tetrachloride and induce the aging of activated hepatic stellate cells accompanied by up-regulating the expression of aging-related proteins. We further demonstrated that depletion of p53 could abrogate up-regulation of interleukin-10 on the expression of senescence-related protein in vivo and vitro. Moreover, p53 knockout in fibrotic mice could block not only the senescence of activated hepatic stellate cells, but also the degradation of fibrosis induced by interleukin-10 gene intervention. Taken together, our results suggested that interleukin-10 gene treatment could attenuate carbon tetrachloride-induced hepatic fibrosis by inducing senescence of activated hepatic stellate cells in vivo, and this induction was closely related to p53 signaling pathway.
C1 [Guo, Qilan; Chen, Minghua; Chen, Qingduo; Xiao, Guitao; Chen, Zhixin; Wang, Xiaozhong; Huang, Yuehong] Fujian Med Univ Union Hosp, Dept Gastroenterol, Fuzhou 350001, Peoples R China.
   [Guo, Qilan; Huang, Yuehong] Fujian Med Univ Union Hosp, Dept Geriatr, Fuzhou 350001, Peoples R China.
RP Wang, XZ; Huang, YH (corresponding author), Fujian Med Univ Union Hosp, Dept Gastroenterol, Fuzhou 350001, Peoples R China.; Huang, YH (corresponding author), Fujian Med Univ Union Hosp, Dept Geriatr, Fuzhou 350001, Peoples R China.
EM 2003huangyh@sina.com; drwangxz@163.com
RI Chen, Ming/GVU-8412-2022
OI HUANG, Yue-Hong/0000-0001-7134-719X
CR Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400
   Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140
   Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445
   Huang YH, 2018, MOL MED REP, V17, P5700, DOI 10.3892/mmr.2018.8592
   Huang YH, 2014, INT J MOL MED, V34, P677, DOI 10.3892/ijmm.2014.1831
   Hung KS, 2005, BIOCHEM BIOPH RES CO, V336, P324, DOI 10.1016/j.bbrc.2005.08.085
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, CELL SIGNAL, V33, P79, DOI 10.1016/j.cellsig.2017.02.006
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kurosaki F, 2018, HUM GENE THER, V29, P1242, DOI 10.1089/hum.2018.024
   Li P., 2017, SCI REP-UK, P742938
   Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026
   Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621
   Mitra A, 2014, HEPATOLOGY, V60, P2027, DOI 10.1002/hep.27392
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Ruigrok MJR, 2018, EUR J PHARM BIOPHARM, V133, P339, DOI 10.1016/j.ejpb.2018.11.005
   Shamskhou EA, 2019, BIOMATERIALS, V203, P52, DOI 10.1016/j.biomaterials.2019.02.017
   Verma SK, 2017, CIRCULATION, V136, P940, DOI 10.1161/CIRCULATIONAHA.117.027889
   Huang YH, 2006, WORLD J GASTROENTERO, V12, P1386, DOI 10.3748/wjg.v12.i9.1386
   Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
NR 32
TC 9
Z9 10
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD FEB
PY 2021
VL 246
IS 4
BP 447
EP 458
DI 10.1177/1535370220960391
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA QG4DY
UT WOS:000617539200010
PM 33028080
OA Green Published
DA 2024-02-19
ER

PT J
AU Lomas-Soria, C
   Cox, LA
   Nathanielsz, PW
   Zambrano, E
AF Lomas-Soria, Consuelo
   Cox, Laura A.
   Nathanielsz, Peter W.
   Zambrano, Elena
TI Sexual dimorphism in liver cell cycle and senescence signalling pathways
   in young and old rats
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article; Early Access
DE liver ageing; RNA-seq; sex differences
ID OXIDATIVE STRESS; HALLMARKS; SYSTEM; AGE
AB At the molecular level, cellular ageing involves changes in multiple gene pathways. Cellular senescence is both an important initiator and a consequence of natural ageing. Senescence results in changes in multiple cellular mechanisms that result in a natural decrease in cell cycle activity. Liver senescence changes impair hepatic function. Given the well-established sexual dimorphism in ageing, we hypothesized that the natural hepatic ageing process is driven by sex-dependent gene mechanisms. We studied our well-characterized normal, chow-fed rat ageing model, lifespan similar to 850 days, in which we have reported ageing of metabolism, reproduction and endocrine function. We performed liver RNA-seq on males and females at 110 and 650 days to determine changes in the cell cycle and cellular senescence signalling pathways. We found that natural liver ageing shows sexual dimorphism in these pathways. RNA-seq revealed more male (3967) than female (283) differentially expressed genes between 110 and 650 days. Cell cycle pathway signalling changes in males showed decreased protein and expression of key genes (Cdk2, Cdk4, Cycd and PCNA) and increased expression ofp57 at 650 vs 110 days. In females, protein and gene expression of cell growth regulators, e.g. p15 and p21, which inhibit cell cycle G1 progression, were increased. The cell senescence pathway also showed sexual dimorphism. Igfbp3, mTOR and p62 gene and protein expression decreased in males while those ofTgfb3 increased in females. Understanding the involvement of cell cycling and cellular senescence pathways in natural ageing will advance evaluation of mechanisms associated with altered ageing and frailty trajectories. Key points In rats RNA-seq analysis showed sexual dimorphism in gene expression across the life-course between 110 and 650 days of life. Fourteen times more liver transcriptome and six times more pathway changes were observed in males compared with females. Significant changes were observed in several signalling pathways during ageing. Bioinformatic analysis were focused on changes in genes and protein products related to cell cycle and cellular senescence pathways. Males showed decreased protein product and expression of the key genes Cdk2 and Cdk4 responsible for cell cycle progression while females increased protein product and expression of p21 and p15, key genes responsible for cell cycle arrest. In conclusion, normative rat hepatic ageing involves changes in cellular pathways that control cell cycle arrest but through changes in different genes in males and females. These findings identify mechanisms that underlie the well-established sexual dimorphism in ageing.
C1 [Lomas-Soria, Consuelo; Zambrano, Elena] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Biol Reprod, Vasco de Quiroga 15, Tlalpan 14080, Mexico.
   [Lomas-Soria, Consuelo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Biol Reprod, CONACyT Catedras, Vasco de Quiroga 15, Tlalpan 14080, Mexico.
   [Cox, Laura A.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Ctr Precis Med, Winston Salem, NC 27101 USA.
   [Cox, Laura A.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA.
   [Nathanielsz, Peter W.] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA.
   [Nathanielsz, Peter W.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA.
C3 Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran -
   Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador
   Zubiran - Mexico; Wake Forest University; Texas Biomedical Research
   Institute; University of Wyoming; Texas Biomedical Research Institute
RP Zambrano, E (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Vasco de Quiroga 15, Mexico City 14080, DF, Mexico.
EM elena.zambranog@incmnsz.mx
OI Lomas, Consuelo/0000-0003-0390-7305
FU Newton RCUK-CONACyT [FONCICYT/49/2016]; National Institutes of Health
   [U19AG057758]
FX This work was funded by Newton RCUK-CONACyT (FONCICYT/49/2016) and
   National Institutes of Health U19AG057758.
CR Baar EL, 2016, AGING CELL, V15, P155, DOI 10.1111/acel.12425
   Barzilai N, 2018, JAMA-J AM MED ASSOC, V320, P1321, DOI 10.1001/jama.2018.9562
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Castro-Rodríguez DC, 2020, INT J OBESITY, V44, P2430, DOI 10.1038/s41366-020-0619-2
   Cheng CJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12905
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637
   Fedarko NS, 2011, CLIN GERIATR MED, V27, P27, DOI 10.1016/j.cger.2010.08.006
   Fushan AA, 2015, AGING CELL, V14, P352, DOI 10.1111/acel.12283
   Guzmán C, 2006, J PHYSIOL-LONDON, V572, P97, DOI 10.1113/jphysiol.2005.103903
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ibáñez CA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01571
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kwekel JC, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0127-9
   Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675
   Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246
   Leontieva OV, 2014, CELL CYCLE, V13, P2656, DOI 10.4161/15384101.2014.949150
   Lomas-Soria C, 2018, J PHYSIOL-LONDON, V596, P4611, DOI 10.1113/JP276372
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mimura S, 2014, INT J MOL MED, V34, P1065, DOI 10.3892/ijmm.2014.1892
   Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Rodríguez-González GL, 2015, INT J OBESITY, V39, P549, DOI 10.1038/ijo.2014.209
   Rodríguez-González GL, 2019, J PHYSIOL-LONDON, V597, P5549, DOI 10.1113/JP278232
   Santos M, 2015, AM J PHYSIOL-REG I, V308, pR219, DOI 10.1152/ajpregu.00398.2014
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Yosef R, 2017, EMBO J, V36, P2280, DOI 10.15252/embj.201695553
   Zambrano E, 2020, J GERONTOL A-BIOL, V75, P2304, DOI 10.1093/gerona/glaa067
   Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475
NR 41
TC 2
Z9 2
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD 2021 SEP
PY 2021
VL 599
IS 18
BP 4309
EP 4320
DI 10.1113/JP281822
EA SEP 2021
PG 12
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA UP9QA
UT WOS:000692426800001
PM 34387378
OA Bronze
DA 2024-02-19
ER

PT J
AU Panda, K
   Sood, V
   Lal, BB
   Khanna, R
   Rastogi, A
   Ramakrishna, G
   Alam, S
AF Panda, Kalpana
   Sood, Vikrant
   Lal, Bikrant Bihari
   Khanna, Rajeev
   Rastogi, Archana
   Ramakrishna, Gayatri
   Alam, Seema
TI Liver histology and hepatic progenitor cell activity in pediatric acute
   liver failure: Implications for clinical outcome
SO PEDIATRIC TRANSPLANTATION
LA English
DT Article; Early Access
DE hepatic progenitor cells; hepatocyte loss; hepatocyte senescence;
   pediatric acute liver failure; regeneration in acute liver failure
ID REGENERATION; CHILDREN; BIOPSY
AB Background: Hepatic progenitor cell (HPC) activity and regenerative process that follows pediatric acute liver failure (PALF) is still not well understood. This clinicopathological study was thus conducted with an aim to study the correlation of liver histology and HPC activity with outcomes in PALF.Methods: All PALF patients with available hepatic histological specimens were included and specimens were analyzed for hepatocyte loss, HPC activity [using cytokeratin (CK) 7, CK19, sex-determining region Y-related high mobility group box(SOX)9 and epithelial cell adhesion molecule (EpCAM)], hepatocyte proliferation (using Ki67), and hepatocyte senescence (using p53 and p21).Results: Ninety-four children were included: 22 (23.4%) survived with native liver (SNL) (i.e., the good outcome group) while rest (i.e., the poor outcome group) either died [33%, 35.1%] or received liver transplant (LT) [39%, 41.5%]. When compared to subjects with poor outcomes, those in the SNL group exhibited significantly less severe hepatocyte loss, fewer HPC/hpf, more proliferating hepatocytes, and less senescent hepatocytes (p < .05). Increasing severity of hepatocyte loss (adjusted OR: 9.95, 95% CI: 4.22-23.45, p < .001) was identified as an independent predictor of poor outcome. Eighty percent children with >50% native hepatocyte loss had poor outcome within 10 days of hospitalization.Conclusion: In PALF, more severe hepatocyte loss, higher number of HPC activation, lesser number of proliferating hepatocytes, and greater number of senescent hepatocytes are associated with a poor outcome. Loss of >50% hepatocytes is an independent predictor of poor outcome in PALF.
C1 [Panda, Kalpana; Sood, Vikrant; Lal, Bikrant Bihari; Khanna, Rajeev; Alam, Seema] Inst Liver & Biliary Sci, Dept Pediat Hepatol, New Delhi, India.
   [Rastogi, Archana] Inst Liver & Biliary Sci, Dept Pathol, New Delhi, India.
   [Ramakrishna, Gayatri] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India.
   [Alam, Seema] Inst Liver & Biliary Sci, Dept Pediat Hepatol, New Delhi 110070, India.
C3 Institute of Liver & Biliary Sciences (ILBS); Institute of Liver &
   Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS);
   Institute of Liver & Biliary Sciences (ILBS)
RP Alam, S (corresponding author), Inst Liver & Biliary Sci, Dept Pediat Hepatol, New Delhi 110070, India.
EM seema_alam@hotmail.com
RI Lal, Bikrant Bihari/IVH-5368-2023
OI Lal, Bikrant Bihari/0000-0001-6275-7736; PANDA,
   KALPANA/0000-0002-7280-5743
FU Indian Council of Medical Research
FX No Statement Available
CR Baloda V, 2022, ARCH PATHOL LAB MED, V146, P846, DOI 10.5858/arpa.2021-0103-OA
   Best J, 2015, HEPATOBIL SURG NUTR, V4, P48, DOI 10.3978/j.issn.2304-3881.2015.01.16
   Best J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00258
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   DONALDSON BW, 1993, HEPATOLOGY, V18, P1370, DOI 10.1016/0270-9139(93)90226-D
   Khuu DN, 2013, CELL TRANSPLANT, V22, P1369, DOI 10.3727/096368912X659853
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   Jain V, 2016, LIVER TRANSPLANT, V22, P1418, DOI 10.1002/lt.24501
   Jung YM, 2007, HEPATOLOGY, V45, P1091, DOI 10.1002/hep.21660
   Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x
   Katoonizadeh A, 2014, LIVER INT, V34, P1464, DOI 10.1111/liv.12573
   Lal BB, 2021, J PEDIATR GASTR NUTR, V73, pE109, DOI 10.1097/MPG.0000000000003249
   Lanthier N, 2015, J HEPATOL, V63, P609, DOI 10.1016/j.jhep.2015.04.003
   Lowes KN, 2003, GUT, V52, P1327, DOI 10.1136/gut.52.9.1327
   Ndekwe P, 2017, WORLD J GASTROENTERO, V23, P4303, DOI 10.3748/wjg.v23.i23.4303
   Nissim O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049611
   Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525
   Prakoso E, 2014, LIVER TRANSPLANT, V20, P1508, DOI 10.1002/lt.24007
   Rastogi A, 2014, VIRCHOWS ARCH, V464, P565, DOI 10.1007/s00428-014-1547-0
   Rastogi A, 2011, VIRCHOWS ARCH, V459, P121, DOI 10.1007/s00428-011-1115-9
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Roskams T, 2003, J HEPATOL, V39, P431, DOI 10.1016/S0168-8278(03)00333-7
   Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614
   Sasaki M, 2018, HISTOPATHOLOGY, V72, P1164, DOI 10.1111/his.13476
   Singhal A, 2012, TRANSPL INT, V25, P658, DOI 10.1111/j.1432-2277.2012.01470.x
   Squires RH, 2006, J PEDIATR-US, V148, P652, DOI 10.1016/j.jpeds.2005.12.051
   Weng HL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00178
NR 30
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1397-3142
EI 1399-3046
J9 PEDIATR TRANSPLANT
JI Pediatr. Transplant.
PD 2023 NOV 30
PY 2023
DI 10.1111/petr.14662
EA NOV 2023
PG 9
WC Pediatrics; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics; Transplantation
GA AQ8Z8
UT WOS:001120031400001
PM 38036869
DA 2024-02-19
ER

PT J
AU Zhong, WZ
   Wang, XW
   Rao, ZQ
   Pan, XX
   Sun, Y
   Jiang, T
   Wang, P
   Zhou, HM
   Wang, XH
AF Zhong, Weizhe
   Wang, Xiaowei
   Rao, Zhuqing
   Pan, Xiongxiong
   Sun, Yu
   Jiang, Tao
   Wang, Ping
   Zhou, Haoming
   Wang, Xuehao
TI Aging aggravated liver ischemia and reperfusion injury by promoting
   hepatocyte necroptosis in an endoplasmic reticulum stress-dependent
   manner
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Liver ischemia and reperfusion injury; aging; endoplasmic reticulum
   stress (ER stress); necroptosis
ID ER STRESS; CELL-DEATH; INFLAMMATION; CONTRIBUTES; NECROSIS
AB Background: Aggravated liver ischemia and reperfusion (IR) injury has been reported in aged mice. Although necroptosis inhibition showed no crucial effect on hepatic IR injury in young mice, whether and how necroptosis affects liver IR injury in aged mice remains unclear.
   Methods: Young and aged mice were subjected to liver IR modeling. Liver injury, hepatocyte necroptosis and endoplasmic reticulum (ER) stress were analyzed in different groups.
   Results: Significantly increased liver necroptosis was found in aged mice post IR compared with young mice. Necroptosis inhibition by necrostatin-1 (Nec-1) decreased hepatocyte necroptosis and liver injury post IR in aged mice, with no significant effects on young mice. Furthermore, IR induced ER stress in both young and aged mice, and enhanced ER stress was observed in aged mice post IR. Administration of 4-phenylbutyrate (4-PBA), an ER stress antagonist, alleviated liver IR injury in both young and aged mice. However, ER stress inhibition reduced hepatocyte necroptosis in aged mice but not in young mice.
   Conclusions: Aging increased ER stress in IR-stressed hepatocytes, leading to aggravated necroptosis and liver IR injury. Our study demonstrated a novel mechanism of ER stress in the regulation of hepatocyte necroptosis in aged livers post IR, which would be a potential therapeutic target to reduce liver IR injury in elderly patients.
C1 [Zhong, Weizhe; Wang, Xiaowei; Sun, Yu; Jiang, Tao; Wang, Ping; Zhou, Haoming; Wang, Xuehao] Nanjing Med Univ, Hepatobiliary Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing 210029, Peoples R China.
   [Zhong, Weizhe; Wang, Xiaowei; Sun, Yu; Jiang, Tao; Wang, Ping; Zhou, Haoming; Wang, Xuehao] Chinese Acad Med Sci, Res Unit Liver Transplantat & Transplant Immunol, Nanjing, Peoples R China.
   [Zhong, Weizhe; Wang, Xiaowei; Sun, Yu; Jiang, Tao; Wang, Ping; Zhou, Haoming; Wang, Xuehao] Chinese Acad Med Sci, Key Lab Liver Transplantat, Nanjing, Peoples R China.
   [Rao, Zhuqing; Pan, Xiongxiong] Nanjing Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Nanjing, Peoples R China.
   [Jiang, Tao] Nanjing Univ, Jinling Hosp, Dept Surg Oncol, Med Sch, Nanjing, Peoples R China.
C3 Nanjing Medical University; Chinese Academy of Medical Sciences - Peking
   Union Medical College; Chinese Academy of Medical Sciences - Peking
   Union Medical College; Nanjing Medical University; Nanjing University
RP Zhou, HM; Wang, XH (corresponding author), Nanjing Med Univ, Hepatobiliary Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing 210029, Peoples R China.
EM hmzhou@njmu.edu.cn; wangxh@njmu.edu.cn
RI zhou, haoming/HMV-1715-2023; luo, yuan/JLS-6416-2023; xiongxiong,
   pan/GPP-4500-2022
OI xiongxiong, pan/0000-0002-2747-3241
FU National Nature Science Foundation of China [81530048, 81870448,
   31930020, 81600450, 81901628]; National Science Foundation of Jiangsu
   Province [BK20191490]; CAMS Innovation Fund for Medical Sciences
   [2019-I2M5-035]; Six Talent Peaks Project in Jiangsu Province
   [2018-WSN-011]; Jiangsu Science and Technology Association Young Science
   and Technology Talents Lifting Project [DG000D4007]; PAPD
FX This work was supported by grants from National Nature Science
   Foundation of China (81530048, 81870448, 31930020, 81600450, 81901628),
   the National Science Foundation of Jiangsu Province (BK20191490), CAMS
   Innovation Fund for Medical Sciences (No. 2019-I2M5-035), Six Talent
   Peaks Project in Jiangsu Province (No. 2018-WSN-011), Jiangsu Science
   and Technology Association Young Science and Technology Talents Lifting
   Project (No. DG000D4007) and A Project Funded by the PAPD.
CR Brubaker AL, 2011, AGING DIS, V2, P346
   Deepa SS, 2018, AGING CELL, V17, DOI 10.1111/acel.12770
   Deutsch M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.126
   Fan H, 2015, NEUROSCIENCE, V311, P362
   Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599
   Ghosh AK, 2015, J GERONTOL A-BIOL, V70, P1320, DOI 10.1093/gerona/glu186
   Gong YT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1029-8
   Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803
   Jiang T, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105711
   Kim DH, 2019, AGING-US, V11, P4125, DOI 10.18632/aging.102042
   Li C, 2020, AGING CELL, V19, DOI 10.1111/acel.13096
   Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110
   Liu XY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2746521
   Ma YM, 2016, ACTA PHARMACOL SIN, V37, P1381, DOI 10.1038/aps.2016.61
   Martínez G, 2017, AGING CELL, V16, P615, DOI 10.1111/acel.12599
   Meng LJ, 2015, P NATL ACAD SCI USA, V112, P11007, DOI 10.1073/pnas.1514730112
   Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109
   Ni HM, 2019, AM J PATHOL, V189, P1363, DOI 10.1016/j.ajpath.2019.03.010
   Nikseresht S, 2019, J CELL PHYSIOL, V234, P1816, DOI 10.1002/jcp.27055
   Ofengeim D, 2017, P NATL ACAD SCI USA, V114, pE8788, DOI 10.1073/pnas.1714175114
   Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314
   Rosentreter D, 2015, SHOCK, V44, P72, DOI 10.1097/SHK.0000000000000371
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Saeed WK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184752
   Saveljeva S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.548
   Yue S, 2017, J IMMUNOL, V198, P3588, DOI 10.4049/jimmunol.1601428
   Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036
   Zhou HM, 2016, TRANSPLANTATION, V100, P365, DOI 10.1097/TP.0000000000001032
   Zhu PJ, 2018, REDOX BIOL, V16, P157, DOI 10.1016/j.redox.2018.02.019
NR 29
TC 17
Z9 19
U1 1
U2 8
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD JUL
PY 2020
VL 8
IS 14
AR 869
DI 10.21037/atm-20-2822
PG 10
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA MS7ZE
UT WOS:000554493100029
PM 32793713
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Dabravolski, SA
   Bezsonov, EE
   Orekhov, AN
AF Dabravolski, Siarhei A.
   Bezsonov, Evgeny E.
   Orekhov, Alexander N.
TI The role of mitochondria dysfunction and hepatic senescence in NAFLD
   development and progression
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Early Access
DE NAFLD; ROS; UPRmt; DNA damage response; Hepatic senescence;
   Mitochondrial dysfunction
ID FATTY LIVER-DISEASE; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA;
   CELLULAR SENESCENCE; CARDIOLIPIN; FIBROSIS; INJURY; P53; PROLIFERATION;
   BIOGENESIS
AB Senescence is a crucial player in several metabolic disorders and chronic inflammatory diseases. Recent data prove the involvement of hepatocyte senescence in the development of NAFLD (non-alcoholic fatty liver disease). As the main energy and ROS (reactive oxygen species) producing organelle, mitochondria play the central role in accelerated senescence and diseases development. In this review, we focus on the role of regulation of mitochondrial Ca2+ homeostasis, NAD+/NADH ratio, UPRmt (mitochondrial unfolded protein response), phospholipids and fatty acid oxidation in hepatic senescence, lifespan and NAFLD disease susceptibility. Additionally, the involvement of mitochondrial and nuclear mutations in lifespan-modulation and NAFLD development is discussed. While nuclear and mitochondria DNA mutations and SNPs (single nucleotide polymorphisms) can be used as effective diagnostic markers and targets for treatments, advanced age should be considered as an independent risk factor for NAFLD development.
C1 [Dabravolski, Siarhei A.] Vitebsk State Acad Vet Med UO VGAVM, Dept Clin Diagnost, 7-11 Dovatora Str, Vitebsk 210026, BELARUS.
   [Bezsonov, Evgeny E.; Orekhov, Alexander N.] Inst Human Morphol, Lab Cellular & Mol Pathol Cardiovasc Syst, 3 Tsyurupa St, Moscow 117418, Russia.
   [Bezsonov, Evgeny E.; Orekhov, Alexander N.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiyskaya St, Moscow 125315, Russia.
   [Orekhov, Alexander N.] Inst Atherosclerosis Res, Dept Basic Res, Moscow 121609, Russia.
C3 Russian Academy of Medical Sciences; Research Institute of Human
   Morphology; Russian Academy of Medical Sciences; Institute of General
   Pathology & Pathophysiology, RAMS
RP Dabravolski, SA (corresponding author), Vitebsk State Acad Vet Med UO VGAVM, Dept Clin Diagnost, 7-11 Dovatora Str, Vitebsk 210026, BELARUS.
EM siarhei.dabravolski@vsavm.by; evgeny.bezsonov@gmail.com;
   a.h.opexob@gmail.com
RI Bezsonov, Evgeny/AAL-1982-2021; Dabravolski, Siarhei/E-8303-2015
OI Bezsonov, Evgeny/0000-0002-9382-8338; Dabravolski,
   Siarhei/0000-0002-0547-6310
FU Russian Science Foundation [18-15-00254]
FX This work was supported by the Russian Science Foundation (Grant
   #18-15-00254) .
CR Abate M, 2020, SEMIN CELL DEV BIOL, V98, P139, DOI 10.1016/j.semcdb.2019.05.022
   Akazawa Y, 2019, MODERN PATHOL, V32, P997, DOI 10.1038/s41379-019-0218-8
   Al-ghamdi HA, 2021, J CLIN EXP HEPATOL, V11, P219, DOI 10.1016/j.jceh.2020.07.003
   Ali ES, 2020, CANCERS, V12, DOI 10.3390/cancers12102755
   Ali ES, 2019, CELL CALCIUM, V82, DOI 10.1016/j.ceca.2019.102057
   Alston CL, 2021, J PATHOL, V254, P430, DOI 10.1002/path.5641
   Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Archer AE, 2018, AM J PHYSIOL-REG I, V315, pR696, DOI 10.1152/ajpregu.00073.2018
   Arena G, 2018, MOL CELL, V69, P594, DOI 10.1016/j.molcel.2018.01.023
   Barnard A, 2019, GUT LIVER, V13, P11, DOI 10.5009/gnl18081
   Becker C, 2018, EMBO REP, V19, DOI 10.15252/embr.201745126
   Bhaskaran S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745009
   Buchard B, 2021, METABOLITES, V11, DOI 10.3390/metabo11010054
   Caldez MJ, 2020, HEPATOL INT, V14, P463, DOI 10.1007/s12072-020-10066-6
   Calzada E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09425-1
   Canivet CM, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165705
   Cevik D, 2015, WORLD J GASTROENTERO, V21, P311, DOI 10.3748/wjg.v21.i1.311
   Chae U, 2019, AGING-US, V11, P7242, DOI 10.18632/aging.102259
   Cheng CX, 2020, CANCER MANAG RES, V12, P13241, DOI 10.2147/CMAR.S285367
   Chocron ES, 2019, BBA-MOL BASIS DIS, V1865, P285, DOI 10.1016/j.bbadis.2018.09.035
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Dodig S, 2019, BIOCHEM MEDICA, V29, DOI 10.11613/BM.2019.030501
   Duncan AL, 2018, BBA-BIOMEMBRANES, V1860, P1035, DOI 10.1016/j.bbamem.2018.01.017
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Flanagan KC, 2018, ONCOTARGET, V9, P21, DOI 10.18632/oncotarget.22940
   Fleury H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10460-1
   Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8
   Giorgi C, 2018, INT REV CEL MOL BIO, V340, P209, DOI 10.1016/bs.ircmb.2018.05.006
   Gómez-Santos B, 2020, AGING CELL, V19, DOI 10.1111/acel.13183
   Han X, 2019, PEERJ, V7, DOI 10.7717/peerj.7568
   Heden TD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8352
   Hernansanz-Agustín P, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030415
   Hirose M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10070532
   Hirose M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092359
   Hsieh JY, 2015, ONCOTARGET, V6, P20084, DOI 10.18632/oncotarget.3907
   Hu FF, 2020, EUR J PHARMACOL, V883, DOI 10.1016/j.ejphar.2020.173286
   Huang YH, 2018, MOL CARCINOGEN, V57, P1087, DOI 10.1002/mc.22827
   Inata Y, 2018, FASEB J, V32, P728, DOI 10.1096/fj.201700576R
   Inoue H, 2021, J CLIN BIOCHEM NUTR, V68, P51, DOI 10.3164/jcbn.20-119
   Ji Li Li, 2019, F1000Res, V8, DOI 10.12688/f1000research.19139.1
   Jiang Y, 2021, LIPIDS HEALTH DIS, V20, DOI 10.1186/s12944-021-01461-5
   Jin MP, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1135-x
   Karakousis ND, 2020, LIVER INT, V40, P2917, DOI 10.1111/liv.14659
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kim JH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186743
   Klein MA, 2020, J BIOL CHEM, V295, P11021, DOI 10.1074/jbc.REV120.011438
   Kondo Y, 2016, GERIATR GERONTOL INT, V16, P4, DOI 10.1111/ggi.12722
   Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Kunji ERS, 2020, BIOCHEM SOC T, V48, P1419, DOI 10.1042/BST20190933
   Kwan SY, 2020, HEPATOLOGY, V71, P275, DOI 10.1002/hep.30807
   Lee JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171922
   Lee YY, 2020, AGING-US, V12, P6700, DOI 10.18632/aging.103029
   Levada K, 2018, J HEPATOL, V68, P996, DOI 10.1016/j.jhep.2018.01.003
   Li DJ, 2021, THERANOSTICS, V11, P4381, DOI 10.7150/thno.53652
   Li H, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/6572342
   Liu JY, 2019, P NATL ACAD SCI USA, V116, P2603, DOI 10.1073/pnas.1818313116
   Liu K, 2017, MOL CELL, V68, P281, DOI 10.1016/j.molcel.2017.09.022
   Liu P, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.589908
   Lu Y, 2021, J CELL MOL MED, V25, P3427, DOI 10.1111/jcmm.16421
   Ma X, 2020, PEERJ, V8, DOI 10.7717/peerj.8930
   Mao XT, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2020.183466
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Nahon P, 2020, HEPAT ONCOL, V7, DOI 10.2217/hep-2020-0017
   Natarajan V, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201800404
   Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3
   Nelsons G, 2018, MECH AGEING DEV, V170, P30, DOI 10.1016/j.mad.2017.08.005
   Nemani N, 2018, CELL CALCIUM, V74, P86, DOI 10.1016/j.ceca.2018.06.006
   Niemann J, 2019, CELL CALCIUM, V82, DOI 10.1016/j.ceca.2019.102055
   Niemann J, 2017, FREE RADICAL BIO MED, V102, P174, DOI 10.1016/j.freeradbiomed.2016.11.035
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Panov AV, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1323028
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Nguyen P, 2018, CELL REP, V24, P1597, DOI 10.1016/j.celrep.2018.07.014
   Ping F, 2017, J DIABETES INVEST, V8, P174, DOI 10.1111/jdi.12555
   Prata Larissa G P Langhi, 2018, Semin Immunol, V40, P101275, DOI 10.1016/j.smim.2019.04.003
   Qian WW, 2018, INT J ONCOL, V53, P2021, DOI 10.3892/ijo.2018.4538
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Reichart G, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13214
   Ren TT, 2018, ANTIOXID REDOX SIGN, V28, P1120, DOI 10.1089/ars.2017.6990
   Schmeer C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111446
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Selen ES, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.135626
   Sen B, 2019, CELL MOL GASTROENTER, V8, P73, DOI 10.1016/j.jcmgh.2019.03.001
   Shen MQ, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/5789127
   Shilovsky GA, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1469, DOI 10.1134/S000629791912006X
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Son JM, 2019, BMB REP, V52, P13, DOI 10.5483/BMBRep.2019.52.1.300
   Song ZL, 2021, HEPATOLOGY, V73, P1594, DOI 10.1002/hep.31582
   Sun XH, 2020, AM J PHYSIOL-CELL PH, V318, pC1200, DOI 10.1152/ajpcell.00062.2020
   Vladimirov GK, 2018, CHEM PHYS LIPIDS, V214, P35, DOI 10.1016/j.chemphyslip.2018.05.007
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wandrer F, 2018, ALIMENT PHARM THER, V48, P270, DOI 10.1111/apt.14802
   Wang XK, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.655557
   Wang Y, 2021, INFLAMMATION, V44, P1246, DOI 10.1007/s10753-021-01442-x
   Wei WQ, 2018, J CELL PHYSIOL, V233, P9121, DOI 10.1002/jcp.26956
   Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wilkinson JA, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14772
   Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706
   Xiao T, 2020, J MOL ENDOCRINOL, V64, P67, DOI 10.1530/JME-19-0207
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yao L, 2020, MOL BIOL REP, V47, P809, DOI 10.1007/s11033-019-05150-6
   Yosef R, 2017, EMBO J, V36, P2280, DOI 10.15252/embj.201695553
   Yu L, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00554-y
   Zhang J, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.921887
   Zheng Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0226-x
   Zhu L, 2021, FREE RADICAL BIO MED, V163, P125, DOI 10.1016/j.freeradbiomed.2020.12.013
   Ziegler DV, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20993-z
NR 113
TC 27
Z9 30
U1 7
U2 38
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD 2021 OCT
PY 2021
VL 142
AR 112041
DI 10.1016/j.biopha.2021.112041
EA AUG 2021
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA UR8YA
UT WOS:000697026300003
PM 34411916
OA gold
DA 2024-02-19
ER

PT J
AU Rohn, F
   Kordes, C
   Buschmann, T
   Reichert, D
   Wammers, M
   Poschmann, G
   Stühler, K
   Benk, AS
   Geiger, F
   Spatz, JP
   Häussinger, D
AF Rohn, Friederike
   Kordes, Claus
   Buschmann, Tobias
   Reichert, Doreen
   Wammers, Marianne
   Poschmann, Gereon
   Stuehler, Kai
   Benk, Amelie S.
   Geiger, Fania
   Spatz, Joachim P.
   Haeussinger, Dieter
TI Impaired integrin α<sub>5</sub>/β<sub>1</sub>-mediated hepatocyte growth
   factor release by stellate cells of the aged liver
SO AGING CELL
LA English
DT Article; Early Access
DE aging; hepatic stellate cells; integrins; laminins; mechanobiology
ID EXTRACELLULAR-MATRIX; PARTIAL-HEPATECTOMY; REGENERATION; LAMININ-511;
   SYSTEM
AB Hepatic blood flow and sinusoidal endothelial fenestration decrease during aging. Consequently, fluid mechanical forces are reduced in the space of Disse where hepatic stellate cells (HSC) have their niche. We provide evidence that integrin alpha(5)/beta(1) is an important mechanosensor in HSC involved in shear stress-induced release of hepatocyte growth factor (HGF), an essential inductor of liver regeneration which is impaired during aging. The expression of the integrin subunits alpha(5) and beta(1) decreases in liver and HSC from aged rats. CRISPR/Cas9-mediated integrin alpha(5) and beta(1) knockouts in isolated HSC lead to lowered HGF release and impaired cellular adhesion. Fluid mechanical forces increase integrin alpha(5) and laminin gene expression whereas integrin beta(1) remains unaffected. In the aged liver, laminin beta 2 and gamma 1 protein chains as components of laminin-521 are lowered. The integrin alpha(5) knockout in HSC reduces laminin expression via mechanosensory mechanisms. Culture of HSC on nanostructured surfaces functionalized with laminin-521 enhances Hgf expression in HSC, demonstrating that these ECM proteins are critically involved in HSC function. During aging, HSC acquire a senescence-associated secretory phenotype and lower their growth factor expression essential for tissue repair. Our findings suggest that impaired mechanosensing via integrin alpha(5)/beta(1) in HSC contributes to age-related reduction of ECM and HGF release that could affect liver regeneration.
C1 [Rohn, Friederike; Kordes, Claus; Buschmann, Tobias; Reichert, Doreen; Wammers, Marianne; Haeussinger, Dieter] Heinrich Heine Univ, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany.
   [Poschmann, Gereon; Stuehler, Kai] Heinrich Heine Univ, Inst Mol Med, Dusseldorf, Germany.
   [Stuehler, Kai] Heinrich Heine Univ Dusseldorf, BMFZ, Mol Prote Lab, Dusseldorf, Germany.
   [Benk, Amelie S.; Geiger, Fania; Spatz, Joachim P.] Max Planck Inst Med Res, Dept Cellular Biophys, Heidelberg, Germany.
   [Benk, Amelie S.; Geiger, Fania; Spatz, Joachim P.] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany.
C3 Heinrich Heine University Dusseldorf; Heinrich Heine University
   Dusseldorf; Heinrich Heine University Dusseldorf; Max Planck Society;
   Ruprecht Karls University Heidelberg
RP Häussinger, D (corresponding author), Heinrich Heine Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM haeussin@uni-duesseldorf.de
RI Kordes, Claus/AFM-1775-2022; Spatz, Joachim P/A-1107-2017
OI Kordes, Claus/0000-0003-0782-1998; Spatz, Joachim P/0000-0003-3419-9807;
   Poschmann, Gereon/0000-0003-2448-0611; Rohn,
   Friederike/0000-0002-2419-2364
FU German Research Foundation (DFG) through the Collaborative Research
   Center Communication and System Relevance during Liver Injury and
   Regeneration [190586431, SFB 974]; AnsmannStiftung fur Altersforschung
   (Dusseldorf); Max Planck Society
FX This study was supported by German Research Foundation (DFG) through the
   Collaborative Research Center SFB 974 Communication and System Relevance
   during Liver Injury and Regeneration (project number 190586431) and the
   AnsmannStiftung fur Altersforschung (Dusseldorf). Joachim P. Spatz
   acknowledges funding by the Max Planck Society.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Biondo-Simões Maria de Lourdes Pessole, 2006, Acta Cir. Bras., V21, P197, DOI 10.1590/S0102-86502006000400002
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Domogatskaya A, 2008, STEM CELLS, V26, P2800, DOI 10.1634/stemcells.2007-0389
   Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48
   Enkhbold C, 2015, J GASTROEN HEPATOL, V30, P1217, DOI 10.1111/jgh.12930
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4
   Grube L, 2018, J PROTEOME RES, V17, P879, DOI 10.1021/acs.jproteome.7b00684
   Haüssinger D, 2006, ACTA PHYSIOL, V187, P249, DOI 10.1111/j.1748-1716.2006.01542.x
   HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Jeon H, 1996, BIOSCI BIOTECH BIOCH, V60, P856, DOI 10.1271/bbb.60.856
   Kim TH, 1997, HEPATOLOGY, V26, P896, DOI 10.1053/jhep.1997.v26.pm0009328311
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P133, DOI 10.1016/0167-4943(91)90024-K
   Kordes C, 2015, Z GASTROENTEROL, V53, P1425, DOI 10.1055/s-0035-1566895
   Kordes C, 2014, J CLIN INVEST, V124, P5503, DOI 10.1172/JCI74119
   Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027
   Kordes C, 2013, CELL PHYSIOL BIOCHEM, V31, P290, DOI 10.1159/000343368
   Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   LINDROOS PM, 1991, HEPATOLOGY, V13, P743, DOI 10.1016/0270-9139(91)92574-R
   Lorenz L, 2018, NATURE, V562, P128, DOI 10.1038/s41586-018-0522-3
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   MASUMOTO A, 1991, BIOCHEM BIOPH RES CO, V174, P90, DOI 10.1016/0006-291X(91)90489-T
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904
   Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031
   Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077
   Noh JK, 2012, TRANSPL P, V44, P1116, DOI 10.1016/j.transproceed.2012.03.007
   Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P2933, DOI 10.1167/iovs.14-15163
   Qin ZP, 2017, J DERMATOL SCI, V88, P289, DOI 10.1016/j.jdermsci.2017.08.003
   Reinehr R, 2010, J BIOL CHEM, V285, P25904, DOI 10.1074/jbc.M110.125781
   Rodin S, 2014, NAT PROTOC, V9, P2354, DOI 10.1038/nprot.2014.159
   Rohn F, 2018, BIOMATERIALS, V180, P36, DOI 10.1016/j.biomaterials.2018.07.008
   Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184
   Schliess F, 2007, FEBS J, V274, P5799, DOI 10.1111/j.1742-4658.2007.06100.x
   Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668
   Stolz DB, 1999, CANCER RES, V59, P3954
   Sumii T, 2016, IN VITRO CELL DEV-AN, V52, P625, DOI 10.1007/s11626-016-9999-y
   Swiderska-Syn M, 2014, GUT, V63, P1333, DOI 10.1136/gutjnl-2013-305962
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   Wettstein M, 1997, HEPATOLOGY, V26, P1560
   Zhu CZ, 2014, J GASTROEN HEPATOL, V29, P1102, DOI 10.1111/jgh.12468
NR 45
TC 22
Z9 23
U1 1
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2020 APR
PY 2020
VL 19
IS 4
AR e13131
DI 10.1111/acel.13131
EA MAR 2020
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LJ8HL
UT WOS:000519244800001
PM 32157808
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Baboota, RK
   Rawshani, A
   Bonnet, L
   Li, XY
   Yang, H
   Mardinoglu, A
   Tchkonia, T
   Kirkland, JL
   Hoffmann, A
   Dietrich, A
   Boucher, J
   Blüher, M
   Smith, U
AF Baboota, Ritesh K.
   Rawshani, Aidin
   Bonnet, Laurianne
   Li, Xiangyu
   Yang, Hong
   Mardinoglu, Adil
   Tchkonia, Tamar
   Kirkland, James L.
   Hoffmann, Anne
   Dietrich, Arne
   Boucher, Jeremie
   Bluher, Matthias
   Smith, Ulf
TI BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical
   progression of NAFLD/NASH
SO NATURE METABOLISM
LA English
DT Article; Early Access
ID NONALCOHOLIC FATTY LIVER; MORPHOGENETIC PROTEIN 4; PROMOTES; FIBROSIS;
   YAP; PATHWAY; INFLAMMATION; HOMEOSTASIS; EXPRESSION; STEATOSIS
AB The role of hepatic cell senescence in human non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is not well understood. To examine this, we performed liver biopsies and extensive characterization of 58 individuals with or without NAFLD/NASH. Here, we show that hepatic cell senescence is strongly related to NAFLD/NASH severity, and machine learning analysis identified senescence markers, the BMP4 inhibitor Gremlin 1 in liver and visceral fat, and the amount of visceral adipose tissue as strong predictors. Studies in liver cell spheroids made from human stellate and hepatocyte cells show BMP4 to be anti-senescent, anti-steatotic, anti-inflammatory and anti-fibrotic, whereas Gremlin 1, which is particularly highly expressed in visceral fat in humans, is pro-senescent and antagonistic to BMP4. Both senescence and anti-senescence factors target the YAP/TAZ pathway, making this a likely regulator of senescence and its effects. We conclude that senescence is an important driver of human NAFLD/NASH and that BMP4 and Gremlin 1 are novel therapeutic targets.
   Baboota et al. investigate senescence as a driver of human NAFLD/NASH and show the roles of BMP4 and its antagonist Gremlin 1 as anti-senescent and pro-senescent molecules, respectively.
C1 [Baboota, Ritesh K.; Bonnet, Laurianne; Boucher, Jeremie; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.
   [Rawshani, Aidin] Univ Gothenburg, Inst Med, Wallenberg Lab Cardiovasc & Metab Res, Gothenburg, Sweden.
   [Bonnet, Laurianne; Boucher, Jeremie] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden.
   [Li, Xiangyu; Yang, Hong; Mardinoglu, Adil] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.
   [Mardinoglu, Adil] Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Host Microbiome Interact, London, England.
   [Tchkonia, Tamar; Kirkland, James L.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA.
   [Hoffmann, Anne; Bluher, Matthias] Univ Leipzig, Helmholtz Inst Metab Obes & Vasc Res HIMAG, Leipzig, Germany.
   [Hoffmann, Anne; Bluher, Matthias] Univ Hosp Leipzig, Leipzig, Germany.
   [Dietrich, Arne] Univ Hosp Leipzig, Sect Bariatr Surg, Dept Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany.
   [Boucher, Jeremie] AstraZeneca, Biosci Metab Res & Early Dev Cardiovasc Renal & M, BioPharmaceut R&D, Gothenburg, Sweden.
C3 University of Gothenburg; University of Gothenburg; University of
   Gothenburg; Royal Institute of Technology; University of London; King's
   College London; Mayo Clinic; Leipzig University; Leipzig University;
   Leipzig University; AstraZeneca
RP Smith, U (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.
EM ulf.smith@medic.gu.se
RI Kirkland, James/F-9159-2016
OI Smith, Ulf/0000-0002-1439-4608; Tchkonia, Tamar/0000-0003-4623-7145;
   Hoffmann, Anne/0000-0003-3258-3397; Bonnet,
   Laurianne/0009-0000-4399-7080; Li, Xiangyu/0000-0002-8301-9959
FU Knut and Alice Wallenberg Foundation [2020.0118]; Swedish Research
   Council [202200688]; Novo Nordisk Foundation [0078138]; Heart and Lung
   Foundation [20220355]; Swedish Diabetes Research Foundation
   [DIA2021-588]; NIH [R37AG013925, P01AG062413, R33AG61456]; Connor Fund;
   Noaber Foundation; Centre for Cellular Imaging, University of
   Gothenburg, as part of the National Microscopy Infrastructure (NMI)
   [VR-RFI 2016-00968]
FX We acknowledge financial support from the Knut and Alice Wallenberg
   Foundation (2020.0118), the Swedish Research Council (202200688), the
   Novo Nordisk Foundation (0078138), the Heart and Lung Foundation
   (20220355) and the Swedish Diabetes Research Foundation (DIA2021-588) to
   U.S. J.L.K. and T.T. were supported by NIH grants R37AG013925,
   P01AG062413 and R33AG61456; the Connor Fund; Robert P. and Arlene R.
   Kogod; Robert J. and Theresa W. Ryan; and the Noaber Foundation. We also
   acknowledge the Centre for Cellular Imaging, University of Gothenburg,
   as part of the National Microscopy Infrastructure (NMI) (VR-RFI
   2016-00968), for support in imaging analysis. We thank Jan Boren and
   Scott L. Friedman for providing IHH and LX-2 cells, respectively. We
   thank Piero Pingitore for help with establishing the 3D spheroid
   cultures. A graphical abstract provided as Supplementary Figure 3 was
   created and exported with BioRender.com under a paid subscription.
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arndt S, 2015, GUT, V64, P973, DOI 10.1136/gutjnl-2014-306968
   Baboota RK, 2021, DIABETES, V70, P303, DOI 10.2337/db20-0884
   Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Tran D, 2014, AGING CELL, V13, P669, DOI 10.1111/acel.12219
   Fan JG, 2006, J CELL PHYSIOL, V207, P499, DOI 10.1002/jcp.20593
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116
   Godoy-Matos AF, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00570-y
   Govaere O, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba4448
   Gustafson B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10688-x
   Haas JT, 2019, NAT METAB, V1, P604, DOI 10.1038/s42255-019-0076-1
   Han CY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13817
   Hayashi Y, 2016, P NATL ACAD SCI USA, V113, P13057, DOI 10.1073/pnas.1603668113
   Hedjazifar S, 2020, DIABETES, V69, P331, DOI 10.2337/db19-0701
   Hoffmann JM, 2020, MOL METAB, V32, P15, DOI 10.1016/j.molmet.2019.11.016
   Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5
   Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838
   Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585
   Konishi T, 2018, AM J PHYSIOL-GASTR L, V314, pG471, DOI 10.1152/ajpgi.00153.2017
   Lee DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11961
   Li J, 2019, EBIOMEDICINE, V40, P43, DOI 10.1016/j.ebiom.2019.01.009
   Li Q, 2021, NAT MED, V27, P1941, DOI 10.1038/s41591-021-01501-8
   Li YG, 2016, TUMOR BIOL, V37, P4501, DOI 10.1007/s13277-015-4287-0
   Li YZ, 2019, CELL REP, V28, P735, DOI 10.1016/j.celrep.2019.06.045
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205
   Lu YC, 2020, INT J MED SCI, V17, P182, DOI 10.7150/ijms.40417
   Ma MY, 2021, INT J GEN MED, V14, P3163, DOI 10.2147/IJGM.S317785
   Mahli A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050457
   Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011
   Mazzocca A, 2015, CANCER RES, V75, P532, DOI 10.1158/0008-5472.CAN-14-1607
   Miyajima C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010171
   Mukai T, 2017, FEBS OPEN BIO, V7, P1009, DOI 10.1002/2211-5463.12240
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Peng Q, 2019, AGING-US, V11, P11520, DOI 10.18632/aging.102552
   Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110
   Rabinowich L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168905
   Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3
   Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3
   Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184
   Sen B, 2019, CELL MOL GASTROENTER, V8, P73, DOI 10.1016/j.jcmgh.2019.03.001
   Sliwinska MA, 2009, MECH AGEING DEV, V130, P24, DOI 10.1016/j.mad.2008.04.011
   Sommer J, 2017, ONCOTARGET, V8, P13059, DOI 10.18632/oncotarget.14371
   Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597
   Sun QJ, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.605967
   Vacca M, 2020, NAT METAB, V2, P514, DOI 10.1038/s42255-020-0214-9
   Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376
   Väremo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111
   Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu ZD, 2010, J CLIN INVEST, V120, P3901, DOI 10.1172/JCI43250
   Yang H, 2020, PROCEEDINGS OF THE 32TH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, SSDBM 2020, DOI [10.1145/3400903.3400925, 10.1016/j.cell.2021.04.048]
   Yang Z, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5022
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Zhang K, 2019, THERANOSTICS, V9, P7566, DOI 10.7150/thno.36942
   Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30029
   Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015
   Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381
NR 63
TC 15
Z9 15
U1 6
U2 21
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2522-5812
J9 NAT METAB
JI Nat. Metab.
PD 2022 AUG
PY 2022
VL 4
IS 8
BP 1007
EP +
DI 10.1038/s42255-022-00620-x
EA AUG 2022
PG 26
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 4C8PS
UT WOS:000842856700004
PM 35995996
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Meseguer-Ripolles, J
   Lucendo-Villarin, B
   Tucker, C
   Ferreira-Gonzalez, S
   Homer, N
   Wang, Y
   Lewis, PJS
   Toledo, EM
   Mellado-Gomez, E
   Simpson, J
   Flint, O
   Jaiswal, H
   Beer, NL
   Karlsen, AE
   Forbes, SJ
   Dear, JW
   Hughes, J
   Hay, DC
AF Meseguer-Ripolles, Jose
   Lucendo-Villarin, Baltasar
   Tucker, Carl
   Ferreira-Gonzalez, Sofia
   Homer, Natalie
   Wang, Yu
   Lewis, Philip J. Starkey
   Toledo, Enrique M.
   Mellado-Gomez, Esther
   Simpson, Joanna
   Flint, Oliver
   Jaiswal, Himjyot
   Beer, Nicola L.
   Karlsen, Allan E.
   Forbes, Stuart J.
   Dear, James W.
   Hughes, Jeremy
   Hay, David C.
TI Dimethyl fumarate reduces hepatocyte senescence following paracetamol
   exposure
SO ISCIENCE
LA English
DT Article
ID FULMINANT HEPATIC-FAILURE; INDUCED LIVER-INJURY; ACETAMINOPHEN
   HEPATOTOXICITY; OXIDATIVE STRESS; N-ACETYLCYSTEINE; CANCER-CELLS; NRF2;
   ACTIVATION; EXPRESSION; APOPTOSIS
AB Liver disease is a major cause of premature death. Oxidative stress in the liver represents a key disease driver. Compounds, such as dimethyl fumarate (DMF), can activate the antioxidant response and are used clinically to treat disease. In this study, we tested the protective properties of DMF before or after paracetamol exposure. Following DMF administration, Nrf2 nuclear translocation was tracked at the single-cell level and target gene transactivation confirmed. Next, the protective properties of DMF were examined following paracetamol exposure. Transcriptomic and biochemical analysis revealed that DMF rescue was underpinned by reduced Nf-kappa B and TGF-beta signaling and cell senescence. Following on from these studies, we employed a Zebrafish model to study paracetamol exposure in vivo. We combined a genetically modified Zebrafish model, expressing green fluorescent protein exclusively in the liver, with automated microscopy. Pre-treatment with DMF, prior to paracetamol exposure, led to reduced liver damage in Zebrafish demonstrating protective properties.
C1 [Meseguer-Ripolles, Jose; Lucendo-Villarin, Baltasar; Ferreira-Gonzalez, Sofia; Wang, Yu; Lewis, Philip J. Starkey; Flint, Oliver; Forbes, Stuart J.; Hay, David C.] Univ Edinburgh, Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.
   [Tucker, Carl; Hughes, Jeremy] Univ Edinburgh, Ctr Inflammat Res, 47 Little France Dr, Edinburgh EH16 4TJ, Midlothian, Scotland.
   [Homer, Natalie; Simpson, Joanna; Dear, James W.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, 47 Little France Dr, Edinburgh, Midlothian, Scotland.
   [Toledo, Enrique M.; Mellado-Gomez, Esther; Jaiswal, Himjyot; Beer, Nicola L.; Karlsen, Allan E.] Novo Nordisk Ltd, Novo Nordisk Res Ctr Oxford NNRCO, Innovat Bldg,Old Rd Campus Roosevelt Dr, Oxford OX3 7FZ, England.
   [Toledo, Enrique M.; Mellado-Gomez, Esther; Jaiswal, Himjyot; Beer, Nicola L.; Karlsen, Allan E.] Novo Nordisk Ltd, Novo Nordisk Pk 1, DK-2760 Malov, Denmark.
C3 University of Edinburgh; University of Edinburgh; University of
   Edinburgh; Novo Nordisk; Novo Nordisk
RP Hay, DC (corresponding author), Univ Edinburgh, Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.
EM davehay@talktalk.net
RI gonzalez, Sofia/JVZ-0275-2024; Hay, David/JZD-9418-2024; Homer, Natalie
   ZM/AAD-2343-2019; Toledo, Enrique M/E-8860-2010
OI Homer, Natalie ZM/0000-0002-9262-2098; Toledo, Enrique
   M/0000-0002-1460-4708; lucendo villarin, baltasar/0000-0003-0796-1632;
   Ferreira-Gonzalez, Sofia/0000-0001-7776-287X; Simpson,
   Joanna/0000-0002-0939-8487
FU MRC Doctoral Training Partnership [MR/K501293/1]; Chief Scientist Office
   [TCS/16/37]
FX This study was supported with awards from the MRC Doctoral Training
   Partnership (MR/K501293/1) and the Chief Scientist Office (TCS/16/37).
   We are grateful to Dr Eoghan O'Duibhir for his assistance with the cell
   phenotyping work.
CR Abdelrahman RS, 2019, LIFE SCI, V217, P251, DOI 10.1016/j.lfs.2018.12.013
   Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344
   Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Bray MA, 2016, NAT PROTOC, V11, P1757, DOI 10.1038/nprot.2016.105
   Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098
   Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x
   DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327
   de Abajo FJ, 2004, BRIT J CLIN PHARMACO, V58, P71, DOI 10.1111/j.1365-2125.2004.02133.x
   Du K, 2016, REDOX BIOL, V10, P148, DOI 10.1016/j.redox.2016.10.001
   Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169
   GILLETTE JR, 1982, ADV EXP MED BIOL, V136, P931
   Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287
   Gosslau A, 2001, J BIOL CHEM, V276, P1814, DOI 10.1074/jbc.M008280200
   HARRISON PM, 1990, LANCET, V335, P1572, DOI 10.1016/0140-6736(90)91388-Q
   Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   James LP, 2009, DRUG METAB DISPOS, V37, P1779, DOI 10.1124/dmd.108.026195
   Karthivashan G, 2015, RSC ADV, V5, P62040, DOI 10.1039/c5ra07838e
   Kastrati I, 2016, J BIOL CHEM, V291, P3639, DOI 10.1074/jbc.M115.679704
   KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Leedale JA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244070
   Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lucendo-Villarin B, 2021, BIOFABRICATION, V13, DOI 10.1088/1758-5090/abbdb2
   Malavolta M, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4159013
   Meseguer-Ripolles J, 2020, JOVE-J VIS EXP, DOI 10.3791/61256
   Mrowietz U, 1999, BRIT J DERMATOL, V141, P424
   North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107
   Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870
   Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012
   PRESCOTT LF, 1983, DRUGS, V25, P290, DOI 10.2165/00003495-198325030-00002
   PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS291, DOI 10.1111/j.1365-2125.1980.tb01812.x
   Prestigiacomo V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201044
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032
   Ruggieri S, 2014, THER CLIN RISK MANAG, V10, P229, DOI 10.2147/TCRM.S53285
   Saidu NEB, 2017, MOL CANCER THER, V16, P529, DOI 10.1158/1535-7163.MCT-16-0405
   Sharma RS, 2018, CELL MOL GASTROENTER, V5, P367, DOI 10.1016/j.jcmgh.2017.11.016
   Sinton MC, 2021, STAR PROTOC, V2, DOI 10.1016/j.xpro.2021.100493
   Sinton MC, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101931
   SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401
   Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tanne J., 2006, BMJ-BRIT MED J, V332, p628.2, DOI [10.1136/bmj.332.7542.628-a, DOI 10.1136/BMJ.332.7542.628-A]
   Vliegenthart ADB, 2017, TOXICOL SCI, V159, P380, DOI 10.1093/toxsci/kfx144
   Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762
   Wang Y, 2019, ISCIENCE, V16, P206, DOI 10.1016/j.isci.2019.05.028
   Wang Y, 2017, JOVE-J VIS EXP, DOI 10.3791/55355
   Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147
   Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9
   Wittbrodt JN, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-36
   Woolbright BL, 2017, J HEPATOL, V66, P836, DOI 10.1016/j.jhep.2016.11.017
   Wu Q, 2017, J IMMUNOL, V198, P3069, DOI 10.4049/jimmunol.1601532
   Xu DW, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01428
   Yan CX, 2018, BIOMED PHARMACOTHER, V105, P274, DOI 10.1016/j.biopha.2018.05.135
   Zou YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107423
NR 60
TC 7
Z9 9
U1 3
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD JUN 25
PY 2021
VL 24
IS 6
AR 102552
DI 10.1016/j.isci.2021.102552
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA TA5PU
UT WOS:000667301700054
PM 34151225
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Sigal, SH
   Rajvanshi, P
   Gorla, GR
   Sokhi, RP
   Saxena, R
   Gebhard, DR
   Reid, LM
   Gupta, S
AF Sigal, SH
   Rajvanshi, P
   Gorla, GR
   Sokhi, RP
   Saxena, R
   Gebhard, DR
   Reid, LM
   Gupta, S
TI Partial hepatectomy-induced polyploidy attenuates hepatocyte replication
   and activates cell aging events
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE liver; ploidy; apoptosis; hepatocyte transplantation
ID ADULT-RAT HEPATOCYTES; EVANS CINNAMON RATS; LIVER-REGENERATION;
   TRANSGENIC MICE; PRIMARY CULTURE; GROWTH-FACTOR; DNA-PLOIDY; STEM-CELL;
   IN-VIVO; TRANSPLANTATION
AB In understanding mechanisms of Liver repopulation with transplanted hepatocytes, we studied the consequences of hepatic polyploidization in the two-thirds partial hepatectomy model of Liver regeneration. Liver repopulation studies using genetically marked rodent hepatocytes showed that the number of previously transplanted hepatocytes did not increase in the liver with subsequential partial hepatectomy. In contrast, recipients undergoing partial hepatectomy before cells were transplanted showed proliferation in transplanted hepatocytes, with kinetics of DNA synthesis differing in transplanted and host hepatocytes. Also, partial hepatectomy caused multiple changes in the rat liver, including accumulation of polyploid hepatocytes along with prolonged depletion of diploid hepatocytes, as well as increased senescence-associated beta-galactosidase and p21 expression. Remnant hepatocytes in the partially hepatectomized Liver showed increased autofluorescence and cytoplasmic complexity on flow cytometry, which are associated with lipofuscin accumulation during cell aging, and underwent apoptosis more frequently. Moreover, hepatocytes from the partially hepatectomized Liver showed attenuated proliferative capacity in cell. culture. These findings were compatible with decreased proliferative potential of hepatocytes experiencing partial hepatectomy compared with hepatocytes from the unperturbed liver. Attenuation of proliferative capacity and other changes in hepatocytes experiencing partial hepatectomy offer novel perspectives concerning liver regeneration in the context of cell ploidy.
C1 Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Ctr Canc Res, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.
   Univ N Carolina, Sch Med, Ctr Gastrointestinal & Biliary Dis Studies, Chapel Hill, NC 27514 USA.
   Univ N Carolina, Sch Med, Program Mol Biol & Biotechnol, Chapel Hill, NC 27514 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine; Yeshiva University; Albert Einstein College of
   Medicine; Yeshiva University; Albert Einstein College of Medicine;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina School of Medicine; University of North
   Carolina School of Medicine; University of North Carolina; University of
   North Carolina Chapel Hill
RP Gupta, S (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, 1300 Morris Pk Ave,Ullmann 625, Bronx, NY 10461 USA.
EM sanjvgupta@pol.net
CR ALISON MR, 1985, BIOL EPITHELIAL CELL
   BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BIESTERFELD S, 1994, J CLIN PATHOL, V47, P38, DOI 10.1136/jcp.47.1.38
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   CRUISE JL, 1989, J CELL PHYSIOL, V140, P195, DOI 10.1002/jcp.1041400202
   DABEVA MD, 1995, AM J PATHOL, V147, P1633
   DIEZFERNANDEZ C, 1993, HEPATOLOGY, V18, P912, DOI 10.1002/hep.1840180424
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   ELDIERY WS, 1994, CANCER RES, V54, P1169
   FujikawaYamamoto K, 1997, CELL STRUCT FUNCT, V22, P399, DOI 10.1247/csf.22.399
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x
   GERLYNG P, 1992, CARCINOGENESIS, V13, P1795, DOI 10.1093/carcin/13.10.1795
   GOLDING M, 1995, HEPATOLOGY, V22, P1243, DOI 10.1016/0270-9139(95)90635-5
   GUPTA S, 1992, HEPATOLOGY, V15, P485, DOI 10.1002/hep.1840150322
   Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213
   Gupta S, 1999, J BIOL CHEM, V274, P2157, DOI 10.1074/jbc.274.4.2157
   Gupta S, 1999, AM J PHYSIOL-GASTR L, V276, pG629, DOI 10.1152/ajpgi.1999.276.3.G629
   Gupta S, 1999, J HEPATOL, V30, P162, DOI 10.1016/S0168-8278(99)80022-1
   GUPTA S, 1991, HEPATOLOGY, V14, P144, DOI 10.1002/hep.1840140124
   HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3
   HARMAN D, 1989, ADV EXP MED BIOL, V266, P3
   HARRIS M, 1971, EXP CELL RES, V66, P329, DOI 10.1016/0014-4827(71)90685-9
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   INGLE DJ, 1957, P SOC EXP BIOL MED, V95, P813, DOI 10.3181/00379727-95-23371
   Kato J, 1996, J CLIN INVEST, V98, P923, DOI 10.1172/JCI118875
   KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   MARCEAU N, 1982, IN VITRO CELL DEV B, V18, P1
   Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1002/hep.1840220622
   MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305
   MICHALOPOULOS G, 1982, CANCER RES, V42, P4673
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mignon A, 1998, NAT MED, V4, P1185, DOI 10.1038/2681
   MITAKA T, 1992, HEPATOLOGY, V16, P440, DOI 10.1002/hep.1840160224
   Nakatani T, 1997, EXP CELL RES, V236, P137, DOI 10.1006/excr.1997.3715
   Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603
   Overturf K, 1997, AM J PATHOL, V151, P1273
   POST J, 1960, ARCH PATHOL, V70, P3141
   PRINTSEVA OY, 1992, AM J HYPERTENS, V5, pS118, DOI 10.1093/ajh/5.6.118S
   Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669
   Rajvanshi P, 1996, HEPATOLOGY, V23, P482
   Rajvanshi P, 1998, EXP CELL RES, V244, P405, DOI 10.1006/excr.1998.4223
   RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   Seglen PO, 1997, CELL BIOL TOXICOL, V13, P301, DOI 10.1023/A:1007487425047
   SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x
   SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139
   SIMPSON GEC, 1963, J PATHOL BACTERIOL, V86, P361, DOI 10.1002/path.1700860211
   SOLOPAEV BP, 1981, B EXP BIOL MED, V90, P1442
   Thunnissen FBJM, 1997, CYTOMETRY, V27, P21, DOI 10.1002/(SICI)1097-0320(19970101)27:1<21::AID-CYTO3>3.0.CO;2-O
   VEMURU RP, 1992, HEPATOLOGY, V16, P968, DOI 10.1002/hep.1840160419
   VINDELOV LL, 1983, CYTOMETRY, V3, P332, DOI 10.1002/cyto.990030505
   WEBBER EM, 1994, AM J PATHOL, V145, P398
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   Yoshida Y, 1996, GASTROENTEROLOGY, V111, P1654, DOI 10.1016/S0016-5085(96)70029-X
NR 59
TC 175
Z9 196
U1 0
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD MAY
PY 1999
VL 276
IS 5
BP G1260
EP G1272
DI 10.1152/ajpgi.1999.276.5.G1260
PG 13
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 197BH
UT WOS:000080344400024
DA 2024-02-19
ER

PT J
AU Udomsinprasert, W
   Sobhonslidsuk, A
   Jittikoon, J
   Honsawek, S
   Chaikledkaew, U
AF Udomsinprasert, Wanvisa
   Sobhonslidsuk, Abhasnee
   Jittikoon, Jiraphun
   Honsawek, Sittisak
   Chaikledkaew, Usa
TI Cellular senescence in liver fibrosis: Implications for age-related
   chronic liver diseases
SO EXPERT OPINION ON THERAPEUTIC TARGETS
LA English
DT Article; Early Access
DE Cellular senescence; telomere shortening; mitochondrial dysfunction;
   liver fibrosis; age-related chronic liver diseases
ID HEPATIC STELLATE CELL; DNA-DAMAGE RESPONSE; SECRETORY PHENOTYPE;
   MITOCHONDRIAL-DNA; COPY NUMBER; CHOLANGIOCYTE SENESCENCE; LIFE-SPAN;
   DYSFUNCTION; REGENERATION; PROGRESSION
AB Introduction New insights indicate a causative link between cellular senescence and liver fibrosis. Senescent hepatic stellate cells (HSCs) facilitate fibrosis resolution, while senescence in hepatocytes and cholangiocytes acts as a potent mechanism driving liver fibrogenesis. In many clinical studies, telomeres and mitochondrial DNA contents, which are both aging biomarkers, were reportedly associated with a degree of liver fibrosis in patients with chronic liver diseases (CLDs); this highlights their potential as biomarkers for liver fibrogenesis. A deeper understanding of mechanisms underlying multi-step progression of senescence may yield new therapeutic strategies for age-related chronic liver pathologies. Areas covered This review examines the recent findings from preclinical and clinical studies on mechanisms of senescence in liver fibrogenesis and its involvement in liver fibrosis. A comprehensive literature search in electronic databases consisting of PubMed and Scopus from inception to 31 August 2021 was performed. Expert opinion Cellular senescence has diagnostic, prognostic, and therapeutic potential in progressive liver complications, especially liver fibrosis. Stimulating or reinforcing the immune response against senescent cells may be a promising and forthright biotherapeutic strategy. This approach will need a deeper understanding of the immune system's ability to eliminate senescent cells and the molecular and cellular mechanisms underlying this process.
C1 [Udomsinprasert, Wanvisa; Jittikoon, Jiraphun] Mahidol Univ, Fac Pharm, Dept Biochem, 447 Sri Ayudhaya Rd, Bangkok 10400, Thailand.
   [Sobhonslidsuk, Abhasnee] Mahidol Univ, Fac Med, Dept Med, Div Gastroenterol & Hepatol,Ramathibodi Hosp, Bangkok, Thailand.
   [Honsawek, Sittisak] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Biochem,Osteoarthrit & Musculoskeleton Res U, Bangkok, Thailand.
   [Chaikledkaew, Usa] Mahidol Univ, Fac Pharm, Dept Pharm, Social & Adm Pharm Div, Bangkok, Thailand.
   [Chaikledkaew, Usa] Mahidol Univ, Mahidol Univ Hlth Technol Assessment MUHTA Grad P, Bangkok, Thailand.
C3 Mahidol University; Mahidol University; Chulalongkorn University;
   Mahidol University; Mahidol University
RP Udomsinprasert, W (corresponding author), Mahidol Univ, Fac Pharm, Dept Biochem, 447 Sri Ayudhaya Rd, Bangkok 10400, Thailand.
EM wanvisa.udo@mahidol.ac.th
OI Udomsinprasert, Wanvisa/0000-0002-1132-7442
FU Mahidol University
FX This work is supported by Mahidol University (Basic Research Fund:
   fiscal year 2021).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Ahsan MK, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00069
   Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Al Suraih MS, 2020, LIVER INT, V40, P2455, DOI 10.1111/liv.14569
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   Alsuraih M, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100250
   Amaya-Montoya M, 2020, ADV THER, V37, P1407, DOI 10.1007/s12325-020-01287-0
   Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bai L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11303-z
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Birch J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600235
   Burton DGA, 2007, ANN NY ACAD SCI, V1119, P20, DOI 10.1196/annals.1404.026
   Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Dalle Pezze Piero, 2014, PLoS Comput Biol, V10, pe1003728, DOI 10.1371/journal.pcbi.1003728
   DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170
   Dimri GP, 1996, BIOL SIGNAL, V5, P154
   Dong K, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.10
   Ezhilarasan D, 2018, HEPATOB PANCREAT DIS, V17, P192, DOI 10.1016/j.hbpd.2018.04.003
   Feng M, 2020, BONE, V139, DOI 10.1016/j.bone.2020.115522
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Fickert P, 2017, J HEPATOL, V67, P619, DOI 10.1016/j.jhep.2017.04.026
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140
   Hashad DI, 2015, GENET TEST MOL BIOMA, V19, P604, DOI 10.1089/gtmb.2015.0132
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hopp AK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080890
   Horng T, 2014, TRENDS IMMUNOL, V35, P253, DOI 10.1016/j.it.2014.02.007
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jones DP, 2015, REDOX BIOL, V5, P71, DOI 10.1016/j.redox.2015.03.004
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kamogashira T, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0002-2
   Karakousis ND, 2020, LIVER INT, V40, P2917, DOI 10.1111/liv.14659
   Kawano Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093749
   Kim D, 2018, LIVER INT, V38, P1839, DOI 10.1111/liv.13886
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002
   Mannaerts I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084071
   Manzella N, 2018, AGING CELL, V17, DOI 10.1111/acel.12811
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210
   Panebianco C, 2017, CLIN EXP MED, V17, P269, DOI 10.1007/s10238-016-0438-x
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481
   Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pinzani M, 2015, DIGEST DIS, V33, P492, DOI 10.1159/000374096
   Pluquet O, 2021, ADV CANCER RES, V150, P285, DOI 10.1016/bs.acr.2021.01.001
   Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0
   Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184
   Regulski MJ, 2017, WOUNDS, V29, P168
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238
   Rowe IA, 2017, DIGEST DIS, V35, P304, DOI 10.1159/000456580
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sagiv A, 2016, AGING-US, V8, P328, DOI 10.18632/aging.100897
   Saile B, 1997, AM J PATHOL, V151, P1265
   Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   Schafer MJ, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0712-x
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Sharvit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076541
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076967
   Sumida Y, 2015, HEPATOL RES, V45, P771, DOI 10.1111/hepr.12408
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016
   Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Trivella JP, 2020, EXPERT OPIN EMERG DR, V25, P59, DOI 10.1080/14728214.2020.1735350
   Udomsinprasert W, 2019, MITOCHONDRION, V47, P1, DOI 10.1016/j.mito.2019.04.006
   Udomsinprasert W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134689
   Urabe Y, 1996, LIVER, V16, P293
   van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200
   Wan JH, 2014, AM J PATHOL, V184, P1763, DOI 10.1016/j.ajpath.2014.02.014
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wandrer F, 2018, ALIMENT PHARM THER, V48, P270, DOI 10.1111/apt.14802
   Wang Lu, 2020, Aging Med (Milton), V3, P48, DOI 10.1002/agm2.12095
   Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200
   Wen YK, 2021, CELL MOL IMMUNOL, V18, P45, DOI 10.1038/s41423-020-00558-8
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x
   Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188
   Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002
   Yen HH, 2012, WORLD J GASTROENTERO, V18, P5084, DOI 10.3748/wjg.v18.i36.5084
   Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001
   Zhou TH, 2019, EBIOMEDICINE, V48, P130, DOI 10.1016/j.ebiom.2019.09.013
   Zhu XL, 2015, ONCOL LETT, V10, P921, DOI 10.3892/ol.2015.3364
NR 129
TC 9
Z9 10
U1 6
U2 25
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1472-8222
EI 1744-7631
J9 EXPERT OPIN THER TAR
JI Expert Opin. Ther. Targets
PD 2021 SEP 2
PY 2021
VL 25
IS 9
BP 799
EP 813
DI 10.1080/14728222.2021.1992385
EA OCT 2021
PG 15
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WZ6WK
UT WOS:000710028600001
PM 34632912
DA 2024-02-19
ER

PT J
AU Cao, YN
   Xue, Y
   Xue, L
   Jiang, XL
   Wang, XL
   Zhang, ZJ
   Yang, J
   Lu, JL
   Zhang, CX
   Wang, WQ
   Ning, G
AF Cao, Yanan
   Xue, Ying
   Xue, Lu
   Jiang, Xiuli
   Wang, Xiaolin
   Zhang, Zhijian
   Yang, Jian
   Lu, Jieli
   Zhang, Changxian
   Wang, Weiqing
   Ning, Guang
TI Hepatic menin recruits SIRT1 to control liver steatosis through histone
   deacetylation
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Menin; SIRT1; Aging; Liver steatosis; Histone deacetylation
ID INSULIN-RESISTANCE; TUMOR-SUPPRESSOR; CALORIE RESTRICTION; MICE;
   RECEPTOR; DISEASE; METABOLISM; GLUCOSE; PROTEIN; PROLIFERATION
AB Background & Aims: The development and progression of nonalcoholic fatty liver disease are associated with aging, obesity, and type 2 diabetes. Understanding the precise regulatory networks of this process will contribute to novel therapeutic strategies.
   Methods: Hepatocyte-specific Men1 knockout mice were generated using Cre/loxP technology. Lipid and glucose metabolic phenotypes and mechanisms were investigated in aging and high-fat diet fed mice.
   Results: The expression of menin, encoded by multiple endocrine neoplasia 1 (Men1) gene, is reduced in the liver of aging mice. Hepatocyte-specific deletion of Men1 induces liver steatosis in aging mice. Menin deficiency promotes high-fat diet-induced liver steatosis in mice. Menin recruits SIRT1 to control hepatic CD36 expression and triglyceride accumulation through histone deacetylation.
   Conclusions: Our work reveals that the adaptor protein menin is critical for the progression of hepatic steatosis during aging and metabolic imbalance. (C) 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Cao, Yanan; Xue, Ying; Xue, Lu; Jiang, Xiuli; Wang, Xiaolin; Zhang, Zhijian; Yang, Jian; Lu, Jieli; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Dept Endocrinol & Metab, Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China.
   [Cao, Yanan; Xue, Ying; Xue, Lu; Jiang, Xiuli; Wang, Xiaolin; Zhang, Zhijian; Yang, Jian; Lu, Jieli; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Endocrinol & Metab, Shanghai 200025, Peoples R China.
   [Ning, Guang] Chinese Acad Sci, Lab Endocrinol & Metab, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China.
   [Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China.
   [Zhang, Changxian] Univ Lyon 1, Lab Genet Mol Signalisat & Canc, CNRS, Fac Med,Ctr Leon Berard,UMR5201, F-69365 Lyon, France.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese
   Academy of Sciences; Shanghai Jiao Tong University; Centre National de
   la Recherche Scientifique (CNRS); Universite Claude Bernard Lyon 1;
   UNICANCER; Centre Leon Berard
RP Ning, G (corresponding author), Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Dept Endocrinol & Metab, Rui Jin Hosp,Sch Med, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.
EM guangning@medmail.com.cn
RI zhang, zhi/HPH-4905-2023; Zhang, Chang Xian/HPG-4064-2023; Xue,
   Ying/JOK-1430-2023; ZHANG, Chang Xian/G-2905-2013; zhu,
   zhu/JDN-0159-2023
OI Xue, Ying/0000-0002-6812-5665; Cao, Yanan/0000-0002-3848-7040; Zhang,
   Chang Xian/0000-0002-5443-8951; Yang, Jian/0000-0002-3390-5127
FU Natural Science Foundation of China [30900702, 81170739, 81130016,
   81270859]; Shanghai Committee of Science and Technology [11140900501]
FX This research is supported by grants from Natural Science Foundation of
   China (30900702, 81170739, 81130016 and 81270859), Shanghai Committee of
   Science and Technology (11140900501).
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014
   Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636
   Bertolino P, 2003, CANCER RES, V63, P4836
   Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Cao YA, 2009, MOL CELL BIOL, V29, P5477, DOI 10.1128/MCB.00335-09
   Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608
   Cheng P, 2011, FEBS LETT, V585, P3403, DOI 10.1016/j.febslet.2011.09.043
   Choi JH, 2005, ARTERIOSCL THROM VAS, V25, P2404, DOI 10.1161/01.ATV.0000184758.07257.88
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Dean PG, 2000, WORLD J SURG, V24, P1437, DOI 10.1007/s002680010237
   Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08
   Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x
   Kaji H, 2012, J BONE MINER METAB, V30, P381, DOI 10.1007/s00774-012-0355-3
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kim H, 2003, CANCER RES, V63, P6135
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Li JZ, 2012, J CLIN INVEST, V122, P4130, DOI 10.1172/JCI65179
   Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252
   McCallum RW, 2006, CLIN ENDOCRINOL, V65, P163, DOI 10.1111/j.1365-2265.2006.02563.x
   Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102
   Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257
   Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4
   Scacheri PC, 2004, MAMM GENOME, V15, P872, DOI 10.1007/s00335-004-2395-z
   Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211
   Wagner Ana M, 2005, Eur J Intern Med, V16, P507, DOI 10.1016/j.ejim.2005.09.008
   Wuescher L, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.7
   Wuescher L, 2011, AM J PHYSIOL-ENDOC M, V301, pE474, DOI 10.1152/ajpendo.00022.2011
   Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013
   Xu XH, 2013, J HEPATOL, V59, P308, DOI 10.1016/j.jhep.2013.03.037
   YangLiu, 2012, J LIPID RES, V53, P358, DOI 10.1194/jlr.M019257
   Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025
   Zhang HL, 2012, ENDOCRINOLOGY, V153, P602, DOI 10.1210/en.2011-1460
   Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037
   Zindy PJ, 2006, HEPATOLOGY, V44, P1296, DOI 10.1002/hep.21367
NR 49
TC 49
Z9 60
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD DEC
PY 2013
VL 59
IS 6
BP 1299
EP 1306
DI 10.1016/j.jhep.2013.07.011
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 254CV
UT WOS:000327141800022
PM 23867312
DA 2024-02-19
ER

PT J
AU Yzydorczyk, C
   Li, N
   Chehade, H
   Mosig, D
   Bidho, M
   Keshavjee, B
   Armengaud, JB
   Nardou, K
   Siddeek, B
   Benahmed, M
   Vergely, C
   Simeoni, U
AF Yzydorczyk, Catherine
   Li, Na
   Chehade, Hassib
   Mosig, Dolores
   Bidho, Mickael
   Keshavjee, Basile
   Armengaud, Jean Baptiste
   Nardou, Katya
   Siddeek, Benazir
   Benahmed, Mohamed
   Vergely, Catherine
   Simeoni, Umberto
TI Transient postnatal overfeeding causes liver stress-induced premature
   senescence in adult mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HIGH-FAT DIET; INSULIN-RESISTANCE; OXIDATIVE STRESS; ADIPOSE-TISSUE;
   EARLY OVERNUTRITION; METABOLIC SYNDROME; CHRONIC HEPATITIS; RATS LEADS;
   OVERWEIGHT; EXPRESSION
AB Unbalanced nutrition early in life is increasingly recognized as an important factor in the development of chronic, non-communicable diseases at adulthood, including metabolic diseases. We aimed to determine whether transient postnatal overfeeding (OF) leads to liver stress-induced premature senescence (SIPS) of hepatocytes in association with liver structure and hepatic function alterations. Litters sizes of male C57BL/6 mice were adjusted to 9 pups (normal feeding, NF) or reduced to 3 pups during the lactation period to induce transient postnatal OF. Compared to the NF group, seven-monthold adult mice transiently overfed during the postnatal period were overweight and developed glucose intolerance and insulin resistance. Their livers showed microsteatosis and fibrosis, while hepatic insulin signaling and glucose transporter protein expressions were altered. Increased hepatic oxidative stress (OS) was observed, with increased superoxide anion production, glucose-6-phosphate dehydrogenase protein expression, oxidative DNA damage and decreased levels of antioxidant defense markers, such as superoxide dismutase and catalase proteins. Hepatocyte senescence was characterized by increased p21(WAF), p53, Acp53, p16(INK4a) and decreased pRb/Rb and Sirtuin-1 (SIRT-1) protein expression levels. Transient postnatal OF induces liver OS at adulthood, associated with hepatocyte SIPS and alterations in liver structure and hepatic functions, which could be mediated by a SIRT-1 deficiency.
C1 [Yzydorczyk, Catherine; Chehade, Hassib; Mosig, Dolores; Bidho, Mickael; Keshavjee, Basile; Armengaud, Jean Baptiste; Nardou, Katya; Siddeek, Benazir; Benahmed, Mohamed; Simeoni, Umberto] CHU Vaudois, Woman Mother Child Dept, Div Pediat, DOHaD Lab, Lausanne, Switzerland.
   [Yzydorczyk, Catherine; Chehade, Hassib; Mosig, Dolores; Bidho, Mickael; Keshavjee, Basile; Armengaud, Jean Baptiste; Nardou, Katya; Siddeek, Benazir; Benahmed, Mohamed; Simeoni, Umberto] Univ Lausanne, Lausanne, Switzerland.
   [Li, Na; Vergely, Catherine] Univ Bourgogne Franche Comte, UFR Sci Sante, Equipe Physiopathol & Epidemiol Cerebro Cardiovas, Dijon, France.
C3 University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV);
   University of Lausanne; Universite de Bourgogne
RP Yzydorczyk, C (corresponding author), CHU Vaudois, Woman Mother Child Dept, Div Pediat, DOHaD Lab, Lausanne, Switzerland.; Yzydorczyk, C (corresponding author), Univ Lausanne, Lausanne, Switzerland.
EM catherine.yzydorczyk@chuv.ch
RI SIMEONI, Umberto/AAQ-1870-2021; Vergely, Catherine/L-9534-2015; Simeoni,
   Umberto/GRO-6971-2022
OI SIMEONI, Umberto/0000-0003-0730-9337; Vergely,
   Catherine/0000-0003-4009-776X; Simeoni, Umberto/0000-0003-0730-9337;
   SIDDEEK, Benazir/0000-0003-2764-6656; Chehade,
   Hassib/0000-0001-5019-2547; YZYDORCZYK, Catherine/0000-0002-0617-7558
FU French Ministry of Research; Institut National de la Sante et de la
   Recherche Medicale (INSERM); CHUV-University of Lausanne, Switzerland
FX The authors gratefully thank the Mouse Pathology Institute, Prof
   Christine Sempoux, Dr. Anne Christine Peyter and Prof. Pedrazzini's lab
   at CHUV/UNIL for the provided technical assistance. This work was
   supported by grants from the French Ministry of Research and the
   Institut National de la Sante et de la Recherche Medicale (INSERM), and
   CHUV-University of Lausanne, Switzerland.
CR Anai M, 1998, DIABETES, V47, P13, DOI 10.2337/diabetes.47.1.13
   Aravinthan A, 2015, EXP CELL RES, V331, P38, DOI 10.1016/j.yexcr.2014.09.025
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197
   Bringhenti I, 2015, NUTR RES, V35, P136, DOI 10.1016/j.nutres.2014.11.006
   Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009
   Conceiçao EPS, 2013, J NUTR BIOCHEM, V24, P81, DOI 10.1016/j.jnutbio.2012.02.010
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Davidowa H, 2004, NEUROSCI LETT, V371, P64, DOI 10.1016/j.neulet.2004.08.042
   de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187
   de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786
   Cunha ACDR, 2009, J NUTR BIOCHEM, V20, P435, DOI 10.1016/j.jnutbio.2008.05.002
   Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Du QW, 2015, PEPTIDES, V70, P23, DOI 10.1016/j.peptides.2015.05.003
   Duque-Guimaraes DE, 2013, TRENDS ENDOCRIN MET, V24, P525, DOI 10.1016/j.tem.2013.05.006
   Favero G, 2015, AGE, V37, DOI 10.1007/s11357-015-9804-y
   Fujita N, 2008, J VIRAL HEPATITIS, V15, P498, DOI 10.1111/j.1365-2893.2008.00972.x
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329
   Habbout A, 2013, J NUTR, V143, P553, DOI 10.3945/jn.112.172825
   Habbout A, 2012, BIOCHIMIE, V94, P117, DOI 10.1016/j.biochi.2011.09.023
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Ho C, 2009, FEBS LETT, V583, P3081, DOI 10.1016/j.febslet.2009.08.031
   Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710
   Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111
   Jenkins NC, 2011, ONCOGENE, V30, P265, DOI 10.1038/onc.2010.419
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Li N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30817
   Liu WP, 2010, MECH AGEING DEV, V131, P601, DOI 10.1016/j.mad.2010.08.006
   Marí M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634
   Meng R, 2011, ANN CLIN LAB SCI, V41, P236
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525
   Muoio DM, 2004, SCIENCE, V306, P425, DOI 10.1126/science.1104680
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005
   Pi-Sunyer FX, 2002, OBES SURG, V12, p6S, DOI 10.3810/pgm.2009.11.2074
   PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P154, DOI 10.1055/s-0029-1211159
   Purushotham A, 2009, AGING-US, V1, P669, DOI 10.18632/aging.100076
   Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540
   Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004
   Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345
   Rodrigues AL, 2007, J ENDOCRINOL, V195, P485, DOI 10.1677/JOE-07-0046
   Rodrigues AL, 2009, J PHYSIOL-LONDON, V587, P2647, DOI 10.1113/jphysiol.2009.169045
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001
   Spolarics Z, 1999, J NUTR, V129, P105, DOI 10.1093/jn/129.1.105
   Stacchiotti A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148115
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   SU Y, 1990, EXP CLIN ENDOCRINOL, V96, P301, DOI 10.1055/s-0029-1211023
   Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187
   Tian XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158657
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Vassallo P. F., 2014, BLOOD
   Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747
   Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6
   Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08
   Yu A, 2013, MOL CELL ENDOCRINOL, V377, P23, DOI 10.1016/j.mce.2013.06.028
   Yzydorczyk C, 2015, ARCH PEDIATRIE, V22, P1047, DOI 10.1016/j.arcped.2015.05.019
   Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251
NR 70
TC 14
Z9 15
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 10
PY 2017
VL 7
AR 12911
DI 10.1038/s41598-017-11756-2
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FJ3SE
UT WOS:000412651300016
PM 29018245
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lu, WY
   Bird, TG
   Boulter, L
   Tsuchiya, A
   Cole, AM
   Hay, T
   Guest, RV
   Wojtacha, D
   Man, TY
   Mackinnon, A
   Ridgway, RA
   Kendall, T
   Williams, MJ
   Jamieson, T
   Raven, A
   Hay, DC
   Iredale, JP
   Clarke, AR
   Sansom, OJ
   Forbes, SJ
AF Lu, Wei-Yu
   Bird, Thomas G.
   Boulter, Luke
   Tsuchiya, Atsunori
   Cole, Alicia M.
   Hay, Trevor
   Guest, Rachel V.
   Wojtacha, Davina
   Man, Tak Yung
   Mackinnon, Alison
   Ridgway, Rachel A.
   Kendall, Timothy
   Williams, Michael J.
   Jamieson, Thomas
   Raven, Alex
   Hay, David C.
   Iredale, John P.
   Clarke, Alan R.
   Sansom, Owen J.
   Forbes, Stuart J.
TI Hepatic progenitor cells of biliary origin with liver repopulation
   capacity
SO NATURE CELL BIOLOGY
LA English
DT Article
ID STEM-CELLS; DUCTULAR REACTIONS; CHOLINE-DEFICIENT; MOUSE-LIVER; ADULT
   LIVER; OVAL CELLS; HEPATOCYTES; DIFFERENTIATION; SENESCENCE; EXPANSION
AB Hepatocytes and cholangiocytes self-renew following liver injury. Following severe injury hepatocytes are increasingly senescent, but whether hepatic progenitor cells (HPCs) then contribute to liver regeneration is unclear. Here, we describe a mouse model where the E3 ubiquitin ligase Mdm2 is inducibly deleted in more than 98% of hepatocytes, causing apoptosis, necrosis and senescence with nearly all hepatocytes expressing p21. This results in florid HPC activation, which is necessary for survival, followed by complete, functional liver reconstitution. HPCs isolated from genetically normal mice, using cell surface markers, were highly expandable and phenotypically stable in vitro. These HPCs were transplanted into adult mouse livers where hepatocyte Mdm2 was repeatedly deleted, creating a non-competitive repopulation assay. Transplanted HPCs contributed significantly to restoration of liver parenchyma, regenerating hepatocytes and biliary epithelia, highlighting their in vivo lineage potency. HPCs are therefore a potential future alternative to hepatocyte or liver transplantation for liver disease.
C1 [Lu, Wei-Yu; Bird, Thomas G.; Guest, Rachel V.; Wojtacha, Davina; Man, Tak Yung; Mackinnon, Alison; Williams, Michael J.; Raven, Alex; Hay, David C.; Forbes, Stuart J.] MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.
   [Boulter, Luke; Kendall, Timothy] MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.
   [Tsuchiya, Atsunori] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata 9518510, Japan.
   [Cole, Alicia M.; Ridgway, Rachel A.; Jamieson, Thomas; Sansom, Owen J.] CRUK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland.
   [Hay, Trevor; Clarke, Alan R.] European Canc Stem Cell Res Inst, Cardiff Sch Biosci, London CF24 4HQ, England.
   [Iredale, John P.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland.
C3 University of Edinburgh; Niigata University; Beatson Institute;
   University of Edinburgh
RP Forbes, SJ (corresponding author), MRC, Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.
EM stuart.forbes@ed.ac.uk
RI Hay, David/JZD-9418-2024; clarke, alan r/P-2820-2014; Iredale, John
   P/C-7300-2013; Lu, Wei-Yu/N-5884-2019; Kendall, Tim/H-2698-2019; Bird,
   Tom/H-3840-2019
OI Lu, Wei-Yu/0000-0002-0419-0257; Kendall, Tim/0000-0002-4174-2786; Bird,
   Tom/0000-0002-6120-1581; Raven, Alexander/0000-0003-4409-9543; Iredale,
   John/0000-0003-2174-5127; Sansom, Owen J./0000-0001-9540-3010; Forbes,
   Stuart/0000-0003-3715-2561; Boulter, Luke/0000-0002-7954-6705; Clarke,
   Alan/0000-0002-4281-426X
FU Wellcome Trust; Academy of Medical Sciences; University of Edinburgh;
   Charles Darwin Scholarship; Edinburgh Overseas Research Scholarship; UK
   Regenerative Medicine Platform; MRC; Cancer Research UK; European
   Research Council; Sir Jules Thorn Charitable Trust; Medical Research
   Council; MRC [G0901697, MR/L012766/1, MR/K026666/1, MR/L022974/1,
   G0900446, G1000868, G0600033] Funding Source: UKRI; Grants-in-Aid for
   Scientific Research [15K08990] Funding Source: KAKEN; Medical Research
   Council [G0600033, G0901697, MR/L022974/1, MR/L012766/1, MR/K026666/1,
   G1000868, G0900446] Funding Source: researchfish; The Sir Jules Thorn
   Charitable Trust [07JTA] Funding Source: researchfish; Versus Arthritis;
   Cancer Research UK [21139] Funding Source: researchfish
FX The authors would like to thank Biogen Idec for supplying the
   Fn14<SUP>KO</SUP> mouse line. We would also like to thank V. Factor for
   kindly supplying the A6 antibody, and M. Alison for proofreading the
   manuscript. We would like to thank F. Rossi, C. Cryer, O. Rodrigues and
   S. Monard for assistance with flow cytometry. T.G.B. is financially
   supported by the Wellcome Trust and the Academy of Medical Sciences.
   W.Y.L. was supported by the University of Edinburgh, Charles Darwin
   Scholarship, Edinburgh Overseas Research Scholarship, and the UK
   Regenerative Medicine Platform. J.P.I is supported by the MRC. O.J.S. is
   financially supported by Cancer Research UK and the European Research
   Council. S.J.F. is supported by the Sir Jules Thorn Charitable Trust,
   the Medical Research Council, and the UK Regenerative Medicine Platform.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110
   Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Dorrell C, 2008, HEPATOLOGY, V48, P1282, DOI 10.1002/hep.22468
   Eischen CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046148
   Erker L, 2010, GASTROENTEROLOGY, V139, P1019, DOI 10.1053/j.gastro.2010.05.082
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133
   Fickert P, 2010, LAB INVEST, V90, P844, DOI 10.1038/labinvest.2010.61
   Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722
   GOLDING M, 1995, HEPATOLOGY, V22, P1243, DOI 10.1016/0270-9139(95)90635-5
   Gonçalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169
   Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613
   Grier JD, 2002, GENESIS, V32, P145, DOI 10.1002/gene.10066
   Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004
   Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105
   Hay DC, 2010, GASTROENTEROLOGY, V139, P729, DOI 10.1053/j.gastro.2010.07.013
   Horslen SP, 2004, TRANSPLANTATION, V77, P1481, DOI 10.1097/01.TP.0000113809.53415.C2
   Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020
   Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486
   Jörs S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585
   Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345
   Lu W. Y., 2015, PROTOC EXCH
   Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261
   Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Qiu Q, 2011, STEM CELLS DEV, V20, P2177, DOI 10.1089/scd.2010.0352
   Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078
   Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003
   Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558
   Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008
   Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008
   Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663
   Tsuchiya A, 2005, GASTROENTEROLOGY, V128, P2089, DOI 10.1053/j.gastro.2005.03.030
   Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
   Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060
NR 54
TC 328
Z9 354
U1 2
U2 62
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD AUG
PY 2015
VL 17
IS 8
BP 971
EP U43
DI 10.1038/ncb3203
PG 25
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CO0NE
UT WOS:000358847700005
PM 26192438
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Panda, S
   Isbatan, A
   Adami, GR
AF Panda, Suchismita
   Isbatan, Ayman
   Adami, Guy R.
TI Modification of the ATM/ATR directed DNA damage response state with
   aging and long after hepatocyte senescence induction <i>in vivo</i>
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE cellular senescence; aging; ATM/ATR; 53BP1; hepatocytes; DNA damage foci
ID CELLULAR SENESCENCE; HUMAN-CELLS; TUMOR SUPPRESSION; GROWTH; BIOMARKER;
   MICE; HETEROCHROMATIN; TUMORIGENESIS; POLYPLOIDY; CHECKPOINT
AB The cellular DNA damage response (DDR) entails the activation of ATM, ATR and/or DNA PK protein kinases that causes modifications of proteins including Chk1, Chk2 and 53BP1, aggregation of DDR proteins into foci, and activation of p53. The DDR is thought to be required for initiation and maintenance of cellular senescence. Potentially senescent cells with DNA damage foci occur in large numbers in vivo with many diseases, but, with the exception of mammalian dermis, there is little evidence for that with normal aging. After experimental induction of cellular senescence in the livers of juvenile mice, there was robust expression of DDR markers in hepatocytes at 1 week; however, by 7 weeks, activation of ATM/ATR kinase targets was limited, although cells with DNA damage foci were present. An analysis of hepatocytes of aged, 22-month-old mice, not experimentally exposed to genotoxins, showed limited activation of ATM/ATR targets, though high numbers of cells with DNA damage foci were found, similar to that seen many weeks after artificial senescence induction in young mice. Based on senescence heterochromatin and SA 9 Gal assays of the 22-month-old mouse liver, more than 20% of hepatocytes were potentially senescent, though only some components of the DDR were enriched. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Panda, Suchismita; Isbatan, Ayman; Adami, Guy R.] Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Dept Oral Med & Diagnost Sci, Chicago, IL 60612 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Adami, GR (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Dept Oral Med & Diagnost Sci, 801 S Paulina St, Chicago, IL 60612 USA.
EM gadami@uic.edu
FU NCI NIH HHS [R01 CA085529-02, R01 CA085529-03, R01 CA085529-04, R01
   CA085529-05, R01 CA085529, R01 CA 85529-05] Funding Source: Medline
CR Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020
   Bahjat FR, 2000, J IMMUNOL, V165, P6559, DOI 10.4049/jimmunol.165.11.6559
   Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453
   Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024
   Chen JH, 2006, FEBS LETT, V580, P6669, DOI 10.1016/j.febslet.2006.11.023
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010
   Cristofalo VJ, 2005, EXP GERONTOL, V40, P836, DOI 10.1016/j.exger.2005.08.005
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DORR RT, 1988, SEMIN ONCOL, V15, P32
   Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005
   Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485
   Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   Herbig U, 2006, MECH AGEING DEV, V127, P16, DOI 10.1016/j.mad.2005.09.002
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Holliday R, 1995, Understanding ageing
   HORNSBY PJ, 2001, HDB BIOL AGING
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Kao CY, 1996, BIOCHEM BIOPH RES CO, V222, P64, DOI 10.1006/bbrc.1996.0698
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004
   Lázaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448
   Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321
   Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719
   Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Puviani AC, 1998, COMP BIOCHEM PHYS A, V121, P99, DOI 10.1016/S1095-6433(98)10109-5
   Roth GS, 1997, MECH AGEING DEV, V98, P231, DOI 10.1016/S0047-6374(97)00110-3
   Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Stocker E, 1971, Beitr Pathol, V144, P400
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   TAMURA J, 1992, J SURG RES, V53, P218, DOI 10.1016/0022-4804(92)90038-2
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682
   Yang NC, 2005, EXP GERONTOL, V40, P813, DOI 10.1016/j.exger.2005.07.011
   Zimmerman HJ, 1999, HEPATOTOXICITY
NR 50
TC 23
Z9 28
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN
PY 2008
VL 129
IS 6
BP 332
EP 340
DI 10.1016/j.mad.2008.02.014
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 315HA
UT WOS:000256867900005
PM 18440596
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Chuang, HL
   Baskaran, R
   Day, CH
   Lin, YM
   Ho, CC
   Ho, TJ
   Chen, RJ
   Mahalakshmi, BK
   Kuo, WW
   Huang, CY
AF Chuang, Ho-Lin
   Baskaran, Rathinasamy
   Hsuan Day, Cecilia
   Lin, Yueh-Min
   Ho, Chih-Chu
   Ho, Tsung-Jung
   Chen, Ray-Jade
   Mahalakshmi, Bharath Kumar
   Kuo, Wei-Wen
   Huang, Chih-Yang
TI Role of potato protein hydrolysate and exercise in preventing high-fat
   diet-induced hepatocyte apoptosis in senescence-accelerated mouse
SO JOURNAL OF FOOD BIOCHEMISTRY
LA English
DT Article; Early Access
DE aging; apoptosis; high-fat diet; liver; SAMP8
ID CARDIAC APOPTOSIS; LIVER-DISEASE; LIPID-ACCUMULATION; ADIPOSE-TISSUE;
   MURINE MODEL; RATS; PATHWAY; SAMP8; EXPRESSION; LIPOLYSIS
AB Nonalcoholic fatty liver disease (NAFLD) is considered to be a serious clinical complication, which could cause significant liver dysfunction including fibrosis, cirrhosis, and cancer. Obesity could lead to NAFLD and contributes to liver disorder and related complicated liver diseases. Effect of exercise combined with alcalase treatment derived potato protein hydrolysate (APPH) on high-fat diet (HFD)-induced hepatic injury was investigated in senescence accelerated mouse-prone 8 (SAMP8) mice in the present study. Mice were divided into six groups (n = 6): Group I-Control, Group II-HFD, Group III-Exercise, Group IV-HFD + APPH, Group V-HFD + Exercise, and Group VI-HFD + Exercise + APPH. Combined APPH treatment and exercise offer better cytoprotection in HFD-induced histological changes than APPH treatment and exercise alone. Further, APPH and exercise activate the cell survival proteins PI3K/Akt and prevent FasL/FADD-mediated apoptosis in HFD fed SAMP8 mouse. APPH with swimming exercise effectively modulate HFD-induced liver damage and apoptosis in aged mice through activation of PI3K/Akt protein. Practical applications Exercise training is proven to reduce the health problems associated with aging and obesity, however, intensity and duration of the exercise differs between individuals. We used integrated pharmacological and nonpharmacological approach as a therapeutic strategy for preventing HFD-induced hepatic injury in aged subjects.
C1 [Chuang, Ho-Lin] China Med Univ, Dept Biol Sci & Technol, Coll Biopharmaceut & Food Sci, Taichung, Taiwan.
   [Chuang, Ho-Lin; Ho, Chih-Chu] HK Zen Heart Grp Biopharmaceut Co Ltd, Wanchai, Hong Kong, Peoples R China.
   [Baskaran, Rathinasamy] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.
   [Hsuan Day, Cecilia] MeiHo Univ, Dept Nursing, Pingtung, Taiwan.
   [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan.
   [Ho, Tsung-Jung] Tzu Chi Univ, Hualien Tzu Chi Hosp, Dept Chinese Med, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan.
   [Chen, Ray-Jade] Taipei Med Univ, Sch Med, Dept Surg, Coll Med, Taipei, Taiwan.
   [Mahalakshmi, Bharath Kumar] Duy Tan Univ, Inst Res & Dev, Da Nang, Vietnam.
   [Kuo, Wei-Wen] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan.
   [Huang, Chih-Yang] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.
   [Huang, Chih-Yang] Tzu Chi Univ Sci & Technol, Buddhist Tzu Chi Med Fdn, Ctr Gen Educ, Hualien, Taiwan.
   [Huang, Chih-Yang] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.
   [Huang, Chih-Yang] Asia Univ, Dept Biotechnol, Taichung, Taiwan.
   [Huang, Chih-Yang] Tzu Chi Univ Sci & Technol, Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Cardiovasc & Mitochondrial Related Dis Res Ctr, Hualien, Taiwan.
C3 China Medical University Taiwan; Asia University Taiwan; Changhua
   Christian Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi
   Hospital; Tzu Chi University; Taipei Medical University; Duy Tan
   University; China Medical University Taiwan; China Medical University
   Taiwan; Tzu Chi University of Science & Technology; China Medical
   University Taiwan; China Medical University Hospital - Taiwan; Asia
   University Taiwan; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi
   Hospital; Tzu Chi University of Science & Technology
RP Huang, CY (corresponding author), Tzu Chi Univ Sci & Technol, Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Cardiovasc & Mitochondrial Related Dis Res Ctr, Hualien, Taiwan.
EM cyhuang@mail.cmu.edu.tw
RI Chen, Ray/GRJ-6736-2022
OI Huang, Chih-Yang/0000-0003-2347-0411
CR Akiguchi I, 2017, NEUROPATHOLOGY, V37, P293, DOI 10.1111/neup.12373
   Valiñas MA, 2015, J AGR FOOD CHEM, V63, P4902, DOI 10.1021/jf505777p
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Chiang WD, 2016, FOOD NUTR RES, V60, DOI [10.3402/fnr.v60.30511, 10.3402/fnr.v60.31417]
   Chicco AJ, 2006, J CARDIOVASC PHARM, V47, P182, DOI 10.1097/01.fjc.0000199682.43448.2d
   De Mejia E, 2006, SEX REPROD MENOP, V4, P91, DOI [DOI 10.1016/J.SRAM.2006.08.012, 10.1016/j.sram.2006.08.012]
   Dumeus S, 2018, CELL PHYSIOL BIOCHEM, V48, P1942, DOI 10.1159/000492518
   Hart KJ, 2001, J APPL PHYSIOL, V91, P1663, DOI 10.1152/jappl.2001.91.4.1663
   Hashida R, 2017, J HEPATOL, V66, P142, DOI 10.1016/j.jhep.2016.08.023
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Hu WS, 2015, INT J MOL SCI, V16, P10158, DOI 10.3390/ijms160510158
   Huang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/275431
   Huang CY, 2015, J FUNCT FOODS, V12, P389, DOI 10.1016/j.jff.2014.11.027
   Kamnerdpetch C, 2007, ENZYME MICROB TECH, V40, P508, DOI 10.1016/j.enzmictec.2006.05.006
   Karuppagounder V, 2017, AGEING RES REV, V35, P291, DOI 10.1016/j.arr.2016.10.006
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Kistler KD, 2011, AM J GASTROENTEROL, V106, P460, DOI 10.1038/ajg.2010.488
   Knorr D., 1977, Journal of Food Processing and Preservation, V1, P235, DOI 10.1111/j.1745-4549.1977.tb00326.x
   Kudoh K, 2003, J NUTR SCI VITAMINOL, V49, P451, DOI 10.3177/jnsv.49.451
   Kujawska M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020259
   Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009
   Lawlor DA, 2014, J CLIN ENDOCR METAB, V99, pE410, DOI 10.1210/jc.2013-3612
   Lee HP, 2019, J FUNCT FOODS, V52, P537, DOI 10.1016/j.jff.2018.11.040
   Lin JY, 2020, AGING-US, V12, P6852, DOI 10.18632/aging.103046
   Lin PP, 2013, INT J MOL MED, V32, P1319, DOI 10.3892/ijmm.2013.1524
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404
   Onishi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195753
   Ou HC, 2010, J AGR FOOD CHEM, V58, P10347, DOI [10.1021/jf101606s, 10.1021/Jf101606s]
   Pisonero-Vaquero S, 2015, MOL NUTR FOOD RES, V59, P879, DOI 10.1002/mnfr.201400913
   Ruiz JCR, 2014, NUTR HOSP, V29, P776
   Ryan Alice S, 2010, Aging health, V6, P551, DOI 10.2217/ahe.10.46
   Singh BP, 2014, PEPTIDES, V54, P171, DOI 10.1016/j.peptides.2014.01.022
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Takeda T., 2013, SENESCENCE ACCELERAT
   Thyfault JP, 2020, DIABETOLOGIA, V63, P1464, DOI 10.1007/s00125-020-05177-6
   Udenigwe CC, 2013, FOOD FUNCT, V4, P777, DOI 10.1039/c3fo30327f
   van Koningsveld GA, 2006, J AGR FOOD CHEM, V54, P6419, DOI 10.1021/jf061278z
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   Wang HF, 2015, INT J MOL MED, V35, P460, DOI 10.3892/ijmm.2014.2021
   Wang LL, 2005, J AGR FOOD CHEM, V53, P9186, DOI 10.1021/jf051213g
   Wang SP, 2008, MOL GENET METAB, V95, P117, DOI 10.1016/j.ymgme.2008.06.012
   Wu KM, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0356-5
   Xiao J., 2013, EVID-BASED COMPL ALT, V2013, P1
   Yang PJ, 2019, DIABETES METAB SYNDR, V12, P1013, DOI 10.2147/DMSO.S206867
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046
NR 48
TC 5
Z9 5
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8884
EI 1745-4514
J9 J FOOD BIOCHEM
JI J. Food Biochem.
PD 2020 DEC
PY 2020
VL 44
IS 12
AR e13525
DI 10.1111/jfbc.13525
EA OCT 2020
PG 9
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA PM2UE
UT WOS:000579291900001
PM 33078424
OA gold
DA 2024-02-19
ER

PT J
AU Qi, X
   Ng, KTP
   Lian, QZ
   Li, CX
   Geng, W
   Ling, CC
   Yeung, WH
   Ma, YY
   Liu, XB
   Liu, H
   Liu, J
   Yang, XX
   Lo, CM
   Man, K
AF Qi, Xiang
   Ng, Kevin Tak-Pan
   Lian, Qizhou
   Li, Chang Xian
   Geng, Wei
   Ling, Chang Chun
   Yeung, Wai Ho
   Ma, Yuen Yuen
   Liu, Xiao Bing
   Liu, Hui
   Liu, Jiang
   Yang, Xin Xiang
   Lo, Chung Mau
   Man, Kwan
TI Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR
   Injury via Inhibition of Hepatic Senescence
SO THERANOSTICS
LA English
DT Article
DE GPx3; IR injury; hepatic senescence; hiPSC-MSCs; liver transplantation
ID MESENCHYMAL STEM-CELLS; ISCHEMIA-REPERFUSION INJURY; LIVER GRAFT INJURY;
   OXIDATIVE STRESS; REPLICATIVE SENESCENCE; CLINICAL-SIGNIFICANCE;
   GENE-EXPRESSION; STROMAL CELLS; TUMOR-GROWTH; SIZE
AB Background and Aims: Down-regulation of GPx3 accelerated hepatic senescence, which further caused overwhelming inflammation and severe liver graft injury. MSCs derived from human induced pluripotent stem cells (hiPSC-MSCs) have been developed as more efficient delivery vehicle with the property of injury tropism. Here, we aimed to explore the suppressive role of GPx3 in hepatic IR injury using novel delivery system of hiPSC-MSCs.
   Methods: The mice IR injury model with partial hepatectomy was established. The engineered hiPSC-MSCs delivering GPx3 was constructed. All the mice were segregated into three groups. hiPSC-MSC-GPx3, hiPSC-MSC-pCDH (vector control) or PBS were injected via portal vein after reperfusion. Liver injury was evaluated by histological and serological test. Hepatic apoptosis was detected by Tunel staining and remnant liver regeneration was assessed by Ki67 staining. The role of hepatic senescence in liver graft injury was evaluated in rat orthotopic liver transplantation model. The suppressive effect of GPx3 on hepatic senescence was examined in mice IR injury model and confirmed in vitro. Hepatic senescence was detected by SA-beta-Gal and P-16/ink4a staining.
   Results: GPx3 can be successfully delivered by hiPSC-MSCs into liver tissues. Histological examination showed that hiPSC-MSC-GPx3 treatment significantly ameliorated hepatic IR injury post-operation. Significantly lower LDH (891.43 +/- 98.45 mU/mL, P<0.05) and AST (305.77 +/- 36.22 IU/L, P<0.01) were observed in hiPSC-MSC-GPx3 group compared with control groups. Less apoptotic hepatocytes were observed and the remnant liver regeneration was more active in hiPSC-MSC-GPx3 group. In rat orthotopic liver transplantation model, more senescent hepatocytes were observed in small-for-size liver graft, in which GPx3 expression was significantly compromised. In mice IR injury model, hiPSC-MSC-GPx3 significantly suppressed hepatic senescence. In addition, rGPx3 inhibited cellular senescence of liver cells in a dose dependent manner. Four candidate genes (CD44, Nox4, IFNG, SERPERINB2) were identified to be responsible for suppressive effect of GPx3 on hepatic senescence.
   Conclusion: Engineered hiPSC-MSCs delivering GPx3 ameliorated hepatic IR injury via inhibition of hepatic senescence.
C1 [Qi, Xiang; Ng, Kevin Tak-Pan; Li, Chang Xian; Geng, Wei; Ling, Chang Chun; Yeung, Wai Ho; Ma, Yuen Yuen; Liu, Xiao Bing; Liu, Hui; Liu, Jiang; Yang, Xin Xiang; Lo, Chung Mau; Man, Kwan] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China.
   [Lo, Chung Mau; Man, Kwan] Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China.
   [Lian, Qizhou] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China.
C3 University of Hong Kong; Collaborative Innovation Center for Diagnosis &
   Treatment of Infectious Diseases; University of Hong Kong
RP Man, K (corresponding author), L9-55,Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.
EM kwanman@hku.hk
RI NG, Kevin Tak-Pan/J-1510-2018; Liu, Jiang/HCH-0324-2022; Lo, Chung
   Mau/C-4352-2009; Lian, Qizhou/Y-1613-2019; Yang, Xinxiang/ISA-6013-2023
OI NG, Kevin Tak-Pan/0000-0001-9822-1335; Lian, Qizhou/0000-0001-8189-7160
FU Collaborative Research Fund [C7027-14G]; HMRF [02132366]; RGC General
   Research Funds [HKU775011M, 17115515, 17115614]; National Science
   Foundation of China (NSFC) [81470903, 81572945, 81320108015]
FX This study was supported by the Collaborative Research Fund (C7027-14G),
   HMRF (No. 02132366), RGC General Research Funds (No. HKU775011M,
   17115515, and 17115614) and National Science Foundation of China (NSFC)
   grants (No. 81470903, 81572945 and 81320108015).
CR Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117
   Albersen M, 2012, J SEX MED, V9, P385, DOI 10.1111/j.1743-6109.2011.02556.x
   Barascu A, 2012, NUCLEUS-PHILA, V3, P411, DOI 10.4161/nucl.21674
   Basile DP, 2012, AM J PHYSIOL-RENAL, V302, pF1494, DOI 10.1152/ajprenal.00691.2011
   Cheng Q, 2014, ANN SURG, V260, P1062, DOI 10.1097/SLA.0000000000000427
   Cuesta S, 2010, EXP GERONTOL, V45, P950, DOI 10.1016/j.exger.2010.08.016
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Geng W, 2015, ONCOTARGET, V6, P28042, DOI 10.18632/oncotarget.4832
   Gropper S.A.S., 2009, ADV NUTR HUMAN METAB
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024
   Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023
   Li CX, 2016, ONCOTARGET, V7, P27711, DOI 10.18632/oncotarget.8509
   Li CX, 2014, ANN SURG, V260, P317, DOI 10.1097/SLA.0000000000000429
   Li CX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-293
   Li YG, 2010, ALCOHOL ALCOHOLISM, V45, P320, DOI 10.1093/alcalc/agq034
   Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312
   Liang TB, 2003, TRANSPLANTATION, V75, P673, DOI 10.1097/01.TP.0000048490.24429.89
   Ling CC, 2014, J HEPATOL, V60, P103, DOI 10.1016/j.jhep.2013.08.017
   Liu HY, 2012, CYTOTHERAPY, V14, P162, DOI 10.3109/14653249.2011.613927
   Man K, 2004, ANN SURG, V240, P159, DOI 10.1097/01.sla.0000129673.13552.c0
   Man K, 2003, ANN SURG, V237, P256, DOI 10.1097/00000658-200302000-00015
   Man K, 2001, ARCH SURG-CHICAGO, V136, P280, DOI 10.1001/archsurg.136.3.280
   Man K, 2008, ANN SURG, V247, P1049, DOI 10.1097/SLA.0b013e31816ffab6XXX
   Man K, 2010, ANN SURG, V251, P1154, DOI 10.1097/SLA.0b013e3181d96e3d
   Manzanares W, 2009, INTENS CARE MED, V35, P882, DOI 10.1007/s00134-008-1356-5
   Nong KT, 2016, CYTOTHERAPY, V18, P1548, DOI 10.1016/j.jcyt.2016.08.002
   Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003
   Pauwels K, 2009, CURR GENE THER, V9, P459, DOI 10.2174/156652309790031120
   Qi X, 2016, THERANOSTICS, V6, P1934, DOI 10.7150/thno.16023
   Qi X, 2014, ONCOTARGET, V5, P11103, DOI 10.18632/oncotarget.2549
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Studeny M, 2002, CANCER RES, V62, P3603
   Sun CK, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-118
   Tao Y, 2016, EXP THER MED, V11, P263, DOI 10.3892/etm.2015.2902
   Tryndyak VP, 2011, MOL NUTR FOOD RES, V55, P411, DOI 10.1002/mnfr.201000300
   Van den Broeke A, 2003, J BIOMED BIOTECHNOL, P9
   VandenDriessehe Thierry, 2003, Current Gene Therapy, V3, P501, DOI 10.2174/1566523034578113
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
NR 41
TC 32
Z9 33
U1 1
U2 22
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2018
VL 8
IS 1
BP 212
EP 222
DI 10.7150/thno.21656
PG 11
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FO8JK
UT WOS:000417132000007
PM 29290803
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Nacarino-Palma, A
   Rico-Leo, EM
   Campisi, J
   Ramanathan, A
   González-Rico, FJ
   Rejano-Gordillo, CM
   Ordiales-Talavero, A
   Merino, JM
   Fernández-Salguero, PM
AF Nacarino-Palma, Ana
   Rico-Leo, Eva M.
   Campisi, Judith
   Ramanathan, Arvind
   Gonzalez-Rico, Francisco J.
   Rejano-Gordillo, Claudia M.
   Ordiales-Talavero, Ana
   Merino, Jaime M.
   Fernandez-Salguero, Pedro M.
TI Aryl hydrocarbon receptor blocks aging-induced senescence in the liver
   and fibroblast cells
SO AGING-US
LA English
DT Article
DE aryl hydrocarbon receptor; hepatocarcinogenesis; senescence; metabolism
ID GROWTH-FACTOR-BETA; DIOXIN RECEPTOR; CELLULAR SENESCENCE; AH RECEPTOR;
   CANCER DEVELOPMENT; INHIBITION; ACTIVATION; EXPRESSION; OVEREXPRESSION;
   TRANSCRIPTION
AB Aging impairs organismal homeostasis leading to multiple pathologies. Yet, the mechanisms and molecular intermediates involved are largely unknown. Here, we report that aged aryl hydrocarbon receptor-null mice ( AhR-/-) had exacerbated cellular senescence and more liver progenitor cells. Senescence-associated markers beta-galactosidase (SA-beta-Gal), p16(Ink4a) and p21(Cip1) and genes encoding senescence-associated secretory phenotype (SASP) factors TNF and IL1 were overexpressed in aged AhR-/- livers. Chromatin immunoprecipitation showed that AhR binding to those gene promoters repressed their expression, thus adjusting physiological levels in AhR+/+ livers. MCP-2, MMP12 and FGF secreted by senescent cells were overproduced in aged AhR-null livers. Supporting the relationship between senescence and stemness, liver progenitor cells were overrepresented in AhR-/- mice, probably contributing to increased hepatocarcinoma burden. These AhR roles are not liver-specific since adult and embryonic AhR-null fibroblasts underwent senescence in culture, overexpressing SA-beta-Gal, p16(Ink4a) and p21(Cip1). Notably, depletion of senescent cells with the senolytic agent navitoclax restored expression of senescent markers in AhR-/- fibroblasts, whereas senescence induction by palbociclib induced an AhR-null-like phenotype in AhR+/+ fibroblasts. AhR levels were downregulated by senescence in mouse lungs but restored upon depletion of p16(Ink4a)-expressing senescent cells. Thus, AhR restricts age-induced senescence associated to a differentiated phenotype eventually inducing resistance to liver tumorigenesis.
C1 [Nacarino-Palma, Ana; Rico-Leo, Eva M.; Gonzalez-Rico, Francisco J.; Rejano-Gordillo, Claudia M.; Ordiales-Talavero, Ana; Merino, Jaime M.; Fernandez-Salguero, Pedro M.] Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, Badajoz 06071, Spain.
   [Nacarino-Palma, Ana; Rico-Leo, Eva M.; Gonzalez-Rico, Francisco J.; Rejano-Gordillo, Claudia M.; Ordiales-Talavero, Ana; Merino, Jaime M.; Fernandez-Salguero, Pedro M.] Inst Univ Invest Biosanitaria Extremadura INUBE, Badajoz 06071, Spain.
   [Campisi, Judith; Ramanathan, Arvind] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Campisi, Judith] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
C3 Universidad de Extremadura; Buck Institute for Research on Aging; United
   States Department of Energy (DOE); Lawrence Berkeley National Laboratory
RP Merino, JM; Fernández-Salguero, PM (corresponding author), Univ Extremadura, Fac Ciencias, Dept Bioquim & Biol Mol, Badajoz 06071, Spain.; Merino, JM; Fernández-Salguero, PM (corresponding author), Inst Univ Invest Biosanitaria Extremadura INUBE, Badajoz 06071, Spain.
EM jmmerino@unex.es; pmfersal@unex.es
RI Nacarino Palma, Ana/AGY-6808-2022; González Rico, Francisco
   Javier/AAS-8540-2021
OI Nacarino Palma, Ana/0000-0002-7392-3821; González Rico, Francisco
   Javier/0000-0002-3755-3667; Rejano-Gordillo, Claudia
   Maria/0000-0003-4586-5975
FU Spanish Ministry of Economy and Competitiveness [SAF2017-82597-R,
   PID2020-114846RB-I00]; Junta de Extremadura [GR18006, IB20014]; RTICC;
   European Union FEDER program; Junta de Extremadura
FX This work was supported by grants to P.M.F-S. from the Spanish Ministry
   of Economy and Competitiveness (SAF2017-82597-R, PID2020-114846RB-I00)
   and from the Junta de Extremadura (GR18006 and IB20014). E.M.R-L. was
   supported by the RTICC and the Junta de Extremadura. A.N.-P., C.M.R.-G.
   and A.O.-T were predoctoral fellows of the Ministry of Science and
   Innovation. F.J.G.-R. was under contract by the Ministry of Science and
   Innovation. All Spanish funding is cosponsored by the European Union
   FEDER program.
CR Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586
   Alexander DL, 1998, J CELL SCI, V111, P3311
   Alvarez D, 2017, AM J PHYSIOL-LUNG C, V313, pL1164, DOI 10.1152/ajplung.00220.2017
   de Mera-Rodriguez JA, 2019, DEV DYNAM, V248, P850, DOI 10.1002/dvdy.74
   Bravo-Ferrer I, 2019, FASEB J, V33, P12644, DOI 10.1096/fj.201901333R
   Brinkmann V, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01561
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Roman AC, 2009, J BIOL CHEM, V284, P25135, DOI 10.1074/jbc.M109.013292
   Chiche A, 2020, EXP GERONTOL, V138, DOI 10.1016/j.exger.2020.111005
   Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020
   Cho YC, 2004, TOXICOL APPL PHARM, V199, P220, DOI 10.1016/j.taap.2003.12.025
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Coutu DL, 2011, AGING-US, V3, P920, DOI 10.18632/aging.100369
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Eckers A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19618
   Fan YX, 2010, CANCER RES, V70, P212, DOI 10.1158/0008-5472.CAN-09-3090
   FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Grubelnik G, 2020, EXP BIOL MED, V245, P456, DOI 10.1177/1535370220905560
   Guerrina N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123882
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Ito T, 2004, J BIOL CHEM, V279, P25204, DOI 10.1074/jbc.M402143200
   Kaiser H, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110797
   Ko Chia- I, 2017, Current Opinion in Toxicology, V2, P1, DOI 10.1016/j.cotox.2017.01.004
   Ko CI, 2014, STEM CELL RES, V12, P296, DOI 10.1016/j.scr.2013.11.007
   Kuo KK, 2016, STEM CELLS, V34, P2613, DOI 10.1002/stem.2447
   Lv FQ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00176
   Mitchell KA, 2006, MOL PHARMACOL, V70, P163, DOI 10.1124/mol.106.023465
   Morales-Hernández A, 2017, STEM CELL RES, V25, P61, DOI 10.1016/j.scr.2017.10.009
   Morales-Hernández A, 2016, NUCLEIC ACIDS RES, V44, P4665, DOI 10.1093/nar/gkw095
   Moreno-Marín N, 2018, ISCIENCE, V4, P44, DOI 10.1016/j.isci.2018.05.006
   Moreno-Marín N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10984-w
   Moro L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111983
   Mosteiro L, 2018, AGING CELL, V17, DOI 10.1111/acel.12711
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200
   Mulero-Navarro S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00045
   Ohnishi K, 2014, BIOCHEM BIOPH RES CO, V455, P10, DOI 10.1016/j.bbrc.2014.07.020
   Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005
   Picca A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040805
   Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043
   Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031
   Regina C, 2016, MECH AGEING DEV, V159, P14, DOI 10.1016/j.mad.2016.05.003
   Rhinn M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151837
   Rolf HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032287
   Roman AC, 2018, PHARMACOL THERAPEUT, V185, P50, DOI 10.1016/j.pharmthera.2017.12.003
   Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105
   Ryu Yea Seong, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0305-4
   Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0
   Safe S, 2013, TOXICOL SCI, V135, P1, DOI 10.1093/toxsci/kft128
   Santiago-Josefat B, 2004, J CELL SCI, V117, P849, DOI 10.1242/jcs.00932
   Santiago-Josefat B, 2001, MOL CELL BIOL, V21, P1700, DOI 10.1128/MCB.21.5.1700-1709.2001
   Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731
   Schosserer M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00278
   Szymanska R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2068370
   Wang BS, 2020, TRENDS CANCER, V6, P838, DOI 10.1016/j.trecan.2020.05.004
   Yin X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0119-3
   Yoshida A, 2016, CANCER RES, V76, P2990, DOI 10.1158/0008-5472.CAN-15-2931
   Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313
   Zeng Sulin, 2018, Cancer Transl Med, V4, P70, DOI 10.4103/ctm.ctm_22_18
   Zhang XY, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0595-5
   Zhu CZ, 2014, J GASTROEN HEPATOL, V29, P1102, DOI 10.1111/jgh.12468
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zorin V, 2017, AGING-US, V9, P1404, DOI 10.18632/aging.101240
NR 68
TC 7
Z9 7
U1 4
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD MAY 31
PY 2022
VL 14
IS 10
BP 4281
EP 4304
PG 24
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 4J5XM
UT WOS:000851337000028
PM 35619220
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Sun, TY
   Zhang, LX
   Feng, JL
   Bao, LY
   Wang, JQ
   Song, ZZ
   Mao, ZF
   Li, J
   Hu, ZL
AF Sun, Tianyue
   Zhang, Lanxin
   Feng, Jiali
   Bao, Lingyuan
   Wang, Jiqun
   Song, Zhouzhi
   Mao, Zhifan
   Li, Jian
   Hu, Zelan
TI Characterization of cellular senescence in doxorubicin-induced aging
   mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Early Access
DE Doxorubicin; Senescence; Mice; Metformin
ID DNA-DAMAGE; CELLS; CARDIOMYOCYTES; LIPOFUSCIN; INDUCTION; HALLMARKS;
   APOPTOSIS; BIOMARKER
AB With a rise in the need to develop anti-aging drugs, a growing number of in vivo studies evaluating the efficacy of potential drug candidates have used doxorubicin-induced aging mice. However, changes in the biomarkers of senescent cells have not been reported in detail in these animals. To lay a foundation for the use of doxorubicin-induced aging mice, we examined the biomarkers of hepatic and renal senescent cells in these mice. We found that the 5 mg/kg doxorubicin dose is optimal to induce cellular senescence in mice. Subsequently, using this dose, we found that doxorubicin-induced an increase in senescence-associated beta-galactosidase (SA-beta-gal) positive cells in the kidney and lipofuscin accumulation in the liver. Some markers of senescent cells (p21(WAF1/CIP1), p16(INK4A), and gamma H2AX) were also significantly upregulated by doxorubicin and then counteracted by metformin treatment. These preliminary findings support the application of doxorubicin-induced aging mice as an animal model to evaluate the efficacy of anti-aging drug candidates.
C1 [Sun, Tianyue; Zhang, Lanxin; Feng, Jiali; Bao, Lingyuan; Wang, Jiqun; Song, Zhouzhi; Mao, Zhifan; Li, Jian; Hu, Zelan] East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Frontiers Sci Ctr Mat & Dynam Chem, State Key Lab Bioreactor Engn, 130 Mei Long Rd, Shanghai 200237, Peoples R China.
   [Li, Jian] Dali Univ, Coll Pharm, Yunnan Key Lab Screening & Res Antipathogen Plant, 5 Xue Ren Rd, Dali 671000, Yunnan, Peoples R China.
   [Li, Jian] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Clin Med Sci & Tech Innovat Ctr, Shanghai 200092, Peoples R China.
C3 East China University of Science & Technology; Dali University; Tongji
   University
RP Hu, ZL (corresponding author), East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Frontiers Sci Ctr Mat & Dynam Chem, State Key Lab Bioreactor Engn, 130 Mei Long Rd, Shanghai 200237, Peoples R China.
EM huzelan@ecust.edu.cn
RI Hu, Zelan/AHH-2825-2022; Feng, Jia-Li/K-6565-2013
OI Hu, Zelan/0000-0001-7820-6373; Feng, Jia-Li/0000-0002-9926-0915; Mao,
   Zhifan/0000-0002-3926-2492
FU National Natural Science Foundation of China [22037002, 81772689];
   Shanghai Institutions of Higher Learning - Natural Science Foundation of
   Shanghai [TP2018025, 21ZR1416700]; Innovation Program of Shanghai
   Municipal Education Commission; Innovative Research Team of High-level
   Local Universities in Shanghai; Chinese Special Fund for State Key
   Laboratory of Bioreactor Engineering [2060204]
FX This study was supported by the National Natural Science Foundation of
   China [22037002, 81772689], the Program for Professor of Special
   Appointment [Eastern Scholar TP2018025] at Shanghai Institutions of
   Higher Learning, Sponsored by Natural Science Foundation of Shanghai
   [21ZR1416700], the Innovation Program of Shanghai Municipal Education
   Commission, the Innovative Research Team of High-level Local
   Universities in Shanghai, and the Chinese Special Fund for State Key
   Laboratory of Bioreactor Engineering [2060204].
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Alessio N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22063102
   Aoshiba K, 2003, EUR RESPIR J, V22, P436, DOI 10.1183/09031936.03.00011903
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Chan CH, 2019, MOL CANCER RES, V17, P555, DOI 10.1158/1541-7786.MCR-18-0551
   Chen J, 2017, ELIFE, V6, DOI 10.7554/eLife.31268
   Chen NN, 2015, CANCER IMMUNOL IMMUN, V64, P777, DOI 10.1007/s00262-015-1690-8
   Dang Y, 2020, AGING CELL, V19, DOI 10.1111/acel.13060
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Family F, 2011, J STAT PHYS, V144, P332, DOI 10.1007/s10955-011-0178-y
   Feng MX, 2019, FASEB BIOADV, V1, P579, DOI 10.1096/fba.2019-00041
   Forrest RA, 2012, BIOCHEM PHARMACOL, V83, P1602, DOI 10.1016/j.bcp.2012.02.026
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guo C, 2016, AM J TRANSL RES, V8, P4440
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Jannone G, 2020, J HISTOCHEM CYTOCHEM, V68, P269, DOI 10.1369/0022155420913534
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kohli J, 2021, NAT PROTOC, V16, DOI 10.1038/s41596-021-00505-5
   Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001
   Kumar Surinder, 2016, F1000Res, V5, DOI 10.12688/f1000research.7821.1
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lagoumtzi SM, 2021, FREE RADICAL BIO MED, V171, P169, DOI 10.1016/j.freeradbiomed.2021.05.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Noren Hooten N, 2016, AGING CELL, V15, P572, DOI 10.1111/acel.12469
   Papismadov N, 2017, CELL CYCLE, V16, P1997, DOI 10.1080/15384101.2017.1377500
   Prasanna PL, 2020, LIFE SCI, V250, DOI 10.1016/j.lfs.2020.117599
   Prasnikar E, 2021, AGEING RES REV, V66, DOI 10.1016/j.arr.2020.101251
   Qu AH, 2020, ADV MATER, V32, DOI 10.1002/adma.202000184
   Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111
   Siddiqui MS, 2015, MUTAT RES-REV MUTAT, V766, P1, DOI 10.1016/j.mrrev.2015.07.001
   Sliwinska MA, 2009, MECH AGEING DEV, V130, P24, DOI 10.1016/j.mad.2008.04.011
   Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009
   van Vliet T, 2021, MOL CELL, V81, P2041, DOI 10.1016/j.molcel.2021.03.018
   Veroutis D, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111564
   Wiley CD, 2019, CELL REP, V28, P3329, DOI 10.1016/j.celrep.2019.08.049
   Xia Xian, 2017, F1000Res, V6, P860, DOI 10.12688/f1000research.10692.1
   Xiang CY, 2021, J PHARMACOL SCI, V145, P6, DOI 10.1016/j.jphs.2020.10.002
NR 47
TC 13
Z9 15
U1 12
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD 2022 JUN 5
PY 2022
VL 163
AR 111800
DI 10.1016/j.exger.2022.111800
EA APR 2022
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 5Z7UG
UT WOS:000880173200010
PM 35398171
DA 2024-02-19
ER

PT J
AU Zoli, M
   Magalotti, D
   Bianchi, G
   Gueli, C
   Orlandini, C
   Grimaldi, M
   Marchesini, G
AF Zoli, M
   Magalotti, D
   Bianchi, G
   Gueli, C
   Orlandini, C
   Grimaldi, M
   Marchesini, G
TI Total and functional hepatic blood flow decrease in parallel with ageing
SO AGE AND AGEING
LA English
DT Article
DE ageing; echo-Doppler; functional hepatic flow; D-sorbitol clearance;
   total hepatic flow
ID GALACTOSE ELIMINATION CAPACITY; DOPPLER MEASUREMENTS; INDOCYANINE GREEN;
   LIVER VOLUME; PLASMA-FLOW; AGING MAN; VARIABILITY; CLEARANCE;
   INTEROBSERVER; ULTRASOUND
AB Objectives: to study changes in hepatic blood flow with age.
   Design: functional hepatic flow (FHF) and total hepatic flow (THF) were determined by non-invasive methods in 40 normal subjects in four age groups (<45, 45-60, 61-75 and >75 years). All subjects had normal routine liver function tests and no history of liver disease.
   Results: THF was measured by pulsed echo-Doppler, as the sum of portal and hepatic artery blood flow; FHF was measured by the hepatic clearance of D-sorbitol. THF significantly decreased with age, particularly in subjects over 75 (from 1445 +/- 220 ml/min to 1020 +/- 148; P < 0.001), and a similar reduction was observed in FHF (from 1514 +/- 250 ml/min to 1015 +/- 163; P < 0.001). THF and FHF were strictly correlated in the whole population (r = 0.871; P < 0.001) and both correlated with age (r = -0.510 and r = -0.596, P < 0.005).
   Conclusion: with ageing there is a reduction of hepatic blood flow without any additional intrahepatic shunting.
C1 Univ Bologna, Dipartimento Med Interna, Policlin S Orsola, I-40138 Bologna, Italy.
C3 University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di
   Bologna
RP Zoli, M (corresponding author), Univ Bologna, Dipartimento Med Interna, Policlin S Orsola, Via Massarenti 9, I-40138 Bologna, Italy.
RI bianchi, giampaolo/AAD-6147-2021
OI Marchesini, Giulio/0000-0003-2407-9860
CR [Anonymous], DIS LIVER BILIARY SY
   BARBARA L, 1990, Journal of Hepatology, V10, P353, DOI 10.1016/0168-8278(90)90146-I
   BAUER LA, 1989, CLIN PHARMACY, V8, P54
   CAESAR J, 1961, CLIN SCI, V21, P43
   CARLISLE KM, 1992, GUT, V33, P92, DOI 10.1136/gut.33.1.92
   CLEMENTS D, 1987, J HEPATOL, V5, P282, DOI 10.1016/S0168-8278(87)80033-8
   DEVRIES PJ, 1991, J HEPATOL, V13, P358, DOI 10.1016/0168-8278(91)90081-L
   GILL RW, 1985, ULTRASOUND MED BIOL, V11, P625, DOI 10.1016/0301-5629(85)90035-3
   HOWELL TH, 1978, J AM GERIATR SOC, V26, P385, DOI 10.1111/j.1532-5415.1978.tb05383.x
   KENICHI K, 1990, PROGR LIVER DIS, V9, P603
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   MOLINO G, 1987, DIGEST DIS SCI, V32, P753, DOI 10.1007/BF01296143
   MOLINO G, 1991, DIGEST DIS SCI, V36, P1189, DOI 10.1007/BF01307507
   NAKAMURA T, 1989, J CLIN ULTRASOUND, V17, P261, DOI 10.1002/jcu.1870170406
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   PORT S, 1980, NEW ENGL J MED, V303, P1133, DOI 10.1056/NEJM198011133032001
   RICHARDSON PDI, 1982, FED PROC, V41, P2111
   SABBA C, 1995, HEPATOLOGY, V21, P428, DOI 10.1016/0270-9139(95)90103-5
   SABBA C, 1990, GASTROENTEROLOGY, V98, P1603, DOI 10.1016/0016-5085(90)91097-P
   SCHNEGG M, 1986, J HEPATOL, V3, P164, DOI 10.1016/S0168-8278(86)80022-8
   Seifalian A M, 1991, HPB Surg, V4, P171, DOI 10.1155/1991/68915
   VESTAL RE, 1978, LIVER AGING 1978, P343
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   ZEEH J, 1988, GASTROENTEROLOGY, V95, P749, DOI 10.1016/S0016-5085(88)80024-6
   ZOLI M, 1989, GERONTOLOGY, V35, P61, DOI 10.1159/000213000
   ZOLI M, 1986, J CLIN ULTRASOUND, V14, P429, DOI 10.1002/jcu.1870140605
NR 26
TC 106
Z9 112
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-0729
J9 AGE AGEING
JI Age Ageing
PD JAN
PY 1999
VL 28
IS 1
BP 29
EP 33
DI 10.1093/ageing/28.1.29
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 168LQ
UT WOS:000078694600006
PM 10203201
OA Bronze
DA 2024-02-19
ER

PT J
AU Marshall, A
   Rushbrook, S
   Davies, SE
   Morris, LS
   Scott, IS
   Vowler, SL
   Coleman, N
   Alexander, G
AF Marshall, A
   Rushbrook, S
   Davies, SE
   Morris, LS
   Scott, IS
   Vowler, SL
   Coleman, N
   Alexander, G
TI Relation between hepatocyte G1 arrest, impaired hepatic regeneration,
   and fibrosis in chronic hepatitis C virus infection
SO GASTROENTEROLOGY
LA English
DT Article
ID CELL-CYCLE REGULATION; GENE-EXPRESSION; CORE PROTEIN; HEPATOCELLULAR
   CARCINOMAS; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; LIVER-DAMAGE;
   CANCER; GROWTH; CIRRHOSIS
AB Background& Aims: An increased risk of hepatitis C virus (HCV)-related cirrhosis is associated with hepatic steatosis, older age, and high alcohol consumption, which could be explained by synergistic effects on cell proliferation. We aimed to investigate hepatocyte cell cycle state and phase distribution in chronic HCV infection. Methods: Liver biopsy specimens diagnostic for chronic HCV (70), liver regeneration following transplant-related ischemic-reperfusion injury (15), and "normal" liver adjacent to colorectal cancer metastasis (10) were studied. Immunohistochemistry was used to detect cell cycle phase markers cyclin D1 (maximal in G(1).), cyclin A (S), cyclin B1 (cytoplasmic during G(2)) and phosphorylated histone 3 protein (mitosis), mini-chromosome maintenance protein 2 (Mcm-2; present throughout the cell cycle), and cyclindependent kinase inhibitor p21, which inhibits G:L/S progression. Results: Hepatocyte Mcm-2 expression was elevated in chronic HCV and liver regeneration (13% vs 26.4%) but negligible in "normal" liver. In proportion to Mcm-2, there was no difference in cyclin 131 between chronic HCV infection and liver regeneration (51.6% of Mcm-2-positive hepatocytes vs 52.6%). In co.ntrast, there was a striking reduction in cyclin A (3% vs 16.3%), cyclin 1311 (.4% vs 2.3%), and phosphorylated histone 3 protein (0% vs 3.8%) in chronic HCV infection compared with liver regeneration. In chronic HCV infection, Mcm-2 and p21 expression were associated with fibrosis stage and positive serum HCV RNA. Conclusions: The data are consistent with hepatocyte G(1) arrest in chronic HCV infection. This could impair hepatocellular function and limit hepatic regeneration.
C1 Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.
   Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England.
   Hutchinson MRC Res Ctr, MRC Canc Cell Unit, Cambridge, England.
   Univ Forvie Site, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge, England.
C3 University of Cambridge; Cambridge University Hospitals NHS Foundation
   Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS
   Foundation Trust; Addenbrooke's Hospital; University of Cambridge;
   University of Cambridge
RP Alexander, G (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Box 157,Hills Rd, Cambridge CB2 2QQ, England.
EM gja1000@doctors.org.uk
CR Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432
   Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200
   Basu A, 2002, VIROLOGY, V298, P53, DOI 10.1006/viro.2002.1460
   Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291
   Chen QM, 2000, ANN NY ACAD SCI, V908, P111
   Donato MF, 2001, HEPATOLOGY, V34, P523, DOI 10.1053/jhep.2001.26820
   Dubourdeau M, 2002, J HEPATOL, V37, P486, DOI 10.1016/S0168-8278(02)00241-6
   Farinati F, 1996, HEPATOLOGY, V23, P1468
   Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001
   Freeman A, 2003, J VIRAL HEPATITIS, V10, P345, DOI 10.1046/j.1365-2893.2003.00454.x
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Ghosh AK, 1999, J GEN VIROL, V80, P1179, DOI 10.1099/0022-1317-80-5-1179
   Honda M, 2000, GASTROENTEROLOGY, V118, P152, DOI 10.1016/S0016-5085(00)70424-0
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Koteish A, 2002, ALCOHOL CLIN EXP RES, V26, P1710, DOI 10.1097/01.ALC.0000036923.77613.59
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kwun HJ, 2001, J GEN VIROL, V82, P2235, DOI 10.1099/0022-1317-82-9-2235
   Lake-Bakaar G, 2002, DIGEST DIS SCI, V47, P1644, DOI 10.1023/A:1015800126283
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   Musahl C, 1998, EXP CELL RES, V241, P260, DOI 10.1006/excr.1998.4041
   Noris E, 2002, J VIROL, V76, P12135, DOI 10.1128/JVI.76.23.12135-12148.2002
   Ohashi K, 1996, CANCER, V77, P1747, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1747::AID-CNCR26>3.0.CO;2-X
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999
   Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Ray RB, 1998, GENE, V208, P331, DOI 10.1016/S0378-1119(98)00030-4
   Roelofsen H, 1999, J CELL SCI, V112, P1395
   Rosa JL, 1997, HEPATOLOGY, V25, P324
   Scott IS, 2003, J PATHOL, V201, P187, DOI 10.1002/path.1444
   Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806
   Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3
   Venkatesan A, 2003, VIRUS RES, V94, P85, DOI 10.1016/S0168-1702(03)00136-9
   Wagayama H, 2001, DIGEST DIS SCI, V46, P2074, DOI 10.1023/A:1011977923941
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011
   Yahagi N, 2004, J BIOL CHEM, V279, P20571, DOI 10.1074/jbc.M400884200
NR 39
TC 152
Z9 159
U1 0
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JAN
PY 2005
VL 128
IS 1
BP 33
EP 42
DI 10.1053/j.gastro.2004.09.076
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 886KG
UT WOS:000226225400008
PM 15633121
DA 2024-02-19
ER

PT J
AU Chen, JJ
   Yang, T
   Song, SH
   Liu, QG
   Sun, Y
   Zhao, LH
   Fu, ZR
   Wang, MJ
   Hu, YP
   Chen, F
AF Chen, Jiajia
   Yang, Tao
   Song, Shaohua
   Liu, Qinggui
   Sun, Yu
   Zhao, Linghao
   Fu, Zhiren
   Wang, Min-Jun
   Hu, Yi-Ping
   Chen, Fei
TI Senescence suppressed proliferation of host hepatocytes is precondition
   for liver repopulation
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Hepatocyte senescence; Cell transplantation; Liver repopulation;
   Proliferative precondition; Extracellular matrix
ID IN-VIVO; CELLULAR SENESCENCE; THERAPY; ORIGIN; CANCER; MODEL
AB In the fumarylacetoacetate hydrolase deficient (Fah(-/-)) mouse, massive liver repopulation can be easily obtained after transplanted hepatocytes. Understanding the mechanisms of complete liver repopulation in Fah(-/-) mice will be useful for future clinical application. Here, we found that the endogenous hepatocytes in liver of Fah(-/-) mice undertook senescence during the time of tyrosinemia symptoms. Increase of senescent hepatocytes in Fah(-/-) mice provided proliferative advantage to the transplanted hepatocytes. Importantly, senescent hepatocytes upregulated the expression of extracellular matrix enzyme, contributing to degradation of extracellular matrix components and weakness of cell adhesion and connection. The liver exhibiting a loose architecture provided the space for the engraftment and expansion of transplanted hepatocytes. These findings underscore the underlying mechanisms of completed liver repopulation in Fah(-/-) mice. Senescence followed by loose hepatic parenchyma is a preconditioning for liver repopulation, which would be a promising strategy to achieve therapeutic liver repopulation in clinical settings. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Chen, Jiajia; Yang, Tao; Liu, Qinggui; Sun, Yu; Wang, Min-Jun; Hu, Yi-Ping; Chen, Fei] Second Mil Med Univ, Dept Cell Biol, Ctr Stem Cell & Med, Shanghai 200433, Peoples R China.
   [Song, Shaohua; Fu, Zhiren] Second Mil Med Univ, Changzheng Hosp, Organ Transplantat Ctr, Shanghai 200433, Peoples R China.
   [Zhao, Linghao] Second Mil Med Univ, Estern Hepatobilliary Surg Hosp, Shanghai 200433, Peoples R China.
C3 Naval Medical University; Naval Medical University; Naval Medical
   University
RP Hu, YP; Chen, F (corresponding author), Second Mil Med Univ, Dept Cell Biol, Ctr Stem Cell & Med, Shanghai 200433, Peoples R China.
EM yphu@smmu.edu.cn; twinkky@163.com
RI Fu, zr/JHT-6152-2023; Li, Wei/JLL-4365-2023
FU National Key R&D Program of China [2018YFA0107500]; National Natural
   Science Foundation of China [31601101, 31701186]; China Postdoctoral
   Science Foundation [2017M623361]; Shanghai municipal health and family
   planning commission scientific research project [201640274]
FX This work was supported by National Key R&D Program of China
   (2018YFA0107500), National Natural Science Foundation of China
   (31601101, 31701186), China Postdoctoral Science Foundation
   (2017M623361), Shanghai municipal health and family planning commission
   scientific research project (No. 201640274).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Burton DGA, 2015, AGE, V37, DOI 10.1007/s11357-015-9764-2
   Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen-Plotkin AS, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6003
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Forbes SJ, 2014, NAT REV GASTRO HEPAT, V11, P277, DOI 10.1038/nrgastro.2014.44
   Gramignoli R, 2015, EUR SURG RES, V54, P162, DOI 10.1159/000369552
   He ZY, 2010, AM J PATHOL, V177, P1311, DOI 10.2353/ajpath.2010.091154
   Hempel M, 2015, CELL MOL LIFE SCI, V72, P2599, DOI 10.1007/s00018-015-1861-y
   Huebert RC, 2014, MAYO CLIN PROC, V89, P414, DOI 10.1016/j.mayocp.2013.10.023
   Jörs S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585
   Kaji K, 2016, HEPATOLOGY, V64, P582, DOI 10.1002/hep.28563
   Karnezis AN, 2001, J CLIN INVEST, V108, P383, DOI 10.1172/JCI200111933
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Menthena A, 2011, GASTROENTEROLOGY, V140, P1009, DOI 10.1053/j.gastro.2010.12.003
   Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   Paulk NK, 2012, MOL THER, V20, P1981, DOI 10.1038/mt.2012.154
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003
   Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606
   Serra MP, 2014, INT J RADIAT BIOL, V90, P876, DOI 10.3109/09553002.2014.922714
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   Struecker B, 2014, NAT REV GASTRO HEPAT, V11, P166, DOI 10.1038/nrgastro.2013.204
   Traweger A, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25039
   von Figura G, 2009, J MOL MED, V87, P1165, DOI 10.1007/s00109-009-0509-5
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0013-8
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Xiang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.230
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
NR 39
TC 3
Z9 3
U1 0
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 20
PY 2019
VL 516
IS 2
BP 591
EP 598
DI 10.1016/j.bbrc.2019.06.103
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA IK4SB
UT WOS:000476575500041
PM 31239154
DA 2024-02-19
ER

PT J
AU Kasper, P
   Selle, J
   Vohlen, C
   Wilke, R
   Kuiper-Makris, C
   Klymenko, O
   Bae-Gartz, I
   Schömig, C
   Quaas, A
   Schumacher, B
   Demir, M
   Bürger, M
   Lang, S
   Martin, A
   Steffen, HM
   Goeser, T
   Dötsch, J
   Alcazar, MAA
AF Kasper, Philipp
   Selle, Jaco
   Vohlen, Christina
   Wilke, Rebecca
   Kuiper-Makris, Celien
   Klymenko, Oleksiy
   Bae-Gartz, Inga
   Schoemig, Charlotte
   Quaas, Alexander
   Schumacher, Bjorn
   Demir, Munevver
   Buerger, Martin
   Lang, Sonja
   Martin, Anna
   Steffen, Hans-Michael
   Goeser, Tobias
   Doetsch, Jorg
   Alcazar, Miguel A. Alejandre
TI Perinatal Obesity Induces Hepatic Growth Restriction with Increased DNA
   Damage Response, Senescence, and Dysregulated Igf-1-Akt-Foxo1 Signaling
   in Male Offspring of Obese Mice
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE metabolic programming; liver; maternal obesity; cellular senescence;
   aging
ID MATERNAL OBESITY; LIVER-REGENERATION; PROLIFERATION; EXPRESSION; HEALTH
AB Maternal obesity predisposes for hepato-metabolic disorders early in life. However, the underlying mechanisms causing early onset dysfunction of the liver and metabolism remain elusive. Since obesity is associated with subacute chronic inflammation and accelerated aging, we test the hypothesis whether maternal obesity induces aging processes in the developing liver and determines thereby hepatic growth. To this end, maternal obesity was induced with high-fat diet (HFD) in C57BL/6N mice and male offspring were studied at the end of the lactation [postnatal day 21 (P21)]. Maternal obesity induced an obese body composition with metabolic inflammation and a marked hepatic growth restriction in the male offspring at P21. Proteomic and molecular analyses revealed three interrelated mechanisms that might account for the impaired hepatic growth pattern, indicating prematurely induced aging processes: (1) Increased DNA damage response (gamma H2AX), (2) significant upregulation of hepatocellular senescence markers (Cdnk1a, Cdkn2a); and (3) inhibition of hepatic insulin/insulin-like growth factor (IGF)-1-AKT-p38-FoxO1 signaling with an insufficient proliferative growth response. In conclusion, our murine data demonstrate that perinatal obesity induces an obese body composition in male offspring with hepatic growth restriction through a possible premature hepatic aging that is indicated by a pathologic sequence of inflammation, DNA damage, senescence, and signs of a possibly insufficient regenerative capacity.
C1 [Kasper, Philipp; Buerger, Martin; Lang, Sonja; Martin, Anna; Steffen, Hans-Michael; Goeser, Tobias] Univ Cologne, Univ Hosp Cologne, Fac Med, Clin Gastroenterol & Hepatol, D-50937 Cologne, Germany.
   [Selle, Jaco; Vohlen, Christina; Wilke, Rebecca; Kuiper-Makris, Celien; Alcazar, Miguel A. Alejandre] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Pediat & Adolescent Med,Translat Expt Pediat, D-50937 Cologne, Germany.
   [Vohlen, Christina; Kuiper-Makris, Celien; Bae-Gartz, Inga; Schoemig, Charlotte; Doetsch, Jorg] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Pediat & Adolescent Med, D-50937 Cologne, Germany.
   [Vohlen, Christina; Klymenko, Oleksiy; Alcazar, Miguel A. Alejandre] Justus Liebig Univ Giessen, German Ctr Lung Res DZL, Marburg Lung Ctr UGMLC, Inst Lung Hlth, D-35392 Giessen, Germany.
   [Quaas, Alexander] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Pathol, D-50937 Cologne, Germany.
   [Schumacher, Bjorn; Alcazar, Miguel A. Alejandre] Univ Cologne, Univ Hosp Cologne, Fac Med, Cologne Excellence Cluster Stress Responses Agein, D-50937 Cologne, Germany.
   [Schumacher, Bjorn] Univ Cologne, Univ Hosp Cologne, Fac Med, Inst Genome Stabil Aging & Dis, D-50937 Cologne, Germany.
   [Demir, Munevver] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Campus Virchow Clin, Charite Campus Mitte, D-10117 Berlin, Germany.
   [Alcazar, Miguel A. Alejandre] Univ Cologne, Univ Hosp Cologne, Fac Med, Ctr Mol Med Cologne CMMC, D-50937 Cologne, Germany.
C3 University of Cologne; University of Cologne; University of Cologne;
   Justus Liebig University Giessen; University of Cologne; University of
   Cologne; University of Cologne; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; University of
   Cologne
RP Alcazar, MAA (corresponding author), Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Pediat & Adolescent Med,Translat Expt Pediat, D-50937 Cologne, Germany.; Alcazar, MAA (corresponding author), Justus Liebig Univ Giessen, German Ctr Lung Res DZL, Marburg Lung Ctr UGMLC, Inst Lung Hlth, D-35392 Giessen, Germany.; Alcazar, MAA (corresponding author), Univ Cologne, Univ Hosp Cologne, Fac Med, Cologne Excellence Cluster Stress Responses Agein, D-50937 Cologne, Germany.; Alcazar, MAA (corresponding author), Univ Cologne, Univ Hosp Cologne, Fac Med, Ctr Mol Med Cologne CMMC, D-50937 Cologne, Germany.
EM philipp.kasper@uk-koeln.de; jaco.selle@uk-koeln.de;
   christina.vohlen@uk-koeln.de; rebecca.wilke@uk-koeln.de;
   centina.kuiper-makris@uk-koeln.de; oleksiyklymenko@yahoo.com;
   inga.bae-gartz@uk-koeln.de; charlotte.schoemig@uk-koeln.de;
   alexander.quaas@uk-koeln.de; bjoern.schumacher@uni-koeln.de;
   muenevver.demir@charite.de; martin.buerger@uk-koeln.de;
   sonja.lang@uk-koeln.de; anna.martin@uk-koeln.de;
   hans-michael.steffen@uk-koeln.de; tobias.goeser@uk-koeln.de;
   joerg.doetsch@uk-koeln.de; miguel.alejandre-alcazar@uk-koeln.de
RI Schumacher, Björn/I-4829-2013; Alejandre Alcazar, Miguel/JMC-0483-2023
OI Schumacher, Björn/0000-0001-6097-5238; Selle, Jaco/0000-0002-4981-0931;
   Demir, Munevver/0000-0002-7050-797X; Kasper,
   Philipp/0000-0002-6218-2239; Klymenko, Oleksiy/0000-0003-2156-6460;
   Bae-Gartz, Inga/0000-0002-4061-503X; Schomig,
   Charlotte/0000-0003-0108-0738; Steffen,
   Hans-Michael/0000-0001-6562-3549; Kuiper-Makris,
   Celien/0000-0002-7940-9612
FU Koeln Fortune Program/Faculty of Medicine, University of Cologne
   [07/2020, 378/2021]; Deutsche Forschungsgemeinschaft (DFG) [AL1636/5-1,
   SCHU 2494/15-1]; Oskar Helene Heim Stiftung; Else Kroner Fresenius
   Stiftung [2021_EKEA.148]
FX This work was supported by the Koeln Fortune Program/Faculty of
   Medicine, University of Cologne (grant no. 07/2020 and grant no.
   378/2021 to P.K.), Deutsche Forschungsgemeinschaft (DFG; AL1636/5-1 to
   M.A.A.A.; SCHU 2494/15-1 to BS); Oskar Helene Heim Stiftung (M.A.A.A.);
   Else Kroner Fresenius Stiftung (2021_EKEA.148 to M.A.A.A.).
CR Adamek A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051308
   Aguirre GA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0762-z
   Al-Mansoori L, 2022, INFLAMMATION, V45, P31, DOI 10.1007/s10753-021-01559-z
   Bae-Gartz I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72022-6
   Bankoglu EE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166956
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   Böhm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085
   Breuer S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113735
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Butler EA, 2022, J OBSTET GYNAECOL CA, V44, P131, DOI 10.1016/j.jogc.2021.09.014
   Catalano PM, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1
   Chen Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01176
   Demichev V, 2020, NAT METHODS, V17, P41, DOI 10.1038/s41592-019-0638-x
   Desbois-Mouthon C, 2006, FASEB J, V20, P773, DOI 10.1096/fj.05-4704fje
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Dinger K, 2020, CTS-CLIN TRANSL SCI, V13, P1065, DOI 10.1111/cts.12811
   Dinger K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24168
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Engelmann C, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020652
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3
   Guzzardi MA, 2018, JACC-CARDIOVASC IMAG, V11, P1750, DOI 10.1016/j.jcmg.2017.08.024
   Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250
   Hirani D., 2021, Eur. Respir. J, DOI [10.1183/13993003.02248-2020, DOI 10.1183/13993003.02248-2020]
   Howell KR, 2017, REPRODUCTION, V153, pR97, DOI [10.1530/REP-16-0495, 10.1530/rep-16-0495]
   Kasper P, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051247
   Kasper P, 2017, ENDOCRINOLOGY, V158, P3399, DOI 10.1210/en.2017-00489
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kuiper-Makris C, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.667315
   Lessard-Beaudoin M, 2015, EXP GERONTOL, V63, P27, DOI 10.1016/j.exger.2015.01.003
   Lewandowska M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041213
   Litzenburger T, 2020, CLIN SCI, V134, P921, DOI 10.1042/CS20191229
   Lumbers ER, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00757
   Mau T, 2018, EXP GERONTOL, V105, P27, DOI 10.1016/j.exger.2017.10.014
   Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630
   Morales-Garza LA, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1198-4
   Moritz KM, 2008, ADV ANAT EMBRYOL CEL, V196, P1
   Mortensen OH, 2010, PEDIATR RES, V67, P47, DOI 10.1203/PDR.0b013e3181c4735c
   O'Connor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pestell RG, 2013, AM J PATHOL, V183, P3, DOI 10.1016/j.ajpath.2013.03.001
   Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0
   Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6
   Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004
   Schoonejans JM, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14694
   Sell C, 2015, MOL ENDOCRINOL, V29, P1107, DOI 10.1210/me.2015-1074
   Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40
   Shrestha N, 2020, AM J PHYSIOL-REG I, V319, pR507, DOI 10.1152/ajpregu.00214.2020
   Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300
   Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010
   Varela-Rey M, 2011, EXP BIOL MED, V236, P402, DOI 10.1258/ebm.2011.010352
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Wlodarczyk M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051146
   Yakar S, 2012, ENDOCRIN METAB CLIN, V41, P231, DOI 10.1016/j.ecl.2012.04.008
   Zhao HM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00283
NR 60
TC 4
Z9 4
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2022
VL 23
IS 10
AR 5609
DI 10.3390/ijms23105609
PG 22
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 1Q1KP
UT WOS:000802455900001
PM 35628414
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Vuica, A
   Vukojevic, K
   Hamzic, LF
   Jeric, M
   Puljak, L
   Grkovic, I
   Filipovic, N
AF Vuica, Ana
   Vukojevic, Katarina
   Hamzic, Lejla Ferhatovic
   Jeric, Milka
   Puljak, Livia
   Grkovic, Ivica
   Filipovic, Natalija
TI Expression pattern of CYP24 in liver during ageing in long-term diabetes
SO ACTA HISTOCHEMICA
LA English
DT Article
DE Ageing; Diabetes mellitus; Vitamin D; CYP24; TGF-beta; Liver
ID DRUG-INDUCED OSTEOMALACIA; VITAMIN-D METABOLISM; FIBRILLARY ACIDIC
   PROTEIN; HEPATIC STELLATE CELLS; DORSAL-ROOT GANGLIA; D-RECEPTOR;
   RAT-LIVER; TGF-BETA; FIBROSIS; DISEASE
AB Association of liver calcitriol (active vitamin D metabolite) catabolism with osteomalacia during prolonged use of certain drugs was reported in several recent studies. To examine whether the increased calcitriol catabolism could be a potential link between ageing/diabetes mellitus (DM) and bone loss, we studied the dynamic of expression of CYP24, the main calcitriol catabolising enzyme in the liver of rats during ageing and a long-term experimental DM1. DM1 model was induced with intraperitoneally injected streptozotocin (STZ) (55 mg/Kg). Sprague-Dawley rats were sacrificed 6 and 12 months after the DM1 induction. The immunohistochemical analyses of CYP24 and transforming growth factor beta 1 (TGF-beta 1) expression in the liver were performed. We found that ageing and long-term DM1 resulted in a significantly increased expression of CYP24 in hepatocytes, as well as in non-hepatocyte liver cells (Kupffer cells, hepatic stellate cells and sinusoidal endothelial cells). Ageing and long-term DM1 resulted in an increased expression of TGF-beta 1 as well. Expression of CYP24 coexisted with the expression of TGF-beta 1 in all types of hepatic cells. We concluded that liver has the capacity for an active vitamin D catabolism in different populations of liver cells, especially in sinusoidal endothelial cells, through an expression of CYP24. That capacity is substantially increased during ageing and long-term diabetes mellitus. Increased liver calcitriol catabolism could be one of the mechanisms of the bone metabolism impairment related to ageing and diabetes. (C) 2016 Elsevier GmbH. All rights reserved.
C1 [Vuica, Ana; Vukojevic, Katarina; Jeric, Milka; Grkovic, Ivica; Filipovic, Natalija] Univ Split, Sch Med, Dept Anat Histol & Embryol, Lab Neurocardiol, Soltanska 2, Split 21000, Croatia.
   [Vukojevic, Katarina; Filipovic, Natalija] Univ Split, Sch Med, Dept Anat Histol & Embryol, Lab Early Human Dev, Split, Croatia.
   [Hamzic, Lejla Ferhatovic; Puljak, Livia] Univ Split, Sch Med, Dept Anat Histol & Embryol, Lab Pain Res, Split, Croatia.
C3 University of Split; University of Split; University of Split
RP Filipovic, N (corresponding author), Univ Split, Sch Med, Dept Anat Histol & Embryol, Lab Neurocardiol, Soltanska 2, Split 21000, Croatia.
EM natalija.filipovic@mefst.hr
RI Vukojevic, Katarina/AAU-1906-2020; Grković, Ivica/D-8728-2017; Puljak,
   Livia/D-5080-2017; Vukojevic, Katarina/D-5246-2017; Filipovic,
   Natalija/D-4964-2017
OI Vukojevic, Katarina/0000-0003-2182-2890; Grković,
   Ivica/0000-0001-9010-2091; Puljak, Livia/0000-0002-8467-6061; Vukojevic,
   Katarina/0000-0003-2182-2890; Filipovic, Natalija/0000-0002-8943-4109
FU Ministry of Science, Education and Sports, Republic of Croatia
   [216-2160528-0067]; Croatian Science Foundation (HRZZ) [02.05./28, 8652]
FX The study was funded by the Ministry of Science, Education and Sports,
   Republic of Croatia grant no. 216-2160528-0067 and the Croatian Science
   Foundation (HRZZ) grants nos. 02.05./28 and 8652.
CR Abramovitch S, 2011, GUT, V60, P1728, DOI 10.1136/gut.2010.234666
   Abreu MT, 2004, GUT, V53, P1129, DOI 10.1136/gut.2003.036657
   ADAMS JS, 1983, J CLIN INVEST, V72, P1856, DOI 10.1172/JCI111147
   Armbrecht HJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P298, DOI 10.1016/S0003-9861(02)00636-7
   Bissell DM, 2001, HEPATOLOGY, V34, P859, DOI 10.1053/jhep.2001.28457
   Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157
   Buniatian G, 1996, BIOL CELL, V87, P65, DOI 10.1016/S0248-4900(97)89838-3
   Cameron N, 2002, YEARB PHYS ANTHROPOL, V45, P159, DOI 10.1002/ajpa.10183
   Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20
   Danescu LG, 2009, ENDOCRINE, V35, P11, DOI 10.1007/s12020-008-9115-5
   Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028
   Dusso AS, 1998, AM J KIDNEY DIS, V32, pS13, DOI 10.1053/ajkd.1998.v32.pm9808140
   Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004
   Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Ferhatovic L, 2013, ACTA HISTOCHEM, V115, P496, DOI 10.1016/j.acthis.2012.11.006
   Gascon-Barré M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176
   George N, 2012, BRIT J NUTR, V108, P1410, DOI 10.1017/S0007114511006830
   Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner
   Gulubova MV, 1999, ACTA HISTOCHEM, V101, P213, DOI 10.1016/S0065-1281(99)80020-8
   Halici Z, 2009, EUR J PHARMACOL, V614, P146, DOI 10.1016/j.ejphar.2009.04.042
   Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0
   Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325
   Hayes DP, 2010, BIOGERONTOLOGY, V11, P1, DOI 10.1007/s10522-009-9252-0
   Helvig CF, 2010, KIDNEY INT, V78, P463, DOI 10.1038/ki.2010.168
   Holick MF, 1996, J NUTR, V126, pS1159, DOI 10.1093/jn/126.suppl_4.1159S
   Inouye K, 2001, Biotechnol Annu Rev, V7, P179, DOI 10.1016/S1387-2656(01)07037-5
   Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106
   Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193
   Kawai Y, 1998, CELL TISSUE RES, V292, P395, DOI 10.1007/s004410051069
   Kerry DM, 1996, J BIOL CHEM, V271, P29715, DOI 10.1074/jbc.271.47.29715
   Morley JE, 2008, CLIN GERIATR MED, V24, P395, DOI 10.1016/j.cger.2008.03.005
   Najmi Varzaneh Farnaz, 2013, Acta Med Iran, V51, P236
   Ohyama Y, 2004, FRONT BIOSCI-LANDMRK, V9, P3007, DOI 10.2741/1455
   OHYAMA Y, 1991, J BIOL CHEM, V266, P8690
   Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867
   Portal-Nunez S., 2015, J GERONTOL A
   Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000
   Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004
   Saller A, 2008, AGING CLIN EXP RES, V20, P280
   SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572
   Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002
   Schon Hans-Theo, 2014, Hepatobiliary Surg Nutr, V3, P386, DOI 10.3978/j.issn.2304-3881.2014.11.06
   Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363
   Swami S, 2011, MOL CELL ENDOCRINOL, V347, P61, DOI 10.1016/j.mce.2011.05.010
   Tague SE, 2011, J CHEM NEUROANAT, V41, P1, DOI 10.1016/j.jchemneu.2010.10.001
   Tennakoon AH, 2013, EXP TOXICOL PATHOL, V65, P1159, DOI 10.1016/j.etp.2013.05.008
   Townsend K, 2005, J STEROID BIOCHEM, V97, P103, DOI 10.1016/j.jsbmb.2005.06.004
   van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002
   Vuica A, 2015, EXP GERONTOL, V72, P167, DOI 10.1016/j.exger.2015.10.005
   Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806
   Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wongdee K, 2011, WORLD J DIABETES, V2, P41, DOI 10.4239/wjd.v2.i3.41
   Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392
   Yamaguchi Toru, 2012, Bonekey Rep, V1, P36, DOI 10.1038/bonekey.2012.27
   ZAMBONI L, 1967, J CELL BIOL, V35, pA148
   Zehnder D, 2008, KIDNEY INT, V74, P1343, DOI 10.1038/ki.2008.453
   Zhou CC, 2006, J CLIN INVEST, V116, P1703, DOI 10.1172/JCI27793
NR 59
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0065-1281
EI 1618-0372
J9 ACTA HISTOCHEM
JI Acta Histochem.
PY 2016
VL 118
IS 5
BP 486
EP 495
DI 10.1016/j.acthis.2016.05.001
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DS2JV
UT WOS:000380596700006
PM 27173620
DA 2024-02-19
ER

PT J
AU Sato, T
   Muramatsu, N
   Ito, Y
   Yamamoto, Y
   Nagasawa, T
AF Sato, Tomonori
   Muramatsu, Nao
   Ito, Yoshiaki
   Yamamoto, Yoshio
   Nagasawa, Takashi
TI L-Lysine Attenuates Hepatic Steatosis in Senescence-Accelerated Mouse
   Prone 8 Mice
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE L-lysine; hepatic steatosis; beta-oxidation; PGC-1 alpha
ID FATTY LIVER-DISEASE; ACTIVATED RECEPTOR-ALPHA; INSULIN-RESISTANCE;
   SKELETAL-MUSCLE; COACTIVATOR PGC-1; GENE-EXPRESSION; PROTEIN-KINASE;
   RISK-FACTOR; PPAR-ALPHA; DIET
AB Non-alcoholic hepatic steatosis is a phenotype of metabolic syndrome, and aging is a risk factor for this condition. Senescence-accelerated mouse prone 8 (SAMP8) is a murine model for studying aging-associated disorders. We here investigated the effect of dietary supplementation with L-lysine (Lys) on non-alcoholic hepatic steatosis in SAMP8 mice. Triglyceride (TG) and cholesterol (Choi) accumulated in the livers of SAMP8 mice fed a standard diet at 36 wk of age. However, intake of a Lys-rich diet for 2 mo prevented the accumulation of TG and Chol in the liver. Plasma alanine aminotransferase activity, an index of liver injury, was decreased by Lys. The mRNA expression levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha and carnitine palmitoyltransferase 1 a, which regulate beta-oxidation, were increased in the livers of SAMP8 mice fed the Lys-rich diet. Taken together, our study suggests dietary intake of Lys prevents hepatic steatosis by stimulating beta-oxidation in SAMP8 mice.
C1 [Sato, Tomonori; Ito, Yoshiaki; Nagasawa, Takashi] Iwate Univ, United Grad Sch Agr Sci, Dept Bioresources Sci, Morioka, Iwate 0208550, Japan.
   [Muramatsu, Nao; Ito, Yoshiaki; Nagasawa, Takashi] Iwate Univ, Grad Sch Agr, Dept Biol Chem & Food Sci, Morioka, Iwate 0208550, Japan.
   [Yamamoto, Yoshio] Iwate Univ, Fac Agr, Lab Vet Anat & Cell Biol, Morioka, Iwate 0208550, Japan.
   [Yamamoto, Yoshio] Gifu Univ, United Grad Sch Vet Sci, Dept Basic Vet Sci, Gifu 5011193, Japan.
C3 Iwate University; Iwate University; Iwate University; Gifu University
RP Nagasawa, T (corresponding author), Iwate Univ, United Grad Sch Agr Sci, Dept Bioresources Sci, Morioka, Iwate 0208550, Japan.; Nagasawa, T (corresponding author), Iwate Univ, Grad Sch Agr, Dept Biol Chem & Food Sci, Morioka, Iwate 0208550, Japan.
EM tnaga@iwate-u.ac.jp
FU Sasakawa Scientific Research Grant from The Japan Science Society
FX This work was partly supported by a Sasakawa Scientific Research Grant
   from The Japan Science Society. Amino acids were provided by Ajinomoto
   Co., Inc.
CR Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221
   Cabrera D, 2016, DIGEST DIS SCI, V61, P3190, DOI 10.1007/s10620-016-4285-0
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Cuesta S, 2013, AGE, V35, P659, DOI 10.1007/s11357-012-9397-7
   Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Fujitsuka N, 2016, MOL PSYCHIATR, V21, P1613, DOI 10.1038/mp.2015.220
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   HEVIA P, 1980, J NUTR, V110, P1224, DOI 10.1093/jn/110.6.1224
   Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405
   Jegatheesan P, 2016, CLIN NUTR, V35, P175, DOI 10.1016/j.clnu.2015.01.021
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Katsiki N, 2016, METABOLISM, V65, P1109, DOI 10.1016/j.metabol.2016.05.003
   Koo BK, 2017, J HEPATOL, V66, P123, DOI 10.1016/j.jhep.2016.08.019
   Lee MS, 2006, J MED FOOD, V9, P468, DOI 10.1089/jmf.2006.9.468
   Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051
   Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501
   Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200
   Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Mong MC, 2011, EUR J PHARMACOL, V653, P82, DOI 10.1016/j.ejphar.2010.12.001
   Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798
   Moon JS, 2013, DIABETES METAB J, V37, P278, DOI 10.4093/dmj.2013.37.4.278
   Morales A, 2013, J ANIM PHYSIOL AN N, V97, P263, DOI 10.1111/j.1439-0396.2011.01266.x
   Nishikata N, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.1
   Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Santulli G, 2012, DIABETES, V61, P692, DOI 10.2337/db11-1027
   Sato T, 2017, BIOGERONTOLOGY, V18, P85, DOI 10.1007/s10522-016-9663-7
   Sato T, 2013, J NUTR SCI VITAMINOL, V59, P412, DOI 10.3177/jnsv.59.412
   Shida T, 2018, J GASTROENTEROL, V53, P535, DOI 10.1007/s00535-017-1377-3
   Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   VIVIANI R, 1966, J LIPID RES, V7, P473
   Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605
   White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001
   Xu L, 2013, BBA-MOL BASIS DIS, V1832, P1605, DOI 10.1016/j.bbadis.2013.05.003
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Yokota SI, 2016, AMINO ACIDS, V48, P1013, DOI 10.1007/s00726-015-2149-0
   Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 49
TC 3
Z9 3
U1 0
U2 5
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PY 2018
VL 64
IS 3
BP 192
EP 199
DI 10.3177/jnsv.64.192
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HK2IS
UT WOS:000457734300004
PM 29962430
OA gold
DA 2024-02-19
ER

PT J
AU Liu, HW
   Chan, YC
   Wang, MF
   Wei, CC
   Chang, SJ
AF Liu, Hung-Wen
   Chan, Yin-Ching
   Wang, Ming-Fu
   Wei, Chu-Chun
   Chang, Sue-Joan
TI Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts
   Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in
   Senescence-Accelerated Mouse
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE aging; EGCG; insulin resistance; senescence accelerated mouse
ID OXIDATIVE STRESS; EPIGALLOCATECHIN; DISEASE; MODEL; INFLAMMATION;
   HOMEOSTASIS; METABOLISM; MELATONIN; PATHWAY; OBESITY
AB Aging is accompanied by pathophysiological changes including insulin resistance and fatty liver. Dietary supplementation with (-)-epigallocatechin-3-gallate (EGCG) improves insulin sensitivity and attenuates fatty liver disease. We hypothesized that EGCG could effectively modulate aging-associated changes in glucose and lipid metabolism in senescence-accelerated mice (SAM) prone 8 (SAMP8). Higher levels of glucose, insulin, and free fatty acid, inhibited Akt activity, and decreased glucose transporter 4 (GLUT4) expression were observed in SAMP8 mice compared to the normal aging group, SAM resistant 1 mice. EGCG supplementation for 12 weeks successfully decreased blood glucose and insulin levels via restoring Akt activity and GLUT4 expression and stimulating AMPK alpha activation in skeletal muscle. EGCG up-regulated genes involved in mitochondrial biogenesis and subsequently restored mitochondrial DNA copy number in skeletal muscle of SAMP8 mice. Decreased adipose triglyceride lipase and increased sterol regulatory element binding proteins-1c (SREBP-1c) and carbohydrate responsive element binding protein at mRNA levels were observed in SAMP8 mice in accordance with hepatocellular ballooning and excess lipid accumulation. The pevention of hepatic lipid accumulation by EGCG was mainly attributed to down-regulation of mTOR and SREBP-1c-mediated lipid biosynthesis via suppression of the positive regulator, Akt, and activation of the negative regulator, AMPK alpha, in the liver. EGCG beneficially modulates glucose and lipid homeostasis in skeletal muscle and liver, leading to alleviation of aging-associated metabolic disorders.
C1 [Liu, Hung-Wen; Wei, Chu-Chun; Chang, Sue-Joan] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan.
   [Chan, Yin-Ching; Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
C3 National Cheng Kung University; Providence University - Taiwan
RP Chang, SJ (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, 1 Univ Rd, Tainan 701, Taiwan.
EM sjchang@mail.ncku.edu.tw
RI Wang, Mingfu/AAT-3292-2021
OI Wang, Mingfu/0000-0003-1469-3963; Liu, Hung-Wen/0000-0001-6735-8507;
   Chan, Yin Ching/0000-0001-9602-0775
FU Ministry of Science and Technology, Taiwan [102-2628-B-006-012-MY3]
FX This research was supported by a grant from the National Science Council
   (now the Ministry of Science and Technology), Taiwan, to S.-J.C.
   (102-2628-B-006-012-MY3).
CR Anderson R., 2009, BIOCH BIOPHYS ACTA G, V1790, P1059
   Babu PVA, 2013, J NUTR BIOCHEM, V24, P1777, DOI 10.1016/j.jnutbio.2013.06.003
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Cuesta S, 2013, AGE, V35, P659, DOI 10.1007/s11357-012-9397-7
   DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938
   Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   HOUMARD JA, 1995, DIABETES, V44, P555, DOI 10.2337/diabetes.44.5.555
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Jiang TY, 2013, AGING CELL, V12, P1021, DOI 10.1111/acel.12127
   Jung EJ, 2011, J LIPID RES, V52, P1617, DOI 10.1194/jlr.M015263
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kuzu N, 2008, J GASTROEN HEPATOL, V23, pE465, DOI 10.1111/j.1440-1746.2007.05052.x
   Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201
   Li Y, 2011, DIABETES RES CLIN PR, V93, P205, DOI 10.1016/j.diabres.2011.03.036
   Liao JW, 2010, J FOOD SCI, V75, pT82, DOI 10.1111/j.1750-3841.2010.01638.x
   Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
   Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Meng QY, 2008, REJUV RES, V11, P649, DOI 10.1089/rej.2007.0645
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x
   Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006
   Ortsäter H, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-11
   Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200
   Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Sesti G, 2006, BEST PRACT RES CL EN, V20, P665, DOI 10.1016/j.beem.2006.09.007
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Toledo FGS, 2014, DIABETES, V63, P59, DOI 10.2337/db13-1427
   Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128
   Van Aller GS, 2011, BIOCHEM BIOPH RES CO, V406, P194, DOI 10.1016/j.bbrc.2011.02.010
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wolfram S, 2006, J NUTR, V136, P2512, DOI 10.1093/jn/136.10.2512
   Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8
   Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38
NR 44
TC 56
Z9 58
U1 4
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD SEP 30
PY 2015
VL 63
IS 38
BP 8407
EP 8417
DI 10.1021/acs.jafc.5b02501
PG 11
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA CS7DA
UT WOS:000362243100007
PM 26152236
DA 2024-02-19
ER

PT J
AU Wang, HF
   Hu, L
   Li, L
   Wu, XS
   Fan, ZP
   Zhang, CM
   Wang, JS
   Jia, JD
   Wang, SL
AF Wang, Haifeng
   Hu, Lei
   Li, Le
   Wu, Xiaoshan
   Fan, Zhipeng
   Zhang, Chunmei
   Wang, Jinsong
   Jia, Jidong
   Wang, Songlin
TI Inorganic nitrate alleviates the senescence-related decline in liver
   function
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Article
DE nitrate; liver; senescence; degeneration
ID DIETARY NITRATE; BLOOD-PRESSURE; NITRITE; AGE; SUPPLEMENTATION;
   GLUCOKINASE; INHIBITION; METABOLISM; MODULATION; TOLERANCE
AB Senescence-related decline in liver function is a common complication in the elderly that can lead to impaired health in older individuals. Dietary nitrate supplements have physiological and therapeutic effects on organ function by nitrate (NO3 (-))-nitrite (NO2 (-))-nitric oxide (NO) pathway. However, the role of dietary nitrate on the senescence-related decline in liver function is unclear. The findings of the present study showed that nitrate levels in the serum and liver decreased, whereas the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum increased in ageing mice. Consistently, cell senescence, decreased glycogen levels and increased lipid deposition were found in the liver of aged mice, both glucokinase (GCK) and phosphoenolpyruvate carboxykinase (PCK) were down-regulated (n=10). Daily nitrate intake (0.5 mmol L-1) restored nitrate levels, decreased ALT and AST levels, and prevented cell senescence and structural and glucose and lipid metabolism degeneration in liver tissue both in D-galactose (D-gal)-induced ageing mice (n=10) and in natural aged mice (n=10). In conclusion, the present study demonstrated that the reduction of nitrate levels was correlated with liver degeneration in ageing individuals and that dietary supplement of nitrate could restore the nitrate levels in serum and the liver and prevent ageing-related liver degeneration.
C1 [Wang, Haifeng; Hu, Lei; Li, Le; Wu, Xiaoshan; Zhang, Chunmei; Wang, Jinsong; Wang, Songlin] Capital Med Univ, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Sch Stomatol, Beijing 100050, Peoples R China.
   [Wang, Haifeng] Capital Med Univ, China Rehabil Res Ctr, Sch Rehabil, Dept Stomatol,Beijing Boai Hosp, Beijing 100068, Peoples R China.
   [Fan, Zhipeng] Capital Med Univ, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Sch Stomatol, Lab Mol Signaling & Stem Cells Therapy, Beijing 100050, Peoples R China.
   [Wang, Jinsong; Wang, Songlin] Capital Med Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Beijing 100069, Peoples R China.
   [Jia, Jidong] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing 100050, Peoples R China.
C3 Capital Medical University; Capital Medical University; Capital Medical
   University; Capital Medical University; Capital Medical University
RP Wang, SL (corresponding author), Capital Med Univ, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Sch Stomatol, Beijing 100050, Peoples R China.; Wang, SL (corresponding author), Capital Med Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Beijing 100069, Peoples R China.
EM slwang@ccmu.edu.cn
RI zhang, cl/JDW-6549-2023; Wang, Rong/JQI-7854-2023; Wang,
   Jin/GYA-2019-2022; yang, zhuo/JPK-3133-2023; Wu, Xiaoshan/HJA-9048-2022;
   hu, lei/AAE-6706-2022; zhang, chunmei/IUQ-7038-2023
OI Wang, Rong/0009-0009-5350-5743; 
FU National Natural Science Foundation of China [91649124]; Beijing
   Municipality Government grants (Beijing Scholar Program)
   [Z121100-005212004, PXM2013_014226_000055, PXM2013_014226_000021, PXM
   2013_014226_07_000080, TJSHG201310025005]; National Natural Science
   Foundation [PXM2016_014226_000034, PXM2016_014226_000006,
   PXM2015_014226_000116, PXM2015_014226_000055, PXM2015_014226_000052,
   PXM2014_014226_000048, PXM2014_014226_000013, PXM2014_014226_000053]
FX This work was supported by the National Natural Science Foundation of
   China (91649124) and Beijing Municipality Government grants (Beijing
   Scholar Program- PXM2016_014226_000034, PXM2016_014226_000006,
   PXM2015_014226_000116, PXM2015_014226_000055, PXM2015_014226_000052,
   PXM2014_014226_000048, PXM2014_014226_000013, PXM2014_014226_000053,
   Z121100-005212004, PXM2013_014226_000055, PXM2013_014226_000021, PXM
   2013_014226_07_000080, TJSHG201310025005).
CR Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595
   Bailey SJ, 2009, J APPL PHYSIOL, V107, P1144, DOI 10.1152/japplphysiol.00722.2009
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOLANOS JP, 1994, J NEUROCHEM, V63, P910
   Carlström M, 2010, P NATL ACAD SCI USA, V107, P17716, DOI 10.1073/pnas.1008872107
   Casey DP, 2015, J APPL PHYSIOL, V118, P178, DOI 10.1152/japplphysiol.00662.2014
   Halter JB, 2014, DIABETES, V63, P2578, DOI 10.2337/db14-0020
   Hendgen-Cotta UB, 2012, CIRCULATION, V126, P1983, DOI 10.1161/CIRCULATIONAHA.112.112912
   Hezel M, 2016, FREE RADICAL BIO MED, V99, P87, DOI 10.1016/j.freeradbiomed.2016.07.025
   Hezel MP, 2015, REDOX BIOL, V5, P234, DOI 10.1016/j.redox.2015.05.004
   Hobbs DA, 2013, NUTR RES REV, V26, P210, DOI 10.1017/S0954422413000188
   Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005
   Jin LY, 2013, FREE RADICAL BIO MED, V57, P61, DOI 10.1016/j.freeradbiomed.2012.12.015
   Jonvik KL, 2016, J NUTR, V146, P986, DOI 10.3945/jn.116.229807
   Kobayashi J, 2015, NUTRIENTS, V7, P4911, DOI 10.3390/nu7064911
   Larsen FJ, 2014, AM J CLIN NUTR, V99, P843, DOI 10.3945/ajcn.113.079491
   Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800
   Liao CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010098
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466-c2, 10.1038/nrd2466]
   Palsamy P, 2009, CHEM-BIOL INTERACT, V179, P356, DOI 10.1016/j.cbi.2008.11.008
   Peleli M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00222
   Qin LZ, 2012, P NATL ACAD SCI USA, V109, P13434, DOI 10.1073/pnas.1116633109
   Raczuk Jolanta, 2014, Rocz Panstw Zakl Hig, V65, P15
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rajagopal SK, 2003, J NUTR BIOCHEM, V14, P452, DOI 10.1016/S0955-2863(03)00053-6
   Rammos C, 2014, J AM COLL CARDIOL, V63, P1584, DOI 10.1016/j.jacc.2013.08.691
   Roberts LD, 2015, ADIPOCYTE, V4, P311, DOI 10.1080/21623945.2015.1005525
   Roden M, 2003, BEST PRACT RES CL EN, V17, P365, DOI 10.1016/S1521-690X(03)00031-9
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198
   Toprakçi M, 2000, INT J CLIN LAB RES, V30, P83
   Wakabayashi H, 2002, J SURG RES, V106, P246, DOI 10.1006/jsre.2002.6462
   Weitzberg E, 2013, ANNU REV NUTR, V33, P129, DOI 10.1146/annurev-nutr-071812-161159
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   WYNNE H, 1995, BRIT J CLIN PHARMACO, V40, P203
   Xia DS, 2003, J ORAL PATHOL MED, V32, P95, DOI 10.1034/j.1600-0714.2003.00109.x
   Xia DS, 2003, J DENT RES, V82, P101, DOI 10.1177/154405910308200205
   Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543
   Zhang XM, 2009, BIOMED PHARMACOTHER, V63, P180, DOI 10.1016/j.biopha.2007.07.006
NR 40
TC 19
Z9 22
U1 2
U2 28
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD JAN
PY 2018
VL 61
IS 1
BP 24
EP 34
DI 10.1007/s11427-017-9207-x
PG 11
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA FU3DJ
UT WOS:000423730100004
PM 29307111
DA 2024-02-19
ER

PT J
AU Cheng, NY
   Kim, KH
   Lau, LF
AF Cheng, Naiyuan
   Kim, Ki-Hyun
   Lau, Lester F.
TI Senescent hepatic stellate cells promote liver regeneration through IL-6
   and ligands of CXCR2
SO JCI INSIGHT
LA English
DT Article
ID CELLULAR SENESCENCE; INSULIN-RESISTANCE; INTERLEUKIN-6; HEPATOCYTES;
   GROWTH; CANCER; PROLIFERATION; HEPATECTOMY; CONTRIBUTES; PLASTICITY
AB Senescent cells have long been associated with deleterious effects in aging-related pathologies, although recent studies have uncovered their beneficial roles in certain contexts, such as wound healing. We have found that hepatic stellate cells (HSCs) underwent senescence within 2 days after 2/3 partial hepatectomy (PHx) in young (2-3 months old) mice, and the elimination of these senescent cells by using the senolytic drug ABT263 or by using a genetic mouse model impaired liver regeneration. Senescent HSCs secrete IL-6 and CXCR2 ligands as part of the senescence-associated secretory phenotype, which induces multiple signaling pathways to stimulate liver regeneration. IL-6 activates STAT3, induces Yes-associated protein (YAP) activation through SRC family kinases, and synergizes with CXCL2 to activate ERK1/2 to stimulate hepatocyte proliferation. The administration of either IL-6 or CXCL2 partially restored liver regeneration in mice with senescent cell elimination, and the combination of both fully restored liver weight recovery. Furthermore, the matricellular protein central communication network factor 1 (CCN1, previously called CYR61) was rapidly elevated in response to PHx and induced HSC senescence. Knockin mice expressing a mutant CCN1 unable to bind integrin alpha(6)beta(1), were deficient in senescent cells and liver regeneration after PHx. Thus, HSC senescence, largely induced by CCN1, is a programmed response to PHx and plays a critical role in liver regeneration through signaling pathways activated by IL-6 and ligands of CXCR2.
C1 [Cheng, Naiyuan; Kim, Ki-Hyun; Lau, Lester F.] Univ Illinois, Dept Biochem & Mol Genet, Chicago Coll Med, Chicago, IL 60607 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Lau, LF (corresponding author), UIC, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.
EM LFLau@uic.edu
OI Lau, Lester/0000-0002-4364-2914; Kim, Ki-Hyun/0000-0001-8265-6609
FU NIH [AR061791, DK108994, GM78492]
FX Acknowledgments We thank Unity Biotechnology for providing p16-3MR mice.
   This work was supported by grants from the NIH (AR061791, DK108994,
   GM78492) to LFL.
CR Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Campana L, 2021, NAT REV MOL CELL BIO, V22, P608, DOI 10.1038/s41580-021-00373-7
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chembazhi UV, 2021, GENOME RES, V31, P576, DOI 10.1101/gr.267013.120
   Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596
   Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Dou L, 2013, J BIOL CHEM, V288, P22596, DOI 10.1074/jbc.M112.423145
   Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Gadd VL, 2020, CELL STEM CELL, V27, P557, DOI 10.1016/j.stem.2020.08.016
   Gu XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15973-7
   Güller M, 2008, WORLD J GASTROENTERO, V14, P6339, DOI 10.3748/wjg.14.6339
   Han XM, 2019, STEM CELL REP, V12, P624, DOI 10.1016/j.stemcr.2019.01.010
   He LJ, 2021, SCIENCE, V371, P905, DOI 10.1126/science.abc4346
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Hinds Philip, 2017, F1000Res, V6, P2121, DOI 10.12688/f1000research.11671.1
   Hviid CVB, 2014, SHOCK, V41, P233, DOI 10.1097/SHK.0000000000000105
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8
   Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386
   Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kong L, 2011, MOL CELL BIOCHEM, V348, P11, DOI 10.1007/s11010-010-0632-1
   Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Laberge RM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.199
   Lau LF, 2016, J CELL COMMUN SIGNAL, V10, P121, DOI 10.1007/s12079-016-0324-z
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Lee S, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00107-19
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200
   Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13
   Li WP, 2020, TRENDS CELL BIOL, V30, P329, DOI 10.1016/j.tcb.2020.01.007
   Liu JY, 2019, P NATL ACAD SCI USA, V116, P2603, DOI 10.1073/pnas.1818313116
   Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205
   McKenna E, 2012, CELL CYCLE, V11, P3132, DOI 10.4161/cc.21506
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016
   Modares NF, 2019, HEPATOLOGY, V70, P2075, DOI 10.1002/hep.30774
   Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nitou M, 2000, J ANAT, V197, P635, DOI 10.1046/j.1469-7580.2000.19740635.x
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008
   Paez-Ribes M, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810234
   Planas-Paz L, 2019, CELL STEM CELL, V25, P39, DOI 10.1016/j.stem.2019.04.005
   Pullamsetti SS, 2018, J CLIN INVEST, V128, P1720, DOI 10.1172/JCI120415
   Ren XD, 2003, J CLIN INVEST, V112, P1407, DOI 10.1172/JCI200317391
   Ren XD, 2003, AM J PATHOL, V163, P563, DOI 10.1016/S0002-9440(10)63684-X
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003
   Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004
   Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391
   Speicher T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4862
   Stadtmann A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00263
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Tachibana S, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-6
   Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wilson GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120092
   Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328
   Zarrinpar A, 2013, NAT REV GASTRO HEPAT, V10, P434, DOI 10.1038/nrgastro.2013.88
   Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
NR 85
TC 12
Z9 12
U1 2
U2 8
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD JUL 22
PY 2022
VL 7
IS 14
AR e158207
DI 10.1172/jci.insight.158207
PG 18
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 3F3AK
UT WOS:000830541300001
PM 35708907
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bellanti, F
   Vendemiale, G
AF Bellanti, Francesco
   Vendemiale, Gianluigi
TI The Aging Liver: Redox Biology and Liver Regeneration
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article; Early Access
DE aging liver; liver repopulation; hepatic progenitors; redox homeostasis
ID HEPATIC PROGENITOR CELLS; AGE-RELATED-CHANGES; ENDOPLASMIC-RETICULUM
   STRESS; MITOCHONDRIAL PROTON LEAK; CYTOCHROME B(5) REDUCTASE;
   NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; RAT-LIVER; C/EBP-ALPHA;
   UNCOUPLING PROTEIN-2
AB Significance: During aging, excessive production of reactive species in the liver leads to redox imbalance with consequent oxidative damage and impaired organ homeostasis. Nevertheless, slight amounts of reactive species may modulate several transcription factors, acting as second messengers and regulating specific signaling pathways. These redox-dependent alterations may impact the age-associated decline in liver regeneration.
   Recent Advances: In the last few decades, relevant findings related to redox alterations in the aging liver were investigated. Consistently, recent research broadened understanding of redox modifications and signaling related to liver regeneration. Other than reporting the effect of oxidative stress, epigenetic and post-translational modifications, as well as modulation of specific redox-sensitive cellular signaling, were described. Among them, the present review focuses on Wnt/beta-catenin, the nuclear factor (erythroid-derived 2)-like 2 (NRF2), members of the Forkhead box O (FoxO) family, and the p53 tumor suppressor.
   Critical Issues: Even though alteration in redox homeostasis occurs both in aging and in impaired liver regeneration, the associative mechanisms are not clearly defined. Of note, antioxidants are not effective in slowing hepatic senescence, and do not clearly improve liver repopulation after hepatectomy or transplant in humans.
   Future Directions: Further investigations are needed to define mutual redox-dependent molecular pathways involved both in aging and in the decline of liver regeneration. Preclinical studies aimed at the characterization of these pathways would define possible therapeutic targets for human trials.
C1 [Bellanti, Francesco; Vendemiale, Gianluigi] Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
C3 University of Foggia
RP Bellanti, F (corresponding author), Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
EM francesco.bellanti@unifg.it
OI BELLANTI, Francesco/0000-0002-8196-7373
CR Adachi T, 2005, HEPATOLOGY, V41, P1272, DOI 10.1002/hep.20719
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   ANGERMULLER S, 1987, EUR J CELL BIOL, V45, P137
   Apte U, 2009, AM J PATHOL, V175, P1056, DOI 10.2353/ajpath.2009.080976
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382
   Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413
   Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212
   Battelli MG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3527579
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Bellanti F, 2013, J GERONTOL A-BIOL, V68, P892, DOI 10.1093/gerona/gls332
   Bellet MM, 2016, J BIOL CHEM, V291, P23318, DOI 10.1074/jbc.M116.737114
   Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950
   Bhushan B, 2014, AM J PATHOL, V184, P3013, DOI 10.1016/j.ajpath.2014.07.019
   Bjelakovic G, 2010, ALIMENT PHARM THER, V32, P356, DOI 10.1111/j.1365-2036.2010.04371.x
   Borude P, 2018, AM J PATHOL, V188, P1406, DOI 10.1016/j.ajpath.2018.03.006
   Borude Prachi, 2018, Gene Expression, V18, P115, DOI 10.3727/105221618X15205260749346
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308
   Calabrese V, 2000, NEUROCHEM RES, V25, P1315, DOI 10.1023/A:1007604414773
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   Cavallini G, 2017, MOL CELL BIOCHEM, V431, P97, DOI 10.1007/s11010-017-2979-z
   Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200
   Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006
   Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692
   Cheluvappa R, 2007, ANN NY ACAD SCI, V1114, P88, DOI 10.1196/annals.1396.007
   Cheng YJ, 2017, AGING-US, V9, P1359, DOI 10.18632/aging.101232
   Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Conti V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00024
   Csala M, 2010, ANTIOXID REDOX SIGN, V13, P77, DOI 10.1089/ars.2009.2529
   Dayoub R, 2013, MOL MED, V19, P237, DOI 10.2119/molmed.2013.00027
   De Minicis S, 2006, GASTROENTEROLOGY, V131, P272, DOI 10.1053/j.gastro.2006.05.048
   di Bello G, 2018, EUR J CELL BIOL, V97, P546, DOI 10.1016/j.ejcb.2018.09.004
   Diesen DL, 2010, J SURG RES, V162, P95, DOI 10.1016/j.jss.2009.09.019
   Domek-Lopacinska KU, 2010, MOL NEUROBIOL, V41, P129, DOI 10.1007/s12035-010-8104-x
   Doyle K, 2010, J BIOL CHEM, V285, P17417, DOI 10.1074/jbc.M109.089250
   Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435
   Durazzo M, 2019, MINERVA MED, V110, P35, DOI 10.23736/S0026-4806.18.05858-5
   Enkhbold C, 2015, J GASTROEN HEPATOL, V30, P1217, DOI 10.1111/jgh.12930
   Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Flohé L, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121254
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Foretz M, 2011, J HEPATOL, V54, P827, DOI 10.1016/j.jhep.2010.09.014
   FORMAN HJ, 1975, J BIOL CHEM, V250, P4322
   Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001
   Fritz R, 2007, FREE RADICAL BIO MED, V42, P1119, DOI 10.1016/j.freeradbiomed.2007.01.014
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Gan L, 2009, DRUG METAB DISPOS, V37, P90, DOI 10.1124/dmd.108.023424
   Gaspar RC, 2020, EXP GERONTOL, V139, DOI 10.1016/j.exger.2020.111021
   Gille L, 2000, ARCH BIOCHEM BIOPHYS, V375, P347, DOI 10.1006/abbi.1999.1649
   Goyal MM, 2010, PROTEIN CELL, V1, P888, DOI 10.1007/s13238-010-0113-z
   Gronemeyer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057395
   Gruber J, 2016, CANCERS, V8, DOI 10.3390/cancers8080073
   Guarente L, 2013, EMBO REP, V14, P750, DOI 10.1038/embor.2013.121
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HE PM, 1994, BIOSCI BIOTECH BIOCH, V58, P146, DOI 10.1271/bbb.58.146
   Hinzpeter F, 2017, BIOPHYS J, V112, P767, DOI 10.1016/j.bpj.2016.11.3194
   Ho TC, 2020, P NATL ACAD SCI USA, V117, P6717, DOI 10.1073/pnas.1918028117
   Holmström KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801
   Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   IBER FL, 1994, DRUG AGING, V5, P34, DOI 10.2165/00002512-199405010-00004
   Ikawa-Yoshida A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32399
   Jiang P, 2013, TOXICOL MECH METHOD, V23, P396, DOI 10.3109/15376516.2013.769655
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143
   KALEN A, 1987, BIOCHIM BIOPHYS ACTA, V926, P70, DOI 10.1016/0304-4165(87)90183-8
   Katsuyama M, 2010, J PHARMACOL SCI, V114, P134, DOI 10.1254/jphs.10R01CR
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012
   KITANI K, 1992, GASTROENTEROL JPN, V27, P276, DOI 10.1007/BF02777737
   Köhler UA, 2014, HEPATOLOGY, V60, P670, DOI 10.1002/hep.26964
   Kretzschmar M, 1996, EXP TOXICOL PATHOL, V48, P439
   Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009
   Larrouy D, 1997, BIOCHEM BIOPH RES CO, V235, P760, DOI 10.1006/bbrc.1997.6852
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Liu DP, 2011, ANTIOXID REDOX SIGN, V15, P1669, DOI 10.1089/ars.2010.3644
   Liu Xiaoying, 2019, Liver Res, V3, P55, DOI 10.1016/j.livres.2019.01.002
   Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042
   Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782
   Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259
   Maria CS, 1996, FREE RADICAL RES, V25, P401, DOI 10.3109/10715769609149062
   MARKLUND S, 1980, ACTA PHYSIOL SCAND, P19
   Martin-Montalvo A, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.6
   Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014
   Miler M, 2016, EXP GERONTOL, V84, P49, DOI 10.1016/j.exger.2016.08.014
   Miller CG, 2019, BRIT J PHARMACOL, V176, P532, DOI 10.1111/bph.14498
   Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786
   Moreno-Sánchez R, 2013, FEBS J, V280, P927, DOI 10.1111/febs.12086
   Mrácek T, 2009, ARCH BIOCHEM BIOPHYS, V481, P30, DOI 10.1016/j.abb.2008.10.011
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   Musicco C, 2011, J PROTEOMICS, V74, P2536, DOI 10.1016/j.jprot.2011.05.041
   Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002
   Nagase M, 2018, J CLIN BIOCHEM NUTR, V63, P129, DOI [10.3164/jcbn.17.124, 10.3164/jcbn.17-124]
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Nakamura I, 2013, J BIOL CHEM, V288, P21389, DOI 10.1074/jbc.M112.443440
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538
   NISHINO H, 1986, J BIOCHEM, V100, P1523, DOI 10.1093/oxfordjournals.jbchem.a121859
   Nohl H, 2002, BIOGERONTOLOGY, V3, P125, DOI 10.1023/A:1015288220217
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   Okuyama H, 2008, IUBMB LIFE, V60, P656, DOI 10.1002/iub.102
   Oldford C, 2019, FREE RADICAL BIO MED, V135, P15, DOI 10.1016/j.freeradbiomed.2019.02.012
   Oliva-Vilarnau N, 2020, ADV SCI, V7, DOI 10.1002/advs.202000248
   Ono Y, 2011, SURGERY, V150, P154, DOI 10.1016/j.surg.2011.05.004
   Passman AM, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5702873
   Pauta M, 2016, HEPATOLOGY, V63, P1660, DOI 10.1002/hep.28286
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   Pibiri M, 2015, AGE, V37, DOI 10.1007/s11357-015-9796-7
   Pickering AM, 2017, AGING CELL, V16, P683, DOI 10.1111/acel.12596
   Pizzinat N, 1999, N-S ARCH PHARMACOL, V359, P428, DOI 10.1007/PL00005371
   Pohl C, 2019, SCIENCE, V366, P818, DOI 10.1126/science.aax3769
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005
   Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X
   Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497
   Rhee SG, 2018, ANTIOXID REDOX SIGN, V28, P537, DOI 10.1089/ars.2017.7167
   Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090
   Rose G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029650
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Sabaretnam T, 2010, TOXICOL IN VITRO, V24, P123, DOI 10.1016/j.tiv.2009.08.018
   Samhan-Arias AK, 2014, FREE RADICAL BIO MED, V73, P174, DOI 10.1016/j.freeradbiomed.2014.04.033
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310
   Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112
   Sekine S, 2007, HEPATOLOGY, V45, P361, DOI 10.1002/hep.21523
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   Serra MP, 2015, J HEPATOL, V62, P1341, DOI 10.1016/j.jhep.2015.01.015
   Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496
   Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112
   Serviddio G, 2013, FREE RADICAL BIO MED, V65, P952, DOI 10.1016/j.freeradbiomed.2013.08.174
   Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sies H, 2020, J BIOL CHEM, V295, P13458, DOI 10.1074/jbc.X120.015651
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Sohal RS, 2006, FREE RADICAL BIO MED, V40, P480, DOI 10.1016/j.freeradbiomed.2005.08.037
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   Stirpe F, 2002, AM J GASTROENTEROL, V97, P2079
   Stolz DB, 2002, HEPATOLOGY, V36, P81, DOI 10.1053/jhep.2002.33716
   Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042
   Tao GZ, 2013, J BIOL CHEM, V288, P17214, DOI 10.1074/jbc.M112.445965
   Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766
   Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x
   Toppo S, 2008, ANTIOXID REDOX SIGN, V10, P1501, DOI 10.1089/ars.2008.2057
   Toroser D, 2007, BIOCHEM J, V405, P583, DOI 10.1042/BJ20061868
   Toshima T, 2014, HEPATOLOGY, V60, P290, DOI 10.1002/hep.27140
   Veith Alex, 2018, Current Opinion in Toxicology, V7, P44, DOI 10.1016/j.cotox.2017.10.003
   Vida C, 2011, BIOGERONTOLOGY, V12, P551, DOI 10.1007/s10522-011-9351-6
   Vida C, 2011, J PHYSIOL BIOCHEM, V67, P551, DOI 10.1007/s13105-011-0100-8
   Viña J, 2007, IUBMB LIFE, V59, P249, DOI 10.1080/15216540601178067
   Viña J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5
   Wang Y, 2016, TRENDS CELL BIOL, V26, P367, DOI 10.1016/j.tcb.2015.12.007
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Xiao WS, 2018, ANTIOXID REDOX SIGN, V28, P251, DOI 10.1089/ars.2017.7216
   Xu FM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103606
   Xu SF, 2019, PEERJ, V7, DOI 10.7717/peerj.7429
   Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691
   Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211
   Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575
   Zaini MA, 2018, CELL REP, V22, P497, DOI 10.1016/j.celrep.2017.12.061
   Zeeh J, 1990, Fortschr Med, V108, P651
   Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327
   Zhan SS, 2006, HEPATOLOGY, V43, P435, DOI 10.1002/hep.21093
   Zhang GL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55148-0
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 196
TC 8
Z9 8
U1 3
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD 2021 OCT 1
PY 2021
VL 35
IS 10
BP 832
EP 847
DI 10.1089/ars.2021.0048
EA MAY 2021
PG 16
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA UP9EA
UT WOS:000649420700001
PM 33789448
DA 2024-02-19
ER

PT J
AU Liu, AD
   Guo, ES
   Yang, JK
   Yang, Y
   Liu, SP
   Jiang, XJ
   Hu, Q
   Dirsch, O
   Dahmen, U
   Zhang, CT
   Gewirtz, DA
   Fang, HS
AF Liu, Anding
   Guo, Enshuang
   Yang, Jiankun
   Yang, Yan
   Liu, Shenpei
   Jiang, Xiaojing
   Hu, Qi
   Dirsch, Olaf
   Dahmen, Uta
   Zhang, Cuntai
   Gewirtz, David A.
   Fang, Haoshu
TI Young plasma reverses age-dependent alterations in hepatic function
   through the restoration of autophagy
SO AGING CELL
LA English
DT Article
DE aging; autophagy; hepatocyte; liver injury; liver regeneration; rat;
   senescence; young blood
ID LIVER ISCHEMIA/REPERFUSION INJURY; CHAPERONE-MEDIATED AUTOPHAGY;
   SENESCENT CELLS; CELLULAR SENESCENCE; REJUVENATION; REGENERATION;
   SUPPRESSION; CLEARANCE; RAT
AB Recent studies showing the therapeutic effect of young blood on aging-associated deterioration of organs point to young blood as the solution for clinical problems related to old age. Given that defective autophagy has been implicated in aging and aging-associated organ injuries, this study was designed to determine the effect of young blood on aging-induced alterations in hepatic function and underlying mechanisms, with a focus on autophagy. Aged rats (22 months) were treated with pooled plasma (1 ml, intravenously) collected from young (3 months) or aged rats three times per week for 4 weeks, and 3-methyladenine or wortmannin was used to inhibit young blood-induced autophagy. Aging was associated with elevated levels of alanine transaminase and aspartate aminotransferase, lipofuscin accumulation, steatosis, fibrosis, and defective liver regeneration after partial hepatectomy, which were significantly attenuated by young plasma injections. Young plasma could also restore aging-impaired autophagy activity. Inhibition of the young plasma-restored autophagic activity abrogated the beneficial effect of young plasma against hepatic injury with aging. In vitro, young serum could protect old hepatocytes from senescence, and the antisenescence effect of young serum was abrogated by 3-methyladenine, wortmannin, or small interfering RNA to autophagy-related protein 7. Collectively, our data indicate that young plasma could ameliorate age-dependent alterations in hepatic function partially via the restoration of autophagy.
C1 [Liu, Anding; Yang, Jiankun; Yang, Yan; Liu, Shenpei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Expt Med Ctr, Wuhan, Hubei, Peoples R China.
   [Guo, Enshuang; Jiang, Xiaojing] Wuhan Gen Hosp, Dept Infect Dis, Wuhan, Hubei, Peoples R China.
   [Hu, Qi; Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Geriatr, Tongji Med Coll, Wuhan, Hubei, Peoples R China.
   [Dirsch, Olaf; Dahmen, Uta] Friedrich Schiller Univ Jena, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany.
   [Gewirtz, David A.] Virginia Commonwealth Univ, Massey Canc Ctr, Dept Pharmacol & Toxicol, Richmond, VA USA.
   [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Friedrich Schiller University of Jena; Virginia
   Commonwealth University; Anhui Medical University
RP Fang, HS (corresponding author), Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China.
EM Haoshu.fang@uk-essen.de
RI Yang, Yifan/JTV-1487-2023; Liu, Anding/AAU-2477-2020
OI Fang, Haoshu/0000-0003-3108-6305; Zhang, Cuntai/0000-0002-9044-5032
FU National Natural Science Fund of China (NSFC) [81300343, 81401617]
FX National Natural Science Fund of China (NSFC), Grant/Award Number:
   81300343, 81401617
CR Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Gewirtz DA, 2013, AUTOPHAGY, V9, P808, DOI 10.4161/auto.23922
   Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001
   Kang C, 2016, AUTOPHAGY, V12, P898, DOI 10.1080/15548627.2015.1121361
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110
   Kim JS, 2003, GASTROENTEROLOGY, V124, P494, DOI 10.1053/gast.2003.50059
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Liu AD, 2016, ONCOTARGET, V7, P78372, DOI 10.18632/oncotarget.13281
   Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042
   Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659
   Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257
   Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Salpeter SJ, 2013, DIABETES, V62, P2843, DOI 10.2337/db13-0160
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Terman A, 1999, EXP GERONTOL, V34, P943, DOI 10.1016/S0531-5565(99)00070-4
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Toshima T, 2014, HEPATOLOGY, V60, P290, DOI 10.1002/hep.27140
   Vicente R, 2016, AGING CELL, V15, P400, DOI 10.1111/acel.12455
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 41
TC 45
Z9 47
U1 3
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD FEB
PY 2018
VL 17
IS 1
AR e12708
DI 10.1111/acel.12708
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FS8KX
UT WOS:000422661300021
PM 29210183
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Huang, YH
   Chen, MH
   Guo, QL
   Chen, ZX
   Chen, QD
   Wang, XZ
AF Huang, Yue-Hong
   Chen, Ming-Hua
   Guo, Qi-Lan
   Chen, Zhi-Xin
   Chen, Qing-Duo
   Wang, Xiao-Zhong
TI Interleukin-10 induces senescence of activated hepatic stellate cells
   via STAT3-p53 pathway to attenuate liver fibrosis
SO CELLULAR SIGNALLING
LA English
DT Article
DE Interleukin-10; Senescence; Signal pathway; Hepatic stellate cells;
   Liver fibrosis
AB Hepatic fibrosis is a wound healing process which results in deposition of excessive abnormal extracellular matrix (ECM) in response to various liver injuries. Activated hepatic stellate cells (HSCs) are the major sources of ECM and induction of senescence of activated HSCs is an attractive therapeutic strategy for liver fibrosis. Our previous studies have shown that interleukin-10 (IL-10) attenuates the carbon tetrachloride (CCL4) - and porcine serum-induced liver fibrosis in rats. However, little is known about the mechanisms of IL-10 regulating the senescence of activated HSCs. The aim of this study is to uncover the underlying pathway by which IL-10 mediates activated HSCs senescence to attenuate liver fibrosis. In vivo, we found that IL-10 gene by hydrodynamics-based transfection attenuated CCL4-induced liver fibrosis associated with senescence of activated HSCs in rats. In vitro experiment confirmed that IL-10 could induce senescence of activated HSCs via inhibiting cell proliferation, inducing cell cycle arrest, increasing the SA-beta-Gal activity and enhancing expression of senescence marker protein p53 and p21. Treatment with Pifithrin-alpha, a specific inhibitor of p53, could abrogate IL-10-increased SA-beta-Gal activity and expression of P53 and P21 in activated HSCs. Lastly, IL-10 also increased the expression of total and phosphorylated signal transducers and activators of transcription 3(STAT3) and promoted phosphorylated STAT3 translocation from cytoplasm to nucleus. Treatment with cryptotanshinone, a specific inhibitor of STAT3, could inhibit the phosphorylation of STAT3 and its downstream proteins p53 and p21 expression and decrease the activity of SA-beta-Gal in activated HSCs induced by IL-10. Taken together, IL-10 induced senescence of activated HSCs via STAT3-p53 pathway to attenuate liver fibrosis in rats and present study will provide a new mechanism of antifibrotic effects of IL-10.
C1 [Huang, Yue-Hong; Chen, Ming-Hua; Guo, Qi-Lan; Chen, Zhi-Xin; Chen, Qing-Duo; Wang, Xiao-Zhong] Fujian Med Univ, Dept Gastroenterol, Union Hosp, Fuzhou 350001, Fujian, Peoples R China.
C3 Fujian Medical University
RP Wang, XZ (corresponding author), Fujian Med Univ, Dept Gastroenterol, Union Hosp, Fuzhou 350001, Fujian, Peoples R China.
EM 2003huangyh@sina.com; 634195975@qq.com; 2544771397@qq.com;
   czx8482@sina.com; 443220972@qq.com; drwangxz@163.com
RI Chen, Ming/GVU-8412-2022
OI HUANG, Yue-Hong/0000-0001-7134-719X
FU National Natural Science Foundation of China [81600486]; Natural Science
   Foundation of Fujian Province [2016J01462]; MiddleAged and Young Talents
   Training Fund of Fujian Provincial Health Commission [2018-ZQN-38]; Key
   Clinical Specialty Discipline Construction Program of Fujian, China [49,
   MM Wei Ke Jiao 2012]
FX This work was supported by the National Natural Science Foundation of
   China (grant number 81600486); Natural Science Foundation of Fujian
   Province (grant number 2016J01462); MiddleAged and Young Talents
   Training Fund of Fujian Provincial Health Commission (grant number
   2018-ZQN-38) and the Key Clinical Specialty Discipline Construction
   Program of Fujian, China (Grant no. MM Wei Ke Jiao 2012 No. 49)
CR Banito A, 2013, CELL, V155, P977, DOI 10.1016/j.cell.2013.10.050
   Chen JL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.228
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Huang Y, 2017, EXP CELL RES, V352, P420, DOI 10.1016/j.yexcr.2017.02.038
   Huang YH, 2018, MOL MED REP, V17, P5700, DOI 10.3892/mmr.2018.8592
   Huang YH, 2014, INT J MOL MED, V34, P677, DOI 10.3892/ijmm.2014.1831
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847
   Nallagangula KS, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2017-0083
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Okinaga T, 2013, MED MICROBIOL IMMUN, V202, P167, DOI 10.1007/s00430-012-0282-x
   Ovadya Y, 2018, J CLIN INVEST, V128, P1247, DOI 10.1172/JCI95149
   Rizzuti D, 2015, J INNATE IMMUN, V7, P199, DOI 10.1159/000368232
   Sagiv A, 2018, CELL REP, V22, P3468, DOI 10.1016/j.celrep.2018.03.009
   Shaker ME, 2013, BBA-MOL CELL RES, V1833, P1992, DOI 10.1016/j.bbamcr.2013.02.033
   Shamskhou EA, 2019, BIOMATERIALS, V203, P52, DOI 10.1016/j.biomaterials.2019.02.017
   Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Wells RG, 2015, SEMIN LIVER DIS, V35, P97, DOI [10.1055/s-0035-1550061, 10.1055/s-0035-1554915]
   Yang JF, 2019, J CELL PHYSIOL, V234, P7587, DOI 10.1002/jcp.27521
   Zhou YC, 2012, DIGEST LIVER DIS, V44, P398, DOI 10.1016/j.dld.2011.11.013
NR 25
TC 46
Z9 48
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0898-6568
EI 1873-3913
J9 CELL SIGNAL
JI Cell. Signal.
PD FEB
PY 2020
VL 66
AR 109445
DI 10.1016/j.cellsig.2019.109445
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA KE7RB
UT WOS:000508747700011
PM 31730896
OA hybrid
DA 2024-02-19
ER

PT J
AU Kortum, AJ
   Cloup, EA
   Williams, TL
   Constantino-Casas, F
   Watson, PJ
AF Kortum, Andre J.
   Cloup, Emilie A.
   Williams, Tim L.
   Constantino-Casas, Fernendo
   Watson, Penny J.
TI Hepatocyte expression and prognostic importance of senescence marker p21
   in liver histopathology samples from dogs with chronic hepatitis
SO JOURNAL OF VETERINARY INTERNAL MEDICINE
LA English
DT Article
DE cell cycle arrest; DNA damage; immunohistochemistry; liver disease
ID CELL-CYCLE PROGRESSION; SECRETORY PHENOTYPE; IMMUNOHISTOCHEMICAL
   EXPRESSION; CLINICAL PRESENTATION; LABRADOR-RETRIEVERS; PROTEINS;
   TUMORS; P53; VACUOLATION; CARCINOMA
AB BackgroundObjectiveChronic hepatitis (CH) occurs commonly in dogs but is associated with a variable and largely unpredictable prognosis. p21, a cell-cycle inhibitor and marker of cellular senescence, is upregulated in human liver disease and is a better prognostic marker than histological or clinical scoring systems.
   To quantify hepatocyte p21 immunopositivity in histopathology samples from dogs with CH and determine its association with outcome.
   AnimalsMethodsTwenty-six client-owned dogs with histologically confirmed CH, and 15 dogs with normal liver histology.
   Medical records and liver histopathology samples were retrospectively reviewed to identify cases of CH. Immunohistochemistry for p21 was performed on all samples and hepatocyte immunopositivity was visually quantified. Relationships between p21 and dog age and dog survival time were statistically evaluated.
   ResultsConclusions and Clinical ImportanceHepatocyte p21 immunopositivity in dogs with CH was high (median percentage of positive hepatocytes: 90%, range: 20%-98%) and exceeded 70% in 23/26 cases with no association with age. In control dogs, p21 immunopositivity was low (15% positive hepatocytes in 12/15 cases) and was positively correlated with age (r(s)=0.63; P=.011). Dogs with p21 immunopositivity exceeding 91.8% (upper tercile) had significantly shorter survival compared to dogs with less than 88.9% immunopositivity (lowest tercile; 218 versus 874 days, P=.006). Increasing hepatocyte p21 immunopositivity was significantly negatively associated with survival time (HR 4.12; 95% CI 1.34-12.63; P=.013).
   Marked p21 immunopositivity in dogs with CH might be indicative of widespread hepatocellular senescence. A significant association with survival time also suggests a potential value for p21 quantification in determining prognosis.
C1 [Kortum, Andre J.; Cloup, Emilie A.; Williams, Tim L.; Constantino-Casas, Fernendo; Watson, Penny J.] Univ Cambridge, Queens Vet Sch Hosp, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.
C3 University of Cambridge
RP Kortum, AJ (corresponding author), Univ Cambridge, Queens Vet Sch Hosp, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.
EM ak974@cam.ac.uk
RI Williams, Tim/ADT-2645-2022
OI Watson, Penelope Jayne/0000-0002-7241-9412
FU Petplan Charitable Trust [217-263]
FX Petplan Charitable Trust, Grant/Award Number: 217-263
CR Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bexfield NH, 2011, VET REC, V169, P415, DOI 10.1136/vr.d4665
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Carrasco V, 2011, VET PATHOL, V48, P322, DOI 10.1177/0300985810375050
   Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009
   Chandler HL, 2009, VET OPHTHALMOL, V12, P83, DOI 10.1111/j.1463-5224.2008.00684.x
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Dirksen K, 2017, J VET INTERN MED, V31, P1017, DOI 10.1111/jvim.14716
   Dutto I, 2016, METHODS MOL BIOL, V1336, P123, DOI 10.1007/978-1-4939-2926-9_11
   Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Inoue M, 2000, VET REC, V146, P370, DOI 10.1136/vr.146.13.370
   Inoue M, 2006, J VET MED SCI, V68, P779, DOI 10.1292/jvms.68.779
   JAMES O, 1975, LANCET, V2, P579
   Kim HW, 2017, J VET SCI, V18, P479, DOI 10.4142/jvs.2017.18.4.479
   Klopfleisch R, 2009, RES VET SCI, V87, P91, DOI 10.1016/j.rvsc.2008.12.010
   Martínez-Zamudio RI, 2017, CELL, V170, P1044, DOI 10.1016/j.cell.2017.08.025
   McCulloch K, 2017, AGING CELL, V16, P210, DOI 10.1111/acel.12562
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Peyron C, 2014, REV MED VET-TOULOUSE, V165, P245
   Poldervaart JH, 2009, J VET INTERN MED, V23, P72, DOI 10.1111/j.1939-1676.2008.0215.x
   Raffan E, 2009, J VET INTERN MED, V23, P63, DOI 10.1111/j.1939-1676.2008.0230.x
   Rothuizen J., 2006, WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases
   Selgas AG, 2014, J VET DIAGN INVEST, V26, P246, DOI 10.1177/1040638713520602
   SEVELIUS E, 1995, J SMALL ANIM PRACT, V36, P521, DOI 10.1111/j.1748-5827.1995.tb02801.x
   Shih JL, 2007, J VET INTERN MED, V21, P33, DOI 10.1892/0891-6640(2007)21[33:CHILRC]2.0.CO;2
   STROMBECK DR, 1988, J AM VET MED ASSOC, V193, P1109
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Watanabe S, 2017, CANCER SCI, V108, P563, DOI 10.1111/cas.13184
   Watson PJ, 2004, VET J, V167, P228, DOI 10.1016/S1090-0233(03)00118-7
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   Wu H, 2004, VET PATHOL, V41, P296, DOI 10.1354/vp.41-3-296
   Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154
NR 39
TC 6
Z9 6
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-1676
J9 J VET INTERN MED
JI J. Vet. Intern. Med.
PD SEP-OCT
PY 2018
VL 32
IS 5
BP 1629
EP 1636
DI 10.1111/jvim.15238
PG 8
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA GX0PV
UT WOS:000447414300016
PM 30133945
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Park, J
   Chen, YQ
   Kim, J
   Hwang, E
   Park, GH
   Yang, CH
   Ryter, SW
   Park, JW
   Chung, HT
   Joe, Y
AF Park, Jeongmin
   Chen, Yingqing
   Kim, Jeongha
   Hwang, Eunyeong
   Park, Gyu Hwan
   Yang, Chae Ha
   Ryter, Stefan W.
   Park, Jeong Woo
   Chung, Hun Taeg
   Joe, Yeonsoo
TI CO-Induced TTP Activation Alleviates Cellular Senescence and
   Age-Dependent Hepatic Steatosis <i>via</i> Downregulation of
   <i>PAI</i>-<i>1</i>
SO AGING AND DISEASE
LA English
DT Article; Early Access
DE aging; carbon monoxide; cellular senescence; non-alcoholic fatty liver
   diseases (NAFLD); stress granules; PAI-1; Sirt1; tristetraprolin
ID ESTER-INDUCED HYPERTENSION; DOUBLE-STRAND BREAKS; PROTEIN-KINASE;
   DNA-DAMAGE; INHIBITOR-1; STRESS; TRISTETRAPROLIN; INDUCTION; GRANULES;
   GENE
AB Aging can increase the risk of various hepatic diseases, especially non-alcoholic fatty liver disease (NAFLD). Although the mechanisms underlying the pathogenesis of age-related disorders such as NAFLD remain incompletely understood, recent studies have implicated the accumulation of senescent cells as a contributing factor. Here, we show that tristetraprolin (TTP) deficiency accelerates NAFLD during aging by enhancing the senescence-associated secretory phenotype (SASP) as well as several hallmarks of senescence. The sequestration of plasminogen activator inhibitor (PAI)-1, a mediator of cellular senescence, in stress granules, (SGs) inhibits cellular senescence. In our previous report, we have shown that carbon monoxide (CO), a small gaseous mediator, can induce the assembly of SGs via an integrated stress response. Here, we show that CO treatment promotes the assembly of SGs which can sequester PAI-1, resulting in the inhibition of etoposide (ETO)-induced cellular senescence. Notably, CO-induced TTP activation enhances PAI-1 degradation, leading to protection against ETO-induced cellular senescence. CO-dependent Sirt1 activation promotes the inclusion of TTP into SGs, leading to decreased PAI-1 levels. Therefore, our findings highlight the importance of TTP as a therapeutic target in age-related NAFLD and offer a potential new strategy to reduce the detrimental effects of senescent cells in hepatic disorders.
C1 [Park, Jeongmin; Chung, Hun Taeg; Joe, Yeonsoo] Univ Ulsan, Sch Biol Sci, Ulsan 44610, South Korea.
   [Chen, Yingqing] Dalian Univ, Med Coll, Dept Pharmacol, Dalian, Peoples R China.
   [Kim, Jeongha; Hwang, Eunyeong; Yang, Chae Ha] Daegu Haany Univ, Coll Korean Med, Daegu 42158, South Korea.
   [Park, Gyu Hwan] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Daegu, South Korea.
   [Ryter, Stefan W.] Proterris Inc, Boston, MA 02118 USA.
C3 University of Ulsan; Dalian University; Daegu Haany University;
   Kyungpook National University
RP Chung, HT; Joe, Y (corresponding author), Univ Ulsan, Sch Biol Sci, Ulsan 44610, South Korea.
EM chung@ulsan.ac.kr; jcantibody@ulsan.ac.kr
FU Priority Research Centers Program through the National Research
   Foundation of Korea (NRF) - Ministry of Education [2014R1A6A1030318,
   NRF-2020R1A2C1009192, NRF-2020R1I1A1A01073488, NRF-2020R1A2C1006470,
   2018R1A5A2025272]
FX This work was supported by the Priority Research Centers Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (2014R1A6A1030318), NRF-2020R1A2C1009192 to H.T.C.,
   NRF-2020R1I1A1A01073488 to J.P., NRF-2020R1A2C1006470 to Y. J., and
   2018R1A5A2025272 to Yang.
CR Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Berben L, 2021, CANCERS, V13, DOI 10.3390/cancers13061400
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192
   Bojko A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121501
   Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006
   Chen YQ, 2019, FASEB J, V33, P13905, DOI 10.1096/fj.201901258RR
   Chen YQ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9926284
   Chen YQ, 2019, BIOCHEM BIOPH RES CO, V512, P289, DOI 10.1016/j.bbrc.2019.03.017
   de Magalhaes JP, 2013, NAT REV CANCER, V13, P357, DOI 10.1038/nrc3497
   Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Durkin Marian E, 2013, Bio Protoc, V3
   Eren M, 2014, P NATL ACAD SCI USA, V111, P7090, DOI 10.1073/pnas.1321942111
   Fazeli PK, 2020, GERONTOLOGY, V66, P209, DOI 10.1159/000501745
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Galijatovic A, 2004, J BIOL CHEM, V279, P23969, DOI 10.1074/jbc.M400973200
   Gasek NS, 2021, NATURE AGING, V1, P870, DOI 10.1038/s43587-021-00121-8
   Ghosh AK, 2016, ONCOTARGET, V7, P72443, DOI 10.18632/oncotarget.12494
   Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783
   Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715
   Guzikowski AR, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1524
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7
   Joe Y, 2020, CELL REP, V30, P1063, DOI 10.1016/j.celrep.2019.12.090
   Joe Y, 2018, FASEB J, V32, P2630, DOI 10.1096/fj.201700709RR
   Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004
   Kim HJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12864
   Kim HJ, 2018, CELL MOL IMMUNOL, V15, P1085, DOI 10.1038/s41423-018-0045-8
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Liberale L, 2022, J AM COLL CARDIOL, V79, P837, DOI 10.1016/j.jacc.2021.12.017
   Michishita E, 1998, BIOCHEM BIOPH RES CO, V253, P667, DOI 10.1006/bbrc.1998.9832
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Ogrodnik M, 2021, AGING CELL, V20, DOI 10.1111/acel.13296
   Omer A, 2018, EMBO REP, P19
   Pagiatakis C, 2021, AGING CLIN EXP RES, V33, P737, DOI 10.1007/s40520-019-01430-0
   Park J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2747018
   Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06
   Sandhu C, 2000, CANCER RES, V60, P2616
   Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Spiess BD, 1996, J CARDIOVASC PHARM, V27, pS38
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Tsuda K, 2014, CIRCULATION, V130, P83
   Vamvakas S, 1997, CRIT REV TOXICOL, V27, P155, DOI 10.3109/10408449709021617
   Wang L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01087
   Wu H, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101500
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Yamamoto K, 2005, CARDIOVASC RES, V66, P276, DOI 10.1016/j.cardiores.2004.11.013
   Zheng M, 2019, ARCH BIOCHEM BIOPHYS, V677, DOI 10.1016/j.abb.2019.108185
NR 60
TC 4
Z9 4
U1 0
U2 2
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD 2023 APR
PY 2023
VL 14
IS 2
BP 484
EP 501
DI 10.14336/AD.2023.0120
EA JAN 2023
PG 18
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA M6AS5
UT WOS:000934156800001
PM 37008056
DA 2024-02-19
ER

PT J
AU Abdelmegeed, MA
   Choi, Y
   Ha, SK
   Song, BJ
AF Abdelmegeed, Mohamed A.
   Choi, Youngshim
   Ha, Seung-Kwon
   Song, Byoung-Joon
TI Cytochrome P450-2E1 promotes aging-related hepatic steatosis, apoptosis
   and fibrosis through increased nitroxidative stress
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Liver; Aging; CYP2E1; Steatohepatitis; Apoptosis; Fibrosis;
   Nitroxidative stress
ID FATTY LIVER-DISEASE; AGE-RELATED-CHANGES; OXIDATIVE STRESS;
   MITOCHONDRIAL DYSFUNCTION; HEME OXYGENASE-1; RAT-LIVER; LIFE-SPAN;
   PROTEIN; CYP2E1; EXPRESSION
AB The role of ethanol-inducible cytochrome P450-2E1 (CYP2E1) in promoting aging-dependent hepatic disease is unknown and thus was investigated in this study. Young (7 weeks) and aged female (16 months old) wild-type (WT) and Cyp2el-null mice were used in this study to evaluate age-dependent changes in liver histology, steatosis, apoptosis, fibrosis and many nitroxidative stress parameters. Liver histology showed that aged WT mice exhibited markedly elevated hepatocyte vacuolation, ballooning degeneration, and inflammatory cell infiltration compared to all other groups. These changes were accompanied with significantly higher hepatic triglyceride and serum cholesterol in aged WT mice although serum ALT and insulin resistance were not significantly altered. Aged WT mice showed the highest rates of hepatocyte apoptosis and hepatic fibrosis. Further, the highest levels of hepatic hydrogen peroxide, lipid peroxidation, protein carbonylation, nitration, and oxidative DNA damage were observed in aged WT mice. These increases in the aged WT mice were accompanied by increased levels of mitochondrial nitroxidative stress and alteration of mitochondrial complex III and IV proteins in aged WT mice, although hepatic ATP levels seems to be unchanged. In contrast, the aging-related nitroxidative changes were very low in aged Cyp2el-null mice. These results suggest that CYP2E1 is important in causing aging-dependent hepatic steatosis, apoptosis and fibrosis possibly through increasing nitroxidative stress and that CYP2E1 could be a potential target for translational research in preventing aging related liver disease. Published by Elsevier Inc.
C1 [Abdelmegeed, Mohamed A.; Choi, Youngshim; Ha, Seung-Kwon; Song, Byoung-Joon] NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, 9000 Rockville Pike, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA)
RP Song, BJ (corresponding author), NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM bj.song@nih.gov
FU Intramural Research Program of National Institute on Alcohol Abuse and
   Alcoholism; KRIBB Research Initiative Program (Korean Biomedical
   Scientist Fellowship Program); Korea Research institute of Bioscience
   and Biotechnology, Republic of Korea
FX This research was supported by the Intramural Research Program of
   National Institute on Alcohol Abuse and Alcoholism and by a Grant to
   Youngshim Choi from the KRIBB Research Initiative Program (Korean
   Biomedical Scientist Fellowship Program), and Korea Research institute
   of Bioscience and Biotechnology, Republic of Korea. We are thankful to
   Dr. Frank J. Gonzalez (National Cancer Institute, NIH, Bethesda, MD,
   USA) and Dr. James P. Hardwick (Northeastern Ohio University College of
   Medicine, Rootstown, OH) for providing the WT and Cyp2el-null mice and
   the polyclonal antibodies to different P450 isoforms, respectively. We
   also thank Dr. Klaus Gawrisch for supporting this study.
CR Abdelmegeed MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/149627
   Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V65, P1238, DOI 10.1016/j.freeradbiomed.2013.09.009
   Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018
   Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019
   Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210
   Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017
   Abdelmegeed MA, 2010, BIOCHEM PHARMACOL, V79, P57, DOI 10.1016/j.bcp.2009.07.016
   Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Aubert J, 2011, CLIN RES HEPATOL GAS, V35, P630, DOI 10.1016/j.clinre.2011.04.015
   Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004
   Bhattacharya A, 2011, AGING CELL, V10, P720, DOI 10.1111/j.1474-9726.2011.00712.x
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Bradford BU, 2005, HEPATOLOGY, V41, P336, DOI 10.1002/hep.20532
   Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004
   Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704
   Cederbaum AI, 2003, ALCOHOL, V30, P115, DOI 10.1016/S0741-8329(03)00104-6
   Cefalu CA, 2011, CLIN GERIATR MED, V27, P491, DOI 10.1016/j.cger.2011.07.001
   Colantoni A, 2001, J AM AGING ASSOC, V24, P51, DOI 10.1007/s11357-001-0007-3
   Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110
   Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228
   Gohlke S, 2014, AGE, V36, P57, DOI 10.1007/s11357-013-9543-x
   Gong PF, 2004, FREE RADICAL BIO MED, V36, P307, DOI 10.1016/j.freeradbiomed.2003.10.017
   Goto S, 1997, AGE, V20, P81, DOI 10.1007/s11357-997-0008-y
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x
   Immenschuh S, 2005, CELL MOL BIOL, V51, P471, DOI 10.1170/T652
   Jang S, 2015, REDOX BIOL, V6, P552, DOI 10.1016/j.redox.2015.09.040
   Jiang P, 2013, TOXICOL MECH METHOD, V23, P396, DOI 10.3109/15376516.2013.769655
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001
   Konstandi M, 2013, AM J PHYSIOL-ENDOC M, V304, pE1118, DOI 10.1152/ajpendo.00585.2012
   Kwak HC, 2015, ARCH PHARM RES, V38, P857, DOI 10.1007/s12272-014-0452-z
   Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011, P1, DOI [DOI 10.1155/2011/859415, 10.1155/2011/859415]
   Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063
   Lieber CS, 2004, AM J CLIN NUTR, V79, P502
   Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517
   Liu JB, 2013, REDOX BIOL, V1, P110, DOI 10.1016/j.redox.2012.11.011
   Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222
   Mak KM, 2012, ANAT REC, V295, P40, DOI 10.1002/ar.21525
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   Nie B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/303181
   Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435
   Ortuño-Sahagún D, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/573208
   Park JH, 2015, KOREAN J PHYSIOL PHA, V19, P269, DOI 10.4196/kjpp.2015.19.3.269
   Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101
   Ramesh T, 2012, EXP GERONTOL, V47, P979, DOI 10.1016/j.exger.2012.09.003
   Romano AD, 2014, CURR PHARM DESIGN, V20, P2978, DOI 10.2174/13816128113196660700
   Sadowska-Bartosz I, 2014, FREE RADICAL RES, V48, P1267, DOI 10.3109/10715762.2014.953494
   Safwat MH, 2014, BIOCHEMISTRY-MOSCOW+, V79, P450, DOI 10.1134/S0006297914050095
   Sasaki T, 2013, EXP GERONTOL, V48, P457, DOI 10.1016/j.exger.2013.02.015
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Sergiev PV, 2015, ACTA NATURAE, V7, P9, DOI 10.32607/20758251-2015-7-1-9-18
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sobocanec S, 2008, BIOGERONTOLOGY, V9, P335, DOI 10.1007/s10522-008-9145-7
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Song BJ, 1996, ALCOHOL CLIN EXP RES, V20, pA138, DOI 10.1111/j.1530-0277.1996.tb01764.x
   Song BJ, 2014, REDOX BIOL, V3, P109, DOI 10.1016/j.redox.2014.10.004
   Song BJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/781050
   Stojkovski V, 2013, PHYSIOL RES, V62, P503, DOI 10.33549/physiolres.932514
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Suh SK, 2004, PROTEOMICS, V4, P3401, DOI 10.1002/pmic.200400971
   WANG JH, 1995, AM J PHYSIOL-GASTR L, V269, pG297, DOI 10.1152/ajpgi.1995.269.2.G297
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
NR 78
TC 36
Z9 39
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD FEB
PY 2016
VL 91
BP 188
EP 202
DI 10.1016/j.freeradbiomed.2015.12.016
PG 15
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DD8MQ
UT WOS:000370181400018
PM 26703967
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Luo, XY
   Bai, YQ
   He, SL
   Sun, SF
   Jiang, XK
   Yang, ZY
   Lu, D
   Wei, PR
   Liang, Y
   Peng, C
   Wang, YR
   Sheng, RL
   Han, SY
   Li, XL
   Zhang, BY
AF Luo, Xiaoying
   Bai, Yangqiu
   He, Shuli
   Sun, Suofeng
   Jiang, Xiaoke
   Yang, Zhiyu
   Lu, Di
   Wei, Peiru
   Liang, Yuan
   Peng, Cong
   Wang, Yaru
   Sheng, Ruli
   Han, Shuangyin
   Li, Xiuling
   Zhang, Bingyong
TI Sirtuin 1 ameliorates defenestration in hepatic sinusoidal endothelial
   cells during liver fibrosis via inhibiting stress-induced premature
   senescence
SO CELL PROLIFERATION
LA English
DT Article; Early Access
DE defenestration; hepatic sinusoidal endothelial cell; premature
   senescence; progerin; sirtuin 1
AB Objective: Premature senescence is related to progerin and involves in endothelial dysfunction and liver diseases. Activating sirtuin 1 (SIRT1) ameliorates liver fibrosis. However, the mechanisms of premature senescence in defenestration of hepatic sinusoidal endothelial cells (HSECs) and how SIRT1 affects HSECs fenestrae remain elusive.
   Methods: We employed the CCl4-induced liver fibrogenesis rat models and cultured primary HSECs in vitro, administered with the SIRT1-adenovirus vector, the activator of SIRT1 and knockdown NOX2. We measured the activity of senescence-associated beta-galactosidase (SA-beta-gal) in HSECs. Meanwhile, the protein expression of SIRT1, NOX2, progerin, Lamin A/C, Ac p53 K381 and total p53 was detected by Western blot, co-immunoprecipitation and immunofluorescence.
   Results: In vivo, premature senescence was triggered by oxidative stress during CCl4-induced HSECs defenestration and liver fibrogenesis, whereas overexpressing SIRT1 with adenovirus vector lessened premature senescence to relieve CCl4-induced HSECs defenestration and liver fibrosis. In vitro, HSECs fenestrae disappeared, with emerging progerin-associated premature senescence; these effects were aggravated by H2O2. Nevertheless, knockdown of NOX2, activation of SIRT1 with resveratrol and SIRT1-adenovirus vector inhibited progerin-associated premature senescence to maintain fenestrae through deacetylating p53. Furthermore, more Ac p53 K381 and progerin co-localized with the abnormal accumulation of actin filament (F-actin) in the nuclear envelope of H2O2-treated HSECs; in contrast, these effects were rescued by overexpressing SIRT1.
   Conclusion: SIRT1-mediated deacetylation maintains HSECs fenestrae and attenuates liver fibrogenesis through inhibiting oxidative stress-induced premature senescence.
C1 [Luo, Xiaoying; Bai, Yangqiu; He, Shuli; Sun, Suofeng; Jiang, Xiaoke; Yang, Zhiyu; Lu, Di; Wei, Peiru; Liang, Yuan; Peng, Cong; Wang, Yaru; Sheng, Ruli; Han, Shuangyin; Li, Xiuling; Zhang, Bingyong] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Gastroenterol,Sch Clin Med,Henan Univ, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.
   [Luo, Xiaoying; Sun, Suofeng; Yang, Zhiyu; Lu, Di] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Microbiome Lab, Zhengzhou, Peoples R China.
C3 Zhengzhou University; Henan University; Zhengzhou University
RP Li, XL; Zhang, BY (corresponding author), Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Dept Gastroenterol,Sch Clin Med,Henan Univ, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.
EM luoxiaoying1987@163.com; doctbai@126.com; 1923431332@qq.com;
   sunsuofeng1982@hotmail.com; xiaoke02156@163.com; back99999@126.com;
   ludigraduate@163.com; weipeiru92@163.com; 2578863852@qq.com;
   pengcong2019@163.com; 969095786@qq.com; shrl75@163.com;
   hansyzzu@163.com; zzlixiuling@aliyun.com; zhbingyong@sina.com
RI YI, J/JJE-7713-2023; wen, liang/JNR-7720-2023; li, xiu/GXV-1745-2022;
   WANG, YANG/JFA-8821-2023; Wang, Yahui/JCO-6233-2023; wang,
   ya/HQZ-7558-2023; XIE, WANYING/JNR-9259-2023
FU WBE Liver Fibrosis Foundation [no.CFHPC2019008]; National Natural
   Science Foundation of China [81800551]; Scientific and Technological
   Project of Henan Province [182102310210]; Young Talent Research
   Cultivation Project of School of Clinical Medicine of Henan University
   [2019017]
FX The authors are much grateful to Mr Litao Qin, Dr Shasha Bian and Dr
   Yonghui Dong for essential helps in this study. This study is sponsored
   by WBE Liver Fibrosis Foundation (Grant no.CFHPC2019008), the National
   Natural Science Foundation of China (No. 81800551), the Scientific and
   Technological Project of Henan Province (No. 182102310210) and the Young
   Talent Research Cultivation Project of School of Clinical Medicine of
   Henan University (No.2019017).
CR Akram KM, 2014, INT J CLIN EXP PATHO, V7, P552
   Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021
   Bonello-Palot N, 2014, ATHEROSCLEROSIS, V237, P45, DOI 10.1016/j.atherosclerosis.2014.08.036
   Brady GF, 2018, GASTROENTEROLOGY, V154, P1602, DOI 10.1053/j.gastro.2018.03.026
   Brady GF, 2018, HEPATOLOGY, V67, P1710, DOI 10.1002/hep.29522
   Cheang WS, 2019, PHARMACOL RES, V139, P384, DOI 10.1016/j.phrs.2018.11.041
   Chen HY, 2014, CELL, V159, P829, DOI 10.1016/j.cell.2014.10.028
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Crosas-Molist E, 2015, REDOX BIOL, V6, P106, DOI 10.1016/j.redox.2015.07.005
   Das A, 2019, CELL, V176, P944, DOI 10.1016/j.cell.2019.01.026
   DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376
   Fan LM, 2017, FREE RADICAL BIO MED, V108, P940, DOI 10.1016/j.freeradbiomed.2017.05.008
   Guichard C, 2008, BIOCHEM SOC T, V36, P920, DOI 10.1042/BST0360920
   Jiang JX, 2020, HEPATOLOGY, V72, P1204, DOI 10.1002/hep.31118
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   La Torre M, 2018, AGING CELL, V17, DOI 10.1111/acel.12730
   Luo XY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12991
   Luo XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1670-6
   Luo XY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0567-0
   Luo XY, 2017, REDOX BIOL, V13, P508, DOI 10.1016/j.redox.2017.07.011
   Matsumoto M, 2018, FREE RADICAL BIO MED, V115, P412, DOI 10.1016/j.freeradbiomed.2017.12.019
   Mortezaee K, 2018, CELL BIOCHEM FUNCT, V36, P292, DOI 10.1002/cbf.3351
   Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127
   Osorio FG, 2012, AGING-US, V4, P726, DOI 10.18632/aging.100502
   Perovanovic J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4991
   Piekarowicz K, 2017, CHROMOSOMA, V126, P501, DOI 10.1007/s00412-016-0610-9
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245
   Straub AC, 2008, J CLIN INVEST, V118, P3980, DOI 10.1172/JCI35092
   Wu DY, 2018, CELL DEATH DIFFER, V25, P169, DOI 10.1038/cdd.2017.187
   Zhao HY, 2018, PHARMACOL RES, V128, P327, DOI 10.1016/j.phrs.2017.10.013
NR 31
TC 17
Z9 18
U1 2
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7722
EI 1365-2184
J9 CELL PROLIFERAT
JI Cell Prolif.
PD 2021 MAR
PY 2021
VL 54
IS 3
AR e12991
DI 10.1111/cpr.12991
EA FEB 2021
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA QU6QX
UT WOS:000613307300001
PM 33522656
OA Green Published
DA 2024-02-19
ER

PT J
AU Baiocchi, L
   Glaser, S
   Francis, H
   Kennedy, L
   Felli, E
   Alpini, G
   Gracia-Sancho, J
AF Baiocchi, Leonardo
   Glaser, Shannon
   Francis, Heather
   Kennedy, Lindsey
   Felli, Eric
   Alpini, Gianfranco
   Gracia-Sancho, Jordi
TI Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary
   and Vascular Compartments
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article; Early Access
ID HEPATIC STELLATE CELLS; AGE-RELATED-CHANGES; CELLULAR SENESCENCE;
   FUNCTIONAL-HETEROGENEITY; SINUSOIDAL ENDOTHELIUM; LYSOPHOSPHATIDIC ACID;
   EPITHELIAL AUTOPHAGY; POSSIBLE INVOLVEMENT; PORTAL-HYPERTENSION;
   FIBROSIS
AB The aging process is represented by the time-dependent decay in physiologic functions of living beings. Major interest has been focused in recent years on the determinants of this progressive condition due to its correlative relationship with the onset of diseases. Several hallmark features have been observed in aging, such as genetic alterations, mitochondrial impairment, and telomere shortening. At the cellular level, a senescent phenotype has been identified in response to aging that is characterized by a flat appearance, proliferative arrest, and production of specific molecules. The net effect of these cells in the course of diseases is an argument of debate. In fact, while the onset of a senescent phenotype may prevent tumor spreading, these cells appear to support pathological processes in some conditions. Several studies are now focused on clarifying the specific molecular pathways of aging/senescence in different cells, tissues, or organs. Biliary and vascular components, within the liver, have emerged as important determinants of some form of liver disease. In this review we summarize the most recent achievements on aging/senescence, focusing on the biliary and vascular liver system. Conclusion: Several findings, in both preclinical animal models and on human liver specimens, converge in supporting the presence of specific aging hallmarks in the diseases involving these hepatic compartments.
C1 [Baiocchi, Leonardo] Univ Tor Vergata, Dept Med, Hepatol Unit, Rome, Italy.
   [Glaser, Shannon] Texas A&M Coll Med, Med Physiol, Bryan, TX USA.
   [Francis, Heather; Kennedy, Lindsey; Alpini, Gianfranco] Indiana Univ, Hepatol & Med, Indianapolis, IN 46204 USA.
   [Francis, Heather; Kennedy, Lindsey; Gracia-Sancho, Jordi] Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.
   [Gracia-Sancho, Jordi] IDIBAPS Biomed Res Inst, Liver Vasc Biol, Barcelona, Spain.
   [Gracia-Sancho, Jordi] CIBEREHD, Barcelona, Spain.
   [Felli, Eric; Gracia-Sancho, Jordi] Inselspital Bern, Dept Biomed Res, Hepatol, Bern, Switzerland.
C3 University of Rome Tor Vergata; Texas A&M University System; Texas A&M
   University College Station; Texas A&M Health Science Center; Indiana
   University System; Indiana University-Purdue University Indianapolis; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center; University of Barcelona;
   Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion
   Biomedica en Red; CIBEREHD; University of Bern; University Hospital of
   Bern
RP Gracia-Sancho, J (corresponding author), Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.; Alpini, G (corresponding author), Indiana Univ, Indianapolis, IN 46202 USA.; Gracia-Sancho, J (corresponding author), IDIBAPS Biomed Res Inst, Rossello 149, Barcelona 08036, Spain.
EM galpini@iu.edu; jordi.gracia@idibaps.org
RI FELLI, ERIC/AAK-2912-2020; Felli, Eric/ADT-9709-2022; Gracia-Sancho,
   Jordi/C-8920-2014
OI FELLI, ERIC/0000-0002-5664-6746; Gracia-Sancho,
   Jordi/0000-0001-7736-4089; Kennedy, Lindsey/0000-0001-9224-8940
FU PSC Partners Seeking a Cure; Swiss National Science Foundation
   [SNF320030_189252/1]; Indiana University Health (Hickam Endowed Chair,
   Gastroenterology, Medicine); National Institute of Diabetes and
   Digestive and Kidney Diseases [DK076898, DK107310, DK108959, DK110035,
   DK115184, DK119421]; United States Department of Veteran's Affairs,
   Biomedical Laboratory Research and Development Service [1I01BX003031,
   5I01BX000574]; Instituto de Salud Carlos III/Spanish Ministry of Science
   [FIS PI20/00220]
FX Supported by PSC Partners Seeking a Cure, the Swiss National Science
   Foundation (SNF320030_189252/1), Indiana University Health (Hickam
   Endowed Chair, Gastroenterology, Medicine), National Institute of
   Diabetes and Digestive and Kidney Diseases (DK076898, DK107310,
   DK108959, DK110035, DK115184, and DK119421), United States Department of
   Veteran's Affairs, Biomedical Laboratory Research and Development
   Service (1I01BX003031, 5I01BX000574, Research Career Scientist, Senior
   Research Career Scientist), and Instituto de Salud Carlos III/Spanish
   Ministry of Science (FIS PI20/00220).
CR Ahadi S, 2020, NAT MED, V26, P83, DOI 10.1038/s41591-019-0719-5
   ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   Alvaro D, 2006, WORLD J GASTROENTERO, V12, P3537, DOI 10.3748/wjg.v12.i22.3537
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Charlton M, 2003, LIVER TRANSPLANT, V9, P535
   Cheluvappa R, 2007, EXP GERONTOL, V42, P1012, DOI 10.1016/j.exger.2007.06.001
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   de Vries E, 2017, LIVER INT, V37, P123, DOI 10.1111/liv.13306
   DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351
   DeLeve LD, 2017, SEMIN LIVER DIS, V37, P377, DOI 10.1055/s-0037-1617455
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Durand F, 2019, J HEPATOL, V70, P745, DOI 10.1016/j.jhep.2018.12.009
   Dyson JK, 2018, LANCET, V391, P2547, DOI 10.1016/S0140-6736(18)30300-3
   Ellison-Hughes GM, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2019.09.053
   Fabris L, 2008, HEPATOLOGY, V47, P719, DOI 10.1002/hep.22015
   Gaudio E., 2005, Italian Journal of Anatomy and Embryology, V110, P71
   Gaudio E, 1996, GASTROENTEROLOGY, V111, P1118, DOI 10.1016/S0016-5085(96)70081-1
   Gaudio E, 2006, AM J PHYSIOL-GASTR L, V291, pG307, DOI 10.1152/ajpgi.00507.2005
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010
   Gracia-Sancho J, 2019, NAT REV GASTRO HEPAT, V16, P221, DOI 10.1038/s41575-018-0097-3
   Grosse Laurent, 2020, Cell Metab, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Grosse L, 2020, AGING-US, V12, P11152, DOI 10.18632/aging.103492
   Hall Chad, 2017, Gene Expression, V17, P155, DOI 10.3727/105221616X692568
   Han YY, 2013, EXP BIOL MED, V238, P549, DOI 10.1177/1535370213489926
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hide D, 2020, J GERONTOL A-BIOL, V75, P268, DOI 10.1093/gerona/glz012
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ikeda H, 1998, BIOCHEM BIOPH RES CO, V248, P436, DOI 10.1006/bbrc.1998.8983
   Isaev NK, 2019, REV NEUROSCIENCE, V30, P573, DOI 10.1515/revneuro-2018-0084
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Kaffe E, 2017, HEPATOLOGY, V65, P1369, DOI 10.1002/hep.28973
   Kanno N, 2000, HEPATOLOGY, V31, P555, DOI 10.1002/hep.510310302
   KARDON RH, 1980, GASTROENTEROLOGY, V79, P72
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326
   Kundu D, 2020, GENE EXPRESSION, V20, P77, DOI 10.3727/105221620X15960509906371
   Kyritsi K, 2020, GENE EXPRESSION, V20, P89, DOI 10.3727/105221620X15889714507961
   Lakshminarayanan B, 2016, J AUTOIMMUN, V73, P1, DOI 10.1016/j.jaut.2016.06.005
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201
   Lleo A, 2020, LANCET, V396, P1915, DOI 10.1016/S0140-6736(20)31607-X
   Loarca L, 2017, LAB INVEST, V97, P1385, DOI 10.1038/labinvest.2017.63
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098
   Maeso-Díaz R, 2019, AGING DIS, V10, P684, DOI 10.14336/AD.2019.0127
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Maroni L, 2019, HEPATOLOGY, V70, P883, DOI 10.1002/hep.30466
   Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018
   Marrone G, 2013, J HEPATOL, V58, P98, DOI 10.1016/j.jhep.2012.08.026
   McCay, 1975, NUTR REV, V33, p241
   McDaniel K, 2017, HEPATOLOGY, V65, P544, DOI 10.1002/hep.28831
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Meadows V, 2019, BBA-MOL BASIS DIS, V1865, DOI 10.1016/j.bbadis.2019.165557
   Meng FY, 2014, AM J PHYSIOL-GASTR L, V306, pG759, DOI 10.1152/ajpgi.00018.2014
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   O'Hara SP, 2019, J BIOL CHEM, V294, P18698, DOI 10.1074/jbc.RA119.010176
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   OHARA S, 2017, HEPATOLOGY, V66, P318, DOI DOI 10.1002/hep.29243
   Pinzani M, 1999, SEMIN LIVER DIS, V19, P397, DOI 10.1055/s-2007-1007128
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2020, J AUTOIMMUN, V107, DOI 10.1016/j.jaut.2019.102377
   Sasaki M, 2018, HISTOPATHOLOGY, V72, P1164, DOI 10.1111/his.13476
   Sasaki M, 2015, J GASTROENTEROL, V50, P984, DOI 10.1007/s00535-014-1033-0
   Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6
   Sasaki M, 2012, LIVER INT, V32, P487, DOI 10.1111/j.1478-3231.2011.02656.x
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y
   Simon-Santamaria J, 2010, J GERONTOL A-BIOL, V65, P951, DOI 10.1093/gerona/glq108
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Wan Y, 2019, LAB INVEST, V99, P764, DOI 10.1038/s41374-018-0178-5
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   Wen YK, 2021, CELL MOL IMMUNOL, V18, P45, DOI 10.1038/s41423-020-00558-8
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432
   Wu N, 2020, HEPATOLOGY, V72, P2219, DOI 10.1002/hep.31484
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yanase M, 2000, BIOCHEM BIOPH RES CO, V277, P72, DOI 10.1006/bbrc.2000.3634
   Zhou TH, 2019, EBIOMEDICINE, V48, P130, DOI 10.1016/j.ebiom.2019.09.013
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 99
TC 14
Z9 15
U1 0
U2 9
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD 2021 JUL 21
PY 2021
VL 5
IS 7
BP 1125
EP 1137
DI 10.1002/hep4.1725
EA APR 2021
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA A4DP9
UT WOS:000638684900001
PM 34278165
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, S
   Duan, JJ
   Du, Y
   Xie, JL
   Zhang, HJ
   Li, CY
   Zhang, WS
AF Zhang, Shuai
   Duan, Juanjuan
   Du, Yu
   Xie, Jinlu
   Zhang, Haijing
   Li, Changyu
   Zhang, Wensheng
TI Long Non-coding RNA Signatures Associated With Liver Aging in
   Senescence-Accelerated Mouse Prone 8 Model
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE long non-coding RNA; liver aging; senescence-accelerated mouse prone 8;
   senescence-accelerated mouse resistant 1; RNA sequencing
ID EXPRESSION; TRANSCRIPTS; METABOLISM; ACTIVATION; DISEASE
AB The liver is sensitive to aging because the risk of hepatopathy, including fatty liver, hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, increases dramatically with age. Long non-coding RNAs (lncRNAs) are >200 nucleotides long and affect many pathological and physiological processes. A potential link was recently discovered between lncRNAs and liver aging; however, comprehensive and systematic research on this topic is still limited. In this study, the mouse liver genome-wide lncRNA profiles of 8-month-old SAMP8 and SAMR1 models were explored through deep RNA sequencing. A total of 605,801,688 clean reads were generated. Among the 2,182 identified lncRNAs, 28 were differentially expressed between SAMP8 and SAMR1 mice. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) surveys showed that these substantially dysregulated lncRNAs participated in liver aging from different aspects, such as lipid catabolic (GO: 0016042) and metabolic pathways. Further assessment was conducted on lncRNAs that are most likely to be involved in liver aging and related diseases, such as LNC_000027, LNC_000204E, NSMUST00000144661.1, and ENSMUST00000181906.1 acted on Ces1g. This study provided the first comprehensive dissection of lncRNA landscape in SAMP8 mouse liver. These lncRNAs could be exploited as potential targets for the molecular-based diagnosis and therapy of age-related liver diseases.
C1 [Zhang, Shuai; Du, Yu; Li, Changyu] Zhejiang Chinese Med Univ, Acad Chinese Med Sci, Int Cooperat Lab Mol Med, Hangzhou, Peoples R China.
   [Duan, Juanjuan; Zhang, Haijing; Zhang, Wensheng] Beijing Normal Univ Zhuhai, Adv Inst Nat Sci, Zhuhai Branch, State Key Lab Earth Surface Proc & Resource Ecolo, Zhuhai, Peoples R China.
   [Duan, Juanjuan; Zhang, Haijing; Zhang, Wensheng] Beijing Normal Univ, Fac Geog Sci, Engn Res Ctr Nat Med, Minist Educ, Beijing, Peoples R China.
   [Duan, Juanjuan; Zhang, Haijing; Zhang, Wensheng] Beijing Normal Univ, Fac Geog Sci, Beijing Key Lab Tradit Chinese Med Protect & Util, Beijing, Peoples R China.
   [Xie, Jinlu] Huzhou Univ, Huzhou Cent Hosp, Key Lab Vector Biol & Pathogen Control Zhejiang, Sch Med, Huzhou, Peoples R China.
   [Zhang, Wensheng] Natl & Local United Engn Res Ctr Panax Notoginsen, Kunming, Yunnan, Peoples R China.
C3 Zhejiang Chinese Medical University; Beijing Normal University; Beijing
   Normal University Zhuhai; Beijing Normal University; Beijing Normal
   University; Huzhou University
RP Li, CY (corresponding author), Zhejiang Chinese Med Univ, Acad Chinese Med Sci, Int Cooperat Lab Mol Med, Hangzhou, Peoples R China.; Zhang, WS (corresponding author), Beijing Normal Univ Zhuhai, Adv Inst Nat Sci, Zhuhai Branch, State Key Lab Earth Surface Proc & Resource Ecolo, Zhuhai, Peoples R China.; Zhang, WS (corresponding author), Beijing Normal Univ, Fac Geog Sci, Engn Res Ctr Nat Med, Minist Educ, Beijing, Peoples R China.; Zhang, WS (corresponding author), Beijing Normal Univ, Fac Geog Sci, Beijing Key Lab Tradit Chinese Med Protect & Util, Beijing, Peoples R China.; Zhang, WS (corresponding author), Natl & Local United Engn Res Ctr Panax Notoginsen, Kunming, Yunnan, Peoples R China.
EM lm159@sina.com; zwslab@126.com
FU National Natural Science Foundation of China [81771152]; National Key
   Research and Development Plan of China [2017YFC1702500]; Zhejiang
   Chinese Medical University Research Funding [111100E017/005/007/002]
FX This work was supported by the National Natural Science Foundation of
   China (81771152), the National Key Research and Development Plan of
   China (2017YFC1702500), and the Zhejiang Chinese Medical University
   Research Funding (111100E017/005/007/002).
CR Allison DB, 2020, CHRONOBIOL INT, V37, P1119, DOI 10.1080/07420528.2020.1796699
   Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641
   Bahitham W, 2016, BBA-MOL CELL BIOL L, V1861, P482, DOI 10.1016/j.bbalip.2016.03.009
   Chen FC, 2014, EVOL BIOINFORM, V10, P219, DOI 10.4137/EBO.S20772
   Chen XC, 2018, BMB REP, V51, P280, DOI 10.5483/BMBRep.2018.51.6.025
   Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625
   Conlon DM, 2019, CURR OPIN LIPIDOL, V30, P198, DOI 10.1097/MOL.0000000000000598
   Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111
   Gil N, 2020, NAT REV GENET, V21, P102, DOI 10.1038/s41576-019-0184-5
   Gong CX, 2015, CHRONOBIOL INT, V32, P1254, DOI 10.3109/07420528.2015.1085388
   Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428
   Guo Minglei, 2009, Adv Stud Biol, V1, P61
   He Jieyu, 2018, Aging Med (Milton), V1, P158, DOI 10.1002/agm2.12030
   Hu SJ, 2019, WORLD J CLIN CASES, V7, P691, DOI 10.12998/wjcc.v7.i6.691
   Hu Y, 2019, EUR REV MED PHARMACO, V23, P10072, DOI 10.26355/eurrev_201911_19575
   Huan L, 2016, CANCER SCI, V107, P258, DOI 10.1111/cas.12869
   Jathar S, 2017, ADV EXP MED BIOL, V1008, P283, DOI 10.1007/978-981-10-5203-3_10
   Jiang XY, 2020, MECH AGEING DEV, V188, DOI 10.1016/j.mad.2020.111243
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011, P1, DOI [DOI 10.1155/2011/859415, 10.1155/2011/859415]
   Lim JY, 2018, ARCH BIOCHEM BIOPHYS, V654, P1, DOI 10.1016/j.abb.2018.07.007
   Lim J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090137
   Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209
   Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   Mistry J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-298
   National Institutes of Health, 2016, WORLDS OLD POP GROWS
   National Research Council, 2011, GUIDE CARE USE LAB A, DOI DOI 10.17226/12910
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   Ren HX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2365-3
   Rio DC., 2010, COLD SPRING HARBOR P, V6
   Romeo S, 2016, HEPATOLOGY, V64, P1414, DOI 10.1002/hep.28722
   Seiler J, 2017, NUCLEIC ACIDS RES, V45, P5458, DOI 10.1093/nar/gkx076
   Shahryari A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00196
   Shiota G., 2017, LIVER PATHOPHYSIOLOG, V1st ed., P705
   Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Singh U, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx866
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9
   Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563
   Sun FK, 2017, HEPATOL RES, V47, P566, DOI 10.1111/hepr.12777
   Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646
   Sun P, 2018, HEPATOLOGY, V68, P2212, DOI 10.1002/hep.30075
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Wang JH, 2016, ONCOTARGET, V7, P26949, DOI 10.18632/oncotarget.8877
   Wang L, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5852494
   Wang YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20238
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Wu SR, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4891-7
   Yan PX, 2017, CURR OPIN GENET DEV, V46, P170, DOI 10.1016/j.gde.2017.07.009
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Yun SJ, 2020, J TRACE ELEM MED BIO, V57, P83, DOI 10.1016/j.jtemb.2019.126407
   Zarei M, 2018, MOL METAB, V8, P117, DOI 10.1016/j.molmet.2017.12.008
   Zhang S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.57
   Zhao Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10524-6
NR 61
TC 4
Z9 4
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD JUL 22
PY 2021
VL 9
AR 698442
DI 10.3389/fcell.2021.698442
PG 12
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA TX9VS
UT WOS:000683434200001
PM 34368149
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Nie, YZ
   Zheng, YW
   Taniguchi, H
AF Nie, Yun-Zhong
   Zheng, Yun-Wen
   Taniguchi, Hideki
TI Improving the repopulation capacity of elderly human hepatocytes by
   decoding aging-associated hepatocyte plasticity
SO HEPATOLOGY
LA English
DT Article; Early Access
ID LIVER-REGENERATION; STEM-CELLS; AGE; HOMEOSTASIS; EXPRESSION; REDUCTION;
   DISEASE; EZH2
AB Background and Aims The loss of liver regenerative capacity is the most dramatic age-associated alteration. Because of an incomplete mechanistic understanding of the liver aging process, a successful therapeutic strategy to improve liver regeneration in the elderly has not been developed so far. Hepatocyte plasticity is a principal mechanism for producing new hepatocytes and cholangiocytes during regeneration. This study aims to promote the repopulation capacity of elderly hepatocytes by decoding the underlying mechanism about the regulation of aging on human hepatocyte plasticity. Approach and Results To understand the age-related mechanisms, we established a hepatocyte aging model from human-induced pluripotent stem cells and developed a method for ex vivo characterization of hepatocyte plasticity. We found that hepatocyte plasticity was gradually diminished with aging, and the impaired plasticity was caused by age-induced histone hypoacetylation. Notably, selective inhibition of histone deacetylases could markedly restore aging-impaired plasticity. Based on these findings, we successfully improved the plasticity of elderly primary human hepatocytes that enhanced their repopulation capacity in the liver injury model. Conclusions This study suggests that age-induced histone hypoacetylation impairs hepatocyte plasticity, and hepatocyte plasticity might be a therapeutic target for promoting the regenerative capacity of the elderly liver.
C1 [Nie, Yun-Zhong; Zheng, Yun-Wen; Taniguchi, Hideki] Yokohama City Univ, Dept Regenerat Med, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan.
   [Nie, Yun-Zhong; Taniguchi, Hideki] Univ Tokyo, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci, Div Regenerat Med,Minato Ku, Tokyo, Japan.
   [Zheng, Yun-Wen] Wuyi Univ, Sch Biotechnol & Heath Sci, Guangdong Prov Key Lab Large Anim Models Biomed, Jiangmen 529020, Guangdong, Peoples R China.
   [Zheng, Yun-Wen] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Med & Life Sci, Noda, Chiba, Japan.
   [Zheng, Yun-Wen] Jiangsu Univ, Affiliated Hosp, Inst Regenerat Med, Zhenjiang, Jiangsu, Peoples R China.
   [Zheng, Yun-Wen] Univ Tsukuba, Fac Med, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Tsukuba, Ibaraki, Japan.
   [Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Grad Sch Med, Yokohama, Kanagawa, Japan.
C3 Yokohama City University; University of Tokyo; Wuyi University; Tokyo
   University of Science; Jiangsu University; University of Tsukuba;
   Yokohama City University
RP Taniguchi, H (corresponding author), Yokohama City Univ, Dept Regenerat Med, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan.; Zheng, YW (corresponding author), Wuyi Univ, Sch Biotechnol & Heath Sci, Guangdong Prov Key Lab Large Anim Models Biomed, Jiangmen 529020, Guangdong, Peoples R China.
EM zheng.yunwen.ld@alumni.tsukuba.ac.jp; rtanigu@med.yokohama-cu.ac.jp
RI wang, KiKi/JFZ-3334-2023
FU JST Research Center Network for Realization of Regenerative Medicine
   [17bm0304002h0105]; Japan Agency for Medical Research and Development
   [17fk0310103j0001]; Japan Society for the Promotion of Science KAKENHI
   [18H02866, 18F18101, 20K22946]; Fund for the Promotion of Joint
   International Research (Fostering Joint International Research)
   [18KK0252]; JSPS International Fellowships for Research in Japan
   [P18101]; Grants-in-Aid for Scientific Research [20K22946, 18F18101]
   Funding Source: KAKEN; Austrian Science Fund (FWF) [P18101] Funding
   Source: Austrian Science Fund (FWF)
FX Supported by JST Research Center Network for Realization of Regenerative
   Medicine (17bm0304002h0105); Japan Agency for Medical Research and
   Development (17fk0310103j0001); Japan Society for the Promotion of
   Science KAKENHI (Grant--in--Aid for Scientific Research 18H02866,
   Grant--in--Aid for a JSPS Research Fellow 18F18101, Grant-in--Aid for
   Research Activity Start--up 20K22946); Fund for the Promotion of Joint
   International Research (Fostering Joint International Research
   18KK0252); and JSPS International Fellowships for Research in Japan
   (P18101)
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Chaurasia P, 2014, J CLIN INVEST, V124, P2378, DOI 10.1172/JCI70313
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Durand F, 2019, J HEPATOL, V70, P745, DOI 10.1016/j.jhep.2018.12.009
   Federation AJ, 2014, TRENDS CELL BIOL, V24, P179, DOI 10.1016/j.tcb.2013.09.011
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Germani G, 2012, J HEPATOL, V57, P288, DOI 10.1016/j.jhep.2012.03.017
   Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528
   Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109
   Katsuda T, 2019, ELIFE, V8, DOI 10.7554/eLife.47313
   Katsuda T, 2017, CELL STEM CELL, V20, P41, DOI 10.1016/j.stem.2016.10.007
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim J, 2018, CELL REP, V25, P2808, DOI 10.1016/j.celrep.2018.11.035
   Kopp JL, 2016, NAT CELL BIOL, V18, P238, DOI 10.1038/ncb3309
   Li D, 2016, HEPATOLOGY, V64, P1105, DOI [10.1002/hep.28637, 10.1002/hep.28837]
   Lian R, 2018, MOL CELL BIOCHEM, V439, P35, DOI 10.1007/s11010-017-3133-7
   Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006
   Nie YZ, 2018, EBIOMEDICINE, V35, P114, DOI 10.1016/j.ebiom.2018.08.014
   Nie YZ, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0749-1
   Ono Y, 2011, SURGERY, V150, P154, DOI 10.1016/j.surg.2011.05.004
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   SAWADA N, 1989, EXP CELL RES, V181, P584, DOI 10.1016/0014-4827(89)90115-8
   Sebastián C, 2017, TRENDS ENDOCRIN MET, V28, P85, DOI 10.1016/j.tem.2016.11.001
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499
   Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019
   Uemura T, 2007, LIVER TRANSPLANT, V13, P227, DOI 10.1002/lt.20992
   Vera E, 2016, CELL REP, V17, P1184, DOI 10.1016/j.celrep.2016.09.062
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
   Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112
NR 39
TC 4
Z9 4
U1 2
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2022 OCT
PY 2022
VL 76
IS 4
BP 1030
EP 1045
DI 10.1002/hep.32443
EA APR 2022
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 4P1FP
UT WOS:000776734900001
PM 35243665
DA 2024-02-19
ER

PT J
AU Yang, SQ
   Koteish, A
   Lin, HZ
   Huang, JW
   Roskams, T
   Dawson, V
   Diehl, AM
AF Yang, SQ
   Koteish, A
   Lin, HZ
   Huang, JW
   Roskams, T
   Dawson, V
   Diehl, AM
TI Oval cells compensate for damage and replicative senescence of mature
   hepatocytes in mice with fatty liver disease
SO HEPATOLOGY
LA English
DT Article
ID HEPATIC PROGENITOR CELLS; OXIDATIVE DNA-DAMAGE; AMINOTRANSFERASE LEVELS;
   OB/OB MICE; RAT-LIVER; IN-VITRO; REGENERATION; INJURY; EXPRESSION;
   APOPTOSIS
AB Hepatic steatosis may have a generally benign prognosis, either because most hepatocytes are not significantly injured or mechanisms to replace damaged hepatocytes are induced. To determine the relative importance of these mechanisms, we compared hepatocyte damage and replication in ethanol-fed and ob/ob mice with very indolent fatty liver disease to that of healthy control mice and PARP-1(-1-) mice with targeted disruption of the DNA repair enzyme, poly(ADP-ribose) polymerase. Compared to the healthy controls, both groups with fatty livers had significantly higher serum alanine aminotransferase values, hepatic mitochondrial H2O2 production, and hepatocyte oxidative DNA damage. A significantly smaller proportion of the hepatocytes from fatty livers entered S phase when cultured with mitogens. Moreover, this replicative senescence was not reversed by treating cultured hepatocytes with agents (i.e., betaine or leptin) that improve liver disease in intact ethanol-fed or leptin-deficient mice. Hepatocytes from PARP1(-/-) mice also had more DNA damage and reduced DNA synthesis in response to mitogens. However, neither mice with fatty livers nor PARP-1-deficient mice had atrophic livers. All of the mice with senescent mature hepatocytes exhibited hepatic accumulation of liver progenitor (oval) cells and oval cell numbers increased with the demand for hepatocyte replacement. Therefore, although hepatic oxidant production and damage are generally increased in fatty livers, expansion of hepatic progenitor cell populations helps to compensate for the increased turnover of damaged mature hepatocytes. In conclusion, these results demonstrate that induction of mechanisms to replace damaged hepatocytes is important for limiting the progression of fatty liver disease.
C1 Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA.
   Univ Louvain, Dept Morphol & Mol Pathol & Hepatol, Louvain, Belgium.
   Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA.
C3 Johns Hopkins University; Johns Hopkins University
RP Diehl, AM (corresponding author), Johns Hopkins Univ, Dept Med, 912 Ross Bldg,720 Rutland St, Baltimore, MD 21205 USA.
EM amdiehl@jhmi.edu
RI Dawson, Valina/Y-9757-2019
OI Dawson, Valina/0000-0002-2915-3970; Roskams, Tania/0000-0002-2816-1530
FU NIAAA NIH HHS [R01 AA10154, R01 AA/DK12059] Funding Source: Medline;
   NIDDK NIH HHS [R01 DK53792] Funding Source: Medline
CR Barak AJ, 1997, ALCOHOL CLIN EXP RES, V21, P1100, DOI 10.1111/j.1530-0277.1997.tb04259.x
   Barak AJ, 2001, ALCOHOL, V25, P77, DOI 10.1016/S0741-8329(01)00168-9
   Berry MN, 2000, BIOCHEM SOC T, V28, P131, DOI 10.1042/bst0280131
   BIZZARO N, 1992, ITAL J GASTROENTEROL, V24, P237
   Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3
   Campfield LA, 1996, HORM METAB RES, V28, P619, DOI 10.1055/s-2007-979867
   Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]
   Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Epe B, 2002, BIOL CHEM, V383, P467, DOI 10.1515/BC.2002.049
   Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7
   Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564
   GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825
   Gordon GJ, 2000, AM J PATHOL, V156, P607, DOI 10.1016/S0002-9440(10)64765-7
   Haque S, 1996, LAB INVEST, V75, P699
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Kanbak G, 2001, CELL BIOCHEM FUNCT, V19, P281, DOI 10.1002/cbf.926
   Koteish A, 2002, ALCOHOL CLIN EXP RES, V26, P1710, DOI 10.1097/01.ALC.0000036923.77613.59
   Latif Christine, 2001, TheScientificWorldJOURNAL, V1, P684
   Leclercq IA, 2003, GASTROENTEROLOGY, V124, P1451, DOI 10.1016/S0016-5085(03)00270-1
   Libbrecht L, 2000, J PATHOL, V192, P373, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH700&gt;3.0.CO;2-5
   Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6
   Mandache E, 2002, J CELL MOL MED, V6, P59, DOI 10.1111/j.1582-4934.2002.tb00311.x
   Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361
   NOMURA H, 1988, JPN J MED, V27, P142, DOI 10.2169/internalmedicine1962.27.142
   Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367
   Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5
   Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2
   Rashid A, 1999, HEPATOLOGY, V29, P1131, DOI 10.1002/hep.510290428
   Rickwood D., 1987, Mitochondria: a pratical approach, P1
   Roskams T, 1998, J HEPATOL, V29, P455, DOI 10.1016/S0168-8278(98)80065-2
   Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029
   Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9
   Sell S, 1998, HEPATOLOGY, V27, P317, DOI 10.1002/hep.510270202
   Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900
   Sell S, 2001, WOUND REPAIR REGEN, V9, P467, DOI 10.1046/j.1524-475x.2001.00467.x
   Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797
   Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2
   Sozou PD, 2001, J THEOR BIOL, V213, P573, DOI 10.1006/jtbi.2001.2432
   Takezawa T, 2000, TISSUE ENG, V6, P641, DOI 10.1089/10763270050199587
   Tenzer A., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P35, DOI 10.2174/1568011033353533
   Tian YW, 1997, HISTOCHEM CELL BIOL, V107, P243, DOI 10.1007/s004180050109
   Toussaint O, 2002, INT J BIOCHEM CELL B, V34, P1415, DOI 10.1016/S1357-2725(02)00034-1
   Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev
   Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003
   Yang SQ, 2000, ARCH BIOCHEM BIOPHYS, V378, P259, DOI 10.1006/abbi.2000.1829
   Yang SQ, 2001, HEPATOLOGY, V34, P694, DOI 10.1053/jhep.2001.28054
   Yegorov YE, 2003, FEBS LETT, V541, P6, DOI 10.1016/S0014-5793(03)00298-9
NR 48
TC 124
Z9 128
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD FEB
PY 2004
VL 39
IS 2
BP 403
EP 411
DI 10.1002/hep.20082
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 805OM
UT WOS:000220375600019
PM 14767993
OA Bronze
DA 2024-02-19
ER

PT J
AU Li, YY
   Chen, YG
   Kuang, JJ
   Deng, SL
   Wang, YA
AF Li, Yayong
   Chen, Yuanguo
   Kuang, Jingjie
   Deng, Silei
   Wang, Yina
TI Intermittent hypoxia induces hepatic senescence through promoting
   oxidative stress in a mouse model
SO SLEEP AND BREATHING
LA English
DT Article; Early Access
DE Obstructive sleep apnea; Intermittent hypoxia; Senescence; Antioxidant
ID OBSTRUCTIVE SLEEP-APNEA; FATTY LIVER-DISEASE; ASSOCIATION; INJURY; RATS
AB PurposeMetabolic-associated fatty liver disease (MAFLD) is an aging-related disease. Obstructive sleep apnea (OSA) may cause MAFLD. This study aimed to explore whether or not intermittent hypoxia (IH), the hallmark of OSA, induces liver aging through oxidative stress.MethodsC57BL/6J male mice were administered normal air (control), IH, or antioxidant tempol + IH daily for 6 weeks before the collection of serum and liver tissue samples. A histological examination was conducted to assess liver aging. ELISA was performed to measure liver function indicator levels in the serum and oxidative stress indicator activities in the liver. Western blot analysis was carried out to determine the protein expression of the markers related to oxidative stress, inflammation, and senescence.ResultsCompared with control, IH resulted in significant increases in serum ALT, AST, and TG levels in mice (all P < 0.001), along with lobular inflammation and accumulation of collagen and fat in the liver. The protein levels of inflammatory factors and senescent markers were significantly increased in the IH mouse liver compared with those in the control mouse liver. Meanwhile, IH significantly reduced SOD and CAT activities while enhancing p22(phox) and Nrf2 protein expression in mouse liver compared with control. Importantly, antioxidant therapy with tempol effectively abrogated the effects of IH on oxidative stress response and aging-related liver injury.ConclusionsOur findings suggest that IH induces liver inflammation and aging through oxidative stress. OSA may exacerbate target organ aging and participate in target organ damage. Strategies targeting oxidative stress may prevent and treat OSA-related MAFLD.
C1 [Li, Yayong; Chen, Yuanguo] Cent South Univ, Dept Emergency, Xiangya Hosp 3, Changsha, Peoples R China.
   [Kuang, Jingjie; Deng, Silei; Wang, Yina] Cent South Univ, Dept Geriatr, Xiangya Hosp 2, Changsha, Peoples R China.
C3 Central South University; Central South University
RP Wang, YA (corresponding author), Cent South Univ, Dept Geriatr, Xiangya Hosp 2, Changsha, Peoples R China.
EM wangyina@csu.edu.cn
RI wu, yi/JEP-1581-2023; Zhang, Xiaoyu/JXR-6386-2024; Chen,
   Liang/JXX-7887-2024; Wang, Yuchen/JPW-9345-2023; he, xi/JXN-3817-2024;
   xu, chen/JNE-5010-2023; Li, Kexin/KAO-2519-2024; chen,
   yanhong/JVE-0289-2024; xiang, wei/JXL-3308-2024
FU National Natural Science Foundation of China [81100059]; Natural
   Scientific Fund of Hunan Province [2020JJ4812, 2021JJ31013]; Science and
   Technology Innovation Project of Hunan Province [2018SK52505,
   2020SK53603]; Popular Science Project of Hunan Province in China
   [2021ZK4178]
FX Funding for this study was provided by several organizations, including
   the National Natural Science Foundation of China (Grant No. 81100059),
   the Natural Scientific Fund of Hunan Province (Grant Nos. 2020JJ4812 and
   2021JJ31013), the Science and Technology Innovation Project of Hunan
   Province (Grant Nos. 2018SK52505 and 2020SK53603), and the Popular
   Science Project of Hunan Province (Grant No. 2021ZK4178) in China.
CR Alique M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010195
   Bellezza I, 2018, BBA-MOL CELL RES, V1865, P721, DOI 10.1016/j.bbamcr.2018.02.010
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Braud L, 2017, J NUTR BIOCHEM, V40, P95, DOI 10.1016/j.jnutbio.2016.10.012
   Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726
   Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
   Cotter TG, 2020, GASTROENTEROLOGY, V158, P1851, DOI 10.1053/j.gastro.2020.01.052
   da Rosa DP, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/879419
   Dal S, 2016, EXP BIOL MED, V241, P184, DOI 10.1177/1535370215603837
   Détrait M, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14738
   Ferini-Strambi L, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0451-8
   Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556
   Foglia B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071764
   Guo HJ, 2015, SLEEP BREATH, V19, P969, DOI 10.1007/s11325-015-1128-8
   Huang JF, 2023, NAT SCI SLEEP, V15, P49, DOI 10.2147/NSS.S398971
   Huang MH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.01.44
   Jorquera G., 2022, LIVERS, V2, P116, DOI [10.3390/livers2030010, DOI 10.3390/LIVERS2030010]
   Khalyfa A, 2021, EBIOMEDICINE, V64, DOI 10.1016/j.ebiom.2021.103208
   Kim KS, 2016, AGING DIS, V7, P604, DOI 10.14336/AD.2016.0215
   Koritala BSC, 2021, GENES-BASEL, V12, DOI 10.3390/genes12101627
   Lacedonia D, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0205-7
   Lee SY, 2021, EXP MOL MED, V53, P591, DOI 10.1038/s12276-021-00594-y
   Li L, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0727-x
   Li YY, 2021, AGING DIS, V12, P586, DOI 10.14336/AD.2020.0723
   Luo YF, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23095209
   Mesarwi OA, 2021, AM J RESP CELL MOL, V65, P390, DOI 10.1165/rcmb.2020-0492OC
   Mesarwi OA, 2019, AM J RESP CRIT CARE, V199, P830, DOI 10.1164/rccm.201806-1109TR
   Nanduri J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119762
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Polonis K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63761-7
   Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011
   Regulski MJ, 2017, WOUNDS, V29, P168
   Ren J, 2019, SLEEP BREATH, V23, P825, DOI 10.1007/s11325-018-1741-4
   Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007
   Savransky V, 2009, EXP PHYSIOL, V94, P228, DOI 10.1113/expphysiol.2008.044883
   Tomar A, 2021, J FAM MED PRIM CARE, V10, P3105, DOI 10.4103/jfmpc.jfmpc_412_21
   Trzepizur W, 2018, METABOLISM, V84, P44, DOI 10.1016/j.metabol.2017.11.008
   Xie JY, 2017, IRAN J PUBLIC HEALTH, V46, P1502
   Yang JCZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040872
   Yeo EJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0233-3
   Zhang Jing, 2012, Front Neurol, V3, P179, DOI 10.3389/fneur.2012.00179
NR 41
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1520-9512
EI 1522-1709
J9 SLEEP BREATH
JI Sleep Breath.
PD 2023 JUL 15
PY 2023
DI 10.1007/s11325-023-02878-1
EA JUL 2023
PG 9
WC Clinical Neurology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Respiratory System
GA M3GQ3
UT WOS:001029100300002
PM 37453998
DA 2024-02-19
ER

PT J
AU Sersté, T
   Bourgeois, N
AF Serste, Thomas
   Bourgeois, Nadine
TI Ageing and the liver
SO ACTA GASTRO-ENTEROLOGICA BELGICA
LA English
DT Article; Proceedings Paper
CT Meeting of the Societe-Royal-Belge-de-Gastro-Enterologies
CY OCT 07-08, 2005
CL Brussels, BELGIUM
SP Soc Royal Belge Gasatro Enterol
ID CHRONIC HEPATITIS-C; DONOR AGE; FIBROSIS PROGRESSION; RAT-LIVER;
   TRANSPLANT RECIPIENTS; VIRAL-HEPATITIS; SURVIVAL; CAPACITY; DISEASE;
   VOLUME
AB Age does not spare the liver. We reviewed here the essential actual knowledge about age related modifications of this organ. Liver volume and blood flow decrease with age. Aging is also associated with a decline in the intrinsic metabolic activity of the hepatic parenchyma, and in the gene expression of proteins involved in intermediary metabolism, mitochondrial respiration and drug metabolism. Aged hepatocytes accumulate oxydative DNA damage, responsible for the increase in mutations, particularly in the mitochondrial genome. Histologically, aged hepatocytes are characterized by accumulation of ageing pigments into the cytoplasm and by pseudocapillarization of the sinusoid. Age is also of importance at the time of HCV infection : fibrosis progression is faster when the virus is acquired after 40 years. In liver transplantation, an old transplanted liver is now an identified cause of primary non-function of the graft and an independent cause of mortality after transplantation. The age of the donor is also a predictive factor of the severity of recurrent liver HCV-related disease on the graft.
C1 Erasme Univ Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium.
C3 Universite Libre de Bruxelles
RP Sersté, T (corresponding author), Erasme Univ Hosp, Dept Gastroenterol, Route Lennik 808, B-1070 Brussels, Belgium.
EM thomas.serste@skynet.be
CR Berenguer M, 2005, ACTA GASTRO-ENT BELG, V68, P337
   Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   Feng S, 2005, AM J TRANSPLANT, V5, P425, DOI 10.1111/j.1600-6143.2005.00787.x
   Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Kim WR, 2004, GASTROENTEROLOGY, V127, P749, DOI 10.1053/j.gastro.2004.06.052
   Lake JR, 2005, AM J TRANSPLANT, V5, P549, DOI 10.1111/j.1600-6143.2005.00741.x
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Machicao VI, 2004, TRANSPLANTATION, V77, P84, DOI 10.1097/01.TP.0000095896.07048.BB
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Rifai K, 2004, J HEPATOL, V41, P446, DOI 10.1016/j.jhep.2004.05.013
   SCHMUCKER DL, 1990, EXP GERONTOL, V25, P403, DOI 10.1016/0531-5565(90)90029-2
   Szczesny B, 2003, P NATL ACAD SCI USA, V100, P10670, DOI 10.1073/pnas.1932854100
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
NR 20
TC 35
Z9 37
U1 0
U2 3
PU ACTA MEDICAL BELGICA
PI BRUSSELS
PA AVENUE CIRCULAIRE 138 A, B-1180 BRUSSELS, BELGIUM
SN 0001-5644
J9 ACTA GASTRO-ENT BELG
JI Acta Gastro-Enterol. Belg.
PD JUL-SEP
PY 2006
VL 69
IS 3
BP 296
EP 298
PG 3
WC Gastroenterology & Hepatology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 115NH
UT WOS:000242740500007
PM 17168126
DA 2024-02-19
ER

PT J
AU Maya-Mendoza, A
   Hernández-Muñoz, R
   Gariglio, P
   Aranda-Anzaldo, A
AF Maya-Mendoza, A
   Hernández-Muñoz, R
   Gariglio, P
   Aranda-Anzaldo, A
TI Natural ageing in the rat liver correlates with progressive
   stabilisation of DNA-nuclear matrix interactions and withdrawal of genes
   from the nuclear substructure
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE cell differentiation; cell proliferation; cellular senescence; DNA
   loops; mammalian liver
ID HIGHER-ORDER STRUCTURE; PARTIAL-HEPATECTOMY; CHROMATIN LOOPS; EARLY G1;
   REPLICATION; CELLS; HEPATOCYTE; INTERPHASE; ARCHITECTURE; TRANSCRIPTION
AB In the interphase nucleus, the DNA of higher eukaryotes is organised in supercoiled loops anchored to a nuclear matrix (NM). Replication, transcription and splicing seem to occur at macromolecular complexes organised upon the NM. Thus, the topological relationship between genes located in the loops and the NM appears to be very important for nuclear physiology. Here, we report that natural ageing in the rat liver correlates with a progressive strengthening of the NM framework and the stabilisation of the DNA loop-NM interactions, as well as with a progressive increase in the relative distance of genes to the NM. Both phenomena correlate with the gradual loss of proliferating potential and progression towards terminal differentiation in the hepatocytes, suggesting that wholesale modifications in the topological relationships within the cell nucleus are markers of tissue ageing and senescence, at least in the mammalian liver. We discuss the possible functional implications of such structural modifications that may underlie both terminal hepatocyte differentiation and their eventual replicative senescence. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Autonoma Estado Mexico, Fac Med, Mol Biol Lab, Mexico City 50000, DF, Mexico.
   IPN, CINVESTAV, Dept Genet & Biol Mol, Mexico City 07000, DF, Mexico.
   Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular, Mexico City 04510, DF, Mexico.
C3 Universidad Autonoma del Estado de Mexico; Instituto Politecnico
   Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios
   Avanzados del Instituto Politecnico Nacional; Universidad Nacional
   Autonoma de Mexico
RP Aranda-Anzaldo, A (corresponding author), Univ Autonoma Estado Mexico, Fac Med, Mol Biol Lab, Apartado Postal 428, Mexico City 50000, DF, Mexico.
EM aaa@uaemex.mx
RI Aranda-Anzaldo, Armando/A-6513-2014
OI Aranda-Anzaldo, Armando/0000-0002-5583-5465; Maya-Mendoza,
   Apolinar/0000-0001-7452-9896
CR Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459
   Aranda-Anzaldo A, 1999, BBA-GENE STRUCT EXPR, V1446, P181, DOI 10.1016/S0167-4781(99)00086-X
   Aranda-Anzaldo A, 1998, RES VIROLOGY, V149, P195, DOI 10.1016/S0923-2516(98)80001-0
   Aranda-Anzaldo A, 1997, RES VIROLOGY, V148, P397, DOI 10.1016/S0923-2516(97)83629-1
   ARANDAANZALDO A, 1992, ARCH VIROL, V122, P317, DOI 10.1007/BF01317193
   ARANDAANZALDO A, 1992, ARCH VIROL, V124, P245, DOI 10.1007/BF01309806
   ARANDAANZALDO A, 1989, SPECULAT SCI TECHNOL, V12, P163
   Barboro P, 2003, J CELL BIOCHEM, V88, P113, DOI 10.1002/jcb.10378
   BECKER F, 1974, LIVER, P152
   BEREZNEY R, 1981, EXP CELL RES, V132, P1, DOI 10.1016/0014-4827(81)90076-8
   BEREZNEY R, 1977, J CELL BIOL, V73, P616, DOI 10.1083/jcb.73.3.616
   Berezney R, 1979, CELL NUCLEUS, V7, P413
   BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545
   Boulikas T, 1995, INT REV CYTOL, V162A, P279
   Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2
   BUONGIORNONARDELLI M, 1982, NATURE, V298, P100, DOI 10.1038/298100a0
   Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8
   CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0
   COOK PR, 1991, CELL, V66, P627, DOI 10.1016/0092-8674(91)90109-C
   COOK PR, 1980, NUCLEIC ACIDS RES, V8, P2895, DOI 10.1093/nar/8.13.2895
   Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790
   COOK PR, 1982, EMBO J, V1, P447, DOI 10.1002/j.1460-2075.1982.tb01189.x
   COOK PR, 1976, J CELL SCI, V22, P303
   Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075
   Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119
   Factor VM, 1997, HEPATOLOGY, V26, P1434
   Fausto N, 1997, AM J PATHOL, V151, P1187
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Fountoulakis M, 2002, TOXICOL APPL PHARM, V183, P71, DOI 10.1006/taap.2002.9460
   Gandillet A, 2003, COMP BIOCHEM PHYS A, V134, P665, DOI 10.1016/S1095-6433(02)00374-4
   Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426
   HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149
   Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976
   HOZAK P, 1995, J CELL SCI, V108, P635
   HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I
   Iarovaia OV, 2004, NUCLEIC ACIDS RES, V32, P2079, DOI 10.1093/nar/gkh532
   Ivanovic-Matic S, 2000, IUBMB LIFE, V49, P511, DOI 10.1080/15216540050167052
   JACK EM, 1990, HEPATOLOGY, V11, P286, DOI 10.1002/hep.1840110220
   Jackson DA, 1995, INT REV CYTOL, V162A, P125
   JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x
   Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1
   Lewin B., 1980, GENE EXPRESSION, P360
   Li F, 2001, J CELL BIOL, V154, P283, DOI 10.1083/jcb.200104043
   Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X
   MARTINEZRAMOS I, IN PRESS J CELL BIOC
   MATTA M, 1984, DU-Z KULTUR, P13
   Maya-Mendoza A, 2004, J CELL BIOCHEM, V93, P1084, DOI 10.1002/jcb.20264
   Maya-Mendoza A, 2003, NUCLEIC ACIDS RES, V31, P6168, DOI 10.1093/nar/gkg825
   Maya-Mendoza A, 2003, ANAL BIOCHEM, V313, P196, DOI 10.1016/S0003-2697(02)00611-5
   MICHALOPOULOS GK, 1997, LIVER REGENERATION S, V276, P60
   Misteli T, 2000, J CELL SCI, V113, P1841
   Nickerson JA, 2001, J CELL SCI, V114, P463
   OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   PANDURO A, 1988, HEPATOLOGY, V8, P259, DOI 10.1002/hep.1840080212
   Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6
   PIENTA KJ, 1992, MECH AGEING DEV, V62, P13, DOI 10.1016/0047-6374(92)90140-9
   PIENTA KJ, 1984, J CELL SCI, P123
   RAMANAMURTY CV, 1988, BIOCHIM BIOPHYS ACTA, V949, P27
   Razin SV, 1995, INT REV CYTOL, V162B, P405
   Razin SV, 2001, CELL MOL BIOL LETT, V6, P59
   ROBINSON SI, 1982, CELL, V28, P99, DOI 10.1016/0092-8674(82)90379-8
   ROTI JLR, 1993, ADV RADIAT BIOL, V17, P227
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SAUNDERS PT, 1995, INTRO CATASTROPHE TH, P17
   SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   SMALL D, 1985, NUCLEIC ACIDS RES, V13, P7703, DOI 10.1093/nar/13.21.7703
   SMALL D, 1985, NUCLEIC ACIDS RES, V13, P2413, DOI 10.1093/nar/13.7.2413
   SMITH CA, 1992, CELL BIOL, P81
   Stein GS, 1995, INT REV CYTOL, V162A, P251
   THOM R, 1989, STRUCTURAL STABILITY, P14
   Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024
   Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3
   Visser AE, 1999, J CELL SCI, V112, P3353
   Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103
   Wei XY, 1998, SCIENCE, V281, P1502, DOI 10.1126/science.281.5382.1502
   WHYTE LL, 1949, UNITARY PRINCIPLE PH, P17
   WOLF HK, 1992, HEPATOLOGY, V15, P707, DOI 10.1002/hep.1840150426
   Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016
NR 80
TC 20
Z9 20
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN-JUL
PY 2005
VL 126
IS 6-7
BP 767
EP 782
DI 10.1016/j.mad.2005.01.011
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 932EC
UT WOS:000229536000019
PM 15888332
DA 2024-02-19
ER

PT J
AU Wan, Y
   Meng, FY
   Wu, N
   Zhou, TH
   Venter, J
   Francis, H
   Kennedy, L
   Glaser, T
   Bernuzzi, F
   Invernizzi, P
   Glaser, S
   Huang, QB
   Alpini, G
AF Wan, Ying
   Meng, Fanyin
   Wu, Nan
   Zhou, Tianhao
   Venter, Julie
   Francis, Heather
   Kennedy, Lindsey
   Glaser, Trenton
   Bernuzzi, Francesca
   Invernizzi, Pietro
   Glaser, Shannon
   Huang, Qiaobing
   Alpini, Gianfranco
TI Substance P Increases Liver Fibrosis by Differential Changes in
   Senescence of Cholangiocytes and Hepatic Stellate Cells
SO HEPATOLOGY
LA English
DT Article
ID CELLULAR SENESCENCE; PROTECT MICE; RECEPTOR; GROWTH; PROLIFERATION;
   HETEROGENEITY; STIMULATION; ACTIVATION; INDUCTION; CANCER
AB Substance P (SP) is involved in the proliferation of cholangiocytes in bile duct-ligated (BDL) mice and human cholangiocarcinoma growth by interacting with the neurokinin-1 receptor (NK-1R). To identify whether SP regulates liver fibrosis during cholestasis, wild-type or NK-1R knockout (NK-1R(-/-)) mice that received BDL or sham surgery and multidrug resistance protein 2 knockout (Mdr2(-/-)) mice treated with either an NK-1R antagonist (L-733,060) or saline were used. Additionally, wild-type mice were treated with SP or saline intraperitoneally. In vivo, there was increased expression of tachykinin precursor 1 (coding SP) and NK-1R in both BDL and Mdr2(-/-) mice compared to wild-type mice. Expression of tachykinin precursor 1 and NK-1R was significantly higher in liver samples from primary sclerosing cholangitis patients compared to healthy controls. Knockout of NK-1R decreased BDL-induced liver fibrosis, and treatment with L-733,060 resulted in decreased liver fibrosis in Mdr2(-/-) mice, which was shown by decreased sirius red staining, fibrosis gene and protein expression, and reduced transforming growth factor-beta 1 levels in serum and cholangiocyte supernatants. Furthermore, we observed that reduced liver fibrosis in NK-1R(-/-) mice with BDL surgery or Mdr2(-/-) mice treated with L-733,060 was associated with enhanced cellular senescence of hepatic stellate cells and decreased senescence of cholangiocytes. In vitro, L-733,060 inhibited SP-induced expression of fibrotic genes in hepatic stellate cells and cholangiocytes; treatment with L-733,060 partially reversed the SP-induced decrease of senescence gene expression in cultured hepatic stellate cells and the SP-induced increase of senescencerelated gene expression in cultured cholangiocytes. Conclusion: Collectively, our results demonstrate the regulatory effects of the SP/NK-1R axis on liver fibrosis through changes in cellular senescence during cholestatic liver injury.
C1 [Wan, Ying; Meng, Fanyin; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res, Temple, TX USA.
   [Wan, Ying; Meng, Fanyin; Francis, Heather; Glaser, Trenton; Glaser, Shannon; Alpini, Gianfranco] Scott & White Mem Hosp & Clin, Baylor Scott & White Digest Dis Res Ctr, Temple, TX USA.
   [Wan, Ying; Huang, Qiaobing] Southern Med Univ, Key Lab Shock & Microcirculat Res Guangdong Prov, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China.
   [Meng, Fanyin] Baylor Scott & White Hlth, Operat Funds, Temple, TX USA.
   [Meng, Fanyin; Wu, Nan; Zhou, Tianhao; Venter, Julie; Francis, Heather; Kennedy, Lindsey; Glaser, Shannon; Alpini, Gianfranco] Texas A&M Univ, Hlth Sci Ctr, Div Gastroenterol, Dept Med, Temple, TX USA.
   [Meng, Fanyin; Wu, Nan; Zhou, Tianhao; Venter, Julie; Francis, Heather; Kennedy, Lindsey; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White Hlth, Temple, TX USA.
   [Bernuzzi, Francesca; Invernizzi, Pietro] Humanitas Clin & Res Ctr, Rozzano, Italy.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M Health Science Center; Baylor Health Care System; Scott & White
   Medical Center; Southern Medical University - China; Baylor Health Care
   System; Texas A&M University System; Texas A&M University College
   Station; Texas A&M Health Science Center; Baylor Health Care System;
   IRCCS Humanitas Research Hospital
RP Huang, QB (corresponding author), Southern Med Univ, Key Lab Shock & Microcirculat Res Guangdong Prov, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China.; Alpini, G (corresponding author), Texas A&M Hlth Sci Ctr, Scott & White Digest Dis Res Ctr, Cent Texas Vet Hlth Care Syst, Olin E Teague Med Ctr, 1901 South 1st St,Bldg 205,1R36, Temple, TX 76504 USA.
EM bing@smu.edu.cn; galpini@tamu.edu
RI bernuzzi, francesca/AAQ-7073-2020; Zhou, Tianhao/AAO-3542-2021;
   Invernizzi, Pietro/AAB-8367-2022
OI Zhou, Tianhao/0000-0002-5722-6954; 
FU Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from
   Baylor Scott White; Veterans Affairs Research Career Scientist Award;
   Veterans Affairs Merit awards [5I01BX000574, 5I01BX002192, 1I01BX001724,
   1I01BX003031]; National Institutes of Health [DK058411, DK07698,
   DK107310, DK062975, DK108959]
FX Supported by the Dr. Nicholas C. Hightower Centennial Chair of
   Gastroenterology from Baylor Scott & White, a Veterans Affairs Research
   Career Scientist Award, Veterans Affairs Merit awards (5I01BX000574, to
   G.A.; 5I01BX002192, to S.G.; 1I01BX001724, to F.M.; and 1I01BX003031, to
   H.F.), and the National Institutes of Health (DK058411, DK07698,
   DK107310, and DK062975, to G.A., F.M., and S.G.; DK108959, to H.F.).
CR Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767
   Baghdasaryan A, 2010, GUT, V59, P521, DOI 10.1136/gut.2009.186528
   Bang R, 2004, J PHARMACOL EXP THER, V308, P1174, DOI 10.1124/jpet.103.059329
   Bang R, 2003, J PHARMACOL EXP THER, V305, P31, DOI 10.1124/jpet.102.043539
   Beuers U, 2009, CLIN REV ALLERG IMMU, V36, P1, DOI 10.1007/s12016-008-8084-z
   Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chang VT, 2013, LEUKEMIA LYMPHOMA, V54, P631, DOI 10.3109/10428194.2012.722218
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Dangi A, 2012, J IMMUNOL, V188, P3667, DOI 10.4049/jimmunol.1102460
   EVERARD MJ, 1993, EUR J CANCER, V29A, P1450, DOI 10.1016/0959-8049(93)90019-C
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010
   Han YY, 2013, EXP BIOL MED, V238, P549, DOI 10.1177/1535370213489926
   Herrstedt J, 2008, ANN ONCOL, V19, P110, DOI 10.1093/annonc/mdn105
   Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Koon HW, 2010, AM J PATHOL, V177, P2300, DOI 10.2353/ajpath.2010.100314
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lesage G, 2001, AM J PHYSIOL-GASTR L, V281, pG182, DOI 10.1152/ajpgi.2001.281.1.G182
   Li CP, 1999, AM J GASTROENTEROL, V94, P502, DOI 10.1111/j.1572-0241.1999.883_l.x
   Meng FY, 2014, AM J PHYSIOL-GASTR L, V306, pG759, DOI 10.1152/ajpgi.00018.2014
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Muñoz M, 2014, AMINO ACIDS, V46, P1727, DOI 10.1007/s00726-014-1736-9
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0
   Sasaki M, 2014, DIGEST DIS SCI, V59, P358, DOI 10.1007/s10620-013-2920-6
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013
   Stoyanova II, 2000, ACTA HISTOCHEM, V102, P391, DOI 10.1078/0065-1281-00568
   Sumpter TL, 2012, J IMMUNOL, V189, P3848, DOI 10.4049/jimmunol.1200819
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yoshida S, 2014, GASTROENTEROLOGY, V147, P1378, DOI 10.1053/j.gastro.2014.08.038
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
NR 37
TC 62
Z9 68
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD AUG
PY 2017
VL 66
IS 2
BP 528
EP 541
DI 10.1002/hep.29138
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FB0EH
UT WOS:000405817200021
PM 28256736
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Maeso-Díaz, R
   Ortega-Ribera, M
   Fernández-Iglesias, A
   Hide, D
   Muñoz, L
   Hessheimer, AJ
   Vila, S
   Francés, R
   Fondevila, C
   Albillos, A
   Peralta, C
   Bosch, J
   Tacke, F
   Cogger, VC
   Gracia-Sancho, J
AF Maeso-Diaz, Raquel
   Ortega-Ribera, Marti
   Fernandez-Iglesias, Anabel
   Hide, Diana
   Munoz, Leticia
   Hessheimer, Amelia J.
   Vila, Sergi
   Frances, Ruben
   Fondevila, Constantino
   Albillos, Agustin
   Peralta, Carmen
   Bosch, Jaime
   Tacke, Frank
   Cogger, Victoria C.
   Gracia-Sancho, Jordi
TI Effects of aging on liver microcirculatory function and sinusoidal
   phenotype
SO AGING CELL
LA English
DT Article
ID HEPATIC STELLATE CELLS; CIRRHOTIC RAT LIVERS; NITRIC-OXIDE; IN-VIVO;
   MACROPHAGES; HOMEOSTASIS; EXPRESSION; INCREASES; FIBROSIS; STRESS
AB The socioeconomic and medical improvements of the last decades have led to a relevant increase in the median age of worldwide population. Although numerous studies described the impact of aging in different organs and the systemic vasculature, relatively little is known about liver function and hepatic microcirculatory status in the elderly. In this study, we aimed at characterizing the phenotype of the aged liver in a rat model of healthy aging, particularly focusing on the microcirculatory function and the molecular status of each hepatic cell type in the sinusoid. Moreover, major findings of the study were validated in young and aged human livers. Our results demonstrate that healthy aging is associated with hepatic and sinusoidal dysfunction, with elevated hepatic vascular resistance and increased portal pressure. Underlying mechanisms of such hemodynamic disturbances included typical molecular changes in the cells of the hepatic sinusoid and deterioration in hepatocyte function. In a specific manner, liver sinusoidal endothelial cells presented a dysfunctional phenotype with diminished vasodilators synthesis, hepatic macrophages exhibited a proinflammatory state, while hepatic stellate cells spontaneously displayed an activated profile. In an important way, major changes in sinusoidal markers were confirmed in livers from aged humans. In conclusion, our study demonstrates for the first time that aging is accompanied by significant liver sinusoidal deregulation suggesting enhanced sinusoidal vulnerability to chronic or acute injuries.
C1 [Maeso-Diaz, Raquel; Ortega-Ribera, Marti; Fernandez-Iglesias, Anabel; Hide, Diana; Vila, Sergi; Bosch, Jaime; Gracia-Sancho, Jordi] Univ Barcelona, IDIBAPS Biomed Res Inst, Liver Vasc Biol Res Grp, Barcelona Hepat Hemodynam Lab,Med Sch, Barcelona, Spain.
   [Fernandez-Iglesias, Anabel; Hide, Diana; Munoz, Leticia; Hessheimer, Amelia J.; Vila, Sergi; Frances, Ruben; Fondevila, Constantino; Albillos, Agustin; Peralta, Carmen; Bosch, Jaime; Gracia-Sancho, Jordi] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Madrid, Spain.
   [Munoz, Leticia; Albillos, Agustin] Univ Alcala, Dept Med, Immune Syst Dis Lab, Alcala De Henares, Spain.
   [Hessheimer, Amelia J.; Fondevila, Constantino] Hosp Clin Barcelona, Liver Surg & Transplantat Unit, IDIBAPS, Barcelona, Spain.
   [Frances, Ruben] Fdn FISABIO, Inst Invest Sanit & Biomed Alicante ISABIAL, Alicante, Spain.
   [Albillos, Agustin] Univ Alcala, Hosp Univ Ramon y Cajal, Dept Gastroenterol & Hepatol, IRYCIS, Madrid, Spain.
   [Peralta, Carmen] IDIBAPS, Protect Strategies Hepat Ischemia Reperfus Grp, Barcelona, Spain.
   [Bosch, Jaime; Gracia-Sancho, Jordi] Bern Univ, Dept Biomed Res, Hepatol, Inselspital, Bern, Switzerland.
   [Tacke, Frank] Univ Hosp Aachen, Dept Med 3, Aachen, Germany.
   [Cogger, Victoria C.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW, Australia.
   [Cogger, Victoria C.] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia.
   [Cogger, Victoria C.] Concord Hosp, Sydney, NSW, Australia.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER -
   Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de
   Alcala; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   General University Hospital of Alicante; Universidad Miguel Hernandez de
   Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y
   Biomedica de Alicante (ISABIAL); Hospital Universitario Ramon y Cajal;
   Universidad de Alcala; University of Barcelona; Hospital Clinic de
   Barcelona; IDIBAPS; RWTH Aachen University; RWTH Aachen University
   Hospital; University of Sydney; University of Sydney; ANZAC Research
   Institute; Concord Repatriation General Hospital
RP Gracia-Sancho, J (corresponding author), Rossello 149,4th Floor, Barcelona 08036, Spain.
EM jordi.gracia@idibaps.org
RI Bosch, Jaime/AAF-1006-2022; Fondevila, Constantino/B-8769-2016; Francés,
   Rubén/V-4120-2019; Tacke, Frank/ABF-2212-2020; Díaz, Raquel
   Maeso/K-4766-2015; Research Institute, ANZAC/CAE-9030-2022;
   Fernández-Iglesias, Anabel/AAB-3143-2021; Fernández-Iglesias,
   Anabel/AAD-6811-2020; VILA, SERGI/G-5771-2015; Bosch,
   Jaime/AFF-8344-2022; Hessheimer, Amelia/N-1855-2019; Peralta,
   Carmen/M-8170-2014; Ortega Ribera, Marti/K-9666-2015
OI Fondevila, Constantino/0000-0002-6161-6824; Francés,
   Rubén/0000-0001-5105-1201; Díaz, Raquel Maeso/0000-0002-2448-0251;
   Fernández-Iglesias, Anabel/0000-0003-2364-6675; Fernández-Iglesias,
   Anabel/0000-0003-2364-6675; VILA, SERGI/0000-0003-1706-3916; Hessheimer,
   Amelia/0000-0002-7247-5051; Peralta, Carmen/0000-0002-5767-0676; Hide,
   Diana/0000-0001-7189-9111; Ortega Ribera, Marti/0000-0001-8647-7069
FU Instituto de Salud Carlos III [FIS PI14/00029, PI17/00012, IFI15/00037,
   IFI16/00016, CD15/00050]; European Union FEDER Funds; CERCA Program from
   the Generalitat de Catalunya; Instituto de Salud Carlos III
FX This work was supported by the Instituto de Salud Carlos III (FIS
   PI14/00029 & PI17/00012 to J.G.-S.) the European Union FEDER Funds, "una
   manera de hacer Europa," and the CERCA Program from the Generalitat de
   Catalunya. CIBEREHD is funded by the Instituto de Salud Carlos III.
   R.M.-D. and M.O.-R. have fellowships from the Instituto de Salud Carlos
   III (iPFIS IFI15/00037 & IFI16/00016, respectively). A.F.-I. has a Sara
   Borrell contract from the Instituto de Salud Carlos III (CD15/00050).
CR Arias I., 2009, The Liver, biology and pathobiology
   Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212
   BROUWER A, 1983, MECH AGEING DEV, V21, P205, DOI 10.1016/0047-6374(83)90042-8
   Bruschi FV, 2017, HEPATOLOGY, V65, P1875, DOI 10.1002/hep.29041
   Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902
   de Mesquita FC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02866-y
   Fernández-Iglesias A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00007
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gracia-Sancho J, 2015, HEPATOL INT, V9, P183, DOI 10.1007/s12072-015-9613-5
   Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166
   Gracia-Sancho J, 2007, GASTROENTEROLOGY, V133, P959, DOI 10.1053/j.gastro.2007.06.021
   Gracia-Sancho J, 2011, GUT, V60, P517, DOI 10.1136/gut.2010.220913
   He W., 2016, AGING WORLD 2015 INT
   Hide D, 2014, CLIN SCI, V127, P527, DOI 10.1042/CS20140125
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hori N, 1998, HEPATOLOGY, V28, P1467, DOI 10.1002/hep.510280604
   Iwakiri Y, 2015, TRENDS PHARMACOL SCI, V36, P524, DOI 10.1016/j.tips.2015.05.001
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104
   Kawagishi H, 2010, CANCER RES, V70, P4749, DOI 10.1158/0008-5472.CAN-10-0368
   Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11
   Kroll J, 1998, BIOCHEM BIOPH RES CO, V252, P743, DOI 10.1006/bbrc.1998.9719
   Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018
   Marrone G, 2015, GUT, V64, P1434, DOI 10.1136/gutjnl-2014-308338
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004
   Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761
   Steppan J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000599
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   Uchio K, 2002, LAB INVEST, V82, P619, DOI 10.1038/labinvest.3780456
   Van Landeghem L, 2009, LIVER INT, V29, P650, DOI 10.1111/j.1478-3231.2008.01857.x
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Wang Y, 2015, AGING CELL, V14, P678, DOI 10.1111/acel.12350
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200
   Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494
NR 41
TC 78
Z9 81
U1 3
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2018
VL 17
IS 6
AR e12829
DI 10.1111/acel.12829
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HB9QP
UT WOS:000451427100009
PM 30260562
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Xu, XH
   Hueckstaedt, LK
   Ren, J
AF Xu, Xihui
   Hueckstaedt, Lindsay K.
   Ren, Jun
TI Deficiency of insulin-like growth factor 1 attenuates aging-induced
   changes in hepatic function: Role of autophagy
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE IGF-1; LID; Aging; Autophagy; Hepatocyte; HepG2; FFA
ID CONTRACTILE DYSFUNCTION ROLE; LIFE-SPAN; OXIDATIVE STRESS;
   ENDOPLASMIC-RETICULUM; CARDIAC-HYPERTROPHY; ER STRESS; SENESCENCE;
   LIVER; MICE; ACCUMULATION
AB Background & Aims: Circulating insulin-like growth factor-1 (IGF-1) plays a pivotal role in mediating the aging process. This study was designed to evaluate the effect of liver IGF-1 deficiency (LID) on aging-induced changes in hepatic function and underlying mechanisms, with a focus on autophagy.
   Methods: Plasma and liver samples were obtained from young (3-mo) and aged (24-mo) wild type (WT) and LID mice. Levels of AST, ALT, triglyceride, hepatic lipofuscin, steatosis, fibrosis, and nuclear morphology were analyzed. Western blot was employed to evaluate autophagy. Human HepG2 cells were treated with free fatty acid (FFA) to mimic hepatic aging in the absence or presence of IGF-1 siRNA. SA-beta-gal activity was detected using flow cytometry and a fluorescence microplate reader. GFP-LC3 was used to assess autophagy activity in HepG2 cells.
   Results: Median survival was longer in LID mice compared with WT mice. Aging was associated with elevated levels of triglyceride, AST and ALT, lipofuscin accumulation, steatosis, fibrosis and nuclear injury, which were significantly attenuated by liver IGF-1 deficiency. Levels of autophagy were suppressed in senescent livers, the effect was reversed in the liver of IGF-1 deficient mice. In HepG2 cells, FFA induced the accumulation of beta-gal, which was dramatically suppressed by IGF-1 knockdown. Importantly, inhibiting autophagy using 3-methyladenine mitigated IGF-1 knockdown-induced preservation of autophagic vacuole formation and inhibition of beta-gal accumulation in the presence of FFA in HepG2 cells.
   Conclusions: Our data revealed that IGF-1 deficiency ameliorated aging-induced hepatic injury, possibly through preventing a concomitant diminution in autophagy. These data provide new insight into the role of IGF-1 and autophagy in the management of aging-induced hepatic injury. (C) 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Xu, Xihui; Hueckstaedt, Lindsay K.; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Sch Pharm, Laramie, WY 82071 USA.
C3 University of Wyoming
RP Ren, J (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.
EM jren@uwyo.edu
RI Xu, Xihui/C-2017-2014; Ren, Jun/ACG-5366-2022
OI Xu, Xihui/0000-0003-2569-5243; Ren, Jun/0000-0002-0275-0783
FU NIH/NCRR [P20 RR016474]; NIH/NIGMS [8P20GM103432]
FX NIH/NCRR P20 RR016474 and NIH/NIGMS 8P20GM103432.
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Berasain C, 2010, J HEPATOL, V52, P633, DOI 10.1016/j.jhep.2010.01.020
   Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930
   Bitto A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012592
   Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Chipchase MD, 2003, HEPATOLOGY, V38, P958, DOI 10.1053/jhep.2003.50421
   DAVIES I, 1983, MECH AGEING DEV, V23, P347, DOI 10.1016/0047-6374(83)90035-0
   Debacq-Chainiaux F, 2008, FREE RADICAL BIO MED, V44, P1817, DOI 10.1016/j.freeradbiomed.2008.02.001
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Elis S, 2011, AGING CELL, V10, P547, DOI 10.1111/j.1474-9726.2011.00683.x
   FERLAND G, 1992, MECH AGEING DEV, V64, P49, DOI 10.1016/0047-6374(92)90095-U
   Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Ge W, 2011, FREE RADICAL BIO MED, V51, P1736, DOI 10.1016/j.freeradbiomed.2011.08.002
   Hauck SJ, 2000, FREE RADICAL BIO MED, V28, P970, DOI 10.1016/S0891-5849(00)00186-6
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hua YN, 2012, J CELL MOL MED, V16, P83, DOI 10.1111/j.1582-4934.2011.01307.x
   Hua YN, 2011, BASIC RES CARDIOL, V106, P1173, DOI 10.1007/s00395-011-0222-8
   Hua YA, 2010, J CARDIOVASC PHARM, V55, P49, DOI 10.1097/FJC.0b013e3181c37d86
   Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Kwon HJ, 2011, J HEPATOL, V54, P1168, DOI 10.1016/j.jhep.2010.09.025
   Li J, 2004, EXP GERONTOL, V39, P735, DOI 10.1016/j.exger.2004.02.008
   Li Q, 2008, REJUV RES, V11, P725, DOI 10.1089/rej.2008.0717
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Mak KM, 2012, ANAT REC, V295, P40, DOI 10.1002/ar.21525
   McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817
   Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008
   NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257
   OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5
   OOKA H, 1986, MECH AGEING DEV, V33, P275, DOI 10.1016/0047-6374(86)90052-7
   Pattison JS, 2011, CIRC RES, V109, P151, DOI 10.1161/CIRCRESAHA.110.237339
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018
   Skoien R, 2010, J GASTROEN HEPATOL, V25, pA13
   Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433
   Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934
   Svensson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022640
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Terman A, 1999, EXP GERONTOL, V34, P943, DOI 10.1016/S0531-5565(99)00070-4
   Terman A, 1999, EXP GERONTOL, V34, P755, DOI 10.1016/S0531-5565(99)00045-5
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
NR 55
TC 38
Z9 38
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
J9 J HEPATOL
JI J. Hepatol.
PD AUG
PY 2013
VL 59
IS 2
BP 308
EP 317
DI 10.1016/j.jhep.2013.03.037
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 187DP
UT WOS:000322097400017
PM 23583271
DA 2024-02-19
ER

PT J
AU Habieb, ME
   Mohamed, MA
   El Gamal, DM
   Hawas, AM
   Mohamed, TM
AF Habieb, M. E.
   Mohamed, M. A.
   El Gamal, D. M.
   Hawas, A. M.
   Mohamed, T. M.
TI Anti-aging effect of DL-β-hydroxybutyrate against hepatic cellular
   senescence induced by D-galactose or γ-irradiation via autophagic flux
   stimulation in male rats
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE D-galacose; Ionizing radiation; beta-hydroxybutyric acid; Senescence;
   Autophagy
ID ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; OXIDATIVE STRESS;
   IONIZING-RADIATION; LIPID-PEROXIDATION; MITOCHONDRIAL DYSFUNCTION;
   KETONE-BODIES; MOUSE MODEL; DNA-DAMAGE; LIFE-SPAN
AB The present study aims to shed new light on anti-aging effect of DL-beta-hydroxybutyrate (beta OHB) against hepatic cellular senescence induced by D-galactose or gamma-irradiation. The rats divided into 6 groups. Group 1, control, group 2, exposed to gamma-ray (5 GY), group 3, injected by D-galactose (150 mg/kg) daily for consecutive 6 weeks, which regarded to induce the aging, group 4, injected intraperitoneal by beta-hydroxybutyrate (beta OHB) (72.8 mg/kg) daily for consecutive 14 days, group 5, exposed to gamma-ray then treated with beta OHB daily for consecutive 14 days, group 6, injected daily with D-galactose for consecutive 6 weeks, then treated with beta OHB daily at the last two weeks of D-galactose. Aspartate amino transferase (AST), alanine amino transferase (ALT), Insulin, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were estimated in serum. Moreover, protein expression of Microtubule-associated proteins 1A/1B light chain 3B (LC3-II/LC3-I) ratio, mechanistic target of rapamycin (mTOR), pAMPK, mRNA gene expression of 5' AMP-activated protein kinase (AMPK), Nucleoporin p62 (p62), cyclin-dependent kinase inhibitor 1(P21(CIP1)), cyclin-dependent kinase inhibitor 2A (p16(INK4a)) and DNA fragmentation percentage were measured in liver tissue as a biomarker of cellular senescence. The results confirmed that beta OHB modulated serum level of AST, ALT, insulin, IL-6 and TNF-alpha, protein expression of mTOR and LC3-II/LC3-I ratio, pAMPK and p62 in liver aging model induced by D-galactose or gamma-irradiation. Histopathological examination results of liver tissue indicated coincidence with those recorded by molecular biochemical inspection. Taken together, these findings suggest that beta OHB may be useful in combating hepatic cellular senescence induced by D-galactose or gamma-irradiation via autophagy dependent mechanisms.
C1 [Habieb, M. E.; Mohamed, M. A.; Hawas, A. M.] Egyptian Atom Energy Author, Drug Radiat Res Dept, Natl Ctr Radiat Res & Technol NCRRT, POB 29, Cairo, Egypt.
   [El Gamal, D. M.; Mohamed, T. M.] Tanta Univ, Div Biochem, Dept Chem, Fac Sci, Tanta, Egypt.
C3 Egyptian Knowledge Bank (EKB); National Center for Radiation Research &
   Technology; Egyptian Atomic Energy Authority (EAEA); Egyptian Knowledge
   Bank (EKB); Tanta University
RP Habieb, ME (corresponding author), Egyptian Atom Energy Author, Drug Radiat Res Dept, Natl Ctr Radiat Res & Technol NCRRT, POB 29, Cairo, Egypt.
EM mahmoudhabieb@yahoo.com
RI Mohamed, Tarek M/AAT-8587-2021
OI Mohamed, Tarek M/0000-0002-4015-7542
CR Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376
   Alkhalf MI, 2018, SAUDI J BIOL SCI, V25, P1272, DOI 10.1016/j.sjbs.2018.07.002
   Anderson R., 2018, BIORXIV
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Baker D. J., 2018, J CLIN INVESTIGATION, V128
   Bancroft J.D., 2013, Theory and Practice of Histological Techniques, V7th, P173, DOI DOI 10.1016/B978-0-7020-4226-3.00010-X
   Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001
   Banji D, 2013, BRAIN RES, V1515, P1, DOI 10.1016/j.brainres.2013.03.023
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Butterfield DA, 2014, BBA-MOL BASIS DIS, V1842, P1693, DOI 10.1016/j.bbadis.2014.06.010
   Calini V, 2003, TOXICOL IN VITRO, V17, P561, DOI 10.1016/S0887-2333(03)00116-4
   Camberos-Luna L, 2016, NEUROCHEM RES, V41, P600, DOI 10.1007/s11064-015-1700-4
   Chen JM, 2017, MECH AGEING DEV, V164, P1, DOI 10.1016/j.mad.2017.03.007
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep12115
   Cheng BH, 2009, BRAIN RES, V1286, P25, DOI 10.1016/j.brainres.2009.06.060
   Choragiewicz T. J., 2008, INVEST OPHTHALMOL, V49, P5502
   Christman JW, 2000, BRAIN PATHOL, V10, P153
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x
   D'Agostino DP, 2013, AM J PHYSIOL-REG I, V304, pR829, DOI 10.1152/ajpregu.00506.2012
   Del Campo JA, 2018, WORLD J HEPATOL, V10, P1, DOI 10.4254/wjh.v10.i1.1
   Edwards C, 2014, AGING-US, V6, P621, DOI 10.18632/aging.100683
   Even B, 2018, AGING CELL, V17, DOI 10.1111/acel.12837
   Fauser B, 2019, REPROD BIOMED ONLINE, V38, P5, DOI 10.1016/j.rbmo.2018.12.005
   Ferrucci L, 2016, J GERONTOL A-BIOL, V71, P1184, DOI 10.1093/gerona/glw043
   FLECKNELL PA, 1993, BRIT J ANAESTH, V71, P885, DOI 10.1093/bja/71.6.885
   Gao JQ, 2018, CLIN INTERV AGING, V13, P1859, DOI 10.2147/CIA.S173838
   Gao LJ, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa5b1b
   Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009
   Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214
   Gormsen LC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005066
   Graff EC, 2016, METABOLISM, V65, P102, DOI 10.1016/j.metabol.2015.10.001
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   Harun-Or-Rashid M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1346-7
   He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55
   He RN, 2015, AUTOPHAGY, V11, P740, DOI 10.1080/15548627.2015.1034404
   He Y, 2019, FREE RADICAL BIO MED, V137, P24, DOI 10.1016/j.freeradbiomed.2019.04.012
   Nguyen HQ, 2018, CRIT REV ONCOL HEMAT, V129, P13, DOI 10.1016/j.critrevonc.2018.06.012
   Hori M., 2012, Anti-Aging Med., V9, P125
   Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248
   Hsieh HM, 2011, LIFE SCI, V88, P82, DOI 10.1016/j.lfs.2010.10.021
   Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013
   Hunt N. J., 2019, COMPUTATIONAL STRUCT
   Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419
   Jain SK, 2003, DIABETES CARE, V26, P2139, DOI 10.2337/diacare.26.7.2139
   Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x
   Kashiwaya Y, 1997, AM J CARDIOL, V80, pA50, DOI 10.1016/S0002-9149(97)00458-X
   Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276
   Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152
   Kim DH, 2019, AGING-US, V11, P1283, DOI 10.18632/aging.101838
   Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661
   Kong DF, 2019, HEPATOL RES, V49, P462, DOI 10.1111/hepr.13287
   Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396
   Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201
   LEMAHO Y, 1981, AM J PHYSIOL, V241, pE342, DOI 10.1152/ajpendo.1981.241.5.E342
   Lim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024620
   Liu AJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1461, DOI 10.1271/bbb.80558
   Liu CM, 2010, FOOD CHEM TOXICOL, V48, P2809, DOI 10.1016/j.fct.2010.07.011
   Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3
   Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   Mao Y., 2016, HEPATIC MED EVIDENCE, V8
   Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130
   McDaniel SS, 2011, EPILEPSIA, V52, pe7, DOI 10.1111/j.1528-1167.2011.02981.x
   Mei Y, 2015, BBA-MOL BASIS DIS, V1852, P243, DOI 10.1016/j.bbadis.2014.05.005
   Miyauchi T., 2019, P NATL ACAD SCI USA
   Mosteiro L, 2018, AGING CELL, V17, DOI 10.1111/acel.12711
   Nagao M, 2016, BIOCHEM BIOPH RES CO, V475, P322, DOI 10.1016/j.bbrc.2016.05.097
   Niedernhofer LJ, 2018, ANNU REV BIOCHEM, V87, P295, DOI 10.1146/annurev-biochem-062917-012239
   Peiris H., 2014, OXIDATIVE MED CELLUL
   Plaa G., 1994, PRINCIPLES METHODS T
   Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003
   Redman LM, 2018, CELL METAB, V27, P805, DOI 10.1016/j.cmet.2018.02.019
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Ren J, 2018, TRENDS ENDOCRIN MET, V29, P699, DOI 10.1016/j.tem.2018.08.001
   Rhee JS, 2013, AQUAT TOXICOL, V140, P58, DOI 10.1016/j.aquatox.2013.05.006
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Ruart M, 2019, J HEPATOL, V70, P458, DOI 10.1016/j.jhep.2018.10.015
   Sabokdast M, 2015, DARU, V23, DOI 10.1186/s40199-015-0126-5
   Schofield PN, 2018, INT J RADIAT BIOL, V94, P769, DOI 10.1080/09553002.2017.1388548
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406
   Seol MA, 2012, J VET SCI, V13, P331, DOI 10.4142/jvs.2012.13.4.331
   Shin MJ, 2006, ANN NUTR METAB, V50, P115, DOI 10.1159/000090499
   Sofy S. H., 2014, International Journal of Agriculture and Biosciences, V3, P110
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Sridharan S., 2002, PROTECTIVE EFFECT N
   Sturmlechner I, 2017, NAT REV NEPHROL, V13, P77, DOI 10.1038/nrneph.2016.183
   Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200
   Theurey P, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010022
   Tiwari V, 2019, AM J HUM GENET, V105, P237, DOI 10.1016/j.ajhg.2019.06.005
   Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030
   Turillazzi E, 2016, J CELL MOL MED, V20, P601, DOI 10.1111/jcmm.12748
   Veech RL, 2017, IUBMB LIFE, V69, P305, DOI 10.1002/iub.1627
   Vlassara H, 2001, DIABETES-METAB RES, V17, P436, DOI 10.1002/dmrr.233
   Wang H, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00352
   Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9
   Wang YY, 2016, RADIAT RES, V186, P153, DOI 10.1667/RR14445.1
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Xi XQ, 2019, EUR J PHARMACOL, V863, DOI 10.1016/j.ejphar.2019.172695
   Yamaguchi O., 2019, CIRCULATION J, V18
   Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833
   Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804
   Yu WF, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-73
   Zhang C, 2017, J AQUAT FOOD PROD T, V26, P17, DOI 10.1080/10498850.2015.1082525
   Zhang XL, 2010, NEUROSCI LETT, V473, P224, DOI 10.1016/j.neulet.2010.02.054
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zientara-Rytter K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010040
NR 116
TC 7
Z9 8
U1 1
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JAN-FEB
PY 2021
VL 92
AR 104288
DI 10.1016/j.archger.2020.104288
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA PI2AO
UT WOS:000600899700021
PM 33147533
DA 2024-02-19
ER

PT J
AU Wu, MM
   Yin, F
   Wei, XL
   Ren, RX
   Chen, CQ
   Liu, MH
   Wang, RY
   Yang, L
   Xie, RQ
   Jiang, SY
   Wang, ZM
   Liu, R
   Xu, WT
   Wang, XF
   Li, J
   Wang, H
AF Wu, Miaomiao
   Yin, Fan
   Wei, Xiaoli
   Ren, Ruixue
   Chen, Chongqing
   Liu, Menghua
   Wang, Ruyu
   Yang, Liu
   Xie, Ruiqian
   Jiang, Shanyue
   Wang, Ziming
   Liu, Rui
   Xu, Wentao
   Wang, Xuefu
   Li, Jing
   Wang, Hua
TI Hepatocyte-specific deletion of cellular repressor of E1A-stimulated
   genes 1 exacerbates alcohol-induced liver injury by activating stress
   kinases
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE CREG1; ALD; Apoptosis; Steatosis; Inflammation
ID LYSOSOMAL BIOGENESIS; HEPATIC STEATOSIS; CREG; DISEASE; OVEREXPRESSION;
   PATHOGENESIS; CONTRIBUTES; APOPTOSIS; PATHWAYS; GROWTH
AB Alcohol-associated liver disease (ALD) encompasses a wide range of pathologies from simple steatosis to cirrhosis and hepatocellular carcinoma and is a global health problem. Currently, there are no effective pharmacological treatments for ALD. We have previously demonstrated that aging exacerbates the pathogenesis of ALD, but the underlying mechanisms are still poorly understood. Cellular repressor of E1A-stimulated genes 1 protein (CREG1) is a recently identified small glycoprotein that has been implicated in aging process by promoting cellular senescence and activating stress kinases. Thus, the current study aimed to explore the role of aging associated CREG1 in ALD pathogenesis and CREG1 as a potential therapeutic target. Hepatic and serum CREG1 protein levels were elevated in ALD patients. Elevation of hepatic CREG1 protein and mRNA was also observed in a mouse model of Gao-binge alcohol feeding. Genetic deletion of the Creg1 gene in hepatocytes (Creg1(Delta hep)) markedly exacerbated ethanol-induced liver injury, apoptosis, steatosis and inflammation. Compared to wild-type mice, Creg1(Delta heP) mice had increased phosphorylation of hepatic stress kinases such as apoptosis signal-regulating kinase 1 (ASK1), c-Jun N-terminal kinase (JNK) and p38 but not TGF-beta-activated kinase 1 (TAK1) or extracellular signal-regulated kinase (ERK) after alcohol feeding. In vitro, ethanol treatment elevated the phosphorylation of ASK1, JNK, and p38 in mouse hepatocyte AML-12 cells. This elevation was further enhanced by CREG1 knockdown but alleviated by CREG1 overexpression. Last, treatment with an ASK1 inhibitor abolished ethanol-induced liver injury and upregulated hepatic lipogenesis, proinflammatory genes and stress kinases in Creg1 meP mice. Taken together, our data suggest that CREG1 protects against alcoholic liver injury and inflammation by inhibiting the ASK1-JNK/p38 stress kinase pathway and that CREG1 is a potential therapeutic target for ALD.
C1 [Wu, Miaomiao; Yin, Fan; Chen, Chongqing; Liu, Menghua; Wang, Ruyu; Yang, Liu; Xie, Ruiqian; Jiang, Shanyue; Wang, Xuefu] Anhui Med Univ, Sch Pharm, Hefei 230032, Peoples R China.
   [Wei, Xiaoli; Ren, Ruixue; Wang, Ziming; Liu, Rui; Xu, Wentao; Wang, Hua] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, 81 Meishan Rd, Hefei 230022, Anhui, Peoples R China.
   [Wang, Xuefu; Wang, Hua] Anhui Med Univ, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Peoples R China.
   [Li, Jing] Anhui Med Univ, Sch Life Sci, Hefei 230032, Anhui, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Anhui Medical
   University; Anhui Medical University
RP Wang, H (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, 81 Meishan Rd, Hefei 230022, Anhui, Peoples R China.
EM wanghua@ahmu.edu.cn
RI Lu, Jia/JVO-6891-2024; xuefu, wang/HPE-2143-2023; jiang,
   lei/IWE-1124-2023; zhang, lin/IZQ-4870-2023; wei, xiao/ISB-6027-2023;
   xin, li/JCO-3925-2023; LI, Jing/HNB-5575-2023; liu,
   kaiyuan/JHU-0258-2023; Jiang, Tao/IWM-7503-2023; Li, Jing/GYU-5036-2022;
   zhao, yujie/JLL-1283-2023
OI xuefu, wang/0000-0001-7212-7156; 
FU National Natural Science Foundation of China [81770588/H0315]
FX This study was supported by the National Natural Science Foundation of
   China (81770588/H0315) .
CR Ambade A, 2019, HEPATOLOGY, V69, P1105, DOI 10.1002/hep.30249
   Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032
   Bian ZY, 2009, J CELL MOL MED, V13, P1302, DOI 10.1111/j.1582-4934.2008.00633.x
   Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10
   Ceni E, 2014, WORLD J GASTROENTERO, V20, P17756, DOI 10.3748/wjg.v20.i47.17756
   Crabb DW, 2020, HEPATOLOGY, V71, P306, DOI 10.1002/hep.30866
   Di Bacco A, 2003, ONCOGENE, V22, P5436, DOI 10.1038/sj.onc.1206670
   Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Ghobrial G, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00136
   Han YL, 2010, J MOL CELL CARDIOL, V48, P1225, DOI 10.1016/j.yjmcc.2009.12.018
   Hashimoto M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031276
   Hashimoto M, 2019, FASEB J, V33, P8069, DOI 10.1096/fj.201802147RR
   Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537
   Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009
   Kim HG, 2019, J HEPATOL, V71, P960, DOI 10.1016/j.jhep.2019.06.019
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Liu J, 2021, AUTOPHAGY, V17, P4249, DOI 10.1080/15548627.2021.1909997
   Liu YX, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101444
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Ma J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136496
   Moolmuang B, 2011, CELL CYCLE, V10, P518, DOI 10.4161/cc.10.3.14756
   Ogier JM, 2020, J MOL MED, V98, P335, DOI 10.1007/s00109-020-01878-y
   Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383
   Peng F, 2011, BIOCHEM BIOPH RES CO, V406, P601, DOI 10.1016/j.bbrc.2011.02.100
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Ren R, HEPATOLOGY, V2021
   Ren RX, 2020, INT J BIOL SCI, V16, P3174, DOI 10.7150/ijbs.49535
   Sacher M, 2005, P NATL ACAD SCI USA, V102, P18326, DOI 10.1073/pnas.0505071102
   Sanz-Garcia C, 2019, J HEPATOL, V70, P974, DOI 10.1016/j.jhep.2019.01.021
   Seitz HK, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0014-7
   Song HX, 2021, AUTOPHAGY, V17, P4102, DOI 10.1080/15548627.2021.1904488
   Song HX, 2017, BBA-MOL BASIS DIS, V1863, P1893, DOI 10.1016/j.bbadis.2016.11.015
   Song Q, 2020, J HEPATOL, V73, P783, DOI 10.1016/j.jhep.2020.04.038
   Sun MY, 2015, J MOL CELL CARDIOL, V86, P32, DOI 10.1016/j.yjmcc.2015.07.001
   Wang J, 2013, EXP CELL RES, V319, P1165, DOI 10.1016/j.yexcr.2013.03.010
   Wang SG, 2020, CELL MOL GASTROENTER, V10, P59, DOI 10.1016/j.jcmgh.2020.01.008
   Wang ZG, 2014, HEPATOLOGY, V59, P1381, DOI 10.1002/hep.26912
   Xu L, 2004, J HYPERTENS, V22, P1579, DOI 10.1097/01.hjh.0000133717.48334.cf
   Yang L, 2019, HEPATOLOGY, V69, P294, DOI 10.1002/hep.30203
   Zhang QY, 2017, HEPATOLOGY, V66, P834, DOI 10.1002/hep.29257
   Zhang TZ, 2018, BIOMED PHARMACOTHER, V103, P1355, DOI 10.1016/j.biopha.2018.04.081
   Zhang YT, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00326-6
NR 44
TC 2
Z9 2
U1 3
U2 19
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2022
VL 18
IS 4
BP 1612
EP 1626
DI 10.7150/ijbs.67852
PG 15
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA YY5IX
UT WOS:000754823800022
PM 35280676
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kong, XN
   Feng, DC
   Wang, H
   Hong, F
   Bertola, A
   Wang, FS
   Gao, B
AF Kong, Xiaoni
   Feng, Dechun
   Wang, Hua
   Hong, Feng
   Bertola, Adeline
   Wang, Fu-Sheng
   Gao, Bin
TI Interleukin-22 induces hepatic stellate cell senescence and restricts
   liver fibrosis in mice
SO HEPATOLOGY
LA English
DT Article
ID P53; INFLAMMATION; HEPATOCYTES; APOPTOSIS; IL-22
AB Interleukin (IL)-22 is known to play a key role in promoting antimicrobial immunity, inflammation, and tissue repair at barrier surfaces by binding to the receptors, IL-10R2 and IL-22R1. IL-22R1 is generally thought to be expressed exclusively in epithelial cells. In this study, we identified high levels of IL-10R2 and IL-22R1 expression on hepatic stellate cells (HSCs), the predominant cell type involved in liver fibrogenesis in response to liver damage. In vitro treatment with IL-22 induced the activation of signal transducer and activator of transcription (STAT) 3 in primary mouse and human HSCs. IL-22 administration prevented HSC apoptosis in vitro and in vivo, but surprisingly, the overexpression of IL-22 by either gene targeting (e.g., IL-22 transgenic mice) or exogenous administration of adenovirus expressing IL-22 reduced liver fibrosis and accelerated the resolution of liver fibrosis during recovery. Furthermore, IL-22 overexpression or treatment increased the number of senescence-associated beta-galactosidase-positive HSCs and decreased alpha-smooth muscle actin expression in fibrotic livers in vivo and cultured HSCs in vitro. Deletion of STAT3 prevented IL-22-induced HSC senescence in vitro, whereas the overexpression of a constitutively activated form of STAT3 promoted HSC senescence through p53- and p21-dependent pathways. Finally, IL-22 treatment up-regulated the suppressor of cytokine signaling (SOCS) 3 expression in HSCs. Immunoprecipitation analyses revealed that SOCS3 bound p53 and subsequently increased the expression of p53 and its target genes, contributing to IL-22-mediated HSC senescence. Conclusion: IL-22 induces the senescence of HSCs, which express both IL-10R2 and IL-22R1, thereby ameliorating liver fibrogenesis. The antifibrotic effect of IL-22 is likely mediated by the induction of HSC senescence, in addition to the previously discovered hepatoprotective functions of IL-22. (HEPATOLOGY 2012;56:11501159)
C1 [Kong, Xiaoni; Feng, Dechun; Wang, Hua; Bertola, Adeline; Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD 20892 USA.
   [Hong, Feng] Mt Sinai Sch Med, New York, NY USA.
   [Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); Icahn School of Medicine at Mount
   Sinai; Fifth Medical Center of Chinese PLA General Hospital
RP Gao, B (corresponding author), NIAAA, Lab Liver Dis, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.
EM bgao@mail.nih.gov
RI zhang, hao/JOJ-7093-2023; Feng, Dechun/Q-5962-2016
OI Bertola, Adeline/0000-0002-4885-8423; Wang, Hua/0000-0002-2605-5697
FU National Institute on Alcohol Abuse and Alcoholism, National Institutes
   of Health
FX This work was supported by the intramural program of the National
   Institute on Alcohol Abuse and Alcoholism, National Institutes of
   Health. The authors thank Dr. Michitaka Ozaki (Hokkaido University,
   Sapporo, Japan) for providing the caSTAT3 adenovirus and also Drs.
   Mingquan Zheng and Jay K. Kolls (Louisiana State University, New
   Orleans, LA) for providing IL-22 adenovirus and also thank Dr. Scott
   Friedman (Mount Sinai School of Medicine, New York) for providing the
   LX2 cells.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071
   Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Calabrese V, 2009, MOL CELL, V36, P754, DOI 10.1016/j.molcel.2009.09.044
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Hampel B, 2005, AGING CELL, V4, P325, DOI 10.1111/j.1474-9726.2005.00180.x
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004
   Park O, 2011, HEPATOLOGY, V54, P252, DOI 10.1002/hep.24339
   Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Sitko JC, 2008, CELL SIGNAL, V20, P2221, DOI 10.1016/j.cellsig.2008.08.011
   Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025
   Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593
   Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x
   Xiang XG, 2012, IMMUNOL CELL BIOL, V90, P611, DOI 10.1038/icb.2011.79
   Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023
   Zhang Y, 2011, GASTROENTEROLOGY, V141, P1897, DOI 10.1053/j.gastro.2011.06.051
   Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584
NR 26
TC 302
Z9 328
U1 1
U2 79
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD SEP
PY 2012
VL 56
IS 3
BP 1150
EP 1159
DI 10.1002/hep.25744
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 995WX
UT WOS:000308046700038
PM 22473749
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU CONLON, D
   JOHNSTON, A
   TURNER, P
   OMALLEY, K
   KILFEATHER, S
AF CONLON, D
   JOHNSTON, A
   TURNER, P
   OMALLEY, K
   KILFEATHER, S
TI HEPATIC BETA-ADRENOCEPTOR ADAPTATION DURING PROPRANOLOL ADMINISTRATION
   IS IMPAIRED IN AGING RATS
SO EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION
LA English
DT Article
DE BETA-ADRENOCEPTORS; AGING; ADENYLATE CYCLASE; LIVER; PROPRANOLOL;
   RECEPTOR UP-REGULATION
ID ADRENERGIC-RECEPTOR NUMBER; LINKED ADENYLATE-CYCLASE; AGED RATS;
   BETA-2-ADRENERGIC RECEPTOR; GLUCOSE OUTPUT; AGING RATS; HEART; LIVER;
   BRAIN; DESENSITIZATION
AB Ageing has been associated with changes in beta-adrenoceptor responses and adaptation to prolonged removal of catecholamine stimulation. We have examined the effect of chronic propranolol administration on rat hepatic membrane beta-adrenoceptor density, agonist affinity and response in young (6-7 months) and old (26-7 months) male Wistar rats. Propranolol administration via miniosmotic pumps for 7 days resulted in similar and sustained plasma propranolol levels (approximately 100 ng/ml) in old and young rats. Pretreatment beta-adrenoceptor responses to isoprenaline were significantly higher in old rats. Propranolol administration was associated with significant increases in beta-adrenoceptor response and density (B(max)) in young rats only. Cyclic adenosine 3',5'-monophosphate (cyclic AMP) responses to prostaglandin E1 (PGE1), guanosine triphosphate (GTP), 5'-guanylimidodiphosphate (Gpp(NH)p), forskolin and Mn2+ were not significantly different between young and old rats and were not affected by propranolol administration. Neither ageing or propranolol administration was associated with a change in beta-receptor agonist affinity. These findings demonstrate elevated hepatic beta-adrenoceptor response and impaired hepatic beta-receptor adaptation to beta-adrenoceptor blockade in ageing rats.
C1 ROYAL COLL SURG IRELAND,DEPT CLIN PHARMACOL,DUBLIN 2,IRELAND.
   ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND.
C3 Royal College of Surgeons - Ireland; University of London; Queen Mary
   University London
OI Johnston, Atholl/0000-0001-5787-2270
CR AARONS RD, 1982, J PHARMACOL EXP THER, V221, P439
   BATTAGLIA G, 1988, EUR J PHARMACOL, V145, P281, DOI 10.1016/0014-2999(88)90431-1
   BATTAGLIA G, 1985, T AM SOC NEUROCHEM, V16, P201
   BECKER DM, 1988, PHARMACOLOGY, V36, P172, DOI 10.1159/000138381
   BHAMRA RK, 1985, METHODOLOGY ANAL TOX, V3, P165
   BILEZIKIAN JP, 1983, ENDOCR REV, V4, P378, DOI 10.1210/edrv-4-4-378
   BLAIR JB, 1979, J BIOL CHEM, V254, P7579
   BOUVIER M, 1989, J BIOL CHEM, V264, P16786
   BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561
   CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
   COLLINS S, 1989, ANNU REV PHYSIOL, V51, P203, DOI 10.1146/annurev.ph.51.030189.001223
   COLLINS S, 1989, P NATL ACAD SCI USA, V86, P4853, DOI 10.1073/pnas.86.13.4853
   DAVIES AO, 1984, ANNU REV PHYSIOL, V46, P119
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   DELEAN A, 1980, MOL PHARMACOL, V255, P5
   GLAUBIGER G, 1977, BIOCHEM BIOPH RES CO, V78, P720, DOI 10.1016/0006-291X(77)90238-8
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   GREENBERG LH, 1985, BRAIN RES, V328, P81, DOI 10.1016/0006-8993(85)91325-3
   GREENBERG LH, 1978, SCIENCE, V201, P61, DOI 10.1126/science.208145
   GREENBERG LH, 1979, J PHARMACOL EXP THER, V211, P309
   HARDEN TK, 1983, PHARMACOL REV, V35, P5
   HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947
   HOFFMAN WE, 1985, NEUROBIOL AGING, V6, P117, DOI 10.1016/0197-4580(85)90028-4
   HUANG HH, 1980, EXP AGING RES, V6, P3, DOI 10.1080/03610738008258342
   KARLINER JS, 1986, J AM COLL CARDIOL, V1, pA166
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   KATZ MS, 1987, FASEB J, V46, P567
   KAWAI Y, 1985, J BIOL CHEM, V260, P826
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCCARTY R, 1984, NEUROBIOL AGING, V5, P285, DOI 10.1016/0197-4580(84)90004-6
   MCCARTY R, 1985, J AUTONOM NERV SYST, V12, P15, DOI 10.1016/0165-1838(85)90037-2
   MINNEMAN KP, 1979, SCIENCE, V204, P866, DOI 10.1126/science.35829
   MORGAN NG, 1983, J BIOL CHEM, V258, P9283
   NAMBI P, 1985, J BIOL CHEM, V260, P2165
   NORMAN AB, 1987, J NEUROSCI, V7, P1484
   PEDIGO NW, 1985, LIFE SCI, V37, P1443, DOI 10.1016/0024-3205(85)90084-0
   PEKARY AE, 1983, J GERONTOL, V38, P653, DOI 10.1093/geronj/38.6.653
   PITHA J, 1982, P NATL ACAD SCI-BIOL, V79, P4424, DOI 10.1073/pnas.79.14.4424
   RANDALL PK, 1981, J PHARMACOL EXP THER, V219, P695
   ROTH GS, 1981, J GERONTOL, V36, P391, DOI 10.1093/geronj/36.4.391
   SANDNES D, 1986, PHARMACOL TOXICOL, V62, P199
   SCARPACE PJ, 1981, ENDOCRINOLOGY, V108, P1276, DOI 10.1210/endo-108-4-1276
   SCHLEIFER LS, 1989, J CELL PHYSIOL, V140, P52, DOI 10.1002/jcp.1041400107
   SEVERSON JA, 1981, BRAIN RES, V210, P201, DOI 10.1016/0006-8993(81)90894-5
   SEVERSON JA, 1985, J PHARMACOL EXP THER, V236, P24
   STRUYKERBOUDIER HAJ, 1978, J PHARM PHARMACOL, V30, P576, DOI 10.1111/j.2042-7158.1978.tb13327.x
   SUNDARESAN PR, 1987, HORM RES, V27, P109, DOI 10.1159/000180796
   TSUJIMOTO G, 1987, AM J PHYSIOL, V21, pH513
   TUMAR N, 1990, J GERONTOL, V45, pB48
   VATNER DE, 1985, CIRC RES, V57, P55, DOI 10.1161/01.RES.57.1.55
   WEBB JG, 1981, J CARDIOVASC PHARM, V3, P622
   WOLFE BB, 1982, BRAIN RES, V234, P474, DOI 10.1016/0006-8993(82)90890-3
   WOOD KS, 1987, J BIOL CHEM, V262, P5020
   ZHOU LW, 1984, J GERONTOL, V39, P538, DOI 10.1093/geronj/39.5.538
NR 55
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0922-4106
J9 EUR J PHARM-MOLEC PH
JI Eur. J. Pharmacol.-Molec. Pharmacol. Sect.
PD DEC 12
PY 1991
VL 208
IS 4
BP 323
EP 330
DI 10.1016/0922-4106(91)90078-V
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA GW802
UT WOS:A1991GW80200006
PM 1687736
DA 2024-02-19
ER

PT J
AU Sen, B
   Rastogi, A
   Nath, R
   Shasthry, SM
   Pamecha, V
   Pandey, S
   Gupta, KJ
   Sarin, SK
   Trehanpati, N
   Ramakrishna, G
AF Sen, Bijoya
   Rastogi, Archana
   Nath, Rhisita
   Shasthry, Saggere M.
   Pamecha, Viniyendra
   Pandey, Sonika
   Gupta, Kapuganti Jagadis
   Sarin, Shiv K.
   Trehanpati, Nirupma
   Ramakrishna, Gayatri
TI Senescent Hepatocytes in Decompensated Liver Show Reduced
   UPR<SUP>MT</SUP> and Its Key Player, CLPP, Attenuates Senescence In
   Vitro
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE Cryptogenic Liver Cirrhosis; Mitochondrial Respiration; Mitochondrial
   Unfolded Protein Response; Oxidative Stress
ID HEPATITIS-C; MITOCHONDRIAL; CIRRHOSIS; DISEASE; CELLS; LEADS
AB BACKGROUND AND AIMS: Non-dividing hepatocytes in end-stage liver disease indicates permanent growth arrest similar to senescence. Identifying senescence in vivo is often challenging and mechanisms inhibiting senescence are poorly understood. In lower organisms mitochondrial unfolded protein response (UPRMT) helps in increasing longevity; however, its role in senescence and liver disease is poorly understood. Aim of this study was to identify hepatocyte senescence and the role of UPRMT in cryptogenic cirrhosis.
   METHODS: Doxorubicin was used to induce senescence in non-neoplastic hepatocytes (PH5CH8) and hepatoma cells (HepG2 and Huh7). Senescence-associated markers and unfolded protein response was evaluated by fluorescence microscopy, immunoblotting and gene expression. Explants/biopsies from normal, fibrosis, compensated and decompensated cirrhosis without any known etiology were examined for presence of senescence and UPRMT by immunohistochemistry and gene expression.
   RESULTS: Accumulation of senescent hepatocytes in cryptogenic cirrhosis was associated with reduced proliferation, increased expression of gamma H2AX and p21, together with loss of LaminB1. Dysfunctional mitochondria and compromised UPRMT were key features of senescent hepatocytes both in vitro and also in decompensated cirrhosis. Intriguingly, compensated cirrhotic liver mounted strong UPRMT, with high levels of mitochondrial protease, CLPP. Overexpression of CLPP inhibited senescence in vitro, by reducing mitochondrial ROS and altering oxygen consumption.
   CONCLUSIONS: Our results implicate a role of hepatocyte senescence in cryptogenic cirrhosis together with a crucial role of UPRMT in preventing hepatocyte senescence. A compromised UPRMT may shift the fate of cirrhotic liver toward decompensation by exaggerating hepatocyte senescence. Restoring CLPP levels at least in cell culture appears as a promising strategy in mitohormesis, thereby, preventing senescence and possibly improving hepatocyte function.
C1 [Sen, Bijoya; Nath, Rhisita; Trehanpati, Nirupma; Ramakrishna, Gayatri] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India.
   [Rastogi, Archana] Inst Liver & Biliary Sci, Dept Pathol, New Delhi, India.
   [Shasthry, Saggere M.; Sarin, Shiv K.] Inst Liver & Biliary Sci, Dept Hepatol, New Delhi, India.
   [Pamecha, Viniyendra] Inst Liver & Biliary Sci, Dept Hepatopancreatobiliary & Liver Transplant Su, New Delhi, India.
   [Pandey, Sonika; Gupta, Kapuganti Jagadis] Natl Inst Plant Genome Res, New Delhi, India.
C3 Institute of Liver & Biliary Sciences (ILBS); Institute of Liver &
   Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS);
   Institute of Liver & Biliary Sciences (ILBS); Department of
   Biotechnology (DBT) India; National Institute of Plant Genome Research
   (NIPGR)
RP Ramakrishna, G (corresponding author), Inst Liver & Biliary Sci, Dept Mol & Cellular Med, D1 Block, Delhi 110070, India.
EM rgayatri@ilbs.in
RI Gupta, Kapuganti J/D-3429-2014; Trehanpati, Nirupma/ABH-8533-2020
OI Gupta, Kapuganti J/0000-0002-7090-5097; Trehanpati,
   Nirupma/0000-0002-6109-0033; Sen, Bijoya/0000-0002-5904-1304;
   Ramakrishna, Gayatri/0000-0003-4345-294X
FU UGC senior research fellowship
FX The authors thank Professor T Ramasarma and Dr. Lucy Anderson for
   critical reading and editing of the manuscript. BS is a recipient of UGC
   senior research fellowship. The authors thank Dr. Nobuyuki Kato, Okayama
   University, for providing us the PH5CH8 cells. They also thank DST-FIST
   for infrastructural support. They also thank the anonymous reviewers for
   their valuable inputs.
CR Anwar T, 2016, CELL CYCLE, V15, P1883, DOI 10.1080/15384101.2016.1189041
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Becker C, 2018, EMBO REP, V19, DOI 10.15252/embr.201745126
   Bhaskaran S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745009
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Brady GF, 2018, GASTROENTEROLOGY, V154, P1602, DOI 10.1053/j.gastro.2018.03.026
   Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004
   de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Deepa SS, 2016, FREE RADICAL BIO MED, V91, P281, DOI 10.1016/j.freeradbiomed.2015.12.021
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Gispert S, 2013, HUM MOL GENET, V22, P4871, DOI 10.1093/hmg/ddt338
   Grattagliano I, 2011, CURR DRUG TARGETS, V12, P879, DOI 10.2174/138945011795528877
   Hendrikx T, 2017, CELL MOL GASTROENTER, V4, P441, DOI 10.1016/j.jcmgh.2017.09.002
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Inoue Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078346
   Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0
   Kato N, 1998, J GEN VIROL, V79, P1859, DOI 10.1099/0022-1317-79-8-1859
   Kwan R, 2017, CELL MOL GASTROENTER, V4, P365, DOI 10.1016/j.jcmgh.2017.06.005
   Kwon YH, 2002, J BIOL CHEM, V277, P41417, DOI 10.1074/jbc.M203388200
   Liu LP, 2012, HEPATOLOGY, V55, P1529, DOI 10.1002/hep.24815
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P947, DOI 10.1111/j.1440-1746.2006.04231.x
   Pang LJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0136-y
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Pryde KR, 2016, CELL REP, V17, P2522, DOI 10.1016/j.celrep.2016.11.027
   Rastogi A, 2013, HISTOPATHOLOGY, V62, P731, DOI 10.1111/his.12070
   Reyes-Gordillo K, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3140673
   Schulz AM, 2015, BBA-BIOENERGETICS, V1847, P1448, DOI 10.1016/j.bbabio.2015.03.008
   Seiferling D, 2016, EMBO REP, V17, P953, DOI 10.15252/embr.201642077
   Shimura T, 2016, ONCOTARGET, V7, P3559, DOI 10.18632/oncotarget.6518
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Szczepanowska K, 2016, EMBO J, V35, P2566, DOI 10.15252/embj.201694253
   Thuluvath PJ, 2018, J HEPATOL, V68, P519, DOI 10.1016/j.jhep.2017.11.018
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Williams JA, 2015, BIOMOLECULES, V5, P2619, DOI 10.3390/biom5042619
NR 41
TC 21
Z9 24
U1 5
U2 11
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PY 2019
VL 8
IS 1
BP 73
EP 94
DI 10.1016/j.jcmgh.2019.03.001
PG 22
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA IF0RH
UT WOS:000472784400005
PM 30878663
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, XY
   Xu, GYBC
   Zhou, D
   Pan, YX
AF Zhang, Xiyuan
   Xu, Guanying Bianca
   Zhou, Dan
   Pan, Yuan-Xiang
TI High-fat diet modifies expression of hepatic cellular senescence gene
   p16(INK4a) through chromatin modifications in adult male rats
SO GENES AND NUTRITION
LA English
DT Article
DE High-fat diet; p21(Cip1); Fatty liver; Hepatic cellular senescence;
   Chromatin modification
ID HEPATOCYTE SENESCENCE; CDK INHIBITORS; METHYLATION; KINASE; CANCER;
   MICE; P21; STEATOHEPATITIS; MECHANISMS; RESISTANCE
AB Background: Liver is the crucial organ as a hub for metabolic reactions. p16(INK4a) is a well-established cyclindependent kinase (CDK) inhibitor that plays important role in the molecular pathways of senescence, which lead to irreversible cell cycle arrest with secretion of proinflammatory cytokines and mitochondrial dysfunction. This study tested the hypothesis that cellular senescence regulated by p16(INK4a) is associated with high-fat diet in adult male rats.
   Methods: Sprague Dawley rats were fed a high-fat (HF) diet or a control (C) diet for 9 weeks after weaning. At 12 weeks of age, liver samples of male rats were collected to investigate the key genes and liver physiological status.
   Results: Both mRNA and protein expression level of cellular senescence marker, p16(INK4a), was increased significantly in HF group when compared to C group. A decrease of tri-methylated histone H3 lysine 27 (H3K27Me3) in the coding region of p16(INK4a) was observed. On the other hand, mRNA and protein expression of another inhibitor of cyclindependent kinase, p21(Cip1), was decreased significantly in HF group; however, no significant chromatin modification was found in this gene. Histological analysis demonstrated hepatic steatosis in HF group as well as severe fat accumulation.
   Conclusions: Our study demonstrated that HF diet regulated cellular senescence marker p16(INK4a) through chromatin modifications, which may promote hepatic fat accumulation and steatosis.
C1 [Zhang, Xiyuan] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA.
   [Xu, Guanying Bianca; Pan, Yuan-Xiang] Univ Illinois, Dept Food Sci & Human Nutr, 461 Bevier Hall,MC 182,905 South Goodwin Ave, Urbana, IL 61801 USA.
   [Pan, Yuan-Xiang] Univ Illinois, Div Nutr Sci, 461 Bevier Hall,MC 182,905 South Goodwin Ave, Urbana, IL 61801 USA.
   [Zhou, Dan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Tongren Hosp, Hongqiao Int Inst Med,Fac Public Hlth, Shanghai 200025, Peoples R China.
   [Pan, Yuan-Xiang] Univ Illinois, Illinois Informat Inst, 461 Bevier Hall,MC 182,905 South Goodwin Ave, Urbana, IL 61801 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); University of Illinois System; University of Illinois
   Urbana-Champaign; University of Illinois System; University of Illinois
   Urbana-Champaign; Shanghai Jiao Tong University; University of Illinois
   System; University of Illinois Urbana-Champaign
RP Pan, YX (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, 461 Bevier Hall,MC 182,905 South Goodwin Ave, Urbana, IL 61801 USA.; Pan, YX (corresponding author), Univ Illinois, Div Nutr Sci, 461 Bevier Hall,MC 182,905 South Goodwin Ave, Urbana, IL 61801 USA.; Pan, YX (corresponding author), Univ Illinois, Illinois Informat Inst, 461 Bevier Hall,MC 182,905 South Goodwin Ave, Urbana, IL 61801 USA.
EM yxpan@illinois.edu
RI Pan, Yuan-Xiang/C-6576-2019; Xu, Bianca/HGC-4422-2022
OI Pan, Yuan-Xiang/0000-0003-3219-4367; Xu, Guanying/0000-0002-3361-1962
FU United States Department of Agriculture Cooperative State Research,
   Education, and Extension Service [ILLU-698-374]
FX This project was supported by the United States Department of
   Agriculture Cooperative State Research, Education, and Extension
   Service, Hatch project no. ILLU-698-374.
CR Aini W, 2014, TRANSPL IMMUNOL, V31, P55, DOI 10.1016/j.trim.2014.06.008
   Benatti RO, 2014, BRIT J NUTR, V111, P2112, DOI 10.1017/S0007114514000579
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Capparelli C, 2012, CELL CYCLE, V11, P3599, DOI 10.4161/cc.21884
   Chao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096969
   Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Deminice R, 2015, AMINO ACIDS, V47, P839, DOI 10.1007/s00726-014-1913-x
   Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669
   Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662
   Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525
   Gao MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119784
   Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354
   Healy ME, 2015, J HEPATOL, V62, P599, DOI 10.1016/j.jhep.2014.10.024
   Heden TD, 2014, APPL PHYSIOL NUTR ME, V39, P472, DOI 10.1139/apnm-2013-0410
   Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409
   Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010
   Jung CH, 2013, PHYTOTHER RES, V27, P139, DOI 10.1002/ptr.4687
   Kirpich IA, 2011, J NUTR BIOCHEM, V22, P38, DOI 10.1016/j.jnutbio.2009.11.009
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350
   Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402
   Liu ZG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0128274, 10.1371/journal.pone.0140839]
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240
   Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369
   Ragab SMM, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0087-1
   Sasaki Y, 2000, CANCER LETT, V152, P71, DOI 10.1016/S0304-3835(99)00430-9
   Sasidharan SR, 2014, SCI WORLD J, DOI 10.1155/2014/507197
   Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001
   Seet EL, 2015, LIPIDS, V50, P565, DOI 10.1007/s11745-015-4018-8
   Serra MP, 2014, INT J RADIAT BIOL, V90, P876, DOI 10.3109/09553002.2014.922714
   Shearn CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096553
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808
   Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tan XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061409
   Toshima T, 2014, HEPATOLOGY, V60, P290, DOI 10.1002/hep.27140
   Vilar L, 2008, NUTRITION, V24, P1097, DOI 10.1016/j.nut.2008.05.017
   Wang Y, 2010, GUT, V59, P1625, DOI 10.1136/gut.2010.210526
   Wu J, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-162
   Wu YQ, 2015, BIOCHEM BIOPH RES CO, V466, P599, DOI 10.1016/j.bbrc.2015.09.096
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
   Yoon A, 2017, NUTR RES PRACT, V11, P105, DOI 10.4162/nrp.2017.11.2.105
   Yoruker EE, 2012, EXP THER MED, V4, P865, DOI 10.3892/etm.2012.683
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
   Zhu QC, 2014, WORLD J GASTROENTERO, V20, P8119, DOI 10.3748/wjg.v20.i25.8119
NR 52
TC 21
Z9 24
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1555-8932
EI 1865-3499
J9 GENES NUTR
JI Genes Nutr.
PD MAR 14
PY 2018
VL 13
AR 6
DI 10.1186/s12263-018-0595-5
PG 12
WC Genetics & Heredity; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Nutrition & Dietetics
GA GA0UF
UT WOS:000428029100001
PM 29564021
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU FABBRI, A
   MARCHESINI, G
   BIANCHI, G
   BUGIANESI, E
   ZOLI, M
   PISI, E
AF FABBRI, A
   MARCHESINI, G
   BIANCHI, G
   BUGIANESI, E
   ZOLI, M
   PISI, E
TI KINETICS OF HEPATIC AMINO-NITROGEN CONVERSION IN AGING MAN
SO LIVER
LA English
DT Article
DE ALANINE; AMINO ACIDS; LIVER FUNCTION; LIVER VOLUME; UREA NITROGEN
ID UREA CYCLE ENZYMES; LIVER-FUNCTION; RAT-LIVER; OLD RATS; GLUCAGON;
   CAPACITY; CLEARANCE; CIRRHOSIS; PROTEIN; DISPOSITION
AB Previous studies have shown that hepatic function, quantitatively measured by dynamic liver function tests, progressively declines with ageing. Urea synthesis is a specific process taking place in the liver; a reduced urea synthesis in response to a protein-rich metal has previously been demonstrated in the elderly, but the process has never been standardized in relation to amino acid supply. We measured the hepatic conversion of alpha-amino nitrogen into urea nitrogen in response to alanine infusion in 32 subjects, with normal routine liver and renal function tests and without evidence of previous hepatic disorders, belonging to three different age-groups (less than or equal to 55 years, 56-70, greater than or equal to 71). The functional hepatic nitrogen clearance was reduced on average by 20% in subjects aged 56-70 years, and by 30% in subjects over 70 years old in comparison to the age group under 55 years (ANOVA: P=0.0001), and significantly correlated with age (r=-0.684). No sex differences were observed on the effects of age on hepatic clearance. Also, liver volume, measured by ultrasonography, was reduced with advancing age, but the age-related decrease in hepatic nitrogen conversion was not primarily dependent on decreased liver volume. The measurement of functional hepatic nitrogen clearance has already been validated as a quantitative liver function test in clinical hepatology. In keeping with previous studies, the age-related deceline in hepatic nitrogen conversion points to a decreased functional capacity of the ageing hepatic parenchyma.
C1 UNIV BOLOGNA, POLICLIN S ORSOLA, IST CLIN MED GEN & TERAPIA MED, I-40138 BOLOGNA, ITALY.
C3 IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of
   Bologna
RI Fabbri, Andrea/K-9994-2016; bianchi, giampaolo/AAD-6147-2021
OI Fabbri, Andrea/0000-0002-9837-4638; Marchesini,
   Giulio/0000-0003-2407-9860
CR ALMDAL TP, 1988, ENDOCRINOLOGY, V123, P2182, DOI 10.1210/endo-123-5-2182
   BENDER BS, 1986, LANCET, V2, P11, DOI 10.1016/S0140-6736(86)92559-6
   BIANCHI G, 1991, HEPATOLOGY, V13, P460, DOI 10.1016/0270-9139(91)90299-B
   BOLING JA, 1975, INT J VITAM NUTR RES, V45, P463
   CHANDLER MHH, 1988, CLIN PHARMACOL THER, V43, P436, DOI 10.1038/clpt.1988.55
   DOSSING M, 1982, CLIN PHARMACOL THER, V32, P392, DOI 10.1038/clpt.1982.177
   DUDL RJ, 1977, METABOLISM, V26, P33, DOI 10.1016/0026-0495(77)90125-1
   FAWCETT JK, 1960, J CLIN PATHOL, V13, P156, DOI 10.1136/jcp.13.2.156
   FISCHERNIELSEN A, 1989, J HEPATOL, V9, P190, DOI 10.1016/0168-8278(89)90050-0
   FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4
   GIBSON JA, 1976, CLIN SCI MOL MED, V50, P51, DOI 10.1042/cs0500051
   Goodwin JF, 1970, STAND METH CLIN CHEM, V6, P89, DOI DOI 10.1016/B978-0-12-609106-9.50014-2
   GREENBLATT DJ, 1980, CLIN PHARMACOL THER, V27, P301, DOI 10.1038/clpt.1980.40
   HAMBERG O, 1992, J HEPATOL, V14, P237, DOI 10.1016/0168-8278(92)90164-K
   HANSEN BA, 1985, SCAND J GASTROENTERO, V20, P346, DOI 10.3109/00365528509091662
   HANSEN BA, 1986, J HEPATOL, V2, P468, DOI 10.1016/S0168-8278(86)80058-7
   HEINDORFF H, 1991, CLIN NUTR, V10, P10, DOI 10.1016/0261-5614(91)90075-N
   JONES EA, 1969, CLIN SCI, V37, P825
   KAMPMANN JP, 1975, GERIATRICS, V30, P91
   KMIEC Z, 1985, EXP GERONTOL, V20, P271, DOI 10.1016/0531-5565(85)90052-X
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   MARCHESINI G, 1990, AGE AGEING, V19, P4, DOI 10.1093/ageing/19.1.4
   MARCHESINI G, 1993, METABOLISM, V42, P1263, DOI 10.1016/0026-0495(93)90123-6
   MARTINEZRAMON A, 1990, J HISTOCHEM CYTOCHEM, V38, P371, DOI 10.1177/38.3.2303702
   MORRIS SM, 1987, ARCH BIOCHEM BIOPHYS, V259, P144, DOI 10.1016/0003-9861(87)90479-6
   PETERSEN KF, 1990, HORM METAB RES, V22, P612, DOI 10.1055/s-2007-1004985
   POPPER H, 1985, HEPATOL RAPID LIT RE, V15, P7
   ROBERTS SH, 1977, LANCET, V2, P1193
   SCHIMKE RT, 1962, J BIOL CHEM, V237, P459
   SCHNEGG M, 1986, J HEPATOL, V3, P164, DOI 10.1016/S0168-8278(86)80022-8
   SIMONSON DC, 1983, DIABETOLOGIA, V25, P1
   SKAUNIC V, 1978, LIVER AGING 1978, P115
   SNODGRASS PJ, 1978, J BIOL CHEM, V253, P2748
   SWIFT CG, 1978, EUR J CLIN PHARMACOL, V14, P149, DOI 10.1007/BF00607447
   TYGSTRUP N, 1983, DIAGNOSTIC PROCEDURE, P17
   VILSTRUP H, 1980, GUT, V21, P990, DOI 10.1136/gut.21.11.990
   VILSTRUP H, 1986, EUR J CLIN INVEST, V16, P193, DOI 10.1111/j.1365-2362.1986.tb01328.x
   VILSTRUP H, 1989, DAN MED BULL, V36, P415
   VILSTRUP H, 1990, J HEPATOL, V10, P46, DOI 10.1016/0168-8278(90)90072-Y
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   ZOLI M, 1989, LIVER, V9, P159
NR 41
TC 18
Z9 19
U1 0
U2 1
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0106-9543
J9 LIVER
JI Liver
PD DEC
PY 1994
VL 14
IS 6
BP 288
EP 294
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA PW802
UT WOS:A1994PW80200002
PM 7877432
DA 2024-02-19
ER

PT J
AU Okamura, K
   Sato, M
   Suzuki, T
   Nohara, K
AF Okamura, Kazuyuki
   Sato, Miyuki
   Suzuki, Takehiro
   Nohara, Keiko
TI Inorganic arsenic exposure-induced premature senescence and
   senescence-associated secretory phenotype (SASP) in human hepatic
   stellate cells
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Arsenic; Senescence; Senescence-associated secretory phenotype (SASP);
   Cancer; Liver; Hepatic stellate cell (HSC)
ID CELLULAR SENESCENCE; PLASMINOGEN-ACTIVATOR; POOR-PROGNOSIS; DNA-DAMAGE;
   CANCER; FIBROBLASTS; EXPRESSION; OVEREXPRESSION; OSTEOPONTIN; METASTASIS
AB Exposure to inorganic arsenic has been known to induce cancers in various organs, however, the underlying mechanisms remain unclear. Premature senescence refers to the irreversible growth arrest induced by stress stimuli. The senescence-associated secretory phenotype (SASP), particularly in fibroblasts, has been shown to promote cancer development. In this study, we examined whether arsenite exposure causes premature senescence and induction of SASP in liver fibroblasts using the human hepatic stellate cell line, LX-2. Exposure of LX-2 cells to 5 or 7.5 mu M of sodium arsenite for 144 h induced the features of senescence in the cells, including morphological changes, growth inhibition, increased senescence-associated beta-galactosidase activity, increased P21 gene expression, and decreased LAMINB1 gene expression. The mRNA expressions of SASP factors, such as MMP1, MMP3, IL-8, IL-1 beta, and CXCL1, were also highly upregulated. The wound healing assay revealed that the conditioned medium from LX-2 cells with arsenite-induced senescence increased the migration activity of cells of the human hepatoma cell line, Huh-7. Gene expression data of liver cancer samples from the Human Protein Atlas showed that high expression levels of the SASP factors that were upregulated in the cells with arsenite-induced senescence were strongly associated with a poor prognosis. In addition, the cellular levels of gamma-H2AX, a DNA double-strand break marker, were increased by arsenite exposure, suggesting that DNA damage could contribute to premature senescence induction. These results show that arsenite exposure induces premature senescence in hepatic stellate cells and suggest that the SASP factors from the senescent cells promote hepatic carcinogenesis.
C1 [Okamura, Kazuyuki; Sato, Miyuki; Suzuki, Takehiro; Nohara, Keiko] Natl Inst Environm Studies, Hlth & Environm Risk Div, Tsukuba, Ibaraki 3058506, Japan.
C3 National Institute for Environmental Studies - Japan
RP Okamura, K (corresponding author), Natl Inst Environm Studies, Hlth & Environm Risk Div, Tsukuba, Ibaraki 3058506, Japan.
EM okamura.kazuyuki@nies.go.jp
OI Okamura, Kazuyuki/0000-0003-3882-9722
FU National Institute for Environmental Studies [1617AQ001]; Ministry of
   Education, Culture, Sports, Science and Technology of Japan [18K17363]
FX We express our gratitude to Dr. Hirano, Dr. Udagawa and Ms. Murai (NIES)
   for their experimental supports. We would like to thank Ms. Ikezawa for
   their secretarial assistance. This work was supported by a grant from
   the National Institute for Environmental Studies (1617AQ001, KO) and
   Grant-in-Aid for Young Scientists (B) from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan (18K17363, KO).
CR Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Benedicto A, 2017, ONCOL LETT, V14, P3883, DOI 10.3892/ol.2017.6700
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260
   Chung YP, 2020, ARCH TOXICOL, V94, P89, DOI 10.1007/s00204-019-02607-2
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Dubuisson L, 2000, J PATHOL, V190, P190, DOI 10.1002/(SICI)1096-9896(200002)190:2<190::AID-PATH511>3.0.CO;2-H
   Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379
   Ghosh D, 2020, J CELL SCI, V133, DOI 10.1242/jcs.232470
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184
   Johmura Y, 2014, MOL CELL, V55, P73, DOI 10.1016/j.molcel.2014.05.003
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2
   Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583
   Mao Zhiyong, 2012, Aging (Albany NY), V4, P431
   Martinez VD, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/431287
   MITSUI Y, 1976, EXP CELL RES, V100, P147, DOI 10.1016/0014-4827(76)90336-0
   Morita Y, 1997, HEPATOLOGY, V25, P856, DOI 10.1002/hep.510250412
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461
   Ninomiya Y, 2014, BMB REP, V47, P575, DOI 10.5483/BMBRep.2014.47.10.254
   Okamura K, 2020, TOXICOL APPL PHARM, V408, DOI 10.1016/j.taap.2020.115259
   Okamura K, 2016, ARCH TOXICOL, V90, P793, DOI 10.1007/s00204-015-1500-2
   Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Nguyen PT, 2020, J CANCER RES CLIN, V146, P3255, DOI 10.1007/s00432-020-03374-9
   Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002
   Smith Allan H, 2018, J Natl Cancer Inst, V110, P241, DOI 10.1093/jnci/djx201
   Song T, 2018, J CANCER, V9, P2650, DOI 10.7150/jca.25188
   Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028
   Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9
   Wakita M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15719-6
   Wang BS, 2020, TRENDS CANCER, V6, P838, DOI 10.1016/j.trecan.2020.05.004
   Wang C, 2019, NATURE, V574, P268, DOI 10.1038/s41586-019-1607-3
   Watanabe S, 2017, CANCER SCI, V108, P563, DOI 10.1111/cas.13184
   Yamaguchi Y, 2016, J TOXICOL SCI, V41, P105, DOI 10.2131/jts.41.105
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu XX, 2018, ONCOL LETT, V16, P5299, DOI 10.3892/ol.2018.9281
NR 49
TC 5
Z9 5
U1 3
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD NOV 1
PY 2022
VL 454
AR 116231
DI 10.1016/j.taap.2022.116231
PG 15
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 6Z9YR
UT WOS:000898123800006
PM 36089002
DA 2024-02-19
ER

PT J
AU Hong, IH
   Han, JY
   Goo, MJ
   Hwa, SY
   Ki, MR
   Park, JK
   Hong, KS
   Hwang, OK
   Kim, TH
   Yoo, SE
   Jeong, KS
AF Hong, Il-Hwa
   Han, Jung-Youn
   Goo, Moon-Jung
   Hwa, Sung-Young
   Ki, Mi-Ran
   Park, Jin-Kyu
   Hong, Kyung-Sook
   Hwang, Ok-Kyung
   Kim, Tae-Hwan
   Yoo, Sung-Eun
   Jeong, Kyu-Shik
TI Ascorbic acid deficiency accelerates aging of hepatic stellate cells
   with up-regulation of PPARγ
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE SMP30 knockout mice; Aging; Ascorbic acid; PPAR gamma; Hepatic stellate
   cells; Hypervitaminosis A
ID PROTEIN-30 KNOCKOUT MOUSE; AGE-RELATED-CHANGES; ACTIVATION IN-VIVO;
   VITAMIN-A; CELLULAR SENESCENCE; OXIDATIVE STRESS; SMP30 DEFICIENCY;
   LIVER FIBROSIS; MICE; GENE
AB Senescent cells have been observed in certain aged or damaged tissues. However, the information about the effects of aging on liver cells is limited. In the present study, we have examined age-related histological changes in the livers of senescence marker protein knockout (SMP30(-/-)) mice, which are considered as a murine aging model due to the more sensitive response to apoptotic reagents and due to their shorter life span. In livers of old SMP30(-/-) mice, numerous hepatic stellate cells (HSCs) were hypertrophic and contained abundant microvesicular lipid droplets in cytoplasm. We have found that the expression of peroxisome proliferators-activated receptor gamma (PPAR gamma), which is a protein related to lipid metabolism and HSC quiescence, was increased in hypertrophic HSCs by aging and vitamin C (VC) deficiency, whereas these phenomena were dramatically reduced by antioxidant treatment. Therefore, these prominent phenotypic changes can be considered as aging markers in the livers of animals which are subjected to antioxidant property evaluation.
C1 [Hong, Il-Hwa; Han, Jung-Youn; Goo, Moon-Jung; Ki, Mi-Ran; Park, Jin-Kyu; Hong, Kyung-Sook; Hwang, Ok-Kyung; Kim, Tae-Hwan; Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
   [Yoo, Sung-Eun] Korea Res Inst Chem Technol, Taejon 305606, South Korea.
   [Hwa, Sung-Young] Jinju Bio Food, Jinju, South Korea.
C3 Kyungpook National University; Korea Research Institute of Chemical
   Technology (KRICT)
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
EM jeongks@knu.ac.kr
RI Hong, Kyung Sook/AAX-7067-2021
OI Hong, Kyung Sook/0000-0002-8022-5693
FU Center for Biological Modulators of thee21st Century Frontier, the
   Ministry of Science and Technology, Korea [CBM34-B3003-01-01-00]
FX This research was supported by a grant (code# CBM34-B3003-01-01-00) from
   the Center for Biological Modulators of thee21st Century Frontier R&D
   Program, the Ministry of Science and Technology, Korea. We sincerely
   thank Akihito Ishigami for providing us SMP30 knockout mice.
CR Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268
   Auwerx Johan, 2003, Nucl Recept Signal, V1, pe006
   BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545
   Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666
   Gan Q, 2008, J CELL SCI, V121, P2235, DOI 10.1242/jcs.026633
   Gressner AM, 1996, KIDNEY INT, V49, pS39
   Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200
   Henneberger C, 2000, J NEUROSCI METH, V100, P123, DOI 10.1016/S0165-0270(00)00241-7
   Hong IH, 2011, MAR BIOTECHNOL, V13, P462, DOI 10.1007/s10126-010-9317-8
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Kanel G.C., 2005, DRUG INDUCED TOXIC L, P78
   Kashio A, 2009, BIOCHEM BIOPH RES CO, V390, P394, DOI 10.1016/j.bbrc.2009.09.003
   Kaul D, 2005, EUR J CLIN NUTR, V59, P978, DOI 10.1038/sj.ejcn.1602203
   Kon K, 2002, BIOCHEM BIOPH RES CO, V291, P55, DOI 10.1006/bbrc.2002.6385
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200
   Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365
   Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068
   Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685
   Park JK, 2008, TOXICOLOGY, V246, P132, DOI 10.1016/j.tox.2008.01.006
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Propper H., 1986, PROG LIVER DIS, V8, P659
   Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012
   ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Senoo H, 2007, VITAM HORM, V75, P131, DOI 10.1016/S0083-6729(06)75006-3
   Senoo Haruki, 2004, Medical Electron Microscopy, V37, P3, DOI 10.1007/s00795-003-0230-3
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   van der Loo B, 2004, J CARDIOVASC PHARM, V43, P26, DOI 10.1097/00005344-200401000-00005
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081
NR 45
TC 2
Z9 3
U1 0
U2 5
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
EI 1699-5848
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD FEB
PY 2012
VL 27
IS 2
BP 171
EP 179
PG 9
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA 876ND
UT WOS:000299113400005
PM 22207551
DA 2024-02-19
ER

PT J
AU Wandrer, F
   Han, B
   Liebig, S
   Schlue, J
   Manns, MP
   Schulze-Osthoff, K
   Bantel, H
AF Wandrer, F.
   Han, B.
   Liebig, S.
   Schlue, J.
   Manns, M. P.
   Schulze-Osthoff, K.
   Bantel, H.
TI Senescence mirrors the extent of liver fibrosis in chronic hepatitis C
   virus infection
SO ALIMENTARY PHARMACOLOGY & THERAPEUTICS
LA English
DT Article
ID SECRETORY PHENOTYPE; DNA-DAMAGE; HEPATOCYTE SENESCENCE; CELLULAR
   SENESCENCE; CIRRHOSIS; BIOPSY; CELLS; REGENERATION; ACTIVATION;
   BIOMARKERS
AB Background: Chronic viral hepatitis is linked to fibrotic liver injury that can progress to liver cirrhosis with its associated complications. Recent evidence suggests a role of senescence in liver fibrosis, although the senescence regulators contributing to fibrosis progression remain unclear.
   Aim: To investigate the role of senescence and different senescence markers for fibrosis progression in patients with chronic hepatitis C virus (HCV) infection.
   Methods: The expression of the cell cycle inhibitors p21, p27 and p16 as well as the senescence markers p-HP1c and c-H2AX was analysed in liver tissue with different fibrosis stages. Senescence-associated chitotriosidase activity was measured in sera of HCV patients (n = 61) and age-matched healthy individuals (n = 22).
   Results: We found a remarkable up-regulation of the cell cycle inhibitors and senescence markers in chronic HCV infection compared to healthy liver tissue. Liver tissue with relevant fibrosis stages (F2-3) or cirrhosis (F4) revealed a significant increase in senescent cells compared to livers with no or minimal fibrosis (F0-1). In cirrhotic livers, a significantly higher number of p-HP1c, p21 and p27 positive cells was detected compared to liver tissue with F2-3 fibrosis. Importantly, we identified T-cells as the dominant cell type contributing to increased senescence during fibrosis progression. Compared to healthy individuals, serum chitotriosidase was significantly elevated and correlated with histological fibrosis stages and liver stiffness as assessed by transient elastography.
   Conclusions: Senescence of hepatic T-cells is enhanced in chronic viral hepatitis and increases with fibrosis progression. Serological detection of senescence-associated chitotriosidase might allow for the non-invasive detection of relevant fibrosis stages.
C1 [Wandrer, F.; Liebig, S.; Manns, M. P.; Bantel, H.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.
   [Han, B.] Fritz Lipmann Inst, Leibniz Inst Aging, Jena, Germany.
   [Schlue, J.] Hannover Med Sch, Dept Pathol, Hannover, Germany.
   [Manns, M. P.; Bantel, H.] German Ctr Infect Res DZIF, Hannover, Germany.
   [Schulze-Osthoff, K.] German Canc Consortium DKTK, Heidelberg, Germany.
   [Schulze-Osthoff, K.] German Canc Res Ctr, Heidelberg, Germany.
   [Schulze-Osthoff, K.] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.
C3 Hannover Medical School; Leibniz Institut fur Alternsforschung -
   Fritz-Lipmann-Institut (FLI); Hannover Medical School; German Center for
   Infection Research; Helmholtz Association; German Cancer Research Center
   (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ);
   Eberhard Karls University of Tubingen
RP Bantel, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.
EM bantel.heike@mh-hannover.de
RI Schulze-Osthoff, Klaus/N-9025-2013
OI Schulze-Osthoff, Klaus/0000-0003-1443-2720
FU German Centre for Infection Research (DZIF); Deutsche
   Forschungsgemeinschaft [SFB/TR 209]
FX This study was supported by the German Centre for Infection Research
   (DZIF) and SFB/TR 209 of the Deutsche Forschungsgemeinschaft.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Akbar AN, 2016, TRENDS IMMUNOL, V37, P866, DOI 10.1016/j.it.2016.09.002
   Alexander E, 2013, J CELL SCI, V126, P3738, DOI 10.1242/jcs.128835
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bantel H, 2004, HEPATOLOGY, V40, P1078, DOI 10.1002/hep.20411
   BEDOSSA P, 1994, HEPATOLOGY, V20, P15
   Bellon M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100289
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Castéra L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hildebrand DG, 2013, CELL CYCLE, V12, P1922, DOI 10.4161/cc.24944
   Hoare M, 2013, J HEPATOL, V58, P868, DOI 10.1016/j.jhep.2012.12.009
   Hoare M, 2010, J HEPATOL, V53, P252, DOI 10.1016/j.jhep.2010.03.005
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Ito Y, 2017, TRENDS CELL BIOL, V27, P830, DOI 10.1016/j.tcb.2017.07.004
   Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105
   John K, 2014, HEPATOLOGY, V60, P1346, DOI 10.1002/hep.27250
   Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Martínez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344
   Tachtatzis PM, 2015, INFLAMMATION FIBROSI, V10
   Tapper EB, 2017, NEW ENGL J MED, V377, P756, DOI 10.1056/NEJMra1610570
   Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442
   Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706
   Yosef R, 2017, EMBO J, V36, P2280, DOI 10.15252/embj.201695553
NR 52
TC 20
Z9 21
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-2813
EI 1365-2036
J9 ALIMENT PHARM THER
JI Aliment. Pharmacol. Ther.
PD AUG
PY 2018
VL 48
IS 3
BP 270
EP 280
DI 10.1111/apt.14802
PG 11
WC Gastroenterology & Hepatology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Pharmacology & Pharmacy
GA GM7CW
UT WOS:000438337100003
PM 29863282
OA Bronze
DA 2024-02-19
ER

PT J
AU Huang, YH
   Yang, X
   Meng, Y
   Shao, CC
   Liao, JP
   Li, FW
   Li, R
   Jing, YY
   Huang, AM
AF Huang, Yihua
   Yang, Xue
   Meng, Yan
   Shao, Changchun
   Liao, Jianping
   Li, Fengwei
   Li, Rong
   Jing, Yingying
   Huang, Aimin
TI The hepatic senescence-associated secretory phenotype promotes
   hepatocarcinogenesis through Bcl3-dependent activation of macrophages
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Liver cancer; Hepatic senescence-associated secretory phenotype; Bcl3;
   Macrophage
ID NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; DUCTULAR REACTION; BCL-3
   EXPRESSION; LIVER-CANCER; CELL; SURVEILLANCE; PHOSPHORYLATION;
   INFLAMMATION; PROGRESSION
AB Background Liver cancer is one of the most common malignancies in the world with a poor prognosis. Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, accounting for 80-90% of cases. The initiation and progression of HCC are closely associated with chronic liver inflammation. In addition, HCC is often accompanied by cell senescence. Senescent hepatocytes can secrete various inflammatory factors, collectively called the senescence-associated secretory phenotype (SASP). The SASP has been confirmed to promote the occurrence of liver cancer by affecting the inflammatory microenvironment. However, its role and the underlying mechanism of hepatic SASP in hepatocarcinogenesis are not clearly understood. Therefore, a better understanding of the pathogenic mechanisms of the effect of the hepatic SASP on the occurrence of HCC is still needed. Methods The study aims to explore the role of SASP factors and the underlying mechanism in tumorigenesis and the progression of HCC in vivo. We used diethylnitrosamine (DEN) combined with carbon tetrachloride (CCl4) (DEN-CCl4) to establish liver cancer model in wild-type (WT) mice and Bcl3 knockout (Bcl3(-/-)) mice. beta-galactosidase (beta-gal) staining was performed to evaluate the degree of cellular senescence. Immunohistochemistry (IHC) were used to detect the degree of cellular senescence and the activation of macrophage. PCR chip and clinical tissue chip assays were used to estimate the RNA levels of SASP factors and NF-kappa B related genes, and their protein levels were examined by Western blot assays. Results DEN-CCl4 induced cellular senescence in mouse hepatocytes. In addition, senescent hepatocytes might release a variety of inflammatory factors that further activate macrophages, thereby changing the microenvironmental state and promoting the occurrence of HCC. Mechanistically, the NF-kappa B pathway is important because it regulates the SASP. Therefore, we used a PCR chip to detect the expression of NF-kappa B-related genes in senescent liver tissue. Our results showed that the expression of Bcl3 was increased in senescent hepatocytes, and knocking out Bcl3 significantly inhibited the secretion of hepatocyte SASP factors and the activation of macrophages, thereby inhibiting hepatocarcinogenesis. Finally, in clinical tissues adjacent to HCC tissues in patients, the expression of Bcl3 and IL-8 correlated with poor prognosis in HCC patients. Conclusion The hepatic SASP can further induce the activation of macrophages during hepatocarcinogenesis, thereby promoting the occurrence of HCC, and that this process is closely related to the expression of Bcl3 in hepatocytes.
C1 [Huang, Yihua; Liao, Jianping; Huang, Aimin] Fujian Med Univ, Sch Basic Med Sci, Dept Pathol, 88 Jiaotong Rd, Fuzhou 350004, Fujian, Peoples R China.
   [Yang, Xue; Meng, Yan; Shao, Changchun; Li, Rong] Second Mil Med Univ, Affiliated Hosp 3, Tumor Immunol & Gene Therapy Ctr, Shanghai 200438, Peoples R China.
   [Jing, Yingying] Shanghai Univ, Inst Translat Med, Shanghai 200444, Peoples R China.
   [Li, Fengwei] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 4, Shanghai 200438, Peoples R China.
C3 Fujian Medical University; Naval Medical University; Shanghai
   University; Naval Medical University
RP Huang, AM (corresponding author), Fujian Med Univ, Sch Basic Med Sci, Dept Pathol, 88 Jiaotong Rd, Fuzhou 350004, Fujian, Peoples R China.; Jing, YY (corresponding author), Shanghai Univ, Inst Translat Med, Shanghai 200444, Peoples R China.
EM jingy4172@shu.edu.cn; aimin@fjmu.edu.cn
RI Meng, Yan/HGC-0394-2022; Liao, Jian/GRX-4579-2022
OI Yang, Xue/0000-0003-1965-0399
FU National Key R&D Program of China [2018YFA0107500, 2017YFA0504503];
   Natural Science Foundation of Fujian Province, China [2019J01298];
   National Natural Science Foundation of China [81630070, 81772940,
   81972599, 81972254, 81802737]
FX This project was supported by the National Key R&D Program of China
   (Grant No. 2018YFA0107500, 2017YFA0504503,); Natural Science Foundation
   of Fujian Province, China (Grant No. 2019J01298); National Natural
   Science Foundation of China (Grant No. 81630070, 81772940, 81972599,
   81972254, 81802737).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Alraouji NN, 2021, MOL CARCINOGEN, V60, P51, DOI 10.1002/mc.23270
   Bakouny Z, 2020, NAT MED, V26, P650, DOI 10.1038/s41591-020-0873-9
   BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B
   Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200
   Chang TP, 2014, BBA-MOL CELL RES, V1843, P2620, DOI 10.1016/j.bbamcr.2014.07.012
   Chen X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.405
   Choi HJ, 2010, BIOCHEM BIOPH RES CO, V400, P396, DOI 10.1016/j.bbrc.2010.08.084
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937
   Georgilis A, 2018, CANCER CELL, V34, P85, DOI 10.1016/j.ccell.2018.06.007
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025
   Hoare M, 2013, NAT CELL BIOL, V15, P887, DOI 10.1038/ncb2811
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kocabayoglu P, 2015, J HEPATOL, V63, P141, DOI 10.1016/j.jhep.2015.01.036
   Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lau LN, 2019, EXPERT OPIN THER TAR, V23, P1041, DOI 10.1080/14728222.2019.1565658
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Liu WT, 2020, CELL DEATH DIFFER, V27, P85, DOI 10.1038/s41418-019-0340-7
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620
   Meguro K, 2015, ARTHRITIS RHEUMATOL, V67, P2651, DOI 10.1002/art.39266
   Michaux L, 1996, GENE CHROMOSOME CANC, V15, P38, DOI 10.1002/(SICI)1098-2264(199601)15:1<38::AID-GCC6>3.0.CO;2-5
   NAUMANN M, 1993, EMBO J, V12, P213, DOI 10.1002/j.1460-2075.1993.tb05647.x
   NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557
   O'Carroll C, 2013, CLIN EXP IMMUNOL, V173, P332, DOI 10.1111/cei.12119
   OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H
   Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Poveda J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.89
   Ruhland MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11762
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Singal AG, 2020, J HEPATOL, V72, P250, DOI 10.1016/j.jhep.2019.08.025
   Song L, 2016, GASTROENTEROLOGY, V150, P499, DOI 10.1053/j.gastro.2015.10.017
   Sung H., 2021, CA Cancer J. Clin, V71, P209, DOI DOI 10.3322/caac.21660
   Tachibana Y, 2007, CANCER LETT, V251, P36, DOI 10.1016/j.canlet.2006.10.028
   Tao Y, 2018, ONCOGENE, V37, P5887, DOI 10.1038/s41388-018-0363-4
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Tu KS, 2016, ONCOL REP, V35, P2382, DOI 10.3892/or.2016.4616
   Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wakefield A, 2013, CANCER RES, V73, P745, DOI 10.1158/0008-5472.CAN-12-1321
   Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351
   Wei L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12606-7
   Xiao P, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1440166
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang XR, 2013, J IMMUNOL, V191, P5984, DOI 10.4049/jimmunol.1300611
   Zhu FY, 2015, ONCOL REP, V34, P2643, DOI 10.3892/or.2015.4268
   Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381
NR 60
TC 12
Z9 13
U1 3
U2 21
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD SEP 16
PY 2021
VL 11
IS 1
AR 173
DI 10.1186/s13578-021-00683-5
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA UR1QU
UT WOS:000696531000001
PM 34530917
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shi, Y
   Shu, ZJ
   Wang, H
   Barnes, JL
   Yeh, CK
   Ghosh, PM
   Katz, MS
   Kamat, A
AF Shi, Yun
   Shu, Zhen-Ju
   Wang, Hanzhou
   Barnes, Jeffrey L.
   Yeh, Chih-Ko
   Ghosh, Paramita M.
   Katz, Michael S.
   Kamat, Amrita
TI Altered expression of hepatic β-adrenergic receptors in aging rats:
   implications for age-related metabolic dysfunction in liver
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE beta-arrestin; food restriction; G protein-coupled receptor; G
   protein-coupled receptor serine/threonine kinase; hepatocytes
ID PROTEIN-COUPLED RECEPTORS; SALIVARY CELL-LINE; BETA(2)-ADRENERGIC
   RECEPTOR; ADENYLATE-CYCLASE; BETA-2-ADRENERGIC RECEPTORS; MESSENGER-RNA;
   BETA(1)-ADRENERGIC RECEPTOR; POSTNATAL-DEVELOPMENT; GLUCOSE-TOLERANCE;
   FISCHER-344 RATS
AB Increased beta-adrenergic receptor (beta-AR)-mediated activation of adenylyl cyclase (AC) in rat liver during aging has been linked to age-related increases in hepatic glucose output and hepatosteatosis. In this study. we investigated the expression of beta-ARs, individual receptor subtypes, and G protein-coupled receptor (GPCR) regulatory proteins in livers from aging rats. Radioligand-binding studies demonstrated that beta-AR density increased by greater than threefold in hepatocyte membranes from senescent (24-mo-old) compared with young adult (7-mo-old) rats and that this phenomenon was blocked by food restriction, which is known to retard aging processes in rodents. Competition-binding studies revealed a mixed population of beta(1)- and beta(2)-AR subtypes in liver membranes over the adult life span. with a trend for greater beta(2)-AR density with age. Expression of both beta-AR subtype mRNAs in rat liver increased with age, whereas beta(2)- but not beta(1)-AR protein levels declined in livers of old animals. Immunoreactive beta(2)- but not beta(1)-ARs were preferentially distributed in pericentral hepatic regions. Levels of GRK2/3 and beta-arrestin 2 proteins, which are involved in downregulation of agonist-activated GPCRs, including beta-ARs, increased during aging. Insofar as sympathetic tone increases with age, our findings suggest that, despite enhanced agonist-mediated downregulation of hepatic beta-ARs preferentially affecting the beta(2)-AR subtype. increased generation of both receptor subtypes during aging augments the pool of plasma membrane-bound beta-ARs coupled to AC in hepatocytes. This study thus identifies one or both beta-AR subtypes as possible therapeutic targets involved in aberrant hepatic processes of glucose and lipid metabolism during aging.
C1 [Shi, Yun; Shu, Zhen-Ju; Wang, Hanzhou; Yeh, Chih-Ko; Katz, Michael S.; Kamat, Amrita] South Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.
   [Shi, Yun; Shu, Zhen-Ju; Barnes, Jeffrey L.; Katz, Michael S.; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Wang, Hanzhou; Yeh, Chih-Ko; Katz, Michael S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, San Antonio, TX 78229 USA.
   [Yeh, Chih-Ko; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Ghosh, Paramita M.] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA.
   [Ghosh, Paramita M.] Univ Calif Davis, Dept Biochem, Sacramento, CA 95817 USA.
   [Ghosh, Paramita M.] Vet Affairs Northern Calif Hlth Care Syst, Res Serv, Mather, CA USA.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy
   Memorial Veterans Hospital; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   University of California System; University of California Davis;
   University of California System; University of California Davis
RP Kamat, A (corresponding author), South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.
EM Amrita.Kamat@va.gov
OI Yeh, Chih-Ko/0000-0001-6611-9942
FU Veterans Administration Merit Review Award [1I01BX001744-01]; Kronos
   Longevity Research Institute Award
FX This work was supported by a Veterans Administration Merit Review Award
   (1I01BX001744-01 to A. Kamat) and a Kronos Longevity Research Institute
   Award (to M. S. Katz).
CR ARNER P, 1990, J CLIN ENDOCR METAB, V71, P1119, DOI 10.1210/jcem-71-5-1119
   Baeyens DA, 1998, J CELL PHYSIOL, V175, P333, DOI 10.1002/(SICI)1097-4652(199806)175:3<333::AID-JCP11>3.0.CO;2-6
   BAEYENS DA, 1995, J CELL PHYSIOL, V163, P305, DOI 10.1002/jcp.1041630211
   Black JB, 2016, SEMIN CELL DEV BIOL, V50, P95, DOI 10.1016/j.semcdb.2015.12.015
   Blaxall BC, 2002, MOL CELL BIOCHEM, V232, P1, DOI 10.1023/A:1014819016552
   Cardani R, 2001, HISTOCHEM CELL BIOL, V116, P441, DOI 10.1007/s00418-001-0340-8
   Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128
   Cheluvappa R, 2007, ANN NY ACAD SCI, V1114, P88, DOI 10.1196/annals.1396.007
   CIZZA G, 1995, J CLIN INVEST, V95, P1217, DOI 10.1172/JCI117771
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   Dax EM, 1988, GERONTOLOGIST, V28, p137A
   Faulkner JL, 2005, AM J PATHOL, V167, P1193, DOI 10.1016/S0002-9440(10)61208-4
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   GREEN SA, 1994, J BIOL CHEM, V269, P26215
   GREEN SA, 1992, MOL PHARMACOL, V41, P889
   Gruenewald D. A., 2003, PRINCIPLES GERIATRIC, P819
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   Hellgren I, 2000, BIOL PHARM BULL, V23, P700
   Jin W, 2010, J RECEPT SIG TRANSD, V30, P24, DOI 10.3109/10799890903358206
   Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V483, P452, DOI 10.1016/0005-2744(77)90073-0
   Kamat A, 2008, J GERONTOL A-BIOL, V63, P683, DOI 10.1093/gerona/63.7.683
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   KAWAI Y, 1986, J CLIN ENDOCR METAB, V62, P827, DOI 10.1210/jcem-62-5-827
   Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198
   KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191
   Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878
   Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200
   Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007
   Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868
   Mazzeo RS, 1995, MECH AGEING DEV, V84, P157, DOI 10.1016/0047-6374(95)01643-0
   MINNEMAN KP, 1979, J PHARMACOL EXP THER, V211, P502
   Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812
   SANGHANI MP, 1994, J GERONTOL, V49, pB60, DOI 10.1093/geronj/49.2.B60
   SANO M, 1993, LIFE SCI, V52, P1063, DOI 10.1016/0024-3205(93)90199-D
   Santulli G, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-10
   Santulli G, 2012, DIABETES, V61, P692, DOI 10.2337/db11-1027
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schutzer WE, 2001, AM J PHYSIOL-REG I, V280, pR897, DOI 10.1152/ajpregu.2001.280.3.R897
   Schutzer WE, 2011, VASC PHARMACOL, V55, P178, DOI 10.1016/j.vph.2011.09.001
   Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866
   Shi Y, 2016, EXP GERONTOL, V78, P32, DOI 10.1016/j.exger.2016.03.005
   Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313
   SUPIANO MA, 1993, J GERONTOL, V48, pB173, DOI 10.1093/geronj/48.5.B173
   SUZUKI T, 1992, MOL PHARMACOL, V41, P542
   Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5
   VANERMEN A, 1992, MOL PHARMACOL, V42, P649
   Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335
   Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444
   Yeh CK, 2003, AM J PHYSIOL-CELL PH, V284, pC1164, DOI 10.1152/ajpcell.00343.2002
   Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   Zhang BX, 2000, AM J PHYSIOL-CELL PH, V279, pC1024, DOI 10.1152/ajpcell.2000.279.4.C1024
   ZHOU XM, 1995, CELL SIGNAL, V7, P207, DOI 10.1016/0898-6568(94)00091-O
NR 61
TC 9
Z9 12
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD APR
PY 2018
VL 314
IS 4
BP R574
EP R583
DI 10.1152/ajpregu.00372.2017
PG 10
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA GP8CV
UT WOS:000441138400010
PM 29212811
OA Green Submitted, Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Luo, JL
   Li, L
   Chang, B
   Zhu, ZYM
   Deng, F
   Hu, MY
   Yu, Y
   Lu, X
   Chen, ZL
   Zuo, DM
   Zhou, J
AF Luo, Jialiang
   Li, Lei
   Chang, Bo
   Zhu, Zhengyumeng
   Deng, Fan
   Hu, Mengyao
   Yu, Yu
   Lu, Xiao
   Chen, Zhengliang
   Zuo, Daming
   Zhou, Jia
TI Mannan-Binding Lectin via Interaction With Cell Surface Calreticulin
   Promotes Senescence of Activated Hepatic Stellate Cells to Limit Liver
   Fibrosis Progression
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE Mannan-Binding Lectin; Hepatic Stellate Cell Senescence; Liver Fibrosis
ID GENE POLYMORPHISMS; IMMUNE FUNCTIONS; INNATE; COLLECTIN; MBL
AB BACKGROUND & AIMS: Liver fibrosis represents a hallmark of most chronic liver diseases (CLD) triggered by recurrent liver injury and subsequent myofibroblast transdifferentiations of resident hepatic stellate cells (HSCs). Mannan-binding lectin (MBL) is potentially involved in hepatic fibrosis in CLD through unclear mechanisms. Therefore, we investigated the crosstalk between MBL and HSCs, and the consequent effects on fibrosis progression.
   METHODS: Samples from patients with liver cirrhosis were collected. MBL deficiency (MBL-/-) and wild-type (WT) C57BL/6J mice were used to construct a CCl4-induced liver fibrosis model. Administration of MBL-expressing, liver-specific, adenoassociated virus was performed to restore hepatic MBL expression in MBL-/- mice. The human HSC line LX-2 was used for in vitro experiments.
   RESULTS: MBL levels in patients with liver cirrhosis were correlated with disease severity. In the CCl4-induced liver fibrosis model, MBL-/- mice showed severer liver fibrosis accompanied by reduced senescent activated HSCs in liver tissue compared with WT mice, which could be inhibited by administering MBL-expressing, liver-specific, adeno-associated virus. Moreover, depleting senescent cells with senolytic treatment could abrogate these differences owing to MBL absence. Furthermore, MBL could interact directly with calreticulin associated with low-density lipoprotein receptor-related protein 1 on the cell surface of HSCs, which further promotes senescence in HSCs by upregulating the mammalian target of rapamycin/p53/p21 signaling pathway.
   CONCLUSIONS: MBL as a newfound senescence-promoting modulator and its crosstalk with HSCs in the liver microenvironment is essential for the control of hepatic fibrosis progression, suggesting its potential therapeutic use in treating CLD associated with liver fibrosis.
C1 [Luo, Jialiang; Li, Lei; Chang, Bo; Zhu, Zhengyumeng; Deng, Fan; Hu, Mengyao; Yu, Yu; Lu, Xiao; Chen, Zhengliang; Zhou, Jia] Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangzhou 510515, Guangdong, Peoples R China.
   [Luo, Jialiang; Li, Lei; Zhu, Zhengyumeng; Deng, Fan; Zuo, Daming] Southern Med Univ, Sch Lab Med & Biotechnol, Dept Med Lab, Guangzhou 510515, Guangdong, Peoples R China.
C3 Southern Medical University - China; Southern Medical University - China
RP Zhou, J (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangzhou 510515, Guangdong, Peoples R China.; Zuo, DM (corresponding author), Southern Med Univ, Sch Lab Med & Biotechnol, Dept Med Lab, Guangzhou 510515, Guangdong, Peoples R China.
EM zdaming@smu.edu.cn; yuguomm@smu.edu.cn
RI Zhou, Jia/ISA-2951-2023
OI Zhou, Jia/0000-0001-6107-5469; Zuo, Daming/0000-0003-2003-9474
FU National Natural Science Foundation of China [81971550, 81873872,
   82071781, 82171745]; Science and Technology Planning Project of
   Guangzhou [202002030160]; Guangdong Basic and Applied Basic Research
   Foundation of Guangdong Province [2022A1515012437]
FX This work was supported in part by the National Natural Science
   Foundation of China (81971550, 81873872, 82071781 and 82171745) ,
   Science and Technology Planning Project of Guangzhou (202002030160) ,
   and Guangdong Basic and Applied Basic Research Foundation of Guangdong
   Province (2022A1515012437) .
CR Alsuraih M, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100250
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Barcena-Varela M, 2021, GUT, V70, P388, DOI 10.1136/gutjnl-2019-320205
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bernard M, 2020, AUTOPHAGY, V16, P2004, DOI 10.1080/15548627.2020.1713640
   Bouwman LH, 2005, GASTROENTEROLOGY, V129, P408, DOI 10.1053/j.gastro.2005.06.049
   Cai XY, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104720
   Cai YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062465
   Chen Y, 2021, CELL CALCIUM, V100, DOI 10.1016/j.ceca.2021.102477
   Choteau L, 2016, MUCOSAL IMMUNOL, V9, P767, DOI 10.1038/mi.2015.100
   da Silva BD, 2017, CELL BIOL INT, V41, P946, DOI 10.1002/cbin.10790
   Duus K, 2010, FEBS J, V277, P4956, DOI 10.1111/j.1742-4658.2010.07901.x
   Ehlting C, 2021, BIOL CHEM, V402, P1129, DOI 10.1515/hsz-2021-0209
   Elsallabi O, 2022, MOLECULES, V27, DOI 10.3390/molecules27030738
   Glargaard S, 2018, SCAND J GASTROENTERO, V53, P64, DOI 10.1080/00365521.2017.1386710
   Gupta B, 2008, NITRIC OXIDE-BIOL CH, V18, P266, DOI 10.1016/j.niox.2008.01.009
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445
   Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x
   Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015
   Jia FY, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5986260
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jung SH, 2019, ONCOGENE, V38, P1639, DOI 10.1038/s41388-018-0521-8
   Kang LI, 2015, LAB INVEST, V95, P1117, DOI 10.1038/labinvest.2015.94
   Khor ES, 2020, BIOGERONTOLOGY, V21, P517, DOI 10.1007/s10522-020-09876-w
   Kim YO, 2017, METHODS MOL BIOL, V1559, P279, DOI 10.1007/978-1-4939-6786-5_19
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Koutsounaki E, 2008, J CLIN IMMUNOL, V28, P495, DOI 10.1007/s10875-008-9201-8
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Li JR, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1527650
   Luo L, 2018, CELL REP, V24, P3033, DOI 10.1016/j.celrep.2018.08.028
   Luo XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1670-6
   Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Moon AM, 2020, CLIN GASTROENTEROL H, V18, P2650, DOI 10.1016/j.cgh.2019.07.060
   Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802
   Panebianco C, 2017, CLIN EXP MED, V17, P269, DOI 10.1007/s10238-016-0438-x
   Park KS, 2011, WORLD J GASTROENTERO, V17, P164, DOI 10.3748/wjg.v17.i2.164
   Parola M, 2019, MOL ASPECTS MED, V65, P37, DOI 10.1016/j.mam.2018.09.002
   Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025
   Qin YN, 2014, MOLECULES, V19, P19845, DOI 10.3390/molecules191219845
   Rakhshandehroo M, 2012, AM J PHYSIOL-ENDOC M, V302, pE595, DOI 10.1152/ajpendo.00299.2011
   Salazar G, 2020, AUTOPHAGY, V16, P1092, DOI 10.1080/15548627.2019.1659612
   SASTRY R, 1995, MAMM GENOME, V6, P103, DOI 10.1007/BF00303252
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Scholten D, 2015, LAB ANIM-UK, V49, P4, DOI 10.1177/0023677215571192
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Schwabe RF, 2020, GASTROENTEROLOGY, V158, P1913, DOI 10.1053/j.gastro.2019.11.311
   Shan LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36037
   Song P, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101072
   Sorensen CM, 2006, CLIN EXP IMMUNOL, V145, P173, DOI 10.1111/j.1365-2249.2006.03101.x
   Tag Carmen G, 2015, J Vis Exp, DOI 10.3791/52438
   Van Asbeck EC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-229
   Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8
   Wagner S, 2003, J IMMUNOL, V170, P1462, DOI 10.4049/jimmunol.170.3.1462
   Wells RG, 2015, SEMIN LIVER DIS, V35, P97, DOI [10.1055/s-0035-1550061, 10.1055/s-0035-1554915]
   Wong C, 2013, LANCET RESP MED, V1, P179, DOI 10.1016/S2213-2600(13)70010-9
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Zhang CY, 2016, WORLD J GASTROENTERO, V22, P10512, DOI 10.3748/wjg.v22.i48.10512
   Zhao N, 2017, FASEB J, V31, P2405, DOI 10.1096/fj.201601200RR
NR 64
TC 8
Z9 8
U1 1
U2 10
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PD 2022 
PY 2022
VL 14
IS 1
BP 75
EP 99
DI 10.1016/j.jcmgh.2022.03.011
EA MAY 2022
PG 25
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 3I6JK
UT WOS:000832820300001
PM 35381393
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tachtatzis, PM
   Marshall, A
   Aravinthan, A
   Verma, S
   Penrhyn-Lowe, S
   Mela, M
   Scarpini, C
   Davies, SE
   Coleman, N
   Alexander, GJM
AF Tachtatzis, Phaedra M.
   Marshall, Aileen
   Aravinthan, Aloysius
   Verma, Suman
   Penrhyn-Lowe, Sue
   Mela, Marianna
   Scarpini, Cinzia
   Davies, Susan E.
   Coleman, Nicholas
   Alexander, Graeme J. M.
TI Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B
   Antigen Expression, Telomere Length, Senescence, Inflammation and
   Fibrosis
SO PLOS ONE
LA English
DT Article
ID NATURAL-HISTORY; ARREST; CELLS; AGE
AB Background
   Chronic Hepatitis B virus (HBV) infection can lead to the development of chronic hepatitis, cirrhosis and hepatocellular carcinoma. We hypothesized that HBV might accelerate hepatocyte ageing and investigated the effect of HBV on hepatocyte cell cycle state and biological age. We also investigated the relation between inflammation, fibrosis and cell cycle phase.
   Methods
   Liver samples from patients with chronic HBV (n = 91), normal liver (n = 55) and regenerating liver (n = 15) were studied. Immunohistochemistry for cell cycle phase markers and HBV antigens was used to determine host cell cycle phase. Hepatocyte-specific telomere length was evaluated by quantitative fluorescent in-situ hybridization (Q-FISH) in conjunction with hepatocyte nuclear area and HBV antigen expression. The effects of induced cell cycle arrest and induced cellular senescence on HBV production were assessed in vitro.
   Results
   13.7% hepatocytes in chronic HBV had entered cell cycle, but expression of markers for S, G2 and M phase was low compared with regenerating liver. Hepatocyte p21 expression was increased (10.9%) in chronic HBV and correlated with liver fibrosis. Mean telomere length was reduced in chronic HBV compared to normal. However, within HBV-affected livers, hepatocytes expressing HBV antigens had longer telomeres. Telomere length declined and hepatocyte nuclear size increased as HBV core antigen (HBcAg) expression shifted from the nucleus to cytoplasm. Nuclear co-expression of HBcAg and p21 was not observed. Cell cycle arrest induced in vitro was associated with increased HBV production, in contrast to in vitroinduction of cellular senescence, which had no effect.
   Conclusion
   Chronic HBV infection was associated with hepatocyte G1 cell cycle arrest and accelerated hepatocyte ageing, implying that HBV induced cellular senescence. However, HBV replication was confined to biologically younger hepatocytes. Changes in the cellular location of HBcAg may be related to the onset of cellular senescence.
C1 [Tachtatzis, Phaedra M.] St James Univ Hosp, Dept Hepatol, Leeds, W Yorkshire, England.
   [Marshall, Aileen] Royal Free Hosp, Dept Hepatol, London NW3 2QG, England.
   [Aravinthan, Aloysius; Mela, Marianna; Alexander, Graeme J. M.] Univ Cambridge, Div Gastroenterol & Hepatol, Cambridge, England.
   [Verma, Suman] Kings Coll Hosp London, Inst Liver Studies, London, England.
   [Penrhyn-Lowe, Sue] Univ Cambridge, Hutchison MRC Res Ctr, Cambridge, England.
   [Scarpini, Cinzia; Coleman, Nicholas] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England.
   [Davies, Susan E.] Univ Cambridge, Pancreat Canc Ctr, Cambridge, England.
C3 Saint James's University Hospital; University of London; University
   College London; Royal Free London NHS Foundation Trust; UCL Medical
   School; University of Cambridge; University of London; King's College
   London; King's College Hospital NHS Foundation Trust; King's College
   Hospital; University of Cambridge; University of Cambridge; University
   of Cambridge
RP Tachtatzis, PM (corresponding author), St James Univ Hosp, Dept Hepatol, Leeds, W Yorkshire, England.
EM p.tachtatzis@nhs.net
RI Aravinthan, Aloysious D/I-2557-2019
OI Aravinthan, Aloysious D/0000-0003-0527-5137; Scarpini, Cinzia
   G./0000-0003-4730-5197
FU Hepatology Endowment Fund, Addenbrooke's Hospital, Cambridge;
   Addenbrooke's Hospital NHS Trust; Cancer Research UK [13080] Funding
   Source: researchfish
FX This study received funding for all laboratory costs from the Hepatology
   Endowment Fund, Addenbrooke's Hospital, Cambridge. The salary of PMT was
   paid by Addenbrooke's Hospital NHS Trust.
CR Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641
   BARNABA V, 1990, NATURE, V345, P258, DOI 10.1038/345258a0
   Bellon M, 2008, JNCI-J NATL CANCER I, V100, P98, DOI 10.1093/jnci/djm269
   Borel F, 2002, J CELL SCI, V115, P2829
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Fattovich G, 2003, SEMIN LIVER DIS, V23, P47, DOI 10.1055/s-2003-37590
   FERRARI C, 1986, CLIN EXP IMMUNOL, V66, P497
   Huang Yan-Qing, 2004, Hepatobiliary Pancreat Dis Int, V3, P543
   JUNG MC, 1991, J HEPATOL, V13, P310, DOI 10.1016/0168-8278(91)90074-L
   Kao JiaHorng, 2006, Current Hepatitis Reports, V5, P5, DOI 10.1007/s11901-006-0017-9
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   NAOUMOV N V, 1990, Gastroenterology, V99, P1248
   NAYERSINA R, 1993, J IMMUNOL, V150, P4659
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WU PC, 1993, AM J CLIN PATHOL, V100, P648, DOI 10.1093/ajcp/100.6.648
   Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956
NR 21
TC 31
Z9 34
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2015
VL 10
IS 5
AR e0127511
DI 10.1371/journal.pone.0127511
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CJ2MQ
UT WOS:000355319400039
PM 26024529
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Puche, JE
   Saiman, Y
   Friedman, SL
AF Puche, Juan E.
   Saiman, Yedidya
   Friedman, Scott L.
TI Hepatic Stellate Cells and Liver Fibrosis
SO COMPREHENSIVE PHYSIOLOGY
LA English
DT Article
ID FAT-STORING CELLS; GROWTH-FACTOR-BETA; SINUSOIDAL ENDOTHELIAL-CELLS;
   COLLAGEN GENE-TRANSCRIPTION; P75 NEUROTROPHIN RECEPTOR;
   CARBON-TETRACHLORIDE INTOXICATION; MONOCYTE CHEMOTACTIC PROTEIN-1;
   SMOOTH-MUSCLE-ACTIN; REGULATORY T-CELLS; ACTIVATION IN-VIVO
AB Hepatic stellate cells are resident perisinusoidal cells distributed throughout the liver, with a remarkable range of functions in normal and injured liver. Derived embryologically from septum transversum mesenchyme, their precursors include submesothelial cells that invade the liver parenchyma from the hepatic capsule. In normal adult liver, their most characteristic feature is the presence of cytoplasmic perinuclear droplets that are laden with retinyl (vitamin A) esters. Normal stellate cells display several patterns of intermediate filaments expression (e. g., desmin, vimentin, and/or glial fibrillary acidic protein) suggesting that there are subpopulations within this parental cell type. In the normal liver, stellate cells participate in retinoid storage, vasoregulation through endothelial cell interactions, extracellular matrix homeostasis, drug detoxification, immunotolerance, and possibly the preservation of hepatocyte mass through secretion of mitogens including hepatocyte growth factor. During liver injury, stellate cells activate into alpha smooth muscle actin-expressing contractile myofibroblasts, which contribute to vascular distortion and increased vascular resistance, thereby promoting portal hypertension. Other features of stellate cell activation include mitogen-mediated proliferation, increased fibrogenesis driven by connective tissue growth factor, and transforming growth factor beta 1, amplified inflammation and immunoregulation, and altered matrix degradation. Evolving areas of interest in stellate cell biology seek to understand mechanisms of their clearance during fibrosis resolution by either apoptosis, senescence, or reversion, and their contribution to hepatic stem cell amplification, regeneration, and hepatocellular cancer. (C) 2013 American Physiological Society.
C1 [Puche, Juan E.; Saiman, Yedidya; Friedman, Scott L.] Mt Sinai Hosp, Icahn Sch Med, Div Liver Dis, New York, NY 10029 USA.
   [Puche, Juan E.] Univ CEU San Pablo, Sch Med, Inst Appl Mol Med IMMA, Madrid, Spain.
C3 Icahn School of Medicine at Mount Sinai; San Pablo CEU University
RP Friedman, SL (corresponding author), Mt Sinai Hosp, Icahn Sch Med, Div Liver Dis, New York, NY 10029 USA.
EM scott.friedman@mssm.edu
RI Puche, Juan E/HMP-2853-2023; Puche, Juan/L-9132-2014
FU NIH [DK56621, AA020709, NIDDK F30-DK090986, T32-GM007280]; Alfonso
   Martin Escudero Fundation
FX Work in the authors' laboratory was supported by NIH Grants DK56621,
   AA020709 (to S. L. F.), NIDDK F30-DK090986, and T32-GM007280 (to Y.S.),
   and funds from the Alfonso Martin Escudero Fundation (to J.E.P.).
CR Abramovitch S, 2011, GUT, V60, P1728, DOI 10.1136/gut.2010.234666
   Anania FA, 2001, FREE RADICAL BIO MED, V30, P846, DOI 10.1016/S0891-5849(01)00470-1
   ANTHONY PP, 1978, J CLIN PATHOL, V31, P395, DOI 10.1136/jcp.31.5.395
   Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344
   Apte MV, 2012, J GASTROEN HEPATOL, V27, P69, DOI 10.1111/j.1440-1746.2011.07000.x
   ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270
   ARTHUR MJP, 1992, BIOCHEM J, V287, P701, DOI 10.1042/bj2870701
   Asahina K, 2002, AM J PATHOL, V160, P2191, DOI 10.1016/S0002-9440(10)61167-4
   Asahina K, 2012, J GASTROEN HEPATOL, V27, P80, DOI 10.1111/j.1440-1746.2011.07001.x
   Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119
   Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721
   Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012
   BACHEM MG, 1989, J CLIN CHEM CLIN BIO, V27, P555
   Baghy K, 2012, J HISTOCHEM CYTOCHEM, V60, P262, DOI 10.1369/0022155412438104
   BALLARDINI G, 1994, HEPATOLOGY, V19, P440
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022
   BIOULACSAGE P, 1990, J HEPATOL, V10, P105, DOI 10.1016/0168-8278(90)90080-B
   BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055
   BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887
   Bonacchi A, 2003, GASTROENTEROLOGY, V125, P1060, DOI 10.1016/S0016-5085(03)01194-6
   Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200
   Borkham-Kamphorst E, 2007, J HEPATOL, V46, P1064, DOI 10.1016/j.jhep.2007.01.029
   Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001
   Bourd-Boittin K, 2011, HEPATOLOGY, V54, P2173, DOI 10.1002/hep.24598
   Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088
   Buers I, 2011, HISTOL HISTOPATHOL, V26, P631, DOI 10.14670/HH-26.631
   BURT AD, 1990, HISTOPATHOLOGY, V16, P53, DOI 10.1111/j.1365-2559.1990.tb01060.x
   Byun JS, 2013, J HEPATOL, V58, P342, DOI 10.1016/j.jhep.2012.09.016
   Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472
   Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C
   Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953
   Casini A, 1998, J HEPATOL, V28, P40, DOI 10.1016/S0168-8278(98)80200-6
   Cassiman D, 2006, J HEPATOL, V44, P1098, DOI 10.1016/j.jhep.2005.09.023
   Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793
   Challa AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042989
   Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812
   Chan KM, 2013, HEPATOL RES, V43, P648, DOI 10.1111/j.1872-034X.2012.01110.x
   Chen L, 2012, CELL BIOCHEM FUNCT, V30, P588, DOI 10.1002/cbf.2838
   Chen SL, 2013, HEPATOLOGY, V57, P1285, DOI 10.1002/hep.25975
   Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581
   Costentin CE, 2011, J HEPATOL, V54, P1123, DOI 10.1016/j.jhep.2010.08.027
   Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317
   D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993
   Dangi A, 2012, J IMMUNOL, V188, P3667, DOI 10.4049/jimmunol.1102460
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   De Minicis S, 2007, ARCH BIOCHEM BIOPHYS, V462, P266, DOI 10.1016/j.abb.2007.04.016
   DeBleser PJ, 1997, J HEPATOL, V26, P886, DOI 10.1016/S0168-8278(97)80257-7
   DELEEUW AM, 1984, HEPATOLOGY, V4, P392
   Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126
   Dranoff JA, 2004, AM J PHYSIOL-GASTR L, V287, pG417, DOI 10.1152/ajpgi.00294.2003
   Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405
   Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Enzan H., 1999, Liver Diseases and Hepatic Sinusoidal Cells, P219
   Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220
   Fallowfield JA, 2004, SCOT MED J, V49, P3, DOI 10.1177/003693300404900101
   Fibbi G, 2001, GROWTH FACTORS, V19, P87, DOI 10.3109/08977190109001078
   Fischer R, 2002, GASTROENTEROLOGY, V123, P845, DOI 10.1053/gast.2002.35384
   Fowell AJ, 2011, BIOCHEM BIOPH RES CO, V407, P277, DOI 10.1016/j.bbrc.2011.02.009
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2013, BBA-MOL BASIS DIS, V1832, P865, DOI 10.1016/j.bbadis.2013.03.003
   Friedman SL, 2013, J HEPATOL, V58, P1, DOI 10.1016/j.jhep.2012.10.014
   Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013
   Friedman SL, 2012, P NATL ACAD SCI USA, V109, P9230, DOI 10.1073/pnas.1206645109
   Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974
   FRIEDMAN SL, 1993, AM J PHYSIOL, V264, pG947, DOI 10.1152/ajpgi.1993.264.5.G947
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756
   FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Friedman SL, 2002, SCI MED, V8, P194
   Fritz D, 2007, J MOL BIOL, V371, P585, DOI 10.1016/j.jmb.2007.06.006
   FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1016/0270-9139(95)90540-5
   FUJIO K, 1994, LAB INVEST, V70, P511
   Gao B, 2012, BIOCHIM BIOPHYS ACTA, V1832, P1061
   Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]
   Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200
   Gascon-Barré M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176
   GEERTS A, 1991, HEPATOLOGY, V13, P1193, DOI 10.1016/0270-9139(91)92491-P
   GEERTS A, 1990, J ELECTRON MICR TECH, V14, P247, DOI 10.1002/jemt.1060140306
   GEERTS A, 1989, J HEPATOL, V9, P59, DOI 10.1016/0168-8278(89)90076-7
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007
   Ghiassi-Nejad Z, 2013, HEPATOLOGY, V57, P786, DOI 10.1002/hep.26056
   GIAMPIERI MP, 1981, DIGESTION, V22, P165, DOI 10.1159/000198640
   Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750
   Görbig MN, 2001, J HEPATOL, V34, P222
   Greenbaum LE, 2011, INT J BIOCHEM CELL B, V43, P222, DOI 10.1016/j.biocel.2009.11.006
   Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073
   Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner
   Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x
   Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025
   Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697
   Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604
   Han YP, 2007, J BIOL CHEM, V282, P12928, DOI 10.1074/jbc.M700554200
   Hartland SN, 2009, LIVER INT, V29, P966, DOI 10.1111/j.1478-3231.2009.02070.x
   He H, 2011, HEPATOLOGY, V53, P548, DOI 10.1002/hep.24047
   He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023
   Hellemams K, 2004, HEPATOLOGY, V39, P97, DOI 10.1002/hep.20015
   HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5
   Hernández-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016
   Hernández-Gea V, 2012, AUTOPHAGY, V8, P849, DOI 10.4161/auto.19947
   Hernández-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307
   Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020
   Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890
   Hsieh CC, 2010, TRANSPL P, V42, P4279, DOI 10.1016/j.transproceed.2010.09.139
   Huang GC, 2012, FRONT BIOSCI-LANDMRK, V17, P2495, DOI 10.2741/4067
   Huang GC, 2011, J CELL MOL MED, V15, P1087, DOI 10.1111/j.1582-4934.2010.01072.x
   Iizuka M, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-12
   Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640
   Ikeda N, 2012, HEPATOL RES, V42, P91, DOI 10.1111/j.1872-034X.2011.00893.x
   Imai K, 1998, ANAT REC, V250, P430
   Inagaki Y, 2005, GASTROENTEROLOGY, V129, P259, DOI 10.1053/j.gastro.2005.03.088
   Inagaki Y, 2003, HEPATOLOGY, V38, P890, DOI 10.1053/jhep.2003.50408
   INAGAKI Y, 1995, HEPATOLOGY, V22, P573, DOI 10.1016/0270-9139(95)90582-0
   Inagaki Y, 2001, J CELL PHYSIOL, V187, P117, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S
   Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557
   Ishikawa K, 1999, BIOCHEM BIOPH RES CO, V254, P587, DOI 10.1006/bbrc.1998.9984
   Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548
   Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009
   JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037
   Jezequel AM, 1984, FRONT GASTROINTESTIN, V8, P85, DOI DOI 10.1159/000408420
   Ji JL, 2012, HEPATOLOGY, V56, P332, DOI 10.1002/hep.25650
   Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034
   Jiang JX, 2012, AM J PHYSIOL-GASTR L, V302, pG439, DOI 10.1152/ajpgi.00257.2011
   Jiang ZJ, 2013, EXP THER MED, V5, P165, DOI 10.3892/etm.2012.801
   Jiao JJ, 2012, HEPATOLOGY, V55, P243, DOI 10.1002/hep.24621
   Kageyama Y, 2012, HEPATOLOGY, V56, P1427, DOI 10.1002/hep.25780
   Kalinichenko VV, 2003, HEPATOLOGY, V37, P107, DOI 10.1053/jhep.2003.50005
   Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384
   Kaur S, 2012, J HEPATOL, V57, P1193, DOI 10.1016/j.jhep.2012.07.016
   Kawashima R, 1999, BIOCHEM BIOPH RES CO, V256, P527, DOI 10.1006/bbrc.1999.0372
   Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701
   Khimji A, 2011, PHARMACOL RES, V63, P512, DOI 10.1016/j.phrs.2011.03.005
   Kida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026644
   Kikuchi S, 2005, J BIOL CHEM, V280, P15398, DOI 10.1074/jbc.M414048200
   Kinnman N, 2000, LAB INVEST, V80, P697, DOI 10.1038/labinvest.3780073
   Kinnman N, 2003, LAB INVEST, V83, P163, DOI 10.1097/01.LAB.0000054178.01162.E4
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551
   Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5
   Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x
   Kodama T, 2010, GASTROENTEROLOGY, V138, P2487, DOI 10.1053/j.gastro.2010.02.054
   Kojima N, 1998, HISTOCHEM CELL BIOL, V110, P121, DOI 10.1007/s004180050273
   Kojima S, 2000, BLOOD, V95, P1309
   Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069
   Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029
   Kordes C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051878
   Kristensen DB, 2000, HEPATOLOGY, V32, P268
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kruglov EA, 2006, AM J PHYSIOL-GASTR L, V290, pG765, DOI 10.1152/ajpgi.00308.2005
   Kubota H, 2007, STEM CELLS, V25, P2339, DOI 10.1634/stemcells.2006-0316
   Laleman W, 2007, AM J PHYSIOL-GASTR L, V292, pG556, DOI 10.1152/ajpgi.00196.2006
   Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564
   LEE SJ, 1994, BIOCHEM J, V299, P79, DOI 10.1042/bj2990079
   Lee TF, 2010, J CELL PHYSIOL, V223, P648, DOI 10.1002/jcp.22063
   Lemoinne S, 2013, BBA-MOL BASIS DIS, V1832, P948, DOI 10.1016/j.bbadis.2013.02.019
   Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011
   Li TX, 2012, AM J PHYSIOL-GASTR L, V302, pG948, DOI 10.1152/ajpgi.00359.2011
   Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110
   Libbrecht L, 2002, LIVER, V22, P252, DOI 10.1046/j.0106-9543.2002.01674.x
   Lindquist Jeffrey N., 2000, Journal of Gastroenterology, V35, P80
   Liu ZN, 2011, J HEPATOL, V54, P132, DOI 10.1016/j.jhep.2010.06.020
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427
   MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886
   Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979
   Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002
   Mann J, 2009, ADV DRUG DELIVER REV, V61, P497, DOI 10.1016/j.addr.2009.03.011
   Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111
   Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107
   MARSDEN ER, 1992, LAB INVEST, V67, P427
   Matsumoto K, 2008, DEV BIOL, V319, P234, DOI 10.1016/j.ydbio.2008.04.021
   Mehal WZ, 2007, LIVER IMMUNOLOGY, P99
   Melton AC, 2007, HEPATOLOGY, V45, P1446, DOI 10.1002/hep.21606
   Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049
   MEYER DH, 1990, BIOCHEM BIOPH RES CO, V171, P1122, DOI 10.1016/0006-291X(90)90801-S
   MILANI S, 1994, AM J PATHOL, V144, P528
   Miura K, 2003, BIOCHEM BIOPH RES CO, V311, P415, DOI 10.1016/j.bbrc.2003.09.225
   Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011
   Miyata E, 2008, BLOOD, V111, P2427, DOI 10.1182/blood-2007-07-101261
   Modi AA, 2010, HEPATOLOGY, V51, P201, DOI 10.1002/hep.23279
   MORIWAKI H, 1988, J LIPID RES, V29, P1523
   Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413
   Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136
   MULLHAUPT B, 1994, J BIOL CHEM, V269, P19667
   Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200
   Nieto N, 2002, J BIOL CHEM, V277, P9853, DOI 10.1074/jbc.M110506200
   Niiya M, 2006, J THROMB HAEMOST, V4, P1063, DOI 10.1111/j.1538-7836.2006.01893.x
   Niki T, 1996, HEPATOLOGY, V23, P1538, DOI 10.1002/hep.510230634
   Noetel A, 2013, J HEPATOL, V58, P335, DOI 10.1016/j.jhep.2012.09.024
   Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049
   Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887
   Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005
   Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022
   Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798
   Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003
   Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4
   Odena G, 2012, AM J PHYSIOL-CELL PH, V303, pC355, DOI 10.1152/ajpcell.00192.2012
   Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717
   Ohata M, 1997, AM J PHYSIOL-GASTR L, V272, pG589, DOI 10.1152/ajpgi.1997.272.3.G589
   Okuno M, 1997, HEPATOLOGY, V26, P913, DOI 10.1053/jhep.1997.v26.pm0009328313
   Olaso E, 2003, HEPATOLOGY, V37, P674, DOI 10.1053/jhep.2003.50068
   Olaso E, 2011, AM J PATHOL, V179, P2894, DOI 10.1016/j.ajpath.2011.09.002
   Olsen AL, 2012, GASTROENTEROLOGY, V142, P928, DOI 10.1053/j.gastro.2011.12.038
   Ong A, 2011, LIVER INT, V31, P1047, DOI 10.1111/j.1478-3231.2011.02555.x
   Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182
   Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281
   Parsons CJ, 2011, J BIOL CHEM, V286, P8609, DOI 10.1074/jbc.M110.189118
   Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603
   Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011
   Perez-Tamayo R, 1979, Pathol Annu, V14 Pt 2, P183
   Perugorria MJ, 2012, HEPATOLOGY, V56, P1129, DOI 10.1002/hep.25754
   Pintilie DG, 2010, LAB INVEST, V90, P1199, DOI 10.1038/labinvest.2010.88
   Pinzani M, 2002, FRONT BIOSCI-LANDMRK, V7, pD1720, DOI 10.2741/pinzani
   Pinzani M, 1996, GASTROENTEROLOGY, V110, P534, DOI 10.1053/gast.1996.v110.pm8566602
   Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021
   POPPER H, 1968, ISRAEL J MED SCI, V4, P1
   POPPER H, 1970, AM J MED, V49, P707, DOI 10.1016/S0002-9343(70)80135-8
   Putz-Bankuti C, 2012, LIVER INT, V32, P845, DOI 10.1111/j.1478-3231.2011.02735.x
   Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011
   Racine-Samson L, 1997, J BIOL CHEM, V272, P30911, DOI 10.1074/jbc.272.49.30911
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Ramachandran P, 2012, J HEPATOL, V56, P1417, DOI 10.1016/j.jhep.2011.10.026
   RAMADORI G, 1989, GASTROENTEROLOGY, V97, P163, DOI 10.1016/0016-5085(89)91431-5
   RAMADORI G, 1992, BIOCHEM BIOPH RES CO, V183, P739, DOI 10.1016/0006-291X(92)90545-V
   RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424
   RAMM GA, 1995, AM J PHYSIOL-GASTR L, V269, pG532, DOI 10.1152/ajpgi.1995.269.4.G532
   Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927
   Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571
   Rippe RA, 1999, ALCOHOL CLIN EXP RES, V23, P926, DOI 10.1111/j.1530-0277.1999.tb04205.x
   Rockey DC, 2003, HEPATOLOGY, V37, P4, DOI 10.1053/jhep.2003.50044
   Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222
   ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193
   Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551
   Roderburg C, 2013, J HEPATOL, V58, P736, DOI 10.1016/j.jhep.2012.11.022
   Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922
   ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710
   Rombouts K, 2012, AM J PHYSIOL-CELL PH, V303, pC357, DOI 10.1152/ajpcell.00093.2012
   ROSENBAUM J, 1995, GASTROENTEROLOGY, V109, P1986, DOI 10.1016/0016-5085(95)90767-X
   Roskams T, 2006, J HEPATOL, V45, P1, DOI 10.1016/j.jhep.2006.05.002
   Roskams T, 2004, ANAT REC PART A, V280A, P910, DOI 10.1002/ar.a.20096
   Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168
   Saile B, 1999, HEPATOLOGY, V30, P196, DOI 10.1002/hep.510300144
   Sato M, 1998, CELL BIOL INT, V22, P115, DOI 10.1006/cbir.1998.0234
   Sauvant P, 2011, J PHYSIOL BIOCHEM, V67, P487, DOI 10.1007/s13105-011-0101-7
   Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184
   Schildberg FA, 2011, HEPATOLOGY, V54, P262, DOI 10.1002/hep.24352
   SCHIRMACHER P, 1992, HEPATOLOGY, V15, P5, DOI 10.1002/hep.1840150103
   SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   SCHUPPAN D, 1990, SEMIN LIVER DIS, V10, P1, DOI 10.1055/s-2008-1040452
   Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003
   Schwettmann L, 2008, J HEPATOL, V49, P243, DOI 10.1016/j.jhep.2008.03.020
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444
   Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952
   Sekiya Y, 2011, BIOCHEM BIOPH RES CO, V412, P74, DOI 10.1016/j.bbrc.2011.07.041
   Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598
   Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155
   Shao R, 1999, J BIOL CHEM, V274, P3228, DOI 10.1074/jbc.274.5.3228
   Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152
   Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014
   Shirakami Y, 2012, CARCINOGENESIS, V33, P268, DOI 10.1093/carcin/bgr275
   Shomron N, 2010, THROMB HAEMOSTASIS, V104, P531, DOI 10.1160/TH09-12-0860
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Smedsrod B, 2009, LIVER INT, V29, P490, DOI 10.1111/j.1478-3231.2009.01979.x
   Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589
   Sprenger H, 1999, J HEPATOL, V30, P88, DOI 10.1016/S0168-8278(99)80011-7
   Stärkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X
   Stefanovic B, 1999, MOL CELL BIOL, V19, P4334
   Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201
   Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809
   Steiling H, 2004, AM J PATHOL, V165, P1233, DOI 10.1016/S0002-9440(10)63383-4
   Su YH, 2012, TRANSPL P, V44, P725, DOI 10.1016/j.transproceed.2011.11.049
   Suzuki K, 2008, GASTROENTEROLOGY, V135, P270, DOI 10.1053/j.gastro.2008.03.075
   Syal G, 2012, AM J PHYSIOL-GASTR L, V303, pG1077, DOI 10.1152/ajpgi.00227.2012
   Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511
   Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]
   TAKAHARA T, 1988, LAB INVEST, V59, P509
   Tanaka H, 2012, CLIN REV ALLERG IMMU, V43, P220, DOI 10.1007/s12016-012-8323-1
   Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388
   Taura K, 2008, GASTROENTEROLOGY, V135, P1729, DOI 10.1053/j.gastro.2008.07.065
   Thabut D, 2011, HEPATOLOGY, V54, P573, DOI 10.1002/hep.24427
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200
   Tsukamoto Hide, 2007, J Hepatol, V46, P352, DOI 10.1016/j.jhep.2006.11.002
   Tsukamoto H, 2012, J GASTROEN HEPATOL, V27, P94, DOI 10.1111/j.1440-1746.2011.07022.x
   Ueno T, 1997, HUM PATHOL, V28, P953, DOI 10.1016/S0046-8177(97)90011-3
   Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701
   Viñas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392
   VYAS SK, 1995, GASTROENTEROLOGY, V109, P889, DOI 10.1016/0016-5085(95)90399-2
   WAKE K, 1993, CELL TISSUE RES, V273, P227, DOI 10.1007/BF00312824
   WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404
   Wake K, 1980, Int Rev Cytol, V66, P303
   Wandzioch E, 2004, P NATL ACAD SCI USA, V101, P16549, DOI 10.1073/pnas.0404678101
   Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025
   Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011
   Wang L, 2012, GASTROENTEROLOGY, V143, P1555, DOI 10.1053/j.gastro.2012.08.008
   Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789
   Wang Y, 2006, INT J EXP PATHOL, V87, P177, DOI 10.1111/j.1365-2613.2006.00466.x
   Wang YF, 2010, HEPATOLOGY, V52, P1443, DOI 10.1002/hep.23829
   Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008
   Watanabe N, 2009, THROMB HAEMOSTASIS, V102, P389, DOI 10.1160/TH08-11-0732
   Wells RG, 2005, J CLIN GASTROENTEROL, V39, pS158, DOI 10.1097/01.mcg.0000155516.02468.0f
   WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497
   Wu TJ, 2012, TRANSPL P, V44, P1055, DOI 10.1016/j.transproceed.2012.03.029
   Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017
   YAMADA M, 1987, HEPATOLOGY, V7, P1224, DOI 10.1002/hep.1840070609
   Yamada T, 1997, LIFE SCI, V61, P171, DOI 10.1016/S0024-3205(97)00372-X
   YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0
   Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012
   Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115
   Yin CY, 2012, HEPATOLOGY, V56, P1958, DOI 10.1002/hep.25757
   Yin L, 2002, HISTOL HISTOPATHOL, V17, P65, DOI 10.14670/HH-17.65
   Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347
   Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5
   Zhao Y, 2012, MOL CELL BIOCHEM, V359, P217, DOI 10.1007/s11010-011-1016-x
   Zhu NL, 2012, J BIOL CHEM, V287, P10355, DOI 10.1074/jbc.M111.312751
   Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013
   ZINDY F, 1992, J HEPATOL, V14, P30, DOI 10.1016/0168-8278(92)90127-B
   Zvibel I, 2010, LAB INVEST, V90, P674, DOI 10.1038/labinvest.2010.48
NR 334
TC 519
Z9 597
U1 6
U2 179
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2040-4603
J9 COMPR PHYSIOL
JI Compr. Physiol.
PD OCT
PY 2013
VL 3
IS 4
BP 1473
EP 1492
DI 10.1002/cphy.c120035
PG 20
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA AA1VE
UT WOS:000330883200003
PM 24265236
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Le Couteur, DG
   Fraser, R
   Cogger, VC
   McLean, AJ
AF Le Couteur, DG
   Fraser, R
   Cogger, VC
   McLean, AJ
TI Hepatic pseudocapillarisation and atherosclerosis in ageing
SO LANCET
LA English
DT Article
ID LIPOPROTEIN CHANGES; LIVER SIEVE; RAT-LIVER; CLEARANCE; METABOLISM;
   SINUSOIDS
AB Cardiovascular disease secondary to atherosclerosis Is the main cause of death and disability In Industriallsed countries, and ageing Is the foremost risk factor for atherosclerosis. We present a hypothesis linking age-specific structural change In the liver with accepted pathogenic mechanisms leading to atherosclerosis. Ageing In the liver Is associated with pseudocapillarisation of the sinusoidal endothelium, which Is characterised by thickening of endothellum, basement membrane formation, and defenestration (loss of pores). Fenestrations (pores) normally form a liver sieve that allows passage of chylomicron remnants for subsequent uptake and metabolism by hepatocytes. Ageing Is associated with Impaired clearance of chylomicron remnants, postprandial hypertriglyceridaemia, and hence, atherosclerosis, which we propose Is linked directly to loss of permeability of the liver sieve because of defenestration associated with pseudocapillarisation. Development of methods to maintain fenestrations of sinusoidal endothellum or to facilitate refenestration might be a new therapeutic strategy for management of cardiovascular disease In old people.
C1 Univ Sydney, Concord RG Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia.
   Univ Sydney, Concord RG Hosp, Anzac Res Inst, Sydney, NSW 2006, Australia.
   Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand.
C3 University of Sydney; Concord Repatriation General Hospital; University
   of Sydney; ANZAC Research Institute; Concord Repatriation General
   Hospital; University of Otago
RP Le Couteur, DG (corresponding author), Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
RI Ekanayake, Kanchana/P-8817-2016; Research Institute, ANZAC/CAE-9030-2022
OI Le Couteur, David/0000-0002-4227-5817
CR Abbott RD, 1998, AM J CARDIOL, V82, P172, DOI 10.1016/S0002-9149(98)00310-5
   Cassader M, 1996, AGING CLIN EXP RES, V8, P421, DOI 10.1007/BF03339605
   CLARK SA, 1988, LANCET, V2, P1225
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   COGGER VC, 2001, 2 INT C HEP SPLANCHN
   COHN JS, 1988, J LIPID RES, V29, P469
   Field PA, 2000, METABOLISM, V49, P492, DOI 10.1016/S0026-0495(00)80014-1
   FLOREN CH, 1984, SCAND J GASTROENTERO, V19, P473, DOI 10.1080/00365521.1984.12005755
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRASER R, 1974, ATHEROSCLEROSIS, V19, P327, DOI 10.1016/0021-9150(74)90067-7
   FRASER R, 1978, ATHEROSCLEROSIS, V29, P113, DOI 10.1016/0021-9150(78)90001-1
   Grundy SM, 1999, J AM COLL CARDIOL, V34, P1348, DOI 10.1016/S0735-1097(99)00387-3
   Hazzard W R, 1992, Clin Geriatr Med, V8, P89
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   LATRY P, 1987, HUM PATHOL, V18, P775, DOI 10.1016/S0046-8177(87)80050-3
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   MORETON JR, 1947, SCIENCE, V106, P190, DOI 10.1126/science.106.2748.190
   Phillips C, 2000, ATHEROSCLEROSIS, V148, P283, DOI 10.1016/S0021-9150(99)00275-0
   RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767
   REDGRAVE T G, 1970, Journal of Clinical Investigation, V49, P465, DOI 10.1172/JCI106255
   Watts GF, 2001, ATHEROSCLEROSIS, V157, P519, DOI 10.1016/S0021-9150(01)00534-2
   Weintraub MS, 1996, BRIT MED J, V312, P935, DOI 10.1136/bmj.312.7036.935
   WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Yu KC, 2001, FRONT BIOSCI, V6, P332
   ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473
NR 27
TC 103
Z9 105
U1 0
U2 3
PU LANCET LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0140-6736
J9 LANCET
JI Lancet
PD MAY 4
PY 2002
VL 359
IS 9317
BP 1612
EP 1615
DI 10.1016/S0140-6736(02)08524-0
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 549RN
UT WOS:000175460700031
PM 12047987
DA 2024-02-19
ER

PT J
AU Bianchi, A
   Marchetti, L
   Hall, Z
   Lemos, H
   Vacca, M
   Paish, H
   Green, K
   Elliott, B
   Tiniakos, D
   Passos, JF
   Jurk, D
   Mann, DA
   Wilson, CL
AF Bianchi, Arianna
   Marchetti, Letizia
   Hall, Zoe
   Lemos, Henrique
   Vacca, Michele
   Paish, Hannah
   Green, Kile
   Elliott, Bronte
   Tiniakos, Dina
   Passos, Joao F.
   Jurk, Diana
   Mann, Derek A.
   Wilson, Caroline L.
TI Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis,
   Senescence, and Tumorigenesis
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID SECRETORY PHENOTYPE; ROLES; DEACETYLATION; INFILTRATION; SUPPRESSION;
   NF-KAPPA-B1; DISRUPTION; EXPRESSION; SUBUNIT; OBESITY
AB Age-related chronic inflammation promotes cellular senescence, chronic disease, cancer, and reduced lifespan. In this study, we wanted to explore the effects of a moderate exercise regimen on inflammatory liver disease and tumorigenesis. We used an established model of spontaneous inflammaging, steatosis, and cancer (nfkb1(-/-) mouse) to demonstrate whether 3 mo of moderate aerobic exercise was sufficient to suppress liver disease and cancer development. Interventional exercise when applied at a relatively late disease stage was effective at reducing tissue inflammation (liver, lung, and stomach), oxidative damage, and cellular senescence, and it reversed hepatic steatosis and prevented tumor development. Underlying these benefits were transcriptional changes in enzymes driving the conversion of tryptophan to NAD(+), this leading to increased hepatic NAD(+) and elevated activity of the NAD(+)-dependent deacetylase sirtuin. Increased SIRT activity was correlated with enhanced deacetylation of key transcriptional regulators of inflammation and metabolism, NF-kappa B (p65), and PGC-1 alpha. We propose that moderate exercise can effectively reprogram pre-established inflammatory and metabolic pathologies in aging with the benefit of prevention of disease.
C1 [Bianchi, Arianna; Marchetti, Letizia; Lemos, Henrique; Paish, Hannah; Green, Kile; Tiniakos, Dina; Mann, Derek A.; Wilson, Caroline L.] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Hall, Zoe] Imperial Coll London, Dept Metab Diges & Reprod, Biomol Med, London SW7 2AZ, England.
   [Vacca, Michele] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.
   [Elliott, Bronte] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.
   [Passos, Joao F.; Jurk, Diana] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.
C3 Newcastle University - UK; Imperial College London; University of
   Cambridge; University of Sheffield; Mayo Clinic
RP Wilson, CL (corresponding author), Newcastle Univ, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM c.wilson@ncl.ac.uk
RI Mann, Derek A/E-4765-2011; Vacca, Michele/B-4736-2013; de Paula Lemos,
   Henrique/AAI-2698-2020
OI Vacca, Michele/0000-0002-1973-224X; de Paula Lemos,
   Henrique/0000-0002-0539-3283; Passos, Joao/0000-0001-8765-1890;
   Marchetti, Letizia/0000-0003-1986-4063; , Caroline/0000-0002-9016-6025;
   Green, Kile/0000-0002-4777-5458; Jurk, Diana/0000-0003-4486-0857; Mann,
   Derek/0000-0003-0950-243X
FU Cancer Research U.K. [C18342/A23390]; Medical Research Council (MRC)
   [MR/K0019494/1, MR/R023026/1]; MRC; U.K. Research and Innovation Centre
   for Ageing and Vitality at Newcastle University [MR/L016354]; National
   Institute for Health Research Grant [P01AG62413]; BBSRC [BB/K017314/1]
   Funding Source: UKRI; MRC [MR/R023026/1] Funding Source: UKRI
FX This work was supported by Cancer Research U.K. Programme Grant
   C18342/A23390 and Medical Research Council (MRC) Programme Grants
   MR/K0019494/1 and MR/R023026/1 (to D.A.M.). A.B. was funded by the MRC
   and U.K. Research and Innovation Centre for Ageing and Vitality at
   Newcastle University Award MR/L016354. J.F. P. and D.J. were funded by
   National Institute for Health Research Grant P01AG62413.
CR Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Cartee GD, 2016, CELL METAB, V23, P1034, DOI 10.1016/j.cmet.2016.05.007
   Cartwright TN, 2018, BBA-GENE REGUL MECH, V1861, P962, DOI 10.1016/j.bbagrm.2018.09.001
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Ciolac EG, 2013, CLINICS, V68, P710, DOI 10.6061/clinics/2013(05)20
   Clifford T, 2017, EUR J APPL PHYSIOL, V117, P1727, DOI 10.1007/s00421-017-3667-0
   Connell NJ, 2019, DIABETOLOGIA, V62, P888, DOI 10.1007/s00125-019-4831-3
   Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007
   CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x
   de Araújo CC, 2012, J APPL PHYSIOL, V112, P1206, DOI 10.1152/japplphysiol.01061.2011
   de Valle E, 2016, J EXP MED, V213, P621, DOI 10.1084/jem.20151182
   Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Durstine JL, 2013, J SPORT HEALTH SCI, V2, P3, DOI 10.1016/j.jshs.2012.07.009
   Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025
   Feige JN, 2008, CURR OPIN CELL BIOL, V20, P303, DOI 10.1016/j.ceb.2008.03.012
   Finkin S, 2015, NAT IMMUNOL, V16, P1235, DOI 10.1038/ni.3290
   Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6
   Flynn MG, 2007, AM J LIFESTYLE MED, V1, P220, DOI 10.1177/1559827607300283
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117
   Gleeson M, 2006, EXERC IMMUNOL REV, V12, P34
   Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Hitomi Y, 2019, CELL MOL GASTROENTER, V7, P515, DOI 10.1016/j.jcmgh.2018.11.006
   Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kaustio M, 2017, J ALLERGY CLIN IMMUN, V140, P782, DOI 10.1016/j.jaci.2016.10.054
   Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105
   Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kwon S, 2017, J BIOL CHEM, V292, P17312, DOI 10.1074/jbc.M117.778720
   Lanzillotta A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.76
   Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009
   Liu HE, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00373
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Michan S, 2014, FRONT BIOSCI-LANDMRK, V19, P1300, DOI 10.2741/4283
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   O'Reilly LA, 2018, IMMUNITY, V48, P570, DOI 10.1016/j.immuni.2018.03.003
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700
   Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Sawatzky R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-68
   SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8
   Sharabi K, 2017, CELL, V169, P148, DOI 10.1016/j.cell.2017.03.001
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Tan ZQ, 2016, MOL CANCER THER, V15, P774, DOI 10.1158/1535-7163.MCT-15-0621
   Tuijnenburg P, 2018, J ALLERGY CLIN IMMUN, V142, P1285, DOI 10.1016/j.jaci.2018.01.039
   Wang Y, 2011, FEBS LETT, V585, P986, DOI 10.1016/j.febslet.2010.11.047
   Wilson CL, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms7818, 10.1038/ncomms9901]
   Woods JA, 2012, AGING DIS, V3, P130
   Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Yudkin JS, 2007, HORM METAB RES, V39, P707, DOI 10.1055/s-2007-985898
   Zhao EH, 2019, CANCERS, V11, DOI 10.3390/cancers11121949
NR 63
TC 18
Z9 20
U1 0
U2 10
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD FEB 15
PY 2021
VL 206
IS 4
BP 904
EP 916
DI 10.4049/jimmunol.2001022
PG 13
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA QC4YJ
UT WOS:000614838700024
PM 33441438
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Sun, J
   Li, Y
   Yang, X
   Dong, W
   Yang, JK
   Hu, Q
   Zhang, CT
   Fang, HS
   Liu, AD
AF Sun, Jian
   Li, Ying
   Yang, Xiao
   Dong, Wei
   Yang, Jiankun
   Hu, Qi
   Zhang, Cuntai
   Fang, Haoshu
   Liu, Anding
TI Growth differentiation factor 11 accelerates liver senescence through
   the inhibition of autophagy
SO AGING CELL
LA English
DT Article; Early Access
DE autophagy; hepatocyte; liver; senescence
ID LYSOSOMAL BIOGENESIS; GDF11; AGE; DYSFUNCTION; SIGNALS; BIOLOGY
AB The "rejuvenating" effect of growth differentiation factor 11 (GDF11) is called into question recently, and its role, as well as plausible signaling mechanisms in liver senescence, is unclear. To overexpress or knockdown GDF11, aged male mice are injected with a single dose of adeno-associated viruses-GDF11 or adenovirus-small hairpin RNA-GDF11, respectively. GDF11 overexpression significantly accelerates liver senescence in aged mice, whereas GDF11 knockdown has opposite effects. Concomitantly, autophagic flux is impaired in livers from GDF11 overexpression mice. Conversely, GDF11 knockdown increases autophagic flux. Moreover, rapamycin successfully restores the impaired autophagic flux and alleviates liver senescence in GDF11 overexpression mice, while the GDF11 knockdown-mediated benefits are abolished by the autophagy inhibitor bafilomycin A1. GDF11 leads to a drop in lysosomal biogenesis resulting in defective autophagic flux at autophagosome clearance step. Mechanistically, GDF11 significantly activates mammalian target of rapamycin complex 1 (mTORC1) and subsequently represses transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy. Inhibition of mTORC1 or TFEB overexpression rescues the GDF11-impaired autophagic flux and cellular senescence. Hepatocyte-specific deletion of GDF11 does not alter serum GDF11 levels and liver senescence. Collectively, suppression of autophagic activity via mTORC1/TFEB signaling may be a critical molecular mechanism by which GDF11 exacerbates liver senescence. Rather than a "rejuvenating" agent, GDF11 may have a detrimental effect on liver senescence.
C1 [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, Guangzhou, Guangdong, Peoples R China.
   [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China.
   [Li, Ying; Yang, Xiao; Yang, Jiankun; Liu, Anding] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Expt Med Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.
   [Dong, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Hubei, Peoples R China.
   [Dong, Wei] Hubei Clin Med Res Ctr Hepat Surg, Hubel Key Lab Hepatopancreatobiliary Dis, Wuhan, Hubei, Peoples R China.
   [Dong, Wei] Chinese Acad Med Sci, Minist Educ, Key Lab Organ Transplantat, Wuhan, Hubei, Peoples R China.
   [Dong, Wei] Chinese Acad Med Sci, NHC Key Lab Organ Transplantat, Wuhan, Hubei, Peoples R China.
   [Dong, Wei] Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Hubei, Peoples R China.
   [Hu, Qi; Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China.
   [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University; Huazhong University of
   Science & Technology; Huazhong University of Science & Technology;
   Chinese Academy of Medical Sciences - Peking Union Medical College;
   Chinese Academy of Medical Sciences - Peking Union Medical College;
   Chinese Academy of Medical Sciences - Peking Union Medical College;
   Huazhong University of Science & Technology; Anhui Medical University
RP Liu, AD (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Expt Med Ctr, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.
EM liuandingtjmu@163.com
RI Yang, Yifan/JTV-1487-2023; wang, ya/HQZ-7558-2023
OI Zhang, Cuntai/0000-0002-9044-5032; liu, anding/0000-0003-4667-4572
FU National Natural Science Foundation of China [91849127]; Guangdong Basic
   and Applied Research Foundation [2021A1515010259]
FX National Natural Science Foundation of China, Grant/Award Number:
   91849127; Guangdong Basic and Applied Research Foundation, Grant/Award
   Number: 2021A1515010259
CR Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752
   Ashapkin VV, 2020, ADV EXP MED BIOL, V1260, P107, DOI 10.1007/978-3-030-42667-5_5
   Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003
   Bi JB, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6946037
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Escobar KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12876
   Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113
   Garbern J, 2019, AM J PHYSIOL-HEART C, V317, pH201, DOI 10.1152/ajpheart.00615.2018
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231
   Hinken AC, 2016, AGING CELL, V15, P582, DOI 10.1111/acel.12475
   Hsu CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03340-7
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704
   Liu AD, 2019, FASEB J, V33, P3063, DOI 10.1096/fj.201801234R
   Liu AD, 2018, FASEB J, V32, P5186, DOI 10.1096/fj.201800195R
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042
   Liu WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12794
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320
   Menzies Fiona M, 2012, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1516s54
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Poggioli T, 2016, CIRC RES, V118, P29, DOI 10.1161/CIRCRESAHA.115.307521
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53
   Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006
   Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790
   Ros XBD, 2016, METHODS, V103, P157, DOI 10.1016/j.ymeth.2016.04.003
   Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565
   Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32
   Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592
   Shim MS, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021942118
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527
   Sun Y, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118741
   Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697
   Vázquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9
   Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391
   Wang WJ, 2019, CLIN SCI, V133, P2069, DOI 10.1042/CS20190441
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9
NR 53
TC 10
Z9 11
U1 1
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 JAN
PY 2022
VL 21
IS 1
AR e13532
DI 10.1111/acel.13532
EA DEC 2021
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YG9AI
UT WOS:000729920100001
PM 34905649
OA Green Published
DA 2024-02-19
ER

PT J
AU Gregg, SQ
   Gutiérrez, V
   Robinson, AR
   Woodell, T
   Nakao, A
   Ross, MA
   Michalopoulos, GK
   Rigatti, L
   Rothermel, CE
   Kamileri, I
   Garinis, G
   Stolz, DB
   Niedernhofer, LJ
AF Gregg, Siobhan Q.
   Gutierrez, Veronica
   Robinson, Andria Rasile
   Woodell, Tyler
   Nakao, Atsunori
   Ross, Mark A.
   Michalopoulos, George K.
   Rigatti, Lora
   Rothermel, Carrie E.
   Kamileri, Irene
   Garinis, George
   Stolz, Donna Beer
   Niedernhofer, Laura J.
TI A mouse model of accelerated liver aging caused by a defect in DNA
   repair
SO HEPATOLOGY
LA English
DT Article
ID AGE-RELATED-CHANGES; FUNCTION OXIDASE SYSTEM; SINUSOIDAL ENDOTHELIUM;
   NUCLEAR ABNORMALITIES; DONOR AGE; SENESCENCE; DEFICIENT; MICE;
   PSEUDOCAPILLARIZATION; HEPATOCYTES
AB The liver changes with age, leading to an impaired ability to respond to hepatic insults and increased incidence of liver disease in the elderly. Therefore, there is critical need for rapid model systems to study aging-related liver changes. One potential opportunity is murine models of human progerias or diseases of accelerated aging. Ercc1-/? mice model a rare human progeroid syndrome caused by inherited defects in DNA repair. To determine whether hepatic changes that occur with normal aging occur prematurely in Ercc1-/? mice, we systematically compared liver from 5-month-old progeroid Ercc1-/? mice to old (24-36-month-old) wild-type (WT) mice. Both displayed areas of necrosis, foci of hepatocellular degeneration, and acute inflammation. Loss of hepatic architecture, fibrosis, steatosis, pseudocapillarization, and anisokaryosis were more dramatic in Ercc1-/? mice than in old WT mice. Liver enzymes were significantly elevated in serum of Ercc1-/? mice and old WT mice, whereas albumin was reduced, demonstrating liver damage and dysfunction. The regenerative capacity of Ercc1-/? liver after partial hepatectomy was significantly reduced. There was evidence of increased oxidative damage in Ercc1-/? and old WT liver, including lipofuscin, lipid hydroperoxides and acrolein, as well as increased hepatocellular senescence. There was a highly significant correlation in genome-wide transcriptional changes between old WT and 16-month-old, but not 5-week-old, Ercc1-/? mice, emphasizing that the Ercc1-/? mice acquire an aging profile in early adulthood. Conclusion: There are strong functional, regulatory, and histopathological parallels between accelerated aging driven by a DNA repair defect and normal aging. This supports a role for DNA damage in driving aging and validates a murine model for rapidly testing hypotheses about causes and treatment for aging-related hepatic changes. (HEPATOLOGY 2012)
C1 [Gregg, Siobhan Q.; Gutierrez, Veronica; Robinson, Andria Rasile; Woodell, Tyler; Niedernhofer, Laura J.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Off 2 6, Pittsburgh, PA 15213 USA.
   [Gregg, Siobhan Q.; Gutierrez, Veronica; Niedernhofer, Laura J.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA.
   [Robinson, Andria Rasile] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA.
   [Nakao, Atsunori] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Dept Surg, Pittsburgh, PA USA.
   [Ross, Mark A.; Rothermel, Carrie E.; Stolz, Donna Beer] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA.
   [Michalopoulos, George K.; Rigatti, Lora] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA.
   [Kamileri, Irene; Garinis, George] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.
   [Kamileri, Irene; Garinis, George] Univ Crete, Dept Biol, Iraklion, Greece.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Foundation for
   Research & Technology - Hellas (FORTH); University of Crete
RP Niedernhofer, LJ (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Off 2 6, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.
EM niedernhoferl@upmc.edu
RI Garinis, George A./B-2943-2012
OI Garinis, George A./0000-0002-3200-5004; Gutierrez Coppetti,
   Veronica/0000-0002-6627-0519; Addie, Siobhan/0000-0001-5509-0726
FU National Institute of Environmental Health Sciences [ES016114]; Ellison
   Medical Foundation [AG-NS-0303-05]; University of Pittsburgh Claude D.
   Pepper Center [P30AG024827]; American Federation of Aging Research
   MSTAR; Pittsburgh Center for Kidney Research [P30DK079307]; 
   [P30CA047904]
FX This work was supported by grants from the National Institute of
   Environmental Health Sciences (ES016114), the Ellison Medical Foundation
   (AG-NS-0303-05), and the University of Pittsburgh Claude D. Pepper
   Center (P30AG024827; to L.J.N.), the American Federation of Aging
   Research MSTAR Program (to T. W.), and the Pittsburgh Center for Kidney
   Research Pilot Program (P30DK079307; to D. B. S. and L.J.N). This
   project used the UPCI Cell and Tissue Imaging and Animal Facilities and
   was supported, in part, by award P30CA047904.
CR Adams LA, 2005, DIABETIC MED, V22, P1129, DOI 10.1111/j.1464-5491.2005.01748.x
   Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   ANDREW W, 1962, AM J ANAT, V110, P1, DOI 10.1002/aja.1001100102
   [Anonymous], 2010, NATL VITAL STAT REPO
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   Chipchase MD, 2003, HEPATOLOGY, V38, P958, DOI 10.1053/jhep.2003.50421
   Cruzen C, 2009, CLIN GERIATR MED, V25, P733, DOI 10.1016/j.cger.2009.07.001
   de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9
   del Olmo JA, 1998, J CANCER RES CLIN, V124, P560, DOI 10.1007/s004320050215
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108
   Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kagansky N, 2004, LIVER INT, V24, P588, DOI 10.1111/j.1478-3231.2004.0969.x
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   KITANI K, 1992, GASTROENTEROL JPN, V27, P276, DOI 10.1007/BF02777737
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Labbé A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   López-Diazguerrero NE, 2005, LIFE SCI, V77, P2840, DOI 10.1016/j.lfs.2005.05.034
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Mikkelsen L, 2009, FREE RADICAL BIO MED, V47, P608, DOI 10.1016/j.freeradbiomed.2009.05.030
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Moraes AS, 2007, CYTOM PART A, V71A, P28, DOI 10.1002/cyto.a.20356
   Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0
   Nevedomskaya E, 2010, J PROTEOME RES, V9, P3680, DOI 10.1021/pr100210k
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004
   OHTSUBO K, 1986, MECH AGEING DEV, V36, P125, DOI 10.1016/0047-6374(86)90013-8
   PIERI C, 1980, MECH AGEING DEV, V13, P275, DOI 10.1016/0047-6374(80)90040-8
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541
   SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086
   Stuart GR, 2000, GENETICS, V154, P1291
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V34, P2983, DOI 10.1016/0006-2952(85)90025-5
   Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004
   VRANCKX R, 1995, AM J PHYSIOL-REG I, V268, pR536, DOI 10.1152/ajpregu.1995.268.2.R536
   Wack KE, 2001, HEPATOLOGY, V33, P363, DOI 10.1053/jhep.2001.21998
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Warren A, 2011, CURR GERONTOL GERIAT
   WATANABE T, 1978, VIRCHOWS ARCH B, V27, P307
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Zahn RK, 2000, MECH AGEING DEV, V119, P101, DOI 10.1016/S0047-6374(00)00170-6
NR 69
TC 93
Z9 105
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD FEB
PY 2012
VL 55
IS 2
BP 609
EP 621
DI 10.1002/hep.24713
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 883KM
UT WOS:000299632900029
PM 21953681
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Bopp, A
   Wartlick, F
   Henninger, C
   Kaina, B
   Fritz, G
AF Bopp, A.
   Wartlick, F.
   Henninger, C.
   Kaina, B.
   Fritz, G.
TI Rac1 modulates acute and subacute genotoxin-induced hepatic stress
   responses, fibrosis and liver aging
SO CELL DEATH & DISEASE
LA English
DT Article
DE small GTPases; Rac1; genotoxic stress response; hepatotoxicity;
   fibrosis; aging
ID RHO-GTPASES; LOVASTATIN PROTECTS; DIFFERENTIAL ROLES; CRUCIAL ROLE;
   DNA-DAMAGE; INHIBITION; CELLS; DOXORUBICIN; CDC42; MIGRATION
AB To investigate the importance of the Ras-homologous GTPase Rac1 for the hepatic response to genotoxic insults and liver aging, rac1 was deleted in liver of mice by Mx1-Cre-based recombination. Knockout of rac1 caused complex changes in basal as well as doxorubicin and ionizing radiation-induced mRNA expression of various genotoxic stress response-related genes, including hspa1b, rad51, wrn and xpc. Rac1 deletion protected the liver from acute toxicity following doxorubicin treatment. Moreover, the level of S139 phosphorylated histone H2AX (gamma H2AX), which is indicative of DNA damage, and mRNA expression of pro-inflammatory (IL-6) and pro-fibrotic (CTGF, TGF beta, alpha SMA) factors were mitigated in rac1 knockout animals. By contrast, lack of rac1 promoted subacute hepatotoxicity, which was determined 3 weeks after injection of multiple low doses of doxorubicin by assaying the gamma H2AX level, mitotic index and pro-fibrotic gene expression. Regarding ionizing radiation, rac1 deficiency had no major effects on DNA damage induction or acute pro-inflammatory and pro-fibrotic stress responses. Mice lacking hepatic rac1 for extended period of time (15 months) revealed increased mRNA expression of fibrosis-related factors (CTGF, TGF beta, collagen, MMP1) and fibrotic tissue remodeling. In addition, protein expression of the senescence marker p16 was enhanced in the absence of rac1. Taken together, the data provide evidence that Rac1 is required for doxorubicin-induced DNA damage induction. It is also involved in both the acute and delayed inflammatory and fibrotic stress response in the liver following doxorubicin, but not ionizing radiation, treatment and, furthermore, protects against endogenous liver aging. Cell Death and Disease (2013) 4, e558; doi:10.1038/cddis.2013.57; published online 21 March 2013
C1 [Bopp, A.; Wartlick, F.; Henninger, C.; Fritz, G.] Univ Dusseldorf, Dept Toxicol, D-40225 Dusseldorf, Germany.
   [Bopp, A.; Wartlick, F.; Kaina, B.] Univ Med Ctr Mainz, Dept Toxicol, D-55131 Mainz, Germany.
C3 Heinrich Heine University Dusseldorf; Johannes Gutenberg University of
   Mainz
RP Fritz, G (corresponding author), Univ Dusseldorf, Dept Toxicol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM fritz@uni-duesseldorf.de
RI Kaina, Bernd/AAE-4692-2020
OI Henninger, Christian/0000-0001-6050-1518
FU Deutsche Forschungsgemeinschaft (DGF) [Fr 1241/8-1]
FX We are very grateful to VL Tybulewicz<SUP>18</SUP> for generously
   providing us with the Rac1<SUP>flox/flox/Mx1-Cre</SUP> mouse strain. We
   thank R Kitzinger, L Schumacher and T Brachetti for their excellent
   technical support. Furthermore, we thank K Lackner and A Schad for their
   support regarding blood cell count analysis and histopathological
   examination of liver sections, respectively. This work was supported by
   the Deutsche Forschungsgemeinschaft (DGF) (Fr 1241/8-1).
CR Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035
   Bokoch GM, 2000, IMMUNOL RES, V21, P139, DOI 10.1385/IR:21:2-3:139
   Bourgier C, 2005, GUT, V54, P336, DOI 10.1136/gut.2004.051169
   Canman CE, 1996, NATURE, V384, P213, DOI 10.1038/384213a0
   COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2
   Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487
   Damrot J, 2006, BRIT J PHARMACOL, V149, P988, DOI 10.1038/sj.bjp.0706953
   DIDSBURY J, 1989, J BIOL CHEM, V264, P16378
   Durán RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257
   Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1
   Fritz G, 2011, BRIT MED BULL, V97, P17, DOI 10.1093/bmb/ldq044
   Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4
   Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652
   Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068
   Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hamalukic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026413
   Haydont V, 2007, BRIT J RADIOL, V80, pS32, DOI 10.1259/bjr/58514380
   Haydont V, 2007, INT J RADIAT ONCOL, V68, P1471, DOI 10.1016/j.ijrobp.2007.03.044
   Haydont V, 2007, CLIN CANCER RES, V13, P5331, DOI 10.1158/1078-0432.CCR-07-0625
   Henninger C, 2012, TOXICOL APPL PHARM, V261, P66, DOI 10.1016/j.taap.2012.03.012
   Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e
   Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057
   Huelsenbeck J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.65
   Huelsenbeck SC, 2012, J BIOL CHEM, V287, P38590, DOI 10.1074/jbc.M112.377903
   Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587
   Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550
   Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131
   Mazars A, 2000, ONCOGENE, V19, P1277, DOI 10.1038/sj.onc.1203420
   MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4
   Mizukawa B, 2011, BLOOD, V118, P5235, DOI 10.1182/blood-2011-04-351817
   Mulloy JC, 2008, CELL CYCLE, V7, P3314, DOI 10.4161/cc.7.21.6951
   Nübel T, 2006, CLIN CANCER RES, V12, P933, DOI 10.1158/1078-0432.CCR-05-1903
   Olive PL, 2004, METHOD CELL BIOL, V75, P355
   Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020
   Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463
   Rashid M, 2009, CIRC J, V73, P361, DOI 10.1253/circj.CJ-08-0817
   Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x
   Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049
   Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595
   Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380
   Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67
   van Helden SFG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042563
   Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709
   Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421
   Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997
   Yan TD, 2009, MOL CANCER THER, V8, P1075, DOI 10.1158/1535-7163.MCT-09-0139
   Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024
   Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110
NR 54
TC 27
Z9 27
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAR
PY 2013
VL 4
AR e558
DI 10.1038/cddis.2013.57
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 116FR
UT WOS:000316868700037
PM 23519127
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhou, G
   Bei, JX
   Li, TY
   Zhu, KS
   Tu, ZK
AF Zhou, Guo
   Bei, Jiaxin
   Li, Tianyang
   Zhu, Kangshun
   Tu, Zhengkun
TI TLR3 Mediates Senescence and Immunosurveillance of Hepatic Stellate
   Cells
SO HEPATITIS MONTHLY
LA English
DT Article
DE Hepatic Stellate Cells; Poly I:C; Cellular Senescence; Natural Killer
   Cells
ID TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; LIVER FIBROSIS; KUPFFER
   CELLS; NK CELLS; ACTIVATION; INDUCTION; INJURY; MECHANISMS
AB Background: Activation of hepatic stellate cells (HSCs) is an important driver of liver fibrosis, which is a health problem of global concern, and there is no effective solution for it at the present. Senescent activated HSCs are preferentially killed by natural killer cells (NK cells) to promote the regression of hepatic fibrosis.
   Objectives: The purpose of this study was to investigate the effect of polyinosinic-polycytidylic acid (poly I:C) on HSCs' senescence, a trigger for NK cell-induced cytotoxicity.
   Methods: The senescence of HSCs was assessed bywestern blot, qRT-PCR, and flow cytometry, and NK cell cytotoxicity was assessed in a co-culture of NK cells with poly I:C-treated HSCs by measuring CD107a expression.
   Results: The expression of p16, p21, SA-beta-gal, MICA/MICB, and ULBP2 increased in poly I:C-treated HSCs, rendering them significantly susceptible to NK cell cytotoxicity.
   Conclusions: Poly I:C induces cellular senescence in HSCs and triggers NK cell immunosurveillance, suggesting that the role of poly I:C in HSC senescence may promote fibrosis regression.
C1 [Zhou, Guo; Bei, Jiaxin; Tu, Zhengkun] Guangzhou Med Univ, Dept Minimally Invas Intervent Radiol, Affiliated Hosp 2, Lab Intervent Radiol, Guangzhou, Peoples R China.
   [Zhou, Guo; Bei, Jiaxin; Tu, Zhengkun] Guangzhou Med Univ, Dept Radiol, Affiliated Hosp 2, Guangzhou, Peoples R China.
   [Li, Tianyang; Zhu, Kangshun] First Hosp Jilin Univ, Inst Liver Dis, Changchun, Peoples R China.
C3 Guangzhou Medical University; Guangzhou Medical University; Jilin
   University
RP Tu, ZK (corresponding author), Guangzhou Med Univ, Dept Minimally Invas Intervent Radiol, Affiliated Hosp 2, Lab Intervent Radiol, Guangzhou, Peoples R China.; Tu, ZK (corresponding author), Guangzhou Med Univ, Dept Radiol, Affiliated Hosp 2, Guangzhou, Peoples R China.; Zhu, KS (corresponding author), First Hosp Jilin Univ, Inst Liver Dis, Changchun, Peoples R China.
EM zhksh010@163.com; tuzhengkun@hotmail.com
OI Bei, Jiaxin/0000-0003-4108-3749
FU National Natural Science Foundation of China [81873920]
FX This study was supported by grants from the National Natural Science
   Foundation of China (no.: 81873920).
CR Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Aydin MM, 2018, TURK J GASTROENTEROL, V29, P14, DOI 10.5152/tjg.2018.17330
   Bernard M, 2020, AUTOPHAGY, V16, P2004, DOI 10.1080/15548627.2020.1713640
   Byun JS, 2013, J HEPATOL, V58, P342, DOI 10.1016/j.jhep.2012.09.016
   Chen JQ, 2016, CLIN REV ALLERG IMMU, V50, P1, DOI 10.1007/s12016-015-8473-z
   Chen J, 2019, KIDNEY BLOOD PRESS R, V44, P1063, DOI 10.1159/000502233
   Ebrahimi Hedyeh, 2016, Middle East J Dig Dis, V8, P166
   Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400
   Hou X, 2012, ACTA TROP, V121, P99, DOI 10.1016/j.actatropica.2011.10.008
   Hsu CH, 2019, CELL, V178, P361, DOI 10.1016/j.cell.2019.05.041
   Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445
   Huang YH, 2018, MOL MED REP, V17, P5700, DOI 10.3892/mmr.2018.8592
   Iannello A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27616
   Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee HJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01659
   Levi N, 2020, FEBS J, V287, P2636, DOI 10.1111/febs.15282
   Li HJ, 2015, J CLIN TRANSL HEPATO, V3, P277, DOI 10.14218/JCTH.2015.00026
   Li TY, 2019, J LEUKOCYTE BIOL, V105, P695, DOI 10.1002/JLB.2A0118-031RR
   Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005
   Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025
   Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136
   Nicodemus CF, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.001
   Qu JL, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/7519856
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Ramnath D, 2017, SEMIN CELL DEV BIOL, V61, P22, DOI 10.1016/j.semcdb.2016.08.014
   Regulski MJ, 2017, WOUNDS, V29, P168
   Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206
   Sagiv A, 2016, AGING-US, V8, P328, DOI 10.18632/aging.100897
   Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245
   Seo W, 2016, HEPATOLOGY, V64, P616, DOI 10.1002/hep.28644
   Sghaier I, 2019, BRIT J BIOMED SCI, V76, P35, DOI 10.1080/09674845.2018.1547179
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Tu Z, 2008, J EXP MED, V205, P233, DOI 10.1084/jem.20072195
   Verma R, 2017, J NEUROL SCI, V372, P40, DOI 10.1016/j.jns.2016.11.034
   Wang Y, 2013, J VIRAL HEPATITIS, V20, P385, DOI 10.1111/jvh.12040
   Wijaya RS, 2019, J HEPATOL, V71, P252, DOI 10.1016/j.jhep.2019.03.012
   Zhang CY, 2016, WORLD J GASTROENTERO, V22, P10512, DOI 10.3748/wjg.v22.i48.10512
NR 40
TC 0
Z9 0
U1 0
U2 10
PU KOWSAR PUBL
PI HOENSBROEK
PA PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS
SN 1735-143X
EI 1735-3408
J9 HEPAT MON
JI Hepat. Mon.
PD JUN
PY 2021
VL 21
IS 6
AR e114381
DI 10.5812/hepatmon.114381
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA UX7DM
UT WOS:000701001300005
OA gold
DA 2024-02-19
ER

PT J
AU Gong, ZW
   Tas, E
   Yakar, S
   Muzumdar, R
AF Gong, Zhenwei
   Tas, Emir
   Yakar, Shoshana
   Muzumdar, Radhika
TI Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging
SO MOLECULAR AND CELLULAR ENDOCRINOLOGY
LA English
DT Article
DE Aging; Age-related disease; Lipid metabolism; NAFLD; NASH
ID ACID-BINDING-PROTEIN; GROWTH-FACTOR 21; DE-NOVO LIPOGENESIS;
   CHAPERONE-MEDIATED AUTOPHAGY; AGE-RELATED DECLINE; IMPROVES INSULIN
   SENSITIVITY; NECROSIS-FACTOR-ALPHA; HIV-INFECTED PATIENTS; SERUM LEPTIN
   LEVELS; BODY-COMPOSITION
AB Aging is associated with dysregulation of glucose and lipid metabolism. Various factors that contribute to the dysregulation include both modifiable (e.g. obesity, insulin resistance) and non-modifiable risk factors (age-associated physiologic changes). Although there is no linear relationship between aging and prevalence of non-alcoholic fatty liver disease, current data strongly suggests that advanced age leads to more severe histological changes and poorer clinical outcomes. Hepatic lipid accumulation could lead to significant hepatic and systemic consequences including steatohepatitis, cirrhosis, impairment of systemic glucose metabolism and metabolic syndrome, thereby contributing to age-related diseases. Insulin, leptin and adiponectin are key regulators of the various physiologic processes that regulate hepatic lipid metabolism. Recent advances have expanded our understanding in this field, highlighting the role of novel mediators such as FGF 21, and mitochondria derived peptides. In this review, we will summarize the mediators of hepatic lipid metabolism and how they are altered in aging. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Gong, Zhenwei; Muzumdar, Radhika] Univ Pittsburgh, Sch Med, Dept Pediat, One Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.
   [Gong, Zhenwei; Tas, Emir; Muzumdar, Radhika] UPMC, Childrens Hosp Pittsburgh, One Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.
   [Yakar, Shoshana] NYU, Coll Dent, David B Kriser Dent Ctr, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA.
   [Muzumdar, Radhika] Univ Pittsburgh, Sch Med, Dept Cell Biol, 3500 Terrace St,5362 Biomed Sci Tower, Pittsburgh, PA 15261 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; New York University; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh
RP Muzumdar, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15260 USA.
EM radhika.muzumdar@chp.edu
RI Yakar, Shoshana/IUN-5716-2023; Gong, Zhenwei/G-2435-2012
OI Yakar, Shoshana/0000-0002-2352-1330; 
FU U.S. National Institutes of Health [R01-AG-035114, R56-AG044519]
FX This study was supported by grants R01-AG-035114 and R56-AG044519 to
   R.H.M. from the U.S. National Institutes of Health.
CR Ables GP, 2016, ANN NY ACAD SCI, V1363, P68, DOI 10.1111/nyas.13014
   Adamczak M, 2005, CLIN ENDOCRINOL, V62, P114, DOI 10.1111/j.1365-2265.2004.02182.x
   Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67
   Alkhouri N, 2012, LIVER INT, V32, P297, DOI 10.1111/j.1478-3231.2011.02639.x
   Alkhouri N, 2010, DIGEST DIS SCI, V55, P2644, DOI 10.1007/s10620-009-1075-y
   Angulo Paul, 2002, Ann Hepatol, V1, P12
   Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227
   Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005
   Atzmon G, 2008, J GERONTOL A-BIOL, V63, P447, DOI 10.1093/gerona/63.5.447
   Awazawa M, 2009, BIOCHEM BIOPH RES CO, V382, P51, DOI 10.1016/j.bbrc.2009.02.131
   Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532
   Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Baumgartner RN, 1999, METABOLISM, V48, P378, DOI 10.1016/S0026-0495(99)90089-6
   Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820
   Bergholm R, 2013, INT J OBESITY, V37, P699, DOI 10.1038/ijo.2012.116
   Berk PD, 2008, HEPATOLOGY, V48, P1362, DOI 10.1002/hep.22632
   Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   BORDEWICK U, 1989, BIOL CHEM H-S, V370, P229, DOI 10.1515/bchm3.1989.370.1.229
   Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727
   Bredella MA, 2013, J CLIN ENDOCR METAB, V98, P3864, DOI 10.1210/jc.2013-2063
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Bruinstroop E, 2013, AM J PHYSIOL-ENDOC M, V304, pE1089, DOI 10.1152/ajpendo.00614.2012
   Bruinstroop E, 2012, DIABETES, V61, P1043, DOI 10.2337/db11-1142
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21
   Bruunsgaard H, 2000, LIFE SCI, V67, P2721, DOI 10.1016/S0024-3205(00)00851-1
   Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357
   Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240
   Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   CHAN FKL, 1995, HEPATOLOGY, V22, P1254, DOI 10.1016/0270-9139(95)90636-3
   Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107
   Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016
   Chen GX, 1996, P NATL ACAD SCI USA, V93, P14795, DOI 10.1073/pnas.93.25.14795
   Chen QR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065982
   CHEN SH, 1986, SOMAT CELL MOLEC GEN, V12, P303, DOI 10.1007/BF01570790
   Chitturi S, 2002, HEPATOLOGY, V36, P403, DOI 10.1053/jhep.2002.34738
   Chitturi S, 2007, J GASTROEN HEPATOL, V22, P967, DOI 10.1111/j.1440-1746.2007.04995.x
   Chow JDY, 2014, MOL METAB, V3, P419, DOI 10.1016/j.molmet.2014.02.004
   Cianfarani S, 2014, J PEDIATR-US, V165, P92, DOI 10.1016/j.jpeds.2014.01.052
   Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943
   Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503
   Cordoba-Chacon J, 2015, DIABETES, V64, P3093, DOI 10.2337/db15-0370
   Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713
   Danford D. E., 2013, NUTR AGING ELDERLY
   Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200
   Dentin R, 2012, J HEPATOL, V56, P199, DOI 10.1016/j.jhep.2011.07.019
   Di Lorenzo G, 1999, MECH AGEING DEV, V108, P25, DOI 10.1016/S0047-6374(98)00156-0
   Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830
   Dixon LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056100
   Donati A, 2008, J GERONTOL A-BIOL, V63, P550, DOI 10.1093/gerona/63.6.550
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158
   Einstein FH, 2010, J GERONTOL A-BIOL, V65, P800, DOI 10.1093/gerona/glq078
   Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353
   Erol E, 2003, FASEB J, V17, P347, DOI 10.1096/fj.03-0330fje
   Fan JG, 2005, J GASTROEN HEPATOL, V20, P1825, DOI 10.1111/j.1440-1746.2005.04058.x
   Fan Y, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00218
   Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308
   Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746
   Filippi BM, 2014, AGING-US, V6, P82, DOI 10.18632/aging.100637
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FINKELSTEIN JW, 1972, J CLIN ENDOCR METAB, V35, P665, DOI 10.1210/jcem-35-5-665
   Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193
   Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com
   Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206
   Fukuda I, 2008, ENDOCR J, V55, P977, DOI 10.1507/endocrj.K08E-079
   Fukushima J, 2009, HEPATOL RES, V39, P724, DOI 10.1111/j.1872-034X.2009.00509.x
   Gabriely I, 2002, DIABETES, V51, P1016, DOI 10.2337/diabetes.51.4.1016
   Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005
   Ganz M, 2013, HEPATOL INT, V7, pS771, DOI 10.1007/s12072-013-9468-6
   García-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1
   Gerli R, 2000, MECH AGEING DEV, V121, P37
   Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009
   Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200
   Gomez CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/475139
   Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523
   Gong ZW, 2015, AM J PHYSIOL-ENDOC M, V309, pE283, DOI 10.1152/ajpendo.00043.2015
   Gong ZW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00210
   Green CJ, 2014, NUTRIENTS, V6, P5018, DOI 10.3390/nu6115018
   Guo ZH, 2014, P NATL ACAD SCI USA, V111, P14199, DOI 10.1073/pnas.1414780111
   Gupta S, 2003, MECH AGEING DEV, V124, P503, DOI 10.1016/S0047-6374(03)00028-9
   Hanks LJ, 2015, J CLIN TRANSL ENDOCR, V2, P77, DOI 10.1016/j.jcte.2015.02.001
   Hazlehurst JM, 2013, EUR J ENDOCRINOL, V169, pR27, DOI 10.1530/EJE-13-0296
   Heeboll S, 2016, J GASTROEN HEPATOL, V31, P668, DOI 10.1111/jgh.13151
   Hegarty BD, 2002, DIABETES, V51, P1477, DOI 10.2337/diabetes.51.5.1477
   Henning JR, 2013, HEPATOLOGY, V58, P589, DOI 10.1002/hep.26267
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019
   HOLT PR, 1993, AM J PHYSIOL, V264, pG1, DOI 10.1152/ajpgi.1993.264.1.G1
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290
   Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x
   Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731
   Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280
   Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4
   Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995
   Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006
   Inoue K, 2002, BIOCHEM BIOPH RES CO, V299, P465, DOI 10.1016/S0006-291X(02)02669-4
   IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081
   Isidori AM, 2000, J CLIN ENDOCR METAB, V85, P1954, DOI 10.1210/jc.85.5.1954
   Isoda K, 2005, J BIOL CHEM, V280, P7002, DOI 10.1074/jbc.M412220200
   Jeon TI, 2013, MOL NUTR FOOD RES, V57, P1931, DOI 10.1002/mnfr.201300071
   Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002
   Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X
   JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002
   Jung TS, 2012, LIVER INT, V32, P1565, DOI 10.1111/j.1478-3231.2012.02857.x
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kahraman A, 2010, HEPATOLOGY, V51, P92, DOI 10.1002/hep.23253
   Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JC132914, 10.1172/JCI32914]
   Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283
   Kaushik S, 2016, AUTOPHAGY, V12, P432, DOI 10.1080/15548627.2015.1124226
   Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073
   Kim JY, 2009, AGE, V31, P127, DOI 10.1007/s11357-009-9089-0
   Kim YC, 2011, J NUTR BIOCHEM, V22, P289, DOI 10.1016/j.jnutbio.2010.02.007
   Kineman RD, 2016, ENDOCRINOLOGY, V157, P1728, DOI 10.1210/en.2015-2077
   Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2
   Kirwan JP, 2001, AM J PHYSIOL-ENDOC M, V281, pE1137, DOI 10.1152/ajpendo.2001.281.6.E1137
   Kizer JR, 2010, J GERONTOL A-BIOL, V65, P1208, DOI 10.1093/gerona/glq122
   Kling P, 2012, GEN COMP ENDOCR, V175, P153, DOI 10.1016/j.ygcen.2011.10.014
   Koca SS, 2008, INFLAMMATION, V31, P91, DOI 10.1007/s10753-007-9053-z
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Koh JH, 2009, DIABETES CARE, V32, P147, DOI 10.2337/dc08-1379
   Kroemer G, 2015, J CLIN INVEST, V125, P1, DOI 10.1172/JCI78652
   Kubrusly MS, 2010, HISTOL HISTOPATHOL, V25, P1123, DOI 10.14670/HH-25.1123
   Kulkarni SR, 2013, PHARM RES-DORDR, V30, P2221, DOI 10.1007/s11095-013-1138-9
   Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   Lane M., 1998, Journal of Anti-Aging Medicine, V1, P327, DOI [10.1089/rej.1.1998.1.327, DOI 10.1089/REJ.1.1998.1.327]
   Laron Z, 2008, GROWTH HORM IGF RES, V18, P434, DOI 10.1016/j.ghir.2008.03.003
   Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee C, 2014, AGING CELL, V13, P958, DOI 10.1111/acel.12243
   Lee YM, 2008, HEPATOL INT, V2, P196, DOI 10.1007/s12072-008-9058-1
   Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238
   Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107
   Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059
   Li Y, 2013, J BIOL CHEM, V288, P10490, DOI 10.1074/jbc.M112.429852
   List EO, 2009, DIABETOLOGIA, V52, P1647, DOI 10.1007/s00125-009-1402-z
   List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086
   Liu Z., 2016, IGF 1 INDEPENDENT AC
   Liu ZB, 2016, DIABETES, V65, P3598, DOI 10.2337/db16-0649
   Ma XH, 2002, J GERONTOL A-BIOL, V57, pB225, DOI 10.1093/gerona/57.6.B225
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   Madsen M, 2012, J CLIN ENDOCR METAB, V97, P1227, DOI 10.1210/jc.2011-2681
   Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427
   Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142
   Masetti M, 2014, AGING CLIN EXP RES, V26, P241, DOI 10.1007/s40520-013-0156-0
   Mashek DG, 2013, ADV NUTR, V4, P697, DOI 10.3945/an.113.004648
   Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404
   MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764
   Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009
   Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334
   Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137
   Nanji AA, 2004, J PHARMACOL EXP THER, V310, P417, DOI 10.1124/jpet.103.064717
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Newberry EP, 2012, J LIPID RES, V53, P744, DOI 10.1194/jlr.M020966
   Nishizawa H, 2012, EUR J ENDOCRINOL, V167, P67, DOI 10.1530/EJE-12-0252
   Oosterveer MH, 2014, CELL MOL LIFE SCI, V71, P1453, DOI 10.1007/s00018-013-1505-z
   Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026
   Park C. Y., 2014, FASEB J, P28
   Paschos P, 2009, HIPPOKRATIA, V13, P9
   Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537
   Pinto LD, 2010, LIVER INT, V30, P603, DOI 10.1111/j.1478-3231.2009.02200.x
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106
   Procaccini C, 2010, CURR PHARM DESIGN, V16, P1902, DOI 10.2174/138161210791208884
   Qin Y, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-78
   REID JCW, 1985, BIOCHEM J, V225, P233, DOI 10.1042/bj2250233
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109
   Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424
   Roth GS, 2005, ANN NY ACAD SCI, V1057, P365, DOI 10.1136/annals.1356.027
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Runchey SS, 2014, J GASTROEN HEPATOL, V29, P589, DOI 10.1111/jgh.12437
   Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777
   Ryan AS, 1996, J CLIN ENDOCR METAB, V81, P4433, DOI 10.1210/jc.81.12.4433
   Ryan AS, 2000, SPORTS MED, V30, P327, DOI 10.2165/00007256-200030050-00002
   SADDIK M, 1993, J BIOL CHEM, V268, P25836
   Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x
   Sanches SCL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/574832
   Sanchis-Gomar F, 2015, AGE, V37, DOI 10.1007/s11357-015-9776-y
   Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178
   Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300
   SCHAEFER EJ, 1994, J LIPID RES, V35, P779
   Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43
   Schwarz JM, 2002, J CLIN ENDOCR METAB, V87, P942, DOI 10.1210/jc.87.2.942
   Sesti G, 2014, NUTR METAB CARDIOVAS, V24, P1365, DOI 10.1016/j.numecd.2014.06.012
   Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203
   SHI J, 2012, PLOS ONE, V0007
   Shodell M, 2002, SCAND J IMMUNOL, V56, P518, DOI 10.1046/j.1365-3083.2002.01148.x
   Silha JV, 2003, EUR J ENDOCRINOL, V149, P331, DOI 10.1530/eje.0.1490331
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Singh RK, 2012, INT J OPT, V2012, DOI [10.1155/2012/282041, 10.1155/2012/832086]
   Sirbu A, 2013, GROWTH HORM IGF RES, V23, P2, DOI 10.1016/j.ghir.2012.10.001
   Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894
   Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463
   Stanley TL, 2014, JAMA-J AM MED ASSOC, V312, P380, DOI 10.1001/jama.2014.8334
   Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464
   Sumida Y, 2015, HEPATOL RES, V45, P771, DOI 10.1111/hepr.12408
   Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024
   Tanida M, 2015, J NEUROSCI, V35, P474, DOI 10.1523/JNEUROSCI.1828-14.2015
   Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953
   Thomas T, 2000, METABOLISM, V49, P1278, DOI 10.1053/meta.2000.9519
   Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499
   Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077
   Toogood AA, 2003, HORM RES, V60, P105, DOI 10.1159/000071234
   Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014
   Trak-Smayra V, 2011, INT J EXP PATHOL, V92, P413, DOI 10.1111/j.1365-2613.2011.00793.x
   Tsai JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056250
   Tsai S, 2015, J CLIN INVEST, V125, P2952, DOI 10.1172/JCI77361
   Uygun A, 2000, AM J GASTROENTEROL, V95, P3584
   Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388
   Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112
   VITALE M, 1992, CELL IMMUNOL, V145, P1, DOI 10.1016/0008-8749(92)90307-B
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Völzke H, 2009, EUR J ENDOCRINOL, V161, P705, DOI 10.1530/EJE-09-0374
   Wang GQ, 2015, J LIPID RES, V56, P2238, DOI 10.1194/jlr.R056705
   Wasada T, 2008, METABOLISM, V57, P980, DOI 10.1016/j.metabol.2008.02.015
   Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Woudstra TD, 2004, LIPIDS, V39, P603, DOI 10.1007/s11745-004-1272-9
   Woudstra TD, 2004, LIPIDS, V39, P343, DOI 10.1007/s11745-004-1238-y
   Xia JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113724
   Xiao YZ, 2016, DIABETES, V65, P393, DOI 10.2337/db15-1024
   Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797
   Xu CF, 2013, AM J GASTROENTEROL, V108, P1299, DOI 10.1038/ajg.2013.104
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044136
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yang TX, 2015, ENDOCRINOLOGY, V156, P555, DOI 10.1210/en.2014-1617
   Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200
   Youm YH, 2016, P NATL ACAD SCI USA, V113, P1026, DOI 10.1073/pnas.1514511113
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200
   Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020
   Zadeh ES, 2013, J HEPATOL, V59, P131, DOI 10.1016/j.jhep.2013.02.007
   Zammit VA, 2008, IUBMB LIFE, V60, P347, DOI 10.1002/iub.78
   Zelber-Sagi S, 2006, LIVER INT, V26, P856, DOI 10.1111/j.1478-3231.2006.01311.x
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117008
   Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476
   Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003
   Zhang YMD, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-102
   Zhu SL, 2014, ACTA BIOCH BIOPH SIN, V46, P1041, DOI 10.1093/abbs/gmu097
NR 259
TC 91
Z9 102
U1 3
U2 46
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0303-7207
EI 1872-8057
J9 MOL CELL ENDOCRINOL
JI Mol. Cell. Endocrinol.
PD NOV 5
PY 2017
VL 455
IS C
SI SI
BP 115
EP 130
DI 10.1016/j.mce.2016.12.022
PG 16
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Endocrinology & Metabolism
GA FI8LG
UT WOS:000412253500013
PM 28017785
DA 2024-02-19
ER

PT J
AU Guo, Y
   Zhou, AQ
   Zhang, YY
   Chen, Y
   Chen, YF
   Gao, Y
   Miao, XL
AF Guo, Yan
   Zhou, Anqi
   Zhang, Yuanyuan
   Chen, Ying
   Chen, Yifei
   Gao, Yuan
   Miao, Xiulian
TI Serum response factor activates peroxidasin transcription to block
   senescence of hepatic stellate cells
SO LIFE SCIENCES
LA English
DT Article
DE Liver fibrosis; Hepatic stellate cell; Senescence; ROS
ID EXPRESSION; GENE; SRF; DIFFERENTIATION; PROLIFERATION; MECHANISMS;
   STEATOSIS
AB Aims: Aberrant liver fibrosis is a hallmark event in end-stage liver diseases. Hepatic stellate cells (HSCs) are considered the major source of myofibroblasts in the liver that produce extracellular matrix proteins to promote liver fibrosis. HSCs undergo senescence in response to various stimuli, a process that can be exploited to dampen liver fibrosis. We investigated the role of serum response factor (SRF) in this process.Methods and materials: Senescence was induced HSCs by serum withdrawal or progressive passage. DNA-protein interaction was evaluated by chromatin immunoprecipitation (ChIP).Results: SRF expression was down-regulated in HSCs entering into senescence. Coincidently, SRF depletion by RNAi accelerated HSC senescence. Of note, treatment of an anti-oxidant (N-acetylcysteine or NAC) blocked HSC senescence by SRF deficiency suggesting that SRF may antagonize HSC senescence by eliminating excessive reactive oxygen species (ROS). PCR-array based screening identified peroxidasin (PXDN) as a potential target for SRF in HSCs. PXDN expression was inversely correlated with HSC senescence whereas PXDN knockdown accelerated HSC senescence. Further analysis reveals that SRF directly bound to the PXDN promoter and acti-vated PXDN transcription. Consistently, PXDN over-expression protected whereas PXDN depletion amplified HSC senescence. Finally, PXDN knockout mice displayed diminished liver fibrosis compared to wild type mice when subjected to bile duct ligation (BDL).Significance: Our data suggest that SRF, via its downstream target PXDN, plays a key role in regulating HSC senescence.
C1 [Guo, Yan; Zhou, Anqi; Chen, Ying; Chen, Yifei; Miao, Xiulian] Liaocheng Univ, Inst Biomed Res, Liaocheng, Peoples R China.
   [Guo, Yan; Zhou, Anqi; Chen, Ying; Chen, Yifei; Miao, Xiulian] Liaocheng Univ, Coll Life Sci, Liaocheng, Peoples R China.
   [Zhang, Yuanyuan] Hainan Med Univ, Affiliated Hosp 1, Inst Cardiovasc Res, Hainan Prov Key Lab Trop Cardiovasc Dis Res,Key La, Haikou, Peoples R China.
   [Gao, Yuan] Nanjing Med Univ, Changzhou 2 Peoples Hosp, Dept Hepatobiliary Pancreat Surg, Changzhou, Peoples R China.
   [Gao, Yuan] Nanjing Med Univ, Changzhou 2 Peoples Hosp, Inst Hepatobiliary & Pancreat Dis, Changzhou, Peoples R China.
   [Gao, Yuan] Changzhou 2 Peoples Hosp, 29 Xinglong Xiang, Changzhou 213004, Peoples R China.
   [Miao, Xiulian] Liaocheng Univ, 1 Hunan Rd, Liaocheng 252001, Peoples R China.
C3 Liaocheng University; Liaocheng University; Hainan Medical University;
   Nanjing Medical University; Nanjing Medical University; Liaocheng
   University
RP Gao, Y (corresponding author), Changzhou 2 Peoples Hosp, 29 Xinglong Xiang, Changzhou 213004, Peoples R China.; Miao, XL (corresponding author), Liaocheng Univ, 1 Hunan Rd, Liaocheng 252001, Peoples R China.
EM drgaoyuan@njmu.edu.cn; miaoxiulian@lcu.edu.cn
RI Yuan yuan, Zhang/CAH-6633-2022
OI Gao, Yuan/0000-0002-2140-0092
FU Liaocheng University [318012118]; Health Commission of Jiangsu Province
   [M2022023]
FX Funding This work was supported by grants from Liaocheng University
   (318012118) and Health Commission of Jiangsu Province (M2022023) .
CR Angelova PR, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100510
   Angstenberger M, 2007, GASTROENTEROLOGY, V133, P1948, DOI 10.1053/j.gastro.2007.08.078
   Bathish B, 2020, J BIOL CHEM, V295, P12697, DOI 10.1074/jbc.RA120.014504
   Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222
   Bhattacharya D, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100237
   Bilgic HA, 2023, LIFE SCI, V315, DOI 10.1016/j.lfs.2022.121358
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Boettler T, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100480
   Chen LY, 2023, LIFE SCI, V314, DOI 10.1016/j.lfs.2022.121336
   Chhimwal J, 2022, J NUTR BIOCHEM, V107, DOI 10.1016/j.jnutbio.2022.109062
   Colon S, 2019, AM J PHYSIOL-RENAL, V316, pF360, DOI 10.1152/ajprenal.00291.2018
   da Silva BD, 2017, CELL BIOL INT, V41, P946, DOI 10.1002/cbin.10790
   Dufour JF, 2022, GUT, V71, P2123, DOI 10.1136/gutjnl-2021-326874
   Edwards JS, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100592
   Elferink RO, 2003, GUT, V52, pII42, DOI 10.1136/gut.52.suppl_2.ii42
   Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655
   Filliol A, 2022, NATURE, V610, P356, DOI 10.1038/s41586-022-05289-6
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gandhi Chandrashekhar R, 2012, Trends Cell Mol Biol, V7, P1
   Gest C, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2023.100691
   Greene MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085848
   Hadjihambi A, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100509
   Jiang Z, 2022, LIFE SCI, V307, DOI 10.1016/j.lfs.2022.120848
   Jiao JJ, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2022.100628
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948
   Kong M, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101302
   Kong M, 2019, J MOL MED, V97, P1521, DOI 10.1007/s00109-019-01831-8
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Kostic S, 2020, ACTA HISTOCHEM, V122, DOI 10.1016/j.acthis.2019.151460
   Kunst RF, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100573
   Lahoute C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003910
   Li C., 2023, JHEP REP INNOV HEPAT, V5
   Liu L, 2023, LIFE SCI, V317, DOI 10.1016/j.lfs.2023.121470
   Liu ZY, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101151
   Lu XG, 1998, J GERONTOL A-BIOL, V53, pB3, DOI 10.1093/gerona/53A.1.B3
   Lv FQ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00176
   Mao WB, 2022, PHARMACOL RES, V179, DOI 10.1016/j.phrs.2022.106205
   Melin N, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100508
   Miano JM, 2015, J BIOMED RES, V29, P3, DOI 10.7555/JBR.29.20140151
   Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104
   Niaz Q, 2022, LIFE SCI, V308, DOI 10.1016/j.lfs.2022.120966
   Panayiotou R, 2016, ELIFE, V5, DOI 10.7554/eLife.15460
   Pastore M, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100444
   Pian AK, 2022, LIFE SCI, V311, DOI 10.1016/j.lfs.2022.121161
   Pu SY, 2023, LIFE SCI, V325, DOI 10.1016/j.lfs.2023.121772
   Qian JJ, 2022, LIFE SCI, V310, DOI 10.1016/j.lfs.2022.121117
   Rashidi-Alavijeh J, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2023.100688
   Sakuma K, 2008, BBA-MOL BASIS DIS, V1782, P453, DOI 10.1016/j.bbadis.2008.03.008
   Schmalz F, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2023.100684
   Seedorf K, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2022.100651
   Simbrunner B, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2023.100712
   Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0
   Sojoodi M, 2022, CELL MOL GASTROENTER, V13, P1483, DOI 10.1016/j.jcmgh.2022.01.015
   Su WT, 2023, JHEP REP, V5, DOI 10.1016/j.jhepr.2023.100695
   Sun K, 2009, HEPATOLOGY, V49, P1645, DOI 10.1002/hep.22834
   Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412
   Ting CH, 2014, STEM CELLS DEV, V23, P1206, DOI 10.1089/scd.2013.0231
   Trauner M, 2022, GUT, V71, P194, DOI 10.1136/gutjnl-2021-324305
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   van de Wiel SMW, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100463
   von Kleeck Ryan, 2022, Vasc Biol, V4, P1, DOI 10.1530/VB-21-0018
   Wang Q, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100555
   Wang Y., 2023, JHEP REP INNOV HEPAT, V5
   Wheaton K, 2004, MOL CELL BIOL, V24, P7298, DOI 10.1128/MCB.24.16.7298-7311.2004
   WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Wu T, 2023, REDOX BIOL, V59, DOI 10.1016/j.redox.2022.102586
   Wu XY, 2023, LIFE SCI, V316, DOI 10.1016/j.lfs.2023.121412
   Xie ZY, 2022, LIFE SCI, V307, DOI 10.1016/j.lfs.2022.120878
   Yang YY, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165723
   Zhan YQ, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2022.100532
   Zhang MF, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111572
   Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782
NR 74
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD SEP 1
PY 2023
VL 328
AR 121824
DI 10.1016/j.lfs.2023.121824
EA JUN 2023
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA N4GH5
UT WOS:001036610300001
PM 37270170
DA 2024-02-19
ER

PT J
AU Marcos, R
   Correia-Gomes, C
AF Marcos, Ricardo
   Correia-Gomes, Carla
TI Long live the liver: immunohistochemical and stereological study of
   hepatocytes, liver sinusoidal endothelial cells, Kupffer cells and
   hepatic stellate cells of male and female rats throughout ageing
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Hepatic stellate cells; Kupffer cells; Hepatocytes; Liver; Ageing
ID AGE-RELATED-CHANGES; WISTAR MALE-RATS; A-STORING CELLS; OLD-AGE;
   GENE-EXPRESSION; MAMMALIAN LIVER; EXTRACELLULAR-MATRIX; DRUG-METABOLISM;
   DIETARY-FAT; VITAMIN-E
AB Male/female differences in enzyme activity and gene expression in the liver are known to be attenuated with ageing. Nevertheless, the effect of ageing on liver structure and quantitative cell morphology remains unknown. Male and female Wistar rats aged 2, 6, 12 and 18 months were examined by means of stereological techniques and immunohistochemical tagging of hepatocytes (HEP), liver sinusoidal endothelial cells (LSEC), Kupffer cells (KC) and hepatic stellate cells (HSC) in order to assess the total number and number per gram of these cells throughout life. The mean cell volume of HEP and HSC, the lobular position and the collagen content of the liver were also evaluated with stereological techniques. The number per gram of HSC was similar for both genders and was maintained throughout ageing. The mean volume of HSC was also conserved but differences in the cell body and lobular location were observed. Statistically significant gender differences in HEP were noted in young rats (females had smaller and more binucleated HEP) but were attenuated with ageing. The same occurred for KC and LSEC, since the higher number per gram in young females disappeared in older animals. Liver collagen increased with ageing but only in males. Thus, the numbers of these four cell types are related throughout ageing, with well-defined cell ratios. The shape and lobular position of HSC change with ageing in both males and females. Gender dimorphism in HEP, KC and LSEC of young rat liver disappears with ageing.
C1 [Marcos, Ricardo] Univ Porto, Inst Biomed Sci Abel Salazar, Dept Microscopy, Lab Histol & Embryol,ICBAS UP, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
   [Correia-Gomes, Carla] Scotlands Rural Coll SRUC, Epidemiol Res Unit, Future Farming Syst Grp, Inverness, Scotland.
C3 Universidade do Porto; Scotland's Rural College
RP Marcos, R (corresponding author), Univ Porto, Inst Biomed Sci Abel Salazar, Dept Microscopy, Lab Histol & Embryol,ICBAS UP, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
EM rmarcos@icbas.up.pt
RI Gomes, Carla/HPD-9268-2023; Marcos, Ricardo/HKE-3872-2023
OI Gomes, Carla/0000-0002-2909-4608; Marcos, Ricardo/0000-0001-5502-5991
CR Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883
   Cogger V.C., 2009, LIVER BIOL PATHOBIOL, V5th Edn, P389
   Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x
   DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218
   Eiben R, 1999, EXP TOXICOL PATHOL, V51, P523, DOI 10.1016/S0940-2993(99)80133-X
   ENZAN H, 1991, CELLS OF THE HEPATIC SINUSOID, VOL 3, P226
   EPSTEIN CJ, 1967, P NATL ACAD SCI USA, V57, P327, DOI 10.1073/pnas.57.2.327
   Faggioli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026080
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   GEBHARDT R, 1983, EMBO J, V2, P567, DOI 10.1002/j.1460-2075.1983.tb01464.x
   GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Imai K, 2000, ANAT RECORD, V258, P338, DOI 10.1002/(SICI)1097-0185(20000401)258:4<338::AID-AR2>3.0.CO;2-G
   KITANI K, 1992, GASTROENTEROL JPN, V27, P276, DOI 10.1007/BF02777737
   Kitani K, 2007, AGE, V29, P1, DOI 10.1007/s11357-006-9014-8
   Kumar RK, 2005, METH MOLEC MED, V117, P179
   Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Loustaud-Ratti V, 2016, HEPATOL RES, V46, P22, DOI 10.1111/hepr.12499
   Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826
   Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006
   Manikonda PK, 2012, BIOGERONTOLOGY, V13, P511, DOI 10.1007/s10522-012-9396-1
   Marcos R, 2006, LIVER INT, V26, P116, DOI 10.1111/j.1478-3231.2005.01201.x
   Marcos R, 2004, J MICROSC-OXFORD, V215, P174, DOI 10.1111/j.0022-2720.2004.01366.x
   Marcos R, 2015, J HISTOCHEM CYTOCHEM, V63, P734, DOI 10.1369/0022155415592180
   Marcos R, 2012, J ANAT, V220, P303, DOI 10.1111/j.1469-7580.2012.01475.x
   MARTIN G, 1994, MECH AGEING DEV, V73, P157, DOI 10.1016/0047-6374(94)90048-5
   MARTIN G, 1992, CLIN EXP PHARMACOL P, V19, P537, DOI 10.1111/j.1440-1681.1992.tb00501.x
   Papp V, 2009, LIVER TRANSPLANT, V15, P177, DOI 10.1002/lt.21665
   POPPER H, 1985, HEPATOLOGY, V5, P1224, DOI 10.1002/hep.1840050627
   PORTA EA, 1980, MECH AGEING DEV, V13, P1, DOI 10.1016/0047-6374(80)90128-1
   PORTA EA, 1981, MECH AGEING DEV, V15, P297, DOI 10.1016/0047-6374(81)90137-8
   Ramadori G, 2002, LIVER, V22, P283, DOI 10.1034/j.1600-0676.2002.01726.x
   REID LM, 1992, HEPATOLOGY, V15, P1198, DOI 10.1002/hep.1840150635
   Rojkind M, 2011, J HEPATOL, V54, P187, DOI 10.1016/j.jhep.2010.09.004
   Roskams T., 2007, MACSWEENS PATHOLOGY, V1, P1
   Ruijter JM, 2004, HEPATOLOGY, V39, P343, DOI 10.1002/hep.20068
   Sakai Y, 1997, HEPATOLOGY, V25, P421
   Santos M, 2009, J ANAT, V214, P744, DOI 10.1111/j.1469-7580.2009.01055.x
   Sato M, 2003, CELL STRUCT FUNCT, V28, P105
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Schmucker DL, 2011, CURR GERONTOL GERIAT, V2011, DOI [10.1155/2011/526379, DOI 10.1155/2011/526379]
   Senoo H, 2007, VITAM HORM, V75, P131, DOI 10.1016/S0083-6729(06)75006-3
   Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321
   Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   Vinogradov AE, 2001, GENOME, V44, P350, DOI 10.1139/gen-44-3-350
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   WAGENAAR GTM, 1994, ANAT REC, V239, P441, DOI 10.1002/ar.1092390410
   Warren A, 2011, CURR GERONTOL GERIAT
   Warren A, 2008, MICROCIRCULATION, V15, P191, DOI 10.1080/10739680701600856
   WHEATLEY DN, 1972, EXP CELL RES, V74, P455, DOI 10.1016/0014-4827(72)90401-6
   Yang C, 2013, GASTROENTEROLOGY, V124, P147
   Zeeh J, 2001, ARCH GERONTOL GERIAT, V32, P255, DOI 10.1016/S0167-4943(01)00090-5
NR 61
TC 11
Z9 12
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD DEC
PY 2016
VL 366
IS 3
BP 639
EP 649
DI 10.1007/s00441-016-2490-y
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EE0BO
UT WOS:000389238700011
PM 27595150
DA 2024-02-19
ER

PT J
AU Adjei-Mosi, J
   Sun, Q
   Smithson, SB
   Shealy, GL
   Amerineni, KD
   Liang, ZR
   Chen, HQ
   Wang, M
   Ping, QG
   Han, JY
   Morita, M
   Kamat, A
   Musi, N
   Zang, MW
AF Adjei-Mosi, Jennifer
   Sun, Qing
   Smithson, Steven Blake
   Shealy, Gavyn Lee
   Amerineni, Krupa Dhruvitha
   Liang, Zerong
   Chen, Hanqing
   Wang, Mei
   Ping, Qinggong
   Han, Jingyan
   Morita, Masahiro
   Kamat, Amrita
   Musi, Nicolas
   Zang, Mengwei
TI Age-dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome
   signaling and impairs capacity for liver fibrosis resolution
SO AGING CELL
LA English
DT Article; Early Access
DE aging; alcohol-associated liver disease; hepatocyte-specific SIRT1
   knockout; hepatic stellate cells (HSCs); liver fibrosis; MCC950; NLRP3
   inflammasome
ID MICE; INJURY
AB Our studies indicate that the longevity factor SIRT1 is implicated in metabolic disease; however, whether and how hepatocyte-specific SIRT1 signaling is involved in liver fibrosis remains undefined. We characterized a functional link of age-mediated defects in SIRT1 to the NLRP3 inflammasome during age-related liver fibrosis. In multiple experimental murine models of liver fibrosis, we compared the development of liver fibrosis in young and old mice, as well as in liver-specific SIRT1 knockout (SIRT1 LKO) mice and wild-type (WT) mice. Liver injury, fibrosis, and inflammation were assessed histologically and quantified by real-time PCR analysis. In a model of hepatotoxin-induced liver fibrosis, old mice displayed more severe and persistent liver fibrosis than young mice during liver injury and after injury cessation, as characterized by inhibition of SIRT1, induction of NLRP3, infiltration of macrophages and neutrophils, activation of hepatic stellate cells (HSCs), and excessive deposition and remodeling of the extracellular matrix. Mechanistically, deletion of SIRT1 in hepatocytes resulted in NLRP3 and IL-1 beta induction, pro-inflammatory response, and severe liver fibrosis in young mice, mimicking the ability of aging to impair the resolution of established fibrosis. In an aging mouse model, chronic-plus-binge alcohol feeding-induced liver fibrosis was attenuated by treatment with MCC950, a selective NLRP3 inhibitor. NLRP3 inhibition ameliorated alcoholic liver fibrosis in old mice by repressing inflammation and reducing hepatocyte-derived danger signaling-ASK1 and HMGB1. In conclusion, age-dependent SIRT1 defects lead to NLRP3 activation and inflammation, which in turn impairs the capacity to resolve fibrosis during aging.
C1 [Adjei-Mosi, Jennifer; Sun, Qing; Smithson, Steven Blake; Shealy, Gavyn Lee; Amerineni, Krupa Dhruvitha; Liang, Zerong; Chen, Hanqing; Wang, Mei; Ping, Qinggong; Morita, Masahiro; Kamat, Amrita; Musi, Nicolas; Zang, Mengwei] Barshop Inst Longev, Ctr Hlth Aging, Aging Studies, San Antonio, TX USA.
   [Adjei-Mosi, Jennifer; Sun, Qing; Smithson, Steven Blake; Shealy, Gavyn Lee; Amerineni, Krupa Dhruvitha; Liang, Zerong; Chen, Hanqing; Wang, Mei; Ping, Qinggong; Morita, Masahiro; Kamat, Amrita; Zang, Mengwei] Univ Texas Hlth San Antonio, Dept Mol Med, San Antonio, TX USA.
   [Han, Jingyan] Boston Univ Sch Med, Boston, MA USA.
   [Kamat, Amrita; Musi, Nicolas; Zang, Mengwei] Educ & Clin Ctr, Geriatr Res, South Texas Vet Hlth Care Syst, San Antonio, TX USA.
   [Zang, Mengwei] Univ Texas Hlth San Antonio, Barshop Inst Longev & Aging Studies, Dept Mol Med, 8403 Floyd Curl Dr, MC8257, San Antonio, TX 78229 USA.
   [Zang, Mengwei] STRF South Texas Res Facil, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; Boston University; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital; Geriatric Research Education & Clinical Center; University of
   Texas System; University of Texas Health Science Center at San Antonio
RP Zang, MW (corresponding author), Univ Texas Hlth San Antonio, Barshop Inst Longev & Aging Studies, Dept Mol Med, 8403 Floyd Curl Dr, MC8257, San Antonio, TX 78229 USA.; Zang, MW (corresponding author), STRF South Texas Res Facil, San Antonio, TX 78229 USA.
EM zang@uthscsa.edu
RI han, jingyan/HJG-6568-2022
OI Smithson, Blake/0000-0003-0229-9360; Morita,
   Masahiro/0000-0002-8627-084X
FU National Institute of Diabetes and Digestive and Kidney Diseases [RO1
   DK121527, DK100603]; National Institute on Alcohol Abuse and Alcoholism
   [R21 AA026922]
FX National Institute of Diabetes and Digestive and Kidney Diseases,
   Grant/Award Number: RO1 DK121527; National Institute on Alcohol Abuse
   and Alcoholism, Grant/Award Number: R21 AA026922; National Institute of
   Diabetes and Digestive and Kidney Diseases, Grant/Award Number: DK100603
CR Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Chen HQ, 2018, HEPATOLOGY, V68, P496, DOI 10.1002/hep.29849
   Choudhury A, 2020, ALCOHOL CLIN EXP RES, V44, P1300, DOI 10.1111/acer.14338
   Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7
   Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806
   Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233
   Crabb DW, 2020, HEPATOLOGY, V71, P306, DOI 10.1002/hep.30866
   Ge XD, 2018, HEPATOLOGY, V68, P2380, DOI 10.1002/hep.30093
   Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008
   Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7
   Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893
   He M, 2020, CELL METAB, V31, P580, DOI 10.1016/j.cmet.2020.01.009
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Jun JI, 2018, J CLIN INVEST, V128, P97, DOI 10.1172/JCI93563
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Lackner C, 2019, J HEPATOL, V70, P294, DOI 10.1016/j.jhep.2018.12.003
   Li M, 2018, FASEB J, V32, P500, DOI 10.1096/fj.201700612R
   Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059
   Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492
   Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007
   Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777
   Place DE, 2018, AM J PATHOL, V188, P1021, DOI 10.1016/j.ajpath.2017.12.006
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Ren RX, 2022, HEPATOLOGY, V75, P646, DOI 10.1002/hep.32152
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017
   Weinlich R, 2017, NAT REV MOL CELL BIO, V18, P127, DOI 10.1038/nrm.2016.149
   Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592
   Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
NR 32
TC 5
Z9 5
U1 9
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 MAY
PY 2023
VL 22
IS 5
AR e13811
DI 10.1111/acel.13811
EA MAR 2023
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GX6L0
UT WOS:000962282200001
PM 36999514
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wan, Y
   Ceci, L
   Wu, N
   Zhou, TH
   Chen, LX
   Venter, J
   Francis, H
   Bernuzzi, F
   Invernizzi, P
   Kyritsi, K
   Baker, P
   Huang, QB
   Wu, CD
   Sybenga, A
   Alpini, G
   Meng, FY
   Glaser, S
AF Wan, Ying
   Ceci, Ludovica
   Wu, Nan
   Zhou, Tianhao
   Chen, Lixian
   Venter, Julie
   Francis, Heather
   Bernuzzi, Francesca
   Invernizzi, Pietro
   Kyritsi, Konstantina
   Baker, Paul
   Huang, Qiaobing
   Wu, Chaodong
   Sybenga, Amelia
   Alpini, Gianfranco
   Meng, Fanyin
   Glaser, Shannon
TI Knockout of α-calcitonin gene-related peptide attenuates cholestatic
   liver injury by differentially regulating cellular senescence of hepatic
   stellate cells and cholangiocytes
SO LABORATORY INVESTIGATION
LA English
DT Article
ID FIBROSIS; PROLIFERATION; FIBROGENESIS; EXPRESSION; GROWTH; DESMIN; ACTIN
AB alpha-Calcitonin gene-related peptide (alpha-CGRP) is a 37-amino acid neuropeptide involved in several pathophysiological processes. a-CGRP is involved in the regulation of cholangiocyte proliferation during cholestasis. In this study, we aimed to evaluate if alpha-CGRP regulates bile duct ligation (BDL)-induced liver fibrosis by using a alpha-CGRP knockout (alpha-CGRP(-/-)) mouse model. alpha-CGRP(-/-) and wild-type (WT) mice were subjected to sham surgery or BDL for 7 days. Then, liver fibrosis and cellular senescence as well as the expression of kinase such as p38 and C-Jun N-terminal protein kinase (JNK) in mitogen-activated protein kinases (MAPK) signaling pathway were evaluated in total liver, together with measurement of cellular senescence in cholangiocytes or hepatic stellate cells (HSCs). There was enhanced hepatic expression of Calca (coding alpha-CGRP) and the CGRP receptor components (CRLR, RAMP-1 and RCP) in BDL and in both WT alpha-CGRP(-/-) and BDL alpha-CGRP(-/-) mice, respectively. Moreover, there was increased CGRP serum levels and hepatic mRNA expression of CALCA and CGRP receptor components in late-stage PSC samples compared to healthy control samples. Depletion of alpha-CGRP reduced liver injury and fibrosis in BDL mice that was associated with enhanced cellular senescence of hepatic stellate cells and reduced senescence of cholangiocytes as well as decreased activation of p38 and JNK MAPK signaling pathway. Cholangiocyte supernatant from BDL alpha-CGRP(-/-) mice inhibited the activation and increased cellular senescence of cultured human HSCs (HHSCs) compared to HHSCs stimulated with BDL cholangiocyte supernatant. Taken together, endogenous a-CGRP promoted BDL-induced cholestatic liver fibrosis through differential changes in senescence of HSCs and cholangiocytes and activation of p38 and JNK signaling. Modulation of alpha-CGRP/CGRP receptor signaling may be key for the management of biliary senescence and liver fibrosis in cholangiopathies.
C1 [Wan, Ying] Southwest Med Univ, Dept Pathophysiol, Luzhou 646000, Peoples R China.
   [Ceci, Ludovica; Wu, Nan; Zhou, Tianhao; Chen, Lixian; Venter, Julie; Francis, Heather; Kyritsi, Konstantina; Baker, Paul; Alpini, Gianfranco; Meng, Fanyin; Glaser, Shannon] Texas A&M Univ, Hlth Sci Ctr, Dept Med Physiol, Temple, TX 76508 USA.
   [Francis, Heather; Alpini, Gianfranco; Meng, Fanyin] Cent Texas Vet Hlth Care Syst, Res, Temple, TX 76504 USA.
   [Francis, Heather; Alpini, Gianfranco; Meng, Fanyin; Glaser, Shannon] Baylor Scott & White Hlth, Digest Dis Res Ctr, Temple, TX 76508 USA.
   [Bernuzzi, Francesca; Invernizzi, Pietro] Humanitas Clin & Res Ctr, Rozzano, MI, Italy.
   [Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Key Lab Shock & Microcirculat Res Guangdong Prov, Guangzhou, Guangdong, Peoples R China.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.
   [Sybenga, Amelia] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.
   [Meng, Fanyin] Baylor Scott & White Hlth, Res Fdn, Temple, TX USA.
C3 Southwest Medical University; Texas A&M University System; Texas A&M
   University College Station; Texas A&M Health Science Center; Baylor
   Health Care System; IRCCS Humanitas Research Hospital; Southern Medical
   University - China; Texas A&M University System; Texas A&M University
   College Station; Vanderbilt University; Baylor Health Care System
RP Alpini, G (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Med Physiol, Temple, TX 76508 USA.; Alpini, G (corresponding author), Cent Texas Vet Hlth Care Syst, Res, Temple, TX 76504 USA.; Alpini, G (corresponding author), Baylor Scott & White Hlth, Digest Dis Res Ctr, Temple, TX 76508 USA.
EM gialpini@iu.edu
RI bernuzzi, francesca/AAQ-7073-2020; Chen, Lixian/ABH-3076-2021;
   Invernizzi, Pietro/AAB-8367-2022; Zhou, Tianhao/AAO-3542-2021
OI Zhou, Tianhao/0000-0002-5722-6954
FU Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from
   Baylor Scott White [5I01BX000574]; VA Research Career Scientist Award
   [5I01BX000574]; VA Merit award [5I01BX000574, 1I01BX001724]; NIH
   [DK058411, DK076898, DK107310, DK110035, DK062975, AA025997, AA025157];
   VA Merit Award from the United States Department of Veteran's affairs,
   Biomedical Laboratory Research and Development Service [1I01BX003031];
   R01 from NIH NIDDK [DK108959]; Nature Science foundation of China
   [81873563]
FX This work was supported by the Dr. Nicholas C. Hightower Centennial
   Chair of Gastroenterology from Baylor Scott & White, a VA Research
   Career Scientist Award and a VA Merit award to Dr. Alpini
   (5I01BX000574), a VA Merit Award (1I01BX001724) to Dr. Meng, and the NIH
   grants DK058411, DK076898, DK107310, DK110035, DK062975, AA025997, and
   AA025157 to Drs. Alpini, Meng, and Glaser. Portions of this work were
   supported by (i) a VA Merit Award (1I01BX003031) from the United States
   Department of Veteran's affairs, Biomedical Laboratory Research and
   Development Service and an R01 from NIH NIDDK (DK108959) to Dr. Francis
   (ii) and a Nature Science foundation of China (No. 81873563) to Dr. Wan.
   This material is the result of work supported with resources and the use
   of facilities at the Central Texas Veterans Health Care System, Temple,
   Texas.
CR ANDERSEN SLV, 1993, AM J PHYSIOL-CELL PH, V264, pC41
   Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537
   BALLARDINI G, 1988, VIRCHOWS ARCH B, V56, P45, DOI 10.1007/BF02890000
   Bansal R, 2014, J CONTROL RELEASE, V179, P18, DOI 10.1016/j.jconrel.2014.01.022
   Barry CM, 2015, NEUROSCIENCE, V291, P106, DOI 10.1016/j.neuroscience.2015.01.062
   Beuers U, 2009, CLIN REV ALLERG IMMU, V36, P1, DOI 10.1007/s12016-008-8084-z
   Ehrlich Laurent, 2018, Gene Expression, V18, P197, DOI 10.3727/105221618X15216453076707
   FRANCOCERECEDA A, 1985, N-S ARCH PHARMACOL, V331, P146, DOI 10.1007/BF00634231
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Glaser S, 2000, HEPATOLOGY, V32, P17
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010
   Glaser SS, 2007, LAB INVEST, V87, P914, DOI 10.1038/labinvest.3700602
   Henriksen JH, 2000, METABOLISM, V49, P47, DOI 10.1016/S0026-0495(00)90663-2
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4
   Kamiyoshi A, 2009, LIVER INT, V29, P642, DOI 10.1111/j.1478-3231.2008.01841.x
   Kim J, 2013, J AM SOC NEPHROL, V24, P229, DOI 10.1681/ASN.2012070678
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li WW, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1145-1
   Li XW, 2016, CAN J PHYSIOL PHARM, V94, P1315, DOI 10.1139/cjpp-2015-0602
   Li Y, 1997, NEUROPEPTIDES, V31, P503, DOI 10.1016/S0143-4179(97)90046-9
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Mitra A, 2014, HEPATOLOGY, V60, P2027, DOI 10.1002/hep.27392
   Mogler C, 2015, EMBO MOL MED, V7, P332, DOI 10.15252/emmm.201404246
   Poynard T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-40
   Puche JE, 2013, HEPATOLOGY, V57, P340, DOI 10.1002/hep.26053
   Rahimi RS, 2012, CURR OPIN GASTROEN, V28, P223, DOI 10.1097/MOG.0b013e328351d003
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   SCHMITTGRAFF A, 1991, AM J PATHOL, V138, P1233
   Sheykhzade M, 2018, EUR J PHARMACOL, V829, P85, DOI 10.1016/j.ejphar.2018.04.007
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   TACHE Y, 1992, ANN NY ACAD SCI, V657, P240, DOI 10.1111/j.1749-6632.1992.tb22772.x
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yoon SP, 2018, CELL BIOL TOXICOL, V34, P251, DOI 10.1007/s10565-017-9399-4
   Zhang LP, 2001, PAIN, V89, P265, DOI 10.1016/S0304-3959(00)00378-X
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
NR 39
TC 13
Z9 14
U1 0
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD JUN
PY 2019
VL 99
IS 6
BP 764
EP 776
DI 10.1038/s41374-018-0178-5
PG 13
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA IC8VU
UT WOS:000471260900003
PM 30700848
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Brunt, EM
   Walsh, SN
   Hayashi, PH
   LaBundy, J
   Di Bisceglie, AM
AF Brunt, Elizabeth M.
   Walsh, Sarah N.
   Hayashi, Paul H.
   LaBundy, Jennifer
   Di Bisceglie, Adrian M.
TI Hepatocyte senescence in end-stage chronic liver disease: a study of
   cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for
   progression to hepatocellular carcinoma
SO LIVER INTERNATIONAL
LA English
DT Article
DE chronic liver disease; hepatocellular carcinoma; senescense
ID CHRONIC HEPATITIS-C; DYSPLASTIC NODULES; UNITED-STATES; EXPRESSION;
   CIRRHOSIS; REGENERATION; DIAGNOSIS; FIBROSIS
AB Backgroun: Histologic markers to predict hepatocellular carcinoma (HCC) include small cell change and dysplastic nodules. Hepatocyte senescence is noted in chronic liver disease and may or may not be important in progression to HCC.
   Aim: The study was undertaken to compare standard histologic features of chronic liver disease as well as markers of senescence and proliferation in two groups of biopsies from patients followed for at least a year.
   Methods: Standard histologic evaluation of necroinflammatory activity, fibrosis, steatosis, and iron, internationally accepted criteria of dysplasia, and immunohistochemical markers for proliferation and hepatocyte senescence were compared in 47 liver biopsies from noncholestatic chronic liver disease patients who subsequently either underwent transplant (the Control group, n=19) or had biopsy-proven (HCC group, n=28) over a similar time period of 34.9 months (mean) and 42.5 months (mean) respectively.
   Results: Both groups were predominantly men; the MELD score was higher, and mean age was less in the Control group (46.9 vs 53.8 years, P=0.01). Small cell change was not significantly different in the biopsies between the two groups; neither were grade, stage (Ishak scores), nor presence or location of iron. Steatosis was more common in the group that subsequently developed HCC (P=0.04). The MIB-1 proliferation index was greater in the biopsies from the Control group. The senescence marker p21, and the ratio of p21:MIB-1 were not statistically different between the two groups. However, a Spearman's rank correlation showed a linear correlation of p21/MIB-1 with a greater amount of dyplasia in the explant livers of Controls.
   Conclusions: These findings suggested the Control groups' livers maintained effective removal of cells from the cell cycle by overexpression of p21 and, while not 'protected' from significant involvement by dysplasia, may have been precluded from development of HCC.
C1 St Louis Univ, Sch Med, FDT, Dept Pathol, St Louis, MO 63110 USA.
   St Louis Univ, Sch Med, Liver Ctr, St Louis, MO 63110 USA.
   St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.
C3 Saint Louis University; Saint Louis University; Saint Louis University
RP Brunt, EM (corresponding author), St Louis Univ, Sch Med, FDT, Dept Pathol, 4th Floor,3635 Vista Ave, St Louis, MO 63110 USA.
EM bruntem@slu.edu
CR Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411
   Bialecki ES, 2006, CLIN GASTROENTEROL H, V4, P361, DOI 10.1016/S1542-3565(05)00977-8
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Crary GS, 1998, HEPATOLOGY, V28, P738, DOI 10.1002/hep.510280320
   El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013
   Eleazar JA, 2004, J HEPATOL, V41, P983, DOI 10.1016/j.jhep.2004.08.017
   Hui AM, 1997, HEPATOLOGY, V25, P575, DOI 10.1002/hep.510250314
   ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kobayashi M, 2006, CANCER-AM CANCER SOC, V106, P636, DOI 10.1002/cncr.21607
   Kofman AV, 2005, HEPATOLOGY, V41, P1252, DOI 10.1002/hep.20696
   Kojiro M, 2005, SEMIN LIVER DIS, V25, P133, DOI 10.1055/s-2005-871193
   Libbrecht L, 2005, LIVER INT, V25, P16, DOI 10.1111/j.1478-3231.2005.01016.x
   Lunz JG, 2005, HEPATOLOGY, V41, P1262, DOI 10.1002/hep.20709
   Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Quaglia A, 2005, WORLD J GASTROENTERO, V11, P6262, DOI 10.3748/wjg.v11.i40.6262
   Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194
   Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339
   Wagayama H, 2001, DIGEST DIS SCI, V46, P2074, DOI 10.1023/A:1011977923941
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 24
TC 18
Z9 19
U1 0
U2 5
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1478-3223
J9 LIVER INT
JI Liver Int.
PD JUN
PY 2007
VL 27
IS 5
BP 662
EP 671
DI 10.1111/j.1478-3231.2007.01470.x
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 166GO
UT WOS:000246366500011
PM 17498252
DA 2024-02-19
ER

PT J
AU Zhao, JW
   Bai, DS
   Qi, L
   Cao, WJ
   Du, JY
   Gu, CY
   Zhou, C
   Gao, Y
   Zhang, LL
   Zhao, Y
   Lu, N
AF Zhao, Jiawei
   Bai, Dongsheng
   Qi, Lei
   Cao, Wangjia
   Du, Jiaying
   Gu, Chunyang
   Zhou, Chen
   Gao, Yuan
   Zhang, Lulu
   Zhao, Yue
   Lu, Na
TI The flavonoid GL-V9 alleviates liver fibrosis by triggering senescence
   by regulating the transcription factor GATA4 in activated hepatic
   stellate cells
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article; Early Access
DE GATA4; GL-V9; HSCs; liver fibrosis; senescence
ID CONCISE GUIDE; AUTOPHAGY; MECHANISMS
AB Background and purpose: Liver fibrosis is a critical risk factor for the progression from chronic liver injury to hepatocellular carcinoma. Clinically, there is a lack of therapeutic drugs for liver fibrosis. Previous studies have confirmed that GL-V9, a newly synthesized flavonoid derivative, exhibits anti-inflammatory activity, but whether it has anti-hepatic fibrosis actions remains unclear. This study aimed to investigate the anti-fibrotic activities and potential mechanisms of GL-V9.
   Experimental approach: Bile duct ligation (BDL) and carbon tetrachloride (CCI 4 ) challenges were used to assess the anti-fibrotic effects of GL-V9 in vivo. Mouse primary hepatic stellate cells (pHSCs) and the human HSC line LX2 also served as a liver fibrosis model in vitro. Cellular functions and molecular mechanism were analysed using senescence-associated beta-galactosidase staining, real-time PCR, western blotting, immunofluorescence, and co-immunoprecipitation.
   Key results: GL-V9 attenuated hepatic histopathological injury and collagen accumulation, as well as decreasing the expression of fibrotic genes in vivo. GL-V9 promoted senescence and inhibited the expression of fibrogenic genes in HSCs in vitro. Mechanistic studies revealed that GL-V9 induced senescence by upregulating GATA4 expression in HSCs. Further studies confirmed that GL-V9 stabilized GATA4 by promoting autophagic degradation of P62.
   Conclusion and implications: GL-V9 exerted potent anti-fibrotic effects both in vivo and in vitro by stabilizing GATA4, thereby promoting the senescence of HSCs, and by avoiding its activation and ultimately inhibiting liver fibrosis. This action indicated that the flavonoid GL-V9 is a potential therapeutic candidate for the treatment of liver fibrosis.
C1 [Zhao, Jiawei; Bai, Dongsheng; Qi, Lei; Cao, Wangjia; Du, Jiaying; Gu, Chunyang; Zhou, Chen; Gao, Yuan; Zhao, Yue; Lu, Na] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Physiol, State Key Lab Nat Med,Jiangsu Key Lab Carcinogenes, 24 Tongjiaxiang, Nanjing, Peoples R China.
   [Zhang, Lulu] Nanjing Med Univ, Sch Pharm, Dept Clin Pharmacol, Nanjing, Peoples R China.
   [Zhang, Lulu] Nanjing Med Univ, Sch Pharm, Dept Clin Pharmacol, Nanjing 211166, Jiangsu, Peoples R China.
   [Zhao, Yue; Lu, Na] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Physiol, State Key Lab Nat Med,Jiangsu Key Lab Carcinogenes, 24 Tongjiaxiang, Nanjing 210009, Peoples R China.
C3 China Pharmaceutical University; Nanjing Medical University; Nanjing
   Medical University; China Pharmaceutical University
RP Zhang, LL (corresponding author), Nanjing Med Univ, Sch Pharm, Dept Clin Pharmacol, Nanjing 211166, Jiangsu, Peoples R China.; Zhao, Y; Lu, N (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Physiol, State Key Lab Nat Med,Jiangsu Key Lab Carcinogenes, 24 Tongjiaxiang, Nanjing 210009, Peoples R China.
EM lulu_0219@njmu.edu.cn; yuezhao@cpu.edu.cn; nalu@cpu.edu.cn
RI 赵, 越/IXN-2876-2023
CR Alexander S.P.H., [No title captured]
   Alexander SPH, 2021, BRIT J PHARMACOL, V178, pS264, DOI 10.1111/bph.15541
   Alexander SPH, 2018, BRIT J PHARMACOL, V175, P407, DOI 10.1111/bph.14112
   Bai DS, 2022, AUTOPHAGY, V18, P1673, DOI 10.1080/15548627.2021.1997051
   Bangen JM, 2017, HEPATOLOGY, V66, P1242, DOI 10.1002/hep.29275
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153
   Delgado I, 2014, HEPATOLOGY, V59, P2358, DOI 10.1002/hep.27005
   du Sert NP, 2020, J CEREBR BLOOD F MET, V40, P1769, DOI [10.1177/0271678X20943823, 10.1186/s12917-020-02451-y]
   Eguchi A, 2018, J MOL MED, V96, P575, DOI 10.1007/s00109-018-1642-9
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gao L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09295-7
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   HernandezMunoz R, 1997, HEPATOLOGY, V26, P1100
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020
   Hu P, 2019, FREE RADICAL BIO MED, V145, P237, DOI 10.1016/j.freeradbiomed.2019.09.028
   Kang C, 2016, AUTOPHAGY, V12, P898, DOI 10.1080/15548627.2015.1121361
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li LW, 2011, EUR J PHARMACOL, V670, P13, DOI 10.1016/j.ejphar.2011.08.054
   Lilley E, 2020, BRIT J PHARMACOL, V177, P3611, DOI 10.1111/bph.15178
   Liu H, 2014, AUTOPHAGY, V10, P372, DOI 10.4161/auto.27163
   Loh Z, 2019, BRIT J PHARMACOL, V176, P3775, DOI 10.1111/bph.14768
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Roehlen N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040875
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Zhao Y, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1375640
   Zhu YJ, 2020, MOLECULES, V25, DOI 10.3390/molecules25215033
NR 38
TC 4
Z9 5
U1 3
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD 2023 APR
PY 2023
VL 180
IS 8
BP 1072
EP 1089
DI 10.1111/bph.15997
EA DEC 2022
PG 18
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 9S0HR
UT WOS:000899232500001
PM 36455594
OA Bronze
DA 2024-02-19
ER

PT J
AU Bloomer, SA
AF Bloomer, Steven A.
TI Hepatic Macrophage Abundance and Phenotype in Aging and Liver Iron
   Accumulation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE aging; deferoxamine; hemosiderosis; macrophage polarization
ID RAT-LIVER; DIFFERENTIAL REGULATION; EXPRESSION; PROLIFERATION; CELLS;
   POLARIZATION; METABOLISM; FERRITIN; HEPCIDIN; PROTEIN
AB Liver macrophages serve important roles in iron homeostasis through phagocytosis of effete erythrocytes and the export of iron into the circulation. Conversely, intracellular iron can alter macrophage phenotype. Aging increases hepatic macrophage number and nonparenchymal iron, yet it is unknown whether age-related iron accumulation alters macrophage number or phenotype. To evaluate macrophages in a physiological model of iron loading that mimicked biological aging, young (6 mo) Fischer 344 rats were given one injection of iron dextran (15 mg/kg), and macrophage number and phenotype were evaluated via immunohistochemistry. A separate group of old (24 mo) rats was treated with 200 mg/kg deferoxamine every 12 h for 4 days. Iron administration to young rats resulted in iron concentrations that matched the values and pattern of tissue iron deposition observed in aged animals; however, iron did not alter macrophage number or phenotype. Aging resulted in significantly greater numbers of M1 (CD68(+)) and M2 (CD163(+)) macrophages in the liver, but neither macrophage number nor phenotype were affected by deferoxamine. Double-staining experiments demonstrated that both M1 (iNOS(+)) and M2 (CD163(+)) macrophages contained hemosiderin, suggesting that macrophages of both phenotypes stored iron. These results also suggest that age-related conditions other than iron excess are responsible for the accumulation of hepatic macrophages with aging.
C1 [Bloomer, Steven A.] Penn State Abington, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University
RP Bloomer, SA (corresponding author), Penn State Abington, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
EM sab320@psu.edu
FU Faculty Development Grant from Penn State Abington
FX The author acknowledges the training in histology received from Gail
   Kurriger (1952-2017) at the University of Iowa. Work in the author's
   laboratory was supported by a Faculty Development Grant from Penn State
   Abington.
CR Agoro R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196921
   Bauer I, 1998, HEPATOLOGY, V27, P829, DOI 10.1002/hep.510270327
   Beljaars L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00430
   Bloomer SA, 2021, AM J PHYSIOL-GASTR L, V320, pG496, DOI 10.1152/ajpgi.00286.2020
   Bloomer SA, 2020, HISTOCHEM CELL BIOL, V153, P37, DOI 10.1007/s00418-019-01827-y
   Bloomer SA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092132
   Bloomer SA, 2014, BLOOD CELL MOL DIS, V52, P19, DOI 10.1016/j.bcmd.2013.07.002
   Bloomer SA, 2009, J GERONTOL A-BIOL, V64, P419, DOI 10.1093/gerona/gln056
   BRANCH DR, 1989, BLOOD, V73, P307
   Brown KE, 2006, TRANSL RES, V148, P55, DOI 10.1016/j.trsl.2006.03.002
   Chen HJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78026-6
   CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111
   Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879
   Covarrubias AJ, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00305-3
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003
   Doulias PT, 2008, FREE RADICAL RES, V42, P253, DOI 10.1080/10715760801911649
   Elkord E, 2005, IMMUNOLOGY, V114, P204, DOI 10.1111/j.1365-2567.2004.02076.x
   Gan ZS, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8570818
   Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324
   Handa P, 2019, J LEUKOCYTE BIOL, V105, P1015, DOI 10.1002/JLB.3A0318-108R
   Hayashi H, 2017, MED MOL MORPHOL, V50, P205, DOI 10.1007/s00795-017-0163-x
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   IANCU TC, 1977, BRIT J HAEMATOL, V37, P527, DOI 10.1111/j.1365-2141.1977.tb01026.x
   Kao JK, 2020, ANN HEMATOL, V99, P431, DOI 10.1007/s00277-020-03916-8
   Lin Min, 1997, American Journal of Physiology, V272, pG1355
   Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Nielsen MC, 2020, IMMUNOLOGY, V159, P63, DOI 10.1111/imm.13125
   Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200
   Pereira M, 2019, CELL REP, V28, P498, DOI 10.1016/j.celrep.2019.06.039
   Pervin M, 2021, ANAT HISTOL EMBRYOL, V50, P736, DOI 10.1111/ahe.12718
   Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200
   Pourcelot E, 2015, BBA-MOL CELL RES, V1853, P1596, DOI 10.1016/j.bbamcr.2015.03.009
   Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889
   Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   Wijesundera KK, 2014, EXP MOL PATHOL, V96, P382, DOI 10.1016/j.yexmp.2014.04.003
   Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378
   Zhou Y, 2018, CANCER MED-US, V7, P4012, DOI 10.1002/cam4.1670
NR 42
TC 3
Z9 3
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2022
VL 23
IS 12
AR 6502
DI 10.3390/ijms23126502
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 2K1GK
UT WOS:000816092000001
PM 35742946
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bellanti, F
   di Bello, G
   Tamborra, R
   Amatruda, M
   Lo Buglio, A
   Dobrakowski, M
   Kasperczyk, A
   Kasperczyk, S
   Serviddio, G
   Vendemiale, G
AF Bellanti, Francesco
   di Bello, Giorgia
   Tamborra, Rosanna
   Amatruda, Marco
   Lo Buglio, Aurelio
   Dobrakowski, Michal
   Kasperczyk, Aleksandra
   Kasperczyk, Slawomir
   Serviddio, Gaetano
   Vendemiale, Gianluigi
TI Impact of senescence on the transdifferentiation process of human
   hepatic progenitor-like cells
SO WORLD JOURNAL OF STEM CELLS
LA English
DT Article
DE Senescence; HepaRG cells; Transdifferentiation; Mitochondria;
   Regeneration; Nicotinamide adenine dinucleotide
ID LIFE-SPAN; HEPARG; NAD(+); METABOLISM; LINE; MODEL; MITOCHONDRIAL;
   REGENERATION; HEPATOCYTES; TELOMERASE
AB BACKGROUNDSenescence is characterized by a decline in hepatocyte function, with impairment of metabolism and regenerative capacity. Several models that duplicate liver functions in vitro are essential tools for studying drug metabolism, liver diseases, and organ regeneration. The human HepaRG cell line represents an effective model for the study of liver metabolism and hepatic progenitors. However, the impact of senescence on HepaRG cells is not yet known.AIMTo characterize the effects of senescence on the transdifferentiation capacity and mitochondrial metabolism of human HepaRG cells.METHODSWe compared the transdifferentiation capacity of cells over 10 (passage 10 [P10]) vs P20. Aging was evaluated by senescence-associated (SA) beta-galactosidase activity and the comet assay. HepaRG transdifferentiation was analyzed by confocal microscopy and flow cytometry (expression of cluster of differentiation 49a [CD49a], CD49f, CD184, epithelial cell adhesion molecule [EpCAM], and cytokeratin 19 [CK19]), quantitative PCR analysis (expression of albumin, cytochrome P450 3A4 [CYP3A4], gamma-glutamyl transpeptidase [gamma-GT], and carcinoembryonic antigen [CEA]), and functional analyses (albumin secretion, CYP3A4, and gamma-GT). Mitochondrial respiration and the ATP and nicotinamide adenine dinucleotide (NAD(+))/NAD with hydrogen (NADH) content were also measured.RESULTSSA beta-galactosidase staining was higher in P20 than P10 HepaRG cells; in parallel, the comet assay showed consistent DNA damage in P20 HepaRG cells. With respect to P10, P20 HepaRG cells exhibited a reduction of CD49a, CD49f, CD184, EpCAM, and CK19 after the induction of transdifferentiation. Furthermore, lower gene expression of albumin, CYP3A4, and gamma-GT, as well as reduced albumin secretion capacity, CYP3A4, and gamma-GT activity were reported in transdifferentiated P20 compared to P10 cells. By contrast, the gene expression level of CEA was not reduced by transdifferentiation in P20 cells. Of note, both cellular and mitochondrial oxygen consumption was lower in P20 than in P10 transdifferentiated cells. Finally, both ATP and NAD(+)/NADH were depleted in P20 cells with respect to P10 cells.CONCLUSIONSA mitochondrial dysfunction may limit the transdifferentiation potential of HepaRG cells, with consequent impairment of metabolic and regenerative properties, which may alter applications in basic studies.
C1 [Bellanti, Francesco; di Bello, Giorgia; Tamborra, Rosanna; Amatruda, Marco; Lo Buglio, Aurelio; Serviddio, Gaetano; Vendemiale, Gianluigi] Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
   [Dobrakowski, Michal; Kasperczyk, Aleksandra; Kasperczyk, Slawomir] Med Univ Silesia, Dept Biochem, PL-41808 Zabrze, Poland.
C3 University of Foggia; Medical University Silesia
RP Bellanti, F (corresponding author), Univ Foggia, Dept Med & Surg Sci, Viale Pinto 1, I-71122 Foggia, Italy.
EM francesco.bellanti@unifg.it
CR Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   Anthérieu S, 2012, TOXICOL IN VITRO, V26, P1278, DOI 10.1016/j.tiv.2012.05.008
   Aravinthan A, 2015, EXP CELL RES, V331, P38, DOI 10.1016/j.yexcr.2014.09.025
   Baar MP, 2018, CURR OPIN PHARMACOL, V40, P147, DOI 10.1016/j.coph.2018.05.007
   Birch J, 2018, PHARMACOL THERAPEUT, V183, P34, DOI 10.1016/j.pharmthera.2017.10.005
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Bulutoglu B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229106
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536
   Coates PJ, 2002, J PATHOL, V196, P371, DOI 10.1002/path.1073
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017
   Dubuquoy L, 2015, GUT, V64, P1949, DOI 10.1136/gutjnl-2014-308410
   FABRE G, 1990, EUR J DRUG METAB PH, V15, P165, DOI 10.1007/BF03190200
   García-Prat L, 2017, MOL CELL ENDOCRINOL, V445, P109, DOI 10.1016/j.mce.2016.08.021
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   Han LZ, 2020, KIDNEY BLOOD PRESS R, V45, P314, DOI 10.1159/000504298
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Higuchi Y, 2014, XENOBIOTICA, V44, P146, DOI 10.3109/00498254.2013.836257
   Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026
   Igarashi M, 2019, AGING CELL, V18, DOI 10.1111/acel.12935
   JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592
   Jiang L, 2010, TRANSPL P, V42, P3773, DOI 10.1016/j.transproceed.2010.08.064
   Johnson Sean, 2018, F1000Res, V7, P132, DOI 10.12688/f1000research.12120.1
   Jossé R, 2008, DRUG METAB DISPOS, V36, P1111, DOI 10.1124/dmd.107.019901
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lees JG, 2020, STEM CELLS, V38, P624, DOI 10.1002/stem.3152
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421
   McGill MR, 2011, HEPATOLOGY, V53, P974, DOI 10.1002/hep.24132
   Moimas S, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00138-2019
   NAKABAYASHI H, 1982, CANCER RES, V42, P3858
   Nicaise AM, 2019, P NATL ACAD SCI USA, V116, P9030, DOI 10.1073/pnas.1818348116
   Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002
   Razdan N, 2018, AGING CELL, V17, DOI 10.1111/acel.12838
   Shyh-Chang N, 2017, GENE DEV, V31, P336, DOI 10.1101/gad.293167.116
   Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047
   Sun CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5112
   Troadec MB, 2006, GENOMICS, V87, P93, DOI 10.1016/j.ygeno.2005.08.016
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vasileiou PVS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070686
   Yildiz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064016
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
NR 51
TC 1
Z9 1
U1 1
U2 5
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1948-0210
J9 WORLD J STEM CELLS
JI World J. Stem Cells
PD OCT 26
PY 2021
VL 13
IS 10
BP 1595
EP 1609
DI 10.4252/wjsc.v13.i10.1595
PG 15
WC Cell & Tissue Engineering; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA XB7IA
UT WOS:000721497800012
PM 34786160
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Xiong, XL
   Wang, XL
   Lu, Y
   Wang, E
   Zhang, ZJ
   Yang, J
   Zhang, HJ
   Li, XY
AF Xiong, Xuelian
   Wang, Xiaolin
   Lu, Yan
   Wang, E.
   Zhang, Zhijian
   Yang, Jian
   Zhang, Huijie
   Li, Xiaoying
TI Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated
   downregulation of FXR in aging mice
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Non-alcoholic fatty liver disease; Aging; Endoplasmic reticulum stress;
   Farnesoid X receptor
ID FARNESOID-X-RECEPTOR; FATTY LIVER-DISEASE; UNFOLDED PROTEIN RESPONSE; ER
   STRESS; BILE-ACID; ACTIVATION; SREBP-1C; CHOLESTEROL; METABOLISM;
   INSULIN
AB Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is characterized by an increase in hepatic triglyceride (TG) contents. The prevalence of NAFLD is increased with aging. However, the molecular mechanism for aging-induced fatty liver remains poorly understood.
   Methods: Hepatic TG contents and gene expression profiles were analyzed in body weight-matched young (2 months), middle (8 months) and old (18 months) C57BL/6 mice. Endoplasmic reticulum (ER) stress and farnesoid X receptor (FXR) expression were examined. The mechanism of ER stress activation in the regulation of FXR expression was further investigated.
   Results: In the present study, we found that TG was markedly accumulated and lipogenic genes were up-regulated in the liver of C57BL/6 mice aged 18 months. FXR, a key regulator of hepatic lipid metabolism was down-regulated in these old mice. At molecular levels, ER stress was activated in old mice and repressed FXR expression through inhibition of hepatocyte nuclear factor 1 alpha (HNF1 alpha) transcriptional activity.
   Conclusions: Our findings demonstrate that FXR down-regulation plays a critical role in aging-induced fatty liver. (C) 2013 European Association for the Study of the Liver. Published by Elsevier B. V. All rights reserved.
C1 [Xiong, Xuelian; Wang, Xiaolin; Lu, Yan; Wang, E.; Zhang, Zhijian; Yang, Jian; Zhang, Huijie; Li, Xiaoying] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrinol & Metab, Dept Endocrine & Metab Dis,Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China.
   [Li, Xiaoying] E Inst Shanghai Univ, Key Lab Endocrine Tumors, Shanghai 200025, Peoples R China.
   [Li, Xiaoying] E Inst Shanghai Univ, Div Endocrine & Metab Dis, Shanghai 200025, Peoples R China.
   [Li, Xiaoying] Shanghai Jiao Tong Univ, Ruijin Hosp, Chinese French Lab Genom & Life Sci, Sch Med, Shanghai 200025, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University
RP Li, XY (corresponding author), Shanghai Inst Endocrinol & Metab, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.
EM lixy@sibs.ac.cn
RI zhang, hui/GXH-6098-2022; liang, liang/IAO-8518-2023; Zhang,
   Hw/HPD-4999-2023; Zhang, Hui/HHN-8494-2022; li, xiao/GSN-6181-2022;
   zhang, zhi/HPH-4905-2023; Li, Xiaomei/HNI-0635-2023; ZHANG, hui
   jie/HTN-1690-2023
OI Li, Xiaoying/0000-0002-9383-5757; Yang, Jian/0000-0002-3390-5127
FU National Key Basic Research Program of China (973 Program)
   [2012CB524902]; China Natural Science Foundation [81070681, 81100616,
   81200636, 81000320, 81370959]
FX This study was supported by the grants from National Key Basic Research
   Program of China (973 Program, 2012CB524902), China Natural Science
   Foundation (No. 81070681, 81100616, 81200636, 81000320, 81370959).
CR Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263
   Capel F, 2013, J NUTRIGENET NUTRIGE, V6, P107, DOI 10.1159/000350751
   Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890
   Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042
   Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2
   HILDEN M, 1977, SCAND J GASTROENTERO, V12, P593, DOI 10.3109/00365527709181339
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911
   Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007
   Kanayama T, 2007, J BIOL CHEM, V282, P10290, DOI 10.1074/jbc.M700270200
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Lu Y, 2014, GUT, V63, P170, DOI 10.1136/gutjnl-2012-303150
   Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7
   Miller SDW, 2007, HEPATOLOGY, V46, P496, DOI 10.1002/hep.21689
   Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001
   Özcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8
   Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015
   Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260
   Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871
   Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247
   Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664
   Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131
   Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025
   Xu GR, 2002, J BIOL CHEM, V277, P50491, DOI 10.1074/jbc.M209176200
   Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133
   Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598
   Yang ZX, 2010, HEPATOL INT, V4, P741, DOI 10.1007/s12072-010-9202-6
   Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755
   Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441
   Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001
   Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52
   Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103
NR 43
TC 86
Z9 94
U1 4
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD APR
PY 2014
VL 60
IS 4
BP 847
EP 854
DI 10.1016/j.jhep.2013.12.003
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AD2ZR
UT WOS:000333106600023
PM 24333182
DA 2024-02-19
ER

PT S
AU Cheluvappa, R
   Hilmer, SN
   Kwun, SY
   Cogger, VC
   Le Couteur, DG
AF Cheluvappa, Rajkumar
   Hilmer, Sarah N.
   Kwun, Sun Young
   Cogger, Victoria C.
   Le Couteur, David G.
BE Weller, NJ
   Rattan, SIS
TI Effects of old age on hepatocyte oxygenation
SO HEALTHY AGING AND LONGEVITY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Healthy Aging and Longevity
CY OCT 13-15, 2006
CL Melbourne, AUSTRALIA
DE hepatocyte; aging; hypoxia; pimonidazole; immunohistochemistry
ID DRUG-METABOLISM; LIVER; TENSION
AB Hepatic phase I drug metabolism is diminished in old age. It has been suggested that hepatocyte hypoxia and impaired bioenergetics in old age may contribute to this aging change. Therefore, we sought to determine whether old age was associated with in vivo hypoxia in the aged rat liver. Immunohistochemical studies with the nitroimidazole hypoxia marker, pimonidazole, were carried out in livers from young and old rats. Preliminary studies were performed on four young (4-month-old) and six old (2-year-old) F344 rats to directly visualize the distribution and intensity of pimonidazole staining. There were no significant differences in the distribution or in the intensity of pimonidazole immunohistochemical staining between young and aged rat livers. In conclusion, no major changes in hepatocyte oxygenation were seen in the aged rat liver, and the ATP changes are unlikely to be secondary to hepatocyte hypoxia or impaired oxygen diffusion into the liver. It is thus more likely that age-related reduction in liver ATP is attributable to mitochondrial dysfunction.
C1 Univ Sydney, ANZAC Res Inst, Concord, NSW 2139, Australia.
   [Cheluvappa, Rajkumar; Hilmer, Sarah N.; Kwun, Sun Young; Cogger, Victoria C.; Le Couteur, David G.] Concord RG Hosp, Dept Anat Pathol, Concord, NSW 2139, Australia.
   [Cheluvappa, Rajkumar; Hilmer, Sarah N.; Cogger, Victoria C.; Le Couteur, David G.] Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.
   [Hilmer, Sarah N.] Royal N Shore Hosp, Dept Aged Care, St Leonards, NSW 2065, Australia.
   [Hilmer, Sarah N.] Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia.
C3 University of Sydney; ANZAC Research Institute; Concord Repatriation
   General Hospital; Royal North Shore Hospital; Royal North Shore Hospital
RP Cheluvappa, R (corresponding author), Univ Sydney, ANZAC Res Inst, Hosp Rd, Concord, NSW 2139, Australia.
EM reheluvappa@med.usyd.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; Hilmer, Sarah/AAW-8554-2020;
   Ekanayake, Kanchana/P-8817-2016
OI Hilmer, Sarah/0000-0002-5970-1501; Le Couteur,
   David/0000-0002-4227-5817; Cheluvappa, Rajkumar/0000-0002-3472-9591
CR [Anonymous], KLIO
   Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x
   GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422
   Herrlinger C, 2001, BEST PRACT RES CL GA, V15, P897, DOI 10.1053/bega.2001.0249
   Kang MJ, 2005, BIOGERONTOLOGY, V6, P27, DOI 10.1007/s10522-004-7381-z
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
NR 11
TC 7
Z9 7
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
BN 978-1-57331-680-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2007
VL 1114
BP 88
EP 92
DI 10.1196/annals.1396.007
PG 5
WC Geriatrics & Gerontology; Multidisciplinary Sciences; Physiology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics;
   Physiology
GA BHA05
UT WOS:000251775900011
PM 17717093
DA 2024-02-19
ER

PT J
AU Bird, TG
   Müller, M
   Boulter, L
   Vincent, DF
   Ridgway, RA
   Lopez-Guadamillas, E
   Lu, WY
   Jamieson, T
   Govaere, O
   Campbell, AD
   Ferreira-Gonzalez, S
   Cole, AM
   Hay, T
   Simpson, KJ
   Clark, W
   Hedley, A
   Clarke, M
   Gentaz, P
   Nixon, C
   Bryce, S
   Kiourtis, C
   Sprangers, J
   Nibbs, RJB
   Van Rooijen, N
   Bartholin, L
   McGreal, SR
   Apte, U
   Barry, ST
   Iredale, JP
   Clarke, AR
   Serrano, M
   Roskams, TA
   Sansom, OJ
   Forbes, SJ
AF Bird, Thomas G.
   Mueller, Miryam
   Boulter, Luke
   Vincent, David F.
   Ridgway, Rachel A.
   Lopez-Guadamillas, Elena
   Lu, Wei-Yu
   Jamieson, Thomas
   Govaere, Olivier
   Campbell, Andrew D.
   Ferreira-Gonzalez, Sofia
   Cole, Alicia M.
   Hay, Trevor
   Simpson, Kenneth J.
   Clark, William
   Hedley, Ann
   Clarke, Mairi
   Gentaz, Pauline
   Nixon, Colin
   Bryce, Steven
   Kiourtis, Christos
   Sprangers, Joep
   Nibbs, Robert J. B.
   Van Rooijen, Nico
   Bartholin, Laurent
   McGreal, Steven R.
   Apte, Udayan
   Barry, Simon T.
   Iredale, John P.
   Clarke, Alan R.
   Serrano, Manuel
   Roskams, Tania A.
   Sansom, Owen J.
   Forbes, Stuart J.
TI TGFβ inhibition restores a regenerative response in acute liver injury
   by suppressing paracrine senescence
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID GROWTH-FACTOR-BETA; CELLS; MICE; HEPATOCYTES; INFLAMMATION; MACROPHAGES;
   EXPRESSION; INDUCTION; DETECT; DRIVEN
AB Liver injury results in rapid regeneration through hepatocyte proliferation and hypertrophy. However, after acute severe injury, such as acetaminophen poisoning, effective regeneration may fail. We investigated how senescence may underlie this regenerative failure. In human acute liver disease, and murine models, p21-dependent hepatocellular senescence was proportionate to disease severity and was associated with impaired regeneration. In an acetaminophen injury mouse model, a transcriptional signature associated with the induction of paracrine senescence was observed within 24 hours and was followed by one of impaired proliferation. In mouse genetic models of hepatocyte injury and senescence, we observed transmission of senescence to local uninjured hepatocytes. Spread of senescence depended on macrophage-derived transforming growth factor-beta 1 (TGF beta 1) ligand. In acetaminophen poisoning, inhibition of TGF beta receptor 1 (TGF beta R1) improved mouse survival.TGF beta R1 inhibition reduced senescence and enhanced liver regeneration even when delivered beyond the therapeutic window for treating acetaminophen poisoning. This mechanism, in which injury-induced senescence impairs liver regeneration, is an attractive therapeutic target for developing treatments for acute liver failure.
C1 [Bird, Thomas G.; Mueller, Miryam; Vincent, David F.; Ridgway, Rachel A.; Jamieson, Thomas; Campbell, Andrew D.; Cole, Alicia M.; Clark, William; Hedley, Ann; Gentaz, Pauline; Nixon, Colin; Bryce, Steven; Kiourtis, Christos; Sprangers, Joep; Sansom, Owen J.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.
   [Bird, Thomas G.; Boulter, Luke; Lu, Wei-Yu; Ferreira-Gonzalez, Sofia; Simpson, Kenneth J.; Forbes, Stuart J.] Univ Edinburgh, MRC, Ctr Regenerat Med, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.
   [Bird, Thomas G.; Iredale, John P.; Forbes, Stuart J.] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, 49 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.
   [Boulter, Luke] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.
   [Lopez-Guadamillas, Elena; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid 28029, Spain.
   [Govaere, Olivier; Roskams, Tania A.] Katholieke Univ Leuven, Dept Imaging & Pathol, B-3000 Leuven, Belgium.
   [Govaere, Olivier; Roskams, Tania A.] Univ Hosp Leuven, B-3000 Leuven, Belgium.
   [Hay, Trevor; Clarke, Alan R.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.
   [Clarke, Mairi; Nibbs, Robert J. B.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland.
   [Kiourtis, Christos; Sansom, Owen J.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland.
   [Van Rooijen, Nico] Vrije Univ, Med Ctr, Dept Mol Cell Biol, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
   [Bartholin, Laurent] Lyon I Univ, Ctr Rech Cancerol Lyon, UMR INSERM 1052, UMR S 1052,CNRS 5286, F-69373 Lyon 08, France.
   [McGreal, Steven R.; Apte, Udayan] Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Med Ctr, Kansas City, KS 66160 USA.
   [Barry, Simon T.] AstraZeneca, Oncol, IMED Biotech Unit, Cambridge CB2 0AA, England.
   [Iredale, John P.] Univ Bristol, Senate House,Tyndall Ave, Bristol BS8 1TH, Avon, England.
   [Serrano, Manuel] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Serrano, Manuel] Catalan Inst Res & Adv Studies, Barcelona, Spain.
C3 Beatson Institute; University of Edinburgh; University of Edinburgh;
   University of Edinburgh; Centro Nacional de Investigaciones Oncologicas
   (CNIO); KU Leuven; KU Leuven; University Hospital Leuven; Cardiff
   University; University of Glasgow; University of Glasgow; Vrije
   Universiteit Amsterdam; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Claude Bernard Lyon 1; UNICANCER; Centre
   Leon Berard; University of Kansas; University of Kansas Medical Center;
   AstraZeneca; University of Bristol; Barcelona Institute of Science &
   Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA
RP Bird, TG (corresponding author), Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.; Bird, TG (corresponding author), Univ Edinburgh, MRC, Ctr Regenerat Med, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.; Bird, TG (corresponding author), Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, 49 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.
EM t.bird@beatson.gla.ac.uk
RI Serrano, Manuel/H-2634-2015; Müller, Miryam/AAL-3697-2021; Govaere,
   Olivier/R-9372-2019; Iredale, John P/C-7300-2013; Gonzalez,
   Sofia/HRA-6915-2023; Bartholin, Laurent/Q-6655-2017; Ferreira-Gonzalez,
   Sofia/AAL-9189-2021; Bird, Tom/H-3840-2019; Lu, Wei-Yu/N-5884-2019; Van
   Rooijen, Nico/Z-1578-2019; gonzalez, Sofia/JVZ-0275-2024
OI Müller, Miryam/0000-0002-0751-1407; Govaere,
   Olivier/0000-0002-4426-6930; Bartholin, Laurent/0000-0002-5637-3223;
   Ferreira-Gonzalez, Sofia/0000-0001-7776-287X; Bird,
   Tom/0000-0002-6120-1581; Lu, Wei-Yu/0000-0002-0419-0257; Forbes,
   Stuart/0000-0003-3715-2561; Nibbs, Robert/0000-0002-8150-0044; Campbell,
   Andrew D./0000-0003-3930-1276; Boulter, Luke/0000-0002-7954-6705;
   Kiourtis, Christos/0000-0002-6682-5668; Iredale,
   John/0000-0003-2174-5127; Vincent, David/0000-0001-6482-8040; Sansom,
   Owen J./0000-0001-9540-3010; Roskams, Tania/0000-0002-2816-1530;
   JAMIESON, THOMAS/0000-0003-4015-7216
FU Wellcome Trust [WT081604AIA, WT107492Z]; Medical Research Council (MRC)
   [G1000868]; Sir Jules Thorn Charitable Trust; Scottish Enterprise; MRC
   program grant; CRUK grant [A12481]; NIH [R01 DK98414]; MRC
   [MR/L012766/1, G0900992, MC_PC_15041, MC_PC_15049, MR/P016839/1,
   G1000868, G0600033] Funding Source: UKRI
FX T. G. B. was funded by the Wellcome Trust (WT081604AIA and WT107492Z).
   S. J. F. was funded by a Medical Research Council (MRC) project grant
   (G1000868), the Wellcome Trust, the Sir Jules Thorn Charitable Trust,
   and Scottish Enterprise. J. P. I. was supported by an MRC program grant.
   O. J. S. was supported by CRUK grant #A12481. U.A. was supported by NIH
   grant #R01 DK98414.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259
   Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bartholin L, 2008, GENESIS, V46, P724, DOI 10.1002/dvg.20425
   Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091
   Cole AM, 2010, EMBO MOL MED, V2, P472, DOI 10.1002/emmm.201000101
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Ferner RE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2218
   Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Forbes SJ, 2000, GENE THER, V7, P784, DOI 10.1038/sj.gt.3301143
   Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   HOUCK KA, 1989, J CELL PHYSIOL, V141, P503, DOI 10.1002/jcp.1041410308
   Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880
   Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520
   Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020
   James LP, 2003, TOXICOL SCI, V75, P458, DOI 10.1093/toxsci/kfg181
   Jamieson T, 2012, J CLIN INVEST, V122, P3127, DOI 10.1172/JCI61067
   Jeanblanc M, 2012, ONCOGENE, V31, P3072, DOI 10.1038/onc.2011.481
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001
   Oe S, 2004, HEPATOLOGY, V40, P1098, DOI 10.1002/hep.20426
   OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043
   Reuben A, 2016, ANN INTERN MED, V164, P724, DOI 10.7326/M15-2211
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Takiya S, 1995, J CLIN PATHOL, V48, P1093, DOI 10.1136/jcp.48.12.1093
   Teoh N, 2010, GASTROENTEROLOGY, V138, P1155, DOI 10.1053/j.gastro.2009.11.008
   Valentin-Vega YA, 2008, CELL DEATH DIFFER, V15, P1772, DOI 10.1038/cdd.2008.109
   Vincent DF, 2010, GENESIS, V48, P559, DOI 10.1002/dvg.20653
   Wlodzimirow KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050952
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
   Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580
   Zhu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074535
NR 62
TC 146
Z9 152
U1 2
U2 28
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD AUG 15
PY 2018
VL 10
IS 454
AR eaan1230
DI 10.1126/scitranslmed.aan1230
PG 14
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA GQ3PR
UT WOS:000441579200002
PM 30111642
OA Green Accepted, Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU DENAYER, P
   RENNOTTE, B
   CAUCHETEUX, D
AF DENAYER, P
   RENNOTTE, B
   CAUCHETEUX, D
TI THYROID-HORMONE RECEPTORS IN BRAIN AND LIVER DURING AGING
SO HORMONE AND METABOLIC RESEARCH
LA English
DT Article
DE T3 NUCLEAR RECEPTORS; AGING; THYROID HORMONES
ID NUCLEAR TRIIODOTHYRONINE RECEPTORS; RAT-BRAIN; BINDING; IDENTIFICATION;
   ONTOGENESIS; EXPRESSION; PITUITARY; THYROXINE; TISSUES
AB The binding properties - binding capacity (MBC) and affinity (Ka) - of T3 nuclear receptors were analyzed in cortex, cerebellum and liver of rats aged 3, 6, 12 and 24 months.
   A slight but not significant decrease of Ka was observed in different tissues of normal rats.  In hypothyroid animals the Ka in cortex at 24 months was significantly lower than at 3 months.  During ageing the MBC of brain receptors decreased whereas hepatic receptors were not altered.  Hypothyroidism did not further affect the MBC of the receptors.
   The data indicate that during ageing the T3 nuclear receptors behave differently in brain and liver.  The difference in MBC suggests selectivity in organ sensitivity to thyroid hormones.
C1 CATHOLIC UNIV LOUVAIN,SCH MED,B-1200 BRUSSELS,BELGIUM.
C3 Universite Catholique Louvain; Universite Libre de Bruxelles
RP DENAYER, P (corresponding author), INT INST CELLULAR & MOLEC PATHOL,HORMONE & METAB RES UNIT,75 AVE HIPPOCRATE,B-1200 BRUSSELS,BELGIUM.
CR BENBROOK D, 1987, SCIENCE, V238, P788, DOI 10.1126/science.3672126
   BERNAL J, 1984, ENDOCRINOLOGY, V114, P677, DOI 10.1210/endo-114-2-677
   De Nayer P., 1989, IODINE BRAIN, P51
   DENAYER P, 1981, BIOCHEM BIOPH RES CO, V98, P1
   DENCKLA WD, 1974, J CLIN INVEST, V53, P572, DOI 10.1172/JCI107592
   DOZINVANROYE B, 1979, BRAIN RES, V177, P551, DOI 10.1016/0006-8993(79)90471-2
   FERREIRO B, 1987, ACTA ENDOCRINOL-COP, V116, P205, DOI 10.1530/acta.0.1160205
   GAMBERT SR, 1981, ENDOCRINOLOGY, V108, P27, DOI 10.1210/endo-108-1-27
   GAMBERT SR, 1986, HORM METAB RES, V18, P549
   HODIN RA, 1990, J CLIN INVEST, V85, P101, DOI 10.1172/JCI114398
   HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642
   KVETNY J, 1985, HORM METAB RES, V17, P35, DOI 10.1055/s-2007-1013441
   MARGARITY M, 1985, MECH AGEING DEV, V29, P181, DOI 10.1016/0047-6374(85)90017-X
   MITSHUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5805
   MITSUHASHI T, 1989, J BIOL CHEM, V264, P8900
   MURRAY MB, 1988, J BIOL CHEM, V263, P12770
   OPPENHEIMER JH, 1983, MOL BASIS THYROID HO, P1
   PEREZCASTILLO AJ, 1984, ENDOCRINOLOGY, V117, P2457
   POLK D, 1989, AM J PHYSIOL, V256, pE543, DOI 10.1152/ajpendo.1989.256.4.E543
   SAKURAI A, 1989, MOL ENDOCRINOL, V3, P392, DOI 10.1210/mend-3-2-392
   SANTOS A, 1988, MOL ENDOCRINOL, V2, P992
   Schwartz HL., 1983, Molecular basis of thyroid hormone action, P413, DOI DOI 10.1016/B978-0-12-527560-6.50020-2
   SPAULDING SW, 1987, ENDOCRIN METAB CLIN, V16, P1013, DOI 10.1016/S0889-8529(18)30456-0
   THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259
   VALCANA T, 1978, MOL CELL ENDOCRINOL, V11, P31, DOI 10.1016/0303-7207(78)90030-8
NR 25
TC 11
Z9 12
U1 0
U2 5
PU GEORG THIEME VERLAG
PI STUTTGART
PA P O BOX 30 11 20, D-70451 STUTTGART, GERMANY
SN 0018-5043
J9 HORM METAB RES
JI Horm. Metab. Res.
PD JAN
PY 1991
VL 23
IS 1
BP 12
EP 14
DI 10.1055/s-2007-1003600
PG 3
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EY135
UT WOS:A1991EY13500003
PM 2016075
DA 2024-02-19
ER

PT J
AU Chen, L
   Liang, BY
   Xia, SW
   Wang, FX
   Li, ZH
   Shao, JJ
   Zhang, ZL
   Chen, AP
   Zheng, SZ
   Zhang, F
AF Chen, Li
   Liang, Baoyu
   Xia, Siwei
   Wang, Feixia
   Li, Zhanghao
   Shao, Jiangjuan
   Zhang, Zili
   Chen, Anping
   Zheng, Shizhong
   Zhang, Feng
TI Emodin promotes hepatic stellate cell senescence and alleviates liver
   fibrosis via a nuclear receptor (Nur77)-mediated epigenetic regulation
   of glutaminase 1
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article; Early Access
DE emodin; glutaminolysis; hepatic stellate cell; liver fibrosis;
   methylation; Nur77; senescence
ID NANOMEDICINE; INHIBITION; METABOLISM; MOUSE
AB Background and PurposeSenescence in hepatic stellate cells (HSCs) limits liver fibrosis. Glutaminolysis promotes HSC activation. Here, we investigated how emodin affected HSC senescence involving glutaminolysis. Experimental ApproachSenescence, glutaminolysis metabolites, Nur77 nuclear translocation, glutaminase 1 (GLS1) promoter methylation and related signalling pathways were examined in human HSC-LX2 cells using multiple cellular and molecular approaches. Fibrotic mice with shRNA-mediated knockdown of Nur77 were treated with emodin-vitamin A liposome for investigating the mechanisms in vivo. Human fibrotic liver samples were examined to verify the clinical relevance. Key ResultsEmodin upregulated several key markers of senescence and inhibited glutaminolysis cascade in HSCs. Emodin promoted Nur77 nuclear translocation, and knockdown of Nur77 abolished emodin blockade of glutaminolysis and induction of HSC senescence. Mechanistically, emodin facilitated Nur77/DNMT3b interaction and increased GLS1 promoter methylation, leading to inhibited GLS1 expression and blockade of glutaminolysis. Moreover, the glutaminolysis intermediate & alpha;-ketoglutarate promoted extracellular signal-regulated kinase (ERK) phosphorylation, which in turn phosphorylated Nur77 and reduced its interaction with DNMT3b. This led to decreased GLS1 promoter methylation and increased GLS1 expression, forming an ERK/Nur77/glutaminolysis positive feedback loop. However, emodin repressed ERK phosphorylation and interrupted the feedback cascade, stimulating senescence in HSCs. Studies in mice showed that emodin-vitamin A liposome inhibited glutaminolysis and induced senescence in HSCs, and consequently alleviated liver fibrosis; but knockdown of Nur77 abrogated these beneficial effects. Similar alterations were validated in human fibrotic liver tissues. Conclusions and ImplicationsEmodin stimulated HSC senescence through interruption of glutaminolysis. HSC-targeted delivery of emodin represented a therapeutic option for liver fibrosis.
C1 [Chen, Li; Liang, Baoyu; Xia, Siwei; Wang, Feixia; Li, Zhanghao; Shao, Jiangjuan; Zhang, Zili; Zheng, Shizhong; Zhang, Feng] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing, Peoples R China.
   [Li, Zhanghao] Hong Kong Baptist Univ, Law Sau Fai Inst Advancing Translat Med Bone & Joi, Sch Chinese Med, Hong Kong, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St. Louis, MO USA.
   [Zheng, Shizhong; Zhang, Feng] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
C3 Nanjing University of Chinese Medicine; Hong Kong Baptist University;
   Saint Louis University; Nanjing University of Chinese Medicine
RP Zheng, SZ; Zhang, F (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
EM nytws@njucm.edu.cn; zhangfeng2013@njucm.edu.cn
RI Wang, Jin/KAM-5595-2024
FU National Natural Science Foundation of China [82173874, 82073914]; Major
   Project of the Natural Science Researchof Jiangsu Higher Education
   Institutions [19KJA310005]; QingLan Project of Jiangsu Higher
   Institutions(Young and Middle-Aged Academic Leader); Open Project of
   Chinese Materia Medica First-Class Discipline of Nanjing University of
   Chinese Medicine [2020YLKX022, 2020YLKX023]
FX National Natural Science Foundation of China,Grant/Award Numbers:
   82173874, 82073914;Major Project of the Natural Science Researchof
   Jiangsu Higher Education Institutions,Grant/Award Number: 19KJA310005;
   QingLan Project of Jiangsu Higher Institutions(Young and Middle-Aged
   Academic Leader);Open Project of Chinese Materia Medica First-Class
   Discipline of Nanjing University ofChinese Medicine, Grant/Award
   Numbers:2020YLKX022, 2020YLKX023
CR Ahuja P, 2023, HEPATOLOGY, V77, P213, DOI 10.1002/hep.32501
   Alexander SPH, 2018, BRIT J PHARMACOL, V175, P407, DOI 10.1111/bph.14112
   Baghaei K, 2022, DRUG DISCOV TODAY, V27, P1044, DOI 10.1016/j.drudis.2021.12.012
   Chen QT, 2022, NAT METAB, V4, P1306, DOI 10.1038/s42255-022-00642-5
   Chen ZJ, 2019, J PHARMACOL EXP THER, V370, P695, DOI 10.1124/jpet.118.256156
   Cohn RL, 2023, TRENDS CELL BIOL, V33, P9, DOI 10.1016/j.tcb.2022.04.011
   Crean D, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.589770
   Curtis MJ, 2022, BRIT J PHARMACOL, V179, P3907, DOI 10.1111/bph.15868
   de Bovenkamp MV, 2007, TOXICOL IN VITRO, V21, P545, DOI 10.1016/j.tiv.2006.12.009
   Dong XX, 2020, PHYTOTHER RES, V34, P270, DOI 10.1002/ptr.6532
   Du K, 2020, CELL MOL GASTROENTER, V10, P1, DOI 10.1016/j.jcmgh.2019.12.006
   Du K, 2018, GASTROENTEROLOGY, V154, P1465, DOI 10.1053/j.gastro.2017.12.022
   du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1136/bmjos-2020-100115]
   El-Mezayen NS, 2018, J CONTROL RELEASE, V283, P32, DOI 10.1016/j.jconrel.2018.05.021
   El-Mezayen NS, 2017, J CONTROL RELEASE, V266, P226, DOI 10.1016/j.jconrel.2017.09.035
   Faulkner A, 2020, DIABETOLOGIA, V63, P2205, DOI 10.1007/s00125-020-05230-4
   Foglia B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112700
   Friedman SL, 2022, HEPATOLOGY, V75, P473, DOI 10.1002/hep.32285
   Fu LH, 2018, CHEM SOC REV, V47, P6454, DOI 10.1039/c7cs00891k
   Gyanwali B, 2022, TRENDS ENDOCRIN MET, V33, P136, DOI 10.1016/j.tem.2021.11.003
   Hu NH, 2020, EUR J PHARMACOL, V882, DOI 10.1016/j.ejphar.2020.173269
   Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Kamm DR, 2022, J PHYSIOL-LONDON, V600, P1825, DOI 10.1113/JP281061
   Lei YC, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020304
   Li QQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.559607
   Liebmann M, 2018, P NATL ACAD SCI USA, V115, pE8017, DOI 10.1073/pnas.1721049115
   Lilley E, 2020, BRIT J PHARMACOL, V177, P3611, DOI 10.1111/bph.15178
   Liu F, 2018, MOL MED REP, V18, P3262, DOI 10.3892/mmr.2018.9324
   Masser DR, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-33
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Medzikovic L, 2019, TRENDS CARDIOVAS MED, V29, P429, DOI 10.1016/j.tcm.2018.11.015
   Mejias M, 2020, GASTROENTEROLOGY, V159, P273, DOI 10.1053/j.gastro.2020.03.008
   Ranhotra HS, 2015, J RECEPT SIG TRANSD, V35, P184, DOI 10.3109/10799893.2014.948555
   Sharma S, 2022, BIOCHEM PHARMACOL, V198, DOI 10.1016/j.bcp.2022.114943
   Tu XH, 2021, EUR J MED CHEM, V211, DOI 10.1016/j.ejmech.2020.113020
   Wilmot B, 2016, J CHILD PSYCHOL PSYC, V57, P152, DOI 10.1111/jcpp.12457
   Yin XC, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-05409-0
   Zhang F, 2021, BRIT J PHARMACOL, V178, P2246, DOI 10.1111/bph.15289
   Zhang F, 2018, THERANOSTICS, V8, P610, DOI 10.7150/thno.22237
   Zhang F, 2017, BRIT J PHARMACOL, V174, P409, DOI 10.1111/bph.13701
   Zhang MF, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111572
   Zhao JW, 2023, BRIT J PHARMACOL, V180, P1072, DOI 10.1111/bph.15997
   Zhao XA, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5738101
   Zu C, 2018, BIOCHEM BIOPH RES CO, V505, P973, DOI 10.1016/j.bbrc.2018.09.045
NR 47
TC 1
Z9 1
U1 10
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD 2023 OCT
PY 2023
VL 180
IS 19
BP 2577
EP 2598
DI 10.1111/bph.16156
EA JUN 2023
PG 22
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA Q9PT7
UT WOS:001016327100001
PM 37263753
DA 2024-02-19
ER

PT J
AU Dong, RC
   Wang, XH
   Wang, L
   Wang, CY
   Huang, K
   Fu, T
   Liu, KX
   Wu, JJ
   Sun, HJ
   Meng, Q
AF Dong, Renchao
   Wang, Xiaohui
   Wang, Lu
   Wang, Changyuan
   Huang, Kai
   Fu, Ting
   Liu, Kexin
   Wu, Jingjing
   Sun, Huijun
   Meng, Qiang
TI Yangonin inhibits ethanol-induced hepatocyte senescence via miR-194/FXR
   axis
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Yangonin; Alcoholic liver disease; miR-194; FXR; Cellular senescence
ID FATTY LIVER-DISEASE; CELLULAR SENESCENCE; INJURY; MICRORNAS;
   KAVALACTONES; INFLAMMATION; STEATOSIS; HEPATITIS; APOPTOSIS; PROTECTS
AB Chronic alcohol assumption has been recognized as a major cause of alcoholic liver disease (ALD), which ranges from alcoholic steatohepatitis to fibrosis and hepatocellular carcinoma. Alcoholic liver disease has become the leading cause of liver-related health problem in the world. Herewith, effective therapeutic strategy for alcoholic liver disease is necessary. Yangonin (Yan), a bioactive compound extract from Kava, has been reported to exert hepatoprotective effects via Farnesoid X receptor (FXR) activation. The present study aims to investigate whether Yan ameliorated the ethanol-stimulated liver injury and further to elucidate the mechanisms in vivo and in vitro. Yan improved cell viabilities via cell count kit-8 (CCK-8) methods and obviously reduced aspartate aminotransferase (AST), alanine aminotransferase (ALT), total cholesterol (TC) and total triglyceride (TG) levels. We detected miR-194 levels in ethanol-induced LO2 cells and male C57BL/6 mice by quantitative real-time PCR. Also, the effects of miR-194 on modulating cellular senescence via targeting FXR were further verified. The cellular senescence markers p16, p21, telomerase activity and senescence-related beta-galactosidase (SA-beta-gal) were evaluated by quantitative real-time PCR and Western blot. Also, LO2 cells or liver tissues were stained with special primary antibodies and 4',6'-Diamidino-2-phenylindole (DAPI). The cell cycle was detected by flow cytometry. We observed that Yan significantly inhibited ethanol-induced cellular senescence via FXR activation (P < 0.05). Our results demonstrate that Yan significantly reduced the cellular markers p16, p21 and Hmgal expression and inhibited the cell cycle arrest (P < 0.05). MiR-194 was upregulated in the alcoholic liver disease, which was significantly suppressed by Yan (P < 0.05). Moreover, miR-194 mimic inhibited FXR expression in vitro. In summary, these aggregated data demonstrate that Yan alleviates chronic ethanol-induced liver injury through inhibition of cellular senescence via regulating miR-194/FXR axis.
C1 [Dong, Renchao; Wang, Xiaohui; Wang, Lu; Wang, Changyuan; Liu, Kexin; Wu, Jingjing; Sun, Huijun; Meng, Qiang] Dalian Med Univ, Coll Pharm, Dept Clin Pharmacol, 9 West Sect,Lvshun South Rd, Dalian 116044, Peoples R China.
   [Huang, Kai] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Drug Clin Trial Inst, Wuxi 214023, Jiangsu, Peoples R China.
   [Fu, Ting] Dalian Univ, Affiliated Zhongshan Hosp, Dept Pharm, Dalian, Peoples R China.
C3 Dalian Medical University; Nanjing Medical University; Dalian University
RP Meng, Q (corresponding author), Dalian Med Univ, Coll Pharm, Dept Clin Pharmacol, 9 West Sect,Lvshun South Rd, Dalian 116044, Peoples R China.
EM qiangmeng@dmu.edu.cn
RI Liu, Kexin/GQH-0970-2022; Huang, Kai/JVO-5066-2024
FU National Natural Science Foundation of China [81302826, 81874324];
   Dalian Science and technology innovation fund [2018J12SN065]; Basic
   research project of Education Department of Liaoning Province
   [LZ2019037]
FX This study was supported by a grant from the National Natural Science
   Foundation of China (Nos. 81302826, 81874324), Dalian Science and
   technology innovation fund (No. 2018J12SN065) and Basic research project
   of Education Department of Liaoning Province (LZ2019037).
CR Adachi M, 2005, DIGEST DIS, V23, P255, DOI 10.1159/000090173
   Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002
   Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657
   Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Blaya D, 2016, GUT, V65, P1535, DOI 10.1136/gutjnl-2015-311314
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Dong RC, 2019, PHYTOMEDICINE, V53, P134, DOI 10.1016/j.phymed.2018.09.006
   Dunn W, 2016, CLIN LIVER DIS, V20, P445, DOI 10.1016/j.cld.2016.02.004
   Gao LL, 2016, MOL NUTR FOOD RES, V60, P1902, DOI 10.1002/mnfr.201500878
   Gao XG, 2018, TOXICOL APPL PHARM, V348, P105, DOI 10.1016/j.taap.2018.04.015
   Hartmann P, 2018, HEPATOLOGY, V67, P2150, DOI 10.1002/hep.29676
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Heo MJ, 2019, GUT, V68, P708, DOI 10.1136/gutjnl-2017-315123
   Huanhuan J., 2018, CELL PROLIFERAT, V51
   Ilyas Uorakkottil, 2016, Pharmacogn Rev, V10, P66, DOI 10.4103/0973-7847.176544
   Iracheta-Vellve A, 2018, HEPATOL COMMUN, V2, P1379, DOI 10.1002/hep4.1256
   Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009
   Jin HH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12431
   Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007
   Li ZL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0518-9
   LIEBER CS, 1994, METHOD ENZYMOL, V233, P585
   Ligresti A, 2012, PHARMACOL RES, V66, P163, DOI 10.1016/j.phrs.2012.04.003
   Liu Z., 2017, J BIOMEDICAL RES
   Lívero FAR, 2014, CHEM-BIOL INTERACT, V217, P19, DOI 10.1016/j.cbi.2014.03.014
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Mathurin P, 2015, J HEPATOL, V62, pS38, DOI 10.1016/j.jhep.2015.03.006
   McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223
   Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915
   Momen-Heravi F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0623-9
   Neilson JR, 2008, CELL, V134, P899, DOI 10.1016/j.cell.2008.09.006
   Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4
   Nie HZR, 2017, BBA-MOL BASIS DIS, V1863, P3087, DOI 10.1016/j.bbadis.2017.09.020
   Ogrodnik M, 2019, TRENDS BIOCHEM SCI, V44, P996, DOI 10.1016/j.tibs.2019.06.011
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983
   Ruchi S., 2018, OXIDATIVE MED CELLUL, V2018
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Tan TCH, 2013, ALCOHOL CLIN EXP RES, V37, P1619, DOI 10.1111/acer.12155
   TSUKAMOTO H, 1986, HEPATOLOGY, V6, P814, DOI 10.1002/hep.1840060503
   VALLEE BL, 1957, NEW ENGL J MED, V257, P1055, DOI 10.1056/NEJM195711282572201
   Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009
   von Figura G, 2009, J MOL MED, V87, P1165, DOI 10.1007/s00109-009-0509-5
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wanxia G., 2017, PLOS ONE, V12
   Williams JA, 2014, WORLD J GASTROENTERO, V20, P12908, DOI 10.3748/wjg.v20.i36.12908
   Wruck CJ, 2008, MOL PHARMACOL, V73, P1785, DOI 10.1124/mol.107.042499
   Wu D, 2002, PHYTOMEDICINE, V9, P41, DOI 10.1078/0944-7113-00068
   Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057
   Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028
   Xu TT, 2014, ARCH TOXICOL, V88, P739, DOI 10.1007/s00204-013-1148-8
   Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021
   YOKOYAMA H, 1995, HEPATOLOGY, V21, P1438, DOI 10.1016/0270-9139(95)90067-5
   Zhou Z., 2016, CELL PROLIFERAT, V50, P1
NR 59
TC 8
Z9 9
U1 2
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD JAN 5
PY 2021
VL 890
AR 173653
DI 10.1016/j.ejphar.2020.173653
PG 14
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA PH8WR
UT WOS:000600686100021
PM 33068587
DA 2024-02-19
ER

PT J
AU Sun, Y
   Weng, JD
   Chen, XL
   Ma, SY
   Zhang, YX
   Zhang, F
   Zhang, ZL
   Wang, FX
   Shao, JJ
   Zheng, SZ
AF Sun, Ying
   Weng, Jingdan
   Chen, Xiaolei
   Ma, Shuyao
   Zhang, Yuxin
   Zhang, Feng
   Zhang, Zili
   Wang, Feixia
   Shao, Jiangjuan
   Zheng, Shizhong
TI Oroxylin A activates ferritinophagy to induce hepatic stellate cell
   senescence against hepatic fibrosis by regulating cGAS-STING pathway
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Early Access
DE Liver fibrosis; Oroxylin A; Cell senescence; Ferritinophagy; cGAS-STING
   pathway
ID LIVER FIBROSIS; INHIBITION; FERROPTOSIS; ANGIOGENESIS; EXPRESSION;
   APOPTOSIS; AUTOPHAGY
AB In recent study, the pathological mechanism of liver fibrosis has been associated with hepatic stellate cell (HSC) senescence. Targeted induction of HSC senescence is considered as a new strategy to remove activated HSC. Nevertheless, little is known about the role of ferritinophagy in cell senescence. In this study, we reported that Oroxylin A from Scutellaria baicalensis Georgi can regulate HSC senescence induced by ferritinophagy through the cGAS-STING pathway to reduce liver fibrosis. We first found that Oroxylin A treatment alleviated the pathological changes of liver fibrosis, reduced collagen deposition, and significantly inhibited liver fibrosis. Interestingly, Oroxylin A treatment can activate HSC ferritinophagy and further induce HSC senescence. It is noteworthy that ferritinophagy is mediated by nuclear receptor coactivator 4 (NCOA4), an important selective mediator for ferritin degradation. NCOA4 siRNA causes Oroxylin A to reduce the degree of telomerase activity in HSCs and induce the expression of senescence markers, such as SA-beta-Gal and related marker proteins. Impor-tantly, the cGAS-STING pathway is crucial to the activation of HSC ferritinophagy by Oroxylin A. Specifically, Oroxylin A can promote the secretion of cytokines like IFN-beta by the cGAS-STING pathway to regulate ferriti-nophagy. cGAS siRNA resulted in a dose-dependent decrease in the expression of NCOA4, a significant reduction in the expression level of autophagy-related phenotype, and a decrease in the content of ROS and iron ions in HSCs. In conclusion, we identified the new role of ferritinophagy and the GAS-STING pathway in Oroxylin A-mediated anti-hepatic fibrosis.
C1 [Sun, Ying; Weng, Jingdan; Chen, Xiaolei; Ma, Shuyao; Zhang, Yuxin; Zhang, Feng; Zhang, Zili; Wang, Feixia; Shao, Jiangjuan; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing, Peoples R China.
C3 Nanjing University of Chinese Medicine
RP Shao, JJ; Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing, Peoples R China.
EM jjshao@njucm.edu.cn; nytws@njucm.edu.cn
RI wang, jun/JPY-3635-2023; li, yansong/JXL-5023-2024; Zhang,
   Yuan/JUF-7293-2023; Li, Yan/JRW-0176-2023; WANG, YING/JLM-9219-2023;
   Wang, Jing/JRW-1512-2023; Liu, Jie/JCP-1070-2023; Li, YU/JQV-2716-2023;
   li, fei/JYP-3334-2024; wang, yi/JYO-8193-2024; li, xiang/JCN-9316-2023;
   yang, rui/JHI-3328-2023; Wang, Xuechun/JRX-6509-2023; li,
   li/JVP-2971-2024; liu, yuhao/JWP-0475-2024; Wang, yl/JNR-4963-2023;
   zhang, xiao/JCN-8822-2023; Lu, Jia/JVO-6891-2024; Li, Wei/JLL-4365-2023;
   Yang, Fan/JMA-9594-2023; wang, xiaoqiang/JMT-2783-2023; LI,
   WEI/JUE-9796-2023; Li, Lei/JPE-6543-2023; zhao, yan/JNT-6961-2023; xu,
   chen/JNE-5010-2023; li, tao/JVO-9006-2024; Wang, Yue/JRY-8962-2023; YI,
   J/JJE-7713-2023; wang, xiaoxuan/JMP-6531-2023; Liu, Yang/JVD-6777-2023;
   Zhou, Yue/JHS-8791-2023; zhang, ying/JQX-1479-2023; Wang,
   Xin/JVE-0200-2024; liu, jingwen/JQW-9270-2023; LEI, LEI/JTS-4675-2023;
   WANG, HUI/JFA-9683-2023; li, yifan/JHU-9272-2023; zheng,
   yan/JKJ-3632-2023; yan, yan/JVN-1800-2024; liu, xiao/JLL-2119-2023;
   wang, zhe/JNE-3510-2023; Yang, Fan/JVO-8611-2024; zhao,
   lin/JJF-0406-2023; wang, xi/JNT-5162-2023; zhang, xinyu/JKI-8403-2023;
   li, jiaxin/JNT-5073-2023; li, Li/JPA-0218-2023; Zhang,
   Wei/JKI-3565-2023; wang, xin/JWA-3772-2024; liu, yang/JMB-9083-2023; Li,
   Wen/JQI-4757-2023; Zhang, Yunyi/JHS-3626-2023; yuanyuan,
   Li/JEZ-6497-2023; yang, xiao/JLL-7721-2023; Li, Yao/JJC-2927-2023; Yun,
   Ji/KAL-9759-2024; lu, Li/KBA-2603-2024; Li, Yan/JUU-5189-2023; lin,
   qing/JTU-4293-2023; Li, J N/JXL-5833-2024; wang, wei/JYP-7819-2024;
   Ling, Li/JYO-7043-2024
OI Wang, Yue/0000-0001-8673-6358; 
FU National Natural Science Foundation of China [82274185, 82073914,
   82173874, 82000572]; Natural Science Foundation of Jiangsu Province
   [BK20200840]; Project of the Natural Science Research of Jiangsu Higher
   Education Institutions [19KJA310005, 20KJB310003]; Joint Project of
   Jiangsu Key Labo-ratory for Pharmacology and Safety Evaluation of
   Chinese Materia Medica [JKLPSE202005]; Open Project of Chinese Materia
   Medica First-Class Discipline of Nanjing University of Chinese Medicine
   [2020YLKX023, 2020YLKX022]; National College Student Innovation and
   Entrepreneurship Training Program [202210315143Z]
FX This research was funded by the National Natural Science Foundation of
   China (82274185, 82073914, 82173874, 82000572) , the Natural Science
   Foundation of Jiangsu Province (BK20200840) , the Project of the Natural
   Science Research of Jiangsu Higher Education Institutions (19KJA310005,
   20KJB310003) , the Joint Project of Jiangsu Key Laboratory for
   Pharmacology and Safety Evaluation of Chinese Materia Medica and Yangtze
   River Pharmaceutical (JKLPSE202005) , the Open Project of Chinese
   Materia Medica First-Class Discipline of Nanjing University of Chinese
   Medicine (2020YLKX023, 2020YLKX022) and National College Student
   Innovation and Entrepreneurship Training Program (202210315143Z) .
CR Aguado J, 2021, AGING CELL, V20, DOI 10.1111/acel.13468
   Aydin MM, 2018, TURK J GASTROENTEROL, V29, P14, DOI 10.5152/tjg.2018.17330
   Bellan M, 2018, J CLIN TRANSL HEPATO, V6, P317, DOI 10.14218/JCTH.2018.00006
   Bian ML, 2019, APOPTOSIS, V24, P905, DOI 10.1007/s10495-019-01568-2
   Böttcher K, 2017, ADV DRUG DELIVER REV, V121, P3, DOI 10.1016/j.addr.2017.05.016
   Breitkopf-Heinlein K, 2020, GUT, V69, P975, DOI 10.1136/gutjnl-2019-320203
   Cai XY, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104720
   Chen WW, 2018, INT IMMUNOPHARMACOL, V56, P148, DOI 10.1016/j.intimp.2018.01.029
   Dhar D, 2020, EXP BIOL MED, V245, P96, DOI 10.1177/1535370219898141
   Fang YY, 2021, ACS CENTRAL SCI, V7, P980, DOI 10.1021/acscentsci.0c01592
   Fitsiou E, 2022, SEMIN CANCER BIOL, V81, P5, DOI 10.1016/j.semcancer.2021.03.021
   Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95
   Glück S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586
   Guo Q, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03341-9
   Hou YJ, 2018, P NATL ACAD SCI USA, V115, pE1876, DOI 10.1073/pnas.1718819115
   Jiang Y, 2021, THERANOSTICS, V11, P361, DOI 10.7150/thno.46360
   Jin C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03048-x
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, CELL SIGNAL, V33, P79, DOI 10.1016/j.cellsig.2017.02.006
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Kim CH, 2021, CRIT REV ONCOL HEMAT, V163, DOI 10.1016/j.critrevonc.2021.103367
   Kwon BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155784
   Li BY, 2023, EXP NEUROL, V359, DOI 10.1016/j.expneurol.2022.114269
   Li ZY, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.745561
   Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148
   Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Murthy AMV, 2020, CELL DEATH DIFFER, V27, P2989, DOI 10.1038/s41418-020-00624-8
   Ni MM, 2016, J PHYSIOL BIOCHEM, V72, P9, DOI 10.1007/s13105-015-0452-6
   Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110
   Rao Hui-Ying, 2007, Zhonghua Gan Zang Bing Za Zhi, V15, P897
   Roehlen N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040875
   Sajeev A, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12091185
   Santana-Codina N, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040114
   Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006
   Shen M, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106637
   Takasugi M, 2022, MOL ONCOL, V16, P3333, DOI 10.1002/1878-0261.13268
   Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wahyudi H, 2016, J CONTROL RELEASE, V240, P323, DOI 10.1016/j.jconrel.2016.01.007
   Wang FX, 2022, ACTA PHARM SIN B, V12, P3618, DOI 10.1016/j.apsb.2022.03.014
   Wang XX, 2020, LAB INVEST, V100, P542, DOI 10.1038/s41374-019-0342-6
   Wang ZL, 2018, PHARM BIOL, V56, P465, DOI 10.1080/13880209.2018.1492620
   Wu AM, 2021, REDOX BIOL, V46, DOI 10.1016/j.redox.2021.102131
   Yao JY, 2022, AUTOPHAGY, V18, P1879, DOI 10.1080/15548627.2021.2007027
   Yong H, 2021, LIVER INT, V41, P1969, DOI 10.1111/liv.14895
   Zhang CX, 2018, J CELL BIOCHEM, V119, P2258, DOI 10.1002/jcb.26388
   Zhang SY, 2020, HEPATOLOGY, V72, P1717, DOI 10.1002/hep.31176
   Zhang ZL, 2020, AUTOPHAGY, V16, P1482, DOI 10.1080/15548627.2019.1687985
   Zhang ZL, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101619
   Zhang ZL, 2018, AUTOPHAGY, V14, P2083, DOI 10.1080/15548627.2018.1503146
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
   Zhang ZL, 2013, EUR J PHARMACOL, V721, P133, DOI 10.1016/j.ejphar.2013.09.042
   Zhao D., 2023, OROXYLIN REGULATES C, V187
   Zhao SF, 2017, IUBMB LIFE, V69, P115, DOI 10.1002/iub.1598
   Zhao XA, 2018, BIOMED PHARMACOTHER, V106, P868, DOI 10.1016/j.biopha.2018.07.028
   Zhou DX, 2021, AGING CELL, V20, DOI 10.1111/acel.13316
NR 57
TC 4
Z9 4
U1 6
U2 11
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD 2023 JUN
PY 2023
VL 162
AR 114653
DI 10.1016/j.biopha.2023.114653
EA APR 2023
PG 14
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA F8EL1
UT WOS:000984623200001
PM 37086511
OA gold
DA 2024-02-19
ER

PT J
AU Xu, TH
   Chen, JL
   Zhu, DD
   Chen, LT
   Wang, JX
   Sun, XL
   Hu, B
   Duan, YN
AF Xu, Tianhua
   Chen, Jinling
   Zhu, Dandan
   Chen, Liuting
   Wang, Jianxin
   Sun, Xiaolei
   Hu, Bin
   Duan, Yinong
TI Egg antigen p40 of <i>Schistosoma</i> <i>japonicum</i> promotes
   senescence in activated hepatic stellate cells via SKP2/P27 signaling
   pathway
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROSTATE-CANCER CELLS; CELLULAR SENESCENCE; CYCLE ARREST; FIBROSIS;
   INHIBITION; GROWTH; P53; INTERLEUKIN-10; PROGRESSION; MECHANISMS
AB Schistosomiasis is characterized by egg deposition, granulomatous inflammatory reaction and then subsequent hepatic fibrosis formation. Activated HSCs are regarded as the main effector cells in the progression of liver fibrosis and induction of senescence in hepatic stellate cells (HSCs) is vital to the reversion of hepatic fibrosis. Our previous work has showed that S. japonicum egg antigen p40 (Sjp40) could promote HSCs senescence via a STAT3/p53/p21 mechanism. In this paper, the major aim was to explore whether there are other signaling pathways in the process of Sjp40-induced HSCs aging and the underlying effect of SKP2/P27 signal pathway in this procedure. We observed the Sjp40-induced decrease of a-SMA and the senescence of LX-2 cells, and Sjp40 could upregulate P27 and downregulate the protein level of SKP2. The senescence induced by Sjp40 might be reversed in LX-2 cells that treated with P27-specific siRNA or with SKP2-special over-expression plasmid. In addition, we also demonstrated that the decreased expression of P-Rb and a-SMA induced by Sjp40 were partly restored by SKP2-overexpression. These data suggest that Sjp40 might inhibit HSCs activation by promoting cellular senescence via SKP2/P27 signaling pathway, which put forward novel mechanism in the treatment of liver fibrosis.
C1 [Xu, Tianhua; Chen, Jinling; Zhu, Dandan; Chen, Liuting; Sun, Xiaolei; Hu, Bin; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.
   [Xu, Tianhua] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing 210029, Jiangsu, Peoples R China.
   [Wang, Jianxin] Nantong Univ, Affiliated Hosp, Lab Med Ctr, Nantong 226001, Jiangsu, Peoples R China.
C3 Nantong University; Nanjing Medical University; Nantong University
RP Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.
EM yinongduan@aliyun.com
RI liu, jiajia/ISS-0316-2023; Duan, yinong/GSD-9438-2022; wang,
   xiao/HZI-9156-2023
OI Duan, Yinong/0000-0001-5824-5762; Chen, Jinling/0000-0003-2992-6571; Xu,
   Tianhua/0000-0002-7093-5325
FU National Natural Science Foundation of China [81471975, 81401683,
   81501763, 81171589]; Jiangsu Provincial Natural Science Foundation
   [BK20140435]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD)
FX This work was supported by National Natural Science Foundation of China
   (Grant Numbers 81471975, 81401683, 81501763, 81171589), the Jiangsu
   Provincial Natural Science Foundation (Grant Number BK20140435), the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD).
CR Abouel-Nour MF, 2006, MEM I OSWALDO CRUZ, V101, P365, DOI 10.1590/S0074-02762006000400004
   Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x
   Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60
   Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009
   Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Chen JL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.228
   Chung HJ, 2008, J BIOL CHEM, V283, P25879, DOI 10.1074/jbc.M804272200
   Cito L, 2010, ONCOL REP, V24, P1411, DOI 10.3892/or_00001000
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Dai WP, 2015, LIVER INT, V35, P1234, DOI 10.1111/liv.12660
   Du W, 2009, CURR DRUG TARGETS, V10, P581, DOI 10.2174/138945009788680392
   Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003
   Duval F, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/373295
   Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024
   Fasbender F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00019
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Hahm ER, 2007, MOL CANCER THER, V6, P2686, DOI 10.1158/1535-7163.MCT-07-0217
   Haque I, 2015, ONCOGENE, V34, P3152, DOI 10.1038/onc.2014.250
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Kim SJ, 2014, CELL DEATH DIFFER, V21, P1769, DOI 10.1038/cdd.2014.88
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098
   Lee JJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.501
   Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034
   Li A, 2015, EUR J PHARMACOL, V747, P71, DOI 10.1016/j.ejphar.2014.11.040
   Li ZM, 2016, ONCOTARGET, V7, P18927, DOI 10.18632/oncotarget.7816
   Lin HP, 2015, ONCOTARGET, V6, P6684, DOI 10.18632/oncotarget.3246
   Pramod S, 2014, AM J PHYSIOL-HEART C, V306, pH844, DOI 10.1152/ajpheart.00933.2013
   Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006
   Sun XL, 2015, PARASITOL RES, V114, P4251, DOI 10.1007/s00436-015-4663-0
   Tosello-Trampont AC, 2016, HEPATOLOGY, V63, P799, DOI 10.1002/hep.28389
   Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319
   Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106
   Huang YH, 2006, WORLD J GASTROENTERO, V12, P1386, DOI 10.3748/wjg.v12.i9.1386
   Zhang LJ, 2007, HEPATO-GASTROENTEROL, V54, P2092
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
   Zhou XH, 2010, DIAGN MICR INFEC DIS, V67, P337, DOI 10.1016/j.diagmicrobio.2010.03.003
NR 42
TC 12
Z9 14
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 21
PY 2017
VL 7
AR 275
DI 10.1038/s41598-017-00326-1
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EO7CD
UT WOS:000396847900036
PM 28325896
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Barcena, B
   Salamanca, A
   Pintado, C
   Mazuecos, L
   Villar, M
   Molto, E
   Bonzon-Kulichenko, E
   Vazquez, J
   Andres, A
   Gallardo, N
AF Barcena, Brenda
   Salamanca, Aurora
   Pintado, Cristina
   Mazuecos, Lorena
   Villar, Margarita
   Molto, Eduardo
   Bonzon-Kulichenko, Elena
   Vazquez, Jesus
   Andres, Antonio
   Gallardo, Nilda
TI Aging Induces Hepatic Oxidative Stress and Nuclear Proteomic Remodeling
   in Liver from Wistar Rats
SO ANTIOXIDANTS
LA English
DT Article
DE oxidative stress; aging; aging-associated chronic diseases; liver
   proteome; RNA splicing
ID PEPTIDE IDENTIFICATION; CALORIC RESTRICTION; AGE; DIET; INFLAMMATION;
   EXPRESSION; GENES; PROTEOSTASIS; TRANSLATION; HEPATOCYTES
AB Aging is a continuous, universal, and irreversible process that determines progressive loss of adaptability. The liver is a critical organ that supports digestion, metabolism, immunity, detoxification, vitamin storage, and hormone signaling. Nevertheless, the relationship between aging and the development of liver diseases remains elusive. In fact, although prolonged fasting in adult rodents and humans delays the onset of the disease and increases longevity, whether prolonged fasting could exert adverse effects in old organisms remains incompletely understood. In this work, we aimed to characterize the oxidative stress and nuclear proteome in the liver of 3-month- and 24-month-old male Wistar rats upon 36 h of fasting and its adaptation in response to 30 min of refeeding. To this end, we analyzed the hepatic lipid peroxidation levels (TBARS) and the expression levels of genes associated with fat metabolism and oxidative stress during aging. In addition, to gain a better insight into the molecular and cellular processes that characterize the liver of old rats, the hepatic nuclear proteome was also evaluated by isobaric tag quantitation (iTRAQ) mass spectrometry-based proteomics. In old rats, aging combined with prolonged fasting had great impact on lipid peroxidation in the liver that was associated with a marked downregulation of antioxidant genes (Sod2, Fmo3, and Cyp2C11) compared to young rats. Besides, our proteomic study revealed that RNA splicing is the hepatic nuclear biological process markedly affected by aging and this modification persists upon refeeding. Our results suggest that aged-induced changes in the nuclear proteome could affect processes associated with the adaptative response to refeeding after prolonged fasting, such as those involved in the defense against oxidative stress.</p>
C1 [Barcena, Brenda; Salamanca, Aurora; Mazuecos, Lorena; Villar, Margarita; Andres, Antonio; Gallardo, Nilda] Univ Castilla La Mancha, Fac Sci & Chem Technol, Biochem Sect, Reg Ctr Biomed Res CRIB, Avda Camilo Jose Cela 10, Ciudad Real 13071, Spain.
   [Pintado, Cristina; Molto, Eduardo] Univ Castilla La Mancha, Fac Environm Sci & Biochem, Biochem Sect, Reg Ctr Biomed Res CRIB, Avda. Carlos III S-N, Toledo 45071, Spain.
   [Villar, Margarita] SaBio, Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ronda Toledo S-N, Ciudad Real 13005, Spain.
   [Bonzon-Kulichenko, Elena; Vazquez, Jesus] Ctr Nacl Invest Cardiovasc Carlos III, Cardiovascular Prote Lab, Madrid 28029, Spain.
   [Bonzon-Kulichenko, Elena; Vazquez, Jesus] CIBER Enfermedades Cardiovasc CIBERCV, Madrid 28029, Spain.
C3 Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Investigacion en Recursos Cinegeticos (IREC); Universidad de
   Castilla-La Mancha; Centro Nacional de Investigaciones Cardiovasculares
   (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV
RP Villar, M; Gallardo, N (corresponding author), Univ Castilla La Mancha, Fac Sci & Chem Technol, Biochem Sect, Reg Ctr Biomed Res CRIB, Avda Camilo Jose Cela 10, Ciudad Real 13071, Spain.; Villar, M (corresponding author), SaBio, Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ronda Toledo S-N, Ciudad Real 13005, Spain.
EM brenda.barcena@alu.uclm.es; aurora.Salamanca@alu.uclm.es;
   cristina.pintado@uclm.es; lorena.mazuecos@uclm.es;
   margaritam.villar@uclm.es; eduardo.molto@uclm.es; ebonzon@cnic.es;
   jvazquez@cnic.es; antonio.andres@uclm.es; nilda.gallardo@uclm.es
RI Pintado Losa, Cristina/GVR-7935-2022; Gallardo, Nilda/AAR-3104-2021;
   ANDRES, ANTONIO/G-8794-2015; Villar-Rayo, Marga/J-4155-2012; Pintado
   Losa, Cristina/H-5641-2015; Losa, Cristina Pintado/Q-4887-2019;
   Mazuecos, Lorena/GRX-9532-2022
OI Pintado Losa, Cristina/0000-0002-9369-8318; Gallardo,
   Nilda/0000-0003-3211-569X; ANDRES, ANTONIO/0000-0002-9892-8338;
   Villar-Rayo, Marga/0000-0003-4172-9079; Pintado Losa,
   Cristina/0000-0002-9369-8318; Mazuecos, Lorena/0000-0002-7897-1304
FU Ministerio de Ciencia, Innovacion y Universidades, Spain
   [RTI2018-098643-B-I00]; European Regional Development Fund
   (MCIU/AEI/FEDER, UE); Institutional Aids [GI20174021, 2019-GRIN-26992]
FX This work was supported by Research Grant RTI2018-098643-B-I00 from
   Ministerio de Ciencia, Innovacion y Universidades, Spain, co-financed by
   the European Regional Development Fund (MCIU/AEI/FEDER, UE) and by
   Institutional Aids GI20174021 and 2019-GRIN-26992 (UCLM).
CR Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017
   Akaike Y, 2014, MOL CELL BIOL, V34, P2857, DOI 10.1128/MCB.00333-14
   Albano E, 2005, GUT, V54, P987, DOI 10.1136/gut.2004.057968
   Arrigo T, 2015, WORLD J GASTROENTERO, V21, P384, DOI 10.3748/wjg.v21.i2.384
   Bangru S, 2018, NAT STRUCT MOL BIOL, V25, P928, DOI 10.1038/s41594-018-0129-2
   Baumeier C, 2015, BBA-MOL CELL BIOL L, V1851, P566, DOI 10.1016/j.bbalip.2015.01.013
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Bonzon-Kulichenko E, 2015, J PROTEOME RES, V14, P700, DOI 10.1021/pr5007284
   Bonzon-Kulichenko E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003335
   Borbás T, 2006, EUR J PHARM SCI, V28, P51, DOI 10.1016/j.ejps.2005.12.011
   Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603
   Chang ET, 2016, ONCOTARGET, V7, P10578, DOI 10.18632/oncotarget.7020
   Cote GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041099
   de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057
   del Río-Moreno M, 2019, J CLIN ENDOCR METAB, V104, P3389, DOI 10.1210/jc.2019-00021
   Drinda S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112601
   Ezquerro S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39942
   Falcón-Pérez JM, 2010, PROTEOM CLIN APPL, V4, P407, DOI 10.1002/prca.200900123
   Fernández A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081865
   Fernando DH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205037
   Fontana GA, 2017, NUCLEIC ACIDS RES, V45, P902, DOI 10.1093/nar/gkw780
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Gallardo N, 2007, ENDOCRINOLOGY, V148, P5604, DOI 10.1210/en.2007-0933
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   García-Marqués F, 2016, MOL CELL PROTEOMICS, V15, P1740, DOI 10.1074/mcp.M115.055905
   Gems D, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00212
   Genter MB, 2006, BIOCHEM BIOPH RES CO, V342, P1375, DOI 10.1016/j.bbrc.2006.02.121
   Höhn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Horrillo D, 2013, J BIOL REG HOMEOS AG, V27, P377
   Horrillo Daniel, 2011, Archives of Physiology and Biochemistry, V117, P140, DOI 10.3109/13813455.2011.577435
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Ito F, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8030072
   Jin JL, 2016, CELL REP, V16, P744, DOI 10.1016/j.celrep.2016.06.019
   Kodiha Mohamed, 2012, J Signal Transduct, V2012, P208650, DOI 10.1155/2012/208650
   Korovila I, 2017, REDOX BIOL, V13, P550, DOI 10.1016/j.redox.2017.07.008
   Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008
   Lee S, 2017, ONCOTARGET, V8, P63370, DOI 10.18632/oncotarget.18812
   Liu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000093
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Martínez-Bartolomé S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200
   Maya-Mendoza A, 2005, MECH AGEING DEV, V126, P767, DOI 10.1016/j.mad.2005.01.011
   Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Narce M, 2012, CURR DRUG METAB, V13, P1454, DOI 10.2174/138920012803762693
   Navarro P, 2014, J PROTEOME RES, V13, P1234, DOI 10.1021/pr4006958
   Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h
   Oarada M, 2013, J NUTR BIOCHEM, V24, P1314, DOI 10.1016/j.jnutbio.2012.10.006
   Park EC, 2012, INT J MOL SCI, V13, P17230, DOI 10.3390/ijms131217230
   PORTA EA, 1982, MECH AGEING DEV, V18, P159, DOI 10.1016/0047-6374(82)90085-9
   Romero-Bueno R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070664
   Rudraiah S, 2014, TOXICOLOGY, V325, P85, DOI 10.1016/j.tox.2014.08.013
   Salamanca A, 2015, EXP GERONTOL, V69, P9, DOI 10.1016/j.exger.2015.05.009
   Santoro A, 2021, AGEING RES REV, V71, DOI 10.1016/j.arr.2021.101422
   Sen S, 2015, HEPATOLOGY, V61, P171, DOI 10.1002/hep.27380
   Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652
   Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377
   Sorensen M, 2006, FREE RADICAL RES, V40, P339, DOI 10.1080/10715760500250182
   Stankovic M, 2013, GEN PHYSIOL BIOPHYS, V32, P277, DOI 10.4149/gpb_2013027
   Steinhauser ML, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121434
   van Koppen A, 2018, CELL MOL GASTROENTER, V5, P83, DOI 10.1016/j.jcmgh.2017.10.001
   Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570
   Wang HL, 2019, HEPATOL INT, V13, P454, DOI 10.1007/s12072-019-09950-7
   Wang JK, 2017, CELL METAB, V25, P102, DOI 10.1016/j.cmet.2016.10.003
   Wasselin T, 2014, PROTEOMICS, V14, P1905, DOI 10.1002/pmic.201400051
   Webster NJG, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00133
   Whitton H, 2018, AGING CELL, V17, DOI 10.1111/acel.12742
   Wu P, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.613213
   Yorke A, 2017, J GERONTOL A-BIOL, V72, P897, DOI 10.1093/gerona/glw339
   Yu DS, 2018, J CELL PHYSIOL, V233, P4770, DOI 10.1002/jcp.26270
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
   Zhang Y, 2013, SCI CHINA LIFE SCI, V56, P513, DOI 10.1007/s11427-013-4488-y
   Zheng X, 2020, INT J BIOL SCI, V16, P2442, DOI 10.7150/ijbs.46751
NR 78
TC 10
Z9 11
U1 0
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD OCT
PY 2021
VL 10
IS 10
AR 1535
DI 10.3390/antiox10101535
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA WO3XJ
UT WOS:000712390800001
PM 34679670
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Cavaliere, G
   Catapano, A
   Trinchese, G
   Cimmino, F
   Menale, C
   Petrella, L
   Mollica, MP
AF Cavaliere, Gina
   Catapano, Angela
   Trinchese, Giovanna
   Cimmino, Fabiano
   Menale, Ciro
   Petrella, Lidia
   Mollica, Maria Pina
TI Crosstalk between Adipose Tissue and Hepatic Mitochondria in the
   Development of the Inflammation and Liver Injury during Ageing in
   High-Fat Diet Fed Rats
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE inflammation; adipose tissue; liver diseases; mitochondrial function;
   adipocyte size
ID METABOLIC SYNDROME; OXIDATIVE STRESS; HUMAN OBESITY; ADIPONECTIN;
   DYSFUNCTION; MECHANISM; EXPRESSION; BALANCE; LEPTIN; STATE
AB Obesity is considered an epidemic disorder, due to an imbalance between energy consumption and metabolizable energy intake. This balance is increasingly disrupted during normal aging processes due to the progressive impairment of mechanisms that normally control energy homeostasis. Obesity is triggered by an excessive lipid depots but reflects systemic inflammation along with large adipocytes secreting proinflammatory adipokines, an increase of the free fatty acids levels in the bloodstream, and ectopic lipid accumulation. Hepatic fat accumulation is the most common cause of chronic liver disease, characterized by mitochondrial dysfunction with a consequent impaired fat metabolism and increased oxidative stress. Therefore, mitochondrial dysfunction is associated to hepatic lipid accumulation and related complications. In this study, we assessed the crosstalk between adipose tissue and liver, analyzing the time-course of changes in hepatic mitochondrial fatty acid oxidation capacity versus fatty acid storage, focusing on the contribution of adipose tissue inflammation to hepatic lipid accumulation, using a rodent model of high fat diet-induced obesity. Our results demonstrate that both high-fat diet-induced obesity and aging induce dysregulation of adipose tissue function and similar metabolic alterations mediated by mitochondrial function impairment and altered inflammatory profile. The high fat diet-induced obesity anticipates and exacerbates liver mitochondrial dysfunction that occurs with aging processes.
C1 [Cavaliere, Gina] Univ Perugia, Dept Pharmaceut Sci, I-06126 Perugia, Italy.
   [Cavaliere, Gina; Catapano, Angela; Cimmino, Fabiano; Mollica, Maria Pina] Complesso Univ Monte Sant Angelo, Ctr Servizi Metrol & Tecnol Avanzati CeSMA, Via Cinthia 21, I-80126 Naples, Italy.
   [Catapano, Angela; Trinchese, Giovanna; Cimmino, Fabiano; Petrella, Lidia; Mollica, Maria Pina] Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy.
   [Menale, Ciro] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy.
   [Mollica, Maria Pina] Univ Naples Federico II, Task Force Microbiome Studies, I-80138 Naples, Italy.
C3 University of Perugia; University of Naples Federico II; University of
   Naples Federico II; University of Naples Federico II
RP Mollica, MP (corresponding author), Complesso Univ Monte Sant Angelo, Ctr Servizi Metrol & Tecnol Avanzati CeSMA, Via Cinthia 21, I-80126 Naples, Italy.; Mollica, MP (corresponding author), Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy.; Mollica, MP (corresponding author), Univ Naples Federico II, Task Force Microbiome Studies, I-80138 Naples, Italy.
EM mariapia.mollica@unina.it
RI Catapano, Angela/GXV-0918-2022; Menale, Ciro/J-2855-2014
OI Catapano, Angela/0000-0002-0429-8348; Menale, Ciro/0000-0001-5782-2089;
   Cavaliere, Gina/0000-0001-5890-1002; Petrella,
   Lidia/0000-0002-5084-5760; CIMMINO, FABIANO/0000-0001-5239-4329;
   TRINCHESE, Giovanna/0000-0002-4096-6876
CR ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564
   Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Azzu V, 2020, GASTROENTEROLOGY, V158, P1899, DOI 10.1053/j.gastro.2019.12.054
   Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x
   Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253
   Cairns CB, 1998, AM J PHYSIOL-REG I, V274, pR1376, DOI 10.1152/ajpregu.1998.274.5.R1376
   Cavaliere G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00818
   Cavaliere G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149033
   Chakraborti CK, 2015, WORLD J DIABETES, V6, P1296, DOI 10.4239/wjd.v6.i15.1296
   Cimmino F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22062862
   Degawa-Yamauchi M, 2005, OBES RES, V13, P662, DOI 10.1038/oby.2005.74
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   FLOHE L, 1984, METHOD ENZYMOL, V105, P93
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gan LX, 2015, FRONT MED-PRC, V9, P275, DOI 10.1007/s11684-015-0410-2
   Hausladen A, 1996, METHOD ENZYMOL, V269, P37
   Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853
   Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107
   Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458
   Hukshorn CJ, 2004, J CLIN ENDOCR METAB, V89, P1773, DOI 10.1210/jc.2003-030803
   Iossa S, 2000, BRIT J NUTR, V84, P377
   Johannsen DL, 2012, J CLIN ENDOCR METAB, V97, P242, DOI 10.1210/jc.2011-1798
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Li XR, 2020, P NATL ACAD SCI USA, V117, P32584, DOI 10.1073/pnas.1922169117
   Lin XH, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.706978
   Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010
   Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753
   López-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053
   Lu H, 2009, J CLIN NEUROSCI, V16, P684, DOI 10.1016/j.jocn.2008.04.021
   Luo HQ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08899-9
   Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029
   Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868
   Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924
   MONTOLIU C, 1994, J NEUROCHEM, V63, P1855
   Oda N, 2008, METABOLISM, V57, P268, DOI 10.1016/j.metabol.2007.09.011
   Ou MY, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04752-6
   Petrescu M, 2022, MEDICINA-LITHUANIA, V58, DOI 10.3390/medicina58050641
   Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x
   Roberts SB, 1998, AM J CLIN NUTR, V68, p975S, DOI 10.1093/ajcn/68.4.975S
   Roberts SB, 2000, NUTR REV, V58, P91, DOI 10.1111/j.1753-4887.2000.tb07538.x
   Salvestrini V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00266
   Schutz Y, 2004, INT J OBESITY, V28, pS3, DOI 10.1038/sj.ijo.0802852
   Shimizu I, 2015, INT HEART J, V56, P255, DOI 10.1536/ihj.14-401
   SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P
   Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055
   Taticchi A, 2019, MOLECULES, V24, DOI 10.3390/molecules24244523
   Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008
   Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trinchese G, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01969
   Trinchese G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00032
   Vegiopoulos A, 2017, EMBO J, V36, P1999, DOI 10.15252/embj.201696206
   Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006
   Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256
   Wang JX, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.892719
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Wilson MMG, 2003, J APPL PHYSIOL, V95, P1728, DOI 10.1152/japplphysiol.00313.2003
   Xu ZJ, 2010, DIGEST DIS SCI, V55, P931, DOI 10.1007/s10620-009-0815-3
NR 62
TC 1
Z9 1
U1 4
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB
PY 2023
VL 24
IS 3
AR 2967
DI 10.3390/ijms24032967
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 8V1SL
UT WOS:000930418400001
PM 36769289
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gupta, S
AF Gupta, S
TI Hepatic polyploidy and liver growth control
SO SEMINARS IN CANCER BIOLOGY
LA English
DT Article
DE polyploidy; liver; regeneration; cancer
ID EVANS CINNAMON RATS; SMOOTH-MUSCLE CELLS; IN-VIVO; HEPATOCYTE
   PROLIFERATION; TRANSGENIC MICE; HEPATOCELLULAR-CARCINOMA; TRANSPLANTED
   HEPATOCYTES; PARTIAL-HEPATECTOMY; TUMOR SUPPRESSION; THYROID-HORMONE
AB The onset of cellular polyploidy is recognized in all differ entiated mammalian tissntes. Polyploidy has been noted frequently in the normal liver as well as in pathophysiological states of the liver As insights into the significance of polyploidy accumulate gradually it is becoming clear that cells belonging to high ploidy classes exhibit advancement toward terminal differentiation and cellular senescence with greater probabilities of apoptosis. Involvement of specific genetic abnormalities, such as impaired DNA repair, may lead to hepatocellular polyploidy Working models indicate that extensive polyploidy could lead to organ failure, as well as to oncogenesis with activation of precancerous cell clones. (C) 2000 Academic Press.
C1 Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Comprehens Canc Res Ctr, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Gen Clin Res Ctr, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine
RP Gupta, S (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Ullmann 625,1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM sanjvgupta@pol.net
FU NIDDK NIH HHS [R01 DK46952, P30 DK41296] Funding Source: Medline
CR Aardema MJ, 1998, MUTAT RES-REV MUTAT, V410, P3, DOI 10.1016/S1383-5742(97)00029-X
   ALISON MR, 1985, BIOL EPITHELIAL CELL
   BARBASON H, 1974, CELL TISSUE KINET, V7, P319, DOI 10.1111/j.1365-2184.1974.tb00414.x
   Bellamy COC, 1997, FASEB J, V11, P591, DOI 10.1096/fasebj.11.7.9212083
   BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BIESTERFELD S, 1994, J CLIN PATHOL, V47, P38, DOI 10.1136/jcp.47.1.38
   BILLINGSLEY PF, 1989, ANN TROP MED PARASIT, V83, P93, DOI 10.1080/00034983.1989.11812316
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   Carriere R, 1969, Int Rev Cytol, V25, P201, DOI 10.1016/S0074-7696(08)60204-1
   Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822
   CRUISE JL, 1989, J CELL PHYSIOL, V140, P195, DOI 10.1002/jcp.1041400202
   DALLMAN PR, 1974, J NUTR, V104, P1234, DOI 10.1093/jn/104.10.1234
   Díez-Fernández C, 1998, BRIT J PHARMACOL, V125, P102, DOI 10.1038/sj.bjp.0702014
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DUMM CLAG, 1971, VIRCHOWS ARCH B, V8, P179
   ELDEIRY WS, 1994, CANCER RES, V54, P1169
   ENESCO HE, 1991, MECH AGEING DEV, V59, P69, DOI 10.1016/0047-6374(91)90074-A
   Fausto Nelson, 1994, P1501
   FujikawaYamamoto K, 1997, CELL STRUCT FUNCT, V22, P399, DOI 10.1247/csf.22.399
   Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251
   GERBER MA, 1983, AM J PATHOL, V110, P70
   GERLYNG P, 1992, CARCINOGENESIS, V13, P1795, DOI 10.1093/carcin/13.10.1795
   GRISHAM JW, 1962, CANCER RES, V22, P842
   Guha C, 1999, CANCER RES, V59, P5871
   Gupta S, 1999, AM J PHYSIOL-GASTR L, V276, pG629, DOI 10.1152/ajpgi.1999.276.3.G629
   GUPTA S, 2000, IN PRESS J PATHOL
   HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3
   HARMAN D, 1989, ADV EXP MED BIOL, V266, P3
   Hieter P, 1999, SCIENCE, V285, P210, DOI 10.1126/science.285.5425.210
   HIRAOKA H, 1990, JPN J EXP MED, V60, P31
   HOUCK KA, 1998, J CELL PHYSL, V135, P551
   HYTIROGLOU P, 1995, HEPATOLOGY, V21, P703, DOI 10.1002/hep.1840210316
   KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634
   Kao CY, 1996, BIOCHEM BIOPH RES CO, V222, P64, DOI 10.1006/bbrc.1996.0698
   Kato J, 1996, J CLIN INVEST, V98, P923, DOI 10.1172/JCI118875
   KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   Lalwani ND, 1997, TOXICOL PATHOL, V25, P165, DOI 10.1177/019262339702500206
   Li Q, 1999, MOL CELL BIOL, V19, P5339
   MADRA S, 1995, CARCINOGENESIS, V16, P719, DOI 10.1093/carcin/16.4.719
   Malhi H, 1999, HEPATOLOGY, V30, p254A
   MARCEAU N, 1982, IN VITRO CELL DEV B, V18, P1
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   MELCHIORRI C, 1993, CARCINOGENESIS, V14, P1825, DOI 10.1093/carcin/14.9.1825
   MICHALOPOULOS G, 1982, CANCER RES, V42, P4673
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mignon A, 1998, NAT MED, V4, P1185, DOI 10.1038/2681
   Miller RT, 1996, TOXICOL APPL PHARM, V138, P317, DOI 10.1006/taap.1996.0130
   MORSELT AFW, 1976, BEITR PATHOL, V159, P195
   NADAL C, 1966, EXP CELL RES, V42, P99, DOI 10.1016/0014-4827(66)90324-7
   NAKANISHI K, 1983, BASIC APPL HISTOCHEM, V27, P9
   Nakatani T, 1997, EXP CELL RES, V236, P137, DOI 10.1006/excr.1997.3715
   Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603
   Oren R, 1999, HEPATOLOGY, V30, P903, DOI 10.1002/hep.510300418
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Petersen J, 1998, P NATL ACAD SCI USA, V95, P310, DOI 10.1073/pnas.95.1.310
   POST J, 1960, ARCH PATHOL, V70, P314
   POST J, 1965, EXP CELL RES, V40, P333, DOI 10.1016/0014-4827(65)90266-1
   PRINTSEVA OY, 1992, AM J HYPERTENS, V5, pS118, DOI 10.1093/ajh/5.6.118S
   PRINTSEVA OY, 1989, EXP CELL RES, V184, P342, DOI 10.1016/0014-4827(89)90333-9
   Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669
   Rajvanshi P, 1998, EXP CELL RES, V244, P405, DOI 10.1006/excr.1998.4223
   REID R, 1984, AM J OBSTET GYNECOL, V150, P189, DOI 10.1016/S0002-9378(84)80015-0
   RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734
   Schilsky ML, 1998, LAB ANIM SCI, V48, P156
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SELL S, 1994, MODERN PATHOL, V7, P105
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x
   SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   SIMPSON GEC, 1963, J PATHOL BACTERIOL, V86, P361, DOI 10.1002/path.1700860211
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   SOLOPAEV BP, 1980, B EXP BIOL MED+, V90, P1442, DOI 10.1007/BF00838830
   TAMURA J, 1992, J SURG RES, V53, P218, DOI 10.1016/0022-4804(92)90038-2
   Terada K, 1999, PEDIATR INT, V41, P414, DOI 10.1046/j.1442-200x.1999.01089.x
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   THOGEIRSSON SS, 1993, AM J PATHOL, V142, P1331
   Toraason M, 1999, TOXICOLOGY, V138, P43, DOI 10.1016/S0300-483X(99)00083-9
   Torres S, 1999, AM J PHYSIOL-GASTR L, V276, pG155, DOI 10.1152/ajpgi.1999.276.1.G155
   VIOLAMAGNI MP, 1972, J MICROSC-OXFORD, V96, P191, DOI 10.1111/j.1365-2818.1972.tb04656.x
   VONWANGENHEIM KH, 1995, INT J RADIAT BIOL, V68, P369, DOI 10.1080/09553009514551321
   Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034
   WEBBER EM, 1994, AM J PATHOL, V145, P398
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   WHITE JW, 1985, J NUTR, V115, P271, DOI 10.1093/jn/115.2.271
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   Yin L, 1998, HEPATOLOGY, V27, P73, DOI 10.1002/hep.510270113
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 95
TC 197
Z9 223
U1 0
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-579X
EI 1096-3650
J9 SEMIN CANCER BIOL
JI Semin. Cancer Biol.
PD JUN
PY 2000
VL 10
IS 3
BP 161
EP 171
PG 11
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 336WF
UT WOS:000088325400002
PM 10936066
DA 2024-02-19
ER

PT J
AU Ghosh, PM
   Shu, ZJ
   Zhu, B
   Lu, ZD
   Ikeno, YJ
   Barnes, JL
   Yeh, CK
   Zhang, BX
   Katz, MS
   Kamat, A
AF Ghosh, Paramita M.
   Shu, Zhen-Ju
   Zhu, Bing
   Lu, Zhongding
   Ikeno, Yuji
   Barnes, Jeffrey L.
   Yeh, Chih-Ko
   Zhang, Bin-Xian
   Katz, Michael S.
   Kamat, Amrita
TI Role of β-adrenergic receptors in regulation of hepatic fat accumulation
   during aging
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID ISOLATED RAT HEPATOCYTES; LIVER-DISEASE; MYOCARDIAL-INFARCTION;
   METABOLIC SYNDROME; ADENYLATE-CYCLASE; FISCHER-344 RATS; ADIPOSE-TISSUE;
   AGE; EXPRESSION; ADRENOCEPTOR
AB Excessive fat accumulation in liver (hepatic steatosis) predisposes to hepatic functional and structural impairment and overall metabolic risk. Previous studies noted an association between hepatic steatosis and age in humans and rodents. However, the mechanisms leading to age-associated hepatic fat accumulation remain unknown. Earlier work from our group showed that beta-adrenergic receptor (beta-AR) levels and beta-AR-stimulated adenylyl cyclase activity increase in rat liver during aging. Herewe investigated whether age-associated increases in beta-AR signaling play a role in augmenting hepatic lipid accumulation. We demonstrate an increase in hepatic lipid content during senescence and a significant correlation between hepatic fat content and stimulation of adenylyl cyclase activity by the beta-AR agonist isoproterenol in rat liver. Isoproterenol administration to young and old rodents in vivo increased hepatic lipid accumulation. Furthermore, in vitro overexpression of b1-and b2-AR subtypes in hepatocytes from young rodents increased cellular lipid content, whereas inhibition of beta-ARs by receptor subtype-specific inhibitors reduced lipid levels in hepatocytes from senescent animals. Isoproterenol-induced hepatic lipid accumulation in vivo was prevented by the beta-AR nonselective blocker propranolol, suggesting a novel therapeutic effect of this class of drugs in hepatic steatosis. Acipimox, which inhibits adipose tissue lipolysis, did not alter isoproterenolmediated hepatic fat accumulation; thus beta-AR responsive hepatic lipid accumulation does not appear to be related primarily to altered lipolysis. These findings suggest that augmented hepatic beta-AR signaling during aging may increase lipid accumulation in liver and advocate a possible role for beta-adrenergic blockers in preventing or retarding the development of hepatic steatosis. Journal of Endocrinology (2012) 213, 251-261
C1 [Ghosh, Paramita M.; Yeh, Chih-Ko; Zhang, Bin-Xian; Katz, Michael S.; Kamat, Amrita] S Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr 182, San Antonio, TX 78229 USA.
   [Shu, Zhen-Ju; Barnes, Jeffrey L.; Zhang, Bin-Xian; Katz, Michael S.; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Zhu, Bing; Lu, Zhongding; Yeh, Chih-Ko; Katz, Michael S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, San Antonio, TX 78229 USA.
   [Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.
   [Ikeno, Yuji; Yeh, Chih-Ko; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy
   Memorial Veterans Hospital; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Kamat, A (corresponding author), S Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr 182, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.
EM kamat@uthscsa.edu
OI Yeh, Chih-Ko/0000-0001-6611-9942
FU Department of Veterans Affairs VISN 17; American Heart Association;
   Kronos Longevity Research Institute
FX Grant sponsor: Department of Veterans Affairs VISN 17 award to A K;
   grant sponsor: American Heart Association grant in aid to A K; and grant
   sponsor: Kronos Longevity Research Institute award to M S K.
CR Aarsland A, 1996, ANN SURG, V223, P777, DOI 10.1097/00000658-199606000-00016
   Ahrén B, 2001, ACTA PHYSIOL SCAND, V171, P161, DOI 10.1046/j.1365-201x.2001.00794.x
   ALSHURBAJI A, 1990, SCAND J CLIN LAB INV, V50, P203, DOI 10.3109/00365519009089155
   ARNER P, 1990, J CLIN ENDOCR METAB, V71, P1119, DOI 10.1210/jcem-71-5-1119
   Aronow Wilbert S, 2007, Cardiol Rev, V15, P195, DOI 10.1097/CRD.0b013e3180301b69
   BJORNSSON OG, 1994, EUR J CLIN INVEST, V24, P137, DOI 10.1111/j.1365-2362.1994.tb00979.x
   Cardani R, 2001, HISTOCHEM CELL BIOL, V116, P441, DOI 10.1007/s00418-001-0340-8
   Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   DEIBERT DC, 1980, J CLIN INVEST, V65, P717, DOI 10.1172/JCI109718
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Dowman JK, 2011, DIABETES OBES METAB, V13, P692, DOI 10.1111/j.1463-1326.2011.01403.x
   Enns LC, 2009, J GERONTOL A-BIOL, V64, P1221, DOI 10.1093/gerona/glp133
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   GETTYS TW, 1995, ENDOCRINOLOGY, V136, P2022, DOI 10.1210/en.136.5.2022
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   GREGERMAN RI, 1994, J GERONTOL, V49, pB135, DOI 10.1093/geronj/49.4.B135
   Gruenewald D. A., 2003, PRINCIPLES GERIATRIC, P819
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Jin W, 2010, J RECEPT SIG TRANSD, V30, P24, DOI 10.3109/10799890903358206
   Kamat A, 2004, 86 ANN M END SOC
   Kamat A, 2008, J GERONTOL A-BIOL, V63, P683, DOI 10.1093/gerona/63.7.683
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482
   KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191
   LONNQVIST F, 1990, J CLIN INVEST, V85, P1614, DOI 10.1172/JCI114612
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   Morio B, 2002, ANN SURG, V236, P218, DOI 10.1097/00000658-200208000-00010
   Muscogiuri G, 2011, ENDOCR RES, V36, P74, DOI 10.3109/07435800.2010.539993
   Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   PITTNER RA, 1985, BIOCHEM J, V225, P455, DOI 10.1042/bj2250455
   Rasouli M, 2006, EUR J PHARMACOL, V545, P109, DOI 10.1016/j.ejphar.2006.06.066
   Rigazio S, 2008, AM J PHYSIOL-ENDOC M, V295, pE413, DOI 10.1152/ajpendo.00744.2007
   RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714
   Sanchez-Hidalgo M, 2007, AM J PHYSIOL-REG I, V292, pR2208, DOI 10.1152/ajpregu.00013.2007
   SANGHANI MP, 1994, J GERONTOL, V49, pB60, DOI 10.1093/geronj/49.2.B60
   Sanguino E, 2004, EXP GERONTOL, V39, P1295, DOI 10.1016/j.exger.2004.06.007
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   Sepe A, 2011, GERONTOLOGY, V57, P66, DOI 10.1159/000279755
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   VANERMEN A, 1992, MOL PHARMACOL, V42, P649
   WEXLER BC, 1983, BRIT J EXP PATHOL, V64, P124
   WEXLER BC, 1978, ATHEROSCLEROSIS, V29, P373, DOI 10.1016/0021-9150(78)90084-9
   Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104
   Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335
   Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009
NR 53
TC 54
Z9 59
U1 0
U2 6
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0022-0795
EI 1479-6805
J9 J ENDOCRINOL
JI J. Endocrinol.
PD JUN
PY 2012
VL 213
IS 3
BP 251
EP 261
DI 10.1530/JOE-11-0406
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 946PZ
UT WOS:000304366600006
PM 22457517
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Vilà, L
   Roglans, N
   Alegret, M
   Camins, A
   Pallàs, M
   Sánchez, RM
   Vázquez-Carrera, M
   Laguna, JC
AF Vila, Laia
   Roglans, Nuria
   Alegret, Marta
   Camins, Antoni
   Pallas, Merce
   Sanchez, Rosa Maria
   Vazquez-Carrera, Manuel
   Laguna, Juan Carlos
TI Hypertriglyceridemia and hepatic steatosis in senescence-accelerated
   mouse associate to changes in lipid-related gene expression
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTOR; SPRAGUE-DAWLEY RATS; LIPOPROTEIN
   METABOLISM; FATTY-ACIDS; PPAR-ALPHA; BILE-ACID; KAPPA-B; AGE;
   TRANSCRIPTION; TRIGLYCERIDE
AB Aged rodents show increasing plasma and tissue triglycerides, and reductions in liver peroxisome proliferator-activated receptor alpha (PPAR alpha) and its target genes. We determined whether a similar situation is present in a model of accelerated aging, the senescence-accelerated prone (SAM-P8) mouse. Five-month-old SAM-P8 mice were hypertriglyceridemic, and exhibited hepatic steatosis and reduced fatty acid oxidation versus control 5-month-old senescence-accelerated resistant (SAM-R1) mice, with no differences in PPAR alpha expression and binding activity; in fact, fenofibrate administration to SAM-P8 mice induced a clear PPAR alpha-driven response. Complementary DNA (cDNA) microarray analysis (Affymetrix Mouse Genome 430A 2.0 GeneChip array), Western blot, and electrophoretic mobility shift assay (EMSA) experiments indicated, among other changes, a deficit in farnesoid X receptor (FXR) expression and binding activity in the livers of SAM -P8 mice with respect to SAM-R1 controls. Triglyceride accretion and a deficit in hepatic fatty acid oxidation, features of the aging process in mammals, associate to a deficit in hepatic FXR activity in the SAM-P8 mice.
C1 Univ Barcelona, Inst Biomed, Barcelona, Spain.
   Univ Barcelona, Sch Pharm, Pharmacol Unit, Dept Pharmacol & Therapeut Chem, Barcelona, Spain.
C3 University of Barcelona; University of Barcelona
RP Laguna, JC (corresponding author), Unitat Farmacol, Fac Farm, Avda Diagonal 643, Glassboro, NJ 08028 USA.
EM jclagunae@ub.edu
RI Camins, Antonio/J-5126-2019; Vilà, Laia/ABG-8595-2020; Alegret,
   Marta/C-5086-2017; Roglans, Núria/ABH-1242-2020; Vázquez-Carrera,
   Manuel/H-2612-2015; Pallàs, Mercè/H-3129-2016; Laguna, JCLaguna - Juan
   C./C-5481-2017
OI Camins, Antonio/0000-0002-1229-5956; Alegret, Marta/0000-0002-5652-8651;
   Vázquez-Carrera, Manuel/0000-0001-7138-8207; Pallàs,
   Mercè/0000-0003-3095-4254; Laguna, JCLaguna - Juan
   C./0000-0002-7082-0704; Roglans, Nuria/0000-0002-5018-021X; Vila,
   Laia/0000-0001-7232-2250
CR Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4
   ALEGRET M, 1994, BRIT J PHARMACOL, V112, P551, DOI 10.1111/j.1476-5381.1994.tb13109.x
   Anisfeld AM, 2003, J BIOL CHEM, V278, P20420, DOI 10.1074/jbc.M302505200
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brasaemle DL, 1997, J LIPID RES, V38, P2249
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Corti MC, 1997, CURR OPIN LIPIDOL, V8, P236, DOI 10.1097/00041433-199708000-00008
   Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   GEBEL T, 1992, FEBS LETT, V309, P37, DOI 10.1016/0014-5793(92)80734-X
   GRABIELY I, 2002, DIABETES, V51, P1016
   GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012
   Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049
   Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158
   Kassam A, 2000, J BIOL CHEM, V275, P4345, DOI 10.1074/jbc.275.6.4345
   Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7
   Mahley RW, 1999, J LIPID RES, V40, P1
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Ren SL, 2004, HEPATOLOGY, V40, P910, DOI 10.1002/hep.20382
   Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232
   Román J, 2000, J BIOL CHEM, V275, P14684, DOI 10.1074/jbc.275.19.14684
   Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260
   Sanguino E, 2005, EXP GERONTOL, V40, P588, DOI 10.1016/j.exger.2005.05.006
   Sanguino E, 2004, EXP GERONTOL, V39, P1295, DOI 10.1016/j.exger.2004.06.007
   Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104
NR 34
TC 11
Z9 11
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2007
VL 62
IS 11
BP 1219
EP 1227
DI 10.1093/gerona/62.11.1219
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 272AH
UT WOS:000253829300005
PM 18000141
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Roskams, T
AF Roskams, Tania
TI Relationships Among Stellate Cell Activation, Progenitor Cells, and
   Hepatic Regeneration
SO CLINICS IN LIVER DISEASE
LA English
DT Article
DE Hepatic stellate cells; Liver progenitor cells; Hepatic progenitor
   cells; Liver stem cell niche; Liver progenitor cell niche; Hepatic
   regeneration
ID HEPATOCYTE STEM-CELLS; LIVER-REGENERATION; RAT-LIVER; DUCTULAR
   REACTIONS; EXPRESSION; PROTEIN; MOUSE; SENESCENCE; DISEASES; BIOLOGY
AB Hepatic stellate cells (HSC) play an important role in liver fibrogenesis. They are also key players in liver regeneration as part of the stem cell niche of hepatocytes and hepatic progenitor cells. They produce growth stimulating and inhibiting factors for these epithelial cell compartments. In addition, recent studies suggest a role for HSCs themselves for being progenitors of epithelial cells through a transitional mesenchymal phase.
C1 Univ Leuven, Dept Morphol & Mol Pathol, Head Liver Res Unit, B-3000 Leuven, Belgium.
C3 KU Leuven
RP Roskams, T (corresponding author), Univ Leuven, Dept Morphol & Mol Pathol, Head Liver Res Unit, Minderbroederstr 12, B-3000 Leuven, Belgium.
EM tania.roskams@uz.kuleuven.ac.be
OI Roskams, Tania/0000-0002-2816-1530
CR Alison M, 1998, J HEPATOL, V29, P676, DOI 10.1016/S0168-8278(98)80165-7
   Alison MR, 1996, GASTROENTEROLOGY, V110, P1182, DOI 10.1053/gast.1996.v110.pm8613008
   Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4
   Cassiman D, 2002, J HEPATOL, V37, P527, DOI 10.1016/S0168-8278(02)00263-5
   Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793
   Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   FUJIO K, 1994, LAB INVEST, V70, P511
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Gressner Olav A, 2007, Comp Hepatol, V6, P7, DOI 10.1186/1476-5926-6-7
   HALL PA, 1989, J PATHOL, V158, P275, DOI 10.1002/path.1711580402
   Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486
   Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x
   Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Libbrecht L, 2000, J PATHOL, V192, P373, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH700&gt;3.0.CO;2-5
   Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8
   Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232
   Overturf K, 1998, HUM GENE THER, V9, P295, DOI 10.1089/hum.1998.9.3-295
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   PERUGORRIA MJ, 2008, HEPATOLOGY IN PRESS
   Ros JE, 2003, J PATHOL, V200, P553, DOI 10.1002/path.1379
   Ros JE, 2003, GUT, V52, P1060, DOI 10.1136/gut.52.7.1060
   Roskams T, 2006, J HEPATOL, V45, P1, DOI 10.1016/j.jhep.2006.05.002
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Roskams T, 2003, J HEPATOL, V39, P431, DOI 10.1016/S0168-8278(03)00333-7
   Roskams T, 1998, SEMIN DIAGN PATHOL, V15, P259
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Roskams TA, 2003, SEMIN LIVER DIS, V23, P385
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Theise ND, 2007, GASTROENTEROLOGY, V133, P350, DOI 10.1053/j.gastro.2007.05.040
   Thorgeirsson SS, 2006, HEPATOLOGY, V43, P2, DOI 10.1002/hep.21015
   Vander Borght S, 2006, J HISTOCHEM CYTOCHEM, V54, P1051, DOI 10.1369/jhc.5A6912.2006
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WILSON JW, 1958, J PATHOL BACTERIOL, V76, P441, DOI 10.1002/path.1700760213
   Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   Yin L, 1999, J HEPATOL, V31, P497, DOI 10.1016/S0168-8278(99)80043-9
   Yin L, 2002, HISTOL HISTOPATHOL, V17, P65, DOI 10.14670/HH-17.65
   YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425
NR 45
TC 46
Z9 58
U1 0
U2 14
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1089-3261
EI 1557-8224
J9 CLIN LIVER DIS
JI Clin. Liver Dis.
PD NOV
PY 2008
VL 12
IS 4
BP 853
EP +
DI 10.1016/j.cld.2008.07.014
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 437LF
UT WOS:000265488300009
PM 18984470
DA 2024-02-19
ER

PT J
AU Wan, Y
   McDaniel, K
   Wu, N
   Ramos-Lorenzo, S
   Glaser, T
   Venter, J
   Francis, H
   Kennedy, L
   Sato, K
   Zhou, TH
   Kyritsi, K
   Huang, QB
   Annable, T
   Wu, CD
   Glaser, S
   Alpini, G
   Mengi, FY
AF Wan, Ying
   McDaniel, Kelly
   Wu, Nan
   Ramos-Lorenzo, Sugeily
   Glaser, Trenton
   Venter, Julie
   Francis, Heather
   Kennedy, Lindsey
   Sato, Keisaku
   Zhou, Tianhao
   Kyritsi, Konstantina
   Huang, Qiaobing
   Annable, Tami
   Wu, Chaodong
   Glaser, Shannon
   Alpini, Gianfranco
   Mengi, Fanyin
TI Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID DISEASE PATHOGENESIS; HEPATIC-FIBROSIS; STELLATE CELLS; MICE;
   MICRORNA-34A; EXPRESSION; ACTIVATION; PATHWAYS; PROMOTES; AXIS
AB Alcoholic liver disease remains a major cause of liver-related morbidity and mortality, which ranges from alcoholic steatohepatitis to fibrosis/cirrhosis and hepatocellular carcinoma, and the related mechanisms are understood poorly. In this study, we aimed to investigate the role of miR-34a in alcohol-induced cellular senescence and liver fibrosis. We found that hepatic miR-34a expression was upregulated in ethanol-fed mice and heavy drinkers with steatohepatitis compared with respective controls. Mice treated with miR-34a Vivo-Morpholino developed less severe Liver fibrosis than wild-type mice after 5 weeks of ethanol feeding. Further mechanism exploration showed that inhibition of miR-34a increased cellular senescence of hepatic stellate cells (HSCs) in ethanol-fed mice, although it decreased senescence in total liver and hepatocytes, which was verified by the changes of senescence-associated beta-galactosidase and gene expression. Furthermore, enhanced cellular senescence was observed in liver tissues from steatohepatitis patients compared with healthy controls. In addition, the expression of transforming growth factor-beta 1, drosophila mothers against decapentaplegic protein 2 (Smad2), and Smad3 was decreased after inhibition of miR-34a in ethanol-fed mice. Our in vitro experiments showed that silencing of miR-34a partially blocked activation of HSCs by lipopolysaccharide and enhanced senescence of HSCs. Furthermore, inhibition of miR-34a decreased lipopolysaccharide-induced fibrotic gene expression in cultured hepatocytes. In conclusion, our data suggest that miR-34a functions as a profibrotic factor that promotes alcohol-induced Liver fibrosis by reducing HSC senescence and increasing the senescence of hepatocytes.
C1 [Wan, Ying; McDaniel, Kelly; Francis, Heather; Kennedy, Lindsey; Zhou, Tianhao; Glaser, Shannon; Alpini, Gianfranco; Mengi, Fanyin] Cent Texas Vet Healthcare Syst, Div Res, Temple, TX USA.
   [Wan, Ying; McDaniel, Kelly; Ramos-Lorenzo, Sugeily; Glaser, Trenton; Francis, Heather; Annable, Tami; Glaser, Shannon; Alpini, Gianfranco; Mengi, Fanyin] Baylor Scott & White Healthcare, Baylor Scott & White Hlth Digest Dis Res Ctr, Temple, TX USA.
   [Wan, Ying; McDaniel, Kelly; Wu, Nan; Venter, Julie; Francis, Heather; Kennedy, Lindsey; Sato, Keisaku; Zhou, Tianhao; Kyritsi, Konstantina; Glaser, Shannon; Alpini, Gianfranco; Mengi, Fanyin] Texas A&M Univ, Coll Med, Hlth Sci Ctr, Dept Internal Med, Temple, TX 76508 USA.
   [Wan, Ying] Southwest Med Univ, Dept Pathophysiol, Luzhou, Peoples R China.
   [Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Key Lab Shock & Microcirculat Res Guangdong Prov, Guangzhou, Guangdong, Peoples R China.
   [Annable, Tami] Temple Hlth & Biosci Dist, Temple, TX USA.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA.
C3 Baylor Health Care System; Texas A&M University System; Texas A&M
   University College Station; Texas A&M Health Science Center; Southwest
   Medical University; Southern Medical University - China; Texas A&M
   University System; Texas A&M University College Station
RP Alpini, G; Mengi, FY (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Med, Div Res, 1901 S 1st St,Bldg 205, Temple, TX 76504 USA.; Alpini, G; Mengi, FY (corresponding author), Texas A&M Hlth Sci Ctr, Baylor Scott & White Hlth, Cent Texas Vet Hlth Care Syst, Baylor Scott & White Digest Dis Res Ctr,Coll Med, 1901 S 1st St,Bldg 205, Temple, TX 76504 USA.
EM galpini@medicine.tamhsc.edu; fmeng@medicine.tamhsc.edu
RI Zhou, Tianhao/AAO-3542-2021
OI Zhou, Tianhao/0000-0002-5722-6954; Mcdaniel, Kelly/0000-0003-4328-8844
FU Veterans Affairs Merit Award [1101BX001724, 5101BX000574]; Dr. Nicholas
   C. Hightower Centennial Chair of Gastroenterology from Baylor Scott
   White; Veterans Affairs Research Career Scientist Award; VA Merit Award
   [5101BX002192]; NIH [DK058411, DK076898, DK107310, DK062975,
   RO1DK108959]; US Department of Veteran's Affairs, Biomedical Laboratory
   Research and Development Service [1101BX003031]; Southern California
   Research Center for ALPD and Cirrhosis [P50AA011999]
FX Supported by Veterans Affairs Merit Award 1101BX001724 (F.M.), the Dr.
   Nicholas C. Hightower Centennial Chair of Gastroenterology from Baylor
   Scott & White (G.A.), a Veterans Affairs Research Career Scientist Award
   (G.A.), Veterans Affairs Merit award 5101BX000574 (G.A.), VA Merit Award
   5101BX002192 (S.G.), NIH grants DK058411, DK076898, DK107310, DK062975
   (G.A., F.M., and S.G.), and RO1DK108959 (H.F.), Veterans Affairs Merit
   Award 1101BX003031 from the US Department of Veteran's Affairs,
   Biomedical Laboratory Research and Development Service, and the Southern
   California Research Center for ALPD and Cirrhosis grant P50AA011999.
CR Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Badi I, 2015, J GERONTOL A-BIOL, V70, P1304, DOI 10.1093/gerona/glu180
   Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Cui HC, 2017, AM J RESP CELL MOL, V56, P168, DOI 10.1165/rcmb.2016-0163OC
   Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957
   Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x
   Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Ge XD, 2014, HEPATOLOGY, V59, P1600, DOI 10.1002/hep.26931
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656
   He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672
   Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Huang Y, 2014, EXPERT OPIN THER TAR, V18, P1355, DOI 10.1517/14728222.2014.961424
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li XF, 2015, MOL MED REP, V11, P1017, DOI 10.3892/mmr.2014.2846
   Liu H, 2015, EXP MOL PATHOL, V99, P552, DOI 10.1016/j.yexmp.2015.09.005
   Lv HT, 2010, MOL BIOSYST, V6, P2056, DOI 10.1039/c0mb00064g
   Matsumoto H, 2002, ALCOHOL CLIN EXP RES, V26, p6S, DOI 10.1097/01.ALC.0000026827.79925.C9
   McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223
   Oda Y, 2014, BIOCHEM PHARMACOL, V90, P179, DOI 10.1016/j.bcp.2014.05.002
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rokavec M, 2014, J MOL CELL BIOL, V6, P214, DOI 10.1093/jmcb/mju003
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Shetty SK, 2017, AM J PATHOL, V187, P1016, DOI 10.1016/j.ajpath.2016.12.020
   Simone BA, 2014, INT J RADIAT ONCOL, V90, P44, DOI 10.1016/j.ijrobp.2014.05.003
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tian XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158657
   Tsukamoto Hide, 2008, V447, P33, DOI 10.1007/978-1-59745-242-7_3
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Xiong S, 2008, AM J PHYSIOL-GASTR L, V295, pG512, DOI 10.1152/ajpgi.90327.2008
   Xu XS, 2015, ONCOTARGET, V6, P3988, DOI 10.18632/oncotarget.2905
   Yan GL, 2015, MED SCI MONITOR, V21, P3008, DOI 10.12659/MSM.894000
   Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154
   Zhang FY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0187-x
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
   Zhou H, 2016, HEPATOLOGY, V64, P1978, DOI 10.1002/hep.28811
NR 49
TC 54
Z9 56
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD DEC
PY 2017
VL 187
IS 12
BP 2788
EP 2798
DI 10.1016/j.ajpath.2017.08.027
PG 11
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA FO6WF
UT WOS:000417009100014
PM 29128099
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Singh, BK
   Tripathi, M
   Sandireddy, R
   Tikno, K
   Zhou, J
   Yen, PM
AF Singh, Brijesh Kumar
   Tripathi, Madhulika
   Sandireddy, Reddemma
   Tikno, Keziah
   Zhou, Jin
   Yen, Paul Michael
TI Decreased autophagy and fuel switching occur in a senescent hepatic cell
   model system
SO AGING-US
LA English
DT Article
DE aging; liver; senescence; metabolism; AML12 cells
AB Although aging in the liver contributes to the development of chronic liver diseases such as NAFLD and insulin resistance, little is known about the molecular and metabolic details of aging in hepatic cells. To examine these issues, we used sequential oxidative stress with hydrogen peroxide to induce premature senescence in AML12 hepatic cells. The senescent cells exhibited molecular and metabolic signatures, increased SA-beta Gal and gamma H2A.X staining, and elevated senescence and pro-inflammatory gene expression that resembled livers from aged mice. Metabolic phenotyping showed fuel switching towards glycolysis and mitochondrial glutamine oxidation as well as impaired energy production. The senescent AML12 cells also had increased mTOR signaling and decreased autophagy which likely contributed to the fuel switching from beta-oxidation that occurred in normal AML12 cells. Additionally, senescence-associated secretory phenotype (SASP) proteins from conditioned media of senescent cells sensitized normal AML12 cells to palmitate-induced toxicity, a known pathological effect of hepatic aging. In summary, we have generated senescent AML12 cells which displayed the molecular hallmarks of aging and also exhibited the aberrant metabolic phenotype, mitochondrial function, and cell signaling that occur in the aged liver.
C1 [Singh, Brijesh Kumar; Tripathi, Madhulika; Sandireddy, Reddemma; Tikno, Keziah; Zhou, Jin; Yen, Paul Michael] Duke NUS Med Sch, Cardiovasc & Metab Disorders Program, Singapore 169857, Singapore.
   [Yen, Paul Michael] Duke Univ, Sch Med, Durham, NC 27710 USA.
C3 National University of Singapore; Duke University
RP Singh, BK (corresponding author), Duke NUS Med Sch, Cardiovasc & Metab Disorders Program, Singapore 169857, Singapore.
EM singhbrijeshk@duke-nus.edu.sg
RI Yen, Paul M/V-9857-2019; Singh, Brijesh Kumar/C-1093-2009
OI Singh, Brijesh Kumar/0000-0003-4615-3988
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507
   Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29
   Haas BJ., 2017, STAR FUSION FAST ACC, DOI DOI 10.1101/120295
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111
NR 12
TC 11
Z9 11
U1 0
U2 14
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL 31
PY 2020
VL 12
IS 14
BP 13958
EP 13978
DI 10.18632/aging.103740
PG 21
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA MY8LU
UT WOS:000558669300011
PM 32712601
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhou, XH
   Tan, BW
   Gui, WW
   Zhou, CP
   Zhao, HX
   Lin, XH
   Li, H
AF Zhou, Xiaohai
   Tan, Bowen
   Gui, Weiwei
   Zhou, Caiping
   Zhao, Hanxin
   Lin, Xihua
   Li, Hong
TI IGF2 deficiency promotes liver aging through mitochondrial dysfunction
   and upregulated CEBPB signaling in <sc>d</sc>-galactose-induced aging
   mice
SO MOLECULAR MEDICINE
LA English
DT Article
DE IGF2; Liver; Aging; Mitochondria dysfunction; CEBPB
ID GROWTH-FACTOR 2; INSULIN; SENESCENCE; NEUROPROTECTION; CANCER; GENE
AB Background Liver aging, marked by cellular senescence and low-grade inflammation, heightens susceptibility to chronic liver disease and worsens its prognosis. Insulin-like growth factor 2 (IGF2) has been implicated in numerous aging-related diseases. Nevertheless, its role and underlying molecular mechanisms in liver aging remain largely unexplored.Methods The expression of IGF2 was examined in the liver of young (2-4 months), middle-aged (9-12 months), and old (24-26 months) C57BL/6 mice. In vivo, we used transgenic IGF2f/f; Alb-Cre mice and d-galactose-induced aging model to explore the role of IGF2 in liver aging. In vitro, we used specific short hairpin RNA against IGF2 to knock down IGF2 in AML12 cells. d-galactose and hydrogen peroxide treatment were used to induce AML12 cell senescence.Results We observed a significant reduction of IGF2 levels in the livers of aged mice. Subsequently, we demonstrated that IGF2 deficiency promoted senescence phenotypes and senescence-associated secretory phenotypes (SASPs), both in vitro and in vivo aging models. Moreover, IGF2 deficiency impaired mitochondrial function, reducing mitochondrial respiratory capacity, mitochondrial membrane potential, and nicotinamide adenine dinucleotide (NAD)+/NADH ratio, increasing intracellular and mitochondrial reactive oxygen species levels, and disrupting mitochondrial membrane structure. Additionally, IGF2 deficiency markedly upregulated CCAAT/enhancer-binding protein beta (CEBPB). Notably, inhibiting CEBPB reversed the senescence phenotypes and reduced SASPs induced by IGF2 deficiency.Conclusions In summary, our findings strongly suggest that IGF2 deficiency promotes liver aging through mitochondrial dysfunction and upregulated CEBPB signaling. These results provide compelling evidence for considering IGF2 as a potential target for interventions aimed at slowing down the process of liver aging.
C1 [Zhou, Xiaohai; Tan, Bowen; Gui, Weiwei; Zhou, Caiping; Zhao, Hanxin; Lin, Xihua; Li, Hong] Zhejiang Univ, Affiliated Sir Run Run Shaw Hosp, Sch Med, Dept Endocrinol, Hangzhou, Peoples R China.
C3 Zhejiang University
RP Lin, XH; Li, H (corresponding author), Zhejiang Univ, Affiliated Sir Run Run Shaw Hosp, Sch Med, Dept Endocrinol, Hangzhou, Peoples R China.
EM linxihua@zju.edu.cn; srrshnfm@zju.edu.cn
FU Innovative Research Group Project of the National Natural Science
   Foundation of China
FX Not applicable.
CR Adamek A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051308
   Ajmera V, 2017, HEPATOLOGY, V65, P65, DOI 10.1002/hep.28776
   Anerillas C, 2020, GEROSCIENCE, V42, P397, DOI 10.1007/s11357-020-00183-3
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Azman KF, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111372
   Barakat DJ, 2015, ONCOGENE, V34, P5912, DOI 10.1038/onc.2015.41
   Beletskiy A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041849
   Bergman D, 2013, GERONTOLOGY, V59, P240, DOI 10.1159/000343995
   Boggs K, 2007, J BIOL CHEM, V282, P7982, DOI 10.1074/jbc.M611675200
   Cai YS, 2022, SCI CHINA LIFE SCI, V65, P2354, DOI 10.1007/s11427-022-2161-3
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Castilla-Cortázar I, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-103
   Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005
   Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667
   Garcia-Fernandez M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-123
   García-Huerta P, 2020, ACTA NEUROPATHOL, V140, P737, DOI 10.1007/s00401-020-02183-1
   Gui WW, 2021, J MOL CELL BIOL, V13, P543, DOI 10.1093/jmcb/mjab030
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Kumar D, 2022, ADV SCI, V9, DOI 10.1002/advs.202105120
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09
   Liu JL, 2017, HEPATOLOGY, V66, P2002, DOI 10.1002/hep.29340
   Maeso-Diaz Raquel, 2020, Semin Liver Dis, V40, P373, DOI 10.1055/s-0040-1715446
   Martín-Montañez E, 2017, REDOX BIOL, V13, P69, DOI 10.1016/j.redox.2017.05.012
   Martín-Montañez E, 2021, REDOX BIOL, V46, DOI 10.1016/j.redox.2021.102095
   Martin-Montañez E, 2014, BBA-MOL BASIS DIS, V1842, P1041, DOI 10.1016/j.bbadis.2014.03.010
   Martini H, 2023, FEBS J, V290, P1186, DOI 10.1111/febs.16361
   Miwa S, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158447
   Muhammad Tahir, 2020, Aging (Albany NY), V13, P2118, DOI 10.18632/aging.202214
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536
   Rotwein P, 1991, Growth Factors, V5, P3, DOI 10.3109/08977199109000267
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Salotti J, 2019, EXP GERONTOL, V128, DOI 10.1016/j.exger.2019.110752
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sélénou C, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11121886
   Steinmetz AB, 2016, NEUROBIOL AGING, V44, P9, DOI 10.1016/j.neurobiolaging.2016.04.006
   Tang H, 2022, CELL SIGNAL, V94, DOI 10.1016/j.cellsig.2022.110327
   Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019
   van der Krieken SE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/324815
   VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0
   Wang XF, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb7389
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Yang QL, 2020, FREE RADICAL BIO MED, V156, P1, DOI 10.1016/j.freeradbiomed.2020.05.003
   Zhu YY, 2021, CLIN SCI, V135, P979, DOI 10.1042/CS20210128
NR 45
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1076-1551
EI 1528-3658
J9 MOL MED
JI Mol. Med.
PD NOV 28
PY 2023
VL 29
IS 1
AR 161
DI 10.1186/s10020-023-00752-0
PG 18
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA Z2OM8
UT WOS:001110522400001
PM 38017373
OA gold
DA 2024-02-19
ER

PT J
AU Wakabayashi, H
   Nishiyama, Y
   Ushiyama, T
   Maeba, T
   Maeta, H
AF Wakabayashi, H
   Nishiyama, Y
   Ushiyama, T
   Maeba, T
   Maeta, H
TI Evaluation of the effect of age on functioning hepatocyte mass and liver
   blood flow using liver scintigraphy in preoperative estimations for
   surgical patients: Comparison with CT volumetry
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE 99mTc-GSA; aging; liver volume; functioning hepatocyte mass; liver blood
   flow
ID PORTAL-VEIN EMBOLIZATION; RAT-LIVER; HEPATECTOMY; RESECTION; RECEPTOR;
   BINDING; SAFE; SIZE
AB Background. The effect of age on functioning hepatocyte mass and liver blood flow was examined using Tc-99m-galactosyl-human serum albumin (GSA) liver scintigraphy in patients with liver tumors awaiting surgery.
   Materials and methods. Seventy-two patients with liver tumors, but normal liver parenchyma, were included in this study; patients with compromised hepatic blood flow as a result of vascular invasion or thrombus were excluded. The liver volume, calculated liver volume, and liver blood flow index (K value) were preoperatively determined by liver scintigraphy using GSA. These three parameters and liver volume measured by computed tomography volumetry (CT-LV) and the standard liver volume (ST-LV), calculated from the patient's body surface area, were examined for correlations with the patient's age. The K value was compared with the indocyanine green dye retention rate, and both sets of results were examined for correlation with the patient's age.
   Results. Both the CT-LV and the ST-LV decreased with age, resulting in an unchanged CT-LV/ST-LV ratio with aging. The liver volume and calculated liver volume measured by scintigraphy both decreased with age, even when body size was taken into account. Therefore, in elderly patients, the liver was not morphologically smaller, but the hepatocyte mass in the liver decreased. Furthermore, liver blood flow per unit of functional liver volume determined from the blood flow index did not change with age.
   Conclusions. These results, suggesting a discrepancy between liver volume estimated by CT and actual functioning hepatocyte volume in the elderly, may have a critical impact on preoperative liver functional reserve evaluation prior to hepatic resection in elderly patients. (C) 2002 Elsevier Science (USA).
C1 Takamatsu Natl Hosp, Dept Surg, Kagawa 7610193, Japan.
   Kagawa Med Univ, Dept Radiol, Kagawa, Japan.
   Kagawa Med Univ, Dept Surg 1, Kagawa, Japan.
C3 Kagawa University; Kagawa University
RP Wakabayashi, H (corresponding author), Takamatsu Natl Hosp, Dept Surg, Kagawa 7610193, Japan.
CR deBaere T, 1996, HEPATOLOGY, V24, P1386, DOI 10.1002/hep.510240612
   FONG Y, 1995, ANN SURG, V222, P426
   Fukui A, 2000, ANN NUCL MED, V14, P467, DOI 10.1007/BF02988293
   Fukunaga K, 1999, INT SURG, V84, P199
   GALLI G, 1988, J NUCL MED ALLIED S, V32, P117
   HAKAWA SK, 1991, J NUCL MED, V32, P2233
   IMAMURA H, 1991, HEPATOLOGY, V14, P448, DOI 10.1002/hep.1840140308
   Kiuchi Takaaki, 1994, Nippon Acta Radiologica, V54, P1018
   Kwon AH, 2001, AM J GASTROENTEROL, V96, P541
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LINDNER J, 1997, LIVER AGING, P23
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   MATSUI Y, 1994, J GASTROEN HEPATOL, V9, P613, DOI 10.1111/j.1440-1746.1994.tb01570.x
   Miki K, 2001, J NUCL MED, V42, P733
   OKAMOTO E, 1984, SURGERY, V95, P586
   SATO T, 1975, ACTA PATHOL JAPON, V25, P403
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   TAKENAKA K, 1994, ARCH SURG-CHICAGO, V129, P846
   Tanabe M, 1989, Ann Nucl Med, V3, P25
   URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5
   Vauthey JN, 2000, SURGERY, V127, P512, DOI 10.1067/msy.2000.105294
   VERA DR, 1984, J NUCL MED, V25, P779
   Wakabayashi H, 1997, SURG TODAY, V27, P403, DOI 10.1007/BF02385702
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 26
TC 65
Z9 72
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD AUG
PY 2002
VL 106
IS 2
BP 246
EP 253
DI 10.1006/jsre.2002.6462
PG 8
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA 592BY
UT WOS:000177917900004
PM 12175974
DA 2024-02-19
ER

PT J
AU Ishigami, A
   Masutomi, H
   Handa, S
   Maruyama, N
AF Ishigami, Akihito
   Masutomi, Hirofumi
   Handa, Setsuko
   Maruyama, Naoki
TI Age-associated decrease of senescence marker protein-30/gluconolactonase
   in individual mouse liver cells: Immunohistochemistry and
   immunofluorescence
SO GERIATRICS & GERONTOLOGY INTERNATIONAL
LA English
DT Article
DE aging; gluconolactonase; hepatocyte; nuclear localization signals;
   senescence marker protein-30
ID SMP30/GNL KNOCKOUT MICE; VITAMIN-C DEPLETION; PROTEIN-30 SMP30;
   HEPATOCYTES; DEFICIENCY; EXPRESSION; SECRETION; PROMOTER; SCURVY; ACTIN
AB AimSenescence marker protein-30 (SMP30)/gluconolactonase (GNL) is an age-associated protein in that its presence decreases with aging. Here, we used immunohistochemical analysis to investigate the changes of SMP30/GNL in individual cells of the liver from progressively aged mice.
   MethodsMale C57BL/6 strain mice at 1, 3, 6, 12, 24 and 30 months-of-age were the source of hepatic cells used to detect SMP30/GNL. Liver sections from these mice were subjected to immunohistochemical staining with anti-SMP30/GNL antibody. For immunofluorescent staining, primary cultured hepatocytes from mice at various ages were stained with SMP30/GNL and albumin.
   ResultsIn liver cells from mice of all ages, SMP30/GNL staining appeared in some but not all parenchymal cells, and localized in both the nuclei and cytoplasm. Moreover, SMP30/GNL-positive staining of parenchymal cells was present only around central vein areas, but not at sites of portal veins. Furthermore, the number of SMP30/GNL-positive cells increased as mice aged from 1 to 12 months, then decreased from the 12th to 24th month. Results were similar in primary cultured hepatocytes from mice of various ages.
   ConclusionsSMP30/GNL-positive cells localized mainly around the central veins in the livers of mice and decreased numerically with aging, although there was no age-related change in counts of albumin-positive cells. SMP30/GNL protein occupied the nuclei and cytoplasm. Therefore, nuclear SMP30/GNL protein might be a regulatory factor specific for genes whose expression governs transcription and the aging process. Geriatr Gerontol Int 2015; 15: 804-810.
C1 [Ishigami, Akihito; Masutomi, Hirofumi; Handa, Setsuko; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
OI Ishigami, Akihito/0000-0001-7875-7482
FU Japan Society for the Promotion of Science (JSPS) KAKENHI [24380073,
   23590441]; Grants-in-Aid for Scientific Research [15H04505, 15K15104]
   Funding Source: KAKEN
FX This study was supported by Japan Society for the Promotion of Science
   (JSPS) KAKENHI Grant Number 24380073 (A I) and 23590441 (N M). The
   authors thank Ms P Minick for the excellent English editorial
   assistance.
CR Aizawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053706
   Arai KY, 2009, BIOCHEM BIOPH RES CO, V385, P478, DOI 10.1016/j.bbrc.2009.05.104
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Inai Y, 2003, J NUTR SCI VITAMINOL, V49, P315, DOI 10.3177/jnsv.49.315
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Ishikawa Y, 2012, EXP EYE RES, V94, P85, DOI 10.1016/j.exer.2011.11.010
   Iwama M, 2012, J NUTR SCI VITAMINOL, V58, P169, DOI 10.3177/jnsv.58.169
   Kagami Y, 2013, BIOL PHARM BULL, V36, P2005, DOI 10.1248/bpb.b13-00309
   Koike K, 2010, AM J PHYSIOL-LUNG C, V298, pL784, DOI 10.1152/ajplung.00256.2009
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258
   PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268
   PRENTKI M, 1980, BIOCHIM BIOPHYS ACTA, V627, P262, DOI 10.1016/0304-4165(80)90456-0
   PROCHNIEWICZNAKAYAMA E, 1983, J CELL BIOL, V97, P1663, DOI 10.1083/jcb.97.6.1663
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Sato Y, 2012, J INVEST DERMATOL, V132, P2112, DOI 10.1038/jid.2012.105
   Supakar PC, 2000, BIOCHEM BIOPH RES CO, V272, P436, DOI 10.1006/bbrc.2000.2799
NR 29
TC 10
Z9 14
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-1586
EI 1447-0594
J9 GERIATR GERONTOL INT
JI Geriatr. Gerontol. Int.
PD JUN
PY 2015
VL 15
IS 6
BP 804
EP 810
DI 10.1111/ggi.12347
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CJ8EQ
UT WOS:000355733300017
PM 25311772
DA 2024-02-19
ER

PT J
AU Bonnet, L
   Alexandersson, I
   Baboota, RK
   Kroon, T
   Oscarsson, J
   Smith, U
   Boucher, J
AF Bonnet, Laurianne
   Alexandersson, Ida
   Baboota, Ritesh K. K.
   Kroon, Tobias
   Oscarsson, Jan
   Smith, Ulf
   Boucher, Jeremie
TI Cellular senescence in hepatocytes contributes to metabolic disturbances
   in NASH
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE senescence; NAFLD; NASH; hepatocytes; insulin signaling; metabolism
ID INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; LIVER; ACTIVATION;
   OXIDATION; PATHWAY; GENE; P53
AB Cellular senescence is a state of irreversible cell cycle arrest and has been shown to play a key role in many diseases, including metabolic diseases. To investigate the potential contribution of hepatocyte cellular senescence to the metabolic derangements associated with non-alcoholic steatohepatitis (NASH), we treated human hepatocyte cell lines HepG2 and IHH with the senescence-inducing drugs nutlin-3a, doxorubicin and etoposide. The senescence-associated markers p16, p21, p53 and beta galactosidase were induced upon drug treatment, and this was associated with increased lipid storage, increased expression of lipid transporters and the development of hepatic steatosis. Drug-induced senescence also led to increased glycogen content, and increased VLDL secretion from hepatocytes. Senescence was also associated with an increase in glucose and fatty acid oxidation capacity, while de novo lipogenesis was decreased. Surprisingly, cellular senescence caused an overall increase in insulin signaling in hepatocytes, with increased insulin-stimulated phosphorylation of IR, Akt, and MAPK. Together, these data indicate that hepatic senescence plays a causal role in the development of NASH pathogenesis, by modulating glucose and lipid metabolism, favoring steatosis. Our findings contribute to a better understanding of the mechanisms linking cellular senescence and fatty liver disease and support the development of new therapies targeting senescent cells for the treatment of NASH.
C1 [Bonnet, Laurianne; Kroon, Tobias; Boucher, Jeremie] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden.
   [Bonnet, Laurianne; Alexandersson, Ida; Baboota, Ritesh K. K.; Kroon, Tobias; Smith, Ulf; Boucher, Jeremie] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.
   [Alexandersson, Ida; Kroon, Tobias; Boucher, Jeremie] AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab CVRM, Biosci Metab Res & Early Dev, Gothenburg, Sweden.
   [Oscarsson, Jan] AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab CVRM, Late Stage Dev, Gothenburg, Sweden.
   [Boucher, Jeremie] Evotec Int GmbH, Metab Dis, Gottingen, Germany.
C3 University of Gothenburg; University of Gothenburg; AstraZeneca;
   AstraZeneca; Evotec
RP Boucher, J (corresponding author), Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden.; Boucher, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden.; Boucher, J (corresponding author), AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab CVRM, Biosci Metab Res & Early Dev, Gothenburg, Sweden.; Boucher, J (corresponding author), Evotec Int GmbH, Metab Dis, Gottingen, Germany.
OI Smith, Ulf/0000-0002-1439-4608; Bonnet, Laurianne/0009-0000-4399-7080
FU Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic
   Research; Wallenberg Centre for molecular and translational medicine,
   University of Gothenburg, Sweden
FX We acknowledge financial support from the Knut and Alice Wallenberg
   Foundation, the Swedish Foundation for Strategic Research, and the
   Wallenberg Centre for molecular and translational medicine, University
   of Gothenburg, Sweden. We thank Dr. Silvia Gogg, Dr. Birgit Gustafson
   and Annika Nerstedt from the Lundberg Laboratory for technical help. We
   thank Dr. Mathieu Cinato from Wallenberg laboratory for technical help.
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Baboota RK, 2022, MOL METAB, V64, DOI 10.1016/j.molmet.2022.101558
   Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cusi K, 2017, HEPATOLOGY, V65, P4, DOI 10.1002/hep.28839
   De Gottardi A, 2007, LAB INVEST, V87, P792, DOI 10.1038/labinvest.3700590
   Dharmalingam Mala, 2018, Indian J Endocrinol Metab, V22, P421, DOI 10.4103/ijem.IJEM_585_17
   Dufour J.-F., 2021, ENDOCR METAB SCI, V3, DOI DOI 10.1016/J.ENDMTS.2021.100089
   Engelmann C, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020652
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0
   Iozzo P, 2010, GASTROENTEROLOGY, V139, P846, DOI 10.1053/j.gastro.2010.05.039
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Li Q, 2021, NAT MED, V27, P1941, DOI 10.1038/s41591-021-01501-8
   Lo KA, 2013, CELL REP, V5, P259, DOI 10.1016/j.celrep.2013.08.039
   Lu QR, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.710420
   Marusic M, 2021, CAN J GASTROENTEROL, V2021, DOI 10.1155/2021/6613827
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Miele L, 2003, AM J GASTROENTEROL, V98, P2335, DOI 10.1111/j.1572-0241.2003.07725.x
   Nagano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31758
   Nagarajan SR, 2019, AM J PHYSIOL-ENDOC M, V316, pE578, DOI 10.1152/ajpendo.00365.2018
   Najjar SM, 2019, PHYSIOLOGY, V34, P198, DOI 10.1152/physiol.00048.2018
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Palmer AK, 2019, DIABETOLOGIA, V62, P1835, DOI 10.1007/s00125-019-4934-x
   Prattichizzo F, 2018, AGEING RES REV, V41, P1, DOI 10.1016/j.arr.2017.10.003
   Rines AK, 2016, NAT REV DRUG DISCOV, V15, P786, DOI 10.1038/nrd.2016.151
   Sen B, 2019, CELL MOL GASTROENTER, V8, P73, DOI 10.1016/j.jcmgh.2019.03.001
   Shen H, 2011, CURR PHARM DESIGN, V17, P560, DOI 10.2174/138161211795222603
   Stefan N, 2022, LANCET DIABETES ENDO, V10, P284, DOI 10.1016/S2213-8587(22)00003-1
   Targher G, 2021, NAT REV GASTRO HEPAT, V18, P599, DOI 10.1038/s41575-021-00448-y
   Tomah Shaheen, 2020, Clin Diabetes Endocrinol, V6, P9, DOI 10.1186/s40842-020-00097-1
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Zaharia OP, 2020, DIABETES CARE, V43, P2161, DOI 10.2337/dc20-0329
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
NR 43
TC 4
Z9 4
U1 1
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD AUG 22
PY 2022
VL 13
AR 957616
DI 10.3389/fendo.2022.957616
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 4N1KO
UT WOS:000853778000001
PM 36072934
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kim, IH
   Xu, J
   Liu, X
   Koyama, Y
   Ma, HY
   Diggle, K
   You, YH
   Schilling, JM
   Jeste, D
   Sharma, K
   Brenner, DA
   Kisseleva, T
AF Kim, In Hee
   Xu, Jun
   Liu, Xiao
   Koyama, Yukinori
   Ma, Hsiao-Yen
   Diggle, Karin
   You, Young-Hyun
   Schilling, Jan M.
   Jeste, Dilip
   Sharma, Kumar
   Brenner, David A.
   Kisseleva, Tatiana
TI Aging increases the susceptibility of hepatic inflammation, liver
   fibrosis and aging in response to high-fat diet in mice
SO AGE
LA English
DT Article
DE Aging; High-fat diet; Liver; Fibrosis
ID NONALCOHOLIC STEATOHEPATITIS; C57BL/6J MICE; RISK-FACTORS; DISEASE; AGE;
   PREVALENCE; EXPRESSION; ASSOCIATION; STEATOSIS
AB We aimed to investigate whether aging increases the susceptibility of hepatic and renal inflammation or fibrosis in response to high-fat diet (HFD) and explore the underlying genetic alterations. Middle (10 months old) and old (20 months old) aged, male C57BL/6N mice were fed either a low-fat diet (4 % fat) or HFD (60 % fat) for 4 months. Young (3 months old) aged mice were included as control group. HFD-induced liver and kidney injuries were analyzed by serum and urine assay, histologic staining, immunohistochemistry, and reverse-transcription real-time quantitative polymerase chain reaction. Total RNA sequencing with next-generation technology was done with RNA extracted from liver tissues. With HFD feeding, aged was associated with higher serum alanine aminotransferase levels, marked infiltration of hepatic macrophages, and increased expression of inflammatory cytokines (MCP1, TNF-alpha, IL-1 beta, IL-6, IL-12, IL-17A). Importantly, aged mice showed more advanced hepatic fibrosis and increased expression of fibrogenic markers (Col-I-alpha 1, alpha SMA, TGF-beta 1, TGF-beta 2, TGF beta RII, PDGF, PDGFR beta II, TIMP1) in response to HFD. Aged mice fed on HFD also showed increased oxidative stress and TLR4 expression. In the total RNA seq and gene ontology analysis of liver, old-aged HFD group showed significant up-regulation of genes linked to innate immune response, immune response, defense response, inflammatory response compared to middle-aged HFD group. Meanwhile, aging and HFD feeding showed significant increase in glomerular size and mesangial area, higher urine albumin/creatinine ratio, and advanced renal inflammation or fibrosis. However, the difference of HFD-induced renal injury between old-aged group and middle-aged group was not significant. The susceptibility of hepatic fibrosis as well as hepatic inflammation in response to HFD was significantly increased with aging. In addition, aging was associated with glomerular alterations and increased renal inflammation or fibrosis, while the differential effect of aging on HFD-induced renal injury was not remarkable as shown in the liver.
C1 [Kim, In Hee; Xu, Jun; Liu, Xiao; Koyama, Yukinori; Ma, Hsiao-Yen; Diggle, Karin; Sharma, Kumar; Brenner, David A.; Kisseleva, Tatiana] Univ Calif San Diego, Dept Med, Sch Med, 9500 Gilman Dr 0702, La Jolla, CA 92093 USA.
   [Kim, In Hee] Chonbuk Natl Univ, Dept Internal Med, Med Sch & Hosp, Jeonju, South Korea.
   [You, Young-Hyun] Univ Calif San Diego, Ctr Renal Translat Med, Div Nephrol Hypertens, La Jolla, CA 92093 USA.
   [Schilling, Jan M.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.
   [Jeste, Dilip] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.
   [Jeste, Dilip] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
   [Jeste, Dilip] Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA.
C3 University of California System; University of California San Diego;
   Jeonbuk National University; University of California System; University
   of California San Diego; University of California System; University of
   California San Diego; University of California System; University of
   California San Diego; University of California System; University of
   California San Diego; University of California System; University of
   California San Diego
RP Kisseleva, T (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, 9500 Gilman Dr 0702, La Jolla, CA 92093 USA.
EM tkisseleva@ucsd.edu
OI Brenner, David/0000-0003-2573-525X
FU GlaxoSmithKline Research Fund of the Korean Association
FX This research was supported by The GlaxoSmithKline Research Fund of the
   Korean Association for the study of the Liver (In Hee Kim).
CR Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/EGH.11.4, 10.1586/egh.11.4]
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bolignano D, 2014, AGEING RES REV, V14, P65, DOI 10.1016/j.arr.2014.02.003
   Brenner DA, 2011, HEPATOL RES, V41, P683, DOI 10.1111/j.1872-034X.2011.00814.x
   Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001
   Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Kisseleva T, 2014, HEPATOLOGY, V59, P1671, DOI 10.1002/hep.26955
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mahrouf-Yorgov M, 2011, REJUV RES, V14, P353, DOI 10.1089/rej.2010.1146
   Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   Paik Yong Han, 2011, Korean J Hepatol, V17, P251, DOI 10.3350/kjhep.2011.17.4.251
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   van der Heijden RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16474
   van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738
   WHO, 2011, GLOBAL HLTH AGING
   Wiggins JE, 2012, J GERONTOL A-BIOL, V67, P1358, DOI 10.1093/gerona/gls157
NR 35
TC 59
Z9 67
U1 1
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD AUG
PY 2016
VL 38
IS 4
BP 291
EP 302
DI 10.1007/s11357-016-9938-6
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DY8SJ
UT WOS:000385400700005
PM 27578257
OA Green Published
DA 2024-02-19
ER

PT J
AU Maeso-Díaz, R
   Ortega-Ribera, M
   Lafoz, E
   Lozano, JJ
   Baiges, A
   Francés, R
   Albillos, A
   Peralta, C
   García-Pagán, JC
   Bosch, J
   Cogger, VC
   Gracia-Sancho, J
AF Maeso-Diaz, Raquel
   Ortega-Ribera, Marti
   Lafoz, Erica
   Jose Lozano, Juan
   Baiges, Anna
   Frances, Ruben
   Albillos, Agustin
   Peralta, Carmen
   Carlos Garcia-Pagan, Juan
   Bosch, Jaime
   Cogger, Victoria C.
   Gracia-Sancho, Jordi
TI Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in
   Advanced Chronic Liver Disease
SO AGING AND DISEASE
LA English
DT Article
DE Cirrhosis; portal hypertension; hepatic sinusoid; elderly; liver
   microcirculation
ID SINUSOIDAL ENDOTHELIAL-CELLS; CIRRHOTIC RAT LIVERS; SIMVASTATIN; AGE;
   DYSFUNCTION; INJURY; PSEUDOCAPILLARIZATION; SUSCEPTIBILITY; PROGRESSION;
   ACTIVATION
AB Advanced chronic liver disease (aCLD) represents a major public health concern. aCLD is more prevalent and severe in the elderly, carrying a higher risk of decompensation. We aimed at understanding how aging may impact on the pathophysiology of aCLD in aged rats and humans and secondly, at evaluating simvastatin as a therapeutic option in aged animals. aCLD was induced in young (1 month) and old (16 months) rats. A subgroup of aCLD-old animals received simvastatin (5 mg/kg) or vehicle (PBS) for 15 days. Hepatic and systemic hemodynamic, liver cells phenotype and hepatic fibrosis were evaluated. Additionally, the gene expression signature of cirrhosis was evaluated in a cohort of young and aged cirrhotic patients. Aged animals developed a more severe form of aCLD. Portal hypertension and liver fibrosis were exacerbated as a consequence of profound deregulations in the phenotype of the main hepatic cells: hepatocytes presented more extensive cell-death and poorer function, LSEC were further capillarized, HSC over-activated and macrophage infiltration was significantly increased. The gene expression signature of cirrhosis significantly differed comparing young and aged patients, indicating alterations in sinusoidal-protective pathways and confirming the pre-clinical observations. Simvastatin administration for 15-day to aged cirrhotic rats improved the hepatic sinusoidal milieu, leading to significant amelioration in portal hypertension. This study provides evidence that aCLD pathobiology is different in aged individuals. As the median age of patients with aCLD is increasing, we propose a real-life pre-clinical model to develop more reliable therapeutic strategies. Simvastatin effects in this model further demonstrate its translational potential.
C1 [Maeso-Diaz, Raquel; Ortega-Ribera, Marti; Lafoz, Erica; Baiges, Anna; Carlos Garcia-Pagan, Juan; Bosch, Jaime; Gracia-Sancho, Jordi] Univ Barcelona, IDIBAPS Biomed Res Inst, Barcelona Hepat Hemodynam Lab, Liver Vasc Biol Res Grp,Med Sch, Barcelona, Spain.
   [Jose Lozano, Juan; Baiges, Anna; Frances, Ruben; Albillos, Agustin; Peralta, Carmen; Carlos Garcia-Pagan, Juan; Bosch, Jaime; Gracia-Sancho, Jordi] Biomed Res Network Ctr Hepat & Digest Dis CIBEREH, Madrid, Spain.
   [Frances, Ruben] ISABIAL Fdn FISABIO, Inst Invest Sanitaria & Biomed Alicante, Alicante, Spain.
   [Albillos, Agustin] Univ Alcala, Hosp Univ Ramon Y Cajal, Dept Gastroenterol & Hepatol, IRYCIS, Madrid, Spain.
   [Peralta, Carmen] IDIBAPS, Protect Strategies Hepat Ischemia Reperfus Grp, Barcelona, Spain.
   [Bosch, Jaime; Gracia-Sancho, Jordi] Bern Univ, Dept Biomed Res, Inselspital, Hepatol, Bern, Switzerland.
   [Cogger, Victoria C.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW, Australia.
   [Cogger, Victoria C.] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia.
   [Cogger, Victoria C.] Concord Hosp, Sydney, NSW, Australia.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; General
   University Hospital of Alicante; Universidad Miguel Hernandez de Elche;
   Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica
   de Alicante (ISABIAL); Hospital Universitario Ramon y Cajal; Universidad
   de Alcala; University of Barcelona; Hospital Clinic de Barcelona;
   IDIBAPS; University of Bern; University Hospital of Bern; University of
   Sydney; University of Sydney; ANZAC Research Institute; Concord
   Repatriation General Hospital
RP Gracia-Sancho, J (corresponding author), IDIBAPS, Liver Vasc Biol Res Grp IDIBAPS, Barcelona, Spain.
EM jordi.gracia@idibaps.org
RI Garcia-Pagan, Juan-Carlos/P-6291-2015; Research Institute,
   ANZAC/CAE-9030-2022; Bosch, Jaime/AAF-1006-2022; Francés,
   Rubén/V-4120-2019; Díaz, Raquel Maeso/K-4766-2015; Bosch,
   Jaime/AFF-8344-2022; Baiges, Anna/ABB-1848-2022; Lafoz,
   Erica/HTT-3130-2023; Ortega Ribera, Marti/K-9666-2015; Peralta,
   Carmen/M-8170-2014; Gracia-Sancho, Jordi/C-8920-2014
OI Garcia-Pagan, Juan-Carlos/0000-0001-9032-4954; Francés,
   Rubén/0000-0001-5105-1201; Díaz, Raquel Maeso/0000-0002-2448-0251;
   Baiges, Anna/0000-0002-6963-9203; Ortega Ribera,
   Marti/0000-0001-8647-7069; Peralta, Carmen/0000-0002-5767-0676;
   Gracia-Sancho, Jordi/0000-0001-7736-4089
CR Abraldes JG, 2007, J HEPATOL, V46, P1040, DOI 10.1016/j.jhep.2007.01.020
   Abraldes JG, 2016, GASTROENTEROLOGY, V150, P1160, DOI 10.1053/j.gastro.2016.01.004
   Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604
   Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005
   Bosch J, 2010, J HEPATOL, V53, P558, DOI 10.1016/j.jhep.2010.03.021
   Briones AM, 2009, HYPERTENSION, V54, P142, DOI 10.1161/HYPERTENSIONAHA.109.133710
   Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Fernández-Iglesias A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00007
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gracia-Sancho J, 2019, NAT REV GASTRO HEPAT, V16, P221, DOI 10.1038/s41575-018-0097-3
   Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166
   Gracia-Sancho J, 2007, GASTROENTEROLOGY, V133, P959, DOI 10.1053/j.gastro.2007.06.021
   Guixe-Muntet S, 2017, SCI REP, V7, P1
   He W., 2016, AGING WORLD 2015 INT
   Hide D, 2014, CLIN SCI, V127, P527, DOI 10.1042/CS20140125
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Mahrouf-Yorgov M, 2011, REJUV RES, V14, P353, DOI 10.1089/rej.2010.1146
   Marcellin P, 2018, LIVER INT, V38, P2, DOI 10.1111/liv.13682
   Marrone G, 2015, GUT, V64, P1434, DOI 10.1136/gutjnl-2014-308338
   Mitchell SJ, 2011, J GERONTOL A-BIOL, V66, P400, DOI 10.1093/gerona/glq221
   Moctezuma-Velazquez Carlos, 2018, Curr Treat Options Gastroenterol, V16, P226, DOI 10.1007/s11938-018-0180-4
   Mohanty A, 2016, GASTROENTEROLOGY, V150, P430, DOI 10.1053/j.gastro.2015.10.007
   Natori S, 2003, LIVER TRANSPLANT, V9, P278, DOI 10.1053/jlts.2003.50019
   Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rodríguez S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40461
   Russo L, 2012, HEPATOLOGY, V55, P921, DOI 10.1002/hep.24755
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673
   Tripathi DM, 2018, GASTROENTEROLOGY, V155, P1564, DOI 10.1053/j.gastro.2018.07.022
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Vilaseca M, 2017, LIVER INT, V37, P1002, DOI 10.1111/liv.13436
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   Yamazaki H, 2013, J HISTOCHEM CYTOCHEM, V61, P169, DOI 10.1369/0022155412468590
   Meireles CZ, 2017, SHOCK, V47, P370, DOI 10.1097/SHK.0000000000000734
NR 47
TC 27
Z9 29
U1 2
U2 8
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD AUG
PY 2019
VL 10
IS 4
BP 684
EP 698
DI 10.14336/AD.2019.0127
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA IN6BX
UT WOS:000478762200001
PM 31440376
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU McDaniel, K
   Meng, F
   Wu, N
   Sato, K
   Venter, J
   Bernuzzi, F
   Invernizzi, P
   Zhou, T
   Kyritsi, K
   Wan, Y
   Huang, Q
   Onori, P
   Francis, H
   Gaudio, E
   Glaser, S
   Alpini, G
AF McDaniel, Kelly
   Meng, Fanyin
   Wu, Nan
   Sato, Keisaku
   Venter, Julie
   Bernuzzi, Francesca
   Invernizzi, Pietro
   Zhou, Tianhao
   Kyritsi, Konstantina
   Wan, Ying
   Huang, Qiaobing
   Onori, Paolo
   Francis, Heather
   Gaudio, Eugenio
   Glaser, Shannon
   Alpini, Gianfranco
TI Forkhead Box A2 Regulates Biliary Heterogeneity and Senescence During
   Cholestatic Liver Injury in Mice
SO HEPATOLOGY
LA English
DT Article
ID GALLBLADDER EPITHELIAL-CELLS; HEPATOCYTE-LIKE CELLS;
   FUNCTIONAL-HETEROGENEITY; DIFFERENTIATION; CHOLANGIOCYTES; METHYLATION;
   CHOLANGITIS; EXPRESSION; ENDODERM; NICHE
AB Biliary-committed progenitor cells (small mouse cholangiocytes; SMCCs) from small bile ducts are more resistant to hepatobiliary injury than large mouse cholangiocytes (LGCCs) from large bile ducts. The definitive endoderm marker, forkhead box A2 (FoxA2), is the key transcriptional factor that regulates cell differentiation and tissue regeneration. Our aim was to characterize the translational role of FoxA2 during cholestatic liver injury. Messenger RNA expression in SMCCs and LGCCs was assessed by polymerase chain reaction (PCR) array analysis. Liver tissues and hepatic stellate cells (HSCs) from primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) patients were tested by real-time PCR for methylation, senescence, and fibrosis markers. Bile duct ligation (BDL) and multidrug resistance protein 2 (MDR2) knockout mice (MDR2(-/-)) were used as animal models of cholestatic liver injury with or without healthy transplanted large or small cholangiocytes. We demonstrated that FoxA2 was notably enhanced in murine liver progenitor cells and SMCCs and was silenced in human PSC and PBC liver tissues relative to respective controls that are correlated with the epigenetic methylation enzymes, DNA methyltransferase (DNMT) 1 and DNMT3B. Serum alanine aminotransferase and aspartate aminotransferase levels in nonobese diabetic/severe combined immunodeficiency mice engrafted with SMCCs post-BDL showed significant changes compared to vehicle-treated mice, along with improved liver fibrosis. Enhanced expression of FoxA2 was observed in BDL mouse liver after SMCC cell therapy. Furthermore, activation of fibrosis signaling pathways were observed in BDL/MDR2(-/)-mouse liver as well as in isolated HSCs by laser capture microdissection, and these signals were recovered along with reduced hepatic senescence and enhanced hepatic stellate cellular senescence after SMCC engraft. Conclusion: The definitive endoderm marker and the positive regulator of biliary development, FoxA2, mediates the therapeutic effect of biliary-committed progenitor cells during cholestatic liver injury.
C1 [McDaniel, Kelly; Meng, Fanyin; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Temple, TX USA.
   [Wu, Nan; Sato, Keisaku; Venter, Julie; Zhou, Tianhao; Kyritsi, Konstantina; Glaser, Shannon; Alpini, Gianfranco] Texas A&M HSC, Baylor Scott & White Hlth Digest Dis Res Ctr, Dept Med, Temple, TX USA.
   [Wu, Nan; Sato, Keisaku; Venter, Julie; Zhou, Tianhao; Kyritsi, Konstantina; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White Hlth, Temple, TX USA.
   [McDaniel, Kelly; Meng, Fanyin; Wan, Ying; Francis, Heather] Res Inst, Baylor Scott White Hlth, Temple, TX USA.
   [Bernuzzi, Francesca; Invernizzi, Pietro] Liver Unit & Ctr Autoimmune Liver Dis, Humanitas Clin & Res Ctr, Milan, Italy.
   [Wan, Ying; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Key Lab Shock & Microcirculat Res Guangdong Prov, Guangzhou, Peoples R China.
   [Onori, Paolo; Gaudio, Eugenio] Forens Med & Orthoped Sci, Dept Anat Histol, Rome, Italy.
C3 Baylor Health Care System; Texas A&M University System; Texas A&M
   University College Station; Texas A&M Health Science Center; Baylor
   Health Care System; Baylor Health Care System; Southern Medical
   University - China
RP Meng, F; Alpini, G (corresponding author), Cent Texas Vet Hlth Care Syst, Texas A&M Hlth Sci Ctr Coll Med, Baylor Scott & White Digest Dis Res Ctr, 1901 South 1st St, Bldg 205, Temple, TX 76504 USA.
EM fmeng@tamu.edu; galpini@tamu.edu
RI Onori, Paolo/J-9394-2013; Zhou, Tianhao/AAO-3542-2021; bernuzzi,
   francesca/AAQ-7073-2020; Invernizzi, Pietro/AAB-8367-2022
OI Onori, Paolo/0000-0002-7195-3760; Zhou, Tianhao/0000-0002-5722-6954; 
FU Central Texas Veterans Health Care System
FX We acknowledge Chandler Carroll in the Publications Office, Baylor Scott
   & White Health, for editing assistance. This material is the result of
   work supported by resources at the Central Texas Veterans Health Care
   System. The views expressed in this article are those of the authors and
   do not necessarily represent the views of the Department of Veterans
   Affairs.
CR Ader T, 2006, MECH DEVELOP, V123, P177, DOI 10.1016/j.mod.2005.10.003
   Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG289, DOI 10.1152/ajpgi.1997.272.2.G289
   Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073
   Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023
   Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Cardinale V, 2012, NAT REV GASTRO HEPAT, V9, P231, DOI 10.1038/nrgastro.2012.23
   Christodoulou C, 2011, J CLIN INVEST, V121, P2313, DOI 10.1172/JCI43853
   Fu SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027965
   Glaser S, 2010, AM J PHYSIOL-GASTR L, V299, pG769, DOI 10.1152/ajpgi.00237.2010
   Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6
   Han YY, 2016, J HEPATOL, V64, P1295, DOI 10.1016/j.jhep.2016.02.024
   Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105
   Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036
   Kuver R, 2007, AM J PHYSIOL-GASTR L, V293, pG944, DOI 10.1152/ajpgi.00263.2006
   Lee SP, 2009, AM J PATHOL, V174, P842, DOI 10.2353/ajpath.2009.080262
   Li Long-Cheng, 2007, V402, P371
   Li TG, 2007, GASTROENTEROLOGY, V133, P1660, DOI 10.1053/j.gastro.2007.08.042
   Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201
   Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018
   Lleo A, 2012, HEPATOLOGY, V55, P153, DOI 10.1002/hep.24630
   LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479
   Marzioni M, 2003, AM J PHYSIOL-GASTR L, V284, pG837, DOI 10.1152/ajpgi.00398.2002
   NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263
   Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367
   Strack I, 2011, LAB INVEST, V91, P252, DOI 10.1038/labinvest.2010.162
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x
   Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103
   Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047
   Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516
NR 33
TC 42
Z9 44
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD FEB
PY 2017
VL 65
IS 2
BP 544
EP 559
DI 10.1002/hep.28831
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA EP3RZ
UT WOS:000397300700016
PM 27639079
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Jin, HH
   Lian, NQ
   Zhang, F
   Bian, ML
   Chen, XR
   Zhang, CX
   Jia, Y
   Lu, CF
   Hao, M
   Yao, SY
   Shao, JJ
   Wu, L
   Chen, AP
   Zheng, SZ
AF Jin, Huanhuan
   Lian, Naqi
   Zhang, Feng
   Bian, Mianli
   Chen, Xingran
   Zhang, Chenxi
   Jia, Yan
   Lu, Chunfeng
   Hao, Meng
   Yao, Shunyu
   Shao, Jiangjuan
   Wu, Li
   Chen, Anping
   Zheng, Shizhong
TI Inhibition of YAP signaling contributes to senescence of hepatic
   stellate cells induced by tetramethylpyrazine
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Tetramethylpyrazine; Hepatic stellate cells; Senescence; P53;
   Yes-associated protein
ID LIVER FIBROSIS; CELLULAR SENESCENCE; INDUCED ACTIVATION; PATHWAY; P53;
   LIGUSTRAZINE; APOPTOSIS; GROWTH; ANGIOGENESIS; SUPPRESSION
AB Accumulating evidence indicates that hepatic stellate cells (HSCs) are the central mediators and major effectors in the development of hepatic fibrosis. It iswell-known that regulation of cell proliferation and apoptosis are potential strategies to block the activation of HSCs. Recently, several studies have revealed that induction of HSC senescence could prevent and cure the liver fibrosis. In our previous work, we have demonstrated that the natural product tetramethylpyrazine (TMP) could inhibit the activation of HSCs and ameliorate hepatic fibrosis. The aim of this study was to identify a new role of TMP in the regulation of activated HSC senescence and to elucidate the underlying mechanisms. In this study, our data showed that TMP could promote HSC senescence in vivo and in vitro. Moreover, TMP affected the cell cycle and telomerase activity. We further demonstrated that P53 siRNA or P53 pharmacological inhibitor PFT-aabrogated the TMP-induced HSC senescence in vitro. Meanwhile, similar results were obtained in vivo. Further studies indicated that TMP promoted the expression of P53 through a YAP inhibition-dependent mechanism. Moreover, silencing YAP enhanced TMP induction of activated HSC senescence. Collectively, our results suggested that TMP inhibited the activation of HSCs by inducing senescence and had therapeutic implication for the treatment of liver fibrosis. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Jin, Huanhuan; Lian, Naqi; Zhang, Feng; Bian, Mianli; Chen, Xingran; Zhang, Chenxi; Jia, Yan; Lu, Chunfeng; Hao, Meng; Yao, Shunyu; Wu, Li; Zheng, Shizhong] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
   [Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing 210023, Jiangsu, Peoples R China.
   [Shao, Jiangjuan] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharm, Nanjing 210023, Jiangsu, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63103 USA.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Nanjing University of Chinese Medicine; Saint Louis University
RP Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
EM nytws@163.com
RI WANG, YANG/JFA-8821-2023
OI Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [81270514, 31401210,
   31571455]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions; Youth Natural Science Foundation of Jiangsu
   Province [BK20140955]; Program for Excellent Scientific and
   Technological Innovation Team of Jiangsu Higher Education; Natural
   Science Research General Program of Jiangsu Higher Education
   Institutions [14KJB310011]; Open Project Program of National First-Class
   Key Discipline for Pharmacy of Nanjing University of Chinese Medicine
   [KYLX-0974]; Medical Science and Technology Development Foundation,
   Nanjing Department of Health [YKK14143]; Open Project Program of Jiangsu
   Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia
   Medica [JKLPSE 201502]; Project of the Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This study was supported by the National Natural Science Foundation of
   China (81270514, 31401210, 31571455), a project funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   the Youth Natural Science Foundation of Jiangsu Province (BK20140955),
   2013 Program for Excellent Scientific and Technological Innovation Team
   of Jiangsu Higher Education, the Natural Science Research General
   Program of Jiangsu Higher Education Institutions (14KJB310011), the Open
   Project Program of National First-Class Key Discipline for Pharmacy of
   Nanjing University of Chinese Medicine (KYLX-0974), and Key Project
   supported by Medical Science and Technology Development Foundation,
   Nanjing Department of Health (YKK14143), the Open Project Program of
   Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese
   Materia Medica (JKLPSE 201502) and the Project of the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD).
CR Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042
   Bi L, 2016, INTEGR CANCER THER, V15, P226, DOI 10.1177/1534735416637424
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899
   Cao J, 2015, INT IMMUNOPHARMACOL, V26, P212, DOI 10.1016/j.intimp.2015.03.028
   Chang WJ, 2014, ACTA BIOCH BIOPH SIN, V46, P291, DOI 10.1093/abbs/gmt143
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Di Agostino S, 2016, EMBO REP, V17, P188, DOI 10.15252/embr.201540488
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Fausti F, 2013, CELL DEATH DIFFER, V20, P1498, DOI 10.1038/cdd.2013.101
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li SG, 2015, BIOL PHARM BULL, V38, P396, DOI 10.1248/bpb.b14-00611
   Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026
   Lian NQ, 2015, LAB INVEST, V95, P790, DOI 10.1038/labinvest.2015.59
   Lu CF, 2016, TOXICOLOGY, V365, P35, DOI 10.1016/j.tox.2016.07.018
   Lu CF, 2015, LIFE SCI, V141, P119, DOI 10.1016/j.lfs.2015.08.018
   Maicher A, 2012, NUCLEIC ACIDS RES, V40, P6649, DOI 10.1093/nar/gks358
   Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011
   Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992
   Mitra A, 2014, HEPATOLOGY, V60, P2027, DOI 10.1002/hep.27392
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351
   Rodriguez-Brenes IA, 2010, P NATL ACAD SCI USA, V107, P5387, DOI 10.1073/pnas.0914502107
   Singh V, 2014, ANTIMICROB AGENTS CH, V58, P1389, DOI 10.1128/AAC.01301-13
   Wu XF, 2015, IUBMB LIFE, V67, P312, DOI 10.1002/iub.1348
   Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793
   Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008
   Zhang F, 2016, BIOMED PHARMACOTHER, V78, P204, DOI 10.1016/j.biopha.2016.01.018
   Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286
   Zhang F, 2014, MOL CELL ENDOCRINOL, V382, P197, DOI 10.1016/j.mce.2013.09.020
   Zhang F, 2012, TOXICOL APPL PHARM, V265, P51, DOI 10.1016/j.taap.2012.09.016
   Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408
   Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210
NR 35
TC 32
Z9 35
U1 1
U2 19
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD JAN 1
PY 2017
VL 96
BP 323
EP 333
DI 10.1016/j.ejps.2016.10.002
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA EG0CJ
UT WOS:000390698200036
PM 27717875
DA 2024-02-19
ER

PT J
AU Chandler, H
   Peters, G
AF Chandler, Hollie
   Peters, Gordon
TI Stressing the cell cycle in senescence and aging
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE-RESPONSE; TUMOR-SUPPRESSOR
   LOCUS; HETEROCHROMATIN FOCI; HUMAN FIBROBLASTS; LIVER-CANCER; IN-VIVO;
   P16(INK4A); P53; D1
AB Senescence represents a permanent exit from the cell cycle and its role in curtailing the proliferation of damaged and potentially oncogenic cells has relevance both as a front-line defense against cancer and as an underlying cause of aging. The retinoblastoma protein (RB) and p53 tumor suppressors are central to the process and the growth arrest is primarily implemented by the cyclin-dependent kinase (CDK) inhibitors, p16(INK4a) and p21(CIP1). In contrast to terminal differentiation, senescence is a general response to a diverse range of cellular stresses and is typically accompanied by a characteristic set of phenotypic changes. Of particular note is a secretory program whose autocrine and paracrine effects can advertize the presence of senescent cells within a tissue and promote their clearance by the immune system. In this short review, we will highlight recent advances in understanding the relationship between senescence and aging and the distinction between senescence and terminal differentiation, from a cell cycle perspective.
C1 [Chandler, Hollie; Peters, Gordon] Lincolns Inn Fields Labs, CRUK London Res Inst, London WC2A 3LY, England.
C3 Cancer Research UK
RP Peters, G (corresponding author), Lincolns Inn Fields Labs, CRUK London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.
EM gordon.peters@cancer.org.uk
CR Acosta JC, 2013, NAT CELL BI IN PRESS
   Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6
   Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112
   Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001
   Andrusiak MG, 2013, CELL CYCLE, V12, P1416, DOI 10.4161/cc.24527
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013
   Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684
   Bourgo RJ, 2011, MOL CELL, V43, P663, DOI 10.1016/j.molcel.2011.06.029
   Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Carragher LAS, 2010, EMBO MOL MED, V2, P458, DOI 10.1002/emmm.201000099
   Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Drayton S, 2002, CURR OPIN GENET DEV, V12, P98, DOI 10.1016/S0959-437X(01)00271-4
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005
   Gagrica S, 2012, CANCER RES, V72, P165, DOI 10.1158/0008-5472.CAN-11-2552
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485
   Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x
   Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001
   Jirawatnotai S, 2012, CANCER RES, V72, P4289, DOI 10.1158/0008-5472.CAN-11-3549
   Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kennedy AL, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-16
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312
   Liu Y, 2011, BLOOD, V117, P3257, DOI 10.1182/blood-2010-09-304402
   LUCIBELLO FC, 1993, J CELL SCI, V105, P123
   Marusyk A, 2007, MOL CELL BIOL, V27, P5336, DOI 10.1128/MCB.01316-06
   Matheu A, 2009, AGING CELL, V8, P152, DOI 10.1111/j.1474-9726.2009.00458.x
   Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Monahan KB, 2010, ONCOGENE, V29, P5809, DOI 10.1038/onc.2010.314
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08
   Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106
   Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06
   Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954
   Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Talluri S, 2010, MOL CELL BIOL, V30, P948, DOI 10.1128/MCB.01168-09
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06
NR 73
TC 80
Z9 89
U1 0
U2 35
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
EI 1879-0410
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD DEC
PY 2013
VL 25
IS 6
BP 765
EP 771
DI 10.1016/j.ceb.2013.07.005
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 277CO
UT WOS:000328796200014
PM 23916530
DA 2024-02-19
ER

PT J
AU Ortega-Ribera, M
   Hunt, NJ
   Gracia-Sancho, J
   Cogger, VC
AF Ortega-Ribera, Marti
   Hunt, Nicholas J.
   Gracia-Sancho, Jordi
   Cogger, Victoria C.
TI The Hepatic Sinusoid in Aging and Disease: Update and Advances From the
   20th Liver Sinusoid Meeting
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article; Early Access
ID CIRRHOTIC RAT LIVERS; PORTAL-HYPERTENSION; STELLATE CELLS; OBETICHOLIC
   ACID; LIFE-SPAN; FIBROSIS; REGENERATION; ENDOTHELIUM; STABILIN-1;
   PATHWAYS
AB This is a meeting report of the 2019 Liver Sinusoid Meeting, 20th International Symposium on Cells of the Hepatic Sinusoid, held in Sydney, Australia, in September 2019. The meeting, which was organized by the International Society for Hepatic Sinusoidal Research, provided an update on the recent advances in the field of hepatic sinusoid cells in relation to cell biology, aging, and liver disease, with particular focus on the molecular and cellular targets involved in hepatic fibrosis, nonalcoholic hepatic steatohepatitis, alcoholic liver disease, hepatocellular carcinoma, and cirrhosis. In addition, the meeting highlighted the recent advances in regenerative medicine, targeted nanotechnologies, therapeutics, and novel methodologies.
C1 [Ortega-Ribera, Marti; Gracia-Sancho, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Liver Vasc Biol Res Grp, Barcelona Hepat Hemodynam Unit, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.
   [Hunt, Nicholas J.; Cogger, Victoria C.] Concord Repatriat Gen Hosp, ANZAC Res Inst, Australian Ageing & Alzheimers Inst, Ctr Educ & Res Ageing, Sydney, NSW, Australia.
   [Hunt, Nicholas J.; Cogger, Victoria C.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.
   [Gracia-Sancho, Jordi] Univ Bern, Dept Biomed Res, Inselspital, Hepatol, Bern, Switzerland.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER -
   Centro de Investigacion Biomedica en Red; CIBEREHD; Concord Repatriation
   General Hospital; University of Sydney; ANZAC Research Institute;
   University of Sydney; University of Bern; University Hospital of Bern
RP Gracia-Sancho, J (corresponding author), IDIBAPS, Liver Vasc Biol Res Grp, C Rossello 149, Barcelona 08036, Spain.; Cogger, VC (corresponding author), Univ Sydney, Fac Med & Hlth, Sci Rd, Camperdown, NSW 2050, Australia.
EM jordi.gracia@idibaps.org; victoria.cogger@sydney.edu.au
RI Hunt, Nicholas/AAD-6084-2019; Research Institute, ANZAC/CAE-9030-2022;
   Ortega Ribera, Marti/K-9666-2015; Gracia-Sancho, Jordi/C-8920-2014
OI Hunt, Nicholas/0000-0002-9001-0602; Ortega Ribera,
   Marti/0000-0001-8647-7069; Gracia-Sancho, Jordi/0000-0001-7736-4089
CR Aristu P, 2019, HEPATOLOGY, V70, p44A
   Boyer-Diaz Z, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102358
   Bravo M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56366-2
   Caparrós E, 2018, J HEPATOL, V68, pS472, DOI 10.1016/S0168-8278(18)31192-9
   Cogger VC, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P435
   Dippold RP, 2013, ALCOHOL CLIN EXP RES, V37, pE59, DOI 10.1111/j.1530-0277.2012.01852.x
   Du K, 2018, GASTROENTEROLOGY, V154, P1465, DOI 10.1053/j.gastro.2017.12.022
   Fernández-Iglesias A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00007
   Fickert P, 2019, BBA-MOL BASIS DIS, V1865, P867, DOI 10.1016/j.bbadis.2019.02.004
   Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103
   Gao B, 2019, J HEPATOL, V70, P249, DOI 10.1016/j.jhep.2018.10.023
   García-Pagán JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007
   Gaskell H, 2020, HEPATOL COMMUN, V4, P92, DOI 10.1002/hep4.1448
   Ge XD, 2018, HEPATOLOGY, V68, P2380, DOI 10.1002/hep.30093
   Geng Y, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165621
   Genz B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44865-1
   Gracia-Sancho J, 2019, HEPATOL COMMUN, V3, P987, DOI 10.1002/hep4.1360
   Gracia-Sancho J, 2019, NAT REV GASTRO HEPAT, V16, P221, DOI 10.1038/s41575-018-0097-3
   Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166
   Gracia-Sancho J, 2007, J HEPATOL, V47, P220, DOI 10.1016/j.jhep.2007.03.014
   Guillot A, 2019, HEPATOL COMMUN, V3, P730, DOI 10.1002/hep4.1356
   Guixé-Muntet S, 2019, J HEPATOL, V70, pE437, DOI 10.1016/S0618-8278(19)30858-8
   Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017
   Heymann F, 2015, JOVE-J VIS EXP, DOI 10.3791/52607
   Hide D, 2020, J GERONTOL A-BIOL, V75, P268, DOI 10.1093/gerona/glz012
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005
   Hu ZX, 2018, CELL PHYSIOL BIOCHEM, V51, P470, DOI 10.1159/000495242
   Hunt NJ, 2020, ACS NANO, V14, P1492, DOI 10.1021/acsnano.9b06071
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hunt NJ, 2020, J GERONTOL A-BIOL, V75, P278, DOI 10.1093/gerona/glz153
   Hunt NJ, 2019, AM J PHYSIOL-GASTR L, V316, pG144, DOI 10.1152/ajpgi.00179.2018
   Hunt NJ, 2018, ADV DRUG DELIVER REV, V135, P39, DOI 10.1016/j.addr.2018.09.006
   Kaur S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101277
   Kim A, 2018, HANDB EXP PHARMACOL, V248, P347, DOI 10.1007/164_2017_88
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kitagawa R, 2019, AM J PHYSIOL-GASTR L, V317, pG707, DOI 10.1152/ajpgi.00372.2018
   Kumar VH, 2015, J CLIN DIAGN RES, V9, pFF8, DOI 10.7860/JCDR/2015/12810.5930
   Lamas-Paz A, 2018, WORLD J GASTROENTERO, V24, P5063, DOI 10.3748/wjg.v24.i45.5063
   Lee YA, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P444
   Leung CON, 2016, ONCOTARGET, V7, P29371, DOI 10.18632/oncotarget.8835
   Mabuchi A, 2009, MICROCIRCULATION, V16, P364, DOI 10.1080/10739680902796917
   Machado MV, 2018, J HEPATOL, V68, P550, DOI 10.1016/j.jhep.2017.10.017
   Maeso-Díaz R, 2019, AGING DIS, V10, P684, DOI 10.14336/AD.2019.0127
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Manchanda M, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.25
   Mao H, 2019, NANOPHOTONICS-BERLIN, V8, P1299, DOI 10.1515/nanoph-2019-0066
   Marlini M, 2016, EXP PHYSIOL, V101, P1492, DOI 10.1113/EP085727
   Marrone G, 2013, LIVER FAILURE ETIOLO, P89
   Marrone G, 2015, GUT, V64, P1434, DOI 10.1136/gutjnl-2014-308338
   Matsumoto M, 2018, FREE RADICAL BIO MED, V115, P412, DOI 10.1016/j.freeradbiomed.2017.12.019
   Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988
   Miller CM, 2016, NUCLEIC ACIDS RES, V44, P2782, DOI 10.1093/nar/gkw112
   Mitchell SJ, 2011, J GERONTOL A-BIOL, V66, P400, DOI 10.1093/gerona/glq221
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Motoyama H, 2014, LAB INVEST, V94, P192, DOI 10.1038/labinvest.2013.135
   Nayak IMN, 2017, J CLIN DIAGN RES, V11, pFC06, DOI 10.7860/JCDR/2017/28418.10193
   Neumann-Haefelin E, 2008, GENE DEV, V22, P2721, DOI 10.1101/gad.478408
   Hai NTT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36215-4
   Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359
   Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525
   Odagiri N, 2019, MOL CELL BIOCHEM, V455, P7, DOI 10.1007/s11010-018-3466-x
   Oie CI, 2018, NANOPHOTONICS-BERLIN, V7, P575, DOI 10.1515/nanoph-2017-0055
   Pasarín M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785
   Patsenker E, 2009, HEPATOLOGY, V50, P1501, DOI 10.1002/hep.23144
   Perazzo H, 2017, LIVER INT, V37, P634, DOI 10.1111/liv.13270
   Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155
   Rodriguez-Aguilera JR, 2019, LIVER CIRRHOSIS DEBA, P433
   Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716
   Sato T, 2019, LIFE SCI, V221, P293, DOI 10.1016/j.lfs.2019.02.040
   Schwabl P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27656-y
   Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y
   Smedsrod B, 2009, LIVER INT, V29, P490, DOI 10.1111/j.1478-3231.2009.01979.x
   Solon-Biet SM, 2019, NAT METAB, V1, P532, DOI 10.1038/s42255-019-0059-2
   Sorensen KK, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P422
   Torok NJ, 2016, AM J PHYSIOL-GASTR L, V311, pG667, DOI 10.1152/ajpgi.00050.2016
   Tsochatzis EA, 2017, HEPATOLOGY, V66, P697, DOI 10.1002/hep.29277
   Turaga RC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11675
   Ubeda M, 2016, J HEPATOL, V64, P1049, DOI 10.1016/j.jhep.2015.12.010
   Vilaseca M, 2018, THER ADV GASTROENTER, V11, DOI 10.1177/1756284818811294
   Warren A, 2011, TOXICOL PATHOL, V39, P390, DOI 10.1177/0192623310394212
   Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115
   Zapotoczny B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08555-0
NR 83
TC 2
Z9 2
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD 2020 JUL
PY 2020
VL 4
IS 7
BP 1087
EP 1098
DI 10.1002/hep4.1517
EA APR 2020
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA MI6LP
UT WOS:000529418900001
PM 32626839
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Tao, HX
   Liu, QL
   Zeng, AQ
   Song, LJ
AF Tao, Hongxia
   Liu, Qianglin
   Zeng, Anqi
   Song, Linjiang
TI Unlocking the potential of Mesenchymal stem cells in liver Fibrosis:
   Insights into the impact of autophagy and aging
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article
DE Mesenchymal stem cells; Liver fibrosis; Autophagy; Aging
ID HEPATIC STELLATE CELLS; LIFE-SPAN EXTENSION; AGE-RELATED-CHANGES;
   BONE-MARROW; MECHANISMS; SENESCENCE; RESISTANCE; LONGEVITY; RECEPTOR;
   PROMOTES
AB Liver fibrosis is a chronic liver disease characterized by extracellular matrix protein accumulation, potentially leading to cirrhosis or hepatocellular carcinoma. Liver cell damage, inflammatory responses, and apoptosis due to various reasons induce liver fibrosis. Although several treatments, such as antiviral drugs and immunosuppressive therapies, are available for liver fibrosis, they only provide limited efficacy. Mesenchymal stem cells (MSCs) have become a promising therapeutic option for liver fibrosis, because they can modulate the immune response, promote liver regeneration, and inhibit the activation of hepatic stellate cells that contribute to disease development. Recent studies have suggested that the mechanisms through which MSCs gain their antifibrotic properties involve autophagy and senescence. Autophagy, a vital cellular self-degradation process, is critical for maintaining homeostasis and protecting against nutritional, metabolic, and infection-mediated stress. The therapeutic effects of MSCs depend on appropriate autophagy levels, which can improve the fibrotic process. Nonetheless, aging-related autophagic damage is associated with a decline in MSC number and function, which play a crucial role in liver fibrosis development. This review summarizes the recent advancements in the understanding of autophagy and senescence in MSC-based liver fibrosis treatment, presenting the key findings from relevant studies.
C1 [Tao, Hongxia; Liu, Qianglin; Song, Linjiang] Chengdu Univ Tradit Chinese Med, Sch Med & Life Sci, Chengdu 611137, Sichuan, Peoples R China.
   [Zeng, Anqi] Sichuan Acad Chinese Med Sci, Inst Translat Pharmacol & Clin Applicat, Chengdu 610041, Sichuan, Peoples R China.
C3 Chengdu University of Traditional Chinese Medicine
RP Song, LJ (corresponding author), Chengdu Univ Tradit Chinese Med, Sch Med & Life Sci, Chengdu 611137, Sichuan, Peoples R China.; Zeng, AQ (corresponding author), Sichuan Acad Chinese Med Sci, Inst Translat Pharmacol & Clin Applicat, Chengdu 610041, Sichuan, Peoples R China.
EM zeng6002aq@163.com; songlinjiang@cdutcm.edu.cn
FU Xinglin project of Chengdu University of Traditional Chinese Medicine
   [ZKYY2019, MPRC2021012]
FX Funding The work is supported by Xinglin project of Chengdu University
   of Traditional Chinese Medicine (ZKYY2019, MPRC2021012) .
CR Aglietti RA, 2017, TRENDS IMMUNOL, V38, P261, DOI 10.1016/j.it.2017.01.003
   Ahsan MK, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00069
   An S.Y., GASTROENTEROLOGY
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Basu T, 2018, ENVIRON TOXICOL, V33, P603, DOI 10.1002/tox.22549
   Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004
   Burns M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142630
   Caramés B, 2015, ARTHRITIS RHEUMATOL, V67, P1568, DOI 10.1002/art.39073
   Ceccariglia S, 2020, AUTOPHAGY, V16, P28, DOI 10.1080/15548627.2019.1630223
   Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459
   Chang TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126537
   Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760
   Chen H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42063-7
   Chen YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046512
   Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
   Chhimwal J, 2022, J NUTR BIOCHEM, V107, DOI 10.1016/j.jnutbio.2022.109062
   Condon KJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.222570
   de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187
   Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Dong WJ, 2015, J CELL PHYSIOL, V230, P680, DOI 10.1002/jcp.24792
   Duran A, 2016, CANCER CELL, V30, P595, DOI 10.1016/j.ccell.2016.09.004
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Ezhilarasan D, 2018, HEPATOB PANCREAT DIS, V17, P192, DOI 10.1016/j.hbpd.2018.04.003
   Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95
   García-Prat L, 2016, AUTOPHAGY, V12, P612, DOI 10.1080/15548627.2016.1143211
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gnani D, 2019, AGING CELL, V18, DOI 10.1111/acel.12933
   Hammoutene A, 2020, J HEPATOL, V72, P528, DOI 10.1016/j.jhep.2019.10.028
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Harrell CR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121605
   He YL, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02468-6
   Hernández-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016
   Hong Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27686-6
   Inami Y, 2011, BIOCHEM BIOPH RES CO, V412, P618, DOI 10.1016/j.bbrc.2011.08.012
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jakovljevic J, 2018, BIOMED PHARMACOTHER, V104, P404, DOI 10.1016/j.biopha.2018.05.061
   Ji D, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00645-y
   Jia JY, 2020, DEV CELL, V52, P69, DOI 10.1016/j.devcel.2019.10.025
   Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989
   Jiang Y, 2021, LIPIDS HEALTH DIS, V20, DOI 10.1186/s12944-021-01461-5
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   King EK, 2021, TRENDS BIOCHEM SCI, V46, P687, DOI 10.1016/j.tibs.2021.01.006
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Klionsky DJ, 2021, EMBO J, V40, DOI 10.15252/embj.2021108863
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Kordes C, 2013, CELL PHYSIOL BIOCHEM, V31, P290, DOI 10.1159/000343368
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Laing AG, 2018, IMMUNOTHERAPY-UK, V10, P201, DOI 10.2217/imt-2017-0117
   Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042
   Lee CCI, 2006, STEM CELLS DEV, V15, P209, DOI 10.1089/scd.2006.15.209
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Li N, 2022, CANCER CELL INT, V22, DOI 10.1186/s12935-022-02648-1
   Liang S, 2019, J BIOL CHEM, V294, P12359, DOI 10.1074/jbc.RA119.007409
   Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Liu J, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-02014-w
   Lodder J, 2015, AUTOPHAGY, V11, P1280, DOI 10.1080/15548627.2015.1058473
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Ma Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12709
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013
   Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   Mejias M, 2020, GASTROENTEROLOGY, V159, P273, DOI 10.1053/j.gastro.2020.03.008
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022
   Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Nuschke A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt530
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pei F, 2023, NAT COMMUN, V14, DOI 10.1038/s41467-023-35977-4
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Pfalzgraff A, 2017, BIOCHEM PHARMACOL, V140, P64, DOI 10.1016/j.bcp.2017.05.015
   Pu QQ, 2017, J IMMUNOL, V198, P3205, DOI 10.4049/jimmunol.1601196
   Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184
   RAMM GA, 1994, J CLIN INVEST, V94, P9, DOI 10.1172/JCI117353
   Regmi S, 2021, AUTOPHAGY, V17, P2991, DOI 10.1080/15548627.2020.1850608
   Revuelta M, 2017, AGING CELL, V16, P912, DOI 10.1111/acel.12655
   Roehlen N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040875
   Rohn F, 2020, AGING CELL, V19, DOI 10.1111/acel.13131
   Rong XL, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1204-2
   Ruart M, 2019, J HEPATOL, V70, P458, DOI 10.1016/j.jhep.2018.10.015
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Russell JO, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/8451282
   Sangani R., STEM CELL RES, V15
   Sbrana FV, 2016, STEM CELL REV REP, V12, P621, DOI 10.1007/s12015-016-9690-4
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   Shen B, 2014, INFLAMMATION, V37, P2076, DOI 10.1007/s10753-014-9941-y
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Song Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436242
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096
   Tan YW, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04764-2
   Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010
   Tian S., STEM CELL RES THER, V13
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   van der Helm D, 2019, J CELL MOL MED, V23, P6238, DOI 10.1111/jcmm.14508
   Wang HY, 2020, J CELL PHYSIOL, V235, P2722, DOI 10.1002/jcp.29176
   Wang J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01077
   Watanabe Y., STEM CELL TRANSL MED, V8
   Weiss ARR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01191
   Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x
   Yamamoto T., AUTOPHAGY, V12
   Yao J, 2019, FASEB J, V33, P1695, DOI 10.1096/fj.201800131RR
   Ye M, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/9583932
   Yuan Y, 2020, AGING CELL, V19, DOI 10.1111/acel.13114
   Yue B, 2005, CALCIFIED TISSUE INT, V77, P395, DOI 10.1007/s00223-005-0180-y
   Zhang DY, 2020, CLIN EXP PHARMACOL P, V47, P466, DOI 10.1111/1440-1681.13207
   Zhang JB, 2023, J CONTROL RELEASE, V356, P402, DOI 10.1016/j.jconrel.2023.02.032
   Zhang LL, 2021, STEM CELL REV REP, V17, P2262, DOI 10.1007/s12015-021-10247-2
   Zhang XW, 2020, AUTOPHAGY, V16, P782, DOI 10.1080/15548627.2019.1635383
   Zhang Y, 2022, EUR RESPIR REV, V31, DOI 10.1183/16000617.0134-2022
   Zhang Y, 2014, HEPATOLOGY, V59, P671, DOI 10.1002/hep.26670
   Zheng J, 2020, ADV SCI, V7, DOI 10.1002/advs.201903746
   Zheng XH, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-03042-4
   Zheng Y, 2016, EXP GERONTOL, V75, P64, DOI 10.1016/j.exger.2016.01.004
   Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3
NR 132
TC 1
Z9 1
U1 10
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD AUG
PY 2023
VL 121
AR 110497
DI 10.1016/j.intimp.2023.110497
EA JUN 2023
PG 10
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA L2YA4
UT WOS:001021953900001
PM 37329808
DA 2024-02-19
ER

PT J
AU Park, H
   Ishigami, A
   Shima, T
   Mizuno, M
   Maruyama, N
   Yamaguchi, K
   Mitsuyoshi, H
   Minami, M
   Yasui, K
   Itoh, Y
   Yoshikawa, T
   Fukui, M
   Hasegawa, G
   Nakamura, N
   Ohta, M
   Obayashi, H
   Okanoue, T
AF Park, Hyohun
   Ishigami, Akihito
   Shima, Toshihide
   Mizuno, Masayuki
   Maruyama, Naoki
   Yamaguchi, Kanji
   Mitsuyoshi, Hironori
   Minami, Masahito
   Yasui, Kohichiroh
   Itoh, Yoshito
   Yoshikawa, Toshikazu
   Fukui, Michiaki
   Hasegawa, Goji
   Nakamura, Naoto
   Ohta, Mitsuhiro
   Obayashi, Hiroshi
   Okanoue, Takeshi
TI Hepatic senescence marker protein-30 is involved in the progression of
   nonalcoholic fatty liver disease
SO JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE SMP30; NAFLD; NASH; Insulin resistance; Oxidative stress
ID SMP30/GNL KNOCKOUT MICE; I GENE-EXPRESSION; INSULIN-RESISTANCE;
   COMPONENT ANALYSIS; OXIDATIVE STRESS; STEATOHEPATITIS; LIPOPROTEIN;
   CELLS; OVERPRODUCTION; STIMULATION
AB Both insulin resistance and increased oxidative stress in the liver are associated with the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Senescence marker protein-30 (SMP30) was initially identified as a novel protein in the rat liver, and acts as an antioxidant and antiapoptotic protein. Our aim was to determine whether hepatic SMP30 levels are associated with the development and progression of NAFLD.
   Liver biopsies and blood samples were obtained from patients with an NAFLD activity score (NAS) a parts per thousand currency sign 2 (n = 18), NAS of 3-4 (n = 14), and NAS a parts per thousand yen 5 (n = 66).
   Patients with NAS a parts per thousand yen 5 had significantly lower hepatic SMP30 levels (12.5 +/- A 8.4 ng/mg protein) than patients with NAS a parts per thousand currency sign 2 (30.5 +/- A 14.2 ng/mg protein) and patients with NAS = 3-4 (24.6 +/- A 12.2 ng/mg protein). Hepatic SMP30 decreased in a fibrosis stage-dependent manner. Hepatic SMP30 levels were correlated positively with the platelet count (r = 0.291) and negatively with the homeostasis model assessment of insulin resistance (r = -0.298), the net electronegative charge modified-low-density lipoprotein (r = -0.442), and type IV collagen 7S (r = -0.350). The immunostaining intensity levels of 4-hydroxynonenal in the liver were significantly and inversely correlated with hepatic SMP30 levels. Both serum large very low-density lipoprotein (VLDL) and very small low-density lipoprotein (LDL) levels in patients with NAS a parts per thousand yen 5 were significantly higher than those seen in patients with NAS a parts per thousand currency sign 2, and these lipoprotein fractions were significantly and inversely correlated with hepatic SMP30.
   These results suggest that hepatic SMP30 is closely associated with the pathogenesis of NAFLD, although it is not known whether decreased hepatic SMP30 is a result or a cause of cirrhosis.
C1 [Park, Hyohun; Shima, Toshihide; Mizuno, Masayuki; Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka 5640013, Japan.
   [Ishigami, Akihito] Toho Univ, Dept Biochem, Fac Pharmaceut Sci, Chiba 2748510, Japan.
   [Ishigami, Akihito; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
   [Park, Hyohun; Yamaguchi, Kanji; Mitsuyoshi, Hironori; Minami, Masahito; Yasui, Kohichiroh; Itoh, Yoshito; Yoshikawa, Toshikazu; Okanoue, Takeshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan.
   [Fukui, Michiaki; Hasegawa, Goji; Nakamura, Naoto] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan.
   [Ohta, Mitsuhiro] Kobe Pharmaceut Univ, Dept Med Biochem, Kobe, Hyogo 658, Japan.
   [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto, Japan.
C3 Toho University; Tokyo Metropolitan Institute of Gerontology; Kyoto
   Prefectural University of Medicine; Kyoto Prefectural University of
   Medicine; Kobe Pharmaceutical University
RP Okanoue, T (corresponding author), Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Kawazonocho 1-2, Osaka 5640013, Japan.
EM okanoue@suita.saiseikai.or.jp
RI Shima, Toshihide/AAW-9215-2020
OI Shima, Toshihide/0000-0002-4120-9121; Ishigami,
   Akihito/0000-0001-7875-7482; Fukui, Michiaki/0000-0003-0903-1797
FU Japan Society for the Promotion of Science; Ministry of Health, Labour
   and Welfare
FX This study was supported by a Grant-in-Aid for Scientific Research (C)
   from the Japan Society for the Promotion of Science (Goji Hasegawa), and
   a Grant-in-Aid from the Ministry of Health, Labour and Welfare (Takeshi
   Okanoue).
CR Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z
   Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Farrell GC, 2003, J GASTROEN HEPATOL, V18, P124, DOI 10.1046/j.1440-1746.2003.02989.x
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Griffin Bruce A., 1994, Current Opinion in Lipidology, V5, P200, DOI 10.1097/00041433-199405030-00007
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Jeong DH, 2008, J RADIAT RES, V49, P653, DOI 10.1269/jrr.08042
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   MATSUOKA M, 1990, HEPATOLOGY, V11, P599, DOI 10.1002/hep.1840110412
   Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88
   Okazaki M, 2006, CLIN CHEM, V52, P2049, DOI 10.1373/clinchem.2006.070094
   Packard CJ, 2003, BIOCHEM SOC T, V31, P1066
   Park JK, 2008, TOXICOLOGY, V246, P132, DOI 10.1016/j.tox.2008.01.006
   Parola M, 1996, BIOCHEM BIOPH RES CO, V222, P261, DOI 10.1006/bbrc.1996.0732
   PAROLA M, 1993, BIOCHEM BIOPH RES CO, V194, P1044, DOI 10.1006/bbrc.1993.1927
   Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365
NR 33
TC 30
Z9 37
U1 0
U2 1
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0944-1174
EI 1435-5922
J9 J GASTROENTEROL
JI J. Gastroenterol.
PD APR
PY 2010
VL 45
IS 4
BP 426
EP 434
DI 10.1007/s00535-009-0154-3
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 581SD
UT WOS:000276543800008
PM 19946731
DA 2024-02-19
ER

PT J
AU Duan, YN
   Pan, J
   Chen, JL
   Zhu, DD
   Wang, JX
   Sun, XL
   Chen, LT
   Wu, LT
AF Duan, Yinong
   Pan, Jing
   Chen, Jinling
   Zhu, Dandan
   Wang, Jianxin
   Sun, Xiaolei
   Chen, Liuting
   Wu, Liting
TI Soluble Egg Antigens of <i>Schistosoma japonicum</i> Induce Senescence
   of Activated Hepatic Stellate Cells by Activation of the FoxO3a/SKP2/P27
   Pathway
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CELLULAR SENESCENCE; LIVER FIBROSIS; SKP2 EXPRESSION; REGRESSION;
   PROGRESSION; SUPPRESSES; APOPTOSIS; AKT; RB
AB Background
   Liver fibrosis was viewed as a reversible process. The activation of hepatic stellate cells (HSCs) is a key event in the process of liver fibrosis. The induction of senescence of HSCs would accelerate the clearance of the activated HSCs. Previously, we demonstrated that soluble egg antigens (SEA) of Schistosoma japonicum promoted the senescence of HSCs via STAT3/P53/P21 pathway. In this paper, our study was aimed to explore whether there are other signaling pathways in the process of SEA-induced HSCs aging and the underlying effect of SKP2/P27 signal on senescent HSCs.
   Methodology/Principal findings
   Human hepatic stellate cell line, LX-2 cells, were cultured and stimulated with SEA. Western blot and cellular immunofluorescence analysis were performed to determine the expression of senescence-associated protein, such as P27, SKP2 and FoxO3a. Besides, RNA interfering was applied to knockdown the expression of related protein. The senescence of HSCs was determined by senescence-associated beta-gal staining. We found that SEA increased the expression of P27 protein, whereas it inhibited the expression of SKP2 and FoxO3a. Knockdown of P27 as well as overexpression of SKP2 both suppressed the SEA-induced senescence of HSCs. In addition, the nuclear translocation of FoxO3a from the nucleus to the cytoplasm was induced by SEA stimulation.
   Conclusions/Significance
   The present study demonstrates that SEA promotes HSCs senescence through the FoxO3a/SKP2/P27 pathway.
C1 [Duan, Yinong; Pan, Jing; Chen, Jinling; Zhu, Dandan; Sun, Xiaolei; Chen, Liuting; Wu, Liting] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong, Jiangsu, Peoples R China.
   [Pan, Jing] Nanjing Med Univ, Kangda Coll, Dept Pathogen Biol & Immunol, Lianyungang, Jiangsu, Peoples R China.
   [Wang, Jianxin] Nantong Univ, Affiliated Hosp, Lab Med Ctr, Nantong, Jiangsu, Peoples R China.
C3 Nantong University; Nanjing Medical University; Nantong University
RP Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong, Jiangsu, Peoples R China.
EM yinongduan@aliyun.com
RI Yang, Jing/JFK-4046-2023; liu, jiajia/ISS-0316-2023; Duan,
   yinong/GSD-9438-2022; wang, xiao/HZI-9156-2023; zhang,
   luyu/JJC-4227-2023
OI Yang, Jing/0009-0004-8274-9863; Chen, Jinling/0000-0003-2992-6571; Duan,
   Yinong/0000-0001-5824-5762
FU National Natural Science Foundation of China [81471975, 81401683,
   81501763, 81171589]; Jiangsu provincial Natural Science Foundation
   [BK20140435]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD)
FX This work was supported by National Natural Science Foundation of China
   (Grant Numbers 81471975, 81401683, 81501763, 81171589), the Jiangsu
   provincial Natural Science Foundation (Grant Number BK20140435), the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], ONCOTARGET
   Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Caraballo JM, 2014, ONCOTARGET, V5, P4694, DOI 10.18632/oncotarget.2100
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Davaadelger B, 2016, ONCOTARGET
   Dobson M, 2011, BBA-MOL CELL RES, V1813, P1453, DOI 10.1016/j.bbamcr.2011.05.001
   Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003
   Duval F, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/943497
   Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024
   Ewald JA, 2012, TRANSL ONCOL, V5, P278, DOI 10.1593/tlo.12181
   Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927
   Foo NP, 2011, TOXICOLOGY, V282, P39, DOI 10.1016/j.tox.2011.01.009
   Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013
   Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974
   Fu C, 2015, ONCOTARGET, V6, P24675, DOI 10.18632/oncotarget.5071
   Gu Z., 2013, CLIN DEV IMMUNOL, V2013, DOI DOI 10.1155/2013/134243
   Hayashi S, 2008, EUR J PHARMACOL, V580, P380, DOI 10.1016/j.ejphar.2007.11.015
   Hyun J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10993
   Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341
   Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006
   Kim HK, 2005, J GERONTOL A-BIOL, V60, P4, DOI 10.1093/gerona/60.1.4
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kim SJ, 2014, CELL DEATH DIFFER, V21, P1769, DOI 10.1038/cdd.2014.88
   Kitano M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030038
   Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuo YL, 2006, EMBO J, V25, P1741, DOI 10.1038/sj.emboj.7601054
   Lee JJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.501
   Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815
   Ma KL, 2014, GENET MOL RES, V13, P9931, DOI 10.4238/2014.November.27.22
   Mirzayans R, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951574
   Park KC, 2014, BRIT J PHARMACOL, V171, P4820, DOI 10.1111/bph.12590
   Qi XF, 2015, J MOL CELL CARDIOL, V81, P114, DOI 10.1016/j.yjmcc.2015.01.022
   Ramachandran P, 2009, ANN HEPATOL, V8, P283, DOI 10.1016/S1665-2681(19)31740-5
   Shimura T, 2016, ONCOTARGET, V7, P3559, DOI 10.18632/oncotarget.6518
   Tian Z, 2013, EXP PARASITOL, V134, P447, DOI 10.1016/j.exppara.2013.05.002
   Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319
   Xu HD, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.23
   Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699
   Zhu DD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0640-9
NR 42
TC 18
Z9 19
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005268
DI 10.1371/journal.pntd.0005268
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100091
PM 28036393
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Li, GJ
   Peng, MJ
   Wu, XB
   Liao, HW
   Zhang, L
   Li, Y
   Yang, XF
   Chen, H
AF Li, Guo-Juan
   Peng, Meng-Jie
   Wu, Xiao-Bing
   Liao, Hong-Wu
   Zhang, Li
   Li, Ying
   Yang, Xue-Feng
   Chen, Hong
TI CYCLOOXYGENASE-2 SHORT HAIRPIN RNA LIMITS NONALCOHOLICFATTY LIVER
   DISEASE BY INDUCING LIVER CELL AGING
SO ACTA MEDICA MEDITERRANEA
LA English
DT Article
DE non-alcoholic fatty liver; COX-2; cell aging
ID INDUCED SENESCENCE; IN-VIVO; HEPATOCYTE; PROGRESSION
AB Cyclooxygenase-2 (COX-2) has been involved the initiation and development of nonalcoholic fatty liver disease (NAFLD), however the mechanism within has still remained unclear. This aim of this study was observe the effects of COX-2 short hairpin RNA (COX-2 shRNA) on the liver cell aging in rats with NAFLD induced by a high-fat diet. 48 SD rats divided randomly into four group (n = 12). The rats was induced NAFLD by high fat diet for 12 weeks together with or without COX-2shRNA. Liver fat degeneration and fibrosis was evaluated by Oil red O, HE and MASSON Staining according to the METAVIR scoring system, and liver tissue cell aging by beta-galactose glucoside enzyme staining, COX-2 and a- SMA mRNA expression of liver tissue by real-time fluorescent quantitative PCR. The serum cerealthirdtransaminase (ALT), aspartate transaminase (AST), total cholesterol (TC), trigly-cerides (TG) levels was investigate by enzyme-linked immunosorbent assay (ELISA). The results of this study found liver steatosis degree, liver tissue lipid variable area and liver fibrosis in rats with COX-2shRNA significantly attenuated, and the serum levels of ALT, AST, TC, TG in rats with COX-2shRNA significantly improved. These data suggest COX-2shRNA limits the development of NAFLD through inducing liver cell aging.
C1 [Li, Guo-Juan; Chen, Hong] Southern Med Univ Guangzhou, Zhujiang Hosp, Dept Endocrinol & Metab, Guangzhou 510515, Guangdong, Peoples R China.
   [Li, Guo-Juan; Peng, Meng-Jie; Wu, Xiao-Bing; Liao, Hong-Wu; Zhang, Li; Li, Ying; Yang, Xue-Feng] Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang 421002, Peoples R China.
C3 Southern Medical University - China; University of South China
RP Chen, H (corresponding author), Southern Med Univ Guangzhou, Zhujiang Hosp, Dept Endocrinol & Metab, Guangzhou 510515, Guangdong, Peoples R China.; Yang, XF (corresponding author), Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang 421002, Peoples R China.
EM yxf9988@126.com; chenhong123@smu.edu.cn
RI YANG, Xue/HPI-0953-2023
FU National Natural Science Foundation of China [81373465]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81373465).
CR Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Chen J, 2011, MOL MED REP, V4, P811, DOI 10.3892/mmr.2011.501
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Kim SR, 2008, MECH AGEING DEV, V129, P706, DOI 10.1016/j.mad.2008.09.003
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Serra MP, 2014, INT J RADIAT BIOL, V90, P876, DOI 10.3109/09553002.2014.922714
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   Wan JH, 2014, AM J PATHOL, V184, P1763, DOI 10.1016/j.ajpath.2014.02.014
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Zdanov S, 2009, BIOGERONTOLOGY, V10, P291, DOI 10.1007/s10522-008-9204-0
NR 14
TC 0
Z9 0
U1 0
U2 7
PU CARBONE EDITORE
PI PALERMO
PA VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY
SN 0393-6384
EI 2283-9720
J9 ACTA MEDICA MEDITERR
JI Acta Medica Mediterr.
PY 2018
VL 34
IS 2
BP 409
EP 413
DI 10.19193/0393-6384_2018_2_65
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA GB7TQ
UT WOS:000429278400019
DA 2024-02-19
ER

PT J
AU Jin, HH
   Jia, Y
   Yao, Z
   Huang, JJ
   Hao, M
   Yao, SY
   Lian, NQ
   Zhang, F
   Zhang, CX
   Chen, XR
   Bian, ML
   Shao, JJ
   Wu, L
   Chen, AP
   Zheng, SZ
AF Jin, Huanhuan
   Jia, Yan
   Yao, Zhen
   Huang, Jingjing
   Hao, Meng
   Yao, Shunyu
   Lian, Naqi
   Zhang, Feng
   Zhang, Chenxi
   Chen, Xingran
   Bian, Mianli
   Shao, Jiangjuan
   Wu, Li
   Chen, Anping
   Zheng, Shizhong
TI Hepatic stellate cell interferes with NK cell regulation of fibrogenesis
   via curcumin induced senescence of hepatic stellate cell
SO CELLULAR SIGNALLING
LA English
DT Article
DE Hepatic fibrosis; Natural killer cell; Hepatic stellate cell;
   Senescence; Granule exocytosis
ID NATURAL-KILLER-CELLS; LIVER FIBROSIS; ACTIVATION; MICE; LIGANDS; P53
AB Hepatic fibrosis, a common scarring response to various forms of chronic liver injury, is a precursor to cirrhosis and liver cancer. During liver fibrosis, hepatic stellate cells (HSCs) initially activate and proliferate, which are responsible for the secretion of extracellular matrix components. However, these cells eventually senesce and are cleared by natural killer (NK) cells. Our previous researches have shown that the natural product curcumin could promote the senescence of activated HSC. In this study, we investigated how NK cells target senescent HSC and assessed the effect of this process on liver fibrosis. We found that senescent HSC induced by curcumin are susceptible to NK cells killing, due to the increased expression of NK cell activating ligand major histocompatibility complex class I chain -related genes A (MICA) and UL16-binding proteins 2 (ULBP2), but not Poliovirus Receptor (PVR). Further studies displayed that the interaction between NK cells and senescent LX2 cells stimulated granule exocytosis. Moreover, the inhibition of granule exocytosis weakened the cytotoxicity of NM cells and promoted the accumulation of senescent LX2 cells. Therefore, these aggregated data indicated that NM cells mediated clearance of senescent LX2 cells and granule exocytosis could play a protective role in the improvement of liver fibrosis. (C) 2017 Elsevier Inc All rights reserved.
C1 [Jin, Huanhuan; Jia, Yan; Yao, Zhen; Hao, Meng; Lian, Naqi; Zhang, Feng; Zhang, Chenxi; Chen, Xingran; Bian, Mianli; Wu, Li; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing 210023, Jiangsu, Peoples R China.
   [Huang, Jingjing] Nanjing Univ Chinese Med, Clin Med Coll 1, Dept Cardiol, Nanjing 210023, Jiangsu, Peoples R China.
   [Yao, Shunyu] Nanjing 1 High Sch, Grade 11, Class AP, Nanjing 210023, Jiangsu, Peoples R China.
   [Zhang, Feng; Shao, Jiangjuan; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Therapeut Mat Chinese Med, Nanjing 210023, Jiangsu, Peoples R China.
   [Zhang, Feng; Shao, Jiangjuan; Zheng, Shizhong] Nanjing Univ Chinese Med, State Key Lab Cultivat Base TCM Qual & Efficacy, Nanjing 210023, Jiangsu, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63103 USA.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Nanjing University of Chinese Medicine; Nanjing University of
   Chinese Medicine; Saint Louis University
RP Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
EM nytws@163.com
RI Huang, Jingjing/AFK-4040-2022; huang, jing/JDC-2548-2023; WANG,
   YANG/JFA-8821-2023
OI Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [31571455, 31401210,
   31600653, 81600483, 81270514]; Natural Science Foundation of Jiangsu
   Province [BK20140955]; Open Project Program of Jiangsu Key Laboratory
   for Pharmacology and Safety Evaluation of Chinese Materia Medica [JKLPSE
   201502]; Project of the Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD)
FX This study was supported by the National Natural Science Foundation of
   China (31571455, 31401210, 31600653, 81600483 and 81270514), the Natural
   Science Foundation of Jiangsu Province (BK20140955), the Open Project
   Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation
   of Chinese Materia Medica (JKLPSE 201502), and the Project of the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD).
CR Bi JC, 2014, HEPATOLOGY, V59, P1715, DOI 10.1002/hep.26968
   Hoare M, 2013, J HEPATOL, V58, P868, DOI 10.1016/j.jhep.2012.12.009
   Huang M, 2013, HEPATOLOGY, V57, P277, DOI 10.1002/hep.25959
   Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Langhans B, 2015, J HEPATOL, V62, P398, DOI 10.1016/j.jhep.2014.08.038
   Laser J, 2010, FERTIL STERIL, V93, P2020, DOI 10.1016/j.fertnstert.2008.12.116
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025
   Mitra A, 2014, HEPATOLOGY, V60, P2027, DOI 10.1002/hep.27392
   Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206
   Sagiv A, 2016, AGING-US, V8, P328, DOI 10.18632/aging.100897
   Schildberg FA, 2011, HEPATOLOGY, V54, P262, DOI 10.1002/hep.24352
   Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753
   Shackel NA, 2014, HEPATOLOGY, V59, P2413, DOI 10.1002/hep.26932
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tosello-Trampont AC, 2016, HEPATOLOGY, V63, P799, DOI 10.1002/hep.28389
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yi HS, 2014, HEPATOLOGY, V60, P1044, DOI 10.1002/hep.27137
   Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286
   Zhang F, 2012, TOXICOL APPL PHARM, V265, P51, DOI 10.1016/j.taap.2012.09.016
NR 24
TC 35
Z9 38
U1 0
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0898-6568
EI 1873-3913
J9 CELL SIGNAL
JI Cell. Signal.
PD MAY
PY 2017
VL 33
BP 79
EP 85
DI 10.1016/j.cellsig.2017.02.006
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EP9HA
UT WOS:000397683500009
PM 28188823
DA 2024-02-19
ER

PT J
AU KITANI, K
AF KITANI, K
TI AGING AND THE LIVER - FUNCTIONAL-ASPECTS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE AGING; DRUG METABOLIZING ENZYMES; MEMBRANE ALTERATIONS; PERTURBATION OF
   PROTEOLYSIS; ANTIOXIDANT ENZYMES AND GLUTATHIONE
ID GLUTATHIONE-S-TRANSFERASE; HEPATOCYTE PLASMA-MEMBRANE; LATERAL DIFFUSION
   CONSTANT; AGE-DEPENDENT DECREASE; FUNCTION OXIDASE SYSTEM; PROTEIN-FREE
   DIET; FLUORESCENCE RECOVERY; RAT-LIVER; REDUCTASE ACTIVITIES;
   BILIARY-EXCRETION
AB The drastic decline in the functions of the hepatic microsomal cytochrome monooxygenase system, initially reported in male rat livers, was shown to be due to a feminization of male rat livers with aging. In female rat livers as well as in mouse livers, this system was found to stay unchanged with age. Phase II reactions which showed some decline with aging in male rat livers again stayed fairly stable with age in female rat and mouse livers. Glutathione S-transferase (GST) enzyme activities, which are very stable with age in female rat and mouse livers, demonstrated highly age-dependent changes when dietary conditions were manipulated, suggesting a potential age difference in the homeostatic regulation of this enzyme system. Using the fluorescence recovery after photobleaching (FRAP) technique, unique studies revealed an age-dependent decline in the lateral mobility of proteins in hepatocyte surface membranes. The protease inhibitor model of aging, initially proposed by Ivy for brain cells, has been validated in hepatocytes, demonstrating an accumulation of lipofuscin-like granules in young animals treated with i.p. infusion of leupeptin for only 2 weeks. Antioxidant enzyme activities such as superoxide dismutase (SOD) and catalase (CAT) in the liver were clearly demonstrated not to be reduced in general terms with aging. Rather, a clear increase in CAT enzyme activities with age was demonstrated in female rat livers, thus challenging the concept that intracellular enzyme activities generally decline with aging. In this paper, studies performed in Japan an aging and the liver over the past 30 years, with a focus on its functional aspects, are critically reviewed in terms of the clinical implications of these studies as well as on theories of aging in general.
RP KITANI, K (corresponding author), UNIV TOKYO,FAC MED,RADIOISOTOPE RES INST,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.
CR BOOBIS AR, 1984, XENOBIOTICA, V14, P151, DOI 10.3109/00498258409151404
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P301, DOI 10.1016/0047-6374(92)90043-D
   CARRILLO MC, 1990, MECH AGEING DEV, V56, P237, DOI 10.1016/0047-6374(90)90085-T
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   CARRILLO MC, 1991, BIOCHIM BIOPHYS ACTA, V1077, P325, DOI 10.1016/0167-4838(91)90547-D
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   FUJITA S, 1986, LIVER AGING 1986, P103
   FUJITA S, 1982, LIVER AGING 1982, P55
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IVY GO, 1992, ANN NY ACAD SCI, V674, P89, DOI 10.1111/j.1749-6632.1992.tb27479.x
   IVY GO, 1986, LIVER AGING 1986, P389
   IVY GO, 1991, LIVER AGING 1990, P109
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KANAI S, 1985, ARCH GERONTOL GERIAT, V4, P73, DOI 10.1016/0167-4943(85)90020-2
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   KITAGAWA K, 1990, J MATER SCI LETT, V9, P603, DOI 10.1007/BF00725891
   KITAHARA A, 1982, LIVER AGING 1982, P135
   KITANI K, 1990, BASIC SCIENCE IN TOXICOLOGY, P422
   KITANI K, 1988, HEPATOLOGY, V8, P125, DOI 10.1002/hep.1840080124
   Kitani K., 1991, V8, P417
   KITANI K, 1992, GASTROENTEROL JPN, V27, P276, DOI 10.1007/BF02777737
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P233
   KITANI K, 1988, AGING LIVER GASTROIN, P169
   KITANI K, 1978, LIVER AGING, P145
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   KOFF RS, 1973, GASTROENTEROLOGY, V65, P300
   LAUTERBURG BH, 1980, J PHARMACOL EXP THER, V213, P54
   LUSTYIK G, 1987, BIOCHIM BIOPHYS ACTA, V896, P57, DOI 10.1016/0005-2736(87)90356-7
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   MINER PB, 1983, HEPATOLOGY, V3, P481
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   OHTA M, 1990, BIOCHEM PHARMACOL, V39, P1223, DOI 10.1016/0006-2952(90)90266-N
   OHTA M, 1988, BIOCHEM PHARMACOL, V37, P935
   OMALLEY K, 1971, BMJ-BRIT MED J, V3, P607, DOI 10.1136/bmj.3.5775.607
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REISS U, 1978, LIVER AGING 1978, P55
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   RIKANS LE, 1992, DRUG DEVELOP RES, V26, P461, DOI 10.1002/ddr.430260409
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SMITH DJ, 1988, J LAB CLIN MED, V112, P679
   STOHS SJ, 1982, BIOCHEM PHARMACOL, V31, P2113, DOI 10.1016/0006-2952(82)90429-4
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V34, P2983, DOI 10.1016/0006-2952(85)90025-5
   THOMPSON EN, 1965, GUT, V6, P266, DOI 10.1136/gut.6.3.266
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   WYNNE HA, 1988, AGE AGEING, V17, P401, DOI 10.1093/ageing/17.6.401
   ZSNAGY I, 1990, ARCH GERONTOL GERIAT, V11, P243, DOI 10.1016/0167-4943(90)90068-H
   ZSNAGY I, 1988, BIOCHIM BIOPHYS ACTA, V939, P551, DOI 10.1016/0005-2736(88)90102-2
   ZSNAGY I, 1989, EXP GERONTOL, V24, P317, DOI 10.1016/0531-5565(89)90004-1
   ZSNAGY I, 1993, J GERONTOL, V48, pB86, DOI 10.1093/geronj/48.3.B86
   ZSNAGY I, 1989, J GERONTOL, V44, pB83, DOI 10.1093/geronj/44.4.B83
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1993, MECH AGEING DEV, V71, P85
NR 62
TC 16
Z9 17
U1 1
U2 2
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD SEP-OCT
PY 1994
VL 19
IS 2
BP 145
EP 158
DI 10.1016/0167-4943(94)90036-1
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA PY275
UT WOS:A1994PY27500006
PM 15374281
DA 2024-02-19
ER

PT J
AU Wang, FX
   Li, ZH
   Chen, L
   Yang, T
   Liang, BY
   Zhang, ZL
   Shao, JJ
   Xu, XF
   Yin, GP
   Wang, SJ
   Ding, H
   Zhang, F
   Zheng, SZ
AF Wang, Feixia
   Li, Zhanghao
   Chen, Li
   Yang, Ting
   Liang, Baoyu
   Zhang, Zili
   Shao, Jiangjuan
   Xu, Xuefen
   Yin, Guoping
   Wang, Shijun
   Ding, Hai
   Zhang, Feng
   Zheng, Shizhong
TI Inhibition of ASCT2 induces hepatic stellate cell senescence with
   modified proinflammatory secretome through an IL-1α/NF-κB feedback
   pathway to inhibit liver fibrosis
SO ACTA PHARMACEUTICA SINICA B
LA English
DT Article; Early Access
DE Hepatic stellate cells; Senescence; SASP; ASCT2; Precursor IL-1 alpha;
   NF-kB; Atractylenolide III; Liver fibrosis
ID GROWTH; MYOFIBROBLASTS; GLUTAMINOLYSIS; FERROPTOSIS; ACTIVATION; INJURY
AB Senescence of activated hepatic stellate cells (aHSCs) is a stable growth arrest that is implicated in liver fibrosis regression. Senescent cells often accompanied by a multi-faceted senescence-associated secretory phenotype (SASP). But little is known about how alanine-serine-cysteine transporter type-2 (ASCT2), a high affinity glutamine transporter, affects HSC senescence and SASP during liver fibrosis. Here, we identified ASCT2 is mainly elevated in aHSCs and positively correlated with liver fibrosis in human and mouse fibrotic livers. We first discovered ASCT2 inhibition induced HSCs to senescence in vitro and in vivo. The proinflammatory SASP were restricted by ASCT2 inhibition at senescence initiation to prevent paracrine migration. Mechanically, ASCT2 was a direct target of glutaminolysisdependent proinflammatory SASP, interfering IL-1 alpha/NF-kappa B feedback loop via interacting with precursor IL-1 alpha at Lys82. From a translational perspective, atractylenolide III is identified as ASCT2 inhibitor through directly bound to Asn230 of ASCT2. The presence of eOH group in atractylenolide III is suggested to be favorable for the inhibition of ASCT2. Importantly, atractylenolide III could be utilized to treat liver fibrosis mice. Taken together, ASCT2 controlled HSC senescence while modifying the proinflammatory SASP. Targeting ASCT2 by atractylenolide III could be a therapeutic candidate for liver fibrosis. (c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Wang, Feixia; Li, Zhanghao; Chen, Li; Yang, Ting; Liang, Baoyu; Zhang, Zili; Shao, Jiangjuan; Xu, Xuefen; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing 210023, Peoples R China.
   [Ding, Hai] Nanjing Univ Chinese Med, Nanjing Hosp, Dept Gen Surg, Nanjing 210003, Peoples R China.
   [Yin, Guoping] Nanjing Univ Chinese Med, Nanjing Hosp, Dept Anesthesiol, Nanjing 210003, Peoples R China.
   [Wang, Shijun] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250035, Peoples R China.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Nanjing University of Chinese Medicine; Shandong University of
   Traditional Chinese Medicine
RP Zhang, F; Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing 210023, Peoples R China.
EM 300631@njucm.edu.cn; nytws@njucm.edu.cn
RI li, wei/IUQ-2973-2023; Wang, Guang/JFS-8374-2023; sun,
   chen/JCP-0396-2023; li, zhang/JHV-1750-2023; liu, xy/JEP-3175-2023; wu,
   jialin/JPY-4408-2023; 李, 嘉馨/IWM-4023-2023; yang, yun/IZE-1092-2023; liu,
   lingling/IUQ-7478-2023; Liu, Yixuan/JFJ-2820-2023; zhou,
   wei/JQJ-0490-2023; Yan, Miaochen/JLL-5061-2023; Yang,
   Ying/ADL-4165-2022; liu, xinyu/IWD-6630-2023; Yang, Fei/JLM-3367-2023;
   liu, qi/IQR-4870-2023; Yao, Chen/JVD-6226-2023; 王, 娅冰/JGE-0541-2023; LI,
   SHA/JNR-9956-2023; wang, zhiwen/JDV-9990-2023; ZHOU, YUE/IZE-6277-2023;
   wang, KiKi/JFZ-3334-2023; Zhao, Yi/JFA-7988-2023
OI Yang, Ying/0000-0002-3469-7681; Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [81870423, 82173874,
   82073914]; Major Project of the Natural Science Research of Jiangsu
   Higher Education Institutions [19KJA310005]; Open Project of Chinese
   Materia Medica First-Class Discipline of Nanjing University of Chinese
   Medicine [2020YLXK022, 2020YLXK023]; Open Project of Jiangsu Key
   Laboratory for Pharmacology and Safety Evaluation of Chinese Materia
   Medica [JKLPSE202005]; Qing Lan Project of Jiangsu Higher Institutions
   (Young and Middle-Aged Academic Leader, China); Postgraduate Research &
   Practice Innovation Program of Jiangsu Province [KYCX20_1493]
FX We would like to thank Dr. Shuai Lu (School of Science, China
   Pharmaceutical University, Nanjing, China) for his assistance in
   molecular docking assay. We thank Experiment Center for Science and
   Technology of Nanjing University of Chinese Medicine for assistance in
   experimental instruments. This work was financially supported by the
   National Natural Science Foundation of China (81870423, 82173874 and
   82073914), the Major Project of the Natural Science Research of Jiangsu
   Higher Education Institutions (19KJA310005, China), the Open Project of
   Chinese Materia Medica First-Class Discipline of Nanjing University of
   Chinese Medicine (2020YLXK022 and 2020YLXK023, China), the Open Project
   of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of
   Chinese Materia Medica (JKLPSE202005, China), the Qing Lan Project of
   Jiangsu Higher Institutions (Young and Middle-Aged Academic Leader,
   China), and the Postgraduate Research & Practice Innovation Program of
   Jiangsu Province (KYCX20_1493, China).
CR Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen Q, 2016, IUBMB LIFE, V68, P220, DOI 10.1002/iub.1478
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Du K, 2018, GASTROENTEROLOGY, V154, P1465, DOI 10.1053/j.gastro.2017.12.022
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476
   Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Gu LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052305
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Huai B, 2020, IMMUNOPHARM IMMUNOT, V42, P436, DOI 10.1080/08923973.2020.1806871
   Huang F, 2014, INT J CLIN EXP PATHO, V7, P6006
   Ito Y, 2017, TRENDS CELL BIOL, V27, P830, DOI 10.1016/j.tcb.2017.07.004
   Jia Y, 2018, REDOX BIOL, V19, P375, DOI 10.1016/j.redox.2018.09.007
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Jun JI, 2018, J CLIN INVEST, V128, P97, DOI 10.1172/JCI93563
   Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948
   Kocabayoglu P, 2015, J HEPATOL, V63, P141, DOI 10.1016/j.jhep.2015.01.036
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lane AN, 2020, GENES DIS, V7, P185, DOI 10.1016/j.gendis.2019.10.007
   Lau L, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00586-18
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Liu YD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16954
   Malaquin N, 2016, EXP GERONTOL, V82, P39, DOI 10.1016/j.exger.2016.05.010
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005
   Scalise M, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00096
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Shen M, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106637
   Shimizu K, 2014, BRIT J CANCER, V110, P2030, DOI 10.1038/bjc.2014.88
   van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381
   Wang FX, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0324-8
   Wang MQ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1875471
   Wang S, 2020, J HEPATOL, V73, P210, DOI 10.1016/j.jhep.2020.03.011
   Wang ZM, 2020, LIFE SCI, V255, DOI 10.1016/j.lfs.2020.117818
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wu XX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13498
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012
   Yang LF, 2017, ANNU REV BIOMED ENG, V19, P163, DOI 10.1146/annurev-bioeng-071516-044546
   Zhang F, 2021, BRIT J PHARMACOL, V178, P2246, DOI 10.1111/bph.15289
   Zhang F, 2018, THERANOSTICS, V8, P610, DOI 10.7150/thno.22237
   Zhang J, 2020, ADV SCI, V7, DOI 10.1002/advs.202002306
   Zhang ZL, 2020, AUTOPHAGY, V16, P1482, DOI 10.1080/15548627.2019.1687985
   Zhang ZL, 2018, AUTOPHAGY, V14, P2083, DOI 10.1080/15548627.2018.1503146
NR 52
TC 13
Z9 13
U1 8
U2 14
PU INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
PI BEIJING
PA C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST,
   BEIJING, 100050, PEOPLES R CHINA
SN 2211-3835
EI 2211-3843
J9 ACTA PHARM SIN B
JI Acta Pharm. Sin. B
PD 2022 SEP
PY 2022
VL 12
IS 9
BP 3618
EP 3638
DI 10.1016/j.apsb.2022.03.014
EA SEP 2022
PG 21
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 7S9KS
UT WOS:000911070500002
PM 36176909
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Keppler, D
   Walter, R
   Pérez, C
   Sierra, F
AF Keppler, D
   Walter, R
   Pérez, C
   Sierra, F
TI Increased expression of mature cathepsin B in aging rat liver
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE cysteine peptidases; lysosomes; aging; protein turnover; proteolysis;
   rat (Sprague Dawley)
ID KININOGEN GENE-EXPRESSION; AMINO-ACID-SEQUENCES; MESSENGER-RNA LEVELS;
   CYSTEINE PROTEINASES; HUMAN-FIBROBLASTS; OLD RATS; BRAIN; CELLS;
   ACCUMULATION; AGE
AB Senescence has been proposed as an important safeguard against neoplasia. One of the hallmarks of cellular senescence in vitro as well as human aging in vivo is a reduced intracellular protein catabolism. The pathways affected and the mechanisms responsible for the decrease in overall protein turnover in aging cells are not well understood. Our aim was to determine whether or not expression of one of the major hepatic lysosomal cysteine peptidases, cathepsin B, changes during aging of Sprague-Dawley rats. Cathepsin B activity was assessed in whole rat liver homogenates, and was found to be increased fourfold (P less than or equal to0.001) in aged livers compared with younger counterparts. This was paralleled by an at least a twofold increase in mature cathepsin B protein. Nonetheless, Northern blot analysis of total liver RNA revealed no change in steady-state levels of cathepsin B mRNAs. These findings seem to contradict the present dogma according to which aging tissues have a reduced intracellular capacity to catabolise proteins. We propose that our earlier observation of the accumulation of T-kininogen, a potent but reversible cysteine peptidase inhibitor, in aging rat liver may provide a plausible explanation for this discrepancy.
C1 Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.
   Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA.
   Lankenau Med Res Ctr, Wynnewood, PA 19096 USA.
   Univ Chile, Inst Ciencias Biomed, Santiago, Chile.
C3 Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne
   State University; Lankenau Medical Center; Lankenau Institute for
   Medical Research; Universidad de Chile
RP Keppler, D (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, 540 E Canfield Ave, Detroit, MI 48201 USA.
RI Keppler, Daniel/B-4309-2012
FU NCI NIH HHS [CA-36481] Funding Source: Medline; NIA NIH HHS [AG 13902]
   Funding Source: Medline
CR ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685
   Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X
   AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   ASSFALGMACHLEIDT I, 1990, BIOL CHEM H-S, V371, P211
   BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189
   BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909
   BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
   BERNSTEIN HG, 1990, BRAIN RES BULL, V24, P543, DOI 10.1016/0361-9230(90)90157-U
   CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861
   CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721
   CHAO J, 1988, BIOCHIM BIOPHYS ACTA, V964, P329, DOI 10.1016/0304-4165(88)90033-5
   DICE JF, 1982, J BIOL CHEM, V257, P4624
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DIPAOLO BR, 1992, EXP CELL RES, V201, P500, DOI 10.1016/0014-4827(92)90300-W
   DOVRAT A, 1983, BIOCHIM BIOPHYS ACTA, V757, P164, DOI 10.1016/0304-4165(83)90104-6
   GRAF FM, 1983, J HISTOCHEM CYTOCHEM, V31, P803, DOI 10.1177/31.6.6341462
   HASNAIN S, 1992, J BIOL CHEM, V267, P4713
   HERWALD H, 1995, J BIOL CHEM, V270, P14634
   HIGASHI T, 1986, ACTA MED OKAYAMA, V40, P27
   HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47
   II K, 1985, J HISTOCHEM CYTOCHEM, V33, P1173, DOI 10.1177/33.11.4056381
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   KEPPLER D, 1988, CANCER RES, V48, P6855
   Keppler D, 1996, BIOL CHEM H-S, V377, P301, DOI 10.1515/bchm3.1996.377.5.301
   Keppler D, 1997, MECH AGEING DEV, V98, P151, DOI 10.1016/S0047-6374(97)00080-8
   Keppler D, 1996, BIOCHEM CELL BIOL, V74, P799, DOI 10.1139/o96-086
   KOMINAMI E, 1985, J BIOCHEM-TOKYO, V98, P87, DOI 10.1093/oxfordjournals.jbchem.a135277
   Lah TT, 1998, BIOL CHEM, V379, P125
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x
   MASON RW, 1985, BIOCHEM J, V226, P233, DOI 10.1042/bj2260233
   MATUS A, 1987, BIOCHEMISTRY-US, V26, P8083, DOI 10.1021/bi00399a010
   MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   MULLERESTERL W, 1986, TRENDS BIOCHEM SCI, V11, P336, DOI 10.1016/0968-0004(86)90293-8
   MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W
   NAKAMURA Y, 1991, NEUROSCI LETT, V130, P195, DOI 10.1016/0304-3940(91)90395-A
   Nishishita K, 1996, ARCH BIOCHEM BIOPHYS, V333, P349, DOI 10.1006/abbi.1996.0401
   OHKUBO I, 1984, BIOCHEMISTRY-US, V23, P5691, DOI 10.1021/bi00319a005
   PAN JX, 1993, EXP GERONTOL, V28, P39, DOI 10.1016/0531-5565(93)90018-9
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   REZNICK AZ, 1981, FEBS LETT, V128, P221, DOI 10.1016/0014-5793(81)80085-3
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   SANSEGUNDO B, 1986, FEBS LETT, V201, P251
   SIERRA F, 1992, J BIOL CHEM, V267, P10665
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   TAKAHASHI R, 1990, ARCH BIOCHEM BIOPHYS, V277, P228, DOI 10.1016/0003-9861(90)90573-H
   TAKAHASHI R, 1987, ARCH BIOCHEM BIOPHYS, V257, P200, DOI 10.1016/0003-9861(87)90559-5
   TAKIO K, 1983, P NATL ACAD SCI-BIOL, V80, P3666, DOI 10.1073/pnas.80.12.3666
   TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V208, P353, DOI 10.1006/bbrc.1995.1345
   Wang B, 1998, J BIOL CHEM, V273, P32000, DOI 10.1074/jbc.273.48.32000
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WIEDERANDERS B, 1984, MECH AGEING DEV, V24, P265, DOI 10.1016/0047-6374(84)90112-X
NR 55
TC 24
Z9 27
U1 0
U2 3
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD NOV
PY 2000
VL 302
IS 2
BP 181
EP 188
DI 10.1007/s004410000269
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 376AB
UT WOS:000165434700005
PM 11131129
DA 2024-02-19
ER

PT J
AU Nehme, J
   Yang, DB
   Altulea, A
   Varela-Eirin, M
   Wang, L
   Hu, SM
   Wu, YG
   Togo, J
   Niu, CQ
   Speakman, JR
   Demaria, M
AF Nehme, Jamil
   Yang, Dengbao
   Altulea, Abdullah
   Varela-Eirin, Marta
   Wang, Lu
   Hu, Sumei
   Wu, Yingga
   Togo, Jacques
   Niu, Chaoqun
   Speakman, John R.
   Demaria, Marco
TI High dietary protein and fat contents exacerbate hepatic senescence and
   SASP in mice
SO FEBS JOURNAL
LA English
DT Article; Early Access
DE inflammation; macronutrients composition; SASP; Senescence
ID CELLULAR SENESCENCE; LIFE-SPAN; RESTRICTION; LONGEVITY; HEALTH; RATIO
AB Dietary choices have a profound impact on the aging process. In addition to the total amount of energy intake, macronutrient composition influences both health and lifespan. However, the exact mechanisms by which dietary macronutrients influence onset and progression of age-associated features remain poorly understood. Cellular senescence is a state of stable growth arrest characterized by the secretion of numerous bioactive molecules with pro-inflammatory properties. Accumulation of senescent cells is considered one of the basic mechanisms of aging and an important contributor to chronic inflammation and tissue degeneration. Whether dietary macronutrients affect the accumulation and the phenotype of senescent cells with age is still unknown. Here, we show that feeding on diets with varying ratios of dietary macronutrients for 3 months has a significant effect on different senescence-associated markers in the mouse liver. High protein intake is associated with higher expression levels of the two classical senescence-associated growth arrest genes, p21 and p16. Furthermore, the expression of many pro-inflammatory secretory markers was increased in diets enriched in protein and further enhanced by increases in fat content. These results provide preliminary evidence that dietary macronutrients have a significant influence on senescence markers and merit further investigation.
C1 [Nehme, Jamil; Altulea, Abdullah; Varela-Eirin, Marta; Demaria, Marco] Univ Groningen RUG, Univ Med Ctr Groningen UMCG, European Res Inst Biol Ageing ERIBA, Antonius Deusinglaan, NL-9712 AV Groningen, Netherlands.
   [Nehme, Jamil] Lebanese Univ, Doctoral Sch Sci & Technol, Beirut, Lebanon.
   [Yang, Dengbao; Hu, Sumei; Wu, Yingga; Togo, Jacques; Niu, Chaoqun; Speakman, John R.] Beijing Technol & Business Univ, Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.
   [Wang, Lu] Yantai Univ, Sch Pharm, Yantai, Peoples R China.
   [Hu, Sumei] Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing Engn & Technol Res Ctr Food Addit, Natl Soybean Proc Ind Technol Innovat Ctr, Beijing, Peoples R China.
   [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.
C3 University of Groningen; Chinese Academy of Sciences; Institute of
   Genetics & Developmental Biology, CAS; Beijing Technology & Business
   University; Yantai University; Beijing Technology & Business University;
   University of Aberdeen
RP Demaria, M (corresponding author), Univ Groningen RUG, Univ Med Ctr Groningen UMCG, European Res Inst Biol Ageing ERIBA, Antonius Deusinglaan, NL-9712 AV Groningen, Netherlands.; Speakman, JR (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, 1 Beichen Xilu, Beijing 100101, Peoples R China.
EM j.speakman@abdn.co.uk; m.demaria@umcg.nl
RI Hu, Sumei/GYV-0191-2022; John, Speakman R/A-9494-2008
OI Hu, Sumei/0000-0002-3618-4492; Demaria, Marco/0000-0002-8429-4813; Niu,
   Chaoqun/0000-0003-4241-6082; yang, dengbao/0000-0001-7475-0320; Nehme,
   Jamil/0000-0003-2771-2043
FU National Council for Scientific Research-Lebanese University (CNRS-L)
   scholarship; Chinese Academy of Sciences strategic program [XDB
   13030100]; Dutch Cancer Foundation (KWF)
FX JN is supported by the National Council for Scientific Research-Lebanese
   University (CNRS-L) scholarship. MD is supported by grants from the
   Dutch Cancer Foundation (KWF). The original mouse macronutrient diet
   project that generated the samples was funded by the Chinese Academy of
   Sciences strategic program (Grant XDB 13030100).
CR Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Borghesan M, 2020, TRENDS CELL BIOL, V30, P777, DOI 10.1016/j.tcb.2020.07.002
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Carlsen H, 2009, GENES NUTR, V4, P215, DOI 10.1007/s12263-009-0133-6
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   Febbraio MA, 2014, TRENDS ENDOCRIN MET, V25, P312, DOI 10.1016/j.tem.2014.02.004
   Fontana L, 2018, AGING CELL, V17, DOI 10.1111/acel.12746
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Gu CM, 2008, INT J MOL SCI, V9, P464, DOI 10.3390/ijms9040464
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hu SM, 2018, CELL METAB, V28, P415, DOI 10.1016/j.cmet.2018.06.010
   Kitada M, 2019, EBIOMEDICINE, V43, P632, DOI 10.1016/j.ebiom.2019.04.005
   Korsheninnikova E, 2006, DIABETOLOGIA, V49, P3049, DOI 10.1007/s00125-006-0439-5
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Most J, 2017, AGEING RES REV, V39, P36, DOI 10.1016/j.arr.2016.08.005
   Narnikoshi T, 2007, AM J HYPERTENS, V20, P1085, DOI 10.1016/j.amjhyper.2007.05.007
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291
   Solon-Biet SM, 2015, CELL REP, V11, P1529, DOI 10.1016/j.celrep.2015.05.007
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Speakman JR, 2016, EXP GERONTOL, V86, P28, DOI 10.1016/j.exger.2016.03.011
   Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Sun Q, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3796
   Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
NR 36
TC 8
Z9 8
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD 2023 MAR
PY 2023
VL 290
IS 5
SI SI
BP 1340
EP 1347
DI 10.1111/febs.16292
EA DEC 2021
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 9L4VT
UT WOS:000730116000001
PM 34908245
OA Green Published
DA 2024-02-19
ER

PT J
AU CHATTERJEE, B
   ROY, AK
AF CHATTERJEE, B
   ROY, AK
TI CHANGES IN HEPATIC ANDROGEN SENSITIVITY AND GENE-EXPRESSION DURING AGING
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT 14TH MEETING OF THE INTERNATIONAL STUDY GROUP FOR STEROID HORMONES
CY NOV 30-DEC 02, 1989
CL ROME, ITALY
SP INT STUDY GRP STEROID HORMONES
ID RAT-LIVER; DEPENDENT SYNTHESIS; BINDING-PROTEIN; ALPHA-2U-GLOBULIN;
   RECEPTOR; GLOBULIN; FAMILY
AB The hepatic tissue of the male rat exhibits a gradual decline and ultimate loss in androgen responiveness during in vivo aging.  Appearance of the age-associated androgen insensitivity can be delayed by dietary calorie restriction, an effective means for life-span extension.  The androgen receptor mRNA is detectable in the liver only in its androgen-responsive state.  Pubertal appearance of hepatic androgen sensitivity is remarkably correlated with the concomitant appearance of a cytoplasmic androgen binding (CAB) protein.  Androgen resistance during senescence is associated with the loss of heptic CAB activity as well.  We are investigating the molecular basis for the temporal modulation of this hormone sensitivity through studies on the differential expression of two androgen-responsive marker genes.  These are the androgen-repressible SMP-2, and the androgen-inducible alpha-2u-globulin.  Androgen resistance of hepatocytes during aging results in repression of the alpha-2u-globulin gene, and derepression of the SMP-2 gene.  The structural organizations for both of these genes have been characterized.  The role of nuclear transcription factors (androgen receptor and any other transacting factor(s) which may be involved) in the coordinate regulation of alpha-2u-globulin and SMP-2 during aging and nutritional manipulation is being explored to establish the molecular mechanism of andropause in the liver.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT OBSTET & GYNECOL,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP CHATTERJEE, B (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284, USA.
FU NIDDK NIH HHS [DK-14744] Funding Source: Medline
CR BISHOP JO, 1985, MOL CELL BIOL, V7, P1591
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   DEMYAN WF, 1989, BIOCHEMISTRY-US, V28, P1732, DOI 10.1021/bi00430a046
   DOLAN KP, 1982, J BIOL CHEM, V257, P13527
   KURTZ D T, 1981, Journal of Molecular and Applied Genetics, V1, P29
   MASORO EJ, 1988, J GERONTOL BIOL SCI, V43, P1359
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MILIN B, 1973, NATURE-NEW BIOL, V242, P248, DOI 10.1038/newbio242248a0
   MOTWANI NM, 1984, J BIOL CHEM, V259, P3653
   MURTY CVR, 1988, BIOCHIM BIOPHYS ACTA, V949, P27, DOI 10.1016/0167-4781(88)90050-4
   ROY AK, 1982, J BIOL CHEM, V257, P7834
   ROY AK, 1985, MOL ASPECTS MED, V8, P1, DOI 10.1016/0098-2997(85)90004-4
   ROY AK, 1974, BIOCHIM BIOPHYS ACTA, V354, P213, DOI 10.1016/0304-4165(74)90008-7
   ROY AK, 1983, J BIOL CHEM, V258, P123
   ROY AK, 1988, CROSSROADS AGING, P73
   ROY AK, 1984, MOL BASIS AGING, P143
   SARKAR FH, 1987, BIOCHEMISTRY-US, V26, P3965, DOI 10.1021/bi00387a033
   SHAIN SA, 1977, MECH AGEING DEV, V6, P219, DOI 10.1016/0047-6374(77)90023-9
   SONG CS, 1990, IN PRESS BIOCHEMISTR
   WEINDRUCH R, 1983, RETARDATION AGING DI
NR 22
TC 18
Z9 18
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD NOV 20
PY 1990
VL 37
IS 3
BP 437
EP 445
DI 10.1016/0960-0760(90)90495-7
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA ER476
UT WOS:A1990ER47600017
PM 2257247
DA 2024-02-19
ER

PT J
AU Safwan-Zaiter, H
   Wagner, N
   Michiels, JF
   Wagner, KD
AF Safwan-Zaiter, Hasan
   Wagner, Nicole
   Michiels, Jean-Francois
   Wagner, Kay-Dietrich
TI Dynamic Spatiotemporal Expression Pattern of the Senescence-Associated
   Factor p16Ink4a in Development and Aging
SO CELLS
LA English
DT Article
DE aging; endothelial cells; development; liver; heart; brain; kidney;
   senescence; SASP
ID CELLULAR SENESCENCE; TUMOR-SUPPRESSOR; SECRETORY PHENOTYPE; INK4A LOCUS;
   MOUSE-BRAIN; HUMAN-CELLS; DNA-DAMAGE; IN-VIVO; P16(INK4A); PROLIFERATION
AB A plethora of factors have been attributed to underly aging, including oxidative stress, telomere shortening and cellular senescence. Several studies have shown a significant role of the cyclin-dependent kinase inhibitor p16ink4a in senescence and aging. However, its expression in development has been less well documented. Therefore, to further clarify a potential role of p16 in development and aging, we conducted a developmental expression study of p16, as well as of p19ARF and p21, and investigated their expression on the RNA level in brain, heart, liver, and kidney of mice at embryonic, postnatal, adult, and old ages. P16 expression was further assessed on the protein level by immunohistochemistry. Expression of p16 was highly dynamic in all organs in embryonic and postnatal stages and increased dramatically in old mice. Expression of p19 and p21 was less variable and increased to a moderate extent at old age. In addition, we observed a predominant expression of p16 mRNA and protein in liver endothelial cells versus non-endothelial cells of old mice, which suggests a functional role specifically in liver endothelium of old subjects. Thus, p16 dynamic spatiotemporal expression might implicate p16 in developmental and physiological processes in addition to its well-known function in the build-up of senescence.
C1 [Safwan-Zaiter, Hasan; Wagner, Nicole; Wagner, Kay-Dietrich] Univ Cote dAzur, IBV, Natl Inst Hlth & Med Res INSERM, Natl Ctr Sci Res CNRS, F-06107 Nice, France.
   [Michiels, Jean-Francois] CHU Nice, Dept Pathol, F-06107 Nice, France.
C3 Universite Cote d'Azur; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS);
   CHU Nice
RP Wagner, N; Wagner, KD (corresponding author), Univ Cote dAzur, IBV, Natl Inst Hlth & Med Res INSERM, Natl Ctr Sci Res CNRS, F-06107 Nice, France.
EM Hasan.Safwan-Zaiter@unice.fr; nwagner@unice.fr; michiels.jf@chu-nice.fr;
   kwagner@unice.fr
OI Wagner, Nicole/0000-0002-2746-0707; Wagner, Kay-D./0000-0001-5483-7760
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Lopez-Dominguez JA, 2021, AGING-US, V13, P13380, DOI 10.18632/aging.203110
   ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306
   An ST, 2015, MOL MED REP, V12, P5911, DOI 10.3892/mmr.2015.4133
   Best BP, 2009, REJUV RES, V12, P199, DOI 10.1089/rej.2009.0847
   Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305
   Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chambers CR, 2021, MOL ONCOL, V15, P3242, DOI 10.1002/1878-0261.13042
   Cheong C, 2006, MECH AGEING DEV, V127, P633, DOI 10.1016/j.mad.2006.02.010
   Collins CJ, 2003, AGING CELL, V2, P145, DOI 10.1046/j.1474-9728.2003.00048.x
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Domínguez-Bautista JA, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.587096
   El Maï M, 2014, CELL REP, V9, P1047, DOI 10.1016/j.celrep.2014.09.038
   Faulkner A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63900-0
   Freitas AA, 2011, MUTAT RES-REV MUTAT, V728, P12, DOI 10.1016/j.mrrev.2011.05.001
   Frescas D, 2017, CELL CYCLE, V16, P1526, DOI 10.1080/15384101.2017.1339850
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Hall BM, 2016, AGING-US, V8, P1294, DOI 10.18632/aging.100991
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Henry AM, 2012, MAMM GENOME, V23, P539, DOI 10.1007/s00335-012-9406-2
   Hosako H, 2009, BIRTH DEFECTS RES B, V86, P40, DOI 10.1002/bdrb.20180
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7
   Hudgins AD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00059
   Idda ML, 2020, AGING-US, V12, P4052, DOI 10.18632/aging.102903
   Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   Li Y, 2018, CELL RES, V28, P775, DOI 10.1038/s41422-018-0050-6
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Lv FQ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00176
   Lv FQ, 2017, BIOCHEM BIOPH RES CO, V486, P264, DOI 10.1016/j.bbrc.2017.03.023
   McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331
   MEYER BR, 1989, J AM GERIATR SOC, V37, P791, DOI 10.1111/j.1532-5415.1989.tb02244.x
   Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Minami R, 2003, EXP HEMATOL, V31, P355, DOI 10.1016/S0301-472X(03)00040-7
   Misra Debashish, 2004, Clin Adv Hematol Oncol, V2, P457
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Munro J, 2004, EXP CELL RES, V295, P525, DOI 10.1016/j.yexcr.2004.01.017
   Nacher V, 2010, CELLS TISSUES ORGANS, V191, P84, DOI 10.1159/000231478
   Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Ohtani N, 2009, CANCER SCI, V100, P792, DOI 10.1111/j.1349-7006.2009.01123.x
   PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329
   PARRY D, 1995, EMBO J, V14, P503, DOI 10.1002/j.1460-2075.1995.tb07026.x
   Pulido T, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111561
   QUELLE DE, 1995, CELL, V83, P993
   Ramly E, 2015, SURG CLIN N AM, V95, P53, DOI 10.1016/j.suc.2014.09.009
   Rhinn M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151837
   ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0
   Sato S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8035
   Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0
   Shamloo B, 2019, CANCERS, V11, DOI 10.3390/cancers11081178
   Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592
   Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33
   Sladky VC, 2020, DEV CELL, V52, P335, DOI 10.1016/j.devcel.2019.12.016
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Takeuchi S, 2010, CANCER RES, V70, P9381, DOI 10.1158/0008-5472.CAN-10-0801
   Tchkonia T, 2018, JAMA-J AM MED ASSOC, V320, P1319, DOI 10.1001/jama.2018.12440
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tung S, 2007, ANN NY ACAD SCI, V1116, P499, DOI 10.1196/annals.1402.080
   Vasey DB, 2011, TRANSGENIC RES, V20, P23, DOI 10.1007/s11248-010-9385-6
   Wagner KD, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121623
   Wagner KD, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010041
   Wagner KD, 2017, AGING-US, V9, P1219, DOI 10.18632/aging.101223
   Wagner KD, 2016, PPAR RES, V2016, DOI 10.1155/2016/7631085
   Wagner KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6852
   Wagner N, 2008, ONCOGENE, V27, P3662, DOI 10.1038/sj.onc.1211044
   Wagner N, 2006, AM J PHYSIOL-REG I, V291, pR779, DOI 10.1152/ajpregu.00219.2006
   Wagner N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147675
   Wagner N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094346
   Wagner N, 2011, HUM MOL GENET, V20, P2182, DOI 10.1093/hmg/ddr106
   Wang X, 2020, CELL RES, V30, P1109, DOI 10.1038/s41422-020-0378-6
   Wanner E, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.620089
   Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8
   Wu TB, 2022, CIRCULATION, V145, P586, DOI 10.1161/CIRCULATIONAHA.121.056666
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
   Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691
   Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 94
TC 12
Z9 13
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD FEB
PY 2022
VL 11
IS 3
AR 541
DI 10.3390/cells11030541
PG 20
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA ZA2VP
UT WOS:000756027800001
PM 35159350
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Jin, CJ
   Baumann, A
   Brandt, A
   Engstler, AJ
   Nier, A
   Hege, M
   Schmeer, C
   Kehm, R
   Höhn, A
   Grune, T
   Witte, OW
   Bergheim, I
AF Jin, Cheng Jun
   Baumann, Anja
   Brandt, Annette
   Engstler, Anna Janina
   Nier, Anika
   Hege, Marianne
   Schmeer, Christian
   Kehm, Richard
   Hoehn, Annika
   Grune, Tilman
   Witte, Otto W.
   Bergheim, Ina
TI Aging-related liver degeneration is associated with increased bacterial
   endotoxin and lipopolysaccharide binding protein levels
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE aging; bacterial endotoxin; lipopolysaccharide binding protein; liver
   degeneration; Tlr-4 signaling
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; NONALCOHOLIC STEATOHEPATITIS; HEPATIC
   STEATOSIS; KUPFFER CELLS; AGE; MICE; SUPPLEMENTATION; LONGEVITY;
   APOPTOSIS; INSULIN
AB Aging is a risk factor in the development of many diseases, including liver-related diseases. The two aims of the present study were 1) to determine how aging affects liver health in mice in the absence of any interventions and 2) if degenerations observed in relation to blood endotoxin levels are critical in aging-associated liver degeneration. Endotoxin levels and markers of liver damage, mitochondrial dysfunction, insulin resistance, and apoptosis as well as the Toll-like receptor 4 (Tlr-4) signaling cascade were studied in liver tissue and blood, respectively, of 3- and 24-mo-old male C57BL/6J mice. In a second set of experiments, 3- to 4-mo-old and 14-mo-old female lipopolysaccharide-binding protein (LBP)(-/-) mice and littermates fed standard chow, markers of liver damage, insulin resistance, and mitochondrial dysfunction were assessed. Plasma activity of aspartate aminotransferase and histological signs of hepatic inflammation and fibrosis were significantly higher in old C57BL/6J mice than in young animals. The number of neutrophils, CD8 alpha-positive cells, and mRNA expression of markers of apoptosis were also significantly higher in livers of old C57BL/6J mice compared with young animals, being also associated with a significant induction of hepatic Tlr-4 and LBP expression as well as higher endotoxin levels in peripheral blood. Compared with age-matched littermates, LBP-/- mice display less signs of senescence in liver. Taken together, our data suggest that, despite being fed standard chow, old mice developed liver inflammation and beginning fibrosis and that bacterial endotoxin may play a critical role herein.
   NEW & NOTEWORTHY Old age in mice is associated with marked signs of liver degeneration, hepatic inflammation, and fibrosis. Aging-associated liver degeneration is associated with elevated bacterial endotoxin levels and an induction of lipopolysaccharide-binding protein (LBP) and Toll-like receptor 4-dependent signaling cascades in liver tissue. Furthermore, in old aged LBP-/- mice, markers of senescence seem to be lessened, supporting the hypothesis that bacterial endotoxin levels might be critical in aging-associated decline of liver.
C1 [Jin, Cheng Jun; Baumann, Anja; Brandt, Annette; Engstler, Anna Janina; Nier, Anika; Hege, Marianne; Bergheim, Ina] Friedrich Schiller Univ Jena, Inst Nutr, SD Model Syst Mol Nutr, Jena, Germany.
   [Jin, Cheng Jun] Heinrich Heine Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany.
   [Baumann, Anja; Brandt, Annette; Engstler, Anna Janina; Nier, Anika; Bergheim, Ina] Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Althanstr 14 UZA 2, A-1090 Vienna, Austria.
   [Schmeer, Christian; Witte, Otto W.] Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany.
   [Kehm, Richard; Hoehn, Annika; Grune, Tilman] German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany.
   [Grune, Tilman] German Ctr Diabet Res, Munich, Germany.
C3 Friedrich Schiller University of Jena; Heinrich Heine University
   Dusseldorf; University of Vienna; Friedrich Schiller University of Jena;
   Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)
RP Bergheim, I (corresponding author), Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Althanstr 14 UZA 2, A-1090 Vienna, Austria.
EM ina.bergheim@univie.ac.at
RI Brandt, Annette/HNC-3045-2023
OI Nier, Anika/0000-0003-3772-2261; Grune, Tilman/0000-0003-4775-9973;
   Schmeer, Christian/0000-0002-2289-0126; Hohn,
   Annika/0000-0003-1306-2668; Brandt, Annette/0000-0002-3934-747X; Kehm,
   Richard/0000-0002-2993-4291
FU Deutsche Forschungsgemeinschaft (DFG) [FKZ: BE2376/8-1]
FX This research was in part funded by a grant from the Deutsche
   Forschungsgemeinschaft (DFG) (IB: FKZ: BE2376/8-1).
CR Abdelmegeed MA, 2016, FREE RADICAL BIO MED, V91, P188, DOI 10.1016/j.freeradbiomed.2015.12.016
   Bergheim I, 2006, J PHARMACOL EXP THER, V316, P592, DOI 10.1124/jpet.105.095042
   Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035
   Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006
   Bharrhan S, 2012, INNATE IMMUN-LONDON, V18, P70, DOI 10.1177/1753425910393369
   BRUSSOW H, 1995, CLIN DIAGN LAB IMMUN, V2, P272
   Buddhan S, 2007, PROSTAG LEUKOTR ESS, V76, P349, DOI 10.1016/j.plefa.2007.05.001
   Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834
   Farrell GC, 2014, LIVER INT, V34, P1084, DOI 10.1111/liv.12335
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Ghosh S, 2015, J GERONTOL A-BIOL, V70, P232, DOI 10.1093/gerona/glu067
   GOTO T, 1994, CLIN DIAGN LAB IMMUN, V1, P684, DOI 10.1128/CDLI.1.6.684-688.1994
   Henao-Mejia J, 2013, J AUTOIMMUN, V46, P66, DOI 10.1016/j.jaut.2013.07.001
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622
   Jin CJ, 2017, J GASTROEN HEPATOL, V32, P708, DOI 10.1111/jgh.13488
   Jin CJ, 2015, BRIT J NUTR, V114, P1745, DOI 10.1017/S0007114515003621
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kirpich Irina A, 2015, Clin Liver Dis (Hoboken), V6, P55
   Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012
   LASKIN DL, 1995, HEPATOLOGY, V22, P223, DOI 10.1002/hep.1840220133
   Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Liu HM, 2014, J GERONTOL A-BIOL, V69, P1485, DOI 10.1093/gerona/glt188
   McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092
   Musrati RA, 1998, GEN PHYSIOL BIOPHYS, V17, P193
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Page MM, 2013, AGE, V35, P647, DOI 10.1007/s11357-012-9395-9
   Qureshi AA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-239
   Saffrey MJ, 2014, AGE, V36, P1019, DOI 10.1007/s11357-013-9603-2
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sellmann C, 2017, J NUTR, V147, P2041, DOI 10.3945/jn.117.253815
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   Soudi S, 2013, CELL J, V15, P45
   Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75
   Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122
   STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Tsukamoto H, 2013, J IMMUNOL, V190, P195, DOI 10.4049/jimmunol.1201047
   Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451
   Videla LA, 2001, REDOX REP, V6, P155, DOI 10.1179/135100001101536265
   Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983
   Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051
   Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833
   Yang CJ, 2012, BIOSCIENCE REP, V32, P465, DOI 10.1042/BSR20120034
   Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328
NR 56
TC 22
Z9 22
U1 0
U2 7
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD APR
PY 2020
VL 318
IS 4
BP G736
EP G747
DI 10.1152/ajpgi.00345.2018
PG 12
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Gastroenterology & Hepatology; Physiology
GA LE5TU
UT WOS:000526783800012
PM 32090603
OA Bronze
DA 2024-02-19
ER

PT J
AU Park, J
   Kim, J
   Chen, YQ
   Song, HC
   Chen, YB
   Zheng, M
   Surh, YJ
   Kim, UH
   Park, JW
   Joe, Y
   Chung, HT
AF Park, Jeongmin
   Kim, Jin
   Chen, Yingqing
   Song, Hyun-Chul
   Chen, Yubing
   Zheng, Min
   Surh, Young-Joon
   Kim, Uh-Hyun
   Park, Jeong Woo
   Joe, Yeonsoo
   Chung, Hun Taeg
TI CO ameliorates cellular senescence and aging by modulating the
   miR-34a/Sirt1 pathway
SO FREE RADICAL RESEARCH
LA English
DT Article; Early Access
DE Caenorhabditis elegans; carbon monoxide; haemoxygenase; miR-34a;
   oxidative stress; senescence-associated secretory phenotype; Sirt1
ID CARBON-MONOXIDE; HEME OXYGENASE-1; P53 NETWORK; LIFE-SPAN; STRESS;
   KINASE; ACTIVATION; INDUCTION; SIRT1; ISCHEMIA/REPERFUSION
AB Oxidative stress is recognised as a key factor that can lead to cellular senescence and aging. Carbon monoxide (CO) is produced by haemoxygenase-1 (HO-1), which exerts cytoprotective effects in aging-related diseases, whereas the effect of CO on cellular senescence and aging has not been elucidated. In the current study, we clearly demonstrated that CO delays the process of cellular senescence and aging through regulation of miR-34a and Sirt1 expression. CO reduced H2O2-induced premature senescence in human diploid fibroblast WI-38 cells measured with SA-beta-Gal-staining. Furthermore, CO significantly decreased the expression of senescence-associated secretory phenotype (SASP), including TNF-alpha IL-6, and PAI-1 and increased the transcriptional levels of antioxidant genes, such as HO-1 and NQO1. Moreover, CO apparently enhanced the expression of Sirt1 through down-regulation of miR-34a. Next, to determine whether Sirt1 mediates the inhibitory effect of CO on cellular senescence, we pre-treated WI-38 cells with the Sirt1 inhibitor Ex527 and a miR-34a mimic followed by the administration of H2O2 and evaluated the expression of SASP and antioxidant genes as well as ROS production. According to our results, Sirt1 is crucial for the antiaging and antioxidant effects of CO. Finally, CO prolonged the lifespan of Caenorhabditis elegans and delayed high-fat diet-induced liver aging. Taken together, these findings demonstrate that CO reduces cellular senescence and liver aging through the regulation of miR-34a and Sirt1.
C1 [Park, Jeongmin; Kim, Jin; Song, Hyun-Chul; Chen, Yubing; Park, Jeong Woo; Joe, Yeonsoo; Chung, Hun Taeg] Univ Ulsan, Dept Biol Sci, Ulsan, South Korea.
   [Chen, Yingqing; Kim, Uh-Hyun] Chonbuk Natl Univ, Med Sch, Natl Creat Res Lab Ca2 Signaling Network, Jeonju, South Korea.
   [Chen, Yingqing] Dalian Univ, Med Coll, Dept Pharmacol, Dalian, Peoples R China.
   [Zheng, Min] Yanbian Univ, Affliated Hosp, Dept Neurol, Yanji, Peoples R China.
   [Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea.
   [Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea.
C3 University of Ulsan; Jeonbuk National University; Dalian University;
   Yanbian University; Seoul National University (SNU); Seoul National
   University (SNU)
RP Chung, HT (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan, South Korea.
EM chung@ulsan.ac.kr
RI Chen, Yingqing/AAH-1367-2020
OI Chen, Yingqing/0000-0003-2326-7587
FU Priority Research Centres Programme through the National Research
   Foundation of Korea (NRF) - Ministry of Education [2014R1A6A1030318,
   NRF-019R1I1A3A01058874]; National Natural Science Foundation of China
   [81460212]
FX This work was supported by the Priority Research Centres Programme
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education [2014R1A6A1030318 and NRF-019R1I1A3A01058874] to
   H.T.C. and by National Natural Science Foundation of China [No.
   81460212] to Min Zheng.
CR APPLEGATE LA, 1991, CANCER RES, V51, P974
   Botden IPG, 2012, CLIN SCI, V123, P499, DOI 10.1042/CS20110679
   Brandl A, 2011, EXP CELL RES, V317, P1541, DOI 10.1016/j.yexcr.2011.02.015
   BRENNER S, 1974, GENETICS, V77, P71
   Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chai DD, 2018, CELL PHYSIOL BIOCHEM, V46, P781, DOI 10.1159/000488736
   Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08
   Coluzzi E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010019
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065
   Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729
   Even B, 2018, AGING CELL, V17, DOI 10.1111/acel.12837
   EWING JF, 1992, J NEUROCHEM, V58, P1140, DOI 10.1111/j.1471-4159.1992.tb09373.x
   Frey N, 2018, NAT REV GASTRO HEPAT, V15, P81, DOI 10.1038/nrgastro.2017.146
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hayashi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117677
   He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232
   Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Joe Y, 2018, FASEB J, V32, P2630, DOI 10.1096/fj.201700709RR
   Kim HJ, 2015, BBA-MOL BASIS DIS, V1852, P1550, DOI 10.1016/j.bbadis.2015.04.017
   Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781
   Kulkarni SR, 2014, ANTIOXID REDOX SIGN, V20, P15, DOI 10.1089/ars.2012.5082
   Liu DP, 2011, ANTIOXID REDOX SIGN, V15, P1669, DOI 10.1089/ars.2010.3644
   Liu T, 2018, INT J BIOL MACROMOL, V117, P225, DOI 10.1016/j.ijbiomac.2018.05.174
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Motterlini R, 2004, FASEB J, V18, P284, DOI 10.1096/fj.04-2169fje
   Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530
   Motterlini R, 1998, CIRC RES, V83, P568, DOI 10.1161/01.RES.83.5.568
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680
   Otterbein LE, 2016, CIRC RES, V118, P1940, DOI 10.1161/CIRCRESAHA.116.306588
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Shan HT, 2019, EBIOMEDICINE, V39, P59, DOI 10.1016/j.ebiom.2018.11.056
   Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271
   Suh N, 2017, BMB REP, V50, P572, DOI 10.5483/BMBRep.2017.50.11.174
   Szkudelski T, 2017, BIOMED PHARMACOTHER, V87, P375, DOI 10.1016/j.biopha.2016.12.060
   Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101
   Wang JP, 2016, BIOL TRACE ELEM RES, V170, P415, DOI 10.1007/s12011-015-0475-4
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068
NR 48
TC 3
Z9 3
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD 2020 DEC 1
PY 2020
VL 54
IS 11-12
SI SI
BP 848
EP 858
DI 10.1080/10715762.2019.1710142
EA MAR 2020
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA SK5NU
UT WOS:000524569800001
PM 32228197
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Zhang, J
   Wang, M
   Zhang, ZW
   Luo, ZG
   Liu, F
   Liu, J
AF Zhang, Jun
   Wang, Miao
   Zhang, Zuowei
   Luo, Zhongguang
   Liu, Fei
   Liu, Jie
TI Celecoxib derivative OSU-03012 inhibits the proliferation and activation
   of hepatic stellate cells by inducing cell senescence
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE liver fibrosis; hepatic stellate cell; OSU-03012; senescence
ID LIVER FIBROSIS; MECHANISMS; CANCER; P27(KIP1); GROWTH; AKT
AB Liver fibrosis may lead to portal hypertension, liver failure or hepatocellular carcinoma, and predominantly results from the proliferation and activation of hepatic stellate cells. OSU-03012, a non-cyclooxygenase-inhibiting celecoxib derivative, has been previously demonstrated to promote apoptosis in certain cell types, however, its function in hepatic fibrosis remains unclear. In the current study, the inhibitory effect of OSU-03012 on the proliferation of the LX2 human hepatic stellate cell line was evaluated by cell counting kit-8 assay. Reverse transcription-quantitative polymerase chain reaction was performed in order to examine the expression of -smooth muscle actin and type I collagen, which are representative of LX2 cell activation. The senescence of LX2 cells was measured by senescence-associated -galactosidase staining, and the cell cycle and apoptosis levels were assessed by flow cytometry. The impact of senescence-associated signaling on protein expression was assessed by western blot analysis. OSU-03012 was observed to inhibit cell proliferation and prevent the secretion of profibrotic factors in LX2 cells in a dose-dependent manner. Furthermore, the results demonstrated that OSU-03012 inhibited the proliferation and activation of LX2 via the induction of cell senescence at the G(1) phase, rather than via cell apoptosis. The induction of senescence may be via the upregulation of p16, p21 and p27. In conclusion, the current study provided insight into the pharmacological mechanisms of OSU-03012 in preventing the proliferation and activation of hepatic stellate cells through cell senescence. The current study supports the theory that OSU-03012 is a novel agent for potential use against liver fibrosis.
C1 [Zhang, Jun; Zhang, Zuowei; Luo, Zhongguang; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200040, Peoples R China.
   [Wang, Miao; Liu, Fei] Shanghai Tongji Univ, Shanghai East Hosp, Dept Gastroenterol, Sch Med, Shanghai 200120, Peoples R China.
   [Zhang, Zuowei; Liu, Jie] Fudan Univ, Shanghai Med Sch, Inst Biomed Sci, Shanghai 200032, Peoples R China.
   [Zhang, Zuowei; Liu, Jie] Fudan Univ, Shanghai Med Sch, Dept Immunol, Shanghai 200032, Peoples R China.
C3 Fudan University; Tongji University; Fudan University; Fudan University
RP Liu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Digest Dis, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.
EM liufeiguo2010@163.com; jieliu@fudan.edu.cn
RI wang, wei/JBS-7400-2023; Luo, Zhongguang/HKM-5966-2023; li,
   zhang/JHV-1750-2023; Wang, Guang/JFS-8374-2023; zhang,
   lin/IZQ-4870-2023; wang, jiahui/IXD-1197-2023; liu, peng/JSL-1931-2023
OI Luo, Zhongguang/0000-0002-7620-307X; 
FU National Natural Science Foundation of China [81125001, 91129702,
   81300327, 81170405]
FX The current study was supported by the National Natural Science
   Foundation of China (grant nos. 81125001, 91129702, 81300327 and
   81170405).
CR Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642
   Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542
   Johnson AJ, 2005, BLOOD, V105, P2504, DOI 10.1182/blood-2004-05-1957
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kucab JE, 2005, BREAST CANCER RES, V7, pR796, DOI 10.1186/bcr1294
   Li JN, 2006, J GASTROINTEST SURG, V10, P207, DOI 10.1016/j.gassur.2005.07.025
   Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198
   McCubrey JA, 2006, MOL PHARMACOL, V70, P437, DOI 10.1124/mol.106.026252
   Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115
   Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603
   Wang YC, 2008, CANCER RES, V68, P2820, DOI 10.1158/0008-5472.CAN-07-1336
   Weng SC, 2008, MOL CANCER THER, V7, P800, DOI 10.1158/1535-7163.MCT-07-0434
   Yacoub A, 2006, MOL PHARMACOL, V70, P589, DOI 10.1124/mol.106.025007
   Zhang S, 2007, CLIN CANCER RES, V13, P4750, DOI 10.1158/1078-0432.CCR-07-0136
   Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063
NR 21
TC 15
Z9 16
U1 0
U2 17
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD APR
PY 2015
VL 11
IS 4
BP 3021
EP 3026
DI 10.3892/mmr.2014.3048
PG 6
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA CE3FG
UT WOS:000351711100092
PM 25482718
OA Bronze
DA 2024-02-19
ER

PT J
AU Shriki, A
   Lanton, T
   Sonnenblick, A
   Levkovitch-Siany, O
   Eidelshtein, D
   Abramovitch, R
   Rosenberg, N
   Pappo, O
   Elgavish, S
   Nevo, Y
   Safadi, R
   Peled, A
   Rose-John, S
   Galun, E
   Axelrod, JH
AF Shriki, Anat
   Lanton, Tali
   Sonnenblick, Amir
   Levkovitch-Siany, Orr
   Eidelshtein, Dana
   Abramovitch, Rinat
   Rosenberg, Nofar
   Pappo, Orit
   Elgavish, Sharona
   Nevo, Yuval
   Safadi, Rifaat
   Peled, Amnon
   Rose-John, Stefan
   Galun, Eithan
   Axelrod, Jonathan H.
TI Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence
   Aggregate to Suppress Tumorigenesis
SO CANCER RESEARCH
LA English
DT Article
ID NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; GENOMIC INSTABILITY;
   STELLATE CELLS; MURINE MODEL; BILE-ACIDS; INFLAMMATION; INTERLEUKIN-6;
   HEPATOCYTES
AB Hepatocellular carcinoma (HCC) typically develops on a background of chronic hepatitis for which the proinflammatory cytokine IL6 is conventionally considered a crucial driving factor. Paradoxically, IL6 also acts as a hepatoprotective factor in chronic liver injury. Here we used the multidrug-resistant gene 2 knockout (Mdr2(-/-)) mouse model to elucidate potential roles of IL6 in chronic hepatitis-associated liver cancer. Long-term analysis of three separate IL6/Stat3 signaling-deficient Mdr2(-/-) strains revealed aggravated liver injury with increased dysplastic nodule formation and significantly accelerated tumorigenesis in all strains. Tumorigenesis in the IL6/Stat3-perturbed models was strongly associated with enhanced macrophage accumulation and hepatosteatosis, phenotypes of nonalcoholic steatohepatitis (NASH), as well as with significant reductions in senescence and the senescence-associated secretory phenotype (SASP) accompanied by increased hepatocyte proliferation. These findings reveal a crucial suppressive role for IL6/Stat3 signaling in chronic hepatitis-associated hepatocarcinogenesis by impeding protumorigenic NASH-associated phenotypes and by reinforcing the antitumorigenic effects of the SASP.
   Significance: These findings describe a context-dependent role of IL6 signaling in hepatocarcinogenesis and predict that increased IL6-neutralizing sgp130 levels in some patients with NASH may herald early HCC development.
C1 [Shriki, Anat; Lanton, Tali; Levkovitch-Siany, Orr; Eidelshtein, Dana; Abramovitch, Rinat; Rosenberg, Nofar; Peled, Amnon; Galun, Eithan; Axelrod, Jonathan H.] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, POB 12000, IL-91120 Jerusalem, Israel.
   [Sonnenblick, Amir] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Oncol Div, Tel Aviv, Israel.
   [Sonnenblick, Amir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Abramovitch, Rinat] Hadassah Univ, Human Biol Res Ctr, Wohl Inst Translat Med, Med Ctr, Jerusalem, Israel.
   [Pappo, Orit] Hadassah Hebrew Univ Hosp, Dept Pathol, Jerusalem, Israel.
   [Elgavish, Sharona; Nevo, Yuval] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Hadassah Med Sch, Bioinformat Unit,Fac Med, Jerusalem, Israel.
   [Safadi, Rifaat] Hadassah Hebrew Univ Hosp, Liver Unit, Jerusalem, Israel.
   [Rose-John, Stefan] Christian Albrechts Univ Kiel, Inst Biochem, Kiel, Germany.
C3 Hebrew University of Jerusalem; Hadassah University Medical Center;
   Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Sackler
   Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University
   Medical Center; Hebrew University of Jerusalem; Hadassah University
   Medical Center; Hebrew University of Jerusalem; Hebrew University of
   Jerusalem; Hadassah University Medical Center; University of Kiel
RP Galun, E; Axelrod, JH (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, POB 12000, IL-91120 Jerusalem, Israel.
EM eithang@hadassah.org.il; axelrod@hadassah.org.il
RI Rose-John, Stefan/A-7998-2010; Galun, Eithan/AAD-9117-2022
OI Rose-John, Stefan/0000-0002-7519-3279; Galun, Eithan/0000-0002-6243-6702
FU Israel Science Foundation [ISF1728/11]; Israel Cancer Research Fund
   [8004906]; ISF [2473/2017]; personal ISF [486/2017]; ISF; ICORE [ISF
   41/2011]; Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB841,
   SFB877]; ERC [786575]; Israel Ministry of Science and Technology (MOST);
   Kron foundation; Raskin foundation; Robert Benson foundation; Cluster of
   Excellence "Inflammation at Interfaces"; Kass Research Award-American
   Physicians Fellowship for Medicine in Israel; Israel Cancer Association;
   Israel Cancer Research Foundation Fellowship; Hadassah Medical Center
   Internal Grant; Morasha Program of the Israel Science Foundation grant
   [ISF1728/11]; European Research Council (ERC) [786575] Funding Source:
   European Research Council (ERC)
FX The authors are grateful to Deborah Olam for excellent technical
   assistance, to Neta Barashi for helpful discussions and advice, to Tali
   Bdolah-Abram for expert advice on statistical evaluations, and to the
   Core Research Facility (CRF) and staff members at The Faculty of
   Medicine, the Hebrew University of Jerusalem. J.H. Axelrod was supported
   by grants to from the Israel Science Foundation (ISF 923/14) and the
   Israel Cancer Research Fund (8004906). The work of E. Galun was
   supported by grants from the ISF collaboration with Canada (2473/2017),
   the personal ISF (486/2017) and the ISF and ICORE (ISF 41/2011), the
   Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB841), and the ERC
   advance -GA number 786575 -RxmiRcanceR (to E. Galun) and the Israel
   Ministry of Science and Technology (MOST). The work of E. Galun was also
   supported by the Kron, Raskin, and Robert Benson foundations. The work
   of S. Rose-John was supported by the Deutsche Forschungsgemeinschaft,
   Bonn, Germany (SFB877, Project A1; SFB841, Project C1) and by the
   Cluster of Excellence "Inflammation at Interfaces." A. Sonnenblick was
   supported by grants from the Kass Research Award-American Physicians
   Fellowship for Medicine in Israel, the Israel Cancer Association, Israel
   Cancer Research Foundation Fellowship, Hadassah Medical Center Internal
   Grant, and the Morasha Program of the Israel Science Foundation grant
   (ISF1728/11). fact.
CR Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Barash H, 2010, P NATL ACAD SCI USA, V107, P2207, DOI 10.1073/pnas.0908867107
   Barashi N, 2013, HEPATOLOGY, V58, P1021, DOI 10.1002/hep.26403
   Bergmann J, 2017, HEPATOLOGY, V65, P89, DOI 10.1002/hep.28874
   Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557
   Carloni V, 2014, LIVER INT, V34, P834, DOI 10.1111/liv.12465
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Coulouarn C, 2014, J HEPATOL, V60, P1306, DOI 10.1016/j.jhep.2014.02.003
   Date M, 1998, J HEPATOL, V28, P572, DOI 10.1016/S0168-8278(98)80280-8
   Demetris AJ, 2006, WORLD J GASTROENTERO, V12, P3512, DOI 10.3748/wjg.v12.i22.3512
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009
   Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hefetz-Sela S, 2014, P NATL ACAD SCI USA, V111, P17582, DOI 10.1073/pnas.1409700111
   Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980
   KAKUMU S, 1991, AM J GASTROENTEROL, V86, P1804
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lanton T, 2017, HEPATOLOGY, V65, P1600, DOI 10.1002/hep.29004
   Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200
   Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201
   Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969
   Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449
   Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049
   Malaguarnera M, 1997, INT J CLIN PHARM TH, V35, P385
   Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y
   MAUAD TH, 1994, AM J PATHOL, V145, P1237
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744
   Nechemia-Arbely Y, 2011, J HEPATOL, V54, P922, DOI 10.1016/j.jhep.2010.08.017
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Payne CM, 2008, CLIN EXP GASTROENTER, V1, P19
   Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Potikha T, 2013, HEPATOLOGY, V58, P192, DOI 10.1002/hep.26335
   Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137
   Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Tabibian JH, 2016, HEPATOLOGY, V63, P185, DOI 10.1002/hep.27927
   Takeda K, 1998, J IMMUNOL, V161, P4652
   Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200
   Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75
   Wendum D, 2012, VIRCHOWS ARCH, V460, P291, DOI 10.1007/s00428-012-1202-6
   Zuliani G, 2010, ATHEROSCLEROSIS, V213, P319, DOI 10.1016/j.atherosclerosis.2010.08.074
NR 55
TC 10
Z9 10
U1 1
U2 18
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD SEP
PY 2021
VL 81
IS 18
BP 4766
EP 4777
DI 10.1158/0008-5472.CAN-21-0321
PG 12
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA US0HC
UT WOS:000697117500013
PM 34117031
OA Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Hewitt, G
   Jurk, D
   Marques, FDM
   Correia-Melo, C
   Hardy, T
   Gackowska, A
   Anderson, R
   Taschuk, M
   Mann, J
   Passos, JF
AF Hewitt, Graeme
   Jurk, Diana
   Marques, Francisco D. M.
   Correia-Melo, Clara
   Hardy, Timothy
   Gackowska, Agata
   Anderson, Rhys
   Taschuk, Morgan
   Mann, Jelena
   Passos, Joao F.
TI Telomeres are favoured targets of a persistent DNA damage response in
   ageing and stress-induced senescence
SO NATURE COMMUNICATIONS
LA English
DT Article
ID INFLAMMATORY CYTOKINE SECRETION; CELLULAR SENESCENCE; HUMAN-CELLS;
   TRIGGERS SENESCENCE; MAMMALIAN TELOMERES; TRF2; SEQUENCE; END; PATHWAY;
   FUSIONS
AB Telomeres are specialized nucleoprotein structures, which protect chromosome ends and have been implicated in the ageing process. Telomere shortening has been shown to contribute to a persistent DNA damage response (DDR) during replicative senescence, the irreversible loss of division potential of somatic cells. Similarly, persistent DDR foci can be found in stress-induced senescence, although their nature is not understood. Here we show, using immuno-fluorescent in situ hybridization and ChIP, that up to half of the DNA damage foci in stress-induced senescence are located at telomeres irrespective of telomerase activity. Moreover, live-cell imaging experiments reveal that all persistent foci are associated with telomeres. Finally, we report an age-dependent increase in frequencies of telomere-associated foci in gut and liver of mice, occurring irrespectively of telomere length. We conclude that telomeres are important targets for stress in vitro and in vivo and this has important consequences for the ageing process.
C1 [Hewitt, Graeme; Jurk, Diana; Marques, Francisco D. M.; Correia-Melo, Clara; Anderson, Rhys; Taschuk, Morgan; Passos, Joao F.] Newcastle Univ, Inst Ageing & Hlth, Ageing Res Labs, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Hewitt, Graeme; Jurk, Diana; Marques, Francisco D. M.; Correia-Melo, Clara; Anderson, Rhys; Taschuk, Morgan; Passos, Joao F.] Newcastle Univ, Inst Ageing & Hlth, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Hardy, Timothy; Gackowska, Agata; Mann, Jelena] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK
RP Passos, JF (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Ageing Res Labs, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM joao.passos@ncl.ac.uk
RI Taschuk, Morgan/H-9348-2019
OI Taschuk, Morgan/0000-0003-0677-6902; Correia-Melo,
   Clara/0000-0001-6062-1472; Jurk, Diana/0000-0003-4486-0857; Madeira
   Marques, Francisco/0000-0001-7521-6955; Passos,
   Joao/0000-0001-8765-1890; Hewitt, Graeme/0000-0003-2614-6932; Hardy,
   Timothy/0000-0001-9777-9134
FU BBSRC; FCT (Foundation for Science and Technology, Portugal); University
   of Porto; BBSRC [BB/H022384/1] Funding Source: UKRI; Biotechnology and
   Biological Sciences Research Council [BB/H022384/1] Funding Source:
   researchfish; National Institute for Health Research [ACF-2010-01-007]
   Funding Source: researchfish
FX We would like to thank Dr. Glyn Nelson for technical assistance with
   live-cell imaging and for providing the 53BP1 GFP reporter, Dr. Gabriele
   Saretzki for providing MRC5 fibroblasts transfected with hTERT, Dr
   Fabrizio d'Adda di Fagagna, Prof. Tom Kirkwood and Prof. Thomas von
   Zglinicki for critically reading the manuscript. G.H. is supported by a
   case studentship from BBSRC, C.C.M. is supported by a FCT (Foundation
   for Science and Technology, Portugal) studentship through the GABBA
   program, University of Porto and J.F.P. is supported by a David Phillips
   Fellowship provided by BBSRC.
CR Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275
   Cesare AJ, 2009, NAT STRUCT MOL BIOL, V16, P1244, DOI 10.1038/nsmb.1725
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6
   Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   KRUK PA, 1995, P NATL ACAD SCI USA, V92, P258, DOI 10.1073/pnas.92.1.258
   Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002
   Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719
   Michelson RJ, 2005, GENE DEV, V19, P2546, DOI 10.1101/gad.1293805
   Molenaar C, 2003, EMBO J, V22, P6631, DOI 10.1093/emboj/cdg633
   Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857
   Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g
   Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893
   Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x
   Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X
   Stansel RM, 2001, EMBO J, V20, P5532
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037
NR 40
TC 587
Z9 644
U1 1
U2 73
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB
PY 2012
VL 3
AR 708
DI 10.1038/ncomms1708
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 915XE
UT WOS:000302060100049
PM 22426229
OA Green Published, Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Sarkar, A
   Jin, YH
   DeFelice, BC
   Logan, CY
   Yang, Y
   Anbarchian, T
   Wu, P
   Morri, M
   Neff, NF
   Nguyen, H
   Rulifson, E
   Fish, M
   Kaye, AG
   Jaimes, AMM
   Nusse, R
AF Sarkar, Abby
   Jin, Yinhua
   DeFelice, Brian C.
   Logan, Catriona Y.
   Yang, Yan
   Anbarchian, Teni
   Wu, Peng
   Morri, Maurizio
   Neff, Norma F.
   Nguyen, Huy
   Rulifson, Eric
   Fish, Matthew
   Kaye, Avi Gurion
   Martinez Jaimes, Azalia M.
   Nusse, Roel
TI Intermittent fasting induces rapid hepatocyte proliferation to restore
   the hepatostat in the mouse liver
SO ELIFE
LA English
DT Article
DE liver; regeneration; intermittent fasting; Mouse
ID STEM-CELL FUNCTION; GROWTH-FACTOR 15; DIETARY; MICE; REGENERATION;
   RESTRICTION; HOMEOSTASIS; SENESCENCE; PROMOTES; FATE
AB Nutrient availability fluctuates in most natural populations, forcing organisms to undergo periods of fasting and re-feeding. It is unknown how dietary changes influence liver homeostasis. Here, we show that a switch from ad libitum feeding to intermittent fasting (IF) promotes rapid hepatocyte proliferation. Mechanistically, IF-induced hepatocyte proliferation is driven by the combined action of systemic FGF15 and localized WNT signaling. Hepatocyte proliferation during periods of fasting and re-feeding re-establishes a constant liver-to-body mass ratio, thus maintaining the hepatostat. This study provides the first example of dietary influence on adult hepatocyte proliferation and challenges the widely held view that liver tissue is mostly quiescent unless chemically or mechanically injured.
C1 [Sarkar, Abby; Jin, Yinhua; Logan, Catriona Y.; Anbarchian, Teni; Wu, Peng; Rulifson, Eric; Fish, Matthew; Kaye, Avi Gurion; Martinez Jaimes, Azalia M.; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94304 USA.
   [DeFelice, Brian C.; Morri, Maurizio; Neff, Norma F.] Chan Zuckerberg Biohub, San Francisco, CA USA.
   [Yang, Yan] Stanford Univ, Stanford Ctr Genom Personalized Med, Sch Med, Stanford, CA USA.
   [Wu, Peng] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA USA.
   [Nguyen, Huy] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA USA.
C3 Howard Hughes Medical Institute; Stanford University; Stanford
   University; Stanford University; Stanford University
RP Sarkar, A; Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94304 USA.
EM abby.sarkar@gmail.com; rnusse@stanford.edu
RI Jin, Yinhua/AAU-5460-2021; Nguyen, Huy/AAF-9560-2019
OI Jin, Yinhua/0000-0003-4698-8555; Nguyen, Huy/0000-0002-5896-9661;
   Martinez Jaimes, Azalia/0000-0001-9412-6787; Sarkar,
   Abby/0000-0001-6101-1721; Wu, Peng/0000-0001-6565-0002; DeFelice,
   Brian/0000-0001-8243-0300; Anbarchian, Teni/0000-0002-6973-9896
FU Howard Hughes Medical Institute; Stinehart Reed Foundation; Office of
   the Assistant Secretary of Defense for Health Affairs, through the Peer
   Reviewed Cancer Research Program [W81XWH-17-1-0245]; Damon Runyon Cancer
   Research Foundation [DRSG-28P-19]; National Institutes of Health [P30
   CA124435]
FX Howard Hughes Medical Institute Roel NusseStinehart Reed Foundation Roel
   NusseOffice of the Assistant Secretary of Defense for Health Affairs,
   through the Peer Reviewed Cancer Research Program W81XWH-17-1-0245 Abby
   SarkarDamon Runyon Cancer Research Foundation DRSG-28P-19 Peng
   WuNational Institutes of Health P30 CA124435 Yan Yang
CR Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chen F, 2020, CELL STEM CELL, V26, P27, DOI 10.1016/j.stem.2019.11.001
   Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8
   Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002
   Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807
   Frank DU, 2012, P NATL ACAD SCI USA, V109, pE154, DOI 10.1073/pnas.1115165109
   Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065
   Han S, 2021, NATURE, V595, P415, DOI 10.1038/s41586-021-03707-9
   Hatchwell L, 2020, CELL REP, V30, P3566, DOI 10.1016/j.celrep.2020.02.051
   He LJ, 2021, SCIENCE, V371, P905, DOI 10.1126/science.abc4346
   Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001
   Jin YH, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2203849119
   Kind T, 2018, MASS SPECTROM REV, V37, P513, DOI 10.1002/mas.21535
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P369, DOI 10.1038/s41575-021-00454-0
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008
   Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335
   O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048
   Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382
   Peng WC, 2018, CELL, V175, P1607, DOI 10.1016/j.cell.2018.11.012
   Perugorria MJ, 2019, NAT REV GASTRO HEPAT, V16, P121, DOI 10.1038/s41575-018-0075-9
   Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014
   Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111
   Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019
   Sansone SA, 2007, NAT BIOTECHNOL, V25, P844, DOI 10.1038/nbt0807-846b
   Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016
   Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634
   ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176
   Tsugawa H, 2020, NAT BIOTECHNOL, V38, P1159, DOI 10.1038/s41587-020-0531-2
   Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436
   Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Wei YL, 2021, SCIENCE, V371, P906, DOI 10.1126/science.abb1625
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Yu HMI, 2007, MECH DEVELOP, V124, P146, DOI 10.1016/j.mod.2006.10.002
NR 41
TC 8
Z9 8
U1 6
U2 13
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JAN 31
PY 2023
VL 12
AR e82311
DI 10.7554/eLife.82311
PG 20
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 8M6IU
UT WOS:000924566800001
PM 36719070
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Wu, CX
   Mao, CY
   Deng, J
   Zhang, T
   Zhao, Y
   Guan, ZZ
   Hu, XX
   Qi, XL
AF Wu, C. X.
   Mao, C. Y.
   Deng, J.
   Zhang, T.
   Zhao, Y.
   Guan, Z. Z.
   Hu, X. X.
   Qi, X. L.
TI Fluoride induced down-regulation of IKBKG Gene expression inhibits
   hepatocytes senescence
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article; Early Access
DE Fluorosis; IKBKG; Cell senescence; Hepatocyte
ID NF-KAPPA-B; DNA-DAMAGE; SECRETORY PHENOTYPE; LIVER; APOPTOSIS; GAMMA
AB Background: Accumulating evidences have confirmed that liver is one of the more severely damaged organs during chronic fluorosis. However, the detail mechanism is unclear to data. At present, the objective of this study was to investigate the relationship between down-regulation of IKBKG gene expression and hepatocyte senescence induced by sodium fluoride (NaF). Methods: Chronic fluorosis rats and NaF-exposure human liver L02 cells were reproduced the model of hepatocyte senescence in vivo and in vitro. The mRNA and protein levels of p16, p21 and IKBKG, the IL-8 level were determined. The role of IKBKG in fluoride-induced senescence of hepatocytes was explored by knock down in hepatocytes in vivo and in vitro. Results: The number of senescence-positive cells in rat liver tissues was increased as well as the level of IL-8 and the expression levels of p16, p21 and IKBKG in fluoride exposure to rat depending on the fluoride concentration. The similar results were obtained in NaF treated liver L02 cells, and the number of cells that stagnated in the G2 phase increased significantly. Further, our results confirmed that decreasing the expression of IKBKG in hepatocytes could reduce fluoride-induced hepatocyte senescence and the changes of senescence-related indicators both in vivo and in vitro. Conclusion: These results indicated that the elevated expression of IKBKG was positive relation with the fluorideinduced senescence in hepatocytes, suggesting the hepatocyte senescence might have a special relationship with fluoride-caused liver damage. Because of the present results limitation, the mechanism of fluoride induced senescence in hepatocytes should be concentrated in the future in detail, especially the novel targets for fluoride induced liver injury.
C1 [Wu, C. X.; Mao, C. Y.; Deng, J.; Zhang, T.; Zhao, Y.; Guan, Z. Z.; Qi, X. L.] Guizhou Med Univ, Key Lab Mol Biol, Minist Educ, Key Lab Endem & Minor Dis, Guiyang 550004, Peoples R China.
   [Qi, X. L.] Guizhou Med Univ, Translat Med Res Ctr, Guiyang 550004, Peoples R China.
   [Hu, X. X.] Guizhou Med Univ, Sch Basic Med, Guiyang 550004, Peoples R China.
C3 Guizhou Medical University; Guizhou Medical University; Guizhou Medical
   University
RP Qi, XL (corresponding author), Guizhou Med Univ, Key Lab Mol Biol, Minist Educ, Key Lab Endem & Minor Dis, Guiyang 550004, Peoples R China.; Hu, XX (corresponding author), Guizhou Med Univ, Sch Basic Med, Guiyang 550004, Peoples R China.
EM 251982143@qq.com; xiaolan76@163.com
FU Chinese National Natural Science Foundation [U1812403]; Department of
   Education of Guizhou Province [KY [2021]313]
FX This work was financially supported by the Chinese National Natural
   Science Foundation (U1812403) and the Department of Education of Guizhou
   Province (KY [2021]313).
CR Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Pereira HABD, 2018, TOXICOL APPL PHARM, V358, P68, DOI 10.1016/j.taap.2018.09.010
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Daiwile AP, 2018, ENVIRON TOXICOL PHAR, V57, P159, DOI 10.1016/j.etap.2017.12.015
   Dharmaratne RW, 2019, HUM EXP TOXICOL, V38, P269, DOI 10.1177/0960327118814161
   Efe U, 2021, BIOL TRACE ELEM RES, V199, P136, DOI 10.1007/s12011-020-02121-y
   Fu JX, 2018, J BIOL CHEM, V293, P7268, DOI 10.1074/jbc.RA117.001684
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Janikiewicz J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0105-5
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Perumal E, 2013, TOXICOL LETT, V223, P236, DOI 10.1016/j.toxlet.2013.09.005
   Pinto M, 2017, CELL DEATH DIFFER, V24, P288, DOI 10.1038/cdd.2016.123
   Qi XL, 2013, NEUROCHEM RES, V38, P943, DOI 10.1007/s11064-013-1001-8
   Regulski MJ, 2017, WOUNDS, V29, P168
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105
   Song GH, 2015, BIOL TRACE ELEM RES, V166, P173, DOI 10.1007/s12011-015-0265-z
   Wang AG, 2004, BIOMED ENVIRON SCI, V17, P217
   Wang HW, 2020, CHEMOSPHERE, V241, DOI 10.1016/j.chemosphere.2019.125099
   Wu CX, 2018, J TRACE ELEM MED BIO, V50, P223, DOI 10.1016/j.jtemb.2018.07.010
   Zeng XX, 2020, J TRACE ELEM MED BIO, V60, DOI 10.1016/j.jtemb.2020.126475
   Zhang M, 2008, TOXICOL LETT, V179, P1, DOI 10.1016/j.toxlet.2008.03.002
   Zhang Z, 2014, INT J ENV RES PUB HE, V11, P1020, DOI 10.3390/ijerph110101020
   Zhao J, 2020, AGING-US, V12, P4688, DOI 10.18632/aging.102863
NR 29
TC 2
Z9 4
U1 1
U2 11
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0946-672X
EI 1878-3252
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PD 2022 JAN
PY 2022
VL 69
AR 126896
DI 10.1016/j.jtemb.2021.126896
EA NOV 2021
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA WW7XY
UT WOS:000718125600002
PM 34763226
OA hybrid
DA 2024-02-19
ER

PT J
AU Cui, XP
   Jin, T
AF Cui, Xiaopeng
   Jin, Tang
TI Perfluorooctane sulfonate (PFOS) causes aging damage in the liver
   through the mt-DNA-mediated NLRP3 signaling pathway
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article; Early Access
DE PFOS; NLRP3; Inflammatory factor; Oxidative stress
ID POPULATION; HEALTH
AB Perfluorooctane sulfonate (PFOS) is not readily degradable in the natural environment, and PFOS is widely used in industry. Globally, PFOS exposure occurs in the environment. PFOS is persistent and non-biodegradable. The general public can come into contact with PFOS by inhaling PFOS-contaminated dust and air, drinking contaminated water, eating contaminated food. Thus, PFOS induces potential health damage globally. In this study, the effect of PFOS on aging of the liver was investigated. In an in vitro cellular model, a series of biochemical experiments were conducted via cell proliferation assays, flow cytometry, immunocytochemistry and laser confocal microscopy. It was found that PFOS led to hepatocyte senescence via Sa-& beta;-gal staining and detection of senescence markers (p16, p21 and p53). In addition, PFOS also led to oxidative stress and inflammation. Mechanistic studies have shown that PFOS can lead to elevated mitochondrial ROS in hepatocytes through calcium overload. ROS cause alterations in mitochondrial membrane potential, subsequently inducing mPTP (mitochondrial permeability transition pore) opening, which in turn releases mt-DNA from mitochondria into the cytoplasm, thus activating NLRP3, which causes the senescence of hepatocytes. Based on this, we further analyzed the effect of PFOS on liver aging in vivo and found that PFOS caused the aging of liver tissues. On this basis, we preliminarily investigated the effect of & beta;-carotene on the aging damage caused by PFOS and found that it could alleviate the liver aging caused by PFOS. In summary, the current study shows that PFOS causes aging damage to the liver, and this study provides a more in-depth understanding of the toxicity characteristics of PFOS.
C1 [Cui, Xiaopeng; Jin, Tang] Shanxi Prov Peoples Hosp, Dept Colorectal Surg, Taiyuan, Shanxian, Peoples R China.
C3 Shanxi People's Hospital
RP Jin, T (corresponding author), Shanxi Prov Peoples Hosp, Dept Colorectal Surg, Taiyuan, Shanxian, Peoples R China.
EM tangtang120384@sina.com
CR Abbott BD, 2009, REPROD TOXICOL, V27, P258, DOI 10.1016/j.reprotox.2008.05.061
   Beach SA, 2006, REV ENVIRON CONTAM T, V186, P133, DOI 10.1007/0-387-32883-1_5
   Chakravarti D, 2021, CELL, V184, P306, DOI 10.1016/j.cell.2020.12.028
   Cordero MD, 2018, TRENDS ENDOCRIN MET, V29, P8, DOI 10.1016/j.tem.2017.10.009
   Espartero LJL, 2022, ENVIRON RES, V212, DOI 10.1016/j.envres.2022.113431
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Gao XY, 2020, SCI TOTAL ENVIRON, V738, DOI 10.1016/j.scitotenv.2020.139914
   Grundy E, 2006, AGEING SOC, V26, P105, DOI 10.1017/S0144686X05004484
   Inoue K, 2004, ENVIRON HEALTH PERSP, V112, P1204, DOI 10.1289/ehp.6864
   Izzo C, 2021, LIFE-BASEL, V11, DOI 10.3390/life11010060
   Kärrman A, 2007, ENVIRON INT, V33, P782, DOI 10.1016/j.envint.2007.02.015
   Kim HS, 2011, J TOXICOL SCI, V36, P201, DOI 10.2131/jts.36.201
   Madreiter-Sokolowski CT, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101678
   Marín-Aguilar F, 2020, AGING CELL, V19, DOI 10.1111/acel.13050
   Nakayama SF, 2019, TRAC-TREND ANAL CHEM, V121, DOI 10.1016/j.trac.2019.02.011
   Pontius F, 2019, WATER-SUI, V11, DOI 10.3390/w11102003
   Qiu YB, 2022, INT IMMUNOPHARMACOL, V108, DOI 10.1016/j.intimp.2022.108719
   Saikat S, 2013, ENVIRON SCI-PROC IMP, V15, P329, DOI 10.1039/c2em30698k
   Suh Chunhui, 2012, [JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES, 한국환경보건학회지], V38, P8
   Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Wang T, 2009, ENVIRON SCI TECHNOL, V43, P5171, DOI 10.1021/es900464a
   Zhang HX, 2018, ENVIRON SCI TECHNOL, V52, P12809, DOI 10.1021/acs.est.8b04368
NR 23
TC 0
Z9 0
U1 19
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD 2023 SEP 1
PY 2023
VL 262
AR 115121
DI 10.1016/j.ecoenv.2023.115121
EA JUN 2023
PG 14
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA N0XA0
UT WOS:001034334500001
PM 37385020
OA gold
DA 2024-02-19
ER

PT J
AU Wang, CF
   Jurk, D
   Maddick, M
   Nelson, G
   Martin-Ruiz, C
   von Zglinicki, T
AF Wang, Chunfang
   Jurk, Diana
   Maddick, Mandy
   Nelson, Glyn
   Martin-Ruiz, Carmen
   von Zglinicki, Thomas
TI DNA damage response and cellular senescence in tissues of aging mice
SO AGING CELL
LA English
DT Article
DE aging; DNA damage; mice; senescence; telomere
ID LIFE-SPAN EXTENSION; BETA-GALACTOSIDASE; HUMAN-CELLS; IN-VIVO; CALORIC
   RESTRICTION; TELOMERE; P53; EXPRESSION; VITRO; ACCUMULATION
AB The impact of cellular senescence onto aging of organisms is not fully clear, not at least because of the scarcity of reliable data on the mere frequency of senescent cells in aging tissues. Activation of a DNA damage response including formation of DNA damage foci containing activated H2A.X (gamma-H2A.X) at either uncapped telomeres or persistent DNA strand breaks is the major trigger of cell senescence. Therefore, gamma-H2A.X immunohistochemistry (IHC) was established by us as a reliable quantitative indicator of senescence in fibroblasts in vitro and in hepatocytes in vivo and the age dependency of DNA damage foci accumulation in ten organs of C57Bl6 mice was analysed over an age range from 12 to 42 months. There were significant increases with age in the frequency of foci-containing cells in lung, spleen, dermis, liver and gut epithelium. In liver, foci-positive cells were preferentially found in the centrilobular area, which is exposed to higher levels of oxidative stress. Foci formation in the intestine was restricted to the crypts. It was not associated with either apoptosis or hyperproliferation. That telomeres shortened with age in both crypt and villus enterocytes, but telomeres in the crypt epithelium were longer than those in villi at all ages were confirmed by us. Still, there was no more than random co-localization between gamma-H2A.X foci and telomeres even in crypts from very old mice, indicating that senescence in the crypt enterocytes is telomere independent. The results suggest that stress-dependent cell senescence could play a causal role for aging of mice.
C1 [von Zglinicki, Thomas] Univ Newcastle, Inst Ageing & Hlth, Ageing Res Labs, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
   Univ Newcastle, CISBAN, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP von Zglinicki, T (corresponding author), Univ Newcastle, Inst Ageing & Hlth, Ageing Res Labs, Campus Ageing & Vital, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
EM t.vonzglinicki@ncl.ac.uk
RI Martin-Ruiz, C/JGC-6974-2023; nelson, glyn/A-6346-2009
OI nelson, glyn/0000-0002-1895-4772; von Zglinicki,
   Thomas/0000-0002-5939-0248; Jurk, Diana/0000-0003-4486-0857;
   Martin-Ruiz, Carmen/0000-0002-3361-6974
FU Research into Ageing [252]; BBSRC systems biology grant (CISBAN).; MRC
   [G0601333] Funding Source: UKRI; Medical Research Council [G0601333]
   Funding Source: researchfish
FX We thank Prof. K.L. Rudolph, Ulm, for providing us with tissue samples
   from TERC<SUP>-/-</SUP> mice and Dr Joao Passos for expert experimental
   help. This study was supported by programme grant 252 from Research into
   Ageing and by a BBSRC systems biology grant (CISBAN).
CR Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Bakkenist CJ, 2004, TRENDS CELL BIOL, V14, P339, DOI 10.1016/j.tcb.2004.05.001
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x
   Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   Dimri GP, 2002, CANCER RES, V62, P4736
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fenton M, 2001, ARTERIOSCL THROM VAS, V21, P220, DOI 10.1161/01.ATV.21.2.220
   Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lechel A, 2007, GASTROENTEROLOGY, V132, P1465, DOI 10.1053/j.gastro.2007.01.045
   Lee AC, 2005, CELL CYCLE, V4, P177, DOI 10.4161/cc.4.1.1354
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028
   Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x
   Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Panda S, 2008, MECH AGEING DEV, V129, P332, DOI 10.1016/j.mad.2008.02.014
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   PENDERGRASS WR, 1995, EXP CELL RES, V217, P309, DOI 10.1006/excr.1995.1091
   Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Vasile E, 2001, FASEB J, V15, P458, DOI 10.1096/fj.00-0051com
   von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034
   Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WOLF NS, 1995, EXP CELL RES, V217, P317, DOI 10.1006/excr.1995.1092
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 53
TC 486
Z9 569
U1 4
U2 58
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN
PY 2009
VL 8
IS 3
BP 311
EP 323
DI 10.1111/j.1474-9726.2009.00481.x
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 450RE
UT WOS:000266417700010
PM 19627270
DA 2024-02-19
ER

PT J
AU Zhu, CZ
   Ikemoto, T
   Utsunomiya, T
   Yamada, S
   Morine, Y
   Imura, S
   Arakawa, Y
   Takasu, C
   Ishikawa, D
   Shimada, M
AF Zhu, Chengzhan
   Ikemoto, Tetsuya
   Utsunomiya, Tohru
   Yamada, Shinichiro
   Morine, Yuji
   Imura, Satoru
   Arakawa, Yusuke
   Takasu, Chie
   Ishikawa, Daichi
   Shimada, Mitsuo
TI Senescence-related genes possibly responsible for poor liver
   regeneration after hepatectomy in elderly patients
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE HGF; liver regeneration; Met; p16; senescence
ID CELLULAR SENESCENCE; MARKER PROTEIN-30; DNA-DAMAGE; CANCER; HEPATOCYTES;
   MECHANISMS; EXPRESSION; HEPATITIS; SIRT1; P53
AB Background and AimLiver regeneration likely decreases with age by an, as yet, incompletely understood mechanism, restricting the extent of hepatectomy. We therefore analyzed the effect of aging on liver regeneration and investigated mechanisms associate with poor regeneration of human liver.
   MethodsWe assessed 130 patients who underwent hepatectomy at our institute between 2005 and 2012. The patients were divided into two groups, a younger (age <65 years, n=59) and an older (age >65 years, n=71) group. The expression of hepatocyte growth factor (HGF), its ligand Met, and the senescence-related genes p16, SIRT1 and SMP30 were assessed by qRT-PCR. Simulated preoperative and 1 week and 6 month postoperative liver volumes were evaluated in 11 younger and 11 older patients using a 3D simulation imaging system. Regenerated liver volumes were calculated and compared with clinicopathological factors, and correlations between liver regeneration and gene expression were calculated.
   ResultsHGF and Met expression was significantly lower, and p16 expression significantly higher in older than in younger patients (P<0.05 each). Mean increases in liver volume after 6 months were significantly greater in younger than in older patients (396.5mL, 45.6% vs 159.4mL, 23.3%, P<0.05) but did not differ significantly at 1 week. Furthermore, p16 expression was negatively correlated with liver regeneration in older patients (R=-0.67, P<0.05).
   ConclusionPoor liver regeneration in older patients may be associated with the upregulation of senescence-related genes, such as p16, and the downregulation of regeneration-promoting genes, such as HGF and Met.
C1 [Zhu, Chengzhan; Ikemoto, Tetsuya; Utsunomiya, Tohru; Yamada, Shinichiro; Morine, Yuji; Imura, Satoru; Arakawa, Yusuke; Takasu, Chie; Ishikawa, Daichi; Shimada, Mitsuo] Univ Tokushima, Dept Surg, Tokushima 7708503, Japan.
C3 Tokushima University
RP Shimada, M (corresponding author), Univ Tokushima, Dept Surg, 13-18-15 Kuramoto Cho, Tokushima 7708503, Japan.
EM mitsuo.shimada@tokushima-u.ac.jp
OI Ikemoto, Tetsuya/0000-0001-9800-1359
FU Grants-in-Aid for Scientific Research [23390324] Funding Source: KAKEN
CR Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Hahn WC., 2002, NEW ENGL J MED, V347, P1593, DOI [DOI 10.1056/NEJMRA021902, 10.1056/NEJMra021902]
   Hanaoka J, 2009, SURGERY, V146, P264, DOI 10.1016/j.surg.2009.06.004
   Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   LIN TY, 1979, ANN SURG, V190, P48, DOI 10.1097/00000658-197907000-00011
   NAGASUE N, 1987, ANN SURG, V206, P30, DOI 10.1097/00000658-198707000-00005
   Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002
   Sanada F, 2009, HYPERTENSION, V53, P77, DOI 10.1161/HYPERTENSIONAHA.108.120725
   SAWADA N, 1989, EXP CELL RES, V181, P584, DOI 10.1016/0014-4827(89)90115-8
   Tanemura A, 2012, WORLD J SURG, V36, P1102, DOI 10.1007/s00268-012-1496-1
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Turaga KK, 2011, CA-CANCER J CLIN, V61, P113, DOI 10.3322/caac.20097
   YAMANAKA N, 1993, HEPATOLOGY, V18, P79, DOI 10.1016/0270-9139(93)90510-T
   Yamashiki N, 2006, LIVER TRANSPLANT, V12, P1077, DOI 10.1002/lt.20759
NR 32
TC 25
Z9 27
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD MAY
PY 2014
VL 29
IS 5
BP 1102
EP 1108
DI 10.1111/jgh.12468
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AF4NB
UT WOS:000334688800032
PM 24325248
DA 2024-02-19
ER

PT J
AU KITANI, K
AF KITANI, K
TI AGING OF THE LIVER - FACTS AND THEORIES
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE LIVER; AGING; INTRACELLULAR FUNCTIONS; MEMBRANE FUNCTION
ID HEPATIC DRUG-METABOLISM; AGE-DEPENDENT DECREASE; LATERAL DIFFUSION
   CONSTANT; FUNCTION OXIDASE SYSTEM; FLUORESCENCE RECOVERY;
   BILIARY-EXCRETION; PLASMA-MEMBRANE; GENE-EXPRESSION; OLD-AGE; RATS
AB Although most theories of aging assume that cellular functions decline with aging, many intracellular functions in the liver, such as enzyme activities, stay fairly stable in old age. This does not appear to be an antifact caused by in vitro experimental design, since in vivo pharmacokinetic data also demonstrate that most, if not all, biotransformation capacities of the liver remain stable during the aging process, if we take the decline in liver volume with age into account. Thus, many theories to explain the decline in cellular functions during aging appear to be based on erroneous assumptions.
   The stability of cellular function in old age does not necessarily mean, however, that all cellular functions are identical for young and old organisms. Once unfavorable conditions, such as malnutrition, infection, etc., are involved, the response of the liver is quite different for young and old subjects, demonstrating a more efficient and versatile response in young animal livers in comparison to old livers. Large differences in enzyme activities between young and old organisms appear during stress and especially during recovery from stress. Accordingly, any aging theory needs to explain a potential difference in liver functions (such as response capability) rather than the difference in basal functions.
   In contrast to rather stable intracellular functions, the uptake function of the hepatocyte surface membranes was found to be progressively decreased with age. This was shown for at least two different types of carrier systems in the surface membranes. Although the decrease of carrier unit number for these substances remains a possible causal factor, we suggest that the decline in hepatic uptake with age is at least partially the result of a gradual decrease in the mobility of surface membrane proteins, which can be shown by the fluorescence recovery after photobleaching (FRAP) technique.
   Theories of aging need to be elaborated on the basis of unbiased observations on the actual manifestations of cellular aging.
RP KITANI, K (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL, DEPT CLIN PHYSIOL, 35-2 SAKAECHO, ITABASHI KU, TOKYO 173, JAPAN.
CR ADELMAN RC, 1970, J BIOL CHEM, V245, P1032
   ADELMAN RC, 1979, FED PROC, V38, P1968
   ADELMAN RC, 1971, EXP GERONTOL, V6, P75, DOI 10.1016/0531-5565(71)90051-9
   AU WYW, 1985, CLIN PHARMACOL THER, V37, P472, DOI 10.1038/clpt.1985.74
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P469, DOI 10.1016/0531-5565(78)90059-1
   BIRNBAUM LS, 1980, EXP GERONTOL, V15, P259, DOI 10.1016/0531-5565(80)90030-3
   BONDE J, 1985, BRIT J CLIN PHARMACO, V20, P453, DOI 10.1111/j.1365-2125.1985.tb05096.x
   BOOBIS AR, 1984, XENOBIOTICA, V14, P151, DOI 10.3109/00498258409151404
   BRANDFONBRENER M, 1955, CIRCULATION, V12, P557, DOI 10.1161/01.CIR.12.4.557
   CARRILLO MC, 1990, MECH AGEING DEV, V56, P237, DOI 10.1016/0047-6374(90)90085-T
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   CARRILLO MC, 1991, IN PRESS BIOCH BIOPH
   CHIBA M, 1986, BIOCHEM PHARMACOL, V35, P2628, DOI 10.1016/0006-2952(86)90064-X
   CHIO KS, 1969, SCIENCE, V166, P1535, DOI 10.1126/science.166.3912.1535
   CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019
   ELDRED GE, 1982, SCIENCE, V216, P757, DOI 10.1126/science.7079738
   FUJITA S, 1985, BIOCHEM BIOPH RES CO, V126, P117, DOI 10.1016/0006-291X(85)90579-0
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   FUJITA S, 1989, BIOCHEM PHARMACOL, V38, P3925, DOI 10.1016/0006-2952(89)90669-2
   FUJITA S, 1986, LIVER AGING 1986, P103
   FUJITA S, 1982, LIVER AGING 1982, P55
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   GOTO S, 1991, IN PRESS LIVER AGING
   IVY GO, 1989, ADV EXP MED BIOL, V266, P31
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IVY GO, 1991, IN PRESS MECH AGEING
   IVY GO, 1991, IN PRESS LIVER AGING
   JAMES OFW, 1991, IN PRESS LIVER AGING
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KAO J, 1980, BIOCHEM PHARMACOL, V29, P1191, DOI 10.1016/0006-2952(80)90417-7
   KATO R, 1970, JPN J PHARMACOL, V20, P572, DOI 10.1254/jjp.20.572
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   KITAHARA A, 1982, LIVER AGING 1982, P135
   KITANI K, 1978, EXP GERONTOL, V13, P9, DOI 10.1016/0531-5565(78)90024-4
   KITANI K, 1986, HEPATOLOGY, V6, P316, DOI 10.1002/hep.1840060227
   KITANI K, 1990, LIPOFUSCIN CEROID PI, P75
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   LEE DW, 1981, IN PRESS LIVER AGING
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   MIYASAKA K, 1989, PANCREAS, V4, P346, DOI 10.1097/00006676-198906000-00012
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   OHTA M, 1990, BIOCHEM PHARMACOL, V39, P1223, DOI 10.1016/0006-2952(90)90266-N
   OHTA M, 1988, BIOCHEM PHARMACOL, V37, P935
   RENTON KW, 1984, FOREIGN COMPOUND MET, P289
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RICHARDSON A, 1983, HDB BIOCH MAN, P255
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1982, BIOCHEM PHARMACOL, V31, P2339, DOI 10.1016/0006-2952(82)90527-5
   SATO Y, 1987, ARCH GERONTOL GERIAT, V6, P141, DOI 10.1016/0167-4943(87)90007-0
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   SCHMUCKER DL, 1990, IN PRESS CLIN PHARM
   SHOCK NW, 1987, 842450 BALT LONG STU
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   STIER A, 1982, LIVER AGING 1982, P3
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V34, P2983, DOI 10.1016/0006-2952(85)90025-5
   VESTAL RE, 1975, CLIN PHARMACOL THER, V18, P425
   WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   WYNNE HA, 1989, AGE AGEING, V18, P415, DOI 10.1093/ageing/18.6.415
   ZSNAGY I, 1979, MECH AGEING DEV, V9, P237, DOI 10.1016/0047-6374(79)90102-7
   ZSNAGY I, 1989, J GERONTOL, V44, pB83, DOI 10.1093/geronj/44.4.B83
   ZSNAGY I, 1986, EXP GERONTOL, V21, P555, DOI 10.1016/0531-5565(86)90007-0
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZSNAGY I, 1987, ADV BIOSCI, V64, P393
NR 72
TC 19
Z9 20
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-JUN
PY 1991
VL 12
IS 2-3
BP 133
EP 154
DI 10.1016/0167-4943(91)90024-K
PG 22
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FT598
UT WOS:A1991FT59800005
PM 15374444
DA 2024-02-19
ER

PT J
AU Yang, WB
   Kim, D
   Jiang, W
   Ai, WQ
   Pan, Q
   Rahman, S
   Cai, JJ
   Brashear, WA
   Sun, YX
   Guo, SD
AF Yang, Wanbao
   Kim, Da Mi
   Jiang, Wen
   Ai, Weiqi
   Pan, Quan
   Rahman, Shahina
   Cai, James J.
   Brashear, Wesley A.
   Sun, Yuxiang
   Guo, Shaodong
TI Suppression of FOXO1 attenuates inflamm-aging and improves liver
   function during aging
SO AGING CELL
LA English
DT Article; Early Access
DE aging; FOXO1; inflamm-aging; inflammation; Kupffer cell; liver function;
   monocyte-derived macrophage
ID INSULIN-RESISTANCE; KUPFFER CELLS; MICE LACKING; MACROPHAGES; ALPHA;
   HETEROGENEITY; INACTIVATION; SENSITIVITY; HOMEOSTASIS; METABOLISM
AB The liver is a key metabolic organ that maintains whole-body nutrient homeostasis. Aging-induced liver function alterations contribute to systemic susceptibility to aging-related diseases. However, the molecular mechanisms of liver aging remain insufficiently understood. In this study, we performed bulk RNA-Seq and single-cell RNA-Seq analyses to investigate the underlying mechanisms of the aging-induced liver function changes. We found that liver inflammation, glucose intolerance, and liver fat deposition were aggravated in old mice. Aging significantly increased pro-inflammation in hepatic macrophages. Furthermore, we found that Kupffer cells (KCs) were the major driver to induce pro-inflammation in hepatic macrophages during aging. In KCs, aging significantly increased pro-inflammatory levels; in monocyte-derived macrophages (MDMs), aging had a limited effect on pro-inflammation but led to a functional quiescence in antigen presentation and phagosome process. In addition, we identified an aging-responsive KC-specific (ARKC) gene set that potentially mediates aging-induced pro-inflammation in KCs. Interestingly, FOXO1 activity was significantly increased in the liver of old mice. FOXO1 inhibition by AS1842856 significantly alleviated glucose intolerance, hepatic steatosis, and systemic inflammation in old mice. FOXO1 inhibition significantly attenuated aging-induced pro-inflammation in KCs partially through downregulation of ARKC genes. However, FOXO1 inhibition had a limited effect on aging-induced functional quiescence in MDMs. These results indicate that aging induces pro-inflammation in liver mainly through targeting KCs and FOXO1 is a key player in aging-induced pro-inflammation in KCs. Thus, FOXO1 could be a potential therapeutic target for the treatment of age-associated chronic diseases.
C1 [Yang, Wanbao; Kim, Da Mi; Jiang, Wen; Ai, Weiqi; Pan, Quan; Sun, Yuxiang; Guo, Shaodong] Texas A&M Univ, Coll Agr & Life Sci, Dept Nutr, College Stn, TX USA.
   [Rahman, Shahina] Texas A&M Univ, Dept Stat, College Stn, TX USA.
   [Cai, James J.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA.
   [Brashear, Wesley A.] Texas A&M Univ, High Performance Res Comp, College Stn, TX USA.
   [Sun, Yuxiang] Texas A&M Univ, Coll Agr & Life Sci, Dept Nutr, 373 Olsen Blvd,Cater Mattil Hall,Rm 214D,TAMU 2253, College Stn, TX 77843 USA.
   [Guo, Shaodong] Texas A&M Univ, Coll Agr & Life Sci, Dept Nutr, 373 Olsen Blvd,Cater Mattil Hall,Rm 123A,TAMU 2253, College Stn, TX 77843 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M University System; Texas A&M University College Station; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   University System; Texas A&M University College Station
RP Sun, YX (corresponding author), Texas A&M Univ, Coll Agr & Life Sci, Dept Nutr, 373 Olsen Blvd,Cater Mattil Hall,Rm 214D,TAMU 2253, College Stn, TX 77843 USA.; Guo, SD (corresponding author), Texas A&M Univ, Coll Agr & Life Sci, Dept Nutr, 373 Olsen Blvd,Cater Mattil Hall,Rm 123A,TAMU 2253, College Stn, TX 77843 USA.
EM yuxiang.sun@ag.tamu.edu; shaodong.guo@ag.tamu.edu
RI Sun, Yuxiang/HPH-6656-2023; wu, p/JDW-5015-2023
OI Sun, Yuxiang/0000-0002-7704-0559; Guo, Shaodong/0000-0001-5126-731X;
   Yang, Wanbao/0000-0002-5519-8443
FU National Institutes of Health [R01 DK095118, R01 DK124588, R01 DK120968,
   R01AG064869, R01DK118334]
FX National Institutes of Health, Grant/Award Number: R01 DK095118, R01
   DK120968, R01AG064869, R01DK118334 and R01DK124588
CR Barzilai N, 2012, J GERONTOL A-BIOL, V67, P1329, DOI 10.1093/gerona/gls145
   BOUCHARD C, 1993, ENDOCR REV, V14, P72, DOI 10.1210/er.14.1.72
   Cai J. J., 2020, SCGEATOOLBOX MATLAB
   Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1
   Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071
   Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049
   Chiba T, 2009, MECH AGEING DEV, V130, P420, DOI 10.1016/j.mad.2009.04.004
   CHUMLEA W C, 1989, American Journal of Human Biology, V1, P457, DOI 10.1002/ajhb.1310010408
   Chung KW, 2015, AGING CELL, V14, P524, DOI 10.1111/acel.12305
   Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538
   Curtis R, 2005, NAT REV DRUG DISCOV, V4, P569, DOI 10.1038/nrd1777
   De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007
   DIESSELHOFFDENDULK MMC, 1979, IMMUNOLOGY, V37, P7
   Ding HR, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00177
   Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006
   Fairweather-Tait Susan J, 2014, Mech Ageing Dev, V136-137, P22, DOI 10.1016/j.mad.2013.11.005
   Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Ke BL, 2015, DIABETES, V64, P3355, DOI 10.2337/db15-0242
   Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841
   Kleindorp R, 2011, AGING CELL, V10, P622, DOI 10.1111/j.1474-9726.2011.00698.x
   Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034
   Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11
   Lee S, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI154333
   Li C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126453
   Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006
   McGettigan B, 2019, HEPATOLOGY, V70, P67, DOI 10.1002/hep.30401
   MOORADIAN AD, 1991, J AM GERIATR SOC, V39, P891, DOI 10.1111/j.1532-5415.1991.tb04456.x
   Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714
   Nguyen-Lefebvre Anh Thu, 2015, J Enzymol Metab, V1
   Nov O, 2010, ENDOCRINOLOGY, V151, P4247, DOI 10.1210/en.2010-0340
   O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592
   Prattichizzo F, 2018, AGEING RES REV, V41, P1, DOI 10.1016/j.arr.2017.10.003
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   She SP, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.812431
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   Wandrer F, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2411-6
   Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080
   Wu YX, 2018, DIABETES, V67, P2167, DOI 10.2337/db18-0674
   Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028
   Yang W., 2023, DIABETOLOGIA, V66, P1
   Yang WB, 2019, J ENDOCRINOL, V241, P265, DOI 10.1530/JOE-19-0081
   Yang YJ, 2023, CELL SYST, V14, P302, DOI 10.1016/j.cels.2023.01.004
   Zhang KB, 2019, ENDOCRINOLOGY, V160, P1333, DOI 10.1210/en.2018-00853
   Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527
   Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574
   Zou YL, 2020, NATURE, V585, P603, DOI 10.1038/s41586-020-2732-8
NR 62
TC 3
Z9 3
U1 12
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 OCT
PY 2023
VL 22
IS 10
DI 10.1111/acel.13968
EA AUG 2023
PG 21
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA U5HL2
UT WOS:001052032100001
PM 37602516
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Lalazar, G
   Ilyas, G
   Malik, SA
   Liu, K
   Zhao, EP
   Amir, M
   Lin, Y
   Tanaka, KE
   Czaja, MJ
AF Lalazar, Gadi
   Ilyas, Ghulam
   Malik, Shoaib Ahmad
   Liu, Kun
   Zhao, Enpeng
   Amir, Mohammad
   Lin, Yu
   Tanaka, Kathryn E.
   Czaja, Mark J.
TI Autophagy confers resistance to lipopolysaccharide-induced mouse
   hepatocyte injury
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE Akt; apoptosis; liver; sepsis; tumor necrosis factor
ID FAS-MEDIATED APOPTOSIS; TNF-ALPHA; LIVER-INJURY; OXIDATIVE STRESS;
   PROTECTIVE ROLE; UNITED-STATES; CELL-DEATH; SEPSIS; ACTIVATION;
   EPIDEMIOLOGY
AB During sepsis, bacterial products, particularly LPS, trigger injury in organs such as the liver. This common condition remains largely untreatable, in part due to a lack of understanding of how high concentrations of LPS cause cellular injury. In the liver, the lysosomal degradative pathway of autophagy performs essential hepatoprotective functions and is induced by LPS. We, therefore, examined whether hepatocyte autophagy protects against liver injury from septic levels of LPS. Mice with an inducible hepatocyte-specific knockout of the critical autophagy gene Atg7 were examined for their sensitivity to high-dose LPS. Increased liver injury occurred in knockout mice, as determined by significantly increased serum alanine aminotransferase levels, histological evidence of liver injury, terminal deoxynucleotide transferase-mediated deoxyuridine triphosphate nick end-labeling, and effector caspase-3 and -7 activation. Hepatic inflammation and proinflammatory cytokine induction were unaffected by the decrease in hepatocyte autophagy. Although knockout mice had normal NF-kappa B signaling, hepatic levels of Akt1 and Akt2 phosphorylation in response to LPS were decreased. Cultured hepatocytes from knockout mice displayed a generalized defect in Akt signaling in response to multiple stimuli, including LPS, TNF, and IL-1 beta. Akt activation mediates hepatocyte resistance to TNF cytotoxicity, and anti-TNF antibodies significantly decreased LPS-induced liver injury in knockout mice, indicating that the loss of autophagy sensitized to TNF-dependent liver damage. Hepatocyte autophagy, therefore, protects against LPS-induced liver injury. Conditions such as aging and steatosis that impair hepatic autophagy may predispose to poor outcomes from sepsis through this mechanism.
C1 [Lalazar, Gadi; Ilyas, Ghulam; Liu, Kun; Zhao, Enpeng; Amir, Mohammad; Lin, Yu; Czaja, Mark J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.
   [Lalazar, Gadi; Ilyas, Ghulam; Liu, Kun; Zhao, Enpeng; Amir, Mohammad; Lin, Yu; Czaja, Mark J.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10467 USA.
   [Malik, Shoaib Ahmad; Czaja, Mark J.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA USA.
   [Malik, Shoaib Ahmad] Univ Sargodha, Sargodha Med Coll, Dept Biochem, Sargodha, Pakistan.
   [Tanaka, Kathryn E.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Emory University;
   University of Sargodha; Yeshiva University; Albert Einstein College of
   Medicine
RP Czaja, MJ (corresponding author), Emory Univ, Sch Med, 615 Michael St,Ste 201, Atlanta, GA 30322 USA.
EM mark.j.czaja@emory.edu
RI Malik, Shoaib Ahmad/O-7022-2017
OI Malik, Shoaib Ahmad/0000-0002-0843-8512
FU National Institutes of Health [R01-DK-044234, R01-DK-061498,
   R01-AA-022601, F32-DK-096791, P30-DK-041296]; American Liver Foundation
FX This work was supported in part by National Institutes of Health Grants
   R01-DK-044234, R01-DK-061498, R01-AA-022601 (M. J. Czaja), F32-DK-096791
   (K. Liu), and P30-DK-041296, and an American Liver Foundation
   Postdoctoral Research Fellowship Award (K. Liu).
CR Amir M, 2013, CELL DEATH DIFFER, V20, P878, DOI 10.1038/cdd.2013.21
   Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Belaid A, 2013, AUTOPHAGY, V9, P1629, DOI 10.4161/auto.25880
   Bercault N, 2004, CRIT CARE MED, V32, P998, DOI 10.1097/01.CCM.0000119422.93413.08
   Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324
   Colleran A, 2011, J BIOL CHEM, V286, P22886, DOI 10.1074/jbc.M110.199950
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Czaja MJ, 2011, GASTROENTEROLOGY, V140, P1895, DOI 10.1053/j.gastro.2011.04.038
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Dong ML, 2013, BBA-MOL BASIS DIS, V1832, P848, DOI 10.1016/j.bbadis.2013.02.023
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Liu K, 2015, AUTOPHAGY, V11, P271, DOI 10.1080/15548627.2015.1009787
   Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804
   Luo MXM, 2015, J CELL PHYSIOL, V230, P2382, DOI 10.1002/jcp.24967
   Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200
   Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632
   Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005
   Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje
   Singh R, 2009, AM J PHYSIOL-GASTR L, V297, pG907, DOI 10.1152/ajpgi.00151.2009
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839
   Vachharajani Vidula, 2008, Pathophysiology, V15, P123, DOI 10.1016/j.pathophys.2008.04.008
   Wang YJ, 2004, J BIOL CHEM, V279, P31089, DOI 10.1074/jbc.M404170200
   Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200
   Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8
   Xu Y, 1998, GASTROENTEROLOGY, V115, P1229, DOI 10.1016/S0016-5085(98)70095-2
   Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
NR 37
TC 42
Z9 43
U1 1
U2 15
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD SEP 1
PY 2016
VL 311
IS 3
BP G377
EP G386
DI 10.1152/ajpgi.00124.2016
PG 10
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA DY0FL
UT WOS:000384772600004
PM 27469366
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Malatesta, M
   Boraldi, F
   Annovi, G
   Baldelli, B
   Battistelli, S
   Biggiogera, M
   Quaglino, D
AF Malatesta, Manuela
   Boraldi, Federica
   Annovi, Giulia
   Baldelli, Beatrice
   Battistelli, Serafina
   Biggiogera, Marco
   Quaglino, Daniela
TI A long-term study on female mice fed on a genetically modified soybean:
   effects on liver ageing
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE Ageing; Cell nucleus; Genetically modified soybean; Liver; Mitochondria
ID HEAT-SHOCK PROTEINS; MITOCHONDRIAL NITRIC-OXIDE; GENDER-DIFFERENCES;
   DIFFERENTIAL EXPRESSION; GLYPHOSATE; REGUCALCIN; ARGINASE;
   HEPATOTOXICITY; IDENTIFICATION; ACCUMULATION
AB Liver represents a suitable model for monitoring the effects of a diet, due to its key role in controlling the whole metabolism. Although no direct evidence has been reported so far that genetically modified (GM) food may affect health, previous studies on hepatocytes from young female mice fed on GM soybean demonstrated nuclear modifications involving transcription and splicing pathways. In this study, the effects of this diet were studied on liver of old female mice in order to elucidate possible interference with ageing. The morpho-functional characteristics of the liver of 24-month-old mice, fed from weaning on control or GM soybean, were investigated by combining a proteomic approach with ultrastructural, morphometrical and immunoelectron microscopical analyses. Several proteins belonging to hepatocyte metabolism, stress response, calcium signalling and mitochondria were differentially expressed in GM-fed mice, indicating a more marked expression of senescence markers in comparison to controls. Moreover, hepatocytes of GM-fed mice showed mitochondrial and nuclear modifications indicative of reduced metabolic rate. This study demonstrates that GM soybean intake can influence some liver features during ageing and, although the mechanisms remain unknown, underlines the importance to investigate the long-term consequences of GM-diets and the potential synergistic effects with ageing, xenobiotics and/or stress conditions.
C1 [Malatesta, Manuela] Univ Verona, Dipartimento Sci Morfol Biomed, Sez Anat & Istol, I-37134 Verona, Italy.
   [Boraldi, Federica; Annovi, Giulia; Quaglino, Daniela] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy.
   [Baldelli, Beatrice; Battistelli, Serafina] Univ Urbino, Ist Istol & Anal Lab, I-61029 Urbino, PU, Italy.
   [Biggiogera, Marco] Univ Pavia, Dipartimento Biol Anim, Lab Biol Cellulare & Nuerobiol, I-27100 Pavia, Italy.
C3 University of Verona; Universita di Modena e Reggio Emilia; University
   of Urbino; University of Pavia
RP Malatesta, M (corresponding author), Univ Verona, Dipartimento Sci Morfol Biomed, Sez Anat & Istol, Str Le Grazie 8, I-37134 Verona, Italy.
EM manuela.malatesta@univr.it
RI Boraldi, Federica/D-1263-2015; Quaglino, Daniela/A-9381-2010;
   Biggiogera, Marco/AAH-3543-2019
OI Boraldi, Federica/0000-0002-0277-9017; Quaglino,
   Daniela/0000-0002-4302-5078; MALATESTA, Manuela/0000-0001-8196-9232
FU Agenzia Servizi Settore Agroalimentare delle Marche, Italy
FX We thank M. Storaci of the Istituto Zooprofilattico Sperimentale
   dell'Umbria e delle Marche for his assistance in mouse breeding. This
   work was supported by the Agenzia Servizi Settore Agroalimentare delle
   Marche, Italy.
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X
   BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006
   Dai GL, 2006, TOXICOL SCI, V92, P33, DOI 10.1093/toxsci/kfj192
   Doull J, 2007, FOOD CHEM TOXICOL, V45, P2073, DOI 10.1016/j.fct.2007.08.033
   Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x
   Ewen SWB, 1999, LANCET, V354, P1353, DOI 10.1016/S0140-6736(98)05860-7
   Fakan S, 2004, EUR J HISTOCHEM, V48, P5
   Frasca D, 2003, J IMMUNOL, V170, P719, DOI 10.4049/jimmunol.170.2.719
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fukaya Y, 2004, BIOL PHARM BULL, V27, P1444, DOI 10.1248/bpb.27.1444
   Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528
   Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.3.CO;2-Y
   Gilca M, 2007, J POSTGRAD MED, V53, P207, DOI 10.4103/0022-3859.33869
   Granby K, 2003, FOOD ADDIT CONTAM, V20, P692, DOI 10.1080/0265203031000109477
   Hallén A, 2002, BIOGERONTOLOGY, V3, P307, DOI 10.1023/A:1020155502734
   Hildebrand R, 1980, Adv Anat Embryol Cell Biol, V60, P1
   HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4
   Honoré B, 2004, BIOESSAYS, V26, P901, DOI 10.1002/bies.20075
   Jameson CW, 2004, MED HYPOTHESES, V63, P83, DOI 10.1016/j.mehy.2004.01.021
   Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005
   Kato K, 2006, FRONT BIOSCI-LANDMRK, V11, P2725, DOI 10.2741/2002
   Kuiper HA, 2004, FOOD CHEM TOXICOL, V42, P1195, DOI 10.1016/j.fct.2004.02.004
   KUMAR AN, 1984, EXP GERONTOL, V19, P191, DOI 10.1016/0531-5565(84)90038-X
   LAFARGA M, 1993, ANAT EMBRYOL, V187, P363
   Lin G, 2003, CHEM RES TOXICOL, V16, P768, DOI 10.1021/tx0340302
   Malatesta M, 1998, BREAST CANCER RES TR, V48, P211, DOI 10.1023/A:1005932915429
   Malatesta M, 2005, EUR J HISTOCHEM, V49, P237
   Malatesta M, 2004, ANN NY ACAD SCI, V1019, P379, DOI 10.1196/annals.1297.067
   Malatesta M, 2003, EUR J HISTOCHEM, V47, P385
   Malatesta M, 2003, MECH AGEING DEV, V124, P175, DOI 10.1016/S0047-6374(02)00117-3
   Malatesta M, 2002, CELL STRUCT FUNCT, V27, P173, DOI 10.1247/csf.27.173
   Malatesta M, 2002, J ANAT, V201, P409, DOI 10.1046/j.0021-8782.2002.00103.x
   Marc J, 2005, TOXICOL APPL PHARM, V203, P1, DOI 10.1016/j.taap.2004.07.014
   Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534
   Morris ME, 2003, PHARMACOL REV, V55, P229, DOI 10.1124/pr.55.2.1
   Multhoff G, 2006, HANDB EXP PHARM, V172, P279
   Numao N, 2007, BJU INT, V99, P1495, DOI 10.1111/j.1464-410X.2007.06860.x
   PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x
   Pastorelli R, 2006, MOL CELL PROTEOMICS, V5, P882, DOI 10.1074/mcp.M500415-MCP200
   Patel NN, 2008, XENOBIOTICA, V38, P435, DOI [10.1080/00498250701830267, 10.1080/00498250701830267 ]
   Peixoto F, 2005, CHEMOSPHERE, V61, P1115, DOI 10.1016/j.chemosphere.2005.03.044
   Pujol G, 2002, BIOCHEM BIOPH RES CO, V294, P354, DOI 10.1016/S0006-291X(02)00492-8
   Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1
   Richard S, 2005, ENVIRON HEALTH PERSP, V113, P716, DOI 10.1289/ehp.7728
   Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511
   Sanvido O, 2007, ADV BIOCHEM ENG BIOT, V107, P235, DOI 10.1007/10_2007_048
   Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SCHWARZACHER HG, 1993, ANAT EMBRYOL, V188, P515
   Séralini GE, 2007, ARCH ENVIRON CON TOX, V52, P596, DOI 10.1007/s00244-006-0149-5
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Sverko V, 2004, BIOGERONTOLOGY, V5, P235, DOI 10.1023/B:BGEN.0000038024.58911.6e
   Szarek J, 2000, MAR ENVIRON RES, V50, P263, DOI 10.1016/S0141-1136(00)00088-X
   Tipton KD, 2001, CURR OPIN CLIN NUTR, V4, P493, DOI 10.1097/00075197-200111000-00005
   Tobisawa M, 2003, INT J MOL MED, V12, P577
   Tong BC, 2004, MINI-REV MED CHEM, V4, P823, DOI 10.2174/1389557043403305
   Torres AM, 1996, BIOCHEM PHARMACOL, V51, P1117, DOI 10.1016/0006-2952(95)02407-7
   Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009
   Tudisco R, 2006, ANIM SCI, V82, P193, DOI 10.1079/ASC200530
   Valdez Laura B., 2004, Molecular Aspects of Medicine, V25, P49, DOI 10.1016/j.mam.2004.02.008
   Voss MR, 2003, AM J PHYSIOL-HEART C, V285, pH687, DOI 10.1152/ajpheart.01000.2002
   Wei YH, 2008, J PROTEOME RES, V7, P1729, DOI 10.1021/pr7008059
   Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x
   Yamaguchi M, 2005, INT J MOL MED, V15, P371
   Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085
   Zhang HJ, 2002, J APPL PHYSIOL, V92, P1762, DOI 10.1152/japplphysiol.00733.2001
NR 69
TC 54
Z9 63
U1 1
U2 57
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD NOV
PY 2008
VL 130
IS 5
BP 967
EP 977
DI 10.1007/s00418-008-0476-x
PG 11
WC Cell Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Microscopy
GA 359OR
UT WOS:000259997900013
PM 18648843
DA 2024-02-19
ER

PT J
AU White, RR
   Milholland, B
   de Bruin, A
   Curran, S
   Laberge, RM
   van Steeg, H
   Campisi, J
   Maslov, AY
   Vijg, J
AF White, Ryan R.
   Milholland, Brandon
   de Bruin, Alain
   Curran, Samuel
   Laberge, Remi-Martin
   van Steeg, Harry
   Campisi, Judith
   Maslov, Alexander Y.
   Vijg, Jan
TI Controlled induction of DNA double-strand breaks in the mouse liver
   induces features of tissue ageing
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GENE-EXPRESSION PROFILES; CELLULAR SENESCENCE; DAMAGE RESPONSE;
   HEPATOCYTES; CANCER; CELLS; ACCUMULATION; DEFICIENCY; ACTIVATION;
   ANEUPLOIDY
AB DNA damage has been implicated in ageing, but direct evidence for a causal relationship is lacking, owing to the difficulty of inducing defined DNA lesions in cells and tissues without simultaneously damaging other biomolecules and cellular structures. Here we directly test whether highly toxic DNA double-strand breaks (DSBs) alone can drive an ageing phenotype using an adenovirus-based system based on tetracycline-controlled expression of the SacI restriction enzyme. We deliver the adenovirus to mice and compare molecular and cellular end points in the liver with normally aged animals. Treated, 3-month-old mice display many, but not all signs of normal liver ageing as early as 1 month after treatment, including ageing pathologies, markers of senescence, fused mitochondria and alterations in gene expression profiles. These results, showing that DSBs alone can cause distinct ageing phenotypes in mouse liver, provide new insights in the role of DNA damage as a driver of tissue ageing.
C1 [White, Ryan R.; Milholland, Brandon; Maslov, Alexander Y.; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.
   [de Bruin, Alain] Univ Utrecht, Dutch Mol Pathol Ctr, Dept Pathobiol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands.
   [Curran, Samuel; Laberge, Remi-Martin; Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA.
   [van Steeg, Harry] Natl Inst Publ Hlth & Environm RIVM, NL-3721 MA Bilthoven, Netherlands.
   [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Utrecht
   University; Buck Institute for Research on Aging; Netherlands National
   Institute for Public Health & the Environment; University of California
   System; University of California Berkeley; United States Department of
   Energy (DOE); Lawrence Berkeley National Laboratory
RP White, RR (corresponding author), Albert Einstein Coll Med, Dept Genet, 1301 Morris Pk Ave, Bronx, NY 10461 USA.
EM ryan.white@phd.einstein.yu.edu; jan.vijg@einstein.yu.edu
RI Maslov, Alexander/AAH-3788-2019; de Bruin, Alain/AAL-9195-2020
OI White, Ryan/0000-0001-8344-2549; de Bruin, Alain/0000-0001-8579-2649
FU National Institutes of Health [AG17242]; Ellison Medical Foundation;
   Glenn Foundation; Sue Golding Graduate Division of the Albert Einstein
   College of Medicine; Albert Einstein College of Medicine Human Genome
   Program Pilot project grant; Einstein-Nathan Shock Center of Excellence
   Pilot and feasibility grant [5P30AG038072-05]
FX This work was supported by the National Institutes of Health grant
   AG17242, the Ellison Medical Foundation, the Glenn Foundation, the Sue
   Golding Graduate Division of the Albert Einstein College of Medicine,
   and by the Albert Einstein College of Medicine Human Genome Program
   Pilot project grant (AYM) and the Einstein-Nathan Shock Center of
   Excellence Pilot and feasibility grant 5P30AG038072-05 (AYM). We thank
   Dr Rani Sellers and the Histopathology Core, Dr Shahina Maqbool and the
   Epigenomics Core, Dr Cristina Montagna and the Molecular Cytogenetics
   Core and the Analytical Imaging Facility of the Albert Einstein College
   of Medicine for their help and suggestions. We are also grateful to Dr
   Sameh Youssef of the Dutch Molecular Pathology Center, Faculty of
   Veterinary Medicine, for performing the lipofuscin analysis. We also
   thank Brent Calder for his assistance with the analysis of the RNA-seq
   results and Dr Tao Wang for assistance and recommendations in
   biostatistics.
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   CHONG YC, 1989, CANCER RES, V49, P6652
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Cruickshanks HA, 2013, NAT CELL BIOL, V15, P1495, DOI 10.1038/ncb2879
   Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Ding GH, 2001, EXP MOL PATHOL, V70, P43, DOI 10.1006/exmp.2000.2346
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80
   Faggioli F, 2014, METHODS MOL BIOL, V1136, P291, DOI 10.1007/978-1-4939-0329-0_14
   Faggioli F, 2012, HUM MOL GENET, V21, P5246, DOI 10.1093/hmg/dds375
   Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687
   Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kirschner K, 2007, DNA REPAIR, V6, P304, DOI 10.1016/j.dnarep.2006.10.020
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lans H, 2012, NAT GENET, V44, P836, DOI 10.1038/ng.2363
   Li H, 2008, MECH AGEING DEV, V129, P416, DOI 10.1016/j.mad.2008.02.002
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Maslov AY, 2009, BIOTECHNIQUES, V47, P847, DOI 10.2144/000113237
   Miné-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472
   Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071
   Nakamura T, 2003, J VIROL, V77, P2512, DOI 10.1128/JVI.77.4.2512-2521.2003
   Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268
   Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185
   Park JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002346
   Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289
   Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097
   Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rübe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487
   SATO T, 1975, ACTA PATHOL JAPON, V25, P403
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531
   SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397
   Soutoglou Evi, 2008, J Natl Cancer Inst Monogr, P16, DOI 10.1093/jncimonographs/lgn017
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Velarde MC, 2012, AGING-US, V4, P3, DOI 10.18632/aging.100423
   Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715
   Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   White RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084379
   Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
NR 61
TC 79
Z9 88
U1 0
U2 13
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR
PY 2015
VL 6
AR 6790
DI 10.1038/ncomms7790
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CH0IH
UT WOS:000353702500030
PM 25858675
OA Green Published, Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Krizhanovsky, V
   Yon, M
   Dickins, RA
   Hearn, S
   Simon, J
   Miething, C
   Yee, H
   Zender, L
   Lowe, SW
AF Krizhanovsky, Valery
   Yon, Monica
   Dickins, Ross A.
   Hearn, Stephen
   Simon, Janelle
   Miething, Cornelius
   Yee, Herman
   Zender, Lars
   Lowe, Scott W.
TI Senescence of activated stellate cells limits liver fibrosis
SO CELL
LA English
DT Article
ID ONCOGENE-INDUCED SENESCENCE; NATURAL-KILLER-CELLS; HEPATITIS-B-VIRUS;
   CELLULAR SENESCENCE; HETEROCHROMATIN FORMATION; TRANSGENIC MICE; P53;
   PATHWAY; TUMORIGENESIS; CANCER
AB Cellular senescence acts as a potent mechanism of tumor suppression; however, its functional contribution to noncancer pathologies has not been examined. Here we show that senescent cells accumulate in murine livers treated to produce fibrosis, a precursor pathology to cirrhosis. The senescent cells are derived primarily from activated hepatic stellate cells, which initially proliferate in response to liver damage and produce the extracellular matrix deposited in the fibrotic scar. In mice lacking key senescence regulators, stellate cells continue to proliferate, leading to excessive liver fibrosis. Furthermore, senescent activated stellate cells exhibit gene expression profile consistent with cell-cycle exit, reduced secretion of extracellular matrix components, enhanced secretion of extracellular matrix-degrading enzymes, and enhanced immune surveillance. Accordingly natural killer cells preferentially kill senescent activated stellate cells in vitro and in vivo, thereby facilitating the resolution of fibrosis. Therefore, the senescence program limits the fibrogenic response to acute tissue damage.
C1 [Krizhanovsky, Valery; Yon, Monica; Dickins, Ross A.; Hearn, Stephen; Simon, Janelle; Miething, Cornelius; Zender, Lars; Lowe, Scott W.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.
   [Yon, Monica] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.
   [Yee, Herman] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.
C3 Howard Hughes Medical Institute; Cold Spring Harbor Laboratory;
   Universidade de Sao Paulo; New York University
RP Lowe, SW (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.
EM lowe@cshl.edu
RI Dickins, Ross A/K-2852-2012; Miething, Cornelius/F-9498-2014;
   Krizhanovsky, Valery/D-1336-2010
OI Dickins, Ross A/0000-0003-4112-5304; Miething,
   Cornelius/0000-0003-4699-3805; Hearn, Stephen/0000-0002-2489-2424;
   Krizhanovsky, Valery/0000-0002-3977-5482
FU Leukemia and Lymphoma Society; National Institutes of Health [AG16379];
   National Council for Scientific and Technological Development (CNPq);
   German Research Foundation [ZE-545/2-1]
FX We gratefully acknowledge M. Spector for insightful suggestions and
   critical reading and editing of the manuscript; G. P. Amarante-Mendes
   for reagents and advice; M. J. Bahr for reading the manuscript; M.
   McCurrach for editorial advice; members of the Lowe laboratory for
   stimulating discussions; E. Hernando and L. Chiriboga for IHC; K.
   Diggins, L. Bianco, and the CSHL animal facility for help with animals;
   P. Moody and the CSHL Flow Cytometry facility for help with laser
   scanning cytometry. This work was supported by a postdoctoral fellowship
   from the Leukemia and Lymphoma Society (V. K.) and grant AG16379 from
   the National Institutes of Health (S. W. L.). M. Y. is supported by a
   doctoral fellowship from the National Council for Scientific and
   Technological Development (CNPq). L. Z. is a Seligson Clinical Fellow
   and supported by the German Research Foundation (Emmy Noether Programme,
   ZE-545/2-1 and the Excellence Cluster "Rebirth''). S. W. L. is a Howard
   Hughes Medical Institute investigator.
CR Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045
   Drexler HG, 2000, LEUKEMIA, V14, P777, DOI 10.1038/sj.leu.2401778
   Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Muhanna N, 2007, CLIN EXP IMMUNOL, V148, P338, DOI 10.1111/j.1365-2249.2007.03353.x
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   *NCHS, 2004, NAT VITT STAT REP
   Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863
   Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984
   Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295
   Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008
NR 35
TC 1375
Z9 1538
U1 6
U2 170
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
J9 CELL
JI Cell
PD AUG 22
PY 2008
VL 134
IS 4
BP 657
EP 667
DI 10.1016/j.cell.2008.06.049
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 340SR
UT WOS:000258665800018
PM 18724938
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU KATZ, MS
   DAX, EM
   GREGERMAN, RI
AF KATZ, MS
   DAX, EM
   GREGERMAN, RI
TI BETA-ADRENERGIC REGULATION OF RAT-LIVER GLYCOGENOLYSIS DURING AGING
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE ADENYLATE CYCLASE; BETA-ADRENERGIC RECEPTOR; G-PROTEIN; HEPATOCYTE;
   CATECHOLAMINES
ID ADENYLATE-CYCLASE ACTIVITY; AGE-RELATED-CHANGES; C-MYC TRANSCRIPT;
   CYCLIC-AMP; HEPATIC GLYCOGENOLYSIS; BETA-2-ADRENERGIC RECEPTORS;
   GLUCOSE-PRODUCTION; HORMONE ACTION; CELLS; PHOSPHORYLASE
AB Studies from a number of laboratories demonstrate a biphasic change in beta adrenergic regulation of hepatic glycogenolysis over the life span of the male rat. The beta adrenergic response is prominent in immature animals, declines rapidly during subsequent development to a minimum by the time of young adulthood, and then reemerges during postmaturational development. Age changes in beta adrenergic-responsive adenylate cyclase activity follow a ''U''-shaped curve similar to that described by changes in liver glycogenolytic responsiveness during aging. Developmental and postmaturational changes in beta adrenergic-sensitive adenylate cyclase activation are related to parallel alterations in the density of beta adrenergic receptors and also to functional changes in nonreceptor components of the enzyme. The prevailing view that catecholamines stimulate hepatic glycogenolysis by an alpha adrenergic receptor-mediated, cyclic AMP-independent mechanism is based almost entirely on evidence from young adult male rats. We propose that current concepts of alpha adrenergic-responsive liver glycogenolysis underestimate a physiological role for beta adrenergic responsiveness over the majority of the life span.
C1 FAIRFIELD HOSP,NATL HIV REF LAB,FAIRFIELD,VIC 3078,AUSTRALIA.
   JOHNS HOPKINS UNIV,FRANCIS SCOTT KEY MED CTR,SCH MED,DEPT MED,BALTIMORE,MD 21224.
   UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284.
C3 NSW Health; Fairfield Hospital; Johns Hopkins University; University of
   Texas System; University of Texas Health Science Center at San Antonio
RP KATZ, MS (corresponding author), AUDIE L MURPHY MEM VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN 182,7400 MERTON MINTER BLVD,SAN ANTONIO,TX 78284, USA.
CR ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0
   AGGERBECK M, 1983, J CLIN INVEST, V71, P476, DOI 10.1172/JCI110792
   ARINZE IJ, 1983, ARCH BIOCHEM BIOPHYS, V225, P196, DOI 10.1016/0003-9861(83)90023-1
   BAEYENS DA, 1992, ENDOCRINE SOC, P367
   BAR HP, 1971, CAN J BIOCHEM CELL B, V49, P85, DOI 10.1139/o71-013
   BARSONY J, 1990, P NATL ACAD SCI USA, V87, P1188, DOI 10.1073/pnas.87.3.1188
   BENDECK JL, 1985, PEDIATR RES, V19, P862, DOI 10.1203/00006450-198508000-00018
   BLAIR JB, 1979, J BIOL CHEM, V254, P7579
   BOYD H, 1976, MOL PHARMACOL, V12, P195
   CHAN TM, 1979, J BIOL CHEM, V254, P2428
   CHRISTOFFERSEN T, 1973, BIOCHIM BIOPHYS ACTA, V313, P338, DOI 10.1016/0304-4165(73)90033-0
   DAX EM, 1981, J LIPID RES, V22, P934
   DAX EM, 1990, ENDOCRINOLOGY, V127, P2236, DOI 10.1210/endo-127-5-2236
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   Dax EM, 1988, GERONTOLOGIST, V28, p137A
   EAKES AT, 1992, ENDOCRINE SOC, P370
   EXTON JH, 1988, HEPATOLOGY, V8, P152, DOI 10.1002/hep.1840080129
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   GUARNIERI T, 1980, AM J PHYSIOL, V239, pH501, DOI 10.1152/ajpheart.1980.239.4.H501
   HUERTABAHENA J, 1983, BIOCHIM BIOPHYS ACTA, V763, P112, DOI 10.1016/0167-4889(83)90033-2
   HUTSON NJ, 1976, J BIOL CHEM, V251, P5200
   ISHAC EJN, 1986, P NATL ACAD SCI USA, V83, P53, DOI 10.1073/pnas.83.1.53
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V483, P452, DOI 10.1016/0005-2744(77)90073-0
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   KAWAI Y, 1983, J BIOL CHEM, V258, P4364
   LUM BKB, 1980, LIFE SCI, V26, P1195, DOI 10.1016/0024-3205(80)90063-6
   MAKINO R, 1984, NATURE, V310, P697, DOI 10.1038/310697a0
   MALBON CC, 1978, J BIOL CHEM, V253, P8820
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   MCMILLIAN MK, 1983, J PHARMACOL EXP THER, V227, P181
   MORGAN NG, 1983, J BIOL CHEM, V258, P5103
   RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714
   ROSSBY SP, 1991, J CELL PHYSIOL, V147, P55, DOI 10.1002/jcp.1041470108
   ROY AK, 1984, MOL BASIS AGING, P143
   SACCA L, 1983, AM J PHYSIOL, V245, pE294, DOI 10.1152/ajpendo.1983.245.3.E294
   SAKAI M, 1989, CANCER RES, V49, P5633
   SCARPACE PJ, 1987, J GERONTOL, V42, P442, DOI 10.1093/geronj/42.4.442
   SCHLEIFER LS, 1989, J CELL PHYSIOL, V140, P52, DOI 10.1002/jcp.1041400107
   SEMSEI I, 1989, ONCOGENE, V4, P465
   SHERLINE P, 1972, ENDOCRINOLOGY, V91, P680, DOI 10.1210/endo-91-3-680
   STEINER KE, 1984, FED PROC, V43, P411
   STUDER RK, 1982, J BIOL CHEM, V257, P7987
   STUDER RK, 1989, AM J PHYSIOL, V256, pE392, DOI 10.1152/ajpendo.1989.256.3.E392
   SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401
   TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6
   WAGGONER S, 1990, GENETIC EFFECTS AGIN, V2, P255
NR 49
TC 34
Z9 37
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL-OCT
PY 1993
VL 28
IS 4-5
BP 329
EP 340
DI 10.1016/0531-5565(93)90060-Q
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LQ417
UT WOS:A1993LQ41700005
PM 8224032
DA 2024-02-19
ER

PT J
AU Ziegler, DV
   Vindrieux, D
   Goehrig, D
   Jaber, S
   Collin, G
   Griveau, A
   Wiel, C
   Bendridi, N
   Djebali, S
   Farfariello, V
   Prevarskaya, N
   Payen, L
   Marvel, J
   Aubert, S
   Flaman, JM
   Rieusset, J
   Martin, N
   Bernard, D
AF Ziegler, Dorian, V
   Vindrieux, David
   Goehrig, Delphine
   Jaber, Sara
   Collin, Guillaume
   Griveau, Audrey
   Wiel, Clotilde
   Bendridi, Nadia
   Djebali, Sophia
   Farfariello, Valerio
   Prevarskaya, Natacha
   Payen, Lea
   Marvel, Jacqueline
   Aubert, Sebastien
   Flaman, Jean-Michel
   Rieusset, Jennifer
   Martin, Nadine
   Bernard, David
TI Calcium channel ITPR2 and mitochondria-ER contacts promote cellular
   senescence and aging
SO NATURE COMMUNICATIONS
LA English
DT Article
AB Cellular senescence is induced by stresses and results in a stable proliferation arrest accompanied by a pro-inflammatory secretome. Senescent cells accumulate during aging, promoting various age-related pathologies and limiting lifespan. The endoplasmic reticulum (ER) inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) calcium-release channel and calcium fluxes from the ER to the mitochondria are drivers of senescence in human cells. Here we show that Itpr2 knockout (KO) mice display improved aging such as increased lifespan, a better response to metabolic stress, less immunosenescence, as well as less liver steatosis and fibrosis. Cellular senescence, which is known to promote these alterations, is decreased in Itpr2 KO mice and Itpr2 KO embryo-derived cells. Interestingly, ablation of ITPR2 in vivo and in vitro decreases the number of contacts between the mitochondria and the ER and their forced contacts induce premature senescence. These findings shed light on the role of contacts and facilitated exchanges between the ER and the mitochondria through ITPR2 in regulating senescence and aging. Contacts between mitochondria and endoplasmatic reticulum (ER), and the transfer of calcium between them, have an important role in the regulation of cellular phenotypes, including senescence. Here the authors show that ITPR2 deficient mice display improved aging, associated with a decreased number of contacts between the mitochondria and the ER.
C1 [Ziegler, Dorian, V; Vindrieux, David; Goehrig, Delphine; Jaber, Sara; Collin, Guillaume; Griveau, Audrey; Wiel, Clotilde; Payen, Lea; Flaman, Jean-Michel; Martin, Nadine; Bernard, David] Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard, Inserm,U1052,CNRS,UMR 5286, Lyon, France.
   [Bendridi, Nadia; Rieusset, Jennifer] Lyon 1 Univ, CarMeN Lab, INRA U1397, INSERM,UMR 1060, F-69921 Oullins, France.
   [Djebali, Sophia; Marvel, Jacqueline] Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Int Rech Infectiol, Inserm,U1111,Ecole Normale Super Lyon,CNRS,UMR530, Lyon, France.
   [Farfariello, Valerio; Prevarskaya, Natacha] Univ Sci & Technol Lille, Lab Excellence, SIROC ONCOLille, INSERM,U1003,Equipe Labellisee Ligue Natl Canc,Ca, Villeneuve Dascq, France.
   [Aubert, Sebastien] Univ Lille, CHRU Lille, Ctr Biol Pathol, Inst Pathol,Fac Med, Lille, France.
C3 UNICANCER; Centre Leon Berard; Universite Claude Bernard Lyon 1;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Claude Bernard Lyon 1; INRAE;
   Centre National de la Recherche Scientifique (CNRS); Universite Claude
   Bernard Lyon 1; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON);
   Universite de Lille; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite de Lille; CHU Lille
RP Bernard, D (corresponding author), Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard, Inserm,U1052,CNRS,UMR 5286, Lyon, France.
EM david.bernard@lyon.unicancer.fr
RI Carmen, Team2/Y-7383-2019; Bernard, David/D-6265-2018; Flaman,
   Jean-Michel/K-8415-2018; DJEBALI, SOPHIA/A-1798-2017; marvel,
   jacqueline/H-8638-2014; Rieusset, Jennifer/F-1595-2018
OI Carmen, Team2/0000-0001-9867-5724; Bernard, David/0000-0002-1557-2074;
   Flaman, Jean-Michel/0000-0003-3544-0199; DJEBALI,
   SOPHIA/0000-0002-0567-5387; marvel, jacqueline/0000-0001-6241-459X;
   GRIVEAU, Audrey/0000-0002-5928-6328; ZIEGLER, Dorian
   V./0000-0002-0475-6353; Jaber, Sara/0000-0002-3796-102X; Martin,
   Nadine/0000-0002-4806-2388; BENDRIDI, Nadia/0000-0003-0456-7007; Lab,
   Carmen/0000-0002-5935-3236; Rieusset, Jennifer/0000-0002-1587-2253
FU Fondation ARC pour la recherche sur le cancer; INCA [2018-144];
   Fondation pour la Recherche Medicale FRM [FDT201904008259]
FX We thank the laboratory members for helpful discussions. This work was
   carried out with the support of the Fondation ARC pour la recherche sur
   le cancer and INCA (N degrees 2018-144) to D.B. D.V.Z. is supported by
   the Fondation pour la Recherche Medicale FRM (FDT201904008259). We thank
   Ju Chen for providing Itpr2 KO mice. We thank Julien Ladet and
   laboratory members for helpful suggestions and collaborations.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
   Asrih M, 2015, MOL CELL ENDOCRINOL, V418, P55, DOI 10.1016/j.mce.2015.02.018
   Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255
   Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bartok A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11646-3
   Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035
   Birch J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600235
   Borodkina AV, 2016, AGING-US, V8, P3400, DOI 10.18632/aging.101130
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Csordás G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016
   de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Farfariello V, 2015, BBA-MOL CELL RES, V1853, P1974, DOI 10.1016/j.bbamcr.2015.03.005
   Ferrand M, 2015, AGING-US, V7, P986, DOI 10.18632/aging.100845
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   Kane AE, 2018, CURR OPIN PHYSIOL, V6, P28, DOI 10.1016/j.cophys.2018.03.008
   Khamphaya T, 2018, HEPATOLOGY, V67, P560, DOI 10.1002/hep.29588
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157
   Lamming DW, 2014, AGING CELL, V13, P911, DOI 10.1111/acel.12256
   Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009
   Li HL, 2015, CELL CALCIUM, V58, P565, DOI 10.1016/j.ceca.2015.09.004
   Li L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.169
   Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c
   Ma XJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12831
   Maarouf OH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120546
   Marchi S, 2017, ADV EXP MED BIOL, V997, P49, DOI 10.1007/978-981-10-4567-7_4
   Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015
   Martin N, 2018, CELL CALCIUM, V70, P16, DOI 10.1016/j.ceca.2017.04.001
   Milanovic M, 2018, TRENDS CELL BIOL, V28, P1049, DOI 10.1016/j.tcb.2018.09.001
   Missiroli S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0027-2
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200
   Nelsons G, 2018, MECH AGEING DEV, V170, P30, DOI 10.1016/j.mad.2017.08.005
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ouyang KF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5814
   Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Palmer AK, 2015, DIABETES, V64, P2289, DOI 10.2337/db14-1820
   Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19
   Pawelec G, 2014, EXP GERONTOL, V54, P1, DOI 10.1016/j.exger.2013.11.010
   Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001
   Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153
   Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751
   van Deursen JM, 2019, SCIENCE, V364, P636, DOI 10.1126/science.aaw1299
   van Vliet AR, 2014, BBA-MOL CELL RES, V1843, P2253, DOI 10.1016/j.bbamcr.2014.03.009
   Vervloessem T, 2015, BBA-MOL CELL RES, V1853, P1992, DOI 10.1016/j.bbamcr.2014.12.006
   Weaver D, 2017, BIOPHYS J, V112, p133A, DOI 10.1016/j.bpj.2016.11.735
   Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792
   Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 67
TC 65
Z9 70
U1 8
U2 38
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 1
PY 2021
VL 12
IS 1
AR 720
DI 10.1038/s41467-021-20993-z
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QF5NQ
UT WOS:000616941000001
PM 33526781
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, W
   Zheng, YX
   Sun, SH
   Li, W
   Song, MS
   Ji, QZ
   Wu, ZM
   Liu, ZP
   Fan, YL
   Liu, FF
   Li, JY
   Esteban, CR
   Wang, S
   Zhou, Q
   Belmonte, JCI
   Zhang, WQ
   Qu, J
   Tang, FC
   Liu, GH
AF Wang, Wei
   Zheng, Yuxuan
   Sun, Shuhui
   Li, Wei
   Song, Moshi
   Ji, Qianzhao
   Wu, Zeming
   Liu, Zunpeng
   Fan, Yanling
   Liu, Feifei
   Li, Jingyi
   Esteban, Concepcion Rodriguez
   Wang, Si
   Zhou, Qi
   Belmonte, Juan Carlos Izpisua
   Zhang, Weiqi
   Qu, Jing
   Tang, Fuchou
   Liu, Guang-Hui
TI A genome-wide CRISPR-based screen identifies <i>KAT7</i> as a driver of
   cellular senescence
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID LIFE-SPAN; GENETIC SCREENS; STEM-CELLS; HBO1; TRANSCRIPTION;
   ACETYLATION; MECHANISMS; LONGEVITY; STRESS; CANCER
AB Understanding the genetic and epigenetic bases of cellular senescence is instrumental in developing interventions to slow aging. We performed genome-wide CRISPR-Cas9-based screens using two types of human mesenchymal precursor cells (hMPCs) exhibiting accelerated senescence. The hMPCs were derived from human embryonic stem cells carrying the pathogenic mutations that cause the accelerated aging diseases Werner syndrome and Hutchinson-Gilford progeria syndrome. Genes whose deficiency alleviated cellular senescence were identified, including KAT7, a histone acetyltransferase, which ranked as a top hit in both progeroid hMPC models. Inactivation of KAT7 decreased histone H3 lysine 14 acetylation, repressed p15(INK4b) transcription, and alleviated hMPC senescence. Moreover, lentiviral vectors encoding Cas9/sg-Kat7, given intravenously, alleviated hepatocyte senescence and liver aging and extended life span in physiologically aged mice as well as progeroid Zmpste24(-/-) mice that exhibit a premature aging phenotype. CRISPR-Cas9-based genetic screening is a robust method for systematically uncovering senescence genes such as KAT7, which may represent a therapeutic target for developing aging interventions.
C1 [Wang, Wei; Sun, Shuhui; Song, Moshi; Ji, Qianzhao; Liu, Feifei; Li, Jingyi; Wang, Si; Liu, Guang-Hui] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.
   [Wang, Wei; Wu, Zeming; Liu, Zunpeng; Zhou, Qi; Qu, Jing] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.
   [Wang, Wei; Sun, Shuhui; Liu, Guang-Hui] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Wang, Wei; Sun, Shuhui; Song, Moshi; Ji, Qianzhao; Wu, Zeming; Liu, Zunpeng; Li, Jingyi; Zhou, Qi; Zhang, Weiqi; Qu, Jing; Liu, Guang-Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Zheng, Yuxuan; Tang, Fuchou] Peking Univ, Beijing Adv Innovat Ctr Genom, Biomed Pioneering Innovat Ctr, Sch Life Sci, Beijing 100871, Peoples R China.
   [Zheng, Yuxuan; Tang, Fuchou] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.
   [Li, Wei; Wang, Si; Zhang, Weiqi; Liu, Guang-Hui] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Natl Clin Res Ctr Geriatr Disorders, Xuanwu Hosp, Beijing 100053, Peoples R China.
   [Song, Moshi; Wang, Si; Zhou, Qi; Zhang, Weiqi; Qu, Jing; Liu, Guang-Hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China.
   [Fan, Yanling; Zhang, Weiqi] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing 100101, Peoples R China.
   [Fan, Yanling; Zhang, Weiqi] Chinese Acad Sci, China Natl Ctr Bioinformat, Beijing 100101, Peoples R China.
   [Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
C3 Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy
   of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences;
   Institute of Biophysics, CAS; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS; Peking University; Peking University;
   Capital Medical University; Chinese Academy of Sciences; Chinese Academy
   of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of
   Sciences; Salk Institute
RP Liu, GH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.; Qu, J (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Liu, GH (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Zhang, WQ; Qu, J; Liu, GH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Tang, FC (corresponding author), Peking Univ, Beijing Adv Innovat Ctr Genom, Biomed Pioneering Innovat Ctr, Sch Life Sci, Beijing 100871, Peoples R China.; Tang, FC (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Zhang, WQ; Liu, GH (corresponding author), Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Natl Clin Res Ctr Geriatr Disorders, Xuanwu Hosp, Beijing 100053, Peoples R China.; Zhang, WQ; Qu, J; Liu, GH (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China.; Zhang, WQ (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing 100101, Peoples R China.; Zhang, WQ (corresponding author), Chinese Acad Sci, China Natl Ctr Bioinformat, Beijing 100101, Peoples R China.
EM zhangwq@big.ac.cn; qujing@ioz.ac.cn; tangfuchou@pku.edu.cn;
   ghliu@ioz.ac.cn
RI zhang, chen/JES-0371-2023; zhang, xueying/JMB-7808-2023; li,
   qing/JEF-9044-2023; peng, jy/JMB-2297-2023; Wang,
   Jiacheng/ABE-5948-2020; Sun, Shuhui/T-2092-2019; Li,
   Jinghong/JVP-2806-2024; Zhou, heng/JCN-6493-2023; li,
   jian/IAQ-2794-2023; Liu, Feifei/HOH-3748-2023; zhou, qi/JEF-7253-2023;
   Zhao, Yi/JFA-7988-2023; Liu, Zunpeng/GYR-0792-2022; LI,
   Jing/HNB-5575-2023; xuan, li/JNI-7432-2023
OI peng, jy/0000-0001-9665-1059; Wang, Jiacheng/0000-0003-4327-1508; Liu,
   Feifei/0000-0001-5532-2021; Zhang, Weiqi/0000-0002-8885-5104; Li,
   Wei/0000-0002-4106-0937; Ji, Qianzhao/0009-0007-7012-6513; ,
   Jingyi/0000-0002-3126-7889; Zheng, Yuxuan/0000-0002-7407-5684; Liu,
   Zunpeng/0000-0002-1513-9991
FU National Key Research and Development Program of China [2018YFC2000100,
   2017YFA0103304, 2017YFA0102802, 2018YFA0107203, 2015CB964800,
   2018YFC2000400, 2017YFA0102702, 2020YFA0804000, 2020YFA0112201,
   2020YFA0113400]; Strategic Priority Research Program of the Chinese
   Academy of Sciences [XDA16010100]; National Natural Science Foundation
   of China [81625009, 81921006, 91749202, 81861168034, 81671377, 81822018,
   91749123, 31671429, 91949209, 81701388, 82071588, 81870228, 81922027,
   81801399, 31801010, 31900523, 32000510]; Program of Beijing Municipal
   Science and Technology Commission [Z191100001519005]; Beijing Natural
   Science Foundation [Z190019]; K. C. Wong Education Foundation
   [GJTD-2019-06, GJTD-2019-08]; Key Research Program of the Chinese
   Academy of Sciences [KFZD-SW-221]; Advanced Innovation Center for Human
   Brain Protection [3500-1192012]; Beijing Municipal Commission of Health
   and Family Planning [PXM2018_026283_000002]; Youth Innovation Promotion
   Association of CAS [2016093]; Young Elite Scientists Sponsorship Program
   by CAST [2017QNRC001]; International Partnership Program of Chinese
   Academy of Sciences [152111KYSB20160004]; State Key Laboratory of
   Membrane Biology; State Key Laboratory of Stem Cell and Reproductive
   Biology; Beijing Advanced Innovation Center for Genomics (ICG) at Peking
   University
FX This work was supported by the National Key Research and Development
   Program of China (2018YFC2000100) (to J.Q.), the Strategic Priority
   Research Program of the Chinese Academy of Sciences (XDA16010100) (to
   G.-H.L., J.Q., W.Z., and M.S.), the National Key Research and
   Development Program of China [2017YFA0103304 and 2017YFA0102802 (to
   W.Z.), 2018YFA0107203 (to J.Q.), 2015CB964800 (to G.-H.L.),
   2018YFC2000400 (to J.L.), and 2017YFA0102702 (to F.T.), 2020YFA0804000
   and 2020YFA0112201 (to G.-H.L.), 2020YFA0113400 (to M.S.)], the National
   Natural Science Foundation of China [81625009, 81921006, 91749202, and
   81861168034 (to G.-H.L.); 81671377, 81822018, and 91749123 (to W. Z.);
   31671429 and 91949209 (to J.Q.); 81701388 and 82071588 (to S.W.);
   81870228 and 81922027 (to M.S.); 81801399 (to J.L.); 31801010 (to W.L.);
   31900523 (to S.S.); and 32000510 (to Y.F.)], Program of Beijing
   Municipal Science and Technology Commission (Z191100001519005) (to
   G.-H.L.), Beijing Natural Science Foundation (Z190019) (to G.-H.L.), K.
   C. Wong Education Foundation [GJTD-2019-06 (to J.Q.) and GJTD-2019-08
   (to W.Z.)], the Key Research Program of the Chinese Academy of Sciences
   (KFZD-SW-221) (to J.Q.), Advanced Innovation Center for Human Brain
   Protection (3500-1192012) (to G.-H.L.), Beijing Municipal Commission of
   Health and Family Planning (PXM2018_026283_000002) (to G.-H.L.), Youth
   Innovation Promotion Association of CAS (2016093) (to W. Z.), grants
   from Young Elite Scientists Sponsorship Program by CAST (2017QNRC001)
   (to J.L.), grants from International Partnership Program of Chinese
   Academy of Sciences (152111KYSB20160004) (to Q.Z.),152111KYSB20160004
   (to Y.L.), State Key Laboratory of Membrane Biology, State Key
   Laboratory of Stem Cell and Reproductive Biology, and Beijing Advanced
   Innovation Center for Genomics (ICG) at Peking University.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080
   de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen ZH, 2018, MOL CARCINOGEN, V57, P12, DOI 10.1002/mc.22715
   Chojnowski A, 2015, CELL TISSUE RES, V360, P621, DOI 10.1007/s00441-014-2069-4
   Criscione SW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500882
   Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085
   Davidsohn N, 2019, P NATL ACAD SCI USA, V116, P23505, DOI 10.1073/pnas.1910073116
   Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536
   Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205
   Han S, 2017, NATURE, V544, P185, DOI 10.1038/nature21686
   Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Iwano S, 2018, SCIENCE, V359, P935, DOI 10.1126/science.aaq1067
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001
   Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Karin O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13192-4
   Kim Hyejeong, 2018, Lab Anim Res, V34, P257, DOI 10.5625/lar.2018.34.4.257
   Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450
   Kubben N, 2017, NAT REV MOL CELL BIO, V18, P595, DOI 10.1038/nrm.2017.68
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10
   Liang CQ, 2021, CELL RES, V31, P187, DOI 10.1038/s41422-020-0385-7
   Liu G. H., 2020, DEV CELL
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MacPherson L, 2020, NATURE, V577, P266, DOI 10.1038/s41586-019-1835-6
   Mariño G, 2010, P NATL ACAD SCI USA, V107, P16268, DOI 10.1073/pnas.1002696107
   Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018
   Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584
   Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Peleg S, 2016, TRENDS BIOCHEM SCI, V41, P700, DOI 10.1016/j.tibs.2016.05.008
   Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007
   Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Sen P, 2019, MOL CELL, V73, P684, DOI 10.1016/j.molcel.2019.01.021
   Singh PP, 2019, CELL, V177, P200, DOI 10.1016/j.cell.2019.02.038
   Tacutu R, 2018, NUCLEIC ACIDS RES, V46, pD1083, DOI 10.1093/nar/gkx1042
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Ullrich Nicole J, 2015, Handb Clin Neurol, V132, P249, DOI 10.1016/B978-0-444-62702-5.00018-4
   Uno M, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.10
   Wang F, 2016, AGING CLIN EXP RES, V28, P813, DOI 10.1007/s40520-015-0484-3
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Wu ZM, 2018, PROTEIN CELL, V9, P333, DOI 10.1007/s13238-018-0517-8
   Yang JP, 2017, CELL RES, V27, P1178, DOI 10.1038/cr.2017.86
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
   Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356
   Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031
   Zirkel A, 2018, MOL CELL, V70, P730, DOI 10.1016/j.molcel.2018.03.030
NR 63
TC 59
Z9 71
U1 15
U2 183
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JAN 6
PY 2021
VL 13
IS 575
AR eabd2655
DI 10.1126/scitranslmed.abd2655
PG 13
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA PT1FE
UT WOS:000608364300006
PM 33408182
DA 2024-02-19
ER

PT J
AU HE, PM
   YAMAOKAKOSEKI, S
   YASUMOTO, K
AF HE, PM
   YAMAOKAKOSEKI, S
   YASUMOTO, K
TI AGE-RELATED-CHANGES IN GLUTATHIONE CONCENTRATION,
   GLUTATHIONE-PEROXIDASE, GLUTATHIONE-S-TRANSFERASE, AND
   SUPEROXIDE-DISMUTASE ACTIVITIES IN SENESCENCE-ACCELERATED MICE
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
ID MOUSE SAM; MURINE MODEL; AGING MOUSE; LIFE-SPAN; RATS; REDUCTASE;
   LONGEVITY; CATARACT; LIVER
AB Age-associated changes in several antioxidative factors were studied in blood and liver from mice prone to accelerated senescence aged 0.7 to 1.4 years and mice resistant to accelerated senescence aged 1.0 to 2.1 years. In both strains, activities of hepatic glutathione peroxidase (GSH-Px) and glutathione-S-transferase (GST) decreased significantly with age, and the activity of superoxide dismutase (SOD), and the concentration of glutathione (GSH) in liver and blood cells tended to decrease with age. The GSH concentration in the plasma and blood cells, and the hepatic GST and SOD activities were significantly lower in the mice prone to senescence than other strain, but the hepatic GSH concentration and GSH-Px activity were similar in the two strains. These results suggest that GSH and hepatic antioxidative enzymes are associated to some extent with senescence in mice with accelerated senescence.
C1 KYOTO UNIV, FOOD SCI RES INST, UJI, KYOTO 611, JAPAN.
C3 Kyoto University
CR ABRAHAM EC, 1978, BIOCHEM J, V174, P819, DOI 10.1042/bj1740819
   BAIRD MB, 1971, GERONTOLOGY, V17, P105, DOI 10.1159/000211813
   BEUTLER E, 1985, J LAB CLIN MED, V105, P581
   BLANCO P, 1987, MECH AGEING DEV, V39, P11, DOI 10.1016/0047-6374(87)90082-0
   CSALLANY AS, 1986, INT J VITAM NUTR RES, V56, P143
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   GRIFFITH OH, 1985, METHOD ENZYMAT AN, V3, P521
   Gutteridge J. M. C., 1987, OXYGEN RADICALS TISS, P9
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAZELTON GA, 1984, P SOC EXP BIOL MED, V176, P249
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   He P., 1990, Nippon Eiyo Shokuryo Gakkaishi = Journal of the Japanese Society of Nutrition and Food Science, V43, P121
   HE PM, 1992, J NUTR SCI VITAMINOL, V38, P57, DOI 10.3177/jnsv.38.57
   HOSOKAWA M, 1988, EXP EYE RES, V47, P629, DOI 10.1016/0014-4835(88)90100-5
   HOSOKAWA M, 1984, EXP EYE RES, V38, P105, DOI 10.1016/0014-4835(84)90095-2
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   LANKIN VZ, 1981, B EKSP BIOL MED, V92, P301
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATSUSHITA M, 1986, AM J PATHOL, V125, P276
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NARYSHKIN S, 1981, FED PROC, V40, P789
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PRYOR WA, 1976, FREE RADICAL BIO MED, V2, P56
   PRYOR WA, 1976, FREE RADICAL BIO MED, V1, P239
   PRYOR WA, 1982, FREE RADICAL BIO MED, V5, P223
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   SCHNEIDER D, 1982, FED PROC, V41, P880
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   STARKE PE, 1987, FASEB J, V1, P36, DOI 10.1096/fasebj.1.1.2886388
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
NR 42
TC 7
Z9 7
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD JUN
PY 1994
VL 58
IS 6
BP 1037
EP 1040
DI 10.1271/bbb.58.1037
PG 4
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA NU980
UT WOS:A1994NU98000009
OA Bronze
DA 2024-02-19
ER

PT J
AU Cuesta, S
   Kireev, R
   Forman, K
   García, C
   Escames, G
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
AF Cuesta, Sara
   Kireev, Roman
   Forman, Katherine
   Garcia, Cruz
   Escames, Germaine
   Ariznavarreta, Carmen
   Vara, Elena
   Tresguerres, Jesus A. F.
TI Melatonin improves inflammation processes in liver of
   senescence-accelerated prone male mice (SAMP8)
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Liver; Aging; Inflammation; Cytokines; Senescence-accelerated mouse;
   Melatonin
ID NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; GENE-EXPRESSION; FEMALE RATS;
   SIGNAL-TRANSDUCTION; AGING LIVER; INJURY; CELLS; AGE; ACTIVATION
AB Aging is associated with an increase in oxidative stress and inflammation. The aim of this study was to investigate the effect of aging on various physiological parameters related to inflammation in livers obtained from two types of male mice models: Senescence-accelerated prone (SAMP8) and senescence-accelerated-resistant (SAMR1) mice, and to study the influence of the administration of melatonin (1 mg/kg/day) for one month on old SAMP8 mice on these parameters.
   The parameters studied have been the mRNA expression of TNF-alpha, iNOS, IL-1 beta, HO-1, HO-2, MCP1, NFkB1, NFkB2, NFkB protein or NKAP and IL-10. All have been measured by real-time reverse transcription polymerase chain reaction RT-PCR. Furthermore we analyzed the protein expression of TNF-alpha, iNOS, HO-1, HO-2, and IL-10 by Western-blot.
   Aging increased oxidative stress and inflammation especially in the liver of SAMP8 mice. Treatment with melatonin decreased the mRNA expression of TNF-alpha, IL-1 beta, HO (HO-1 and HO-2), iNOS, MCP1, NF kappa B1, NF kappa B2 and NKAP in old male mice. The protein expression of TNF-alpha, IL-1 beta was also decreased and IL-10 increased with melatonin treatment and no significant differences were observed in the rest of parameters analyzed. The present study showed that aging was related to inflammation in livers obtained from old male senescence prone mice (SAMP8) and old male senescence resistant mice (SAMR1) being the alterations more evident in the former. Exogenous administration of melatonin was able to reduce inflammation. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Tresguerres, Jesus A. F.] Univ Complutense Madrid, Sch Med, Dept Physiol, E-28040 Madrid, Spain.
   [Garcia, Cruz; Vara, Elena] Univ Complutense Madrid, Sch Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.
   [Escames, Germaine] Univ Granada, Inst Biotechnol, Dept Physiol, Granada, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid;
   University of Granada
RP Tresguerres, JAF (corresponding author), Univ Complutense Madrid, Dept Physiol, Sch Med, Lab Expt Endocrinol, Avda Complutense S-N, E-28040 Madrid, Spain.
EM guerres@med.ucm.es
RI Escames, Germaine/N-7501-2016; Garcia, Cruz/GRF-6283-2022;
   Cuesta-Sancho, Sara/HLW-5541-2023
OI Escames, Germaine/0000-0003-1256-7656; Cuesta-Sancho,
   Sara/0000-0002-9890-1063; Kireev, Roman/0000-0002-6105-2440
FU Instituto de Salud Carlos III (RETICEF) [RD06/0013 RD06/0013/0008];
   Consejeria de Innovacion; Ciencia y Empresa; Junta de Andalucia
   [P07-CTS-03135, PI081644 (ISCIII), SAF 2007 66878-C02-01]; CONICYT,
   Government of Chile
FX This work has been possible trough grants from Instituto de Salud Carlos
   III (RETICEF RD06/0013 RD06/0013/0008), Consejeria de Innovacion,
   Ciencia y Empresa, Junta de Andalucia (P07-CTS-03135), PI081644 (ISCIII)
   and SAF 2007 66878-C02-01. Thanks are given to D. Campon for his
   technical support. K. Forman was supported by CONICYT Pre-Doctoral
   Fellowship, Government of Chile.
CR ACUNACASTROVIEJO D, 1995, J PINEAL RES, V19, P57
   Ali S, 2004, CELL BIOCHEM FUNCT, V22, P67, DOI 10.1002/cbf.1082
   Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x
   Alonso M, 2006, J PINEAL RES, V41, P8, DOI 10.1111/j.1600-079X.2006.00323.x
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700
   BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285
   BAUERLE P, 1994, INMUNOLOGY, V12, P141
   Cardinali D P, 1998, Sleep Med Rev, V2, P175, DOI 10.1016/S1087-0792(98)90020-X
   Castillo C, 2005, J PINEAL RES, V38, P240, DOI 10.1111/j.1600-079X.2004.00199.x
   Chen DY, 2003, BIOCHEM BIOPH RES CO, V310, P720, DOI 10.1016/j.bbrc.2003.09.074
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Cuzzocrea S, 2001, EUR J PHARMACOL, V426, P1, DOI 10.1016/S0014-2999(01)01175-X
   Forman K, 2010, BIOGERONTOLOGY, V11, P275, DOI 10.1007/s10522-009-9245-z
   Gasbarrini A, 1998, SCAND J GASTROENTERO, V33, P1107
   Gee JR, 2005, EXP GERONTOL, V40, P409, DOI 10.1016/j.exger.2005.01.010
   Goto M, 1999, CYTOKINE, V11, P16, DOI 10.1006/cyto.1998.0390
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   HOBBS MV, 1993, J IMMUNOL, V150, P3602
   Hon WM, 2002, ANN NY ACAD SCI, V962, P275, DOI 10.1111/j.1749-6632.2002.tb04074.x
   Jaworek J, 2005, J PINEAL RES, V38, P73, DOI 10.1111/j.1600-079X.2004.00179.x
   Jiménez-Ortega V, 2009, REDOX REP, V14, P132, DOI 10.1179/135100009X392548
   Kireev RA, 2008, J PINEAL RES, V45, P394, DOI 10.1111/j.1600-079X.2008.00606.x
   Kireev RA, 2007, BIOGERONTOLOGY, V8, P469, DOI 10.1007/s10522-007-9089-3
   Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2
   Korkmaz A, 2009, MOL MED, V15, P43, DOI 10.2119/molmed.2008.00117
   KUBO M, 1990, EUR J IMMUNOL, V20, P1289, DOI 10.1002/eji.1830200614
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mazzon E, 2006, J PINEAL RES, V41, P363, DOI 10.1111/j.1600-079X.2006.00378.x
   MILLER RA, 1991, INT REV CYTOL, V124, P187
   Nussler AK, 1999, LANGENBECK ARCH SURG, V384, P222, DOI 10.1007/s004230050196
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Park HJ, 2007, J PINEAL RES, V43, P121, DOI 10.1111/j.1600-079X.2007.00452.x
   Patriarca S, 2007, BIOGERONTOLOGY, V8, P365, DOI 10.1007/s10522-006-9079-x
   Reiter RJ, 2000, NEWS PHYSIOL SCI, V15, P246
   RIANCHO JA, 1994, GERONTOLOGY, V40, P8
   Sasaki M, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-3
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4
   Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148
   TOLEDOPEREYRA LH, 1994, J AM COLL SURGEONS, V179, P758
   Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165
   Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795
NR 51
TC 63
Z9 70
U1 1
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2010
VL 45
IS 12
BP 950
EP 956
DI 10.1016/j.exger.2010.08.016
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 695KE
UT WOS:000285368200004
PM 20817086
DA 2024-02-19
ER

PT J
AU Huda, N
   Khambu, B
   Liu, G
   Nakatsumi, H
   Yan, SM
   Chen, XY
   Ma, MCL
   Dong, Z
   Nakayama, KI
   Yin, XM
AF Huda, Nazmul
   Khambu, Bilon
   Liu, Gang
   Nakatsumi, Hirokazu
   Yan, Shengmin
   Chen, Xiaoyun
   Ma, Michelle
   Dong, Zheng
   Nakayama, Keiichi I.
   Yin, Xiao-Ming
TI Senescence Connects Autophagy Deficiency to Inflammation and Tumor
   Progression in the Liver
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE Chemokines; CCR2; CD11b; CDK Inhibitors; Liver Injury
ID CELLULAR SENESCENCE; CELLS; BIOMARKER; PROMOTES; NRF2; MICE
AB BACKGROUND & AIMS: Cellular senescence frequently is present in injured livers. The induction mechanism and the pathologic role are not always clear. We aimed to understand the dynamics of senescence induction and progression, and the mechanism responsible for the pathology using a mouse model that disables the essential process of autophagy.
   METHODS: Mice deficient in key autophagy genes Atg 7 or Atg5 in the liver were used. Senescence was measured using established cellular and molecular signatures. The mechanistic roles of nuclear factor erythroid 2 (NRF2), forkhead box K1, and C-C motif chemokine receptor 2 (CCR2) were assessed using mouse genetic models. Liver functions, pathology, and tumor development were measured using biochemical and histologic approaches.
   RESULTS: Inducible deletion of Atg7 rapidly up-regulated cyclin-dependent kinase inhibitors independently of injury and induced senescence-associated beta-galactosidase activities and senescence-associated secretory phenotype (SASP). Sustained activation of NRF2 was the major factor causing senescence by mediating oxidative DNA damage and up-regulating CC motif chemokine ligand 2, a key component of autophagy-related SASP, via the NRF2-forkhead box K1 axis. Senescence was responsible for hepatic inflammation through CCR2mediated recruitment of CD11b(+) monocytes and CD3(+) T cells. The CCR2-mediated process in turn enhanced senescence and SASP by up-regulating cyclin-dependent kinase inhibitors and chemokines. Thus, senescence and inflammation can mutually augment each other, forming an amplification loop for both events. The CCR2-mediated process also modulated liver injury and tumor progression at the later stage of autophagy deficiency-related pathology.
   CONCLUSIONS: These results provide the insight that hepatic senescence can occur early in the disease process, triggers inflammation and is enhanced by inflammation, and has long-term effects on liver injury and tumor progression.
C1 [Huda, Nazmul; Khambu, Bilon; Liu, Gang; Yan, Shengmin; Chen, Xiaoyun; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.
   [Khambu, Bilon; Liu, Gang; Yan, Shengmin; Ma, Michelle; Yin, Xiao-Ming] Tulane Univ, Dept Pathol & Lab Med, Sch Med, New Orleans, LA 70112 USA.
   [Nakatsumi, Hirokazu; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka, Japan.
   [Dong, Zheng] Augusta Univ, Dept Cellular Biol & Anat, Med Coll Georgia, Augusta, Georgia.
   [Dong, Zheng] Charlie Norwood VA Med Ctr, Res Dept, Augusta, Georgia.
   [Yin, Xiao-Ming] Tulane Univ, Dept Pathol & Lab Med, Sch Med, New Orleans, LA 70112 USA.
C3 Indiana University System; Indiana University Bloomington; Tulane
   University; Kyushu University; Tulane University
RP Yin, XM (corresponding author), Tulane Univ, Dept Pathol & Lab Med, Sch Med, New Orleans, LA 70112 USA.
EM xmyin@tulane.edu
RI Nakayama, Keiichi I/N-1527-2014; Yan, Shengmin/W-4643-2017
OI Nakayama, Keiichi I/0000-0002-7185-1529; Yan,
   Shengmin/0000-0003-4012-9557
FU National Institutes of Health [DK116605]
FX Funding This work was supported in part by National Institutes of Health
   grant DK116605 (X.-M.Y.) .
CR Bantubungi K, 2014, DIABETES, V63, P3199, DOI 10.2337/db13-1921
   Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Frey N, 2018, NAT REV GASTRO HEPAT, V15, P81, DOI 10.1038/nrgastro.2017.146
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Goldsmith J, 2014, METHOD ENZYMOL, V542, P25, DOI 10.1016/B978-0-12-416618-9.00002-9
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Hughes CE, 2018, FEBS J, V285, P2944, DOI 10.1111/febs.14466
   Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367
   Khambu B, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2536-7
   Khambu B, 2019, HEPATOLOGY, V69, P2196, DOI 10.1002/hep.30407
   Khambu B, 2018, SEMIN LIVER DIS, V38, P308, DOI 10.1055/s-0038-1669939
   Khambu B, 2018, J CLIN INVEST, V128, P2419, DOI 10.1172/JCI91814
   Klionsky DJ, 2021, EMBO J, V40, DOI 10.15252/embj.2021108863
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Loyher PL, 2016, CANCER RES, V76, P6483, DOI 10.1158/0008-5472.CAN-16-0984
   Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042
   Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716
   Nakatsumi H, 2017, CELL REP, V21, P2471, DOI 10.1016/j.celrep.2017.11.014
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Ni HM, 2014, J HEPATOL, V61, P617, DOI 10.1016/j.jhep.2014.04.043
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679
   Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354
   Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344
   Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211
   White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Yuan H, 2021, MOL CELL BIOCHEM, V476, P247, DOI 10.1007/s11010-020-03901-9
   Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019
NR 44
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PD 2022 
PY 2022
VL 14
IS 2
BP 333
EP 355
DI 10.1016/j.jcmgh.2022.04.003
EA JUL 2022
PG 23
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 3U5CE
UT WOS:000840987800001
PM 35398596
OA Green Published
DA 2024-02-19
ER

PT J
AU Shirakami, Y
   Kato, J
   Maeda, T
   Ideta, T
   Imai, K
   Sakai, H
   Shiraki, M
   Shimizu, M
AF Shirakami, Yohei
   Kato, Junichi
   Maeda, Toshihide
   Ideta, Takayasu
   Imai, Kenji
   Sakai, Hiroyasu
   Shiraki, Makoto
   Shimizu, Masahito
TI Skeletal muscle atrophy is exacerbated by steatotic and fibrotic
   liver-derived TNF-α in senescence-accelerated mice
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Early Access
DE NASH; Sarcopenia; Skeletal muscle; Steatohepatitis; TNF-alpha
ID SARCOPENIA; MOUSE; MODEL
AB Background and Aim: Although liver diseases, including non-alcoholic steatohepatitis, are associated with skeletal muscle atrophy, the mechanism behind their association has not been fully elucidated. In this study, the effects of aging and non-alcoholic steatohepatitis on the skeletal muscle, and the interaction between the liver and muscle were investigated using a diet-induced non-alcoholic steatohepatitis model in senescence-accelerated mice.Methods: A total of four groups of senescence-accelerated mice and the control mice were fed either a non-alcoholic steatohepatitis-inducing or control diet, and their livers and skeletal muscles were removed for examinations.Results: In the senescence-accelerated/non-alcoholic steatohepatitis group, serum level of alanine aminotransferase was markedly elevated and histopathology of non-alcoholic steatohepatitis was significant. Skeletal muscles were also markedly atrophied. The expression of the ubiquitin ligase Murf1 in the muscle was significantly increased with muscle atrophy, while that of Tnfa was not significantly different. In contrast, the hepatic Tnfa expression and serum TNF-alpha levels were significantly increased in the senescence-accelerated/non-alcoholic steatohepatitis group. These results suggest that liver-derived TNF-alpha might promote muscle atrophy associated with steatohepatitis and aging through Murf-1. The metabolomic analysis of skeletal muscle indicated higher spermidine and lower tryptophan levels in the steatohepatitis-diet group.Conclusions: The findings of this study revealed an aspect of liver-muscle interaction, which might be important in developing treatments for sarcopenia associated with liver diseases.
C1 [Shirakami, Yohei; Kato, Junichi; Maeda, Toshihide; Ideta, Takayasu; Imai, Kenji; Sakai, Hiroyasu; Shiraki, Makoto; Shimizu, Masahito] Gifu Univ, Grad Sch Med, Dept Gastroenterol, 1-1 Yanagido, Gifu 5011194, Japan.
C3 Gifu University
RP Shirakami, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Gastroenterol, 1-1 Yanagido, Gifu 5011194, Japan.
EM ys2443@gifu-u.ac.jp
CR Bhanji RA, 2017, HEPATOLOGY, V66, P2055, DOI 10.1002/hep.29420
   Ebadi M, 2019, J GASTROENTEROL, V54, P845, DOI 10.1007/s00535-019-01605-6
   Gumucio JP, 2013, ENDOCRINE, V43, P12, DOI 10.1007/s12020-012-9751-7
   Hatazawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129084
   Hosokawa M, 2002, MECH AGEING DEV, V123, P1553, DOI 10.1016/S0047-6374(02)00091-X
   Ishizuka K, 2020, J GASTROEN HEPATOL, V35, P1437, DOI 10.1111/jgh.15006
   Kato J, 2019, GASTROINTEST DISORD, V1, P273, DOI 10.3390/gidisord1020023
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kurosawa T, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03353-5
   Lee NKL, 2011, J CELL PHYSIOL, V226, P1453, DOI 10.1002/jcp.22569
   Li YF, 2020, ALCOHOL CLIN EXP RES, V44, P66, DOI 10.1111/acer.14221
   Lucas C, 2018, CLIN EXP HEPATOL, V4, P165, DOI 10.5114/ceh.2018.78120
   Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008
   Meyer F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155357
   Miyazaki T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79916-5
   Nagano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073404
   Nakamura S, 2019, J BONE MINER METAB, V37, P627, DOI 10.1007/s00774-018-0964-6
   Ninomiya S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12040978
   Nishikawa H, 2016, INTERNAL MED, V55, P855, DOI 10.2169/internalmedicine.55.6298
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Omori S, 2020, CELL METAB, V32, P814, DOI 10.1016/j.cmet.2020.09.006
   Ooi PH, 2019, LIVER TRANSPLANT, V25, P1422, DOI 10.1002/lt.25591
   Pan LY, 2021, EXP GERONTOL, V154, DOI 10.1016/j.exger.2021.111544
   Patel HJ, 2017, LIFE SCI, V170, P56, DOI 10.1016/j.lfs.2016.11.033
   Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739
   Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S
   Saoi M, 2021, METABOLITES, V11, DOI 10.3390/metabo11100672
   Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030
   Shirakami Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23092284
   Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y
   Thoma A, 2018, ADV EXP MED BIOL, V1088, P267, DOI 10.1007/978-981-13-1435-3_12
   Uchitomi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46929-8
NR 32
TC 3
Z9 3
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD 2023 MAY
PY 2023
VL 38
IS 5
BP 800
EP 808
DI 10.1111/jgh.16171
EA MAR 2023
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AR5H1
UT WOS:000952370700001
PM 36890117
DA 2024-02-19
ER

PT J
AU Luo, S
   Xiao, S
   Ai, Y
   Wang, B
   Wang, YF
AF Luo, Sang
   Xiao, Shuai
   Ai, Yang
   Wang, Ben
   Wang, Yefu
TI Changes in the hepatic differentiation potential of human mesenchymal
   stem cells aged in vitro
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article; Early Access
DE Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs); cell
   aging; hepatic; differentiation
ID MARROW STROMAL CELLS; UMBILICAL-CORD; BONE-MARROW; BIOARTIFICIAL LIVER;
   TRANSPLANTATION; SENESCENCE; GENERATION; CULTURE
AB Background: Due to their multipotency and ability for self-renewal, human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) hold great promise for generating hepatocytes. Previous research has successfully generated hepatocytes from early-passage [i.e., passage (P)3] hUC-MSCs; however, the populations of early-passage cells are limited, and these cells cannot produce sufficient functional hepatocytes for large-scale application in clinical therapy. Thus, a thorough investigation of the hepatic differentiation potential of in vitro-aged hUC-MSCs is needed. Methods: hUC-MSCs were passaged in vitro and subcultured every 3 days up to P8, and their morphology, proliferative capacity, liver-specific marker expression, and liver function at the end of each passage were analyzed. The efficiency of the hepatogenic differentiation of hUC-MSCs driven by a functional hit 1 (FH1)-based strategy at different passages was also evaluated. Results: The in vitro-aged hUC-MSCs gradually displayed morphological inhomogeneity, had reduced proliferative capability, and exhibited senescent properties while maintaining adipogenic and osteogenic differentiation potential. Additionally, senescence also decreased the expression of messenger RNA (mRNA) levels in albumin (ALB) and alpha 1-antitrpsin (A1AT) in these cells and their relative protein expression, which is the marker of a mature hepatocyte. The liver function of the in vitro-aged hUC-MSCs also deteriorated gradually. Finally, the percentage of hepatocyte-like cells (HLCs) generated from in vitro-aged hUC-MSCs reduced significantly, and the mature hepatocyte functions, such as ALB secretion, glycogen synthesis, low-density lipoprotein (LDL) intake, and indocyanine green (ICG) uptake, also changed. Conclusions: hUC-MSCs possess mature hepatocytes' specific markers and functions, which change gradually as they undergo cell senescence. Due to the loss of these properties within in vitro subcultures, the hepatic differentiation efficiency of in vitro-aged hUC-MSCs decreased dramatically in the late passage (P8). The current study provides valuable information can inform future research on liver disease.
C1 [Luo, Sang; Xiao, Shuai; Ai, Yang; Wang, Ben; Wang, Yefu] Wuhan Univ, Sch Life Sci, State Key Lab Virol, Wuhan, Peoples R China.
C3 Wuhan University
RP Wang, YF (corresponding author), Wuhan Univ, Sch Life Sci, State Key Lab Virol, Wuhan, Peoples R China.
EM wangyefu@whu.edu.cn
RI Xiao, Shuai/IYJ-3894-2023
OI Xiao, Shuai/0000-0002-2313-3186
FU China Postdoctoral Science Foundation [2016M592375]; Hubei Province's
   Health and Family Planning Scientific Research Project [WJ2017Q002];
   Wuhan Enterprise Technology Innovation Project [2018060402011244];
   "Guanggu 3551 Talents" Project (11th batch; Donghu High-Tech Zone,
   Wuhan, 2018)
FX We would like to thank Dr. Zhou li for his help and valuable suggestions
   during our study. We thank all members of the laboratory for sharing
   reagents and advice. Funding: This study was supported by the China
   Postdoctoral Science Foundation (No. 2016M592375) , Hubei Province's
   Health and Family Planning Scientific Research Project (No. WJ2017Q002)
   , the Wuhan Enterprise Technology Innovation Project (No.
   2018060402011244) , and the "Guanggu 3551 Talents" Project (11th batch;
   Donghu High-Tech Zone, Wuhan, 2018) .
CR Allen JW, 2002, SEMIN CELL DEV BIOL, V13, P447, DOI 10.1016/S1084952102001337
   An SY, 2014, TISSUE CELL, V46, P127, DOI 10.1016/j.tice.2013.12.006
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Awad HA, 2003, TISSUE ENG, V9, P1301, DOI 10.1089/10763270360728215
   Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709
   Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Chamuleau RAFM, 2005, METAB BRAIN DIS, V20, P327, DOI 10.1007/s11011-005-7914-4
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   Dutkowski P, 2014, BRIT J SURG, V101, P739, DOI 10.1002/bjs.9540
   Dutkowski P, 2015, GASTROENTEROLOGY, V148, P307, DOI 10.1053/j.gastro.2014.08.045
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   FRIEDENSTEIN AJ, 1982, EXP HEMATOL, V10, P217
   HAYFLICK L, 1989, EXP GERONTOL, V24, P355, DOI 10.1016/0531-5565(89)90043-0
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529
   Hu Y, 2003, J LAB CLIN MED, V141, P342, DOI 10.1016/S0022-2143(03)00022-2
   Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005
   Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286
   Kestendjieva S, 2008, CELL BIOL INT, V32, P724, DOI 10.1016/j.cellbi.2008.02.002
   Kim WR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14126
   Koç ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Liu WH, 2015, J CELL MOL MED, V19, P511, DOI 10.1111/jcmm.12482
   Luo S, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-21-2829
   Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175
   Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Strain AJ, 2002, SCIENCE, V295, P1005, DOI 10.1126/science.1068660
   Tang XJ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.02.41
   Wang H, 2015, STEM CELLS DEV, V24, P2536, DOI 10.1089/scd.2015.0018
   Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273
   Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x
   Yang YHK, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0876-3
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205
   Zhang YN, 2009, CYTOTHERAPY, V11, P548, DOI 10.1080/14653240903051533
NR 37
TC 4
Z9 4
U1 1
U2 5
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD 2021 NOV
PY 2021
VL 9
IS 21
DI 10.21037/atm-21-4918
EA OCT 2021
PG 16
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA XC8EB
UT WOS:000710913400001
PM 34926672
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fujita, T
   Shirasawa, T
   Maruyama, N
AF Fujita, T
   Shirasawa, T
   Maruyama, N
TI Expression and structure of senescence marker protein-30 (SMP30) and its
   biological significance
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 2nd International NILS Workshop on Longevity Sciences - Roles of Protein
   in Aging and Age-Associated Disorders
CY NOV 29-30, 1997
CL OBU, JAPAN
SP NILS
DE aging; Ca2+-binding protein; cDNA; Ca2+ homeostasis hepatocyte; liver;
   renal tubular epithelia; SMP30; senescence marker protein-30
ID GENE-EXPRESSION; RAT-LIVER; MEMBRANE
AB We previously identified a novel protein, the amounts of which are down-regulated in an androgen-independent manner with aging in the rat liver. We designated this protein as senescence marker protein-30 (SMP30). SMP30 is preferentially expressed in cytosol of hepatocytes and renal tubular epithelia, and its expression is maintained at high level throughout the tissue maturing stage as well as young and adult stages, but decreases during senescent stages in both sexes. Subsequently, we cloned cDNAs encoding SMP30 from rat, human and mouse and found that the amino acid sequence of SMP30 is well conserved with remarkable homology among these species. We also determined the genome organization and 5' flanking region of SMP30 in mouse genome. In the meantime, SMP30 turned out to be identical to a Ca2+-binding protein called regucaltin. In order to elucidate the functional significance of SMP30, we have generated Hep G2 cells that stably express large amounts of SMP30 by transfecting human SMP30 cDNA. Cell biological analyses on these SMP30 transfectants suggest that SMP30 regulates Ca2+ homeostasis by enhancing plasma membrane Ca2+-pumping activity in Hep G2 cells. This result implies that the down-regulation of SMP30 may contribute to hepatic deterioration of cellular Functions during aging. In this review, we present a overview of SMP30 in its structure, expression and possible physiological roles. We also discuss hypothetical role(s) of SMP30 in aging and Ca2+ homeostasis. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 173, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Genet, Itabashi Ku, Tokyo 173, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan
   Institute of Gerontology
RP Fujita, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 173, Japan.
CR DOWD DR, 1992, MOL ENDOCRINOL, V6, P1843, DOI 10.1210/me.6.11.1843
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1986, ANAL BIOCHEM, V159, P8, DOI 10.1016/0003-2697(86)90299-X
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   TODA T, 1984, ELECTROPHORESIS, V5, P42, DOI 10.1002/elps.1150050108
   TODA T, 1982, ANAL BIOCHEM, V119, P167, DOI 10.1016/0003-2697(82)90682-0
   VARGHESE S, 1988, J BIOL CHEM, V263, P9776
   Yamaguchi M. A., 1992, CALCIUM INHIBITION, P19
NR 15
TC 35
Z9 43
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR 15
PY 1999
VL 107
IS 3
BP 271
EP 280
DI 10.1016/S0047-6374(98)00136-5
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 192VC
UT WOS:000080099400006
PM 10360682
DA 2024-02-19
ER

PT J
AU Kyrylenko, S
   Korhonen, P
   Kyrylenko, O
   Roschier, M
   Salminen, A
AF Kyrylenko, S
   Korhonen, P
   Kyrylenko, O
   Roschier, M
   Salminen, A
TI Expression of transcriptional repressor proteins mSin3A and 3B during
   aging and replicative senescence
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE histone acetylation; cellular senescence; WI-38 fibroblasts; chromatin
ID HISTONE ACETYLATION; CELLULAR SENESCENCE; CHROMATIN STRUCTURE; NEURONAL
   APOPTOSIS; DNA METHYLATION; KAPPA-B; MECHANISMS; GENES
AB Sin3 proteins have a key role in transcriptional repression mediated by histone deacetylation, Mammalian Sin3 proteins, mSin3A and 3B, act as adapter molecules which bind both to repressive transcription factors and to the methyl-CpG-binding proteins (MeCPs) and recruit histone deacetylases to assemble a multiprotein repressor complex. We have recently observed (Biochem. Biophys. Res. Commun. 252, 274-277, 1998) that the expression of mSin3A but not mSin3B protein is induced during neuronal apoptosis, The purpose of this study was to find out whether aging and replicative senescence affect the expression levels of mSin3A and 3B repressor proteins. We studied the expression levels of mSin3A and 3B mnNAs and proteins both in replicative senescence model of WI-38 fibroblasts and in liver and brain tissues of young (4-6 months) and old (26-30 months) male Wister rats. Replicative senescence of human WI-38 fibroblasts did not affect the expression levels of mSin3A and 3B mRNAs. However, the late passage WI-38 fibroblasts showed a significant decline in the expression level of mSin3A protein. Immortalization of WI-38 fibroblasts with SV-40 transformation increased the expression level of 6.0 kb mSin3A mRNA Aging of Wistar rats did not affect; the expression levels of either mSin3A or mSin3B mRNAs in the liver and frontal cortex. Similarly, the protein levels of mSin3A and 3B were unaffected in the hippocampus, cerebellum and liver tissues during aging These results show that aging in vivo, in contrast to replicative senescence, does not affect the expression levels of mSin3A and 3B repressor proteins. However, this does not exclude the possible age-related functional changes mediated by mSin3-histone deacetylase complexes. (C) 2000 Academic Press.
C1 Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland.
   Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland.
C3 University of Eastern Finland; University of Eastern Finland; Kuopio
   University Hospital
RP Salminen, A (corresponding author), Univ Kuopio, Dept Neurol & Neurosci, POB 1627, FIN-70211 Kuopio, Finland.
CR Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6
   Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   CATANIA J, 1991, MUTAT RES, V256, P283, DOI 10.1016/0921-8734(91)90019-8
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   Gartenberg MR, 2000, CURR OPIN MICROBIOL, V3, P132, DOI 10.1016/S1369-5274(00)00064-3
   Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664
   Guarente L, 1996, CELL, V86, P9, DOI 10.1016/S0092-8674(00)80072-0
   Helenius M, 1999, EXP CELL RES, V248, P194, DOI 10.1006/excr.1999.4393
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125
   Korhonen P, 1998, BIOCHEM BIOPH RES CO, V252, P274, DOI 10.1006/bbrc.1998.9629
   Kyrylenko S, 1999, MOL BRAIN RES, V73, P198, DOI 10.1016/S0169-328X(99)00259-4
   Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691
   Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121
   ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34
   PETRICEVIC M, 1978, MECH AGEING DEV, V8, P241, DOI 10.1016/0047-6374(78)90023-4
   PINA B, 1988, EUR J BIOCHEM, V174, P311, DOI 10.1111/j.1432-1033.1988.tb14099.x
   Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905
   Ryan J M, 1975, Adv Exp Med Biol, V53, P123
   Salminen A, 1997, BIOCHEM BIOPH RES CO, V238, P712, DOI 10.1006/bbrc.1997.7371
   SCHRODER H, 1998, ALZHEIMERS DIS REV, V3, P20
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599
   Villeponteau B, 1997, EXP GERONTOL, V32, P383, DOI 10.1016/S0531-5565(96)00155-6
   Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5
NR 28
TC 5
Z9 5
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 28
PY 2000
VL 275
IS 2
BP 455
EP 459
DI 10.1006/bbrc.2000.3325
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 349WZ
UT WOS:000089069700034
PM 10964686
DA 2024-02-19
ER

PT J
AU Huang, CC
   Chiang, WD
   Huang, WC
   Huang, CY
   Hsu, MC
   Lin, WT
AF Huang, Chi-Chang
   Chiang, Wen-Dee
   Huang, Wen-Ching
   Huang, Chih-Yang
   Hsu, Mei-Chich
   Lin, Wan-Teng
TI Hepatoprotective Effects of Swimming Exercise against
   D-Galactose-Induced Senescence Rat Model
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID CELLULAR SENESCENCE; OXIDATIVE STRESS; ADIPOSE-TISSUE; LIVER-DISEASE;
   AST/ALT RATIO; RISK-FACTORS; INJURY; P53; EXPRESSION; FIBROSIS
AB This study investigates whether a 12-week swimming exercise training can prevent liver damage or senescence associated biomarkers in an experimental aging model in rats. Twenty-three male Sprague-Dawley rats were divided into four groups: vehicle treatment with sedentary control (C, n = 6), aging induction with sedentary (A, n = 6), vehicle treatment with swimming exercise (SW, n = 5), and aging induction with swimming exercise (A + SW, n = 6). Rats in groups A and AS received intraperitoneal D-galactose injections (150 mg/kg/day) for 12 weeks to induce aging. Rats in groups SW and A + SW were subjected to swimming exercise training for 12 weeks. Body weight, liver weight, epididymal fat mass, blood biochemistry, and liver pathology were performed at the end of the experiment. Hepatic senescence protein markers such as beta-galactosidase, p53, and p21, as well as the inflammatory mediator, IL-6, were examined. The D-galactose-treated rats exhibited increases in AST and gamma-GT plasma levels and beta-galactosidase protein expression compared to the control group. Swimming exercise significantly reduced BW, epididymal fatmass, gamma-GT activity, and p53, p21, and IL-6 protein levels compared to the aging group. These results suggest that a 12-week swimming exercise program suppresses senescence markers and downregulates inflammatory mediator in the liver tissues of D-galactose-induced aging rats.
C1 [Huang, Chi-Chang] Natl Taiwan Sport Univ, Grad Inst Sports Sci, Coll Exercise & Hlth Sci, Tao Yuan 33301, Taiwan.
   [Chiang, Wen-Dee] Tunghai Univ, Dept Food Sci, Taichung 40704, Taiwan.
   [Huang, Wen-Ching] Natl Taiwan Sport Univ, Grad Inst Athlet & Coaching Sci, Tao Yuan 33301, Taiwan.
   [Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.
   [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
   [Hsu, Mei-Chich] Kaohsiung Med Univ, Dept Sports Med, Kaohsiung 80708, Taiwan.
   [Lin, Wan-Teng] Tunghai Univ, Dept Hospitality, Taichung 40704, Taiwan.
C3 Tunghai University; China Medical University Taiwan; Asia University
   Taiwan; Kaohsiung Medical University; Tunghai University
RP Lin, WT (corresponding author), Tunghai Univ, Dept Hospitality, Taichung 40704, Taiwan.
EM 040770@thu.edu.tw
RI Yuang, Chih-Yang/O-5111-2015; Huang, Chi-Chang/A-3280-2013
OI Hsu, Mei-Chich/0000-0001-9830-8641; Huang,
   Chi-Chang/0000-0003-1446-6787; Lin, Wan-Teng/0000-0001-7700-3398
FU National Science Council, Taiwan [NSC99-2410-H029-059-MY2]; Tunghai
   University for Global Research and Education on Environment and Society,
   Taiwan [GREEnS 004-3]
FX This Research Grant was funded by the National Science Council, Taiwan
   (NSC99-2410-H029-059-MY2) and an Institutional Grant from Tunghai
   University for Global Research and Education on Environment and Society
   (GREEnS 004-3), Taiwan.
CR Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004
   Buemi M, 2005, REJUV RES, V8, P101, DOI 10.1089/rej.2005.8.101
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen CF, 2006, PSYCHONEUROENDOCRINO, V31, P805, DOI 10.1016/j.psyneuen.2006.03.004
   Chevion S, 2003, P NATL ACAD SCI USA, V100, P5119, DOI 10.1073/pnas.0831097100
   Cress ME, 1999, J GERONTOL A-BIOL, V54, pM242, DOI 10.1093/gerona/54.5.M242
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ding Q, 2012, J NUTR BIOCHEM, V23, P867, DOI 10.1016/j.jnutbio.2011.04.011
   Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427
   Fan SH, 2009, INT IMMUNOPHARMACOL, V9, P91, DOI 10.1016/j.intimp.2008.10.008
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   Hart KJ, 2001, J APPL PHYSIOL, V91, P1663, DOI 10.1152/jappl.2001.91.4.1663
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Ho TJ, 2012, EUR J APPL PHYSIOL, V112, P2943, DOI 10.1007/s00421-011-2270-z
   Kaliora AC, 2007, PHARMACOL RES, V56, P99, DOI 10.1016/j.phrs.2007.04.018
   Keating SE, 2012, J HEPATOL, V57, P157, DOI 10.1016/j.jhep.2012.02.023
   Kumar Anil, 2011, Int J Alzheimers Dis, V2011, P347569, DOI 10.4061/2011/347569
   Liu Y, 2009, ACTA OCEANOL SIN, V28, P107
   Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043
   Lu J, 2010, BRAIN PATHOL, V20, P598, DOI 10.1111/j.1750-3639.2009.00339.x
   Luckey SW, 2001, EXP MOL PATHOL, V71, P226, DOI 10.1006/exmp.2001.2399
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Nicklas BJ, 2008, J AM GERIATR SOC, V56, P2045, DOI 10.1111/j.1532-5415.2008.01994.x
   Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074
   Nyblom H, 2006, LIVER INT, V26, P840, DOI 10.1111/j.1478-3231.2006.01304.x
   Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49
   Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x
   Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200
   SCHWARTZMAN RA, 1993, ENDOCRINOLOGY, V133, P591, DOI 10.1210/en.133.2.591
   Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3
   Silverman NE, 2009, CALCIFIED TISSUE INT, V84, P257, DOI 10.1007/s00223-009-9232-z
   Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yi ZJ, 2009, EXP GERONTOL, V44, P760, DOI 10.1016/j.exger.2009.08.011
NR 41
TC 28
Z9 32
U1 2
U2 12
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2013
VL 2013
AR 275431
DI 10.1155/2013/275431
PG 9
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA 177EO
UT WOS:000321358500001
PM 23843869
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Hilmer, SN
   Warren, A
   Cogger, VC
   Fraser, R
   McLean, AJ
   Sullivan, D
   Le Couteur, DG
AF Hilmer, SN
   Warren, A
   Cogger, VC
   Fraser, R
   McLean, AJ
   Sullivan, D
   Le Couteur, DG
TI The effect of aging on the immunohistochemistry of apolipoprotein E in
   the liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE apolipoprotein E; liver; aging; immunohistochemistry
ID CHYLOMICRON REMNANTS; LIPOPROTEIN METABOLISM; HEPATIC-UPTAKE;
   MESSENGER-RNA; RAT-LIVER; AGE; ATHEROSCLEROSIS; CHOLESTEROL; YOUNG;
   PSEUDOCAPILLARIZATION
AB Apolipoprotein E (apoE) is involved in hepatic disposition of chylomicron remnants, which is impaired in old age. Isofomis of apoE have been implicated in age-related diseases and possibly the aging process itself. Because the effects of old age on expression and distribution of apoE in the liver have not been reported, we studied the effect of old age on the immunohistochemistry of apoE in the livers of humans and the non-human primate, Papio hamadryas. Overall, old age was not associated with marked changes in the expression of apoE between adult (48 +/- 19 years) and old (82 +/- 5 years) humans. However, there was a change in the distribution of apoE staining. The livers of older humans displayed increased hepatocyte cytoplasmic staining and reduced peri-sinusoidal staining. Similar trends were noted in the livers from the baboons. Such findings are suggestive of altered apoE recycling in old age and have implications for age-related dyslipidaemia. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Sydney, Concord RG Hosp C25, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.
   Univ Sydney, Concord RG Hosp C25, ANZAC Res Inst, Concord, NSW 2139, Australia.
   Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand.
   Univ Melbourne, Natl Ageing Res Inst, Parkville, Vic, Australia.
   Royal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia.
C3 University of Sydney; University of Sydney; ANZAC Research Institute;
   University of Otago; University of Melbourne; National Ageing Research
   Institute; University of Sydney; NSW Health; Royal Prince Alfred
   Hospital
RP Le Couteur, DG (corresponding author), Univ Sydney, Concord RG Hosp C25, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.
EM dlecouteur@med.usyd.edu.au
RI Ekanayake, Kanchana/P-8817-2016; Research Institute,
   ANZAC/CAE-9030-2022; Hilmer, Sarah/AAW-8554-2020
OI Hilmer, Sarah/0000-0002-5970-1501; Le Couteur, David/0000-0002-4227-5817
CR Borel P, 1998, J GERONTOL A-BIOL, V53, pB133, DOI 10.1093/gerona/53A.2.B133
   Cassader M, 1996, AGING CLIN EXP RES, V8, P421, DOI 10.1007/BF03339605
   Chiang AN, 1999, J HYPERTENS, V17, P793, DOI 10.1097/00004872-199917060-00011
   Chou SC, 1996, BIOCHEM MOL BIOL INT, V38, P847
   Cooper AD, 1997, J LIPID RES, V38, P2173
   Corti MC, 1997, CURR OPIN LIPIDOL, V8, P236, DOI 10.1097/00041433-199708000-00008
   DAVIS RA, 1989, J BIOL CHEM, V264, P8970
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   Fazio S, 2000, TRENDS CARDIOVAS MED, V10, P23, DOI 10.1016/S1050-1738(00)00033-5
   HAMILTON RL, 1990, J LIPID RES, V31, P1589
   Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200
   Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200
   Heeren J, 2001, CURR OPIN LIPIDOL, V12, P255, DOI 10.1097/00041433-200106000-00003
   Heijmans BT, 2000, EXP GERONTOL, V35, P865, DOI 10.1016/S0531-5565(00)00171-6
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LIN CT, 1986, J CLIN INVEST, V78, P947, DOI 10.1172/JCI112685
   Linton MF, 1998, J CLIN INVEST, V101, P1726, DOI 10.1172/JCI2181
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507
   Mahley RW, 1999, J LIPID RES, V40, P1
   Massimi M, 1999, HEPATOLOGY, V29, P1549, DOI 10.1002/hep.510290504
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0
   Relas H, 2000, J GERONTOL A-BIOL, V55, pB515, DOI 10.1093/gerona/55.11.B515
   SHIMANO H, 1994, J CLIN INVEST, V93, P2215, DOI 10.1172/JCI117218
   Smith JD, 2002, AGEING RES REV, V1, P345, DOI 10.1016/S1568-1637(02)00005-3
   STANGE EF, 1984, J LIPID RES, V25, P703
   WEINTRAUB M, 1992, J GERONTOL, V47, pB209, DOI 10.1093/geronj/47.6.B209
NR 30
TC 12
Z9 12
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2004
VL 39
IS 1
BP 53
EP 57
DI 10.1016/j.exger.2003.09.016
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 766ZF
UT WOS:000188413100008
PM 14724064
DA 2024-02-19
ER

PT J
AU Lee, DY
   Lee, SJ
   Chandrasekaran, P
   Lamichhane, G
   O'Connell, JF
   Egan, JM
   Kim, Y
AF Lee, Da-Yeon
   Lee, Su-Jeong
   Chandrasekaran, Prabha
   Lamichhane, Gopal
   O'Connell, Jennifer F.
   Egan, Josephine M.
   Kim, Yoo
TI Dietary Curcumin Attenuates Hepatic Cellular Senescence by Suppressing
   the MAPK/NF-κB Signaling Pathway in Aged Mice
SO ANTIOXIDANTS
LA English
DT Article
DE curcumin; liver; cellular senescence; MAPK; NF-& kappa;B; senolytic
ID LIFE-SPAN; P38 MAPK; KAPPA-B; OBESITY; HALLMARKS; DISEASE
AB Dietary interventions with bioactive compounds have been found to suppress the accumulation of senescent cells and senescence-associated secretory phenotypes (SASPs). One such compound, curcumin (CUR), has beneficial health and biological effects, including antioxidant and anti-inflammatory properties, but its ability to prevent hepatic cellular senescence is unclear. The objective of this study was to investigate the effects of dietary CUR as an antioxidant on hepatic cellular senescence and determine its benefits on aged mice. We screened the hepatic transcriptome and found that CUR supplementation led to the downregulation of senescence-associated hepatic gene expressions in both usually fed and nutritionally challenged aged mice. Our results showed that CUR supplementation enhanced antioxidant properties and suppressed mitogen-activated protein kinase (MAPK) signaling cascades in the liver, particularly c-Jun N-terminal kinase (JNK) in aged mice and p38 in diet-induced obese aged mice. Furthermore, dietary CUR decreased the phosphorylation of nuclear factor-?B (NF-?B), a downstream transcription factor of JNK and p38, and inhibited the mRNA expression of proinflammatory cytokines and SASPs. The potency of CUR administration was demonstrated in aged mice via enhanced insulin homeostasis along with declined body weight. Taken together, these results suggest that CUR supplementation may be a nutritional strategy to prevent hepatic cellular senescence.
C1 [Lee, Da-Yeon; Lee, Su-Jeong; Lamichhane, Gopal; Kim, Yoo] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA.
   [Chandrasekaran, Prabha; O'Connell, Jennifer F.; Egan, Josephine M.] Natl Inst Aging, Lab Clin Invest, Baltimore, MD 21224 USA.
C3 Oklahoma State University System; Oklahoma State University -
   Stillwater; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA)
RP Kim, Y (corresponding author), Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA.
EM dayeon.lee@okstate.edu; crystal.lee10@okstate.edu;
   prabha.chandrasekaran@nih.gov; jennifer.oconnell@nih.gov;
   eganj@grc.nia.nih.gov; yoo.kim@okstate.edu
RI lamichhane, Gopal/AHD-4491-2022
OI lamichhane, Gopal/0000-0003-1487-7578; Lee, Da-Yeon/0000-0002-4085-0689
FU Intramural Research Program of the National Institute on Aging (NIA);
   OTTOGI HAM TAIHO Foundation (South Korea) [1-503351]
FX This research was funded by the Intramural Research Program of the
   National Institute on Aging (NIA) and the OTTOGI HAM TAIHO Foundation
   (South Korea) (Funding number: 1-503351).
CR Anerillas C, 2020, GEROSCIENCE, V42, P397, DOI 10.1007/s11357-020-00183-3
   Avtanski D, 2019, ANIM MODEL EXP MED, V2, P252, DOI 10.1002/ame2.12084
   Beamer E, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.635636
   Bielak-Zmijewska A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051239
   Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132
   Bonnet L, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.957616
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Castro RE, 2013, J HEPATOL, V58, P119, DOI 10.1016/j.jhep.2012.08.008
   Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409
   Cheng X, 2021, REDOX BIOL, V40, DOI 10.1016/j.redox.2021.101863
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z
   Ding LL, 2016, TOXICOL APPL PHARM, V304, P99, DOI 10.1016/j.taap.2016.05.011
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Hassan MH, 2022, EVID-BASED COMPL ALT, V2022, DOI 10.1155/2022/9707278
   He HJ, 2012, WORLD J DIABETES, V3, P94, DOI 10.4239/wjd.v3.i5.94
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Kim Y, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0377-0
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kotha RR, 2019, MOLECULES, V24, DOI 10.3390/molecules24162930
   Kumar SSD, 2018, MOLECULES, V23, DOI 10.3390/molecules23040835
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Lee KS, 2010, REJUV RES, V13, P561, DOI 10.1089/rej.2010.1031
   Lee SJ, 2022, AGING-US, V14, P225, DOI 10.18632/aging.203821
   Li S, 2021, FOOD RES INT, V143, DOI 10.1016/j.foodres.2021.110270
   Li W, 2019, MECH AGEING DEV, V181, P1, DOI 10.1016/j.mad.2019.05.001
   Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008
   Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Martinez-Zamudio Ricardo Ivan, 2017, Cell, V170, P816, DOI 10.1016/j.cell.2017.07.049
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Olivieri F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9076485
   Paez-Ribes M, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810234
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502
   Porcher L, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02252-6
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009
   Shen LR, 2013, BIOFACTORS, V39, P133, DOI 10.1002/biof.1086
   Singh RK, 2017, PHARMACOL REP, V69, P746, DOI 10.1016/j.pharep.2017.03.023
   Stohs SJ, 2020, MOLECULES, V25, DOI 10.3390/molecules25061397
   Torres J, 2011, INVEST OPHTH VIS SCI, V52, P5842, DOI 10.1167/iovs.10-6673
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wu X, 2021, J NUTR, V151, P3678, DOI 10.1093/jn/nxab320
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004
   Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9
   Zhong Y, 2022, NUTR METAB, V19, DOI 10.1186/s12986-022-00712-1
   Zhu MS, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320964125
NR 52
TC 4
Z9 4
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD JUN
PY 2023
VL 12
IS 6
AR 1165
DI 10.3390/antiox12061165
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA K7HG8
UT WOS:001018107700001
PM 37371895
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wu, HY
   Wu, LX
   Xiao, LX
   Gu, YQ
   Liu, HX
   Zhang, LH
   Zhang, MG
   Qi, L
AF Wu, Hongyan
   Wu, Lixia
   Xiao, Linxia
   Gu, Yaqin
   Liu, Hongxia
   Zhang, Lihu
   Zhang, Mingguang
   Qi, Liang
TI Atractylenolide III suppresses senescence-associated secretome via
   inhibiting cGAS/NF-κB pathway in hepatic stellate cells
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Article; Early Access
DE atractylenolide III; cGAS; NF-kappa B signalling; hepatic stellate cell;
   paracrine effects; senescence
ID PHENOTYPE
AB Senescence of activated hepatic stellate cells (aHSCs) is a stable growth arrest that is implicated in liver fibrosis regression. Senescent cells often accompanied by a multi-faceted senescence-associated secretory phenotype (SASP). Induction of aHSCs senescence by inhibiting SASP may be a potential therapeutic model against hepatic fibrosis. To evaluate the role of atractylenolide III (ATR III) in the development of chemotherapeutic drug-induced SASPs in hepatic stellate cells. Etoposide-induced senescent HSC-LX2 model was established and treated with ATR III at different concentrations (20, 30 and 40 mu M). We found that ATR III dose-dependently enhanced senescence in etoposide-induced LX2 cells. ATR III dose-dependently decreased the release and expression of SASP factors (interleukin [IL]-1 alpha, IL-1 beta, IL6 and IL-8) in senescent cells. ATR III regulated cyclic GMP-AMP synthase (cGAS)/nuclear factor kappa (NF-kappa B) signalling to affect SASP expression in senescent cells. The addition of 2'3 ' cGAMP counteracted the effect of ATR III. The release of SASP factors in the conditioned medium from senescent cells could affect cell migration, proliferation and contraction through paracrine manner. Our results indicated ATR III could still enter senescence and prevent the production of SASP and its paracrine effects in senescent cells, an effect that may be related to the possible inhibition of cGAS/NF-kappa B signalling by ATR III. Our study proves that ATR III may be an effective potential drug against liver fibrosis by promoting aHSC senescence, which can provide a new choice for the future clinical treatment of liver fibrosis.
C1 [Wu, Hongyan; Zhang, Lihu] Jiangsu Vocat Coll Med, Inst Biomed Technol, Yancheng, Peoples R China.
   [Wu, Hongyan; Xiao, Linxia; Gu, Yaqin; Liu, Hongxia; Zhang, Lihu; Zhang, Mingguang; Qi, Liang] Jiangsu Vocat Coll Med, Sch Pharmacol, Yancheng, Peoples R China.
   [Wu, Lixia] Lujiang Peoples Hosp, Dept Pediat, Hefei, Peoples R China.
   [Wu, Hongyan; Qi, Liang] Jiangsu Vocat Coll Med, Inst Biomed Technol, Yancheng, Jiangsu, Peoples R China.
C3 Jiangsu Vocational College of Medicine; Jiangsu Vocational College of
   Medicine; Jiangsu Vocational College of Medicine
RP Wu, HY; Qi, L (corresponding author), Jiangsu Vocat Coll Med, Inst Biomed Technol, Yancheng, Jiangsu, Peoples R China.
EM why20133055@163.com; qiliangql@126.com
OI Wu, Hongyan/0000-0002-0184-2360
FU National Natural Science Foundation of China [82274339, 81873134];
   Natural Science Foundation of the Jiangsu Higher Education Institutions
   of China [22KJD360002]; Medical Scientific Research Project of Jiangsu
   Provincial Commission of Health [Z2022073]
FX National Natural Science Foundation of China, Grant/Award Numbers:
   82274339, 81873134; Natural Science Foundation of the Jiangsu Higher
   Education Institutions of China, Grant/Award Number: 22KJD360002;
   Medical Scientific Research Project of Jiangsu Provincial Commission of
   Health, Grant/Award Number: Z2022073
CR Abreu-Blanco MT, 2012, CELL MOL LIFE SCI, V69, P2469, DOI 10.1007/s00018-012-0928-2
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Glück S, 2019, CURR OPIN IMMUNOL, V56, P31, DOI 10.1016/j.coi.2018.09.013
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Gu LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052305
   Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018
   Huai B, 2020, IMMUNOPHARM IMMUNOT, V42, P436, DOI 10.1080/08923973.2020.1806871
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wang FX, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0324-8
   Wang MQ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1875471
   Zhang F, 2021, BRIT J PHARMACOL, V178, P2246, DOI 10.1111/bph.15289
NR 20
TC 1
Z9 1
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1870
EI 1440-1681
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD 2023 APR
PY 2023
VL 50
IS 4
BP 316
EP 324
DI 10.1111/1440-1681.13753
EA JAN 2023
PG 9
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA 9I0JK
UT WOS:000924213300001
PM 36648378
DA 2024-02-19
ER

PT J
AU Zhang, SQ
   Zhou, JH
   Wang, QY
   Wen, PT
   Han, YY
   Hong, QX
AF Zhang, Suqin
   Zhou, Jianhua
   Wang, Qiuyue
   Wen, Peitong
   Han, Yingying
   Hong, Qingxiang
TI The Action and Mechanism of Action of Icariin on Human Hepatic
   Sinusoidal Endothelial Cell Senescence: A Laboratory Study
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE exosomes; hepatitis B virus; microRNA-22-3p; senescence; sirtuin 1;
   traditional Chinese medicine
AB Objective: Icariin (ICA) may have an antiaging effect. However, whether this applies to its hepatic cell remains unclear. The aim of this study was to explore the effect and mechanism of action of ICA on hepatic cell senescence.Methods: Serum exosomes isolated from patients with hepatitis B virus-induced liver cirrhosis were utilized to induce senescent phenotypes of human hepatic sinusoidal endothelial cells (HHSECs). ICA, microRNA-22-3p (miR-22-3p) inhibitor and mimic, and sirtuin 1 (SIRT1) overexpression were applied, to investigate the effect of ICA. Senescence-associated 0-galactosidase (SA-0 -gal) staining, flow cytometry, and quantitative real-time polymerase chain reaction and Western blot were employed to determine cellular senescence, cell cycle progression, and RNA and protein levels, respectively. A dual-luciferase reporter gene assay was performed to validate the binding between miR-22-3p and SIRT1.Results: Serum exosomes significantly promoted the senescent phenotypes of HHSECs, as revealed by the increased SA-0-gal positive cell number and cell cycle arrest at G1 phase. However, ICA significantly reversed these alterations, in a dose-dependent manner. miR-22-3p was shown to target SIRT1. miR-22-3p upregulation significantly promoted cell senescence and significantly downregulated SIRT1 levels, which could be duplicated by overexpressing SIRT1. Furthermore, the suppressive effect of ICA on cellular senescence and its promoting action on upregulating SIRT1 were significantly reversed by overexpressing miR-22-3p. Conclusions: ICA has an anti-aging effect on human hepatic sinusoidal endothelial cells, which is effected through miR-22-3p and its target SIRT1.
C1 [Zhang, Suqin; Zhou, Jianhua; Wang, Qiuyue; Wen, Peitong; Han, Yingying; Hong, Qingxiang] Shanghai Eighth Peoples Hosp, Dept Tradit Chinese Med, Shanghai 200235, Peoples R China.
RP Zhang, SQ; Zhou, JH (corresponding author), Shanghai Eighth Peoples Hosp, Dept Tradit Chinese Med, Shanghai 200235, Peoples R China.
EM zhangsuqin2021@163.com; shprozhou@163.com
FU Jiangsu University Medical Clinical Science and Technology Development
   Fund [JLY2021105]; Xuhui District Health System Talent Training Plan;
   Hong Qingxiang National Inheritance Studio of Famous and Old Traditional
   Chinese Medicine Experts at the Basic Level; Shanghai Key Specialty
   Training Project of Traditional Chinese Medicine
FX This study was funded by Jiangsu University Medical Clinical Science and
   Technology Development Fund (JLY2021105), Xuhui District Health System
   Talent Training Plan, and Hong Qingxiang National Inheritance Studio of
   Famous and Old Traditional Chinese Medicine Experts at the Basic Level,
   and Shanghai Key Specialty Training Project of Traditional Chinese
   Medicine.
CR [Anonymous], 2008, PLOS ONE
   Chen FJ, 2019, J PHARMACOL EXP THER, V369, P121, DOI 10.1124/jpet.118.253310
   Chen J, 2012, AM J PATHOL, V180, P973, DOI 10.1016/j.ajpath.2011.11.033
   Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008
   D'Anca M, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00232
   Du SS, 2021, PHARMACOL RES, V165, DOI 10.1016/j.phrs.2020.105278
   Gámez-Valero A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9111095
   Guan RJ, 2019, AGING-US, V11, P11844, DOI 10.18632/aging.102454
   Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005
   Kida Y, 2016, CAN J CARDIOL, V32, P634, DOI 10.1016/j.cjca.2015.11.022
   Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048
   Li CR, 2015, LIFE SCI, V126, P57, DOI 10.1016/j.lfs.2015.01.006
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629
   Natale F, 2022, STEM CELLS, V40, P318, DOI 10.1093/stmcls/sxab026
   Oh M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061715
   Wang F, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.537519
   Wang SH, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.844047
   Wang Xueqin, 2017, Mol Med Rep, V16, P3242, DOI 10.3892/mmr.2017.7001
   Wang Z, 2018, OSTEOPOROSIS INT, V29, P535, DOI 10.1007/s00198-017-4255-1
   Xia L, 2022, BIOL CELL, V114, P127, DOI 10.1111/boc.202100086
   Xu CQ, 2020, MOL MED REP, V22, P3833, DOI 10.3892/mmr.2020.11458
   Xu D, 2013, ADV DRUG DELIVER REV, V65, P368, DOI 10.1016/j.addr.2012.07.010
   Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100
   Zheng MQ, 2020, CELL BIOL INT, V44, P764, DOI 10.1002/cbin.11271
NR 25
TC 0
Z9 0
U1 0
U2 0
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD MAR-APR
PY 2023
VL 37
IS 2
BP 885
EP 895
DI 10.23812/j.biol.regul.homeost.agents.20233702.90
PG 11
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA D1QN2
UT WOS:000966537200001
DA 2024-02-19
ER

PT J
AU Okatani, Y
   Wakatsuki, A
   Reiter, RJ
AF Okatani, Y
   Wakatsuki, A
   Reiter, RJ
TI Melatonin protects hepatic mitochondrial respiratory chain activity in
   senescence-accelerated mice
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
ID MICROSOMAL MEMBRANE-FLUIDITY; GLUTATHIONE-PEROXIDASE; OXIDATIVE DAMAGE;
   INHIBITION; METABOLITE; PREVENT
AB Mitochondrial oxidative damage from free radicals may be a factor underlying aging, and melatonin. a powerful free radical scavenger, may participate in mitochondrial metabolism. We measured respirators chain complex I and IV activities in liver mitochondria from a strain of senescence-accelerated prone mice (SAMP8) and a strain of senescence-accelerated resistant mice (SAMR1) at age 3. 6. and 12 months. No age-associated effects were found in either complex I and IV activities. thiobarbituric acid-reactive substances (TBARS). or glutathione peroxidase (GPx) activity in SAMR1. In contrast. SAMP8 showed significant age-associated decreases in complex I and IV activities. While no age effect was found in TBARS in SAMP8. TBARS levels in SAMP8 were significantly more abundant than in SAMR1. GPx activity in SAMP8 decreased significantly by 12 months. Daily oral melatonin administration (2 mug/mL of drinking fluid) beginning when the mice A ere 7 months old significantly increased complex I and IV activity, decreased TBARS. and increased GPx activities in both SAMR1 and SAMP8 at 12 months. The implication of the findings is that melatonin may be beneficial during aging as it reduced the deteriorative oxidative changes in mitochondria and other portions of the cell associated with advanced age.
C1 Kochi Med Sch, Dept Clin Nursing Sci, Kochi 783, Japan.
   Kochi Med Sch, Dept Obstet & Gynecol, Kochi 783, Japan.
   Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78285 USA.
C3 Kochi University; Kochi University; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Okatani, Y (corresponding author), Kochi Med Sch, Dept Clin Nursing Sci, Kochi 783, Japan.
EM okataniy@med.kochi-ms.ac.jp
CR Acuña-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x
   Agapito MT, 2001, J PINEAL RES, V31, P23, DOI 10.1034/j.1600-079X.2001.310104.x
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165
   BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8
   Ceraulo L, 1999, J PINEAL RES, V26, P108, DOI 10.1111/j.1600-079X.1999.tb00570.x
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   Garcia JJ, 1997, FEBS LETT, V408, P297, DOI 10.1016/S0014-5793(97)00447-X
   García JJ, 1998, J MEMBRANE BIOL, V162, P59, DOI 10.1007/s002329900342
   HARMAN D, 1994, ANN NY ACAD SCI, V747, P1
   HOGEBOOM GH, 1955, METHOD ENZYMOL, V1, P16, DOI 10.1016/0076-6879(55)01007-0
   LIVERA MA, 1997, FREE RADICAL BIO MED, V23, P706
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAESTRONI GJM, 1993, J PINEAL RES, V14, P1, DOI 10.1111/j.1600-079X.1993.tb00478.x
   Martín M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MORENOSANCHEZ R, 1991, BIOCHEM PHARMACOL, V41, P1479, DOI 10.1016/0006-2952(91)90564-L
   Morioka N, 1999, J PINEAL RES, V27, P202, DOI 10.1111/j.1600-079X.1999.tb00616.x
   NAKAHARA H, 1994, FREE RADICAL BIO MED, V16, P621
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Okatani Y, 2000, J PINEAL RES, V28, P89, DOI 10.1034/j.1600-079X.2001.280204.x
   Okatani Y, 2001, J PINEAL RES, V30, P199, DOI 10.1034/j.1600-079X.2001.300402.x
   Pablos M.I., 1997, NEUROENDOCRINOL LETT, V18, P49
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   Qi WB, 2000, J PINEAL RES, V29, P54, DOI 10.1034/j.1600-079X.2000.290108.x
   Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360
   Reiter RJ, 1999, ADV EXP MED BIOL, V467, P379
   Reiter RJ, 1999, MECH AGEING DEV, V110, P157, DOI 10.1016/S0047-6374(99)00058-5
   REITER RJ, 1992, BIOESSAYS, V14, P169, DOI 10.1002/bies.950140307
   Reiter RJ., 2000, CURR TOP BIOPHYS, V24, P171
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tan DX, 2001, FASEB J, V15, P2294, DOI 10.1096/fj.01-0309fje
   Tan DX, 1998, BIOCHEM BIOPH RES CO, V253, P614, DOI 10.1006/bbrc.1998.9826
   TAN DX, 1985, FREE RADICAL BIO MED, V29, P1177
   Tesoriere L, 2001, J PINEAL RES, V31, P114, DOI 10.1034/j.1600-079x.2001.310204.x
   Turjanski AG, 2001, J PINEAL RES, V31, P97, DOI 10.1034/j.1600-079x.2001.310201.x
   Wakatsuki A, 2000, J PINEAL RES, V28, P136
   Wakatsuki A, 2001, J PINEAL RES, V31, P167, DOI 10.1034/j.1600-079x.2001.310211.x
   YAGI K, 1989, EXP GERONTOL, V24, P49
NR 43
TC 57
Z9 60
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD APR
PY 2002
VL 32
IS 3
BP 143
EP 148
DI 10.1034/j.1600-079x.2002.1o106.x
PG 6
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 543KY
UT WOS:000175102200003
PM 12074097
DA 2024-02-19
ER

PT J
AU Barth, E
   Srivastava, A
   Stojiljkovic, M
   Frahm, C
   Axer, H
   Witte, OW
   Marz, M
AF Barth, Emanuel
   Srivastava, Akash
   Stojiljkovic, Milan
   Frahm, Christiane
   Axer, Hubertus
   Witte, Otto W.
   Marz, Manja
TI Conserved aging-related signatures of senescence and inflammation in
   different tissues and species
SO AGING-US
LA English
DT Article
DE aging; inflammaging; senescence; RNA-Seq; transcriptomics
ID EPIDERMAL STEM-CELLS; NOTCH LIGAND JAG2; CELLULAR SENESCENCE; NADPH
   OXIDASES; SCAVENGER RECEPTORS; IN-VITRO; EVOLUTIONARY; BETA; APOPTOSIS;
   BINDING
AB Increasing evidence indicates that chronic inflammation and senescence are the cause of many severe age-related diseases, with both biological processes highly upregulated during aging. However, until now, it has remained unknown whether specific inflammation- or senescence-related genes exist that are common between different species or tissues. These potential markers of aging could help to identify possible targets for therapeutic interventions of aging-associated afflictions and might also deepen our understanding of the principal mechanisms of aging. With the objective of identifying such signatures of aging and tissue-specific aging markers, we analyzed a multitude of cross-sectional RNA-Seq data from four evolutionarily distinct species (human, mouse and two fish) and four different tissues (blood, brain, liver and skin). In at least three different species and three different tissues, we identified several genes that displayed similar expression patterns that might serve as potential aging markers. Additionally, we show that genes involved in aging-related processes tend to be tighter controlled in long-lived than in average-lived individuals. These observations hint at a general genetic level that affect an individual's life span. Altogether, this descriptive study contributes to a better understanding of common aging signatures as well as tissue-specific aging patterns and supplies the basis for further investigative age-related studies.
C1 [Barth, Emanuel; Marz, Manja] Friedrich Schiller Univ Jena, Fac Math & Comp Sci, Bioinformat High Throughput Anal, Jena, Germany.
   [Barth, Emanuel; Marz, Manja] FLI Leibniz Inst Age Res, Jena, Germany.
   [Srivastava, Akash; Stojiljkovic, Milan; Frahm, Christiane; Axer, Hubertus; Witte, Otto W.] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany.
   [Marz, Manja] EVBC, Jena, Germany.
C3 Friedrich Schiller University of Jena; Leibniz Institut fur
   Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller
   University of Jena
RP Barth, E (corresponding author), Friedrich Schiller Univ Jena, Fac Math & Comp Sci, Bioinformat High Throughput Anal, Jena, Germany.; Barth, E (corresponding author), FLI Leibniz Inst Age Res, Jena, Germany.
EM emanuel.barth@uni-jena.de
RI Witte, Otto/P-4127-2018; Axer, Hubertus/B-4592-2010; SRIVASTAVA,
   AKASH/AAG-4450-2021
OI Witte, Otto/0000-0003-2101-4105; Axer, Hubertus/0000-0002-3191-2796;
   Barth, Emanuel/0000-0003-0803-8858; Srivastava,
   Akash/0000-0002-5959-3926; Marz, Manja/0000-0003-4783-8823
FU Carl Zeiss Stiftung; Ministry for Economics, Sciences and Digital
   Society of Thuringia (TMWWDG) [RegenerAging-52-5581-413-FSU-I03/14]; DFG
   [Wi 830/11-2, Wi830/12-1]; EU BrainAge [FP7/279281]; MBF JenAge
FX This work received financial support by the Carl Zeiss Stiftung (MM),
   the Ministry for Economics, Sciences and Digital Society of Thuringia
   (TMWWDG), under the framework of the ProExcellence Initiative
   RegenerAging [RegenerAging-52-5581-413-FSU-I03/14 EB]. MBF JenAge (OW),
   DFG Wi 830/11-2, DFG Wi830/12-1 (OW) and EU BrainAge (FP7/279281)(OW).
CR Baciou L, 2018, MECH AGEING DEV, V172, P30, DOI 10.1016/j.mad.2017.11.001
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Barton BE, 2005, EXPERT OPIN THER TAR, V9, P737, DOI 10.1517/14728222.9.4.737
   BAUMGART M, 2017, MIRNA CATALOGUE NCRN, V0018
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhatia-Dey N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00013
   Bohm Ingrid, 2003, Mol Imaging Biol, V5, P2, DOI 10.1016/S1536-1632(03)00024-6
   Borysenko CW, 2005, BIOCHEM BIOPH RES CO, V328, P794, DOI 10.1016/j.bbrc.2005.01.017
   Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Chiron D, 2012, BLOOD CELL MOL DIS, V48, P247, DOI 10.1016/j.bcmd.2012.01.006
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   COUGHLIN SR, 1992, J CLIN INVEST, V89, P351, DOI 10.1172/JCI115592
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   de Magalhaes JP, 2010, AGEING RES REV, V9, P315, DOI 10.1016/j.arr.2009.10.006
   Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016
   Dubinski Andrzej, 2007, Pol Merkur Lekarski, V22, P291
   Frahm C, 2017, NEUROBIOL AGING, V52, P23, DOI 10.1016/j.neurobiolaging.2016.12.016
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972
   Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001
   Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999
   Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x
   Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51
   Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020
   Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   HARAYAMA S, 1992, ANNU REV MICROBIOL, V46, P565, DOI 10.1146/annurev.micro.46.1.565
   He JQ, 2003, ONCOGENE, V22, P4524, DOI 10.1038/sj.onc.1206767
   Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457
   Hernandes MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-36
   Hervé C, 2006, CURR GENET, V49, P190, DOI 10.1007/s00294-005-0044-z
   Honda Z, 2002, J BIOCHEM, V131, P773, DOI 10.1093/oxfordjournals.jbchem.a003164
   Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Irizar PA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02395-2
   Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001
   Kashatus DF, 2013, EXP CELL RES, V319, P2337, DOI 10.1016/j.yexcr.2013.06.020
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim H, 2018, P NATL ACAD SCI USA, V115, pE11128, DOI 10.1073/pnas.1814044115
   Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114
   Labbé E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697
   Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688
   Maouche-Chrétien L, 1998, ONCOGENE, V17, P1245, DOI 10.1038/sj.onc.1202048
   McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058
   McCullough JL, 2006, ANN NY ACAD SCI, V1067, P323, DOI 10.1196/annals.1354.044
   MILATOVICH A, 1991, GENOMICS, V11, P1040, DOI 10.1016/0888-7543(91)90030-I
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   Miquel J., 1986, FREE RADICALS AGING, P51
   Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840
   Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733
   Noubade R, 2014, NATURE, V509, P235, DOI 10.1038/nature13152
   Novakowski KE, 2016, IMMUNOL CELL BIOL, V94, P646, DOI 10.1038/icb.2016.20
   Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187
   Pamplona R, 2003, BIOL AGING MODULAT, V1, P47
   Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470
   Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508
   Plüddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004
   Prattichizzo F, 2016, AGING-US, V8, P3159, DOI 10.18632/aging.101133
   Reichwald K, 2015, CELL, V163, P1527, DOI 10.1016/j.cell.2015.10.071
   Ren J, 2018, INT J ONCOL, V52, P1934, DOI 10.3892/ijo.2018.4355
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007
   Sahoo S, 2016, CLIN SCI, V130, P317, DOI 10.1042/CS20150087
   Sakamoto T, 2014, GENES CELLS, V19, P778, DOI 10.1111/gtc.12175
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Scioli MG, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-19
   Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000
   SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581
   Simicek M, 2013, NAT CELL BIOL, V15, P1220, DOI 10.1038/ncb2847
   Slattery SD, 2009, CELL CYCLE, V8, P2984
   Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969
   So Eui Young, 2014, BMC Cancer, V14, P548, DOI 10.1186/1471-2407-14-548
   Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016
   Stern MM, 2007, AGING CELL, V6, P439, DOI 10.1111/j.1474-9726.2007.00318.x
   Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012
   Toppo S, 2008, ANTIOXID REDOX SIGN, V10, P1501, DOI 10.1089/ars.2008.2057
   van der Horst A, 2009, CELL CYCLE, V8, P3742, DOI 10.4161/cc.8.22.10047
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673
   Vasto Sonya, 2004, Immun Ageing, V1, P1, DOI 10.1186/1742-4933-1-1
   Villar J, 2019, CHEST, V155, P587, DOI 10.1016/j.chest.2018.10.022
   Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3
   Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700
   Wu H, 2010, NEUROCHEM INT, V57, P248, DOI 10.1016/j.neuint.2010.06.002
   Yamamoto S, 1999, IMMUNOL TODAY, V20, P278, DOI 10.1016/S0167-5699(99)01464-4
   Yu Y, 2015, CELL MOL NEUROBIOL, V35, P71, DOI 10.1007/s10571-014-0101-6
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098
   Zhang ML, 2017, ONCOL RES, V25, P83, DOI 10.3727/096504016X14719078133447
   Zhang SB, 2018, CELL TRANSPLANT, V27, P729, DOI 10.1177/0963689717725755
   Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204
NR 101
TC 24
Z9 26
U1 1
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT 15
PY 2019
VL 11
IS 19
BP 8556
EP 8572
DI 10.18632/aging.102345
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA JE7TG
UT WOS:000490892100035
PM 31606727
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Youssef, J
   Badr, M
AF Youssef, J
   Badr, M
TI Biology of senescent liver peroxisomes: Role in hepatocellular aging and
   disease
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
DE aging; peroxisomal disorders; peroxisome proliferator-activated
   receptors; peroxisomes
ID PROLIFERATOR-ACTIVATED RECEPTOR; HEPATO-RENAL SYNDROME; FATTY-ACID
   OXIDATION; AGE-RELATED-CHANGES; RAT-LIVER; PPAR-ALPHA;
   SIGNAL-TRANSDUCTION; GENE-EXPRESSION; BETA-OXIDATION;
   ELECTRON-MICROSCOPY
AB Despite rising interest in the health problems of the elderly, information on senescence-related alterations in essential metabolic pathways and their responses to various chemicals is scarce. Although peroxisomal pathways are involved in a multitude of cellular functions, little attention has been given to the potential relationship between senescence of these organelles and the process of aging and disease. Although the prevailing experimental evidence points to a decline in liver peroxisomal enzyme activities and a muted response to peroxisome-proliferating chemicals in aged animals, it is also evident that aged animals are more susceptible, in comparison to their young counterparts, to the hepatocarcinogenic effects of these chemicals. Furthermore, little is known about extraperoxisomal effects of peroxisome proliferators in aged animals. This review evaluates published studies on the impact of aging on basal hepatic peroxisomal metabolism, response to peroxisome proliferators, and changes in signal transduction pathways involved in these processes, with the aim of stimulating research efforts in this important area. The potential intricate relationship among senescent peroxisomes, aged hepatocytes, and health are also discussed.
C1 Univ Missouri, Kansas City, MO 64108 USA.
C3 University of Missouri System; University of Missouri Kansas City
RP Badr, M (corresponding author), Univ Missouri, 2411 Holmes St,M3-115, Kansas City, MO 64108 USA.
FU NCI NIH HHS [CA/OD 74384] Funding Source: Medline
CR BADR M, 1991, TOXICOLOGIST, V187, P11
   BADR M, UNPUB
   BAYLY AC, 1994, J CELL BIOL, V125, P197, DOI 10.1083/jcb.125.1.197
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   BENTLEY P, 1993, FOOD CHEM TOXICOL, V31, P857, DOI 10.1016/0278-6915(93)90225-N
   Berger J, 1999, J BIOL CHEM, V274, P6718, DOI 10.1074/jbc.274.10.6718
   BIRNBAUM LS, 1980, EXP GERONTOL, V15, P259, DOI 10.1016/0531-5565(80)90030-3
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   CASTELEIN H, 1994, J BIOL CHEM, V269, P26754
   CATTLEY RC, 1991, CARCINOGENESIS, V12, P469, DOI 10.1093/carcin/12.3.469
   CONE CD, 1971, J THEOR BIOL, V30, P151, DOI 10.1016/0022-5193(71)90042-7
   Cutler RG., 1982, TESTING THEORIES AGI
   DELAIGLESIA FA, 1982, ATHEROSCLEROSIS, V43, P19, DOI 10.1016/0021-9150(82)90096-X
   DELRIO LA, 1990, EXPERIENTIA, V46, P989, DOI 10.1007/BF01940651
   Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DICE JF, 1985, HEPATOLOGY, V5, P508, DOI 10.1002/hep.1840050328
   Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555
   EACHO PI, 1986, TOXICOL APPL PHARM, V83, P430, DOI 10.1016/0041-008X(86)90225-5
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663
   Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831
   Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312
   FORNOS P, 1982, FASEB J, V4, pA302
   FRINGES B, 1982, ANN NY ACAD SCI, V386, P514, DOI 10.1111/j.1749-6632.1982.tb21467.x
   FRINGES B, 1982, LAB INVEST, V47, P19
   GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62
   GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653
   Greene M. E., 1995, Gene Expression, V4, P281
   Gustafsson JA, 1998, NUTR REV, V56, pS20
   HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   HEY MJ, 1976, NATURE, V262, P807, DOI 10.1038/262807a0
   HORIE S, 1981, J BIOCHEM, V90, P1691, DOI 10.1093/oxfordjournals.jbchem.a133645
   HUBER W, 1991, CANCER RES, V51, P1789
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   JAKOBS BS, 1991, BIOCHEM BIOPH RES CO, V178, P842, DOI 10.1016/0006-291X(91)90967-C
   KLIEWER S, 1994, P NATL ACAD SCI USA, V91, P7344
   Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318
   KRAUPPGRASL B, 1991, CANCER RES, V51, P666
   LAKE BG, 1989, TOXICOL APPL PHARM, V99, P148, DOI 10.1016/0041-008X(89)90120-8
   LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421
   LEVY E, 1968, AM J PATHOL, V52, P477
   MAKARIDES S, 1983, BIOL REV, V58, P343
   MASTERS CJ, 1995, MECH AGEING DEV, V80, P69, DOI 10.1016/0047-6374(94)01563-2
   Miller RT, 1996, CARCINOGENESIS, V17, P1337, DOI 10.1093/carcin/17.6.1337
   MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4
   Mukherjee R, 1998, ARTERIOSCL THROM VAS, V18, P272, DOI 10.1161/01.ATV.18.2.272
   MUKHERJEE R, 1994, J STEROID BIOCHEM, V51, P157, DOI 10.1016/0960-0760(94)90089-2
   NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369
   OBrien ML, 1996, CARCINOGENESIS, V17, P185, DOI 10.1093/carcin/17.2.185
   OESCH F, 1988, ARCH TOXICOL S, V12, P248
   PAGET GE, 1963, J ATHEROSCLER RES, V3, P729, DOI 10.1016/S0368-1319(63)80059-9
   Pallet V, 1997, MECH AGEING DEV, V99, P123, DOI 10.1016/S0047-6374(97)00098-5
   Perichon R, 1996, MECH AGEING DEV, V87, P115, DOI 10.1016/0047-6374(96)01705-8
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   RIGATUSO JL, 1970, J HISTOCHEM CYTOCHEM, V18, P893, DOI 10.1177/18.12.893
   RIKANS LE, 1987, J PHARMACOL EXP THER, V243, P20
   ROBERTS RA, 1995, CARCINOGENESIS, V16, P1693, DOI 10.1093/carcin/16.8.1693
   Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43
   ROTH GS, 1995, TRENDS NEUROSCI, V18, P203, DOI 10.1016/0166-2236(95)93902-A
   Roth GS, 1997, MECH AGEING DEV, V98, P231, DOI 10.1016/S0047-6374(97)00110-3
   Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5
   SAKUMA M, 1992, BIOCHEM PHARMACOL, V43, P1269
   SCHAPIRO H, 1982, EXPERIENTIA, V38, P1075, DOI 10.1007/BF01955375
   SCHMUCKER DL, 1980, P SOC EXP BIOL MED, V165, P178
   SCHUTGENS RBH, 1986, EUR J PEDIATR, V144, P430, DOI 10.1007/BF00441734
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015
   Shimozawa N, 1998, BIOCHEM BIOPH RES CO, V243, P368, DOI 10.1006/bbrc.1997.8067
   Singh I, 1997, MOL CELL BIOCHEM, V167, P1, DOI 10.1023/A:1006883229684
   SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203
   SINGH I, 1991, ARCH BIOCHEM BIOPHYS, V286, P277, DOI 10.1016/0003-9861(91)90041-G
   Soliman MS, 1997, BIOCHEM PHARMACOL, V53, P1369, DOI 10.1016/S0006-2952(97)87956-7
   STAUBLI W, 1969, J CELL BIOL, V42, P92, DOI 10.1083/jcb.42.1.92
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   Su JL, 1998, HYBRIDOMA, V17, P47, DOI 10.1089/hyb.1998.17.47
   TAKAI Y, 1984, ADV CYCLIC NUCL PROT, V18, P119
   Tauchi H., 1978, LIVER AGING 1978, P3
   THOMAS H, 1989, BIOCHEM PHARMACOL, V38, P4291, DOI 10.1016/0006-2952(89)90528-5
   TOLBERT NE, 1981, ANNU REV BIOCHEM, V50, P133, DOI 10.1146/annurev.bi.50.070181.001025
   Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237
   TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315
   VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105
   Warner HR, 1997, CURR TOP CELL REGUL, V35, P107, DOI 10.1016/S0070-2137(97)80004-0
   WATANABE T, 1989, BIOCHEM PHARMACOL, V38, P367
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   WILSON PD, 1975, GERONTOLOGY, V21, P81, DOI 10.1159/000212035
   Wolf G, 1998, NUTR REV, V56, P61, DOI 10.1111/j.1753-4887.1998.tb01693.x
   XIA EN, 1995, J NUTR, V125, P195
   Xin X, 1999, FASEB J, V13, pA39
   XU L, 1995, HORM METAB RES, V27, P76, DOI 10.1055/s-2007-979912
   YAMOTO T, 1995, TOXICOL LETT, V78, P141, DOI 10.1016/0378-4274(94)03247-5
   Youssef J, 1998, CRIT REV TOXICOL, V28, P1, DOI 10.1080/10408449891344182
   ZSNAGY I, 1979, MECH AGEING DEV, V9, P237, DOI 10.1016/0047-6374(79)90102-7
NR 96
TC 29
Z9 29
U1 0
U2 2
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD OCT
PY 1999
VL 107
IS 10
BP 791
EP 797
DI 10.2307/3454575
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 246BR
UT WOS:000083143700021
PM 10504144
OA gold
DA 2024-02-19
ER

PT J
AU Kang, K
   Xia, AR
   Meng, FR
   Chunyu, J
   Sun, X
   Ren, GP
   Yu, D
   Jiang, XH
   Tang, L
   Xiao, W
   Li, DS
AF Kang, Kai
   Xia, Anran
   Meng, Fanrui
   Chunyu, Jian
   Sun, Xu
   Ren, Guiping
   Yu, Dan
   Jiang, Xinghao
   Tang, Lei
   Xiao, Wei
   Li, Deshan
TI FGF21 alleviates chronic inflammatory injury in the aging process
   through modulating polarization of macrophages
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article; Early Access
DE FGF21; Senescence; SASP; Oxidant stress; Macrophage phenotype
ID GROWTH-FACTOR 21; CELLS; AMPK; RECEPTOR; INHIBITION; ACTIVATION;
   SENESCENCE; PHENOTYPE; MARROW; TLR4
AB Previous studies reported that FGF21 prolongs life span and delays the body senescence, but the mechanism is not clear. The present study was designed to investigate the effects of FGF21 on hepatic senescence in aging mice and further research the mechanism. The 14-month-old male mice were administered with PBS, FGF21 or metformin once daily for 6 months. Results showed that FGF21 alleviated liver injury and inhibited accumulation of senescence markers SASP, P53 and P16 in the livers of aging mice. Subsequently we found that the aging mice treated by FGF21 showed transition of type 1 macrophages (M1) to type 2 macrophages (M2) in the livers. Next, we used THP-1 macrophages triggered by LPS to study effects of FGF21 on macrophages. Macrophages triggered by LPS exhibited features of M1, but the addition of FGF21 decreased the expression of M1 markers, and promoted the macrophages to exhibit features of M2. Results showed that the effects of FGF21 on macrophages were associated with the AMPK pathway. After adding AMPK inhibitor, the effects of FGF21 were inhibited, which was associated with the NF-kappa B signaling pathway. Finally, co-culturing differentiated macrophages and hepatocytes, we found that the large amount of pro-inflammatory factors such as IL-6 promoted hepatocyte senescence, which exhibited enhanced P53, P16 and beta-galactosidase. This was contrary to hepatocytes co-cultured with macrophages treated by FGF21. These results indicate that FGF21 alleviates hepatic senescence injury by modulating the polarization of macrophages through the AMPK /NF-kappa B signaling pathway.
C1 [Kang, Kai; Xia, Anran; Meng, Fanrui; Chunyu, Jian; Sun, Xu; Ren, Guiping; Jiang, Xinghao; Li, Deshan] Northeast Agr Univ, Harbin, Peoples R China.
   [Tang, Lei] Harbin Weike Biotechnol CO LTD, Harbin, Peoples R China.
   [Yu, Dan; Xiao, Wei] Jiangsu Kanion Pharmaceut CO LTD, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Jiangsu, Peoples R China.
C3 Northeast Agricultural University - China
RP Xiao, W (corresponding author), Jiangsu Kanion Pharmaceut CO LTD, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Jiangsu, Peoples R China.; Li, DS (corresponding author), Northeast Agr Univ, Sch Life Sci, Harbin, Heilongjiang, Peoples R China.
EM 2715043773@qq.com; 1341674939@qq.com; 1192841993@qq.com;
   1176252003@qq.com; 1172801855@qq.com; 516702773@qq.com;
   626319662@qq.com; 1101833649@qq.com; tanglei8582@163.com;
   xw_kanion@163.com; deshanli@163.com
RI tang, lei/JCO-4117-2023
FU major prophase project of Heilongjiang development and reform commission
   [[2011] 1570]; Education Department of Heilongjiang Province
   [TSTAU-R2018017]; National Key R&D Program of China [2017YFD0501102,
   2017Y FD0501103-03]
FX Acknowledgements This work was supported by a grant from the major
   prophase project of Heilongjiang development and reform commission (
   [2011] 1570) , Education Department of Heilongjiang Province
   (TSTAU-R2018017) and National Key R&D Program of China (2017YFD0501102,
   2017Y FD0501103-03) .
CR Bas S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-46
   Brunt VE, 2019, J PHYSIOL-LONDON, V597, P2361, DOI 10.1113/JP277336
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Corso-Díaz X, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107525
   Dan HX, 2020, MOL ONCOL, V14, P795, DOI 10.1002/1878-0261.12644
   Dodig S, 2019, BIOCHEM MEDICA, V29, DOI 10.11613/BM.2019.030501
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Gao SS, 2015, J MOL CELL CARDIOL, V85, P131, DOI 10.1016/j.yjmcc.2015.04.025
   Gibon E, 2016, REGEN ENG TRANSL MED, V2, P98, DOI 10.1007/s40883-016-0016-5
   Gyllenhammer LE, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2713
   Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Jiang LH, 2020, NEURAL REGEN RES, V15, P1245, DOI 10.4103/1673-5374.272575
   Juskewitch JE, 2012, SCI REP-UK, V2, DOI 10.1038/srep00918
   Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834
   Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68
   Kim SM, 2020, EXP THER MED, V19, P2161, DOI 10.3892/etm.2020.8472
   Lee B, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/4892415
   Lee JA, 2018, EXP NEUROBIOL, V27, P408, DOI 10.5607/en.2018.27.5.408
   Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238
   Liu MX, 2019, J CELL PHYSIOL, V234, P18731, DOI 10.1002/jcp.28513
   Liu N., 2020, INT J MOL SCI, V21
   Liu T, 2018, INT J BIOL MACROMOL, V117, P225, DOI 10.1016/j.ijbiomac.2018.05.174
   Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516
   Mindur JE, 2019, ARTERIOSCL THROM VAS, V39, P1275, DOI 10.1161/ATVBAHA.119.311994
   Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116
   Murakami Y, 2012, J IMMUNOL, V189, P5066, DOI 10.4049/jimmunol.1103156
   Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18
   Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268
   Patel U, 2017, DRUG DISCOV TODAY, V22, P186, DOI 10.1016/j.drudis.2016.08.006
   Peng XW, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8978704
   Peng YC, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01830-4
   Puzianowska-Kuznicka M, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0076-x
   Ramirez A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-27
   Rhinn M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151837
   Salazar N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00406
   Schwaderer J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2348-9
   Sergiev PV, 2015, ACTA NATURAE, V7, P9, DOI 10.32607/20758251-2015-7-1-9-18
   Shi YL, 2020, INFLAMMATION, V43, P1611, DOI 10.1007/s10753-020-01236-7
   Tanajak P, 2015, J ENDOCRINOL, V227, pR13, DOI 10.1530/JOE-15-0289
   Tarantini S, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101192
   Tominaga K, 2015, PATHOBIOL AGING AGE, V5, DOI 10.3402/pba.v5.27743
   Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225
   Vida C, 2017, REDOX BIOL, V12, P423, DOI 10.1016/j.redox.2017.03.005
   Wang N, 2018, BIOMED PHARMACOTHER, V108, P1825, DOI 10.1016/j.biopha.2018.09.143
   Wang QZ, 2018, MOL NEUROBIOL, V55, P4702, DOI 10.1007/s12035-017-0663-7
   Wang XM, 2016, EXP CELL RES, V346, P147, DOI 10.1016/j.yexcr.2016.06.020
   Wang Y., 2020, CELL BIOL INT
   Xu PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155598
   Yun-Hee Youm T.L.H., 2015, PNAS
   Zhang B, 2016, NEUROBIOL AGING, V47, P157, DOI 10.1016/j.neurobiolaging.2016.07.029
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
   Zhong ZZ, 2020, NEUROBIOL DIS, V143, DOI 10.1016/j.nbd.2020.104945
NR 53
TC 7
Z9 7
U1 2
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD 2021 JUL
PY 2021
VL 96
AR 107634
DI 10.1016/j.intimp.2021.107634
EA APR 2021
PG 12
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA SV8NW
UT WOS:000664075400002
PM 33872851
DA 2024-02-19
ER

PT J
AU Seo, YH
   Jung, HJ
   Shin, HT
   Kim, YM
   Yim, H
   Chung, HY
   Lim, IK
   Yoon, G
AF Seo, Yong-Hak
   Jung, Hyun-Jung
   Shin, Hyun-Taek
   Kim, You-Mie
   Yim, Hyunee
   Chung, Hae-Young
   Lim, In Kyoung
   Yoon, Gyesoon
TI Enhanced glycogenesis is involved in cellular senescence via GSK3/GS
   modulation
SO AGING CELL
LA English
DT Article
DE aging; cellular senescence; glycogenesis; glycogen synthase; GSK3;
   reactive oxygen species
ID RABBIT SKELETAL-MUSCLE; SYNTHASE KINASE-3; HEPATIC GLUCOSE; OXIDATIVE
   STRESS; LIFE-SPAN; INSULIN; ACTIVATION; CELLS; METABOLISM; SURVIVAL
AB Glycogen biogenesis and its response to physiological stimuli have often been implicated in age-related diseases. However, their direct relationships to cell senescence and aging have not been clearly elucidated. Here, we report the central involvement of enhanced glycogenesis in cellular senescence. Glycogen accumulation, glycogen synthase (GS) activation, and glycogen synthase kinase 3 (GSK3) inactivation commonly occurred in diverse cellular senescence models, including the liver tissues of aging F344 rats. Subcytotoxic concentrations of GSK3 inhibitors (SB415286 and LiCl) were sufficient to induce cellular senescence with increased glycogenesis. Interestingly, the SB415286-induced glycogenesis was irreversible, as were increased levels of reactive oxygen species and gain of senescence phenotypes. Blocking GSK3 activity using siRNA or dominant negative mutant (GSK3 beta-K85A) also effectively induced senescence phenotypes, and GS knock-down significantly attenuated the stress-induced senescence phenotypes. Taken together, these results clearly demonstrate that augmented glycogenesis is not only common, but is also directly linked to cellular senescence and aging, suggesting GSK3 and GS as novel modulators of senescence, and providing new insight into the metabolic backgrounds of aging and aging-related pathogenesis.
C1 [Seo, Yong-Hak; Jung, Hyun-Jung; Shin, Hyun-Taek; Kim, You-Mie; Lim, In Kyoung; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea.
   [Chung, Hae-Young] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.
   [Seo, Yong-Hak; Jung, Hyun-Jung; Shin, Hyun-Taek; Yoon, Gyesoon] Ajou Univ, Grad Sch, Dept Mol Sci & Technol, Suwon 443721, South Korea.
   [Yim, Hyunee] Ajou Univ, Sch Med, Dept Pathol, Suwon 443721, South Korea.
C3 Ajou University; Pusan National University; Ajou University; Ajou
   University
RP Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea.
EM ypeace@ajou.ac.kr
OI Lim, In Kyoung/0000-0002-2399-607X
FU Korean Science and Engineering Foundation; Korean government (MOST)
   [R13-2003-019-01004-0, KRF-2007-313C00575, KRF-2005-041-C00354]
FX This work was supported by the Korean Science and Engineering Foundation
   (KOSEF) Grant funded by the Korean government (MOST)
   (R13-2003-019-01004-0), Korea Research Foundation Grant funded by the
   Korean Government (KRF-2007-313C00575 & KRF-2005-041-C00354). We thank
   the Aging Tissue Bank (Pusan, Korea) for the supply of the aged tissues.
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Ban K.C., 2003, LEUKEMIA RES, V27, P1159
   Bartke A, 2001, TRENDS ENDOCRIN MET, V12, P233, DOI 10.1016/S1043-2760(01)00426-X
   Bollen M, 1998, BIOCHEM J, V336, P19, DOI 10.1042/bj3360019
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   CLINE GW, 1994, J CLIN INVEST, V94, P2369, DOI 10.1172/JCI117602
   Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9
   Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075
   DALLAGLIO E, 1987, J GERONTOL, V42, P168, DOI 10.1093/geronj/42.2.168
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498
   Eldar-Finkelman H, 2003, EXPERT OPIN INV DRUG, V12, P1511, DOI 10.1517/13543784.12.9.1511
   EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7
   Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001
   GERTZ HJ, 1985, MECH AGEING DEV, V31, P25, DOI 10.1016/0047-6374(85)90024-7
   HARRIS RA, 2006, TXB BIOCH CLIN CORRE, P581
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033
   Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   KHANDELWAL RL, 1984, MECH AGEING DEV, V28, P13, DOI 10.1016/0047-6374(84)90149-0
   Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Kurokawa T, 1997, MECH AGEING DEV, V97, P227, DOI 10.1016/S0047-6374(97)00063-8
   Liao XB, 2003, MOL CANCER THER, V2, P1215
   Locher R, 2002, HYPERTENSION, V39, P645, DOI 10.1161/hy0202.103473
   MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200
   MATSUMURA T, 1979, J GERONTOL, V34, P328, DOI 10.1093/geronj/34.3.328
   Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045
   MOORE SA, 1981, J NEUROL SCI, V52, P289, DOI 10.1016/0022-510X(81)90012-5
   MYSLIWSKI A, 1992, ARCH GERONTOL GERIAT, V14, P85, DOI 10.1016/0167-4943(92)90009-S
   PAGLIASSOTTI MJ, 1992, ANNU REV PHYSIOL, V54, P847, DOI 10.1146/annurev.ph.54.030192.004215
   Pagliassotti MJ, 1996, J CLIN INVEST, V97, P81, DOI 10.1172/JCI118410
   Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100
   ROBBINS E, 1970, J EXP MED, V131, P1211, DOI 10.1084/jem.131.6.1211
   Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102
   RYLATT DB, 1980, EUR J BIOCHEM, V107, P529
   Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002
   Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041
   SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403
   SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015
   Takashima A, 2006, J ALZHEIMERS DIS, V9, P309
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tissenbaum HA, 1998, GENETICS, V148, P703
   Wang XM, 2002, BIOCHEM J, V367, P475, DOI 10.1042/BJ20020677
   Wang YM, 2006, J INFRARED MILLIM W, V25, P50
   Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034
   Yoon G, 2002, BIOCHEM J, V366, P613, DOI 10.1042/BJ20011445
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262
   Zmijewski JW, 2004, AGING CELL, V3, P309, DOI 10.1111/j.1474-9728.2004.00117.x
NR 56
TC 66
Z9 69
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2008
VL 7
IS 6
BP 894
EP 907
DI 10.1111/j.1474-9726.2008.00436.x
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 376LF
UT WOS:000261184400011
PM 18782348
OA hybrid
DA 2024-02-19
ER

PT J
AU You, M
   Liu, R
   Wei, C
   Wang, XJ
   Yu, XC
   Li, Z
   Mao, RX
   Hu, JN
   Zhu, N
   Liu, XR
   Fan, R
   Li, Y
   Xu, MH
AF You, Mei
   Liu, Rui
   Wei, Chan
   Wang, Xiujuan
   Yu, Xiaochen
   Li, Zhen
   Mao, Ruixue
   Hu, Jiani
   Zhu, Na
   Liu, Xinran
   Fan, Rui
   Li, Yong
   Xu, Meihong
TI Exogenous Nucleotides Ameliorate Ageing-Related Intestinal Inflammation
   in Senescence-Accelerated Mouse Prone-8 (SAMP8) Mice
SO NUTRIENTS
LA English
DT Article
DE exogenous nucleotides; intestine; inflammation; immunity
ID FORMULA-FED INFANTS; DIETARY NUCLEOTIDES; SUPPRESSION; MICROBIOTA; LIVER
AB As one of the most important barriers in the body, the intestinal barrier is a key factor in maintaining human health. Ageing of the intestine is a degenerative process that is closely associated with a variety of poor health conditions in the elderly. Inflammation and the immune system are anti-ageing targets that can regulate the function of the intestine. Nucleotides (NTs) are involved in important physiological and biochemical reactions in the body, but there are few studies about their effect on the ageing intestine. This paper examines the role of exogenous NTs in the ageing intestine. For this purpose, we used senescence-accelerated mouse prone-8 (SAMP8) mice and senescence-accelerated mouse resistant 1 (SAMR1) mice for the experiment, and randomly divided the mice into NTs-free, Normal Control, NTs-low, NTs-medium, NTs-high, and SAMR1 groups. After 9 months of intervention, we collected the colon tissue of mice for testing. In our study, exogenous NTs could increase bodyweight of mice during ageing and improve the morphological structure of the intestine, and we found that NTs could promote the secretion of intestinal protective factors, such as TFF3 and TE. Furthermore, supplementation with NTs suppressed intestinal inflammation and improved intestinal immunity, possibly by activating the p38 signaling pathway. These results suggest that exogenous NTs are able to maintain the health condition of the ageing intestine.
C1 [You, Mei; Liu, Rui; Wei, Chan; Wang, Xiujuan; Yu, Xiaochen; Li, Zhen; Mao, Ruixue; Hu, Jiani; Zhu, Na; Liu, Xinran; Fan, Rui; Li, Yong; Xu, Meihong] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100191, Peoples R China.
   [You, Mei; Liu, Rui; Wei, Chan; Wang, Xiujuan; Yu, Xiaochen; Li, Zhen; Mao, Ruixue; Hu, Jiani; Zhu, Na; Liu, Xinran; Fan, Rui; Li, Yong; Xu, Meihong] Peking Univ, Beijing Key Lab Toxicol Res & Risk Assessment Food, Beijing 100191, Peoples R China.
C3 Peking University; Peking University
RP Xu, MH (corresponding author), Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100191, Peoples R China.; Xu, MH (corresponding author), Peking Univ, Beijing Key Lab Toxicol Res & Risk Assessment Food, Beijing 100191, Peoples R China.
EM 1610306135@pku.edu.cn; xumeihong@bjmu.edu.cn
RI zhang, yue/JAC-3705-2023; lu, Li/KBA-2603-2024
OI Li, Yong/0000-0003-3914-5840; Xu, Meihong/0000-0001-7201-6982
FU Peking University Youth Talent Support Program [BMU2021YJ036]
FX This research is partially supported by the Peking University Youth
   Talent Support Program (BMU2021YJ036).
CR Ahmadi S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132055
   Aihara E, 2017, ANNU REV PHYSIOL, V79, P357, DOI 10.1146/annurev-physiol-021115-105447
   Arnold JW, 2021, MICROBIOME, V9, DOI 10.1186/s40168-020-00980-0
   Boraschi D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005624
   BUENO J, 1994, GUT, V35, P926, DOI 10.1136/gut.35.7.926
   Cai XX, 2016, FOOD FUNCT, V7, P2898, DOI 10.1039/c5fo01580d
   Cai XX, 2016, MOLECULES, V21, DOI 10.3390/molecules21040435
   Canovas B, 2021, NAT REV MOL CELL BIO, V22, P346, DOI 10.1038/s41580-020-00322-w
   Chen LH, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041116
   Chen P, 2021, FOOD FUNCT, V12, P11938, DOI [10.1039/d1fo02440j, 10.1039/D1FO02440J]
   Ding T, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.820799
   Ellis PS, 2022, IMMUN AGEING, V19, DOI 10.1186/s12979-022-00287-8
   Emidio NB, 2019, TRENDS BIOCHEM SCI, V44, P387, DOI 10.1016/j.tibs.2019.01.004
   Englander EW, 2005, AGEING RES REV, V4, P564, DOI 10.1016/j.arr.2005.06.005
   Fang X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.792746
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hou QH, 2023, PHARMACOL RES, V188, DOI 10.1016/j.phrs.2023.106676
   Irimia D, 2018, TRENDS BIOTECHNOL, V36, P923, DOI 10.1016/j.tibtech.2018.03.011
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Kurokawa T, 1998, MECH AGEING DEV, V102, P25, DOI 10.1016/S0047-6374(98)00009-8
   Li Y, 2021, AGING DIS, V12, P2052, DOI 10.14336/AD.2021.0418
   LopezNavarro AT, 1996, GASTROENTEROLOGY, V110, P1760, DOI 10.1053/gast.1996.v110.pm8964401
   Ma HH, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1086192
   Miró L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121346
   Mojiri A, 2021, EUR HEART J, V42, P4352, DOI 10.1093/eurheartj/ehab547
   ORTEGA MA, 1995, LIFE SCI, V56, P1623, DOI 10.1016/0024-3205(95)00129-T
   Paradis T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052506
   Pellegrini C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103523
   Sánchez-Pozo A, 2002, BRIT J NUTR, V87, pS135, DOI 10.1079/BJN2001467
   SANDERSON IR, 1994, J NUTR, V124, pS131, DOI 10.1093/jn/124.suppl_1.131S
   Shin DY, 2009, INT J ONCOL, V35, P1499, DOI 10.3892/ijo_00000469
   Singh R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07859-7
   Singhal A, 2008, AM J CLIN NUTR, V87, P1785, DOI 10.1093/ajcn/87.6.1785
   Singhal A, 2010, PEDIATRICS, V126, pE946, DOI 10.1542/peds.2009-2609
   Sun J, 2023, REDOX BIOL, V59, DOI 10.1016/j.redox.2022.102565
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Ticinesi A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121303
   Tran L, 2014, NEUROGASTROENT MOTIL, V26, P410, DOI 10.1111/nmo.12290
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Walker EM, 2019, GEROSCIENCE, V41, P739, DOI 10.1007/s11357-019-00099-7
   Yamauchi K, 2002, J APPL PHYSIOL, V93, P161, DOI 10.1152/japplphysiol.01084.2001
   Youngman MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002082
   Zhao Y, 2023, NAT REV IMMUNOL, V23, P75, DOI 10.1038/s41577-022-00751-y
   Zhu N, 2023, MOLECULES, V28, DOI 10.3390/molecules28031226
   Zhu N, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093279
NR 48
TC 1
Z9 1
U1 6
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAY 29
PY 2023
VL 15
IS 11
AR 2533
DI 10.3390/nu15112533
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA I9ZQ4
UT WOS:001006294900001
PM 37299496
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ma, MY
   Wei, N
   Yang, JR
   Ding, TT
   Song, AP
   Chen, LR
   Zheng, SG
   Jin, HH
AF Ma, Mingyue
   Wei, Na
   Yang, Jieren
   Ding, Tingting
   Song, Anping
   Chen, Lerong
   Zheng, Shuguo
   Jin, Huanhuan
TI Schisandrin B promotes senescence of activated hepatic stellate cell via
   NCOA4-mediated ferritinophagy
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article
DE Cellular senescence; nuclear receptor coactivator 4; hepatic fibrosis
ID LIVER FIBROSIS; OXIDATIVE STRESS; IRON HOMEOSTASIS; FERROPTOSIS;
   MECHANISMS
AB Context Schisandrin B (Sch B), an active ingredient from Schisandrae chinensis (Turcz.) Baill. (Schisandraceae) Fructus, possesses diverse pharmacological activities including antitumor, anti-inflammation, and hepatoprotection. Objective To explore the effect of Sch B on activated HSCs senescence in hepatic fibrosis and the mechanisms implicated. Materials and methods ICR mice with CCl4-induced hepatic fibrosis were supplemented with Sch B (40 mg/kg) for 30 d and LX2 cells were treated with Sch B (5, 10 and 20 mu M) for 24 h. Cellular senescence was assessed by senescence-related indicators senescence-associated beta-galactosidase (SA-beta-gal) activity and the expression of p16, p21, p53, gamma-H2AX, H3K9me3, TERT, TRF1, and TRF2. Ferric ammonium citrate (FAC) and NCOA4 siRNA were used to evaluate the mechanisms underlying Sch B's regulation of cellular senescence. Results Sch B (40 mg/kg) reduced serum levels of AST and ALT (53.2% and 63.6%), alleviated hepatic collagen deposition, and promoted activated HSCs senescence in mice. Treatment with Sch B (20 mu M) decreased cell viability to 80.38 +/- 4.87% and elevated SA-beta-gal activity, with the levels of p16, p21 and p53 increased by 4.5-, 2.9-, and 3.5-fold and the levels of TERT, TRF1 and TRF2 decreased by 2.4-, 2.7-, and 2.6-fold in LX2 cells. FAC (400 mu M) enhanced Sch B's effect mentioned above. NCOA4 siRNA weakened the effects of Sch B on iron deposition and HSCs senescence. Conclusions Sch B could ameliorate hepatic fibrosis through the promotion of activated HSCs senescence, which might be attributed to its induction of NCOA4-mediated ferritinophagy and subsequent iron overload.
C1 [Ma, Mingyue; Wei, Na; Yang, Jieren; Ding, Tingting; Song, Anping; Chen, Lerong; Zheng, Shuguo; Jin, Huanhuan] Wannan Med Coll, Sch Pharm, Dept Pharmacol, 22 Wenchang West Rd, Wuhu, Anhui, Peoples R China.
   [Zheng, Shuguo; Jin, Huanhuan] Wannan Med Coll, Sch Pharm, Lab Pharmacol Chinese Med, Wuhu, Anhui, Peoples R China.
C3 Wannan Medical College; Wannan Medical College
RP Zheng, SG; Jin, HH (corresponding author), Wannan Med Coll, Sch Pharm, Dept Pharmacol, 22 Wenchang West Rd, Wuhu, Anhui, Peoples R China.
EM zhengsg2000@163.com; huanhuanjin@wnmc.edu.cn
OI Ma, mingyue/0000-0002-2394-1300
FU National Natural Science Foundation of China [81900531]; major Project
   of Natural Science Research Projects of Anhui Higher Education
   Institutions [2022AH040172]; National College Students Innovation and
   Entrepreneurship Training Program [202110368050]; key program of China
   Medicine Education Association for major scientific research and medical
   technology problems [2022KTZ020]
FX This study was supported by the National Natural Science Foundation of
   China (81900531), the major Project of Natural Science Research Projects
   of Anhui Higher Education Institutions (2022AH040172), the National
   College Students Innovation and Entrepreneurship Training Program
   (202110368050) and the key program of China Medicine Education
   Association for major scientific research and medical technology
   problems (2022KTZ020).
CR Ameziane-El-Hassani R, 2017, METHODS MOL BIOL, V1534, P139, DOI 10.1007/978-1-4939-6670-7_13
   Azarm K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17133-4
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012
   Chen QS, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-21-4602
   Chen QS, 2017, DRUG DES DEV THER, V11, P2179, DOI 10.2147/DDDT.S137507
   Chen WJ, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11050865
   Coluzzi E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010019
   Dang Y, 2020, AGING CELL, V19, DOI 10.1111/acel.13060
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416
   Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053
   El Maï M, 2021, CANCERS, V13, DOI 10.3390/cancers13122998
   Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8
   Haase M, 2010, J AM COLL CARDIOL, V55, P2024, DOI 10.1016/j.jacc.2009.12.046
   Halcrow PW, 2021, SEMIN CANCER BIOL, V76, P74, DOI 10.1016/j.semcancer.2021.06.013
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, CELL SIGNAL, V33, P79, DOI 10.1016/j.cellsig.2017.02.006
   Kong ZY, 2019, BIOMED PHARMACOTHER, V109, P2043, DOI 10.1016/j.biopha.2018.11.030
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Leong PK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6171658
   Li N, 2020, FREE RADICAL BIO MED, V160, P303, DOI 10.1016/j.freeradbiomed.2020.08.009
   Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308
   Mangan D, 2021, AGING-US, V13, P23407, DOI 10.18632/aging.203612
   Fernández-Real JM, 2014, LANCET DIABETES ENDO, V2, P513, DOI 10.1016/S2213-8587(13)70174-8
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nakamura T, 2019, BBA-GEN SUBJECTS, V1863, P1398, DOI 10.1016/j.bbagen.2019.06.010
   Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3
   Oyama K, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0187-z
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Qi XY, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.13107
   Roy N, 2012, INT J MOL SCI, V13, P11012, DOI 10.3390/ijms130911012
   Santana-Codina N, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040114
   Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028
   Shmulevich R, 2021, ANTIOXID REDOX SIGN, V34, P324, DOI 10.1089/ars.2020.8043
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wang CQ, 2020, ARTIF CELL NANOMED B, V48, P473, DOI 10.1080/21691401.2020.1717507
   Wang LQ, 2022, NAT REV CANCER, V22, P340, DOI 10.1038/s41568-022-00450-9
   Xiu ZR, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.930958
   Yang F, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12422
   Yang K, 2022, J ETHNOPHARMACOL, V284, DOI 10.1016/j.jep.2021.114759
   Yuan P, 2021, J CELL MOL MED, V25, P7354, DOI 10.1111/jcmm.16764
   Zhang H, 2019, CHEM-BIOL INTERACT, V309, DOI 10.1016/j.cbi.2019.05.041
   Zhang MF, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111572
   Zhang Y, 2014, WORLD J GASTROENTERO, V20, P6523, DOI 10.3748/wjg.v20.i21.6523
NR 47
TC 1
Z9 1
U1 17
U2 28
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD DEC 31
PY 2023
VL 61
IS 1
BP 621
EP 629
DI 10.1080/13880209.2023.2189908
PG 9
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA C5XF8
UT WOS:000962635400001
PM 37010139
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Cabiati, M
   Salvadori, C
   Sapio, A
   Burchielli, S
   Carlucci, L
   Moscato, S
   Sabatino, L
   Caselli, C
   Mattii, L
   Del Ry, S
AF Cabiati, Manuela
   Salvadori, Costanza
   Sapio, Annalaura
   Burchielli, Silvia
   Carlucci, Lucia
   Moscato, Stefania
   Sabatino, Laura
   Caselli, Chiara
   Mattii, Letizia
   Del Ry, Silvia
TI Aging and biomarkers: Transcriptional levels evaluation of
   <i>Osteopontin</i>/<i>miRNA</i>-<i>181a</i> axis in hepatic tissue of
   rats in different age ranges
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Osteopontin; miRNA; Long non-coding RNA; Telomeres
ID GENE-EXPRESSION; RNA; SENESCENCE; LNCRNAS; BRAIN; LIVER
AB Osteopontin (OPN), a novel hepatic damage marker, as well as several non-coding RNA seem to be associated with liver aging, a little studied and not yet defined process. The aim of the study was to evaluate the expression variations of OPN and miRNA-181a, the transcriptional profiling of long non coding (lnc) RNA GAS-5/miRNA-222 axis and lncRNA NEAT-1 in liver tissue of rats. In addition, to monitor the senescence process, the telomere shortening and TERT/TERC gene expression were also measured.
   Three groups of male Wistar rats were studied: A (n = 6, young); B (n = 13, adult); C (n = 10, old). Total RNA, including miRNAs, was extracted from liver and analysed by Real-Time PCR. Ultrasound and biochemical evaluation were performed in all rats as well as the histological analysis.
   OPN mRNA resulted lower in C with respect to A and B while miRNA-181a expression was significantly increased as a function of age. An increasing of both NEAT-1 and miRNA-222 expression as a function of age in parallel with a decreasing of GAS-5 expression in young and old rats, but not in the adults, was observed. A positive correlation was detected between miRNA-181a and miRNA-222. The hepatic ultrasound analysis revealed areas of hyperechogenicity distributed as a function of age. A significant telomere shortening was measured as a function of age while the two subunits TERT and TERC expressions showed an opposite trend.
   This work could provide a valid starting point to better understand the physiopathological changes during aging, pinpointing in the OPN/miRNA-181a axis significant predictors of successful aging.
C1 [Cabiati, Manuela; Salvadori, Costanza; Sapio, Annalaura; Sabatino, Laura; Caselli, Chiara; Del Ry, Silvia] CNR, Lab Biochem & Mol Biol, Inst Clin Physiol, Pisa, Italy.
   [Burchielli, Silvia] G Monasterio Fdn, Pisa, Italy.
   [Carlucci, Lucia; Del Ry, Silvia] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.
   [Moscato, Stefania; Mattii, Letizia] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.
   [Moscato, Stefania; Mattii, Letizia] Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica
   (IFC-CNR); Scuola Superiore Sant'Anna; University of Pisa; University of
   Pisa
RP Del Ry, S (corresponding author), CNR, Inst Clin Physiol, Via Giuseppe Moruzzi 1, I-56124 Pisa, Italy.
EM delry@ifc.cnr.it
RI Sabatino, Laura/AAX-8985-2020; Mattii, Letizia/AAZ-4735-2021; Caselli,
   Chiara/I-7922-2014; Del Ry, Silvia/C-1149-2015; MATTII,
   LETIZIA/B-6123-2018; Cabiati, Manuela/K-1306-2014; MOSCATO,
   STEFANIA/B-6151-2018
OI Sabatino, Laura/0000-0002-9283-5042; Caselli,
   Chiara/0000-0001-6705-2460; Del Ry, Silvia/0000-0001-7163-245X; MATTII,
   LETIZIA/0000-0001-6835-7987; Cabiati, Manuela/0000-0002-0811-6257;
   MOSCATO, STEFANIA/0000-0001-9283-6902
CR Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115
   Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011
   Arranz L, 2010, AGE, V32, P451, DOI 10.1007/s11357-010-9151-y
   Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Chen LC, 1996, INFECT IMMUN, V64, P4288, DOI 10.1128/IAI.64.10.4288-4298.1996
   Dimitrijevic M, 2013, EXP GERONTOL, V48, P1243, DOI 10.1016/j.exger.2013.07.001
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Giaimo S, 2012, AGING CELL, V11, P378, DOI 10.1111/j.1474-9726.2012.00807.x
   Gombar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-353
   Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710
   Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018
   Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102
   Li XD, 2016, PEERJ, V4, DOI 10.7717/peerj.2058
   Lio D, 2002, GENES IMMUN, V3, P30, DOI 10.1038/sj.gene.6363827
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   Martin JE, 2007, J PATHOL, V211, P111, DOI 10.1002/path.2122
   Martino A, 2011, J BIOTECHNOL, V153, P92, DOI 10.1016/j.jbiotec.2011.04.002
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646
   Muller Ludmila, 2019, Subcell Biochem, V91, P21, DOI 10.1007/978-981-13-3681-2_2
   Oh BK, 2004, EXP CELL RES, V298, P445, DOI 10.1016/j.yexcr.2004.04.032
   Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   Phillips PM, 2010, J AM ASSOC LAB ANIM, V49, P792
   Rippo MR, 2014, EXP GERONTOL, V56, P154, DOI 10.1016/j.exger.2014.03.002
   Sabatino L, 2013, ENVIRON MOL MUTAGEN, V54, P299, DOI 10.1002/em.21783
   Sanchis-Gomar F, 2016, CLIN CHEM LAB MED, V54, P873, DOI 10.1515/cclm-2015-0821
   Serna E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00961
   Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776
   Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1
   Yu FJ, 2015, J BIOL CHEM, V290, P28286, DOI 10.1074/jbc.M115.683813
NR 39
TC 10
Z9 10
U1 0
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2020
VL 133
AR 110879
DI 10.1016/j.exger.2020.110879
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KS3MM
UT WOS:000518215600005
PM 32061643
DA 2024-02-19
ER

PT J
AU Mohamad, M
   Mitchell, SJ
   Wu, LE
   White, MY
   Cordwell, SJ
   Mach, J
   Solon-Biet, SM
   Boyer, D
   Nines, D
   Das, A
   Li, SYC
   Warren, A
   Hilmer, SN
   Fraser, R
   Sinclair, DA
   Simpson, SJ
   de Cabo, R
   Le Couteur, DG
   Cogger, VC
AF Mohamad, Mashani
   Mitchell, Sarah Jayne
   Wu, Lindsay Edward
   White, Melanie Yvonne
   Cordwell, Stuart James
   Mach, John
   Solon-Biet, Samantha Marie
   Boyer, Dawn
   Nines, Dawn
   Das, Abhirup
   Li, Shi-Yun Catherine
   Warren, Alessandra
   Hilmer, Sarah Nicole
   Fraser, Robin
   Sinclair, David Andrew
   Simpson, Stephen James
   de Cabo, Rafael
   Le Couteur, David George
   Cogger, Victoria Carroll
TI Ultrastructure of the liver microcirculation influences hepatic and
   systemic insulin activity and provides a mechanism for age-related
   insulin resistance
SO AGING CELL
LA English
DT Article
DE ageing; aging; fenestrations; fenestrae; endothelium; hyperinsulinemia
ID SINUSOIDAL ENDOTHELIUM; ADIPOSE-TISSUE; POLOXAMER 407; FATTY LIVER;
   OLD-AGE; METABOLISM; SIEVE; MODEL; ATHEROSCLEROSIS; HYPERLIPIDEMIA
AB While age-related insulin resistance and hyperinsulinemia are usually considered to be secondary to changes in muscle, the liver also plays a key role in whole-body insulin handling and its role in age-related changes in insulin homeostasis is largely unknown. Here, we show that patent pores called 'fenestrations' are essential for insulin transfer across the liver sinusoidal endothelium and that age-related loss of fenestrations causes an impaired insulin clearance and hyperinsulinemia, induces hepatic insulin resistance, impairs hepatic insulin signaling, and deranges glucose homeostasis. To further define the role of fenestrations in hepatic insulin signaling without any of the long-term adaptive responses that occur with aging, we induced acute defenestration using poloxamer 407 (P407), and this replicated many of the age-related changes in hepatic glucose and insulin handling. Loss of fenestrations in the liver sinusoidal endothelium is a hallmark of aging that has previously been shown to cause deficits in hepatic drug and lipoprotein metabolism and now insulin. Liver defenestration thus provides a new mechanism that potentially contributes to age-related insulin resistance.
C1 [Mohamad, Mashani; Solon-Biet, Samantha Marie; Warren, Alessandra; Le Couteur, David George; Cogger, Victoria Carroll] Univ Sydney, Ageing & Alzheimers Inst, Ctr Educ & Res Ageing, Sydney, NSW, Australia.
   [Mohamad, Mashani; Solon-Biet, Samantha Marie; Warren, Alessandra; Le Couteur, David George] Concord Hosp, Sydney, NSW, Australia.
   [Mohamad, Mashani; Solon-Biet, Samantha Marie; Warren, Alessandra; Le Couteur, David George; Cogger, Victoria Carroll] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia.
   [Mohamad, Mashani] Univ Teknol MARA, Fac Pharm, Selangor, Malaysia.
   [Mitchell, Sarah Jayne; Boyer, Dawn; Nines, Dawn; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Wu, Lindsay Edward; Das, Abhirup; Li, Shi-Yun Catherine; Sinclair, David Andrew] Univ New South Wales, Sch Med Sci, Lab Ageing Res, Sydney, NSW, Australia.
   [White, Melanie Yvonne; Cordwell, Stuart James; Solon-Biet, Samantha Marie; Simpson, Stephen James; Le Couteur, David George; Cogger, Victoria Carroll] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.
   [Mach, John; Hilmer, Sarah Nicole] Royal North Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia.
   [Mach, John; Hilmer, Sarah Nicole] Univ Sydney, Sydney, NSW, Australia.
   [Fraser, Robin] Univ Otago, Dept Pathol, Christchurch, New Zealand.
   [Sinclair, David Andrew] Harvard Med Sch, Dept Genet, Boston, MA USA.
C3 University of Sydney; Concord Repatriation General Hospital; University
   of Sydney; ANZAC Research Institute; Universiti Teknologi MARA; National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA);
   University of New South Wales Sydney; University of Sydney; University
   of Sydney; Kolling Institute of Medical Research; Royal North Shore
   Hospital; University of Sydney; University of Otago; Harvard University;
   Harvard Medical School
RP Cogger, VC (corresponding author), Concord Hosp, ANZAC Res Inst, Gate 3,Hosp Rd, Sydney, NSW 2139, Australia.
EM victoria.cogger@sydney.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; de Cabo, Rafael
   Carlos/E-7996-2010; Wu, Lindsay/AAA-1486-2021; wang, jie/HTQ-4920-2023;
   Das, Abhirup/AAF-5129-2019; Wu, Lindsay/GQI-1179-2022; Hilmer,
   Sarah/AAW-8554-2020; de Cabo, Rafael/J-5230-2016; Solon-Biet,
   Samantha/R-6551-2017
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; Wu,
   Lindsay/0000-0002-1599-7574; Wu, Lindsay/0000-0002-1599-7574; Hilmer,
   Sarah/0000-0002-5970-1501; Simpson, Stephen J./0000-0003-0256-7687;
   White, Melanie/0000-0003-2571-2816; Le Couteur,
   David/0000-0002-4227-5817; de Cabo, Rafael/0000-0002-3354-2442;
   Cordwell, Stuart/0000-0002-0995-0171; Solon-Biet,
   Samantha/0000-0003-0608-958X; Das, Abhirup/0000-0003-1866-457X
FU Ageing and Alzheimer's Research Foundation; National Institute on Aging,
   National Institutes of Health
FX We acknowledge the financial support from the Ageing and Alzheimer's
   Research Foundation. This study was funded in part by the National
   Institute on Aging, National Institutes of Health, and facilitated by
   the Sydney Mass Spectrometry Core Facility (MSCF).
CR Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Bose SK, 2014, WORLD J DIABETES, V5, P52, DOI 10.4239/wjd.v5.i1.52
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Chai SY, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-7
   Cogger VC, 2009, LIVER BIOL PATHOBIOL, P387
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082
   Engholm-Keller K, 2012, J PROTEOMICS, V75, P5749, DOI 10.1016/j.jprot.2012.08.007
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Fraser R, 2012, PATHOLOGY, V44, P181, DOI 10.1097/PAT.0b013e328351bcc8
   Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003
   Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108
   GAHRTON G, 1964, EXP CELL RES, V34, P488, DOI 10.1016/0014-4827(64)90234-4
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005
   IZZO JL, 1969, ARCH INTERN MED, V123, P272
   Jamieson HA, 2007, DIABETOLOGIA, V50, P1969, DOI 10.1007/s00125-007-0739-4
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Johnston TP, 2004, J CARDIOVASC PHARM, V43, P595, DOI 10.1097/00005344-200404000-00016
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Kawaguchi T, 2011, WORLD J HEPATOL, V3, P99, DOI 10.4254/wjh.v3.i5.99
   Kotronen A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1709, DOI 10.1152/ajpendo.00444.2007
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Majumdar S, 2012, DIABETOLOGIA, V55, P450, DOI 10.1007/s00125-011-2343-x
   McMahon AC, 2013, ACTA DIABETOL, V50, P645, DOI 10.1007/s00592-011-0358-x
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Mitchell SJ, 2012, PHARMACOLOGY, V90, P233, DOI 10.1159/000341724
   Mitchell SJ, 2011, J PHARM SCI-US, V100, P334, DOI 10.1002/jps.22235
   MULLER MJ, 1992, GASTROENTEROLOGY, V102, P2033
   Oya J, 2014, INTERNAL MED, V53, P941, DOI 10.2169/internalmedicine.53.1580
   PHILIPPE J, 1981, J CLIN INVEST, V67, P673, DOI 10.1172/JCI110082
   Rojas JM, 2014, DIABETES OBES METAB, V16, P33, DOI 10.1111/dom.12332
   Sandqvist M, 2011, J CLIN ENDOCR METAB, V96, pE1320, DOI 10.1210/jc.2011-0233
   SODOYEZ JC, 1980, AM J PHYSIOL, V239, pE3, DOI 10.1152/ajpendo.1980.239.1.E3
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Taguchi K, 2014, J MED INVESTIG, V61, P180, DOI 10.2152/jmi.61.180
   Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228
   Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1
   Warren A, 2011, TOXICOL PATHOL, V39, P390, DOI 10.1177/0192623310394212
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   XU N, 1990, J PHARMACOL EXP THER, V254, P914
NR 47
TC 50
Z9 53
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2016
VL 15
IS 4
BP 706
EP 715
DI 10.1111/acel.12481
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DW5WN
UT WOS:000383718400011
PM 27095270
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Witte, S
   Boshnakovska, A
   Öezemir, M
   Chowdhury, A
   Rehling, P
   Aich, A
AF Witte, Steffen
   Boshnakovska, Angela
   Oezemir, Metin
   Chowdhury, Arpita
   Rehling, Peter
   Aich, Abhishek
TI Defective COX1 expression in aging mice liver
SO BIOLOGY OPEN
LA English
DT Article
DE Ageing; Mitochondria; Nanopore; Transcriptomics
ID MITOCHONDRIAL-DNA MUTATIONS; POINT MUTATIONS; GENE-EXPRESSION;
   TRANSCRIPTION; BIOGENESIS; DISEASE
AB Mitochondrial defects are associated with aging processes and age-related diseases, including cardiovascular diseases, neurodegenerative diseases and cancer. In addition, some recent studies suggest mild mitochondrial dysfunctions appear to be associated with longer lifespans. In this context, liver tissue is considered to be largely resilient to aging and mitochondrial dysfunction. Yet, in recent years studies report dysregulation of mitochondrial function and nutrient sensing pathways in ageing livers. Therefore, we analyzed the effects of the aging process on mitochondrial gene expression in liver using wildtype C57BL/6N mice. In our analyses, we observed alteration in mitochondrial energy metabolism with age. To assess if defects in mitochondrial gene expression are linked to this decline, we applied a Nanopore sequencing based approach for mitochondrial transcriptomics. Our analyses show that a decrease of the Cox1 transcript correlates with reduced respiratory complex IV activity in older mice livers.
C1 [Witte, Steffen; Boshnakovska, Angela; Oezemir, Metin; Chowdhury, Arpita; Rehling, Peter; Aich, Abhishek] Univ Med Ctr, Dept Cellular Biochem, D-37073 Gottingen, Germany.
   [Rehling, Peter; Aich, Abhishek] Univ Gottingen, Cluster Excellence Multiscale Bioimaging Mol Mach, D-37075 Gottingen, Germany.
   [Rehling, Peter] Fraunhofer Inst Translat Med & Pharmacol ITMP, Translat Neuroinflammat & Automated Microscopy, D-37075 Gottingen, Germany.
   [Rehling, Peter] Max Planck Inst Multidisciplinary Sci, D-37077 Gottingen, Germany.
C3 University of Gottingen; University of Gottingen
RP Rehling, P (corresponding author), Univ Med Ctr, Dept Cellular Biochem, D-37073 Gottingen, Germany.; Rehling, P (corresponding author), Univ Gottingen, Cluster Excellence Multiscale Bioimaging Mol Mach, D-37075 Gottingen, Germany.; Rehling, P (corresponding author), Fraunhofer Inst Translat Med & Pharmacol ITMP, Translat Neuroinflammat & Automated Microscopy, D-37075 Gottingen, Germany.; Rehling, P (corresponding author), Max Planck Inst Multidisciplinary Sci, D-37077 Gottingen, Germany.
EM peter.rehling@medizin.uni-goettingen.de
RI Coady, Jordan/HZK-6210-2023
OI Boshnakovska, Angela/0009-0008-3572-0223
FU Deutsche Forschungsgemeinschaft (DFG) [Germany?s Excellence Strategy-EXC
   2067/1- 390729940]; DFG [SFB1002]; University Medical Center Go?
FX Funding P.R. and A.A. are funded by the Deutsche Forschungsgemeinschaft
   (DFG) under Germany?s Excellence Strategy-EXC 2067/1- 390729940. A.C.
   was funded by the DFG, SFB1002. Open Access funding provided by
   University Medical Center Go? ttingen: Universitatsmedizin Gottingen.
   Deposited in PMC for immediate release.
CR Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barshad G, 2018, TRENDS GENET, V34, P682, DOI 10.1016/j.tig.2018.05.009
   Basu U, 2020, J BIOL CHEM, V295, P18406, DOI 10.1074/jbc.REV120.011202
   Chen PB, 2018, LIPIDS, V53, P271, DOI 10.1002/lipd.12037
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   D'Souza AR, 2018, ESSAYS BIOCHEM, V62, P309, DOI 10.1042/EBC20170102
   Han D, 2012, J BIOL CHEM, V287, P42165, DOI 10.1074/jbc.M112.377374
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang ZQ, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00055-0
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Kauppila TES, 2018, P NATL ACAD SCI USA, V115, pE9620, DOI 10.1073/pnas.1721683115
   Kotrys AV, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010017
   Kraft F, 2019, MED GENET-BERLIN, V31, P198, DOI 10.1007/s11825-019-0249-z
   Lysek-Gladysinska M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030502
   McCoin CS, 2019, AM J PHYSIOL-ENDOC M, V317, pE298, DOI 10.1152/ajpendo.00098.2019
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199
   Perelló-Amorós M, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.678985
   Pibiri M, 2015, AGE, V37, DOI 10.1007/s11357-015-9796-7
   Player R, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6557-5
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Sugrue MM, 2001, BIOL SIGNAL RECEPT, V10, P176
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wang YH, 2021, NAT BIOTECHNOL, V39, P1348, DOI 10.1038/s41587-021-01108-x
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Wolf AM, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00479-6
   ZHANG CF, 1993, BIOCHEM BIOPH RES CO, V195, P1104, DOI 10.1006/bbrc.1993.2158
   Zhang MJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62293
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 40
TC 2
Z9 2
U1 3
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 2046-6390
J9 BIOL OPEN
JI Biol. Open
PD MAR
PY 2023
VL 12
IS 3
AR bio059844
DI 10.1242/bio.059844
PG 10
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA E1UN8
UT WOS:000973471200006
PM 36861685
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Igarashi, N
   Miyata, K
   Loo, TM
   Chiba, M
   Hanyu, A
   Nishio, M
   Kawasaki, H
   Zheng, H
   Toyokuni, S
   Kon, S
   Moriyama, K
   Fujita, Y
   Takahashi, A
AF Igarashi, Nanase
   Miyata, Kenichi
   Loo, Tze Mun
   Chiba, Masatomo
   Hanyu, Aki
   Nishio, Mika
   Kawasaki, Hiroko
   Zheng, Hao
   Toyokuni, Shinya
   Kon, Shunsuke
   Moriyama, Keiji
   Fujita, Yasuyuki
   Takahashi, Akiko
TI Hepatocyte growth factor derived from senescent cells attenuates cell
   competition-induced apical elimination of oncogenic cells
SO NATURE COMMUNICATIONS
LA English
DT Article
ID MESENCHYMAL TRANSITION; TRANSFORMED-CELLS; LIVER-CANCER; IN-VIVO; DNA;
   METASTASIS; EXTRUSION; HEALTH; MET
AB Ras mutations induce cell competition and cellular senescence to inhibit the proliferation of oncogenic mutated cells. Here the authors demonstrate that cellular senescence inhibits cell competition-induced elimination of oncogenic cells through HGF signalling.
   Cellular senescence and cell competition are important tumor suppression mechanisms that restrain cells with oncogenic mutations at the initial stage of cancer development. However, the link between cellular senescence and cell competition remains unclear. Senescent cells accumulated during the in vivo aging process contribute toward age-related cancers via the development of senescence-associated secretory phenotype (SASP). Here, we report that hepatocyte growth factor (HGF), a SASP factor, inhibits apical extrusion and promotes basal protrusion of Ras-mutated cells in the cell competition assay. Additionally, cellular senescence induced by a high-fat diet promotes the survival of cells with oncogenic mutations, whereas crizotinib, an inhibitor of HGF signaling, provokes the removal of mutated cells from mouse livers and intestines. Our study provides evidence that cellular senescence inhibits cell competition-mediated elimination of oncogenic cells through HGF signaling, suggesting that it may lead to cancer incidence during aging.
C1 [Igarashi, Nanase; Miyata, Kenichi; Loo, Tze Mun; Chiba, Masatomo; Hanyu, Aki; Nishio, Mika; Kawasaki, Hiroko; Takahashi, Akiko] Japanese Fdn Canc Res, Inst Canc, Project Cellular Senescence, Tokyo, Japan.
   [Igarashi, Nanase; Moriyama, Keiji] Tokyo Med & Dent Univ, Dept Maxillofacial Orthognath, Tokyo, Japan.
   [Miyata, Kenichi; Takahashi, Akiko] Japanese Fdn Canc Res, Canc Cell Commun Project, NEXT Ganken Program, Tokyo, Japan.
   [Zheng, Hao; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi, Japan.
   [Kon, Shunsuke] Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Chiba, Japan.
   [Fujita, Yasuyuki] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Kyoto, Japan.
   [Takahashi, Akiko] Japan Agcy Med Res & Dev AMED, Adv Res & Dev Programs Med Innovat PRIME, Tokyo, Japan.
C3 Japanese Foundation for Cancer Research; Tokyo Medical & Dental
   University (TMDU); Japanese Foundation for Cancer Research; Nagoya
   University; Tokyo University of Science; Kyoto University
RP Takahashi, A (corresponding author), Japanese Fdn Canc Res, Inst Canc, Project Cellular Senescence, Tokyo, Japan.; Takahashi, A (corresponding author), Japanese Fdn Canc Res, Canc Cell Commun Project, NEXT Ganken Program, Tokyo, Japan.; Takahashi, A (corresponding author), Japan Agcy Med Res & Dev AMED, Adv Res & Dev Programs Med Innovat PRIME, Tokyo, Japan.
EM akiko.takahashi@jfcr.or.jp
RI ; Toyokuni, Shinya/C-1358-2010; Moriyama, Keiji/AAC-3193-2019
OI Miyata, Kenichi/0000-0002-8618-3105; Toyokuni,
   Shinya/0000-0002-5757-1109; Moriyama, Keiji/0000-0003-0580-4510;
   Takahashi, Akiko/0000-0003-1904-7645
FU Japan Agency of Medical Research and Development (AMED)-PRIME
   [19gm6110023h0001]; Japan Science and Technology Agency (JST)-Moonshot
   RD [JPMJPS2022]; Japan Society for the Promotion of Science (JSPS)
   [17H05628, 19K22571]; Cell Science Research Foundation; Astellas
   Foundation for Research on Metabolic Disorders
FX We thank R.S. Nozawa for technical assistance for the confocal
   microscopy analysis and the members of Takahashi's laboratory for
   helpful discussion during the preparation of this manuscript. This work
   was supported in part by grants from Japan Agency of Medical Research
   and Development (AMED)-PRIME under grant number 19gm6110023h0001, Japan
   Science and Technology Agency (JST)-Moonshot R&D under grant number
   JPMJPS2022, Japan Society for the Promotion of Science (JSPS) under
   grant number 17H05628 and 19K22571, The Cell Science Research
   Foundation, and Astellas Foundation for Research on Metabolic Disorders.
CR Bedoui S, 2020, NAT REV MOL CELL BIO, V21, P678, DOI 10.1038/s41580-020-0270-8
   Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261
   Bowling S, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167486
   Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102
   Colom B, 2021, NATURE, V598, P510, DOI 10.1038/s41586-021-03965-7
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   DIRENZO MF, 1995, CLIN CANCER RES, V1, P147
   Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779
   Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853
   Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kon S, 2021, DEV BIOL, V476, P112, DOI 10.1016/j.ydbio.2021.03.015
   Kon S, 2017, NAT CELL BIOL, V19, P530, DOI 10.1038/ncb3509
   Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146
   Levayer R, 2016, CURR BIOL, V26, P670, DOI 10.1016/j.cub.2015.12.072
   Liu N, 2019, NATURE, V568, P344, DOI 10.1038/s41586-019-1085-7
   Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Marques-Reis M, 2021, DEV BIOL, V476, P79, DOI 10.1016/j.ydbio.2021.03.009
   Maruyama T, 2017, CURR OPIN CELL BIOL, V48, P106, DOI 10.1016/j.ceb.2017.06.007
   Matamoro-Vidal A, 2019, CURR BIOL, V29, pR762, DOI 10.1016/j.cub.2019.06.030
   Merino MM, 2015, CELL, V160, P461, DOI 10.1016/j.cell.2014.12.017
   Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017
   Miyata K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025647118
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Ohsawa S, 2018, DEV CELL, V44, P284, DOI 10.1016/j.devcel.2018.01.009
   Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433
   Sasaki A, 2018, CELL REP, V23, P974, DOI 10.1016/j.celrep.2018.03.104
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Takahashi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15287
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822
   Vaughen J, 2016, DEV CELL, V39, P683, DOI 10.1016/j.devcel.2016.11.015
   Vishwakarma M, 2020, NAT REV CANCER, V20, P187, DOI 10.1038/s41568-019-0231-8
   Wakita M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15719-6
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
NR 48
TC 10
Z9 10
U1 0
U2 16
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUL 18
PY 2022
VL 13
IS 1
AR 4157
DI 10.1038/s41467-022-31642-4
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 3A3NQ
UT WOS:000827171100008
PM 35851277
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Christensen, NM
   Ringholm, S
   Buch, BT
   Gudiksen, A
   Halling, JF
   Pilegaard, H
AF Christensen, Natascha Masselkhi
   Ringholm, Stine
   Buch, Bjorg Thiellesen
   Gudiksen, Anders
   Halling, Jens Frey
   Pilegaard, Henriette
TI Muscle PGC-1α modulates hepatic mitophagy regulation during aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Early Access
DE Liver; Metabolism; Autophagy; Parkin; Aging; PGC-1?
ID AGE-ASSOCIATED CHANGES; HUMAN SKELETAL-MUSCLE; OXIDATIVE DNA-DAMAGE;
   GENE-EXPRESSION; WHITE FAT; EXERCISE; LIVER; PROTEINS; STRESS;
   BIOGENESIS
AB Aging has been suggested to be associated with changes in oxidative capacity, autophagy, and mitophagy in the liver, but a simultaneous evaluation of these key cellular processes is lacking. Moreover, skeletal muscle tran-scriptional coactivator peroxisome proliferator-activated receptor gamma coactivator (PGC)-1 alpha has been re-ported to mediate inter-organ signaling through myokines with regulatory effects in the liver, but the potential role of muscle PGC-1 alpha on hepatic changes with age remains to be resolved. The aim of the present study was therefore to investigate 1) the effect of aging on mitochondrial autophagy and mitophagy capacity in mouse liver and 2) whether muscle PGC-1 alpha is required for maintaining autophagy and mitophagy capacity in the liver during aging. The liver was obtained from young (Young) and aged (Aged) inducible muscle-specific PGC-1 alpha knockout (iMKO) and floxed littermate control mice (Lox). Aging increased liver p62, Parkin and BCL2/adenovirus E1B 19 kDa protein-interacting protein (BNIP)3 protein with no effect of muscle specific PGC-1 alpha knockout, while liver Microtubule-associated protein 1A/1B-light chain 3(LC3) II/I was unchanged with age, but tended to be lower in iMKO mice than in controls. Markers of liver mitochondrial oxidative capacity and oxidative stress were un-changed with age and iMKO. However, Parkin protein levels in isolated liver mitochondria were 2-fold higher in Aged iMKO mice than in Aged controls. In conclusion, aging had no effect on oxidative capacity and lipid peroxidation in the liver. However, aging was associated with increased levels of autophagy and mitophagy markers. Moreover, muscle PGC-1 alpha appears to regulate hepatic mitochondrial translocation of Parkin in aged mice, suggesting that the metabolic capacity of skeletal muscle can modulate mitophagy regulation in the liver during aging.
C1 [Christensen, Natascha Masselkhi; Ringholm, Stine; Buch, Bjorg Thiellesen; Gudiksen, Anders; Halling, Jens Frey; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Univ Pk 13, DK-2100 Copenhagen, Denmark.
C3 University of Copenhagen
RP Pilegaard, H (corresponding author), Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Univ Pk 13, DK-2100 Copenhagen, Denmark.
EM hpilegaard@bio.ku.dk
RI Halling, Jens Frey/H-4700-2015
OI Halling, Jens Frey/0000-0002-8638-6746
FU Danish Council for Independent Research, Medical Sciences [4181-00078]
FX This study was funded by grants from the Danish Council for Independent
   Research, Medical Sciences (4181-00078) .
CR Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009
   Almendro V, 2008, OBESITY, V16, P285, DOI 10.1038/oby.2007.47
   Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Brandt N, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13651
   Buch BT, 2020, FASEB J, V34, P8653, DOI 10.1096/fj.201903113RR
   Carter HN, 2018, J PHYSIOL-LONDON, V596, P3567, DOI 10.1113/JP275998
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Eid N, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00100
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Gao DQ, 2004, AM J PHYSIOL-GASTR L, V287, pG1070, DOI 10.1152/ajpgi.00228.2004
   Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009
   Guo L, 2008, BASIC CLIN PHARMACOL, V103, P222, DOI 10.1111/j.1742-7843.2008.00258.x
   Haase TN, 2011, AM J PHYSIOL-REG I, V301, pR1501, DOI 10.1152/ajpregu.00775.2010
   Halling JF, 2019, AM J PHYSIOL-ENDOC M, V317, pE513, DOI 10.1152/ajpendo.00059.2019
   Halling JF, 2017, EXP GERONTOL, V96, P1, DOI 10.1016/j.exger.2017.05.020
   He W, 2015, An Aging World
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47
   Kristensen CM, 2017, EXP GERONTOL, V98, P124, DOI 10.1016/j.exger.2017.08.006
   Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007
   Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Liu WJ, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0031-z
   Liu X., 2017, Liver Pathophysiology, P391
   Lowry O.H., 1972, FLEXIBLE SYSTEM ENZY
   Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7
   Martinez E, 2017, VIRULENCE, V8, P571, DOI 10.1080/21505594.2017.1305532
   McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806
   Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003
   Santos-Alves E, 2015, LIFE SCI, V135, P124, DOI 10.1016/j.lfs.2015.06.007
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
NR 45
TC 2
Z9 2
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD 2023 FEB
PY 2023
VL 172
AR 112046
DI 10.1016/j.exger.2022.112046
EA DEC 2022
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 7T1NR
UT WOS:000911215200001
PM 36521568
OA hybrid
DA 2024-02-19
ER

PT J
AU Zhang, DG
   Jiang, MY
   Miao, DS
AF Zhang, DingGuo
   Jiang, MinYue
   Miao, DengShun
TI Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells
   Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse
SO PLOS ONE
LA English
DT Article
ID HEPATOCYTE GROWTH-FACTOR; HEPATIC-FIBROSIS; CLINICAL-TRIALS; SENESCENCE;
   DIFFERENTIATION; ASSOCIATION; ACTIVATION; EXPRESSION; MORTALITY; PROTEIN
AB Background: Human amniotic membrane-derived mesenchymal stem cells (hAMCs) have the potential to reduce heart and lung fibrosis, but whether could reduce liver fibrosis remains largely unknown.
   Methodology/Principal Findings: Hepatic cirrhosis model was established by infusion of CCl4 (1 ml/kg body weight twice a week for 8 weeks) in immunocompetent C57Bl/6J mice. hAMCs, isolated from term delivered placenta, were infused into the spleen at 4 weeks after mice were challenged with CCl4. Control mice received only saline infusion. Animals were sacrificed at 4 weeks post-transplantation. Blood analysis was performed to evaluate alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Histological analysis of the livers for fibrosis, hepatic stellate cells activation, hepatocyte apoptosis, proliferation and senescence were performed. The donor cell engraftment was assessed using immunofluorescence and polymerase chain reaction. The areas of hepatic fibrosis were reduced (6.2%+/- 2.1 vs. control 9.6%+/- 1.7, p<0.05) and liver function parameters (ALT 539.6 +/- 545.1 U/dl, AST 589.7 +/- 342.8 U/dl, vs. control ALT 139.1 +/- 138.3 U/dl, p<0.05 and AST 212.3 +/- 110.7 U/dl, p<0.01) were markedly ameliorated in the hAMCs group compared to control group. The transplantation of hAMCs into liver-fibrotic mice suppressed activation of hepatic stellate cells, decreased hepatocyte apoptosis and promoted liver regeneration. More interesting, hepatocyte senescence was depressed significantly in hAMCs group compared to control group. Immunofluorescence and polymerase chain reaction revealed that hAMCs engraftment into host livers and expressed the hepatocyte-specific markers, human albumin and alpha-fetoproteinran.
   Conclusions/Significance: The transplantation of hAMCs significantly decreased the fibrosis formation and progression of CCl4-induced cirrhosis, providing a new approach for the treatment of fibrotic liver disease.
C1 [Zhang, DingGuo; Jiang, MinYue; Miao, DengShun] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China.
C3 Nanjing Medical University
RP Zhang, DG (corresponding author), Nanjing Med Univ, Res Ctr Bone & Stem Cells, Nanjing, Peoples R China.
EM dsmiao@njmu.edu.cn
OI dingguo, zhang/0000-0003-0041-6180; Miao, Dengshun/0000-0002-2682-3502
FU National Natural Science Foundation of China [81000058, 30830103];
   Postdoctoral Science Foundation of China [20100471352]
FX This project was supported by the National Natural Science Foundation of
   China (Grant No. 81000058 to DGZ, 30830103 to DSM) and the Postdoctoral
   Science Foundation of China (Grant No. 20100471352 to DGZ). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066
   Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398
   Autiero I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006226
   Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Cai J, 2002, HEPATOLOGY, V36, P386, DOI 10.1053/jhep.2002.34614
   Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857
   Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436
   Chernykh ER, 2007, B EXP BIOL MED+, V144, P640, DOI 10.1007/s10517-007-0393-3
   Gao F, 2007, CAN J CARDIOL, V23, P891
   Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006
   Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040
   HUANG YW, 2010, HEPATOLOGY
   Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419
   Khan AA, 2010, CELL TRANSPLANT, V19, P409, DOI 10.3727/096368910X498241
   Kim H, 2009, STEM CELLS, V27, P1686, DOI 10.1002/stem.87
   Kisseleva T, 2010, CURR OPIN GASTROEN, V26, P395, DOI 10.1097/MOG.0b013e32833a6bec
   Lefkowitch JH, 2008, CURR OPIN GASTROEN, V24, P269, DOI 10.1097/MOG.0b013e3282f8e28f
   Marcus AJ, 2008, DIFFERENTIATION, V76, P130, DOI 10.1111/j.1432-0436.2007.00194.x
   Mohamadnejad M, 2007, WORLD J GASTROENTERO, V13, P3359, DOI 10.3748/wjg.v13.i24.3359
   MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8
   Moriya K, 2007, WORLD J GASTROENTERO, V13, P866, DOI 10.3748/wjg.v13.i6.866
   Morrison DS, 2006, LANCET, V367, P1899, DOI 10.1016/S0140-6736(06)68836-3
   MUHANNA N, 2010, GUT
   Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730
   Nieto N, 2005, J BIOL CHEM, V280, P30963, DOI 10.1074/jbc.M503569200
   Pai M, 2008, AM J GASTROENTEROL, V103, P1952, DOI 10.1111/j.1572-0241.2008.01993.x
   Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420
   Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274
   Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3
   SALAMA H, 2010, CELL TRANSPLANT
   Scalera F, 2009, BIOCHEM BIOPH RES CO, V390, P703, DOI 10.1016/j.bbrc.2009.10.033
   Silveira MG, 2010, HEPATOLOGY, V52, P349, DOI 10.1002/hep.23637
   Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019
   Tamagawa T, 2007, HUM CELL, V20, P77, DOI 10.1111/j.1749-0774.2007.00032.x
   Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9
   Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260
   Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593
   Vizzutti F, 2009, ANN HEPATOL, V8, P89
   Watanabe A, 2007, HEPATOLOGY, V46, p870A
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu J, 1999, Expert Opin Investig Drugs, V8, P585, DOI 10.1517/13543784.8.5.585
   Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167
   YOKOI Y, 1988, LIVER, V8, P48
   Zatonski WA, 2010, EUR ADDICT RES, V16, P193, DOI 10.1159/000317248
   Zhao P, 2005, TRANSPLANTATION, V79, P528, DOI 10.1097/01.TP.0000149503.92433.39
NR 48
TC 64
Z9 80
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 4
PY 2011
VL 6
IS 2
AR e16789
DI 10.1371/journal.pone.0016789
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 717IN
UT WOS:000287037000021
PM 21326862
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Wu, N
   Meng, FY
   Zhou, TH
   Venter, J
   Giang, TK
   Kyritsi, K
   Wu, CD
   Alvaro, D
   Onori, P
   Mancinelli, R
   Gaudio, E
   Francis, H
   Alpini, G
   Glaser, S
   Franchitto, A
AF Wu, Nan
   Meng, Fanyin
   Zhou, Tianhao
   Venter, Julie
   Giang, Thao K.
   Kyritsi, Konstantina
   Wu, Chaodong
   Alvaro, Domenico
   Onori, Paolo
   Mancinelli, Romina
   Gaudio, Eugenio
   Francis, Heather
   Alpini, Gianfranco
   Glaser, Shannon
   Franchitto, Antonio
TI The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and
   Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated
   Biliary Senescence
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID PRIMARY SCLEROSING CHOLANGITIS; FUNCTIONAL-HETEROGENEITY;
   EPITHELIAL-CELLS; CELLULAR SENESCENCE; RAT CHOLANGIOCYTES;
   GENE-EXPRESSION; MDR2(-/-) MICE; SECRETIN; PROLIFERATION; LIGATION
AB Activation of the secretin (Sct)/secretin receptor (SR) axis stimulates ductular reaction and liver fibrosis, which are hallmarks of cholangiopathies. Our aim was to define the role of Sct-regulated cellular senescence, and we demonstrated that both ductular reaction and liver fibrosis are significantly reduced in Sct(-/-), SR-/-, and Sct(-/-)/SR (-/-) bile duct ligated (BDL) mice compared with BDL wild-type mice. The reduction in hepatic fibrosis in Sct(-/-), SR-/-, and Sct(-/-)/SR (-/-) BDL mice was accompanied by reduced transforming growth factor-beta 1 levels in serum and cholangiocyte supernatant, as well as decreased expression of markers of cellular senescence in cholangiocytes in contrast to enhanced cellular senescence in hepatic stellate cells compared with BDL wild-type mice. Secretin directly stimulated the senescence of cholangiocytes and regulated, by a paracrine mechanism, the senescence of hepatic stellate cells and liver fibrosis via modulation of transforming growth factor-beta 1 biliary secretion. Targeting senescent cholangiocytes may represent a novel therapeutic approach for ameliorating hepatic fibrosis during cholestatic liver injury.
C1 [Wu, Nan; Zhou, Tianhao; Venter, Julie; Giang, Thao K.; Kyritsi, Konstantina; Francis, Heather; Alpini, Gianfranco; Glaser, Shannon] Texas A&M Univ, Coll Med, Dept Res, Dept Med Physio, Temple, TX 76508 USA.
   [Meng, Fanyin; Francis, Heather; Alpini, Gianfranco; Glaser, Shannon] Cent Texas Vet Hlth Care Syst, Temple, TX USA.
   [Meng, Fanyin; Francis, Heather; Alpini, Gianfranco; Glaser, Shannon] Baylor Scott & White Hlth Care, Baylor Scott & White Digest Dis Res Ctr, Temple, TX USA.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA.
   [Alvaro, Domenico] Sapienza, Dept Gastroenterol, Rome, Italy.
   [Onori, Paolo; Mancinelli, Romina; Gaudio, Eugenio; Franchitto, Antonio] Sapienza, Dept Anat Histol Forens Med & Orthopaed Sci, Rome, Italy.
   [Franchitto, Antonio] Sapienza, Dept Med, Rome, Italy.
   [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy.
C3 Texas A&M University System; Baylor Health Care System; Texas A&M
   University System; Texas A&M University College Station; Sapienza
   University Rome; Sapienza University Rome; Sapienza University Rome
RP Alpini, G (corresponding author), Cent Texas Vet Hlth Care Syst, Texas A&M Hlth Sci Ctr Coll Med, Olin E Teague Med Ctr, 1901 S First St,Bldg 205,1R60, Temple, TX 76504 USA.
EM galpini@medicine.tamhsc.edu
RI Onori, Paolo/J-9394-2013; ALVARO, Domenico/J-8600-2018; Zhou,
   Tianhao/AAO-3542-2021; Franchitto, Antonio/C-8095-2009; Mancinelli,
   Romina/Y-4540-2018
OI Onori, Paolo/0000-0002-7195-3760; ALVARO, Domenico/0000-0003-3771-9644;
   Zhou, Tianhao/0000-0002-5722-6954; Mancinelli,
   Romina/0000-0003-2040-0581
FU Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology from
   Scott White; Veterans Affairs (VA) Research Career Scientist Award, US
   Department of Veterans Affairs Biomedical Laboratory Research and
   Development Service VA Merit Awards [5I01BX000574, 5I01BX002192,
   1I01BX001724, 1I01BX003031]; University of Rome La Sapienza; NIH
   [DK054811, DK115184, DK076898, DK107310, DK062975, DK108959, DK095862];
   American Diabetes Association [1-17-IBS-145]; Central Texas Veterans
   Health Care System
FX Supported in part by the Dr. Nicholas C. Hightower Centennial Chair of
   Gastroenterology from Scott & White, a Veterans Affairs (VA) Research
   Career Scientist Award, US Department of Veterans Affairs Biomedical
   Laboratory Research and Development Service VA Merit Awards 5I01BX000574
   (G.A.), 5I01BX002192 (S.G.), 1I01BX001724 (F.M.), and 1I01BX003031
   (H.F.), University of Rome La Sapienza (P.O.), NIH grants DK054811
   (G.A., S.G., and F.M.), DK115184 (G.A., S.G., and F.M.), DK076898 (G.A.,
   S.G., and F.M.), DK107310 (G.A., S.G., and F.M.), DK062975 (G.A., S.G.,
   and F.M.), DK108959 (H.F.), and DK095862 (C.W.), American Diabetes
   Association grant 1-17-IBS-145 (C.W.), and the Central Texas Veterans
   Health Care System.
CR Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG289, DOI 10.1152/ajpgi.1997.272.2.G289
   Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG1064, DOI 10.1152/ajpgi.1997.272.5.G1064
   Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767
   ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   ALPINI G, 1994, AM J PHYSIOL, V266, pG922, DOI 10.1152/ajpgi.1994.266.5.G922
   Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073
   ALVARO D, 1993, J CLIN INVEST, V92, P1314, DOI 10.1172/JCI116705
   Alvaro D, 1997, AM J PHYSIOL-GASTR L, V273, pG303, DOI 10.1152/ajpgi.1997.273.2.G303
   Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023
   Braga TT, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00602
   Chen BY, 2010, J MEMBRANE BIOL, V235, P17, DOI 10.1007/s00232-010-9252-7
   Dutta AK, 2013, AM J PHYSIOL-GASTR L, V304, pG87, DOI 10.1152/ajpgi.00154.2012
   Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970
   Feng XX, 2015, CANCER SCI, V106, P559, DOI 10.1111/cas.12632
   Fiorotto R, 2011, GASTROENTEROLOGY, V141, P1498, DOI 10.1053/j.gastro.2011.06.052
   Francis H, 2007, AM J PHYSIOL-CELL PH, V293, pC1252, DOI 10.1152/ajpcell.00031.2007
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6
   Guerrier Micheleine, 2014, Hepatobiliary Surg Nutr, V3, P118, DOI 10.3978/j.issn.2304-3881.2014.04.04
   Han YY, 2013, EXP BIOL MED, V238, P549, DOI 10.1177/1535370213489926
   ISHII M, 1989, GASTROENTEROLOGY, V97, P1236, DOI 10.1016/0016-5085(89)91695-8
   Jones H, 2016, HEPATOLOGY, V64, P1202, DOI 10.1002/hep.28704
   Klein S, 2012, LAB INVEST, V92, P1440, DOI 10.1038/labinvest.2012.106
   Körner M, 2006, J HEPATOL, V45, P825, DOI 10.1016/j.jhep.2006.06.016
   Lan T, 2018, HEPATOLOGY, V68, P1070, DOI 10.1002/hep.29885
   Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006
   LeSage GD, 1999, AM J PHYSIOL-GASTR L, V276, pG1289, DOI 10.1152/ajpgi.1999.276.5.G1289
   LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Mancinelli R, 2010, AM J PATHOL, V176, P1790, DOI 10.2353/ajpath.2010.090677
   MARTINEZANSO E, 1994, HEPATOLOGY, V19, P1400, DOI 10.1016/0270-9139(94)90234-8
   McDaniel K, 2017, HEPATOLOGY, V65, P544, DOI 10.1002/hep.28831
   MCGILL JM, 1994, AM J PHYSIOL, V266, pG731, DOI 10.1152/ajpgi.1994.266.4.G731
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   Puche JE, 2013, HEPATOLOGY, V57, P340, DOI 10.1002/hep.26053
   Sato K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10694-3
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Spirlì C, 2001, GASTROENTEROLOGY, V121, P156, DOI 10.1053/gast.2001.25516
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x
   Valente R, 2016, NEW ENGL J MED, V375, P2500
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yang H, 2018, ENVIRON SCI POLLUT R, V25, P867, DOI 10.1007/s11356-017-0344-0
   Zerlanko BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035460
NR 49
TC 26
Z9 28
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD OCT
PY 2018
VL 188
IS 10
BP 2264
EP 2280
DI 10.1016/j.ajpath.2018.06.015
PG 17
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA GV8SN
UT WOS:000446415800011
PM 30036520
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Ho, TC
   Wang, EY
   Yeh, KH
   Jeng, YM
   Horng, JH
   Wu, LL
   Chen, YT
   Huang, HC
   Hsu, CL
   Chen, PJ
   Yeh, SH
   Chen, DS
AF Ho, Tung-Ching
   Wang, Er-Yea
   Yeh, Kun-Huei
   Jeng, Yung-Ming
   Horng, Jau-Hau
   Wu, Li-Ling
   Chen, Yi-Tzu
   Huang, Hsuan-Cheng
   Hsu, Chia-Lang
   Chen, Pei-Jer
   Yeh, Shiou-Hwei
   Chen, Ding-Shinn
TI Complement C1q mediates the expansion of periportal hepatic progenitor
   cells in senescence-associated inflammatory liver
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE inflammation; microenvironment; periportal; progenitor cell; liver
   cancer
ID STEM-CELLS; HEPATOCELLULAR-CARCINOMA; MATURE HEPATOCYTES; BETA-CATENIN;
   REGENERATION; DIFFERENTIATION; SURVEILLANCE; INHIBITION; MUTATIONS;
   DISTINCT
AB Most hepatocellular carcinomas (HCCs) develop in patients with chronic hepatitis, which creates a microenvironment for the growth of hepatic progenitor cells (HPCs) at the periportal area and subsequent development of HCCs. We investigated the signal from the inflammatory liver for this pathogenic process in the hepatic conditional beta-catenin knockout mouse model. Senescent beta-catenin-depleted hepatocytes in aged mice create an inflammatory microenvironment that stimulates periportal HPC expansion but arrests differentiation, which predisposes mice to the development of liver tumors. The release of complement C1q from macrophages in the inflammatory niche was identified as the unorthodox signal that activated the beta-catenin pathway in periportal HPCs and was responsible for their expansion and de-differentiation. C1q inhibitors blocked the beta-catenin pathway in both the expanding HPCs and the liver tumors but spared its orthodox pathway in pericentral normal hepatocytes. This mechanism has been validated in human liver specimens from patients with chronic hepatitis. Taken together, these results demonstrate that C1q-mediated activation of beta-catenin pathway in periportal HPCs is a previously unrecognized mechanism for replenishing hepatocytes in the inflammatory liver and, if unchecked, for promoting hepatocarcinogenesis. C1q may become a new target for blocking carcinogenesis in patients with chronic hepatitis.
C1 [Ho, Tung-Ching; Wang, Er-Yea; Horng, Jau-Hau; Chen, Yi-Tzu; Yeh, Shiou-Hwei] Natl Taiwan Univ, Dept & Grad Inst Med Microbiol, Taipei 100, Taiwan.
   [Yeh, Kun-Huei; Hsu, Chia-Lang] Natl Taiwan Univ, Grad Inst Clin Oncol, Taipei 100, Taiwan.
   [Jeng, Yung-Ming] Natl Taiwan Univ, Grad Inst Pathol, Taipei 100, Taiwan.
   [Wu, Li-Ling] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan.
   [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.
   [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan.
   [Chen, Pei-Jer; Yeh, Shiou-Hwei] Natl Taiwan Univ, Ctr Genom Med, Taipei 100, Taiwan.
   [Chen, Pei-Jer; Chen, Ding-Shinn] Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei 100, Taiwan.
   [Chen, Pei-Jer; Yeh, Shiou-Hwei; Chen, Ding-Shinn] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan.
   [Chen, Pei-Jer; Chen, Ding-Shinn] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.
   [Yeh, Shiou-Hwei] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan.
   [Chen, Ding-Shinn] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.
C3 National Taiwan University; National Taiwan University; National Taiwan
   University; National Yang Ming Chiao Tung University; National Yang Ming
   Chiao Tung University; National Yang Ming Chiao Tung University;
   National Taiwan University; National Taiwan University; National Taiwan
   University Hospital; National Taiwan University; National Taiwan
   University; National Taiwan University Hospital; National Taiwan
   University; National Taiwan University Hospital; Academia Sinica -
   Taiwan
RP Yeh, SH (corresponding author), Natl Taiwan Univ, Dept & Grad Inst Med Microbiol, Taipei 100, Taiwan.; Yeh, SH (corresponding author), Natl Taiwan Univ, Ctr Genom Med, Taipei 100, Taiwan.; Chen, DS (corresponding author), Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei 100, Taiwan.; Yeh, SH; Chen, DS (corresponding author), Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan.; Chen, DS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.; Chen, DS (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.
EM shyeh@ntu.edu.tw; chends@ntu.edu.tw
RI Chen, Yi Tzu/JAX-8015-2023; Wu, Li-Ling/ADT-8124-2022; Huang,
   Hsuan-Cheng/C-7266-2011; Yeh, Kun-Huei/HGD-3316-2022; Hsu,
   Chia-Lang/O-1458-2013
OI Wu, Li-Ling/0000-0002-2293-6999; Hsu, Chia-Lang/0000-0002-7447-8045;
   Chen, Pei-Jer/0000-0001-8316-3785; YEH, Kun-Huei/0000-0002-7306-174X;
   Ho, Tung-Ching/0000-0002-9662-7363
FU Ministry of Science and Technology, Taiwan [MOST104-2314-B-002-023-MY3,
   MOST107-2321-B-001-025, MOST108-3017-F-002-004,
   MOST108-2314-B-002-141-MY3]; National Taiwan University [NTU103C101-12];
   Center of Precision Medicine from The Featured Areas Research Center
   Program within the Ministry of Education in Taiwan
FX We thank the Taiwan Liver Cancer Network for providing samples and
   related data (all anonymous) for our research. We also thank the staff
   of the imaging core at the First Core Labs, National Taiwan University
   College of Medicine for technical assistance, and the Laboratory Animal
   Center, National Taiwan University College of Medicine for technical
   support in pathological analysis. We would like to acknowledge the
   service provided by the Flow Cytometric Analyzing and Sorting Core of
   the First Core Laboratory, National Taiwan University College of
   Medicine. This study was financially supported by grants from the
   Ministry of Science and Technology, Taiwan (MOST104-2314-B-002-023-MY3,
   MOST107-2321-B-001-025, MOST108-3017-F-002-004, and
   MOST108-2314-B-002-141-MY3), the National Taiwan University
   (NTU103C101-12) and the Center of Precision Medicine from The Featured
   Areas Research Center Program within the framework of the Higher
   Education Sprout Project of the Ministry of Education in Taiwan.
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Beinrohr L, 2008, TRENDS MOL MED, V14, P511, DOI 10.1016/j.molmed.2008.09.009
   Bohne F, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008793
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046
   Ceulemans A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.543
   Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300
   He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031
   Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Khurana S, 2008, AM J PATHOL, V173, P1818, DOI 10.2353/ajpath.2008.080411
   Kitade M, 2016, HEPATOL RES, V46, P1187, DOI 10.1111/hepr.12682
   Krishnamurthy N, 2018, CANCER TREAT REV, V62, P50, DOI 10.1016/j.ctrv.2017.11.002
   Leonardi GC, 2012, INT J ONCOL, V40, P1733, DOI 10.3892/ijo.2012.1408
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047
   Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010
   Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369
   Ortica S, 2014, FASEB J, V28, P603, DOI 10.1096/fj.13-235903
   Park ES, 2013, HEPATOLOGY, V58, P762, DOI 10.1002/hep.26379
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Roos A, 2001, J IMMUNOL, V167, P7052, DOI 10.4049/jimmunol.167.12.7052
   Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558
   Russell JO, 2019, HEPATOLOGY, V69, P742, DOI 10.1002/hep.30270
   Sjöberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003
   Spirig R, 2008, MOL IMMUNOL, V45, P4084, DOI 10.1016/j.molimm.2008.07.024
   Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2
   Tornesello ML, 2013, GENOMICS, V102, P74, DOI 10.1016/j.ygeno.2013.04.001
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Wang C, 2012, HEPATOLOGY, V55, P108, DOI 10.1002/hep.24675
   Wang EY, 2011, P NATL ACAD SCI USA, V108, P18384, DOI 10.1073/pnas.1116386108
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089
   Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   Yeoh GCT, 2007, HEPATOLOGY, V45, P486, DOI 10.1002/hep.21535
   Zhou WC, 2017, LIVER INT, V37, P1632, DOI 10.1111/liv.13427
NR 42
TC 9
Z9 12
U1 3
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 24
PY 2020
VL 117
IS 12
BP 6717
EP 6725
DI 10.1073/pnas.1918028117
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KX4AI
UT WOS:000521821800058
PM 32139604
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Fernández-García, C
   Rancan, L
   Paredes, SD
   Montero, C
   de la Fuente, M
   Vara, E
   Tresguerres, JAF
AF Fernandez-Garcia, Cristina
   Rancan, Lisa
   Paredes, Sergio D.
   Montero, Cesar
   de la Fuente, Monica
   Vara, Elena
   Tresguerres, Jesus A. F.
TI Xanthohumol exerts protective effects in liver alterations associated
   with aging
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Liver; Aging; Inflammation; Senescence-accelerated mouse; Xanthohumol
ID HUMULUS-LUPULUS L.; TNF-ALPHA; AGE; BRAIN; SENESCENCE; APOPTOSIS;
   MELATONIN; RESPONSES; TISSUES; INJURY
AB Background and aimsAging is associated with a deregulation of biological systems that lead to an increase in oxidative stress, inflammation, and apoptosis, among other effects. Xanthohumol is the main preylated chalcone present in hops (Humulus lupulus L.) whose antioxidant, anti-inflammatory and chemopreventive properties have been shown in recent years. In the present study, the possible protective effects of xanthohumol on liver alterations associated with aging were evaluated.MethodsMale young and old senescence-accelerated prone mice (SAMP8), aged 2 and 10 months, respectively, were divided into four groups: non-treated young, non-treated old, old treated with 1mg/kg/day xanthohumol, and old treated with 5mg/kg/day xanthohumol. Male senescence-accelerated resistant mice (SAMR1) were used as controls. After 30 days of treatment, animals were sacrificed and livers were collected. mRNA (AIF, BAD, BAX, Bcl-2, eNOS, HO-1, IL-1, NF-B2, PCNA, sirtuin 1 and TNF-) and protein expressions (BAD, BAX, AIF, caspase-3, Blc-2, eNOS, iNOS, TNF-, IL1, NF-B2, and IL10) were measured by RT-PCR and Western blotting, respectively. Mean values were analyzed using ANOVA.ResultsA significant increase in mRNA and protein levels of oxidative stress, pro-inflammatory and proliferative markers, as well as pro-apoptotic parameters was shown in old non-treated SAMP8 mice compared to the young SAMP8group and SAMR1 mice. In general, age-related oxidative stress, inflammation and apoptosis were significantly decreased (p<0.05) after XN treatment. In most cases, this effect was dose-dependent.ConclusionsXN was shown to modulate inflammation, apoptosis, and oxidative stress in aged livers, exerting a protective effect in hepatic alterations.
C1 [Fernandez-Garcia, Cristina; Rancan, Lisa; Montero, Cesar; Vara, Elena] Univ Complutense Madrid, Sch Med, Dept Biochem & Mol Biol, Avda Complutense S-N, E-28040 Madrid, Spain.
   [Paredes, Sergio D.; Tresguerres, Jesus A. F.] Univ Complutense Madrid, Sch Med, Dept Physiol, Avda Complutense S-N, E-28040 Madrid, Spain.
   [de la Fuente, Monica] Univ Complutense Madrid, Dept Physiol Genet & Microbiol, Sch Biol, C Jose Antonio Novais 12, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid;
   Complutense University of Madrid
RP Rancan, L (corresponding author), Univ Complutense Madrid, Sch Med, Dept Biochem & Mol Biol, Avda Complutense S-N, E-28040 Madrid, Spain.
EM lisaranc@ucm.es
RI Paredes, Sergio D./P-5146-2019; Paredes, Sergio D./HKV-1195-2023; DE LA
   FUENTE, MONICA/ABG-6991-2020; Rancan, Lisa/G-8938-2017
OI Paredes, Sergio D./0000-0002-4646-4199; Paredes, Sergio
   D./0000-0002-4646-4199; Rancan, Lisa/0000-0003-1556-192X
FU Red de Fragilidad y Envejecimiento RETICEF [RD12/0043/0032]; GRUPOS
   UCM-BSCH [GR35/10-A]
FX This study was supported by Grants from Red de Fragilidad y
   Envejecimiento RETICEF (RD12/0043/0032) and GRUPOS UCM-BSCH (GR35/10-A).
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Cau SBA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00218
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2
   García-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3
   Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008
   Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886
   Lee IS, 2011, NEUROCHEM INT, V58, P153, DOI 10.1016/j.neuint.2010.11.008
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu B., 2012, Adv Biosci Biotechnol, V3, P705, DOI [10.4236/abb.2012.326091, DOI 10.4236/ABB.2012.326091]
   Meador BM, 2008, J APPL PHYSIOL, V104, P991, DOI 10.1152/japplphysiol.01079.2007
   MONTOLIU C, 1994, J NEUROCHEM, V63, P1855
   Paredes SD, 2015, BIORESEARCH OPEN ACC, V4, P407, DOI 10.1089/biores.2015.0032
   Paredes SD, 2014, HORM MOL BIOL CLIN I, V18, P79, DOI 10.1515/hmbci-2014-0016
   Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397
   Peluso I, 2013, MOL NUTR FOOD RES, V57, P784, DOI 10.1002/mnfr.201200721
   Pinto C, 2014, TOXICOL REP, V1, P726, DOI 10.1016/j.toxrep.2014.09.004
   Preedy V, 2014, OXIDATIVE STRESS FRA
   Puig A, 2016, EXP GERONTOL, V75, P1, DOI 10.1016/j.exger.2015.11.021
   Rancán L, 2017, J NUTR BIOCHEM, V49, P133, DOI [10.1016/j.jnutbio.2017.07.011, 10.]
   Sanz Alberto, 2008, Curr Aging Sci, V1, P10
   Schipper HM, 2000, EXP GERONTOL, V35, P821, DOI 10.1016/S0531-5565(00)00148-0
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tresguerres Jesus A F, 2012, Curr Aging Sci, V5, P242
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   Vanhoecke B, 2005, INT J CANCER, V117, P889, DOI 10.1002/ijc.21249
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   Zhang B, 2015, FREE RADICAL BIO MED, V89, P486, DOI 10.1016/j.freeradbiomed.2015.09.021
NR 33
TC 19
Z9 21
U1 0
U2 22
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD MAR
PY 2019
VL 58
IS 2
BP 653
EP 663
DI 10.1007/s00394-018-1657-6
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HR1XO
UT WOS:000462929800015
PM 29536163
DA 2024-02-19
ER

PT J
AU Li, CM
   Parkhouse, WS
AF Li, CM
   Parkhouse, WS
TI Effects of aging on hepatic IGF-I signaling
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE receptors; IRS-1; ERK; PKB; transcription factors
ID GROWTH-FACTOR-I; PROTEIN-SYNTHESIS; RECEPTOR GENE; RAT LIVER; INSULIN;
   BINDING; PHOSPHORYLATION; HEPATOCYTES; AGE; ACTIVATION
AB Little is known regarding hepatic insulin-like growth factor-1 IGF-I signaling with aging despite the observation that other tissues demonstrate resistance to IGF-I with aging and declines in liver mass accompany aging. Our aim was to determine if the IGF-I-induced signaling process changes with aging. Young (5 months) and old (24 months) C57BL/6 mice hepatic tissues and blood samples were taken 20 min after an intraperitoneal injection of desIGF-I. Age had no significant effect on plasma glucose, insulin and total IGF-I levels. IRS-1 protein was significantly decreased (33%) with aging. Basal phosphorylation of IRS-1, PKB and ERK were unaffected whereas basal phosphorylation of CREB and FKHR were significantly increased (37 and 33%, respectively) with aging. desIGF-I caused a significant decrease in plasma glucose concentrations in both young (53%) and old (44%) mice. desIGF-I administration significantly increased the phosphorylation of IRS-1 in both Young (104%) and old (89%) hepatic tissues. Similarly, the phosphorylation of PKB was dramatically enhanced in both young (527%) and old (350%) hepatic tissues after desIGF-I stimulation. By contrast, desIGF-I administration had no significant effects on the phosphorylation of ERK and phosphorylation of transcription factors CRFB and FKHR in both young and old hepatic tissues. These data suggest that aging dose not impair IGF-I signaling in hepatic tissues. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Simon Fraser Univ, Sch Kinesiol, Metab Biochem Lab, Burnaby, BC V5A 1S6, Canada.
C3 Simon Fraser University
RP Parkhouse, WS (corresponding author), Simon Fraser Univ, Sch Kinesiol, Metab Biochem Lab, Burnaby, BC V5A 1S6, Canada.
CR BAXTER RC, 1978, METABOLISM, V27, P503, DOI 10.1016/0026-0495(78)90014-8
   CARO JF, 1988, J CLIN INVEST, V81, P976, DOI 10.1172/JCI113451
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Ceda GP, 1998, J CLIN ENDOCR METAB, V83, P499, DOI 10.1210/jc.83.2.499
   COLA GD, 1997, J CLIN INVEST, V99, P2538
   Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X
   FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443
   Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184
   Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125
   KOCH KS, 1982, BIOCHEM BIOPH RES CO, V109, P1054, DOI 10.1016/0006-291X(82)92046-0
   LEFFERT HL, 1977, GROWTH NUTRITION MET, V3, P225
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Park BC, 1999, BIOCHEMISTRY-US, V38, P7517, DOI 10.1021/bi9830718
   POEHLMAN ET, 1990, J CLIN ENDOCR METAB, V71, P1468, DOI 10.1210/jcem-71-6-1468
   Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761
   Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491
   SANTOS A, 1994, MOL CELL ENDOCRINOL, V101, P85, DOI 10.1016/0303-7207(94)90222-4
   SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591
   Severgnini S, 1999, J GERONTOL A-BIOL, V54, pB111, DOI 10.1093/gerona/54.3.B111
   Sjögren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088
   SONNTAG WE, 1992, J GERONTOL, V47, pB159, DOI 10.1093/geronj/47.5.B159
   Sugimoto T, 1998, EUR J ENDOCRINOL, V138, P633, DOI 10.1530/eje.0.1380633
   Timiras PS, 1994, PHYSL BASIS AGING GE, P247
   TOMAS FM, 1992, BIOCHEM J, V282, P91, DOI 10.1042/bj2820091
   VENKATESAN N, 1990, AM J PHYSIOL, V258, pE329, DOI 10.1152/ajpendo.1990.258.2.E329
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451
   Willis PE, 1997, AM J PHYSIOL-ENDOC M, V272, pE397, DOI 10.1152/ajpendo.1997.272.3.E397
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yau L, 1999, EUR J BIOCHEM, V266, P1147, DOI 10.1046/j.1432-1327.1999.00968.x
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 31
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR 31
PY 2002
VL 123
IS 6
BP 603
EP 612
AR PII S0047-6374(01)00408-0
DI 10.1016/S0047-6374(01)00408-0
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 580MJ
UT WOS:000177238100006
PM 11850024
DA 2024-02-19
ER

PT J
AU Eggert, T
   Wolter, K
   Ji, JL
   Ma, C
   Yevsa, T
   Klotz, S
   Medina-Echeverz, J
   Longerich, T
   Forgues, M
   Reisinger, F
   Heikenwalder, M
   Wang, XW
   Zender, L
   Greten, TF
AF Eggert, Tobias
   Wolter, Katharina
   Ji, Juling
   Ma, Chi
   Yevsa, Tetyana
   Klotz, Sabrina
   Medina-Echeverz, Jose
   Longerich, Thomas
   Forgues, Marshonna
   Reisinger, Florian
   Heikenwalder, Mathias
   Wang, Xin Wei
   Zender, Lars
   Greten, Tim F.
TI Distinct Functions of Senescence-Associated Immune Responses in Liver
   Tumor Surveillance and Tumor Progression
SO CANCER CELL
LA English
DT Article
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; HEPATOCELLULAR-CARCINOMA;
   SUPPRESSOR-CELLS; NK CELLS; CANCER; CHEMOTHERAPY
AB Oncogene-induced senescence causes hepatocytes to secrete cytokines, which induce their immune-mediated clearance to prevent tumor initiation, a process termed "senescence surveillance." However, senescent hepatocytes give rise to hepatocellular carcinomas (HCCs), if the senescence program is bypassed or if senescent cells are not cleared. Here, we show context-specific roles for CCR2(+) myeloid cells in liver cancer. Senescence surveillance requires the recruitment and maturation of CCR2(+) myeloid cells, and CCR2 ablation caused outgrowth of HCC. In contrast, HCC cells block the maturation of recruited myeloid precursors, which, through NK cell inhibition, promote growth of murine HCC and worsen the prognosis and survival of human HCC patients. Thus, while senescent hepatocyte-secreted chemokines suppress liver cancer initiation, they may accelerate the growth of fully established HCC.
C1 [Eggert, Tobias; Ma, Chi; Medina-Echeverz, Jose; Greten, Tim F.] NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.
   [Wolter, Katharina; Yevsa, Tetyana; Klotz, Sabrina; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Gastrointestinal Oncol, D-72076 Tubingen, Germany.
   [Ji, Juling; Forgues, Marshonna; Wang, Xin Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   [Longerich, Thomas] Univ Hosp RWTH Aachen, Inst Pathol, D-52074 Aachen, Germany.
   [Reisinger, Florian; Heikenwalder, Mathias] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany.
   [Reisinger, Florian; Heikenwalder, Mathias] Helmholtz Zentrum Munchen, D-81675 Munich, Germany.
   [Reisinger, Florian; Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, D-69120 Heidelberg, Germany.
   [Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69120 Heidelberg, Germany.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Eberhard Karls University of Tubingen; National Institutes of
   Health (NIH) - USA; NIH National Cancer Institute (NCI); RWTH Aachen
   University; RWTH Aachen University Hospital; Technical University of
   Munich; Helmholtz Association; Helmholtz-Center Munich - German Research
   Center for Environmental Health; Helmholtz Association; German Cancer
   Research Center (DKFZ); Helmholtz Association; German Cancer Research
   Center (DKFZ)
RP Greten, TF (corresponding author), NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.; Zender, L (corresponding author), Univ Tubingen, Dept Internal Med 1, Div Gastrointestinal Oncol, D-72076 Tubingen, Germany.; Zender, L (corresponding author), German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69120 Heidelberg, Germany.
EM lars.zender@med.uni-tuebingen.de; tim.greten@nih.gov
RI Wang, Xin Wei/B-6162-2009; Ji, Juling/AAT-2550-2021; Greten, Tim
   F/B-3127-2015; Ji, Juling/AAU-1464-2020; Heikenwalder,
   Mathias/AAA-2269-2020
OI Wang, Xin Wei/0000-0001-9735-606X; Ji, Juling/0000-0001-6500-8052;
   Greten, Tim F/0000-0002-0806-2535; Ji, Juling/0000-0001-6500-8052;
   Medina Echeverz, Jose/0000-0002-6160-8840; Yevsa,
   Tetyana/0000-0003-0377-9198; , Chi/0000-0002-4171-0813
FU German Research Foundation (DFG) [FOR2314, SFB685]; Gottfried Wilhelm
   Leibniz Program; European Research Council; German Ministry for
   Education and Research (BMBF); German Universities Excellence
   Initiative; German Center for Translational Cancer Research (DKTK);
   German-Israeli Cooperation in Cancer Research (DKFZ-MOST); ERC; Stiftung
   Experimentelle Biomedizin (Hofschneider Stiftung); Pre-clinical
   Comprehensive Center (PCCC); Helmholtz foundation; Intramural Research
   Program of the NIH; NCI
FX This work was supported by the German Research Foundation (DFG; grants
   FOR2314 [L.Z.] and SFB685 [L.Z.]), the Gottfried Wilhelm Leibniz Program
   (L.Z.), the European Research Council (projects 'CholangioConcept'
   [L.Z.], 'Heptromic'[L.Z.]), the German Ministry for Education and
   Research (BMBF) (eMed [Multiscale HCC]) (L.Z.), the German Universities
   Excellence Initiative (third funding line: 'future concept') (L.Z.), the
   German Center for Translational Cancer Research (DKTK) (L.Z.), and the
   German-Israeli Cooperation in Cancer Research (DKFZ-MOST) (L.Z.). M.H.
   was supported by an ERC starting grant (LiverCancer mechanism), the
   Stiftung Experimentelle Biomedizin (Hofschneider Stiftung), the
   Pre-clinical Comprehensive Center (PCCC), and the Helmholtz foundation.
   T.F.G. and X.W.W. were supported by the Intramural Research Program of
   the NIH, NCI. We thank Dr. Michael J. Kruhlak (NIH) for technical
   assistance with scanning of liver section slides and Florian Heinzmann
   (University Hospital, Tubingen) for the generation of knockdown
   validated shRNAs.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Cai L, 2008, CLIN IMMUNOL, V129, P428, DOI 10.1016/j.clim.2008.08.012
   Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027
   Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175
   Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506
   Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020
   Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054
   Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783
   Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240
   Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635
   Mudbhary R, 2014, CANCER CELL, V25, P196, DOI 10.1016/j.ccr.2014.01.003
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825
   Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138
   Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607
   Strauss L, 2015, CANCER CELL, V28, P253, DOI 10.1016/j.ccell.2015.07.006
   Struthers M, 2010, CURR TOP MED CHEM, V10, P1278, DOI 10.2174/156802610791561255
   Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044
   Taketomi A, 1998, CANCER, V83, P58, DOI 10.1002/(SICI)1097-0142(19980701)83:1<58::AID-CNCR8>3.0.CO;2-A
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Wu Y, 2013, HEPATOLOGY, V57, P1107, DOI 10.1002/hep.26192
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yildiz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064016
   Yuzefpolskiy Y, 2015, CELL MOL IMMUNOL, V12, P400, DOI 10.1038/cmi.2014.48
   Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574
NR 36
TC 350
Z9 375
U1 5
U2 44
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1535-6108
EI 1878-3686
J9 CANCER CELL
JI Cancer Cell
PD OCT 10
PY 2016
VL 30
IS 4
BP 533
EP 547
DI 10.1016/j.ccell.2016.09.003
PG 15
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA DY7SO
UT WOS:000385329800008
PM 27728804
OA hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU Ishigami, T
   Fujita, T
   Simbula, G
   Columbano, A
   Kikuchi, K
   Ishigami, A
   Shimosawa, T
   Arakawa, Y
   Maruyama, N
AF Ishigami, T
   Fujita, T
   Simbula, G
   Columbano, A
   Kikuchi, K
   Ishigami, A
   Shimosawa, T
   Arakawa, Y
   Maruyama, N
TI Regulatory effects of senescence marker protein 30 on the proliferation
   of hepatocytes
SO PATHOLOGY INTERNATIONAL
LA English
DT Article
DE carbon tetrachloride; cell death; cell proliferation; lead nitrate;
   liver; mitosis; phenobarbital; regeneration; senescence marker
   protein-30 (SMP 30)
ID LIVER-CELL PROLIFERATION; RAT-LIVER; SMP30; HYPERPLASIA; EXPRESSION;
   REGUCALCIN; DEATH; RNA
AB Senescence marker protein 30 (SMP 30) is preferentially expressed in the liver. One of its remarkable functions is the protection of cells against various injuries by enhancement of membrane calcium-pump activity. We analyzed the role of SMP 30 in hepatocyte proliferation. SMP 30 expression was decreased initially, then increased along with hepatic regeneration, after carbon tetrachloride (CCl4) administration. SMP 30 expression was decreased in the necrotic phase and then gradually increased. Its increase was slightly delayed just after the mitotic phase. These results lead us to speculate that mitoses of hepatic cells induce enhanced SMP 30 expression. In contrast, administration of lead nitrate,(LN) as a hepatic mitogen induced a more stable increase of SMP 30 expression. To estimate the effect of SMP 30 on cell proliferation, we evaluated hepatic mitosis in wild-type and SMP 30-deficient knockout (KO) mice after CCl4 administration. We found an increase in mitotic numbers in hepatocytes of KO mice. This result suggests that SMP 30 has a suppressive effect on cell proliferation. Suppressive activity of SMP 30 cDNA was shown in cultured hepatoblastic cells. Our results suggest that SMP 30 performs a regulatory function in liver regeneration.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
   Nihon Univ, Sch Med, Dept Internal Med, Tokyo, Japan.
   Univ Cagliari, Inst Patol Sperimentale, Cagliari, Italy.
C3 Tokyo Metropolitan Institute of Gerontology; Nihon University;
   University of Cagliari
RP Maruyama, N (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.
RI Columbano, Amedeo/C-7463-2011; Simbula, Gabriella/AAN-4390-2020;
   Shimosawa, Tatsuo/A-2920-2015
OI Columbano, Amedeo/0000-0002-6956-9030; Simbula,
   Gabriella/0000-0003-4946-532X; Shimosawa, Tatsuo/0000-0002-8742-5129;
   Ishigami, Akihito/0000-0001-7875-7482
CR Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   COLUMBANO A, 1985, LAB INVEST, V52, P670
   Columbano A, 1984, Toxicol Pathol, V12, P89
   COLUMBANO A, 1983, AM J PATHOL, V110, P83
   COLUMBANO A, 1987, CANCER RES, V47, P5557
   CONI P, 1989, CANCER LETT, V47, P115, DOI 10.1016/0304-3835(89)90186-9
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   IIDA H, 1990, J BIOL CHEM, V265, P21216
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123
   LEDDACOLUMBANO GM, 1991, APOPTOSIS MOL BASIS, P101
   LINDSAY HD, 1995, J CELL SCI, V108, P3557
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P25
   RECKNAGEL RO, 1960, AM J PATHOL, V36, P521
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SNOW P, 1993, J CELL BIOL, V122, P387, DOI 10.1083/jcb.122.2.387
   SPEKSNIJDER JE, 1989, P NATL ACAD SCI USA, V86, P6607, DOI 10.1073/pnas.86.17.6607
   STEINHARDT RA, 1988, NATURE, V332, P365
   Supakar PC, 2000, BIOCHEM BIOPH RES CO, V272, P436, DOI 10.1006/bbrc.2000.2799
   YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V146, P71, DOI 10.1007/BF00926884
NR 26
TC 21
Z9 28
U1 0
U2 1
PU BLACKWELL PUBLISHING ASIA
PI CARLTON
PA 54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA
SN 1320-5463
J9 PATHOL INT
JI Pathol. Int.
PD JUL
PY 2001
VL 51
IS 7
BP 491
EP 497
DI 10.1046/j.1440-1827.2001.01238.x
PG 7
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 516QC
UT WOS:000173565500001
PM 11472560
DA 2024-02-19
ER

PT J
AU Zhou, CC
   Yang, X
   Hua, X
   Liu, J
   Fan, MB
   Li, GQ
   Song, J
   Xu, TY
   Li, ZY
   Guan, YF
   Wang, P
   Miao, CY
AF Zhou, Can-Can
   Yang, Xi
   Hua, Xia
   Liu, Jian
   Fan, Mao-Bing
   Li, Guo-Qiang
   Song, Jie
   Xu, Tian-Ying
   Li, Zhi-Yong
   Guan, Yun-Feng
   Wang, Pei
   Miao, Chao-Yu
TI Hepatic NAD<SUP>+</SUP> deficiency as a therapeutic target for
   non-alcoholic fatty liver disease in ageing
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
ID COLONY-ENHANCING FACTOR; CONCISE GUIDE; NICOTINAMIDE
   PHOSPHORIBOSYLTRANSFERASE; SALVAGE PATHWAY; PHARMACOLOGY; METABOLISM;
   ACTIVATION; APOPTOSIS; PROTECTS; FIBROSIS
AB Background and PurposeAgeing is an important risk factor of non-alcoholic fatty liver disease (NAFLD). Here, we investigated whether the deficiency of nicotinamide adenine dinucleotide (NAD(+)), a ubiquitous coenzyme, links ageing with NAFLD.
   Experimental ApproachHepatic concentrations of NAD(+), protein levels of nicotinamide phosphoribosyltransferase (NAMPT) and several other critical enzymes regulating NAD(+) biosynthesis, were compared in middle-aged and aged mice or patients. The influences of NAD(+) decline on the steatosis and steatohepatitis were evaluated in wild-type and H247A dominant-negative, enzymically-inactive NAMPT transgenic mice (DN-NAMPT) given normal or high-fat diet (HFD).
   Key ResultsHepatic NAD(+) level decreased in aged mice and humans. NAMPT-controlled NAD(+) salvage, but not de novo biosynthesis pathway, was compromised in liver of elderly mice and humans. Given normal chow, middle-age DN-NAMPT mice displayed systemic NAD(+) reduction and had moderate NAFLD phenotypes, including lipid accumulation, enhanced oxidative stress, triggered inflammation and impaired insulin sensitivity in liver. All these NAFLD phenotypes, especially release of pro-inflammatory factors, Kupffer cell accumulation, monocytes infiltration, NLRP3 inflammasome pathway and hepatic fibrosis (Masson's staining and -SMA staining), deteriorated further under HFD challenge. Oral administration of nicotinamide riboside, a natural NAD(+) precursor, completely corrected these NAFLD phenotypes induced by NAD(+) deficiency alone or HFD, whereas adenovirus-mediated SIRT1 overexpression only partially rescued these phenotypes.
   Conclusions and ImplicationsThese results provide the first evidence that ageing-associated NAD(+) deficiency is a critical risk factor for NAFLD, and suggest that supplementation with NAD(+) substrates may be a promising therapeutic strategy to prevent and treat NAFLD.
C1 [Zhou, Can-Can; Yang, Xi; Hua, Xia; Fan, Mao-Bing; Li, Guo-Qiang; Song, Jie; Xu, Tian-Ying; Li, Zhi-Yong; Guan, Yun-Feng; Wang, Pei; Miao, Chao-Yu] Second Mil Med Univ, Dept Pharmacol, Shanghai, Peoples R China.
   [Liu, Jian] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China.
C3 Naval Medical University; Naval Medical University
RP Wang, P; Miao, CY (corresponding author), Second Mil Med Univ, Dept Pharmacol, Shanghai, Peoples R China.
EM pwang@smmu.edu.cn; cymiao@smmu.edu.cn
RI WANG, PEI/AAH-3926-2019
OI WANG, PEI/0000-0002-1650-3353; Miao, Chao-Yu/0000-0002-8176-3434
FU National Natural Science Foundation of China [81373414, 81130061,
   81473208, 81422049]; National 863 Plan Young Scientist Program of China
   [2015AA020943]
FX This work was supported by grants from National Natural Science
   Foundation of China (no. 81373414, no. 81130061, no. 81473208 and no.
   81422049) and the National 863 Plan Young Scientist Program of China
   (no. 2015AA020943).
CR Alexander SPH, 2015, BRIT J PHARMACOL, V172, P6024, DOI 10.1111/bph.13354
   Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5956, DOI 10.1111/bph.13352
   Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5979, DOI 10.1111/bph.13353
   Alexander SPH, 2015, BRIT J PHARMACOL, V172, P6110, DOI 10.1111/bph.13355
   Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024
   Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cantó C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856
   Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148
   de Boer JF, 2009, AM J PHYSIOL-GASTR L, V296, pG196, DOI 10.1152/ajpgi.00029.2008
   Fabbro D, 2015, BRIT J PHARMACOL, V172, P2675, DOI 10.1111/bph.13096
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Heyes MP, 1997, BIOCHEM J, V326, P351, DOI 10.1042/bj3260351
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI 10.1172/JCI19930
   Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005
   Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI [10.1038/jcbfm.2010.220, 10.1111/j.1476-5381.2010.00872.x]
   Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032
   Liang W, 2015, BRIT J PHARMACOL, V172, P5293, DOI 10.1111/bph.13315
   Liu C, 2009, CRIT CARE MED, V37, P634, DOI 10.1097/CCM.0b013e31819598f5
   McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955
   Moschen AR, 2011, HEPATOLOGY, V54, P675, DOI 10.1002/hep.24416
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763
   Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803
   Pathil A, 2014, BRIT J PHARMACOL, V171, P5113, DOI 10.1111/bph.12837
   Penke M, 2015, MOL CELL ENDOCRINOL, V412, P65, DOI 10.1016/j.mce.2015.05.028
   Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641
   Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003
   Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L
   Ruggieri S, 2015, BBA-PROTEINS PROTEOM, V1854, P1138, DOI 10.1016/j.bbapap.2015.02.021
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037
   Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061
   Tummala KS, 2014, CANCER CELL, V26, P826, DOI 10.1016/j.ccell.2014.10.002
   Tziomalos K, 2015, METABOLISM, V64, P1215, DOI 10.1016/j.metabol.2015.07.003
   Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906
   Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639
   Wang P, 2014, AUTOPHAGY, V10, P1535, DOI 10.4161/auto.29203
   Wang P, 2014, CARDIOVASC RES, V102, P448, DOI 10.1093/cvr/cvu056
   Wang P, 2012, DIABETES, V61, P1051, DOI 10.2337/db11-1180
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
   Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhang RY, 2011, ANAL BIOCHEM, V412, P18, DOI 10.1016/j.ab.2010.12.035
   Zhang ZF, 2014, BIOCHEM PHARMACOL, V91, P74, DOI 10.1016/j.bcp.2014.07.002
   Zhao Y, 2015, STROKE, V46, P1966, DOI 10.1161/STROKEAHA.115.009216
   Zhong W, 2009, HEPATOLOGY, V50, P1524, DOI 10.1002/hep.23189
NR 59
TC 131
Z9 149
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD AUG
PY 2016
VL 173
IS 15
BP 2352
EP 2368
DI 10.1111/bph.13513
PG 17
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA DR7HW
UT WOS:000380071600004
PM 27174364
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Okatani, Y
   Wakatsuki, A
   Reiter, RJ
   Miyahara, Y
AF Okatani, Y
   Wakatsuki, A
   Reiter, RJ
   Miyahara, Y
TI Hepatic mitochondrial dysfunction in senescence-accelerated mice:
   correction by long-term, orally administered physiological levels of
   melatonin
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE aging; antioxidants; free radical; mitochondria; respiratory chain;
   senescence-accelerated mice
ID MICROSOMAL MEMBRANE FLUIDITY; CENTRAL-NERVOUS-SYSTEM; FREE-RADICAL
   THEORY; FETAL-RAT BRAIN; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE;
   LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; LIFE-SPAN
AB Mitochondrial oxidative damage from free radicals may be a factor underlying aging. We investigated whether long-term administration of physiological levels of melatonin, a direct free radical scavenger and indirect antioxidant, influences mitochondrial respiratory activity in liver of senescence-accelerated mice (SAM). Liver was obtained in the middle of dark period of the daily light:dark cycle from SAMP8, a strain of mice prone to accelerated senescence, and from SAMR1, a senescence-resistant strain, at 6 and 12 months of age. Respiratory control index (RCI), adenosine-5-diphosphate (ADP)/O ratio, State 3 respiration and dinitophenol (DNP)-dependent uncoupled respiration exhibited significant age-associated decreases in SAMP8. SAMP8 also showed significant age-associated reductions in respiratory chain complex I and IV activities. No age-related effects were found in these parameters in SAMR1. Daily oral melatonin administration (2 mug/mL of drinking fluid) beginning at 7 months of age significantly increased RCI, State 3 respiration, DNP-dependent uncoupled respiration, and complex I and IV activities in both mouse strains when they were 12 months old. These results reveal age-related reductions in mitochondrial function in SAM mice which are modified by melatonin; the most likely explanation for the corrective actions of melatonin relate to its antioxidative actions in mitochondria and other portions of the cell. The implication of the findings is that melatonin may be beneficial during aging as it reduces the deteriorative oxidative changes in mitochondria and other portions of the cell associated with advanced age.
C1 Kochi Med Sch, Dept Clin Nursing Sci, Nanko Ku, Kochi 7838505, Japan.
   Kochi Med Sch, Dept Obstet & Gynecol, Kochi, Japan.
   Univ Texas, Hlth Sci Ctr, Dept Struct & Cellular Biol, San Antonio, TX USA.
C3 Kochi University; Kochi University; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Okatani, Y (corresponding author), Kochi Med Sch, Dept Clin Nursing Sci, Nanko Ku, Kochi 7838505, Japan.
CR Absi E, 2000, J PINEAL RES, V29, P40, DOI 10.1034/j.1600-079X.2000.290106.x
   Acuña-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165
   BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8
   Ceraulo L, 1999, J PINEAL RES, V26, P108, DOI 10.1111/j.1600-079X.1999.tb00570.x
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   Garcia JJ, 1997, FEBS LETT, V408, P297, DOI 10.1016/S0014-5793(97)00447-X
   García JJ, 1998, J MEMBRANE BIOL, V162, P59, DOI 10.1007/s002329900342
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOGEBOOM GH, 1985, METHOD ENZYMOL, V181, P16
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   Livrea MA, 1997, FREE RADICAL BIO MED, V23, P706, DOI 10.1016/S0891-5849(97)00018-X
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAESTRONI GJM, 1993, J PINEAL RES, V14, P1, DOI 10.1111/j.1600-079X.1993.tb00478.x
   Martín M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MORENOSANCHEZ R, 1991, BIOCHEM PHARMACOL, V41, P1479, DOI 10.1016/0006-2952(91)90564-L
   Morioka N, 1999, J PINEAL RES, V27, P202, DOI 10.1111/j.1600-079X.1999.tb00616.x
   NAKAHARA H, 1994, FREE RADICAL BIO MED, V16, P621
   Okatani Y, 2000, J PINEAL RES, V28, P89, DOI 10.1034/j.1600-079X.2001.280204.x
   Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x
   Okatani Y, 2002, NEUROBIOL AGING, V23, P639, DOI 10.1016/S0197-4580(02)00005-2
   Pablos M.I., 1997, NEUROENDOCRINOL LETT, V18, P49
   Reiter RJ, 1999, ADV EXP MED BIOL, V467, P379
   Reiter RJ, 1999, MECH AGEING DEV, V110, P157, DOI 10.1016/S0047-6374(99)00058-5
   Reiter RJ, 2001, ANN NY ACAD SCI, V939, P200
   REITER RJ, 1992, BIOESSAYS, V14, P169, DOI 10.1002/bies.950140307
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   Reiter RJ., 2000, CURR TOP BIOPHYS, V24, P171
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tan DX, 2001, FASEB J, V15, P2294, DOI 10.1096/fj.01-0309fje
   Tan DX, 1998, BIOCHEM BIOPH RES CO, V253, P614, DOI 10.1006/bbrc.1998.9826
   Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4
   Tesoriere L, 2001, J PINEAL RES, V31, P114, DOI 10.1034/j.1600-079x.2001.310204.x
   Turjanski AG, 2001, J PINEAL RES, V31, P97, DOI 10.1034/j.1600-079x.2001.310201.x
   Wakatsuki A, 2001, J PINEAL RES, V31, P167, DOI 10.1034/j.1600-079x.2001.310211.x
NR 43
TC 55
Z9 58
U1 0
U2 1
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0742-3098
J9 J PINEAL RES
JI J. Pineal Res.
PD OCT
PY 2002
VL 33
IS 3
BP 127
EP 133
DI 10.1034/j.1600-079X.2002.02109.x
PG 7
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 590YL
UT WOS:000177852400001
PM 12220325
DA 2024-02-19
ER

PT J
AU Yuan, GS
   Hua, BX
   Cai, TT
   Xu, LR
   Li, EM
   Huang, YQ
   Sun, N
   Yan, ZQ
   Lu, C
   Qian, RZ
AF Yuan, Gongsheng
   Hua, Bingxuan
   Cai, Tingting
   Xu, Lirong
   Li, Ermin
   Huang, Yiqing
   Sun, Ning
   Yan, Zuoqin
   Lu, Chao
   Qian, Ruizhe
TI Clock mediates liver senescence by controlling ER stress
SO AGING-US
LA English
DT Article
DE circadian locomotor output cycles kaput; endoplasmic reticulum stress;
   ROS; PDIA3; UPR; PERK
ID ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; CIRCADIAN CLOCK;
   CELL-DEATH; INFLAMMATORY RESPONSE; AGING BRAIN; PROTEIN; DEFICIENCY;
   RESISTANCE; SYSTEM
AB Accumulated evidence indicates that circadian genes regulate cell damage and senescence in most mammals. Endoplasmic reticulum (ER) stress and reactive oxygen species (ROS) regulate longevity in many organisms. However, the specific mechanisms of the relationship between the circadian clock and the two stress processes in organisms are poorly understood. Here, we show that Clock-mediated Pdia3 expression is required to sustain reactive oxidative reagents and ER stress. First, ER stress and ROS are strongly activated in the liver tissue of Clock(Delta 19) mutant mice, which exhibit a significant aging phenotype. Next, transcription of Pdia3 is mediated by the circadian gene Clock, but this process is affected by the Clock(Delta 19) mutant due to the low affinity of the E-box motif in the promoter. Finally, ablation of Pdia3 with siRNA causes ER stress with sustained phosphorylation of PERK and eIF1 alpha, resulting in exaggerated up-regulation of UPR target genes and increased apoptosis as well as ROS. Moreover, the combined effects result in an imbalance of cell homeostasis and ultimately lead to cell damage and senescence. Taken together, this study identified the circadian gene Clock as a regulator of ER stress and senescence, which will provide a reference for the clinical prevention of aging.
C1 [Yuan, Gongsheng; Cai, Tingting; Xu, Lirong; Li, Ermin; Sun, Ning; Lu, Chao; Qian, Ruizhe] Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China.
   [Yuan, Gongsheng; Huang, Yiqing; Sun, Ning; Lu, Chao; Qian, Ruizhe] Fudan Univ, Res Ctr Aging & Med, Shanghai Key Lab Clin Geriatr Med, Shanghai 200032, Peoples R China.
   [Hua, Bingxuan; Yan, Zuoqin] Fudan Univ, Zhongshan Hosp, Dept Orthoped, Shanghai 200032, Peoples R China.
   [Sun, Ning] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.
   [Huang, Yiqing] Fudan Univ, Huadong Hosp, Shanghai Med Coll, Dept Gastroenterol, Shanghai 200040, Peoples R China.
C3 Fudan University; Fudan University; Fudan University; Fudan University;
   Fudan University
RP Lu, C; Qian, RZ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China.; Lu, C; Qian, RZ (corresponding author), Fudan Univ, Res Ctr Aging & Med, Shanghai Key Lab Clin Geriatr Med, Shanghai 200032, Peoples R China.
EM luchao@shmu.edu.cn; rzqian@shmu.edu.cn
RI Sun, Ning/HLX-6289-2023; 许, 利荣/ITV-5825-2023; Lu, Chao/P-7078-2019;
   Yuan, Gongsheng/AAZ-3065-2021; Yan, Zuoqin/AAZ-2059-2020
OI Lu, Chao/0000-0002-9484-6415; Sun, Ning/0000-0002-7861-3646; Yuan,
   Gongsheng/0000-0002-5897-0064; qian, ruizhe/0000-0002-5992-2902
FU National Science Foundation Fostering Talents in Basic Research of China
   [J1310009]; National Natural Science Foundation of China (NSFC)
   [81570771, 81322003, 31571527]; Recruitment Program of Global Experts of
   the Organization Department of the Central Committee of the CPC; Science
   and Technology Commission of Shanghai Municipality [13JC1401704];
   Shanghai Key Laboratory of Clinical Geriatric Medicine [13dz2260700];
   Shanghai Municipal Commission of Health and Family Planning, Key
   developing disciplines [201440550]
FX This work was supported by the National Science Foundation Fostering
   Talents in Basic Research of China No. J1310009 (RZ.Q.); the National
   Natural Science Foundation of China (NSFC) No. 81570771 (RZ.Q.), No.
   81322003 (N.S.), No. 31571527 (N.S.), the Recruitment Program of Global
   Experts of the Organization Department of the Central Committee of the
   CPC (N.S.); the Science and Technology Commission of Shanghai
   Municipality (No. 13JC1401704) (N.S.); Shanghai Key Laboratory of
   Clinical Geriatric Medicine No. 13dz2260700 (C.L.) and Shanghai
   Municipal Commission of Health and Family Planning, Key developing
   disciplines (201440550) (YQ.H).
CR Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107
   Antoch MP, 2008, CELL CYCLE, V7, P1197, DOI 10.4161/cc.7.9.5886
   Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633
   Bugaut H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065181
   Chow HM, 2015, NAT REV NEUROSCI, V16, P672, DOI 10.1038/nrn4020
   Debruyne J, 2008, J GENET, V87, P437, DOI 10.1007/s12041-008-0066-7
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241
   Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015
   Eletto D, 2014, MOL CELL, V53, P562, DOI 10.1016/j.molcel.2014.01.004
   Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025
   Hutt DM, 2009, FEBS LETT, V583, P2639, DOI 10.1016/j.febslet.2009.07.014
   Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289
   Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380
   Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109
   Lee J, 2015, DIABETES OBES METAB, V17, P123, DOI 10.1111/dom.12524
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925
   Maillo C, 2017, NAT CELL BIOL, V19, P94, DOI 10.1038/ncb3461
   Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253
   Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062
   Moore PC, 2017, NAT CELL BIOL, V19, P79, DOI 10.1038/ncb3460
   Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844
   PRINZ PN, 1990, NEW ENGL J MED, V323, P520
   Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0
   Shimomura K, 2013, ELIFE, V2, DOI 10.7554/eLife.00426
   Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750
   Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33
NR 35
TC 28
Z9 32
U1 0
U2 18
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC
PY 2017
VL 9
IS 12
BP 2647
EP 2665
DI 10.18632/aging.101353
PG 19
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FR2QA
UT WOS:000418910700021
PM 29283886
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Jadeja, RN
   Jones, MA
   Fromal, O
   Powell, FL
   Khurana, S
   Singh, N
   Martin, PM
AF Jadeja, Ravirajsinh N.
   Jones, Malita A.
   Fromal, Ollya
   Powell, Folami L.
   Khurana, Sandeep
   Singh, Nagendra
   Martin, Pamela M.
TI Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis
SO AGING-US
LA English
DT Article
DE aging; steatosis; GPR109A; lipid metabolism
ID FATTY LIVER-DISEASE; NICOTINIC-ACID; TRANSCRIPTIONAL REGULATION;
   MOLECULAR-IDENTIFICATION; OXIDATIVE STRESS; RECEPTORS; ADIPONECTIN;
   EXPRESSION; PROTEIN
AB GPR109A agonists have been used for the treatment of obesity however, the role of GPR109A in regulating aging-associated alterations in lipid metabolism is unknown. In this study we used Gpr109a(-/-) mice to investigate the effect of aging in the regulation of lipid accumulation. We observed that in mouse and human livers, in addition to Kupffer cells, GPR109A is expressed in hepatocytes. Over 12 months, compared to wild type (WT), Gpr109a(-/-) mice gained significantly more weight. Food intake and levels of serum lipids were similar among both groups. Compared to age-matched WT mice, 12-months old Gpr109a(-/-) mice had significantly increased liver weight, hepatic steatosis and serum markers of liver injury. The fatty liver phenotype in Gpr109a(-/-) mice was associated with increased hepatic expression of lipogenesis genes and decreased expression of lipolysis genes. Gpr109a(-/-) mice had significantly increased fat tissues, which was associated with significant increase in adipocyte diameter and surface area. Adipose tissue from Gpr109a(-/-) mice had increased expression of lipogenesis genes; however, expression of lipolytic genes was similar in both groups. Collectively, these results indicate that during aging, GPR109A modulates de novo lipid accumulation in liver and adipose tissue, and its dysregulation can lead to age- associated obesity and hepatic steatosis.
C1 [Jadeja, Ravirajsinh N.; Jones, Malita A.; Fromal, Ollya; Powell, Folami L.; Singh, Nagendra; Martin, Pamela M.] Augusta Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30912 USA.
   [Jadeja, Ravirajsinh N.; Powell, Folami L.; Martin, Pamela M.] Augusta Univ, James & Jean Culver Vis Discovery Inst, Med Coll Georgia, Augusta, GA 30912 USA.
   [Powell, Folami L.] Augusta Univ, Educ Innovat Inst, Med Coll Georgia, Augusta, GA 30912 USA.
   [Khurana, Sandeep] Geisinger Med Ctr, Div Gastroenterol, Hepatol & Nutr & Weight Management, Danville, PA 17822 USA.
   [Singh, Nagendra; Martin, Pamela M.] Augusta Univ, Georgia Canc Ctr, Med Coll Georgia, Augusta, GA 30912 USA.
   [Martin, Pamela M.] Augusta Univ, Dept Ophthalmol, Med Coll Georgia, Augusta, GA 30912 USA.
C3 University System of Georgia; Augusta University; University System of
   Georgia; Augusta University; University System of Georgia; Augusta
   University; Geisinger Medical Center; University System of Georgia;
   Augusta University; University System of Georgia; Augusta University
RP Jadeja, RN; Martin, PM (corresponding author), Augusta Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30912 USA.; Jadeja, RN; Martin, PM (corresponding author), Augusta Univ, James & Jean Culver Vis Discovery Inst, Med Coll Georgia, Augusta, GA 30912 USA.; Martin, PM (corresponding author), Augusta Univ, Georgia Canc Ctr, Med Coll Georgia, Augusta, GA 30912 USA.; Martin, PM (corresponding author), Augusta Univ, Dept Ophthalmol, Med Coll Georgia, Augusta, GA 30912 USA.
EM rjadeja@augusta.edu; pmmartin@augusta.edu
OI Jadeja, Ravirajsinh/0000-0002-1712-454X; Singh,
   Nagendra/0000-0003-2540-6990
FU NIH [EY022704, DK103576]
FX NIH Grants EY022704 to Pamela M. Martin and DK103576 to Nagendra Singh
   supported this study.
CR Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x
   Caminhotto RD, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0184-4
   de Sá PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Ganji SH, 2004, J LIPID RES, V45, P1835, DOI 10.1194/jlr.M300403-JLR200
   Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1
   Hanson J, 2010, J CLIN INVEST, V120, P2910, DOI 10.1172/JCI42273
   Huang JS, 2011, MOL PATHOL LIB, V5, P133, DOI 10.1007/978-1-4419-7107-4_10
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Karnikowski M, 2007, SAO PAULO MED J, V125, P333, DOI 10.1590/S1516-31802007000600006
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Lauring B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003877
   Liang WF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090827, 10.1371/journal.pone.0109757]
   Lillie R., 1943, Arch. Pathol., V36, P432
   Liu LF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-212
   Lonardo A, 2016, WORLD J GASTROENTERO, V22, P9674, DOI 10.3748/wjg.v22.i44.9674
   Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734
   Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586
   Martin PM, 2009, MOL VIS, V15, P362
   Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613
   Plaisance EP, 2008, METABOLISM, V57, P404, DOI 10.1016/j.metabol.2007.10.018
   Plaisance EP, 2009, AM J PHYSIOL-ENDOC M, V296, pE549, DOI 10.1152/ajpendo.91004.2008
   Polimeni L, 2015, WORLD J HEPATOL, V7, P1325, DOI 10.4254/wjh.v7.i10.1325
   Premoli A, 2009, Minerva Gastroenterol Dietol, V55, P71
   Saponaro C, 2015, NUTRIENTS, V7, P9453, DOI 10.3390/nu7115475
   Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5
   Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041
   Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466
   Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824
   Urrunaga NH, 2015, FREE RADICAL BIO MED, V78, P66, DOI 10.1016/j.freeradbiomed.2014.09.032
   Wanders D, 2011, DIABETES OBES METAB, V13, P685, DOI 10.1111/j.1463-1326.2011.01400.x
   Wanders D, 2012, BIOCHEM BIOPH RES CO, V425, P278, DOI 10.1016/j.bbrc.2012.07.082
   Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074
   Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200
   Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005
NR 40
TC 20
Z9 25
U1 0
U2 8
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JAN 31
PY 2019
VL 11
IS 2
BP 386
EP 400
DI 10.18632/aging.101743
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HM3OW
UT WOS:000459384600014
PM 30659164
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Wei, J
   Zhang, GK
   Zhang, X
   Xu, DX
   Gao, J
   Fan, JG
AF Wei, Jie
   Zhang, Guokun
   Zhang, Xiao
   Xu, Dexin
   Gao, Jun
   Fan, Jungang
TI Anthocyanins Delay Ageing-Related Degenerative Changes in the Liver
SO PLANT FOODS FOR HUMAN NUTRITION
LA English
DT Article
DE Aronia melanocarpa anthocyanins; Aged; DNA damage; Genome stability
ID DNA-DAMAGE; CARBON-TETRACHLORIDE; MELANOCARPA; DISEASES; REPAIR; MICE
AB Liver ageing is a significant risk factor for chronic liver diseases. Anthocyanin is a food additive that has previously shown efficacy in increasing longevity. Here, we tested whether anthocyanins could protect young mice from accelerated ageing of the liver. Kunming mice were injected with D-galactose to accelerate ageing and were given 20 or 40 mg/kg anthocyanins as an intervention. After eight weeks, whole liver function and structure were evaluated, and the expression levels of genes involved in the DNA damage signalling pathway were assessed by Western blot analysis. Anthocyanins delayed the reduction of the liver index (p < 0.05), hepatic tissue injury and fibrosis. Anthocyanins also maintained the stability of the redox system (GSH-PX, T-SOD and MDA) in plasma and liver structures (p < 0.001) and reduced the levels of inflammatory factors (IL-1, IL-6 and TNF-alpha) in the liver (p < 0.05). Moreover, the expression levels of sensors (ATM and ATR), mediators (H2AX and gamma-H2AX) and effectors (Chk1, Chk2, p53 and p-p53) in the DNA damage signalling pathway were all reduced. Anthocyanins could be widely used in the field of health products to slow ageing-related deterioration of liver function and structure by inhibiting DNA damage.
C1 [Wei, Jie; Zhang, Guokun; Zhang, Xiao; Xu, Dexin] Liaoning Univ, Sch Life Sci, Chongshan Middle Rd 66, Shenyang 110036, Liaoning, Peoples R China.
   [Gao, Jun; Fan, Jungang] Liaoning Forestry Acad, Shenyang 110032, Liaoning, Peoples R China.
C3 Liaoning University
RP Wei, J (corresponding author), Liaoning Univ, Sch Life Sci, Chongshan Middle Rd 66, Shenyang 110036, Liaoning, Peoples R China.
EM J.Wei2015@hotmail.com
RI Zhang, Guokun/AAQ-2692-2021
OI Zhang, Guokun/0000-0003-2177-418X
FU Science and Technology Government Department Fund in Liaoning province
   [LYB201611, LZ2015044, 2015020654]; National Natural Science Foundation
   of China [31701656]
FX This research was supported by the Science and Technology Government
   Department Fund in Liaoning province (Grant No. LYB201611, LZ2015044,
   2015020654) and the National Natural Science Foundation of China (Grant
   No. 31701656).
CR Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hügel HM, 2016, PHYTOMEDICINE, V23, P220, DOI 10.1016/j.phymed.2015.12.012
   Jiang XW, 2015, J AGR FOOD CHEM, V63, P6221, DOI 10.1021/acs.jafc.5b02181
   Jiang ZH, 2016, NAT PROD RES, V30, P469, DOI 10.1080/14786419.2015.1020492
   Kulling SE, 2008, PLANTA MED, V74, P1625, DOI 10.1055/s-0028-1088306
   Lin BW, 2017, BRIT J PHARMACOL, V174, P1226, DOI 10.1111/bph.13627
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Popovic D, 2016, LIFE SCI, V157, P168, DOI 10.1016/j.lfs.2016.06.007
   Rhind N, 2000, J CELL SCI, V113, P3889
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Soares JP, 2014, AGING-US, V6, P432, DOI 10.18632/aging.100667
   Subash S, 2014, NEURAL REGEN RES, V9, P1557, DOI 10.4103/1673-5374.139483
   Wei J, 2017, J AGR FOOD CHEM, V65, P5973, DOI 10.1021/acs.jafc.7b02136
   Wei J, 2016, INDIAN J PHARM EDUC, V50, P368, DOI 10.5530/Ijper.50.3.8
NR 16
TC 15
Z9 15
U1 2
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-9668
EI 1573-9104
J9 PLANT FOOD HUM NUTR
JI Plant Food Hum. Nutr.
PD DEC
PY 2017
VL 72
IS 4
BP 425
EP 431
DI 10.1007/s11130-017-0644-z
PG 7
WC Plant Sciences; Chemistry, Applied; Food Science & Technology; Nutrition
   & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Chemistry; Food Science & Technology; Nutrition &
   Dietetics
GA FO9BT
UT WOS:000417183700014
PM 29075987
DA 2024-02-19
ER

PT J
AU Huang, Y
   Miyamoto, D
   Li, PL
   Sakai, Y
   Hara, T
   Adachi, T
   Soyama, A
   Hidaka, M
   Kanetaka, K
   Gu, WL
   Eguchi, S
AF Huang, Yu
   Miyamoto, Daisuke
   Li, Pei-Lin
   Sakai, Yusuke
   Hara, Takanobu
   Adachi, Tomohiko
   Soyama, Akihiko
   Hidaka, Masaaki
   Kanetaka, Kengo
   Gu, Wei-Li
   Eguchi, Susumu
TI Chemical conversion of aged hepatocytes into bipotent liver progenitor
   cells
SO HEPATOLOGY RESEARCH
LA English
DT Article; Early Access
DE aging; chemically induced liver progenitor cells; cholangiocyte;
   hepatocyte; hepatocyte growth factor
ID DUCTULAR REACTION; HUMANS AGE; FIBROSIS; DIFFERENTIATION;
   CHOLANGIOCYTES; HEPATITIS; RATS; OLD
AB Aim In the aging society, understanding the influence of hepatocyte age on hepatocyte donation may inform efforts to expand alternative cell sources to mitigate liver donor shortage. A combination of the molecules Y27632, A-83-01, and CHIR99021 has been used to reprogram rodent young hepatocytes into chemically induced liver progenitor (CLiP) cells; however, whether it could also reprogram aged hepatocytes has not yet been elucidated.
   Methods Primary hepatocytes were isolated from aged and young donor rats, respectively. Hepatic histological changes were evaluated. Differences in gene expression in hepatocytes were identified. The in vitro reprogramming plasticity of hepatocytes as evidenced by CLiP conversion and the hepatocyte and cholangiocyte maturation capacity of reprogrammed CLIPs were analyzed. The effect of hepatocyte growth factor (HGF) on cell propagation was also investigated.
   Results The histological findings revealed ongoing liver damage with inflammation, fibrosis, senescence, and ductular reaction in aged livers. Microarray analysis showed altered gene expression profiles in hepatocytes from aged donors, especially with regard to metabolic pathways. Aged hepatocytes could be converted into CLiPs (Aged-CLiPs) expressing progenitor cell markers, but with a relatively low proliferative rate compared with young hepatocytes. Aged-CLiPs possessed both hepatocyte and cholangiocyte maturation capacity. HGF facilitated CLiP conversion in aged hepatocytes, which was partly related to the activation of Erk1 and Akt1 signaling.
   Conclusions Aged rat hepatocytes have retained reprogramming plasticity as evidenced by CLiP conversion in culture. HGF promoted proliferation and CLiP conversion in aged hepatocytes. Hepatocytes from aged donors may be used as an alternative cell source to mitigate donor shortage.
C1 [Huang, Yu; Miyamoto, Daisuke; Li, Pei-Lin; Sakai, Yusuke; Hara, Takanobu; Adachi, Tomohiko; Soyama, Akihiko; Hidaka, Masaaki; Kanetaka, Kengo; Eguchi, Susumu] Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
   [Huang, Yu; Li, Pei-Lin; Gu, Wei-Li] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Dept Surg, Guangzhou, Peoples R China.
   [Sakai, Yusuke] Kyushu Univ, Grad Sch, Dept Chem Engn, Fac Engn, Fukuoka, Japan.
C3 Nagasaki University; South China University of Technology; Kyushu
   University
RP Eguchi, S (corresponding author), Nagasaki Univ, Dept Surg, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
EM sueguchi@nagasaki-u.ac.jp
RI Huang, Yu/AAG-7901-2021; PEILIN, LI/HPG-2595-2023; Hidaka,
   Masaaki/AAE-5826-2020
OI Huang, Yu/0000-0002-6668-0702; PEILIN, LI/0000-0002-9136-0882; Hidaka,
   Masaaki/0000-0001-8191-6405; Sakai, Yusuke/0000-0001-7999-9731
FU Japan Agency for Medical Research and Development [20bm0404042h0002]
FX The studies were supported by Japan Agency for Medical Research and
   Development (20bm0404042h0002). We thank lab assistant Tomomi Murai for
   preparing the culture medium, Hideko Hasegawa for preparing paraffin
   tissue and H&E staining.
CR Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011
   Arai H, 2015, GERIATR GERONTOL INT, V15, P673, DOI 10.1111/ggi.12450
   Baimakhanov Z, 2016, CELL TRANSPLANT, V25, P549, DOI 10.3727/096368915X688669
   Basso A, 1998, J GERONTOL A-BIOL, V53, pB111, DOI 10.1093/gerona/53A.2.B111
   Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084
   Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Du C, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0794-4
   Fiorotto R, 2018, HEPATOLOGY, V67, P972, DOI 10.1002/hep.29400
   Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Huang Y, 2021, J HEPATO-BIL-PAN SCI, V28, P913, DOI 10.1002/jhbp.882
   Huang Y, 2020, J BIOSCI BIOENG, V130, P545, DOI 10.1016/j.jbiosc.2020.07.009
   Huang Y, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/3975689
   Huang Y, 2019, J HEPATOL, V71, P438, DOI 10.1016/j.jhep.2019.03.017
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Katsuda T, 2019, ELIFE, V8, DOI 10.7554/eLife.47313
   Katsuda T, 2019, METHODS MOL BIOL, V1905, P117, DOI 10.1007/978-1-4939-8961-4_11
   Katsuda T, 2017, CELL STEM CELL, V20, P41, DOI 10.1016/j.stem.2016.10.007
   Kim Y, 2019, J HEPATOL, V70, P97, DOI 10.1016/j.jhep.2018.09.007
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011, P1, DOI [DOI 10.1155/2011/859415, 10.1155/2011/859415]
   Li WP, 2020, TRENDS CELL BIOL, V30, P329, DOI 10.1016/j.tcb.2020.01.007
   Pineda ET, 2013, CELLS TISSUES ORGANS, V197, P399, DOI 10.1159/000346166
   Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Sakai Y, 2015, BIOMATERIALS, V65, P66, DOI 10.1016/j.biomaterials.2015.06.046
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270
   Wang PW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101184
NR 29
TC 5
Z9 5
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD 2021 MAR
PY 2021
VL 51
IS 3
BP 323
EP 335
DI 10.1111/hepr.13609
EA FEB 2021
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA RB8KN
UT WOS:000620194200001
PM 33378128
DA 2024-02-19
ER

PT J
AU Jin, H
   Lian, N
   Zhang, F
   Chen, L
   Chen, Q
   Lu, C
   Bian, M
   Shao, J
   Wu, L
   Zheng, S
AF Jin, H.
   Lian, N.
   Zhang, F.
   Chen, L.
   Chen, Q.
   Lu, C.
   Bian, M.
   Shao, J.
   Wu, L.
   Zheng, S.
TI Activation of PPARγ/P53 signaling is required for curcumin to induce
   hepatic stellate cell senescence
SO CELL DEATH & DISEASE
LA English
DT Article
ID LIVER FIBROSIS; OXIDATIVE STRESS; PPAR-GAMMA; EXPRESSION; P53;
   FIBROGENESIS; CONTRIBUTES; APOPTOSIS; REVERSAL; ARREST
AB Activation of quiescent hepatic stellate cells (HSCs) is the major event in hepatic fibrogenesis, along with enhancement of cell proliferation and overproduction of extracellular matrix. Although inhibition of cell proliferation and induction of apoptosis are potential strategies to block the activation of HSCs, a better understanding of the senescence of activated HSCs can provide a new therapeutic strategy for prevention and treatment of liver fibrosis. The antioxidant curcumin, a phytochemical from turmeric, has been shown to suppress HSC activation in vitro and in vivo. The current work was aimed to evaluate the effect of curcumin on senescence of activated HSCs and to elucidate the underlying mechanisms. In this study, curcumin promoted the expression of senescence marker Hmga1 in rat fibrotic liver. In addition, curcumin increased the number of senescence-associated a-galactosidase-positive HSCs in vitro. At the same time, curcumin induced HSC senescence by elevating the expression of senescence markers P16, P21 and Hmga1, concomitant with reduced abundance of HSC activation markers a-smooth muscle actin and alpha 1(I)-procollagen in cultured HSCs. Moreover, curcumin affected the cell cycle and telomerase activity. We further demonstrated that P53 pharmacological inhibitor pifithrin-alpha (PFT-alpha) or transfection with P53 siRNA abrogated the curcumin-induced HSC senescence in vitro. Meanwhile, curcumin disruption of P53 leading to increased senescence of activated HSCs was further verified in vivo. Further studies indicated that curcumin promoted the expression of P53 through a PPAR gamma activation-dependent mechanism. Moreover, promoting PPAR gamma transactivating activity by a PPAR gamma agonist 15d-PGJ2 markedly enhanced curcumin induction of senescence of activated HSCs. However, the PPAR gamma antagonist PD68235 eliminated curcumin induction of HSC senescence. Taken together, our results provided a novel insight into the mechanisms underlying curcumin inhibition of HSC activation through inducing senescence.
C1 [Jin, H.; Lian, N.; Zhang, F.; Chen, L.; Chen, Q.; Lu, C.; Bian, M.; Wu, L.; Zheng, S.] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
   [Zhang, F.; Zheng, S.] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing 210023, Jiangsu, Peoples R China.
   [Shao, J.] Nanjing Univ Chinese Med, Dept Pharm, Sch Pharm, Nanjing 210023, Jiangsu, Peoples R China.
C3 Nanjing University of Chinese Medicine; Nanjing University of Chinese
   Medicine; Nanjing University of Chinese Medicine
RP Zheng, S (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
EM nytws@163.com
OI Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [81270514, 31401210,
   31571455]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions; Youth Natural Science Foundation of Jiangsu
   Province [BK20140955]; Program for Excellent Scientific and
   Technological Innovation Team of Jiangsu Higher Education; Natural
   Science Research General Program of Jiangsu Higher Education
   Institutions [14KJB310011]; Open Project Program of National First-Class
   Key Discipline for Pharmacy of Nanjing University of Chinese Medicine
   [KYLX-0974]; Key Project - Medical Science and Technology Development
   Foundation, Nanjing Department of Health [YKK14143]; Open Project
   Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation
   of Chinese Materia Medica [JKLPSE 201502]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This study was supported by the National Natural Science Foundation of
   China (81270514, 31401210, 31571455), a project funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   the Youth Natural Science Foundation of Jiangsu Province (BK20140955),
   2013 Program for Excellent Scientific and Technological Innovation Team
   of Jiangsu Higher Education, the Natural Science Research General
   Program of Jiangsu Higher Education Institutions (14KJB310011), the Open
   Project Program of National First-Class Key Discipline for Pharmacy of
   Nanjing University of Chinese Medicine (KYLX-0974), and Key Project
   supported by Medical Science and Technology Development Foundation,
   Nanjing Department of Health (YKK14143), the Open Project Program of
   Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese
   Materia Medica (JKLPSE 201502) and the Project of the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD).
CR Adamovich Y, 2014, CELL DEATH DIFFER, V21, P1451, DOI 10.1038/cdd.2014.60
   Bitto A, 2014, METHODS MOL BIOL, V1170, P145, DOI 10.1007/978-1-4939-0888-2_8
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Fu YM, 2008, MOL PHARMACOL, V73, P399, DOI 10.1124/mol.107.039818
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Jacobs JJL, 2013, NAT REV MOL CELL BIO, V14, DOI 10.1038/nrm3544
   Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x
   Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026
   Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Sasaki M, 2015, HISTOL HISTOPATHOL, V30, P267, DOI 10.14670/HH-30.267
   Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Serrano M, 2010, NATURE, V464, P363, DOI 10.1038/464363a
   Singh V, 2014, ANTIMICROB AGENTS CH, V58, P1389, DOI 10.1128/AAC.01301-13
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189
   von Figura G, 2009, J MOL MED, V87, P1165, DOI 10.1007/s00109-009-0509-5
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Xu JY, 2003, AM J PHYSIOL-GASTR L, V285, pG20, DOI 10.1152/ajpgi.00474.2002
   Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286
   Zhang F, 2012, TOXICOL APPL PHARM, V265, P51, DOI 10.1016/j.taap.2012.09.016
   Zhang ZL, 2013, EUR J PHARMACOL, V721, P133, DOI 10.1016/j.ejphar.2013.09.042
   Zheng SZ, 2004, BIOCHEM J, V384, P149, DOI 10.1042/BJ20040928
   Zhou YJ, 2007, LAB INVEST, V87, P488, DOI 10.1038/labinvest.3700532
NR 37
TC 108
Z9 119
U1 0
U2 11
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD APR
PY 2016
VL 7
AR e2189
DI 10.1038/cddis.2016.92
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DK9UR
UT WOS:000375277600016
PM 27077805
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gaspar, RC
   Muñoz, VR
   Nakandakari, SCBR
   Vieira, RFL
   da Conceiçao, LR
   de Oliveira, F
   Crisol, BM
   da Silva, ASR
   Cintra, DE
   de Moura, LP
   Ropelle, ER
   Zaghloul, I
   Mekary, RA
   Pauli, JR
AF Gaspar, Rafael Calais
   Munoz, Vitor Rosetto
   Branco Ramos Nakandakari, Susana Castelo
   Lins Vieira, Renan Fudoli
   da Conceicao, Luciana Renata
   de Oliveira, Fellipe
   Crisol, Barbara Moreira
   da Silva, Adelino S. R.
   Cintra, Dennys Esper
   de Moura, Leandro Pereira
   Ropelle, Eduardo Rochete
   Zaghloul, Iman
   Mekary, Rania A.
   Pauli, Jose Rodrigo
TI Aging is associated with increased TRB3, ER stress, and hepatic glucose
   production in the liver of rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Gluconeogenesis; Insulin; resistance; Er stress; TRB3
ID ENDOPLASMIC-RETICULUM STRESS; INSULIN-RECEPTOR SUBSTRATE-1;
   PHOSPHATIDYLINOSITOL 3-KINASE; REDUCES GLUCONEOGENESIS;
   PHYSICAL-EXERCISE; TRIBBLES HOMOLOG; METABOLISM; OBESITY; MUSCLE; APPL1
AB TRB3, a mammalian homolog of Drosophila tribbles, plays an important role in multiple tissues and it has been implicated in stress response regulation and metabolic control. However, the role of hepatic TRB3 and its relationship with endoplasmic reticulum stress (ER stress) during aging has not been elucidated. Thus, the present study aimed to explore the association of aging with TRB3 and ER stress on the hepatic glucose production in Wistar rats. We found the TRB3 protein content to be higher in livers of old rats (27 months) compared to young (3 months) and middle-aged (17 months) rats. The increased content of hepatic TRB3 of the old rats was associated with insulin resistance (decreased protein kinase B (Akt) and Forkhead Box O1 (FoxO1) phosphorylation) and increased enzymes of gluconeogenesis (phosphoenolpyruvate carboxykinase (PEPCK) and Glucose 6-phosphatase (G6Pase)). Moreover, aging was associated with activation of the endoplasmic reticulum stress pathway-related molecules, with an increase in phosphorylation of Inositol-requiring enzyme 1 (p-IRE1 alpha), the protein kinase RNA-like endoplasmic reticulum kinase (p-PERK), eukaryotic translation initiation factor-alpha (peIF2 alpha), binding immunoglobulin protein (BiP), and the C/EBP homologous protein (CHOP) contents in rats. These molecular changes resulted in increased liver glucose production in response to the pyruvate challenge and hyperglycemia of the old rats. In conclusion, our results suggested that, by interfering with insulin signaling in the liver, TRB3 was associated with ER stress and increased hepatic glucose production in aging rats.
C1 [Gaspar, Rafael Calais; Munoz, Vitor Rosetto; Lins Vieira, Renan Fudoli; da Conceicao, Luciana Renata; de Oliveira, Fellipe; Crisol, Barbara Moreira; de Moura, Leandro Pereira; Ropelle, Eduardo Rochete; Pauli, Jose Rodrigo] Univ Estadual Campinas, Lab Mol Biol Exercise LaBMEx, UNICAMP, Limeira, SP, Brazil.
   [Branco Ramos Nakandakari, Susana Castelo; Cintra, Dennys Esper] Univ Estadual Campinas, Lab Nutr Genom LabGeN, UNICAMP, Limeira, SP, Brazil.
   [da Silva, Adelino S. R.] Univ Sao Paulo, Ribeirao Preto Med Sch, Postgrad Program Rehabil & Funct Performance, Ribeirao Preto, SP, Brazil.
   [da Silva, Adelino S. R.] Univ Sao Paulo, Sch Phys Educ & Sport Ribeirao Preto, Postgrad Program Phys Educ & Sport, Ribeirao Preto, SP, Brazil.
   [Cintra, Dennys Esper; de Moura, Leandro Pereira; Ropelle, Eduardo Rochete; Pauli, Jose Rodrigo] Univ Estadual Campinas, OCRC Obes & Comorbid Res Ctr, UNICAMP, Campinas, SP, Brazil.
   [Zaghloul, Iman; Mekary, Rania A.] Massachusetts Coll Pharm & Hlth Sci MCPHS Univ, Boston, MA USA.
   [Mekary, Rania A.] Harvard Med Sch, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA.
C3 Universidade Estadual de Campinas; Universidade Estadual de Campinas;
   Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade
   Estadual de Campinas; Harvard University; Harvard Medical School;
   Brigham & Women's Hospital
RP Pauli, JR (corresponding author), 1300 Pedro Zaccaria St Postal Code 1068, BR-13484350 Limeira, SP, Brazil.
EM rodrigo.pauli@fca.unicamp.br
RI Muñoz, Vitor R/N-4793-2015; Silva, Adelino/J-7379-2013; Ropelle, Eduardo
   R/C-3977-2012; Vieira, Renan Fudoli Lins/ABA-9442-2020; Pauli, José
   Rdrigo/AAD-2763-2021; Crisol, Barbara/IAQ-0653-2023; Cintra, Dennys
   E/N-7758-2017; Silva, Adelino/P-3400-2019; Gaspar, Rafael/N-4771-2015
OI Muñoz, Vitor R/0000-0003-4280-6558; Silva, Adelino/0000-0002-9679-8357;
   Ropelle, Eduardo R/0000-0003-1655-9557; Pauli, José
   Rdrigo/0000-0002-6129-1521; Cintra, Dennys E/0000-0002-7954-5630; Silva,
   Adelino/0000-0002-9679-8357; Gaspar, Rafael/0000-0002-2208-3527; Vieira,
   Renan Fudoli Lins/0000-0002-6525-7996; Mekary,
   Rania/0000-0003-1636-0759; Crisol, Barbara/0000-0003-2026-2844
FU National Council for Scientific and Technological Development (CNPq)
   [442542/2014-3, 306535/2017-3]; Coordination for the Improvement of
   Higher Education Personnel (CAPES) [001]; Sao Paulo Research Foundation
   (FAPESP) [2017/20542-3, 2018/07568-6, 2018/20872-6, 2019/00227-1]
FX The work was supported by National Council for Scientific and
   Technological Development (CNPq; process number 442542/2014-3 and
   306535/2017-3), Coordination for the Improvement of Higher Education
   Personnel (CAPES; finance code 001), and Sao Paulo Research Foundation
   (FAPESP; process numbers 2017/20542-3, 2018/07568-6, 2018/20872-6 and
   2019/00227-1).
CR Aoyama H, 2006, INT J MOL MED, V18, P433
   Arizmendi C., 1999, J BIOL CHEM, V287, P37340
   Cakir I, 2019, TRENDS ENDOCRIN MET, V30, P163, DOI 10.1016/j.tem.2019.01.002
   Canciglieri PH, 2018, LIFE SCI, V210, P209, DOI 10.1016/j.lfs.2018.09.006
   Choi RH, 2019, FASEB J, V33, P5654, DOI 10.1096/fj.201802145RR
   Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010
   da Rocha AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140020
   de Moura LP, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-8
   Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817
   FOLLI F, 1992, J BIOL CHEM, V267, P22171
   Gan L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01507
   Gaspar RC, 2018, CYTOKINE, V110, P87, DOI 10.1016/j.cyto.2018.04.013
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Kim DH, 2019, AGING-US, V11, P4125, DOI 10.18632/aging.102042
   Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851
   Kumashiro N, 2013, DIABETES, V62, P2183, DOI 10.2337/db12-1311
   Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861
   MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997
   Marinho R, 2012, J CELL PHYSIOL, V227, P2917, DOI 10.1002/jcp.23037
   Marinho R, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0064-x
   Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200
   Muñoz VR, 2018, J PHYSIOL SCI, V68, P493, DOI 10.1007/s12576-017-0559-3
   O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079
   Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pereira RM, 2019, J ENDOCRINOL, V241, P59, DOI 10.1530/JOE-18-0567
   Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80
   Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100
   Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032
   SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803
   SATRUSTEGUI J, 1986, FEBS LETT, V197, P159, DOI 10.1016/0014-5793(86)80318-0
   Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200
   Tikhanovich I., 2014, FOXO TRANSCRIPTION F, V28, P125
   VITORICA J, 1981, ENZYME, V26, P144
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
NR 39
TC 9
Z9 9
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT 1
PY 2020
VL 139
AR 111021
DI 10.1016/j.exger.2020.111021
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA NM0QV
UT WOS:000567810700015
PM 32659331
DA 2024-02-19
ER

PT J
AU Massemin, A
   Goehrig, D
   Flaman, JM
   Jaber, S
   Griveau, A
   Djebali, S
   Marcos, E
   Payen, L
   Marvel, J
   Parent, R
   Adnot, S
   Bertolino, P
   Rieusset, J
   Tortereau, A
   Vindrieux, D
   Bernard, D
AF Massemin, Amelie
   Goehrig, Delphine
   Flaman, Jean-Michel
   Jaber, Sara
   Griveau, Audrey
   Djebali, Sophia
   Marcos, Elisabeth
   Payen, Lea
   Marvel, Jacqueline
   Parent, Romain
   Adnot, Serge
   Bertolino, Philippe
   Rieusset, Jennifer
   Tortereau, Antonin
   Vindrieux, David
   Bernard, David
TI Loss of <i>Pla2r1</i> decreases cellular senescence and age-related
   alterations caused by aging and Western diets
SO AGING CELL
LA English
DT Article; Early Access
DE aging; cellular senescence; liver; Western diet
ID FATTY LIVER-DISEASE; STELLATE CELLS; IMMUNOSENESCENCE
AB Cellular senescence is induced by many stresses including telomere shortening, DNA damage, oxidative, or metabolic stresses. Senescent cells are stably cell cycle arrested and they secrete many factors including cytokines and chemokines. Accumulation of senescent cells promotes many age-related alterations and diseases. In this study, we investigated the role of the pro-senescent phospholipase A2 receptor 1 (PLA2R1) in regulating some age-related alterations in old mice and in mice subjected to a Western diet, whereas aged wild-type mice displayed a decreased ability to regulate their glycemia during glucose and insulin tolerance tests, aged Pla2r1 knockout (KO) mice efficiently regulated their glycemia and displayed fewer signs of aging. Loss of Pla2r1 was also found protective against the deleterious effects of a Western diet. Moreover, these Pla2r1 KO mice were partially protected from diet-induced senescent cell accumulation, steatosis, and fibrosis. Together these results support that Pla2r1 drives several age-related alterations, especially in the liver, arising during aging or through a Western diet.
C1 [Massemin, Amelie; Goehrig, Delphine; Flaman, Jean-Michel; Jaber, Sara; Griveau, Audrey; Parent, Romain; Bertolino, Philippe; Vindrieux, David; Bernard, David] Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard, Inserm U1052,CNRS UMR 5286, Lyon, France.
   [Massemin, Amelie; Goehrig, Delphine; Flaman, Jean-Michel; Bertolino, Philippe; Vindrieux, David; Bernard, David] Equipe Labellisee Ligue Canc, Lyon, France.
   [Djebali, Sophia; Marvel, Jacqueline] Univ Lyon, Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Ctr Int Rech Infectiol,Inserm U1111,CNRS UMR5308, Lyon, France.
   [Marcos, Elisabeth] Hop Henri Mondor, AP HP, Dept Physiol Explorat fonct, INSERM U955,FHU SENEC, Creteil, France.
   [Payen, Lea] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Lab Biochim & Biol Mol, Pierre Benite, France.
   [Rieusset, Jennifer] Lyon 1 Univ, CarMeN Lab, UMR INSERM U1060, INRA U1397, Pierre Benite, France.
   [Tortereau, Antonin] Univ Lyon, VetAgro Sup, Interact Cellules Environm ICE, Marcy Letoile, France.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); UNICANCER; Centre Leon Berard; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Claude Bernard Lyon 1; Universite Claude Bernard Lyon 1; Centre National
   de la Recherche Scientifique (CNRS); CNRS - National Institute for
   Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Henri-Mondor - APHP; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Claude Bernard Lyon 1; CHU Lyon; Universite Claude Bernard Lyon 1;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   INRAE; VetAgro Sup
RP Bernard, D (corresponding author), Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard, Inserm U1052,CNRS UMR 5286, Lyon, France.
EM david.bernard@lyon.unicancer.fr
RI Bertolino, philippe/D-4072-2018; DJEBALI, SOPHIA/A-1798-2017; Bernard,
   David/D-6265-2018
OI Bertolino, philippe/0000-0001-8064-8269; flaman,
   jean-michel/0000-0003-3544-0199; DJEBALI, SOPHIA/0000-0002-0567-5387;
   Parent, Romain/0000-0002-3645-7008; Bernard, David/0000-0002-1557-2074
FU We thank laboratory members for helpful suggestions and collaborations,
   Audrey Ziverec for creating ImageJ automatic macro and Brigitte Manship
   for correcting and editing the manuscript. This work was supported by la
   ligue rgionale AURA contre le C; Ligue Contre le Cancer
FX Ligue Contre le Cancer
CR Aghali A, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11111781
   Aiello A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02247
   Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Barbé-Tuana FM, 2021, AGING-US, V13, P1686, DOI 10.18632/aging.202527
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Beaulieu D, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00752-2020
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0
   Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chang A. M., 2011, Handbook of the Biology of Aging, V4, P373, DOI [10.1016/B978-0-12-378638-8.00017-8, DOI 10.1016/B978-0-12-378638-8.00017-8]
   Chao HW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020298
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cox LS, 2020, LANCET HEALTH LONGEV, V1, pE55, DOI 10.1016/S2666-7568(20)30011-8
   Dees C, 2021, EXP DERMATOL, V30, P121, DOI 10.1111/exd.14193
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530
   Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752
   Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588
   Griveau A, 2018, AGING CELL, V17, DOI 10.1111/acel.12835
   Hanasaki K, 1997, J BIOL CHEM, V272, P32792, DOI 10.1074/jbc.272.52.32792
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Huna A, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03468-3
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Kalyani RR, 2013, ENDOCRIN METAB CLIN, V42, P333, DOI 10.1016/j.ecl.2013.02.010
   Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002
   Kowald A, 2020, AGING CELL, V19, DOI 10.1111/acel.13270
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Lian JY, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00986-z
   Mehdizadeh M, 2022, NAT REV CARDIOL, V19, P250, DOI 10.1038/s41569-021-00624-2
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Merdji H, 2021, VASC PHARMACOL, V141, DOI 10.1016/j.vph.2021.106922
   Mishina H, 2014, CIRC RES, V114, P493, DOI 10.1161/CIRCRESAHA.114.302319
   Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728
   Nassir Fatiha, 2015, Gastroenterol Hepatol (N Y), V11, P167
   Nolin JD, 2016, AM J RESP CELL MOL, V55, P825, DOI 10.1165/rcmb.2015-0150OC
   Ogrodnik M, 2017, CELL STRESS, V1, P70, DOI 10.15698/cst2017.10.108
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Risk C., 2018, Hyperglycemia, and Cardiovascular Risk, V123, P886, DOI [10.1161/CIRCRESAHA.118.312806, DOI 10.1161/CIRCRESAHA.118.312806]
   Rodriguez IJ, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.604591
   Rossi M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071740
   Saul D, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32552-1
   Schafer MJ, 2017, MOL CELL ENDOCRINOL, V455, P93, DOI 10.1016/j.mce.2016.08.047
   Victorelli S, 2017, EBIOMEDICINE, V21, P14, DOI 10.1016/j.ebiom.2017.03.027
   Vindrieux D, 2013, CANCER RES, V73, P6334, DOI 10.1158/0008-5472.CAN-13-0318
   Walton KL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00461
   Xu WL, 2020, SEMIN IMMUNOPATHOL, V42, P559, DOI 10.1007/s00281-020-00824-x
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
NR 64
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 SEP 4
PY 2023
DI 10.1111/acel.13971
EA SEP 2023
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA R1EL8
UT WOS:001061841600001
PM 37667516
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lee, SJ
   Lee, DY
   O'Connell, JF
   Egan, JM
   Kim, Y
AF Lee, Su-Jeong
   Lee, Da-Yeon
   O'Connell, Jennifer F.
   Egan, Josephine M.
   Kim, Yoo
TI Black Ginseng Ameliorates Cellular Senescence via p53-p21/p16 Pathway in
   Aged Mice
SO BIOLOGY-BASEL
LA English
DT Article
DE black ginseng; cellular senescence; senolytics; complement C1q;
   beta-catenin; p53; p21; p16
ID COMPLEMENT; EXPRESSION; MECHANISMS; EXTRACT; DISEASE; CELLS; WHITE; C1Q;
   RED; P53
AB Simple Summary The goal of this study was to examine if BG impacts the aging process, specifically cellular senescence, using in vitro and aged mouse models. Primary mouse embryonic fibroblasts (MEFs) and aged mice (18 months old) showed that BG supplementation retarded cellular senescence. Of note, BG-supplemented aged mice had remarkedly altered hepatic genes involved in the aging process as it caused less activation of the canonical senescence pathway. These observations demonstrated that BG positively impacts the age-related phenotype by controlling the expression of cellular senescence in the liver and other metabolic organs such as skeletal muscle and white adipose tissue.
   Cellular senescence, one of the hallmarks of aging, refers to permanent cell cycle arrest and is accelerated during the aging process. Black ginseng (BG), prepared by a repeated steaming and drying process nine times from fresh ginseng (Panax ginseng C.A. Meyer), is garnering attention for herbal medicine due to its physiological benefits against reactive oxygen species (ROS), inflammation, and oncogenesis, which are common cues to induce aging. However, which key nodules in the cellular senescence process are regulated by BG supplementation has not been elucidated yet. In this study, we investigated the effects of BG on cellular senescence using in vitro and aged mouse models. BG-treated primary mouse embryonic fibroblasts (MEFs) in which senescence was triggered by ionizing radiation (IR) expressed less senescence-associated beta-galactosidase (SA-beta-gal)-positive stained cells. In our aged mice (18 months old) study, BG supplementation (300 mg/kg) for 4 weeks altered hepatic genes involved in the aging process. Furthermore, we found BG supplementation downregulated age-related inflammatory genes, especially in the complement system. Based on this observation, we demonstrated that BG supplementation led to less activation of the canonical senescence pathway, p53-dependent p21 and p16, in multiple metabolic organs such as liver, skeletal muscle and white adipose tissue. Thus, we suggest that BG is a potential senolytic candidate that retards cellular senescence.
C1 [Lee, Su-Jeong; Lee, Da-Yeon; Kim, Yoo] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA.
   [O'Connell, Jennifer F.; Egan, Josephine M.] Natl Inst Aging NIA, Lab Clin Invest, Baltimore, MD 21224 USA.
C3 Oklahoma State University System; Oklahoma State University - Stillwater
RP Kim, Y (corresponding author), Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA.
EM crystal.lee10@okstate.edu; dayeon.lee@okstate.edu;
   jennifer.oconnell@nih.gov; eganj@grc.nia.nih.gov; yoo.kim@okstate.edu
OI Kim, Yoo/0000-0002-4525-1319; Lee, Da-Yeon/0000-0002-4085-0689; Lee,
   Su-Jeong/0000-0003-0819-8982; O'Connell, Jennifer
   Fiori/0000-0002-4679-0023
FU Intramural Research Program of the National Institute on Aging; Vice
   President of Research's office at Oklahoma State University [1-156214]
FX This research is supported by the Intramural Research Program of the
   National Institute on Aging, and by start-up funding from the Vice
   President of Research's office at Oklahoma State University (1-156214).
CR An MY, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10010062
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Choudhry QN, 2019, J GINSENG RES, V43, P179, DOI 10.1016/j.jgr.2017.10.003
   Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912
   Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139
   Filipová A, 2015, CELL BIOL INT, V39, P943, DOI 10.1002/cbin.10462
   Hara E, 1996, MOL CELL BIOL, V16, P859
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Jeong SY, 2020, AM J CHINESE MED, V48, P1091, DOI 10.1142/S0192415X20500536
   Jin Y, 2015, PLANT FOOD HUM NUTR, V70, P141, DOI 10.1007/s11130-015-0470-0
   Jung JS, 2010, BIOCHEM BIOPH RES CO, V397, P323, DOI 10.1016/j.bbrc.2010.05.117
   Kang KS, 2006, BIOL PHARM BULL, V29, P750, DOI 10.1248/bpb.29.750
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913
   Kouser L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00317
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Lee MR, 2011, J GINSENG RES, V35, P421, DOI 10.5142/jgr.2011.35.4.421
   Lee S.-J., 2022, UNPUB
   Lee SR, 2009, TOXICOL IN VITRO, V23, P47, DOI 10.1016/j.tiv.2008.10.001
   Lee SJ, 2022, AGING-US, V14, P225, DOI 10.18632/aging.203821
   Lee YY, 2019, PHYTOMEDICINE, V54, P169, DOI 10.1016/j.phymed.2018.09.186
   Lehmann M, 2020, CELL SIGNAL, V70, DOI 10.1016/j.cellsig.2020.109588
   Li WJ, 2020, EXP THER MED, V20, P2631, DOI 10.3892/etm.2020.9022
   Li W, 2019, MECH AGEING DEV, V181, P1, DOI 10.1016/j.mad.2019.05.001
   Li XG, 2012, LIFE SCI J, V9, P679
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   Liu JY, 2019, P NATL ACAD SCI USA, V116, P2603, DOI 10.1073/pnas.1818313116
   Liu ZH, 2020, CLIN SCI, V134, P315, DOI 10.1042/CS20190966
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mankhong S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061385
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Metwaly AM, 2019, MOLECULES, V24, DOI 10.3390/molecules24101856
   Mijit M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030420
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047
   Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252
   Nayak A, 2010, IMMUNOL LETT, V131, P139, DOI 10.1016/j.imlet.2010.03.012
   Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016
   Paez-Ribes M, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810234
   Palmer AK, 2019, DIABETOLOGIA, V62, P1835, DOI 10.1007/s00125-019-4934-x
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Park JY, 2018, J GINSENG RES, V42, P524, DOI 10.1016/j.jgr.2017.07.006
   Pérez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691
   Prange W, 2003, J PATHOL, V201, P250, DOI 10.1002/path.1448
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Schafer MJ, 2017, MOL CELL ENDOCRINOL, V455, P93, DOI 10.1016/j.mce.2016.08.047
   Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011
   Song JH, 2020, J GINSENG RES, V44, P267, DOI 10.1016/j.jgr.2018.12.005
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yoon SJ, 2015, BIOCHEM BIOPH RES CO, V463, P1184, DOI 10.1016/j.bbrc.2015.06.080
   Zamboni M, 2021, EXP GERONTOL, V143, DOI 10.1016/j.exger.2020.111162
   Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9
NR 61
TC 4
Z9 4
U1 6
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD AUG
PY 2022
VL 11
IS 8
AR 1108
DI 10.3390/biology11081108
PG 12
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 4B8YC
UT WOS:000846054300001
PM 35892965
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Luo, D
   Jin, B
   Zhai, XY
   Li, J
   Liu, CY
   Guo, W
   Li, JX
AF Luo, Dan
   Jin, Bin
   Zhai, Xiangyu
   Li, Jing
   Liu, Chuanyong
   Guo, Wei
   Li, Jingxin
TI Oxytocin promotes hepatic regeneration in elderly mice
SO ISCIENCE
LA English
DT Article
ID FATTY LIVER-DISEASE; AUTOPHAGY MAINTAINS; RISK-FACTORS; CELLS;
   HEPATOCYTES; PROGRESSION; PREVALENCE; METABOLISM; FIBROSIS; MOUSE
AB Liver aging impairs the ability of hepatocyte regeneration. Recent studies have found that oxytocin (OT) plays an important role in promoting tissue repair and maintaining differentiation and regeneration of stem cells. Here, we reported that OT receptors, which are specifically located in hepatocytes, decrease with aging in human and mice. Interestingly, the level of serum OT also decline with age. Notably, OT promotes hepatocyte regeneration only in aged mice but not in young mice in vitro and in vivo. Further studies reveal that OT promotes autophagy in either AML12 mouse hepatocytes or aged mice after partial hepatectomy or with CCl4-induced acute liver injury. In conclusion, OT promotes liver regeneration, especially in aged mice, which may be achieved by promoting autophagy. All these results support the possibility of OT and its analog being a potent anti-aging drug and promote liver rejuvenation.
C1 [Luo, Dan; Liu, Chuanyong; Li, Jingxin] Shandong Univ, Dept Physiol, Sch Basic Med Sci, Cheeloo Coll Med, Jinan 250012, Peoples R China.
   [Jin, Bin; Zhai, Xiangyu; Guo, Wei] Shandong Univ, Dept Gen Surg, Qilu Hosp, Jinan 250012, Peoples R China.
   [Li, Jing] Cent Hosp Zibo, Dept Pathol, Zibo 255036, Peoples R China.
C3 Shandong University; Shandong University
RP Li, JX (corresponding author), Shandong Univ, Dept Physiol, Sch Basic Med Sci, Cheeloo Coll Med, Jinan 250012, Peoples R China.; Guo, W (corresponding author), Shandong Univ, Dept Gen Surg, Qilu Hosp, Jinan 250012, Peoples R China.
EM jingxin@sdu.edu.cn; guowei_182@126.com
RI wang, qi/ITT-9652-2023; li, jy/HTT-1535-2023; LI, Jing/HNB-5575-2023;
   Liu, Jing/IQX-0664-2023; Li, Jing/GYU-5036-2022; li, jian/IAQ-2794-2023;
   Luo, Dan/HZM-2412-2023; cao, yutong/JJF-4531-2023
OI Li, Jing/0000-0002-0319-9700; li, jingxin/0000-0001-7370-703X
FU National Key Research and Development Program of China [2016YFC1302203];
   Taishan Scholars Program, Shandong Key Research and Development Program
   [2017GSF218032, 2019GSF108012]; Rongxiang Regenerative Medicine
   Foundation of Shandong University [2019SDRX-13]
FX This work was supported by grants from the National Key Research and
   Development Program of China (2016YFC1302203), Taishan Scholars Program,
   Shandong Key Research and Development Program (2017GSF218032,
   2019GSF108012), and Rongxiang Regenerative Medicine Foundation of
   Shandong University (No. 2019SDRX-13).
CR Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3
   Beranger GE, 2014, ENDOCRINOLOGY, V155, P1340, DOI 10.1210/en.2013-1688
   Cho SY, 2019, BRIT J DERMATOL, V181, P1216, DOI 10.1111/bjd.17824
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127
   Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082
   Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781
   Friebe-Hoffmann U, 2007, REGUL PEPTIDES, V142, P78, DOI 10.1016/j.regpep.2007.01.012
   Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Hodes RJ, 2016, ANN NY ACAD SCI, V1386, P45, DOI 10.1111/nyas.13299
   Houshmand F, 2009, PEPTIDES, V30, P2301, DOI 10.1016/j.peptides.2009.09.010
   Hu HL, 2018, CELL, V175, P1591, DOI 10.1016/j.cell.2018.11.013
   Jankowski M, 1998, P NATL ACAD SCI USA, V95, P14558, DOI 10.1073/pnas.95.24.14558
   Ji HY, 2019, CARCINOGENESIS, V40, P1395, DOI 10.1093/carcin/bgz064
   Kung JWC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/984248
   Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001
   Mankarious A, 2016, INT J ONCOL, V48, P1805, DOI 10.3892/ijo.2016.3410
   Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ryder SD, 2004, GUT, V53, P451, DOI 10.1136/gut.2003.021691
   SOLOFF MS, 1977, FED PROC, V36, P1861
   Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634
   Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9
   Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243
   Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   Serrano MT, 2010, CLIN TRANSPLANT, V24, P543, DOI 10.1111/j.1399-0012.2009.01135.x
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   Wakabayashi H, 2002, J SURG RES, V106, P246, DOI 10.1006/jsre.2002.6462
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
   Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060
   Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516
   Zhou J, 2017, AGING-US, V9, P583, DOI 10.18632/aging.101181
NR 45
TC 9
Z9 9
U1 1
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD FEB 19
PY 2021
VL 24
IS 2
AR 102125
DI 10.1016/j.isci.2021.102125
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA QL7MH
UT WOS:000621266700095
PM 33659883
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Schmucker, DL
AF Schmucker, DL
TI Aging and the liver: An update
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID HEPATIC DRUG-METABOLISM; EPIDERMAL GROWTH-FACTOR; RAT-LIVER; OLD RATS;
   HEPATOCELLULAR-CARCINOMA; STEREOLOGICAL ANALYSIS; QUANTITATIVE-ANALYSIS;
   LYSOSOMAL ACTIVITY; HUMAN HEPATOCYTES; AGE
AB The issue of whether or not liver function is compromised in the elderly population remains unresolved. Numerous age-related changes in hepatic structure and function have been described but many of these observations are qualitative, were made under suboptimal experimental conditions, or are simply contradictory Changes in hepatocellular structural parameters, e.g., increased hepatocyte size, increase in the number of binucleated cells, altered mitochondria, and endoplasmic reticulum, have been reported. However, quantitative morphological analyses have refuted many of these observations. There are few functional data that col relate with structural changes. Serum and biliary cholesterol appear to rise, predisposing elderly people to increased incidences of corollary disease and gallstones, respectively. The rats of liver regeneration declines ill old animals, but the regenerative capacity remains unchanged, perhaps reflecting all age-associated reduction in the response to hepatotrophic factors. This senescent change has important clinical implications with regard to surgical intervention for liver disease, e.g., resection or transplantation. Nevertheless, most outcomes studies suggest that age alone should riot be a determining factor in such clinical decisions. Geriatric patients exhibit a decline ill the hepatic clearance of certain drugs and a marked increase in the frequency of adverse drug reactions, reflecting an increase in polypharmacy regimens and declines in liver volume and blood flow rather than reduced Phase I metabolism. Although the livers of elderly subjects are characterized by a decline in adaptive responsiveness and reduced reserve capacity, clinical tests suggest that liver function is well-maintained in this age group.
C1 Dept Vet Affairs Med Ctr, Cell Biol & Aging Sect 115E, San Francisco, CA 94121 USA.
   Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco
RP Schmucker, DL (corresponding author), Dept Vet Affairs Med Ctr, Cell Biol & Aging Sect 115E, 4150 Clement St, San Francisco, CA 94121 USA.
EM SCHMUCKER.DOUGLAS_L@SANFRANCISCO.VA.GOV
CR ADAM R, 1991, TRANSPLANT P, V23, P2602
   Adelman RC, 1972, ADV GERONTOLOGICAL R, V4, P1
   ANDREW W, 1971, ANATOMY AGING MAN AN
   BARZ H, 1977, EXP PATHOL-JENA, V14, P55, DOI 10.1016/S0014-4908(77)80091-4
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   BIANCHI L, 1988, FALK S SERIES, V47
   BLAND G, 1991, INT CONGR SER, V940, P279
   BOHNEN N, 1992, Z GERONTOL, V25, P339
   Bowman Lee, 1996, Pharmacoepidemiology and Drug Safety, V5, P9, DOI 10.1002/(SICI)1099-1557(199601)5:1<9::AID-PDS192>3.3.CO;2-U
   BRAVO E, 1994, J BIOCHEM-TOKYO, V115, P833, DOI 10.1093/oxfordjournals.jbchem.a124425
   BROMLEY PN, 1994, TRANSPLANTATION, V58, P800, DOI 10.1097/00007890-199410150-00009
   CARRIERE R, 1967, EXP CELL RES, V46, P533, DOI 10.1016/0014-4827(67)90379-5
   CASTELLI WP, 1989, AM J CARDIOL, V63, pH12
   CHEN MF, 1991, ACTA CHIR-EUR J SURG, V157, P591
   DAVID H, 1985, EXP PATHOL-JENA, P1
   DELACRUZ J, 1990, INT J BIOCHEM, V22, P729, DOI 10.1016/0020-711X(90)90008-Q
   DEPRIESTER W, 1984, MECH AGEING DEV, V26, P205, DOI 10.1016/0047-6374(84)90094-0
   DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   ERICSSON S, 1991, LIVER AGING 1990, P295
   FABBRI A, 1994, LIVER, V14, P288
   FINDOR J, 1973, ACTA HEPATO-GASTRO, V20, P200
   FLORINI J R, 1975, Experimental Aging Research, V1, P137, DOI 10.1080/03610737508257955
   FONG Y, 1995, ANN SURG, V222, P426
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   GAHAN PB, 1984, EXP GERONTOL, V19, P355, DOI 10.1016/0531-5565(84)90044-5
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1053/jhep.1996.v24.pm0008707288
   HORBACH GJM, 1987, REV BIOL RES AGING, V3, P485
   HROBACH GJ, 1986, THESIS U MAASTRICHT
   HUNT CM, 1992, MECH AGEING DEV, V64, P189, DOI 10.1016/0047-6374(92)90106-N
   HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G
   HURWITZ N, 1969, BMJ-BRIT MED J, V279, P536
   JOH T, 1986, CLIN CHIM ACTA, V158, P81, DOI 10.1016/0009-8981(86)90118-X
   KATO R, 1968, J BIOCHEM-TOKYO, V63, P406
   KITANI K, 1986, HEPATOLOGY, V6, P316, DOI 10.1002/hep.1840060227
   Knook D L, 1975, Adv Exp Med Biol, V53, P155
   KNOOK DL, 1976, MECH AGEING DEV, V5, P389, DOI 10.1016/0047-6374(76)90036-1
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   LINDNER J, 1977, LIVER AGEING, P23
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   MARTI U, 1993, HEPATOLOGY, V18, P1432, DOI 10.1002/hep.1840180623
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MENTHA G, 1992, BRIT J SURG, V79, P557, DOI 10.1002/bjs.1800790627
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MUNRO HN, 1978, POSTGRAD MED, V63, P143, DOI 10.1080/00325481.1978.11714785
   NAGASUE N, 1993, SURGERY, V113, P148
   NAGINO M, 1993, WORLD J SURG, V17, P250, DOI 10.1007/BF01658937
   NOLAN L, 1988, J AM GERIATR SOC, V36, P142, DOI 10.1111/j.1532-5415.1988.tb01785.x
   O'Mahony M S, 1994, Semin Gastrointest Dis, V5, P197
   OHTSUBO K, 1986, MECH AGEING DEV, V36, P125, DOI 10.1016/0047-6374(86)90013-8
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   RABES HM, 1969, CANCER RES, V29, P817
   RICHARDSON A, 1985, REV BIOL RES AGING, V2, P395
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SATO T, 1979, MECH AGEING DEV, V11, P171, DOI 10.1016/0047-6374(79)90052-6
   SATO T, 1975, ACTA PATHOL JAPON, V25, P403
   SAWADA N, 1988, CANCER RES, V48, P1618
   SAWADA N, 1989, EXP CELL RES, V181, P584, DOI 10.1016/0014-4827(89)90115-8
   SCHMUCKER DL, 1985, GASTROENTEROLOGY, V88, P436, DOI 10.1016/0016-5085(85)90504-9
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   SCHMUCKER DL, 1979, AGE, V2, P93, DOI 10.1007/BF02432213
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1977, SCIENCE, V197, P1005, DOI 10.1126/science.887935
   SCHMUCKER DL, 1990, EXP GERONTOL, V25, P403, DOI 10.1016/0531-5565(90)90029-2
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SCHMUCKER DL, 1990, J ELECT MICROSCOP, V14, P102
   SLEYSTER EC, 1980, MECH AGEING DEV, V14, P443, DOI 10.1016/0047-6374(80)90015-9
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   Tauchi H., 1978, LIVER AGING 1978, P3
   THOMPSON EN, 1965, GUT, V6, P266, DOI 10.1136/gut.6.3.266
   THOMPSON EN, 1977, LIVER AGEING, P115
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   Van Bezooijen CFA, 1972, MECH AGEING DEV, V1, P351, DOI 10.1016/0047-6374(72)90079-6
   VANBEZOOIJEN CFA, 1983, PHARM MORPHOLOGICAL, P115
   VANBEZZOIJEN CF, 1978, LIVER AGING 1978, P227
   VANMANEN R, 1983, MECH AGEING DEV, V22, P159, DOI 10.1016/0047-6374(83)90109-4
   WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   WING SS, 1991, BIOCHEM J, V275, P165, DOI 10.1042/bj2750165
   WOODHOUSE KW, 1989, TOPICS AGING RES EUR, V13
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 86
TC 129
Z9 136
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 1998
VL 53
IS 5
BP B315
EP B320
DI 10.1093/gerona/53A.5.B315
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 120JK
UT WOS:000075953100001
PM 9754128
OA Bronze
DA 2024-02-19
ER

PT J
AU Frohlich, J
   Raffaele, M
   Skalova, H
   Leire, E
   Pata, I
   Pata, P
   Gorbunova, V
   Vinciguerra, M
AF Frohlich, Jan
   Raffaele, Marco
   Skalova, Helena
   Leire, Eric
   Pata, Illar
   Pata, Pille
   Gorbunova, Vera
   Vinciguerra, Manlio
TI Human centenarian-associated SIRT6 mutants modulate hepatocyte
   metabolism and collagen deposition in multilineage hepatic 3D spheroids
SO GEROSCIENCE
LA English
DT Article; Early Access
DE SIRT6; Liver; Spheroids; Aging; Hepatocytes; Hepatic stellate cells;
   Metabolomics
ID FATTY LIVER-DISEASE; ENHANCING METABOLOMICS RESEARCH; STRAND-BREAK
   REPAIR; HEPATOCELLULAR-CARCINOMA; CARDIAC-HYPERTROPHY; PROTECTS;
   OBESITY; CANCER; STEATOHEPATITIS; EPIDEMIOLOGY
AB Non-alcoholic fatty liver disease (NAFLD), encompassing fatty liver and its progression into nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC), is one of the rapidly rising health concerns worldwide. SIRT6 is an essential nuclear sirtuin that regulates numerous pathological processes including insulin resistance and inflammation, and recently it has been implicated in the amelioration of NAFLD progression. SIRT6 overexpression protects from formation of fibrotic lesions. However, the underlying molecular mechanisms are not fully delineated. Moreover, new allelic variants of SIRT6 (N308K/A313S) were recently associated with the longevity in Ashkenazi Jews by improving genome maintenance and DNA repair, suppressing transposons and killing cancer cells. Whether these new SIRT6 variants play different or enhanced roles in liver diseases is currently unknown. In this study, we aimed to clarify how these new centenarian-associated SIRT6 genetic variants affect liver metabolism and associated diseases. We present evidence that overexpression of centenarian-associated SIRT6 variants dramatically altered the metabolomic and secretomic profiles of unchallenged immortalized human hepatocytes (IHH). Most amino acids were increased in the SIRT6 N308K/A313S overexpressing IHH when compared to IHH transfected with the SIRT6 wild-type sequence. Several unsaturated fatty acids and glycerophospholipids were increased, and ceramide tended to be decreased upon SIRT6 N308K/A313S overexpression. Furthermore, we found that overexpression of SIRT6 N308K/A313S in a 3D hepatic spheroid model formed by the co-culture of human immortalized hepatocytes (IHH) and hepatic stellate cells (LX2) inhibited collagen deposition and fibrotic gene expression in absence of metabolic or dietary challenges. Hence, our findings suggest that novel longevity associated SIRT6 N308K/A313S variants could favor the prevention of NASH by altering hepatocyte proteome and lipidome.
C1 [Frohlich, Jan; Raffaele, Marco; Skalova, Helena; Vinciguerra, Manlio] St Annes Univ Hosp, Int Clin Res Ctr, Pekarska 53, Brno 65691, Czech Republic.
   [Leire, Eric] GenFlow Biosci Srl, Charleroi, Belgium.
   [Leire, Eric] Clin 135, Brussels, Belgium.
   [Pata, Illar; Pata, Pille] IVEX Lab, Tallinn, Estonia.
   [Pata, Pille] Tallinn Univ Technol, Dept Chem & Biotechnol, Tallinn, Estonia.
   [Gorbunova, Vera] Univ Rochester, Dept Biol & Med, Rochester, NY USA.
   [Vinciguerra, Manlio] Res Inst Med Univ, Dept Translat Stem Cell Biol, Varna, Bulgaria.
   [Vinciguerra, Manlio] Liverpool John Moores Univ, Liverpool Ctr Cardiovasc Sci LCCS, Liverpool, England.
C3 St Anne's University Hospital Brno (FNUSA-ICRC); Tallinn University of
   Technology; University of Rochester; Liverpool John Moores University
RP Vinciguerra, M (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Pekarska 53, Brno 65691, Czech Republic.
EM manlio.vinciguerra@fnusa.cz
RI Vinciguerra, Manlio/N-1309-2015; Pata, Illar/HLH-7992-2023; Frohlich,
   Jan/AAI-4184-2021
OI Vinciguerra, Manlio/0000-0002-1768-3894; Frohlich,
   Jan/0000-0002-8312-0483
FU GenFlow Biosciences (Cambridge, MA, US); Ministry of Education and
   Science of Bulgaria; Bulgarian National Science Fund [KP-06-DV/4];
   European Regional Development Fund-Project MAGNET [KP-06-N53/6]; 
   [CZ.02.1.01/0.0/0.0/15_003/0000492]
FX This work was supported by an ad hoc grant of GenFlow Biosciences
   (Cambridge, MA, US); by the Ministry of Education and Science of
   Bulgaria under the National Scientific Programme "Excellent Research and
   People for the Development of European Science" 2021 (VIHREN) of the
   Bulgarian National Science Fund, contract #KP-06-DV/4 from 15.12.2021;
   by the Bulgarian National Science Fund, contract #KP-06-N53/6 from
   11.11.2021; and by the European Regional Development Fund-Project MAGNET
   (No. CZ.02.1.01/0.0/0.0/15_003/0000492)
CR Aggarwal S, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00356
   Atzmon G, 2004, J AM GERIATR SOC, V52, P274, DOI 10.1111/j.1532-5415.2004.52068.x
   Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106
   Ayonrinde OT, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100261
   Bang In Hyuk, 2019, Exp Mol Med, V51, P1
   Barr J, 2012, J PROTEOME RES, V11, P2521, DOI 10.1021/pr201223p
   Beltrao P, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304521
   Berzlanovich AM, 2005, J GERONTOL A-BIOL, V60, P862, DOI 10.1093/gerona/60.7.862
   Brunner SF, 2019, NATURE, V574, P538, DOI 10.1038/s41586-019-1670-9
   Chen L, 2019, J BIOL CHEM, V294, P1579, DOI 10.1074/jbc.RA118.005309
   D'Onofrio N, 2018, ANTIOXID REDOX SIGN, V28, P711, DOI 10.1089/ars.2017.7178
   De Gottardi A, 2007, LAB INVEST, V87, P792, DOI 10.1038/labinvest.3700590
   Demolli S, 2015, J MOL CELL CARDIOL, V88, P111, DOI 10.1016/j.yjmcc.2015.10.009
   Dessai AS, 2023, CANCER GENE THER, V30, P548, DOI 10.1038/s41417-022-00521-x
   Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   Friden M, 2022, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.814951
   Frohlich J, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158920
   Fujisawa K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103451
   Giallongo S, 2022, STEM CELLS, V40, P35, DOI 10.1093/stmcls/sxab004
   Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865
   Golabi P, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0972-6
   Gores GJ, 2014, NAT REV GASTRO HEPAT, V11, P645, DOI 10.1038/nrgastro.2014.157
   Hardy T, 2020, CONTEMP CLIN TRIALS, V98, DOI 10.1016/j.cct.2020.106175
   Hirvonen K, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0401-z
   Holecek M, 2017, NUTRITION, V41, P80, DOI 10.1016/j.nut.2017.04.003
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Jegatheesan P, 2016, BRIT J NUTR, V116, P191, DOI 10.1017/S0007114516001793
   Ka SO, 2017, FASEB J, V31, P3999, DOI 10.1096/fj.201700098RR
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x
   Kanwal F, 2021, GASTROENTEROLOGY, V161, P1030, DOI 10.1053/j.gastro.2021.04.074
   Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009
   Kodo K, 2016, NAT CELL BIOL, V18, P1031, DOI 10.1038/ncb3411
   Korotkov A, 2021, TRENDS CELL BIOL, V31, P994, DOI 10.1016/j.tcb.2021.06.009
   Kuang JY, 2017, DIABETES, V66, P1159, DOI 10.2337/db16-1225
   Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033
   Lee DY, 2019, J CANCER PREV, V24, P72, DOI 10.15430/JCP.2019.24.2.72
   Lin HY, 2016, TRANSL CANCER RES, V5, pS951, DOI 10.21037/tcr.2016.10.55
   Lo Re O, 2018, EPIGENETICS-US, V13, P829, DOI 10.1080/15592294.2018.1514239
   Lo Re O, 2018, HEPATOLOGY, V67, P636, DOI 10.1002/hep.29519
   Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723
   Martínez-Arranz I, 2015, J PROTEOMICS, V127, P275, DOI 10.1016/j.jprot.2015.01.019
   Martínez-Arranz I, 2015, DATA BRIEF, V3, P155, DOI 10.1016/j.dib.2015.02.008
   Mazzoccoli G, 2016, CURR DRUG TARGETS, V17, P783, DOI 10.2174/1389450117666151209120831
   Menghini R, 2022, MOL METAB, V59, DOI 10.1016/j.molmet.2022.101454
   Mouralidarane A, 2015, INT J OBESITY, V39, P1339, DOI 10.1038/ijo.2015.85
   Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005
   Pazienza V, 2014, AGING-US, V6, P35, DOI 10.18632/aging.100632
   Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536
   Pingitore P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071629
   Raffaele M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080277
   Ramos MJ, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103549
   Reeves HL, 2016, DIGEST DIS SCI, V61, P1234, DOI 10.1007/s10620-016-4085-6
   Roichman A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23545-7
   Roichman A, 2017, J GERONTOL A-BIOL, V72, P603, DOI 10.1093/gerona/glw152
   Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8
   Schwabe RF, 2020, GASTROENTEROLOGY, V158, P1913, DOI 10.1053/j.gastro.2019.11.311
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sikarwar AS, 2019, J MEMBRANE BIOL, V252, P509, DOI 10.1007/s00232-019-00091-4
   Simon M, 2022, EMBO J, V41, DOI 10.15252/embj.2021110393
   Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961
   Szántó M, 2020, GENE DEV, V34, P321, DOI 10.1101/gad.334284.119
   TenNapel MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115616
   Tian X, 2019, CELL, V177, P622, DOI 10.1016/j.cell.2019.03.043
   Tilg H, 2021, NAT METAB, V3, P1596, DOI 10.1038/s42255-021-00501-9
   Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37
   Tonkin J, 2012, CURR OPIN PHARMACOL, V12, P372, DOI 10.1016/j.coph.2012.02.010
   Van Meter M, 2011, CELL CYCLE, V10, P3153, DOI 10.4161/cc.10.18.17435
   Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010
   Vinciguerra M, 2013, HEPATOLOGY, V58, P830, DOI 10.1002/hep.26212
   Vvedenskaya O, 2021, J LIPID RES, V62, DOI 10.1016/j.jlr.2021.100104
   Xiong XW, 2016, J ENDOCRINOL, V231, P159, DOI 10.1530/JOE-16-0317
   Yao L, 2017, CELL REP, V20, P641, DOI 10.1016/j.celrep.2017.06.069
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Zhong XL, 2020, CELL MOL GASTROENTER, V10, P341, DOI 10.1016/j.jcmgh.2020.04.005
NR 76
TC 3
Z9 3
U1 2
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 APR
PY 2023
VL 45
IS 2
BP 1177
EP 1196
DI 10.1007/s11357-022-00713-1
EA DEC 2022
PG 20
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 8I9UK
UT WOS:000900810400002
PM 36534275
OA Green Published
DA 2024-02-19
ER

PT J
AU Chen, JL
   Pan, J
   Wang, JX
   Song, K
   Zhu, DD
   Huang, CQ
   Duan, YN
AF Chen, Jinling
   Pan, Jing
   Wang, Jianxin
   Song, Ke
   Zhu, Dandan
   Huang, Caiqun
   Duan, Yinong
TI Soluble egg antigens of <i>Schistosoma</i> <i>japonicum</i> induce
   senescence in activated hepatic stellate cells by activation of the
   STAT3/p53/p21 pathway
SO Scientific Reports
LA English
DT Article
ID LIVER FIBROSIS; CELLULAR SENESCENCE; CANCER-CELLS; DNA-DAMAGE; T-CELLS;
   APOPTOSIS; FIBROGENESIS; EXPRESSION; P53; PROLIFERATION
AB Liver fibrosis is characterized by the activation of hepatic stellate cells (HSCs). Recent findings suggest that senescence of activated HSCs might limit the development of liver fibrosis. Based on previously observed anti-fibrotic effects of soluble egg antigens from Schistosoma japonicum in vitro, we hypothesized that SEA might play a crucial role in alleviating liver fibrosis through promoting senescence of activated HSCs. We show here that SEA inhibited expression of alpha-SMA and procollagen I and promoted senescence of activated HSCs in vitro. In addition, SEA induced an increased expression of P-p53 and p21. Knockdown of p53 inhibited the expression of p21 and failed to induce senescence of activated-HSCs. Phosphorylated STAT3 was elevated upon SEA stimulation, while loss of STAT3 decreased the level of p53 and senescence of HSCs. Results from immunoprecipitation analysis demonstrated that SOCS3 might be involved in the SEA-induced senescence in HSCs through its interaction with p53. This study demonstrates the potential capacity of SEA in restricting liver fibrosis through promoting senescence in HSCs. Furthermore, a novel STAT3-p53-p21 pathway might participate in the observed SEA-mediated senescence of HSCs. Our results suggest that SEA might carry potential therapeutic effects of restraining liver fibrosis through promoting senescence.
C1 [Chen, Jinling; Pan, Jing; Zhu, Dandan; Huang, Caiqun; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.
   [Wang, Jianxin] Nantong Univ, Affiliated Hosp, Lab Med Ctr, Nantong 226001, Jiangsu, Peoples R China.
   [Song, Ke] Peoples Liberat Army, Cent Hosp 153, Orthoped & Traumatol Ctr, Zhengzhou 450042, Henan, Peoples R China.
C3 Nantong University; Nantong University
RP Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China.
EM yinongduan@aliyun.com
RI liu, jiajia/ISS-0316-2023; Duan, yinong/GSD-9438-2022; wang,
   xiao/HZI-9156-2023
OI Chen, Jinling/0000-0003-2992-6571
FU National Natural Science Foundation of China [81471975, 81171589,
   81401683, 81501763]; Jiangsu provincial Natural Science Foundation
   [BK20140435]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD); Nantong University [14B36]
FX This work was supported by National Natural Science Foundation of China
   (Grant Numbers 81471975, 81171589, 81401683, 81501763), the Jiangsu
   provincial Natural Science Foundation (Grant Number BK20140435), the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD) and the Fund of Doctoral Research in Nantong
   University (Grant Number 14B36).
CR Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x
   Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009
   Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479
   Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Capparelli C, 2012, CELL CYCLE, V11, P3599, DOI 10.4161/cc.21884
   Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058
   Deng YR, 2013, J AUTOIMMUN, V46, P25, DOI 10.1016/j.jaut.2013.07.008
   Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003
   Tran D, 2014, AGING CELL, V13, P669, DOI 10.1111/acel.12219
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Fitzgerald AL, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.44
   Gao B, 2013, BBA-MOL BASIS DIS, V1832, P1061, DOI 10.1016/j.bbadis.2012.09.008
   Gu Z., 2013, CLIN DEV IMMUNOL, V2013, DOI DOI 10.1155/2013/134243
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kojima Hirotada, 2013, JAKSTAT, V2, pe25763, DOI 10.4161/jkst.25763
   Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005
   Lee JJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.501
   Liu P, 2013, WORLD J GASTROENTERO, V19, P1230, DOI 10.3748/wjg.v19.i8.1230
   Lundy SK, 2001, INFECT IMMUN, V69, P271, DOI 10.1128/IAI.69.1.271-280.2001
   Nevzorova YA, 2012, HEPATOLOGY, V56, P1140, DOI 10.1002/hep.25736
   Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Sitko JC, 2008, CELL SIGNAL, V20, P2221, DOI 10.1016/j.cellsig.2008.08.011
   Suárez-Cuenca JA, 2008, EXP BIOL MED, V233, P827, DOI 10.3181/0709-RM-247
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106
   Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623
   Xu MY, 2014, BBA-MOL BASIS DIS, V1842, P2237, DOI 10.1016/j.bbadis.2014.07.025
   Yu YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01675
   Zhang H, 2015, J BIOL CHEM, V290, P1129, DOI 10.1074/jbc.M114.590943
   Zhu DD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0640-9
   Zhu ZX, 2016, INT IMMUNOPHARMACOL, V35, P185, DOI 10.1016/j.intimp.2016.03.044
NR 43
TC 24
Z9 27
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 4
PY 2016
VL 6
AR 30957
DI 10.1038/srep30957
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DS6LQ
UT WOS:000380893700001
PM 27489164
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sim, BC
   Kang, YE
   You, SK
   Lee, SE
   Nga, HT
   Lee, HY
   Nguyen, TL
   Moon, JS
   Tian, JW
   Jang, HJ
   Lee, JE
   Yi, HS
AF Sim, Byeong Chang
   Kang, Yea Eun
   You, Sun Kyoung
   Lee, Seong Eun
   Nga, Ha Thi
   Lee, Ho Yeop
   Nguyen, Thi Linh
   Moon, Ji Sun
   Tian, Jingwen
   Jang, Hyo Ju
   Lee, Jeong Eun
   Yi, Hyon-Seung
TI Hepatic T-cell senescence and exhaustion are implicated in the
   progression of fatty liver disease in patients with type 2 diabetes and
   mouse model with nonalcoholic steatohepatitis
SO CELL DEATH & DISEASE
LA English
DT Article
ID MAGNETIC-RESONANCE ELASTOGRAPHY; MECHANISMS; FIBROSIS; THERAPY;
   LYMPHOCYTES; VARIABILITY; OBESITY; BIOPSY
AB Immunosenescence and exhaustion are involved in the development and progression of type 2 diabetes (T2D) and metabolic liver diseases, including fatty liver, fibrosis, and cirrhosis, in humans. However, the relationships of the senescence and exhaustion of T cells with insulin resistance-associated liver diseases remain incompletely understood. To better define the relationship of T2D with nonalcoholic fatty liver disease, 59 patients (mean age 58.7 +/- 11.0 years; 47.5% male) with T2D were studied. To characterize their systemic immunophenotypes, peripheral blood mononuclear cells were analyzed using flow cytometry. Magnetic resonance imaging (MRI)-based proton density fat fraction and MRI-based elastography were performed using an open-bore, vertical-field 3.0 T scanner to quantify liver fat and fibrosis, respectively. The participants with insulin resistance had a significantly larger population of CD28 - CD57+ senescent T cells among the CD4+ and CD8 + T cells than those with lower Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) values. The abundances of senescent CD4+ and CD8 + T cells and the HOMA-IR positively correlated with the severity of liver fibrosis, assessed using MRI-based elastography. Interleukin 15 from hepatic monocytes was found to be an inducer of bystander activation of T cells, which is associated with progression of liver disease in the participants with T2D. Furthermore, high expression of genes related to senescence and exhaustion was identified in CD4+ and CD8 + T cells from the participants with nonalcoholic steatohepatitis or liver cirrhosis. Finally, we have also demonstrated that hepatic T-cell senescence and exhaustion are induced in a diet or chemical-induced mouse model with nonalcoholic steatohepatitis. In conclusion, we have shown that T-cell senescence is associated with insulin resistance and metabolic liver disease in patients with T2D.
C1 [Sim, Byeong Chang; Nga, Ha Thi; Lee, Ho Yeop; Nguyen, Thi Linh; Moon, Ji Sun; Tian, Jingwen; Jang, Hyo Ju; Yi, Hyon-Seung] Chungnam Natl Univ, Sch Med, Lab Endocrinol & Immune Syst, Daejeon, South Korea.
   [Sim, Byeong Chang; Nga, Ha Thi; Lee, Ho Yeop; Nguyen, Thi Linh; Tian, Jingwen; Jang, Hyo Ju; Yi, Hyon-Seung] Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon, South Korea.
   [Kang, Yea Eun; Lee, Seong Eun; Yi, Hyon-Seung] Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon, South Korea.
   [You, Sun Kyoung; Lee, Jeong Eun] Chungnam Natl Univ Hosp, Dept Radiol, Daejeon, South Korea.
C3 Chungnam National University; Chungnam National University; Chungnam
   National University; Chungnam National University; Chungnam National
   University Hospital
RP Yi, HS (corresponding author), Chungnam Natl Univ, Sch Med, Lab Endocrinol & Immune Syst, Daejeon, South Korea.; Yi, HS (corresponding author), Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon, South Korea.; Yi, HS (corresponding author), Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon, South Korea.; Lee, JE (corresponding author), Chungnam Natl Univ Hosp, Dept Radiol, Daejeon, South Korea.
EM antbantb@naver.com; jmpbooks@cnu.ac.kr
FU We are grateful to the participants in these cohorts, as well as the
   field staff of the Department of Endocrinology and Metabolism of
   Chungnam National University Hospital. The graphical abstract was
   created using BioRender.com.; Department of Endocrinology and Metabolism
   of Chungnam National University Hospital
FX We are grateful to the participants in these cohorts, as well as the
   field staff of the Department of Endocrinology and Metabolism of
   Chungnam National University Hospital. The graphical abstract was
   created using BioRender.com.
CR Allison RD, 2009, J INFECT DIS, V200, P619, DOI 10.1086/600107
   Bae JC, 2022, ENDOCRINOL METAB, V37, P455, DOI 10.3803/EnM.2022.1434
   Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706
   Dudek M, 2021, NATURE, V592, DOI 10.1038/s41586-021-03233-8
   Giubilato S, 2011, EUR HEART J, V32, P1214, DOI 10.1093/eurheartj/ehq499
   Harrison SA, 2006, J CLIN GASTROENTEROL, V40, P68, DOI 10.1097/01.mcg.0000190774.91875.d2
   Horst AK, 2016, CELL MOL IMMUNOL, V13, P277, DOI 10.1038/cmi.2015.112
   Kim J, 2018, IMMUNITY, V48, P161, DOI 10.1016/j.immuni.2017.11.025
   Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415
   Lacraz G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162995
   Lau EYM, 2019, CLIN EXP IMMUNOL, V197, P205, DOI 10.1111/cei.13344
   Lebossé F, 2019, EBIOMEDICINE, V49, P258, DOI 10.1016/j.ebiom.2019.10.011
   Lee BW, 2020, DIABETES METAB J, V44, P382, DOI 10.4093/dmj.2020.0010
   LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207
   Ma LC, 2021, J HEPATOL, V75, P1397, DOI 10.1016/j.jhep.2021.06.028
   McKinney EF, 2016, CURR OPIN IMMUNOL, V43, P74, DOI 10.1016/j.coi.2016.09.005
   Morisaka H, 2018, J MAGN RESON IMAGING, V47, P1268, DOI 10.1002/jmri.25868
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7
   Ota T, 2013, DIABETES METAB J, V37, P165
   Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055
   Pavlides M, 2017, AM J CLIN PATHOL, V147, P364, DOI 10.1093/ajcp/aqx011
   Pfister D, 2021, NATURE, V592, P450, DOI 10.1038/s41586-021-03362-0
   Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084
   Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001
   Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606
   Siewko K, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4734063
   Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Venkatesh SK, 2013, J MAGN RESON IMAGING, V37, P544, DOI 10.1002/jmri.23731
   Wabitsch S, 2022, J HEPATOL, V77, P748, DOI 10.1016/j.jhep.2022.03.010
   Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901
   Wang S, 2023, SCI TRANSL MED, V15, DOI 10.1126/scitranslmed.add3949
   Wang ZY, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-98806-y
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4
   Yi HS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1494-4
   Yi HS, 2013, J GASTROEN HEPATOL, V28, P99, DOI 10.1111/jgh.12017
   Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689
NR 40
TC 1
Z9 1
U1 3
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD SEP 21
PY 2023
VL 14
IS 9
AR 618
DI 10.1038/s41419-023-06146-8
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA T1NV3
UT WOS:001075731500001
PM 37735474
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hardwick, LJA
   Kortum, AJ
   Constantino-Casas, F
   Watson, PJ
AF Hardwick, Laura J. A.
   Kortum, Andre J.
   Constantino-Casas, Fernando
   Watson, Penny J.
TI Breed-related expression patterns of Ki67, γH2AX, and p21 during ageing
   in the canine liver
SO VETERINARY RESEARCH COMMUNICATIONS
LA English
DT Article; Early Access
DE Ageing; Canine; Ki67; Liver; Senescence
AB Cellular senescence is a molecular hallmark of ageing that is associated with multiple pathologies, and DNA damage marker gamma H2AX, together with cell cycle inhibitor p21, have been used as senescence markers in multiple species including dogs. Idiopathic canine chronic hepatitis has recognised breed-related differences in predisposition and prognosis, but reasons behind this are poorly understood. This retrospective study using archived post mortem tissue aimed to provide insight into liver ageing in 51 microscopically normal canine livers across seven breed categories, including those with and without increased risk of chronic hepatitis. Immunohistochemistry was conducted for gamma H2AX, p21, and cell proliferation marker Ki67, and the mean number of positive hepatocytes per high power field was determined. All three markers were strongly correlated to each other, but no age-dependent expression was seen in the combined study population. Overall expression levels were low in most dogs, with median values representing less than 1.5% of hepatocytes, but this increased to 20-30% in individual dogs at the upper end of the range. Individual breed differences were noted in two breeds that have increased risk of chronic hepatitis, with English Springer Spaniels having lower expression of Ki67 than other dogs, and Labradors having higher expression of Ki67 and gamma H2AX than other dogs. These results warrant further investigation in these breeds and highlight a need to validate reliable markers of cellular senescence in dogs.
C1 [Hardwick, Laura J. A.; Kortum, Andre J.; Constantino-Casas, Fernando; Watson, Penny J.] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.
   [Hardwick, Laura J. A.] Univ Cambridge, Peterhouse, Trumpington St, Cambridge CB2 1RD, England.
C3 University of Cambridge; University of Cambridge
RP Hardwick, LJA (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.; Hardwick, LJA (corresponding author), Univ Cambridge, Peterhouse, Trumpington St, Cambridge CB2 1RD, England.
EM ljah2@cam.ac.uk
FU Peterhouse Research Fellowship; UK Kennel Club Charitable Trust
   Scientific Project Grant [RG99279-LH]
FX LJAH was funded by a Peterhouse Research Fellowship and a UK Kennel Club
   Charitable Trust Scientific Project Grant [RG99279-LH]. The funding
   sources had no involvement in the study design, data collection,
   analysis, writing of the report or decision to publish.
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bexfield NH, 2012, VET J, V193, P124, DOI 10.1016/j.tvjl.2011.11.024
   Bexfield NH, 2011, VET REC, V169, P415, DOI 10.1136/vr.d4665
   Delhaye M, 1996, HEPATOLOGY, V23, P1003, DOI 10.1002/hep.510230510
   Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9
   Fonseca-Alves CE, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1304-0
   Gilmore KM, 2015, EXP GERONTOL, V71, P14, DOI 10.1016/j.exger.2015.08.008
   Kaeberlein M, 2016, MAMM GENOME, V27, P279, DOI 10.1007/s00335-016-9638-7
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kortum AJ, 2018, J VET INTERN MED, V32, P1629, DOI 10.1111/jvim.15238
   Kraus C, 2013, AM NAT, V181, P492, DOI 10.1086/669665
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mah LJ, 2010, EPIGENETICS-US, V5, P129, DOI 10.4161/epi.5.2.11080
   Merz SE, 2019, J COMP PATHOL, V173, P41, DOI 10.1016/j.jcpa.2019.10.004
   Merz SE, 2019, VET PATHOL, V56, P715, DOI 10.1177/0300985819843683
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Raffan E, 2016, CELL METAB, V23, P893, DOI 10.1016/j.cmet.2016.04.012
   Shih JL, 2007, J VET INTERN MED, V21, P33, DOI 10.1892/0891-6640(2007)21[33:CHILRC]2.0.CO;2
   Sobecki M, 2017, CANCER RES, V77, P2722, DOI 10.1158/0008-5472.CAN-16-0707
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
NR 24
TC 2
Z9 2
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-7380
EI 1573-7446
J9 VET RES COMMUN
JI Vet. Res. Commun.
PD 2021 FEB
PY 2021
VL 45
IS 1
BP 21
EP 30
DI 10.1007/s11259-020-09784-x
EA DEC 2020
PG 10
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA PU7EB
UT WOS:000597985700001
PM 33301127
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Liu, WJ
   Zhang, LQ
   Xuan, K
   Hu, CH
   Liu, SY
   Liao, L
   Li, B
   Jin, F
   Shi, ST
   Jin, Y
AF Liu, Wenjia
   Zhang, Liqiang
   Xuan, Kun
   Hu, Chenghu
   Liu, Shiyu
   Liao, Li
   Li, Bei
   Jin, Fang
   Shi, Songtao
   Jin, Yan
TI <i>Alpl</i> prevents bone ageing sensitivity by specifically regulating
   senescence and differentiation in mesenchymal stem cells
SO BONE RESEARCH
LA English
DT Article
ID ALKALINE-PHOSPHATASE; ATP; METABOLISM; ADENOSINE; PATHWAY; ENZYME;
   PROLIFERATION; MAINTENANCE; ACTIVATION; INHIBITION
AB Mutations in the liver/bone/kidney alkaline phosphatase (Alpl) gene cause hypophosphatasia (HPP) and early-onset bone dysplasia, suggesting that this gene is a key factor in human bone development. However, how and where Alpl acts in bone ageing is largely unknown. Here, we determined that ablation of Alpl induces prototypical premature bone ageing characteristics, including bone mass loss and marrow fat gain coupled with elevated expression of p16(INK4A) (p16) and p53 due to senescence and impaired differentiation in mesenchymal stem cells (MSCs). Mechanistically, Alpl deficiency in MSCs enhances ATP release and reduces ATP hydrolysis. Then, the excessive extracellular ATP is, in turn, internalized by MSCs and causes an elevation in the intracellular ATP level, which consequently inactivates the AMPKa pathway and contributes to the cell fate switch of MSCs. Reactivating AMPKa by metformin treatment successfully prevents premature bone ageing in Alpl(+/-) mice by improving the function of endogenous MSCs. These results identify a previously unknown role of Alpl in the regulation of ATP-mediated AMPKa alterations that maintain MSC stemness and prevent bone ageing and show that metformin offers a potential therapeutic option.
C1 [Liu, Wenjia; Zhang, Liqiang; Xuan, Kun; Liu, Shiyu; Li, Bei; Jin, Fang; Jin, Yan] Fourth Mil Med Univ, MS State Key Lab, Xian, Shaanxi, Peoples R China.
   [Liu, Wenjia; Zhang, Liqiang; Xuan, Kun; Liu, Shiyu; Li, Bei; Jin, Fang; Jin, Yan] Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Xian, Shaanxi, Peoples R China.
   [Liu, Wenjia; Zhang, Liqiang; Xuan, Kun; Liu, Shiyu; Li, Bei; Jin, Fang; Jin, Yan] Fourth Mil Med Univ, Shaanxi Int Joint Res Ctr Oral Dis, Ctr Tissue Engn, Sch Stomatol, Xian, Shaanxi, Peoples R China.
   [Liu, Wenjia; Zhang, Liqiang; Hu, Chenghu; Liao, Li; Jin, Yan] Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China.
   [Shi, Songtao] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA.
C3 Air Force Military Medical University; Air Force Military Medical
   University; Air Force Military Medical University; University of
   Pennsylvania
RP Jin, Y (corresponding author), Fourth Mil Med Univ, MS State Key Lab, Xian, Shaanxi, Peoples R China.; Jin, Y (corresponding author), Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Xian, Shaanxi, Peoples R China.; Jin, Y (corresponding author), Fourth Mil Med Univ, Shaanxi Int Joint Res Ctr Oral Dis, Ctr Tissue Engn, Sch Stomatol, Xian, Shaanxi, Peoples R China.; Jin, Y (corresponding author), Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China.
EM yanjin@fmmu.edu.cn
RI Jin, Jin/JTV-5024-2023; liu, shiyu/HTR-8039-2023; Hu,
   Cheng-Hu/I-4210-2013; zhang, min/IYI-9869-2023; liu,
   shiyu/JSL-3045-2023; Zhao, Min/JGM-3156-2023; Liao, Li/U-6866-2017
OI Hu, Cheng-Hu/0000-0003-2443-6485; Zhang, Liqiang/0000-0002-4091-3619;
   Liao, Li/0000-0003-0030-1009; Jin, Yan/0000-0002-2586-1152
FU Nature Science Foundation of China [81620108007, 31571532, 31601099];
   National Key Research and Development Program of China [2016YFC1101400];
   National Institutes of Health, Department of Health and Human Services
   [R01DE017449]
FX This work was financially supported by grants from the Nature Science
   Foundation of China (81620108007), National Key Research and Development
   Program of China (2016YFC1101400), Nature Science Foundation of China
   (31571532, 31601099) and National Institutes of Health, Department of
   Health and Human Services (R01DE017449 to S.S.).
CR Anisimov VN, 2013, CELL CYCLE, V12, P3483, DOI 10.4161/cc.26928
   [Anonymous], 1907, COLL AGR B TOKYO IMP
   Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025
   Berlier JL, 2015, STEM CELLS, V33, P211, DOI 10.1002/stem.1831
   Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028
   BOLGER JT, 1975, ARCH PHYS MED REHAB, V56, P36
   Bowler WB, 2001, BONE, V28, P507, DOI 10.1016/S8756-3282(01)00430-6
   Buchet R, 2013, METHODS MOL BIOL, V1053, P27, DOI 10.1007/978-1-62703-562-0_3
   Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4
   Cavaliere F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00211
   Chang CY, 2016, RADIOGRAPHICS, V36, P1871, DOI 10.1148/rg.2016160004
   Chen SC, 2017, MOL CELL ENDOCRINOL, V443, P176, DOI 10.1016/j.mce.2017.01.049
   Choi IS, 2015, NEUROPHARMACOLOGY, V93, P94, DOI 10.1016/j.neuropharm.2015.01.020
   Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023
   Ciciarello M, 2013, STEM CELLS DEV, V22, P1097, DOI 10.1089/scd.2012.0432
   COLEMAN JE, 1983, ADV ENZYMOL RAMB, V55, P381
   Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138
   Coppi E, 2007, STEM CELLS, V25, P1840, DOI 10.1634/stemcells.2006-0669
   Estève D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1815982
   Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015
   Ferrari D, 2011, EXP HEMATOL, V39, P360, DOI 10.1016/j.exphem.2010.12.001
   Foster BL, 2017, J DENT RES, V96, P81, DOI 10.1177/0022034516663633
   Gallagher J. A., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P125
   Garnero P, 2008, MOL DIAGN THER, V12, P157, DOI 10.1007/BF03256280
   Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129
   Grosser P, 1912, BIOCHEM Z, V39, P171
   HAHNEL AC, 1990, DEVELOPMENT, V110, P555
   Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013
   Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2
   Jeyabalan J, 2012, J ENDOCRINOL, V212, P277, DOI 10.1530/JOE-11-0306
   Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019
   KUMAGAI H, 1991, J BONE MINER RES, V6, P697
   Li HJ, 2017, J CLIN INVEST, V127, P1241, DOI 10.1172/JCI89511
   Liu SY, 2015, CELL METAB, V22, P606, DOI 10.1016/j.cmet.2015.08.018
   Liu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.65
   Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005
   Maj T, 2017, NAT IMMUNOL, V18, P1332, DOI 10.1038/ni.3868
   MERCHANTLARIOS H, 1985, DIFFERENTIATION, V29, P145, DOI 10.1111/j.1432-0436.1985.tb00308.x
   Millan J. L., 2006, MAMMALIAN ALKALINE P, P105
   Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046
   Mornet E, 2008, BEST PRACT RES CL RH, V22, P113, DOI 10.1016/j.berh.2007.11.003
   Noronha-Matos JB, 2016, J CELL PHYSIOL, V231, P1852, DOI 10.1002/jcp.25303
   Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651
   Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750
   Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Podhorecka M, 2017, POSTEP HIG MED DOSW, V71, P170
   Qian YR, 2016, MOL CANCER RES, V14, P1087, DOI 10.1158/1541-7786.MCR-16-0118
   REZENDE AA, 1994, BIOCHEM J, V301, P517, DOI 10.1042/bj3010517
   Riddle RC, 2007, J BONE MINER RES, V22, P589, DOI 10.1359/JBMR.070113
   Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025
   Street SE, 2013, J NEUROSCI, V33, P11314, DOI 10.1523/JNEUROSCI.0133-13.2013
   VANHOOF VO, 1994, CRIT REV CL LAB SCI, V31, P197, DOI 10.3109/10408369409084677
   WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45
   Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173
   WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439
   Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356
   Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4
NR 58
TC 45
Z9 51
U1 1
U2 21
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2095-4700
EI 2095-6231
J9 BONE RES
JI Bone Res.
PD SEP 11
PY 2018
VL 6
AR 27
DI 10.1038/s41413-018-0029-4
PG 15
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GT6UB
UT WOS:000444654800002
PM 30210899
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Serna-Salas, SA
   Arroyave-Ospina, JC
   Zhang, MF
   Damba, T
   Buist-Homan, M
   Munoz-Ortega, MH
   Ventura-Juarez, J
   Moshage, H
AF Serna-Salas, Sandra A.
   Arroyave-Ospina, Johanna C.
   Zhang, Mengfan
   Damba, Turtushikh
   Buist-Homan, Manon
   Munoz-Ortega, Martin H.
   Ventura-Juarez, Javier
   Moshage, Han
TI α-1 Adrenergic receptor antagonist doxazosin reverses hepatic stellate
   cells activation <i>via</i> induction of senescence
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Early Access
DE Stellate cells; Liver fibrosis; Senescence; a1-Adrenergic signaling;
   Norepinephrine; Protein kinase C; Phospholipase C; Cell proliferation
ID SECRETORY PHENOTYPE; PROLIFERATION; INHIBITION; FIBROSIS; GROWTH
AB Background: Activated hepatic stellate cells (aHSCs) are the main effector cells during liver fibrogenesis. alpha-1 adrenergic antagonist doxazosin (DX) was shown to be anti-fibrotic in an in vivo model of liver fibrosis (LF), but the mechanism remains to be elucidated. Recent studies suggest that reversion of LF can be achieved by inducing cellular senescence characterized by irreversible cell-cycle arrest and acquisition of the senescence-associated secretory phenotype (SASP).
   Aim: To elucidate the mechanism of the anti-fibrotic effect of DX and determine whether it induces senescence.
   Methods: Primary culture-activated rat HSCs were used. mRNA and protein expression were measured by qPCR and Western blot, respectively. Cell proliferation was assessed by BrdU incorporation and xCelligence analysis. TGF-13 was used for maximal HSC activation. Norepinephrine (NE), PMA and m-3M3FBS were used to activate alpha-1 adrenergic signaling.
   Results: Expression of Col1 alpha 1 was significantly decreased by DX (10 mu mol/L) at mRNA (-30 %) and protein level (-50 %) in TGF-13 treated aHSCs. DX significantly reduced aHSCs proliferation and increased expression of senescence and SASP markers. PMA and m-3M3FBS reversed the effect of DX on senescence markers.
   Conclusion: Doxazosin reverses the fibrogenic phenotype of aHSCs and induces the senescence phenotype.
C1 [Serna-Salas, Sandra A.; Ventura-Juarez, Javier] Autonomous Univ Aguascalientes, Dept Morphol, Aguascalientes, Mexico.
   [Serna-Salas, Sandra A.; Arroyave-Ospina, Johanna C.; Zhang, Mengfan; Damba, Turtushikh; Buist-Homan, Manon; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.
   [Buist-Homan, Manon; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands.
   [Munoz-Ortega, Martin H.] Autonomous Univ Aguascalientes, Dept Chem, Aguascalientes, Mexico.
   [Damba, Turtushikh] Mongolian Natl Univ Med Sci, Sch Pharm, Ulaanbaatar, Mongolia.
C3 Universidad Autonoma de Aguascalientes; University of Groningen;
   University of Groningen; Universidad Autonoma de Aguascalientes;
   Mongolian National University of Medical Sciences
RP Ventura-Juarez, J (corresponding author), Autonomous Univ Aguascalientes, Dept Morphol, Aguascalientes, Mexico.
EM jventur@correo.uaa.mx
RI Ventura-Juárez, Javier/HII-7843-2022; Muñoz-Ortega,
   Martin/JSK-2417-2023; Damba, Turtushikh/ABD-9709-2020
OI Muñoz-Ortega, Martin/0000-0002-1961-6919; Damba,
   Turtushikh/0000-0003-3141-249X; Serna Salas, Sandra
   A./0000-0002-7116-5844; Zhang, Mengfan/0000-0002-2587-9395; Moshage,
   Han/0000-0002-4764-0246; Arroyave Ospina, Johanna
   Carolina/0000-0003-2874-3191
FU CONACyT Funds [A1-S-21375]
FX Funding Project no. A1-S-21375, CONACyT, Mexico, Fellowship no. 701914
   CONACyT to Sandra Alejandra Serna Salas.
CR Al-Haj L, 2012, NUCLEIC ACIDS RES, V40, P7739, DOI 10.1093/nar/gks545
   Serna-Salas SA, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4706976
   Aoshiba K, 2013, EXP TOXICOL PATHOL, V65, P1053, DOI 10.1016/j.etp.2013.04.001
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Damba T, 2019, NITRIC OXIDE-BIOL CH, V92, P26, DOI 10.1016/j.niox.2019.08.004
   Hernández-Ortega LD, 2012, J GASTROEN HEPATOL, V27, P1865, DOI 10.1111/j.1440-1746.2012.07262.x
   Di Mitri D, 2016, TRENDS CELL BIOL, V26, P215, DOI 10.1016/j.tcb.2015.10.005
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   García-Sáinz JA, 1999, ARCH MED RES, V30, P449, DOI 10.1016/S0188-0128(99)00059-7
   Govekar R.B, 2012, ANEMIA, P1
   Han C, 2008, J CELL PHYSIOL, V216, P486, DOI 10.1002/jcp.21420
   Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Kocabayoglu P, 2015, J HEPATOL, V63, P141, DOI 10.1016/j.jhep.2015.01.036
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4
   Lachowski D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43759-6
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365
   Mellone M, 2017, AGING-US, V9, P128, DOI 10.18632/aging.101127
   Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Oben JA, 2003, BIOCHEM BIOPH RES CO, V302, P685, DOI 10.1016/S0006-291X(03)00232-8
   Park JW, 2017, BIOCHEM BIOPH RES CO, V493, P1548, DOI 10.1016/j.bbrc.2017.10.021
   Petrova NV, 2016, AGING CELL, V15, P999, DOI 10.1111/acel.12518
   Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011
   Ramm GA, 2003, DIGEST DIS SCI, V48, P790, DOI 10.1023/A:1022857313917
   Rippe RA, 2004, GASTROENTEROLOGY, V127, P1260, DOI 10.1053/j.gastro.2004.08.028
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Sigala B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072928
   STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802
   Tardelli M, 2017, SCI REP-UK, V7, P1
   Tung D, 2013, PHARMACOLOGY, V91, P29, DOI 10.1159/000343762
   Xu JY, 2003, AM J PHYSIOL-GASTR L, V285, pG20, DOI 10.1152/ajpgi.00474.2002
   Zhang MF, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111572
NR 38
TC 6
Z9 6
U1 1
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD 2022 JAN
PY 2022
VL 201
AR 111617
DI 10.1016/j.mad.2021.111617
EA JAN 2022
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 0W1UL
UT WOS:000788820800003
PM 34958827
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Okamura, K
   Suzuki, T
   Nohara, K
AF Okamura, Kazuyuki
   Suzuki, Takehiro
   Nohara, Keiko
TI Gestational arsenite exposure augments hepatic tumors of C3H mice by
   promoting senescence in F1 and F2 offspring via different pathways
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Arsenic; Tumor; Liver; Senescence; Multigenerational Effect; SASP
ID SPONTANEOUS PRIMARY HEPATOMAS; HEPATOCELLULAR-CARCINOMA; CELLULAR
   SENESCENCE; OXIDATIVE STRESS; CDK INHIBITORS; LIVER-CANCER; CELLS;
   TUMORIGENESIS; SURVEILLANCE; REGULATORS
AB Previous studies showed that gestational arsenite exposure increases incidence of hepatic tumors in the F1 and F2 male offspring in C3H mice. However, the mechanisms are largely unknown. In this study, we focused on whether cellular senescence and the senescence-associated secretory phenotype (SASP) contribute to tumor formation in C3H mice, and whether gestational arsenite exposure augments hepatic tumors through enhancement of cellular senescence. Three senescence markers (p16, p21 and p15) and two SASP factors (Cxcl1 and Mmp14) were increased in hepatic tumor tissues of 74- or 100-weeks-old C3H mice without arsenite exposure, and treatment with a senolytic drug (ABT-263) diminished hepatic tumor formation. Gestational arsenite exposure enhanced the expression of p16, p21 and Mmp14 in F1 and p15 and Cxcl1 in F2, respectively. Exploring the mechanisms by which arsenite exposure promotes cellular senescence, we found that the expression of antioxidant enzymes (Sod1 and Cat) were reduced in the tumors of F1 in the arsenite group, and Tgf-beta and the receptors of Tgf-beta were increased in the tumors of F2 in the arsenite group. Furthermore, the analysis of the Cancer Genome Atlas database showed that gene expression levels of the senescence markers and SASP factors were increased and associated with poor prognosis in human hepatocellular carcinoma (HCC). These results suggest that cellular senescence and SASP have important roles in hepatic tumorigenesis in C3H mice as well as HCC in humans, and gestational arsenite exposure of C3H mice enhances senescence in F1 and F2 via oxidative stress and Tgf-beta activation, respectively.
C1 [Okamura, Kazuyuki; Suzuki, Takehiro; Nohara, Keiko] Natl Inst Environm Studies, Ctr Hlth & Environm Risk Res, Tsukuba, Ibaraki 3058506, Japan.
C3 National Institute for Environmental Studies - Japan
RP Nohara, K (corresponding author), Natl Inst Environm Studies, Ctr Hlth & Environm Risk Res, Tsukuba, Ibaraki 3058506, Japan.
EM keikon@nies.go.jp
OI Okamura, Kazuyuki/0000-0003-3882-9722
FU National Institute for Environmental Studies [1115AA082, 1315AT001,
   1620AA041]; Ministry of Education, Culture, Sports, Science and
   Technology of Japan [15K21611, 26293154]; Grants-in-Aid for Scientific
   Research [15K21611, 26293154] Funding Source: KAKEN
FX This work was partly supported by the National Institute for
   Environmental Studies (1115AA082; 1315AT001; 1620AA041, KN),
   Grant-in-Aid for Young Scientists (B) (15K21611, KO) and Grant-in-Aid
   for Scientific Research (B) (26293154, KN) from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan. The funders
   had no role in the design of the study; in the collection, analyses, or
   interpretation of data; in the writing of the manuscript, or in the
   decision to publish the results.
CR AGNEW LRC, 1952, CANCER RES, V12, P757
   Amini M, 2008, ENVIRON SCI TECHNOL, V42, P3669, DOI 10.1021/es702859e
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Barouki R, 2018, ENVIRON INT, V114, P77, DOI 10.1016/j.envint.2018.02.014
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013
   BURNS EDWARD L., 1940, AMER JOUR CANCER, V39, P25
   Burns EL, 1943, CANCER RES, V3, P691
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Calado RT, 2013, SEMIN HEMATOL, V50, P165, DOI 10.1053/j.seminhematol.2013.03.030
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Devesa V, 2006, TOXICOLOGY, V224, P147, DOI 10.1016/j.tox.2006.04.041
   Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Hanson MA, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw002
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hoare M, 2018, ANNU REV CANC BIOL, V2, P175, DOI 10.1146/annurev-cancerbio-030617-050352
   Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0
   Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kawamura H, 2018, STEM CELL REP, V10, P920, DOI 10.1016/j.stemcr.2018.01.030
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Komichi S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091002
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144
   Li GQ, 2013, BIOCHEM BIOPH RES CO, V434, P809, DOI 10.1016/j.bbrc.2013.04.018
   Matsunaga H, 2015, ANN SURG ONCOL, V22, P3079, DOI 10.1245/s10434-014-4292-3
   Matsushita J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4221-0
   Miyazono K, 2000, J CELL SCI, V113, P1101
   Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193
   Nohara K, 2006, TOXICOLOGY, V225, P204, DOI 10.1016/j.tox.2006.06.005
   Nohara K, 2016, J APPL TOXICOL, V36, P105, DOI 10.1002/jat.3149
   Nohara K, 2012, TOXICOL SCI, V129, P293, DOI 10.1093/toxsci/kfs203
   Okamura K, 2019, CANCER SCI, V110, P2629, DOI 10.1111/cas.14104
   Okamura K, 2016, ARCH TOXICOL, V90, P793, DOI 10.1007/s00204-015-1500-2
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Pole A, 2016, AIMS MOL SCI, V3, P300, DOI 10.3934/molsci.2016.3.300
   Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903
   Ramakrishna G, 2013, LIVER CANCER, V2, P367, DOI 10.1159/000343852
   Ran SS, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/9414196
   Schenken JR, 1943, CANCER RES, V3, P693
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   SHIMKIN MB, 1946, J NATL CANCER I, V7, P71
   Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832
   Sumi D, 2015, ARCH TOXICOL, V89, P1751, DOI 10.1007/s00204-014-1326-3
   Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002
   Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836
   Tutusaus Anna, 2018, Oncotarget, V9, P16701, DOI 10.18632/oncotarget.24673
   Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070
   Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4
   Wang B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-98
   Wang C, 2019, NATURE, V574, P268, DOI 10.1038/s41586-019-1607-3
   Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007
   Xie K, 2018, P NATL ACAD SCI USA, V115, pE2348, DOI 10.1073/pnas.1707337115
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yousefzadeh MJ, 2020, GEROSCIENCE, V42, P951, DOI 10.1007/s11357-020-00185-1
   Yuan Y, 2010, EPIDEMIOLOGY, V21, P103, DOI 10.1097/EDE.0b013e3181c21e46
   Zhang Y, 2017, INT J APPL MECH, V9, DOI 10.1142/S1758825117500041
   Zhao XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021980
NR 70
TC 4
Z9 4
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD DEC 1
PY 2020
VL 408
AR 115259
DI 10.1016/j.taap.2020.115259
PG 12
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA OU9YO
UT WOS:000591879000001
PM 33010264
DA 2024-02-19
ER

PT J
AU Kuhla, A
   Hauke, M
   Sempert, K
   Vollmar, B
   Zechner, D
AF Kuhla, Angela
   Hauke, Mandy
   Sempert, Kai
   Vollmar, Brigitte
   Zechner, Dietmar
TI Senescence-dependent impact of anti-RAGE antibody on endotoxemic liver
   failure
SO AGE
LA English
DT Article
DE Senescence; Oxidative stress; Advanced glycation end products; RAGE
   blockade; Inflammation
ID GLYCATION END-PRODUCTS; SIGNAL-TRANSDUCTION; THERAPEUTIC TARGET; SOLUBLE
   RECEPTOR; TUMOR-GROWTH; SEPSIS; MICE; INFLAMMATION; BLOCKADE; INJURY
AB Aging often restricts the capacity of the immune system. Endotoxemia is characterized by an immune response initiated by a group of pattern recognition receptors including the receptor for advanced glycation end products (RAGE). The aim of this study was to clarify to which extent RAGE and its signaling pathways such as the so called mitogen-activated protein kinase (MAPK) pathways can contribute to the perpetuation of inflammation in the aging organism. We used senescence-accelerated-prone (SAMP8) and senescence-accelerated-resistant (SAMR1) mice and studied them at the age of 2 and 6 months. Livers of SAMP8 mice had significantly higher malondialdehyde concentrations and a modest reduction of glyoxalase-I expression. Consequently, the abundance of highly modified advanced glycation end products was increased in the liver and plasma of these mice. After galactosamine/lipopolysaccharide-induced acute liver injury, significant activation of the MAPK cascade was observed in both mouse strains. Administration of an anti-RAGE antibody diminished p42/44-phosphorylation as well as tissue injury in SAMP8 mice, whereas the identical treatment in SAMR1 mice leads to a significant increase in p42/44-phosphorylation and intensified liver injury. This observation suggests that dependent on the senescence of the organism, anti-RAGE antibody can have differential effects on the progression of endotoxemic liver failure.
C1 [Kuhla, Angela; Hauke, Mandy; Sempert, Kai; Vollmar, Brigitte; Zechner, Dietmar] Univ Rostock, Inst Expt Surg, D-18057 Rostock, Germany.
C3 University of Rostock
RP Zechner, D (corresponding author), Univ Rostock, Inst Expt Surg, Schillingallee 69A, D-18057 Rostock, Germany.
EM dietmar.zechner@uni-rostock.de
CR Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306
   Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183
   Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7
   Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164
   Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36
   Christaki E, 2012, CURR OPIN INFECT DIS, V25, P304, DOI 10.1097/QCO.0b013e3283519b82
   Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642
   Eipel C, 2004, AM J PHYSIOL-GASTR L, V286, pG769, DOI 10.1152/ajpgi.00275.2003
   Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3
   Hou FF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351296
   Huang WC, 2012, INFLAMMATION, V35, P350, DOI 10.1007/s10753-011-9325-5
   Jin HK, 2008, CLIN CANCER RES, V14, P7733, DOI 10.1158/1078-0432.CCR-08-0670
   Kuhla A, 2008, APOPTOSIS, V13, P1427, DOI 10.1007/s10495-008-0269-7
   Kuhla A, 2010, LAB INVEST, V90, P1189, DOI 10.1038/labinvest.2010.84
   Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315
   Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184
   NEEPER M, 1992, J BIOL CHEM, V267, P14998
   Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012
   Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053
   Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230
   Reynolds PR, 2008, AM J PHYSIOL-LUNG C, V294, pL1094, DOI 10.1152/ajplung.00318.2007
   Sebeková K, 2002, J HEPATOL, V36, P66, DOI 10.1016/S0168-8278(01)00232-X
   Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575
   Susa Y, 2009, CRIT CARE MED, V37, P2619, DOI 10.1097/CCM.0b013e3181a930f7
   Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626
   Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014
   van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730
   Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692
   Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253
   Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371
   Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC
   Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827
NR 32
TC 4
Z9 4
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD DEC
PY 2013
VL 35
IS 6
BP 2153
EP 2163
DI 10.1007/s11357-012-9506-7
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 240MK
UT WOS:000326100600010
PM 23319363
OA Green Published
DA 2024-02-19
ER

PT J
AU Liu, YS
   He, JT
   Ji, SY
   Wang, QS
   Pu, H
   Jiang, TT
   Meng, LY
   Yang, XW
   Ji, JG
AF Liu, Yashu
   He, Jintang
   Ji, Shaoyi
   Wang, Qingsong
   Pu, Hai
   Jiang, Tingting
   Meng, Lingyao
   Yang, Xiuwei
   Ji, Jianguo
TI Comparative studies of early liver dysfunction in senescence-accelerated
   mouse using mitochondrial proteomics approaches
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Article
ID AGE-RELATED-CHANGES; HEPATIC STEATOSIS; 3-HYDROXY-3-METHYLGLUTARYL-COA
   SYNTHASE; DIFFERENTIAL EXPRESSION; ANIMAL-MODEL; FATTY-ACIDS; OXIDATION;
   MICE; BRAIN; ALPHA
AB The liver is a complex and unique organ responsible for a breadth of functions crucial to sustaining life, especially for various metabolic processes in its mitochondria. Senescence-accelerated mouse prone/8 (SAMP8), a widely used aging model, exhibits an oxidative stress-induced aging phenotype and severe mitochondria-related liver pathology that are not seen in senescence-accelerated mouse resistant/1 (SAMR1). Here we used both two-dimensional electrophoresis- and ICAT-based mitochondrial proteomics analysis to view the liver mitochondrial protein alterations between SAMP8 and SAMR1. Compared with SAMR1, decreased expression and activity of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase were detected in SAMP8 at 6 months old (SAMP8-6m). As the key enzyme of ketogenesis, 3-hydroxy-3-methylglutaryl-CoA synthase is well known to be transcriptionally regulated by peroxisome proliferator-activated receptor alpha, which was also expressed at lower levels in SAMP8-6m livers. In addition, down-regulation of two peroxisome proliferator-activated receptor alpha target gene products (acyl-CoA oxidase and enoyl-CoA hydratase), elevation of triglyceride, and reduction of acetyl-CoA were observed, indicating abnormal fatty acid metabolism in SAMP8-6m livers. In addition eight proteins (NDUAA, NDUBA, NDUB7, NDUS1, NDUS3, NDUV1, ETFA, and UCRI) of mitochondrial complexes were down-regulated in SAMP8-6m, resulting in mitochondria-related liver dysfunction characterized by enhanced oxidative stress-induced molecular damage ( lipid peroxide and oxidized protein) and depressed energy production (ATP). Glutamine synthetase and ornithine aminotransferase involved in glutamine synthesis were up-regulated in SAMP8 livers at both 1 and 6 months old that may be related to the accumulation of glutamate and glutamine. Our work provided useful clues to understanding the molecular mechanism underlying liver dysfunction in senescence-accelerated mouse.
C1 [Liu, Yashu; He, Jintang; Wang, Qingsong; Pu, Hai; Jiang, Tingting; Meng, Lingyao; Ji, Jianguo] Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.
   [Ji, Shaoyi; Yang, Xiuwei] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100083, Peoples R China.
   [Ji, Shaoyi; Yang, Xiuwei] Peking Univ, Sch Pharmaceut Sci, Dept Nat Med, Beijing 100083, Peoples R China.
C3 Peking University; Peking University; Peking University
RP Ji, JG (corresponding author), Peking Univ, Coll Life Sci, Natl Lab Prot Engn & Plant Genet Engn, POB 31, Beijing 100871, Peoples R China.
EM jijg@pku.edu.cn
RI Liu, Yashu/F-9519-2011; He, Jintang/G-8671-2013
OI Jiang, Tingting/0000-0002-5372-0656
FU National Key Basic Research Program of China [2006CB910103]
FX This work was supported by the National Key Basic Research Program of
   China (Grant 2006CB910103). The costs of publication of this article
   were defrayed in part by the payment of page charges. This article must
   therefore be hereby marked "advertisement" in accordance with 18 U. S.
   C. Section 1734 solely to indicate this fact.
CR Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780
   Bailey SM, 2005, FREE RADICAL BIO MED, V38, P175, DOI 10.1016/j.freeradbiomed.2004.10.011
   Baltazar MF, 1999, MICROBIOL-UK, V145, P271, DOI 10.1099/13500872-145-1-271
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
   Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   Day CP, 1998, HEPATOLOGY, V27, P1463, DOI 10.1002/hep.510270601
   DEAN RT, 1992, MUTAT RES, V275, P387, DOI 10.1016/0921-8734(92)90041-M
   Dreger M, 2003, MASS SPECTROM REV, V22, P27, DOI 10.1002/mas.10047
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s
   He JT, 2007, J PROTEOME RES, V6, P3509, DOI 10.1021/pr070197v
   Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   KITAMURA Y, 1992, NEUROSCI LETT, V137, P169, DOI 10.1016/0304-3940(92)90396-O
   Lee SST, 2004, J LIPID RES, V45, P2025, DOI 10.1194/jlr.M400078-JLR200
   Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4
   Levillain O, 2007, AM J PHYSIOL-RENAL, V292, pF1016, DOI 10.1152/ajprenal.00408.2006
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   Nishikawa T, 1998, NEUROSCI LETT, V254, P69, DOI 10.1016/S0304-3940(98)00646-6
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   PANDE SV, 1971, J BIOL CHEM, V246, P5384
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929
   QUANT PA, 1989, BIOCHEM J, V262, P159, DOI 10.1042/bj2620159
   REED WD, 1977, BIOCHEM J, V164, P27, DOI 10.1042/bj1640027
   RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767
   Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tomás-Zapico C, 2006, CAN J PHYSIOL PHARM, V84, P213, DOI 10.1139/Y05-111
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   WEBB JT, 1980, SCIENCE, V208, P293, DOI 10.1126/science.6102799
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   Yang W, 2006, PROTEOMICS, V6, P2982, DOI 10.1002/pmic.200500036
   Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Yu WX, 2005, J BIOL CHEM, V280, P11731, DOI 10.1074/jbc.M412898200
NR 40
TC 48
Z9 50
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
EI 1535-9484
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD SEP
PY 2008
VL 7
IS 9
BP 1737
EP 1747
DI 10.1074/mcp.M800109-MCP200
PG 11
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 347PZ
UT WOS:000259154800011
PM 18515266
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Fujita, Y
   Makishima, M
   Bhawal, UK
AF Fujita, Yu
   Makishima, Makoto
   Bhawal, Ujjal K.
TI Differentiated embryo chondrocyte 1 (DEC1) is a novel negative regulator
   of hepatic fibroblast growth factor 21 (FGF21) in aging mice
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE DEC1; FGF21; Aging; Liver; Hepatic homeostasis
ID TRANSCRIPTION FACTOR; EXPRESSION; METABOLISM; ACTIVATION; OBESITY;
   STRESS; STRA13; KINASE; FAMILY; GENE
AB Human differentiated embryo chondrocyte expressed gene 1 (DEC1) is frequently used as a marker of senescence in vivo. Fibroblast growth factor 21 (FGF21), a novel endocrine-like member of the FGF superfamily, is highly expressed in the liver, and FGF21-transgenic mice have extended lifespans. Thus, we hypothesized that FGF21 may play a role in the DEC1-mediated aging process. In this study, DEC1 knockout (KO) mice were used to characterize the mechanism by which FGF21 protects mice from aging. Aging is strongly diminished in DEC1 KO mice, which is reflected by decreased lipid levels and oxidative stress, leading to an amelioration of liver function and structure. The expression of FGF21 decreased with aging in wild-type (WT) mice, whereas ATF4, Phospho-ERK and Phospho-p38 expression was maintained and was accompanied by a compensatory rise of FGF21 mRNA and protein expression in DEC1 KO mice. Over-expression of DEC1 markedly abolished the hepatic expression of FGF21, and siRNA-mediated inhibition of endogenous DEC1 increased the expression of FGF21. DEC1 further diminished the expression of ATF4 in HepG2 cells over-expressing DEC1. The induction of FGF21 and ATF4 at the mRNA and protein levels during the course of aging supports the view that DEC1 KO mice are able to restore the age-related imbalance of metabolism. Collectively, the data obtained in this study suggest that DEC1 is a novel negative regulator of hepatic FGF21 expression. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Fujita, Yu] Nihon Univ, Sch Dent Matsudo, Dept Anesthesiol, Matsudo, Chiba 2718587, Japan.
   [Makishima, Makoto] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem, Tokyo 1738610, Japan.
   [Bhawal, Ujjal K.] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, 2-870-1 Sakae Cho Nishi, Matsudo, Chiba 2718587, Japan.
C3 Nihon University; Nihon University; Nihon University
RP Bhawal, UK (corresponding author), Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, 2-870-1 Sakae Cho Nishi, Matsudo, Chiba 2718587, Japan.
EM bhawal.ujjal.kumar@nihon-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [15101274]; Nihon University Multidisciplinary Research Grant;
   Grants-in-Aid for Scientific Research [15K11274] Funding Source: KAKEN
FX We thank Professor Yukio Kato and Professor Takeshi Kawamoto (Hiroshima
   University) for their helpful contributions to this work. This work was
   supported by Grants-in-Aid (15101274; Ujjal K. Bhawal) from the Ministry
   of Education, Culture, Sports, Science and Technology of Japan and a
   Nihon University Multidisciplinary Research Grant for 2014-2015.
CR Bhawal UK, 2011, J PATHOL, V224, P420, DOI 10.1002/path.2878
   Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052
   Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107
   Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   Dammann P, 2012, J GERONTOL A-BIOL, V67, P573, DOI 10.1093/gerona/glr208
   Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281
   He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443
   Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960
   Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357
   Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014
   Kong B, 2014, AM J PHYSIOL-GASTR L, V306, pG893, DOI 10.1152/ajpgi.00337.2013
   Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915
   Liu YL, 2012, TOXICOL APPL PHARM, V264, P212, DOI 10.1016/j.taap.2012.08.003
   Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253
   Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005
   Mendelsohn AR, 2014, REJUV RES, V17, P306, DOI 10.1089/rej.2014.1577
   Pazdro R, 2012, EXP DIABETES RES, DOI 10.1155/2012/137607
   Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200
   Rolewska P, 2013, EXP GERONTOL, V48, P29, DOI 10.1016/j.exger.2012.04.012
   Sato F, 2015, BIOCHEM BIOPH RES CO, V467, P711, DOI 10.1016/j.bbrc.2015.10.077
   Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960
   Suh YS, 2001, MECH AGEING DEV, V122, P1797, DOI 10.1016/S0047-6374(01)00301-3
   Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297
   Suzuki M, 2014, BIOCHEM BIOPH RES CO, V455, P390, DOI 10.1016/j.bbrc.2014.11.030
   Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866
   Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750
   Varela-Rey M, 2011, EXP BIOL MED, V236, P402, DOI 10.1258/ebm.2011.010352
   Wan XS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807874
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
NR 30
TC 21
Z9 22
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 15
PY 2016
VL 469
IS 3
BP 477
EP 482
DI 10.1016/j.bbrc.2015.12.045
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA DC6TP
UT WOS:000369352800023
PM 26697751
DA 2024-02-19
ER

PT J
AU Ezaki, T
   Mitsudomi, T
   Ikeda, M
   Yoshida, Y
   Okamura, T
   Ohnari, N
AF Ezaki, T
   Mitsudomi, T
   Ikeda, M
   Yoshida, Y
   Okamura, T
   Ohnari, N
TI Hepatic inflow vessels caliber as an index for liver function
SO HEPATO-GASTROENTEROLOGY
LA English
DT Article
DE hepatic angiogram; liver cirrhosis; hepatic artery; portal vein
ID DISEASE
AB Background/Aims: Little is known about the serial change of the hepatic inflow vessels' caliber in the chronically diseased liver. We have analyzed the caliber change in patients with esophageal varices and examined relationship between hepatic inflow vessels diameter and age of patients who had no liver disease.
   Materials and Methods: (i) Diameters of the hepatic inflow vessels was measured on angiogram in five patients with chronic liver disease. They underwent liver angiography twice with an. interval of more than 10 months. The caliber change was analyzed. (ii) Thirty-nine patients without chronic Liver disease were analyzed to examine vessel diameter change with aging.
   Results: (i) The left hepatic artery diameter increased in size during the follow-up periods. On the other hand, the portal vein caliber increased in three cases excluding two cases whose Child grade did not change from A. (ii) The hepatic artery and the portal vein diameter had a tendency to become smaller with aging in thirty-nine patients who underwent hepatic angiography and had no liver disease.
   Conclusions: Hepatic inflow vessels' caliber change, particularly increase in hepatic artery diameter, has a potential of suggesting the liver function to some extent.
C1 UNIV OCCUPAT & ENVIRONM HLTH,SCH MED,DEPT SURG 2,KITAKYUSHU,FUKUOKA 807,JAPAN.
   UNIV OCCUPAT & ENVIRONM HLTH,SCH MED,DEPT OCCUPAT HLTH ECONOM,KITAKYUSHU,FUKUOKA 807,JAPAN.
   UNIV OCCUPAT & ENVIRONM HLTH,SCH MED,DEPT RADIOL,KITAKYUSHU,FUKUOKA 807,JAPAN.
C3 University of Occupational & Environmental Health - Japan; University of
   Occupational & Environmental Health - Japan; University of Occupational
   & Environmental Health - Japan
OI Mitsudomi, Tetsuya/0000-0001-9860-8505
CR Child CG, 1964, MAJOR PROBLEMS CLIN, V1, P1
   EZAKI T, 1992, BRIT J SURG, V79, P224, DOI 10.1002/bjs.1800790311
   EZAKI T, 1992, BRIT MED J, V304, P196, DOI 10.1136/bmj.304.6821.196
   LJUBICIC N, 1990, SCAND J GASTROENTERO, V25, P395, DOI 10.3109/00365529009095505
   MORENO AH, 1967, J CLIN INVEST, V46, P436, DOI 10.1172/JCI105545
   SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722
   SPINA GP, 1990, WORLD J SURG, V14, P115, DOI 10.1007/BF01670559
   TONI R, 1985, J CLIN ULTRASOUND, V13, P611
   TYGSTRUP N, 1962, J CLIN INVEST, V41, P447, DOI 10.1172/JCI104497
NR 9
TC 4
Z9 4
U1 0
U2 0
PU H G E UPDATE MEDICAL PUBL LTD.
PI ATHENS
PA PO BOX 17160, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD MAR-APR
PY 1996
VL 43
IS 8
BP 427
EP 431
PG 5
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA UL885
UT WOS:A1996UL88500018
PM 8714239
DA 2024-02-19
ER

PT J
AU Kondo, Y
   Ishigami, A
   Kubo, S
   Handa, S
   Gomi, K
   Hirokawa, K
   Kajiyama, N
   Chiba, T
   Shimokado, K
   Maruyama, N
AF Kondo, Y
   Ishigami, A
   Kubo, S
   Handa, S
   Gomi, K
   Hirokawa, K
   Kajiyama, N
   Chiba, T
   Shimokado, K
   Maruyama, N
TI Senescence marker protein-30 is a unique enzyme that hydrolyzes
   diisopropyl phosphorofluoridate in the liver
SO FEBS LETTERS
LA English
DT Article
DE diisopropyl phosphorofluoridate; senescence marker protein-30;
   paraoxonase; luciferin-regenerating enzyme; enzyme; hepatocyte; aging
ID KNOCKOUT MOUSE; RAT-LIVER; SMP30; IDENTIFICATION; PURIFICATION;
   HEPATOCYTES; EXPRESSION; LUCIFERIN; MEMBRANE; HOMOLOG
AB Senescence marker protein-30 (SMP30) was originally identified as a novel protein in the rat liver, the expression of which decreases androgen-independently with aging. We have now characterized a unique property of SMP30, the hydrolysis of diisopropyl phosphorofluoridate (DFP), which is similar to the chemical warfare nerve agents sarine, soman and tabun. Hydrolysis of DFP was stimulated equally well by 1 MM MgCl2, MnCl2 or CoCl2, to a lesser extent by 1 mM CdCl2 but not at all by 1 mM CaCl2. No Ca-45(2+) -binding activity was detected for purified SMP30, suggesting that SMP30 is not a calcium-binding protein, as others previously stated. Despite the sequence similarity between SMP30 and a serum paraoxonase (PON), the inability of SMP30 to hydrolvze PON-specific substrates such as paraoxon, dihydrocoumarin gamma-nonalactone, and delta-dodecanolactone indicate that SMP30 is distinct from the PON family. We previously established SMP30 knockout mice and have now tested DFPase activity in their livers. The livers from wild-type mice contained readily detectable DFPase activity, whereas no such enzyme activity was found in livers from SMP30 knockout mice. Moreover, the hepatocytes of SMP30 knockout mice were far more susceptible to DFP-induced cytotoxicity than those from the wild-type. These results indicate that SMP30 is a unique DFP hydrolyzing enzyme in the liver and has an important detoxification effect on DFP. Consequently, a reduction of SMP30 expression might account for the age-associated deterioration of cellular functions and enhanced susceptibility to harmful stimuli in aged tissue. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
   Tokyo Med & Dent Univ, Tokyo 1138510, Japan.
   Kikkoman Foods Inc, Div Res & Dev, Chiba 2780037, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental
   University (TMDU); Kikkoman Corporation
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami,
   Akihito/0000-0001-7875-7482
CR Billecke SS, 1999, CHEM-BIOL INTERACT, V119, P251, DOI 10.1016/S0009-2797(99)00034-4
   Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   GAN KN, 1991, DRUG METAB DISPOS, V19, P100
   Gomi K, 2002, GENE, V294, P157, DOI 10.1016/S0378-1119(02)00764-3
   Gomi K, 2001, J BIOL CHEM, V276, P36508, DOI 10.1074/jbc.M105528200
   Goto SG, 2000, J INSECT PHYSIOL, V46, P1111, DOI 10.1016/S0022-1910(99)00221-8
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   ISHIGAMI A, 1994, J CELL PHYSIOL, V158, P231, DOI 10.1002/jcp.1041580204
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Josse D, 1999, BIOCHEMISTRY-US, V38, P2816, DOI 10.1021/bi982281h
   La Du BN, 1999, CHEM-BIOL INTERACT, V119, P379, DOI 10.1016/S0009-2797(99)00049-6
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5
   MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   Nakajima Y, 2000, J BIOCHEM-TOKYO, V127, P901, DOI 10.1093/oxfordjournals.jbchem.a022685
   YAMAGUCHI M, 1981, CHEM PHARM BULL, V29, P567
NR 25
TC 44
Z9 55
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JUL 16
PY 2004
VL 570
IS 1-3
BP 57
EP 62
DI 10.1016/j.febslet.2004.06.028
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 840UM
UT WOS:000222885400011
PM 15251439
OA Bronze
DA 2024-02-19
ER

PT J
AU Feng, Q
   Xia, WK
   Feng, Z
   Tan, YJ
   Zhang, YX
   Liu, DS
   Zhang, GM
AF Feng, Qin
   Xia, Wenkai
   Feng, Zhong
   Tan, Yujun
   Zhang, Yongxia
   Liu, Deshan
   Zhang, Guimin
TI The accelerated organ senescence and proteotoxicity in thyrotoxicosis
   mice
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article; Early Access
DE cardiac hypertrophy; organ senescence; proteotoxicity; ribosome;
   splicing; ubiquitin-proteasome system
ID UBIQUITIN-PROTEASOME SYSTEM; THYROID-HORMONE; CARDIOVASCULAR-DISEASE;
   RIBOSOME BIOGENESIS; DYSFUNCTION; MECHANISMS; PHYSIOLOGY; THYROXINE;
   LANDSCAPE; COVID-19
AB The mechanism of aging has always been the focus of research, because aging is related to disease susceptibility and seriously affects people's quality of life. The diseases also accelerate the aging process, especially the pathological changes of substantive organs, such as cardiac hypertrophy, severely shortened lifespan. So, lesions in organs are both a consequence and a cause of aging. However, the disease in a given organ is not in isolation but is a systemic problem. Our previous study found that thyrotoxicosis mice model has aging characteristics including immunosenescence, lipotoxicity, malnutrition. But all these characteristics will lead to organ senescence, therefore, this study continued to study the aging changes of important organs such as heart, liver, and kidney in thyrotoxicosis mice using tandem mass tags (TMT) proteomics method. The results showed that the excess thyroxine led to cardiac hypertrophy. In the liver, the ability to synthesize functional proteins, detoxify, and metabolism were declined. The effect on the kidney was the decreased ability of detoxify and metabolism. The main finding of the present study was that the acceleration of organ senescence by excess thyroxine was due to proteotoxicity. The shared cause of proteotoxicity in the three organs included the intensify of oxidative phosphorylation, the redundancy production of ribosomes, and the lack of splicing and ubiquitin proteasome system function. Totally, proteotoxicity was another parallel between thyrotoxicosis and aging in addition to lipotoxicity. Our research provided a convenient and appropriate animal model for exploring aging mechanism and antiaging drugs.
   The schematic diagram of accelerated aging mechanism in thyrotoxicosis mice. In thyrotoxicosis mice, accelerated metabolism resulting from excessive thyroxine was the trigger, accelerating metabolic processes lead to lipotoxicity, aberrant translation of ribosomes and deficient splicing, and ubiquitin proteasome system led to proteotoxicity, lipotoxicity, and proteotoxicity generated during accelerated metabolism were responsible for immunosenescence and organ senescence. The cardiac hypertrophy, decreased hepatic synthetic capacity, and decreased hepatic and renal metabolic capacity were all associated with aging.image
C1 [Feng, Qin; Xia, Wenkai; Feng, Zhong; Tan, Yujun; Zhang, Yongxia; Zhang, Guimin] Lunan Pharmaceut Grp Co Ltd, State Key Lab Integrat & Innovat Class Formula & M, Linyi, Shandong, Peoples R China.
   [Feng, Zhong] Sun Yat Sen Univ, Sch Pharmaceut Sci, Shenzhen, Peoples R China.
   [Liu, Deshan] Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan, Shandong, Peoples R China.
C3 Sun Yat Sen University; Shandong University
RP Zhang, GM (corresponding author), Lunan Pharmaceut Grp Co Ltd, State Key Lab Integrat & Innovat Class Formula & M, Linyi, Shandong, Peoples R China.; Liu, DS (corresponding author), Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan, Shandong, Peoples R China.
EM liudeshan@sdu.edu.cn; lunanzhangguimin@163.com
OI feng, qin/0000-0003-0808-7385
FU We thank the Shanghai LuMing Biological Technology Co., LTD (Shanghai,
   China) for providing proteomics and metabonomics services.
FX We thank the Shanghai LuMing Biological Technology Co., LTD (Shanghai,
   China) for providing proteomics and metabonomics services.
CR Anyetei-Anum CS, 2018, J ENDOCRINOL, V237, pR19, DOI 10.1530/JOE-17-0708
   Asher A, 2021, PROSTAG LEUKOTR ESS, V166, DOI 10.1016/j.plefa.2021.102250
   Barreto-Chaves MLM, 2020, ENDOCR CONNECT, V9, pR59, DOI 10.1530/EC-19-0543
   Biji A, 2021, EBIOMEDICINE, V70, DOI 10.1016/j.ebiom.2021.103525
   Bozhkov AI, 2014, EXP GERONTOL, V60, P173, DOI 10.1016/j.exger.2014.10.017
   Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042
   Carnemolla A, 2014, HUM MOL GENET, V23, P3641, DOI 10.1093/hmg/ddu073
   Cenko E, 2021, CARDIOVASC RES, V117, P2705, DOI 10.1093/cvr/cvab298
   Chambraud B, 2021, AUTOPHAGY, V17, P3491, DOI 10.1080/15548627.2021.1875611
   Chang Hung-Chun, 2007, Cell, V128, P212
   Chen YY, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101205
   Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007
   Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973
   Chondrogianni N, 2014, FREE RADICAL BIO MED, V71, P303, DOI 10.1016/j.freeradbiomed.2014.03.031
   Chung KW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040880
   Cruz-Topete D, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00347
   Dittner C, 2019, MOL METAB, V25, P20, DOI 10.1016/j.molmet.2019.05.005
   El-Kurdi B, 2020, GASTROENTEROLOGY, V159, P1015, DOI 10.1053/j.gastro.2020.05.057
   Feng Q, 2021, MOL BIOMED, V2, DOI 10.1186/s43556-021-00052-1
   Feng Q, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.983501
   Feng Q, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.864929
   Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080
   Foo J, 2022, TRENDS MICROBIOL, V30, P679, DOI 10.1016/j.tim.2021.12.011
   Gauthier BR, 2020, AGING CELL, V19, DOI 10.1111/acel.13260
   Gilda JE, 2017, J PHYSIOL-LONDON, V595, P4051, DOI 10.1113/JP273607
   Giorgi C, 2018, INT REV CEL MOL BIO, V340, P209, DOI 10.1016/bs.ircmb.2018.05.006
   Gomez CR, 2021, GEROSCIENCE, V43, P2515, DOI 10.1007/s11357-021-00394-2
   Guarnotta V, 2021, REV ENDOCR METAB DIS, V22, P703, DOI 10.1007/s11154-020-09598-x
   Gyuricza IG, 2022, GENOME RES, V32, P838, DOI 10.1101/gr.275672.121
   Hajam YA, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030552
   Hammes SR, 2015, BEST PRACT RES CL EN, V29, P581, DOI 10.1016/j.beem.2015.04.001
   Han LKM, 2019, PSYCHONEUROENDOCRINO, V106, P293, DOI 10.1016/j.psyneuen.2019.04.004
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hasan KMM, 2012, AGE, V34, P1421, DOI 10.1007/s11357-011-9319-0
   Henning Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113698
   Hodes RJ, 2016, ANN NY ACAD SCI, V1386, P45, DOI 10.1111/nyas.13299
   Hui HP, 2017, ONCOTARGET, V8, P15663, DOI 10.18632/oncotarget.14933
   Jahanafrooz Z, 2022, GENE, V808, DOI 10.1016/j.gene.2021.145963
   Kalra S, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/9641846
   Khan R, 2020, CARDIOL RES, V11, P68, DOI 10.14740/cr1034
   Kirtipal N, 2022, INFECT GENET EVOL, V99, DOI 10.1016/j.meegid.2022.105254
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Kovilakath Anna, 2020, J Lipid Atheroscler, V9, P23, DOI 10.12997/jla.2020.9.1.23
   Low YH, 2021, MOL NEUROBIOL, V58, P631, DOI 10.1007/s12035-020-02137-4
   Lynch SM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10123367
   Mammen JS, 2015, THYROID, V25, P979, DOI 10.1089/thy.2015.0180
   Matsumoto C, 2018, J MOL CELL CARDIOL, V124, P114, DOI 10.1016/j.yjmcc.2018.07.094
   McLendon PM, 2015, CIRC RES, V116, P1863, DOI 10.1161/CIRCRESAHA.116.305372
   Meller A, 2021, EXP CELL RES, V399, DOI 10.1016/j.yexcr.2021.112474
   Meyer-Schwesinger C, 2019, NAT REV NEPHROL, V15, P393, DOI 10.1038/s41581-019-0148-1
   Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001
   Ramos PM, 2020, EXP DERMATOL, V29, P1250, DOI 10.1111/exd.14220
   Nie X, 2021, CELL, V184, P775, DOI 10.1016/j.cell.2021.01.004
   Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023
   Osuna Patricia Mejia, 2017, Methodist Debakey Cardiovasc J, V13, P60, DOI 10.14797/mdcj-13-2-60
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Predmore JM, 2010, CIRCULATION, V121, P997, DOI 10.1161/CIRCULATIONAHA.109.904557
   Rakov H, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0159-1
   Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344
   Scarborough EA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21685-4
   Schlossarek S, 2014, J MOL CELL CARDIOL, V71, P25, DOI 10.1016/j.yjmcc.2013.12.016
   Schlossarek S, 2011, CURR OPIN CARDIOL, V26, P190, DOI 10.1097/HCO.0b013e32834598fe
   Simonsick EM, 2016, J GERONTOL A-BIOL, V71, P961, DOI 10.1093/gerona/glv226
   Smith CL, 2012, MAMM GENOME, V23, P653, DOI 10.1007/s00335-012-9421-3
   Sultana R, 2022, HELIYON, V8, DOI 10.1016/j.heliyon.2021.e08651
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Tang Yun-Chi, 2007, Cell, V128, P412
   Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0
   Tiku V, 2018, TRENDS CELL BIOL, V28, P662, DOI 10.1016/j.tcb.2018.03.007
   Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002
   Trüeb RM, 2021, EXP DERMATOL, V30, P288, DOI 10.1111/exd.14259
   Turi Z, 2019, AGING-US, V11, P2512, DOI 10.18632/aging.101922
   Tye BW, 2019, ELIFE, V8, DOI 10.7554/eLife.43002
   van den Hoogenhof MMG, 2016, CIRC RES, V118, P454, DOI 10.1161/CIRCRESAHA.115.307872
   Vegiopoulos A, 2017, EMBO J, V36, P1999, DOI 10.15252/embj.201696206
   Venediktova N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111744
   Violi F, 2020, CIRC RES, V127, P400, DOI 10.1161/CIRCRESAHA.120.317173
   Wang F, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.675465
   Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180
   Xia SW, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105218
   Yan MJ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9570325
   Yan YC, 2021, MOL THER, V29, P2253, DOI 10.1016/j.ymthe.2021.03.004
   Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
   Zuo PY, 2020, NUTRITION, V78, DOI 10.1016/j.nut.2020.110930
NR 85
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD 2023 OCT
PY 2023
VL 238
IS 10
BP 2481
EP 2498
DI 10.1002/jcp.31108
EA SEP 2023
PG 18
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA U5VN4
UT WOS:001076000500001
PM 37750538
DA 2024-02-19
ER

PT J
AU Chen, JL
   Xu, TH
   Zhu, DD
   Wang, JX
   Huang, CQ
   Lyu, L
   Hu, B
   Sun, W
   Duan, YN
AF Chen, Jinling
   Xu, Tianhua
   Zhu, Dandan
   Wang, Jianxin
   Huang, Caiqun
   Lyu, Lei
   Hu, Bin
   Sun, Wei
   Duan, Yinong
TI Egg antigen p40 of <i>Schistosoma japonicum</i> promotes senescence in
   activated hepatic stellate cells by activation of the STAT3/p53/p21
   pathway
SO CELL DEATH & DISEASE
LA English
DT Article
ID CELLULAR SENESCENCE; LIVER FIBROSIS; NATURAL-KILLER; APOPTOSIS;
   INTERLEUKIN-10; MECHANISMS; REGRESSION; DIOSCIN; ROLES; SJP40
AB Liver fibrosis is a serious disease that is characterized by the excess deposition of extracellular matrix (ECM) components. Activated hepatic stellate cells (HSCs) are a major source of ECM and serve as a key regulator in liver fibrogenesis. Inactivation of HSCs is essential for liver fibrotic regression. The present study explores the underlying mechanisms of Schistosoma japonicum egg antigen p40 (Sjp40) promoting senescence in HSCs and antifibrosis. For the first time we report that Sjp40 inhibits the activation and proliferation of an immortalized human HSC line (LX-2 cells) and promotes cellular senescence and cell cycle arrest. Sjp40 through action on the STAT3/p53/p21 pathway triggered cellular senescence, while knockdown of p53 or STAT3 partly restored cell senescence. In addition, Sjp40-induced cellular senescence caused LX-2 cells to be more sensitive to a human NK cell line (YT cells). Together these findings provide novel insights into the mechanism of antifibrosis and may have implications for the development of antifibrosis therapies.
C1 [Chen, Jinling; Xu, Tianhua; Zhu, Dandan; Huang, Caiqun; Lyu, Lei; Hu, Bin; Sun, Wei; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
   [Wang, Jianxin] Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.
C3 Nantong University; Nantong University
RP Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM yinongduan@aliyun.com
RI Duan, yinong/GSD-9438-2022; wang, xiao/HZI-9156-2023
OI Chen, Jinling/0000-0003-2992-6571; Xu, Tianhua/0000-0002-7093-5325
FU National Natural Science Foundation of China [81471975, 81401683,
   81501763, 81171589]; Jiangsu provincial Natural Science Foundation
   [BK20140435]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD); Fund of Doctoral Research in Nantong
   University [14B36]
FX We thank Prof. Haiming Wei, University of Science and Technology of
   China for providing us with YT cells. This work was supported by
   National Natural Science Foundation of China (Grant Numbers 81471975,
   81401683, 81501763, 81171589), the Jiangsu provincial Natural Science
   Foundation (Grant Number BK20140435), the Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD) and the Fund
   of Doctoral Research in Nantong University (Grant Number 14B36).
CR Abouel-Nour MF, 2006, MEM I OSWALDO CRUZ, V101, P365, DOI 10.1590/S0074-02762006000400004
   Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x
   Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60
   Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009
   Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479
   Bai T, 2013, INT IMMUNOPHARMACOL, V15, P275, DOI 10.1016/j.intimp.2012.12.020
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   CAO M, 1993, MOL BIOCHEM PARASIT, V58, P169, DOI 10.1016/0166-6851(93)90102-4
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Dai WP, 2015, LIVER INT, V35, P1234, DOI 10.1111/liv.12660
   Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393
   Duan YN, 2011, PARASITOLOGY, V138, P1003, DOI 10.1017/S0031182011000667
   Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003
   Duval F, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/373295
   Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Gao B, 2013, BBA-MOL BASIS DIS, V1832, P1061, DOI 10.1016/j.bbadis.2012.09.008
   Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400
   Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551
   Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1
   Huna A, 2015, CELL CYCLE, V14, P2969, DOI 10.1080/15384101.2015.1056948
   Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Kojima Hirotada, 2013, JAKSTAT, V2, pe25763, DOI 10.4161/jkst.25763
   Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172
   Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034
   Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18038
   Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025
   Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006
   Sun XL, 2015, PARASITOL RES, V114, P4251, DOI 10.1007/s00436-015-4663-0
   Wang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061792
   Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106
   Wei YF, 2015, CELL PHYSIOL BIOCHEM, V35, P1599, DOI 10.1159/000373974
   Huang YH, 2006, WORLD J GASTROENTERO, V12, P1386, DOI 10.3748/wjg.v12.i9.1386
   Zhang LJ, 2007, HEPATO-GASTROENTEROL, V54, P2092
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
   Zhou XH, 2010, DIAGN MICR INFEC DIS, V67, P337, DOI 10.1016/j.diagmicrobio.2010.03.003
NR 47
TC 28
Z9 29
U1 2
U2 7
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUL
PY 2016
VL 7
AR e2315
DI 10.1038/cddis.2016.228
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DS6VD
UT WOS:000380920200005
PM 27468691
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Meadows, V
   Kennedy, L
   Hargrove, L
   Demieville, J
   Meng, FY
   Virani, S
   Reinhart, E
   Kyritsi, K
   Invernizzi, P
   Yang, ZH
   Wu, N
   Liangpunsakul, S
   Alpini, G
   Francis, H
AF Meadows, Vik
   Kennedy, Lindsey
   Hargrove, Laura
   Demieville, Jennifer
   Meng, Fanyin
   Virani, Shohaib
   Reinhart, Evan
   Kyritsi, Konstantina
   Invernizzi, Pietro
   Yang, Zhihong
   Wu, Nan
   Liangpunsakul, Suthat
   Alpini, Gianfranco
   Francis, Heather
TI Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment
   inhibits mast cell migration and decreases biliary damage/senescence and
   liver fibrosis in Mdr2<SUP>-/-</SUP> mice
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Mast cells; Stem cell factor; Fibrosis; PSC; Migration
ID C-KIT RECEPTOR; SCLEROSING CHOLANGITIS; CHOLANGIOCYTES; HYPERPLASIA;
   SENESCENCE; EXPRESSION
AB Primary sclerosing cholangitis (PSC) is characterized by increased mast cell (MC) infiltration, biliary damage and hepatic fibrosis. Cholangiocytes secrete stem cell factor (SCF), which is a chemoattractant for c-kit expressed on MCs. We aimed to determine if blocking SCF inhibits MC migration, biliary damage and hepatic fibrosis.
   Methods: FVB/NJ and Mdr2(-/-) mice were treated with Mismatch or SCF Vivo-Morpholinos. We measured (i) SCF expression and secretion; (ii) hepatic damage; (iii) MC migration/activation and histamine signaling; (iv) ductular reaction and biliary senescence; and (v) hepatic fibrosis. In human PSC patients, SCF expression and secretion were measured. In vitro, cholangiocytes were evaluated for SCF expression and secretion. Biliary proliferation/senescence was measured in cholangiocytes pretreated with 0.1% BSA or the SCF inhibitor, ISK03. Cultured HSCs were stimulated with cholangiocyte supernatant and activation measured. MC migration was determined with cholangiocytes pretreated with BSA or ISK03 loaded into the bottom of Boyden chambers and MCs into top chamber.
   Results: Biliary SCF expression and SCF serum levels increase in human PSC. Cholangiocytes, but not hepatocytes, from SCF Mismatch Mdr2(-/-) mice have increased SCF expression and secretion. Inhibition of SCF in Mdr2(-/-) mice reduced (i) hepatic damage; (ii) MC migration; (iii) histamine and SCF serum levels; and (iv) ductular reaction/biliary senescence/hepatic fibrosis. In vitro, cholangiocytes express and secrete SCF. Blocking biliary SCF decreased MC migration, biliary proliferation/senescence, and HSC activation.
   Conclusion: Cholangiocytes secrete increased levels of SCF inducing MC migration, contributing to biliary damage/hepatic fibrosis. Targeting MC infiltration may be an option to ameliorate PSC progression.
C1 [Meadows, Vik; Demieville, Jennifer; Meng, Fanyin; Alpini, Gianfranco; Francis, Heather] Cent Texas Vet Hlth Care Syst, Res, College Stn, TX USA.
   [Meadows, Vik; Kennedy, Lindsey; Hargrove, Laura; Virani, Shohaib; Reinhart, Evan; Kyritsi, Konstantina; Alpini, Gianfranco; Francis, Heather] Texas A&M Univ, Coll Med, Dept Med Physiol, College Stn, TX 77843 USA.
   [Yang, Zhihong; Wu, Nan; Liangpunsakul, Suthat] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.
   [Invernizzi, Pietro] Humanitas Clin & Res Ctr, Milan, Italy.
   [Meadows, Vik; Kennedy, Lindsey; Meng, Fanyin; Kyritsi, Konstantina; Alpini, Gianfranco; Francis, Heather] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.
   [Invernizzi, Pietro] Univ Milano Bicocca, Dept Med & Surg, Div Gastroenterol, Monza, Italy.
   [Invernizzi, Pietro] Univ Milano Bicocca, Dept Med & Surg, Ctr Autoimmune Liver Dis, Monza, Italy.
C3 Texas A&M University System; Texas A&M University College Station;
   Indiana University System; Indiana University Bloomington; US Department
   of Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Richard L. Roudebush VA Medical Center;
   Indiana University System; Indiana University Bloomington; University of
   Milano-Bicocca; University of Milano-Bicocca
RP Francis, H (corresponding author), Cent Texas Vet Hlth Care Syst, Res, College Stn, TX USA.
EM heafranc@iu.edu
RI Invernizzi, Pietro/AAB-8367-2022; Meadows, Vik/AAB-4672-2021
FU Central Texas Veterans Health Care System and Richard L. Roudebush VA
   Medical Center; U.S. Department of Veterans Affairs, Biomedical
   Laboratory Research and Development Service [1I01BX003031, 4I01BX000574,
   5I01BX001724]; NIH NIDDK [DK108959]; Indiana University School of
   Medicine, Indianapolis, Indiana; Baylor Scott & White Health, Temple,
   Texas
FX This material is the result of work supported by resources at the
   Central Texas Veterans Health Care System and Richard L. Roudebush VA
   Medical Center. The views expressed in this article are those of the
   authors and do not necessarily represent the views of the Department of
   Veterans Affairs. The studies were supported by a SRCS Award to Dr.
   Alpini, VA Merit Awards (1I01BX003031, HF; 4I01BX000574, GA;
   5I01BX001724, FM) from the U.S. Department of Veterans Affairs,
   Biomedical Laboratory Research and Development Service and NIH NIDDK
   grant (DK108959, HF) along with funds from Indiana University School of
   Medicine (GA and HF), Indianapolis, Indiana and Baylor Scott & White
   Health (GA and FM), Temple, Texas.
CR Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x
   Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023
   Brzezinska-Blaszczyk E, 2007, J INTERF CYTOK RES, V27, P911, DOI 10.1089/jir.2006.0158
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Fickert P, 2006, GASTROENTEROLOGY, V130, P465, DOI 10.1053/j.gastro.2005.10.018
   GALLI SJ, 1993, AM J PATHOL, V142, P965
   Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119
   Hargrove L, 2017, HEPATOLOGY, V65, P1991, DOI 10.1002/hep.29079
   Johnson C, 2016, AM J PATHOL, V186, P123, DOI 10.1016/j.ajpath.2015.09.016
   Jones H, 2016, HEPATOLOGY, V64, P1202, DOI 10.1002/hep.28704
   Kennedy L, 2018, HEPATOLOGY, V68, P1042, DOI 10.1002/hep.29898
   Kennedy L, 2018, AM J PATHOL, V188, P600, DOI 10.1016/j.ajpath.2017.11.016
   Kennedy LL, 2014, LAB INVEST, V94, P1406, DOI 10.1038/labinvest.2014.129
   Kyritsi K, 2017, AM J PATHOL, V187, P1551, DOI 10.1016/j.ajpath.2017.03.013
   Lee CW, 2019, SURG CLIN N AM, V99, P185, DOI 10.1016/j.suc.2018.11.003
   Mansuroglu T, 2009, LAB INVEST, V89, P562, DOI 10.1038/labinvest.2009.15
   MEININGER CJ, 1992, BLOOD, V79, P958
   Meng FY, 2012, HEPATOLOGY, V55, P209, DOI 10.1002/hep.24673
   Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025
   Rajapaksha Indu G, 2019, World J Gastrointest Pathophysiol, V10, P1, DOI 10.4291/wjgp.v10.i1.1
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Sibilano R, 2014, EUR J IMMUNOL, V44, P2558, DOI 10.1002/eji.201444546
   Trauner M, 2010, DIGEST DIS, V28, P99, DOI 10.1159/000282072
   Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wu N, 2018, AM J PATHOL, V188, P2264, DOI 10.1016/j.ajpath.2018.06.015
   Yin DD, 2018, MOL MED REP, V17, P7356, DOI 10.3892/mmr.2018.8776
   Young KC, 2016, PEDIATR RES, V79, P637, DOI 10.1038/pr.2015.275
   Zhang M, 2011, CANCER LETT, V303, P108, DOI 10.1016/j.canlet.2011.01.017
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 30
TC 23
Z9 24
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD DEC 1
PY 2019
VL 1865
IS 12
AR 165557
DI 10.1016/j.bbadis.2019.165557
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA JM2FW
UT WOS:000496037700010
PM 31521820
OA Green Submitted, hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU Liu, QG
   Chen, F
   Yang, T
   Su, J
   Song, SH
   Fu, ZR
   Li, Y
   Hu, YP
   Wang, MJ
AF Liu, Qinggui
   Chen, Fei
   Yang, Tao
   Su, Jing
   Song, Shaohua
   Fu, Zhi-Ren
   Li, Yao
   Hu, Yi-Ping
   Wang, Min-Jun
TI Aged-related Function Disorder of Liver is Reversed after Exposing to
   Young Milieu <i>via</i> Conversion of Hepatocyte Ploidy
SO AGING AND DISEASE
LA English
DT Article
DE rejuvenation; hepatocyte polyploidy; liver regeneration; liver
   steatosis; young milieu
ID PARTIAL-HEPATECTOMY; REGENERATING LIVER; C/EBP-ALPHA; SENESCENCE;
   PROLIFERATION; INHIBITION; CELLS; MICE; REPLICATION; BIOMARKER
AB Previous study showed that senescent hepatocytes from aged liver could be rejuvenated after repopulated in the young recipient liver. The proliferative capacity of hepatocytes was restored with the senescence reversal. However, it is unknown whether metabolic and homeostatic function of aged liver, as well as age-dependent liver steatosis could be rejuvenated or alleviated. Here, we found that senescent hepatocytes from aged liver were rejuvenated after exposing to young blood. An autonomous proliferation of senescent hepatocytes which resulting in ploidy reversal might be the underlying mechanism of senescent reversal. After performing 2/3 partial hepatectomy (2/3PHx) in young blood exposed old liver, delayed DNA synthesis of senescent hepatocytes was rescued and the number of BrdU positive hepatocytes was restored from 4.39 +/- 2.30% to 17.85 +/- 3.21%, similarly to that in the young mice at 36 hours post 2/3PHx. Moreover, Cyclin A2 and Cyclin E1 overexpression of hepatocytes in aged liver facilitating the G1/S phase transition was contributed to enhance liver regeneration. Furthermore, lipid droplet spread widely in the elderly human liver and old mouse liver, but this aged-associated liver steatosis was alleviated as senescence reversal. Collectively, our study provides new thoughts for effectively preventing age-related liver diseases.
C1 [Liu, Qinggui; Chen, Fei; Yang, Tao; Su, Jing; Hu, Yi-Ping; Wang, Min-Jun] Second Mil Med Univ, Ctr Stem Cell & Med, Dept Cell Biol, Naval Med Univ, Shanghai, Peoples R China.
   [Song, Shaohua; Fu, Zhi-Ren] Second Mil Med Univ, Naval Med Univ, Changzheng Hosp, Shanghai, Peoples R China.
   [Li, Yao] Fudan Univ, State Key Lab Genet Engn, Shanghai, Peoples R China.
C3 Naval Medical University; Naval Medical University; Fudan University
RP Hu, YP; Wang, MJ (corresponding author), Second Mil Med Univ, Ctr Stem Cell & Med, Shanghai, Peoples R China.
EM yphu@smmu.edu.cn; mjwang@smmu.edu.cn
RI ZHU, JIALI/JNE-3065-2023; Fu, zr/JHT-6152-2023; cheng,
   chen/JHS-9462-2023; Li, Wei/JLL-4365-2023
FU National Key R&D Program of China [2018YFA0107500]; National Natural
   Science Foundation of China [32070732, 31601101, 31701186, 31970753];
   Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan
   University [SKLGE1901]
FX This work was support by National Key R&D Program of China
   (2018YFA0107500), National Natural Science Foundation of China
   (32070732, 31601101, 31701186, 31970753), Open Research Fund of State
   Key Laboratory of Genetic Engineering, Fudan University (No. SKLGE1901).
CR Allaire M, 2020, CLIN RES HEPATOL GAS, V44, P6, DOI 10.1016/j.clinre.2019.07.011
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067
   Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Emilsson V, 2019, NAT MED, V25, P1815, DOI 10.1038/s41591-019-0677-y
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Gjelsvik KJ, 2019, TRENDS GENET, V35, P6, DOI 10.1016/j.tig.2018.10.005
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Liu AD, 2019, FASEB J, V33, P3063, DOI 10.1096/fj.201801234R
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089
   Matsumoto T, 2020, CELL STEM CELL, V26, DOI 10.1016/j.stem.2019.11.014
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Nguyen P, 2018, CELL REP, V24, P1597, DOI 10.1016/j.celrep.2018.07.014
   Pibiri M, 2018, AGING-US, V10, P1801, DOI 10.18632/aging/101524
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Salpeter SJ, 2013, DIABETES, V62, P2843, DOI 10.2337/db13-0160
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Stock P, 2017, AM J PATHOL, V187, P553, DOI 10.1016/j.ajpath.2016.11.016
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Valenti L, 2014, CELL CYCLE, V13, P1371, DOI 10.4161/cc.28754
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang MJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0186-1
   Wang MJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.167
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Wei SY, 2019, J FORMOS MED ASSOC
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Wilkinson PD, 2019, HEPATOLOGY, V69, P1242, DOI 10.1002/hep.30286
   Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Xu XH, 2013, J HEPATOL, V59, P308, DOI 10.1016/j.jhep.2013.03.037
   Zhang HX, 2019, GEROSCIENCE, V41, P275, DOI 10.1007/s11357-019-00075-1
NR 49
TC 2
Z9 2
U1 1
U2 10
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD AUG 1
PY 2021
VL 12
IS 5
BP 1238
EP 1251
DI 10.14336/AD.2020.1227
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TU5FF
UT WOS:000681061500010
PM 34341705
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Shackel, NA
   Vadas, MA
   Gamble, JR
   McCaughan, GW
AF Shackel, Nicholas A.
   Vadas, Mathew A.
   Gamble, Jennifer R.
   McCaughan, Geoffrey W.
TI Beyond Liver Fibrosis: Hepatic Stellate Cell Senescence Links Obesity to
   Liver Cancer by Way of the Microbiome
SO HEPATOLOGY
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; EXPRESSION
AB Obesity has become more prevalent in most developed countries over the past few decades, and is increasingly recognized as a major risk factor for several common types of cancer. As the worldwide obesity epidemic has shown no signs of abating, better understanding of the mechanisms underlying obesity-associated cancer is urgently needed. Although several events were proposed to be involved in obesity-associated cancer, the exact molecular mechanisms that integrate these events have remained largely unclear. Here we show that senescence-associated secretory phenotype (SASP) has crucial roles in promoting obesity-associated hepatocellular carcinoma (HCC) development in mice. Dietary or genetic obesity induces alterations of gut microbiota, thereby increasing the levels of deoxycholic acid (DCA), a gut bacterial metabolite known to cause DNA damage. The enterohepatic circulation of DCA provokes SASP phenotype in hepatic stellate cells (HSCs), which in turn secretes various inflammatory and tumour-promoting factors in the liver, thus facilitating HCC development in mice after exposure to chemical carcinogen. Notably, blocking DCA production or reducing gut bacteria efficiently prevents HCC development in obese mice. Similar results were also observed in mice lacking an SASP inducer or depleted of senescent HSCs, indicating that the DCA-SASP axis in HSCs has key roles in obesity-associated HCC development. Moreover, signs of SASP were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis, indicating that a similar pathway may contribute to at least certain aspects of obesity-associated HCC development in humans as well. These findings provide valuable new insights into the development of obesity-associated cancer and open up new possibilities for its control.
C1 [Shackel, Nicholas A.; McCaughan, Geoffrey W.] Centenary Inst, Liver Injury & Canc Grp, Sydney, NSW, Australia.
   [Shackel, Nicholas A.; McCaughan, Geoffrey W.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia.
   [Vadas, Mathew A.; Gamble, Jennifer R.] Univ Sydney, Vasc Biol Program, Centenary Inst, Sydney, NSW 2006, Australia.
C3 University of Sydney; Centenary Institute; NSW Health; Royal Prince
   Alfred Hospital; University of Sydney; University of Sydney; Centenary
   Institute
RP Shackel, NA (corresponding author), Centenary Inst, Liver Injury & Canc Grp, Sydney, NSW, Australia.
RI Vadas, Mathew/R-1378-2019
OI Gamble, Jennifer/0000-0002-0179-9964; MCCAUGHAN,
   GEOFFREY/0000-0002-1483-1636
CR Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305
   KITAZAWA S, 1990, CARCINOGENESIS, V11, P1323, DOI 10.1093/carcin/11.8.1323
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Torres DM, 2012, SEMIN LIVER DIS, V32, P30, DOI 10.1055/s-0032-1306424
   White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
NR 11
TC 16
Z9 17
U1 2
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 2014
VL 59
IS 6
BP 2413
EP 2415
DI 10.1002/hep.26932
PG 3
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AJ3LF
UT WOS:000337567100040
PM 24273014
OA Bronze
DA 2024-02-19
ER

PT J
AU Guo, ML
   Gong, L
   He, L
   Lehman-McKeeman, L
   Wan, YJY
AF Guo, Minglei
   Gong, Lei
   He, Lin
   Lehman-McKeeman, Lois
   Wan, Yu-Jui Yvonne
TI Hepatocyte RXRalpha deficiency in matured and aged mice: impact on the
   expression of cancer-related hepatic genes in a gender-specific manner
SO BMC GENOMICS
LA English
DT Article
ID RETINOID-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN
   HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; MOUSE-LIVER; ALPHA; ACID;
   CELLS; CARCINOGENESIS; INFLAMMATION
AB Background: The occurrence of liver cancer is higher in males than in females, and the incidence increases during aging. Signaling pathways regulated by retinoid x receptor alpha (RXR alpha) are involved in hepatocellular carcinogenesis. The phenotype of hepatocyte RXRa deficient mice is different between genders. To explore the impact of hepatocyte RXRa deficiency on gender-dependent hepatic gene expression, we compared the expression profiles of cancer-related genes in 6 and 24 month old male and female mice.
   Results: In 6 month old mice, male mutant mice showed more cancer-related genes with alteration in mRNA levels than females did (195 vs. 60). In aged mice (24 month), female mutant mice showed greater deviation in mRNA expression levels of cancer-related genes than their male counterparts (149 vs. 82). The genes were classified into five categories according to their role in carcinogenesis: apoptosis, metastasis, cell growth, stress, and immune respnse. In each category, dependent upon age and gender, the genes as well as the number of genes with altered mRNA levels due to RXRa deficiency varies.
   Conclusion: The change in hepatic cancer-related gene expression profiles due to RXRa deficiency was gender- and age-dependent. The alteration of mRNA levels of cancer-related genes implied that aberrant RXRa signaling could potentially increase the risk of liver cancer and that retinoid signaling might contribute to gender- and age-associated liver cancer incidence.
C1 [Guo, Minglei; He, Lin; Wan, Yu-Jui Yvonne] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.
   [Gong, Lei; Lehman-McKeeman, Lois] Bristol Myers Squibb Co, Discovery Toxicol, Princeton, NJ 08543 USA.
C3 University of Kansas; University of Kansas Medical Center; Bristol-Myers
   Squibb
RP Wan, YJY (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.
EM mguo@kumc.edu; lei.gong@bms.com; lhe@kumc.edu;
   Lois.Lehman-McKeeman@bms.com; ywan@kumc.edu
OI Guo, Ming-Lei/0000-0003-2969-0802
FU NIH [CA53596, AA12081, AA14147]; COBRE [P20 RR021940]
FX This work is supported by NIH grants CA53596, AA12081, AA14147, and
   COBRE grant P20 RR021940. We thank Ms. Barbara Brede for proofreading of
   this manuscript.
CR Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397
   Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200
   Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606
   Cai Y, 2003, ENDOCRINOLOGY, V144, P2311, DOI 10.1210/en.2002-0129
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chen Y, 2007, CANCER RES, V67, P10361, DOI 10.1158/0008-5472.CAN-06-4758
   Chuang KH, 2005, MOL ENDOCRINOL, V19, P1200, DOI 10.1210/me.2004-0181
   Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827
   Feart C, 2005, EUR J ENDOCRINOL, V152, P449, DOI 10.1530/eje.1.01858
   Frick KM, 2000, NEUROSCIENCE, V95, P293
   Gopal-Srivastava R, 1998, J BIOL CHEM, V273, P17954, DOI 10.1074/jbc.273.28.17954
   Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8
   Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2
   Hawighorst T, 2002, ONCOGENE, V21, P7945, DOI 10.1038/sj.onc.1205956
   Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564
   Holvik Kristin, 2007, BMC Endocr Disord, V7, P9, DOI 10.1186/1472-6823-7-9
   Imai T, 2001, P NATL ACAD SCI USA, V98, P4581, DOI 10.1073/pnas.071056098
   Kanamori T, 2007, CANCER SCI, V98, P431, DOI 10.1111/j.1349-7006.2006.00384.x
   Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016
   Kintscher U, 2000, EUR J PHARMACOL, V401, P259, DOI 10.1016/S0014-2999(00)00461-1
   Ma D, 1997, BLOOD, V90, P2738, DOI 10.1182/blood.V90.7.2738.2738_2738_2746
   Moriwaki H, 2007, HEPATOL RES, V37, pS299, DOI 10.1111/j.1872-034X.2007.00201.x
   Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223
   Park E, 2007, MOL CELL ENDOCRINOL, V278, P7, DOI 10.1016/j.mce.2007.08.002
   Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840
   Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567
   Suzui M, 2004, MOL CANCER THER, V3, P309
   Tetzlaff J, 2007, J NEUROENDOCRINOL, V19, P383, DOI 10.1111/j.1365-2826.2007.01538.x
   Wan YJY, 2000, J BIOL CHEM, V275, P28285
   Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000
   Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459
   Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206
   Ye P, 2005, CHINESE MED J-PEKING, V118, P1093
   Zhang H, 2000, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V22, P322
NR 36
TC 6
Z9 7
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD AUG 28
PY 2008
VL 9
AR 403
DI 10.1186/1471-2164-9-403
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 357CL
UT WOS:000259823800002
PM 18755030
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Mello, T
   Materozzi, M
   Zanieri, F
   Simeone, I
   Ceni, E
   Bereshchenko, O
   Polvani, S
   Tarocchi, M
   Marroncini, G
   Nerlov, C
   Guasti, D
   Bani, D
   Pinzani, M
   Galli, A
AF Mello, Tommaso
   Materozzi, Maria
   Zanieri, Francesca
   Simeone, Irene
   Ceni, Elisabetta
   Bereshchenko, Oxana
   Polvani, Simone
   Tarocchi, Mirko
   Marroncini, Giada
   Nerlov, Claus
   Guasti, Daniele
   Bani, Daniele
   Pinzani, Massimo
   Galli, Andrea
TI Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and
   enhances hepatocellular carcinoma progression
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article; Early Access
DE Pontin; mTOR; Akt; glucose metabolism; cancer
ID X-RECEPTOR; PONTIN; MTOR; LIPOGENESIS; CANCER; EPIDEMIOLOGY;
   GLUCOKINASE; SREBP-1C; STRESS; REPTIN
AB RuvBL1 is an AAA+ ATPase whose expression in hepatocellular carcinoma (HCC) correlates with a poor prognosis. In vitro models suggest that targeting RuvBL1 could be an effective strategy against HCC. However, the role of RuvBL1 in the onset and progression of HCC remains unknown. To address this question, we developed a RuvBL1(hep+/-) mouse model and evaluated the outcome of DEN-induced liver carcinogenesis up to 12 months of progression. We found that RuvBL1 haploinsufficiency initially delayed the onset of liver cancer, due to a reduced hepatocyte turnover in RuvBL1(hep+/-) mice. However, RuvBL1(hep+/-)mice eventually developed HCC nodules that, with aging, grew larger than in the control mice. Moreover, RuvBL1(hep+/-) mice developed hepatic insulin resistance and impaired glucose homeostasis. We could determine that RuvBL1 regulates insulin signaling through the Akt/mTOR pathway in liver physiology in vivo as well as in normal hepatocytic and HCC cells in vitro. Whole transcriptome analysis of mice livers confirmed the major role of RuvBL1 in the regulation of hepatic glucose metabolism. Finally, RuvBL1 expression was found significantly correlated to glucose metabolism and mTOR signaling by bioinformatic analysis of human HCC sample from the publicly available TGCA database. These data uncover a role of RuvBL1 at the intersection of liver metabolism, hepatocyte proliferation and HCC development, providing a molecular rationale for its overexpression in liver cancer.
C1 [Mello, Tommaso; Materozzi, Maria; Zanieri, Francesca; Simeone, Irene; Ceni, Elisabetta; Polvani, Simone; Tarocchi, Mirko; Marroncini, Giada; Galli, Andrea] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Florence, Italy.
   [Bereshchenko, Oxana] Univ Perugia, Fac Med, Perugia, Italy.
   [Nerlov, Claus] Univ Oxford, Radcliffe Dept Med, Weatherall Inst Mol Med, MRC Mol Hematol Unit, Oxford, England.
   [Guasti, Daniele; Bani, Daniele] Univ Florence, Dept Clin & Expt Med, Florence, Italy.
   [Pinzani, Massimo] UCL Inst Liver & Digest Hlth, London, England.
C3 University of Florence; University of Perugia; University of Oxford;
   University of Florence; University of London; University College London
RP Mello, T (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Florence, Italy.
EM tommaso.mello@unifi.it
RI Mello, Tommaso/I-4715-2012; Materozzi, Maria/AAN-3793-2020; Mello,
   Tommaso/AAO-7831-2021
OI Mello, Tommaso/0000-0002-6192-6902; Mello, Tommaso/0000-0002-6192-6902;
   TAROCCHI, MIRKO/0000-0002-7767-5116; DANIELE,
   GUASTI/0000-0002-2856-6829; Galli, Andrea/0000-0001-5416-6290;
   Bereshchenko, Oxana/0000-0002-2772-6042; Materozzi,
   Maria/0000-0002-1179-4825; Marroncini, Giada/0000-0002-6611-8103
FU Ente Cassa di Risparmio di Firenze [2013.0673]; Ministero della Salute
   [GR-2009-1600315]; MRC [MC_UU_00016/7, G0701761, MC_UU_12009/7,
   G0900892] Funding Source: UKRI
FX Grant sponsor: Ente Cassa di Risparmio di Firenze; Grant number:
   2013.0673; Grant sponsor: Ministero della Salute; Grant number:
   GR-2009-1600315
CR Assimon VA, 2019, ACS CHEM BIOL, V14, P236, DOI 10.1021/acschembio.8b00904
   Bereshchenko O, 2012, HAEMATOL-HEMATOL J, V97, P1291, DOI 10.3324/haematol.2011.060251
   Breig O, 2014, LEUKEMIA, V28, P1271, DOI 10.1038/leu.2013.376
   Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095
   Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101
   Cloutier P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15615
   Ducat D, 2008, MOL BIOL CELL, V19, P3097, DOI 10.1091/mbc.E07-11-1202
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Elkaim J, 2012, BIOCHEM J, V443, P549, DOI 10.1042/BJ20111779
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088
   Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015
   Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215
   Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Izumi N, 2012, CANCER SCI, V103, P50, DOI 10.1111/j.1349-7006.2011.02112.x
   Izumi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000468
   Javary J, 2018, GUT, V67, P2192, DOI 10.1136/gutjnl-2017-314208
   Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016
   Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210
   Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369
   Kim K, 2012, HEPATOLOGY, V55, P1727, DOI 10.1002/hep.25537
   Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003
   Kimura T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13130
   Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001
   Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Mao YQ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00058
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Sun XW, 2016, J BIOL CHEM, V291, P1115, DOI 10.1074/jbc.M115.668269
   Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247
   Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yuan XS, 2016, TUMOR BIOL, V37, P16015, DOI 10.1007/s13277-016-5452-9
NR 37
TC 14
Z9 14
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7136
EI 1097-0215
J9 INT J CANCER
JI Int. J. Cancer
PD 2020 JUN 15
PY 2020
VL 146
IS 12
BP 3410
EP 3422
DI 10.1002/ijc.32787
EA NOV 2019
PG 13
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA LG1BS
UT WOS:000499098800001
PM 31721195
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Nguyen, P
   Valanejad, L
   Cast, A
   Wright, M
   Garcia, JM
   El-Serag, HB
   Karns, R
   Timchenko, NA
AF Phuong Nguyen
   Valanejad, Leila
   Cast, Ashley
   Wright, Mary
   Garcia, Jose M.
   El-Serag, Hashem B.
   Karns, Rebekah
   Timchenko, Nikolai A.
TI Elimination of Age-Associated Hepatic Steatosis and Correction of Aging
   Phenotype by Inhibition of cdk4-C/EBPα-p300 Axis
SO CELL REPORTS
LA English
DT Article
ID FATTY LIVER-DISEASE; C/EBP-ALPHA; DNA-DAMAGE; CANCER; MICE;
   REGENERATION; PROGRESSION; LIPOGENESIS; GANKYRIN; DELETION
AB The aging liver is affected by several disorders, including steatosis, that can lead to a decline of liver functions. Here, we present evidence that the cdk4-C/EBP alpha-p300 axis is a critical regulator of age-associated disorders, including steatosis. We found that patients with non-alcoholic fatty liver disease (NAFLD) have increased levels of cdk4 and that cdk4-resistant C/EBP alpha-S193A mice do not develop hepatic steatosis with advancing age. Underlying mechanisms include a block in C/EBP alpha activation and subsequent failure in activation of enzymes involved in the development of NAFLD. Inhibition of cdk4 in aged wild-type (WT) mice by a specific cdk4 inhibitor, PD-0332991, reduces C/EBP alpha-p300 complexes and eliminates hepatic steatosis. Moreover, the inhibition of cdk4 in aged mice reverses many age-related disorders. Mechanisms of correction include elimination of cellular senescence and alterations in the chromatin structure of hepatocytes. Thus, the inhibition of cdk4 might be considered as a therapeutic approach to correct age-associated liver disorders.
C1 [Phuong Nguyen; Valanejad, Leila; Cast, Ashley; Wright, Mary; Timchenko, Nikolai A.] Cincinnati Childrens Hosp Med Ctr, Dept Surg, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   [Karns, Rebekah] Cincinnati Childrens Hosp Med Ctr, Dept Gastroenterol Hepatol & Nutr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   [Garcia, Jose M.] VA Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA.
   [Garcia, Jose M.] Univ Washington, Seattle, WA 98108 USA.
   [El-Serag, Hashem B.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety IQuESt, Houston, TX 77030 USA.
   [El-Serag, Hashem B.] Baylor Coll Med, Sect Gastroenterol & Hepatol, One Baylor Plaza, Houston, TX 77030 USA.
   [El-Serag, Hashem B.] Michael E DeBakey VA Med Ctr, One Baylor Plaza, Houston, TX 77030 USA.
C3 Cincinnati Children's Hospital Medical Center; Cincinnati Children's
   Hospital Medical Center; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Vet Affairs Puget Sound Health Care System;
   Geriatric Research Education & Clinical Center; University of
   Washington; University of Washington Seattle; Baylor College of
   Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Timchenko, NA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Surg, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
EM nikolai.timchenko@cchmc.org
FU NIH [R01DK102597, R01CA159942]; Cincinnati Children's Hospital Medical
   Center (CCHMC) [SP15]
FX This work is supported by NIH grants R01DK102597 and R01CA159942
   (N.A.T.) and by Internal Development Funds from Cincinnati Children's
   Hospital Medical Center (CCHMC) (SP15 to N.A.T.).
CR Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Baker Stacey J, 2012, Genes Cancer, V3, P658, DOI 10.1177/1947601913478972
   Boursier J, 2016, CLIN LIVER DIS, V20, P263, DOI 10.1016/j.cld.2015.10.012
   Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
   Denechaud PD, 2016, J CLIN INVEST, V126, P137, DOI 10.1172/JCI81542
   Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X
   Engin A, 2017, ADV EXP MED BIOL, V960, P443, DOI 10.1007/978-3-319-48382-5_19
   Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509
   Guillory B, 2018, AGING CELL, V17, DOI 10.1111/acel.12688
   Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191
   Jelenik T, 2017, DIABETES, V66, P2241, DOI 10.2337/db16-1147
   Jiang YJ, 2013, HEPATOLOGY, V57, P1098, DOI 10.1002/hep.26146
   Jin JL, 2016, CELL REP, V16, P744, DOI 10.1016/j.celrep.2016.06.019
   Jin JL, 2015, HEPATOLOGY, V61, P315, DOI 10.1002/hep.27295
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Jois T, 2017, MOL METAB, V6, P1381, DOI 10.1016/j.molmet.2017.07.006
   Kawagishi H, 2008, EMBO J, V27, P1481, DOI 10.1038/emboj.2008.76
   Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060857
   Machado MV, 2016, GASTROENTEROLOGY, V150, P1769, DOI 10.1053/j.gastro.2016.02.066
   Newberry EP, 2017, HEPATOLOGY, V65, P836, DOI 10.1002/hep.28941
   Newberry EP, 2015, AM J PHYSIOL-GASTR L, V309, pG648, DOI 10.1152/ajpgi.00170.2015
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Oh AR, 2016, BMB REP, V49, P105, DOI 10.5483/BMBRep.2016.49.2.173
   Salamanca A, 2015, EXP GERONTOL, V69, P9, DOI 10.1016/j.exger.2015.05.009
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Softic S, 2017, J CLIN INVEST, V127, P4059, DOI 10.1172/JCI94585
   Sugimoto M, 2006, MOL CELL BIOL, V26, P502, DOI 10.1128/MCB.26.2.502-512.2006
   Timchenko NA, 2011, MOL PATHOL LIB, V5, P279, DOI 10.1007/978-1-4419-7107-4_19
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Valanejad L, 2017, CARCINOGENESIS, V38, P738, DOI 10.1093/carcin/bgx050
   Valenti L, 2014, CELL CYCLE, V13, P1371, DOI 10.4161/cc.28754
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933
   Zhang XP, 2012, BIOPHYS J, V102, P2251, DOI 10.1016/j.bpj.2012.04.002
NR 39
TC 33
Z9 36
U1 1
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD AUG 7
PY 2018
VL 24
IS 6
BP 1597
EP 1609
DI 10.1016/j.celrep.2018.07.014
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GP6MM
UT WOS:000440995100020
PM 30089269
OA gold, Green Accepted
DA 2024-02-19
ER

PT J
AU Duan, JL
   Ruan, B
   Song, P
   Fang, ZQ
   Yue, ZS
   Liu, JJ
   Dou, GR
   Han, H
   Wang, L
AF Duan, Juan-Li
   Ruan, Bai
   Song, Ping
   Fang, Zhi-Qiang
   Yue, Zhen-Sheng
   Liu, Jing-Jing
   Dou, Guo-Rui
   Han, Hua
   Wang, Lin
TI Shear stress-induced cellular senescence blunts liver regeneration
   through Notch-sirtuin 1-P21/P16 axis
SO HEPATOLOGY
LA English
DT Article; Early Access
ID CELLS; DISEASES
AB Background and Aims The mechanisms involved in liver regeneration after partial hepatectomy (pHx) are complicated. Cellular senescence, once linked to aging, plays a pivotal role in wound repair. However, the regulatory effects of cellular senescence on liver regeneration have not been fully elucidated. Approach and Results Mice subjected to pHx were analyzed 14 days after surgery. The incomplete remodeling of liver sinusoids affected shear stress-induced endothelial nitric oxide synthase (eNOS) signaling on day 14, resulting in the accumulation of senescent LSECs. Removing macrophages to augment LSEC senescence led to a malfunction of the regenerating liver. A dynamic fluctuation in Notch activity accompanied senescent LSEC accumulation during liver regeneration. Endothelial Notch activation by using Cdh5-CreERT NICeCA mice triggered LSEC senescence and senescence-associated secretory phenotype, which disrupted liver regeneration. Blocking the Notch by gamma-secretase inhibitor (GSI) diminished senescence and promoted LSEC expansion. Mechanically, Notch-hairy and enhancer of split 1 signaling inhibited sirtuin 1 (Sirt1) transcription by binding to its promoter region. Activation of Sirt1 by SRT1720 neutralized the up-regulation of P53, P21, and P16 caused by Notch activation and eliminated Notch-driven LSEC senescence. Finally, Sirt1 activator promoted liver regeneration by abrogating LSEC senescence and improving sinusoid remodeling. Conclusions Shear stress-induced LSEC senescence driven by Notch interferes with liver regeneration after pHx. Sirt1 inhibition accelerates liver regeneration by abrogating Notch-driven senescence, providing a potential opportunity to target senescent cells and facilitate liver repair after injury.
C1 [Duan, Juan-Li; Ruan, Bai; Song, Ping; Fang, Zhi-Qiang; Yue, Zhen-Sheng; Liu, Jing-Jing; Han, Hua; Wang, Lin] Fourth Mil Med Univ, Xi Jing Hosp, Dept Hepatobiliary Surg, Chang Le Xi St 169, Xian 710032, Peoples R China.
   [Ruan, Bai; Han, Hua] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian, Peoples R China.
   [Ruan, Bai] Fourth Mil Med Univ, Ctr Clin Aerosp Med, Xian, Peoples R China.
   [Ruan, Bai] Fourth Mil Med Univ, Dept Aviat Med, Xian, Peoples R China.
   [Yue, Zhen-Sheng; Dou, Guo-Rui] Fourth Mil Med Univ, Xi Jing Hosp, Dept Ophthalmol, Chang Le Xi St 169, Xian 710032, Peoples R China.
C3 Air Force Military Medical University; Air Force Military Medical
   University; Air Force Military Medical University; Air Force Military
   Medical University; Air Force Military Medical University
RP Wang, L (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, Dept Hepatobiliary Surg, Chang Le Xi St 169, Xian 710032, Peoples R China.; Dou, GR (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, Dept Ophthalmol, Chang Le Xi St 169, Xian 710032, Peoples R China.; Han, H (corresponding author), Fourth Mil Med Univ, Dept Biochem & Mol Biol, Chang Le Xi St 169, Xian 710032, Peoples R China.
EM douguorui@hotmail.com; huahan@fmmu.edu.cn; fierywang@163.com
RI LI, Jing/HNB-5575-2023
FU Ministry of Science and Technology of the People's Republic of China
   [2016YFA0102100, 2015CB553702]; National Natural Science Fundation of
   China [81422009, 81870430, 81770560, 81800533, 31730041, 31671523]
FX This work was supported by grants from Ministry of Science and
   Technology of the People's Republic of China (2016YFA0102100 [The
   National Key Research and Development Program of China: Stem Cell and
   Translational Research], 2015CB553702) and National Natural Science
   Fundation of China 81422009, 81870430, 81770560, 81800533, 31730041, and
   31671523
CR Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2018, J CLIN INVEST, V128, P1208, DOI 10.1172/JCI95145
   Benson EK, 2014, ONCOGENE, V33, P3959, DOI 10.1038/onc.2013.378
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26003
   Cheng LQ, 2017, J MOL MED, V95, P1257, DOI 10.1007/s00109-017-1581-x
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Duan JL, 2018, HEPATOLOGY, V68, P677, DOI 10.1002/hep.29834
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Grosse Laurent, 2020, Cell Metab, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hoare M, 2017, CELL CYCLE, V16, P239, DOI 10.1080/15384101.2016.1248730
   Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753
   Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li PH, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101165
   Liu ZH, 2015, CANCER BIOL THER, V16, P353, DOI 10.1080/15384047.2015.1016662
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4
   Min E, 2019, EXP CELL RES, V376, P92, DOI 10.1016/j.yexcr.2019.01.005
   Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473
   Rhinn M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.151837
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Teo YV, 2019, CELL REP, V27, P997, DOI 10.1016/j.celrep.2019.03.104
   Theodosiou A, 2009, MOL BIOL EVOL, V26, P1631, DOI 10.1093/molbev/msp075
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945
   Waltl I, 2018, NEUROBIOL DIS, V110, P192, DOI 10.1016/j.nbd.2017.12.001
   Wan JH, 2015, NUCLEIC ACIDS RES, V43, P3591, DOI 10.1093/nar/gkv238
   Xu CY, 2020, NAT CELL BIOL, V22, P1170, DOI 10.1038/s41556-020-00579-5
   Yagi S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218414
   Yang BH, 2013, CELL MOL BIOENG, V6, P346, DOI 10.1007/s12195-013-0276-9
   Zafarnia S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00904
   Zhang C, 2020, AGING-US, V12, P1272, DOI 10.18632/aging.102682
   Zhang HT, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03416-1
   Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422
NR 42
TC 31
Z9 34
U1 9
U2 63
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2022 MAR
PY 2022
VL 75
IS 3
BP 584
EP 599
DI 10.1002/hep.32209
EA DEC 2021
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YY3YH
UT WOS:000727612600001
PM 34687050
DA 2024-02-19
ER

PT J
AU Nishizawa, H
   Iguchi, G
   Fukuoka, H
   Takahashi, M
   Suda, K
   Bando, H
   Matsumoto, R
   Yoshida, K
   Odake, Y
   Ogawa, W
   Takahashi, Y
AF Nishizawa, Hitoshi
   Iguchi, Genzo
   Fukuoka, Hidenori
   Takahashi, Michiko
   Suda, Kentaro
   Bando, Hironori
   Matsumoto, Ryusaku
   Yoshida, Kenichi
   Odake, Yukiko
   Ogawa, Wataru
   Takahashi, Yutaka
TI IGF-I induces senescence of hepatic stellate cells and limits fibrosis
   in a p53-dependent manner
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GROWTH-FACTOR-I; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS;
   REDUCES FIBROGENESIS; CELLULAR SENESCENCE; REPLACEMENT THERAPY; HORMONE
   DEFICIENCY; INSULIN-RESISTANCE; CIRRHOTIC RATS; FACTOR AXIS
AB Hepatic fibrosis in nonalcoholic steatohepatitis (NASH) and cirrhosis determines patient prognosis; however, effective treatment for fibrosis has not been established. Oxidative stress and inflammation activate hepatic stellate cells (HSCs) and promote fibrosis. In contrast, cellular senescence inhibits HSCs' activity and limits fibrosis. The aim of this study was to explore the effect of IGF-I on NASH and cirrhotic models and to clarify the underlying mechanisms. We demonstrate that IGF-I significantly ameliorated steatosis, inflammation, and fibrosis in a NASH model, methionine-choline-deficient diet-fed db/db mice and ameliorated fibrosis in cirrhotic model, dimethylnitrosamine-treated mice. As the underlying mechanisms, IGF-I improved oxidative stress and mitochondrial function in the liver. In addition, IGF-I receptor was strongly expressed in HSCs and IGF-I induced cellular senescence in HSCs in vitro and in vivo. Furthermore, in mice lacking the key senescence regulator p53, IGF-I did not induce cellular senescence in HSCs or show any effects on fibrosis. Taken together, these results indicate that IGF-I induces senescence of HSCs, inactivates these cells and limits fibrosis in a p53-dependent manner and that IGF-I may be applied to treat NASH and cirrhosis.
C1 [Nishizawa, Hitoshi; Iguchi, Genzo; Fukuoka, Hidenori] Kobe Univ Hosp, Div Diabet & Endocrinol, Kobe, Hyogo, Japan.
   [Takahashi, Michiko] Kobe Univ Hosp, Dept Nutr, Kobe, Hyogo, Japan.
   [Suda, Kentaro; Bando, Hironori; Matsumoto, Ryusaku; Yoshida, Kenichi; Odake, Yukiko; Ogawa, Wataru; Takahashi, Yutaka] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo, Japan.
C3 Kobe University; Kobe University; Kobe University
RP Takahashi, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo, Japan.
EM takahash@med.kobe-u.ac.jp
RI OGAWA, Wataru/AAQ-9586-2020; Fukuoka, Hidenori/AHC-2224-2022; Fukuoka,
   Hidenori/AAK-1045-2020; Hidenori, Fukuoka/AAK-1812-2020; Bando,
   Hironori/JWP-5467-2024
OI Fukuoka, Hidenori/0000-0001-9255-653X; Fukuoka,
   Hidenori/0000-0001-9255-653X; Bando, Hironori/0000-0002-7421-2714;
   Iguchi, Genzo/0000-0001-8810-0230; Suda, Kentaro/0000-0001-6734-5183
FU Japanese Ministry of Education, Culture, Sports, Science, and Technology
   [20200079, 20390262, 26670459, 16H5332]; Daiichi Sankyo Foundation of
   Life Science; Naito Kinen Foundation; Japanese Ministry of Health,
   Labor, and Welfare; Grants-in-Aid for Scientific Research [20390262,
   20200079, 26670459] Funding Source: KAKEN
FX The authors are very grateful to Prof. Yoshitake Hayashi for the
   pathological evaluation and Dr. Tomohiro Ogawa and Prof. Norihumi Kawada
   for their technical advises to isolate HSCs. We also thank to Ms. Chika
   Ogata and Ms. Kayo Imura for their excellent technical assistance. This
   work was supported in part by a Grant-in-Aid for Scientific Research
   from the Japanese Ministry of Education, Culture, Sports, Science, and
   Technology 20200079, 20390262, 26670459, and 16H5332, Grants-in-Aid for
   Scientific Research (research on hypothalamic-hypophyseal disorders)
   from the Japanese Ministry of Health, Labor, and Welfare, Daiichi Sankyo
   Foundation of Life Science, and Naito Kinen Foundation. Y.T. received
   these grants.
CR Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521
   Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227
   Boettcher E, 2012, ALIMENT PHARM THER, V35, P66, DOI 10.1111/j.1365-2036.2011.04912.x
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Conchillo M, 2005, J HEPATOL, V43, P630, DOI 10.1016/j.jhep.2005.03.025
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Dibra D, 2016, HEPATOLOGY, V63, P1000, DOI 10.1002/hep.28379
   Fiore EJ, 2015, STEM CELLS DEV, V24, P791, DOI 10.1089/scd.2014.0174
   García-Fernández M, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-7
   Handayaningsih AE, 2012, BIOCHEM BIOPH RES CO, V425, P478, DOI 10.1016/j.bbrc.2012.07.140
   Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290
   Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lorenzo-Zúñiga V, 2006, GUT, V55, P1306, DOI 10.1136/gut.2005.079988
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Matsumoto R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140189
   Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179
   Muguerza B, 2001, BBA-MOL BASIS DIS, V1536, P185, DOI 10.1016/S0925-4439(01)00045-X
   Nishizawa H, 2012, BIOCHEM BIOPH RES CO, V423, P295, DOI 10.1016/j.bbrc.2012.05.115
   Nishizawa H, 2012, EUR J ENDOCRINOL, V167, P67, DOI 10.1530/EJE-12-0252
   Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pérez R, 2008, WORLD J GASTROENTERO, V14, P2731, DOI 10.3748/wjg.14.2731
   Picardi A, 1997, J HEPATOL, V26, P191, DOI 10.1016/S0168-8278(97)80026-8
   Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929
   Sanz S, 2005, GUT, V54, P134, DOI 10.1136/gut.2003.024505
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Sjögren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088
   Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521
   Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72
   Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412
   Soon RK, 2010, GASTROENTEROLOGY, V139, P1730, DOI 10.1053/j.gastro.2010.07.046
   Sumida Y., 2014, HEPATOL RES
   Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024
   Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322
   TSUKADA T, 1993, ONCOGENE, V8, P3313
   Wu J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-30
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
NR 44
TC 100
Z9 102
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 10
PY 2016
VL 6
AR 34605
DI 10.1038/srep34605
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DY2MN
UT WOS:000384926800001
PM 27721459
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Cho, YM
   Bae, SH
   Choi, BK
   Cho, SY
   Song, CW
   Yoo, JK
   Paik, YK
AF Cho, YM
   Bae, SH
   Choi, BK
   Cho, SY
   Song, CW
   Yoo, JK
   Paik, YK
TI Differential expression of the liver proteome in senescence accelerated
   mice
SO PROTEOMICS
LA English
DT Article
DE aging; matrix-assisted laser desorption/ionization mass
   spectrometry-time of flight; selenium binding protein; senescence
   accelerated mouse; two-dimensional gel electrophoresis
ID AGE-RELATED-CHANGES; MOUSE SAM; GLUTAMATE-DEHYDROGENASE;
   SUPEROXIDE-DISMUTASE; SELENIUM-BINDING; ALDOSE REDUCTASE; MESSENGER-RNA;
   MURINE MODEL; DISEASE; CANCER
AB The senescence-accelerated mouse (SAM) is a useful animal model to study aging or age-associated disorders due to its inherited aging phenotype. To investigate proteins involved in the aging process in liver, we compared the young (4- or 20-week old) and the aged group (50-week-old) of SAMP8 (short life span) and SAMR1 (control) mice, and identified 85 differentially expressed distinct proteins comprising antioxidation, glucose/amino acid metabolism, signal transduction and cell cycle systems using proteomics tools. For the antioxidation system, the aged SAMP8 mice showed a large increase in glutathione peroxidase and decreases in glutathione-S-transferase and peroxiredoxin, ranging from 2.5- to 5-fold, suggesting lower detoxification potentials for oxidants in the aged SAMP8 liver. Similarly, levels of key glycolytic enzymes decreased greatly in the aged SAMP8 compared to SAMR1, indicating a disturbance in glucose homeostasis that may be closely related to the typical deficits in learning and memory of the aged SAMP8. Protein profiles of amino acid metabolic enzymes suggest that accumulation of glutamine and glutamate in tissues of the aged SAMP8 may be due to hyperexpression of ornithine aminotransferase and/or glutamate dehydrogenase. Decreases in levels of proteins involved in signal transduction/apoptosis (e.g., cathepsin B) in the aged SAMP8 may support the previously proposed negative relationship between apoptosis and aging. However, the changes described above were not markedly seen in the young group of both strains. For cell cycle systems, levels of selenium binding protein increased about four-fold with age in SAMP8. Yet, almost no change occurred in either the young or the aged SAMR1, which may explain problems associated with cell proliferation and tissue regeneration in the aged SAMP8. In conclusion, composite profiles of key proteins involved in age-related processes enable assessment of accelerated senescence and the appearance of senescence-related pathologies in the aged SAMP8.
C1 Yonsei Univ, Yonsei Proteome Res Ctr, Res Ctr, Dept Biochem & Bioprod, Seoul 120749, South Korea.
   Korea Res Inst Chem Technol, Lab Toxicogenom, Taejon 305606, South Korea.
C3 Yonsei University; Korea Research Institute of Chemical Technology
   (KRICT)
RP Paik, YK (corresponding author), Yonsei Univ, Yonsei Proteome Res Ctr, Res Ctr, Dept Biochem & Bioprod, S309 Kwahakwon,134 Shinchon Dong, Seoul 120749, South Korea.
EM paikyk@yonsei.ac.kr
CR Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333
   BANSAL MP, 1990, CARCINOGENESIS, V11, P2071, DOI 10.1093/carcin/11.11.2071
   Bodyrev AA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1157, DOI 10.1023/A:1012441215506
   Bolzan AD, 1997, CLIN BIOCHEM, V30, P449, DOI 10.1016/S0009-9120(97)00047-7
   Boon L, 1999, HISTOCHEM CELL BIOL, V111, P445, DOI 10.1007/s004180050380
   Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8
   DEMPSEY JL, 1986, ENVIRON MOL MUTAGEN, V8, P385, DOI 10.1002/em.2860080307
   Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3
   Elahi D, 2000, EUR J CLIN NUTR, V54, pS112, DOI 10.1038/sj.ejcn.1601032
   Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200
   Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352
   Giometti CS, 2000, ELECTROPHORESIS, V21, P2162
   Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3
   GUTTERIDGE JMC, 1993, FREE RADICAL RES COM, V19, P141, DOI 10.3109/10715769309111598
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720
   Higashitsuji H, 2002, CANCER CELL, V2, P335, DOI 10.1016/S1535-6108(02)00152-6
   Hosokawa M, 1997, EXP GERONTOL, V32, P111, DOI 10.1016/S0531-5565(96)00078-2
   HOTTA N, 1995, BIOMED PHARMACOTHER, V49, P232, DOI 10.1016/0753-3322(96)82629-1
   Huijmans JGM, 2000, PEDIATRICS, V106, P596, DOI 10.1542/peds.106.3.596
   KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323, DOI 10.1002/dmr.5610040403
   KITAMURA Y, 1992, NEUROSCI LETT, V137, P169, DOI 10.1016/0304-3940(92)90396-O
   LANFEAR J, 1993, CARCINOGENESIS, V14, P335, DOI 10.1093/carcin/14.3.335
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   Morley JE, 2002, BIOGERONTOLOGY, V3, P57, DOI 10.1023/A:1015207429786
   MORRISON DG, 1988, CARCINOGENESIS, V9, P1801, DOI 10.1093/carcin/9.10.1801
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   Nomura Y, 1999, NEUROBIOL AGING, V20, P111, DOI 10.1016/S0197-4580(99)00006-8
   Nomura Y, 1996, ANN NY ACAD SCI, V786, P410, DOI 10.1111/j.1749-6632.1996.tb39080.x
   NOMURA Y, 1991, NMDA RECEPTOR RELATED AGENTS : BIOCHEMISTRY, PHARMACOLOGY AND BEHAVIOR, P287
   Odagiri Y, 1998, NAT GENET, V19, P116, DOI 10.1038/468
   Otsuka M, 2001, BIOCHEM BIOPH RES CO, V289, P876, DOI 10.1006/bbrc.2001.6047
   Palumbo B, 1997, NEUROSCI LETT, V231, P59, DOI 10.1016/S0304-3940(97)00538-7
   Park KS, 2002, HEPATOLOGY, V35, P1459, DOI 10.1053/jhep.2002.33204
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   Seiler Nikolaus, 2000, Current Drug Targets, V1, P119, DOI 10.2174/1389450003349254
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Smith JD, 2002, AGEING RES REV, V1, P345, DOI 10.1016/S1568-1637(02)00005-3
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   WIE X, 1999, NEUROSCI LETT, V268, P139
   WU L, 1995, CARCINOGENESIS, V16, P1579, DOI 10.1093/carcin/16.7.1579
   Yabe-Nishimura C, 1998, PHARMACOL REV, V50, P21
   Yagi K, 1995, ATHEROSCLEROSIS, V118, P233, DOI 10.1016/0021-9150(95)05609-2
NR 49
TC 65
Z9 69
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD OCT
PY 2003
VL 3
IS 10
BP 1883
EP 1894
DI 10.1002/pmic.200300562
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 736JW
UT WOS:000186168500005
PM 14625850
DA 2024-02-19
ER

PT J
AU Bloomer, SA
   Brown, KE
   Buettner, GR
   Kregel, KC
AF Bloomer, Steven A.
   Brown, Kyle E.
   Buettner, Garry R.
   Kregel, Kevin C.
TI Dysregulation of hepatic iron with aging: implications for heat
   stress-induced oxidative liver injury
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE reactive oxygen species; deferoxamine; hyperthermia; electron
   paramagnetic resonance spectroscopy; inflammation
ID WHOLE-BODY HYPERTHERMIA; INDUCED CELL-DEATH; NF-KAPPA-B; CALORIC
   RESTRICTION; ANTIOXIDANT ENZYME; PROTEIN EXPRESSION; REPERFUSION INJURY;
   OLD RATS; DEFEROXAMINE; HEPCIDIN
AB Environmental heat stress is associated with an age-related increase in hepatic oxidative damage and an exaggerated state of oxidative stress. The purpose of this investigation was to evaluate the regulation of hepatic iron after heat stress. A secondary aim was to determine a potential role for iron in heat stress-induced liver injury. Hyperthermia-induced alterations in hepatic iron were evaluated in young (6 mo) and old (24 mo) Fischer 344 rats by exposing them to a two-heat stress protocol. Livers were harvested at several time points after the second heating and assayed for labile and nonheme iron. In the control condition, there was no difference in labile iron between age groups. Both labile iron and storage iron were not altered by hyperthermia in young rats, but both were increased immediately after heating in old rats. To evaluate a role for iron in liver injury, hepatic iron content was manipulated in young and old rats, and then both groups were exposed to heat stress. Iron administration to young rats significantly increased hepatic iron content and ferritin but did not affect markers of lipid peroxidation under control conditions or after heat stress. In old rats, iron chelation with deferoxamine prevented the increase in nonheme iron, labile iron, ferritin, and lipid peroxidation after heat stress. These results suggest that iron may play a role in hepatic injury after hyperthermia. Thus, dysregulation of iron may contribute to the gradual decline in cellular and physiological function that occurs with aging.
C1 [Bloomer, Steven A.; Kregel, Kevin C.] Univ Iowa, Dept Integrat Physiol, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Iowa City Veterans Adm Med Ctr, Iowa City, IA USA.
   [Brown, Kyle E.] Roy J & Lucille A Carver Coll Med, Div Gastroenterol Hepatol, Iowa City, IA USA.
   [Brown, Kyle E.; Buettner, Garry R.; Kregel, Kevin C.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Radiat Oncol, Program Free Rad & Radiat Biol, Iowa City, IA USA.
C3 University of Iowa; University of Iowa
RP Kregel, KC (corresponding author), Univ Iowa, Dept Integrat Physiol, 532 Field House, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
OI Brown, Kyle/0000-0002-8206-036X; Buettner, Garry/0000-0002-5594-1903
FU NIA NIH HHS [AG-12350] Funding Source: Medline
CR AMBROSIO G, 1987, CIRCULATION, V76, P906, DOI 10.1161/01.CIR.76.4.906
   BALIGA R, 1993, BIOCHEM J, V291, P901, DOI 10.1042/bj2910901
   BONKOWSKY HL, 1981, BIOCHEM J, V196, P57, DOI 10.1042/bj1960057
   Brown KE, 2003, LIVER INT, V23, P232, DOI 10.1034/j.1600-0676.2003.00832.x
   Brown KE, 2007, TOXICOL APPL PHARM, V223, P180, DOI 10.1016/j.taap.2007.05.011
   CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700
   Caputa M, 2000, EUR J APPL PHYSIOL, V82, P142, DOI 10.1007/s004210050664
   Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Dendorfer A, 2005, FREE RADICAL BIO MED, V38, P117, DOI 10.1016/j.freeradbiomed.2004.10.015
   Ershler WB, 2003, J AM GERIATR SOC, V51, pS18
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Ganz T, 2006, AM J PHYSIOL-GASTR L, V290, pG199, DOI 10.1152/ajpgi.00412.2005
   Hall DM, 1999, AM J PHYSIOL-GASTR L, V276, pG1195, DOI 10.1152/ajpgi.1999.276.5.G1195
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   Hall DM, 2001, J GERONTOL A-BIOL, V56, pB259, DOI 10.1093/gerona/56.6.B259
   Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   HERNANDEZ LA, 1987, AM J PHYSIOL, V253, pG49, DOI 10.1152/ajpgi.1987.253.1.G49
   HUBBARD RW, 1976, AM J PHYSIOL, V231, P1119, DOI 10.1152/ajplegacy.1976.231.4.1119
   Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017
   KNOCHEL JP, 1974, ARCH INTERN MED, V133, P841, DOI 10.1001/archinte.133.5.841
   KONDO H, 1988, HEPATOLOGY, V8, P32, DOI 10.1002/hep.1840080108
   KREGEL KC, 1990, J APPL PHYSIOL, V69, P2043, DOI 10.1152/jappl.1990.69.6.2043
   KREGEL KC, 1988, J APPL PHYSIOL, V64, P2582, DOI 10.1152/jappl.1988.64.6.2582
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Kurz T, 2004, BIOCHEM J, V378, P1039, DOI 10.1042/BJ20031029
   LEVINE JA, 1969, AM J MED, V47, P251, DOI 10.1016/0002-9343(69)90151-X
   Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137
   Liachenko S, 2003, J CEREBR BLOOD F MET, V23, P574, DOI 10.1097/01.WCB.0000057742.00152.3F
   Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Ollinger K, 1997, J BIOL CHEM, V272, P23707, DOI 10.1074/jbc.272.38.23707
   OZAKI M, 1988, BIOCHEM J, V250, P589, DOI 10.1042/bj2500589
   PALLER MS, 1994, FREE RADICAL BIO MED, V17, P597, DOI 10.1016/0891-5849(94)90099-X
   Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0
   Pourzand C, 1999, P NATL ACAD SCI USA, V96, P6751, DOI 10.1073/pnas.96.12.6751
   Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7
   REIF DW, 1988, ARCH BIOCHEM BIOPHYS, V264, P238, DOI 10.1016/0003-9861(88)90590-5
   ROWELL LB, 1974, PHYSIOL REV, V54, P75, DOI 10.1152/physrev.1974.54.1.75
   Roy CN, 2005, CURR OPIN HEMATOL, V12, P107, DOI 10.1097/00062752-200503000-00001
   Saad SY, 2001, PHARMACOL RES, V43, P211, DOI 10.1006/phrs.2000.0769
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   SMITH JK, 1989, AM J PHYSIOL, V256, pH1472, DOI 10.1152/ajpheart.1989.256.5.H1472
   Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0
   Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800
   Torrance JD, 1980, Methods in Hematology: Iron, V1, P90
   Trey JE, 1995, CRIT REV ONCOL HEMAT, V21, P1, DOI 10.1016/1040-8428(94)00141-3
   WOLFE L, 1985, NEW ENGL J MED, V312, P1600, DOI 10.1056/NEJM198506203122503
   Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631
   Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200
   YOUNG SP, 1994, LIVER BIOL PATHOLOGY
   Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6
   Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 55
TC 22
Z9 24
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD APR
PY 2008
VL 294
IS 4
BP R1165
EP R1174
DI 10.1152/ajpregu.00719.2007
PG 10
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 282NN
UT WOS:000254574600008
PM 18272664
DA 2024-02-19
ER

PT J
AU Vilà, L
   Roglans, N
   Alegret, M
   Camins, A
   Pallàs, M
   Sánchez, RM
   Vázquez-Carrera, M
   Laguna, JC
AF Vila, Laia
   Roglans, Nuria
   Alegret, Marta
   Camins, Antoni
   Pallas, Merce
   Maria Sanchez, Rosa
   Vazquez-Carrera, Manuel
   Carlos Laguna, Juan
TI Hepatic Gene Expression Changes in an Experimental Model of Accelerated
   Senescence: The SAM-P8 Mouse
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE SAM mice; Liver; Inflammation; Xenobiotic metabolism
ID NF-KAPPA-B; OXIDATIVE STRESS; MURINE MODEL; AGE; DISEASE; LIVER;
   ACTIVATION; TARGET; SAMP8; MICE
AB The senescence-accelerated mouse (SAM) is an experimental model of aging, established through phenotypic selection from a common genetic pool of AKR/J mice. Here we use complementary DNA microarray, Western blot, and electrophoretic mobility shift assay to consider whether changes in liver gene expression observed in 5-month-old SAM-prone 8 (P8) mice, compared to SAM-R1 controls, are similar to those reported in aged rodents. Livers from SAM-P8 mice presented 88 differentially expressed transcripts, 59% of which were upregulated and 41% were downregulated. Of these, 14% were related to inflammatory/immunity processes, 10% were related to the xenobiotic metabolism (XM) and 3% to nervous system pathophysiology (NSP). Depressed expression and activity of genes related to XM, and altered expression of genes related to NSP. are similar to changes observed in aged rodents. Increased expression of heat shock protein 1 and Jun-B, reduced activity of activator protein 1 and absence of nuclear factor-kappa B activation indicate the lack of a strong liver inflammatory response in 5-month-old SAM-P8 mice.
C1 [Carlos Laguna, Juan] Univ Barcelona, Fac Farm, Unitat Farmacol, Sch Pharm,Dept Pharmacol & Therapeut Chem, E-08028 Barcelona, Spain.
   Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain.
C3 University of Barcelona; University of Barcelona
RP Laguna, JC (corresponding author), Univ Barcelona, Fac Farm, Unitat Farmacol, Sch Pharm,Dept Pharmacol & Therapeut Chem, Avda Diagonal 643, E-08028 Barcelona, Spain.
EM jclagunae@ub.edu
RI Alegret, Marta/C-5086-2017; Laguna, JCLaguna - Juan C./C-5481-2017;
   Camins, Antonio/J-5126-2019; Roglans, Núria/ABH-1242-2020;
   Vázquez-Carrera, Manuel/H-2612-2015; Pallas, Merce/H-3129-2016
OI Alegret, Marta/0000-0002-5652-8651; Laguna, JCLaguna - Juan
   C./0000-0002-7082-0704; Camins, Antonio/0000-0002-1229-5956;
   Vázquez-Carrera, Manuel/0000-0001-7138-8207; Roglans,
   Nuria/0000-0002-5018-021X; Pallas, Merce/0000-0003-3095-4254; Vila,
   Laia/0000-0001-7232-2250
FU Fundacio Privada Catalana de Nutricio i Lipids (FPCNL); Ministerio de
   Ciencia y Tecnologia (MCYT) [SAF2004-03045]; Red de Grupos en Diabetes
   Mellitus (REDIMET); Fondo Europeo de Desarrollo Regional (FEDER);
   University of Barcelona
FX This work was supported by grants from Fundacio Privada Catalana de
   Nutricio i Lipids (FPCNL), Ministerio de Ciencia y Tecnologia (MCYT;
   SAF2004-03045), Red de Grupos en Diabetes Mellitus (REDIMET), and Fondo
   Europeo de Desarrollo Regional (FEDER) funds, Laia Vila was supported by
   a Research and Teaching Grant from the University of Barcelona.
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berger P, 2004, NEUROBIOL DIS, V17, P290, DOI 10.1016/j.nbd.2004.07.014
   Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Chand HS, 2005, THROMB HAEMOSTASIS, V94, P1122, DOI 10.1160/TH05-07-0509
   Corti MC, 1997, CURR OPIN LIPIDOL, V8, P236, DOI 10.1097/00041433-199708000-00008
   DAY JC, 2003, POPULATION PROJECTIO, P25
   Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101
   Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Hirata K, 2004, GLIA, V47, P325, DOI 10.1002/glia.20037
   Larbi A, 2006, BIOGERONTOLOGY, V7, P399, DOI 10.1007/s10522-006-9055-5
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Okada H, 2005, INT J ONCOL, V26, P369
   Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004
   Qyang YB, 2004, BIOCHEMISTRY-US, V43, P5352, DOI 10.1021/bi049826u
   Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232
   Sanguino E, 2004, EXP GERONTOL, V39, P1295, DOI 10.1016/j.exger.2004.06.007
   Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034
   SANGUINO E, 2005, BIOCHEM PHARMACOL, V68, P1411
   Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009
   Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131
   Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Tomasini R, 2005, ONCOGENE, V24, P8093, DOI 10.1038/sj.onc.1208951
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   Wang HB, 2003, CLIN PHARMACOKINET, V42, P1331, DOI 10.2165/00003088-200342150-00003
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Wei XL, 1999, NEUROSCI LETT, V268, P139, DOI 10.1016/S0304-3940(99)00396-1
   Yaghootfam A, 2005, EUR J NEUROSCI, V21, P711, DOI 10.1111/j.1460-9568.2005.03891.x
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Zenilman ME, 1998, CURR PROB SURG, V35, P104
NR 36
TC 3
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD OCT
PY 2008
VL 63
IS 10
BP 1043
EP 1052
DI 10.1093/gerona/63.10.1043
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 366LS
UT WOS:000260483600004
PM 18948554
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Yang, JF
   Lu, YC
   Yang, PP
   Chen, QF
   Wang, Y
   Ding, Q
   Xu, T
   Li, XF
   Li, CY
   Huang, C
   Meng, XM
   Li, J
   Zhang, L
   Wang, X
AF Yang, Junfa
   Lu, Yuchen
   Yang, Peipei
   Chen, Qingfeng
   Wang, Yang
   Ding, Qi
   Xu, Tao
   Li, Xiaofeng
   Li, Changyao
   Huang, Cheng
   Meng, Xiaoming
   Li, Jun
   Zhang, Lei
   Wang, Xiao
TI MicroRNA-145 induces the senescence of activated hepatic stellate cells
   through the activation of p53 pathway by ZEB2
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
DE HSCs senescence; liver fibrosis; mi-145; p53; SA-beta-Gal
ID SOLUBLE EGG ANTIGENS; APOPTOSIS; MECHANISM; FIBROSIS; CANCER
AB Activation of quiescent hepatic stellate cells (HSCs) is the major event in liver fibrosis, along with enhancement of cell proliferation and overproduction of extracellular matrix. Recent findings suggest that senescence of activated HSCs might limit the development of liver fibrosis. The p53, a guardian of the genome is associated with liver fibrosis, has been shown to regulate HSCs senescence. In this study, we report that microRNA-145 (miR-145) and p53 were downregulated in vivo and in vitro, concomitant with the enhanced expression of zinc finger E-box binding homeobox 2 (ZEB2). In addition, overexpression of miR-145 and p53 led to upregulation of the number of senescence-associated beta-galactosidase-positive HSCs and the expression of senescence markers p16 and p21, along with the reduced abundance of HSC activation markers alpha-smooth muscle actin and type I collagen in activated HSCs. Furthermore, silencing of ZEB2 promoted senescence of activated HSCs. Moreover, we also demonstrated that miR-145 specifically targeted the 3 '-untranslated regions of ZEB2. In vitro promoter regulation studies show that ZEB2 could bind to the E-box of the p53 promoter as well as inhibit its promoter activity and thus suppress the expression of p53, which in turn repressed activated HSCs senescence. Taken together, our results describe a novel miR-145-ZEB2-p53 regulatory line might participate in the senescence of activated HSCs and might carry potential therapeutic targets for restraining liver fibrosis.
C1 [Yang, Junfa; Lu, Yuchen; Yang, Peipei; Wang, Yang; Ding, Qi; Xu, Tao; Li, Xiaofeng; Li, Changyao; Huang, Cheng; Meng, Xiaoming; Li, Jun; Zhang, Lei] Anhui Med Univ, Sch Pharm, Anhui Key Lab Bioact Nat Prod, Hefei, Anhui, Peoples R China.
   [Yang, Junfa; Lu, Yuchen; Yang, Peipei; Wang, Yang; Ding, Qi; Xu, Tao; Li, Xiaofeng; Li, Changyao; Huang, Cheng; Meng, Xiaoming; Li, Jun; Zhang, Lei] Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Minist Educ, Hefei, Anhui, Peoples R China.
   [Yang, Junfa; Lu, Yuchen; Yang, Peipei; Wang, Yang; Ding, Qi; Xu, Tao; Li, Xiaofeng; Li, Changyao; Huang, Cheng; Meng, Xiaoming; Li, Jun; Zhang, Lei] Anhui Inst Innovat Drugs, Anhui Prov Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China.
   [Chen, Qingfeng] Anhui Med Univ, Dept Clin Med, Clin Med Coll, Hefei, Anhui, Peoples R China.
   [Wang, Xiao] Anhui Med Univ, Dept Radiol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Anhui Medical
   University; Anhui Medical University
RP Zhang, L; Wang, X (corresponding author), Anhui Med Univ, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
EM zhanglei-1@ahmu.edu.cn; hfwangxiao@aliyun.com
RI lu, yang/IWE-3635-2023; Zhang, Xiaofeng/JMC-6060-2023; LI,
   WEI/ISS-1208-2023; li, xiao/GSN-6181-2022; Lu, Jia/JVO-6891-2024; liang,
   liang/IAO-8518-2023; zhao, lin/JPK-8436-2023; li,
   xiaofeng/GXF-9442-2022; yin, yue/JQV-9753-2023; zhang,
   xueying/JMB-7808-2023; WANG, HUI/JFA-9683-2023
OI Zhang, Xiaofeng/0000-0003-2738-3286; 
FU Anhui Natural Science Foundation [1608085MH234]; Intercollegiate Key
   Projects of Nature Science of Anhui Province [KJ2017A169, KJ2014A124];
   Key Research Foundation of Higher Education of Anhui Province
   [gxfx2017011]
FX The Anhui Natural Science Foundation, Grant/Award Number: 1608085MH234;
   This work was supported by the Intercollegiate Key Projects of Nature
   Science of Anhui Province, Grant/Award Numbers: KJ2017A169),
   (KJ2014A124; Key Research Foundation of Higher Education of Anhui
   Province, Grant/Award Number: gxfx2017011
CR Adamovich Y, 2014, CELL DEATH DIFFER, V21, P1451, DOI 10.1038/cdd.2014.60
   Balli D, 2013, EMBO J, V32, P231, DOI 10.1038/emboj.2012.336
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Cunnington RH, 2014, J CELL SCI, V127, P40, DOI 10.1242/jcs.126722
   Deshpande SD, 2013, DIABETES, V62, P3151, DOI 10.2337/db13-0305
   Drusco A, 2017, ADV CANCER RES, V135, P1, DOI 10.1016/bs.acr.2017.06.005
   Duan YN, 2014, INT J PARASITOL, V44, P217, DOI 10.1016/j.ijpara.2013.11.003
   Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Goossens S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6794
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023
   Hu W, 2017, J INT MED RES, V45, P1054, DOI 10.1177/0300060517709614
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   KAWADA N, 1992, BIOCHEM J, V285, P367, DOI 10.1042/bj2850367
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026
   Men RT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40468
   Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049
   Pant V, 2013, GENE DEV, V27, P1857, DOI 10.1101/gad.227249.113
   Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4
   ROCKEY DC, 1995, BIOCHEM BIOPH RES CO, V207, P725, DOI 10.1006/bbrc.1995.1247
   Roderburg C, 2013, J HEPATOL, V58, P736, DOI 10.1016/j.jhep.2012.11.022
   ROY B, 1994, MOL CELL BIOL, V14, P7805, DOI 10.1128/MCB.14.12.7805
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Song XD, 2013, LAB INVEST, V93, P1219, DOI 10.1038/labinvest.2013.108
   Soon RK, 2008, CLIN LIVER DIS, V12, P791, DOI 10.1016/j.cld.2008.07.004
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489
   Vigneron A, 2010, AGING-US, V2, P471, DOI 10.18632/aging.100189
   Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864
   Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
   Yang JF, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00980
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Zhang WC, 2014, TUMOR BIOL, V35, P6235, DOI 10.1007/s13277-014-2202-8
   Zhou DD, 2016, MOL IMMUNOL, V75, P151, DOI 10.1016/j.molimm.2016.05.018
NR 45
TC 25
Z9 26
U1 1
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAY
PY 2019
VL 234
IS 5
BP 7587
EP 7599
DI 10.1002/jcp.27521
PG 13
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA HK7AQ
UT WOS:000458138600195
PM 30479019
DA 2024-02-19
ER

PT J
AU Cogger, VC
   Warren, A
   Fraser, R
   Ngu, M
   McLean, AJ
   Le Couteur, DG
AF Cogger, VC
   Warren, A
   Fraser, R
   Ngu, M
   McLean, AJ
   Le Couteur, DG
TI Hepatic sinusoidal pseudocapillarization with aging in the non-human
   primate
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; baboons; defenestration; pseudocapillarization
ID BABOON PAPIO-HAMADRYAS; TRANSITIONAL CELLS; DRUG CLEARANCE;
   LIVER-DISEASE; RAT-LIVER; ALCOHOL; AGE; ATHEROSCLEROSIS; BIOCHEMISTRY;
   HEMATOLOGY
AB Background/Aims: Age-related changes in the hepatic sinusoid termed pseudocapillarization have been reported in the rat and human and have implications for disease susceptibility in old age. In this study, we investigated whether similar changes occur in the livers of old baboons and thus represent a widespread aging change. Methods: Liver tissue from five young baboons (5.4 +/- 0.5 yrs) and five old baboons (21.8 +/- 0.7 yrs) was compared by transmission electron microscopy, scanning electron microscopy and immunohistochemistry. Results: The thickness of the sinusoidal endothelium was increased in old baboons (130 +/- 8 nm versus 186 +/- 9 nm, P < 0.001) and the frequency of endothelial fenestrae decreased, with the porosity declining from 4.2 +/- 0.5% to 2.4 +/- 0.4% (P = 0.006). The expression of laminin and von Willebrands factor was more extensive in old baboons. Novel perisinusoidal ring-shaped cells, probably fat-engorged stellate cells, were prominent in the old baboons. Conclusions: Pseudocapillarization is a significant age-related change in the baboon liver. Aging in baboons is associated with a novel aging change in the stellate cell not reported in other species. Hepatic pseudocapillarization is a widespread aging liver change found in several species including humans and other non-human primates. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Sydney, Ctr Educ & Res Aging, Concord Hosp, Sydney, NSW 2139, Australia.
   Univ Sydney, ANZAC Res Inst, Concord Hosp, Sydney, NSW 2139, Australia.
   Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand.
   Concord Hosp, Dept Gastroenterol, Sydney, NSW, Australia.
   Univ Melbourne, Natl Ageing Res Inst, Parkville, Vic 3052, Australia.
C3 University of Sydney; Concord Repatriation General Hospital; Concord
   Repatriation General Hospital; University of Sydney; ANZAC Research
   Institute; University of Otago; Concord Repatriation General Hospital;
   University of Melbourne; National Ageing Research Institute
RP Cogger, VC (corresponding author), Univ Sydney, Ctr Educ & Res Aging, Concord Hosp, Sydney, NSW 2139, Australia.
RI Ekanayake, Kanchana/P-8817-2016; Research Institute, ANZAC/CAE-9030-2022
OI Le Couteur, David/0000-0002-4227-5817
CR Birrell AM, 1996, J MED PRIMATOL, V25, P287, DOI 10.1111/j.1600-0684.1996.tb00212.x
   BRAET F, 1995, HEPATOLOGY, V21, P180, DOI 10.1002/hep.1840210130
   Cassader M, 1996, AGING CLIN EXP RES, V8, P421, DOI 10.1007/BF03339605
   COGGER VC, 2001, 2 INT C HEP SPLANCHN
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   Harewood WJ, 1999, J MED PRIMATOL, V28, P19, DOI 10.1111/j.1600-0684.1999.tb00085.x
   Harewood WJ, 2000, J MED PRIMATOL, V29, P415, DOI 10.1111/j.1600-0684.2000.290606.x
   Heffernan S, 1996, DIABETES RES CLIN PR, V34, P65, DOI 10.1016/S0168-8227(96)01335-6
   HEFFERNAN S, 1995, J MED PRIMATOL, V24, P29, DOI 10.1111/j.1600-0684.1995.tb00141.x
   HIGASHI N, 2002, 11 INT S CELLS HEP S
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   MAK KM, 1984, HEPATOLOGY, V4, P386, DOI 10.1002/hep.1840040306
   MAK KM, 1988, HEPATOLOGY, V8, P1027, DOI 10.1002/hep.1840080508
   MAK KM, 1984, GASTROENTEROLOGY, V87, P188
   MAK KM, 1986, ARCH PATHOL LAB MED, V110, P513
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Miller RT, 1997, APPL IMMUNOHISTOCHEM, V5, P63, DOI 10.1097/00022744-199703000-00010
   MIYAKAWA H, 1985, GASTROENTEROLOGY, V88, P143, DOI 10.1016/S0016-5085(85)80146-3
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114
   Yang MC, 2002, PHARMACOL TOXICOL, V90, P203, DOI 10.1034/j.1600-0773.2002.900406.x
NR 27
TC 75
Z9 78
U1 1
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT
PY 2003
VL 38
IS 10
BP 1101
EP 1107
DI 10.1016/j.exger.2003.07.002
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 744RE
UT WOS:000186645300010
PM 14580863
DA 2024-02-19
ER

PT J
AU Inoue, H
   Shimizu, Y
   Yoshikawa, H
   Arakawa, K
   Tanaka, M
   Morimoto, H
   Sato, A
   Takino, Y
   Ishigami, A
   Takahashi, N
   Uehara, M
AF Inoue, Hirofumi
   Shimizu, Yusaku
   Yoshikawa, Hiroto
   Arakawa, Kohta
   Tanaka, Miori
   Morimoto, Hiromu
   Sato, Ayami
   Takino, Yuka
   Ishigami, Akihito
   Takahashi, Nobuyuki
   Uehara, Mariko
TI Resveratrol Upregulates Senescence Marker Protein 30 by Activating
   AMPK/Sirt1-Foxo1 Signals and Attenuating
   H<sub>2</sub>O<sub>2</sub>-Induced Damage in FAO Rat Liver Cells
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE Resveratrol; SMP30; AMPK; SIRT1; H2O2
ID OXIDATIVE STRESS; DOWN-REGULATION; SIRT1; SMP30; AGE
AB Resveratrol (RSV) is a polyphenol with numerous biological functions, including anti-inflammatory, antioxidant, and anti-aging activities. The novel senescence marker protein-30 (SMP30) indicates aging, and it suppresses hepatic oxidative stress. However, the effects of RSV on SMP30 expression regulation remain unclear. We observed that RSV positively regulates SMP30 expression in rat hepatoma-derived FAO cells. However, this was abolished by Compound C and EX-527 that specifically inhibit AMP-activated protein kinase (AMPK) and Silent Information Regulator T1 (Sirt1), respectively. We predicted binding sites for AMPK, forkhead box protein O1 (Foxo1), and Sirt1 downstream molecules as possible SMP30 promoters using the JASPAR and UniProtKB databases. We identified a Foxo1 binding site in the promoter region of SMP30. Inhibiting Foxo1 with AS1842527 also decreased the RSV-induced upregulation of SMP30 expression. Moreover, RSV suppressed the substantial downregulation of SMP30 expression caused by oxidative stress and hydrogen peroxide (H2O2) and released accumulated lactate dehydrogenase. These results demonstrate that, as a novel food factor, RSV-induced upregulation of SMP30 by activating AMPK/Sirt1-Foxo1 signaling and may attenuates H2O2-induced oxidative damage. The findings of this study offer new perspectives of the anti-ageing properties of RSV.
C1 [Inoue, Hirofumi; Shimizu, Yusaku; Yoshikawa, Hiroto; Arakawa, Kohta; Tanaka, Miori; Morimoto, Hiromu; Takahashi, Nobuyuki; Uehara, Mariko] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Tokyo 1568502, Japan.
   [Sato, Ayami; Takino, Yuka; Ishigami, Akihito] Tokyo Metropolitan Inst Geriatr & Gerontol TMIG, Mol Regulat Aging, Tokyo 1730015, Japan.
C3 Tokyo University of Agriculture
RP Uehara, M (corresponding author), Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Tokyo 1568502, Japan.
EM mari@nodai.ac.jp
OI Tanaka, Miori/0000-0002-2690-3780
FU Tokyo NODAI Research Program for Excellent Doctoral Students
FX We thank all members of our research group for their experimental help
   and discussion. This experiment was partially subsidized by Tokyo NODAI
   Research Program for Excellent Doctoral Students.
CR Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177
   [Anonymous], maceut, V25, P1345
   Avelar RA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01990-9
   Bellaver B, 2014, TOXICOL IN VITRO, V28, P479, DOI 10.1016/j.tiv.2014.01.006
   Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Chai RF, 2017, MOL MED REP, V16, P8037, DOI 10.3892/mmr.2017.7612
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Ding CY, 2018, CELL PHYSIOL BIOCHEM, V45, P1316, DOI 10.1159/000487559
   Feng DY, 2004, ANN NY ACAD SCI, V1019, P360, DOI 10.1196/annals.1297.062
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   He Q, 2017, INT IMMUNOPHARMACOL, V50, P208, DOI 10.1016/j.intimp.2017.06.029
   Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015
   Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341
   Inoue H, 2021, J CLIN BIOCHEM NUTR, V68, P51, DOI 10.3164/jcbn.20-119
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Jung KJ, 2006, ANTIOXID REDOX SIGN, V8, P671, DOI 10.1089/ars.2006.8.671
   Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003
   Li YR, 2018, BIOFACTORS, V44, P69, DOI 10.1002/biof.1400
   Patel KR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005870
   Rafe T, 2019, CURR PHARM DESIGN, V25, P1345, DOI 10.2174/1381612825666190410153307
   Roig R, 2002, BBA-GEN SUBJECTS, V1572, P25, DOI 10.1016/S0304-4165(02)00273-8
   Saldanha JF, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963217
   Sato Y, 2014, GERIATR GERONTOL INT, V14, P989, DOI 10.1111/ggi.12162
   Schwager J, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1823-z
   Shinto S, 2018, J CLIN BIOCHEM NUTR, V62, P132, DOI 10.3164/jcbn.17-60
   Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130
   Yang HY, 2017, ONCOTARGET, V8, P25310, DOI 10.18632/oncotarget.15813
   Yao CJ, 2022, AGING-US, V14, P2400, DOI 10.18632/aging.203949
NR 33
TC 0
Z9 0
U1 2
U2 2
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PY 2023
VL 69
IS 5
BP 388
EP 393
DI 10.3177/jnsv.69.388
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA Y9VY6
UT WOS:001108677000010
PM 37940580
OA gold
DA 2024-02-19
ER

PT J
AU Cheng, YJ
   Wang, X
   Wang, B
   Zhou, H
   Dang, SP
   Shi, YF
   Hao, L
   Luo, QQ
   Jin, M
   Zhou, QJ
   Zhang, YY
AF Cheng, Yiji
   Wang, Xue
   Wang, Bei
   Zhou, Hong
   Dang, Shipeng
   Shi, Yufang
   Hao, Li
   Luo, Qingquan
   Jin, Min
   Zhou, Qianjun
   Zhang, Yanyun
TI Aging-associated oxidative stress inhibits liver progenitor cell
   activation in mice
SO AGING-US
LA English
DT Article
DE aging; stem cells; liver regeneration; neutrophil; reactive oxygen
   species
ID HEPATIC OVAL CELLS; CHOLINE-DEFICIENT; STEM-CELLS; DONOR AGE; RAT;
   MYELOPEROXIDASE; ETHIONINE; CULTURE; TRANSPLANTATION; NEUTROPHILS
AB Recent studies have discovered aging-associated changes of adult stem cells in various tissues and organs, which potentially contribute to the organismal aging. However, aging-associated changes of liver progenitor cells (LPCs) remain elusive. Employing young (2-month-old) and old (24-month-old) mice, we found diverse novel alterations in LPC activation during aging. LPCs in young mice could be activated and proliferate upon liver injury, whereas the counterparts in old mice failed to respond and proliferate, leading to the impaired liver regeneration. Surprisingly, isolated LPCs from young and old mice did not exhibit significant difference in their clonogenic and proliferative capacity. Later, we uncovered that the decreased activation and proliferation of LPCs were due to excessive reactive oxygen species produced by neutrophils infiltrated into niche, which was resulted from chemokine production from activated hepatic stellate cells during aging. This study demonstrates aging-associated changes in LPC activation and reveals critical roles for the stem cell niche, including neutrophils and hepatic stellate cells, in the negative regulation of LPCs during aging.
C1 [Cheng, Yiji; Wang, Xue; Luo, Qingquan; Zhou, Qianjun; Zhang, Yanyun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.
   [Cheng, Yiji; Wang, Xue; Luo, Qingquan; Zhou, Qianjun; Zhang, Yanyun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Shanghai, Peoples R China.
   [Wang, Bei; Zhou, Hong; Dang, Shipeng; Shi, Yufang; Jin, Min; Zhang, Yanyun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.
   [Wang, Bei; Zhou, Hong; Dang, Shipeng; Shi, Yufang; Jin, Min; Zhang, Yanyun] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China.
   [Hao, Li] Anhui Med Univ, Affiliated Hosp 1, Clin Lab, Hefei, Peoples R China.
C3 Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong
   University; Anhui Medical University
RP Zhou, QJ; Zhang, YY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.; Zhou, QJ; Zhang, YY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Shanghai, Peoples R China.; Zhang, YY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.; Zhang, YY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China.
EM qianjunzhou@yahoo.com; yyzhang@sibs.ac.cn
RI Zhou, Qian/JMB-8448-2023; zhou, qian/HSG-2858-2023; Shi,
   Yufang/AAE-4431-2020; qian, zhou/JGM-3505-2023
OI Shi, Yufang/0000-0001-8964-319X; 
FU Ministry of Science and Technology of China [2015CB943300, 2011CB966200,
   2014CB943300]; Strategic Priority Research Program of the Chinese
   Academy of Sciences [XDA01040000]; National Natural Science Foundation
   of China [81130057, 81373164, 31300708, 81471217]; Program of Science
   and Technology Commission of Shanghai Municipality [14ZR1446300,
   13ZR1423200, 12ZR1415900]
FX This work was supported by the Ministry of Science and Technology of
   China (2015CB943300, 2011CB966200, 2014CB943300), Strategic Priority
   Research Program of the Chinese Academy of Sciences (XDA01040000),
   National Natural Science Foundation of China (81130057, 81373164,
   31300708, 81471217), the Program of Science and Technology Commission of
   Shanghai Municipality (14ZR1446300, 13ZR1423200, 12ZR1415900).
CR Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624
   Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751
   Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011
   Cai X, 2012, HEPATOLOGY, V56, P1804, DOI 10.1002/hep.25874
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247
   De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217
   Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112
   Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435
   Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807
   FARBER E, 1956, CANCER RES, V16, P142
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Feng DC, 2012, GASTROENTEROLOGY, V143, P188, DOI 10.1053/j.gastro.2012.03.044
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jelnes P, 2007, HEPATOLOGY, V45, P1462, DOI 10.1002/hep.21569
   Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001
   Koh M, 2006, SURG TODAY, V36, P457, DOI 10.1007/s00595-005-3183-4
   Lakshman R, 2005, J CLIN PATHOL, V58, P1339, DOI 10.1136/jcp.2004.025098
   Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044805
   Maher JJ, 1998, AM J PHYSIOL-GASTR L, V275, pG847, DOI 10.1152/ajpgi.1998.275.4.G847
   Maschmeyer P, 2011, JOVE-J VIS EXP, DOI 10.3791/2710
   Ogawa Kishiko, 2008, Immun Ageing, V5, P13, DOI 10.1186/1742-4933-5-13
   Pillai MM, 2006, BLOOD, V107, P3520, DOI 10.1182/blood-2005-10-4285
   Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Sawayama Y, 2008, LEUKEMIA, V22, P956, DOI 10.1038/leu.2008.8
   Schenk BI, 2002, J IMMUNOL, V169, P2602, DOI 10.4049/jimmunol.169.5.2602
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Son TG, 2005, FREE RADICAL RES, V39, P283, DOI 10.1080/10715760500053461
   Starr ME, 2011, FREE RADICAL BIO MED, V50, P371, DOI 10.1016/j.freeradbiomed.2010.11.013
   Strick-Marchand H, 2008, J IMMUNOL, V181, P2764, DOI 10.4049/jimmunol.181.4.2764
   Suzuki K, 1996, J APPL PHYSIOL, V81, P1213, DOI 10.1152/jappl.1996.81.3.1213
   Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191
   Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Wu CX, 2009, WORLD J GASTROENTERO, V15, P1506, DOI 10.3748/wjg.15.1506
   Wu CT, 2003, HEPATOLOGY, V38, P1018, DOI 10.1053/jhep.2003.50407
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang Y, 2014, HEPATOLOGY, V59, P671, DOI 10.1002/hep.26670
   Zhao F, 2011, BLOOD, V117, P1723, DOI 10.1182/blood-2010-04-281659
NR 43
TC 23
Z9 26
U1 0
U2 10
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD MAY
PY 2017
VL 9
IS 5
BP 1359
EP 1374
DI 10.18632/aging.101232
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EZ1JR
UT WOS:000404467700005
PM 28458256
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, F
   Zhang, M
   Wang, AX
   Xu, MC
   Wang, C
   Xu, GF
   Zhang, B
   Zou, XP
   Zhuge, YZ
AF Zhang, Feng
   Zhang, Ming
   Wang, Aixiu
   Xu, Mingcui
   Wang, Chen
   Xu, Guifang
   Zhang, Bin
   Zou, Xiaoping
   Zhuge, Yuzheng
TI TWEAK increases SIRT1 expression and promotes p53 deacetylation
   affecting human hepatic stellate cell senescence
SO CELL BIOLOGY INTERNATIONAL
LA English
DT Article
DE cell senescence; hepatic stellate cell; liver fibrosis; tumor necrosis
   factor-like weak inducer of apoptosis
ID LIVER PROGENITOR-CELL; FIBROSIS; CANCER; REGENERATION; FIBROGENESIS;
   MECHANISMS; RESPONSES; GROWTH; MICE
AB To detect the effects of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) on SIRT1 expression and p53 deacetylation, involving cell senescence, in activated human hepatic stellate cell (HSC) in vitro, human HSC LX-2 was cultured with TWEAK for 24h. The result showed that the expression of membrane receptor Fn14 was remarkably increased by TWEAK, which upregulated SIRT1 in LX-2 cells, detected by Western blotting and real-time PCR. The expression of p53 was not significantly altered; however, the ac-p53 was decreased. Furthermore, the viability of LX-2 cells was significantly enhanced by TWEAK. The activity of SA--Gal was notably inhibited, showing a suppressing effect of TWEAK on the senescence of activated HSC. Primary cultured HSC on days 7 and 11 was used to examine the expression of TWEAK, Fn14, SIRT1, and the activity of SA--Gal. The result indicated that the mRNA of TWEAK, SIRT1, and Fn14 was all decreased on day 11 compared to that on day 7, and the activity of SA--Gal was higher on day 11 than that on day 7. The present study suggested that TWEAK enhanced the expression of SIRT1 and decreased the acetylation of p53, probably inhibiting the senescence of activated HSC in vitro, which provides a molecular basis for TWEAK as a potential target in the therapy of liver fibrosis.
C1 [Zhang, Feng; Zhang, Ming; Wang, Aixiu; Xu, Mingcui; Wang, Chen; Xu, Guifang; Zhang, Bin; Zou, Xiaoping; Zhuge, Yuzheng] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Gastroenterol, 321 Zhongshan Rd, Nanjing 210008, Peoples R China.
C3 Nanjing University
RP Zhuge, YZ (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Gastroenterol, 321 Zhongshan Rd, Nanjing 210008, Peoples R China.
EM yuzheng9111963@aliyun.com
RI Wang, Chen/H-3715-2018; Xia, Xianfeng/F-9169-2011
OI Wang, Chen/0000-0001-6544-4065; 
FU National Natural Science Foundation of China [8157040652]; key projects
   from Medical Science and technology development Foundation, Nanjing
   Department of Health, China [ZKX14017]
FX This work was supported by National Natural Science Foundation of China
   (no. 8157040652) and key projects from Medical Science and technology
   development Foundation, Nanjing Department of Health, China (no.
   ZKX14017).
CR Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x
   Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005
   Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274
   Chen SL, 2013, BIODRUGS, V27, P25, DOI 10.1007/s40259-012-0005-2
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379
   Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486
   Jang SY, 2011, FEBS LETT, V585, P3360, DOI 10.1016/j.febslet.2011.09.027
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuramitsu K, 2013, AM J PATHOL, V183, P182, DOI 10.1016/j.ajpath.2013.03.018
   Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Ramakrishna G, 2012, EUR J CELL BIOL, V91, P739, DOI 10.1016/j.ejcb.2012.08.002
   Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013
   Shafritz DA, 2010, HEPATOLOGY, V52, P13, DOI 10.1002/hep.23750
   Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315
   Tirnitz-Parker JEE, 2014, HEPATOLOGY, V59, P1198, DOI 10.1002/hep.26701
   Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488
   Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang Chen BJ, 2014, PLOS ONE, V9
NR 31
TC 13
Z9 13
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1065-6995
EI 1095-8355
J9 CELL BIOL INT
JI Cell Biol. Int.
PD FEB
PY 2017
VL 41
IS 2
BP 147
EP 154
DI 10.1002/cbin.10706
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EJ6EQ
UT WOS:000393312200004
PM 27888541
DA 2024-02-19
ER

PT J
AU Nucci, RAB
   Teodoro, ACD
   Neto, WK
   Silva, WD
   de Souza, RR
   Anaruma, CA
   Gama, EF
AF Baptista Nucci, Ricardo Aparecido
   de Souza Teodoro, Ana Caroline
   Neto, Walter Krause
   Silva, Wellington de Assis
   de Souza, Romeu Rodrigues
   Anaruma, Carlos Alberto
   Gama, Eliane Florencio
TI Effects of testosterone administration on liver structure and function
   in aging rats
SO AGING MALE
LA English
DT Article
DE Liver; aging; testosterone; hepatic structure; male hormone
ID LIPID PROFILE; MEN; EXERCISE; UNDECANOATE; PROPIONATE; METABOLISM;
   MORPHOLOGY; THERAPY; GROWTH; SIZE
AB Aging males have a decrease in testosterone levels, by which the testosterone treatment may influence in a negatively fashion the liver.Aim: This study aimed to analyze the effects of aging with or without testosterone administration on the liver components of animals.Methods: Wistar rats were divided into three groups: 20 months' group (G20), 24 months' group (G24), group treated with testosterone for 16 weeks (GT). All groups were sacrificed at 24 months except for G20 that was sacrificed at 20 months.Results: Aging and testosterone treatment alters the body weight (BW), liver weight (LW) and relative liver weight. Besides, testosterone increased the mitogen capacity of hepatocytes. Nonetheless, we reinforce the negative effects of testosterone on old animals' liver as chronic hepatic congestion and/or cholestasis. In addition, we observed that testosterone plays an important role on hepatic glycogen stores.Conclusions: Our study showed many implications for the knowledge about the effects of aging with or without testosterone administration on old animals' liver.
C1 [Baptista Nucci, Ricardo Aparecido; de Souza Teodoro, Ana Caroline; de Souza, Romeu Rodrigues; Gama, Eliane Florencio] Univ Sao Judas Tadeu, Dept Aging Sci, 546 Taquari St, Sao Paulo, Brazil.
   [Neto, Walter Krause; Silva, Wellington de Assis; de Souza, Romeu Rodrigues; Gama, Eliane Florencio] Univ Sao Judas Tadeu, Phys Educ Dept, Sao Paulo, Brazil.
   [Anaruma, Carlos Alberto] Julio de Mesquita Filho Sao Paulo State Univ, Phys Educ Dept, Sao Paulo, Brazil.
C3 Universidade Sao Judas Tadeu; Universidade Sao Judas Tadeu; Universidade
   Estadual Paulista
RP Nucci, RAB (corresponding author), Univ Sao Judas Tadeu, Dept Aging Sci, 546 Taquari St, Sao Paulo, Brazil.
EM r.aparecido.nucci@uol.com.br
RI Neto, Walter Krause/R-2323-2017; Nucci, Ricardo Aparecido
   Baptista/A-4577-2017; Teodoro, Ana/B-5840-2011; Gama, Eliane
   Florencio/G-1741-2014
OI Neto, Walter Krause/0000-0002-6881-0208; Nucci, Ricardo Aparecido
   Baptista/0000-0001-5649-2145; Teodoro, Ana/0000-0002-8043-6431; Gama,
   Eliane Florencio/0000-0002-9770-8819
CR Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011
   [Anonymous], 2013, Definition of an older or elderly person
   Aparicio VA, 2013, NUTR HOSP, V28, P127, DOI 10.3305/nh.2013.28.1.6055
   Bagatell CJ, 1996, NEW ENGL J MED, V334, P707, DOI 10.1056/NEJM199603143341107
   Bento-Silva MT, 2010, BRAZ J PHARM SCI, V46, P79, DOI 10.1590/S1984-82502010000100009
   Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101
   DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Fitts JM, 2004, J ANDROL, V25, P523
   Goncalves L, 2014, AGING MALE, V17, P243, DOI 10.3109/13685538.2014.919252
   GORE RM, 1994, AM J ROENTGENOL, V162, P71, DOI 10.2214/ajr.162.1.8273693
   Herbst KL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1112, DOI 10.1152/ajpendo.00524.2002
   Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844
   Lise M L, 1999, Rev Assoc Med Bras (1992), V45, P364
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lunenfeld B, 2013, AGING MALE, V16, P143, DOI 10.3109/13685538.2013.853731
   LYDEN E, 1995, METABOLISM, V44, P445, DOI 10.1016/0026-0495(95)90050-0
   Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Osterberg EC, 2014, INDIAN J UROL, V30, P2, DOI 10.4103/0970-1591.124197
   Pignata S, 1998, EUR J CANCER, V34, P25, DOI 10.1016/S0959-8049(97)00317-1
   Ramamani A, 1999, CAN J PHYSIOL PHARM, V77, P300, DOI 10.1139/cjpp-77-4-300
   Spitzer M, 2013, NAT REV ENDOCRINOL, V9, P414, DOI 10.1038/nrendo.2013.73
   Tan WS, 2013, BJU INT, V111, P1130, DOI 10.1111/bju.12037
   Tanasov VS, 2014, INT J MORPHOL, V32, P756, DOI 10.4067/S0717-95022014000300002
   Vieira RP, 2008, MED SCI SPORT EXER, V40, P842, DOI 10.1249/MSS.0b013e3181666f1c
   Vigorito C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00051
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 31
TC 6
Z9 7
U1 1
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1368-5538
EI 1473-0790
J9 AGING MALE
JI Aging Male
PY 2017
VL 20
IS 2
BP 134
EP 137
DI 10.1080/13685538.2017.1284779
PG 4
WC Endocrinology & Metabolism; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Urology & Nephrology
GA EX1OV
UT WOS:000402995100010
PM 28590831
OA Green Published
DA 2024-02-19
ER

PT J
AU Jiang, MH
   Fei, J
   Lan, MS
   Lu, ZP
   Liu, M
   Fan, WW
   Gao, X
   Lu, DR
AF Jiang, M. H.
   Fei, J.
   Lan, M. S.
   Lu, Z. P.
   Liu, M.
   Fan, W. W.
   Gao, X.
   Lu, D. R.
TI Hypermethylation of hepatic <i>Gck</i> promoter in ageing rats
   contributes to diabetogenic potential
SO DIABETOLOGIA
LA English
DT Article
DE ageing; diabetes; glucokinase; insulin resistance; methylation
ID DEPENDENT DIABETES-MELLITUS; PANCREATIC BETA-CELL; INSULIN-RESISTANCE;
   GLUCOKINASE GENE; LIVER GLUCOKINASE; DNA METHYLATION; GLYCOGEN-SYNTHASE;
   PROSTATE-CANCER; GLUCOSE; METABOLISM
AB Aims/hypothesis Hepatic glucokinase (GCK) is a key enzyme in glucose utilisation. Downregulation of its activity is associated with insulin resistance and type 2 diabetes mellitus. However, it is unknown whether hepatic Gck expression is influenced by age and is involved in ageing-mediated diabetes, and whether the degree of methylation of the hepatic Gck promoter is correlated with the transcription of Gck. To address the question, we evaluated hepatic Gck transcription and promoter methylation in young (14 weeks), adult (40 weeks) and aged (80 weeks) rats.
   Methods Hepatic glycogen, Gck expression and the kinase activity of GCK were measured in three age groups. The CpG methylation status was determined by both bisulphite direct sequencing and clone sequencing of the PCR amplificates of Gek promoter. The causal relationship between Gck methylation and mRNA expression was confirmed by treating rat primary hepatocytes with 5-aza-2'-deoxycytidine (5-Aza-CdR).
   Results We have shown an age-associated decline in hepatic glycogen, Gck expression levels and the kinase activity of hepatic GCK. The eleven CpG sites studied displayed age-related progressive methylation changes in hepatic Gck promoter, which were confirmed by two methods: direct and clone sequencing. After 5-Aza-CdR treatment of rat primary hepatocytes, there was a fourfold increase in Gck expression.
   Conclusions/interpretation Our results demonstrate that an age-related increase in methylation is negatively associated with hepatic Gck expression, suggesting that DNA methylation could be involved in increasing age-dependent susceptibility to hepatic insulin resistance and diabetes. Thus, the epigenctic modification of the hepatic Gck promoter may represent an important marker for diabetogenic potential during the ageing process.
C1 [Lu, D. R.] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.
   Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.
   [Lan, M. S.] Childrens Hosp, Res Inst Children, Dept Pediat, LSUHSC, New Orleans, LA USA.
   [Liu, M.; Gao, X.] Fudan Univ, Zhongshan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China.
C3 Fudan University; Fudan University; Louisiana State University System;
   Louisiana State University Health Sciences Center New Orleans;
   Children's Hospital of New Orleans; Fudan University
RP Lu, DR (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.
EM drlu@fudan.edu.cn
RI Lan, Michael/CAF-1839-2022; Anthropology, MOE KeyLab Fudan/A-9454-2010;
   Lu, Zhipeng/IWV-4341-2023; Lu, Zhipeng/E-1736-2017
OI Lu, Zhipeng/0000-0001-5124-7546; Lu, Daru/0000-0001-6748-7966
CR ADELMAN RC, 1970, J BIOL CHEM, V245, P1032
   Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479
   ANTONSSON BE, 1987, CANCER RES, V47, P3672
   Bogdarina I, 2004, LIFE SCI, V74, P1407, DOI 10.1016/j.lfs.2003.08.017
   BONTEMPS F, 1978, BIOCHEM J, V174, P603, DOI 10.1042/bj1740603
   BOSSARD P, 1993, EUR J BIOCHEM, V215, P883, DOI 10.1111/j.1432-1033.1993.tb18106.x
   Burns N, 2007, DIABETOLOGIA, V50, P1500, DOI 10.1007/s00125-007-0655-7
   CARO JF, 1995, HORM METAB RES, V27, P19, DOI 10.1055/s-2007-979899
   Chen J, 2006, J GERONTOL A-BIOL, V61, P20, DOI 10.1093/gerona/61.1.20
   DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574
   Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Frese T, 2007, HORM METAB RES, V39, P567, DOI 10.1055/s-2007-984471
   Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8
   Gomis RR, 2003, J BIOL CHEM, V278, P9740, DOI 10.1074/jbc.M212151200
   GROOP LC, 1993, DIABETOLOGIA, V36, P1326, DOI 10.1007/BF00400814
   Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65
   Hampson LJ, 2005, DIABETES, V54, P617, DOI 10.2337/diabetes.54.3.617
   Härndahl L, 2006, FEBS J, V273, P336, DOI 10.1111/j.1742-4658.2005.05067.x
   IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740
   Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346
   Li LC, 2000, CANCER RES, V60, P702
   Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938
   LYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838
   MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936
   MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838
   Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484
   Millar DS, 1999, ONCOGENE, V18, P1313, DOI 10.1038/sj.onc.1202415
   Murumägi A, 2003, J BIOL CHEM, V278, P19784, DOI 10.1074/jbc.M210437200
   Ngo V, 1996, MOL CELL BIOL, V16, P3245
   Paul CL, 1996, BIOTECHNIQUES, V21, P126
   Pereira S, 2008, DIABETES, V57, P56, DOI 10.2337/db07-0887
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   da Silva RCQ, 2007, J DIABETES COMPLICAT, V21, P84, DOI 10.1016/j.jdiacomp.2005.11.006
   Raz I, 2005, DIABETES-METAB RES, V21, P3, DOI 10.1002/dmrr.493
   REAVEN GM, 1985, J AM GERIATR SOC, V33, P286, DOI 10.1111/j.1532-5415.1985.tb07118.x
   ROWE JW, 1983, J CLIN INVEST, V158, P1
   SALAS M, 1963, J BIOL CHEM, V238, P3535
   SALAVERT A, 1982, J BIOL CHEM, V257, P13404
   Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756
   Stewart KJ, 2005, ANN NY ACAD SCI, V1055, P193, DOI 10.1196/annals.1323.029
   Stirzaker C, 1997, CANCER RES, V57, P2229
   STOFFEL M, 1992, NAT GENET, V2, P153, DOI 10.1038/ng1092-153
   Tao Q, 1998, BLOOD, V91, P1373, DOI 10.1182/blood.V91.4.1373
   TEMPLETON M, 1961, J HISTOCHEM CYTOCHEM, V9, P670, DOI 10.1177/9.6.670
   VANDERVIES J, 1954, BIOCHEM J, V57, P410, DOI 10.1042/bj0570410
   VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0
   WALKER DG, 1964, BIOCHEM J, V90, P360, DOI 10.1042/bj0900360
NR 50
TC 64
Z9 67
U1 0
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD AUG
PY 2008
VL 51
IS 8
BP 1525
EP 1533
DI 10.1007/s00125-008-1034-8
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 329EE
UT WOS:000257848900023
PM 18496667
OA Bronze
DA 2024-02-19
ER

PT J
AU Somsura, R
   Kamkajon, K
   Chaimongkolnukul, K
   Chantip, S
   Teerapornpuntakit, J
   Wongdee, K
   Kamonsutthipaijit, N
   Tangtrongsup, S
   Panupinthu, N
   Tiyasatkulkovit, W
   Charoenphandhu, N
AF Somsura, Ratthapon
   Kamkajon, Kanokwan
   Chaimongkolnukul, Khuanjit
   Chantip, Surachai
   Teerapornpuntakit, Jarinthorn
   Wongdee, Kannikar
   Kamonsutthipaijit, Nuntaporn
   Tangtrongsup, Suwimol
   Panupinthu, Nattapon
   Tiyasatkulkovit, Wacharaporn
   Charoenphandhu, Narattaphol
TI Tissue-specific expression of senescence biomarkers in spontaneously
   hypertensive rats: evidence of premature aging in
SO PEERJ
LA English
DT Article
DE Hypertension; Cellular senescence; Cyclin-dependent kinase inhibitor
   (CDKI); Senescence-associated secretory phenotype (SASP); Spontaneously
   hypertensive rat (SHR)
ID BONE-MINERAL DENSITY; ORGAN DAMAGE; MECHANISMS; PRESSURE; CELLS; TIMPS;
   SIZE
AB Background: Cellular senescence is an age-related physiological process that contributes to tissue dysfunction and accelerated onset of chronic metabolic diseases including hypertension. Indeed, elevation of blood pressure in hypertension coincides with premature vascular aging and dysfunction. In addition, onsets of metabolic disturbance and osteopenia in patients with hypertension have also been reported. It is possible that hypertension enhances premature aging and causes progressive loss of function in multiple organs. However, the landscape of cellular senescence in critical tissues affected by hypertension remains elusive. Materials and Methods: Heart, liver, bone, hypothalamus, and kidney were collected from spontaneously hypertensive rats (SHR) and age-and sex-matched normotensive Wistar rats (WT) at 6, 12, 24 and 36 weeks of age (n = 10 animals/ group). Changes in mRNA levels of senescence biomarkers namely cyclin-dependent kinase (CDK) inhibitors (CDKIs), i.e., Cdkn2a (encoding p16Ink4a) and Cdkn1a (encoding p21cip1) as well as senescence-associated secretory phenotypes (SASPs), i.e., Timp1, Mmp12, Il6 and Cxcl1, were determined. Additionally, bone collagen alignment and hydroxy apatite crystal dimensions were determined by synchrotron radiation small-and wide-angle X-ray scattering (SAXS/WAXS) techniques.Results: Real-time PCR revealed that transcript levels of genes encoding CDKIs and SASPs in the heart and liver were upregulated in SHR from 6 to 36 weeks of age. Expression of Timp1 and Cxcl1 was increased in bone tissues isolated from 36-week-old SHR. In contrast, we found that expression levels of Timp1 and Il6 mRNA were decreased in hypothalamus and kidney of SHR in all age groups. Simultaneous SAXS/WAXS analysis also revealed misalignment of bone collagen fibers in SHR as compared to WT.Conclusion: Premature aging was identified in an organ directly affected by high blood pressure (i.e., heart) and those with known functional defects in SHR (i.e., liver and bone). Cellular senescence was not evident in organs with autoregulation of blood pressure (i.e., brain and kidney). Our study suggested that cellular senescence is induced by persistently elevated blood pressure and in part, leading to organ dysfunction. Therefore, interventions that can both lower blood pressure and prevent cellular senescence should provide therapeutic benefits for treatment of cardiovascular and metabolic consequences.
C1 [Somsura, Ratthapon; Tiyasatkulkovit, Wacharaporn] Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok, Thailand.
   [Somsura, Ratthapon] Chulalongkorn Univ, Fac Sci, Dept Biol, Master Sci Program Zool, Bangkok, Thailand.
   [Kamkajon, Kanokwan; Tangtrongsup, Suwimol; Panupinthu, Nattapon; Charoenphandhu, Narattaphol] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok, Thailand.
   [Kamkajon, Kanokwan; Teerapornpuntakit, Jarinthorn; Wongdee, Kannikar; Tangtrongsup, Suwimol; Panupinthu, Nattapon; Charoenphandhu, Narattaphol] Mahidol Univ, Fac Sci, Ctr Calcium & Bone Res COCAB, Bangkok, Thailand.
   [Chaimongkolnukul, Khuanjit; Chantip, Surachai] Mahidol Univ, Natl Lab Anim Ctr, Nakhon Pathom, Thailand.
   [Teerapornpuntakit, Jarinthorn] Naresuan Univ, Fac Med Sci, Dept Physiol, Phitsanulok, Thailand.
   [Wongdee, Kannikar] Burapha Univ, Fac Allied Hlth Sci, Chon Buri, Thailand.
   [Kamonsutthipaijit, Nuntaporn] Synchrotron Light Res Inst Publ Org, Nakhon Ratchasima, Thailand.
   [Charoenphandhu, Narattaphol] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand.
   [Charoenphandhu, Narattaphol] Acad Sci, Royal Soc Thailand, Bangkok, Thailand.
C3 Chulalongkorn University; Chulalongkorn University; Mahidol University;
   Mahidol University; Mahidol University; Naresuan University; Burapha
   University; Mahidol University
RP Tiyasatkulkovit, W (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok, Thailand.; Charoenphandhu, N (corresponding author), Mahidol Univ, Fac Sci, Dept Physiol, Bangkok, Thailand.; Charoenphandhu, N (corresponding author), Mahidol Univ, Fac Sci, Ctr Calcium & Bone Res COCAB, Bangkok, Thailand.; Charoenphandhu, N (corresponding author), Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand.; Charoenphandhu, N (corresponding author), Acad Sci, Royal Soc Thailand, Bangkok, Thailand.
EM wacharaporn.ti@chula.ac.th; nattapon.pan@mahidol.ac.th
RI Teerapornpuntakit, Jarinthorn/GPS-5797-2022
OI Teerapornpuntakit, Jarinthorn/0000-0001-5012-0842
FU Prasert Prasarttong-Osoth Research Grant; Graduate School Thesis Grant,
   Chulalongkorn University
FX The present study was supported by Mahidol University-Postdoctoral Grant
   (to Narattaphol Charoenphandhu and Kanokwan Kamkajon), the Distinguished
   Research Professor Grant from National Research Council of
   Thailand-Mahidol University (to Narattaphol Charoenphandhu), Mahidol
   University (Fundamental Fund: fiscal year 2022 and 2023 by National
   Science Research and Innovation Fund (NSRF); to Nattapon Panupinthu and
   Narattaphol Charoenphandhu, respectively), the Faculty of Science,
   Mahidol University (CIF/CNI grant to Nattapon Panupinthu and Narattaphol
   Charoenphandhu), the Prasert Prasarttong-Osoth Research Grant (to
   Narattaphol Charoenphandhu) and Graduate School Thesis Grant,
   Chulalongkorn University (to Ratthapon Somsura). Kanokwan Kamkajon was a
   postdoctoral fellow awarded by Mahidol University. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.r Charoenphandhu) , the Prasert
   Prasarttong-Osoth Research Grant (to Narattaphol Charoenphandhu) , and
   Graduate School Thesis Grant, Chulalongkorn University (to Ratthapon
   Somsura) . Kanokwan Kamkajon was a postdoctoral fellow awarded by
   Mahidol University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Afsar B, 2023, BIOGERONTOLOGY, V24, P457, DOI 10.1007/s10522-023-10031-4
   Ansari A, 2023, BIOL SEX DIFFER, V14, DOI 10.1186/s13293-023-00519-6
   Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005
   Beck J, 2020, VET PATHOL, V57, P747, DOI 10.1177/0300985820943841
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Bisogni V, 2020, INTEGR BLOOD PRESS C, V13, P157, DOI 10.2147/IBPC.S223341
   Bolamperti S, 2022, BONE RES, V10, DOI 10.1038/s41413-022-00219-8
   Byun HO, 2015, BMB REP, V48, P549, DOI 10.5483/BMBRep.2015.48.10.122
   Cabral-Pacheco GA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249739
   Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001
   Farr JN, 2019, BONE, V121, P121, DOI 10.1016/j.bone.2019.01.015
   Farr JN, 2016, J BONE MINER RES, V31, P1920, DOI 10.1002/jbmr.2892
   Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043
   González-Gualda E, 2021, FEBS J, V288, P56, DOI 10.1111/febs.15570
   Guo J, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01251-0
   Harvey A, 2015, J MOL CELL CARDIOL, V83, P112, DOI 10.1016/j.yjmcc.2015.04.011
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3
   Heymans S, 2005, CIRCULATION, V112, P1136, DOI 10.1161/CIRCULATIONAHA.104.516963
   Hong MH, 2022, BIOMATER RES, V26, DOI 10.1186/s40824-022-00288-0
   Hu C, 2022, AGING DIS, V13, P103, DOI 10.14336/AD.2021.0927
   Hu ZQ, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000026276
   Ishikawa Joji, 2019, Circ Rep, V1, P502, DOI 10.1253/circrep.CR-19-0084
   Izzo C, 2021, LIFE-BASEL, V11, DOI 10.3390/life11010060
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008
   Lange C, 2011, J STRUCT BIOL, V176, P159, DOI 10.1016/j.jsb.2011.08.003
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Lemarié CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018
   Li XS, 2016, J CLIN HYPERTENS, V18, P1106, DOI 10.1111/jch.12848
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lorell BH, 2000, CIRCULATION, V102, P470
   Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163
   Maciel-Barón LA, 2016, AGE, V38, DOI 10.1007/s11357-016-9886-1
   Magassa S, 2021, J AM SOC NEPHROL, V32, P1974, DOI 10.1681/ASN.2021020231
   Marusic M, 2021, CAN J GASTROENTEROL, V2021, DOI 10.1155/2021/6613827
   McCarthy CG, 2019, AM J HYPERTENS, V32, P709, DOI 10.1093/ajh/hpz052
   Mills KT, 2020, NAT REV NEPHROL, V16, P223, DOI 10.1038/s41581-019-0244-2
   Nakagami H, 2023, HYPERTENS RES, V46, P539, DOI 10.1038/s41440-022-01117-6
   Nilsson PM, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00006
   OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282
   Pagan LU, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020336
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Reckelhoff JF, 1999, HYPERTENSION, V34, P920, DOI 10.1161/01.HYP.34.4.920
   Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Sun Y, 2018, TRENDS MOL MED, V24, P871, DOI 10.1016/j.molmed.2018.08.002
   Suvila K, 2022, HYPERTENSION, V79, P516, DOI 10.1161/HYPERTENSIONAHA.121.18786
   Tiyasatkulkovit W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48797-8
   Tsuda K, 2001, AM J HYPERTENS, V14, P704, DOI 10.1016/S0895-7061(01)01303-6
   Turunen MJ, 2016, J STRUCT BIOL, V195, P337, DOI 10.1016/j.jsb.2016.07.005
   Tuttle CSL, 2021, AGEING RES REV, V68, DOI 10.1016/j.arr.2021.101334
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499
   Xi YM, 2020, EXP CELL RES, V389, DOI 10.1016/j.yexcr.2020.111930
   Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282
NR 60
TC 0
Z9 0
U1 1
U2 1
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD OCT 19
PY 2023
VL 11
AR e16300
DI 10.7717/peerj.16300
PG 25
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA Y9WF4
UT WOS:001108683900009
PM 37872946
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Jannone, G
   Rozzi, M
   Najimi, M
   Decottignies, A
   Sokal, EM
AF Jannone, Giulia
   Rozzi, Milena
   Najimi, Mustapha
   Decottignies, Anabelle
   Sokal, Etienne M.
TI An Optimized Protocol for Histochemical Detection of
   Senescence-associated Beta-galactosidase Activity in Cryopreserved Liver
   Tissue
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article; Early Access
DE beta-galactosidase; bile duct resection; biliary cirrhosis;
   cryopreservation; liver tissue; senescence
ID HEPATOCYTE SENESCENCE; ACINAR DISTRIBUTION; METABOLIC ZONATION;
   BILIARY-CIRRHOSIS; STELLATE CELLS; FIBROSIS; BIOMARKER; CULTURE;
   ENZYMES; MARKERS
AB Senescence-associated beta-galactosidase (SA-beta-gal) activity assay is commonly used to evaluate the increased beta-galactosidase (beta-gal) activity in senescent cells related to enhanced lysosomal activity. Although the optimal pH for beta-gal is 4.0, this enzymatic activity has been most commonly investigated at a suboptimal pH by using histochemical reaction on fresh tissue material. In the current study, we optimized a SA-beta-gal activity histochemistry protocol that can also be applied on cryopreserved hepatic tissue. This protocol was developed on livers obtained from control rats and after bile duct resection (BDR). A significant increase in beta-gal liver activity was observed in BDR rats vs controls after 2 hr of staining at physiological pH 4.0 (6.98 +/- 1.19% of stained/total area vs 0.38 +/- 0.22; p<0.01) and after overnight staining at pH 5.8 (24.09 +/- 6.88 vs 0.12 +/- 0.08; p<0.01). Although we noticed that beta-gal activity staining decreased with cryopreservation time (from 4 to 12 months of storage at -80C; p<0.05), the enhanced staining observed in BDR compared with controls remained detectable up to 12 months after cryopreservation (p<0.01). In conclusion, we provide an optimized protocol for SA-beta-gal activity histochemical detection at physiological pH 4.0 on long-term cryopreserved liver tissue:
C1 [Jannone, Giulia; Rozzi, Milena; Najimi, Mustapha; Sokal, Etienne M.] Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, Ave Emmanuel Mounier 52,B1-52-03, B-1200 Brussels, Belgium.
   [Decottignies, Anabelle] Catholic Univ Louvain, Duve Inst, Genet & Epigenet Alterat Genomes Grp, Brussels, Belgium.
C3 Universite Catholique Louvain; Universite Catholique Louvain
RP Jannone, G (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, Ave Emmanuel Mounier 52,B1-52-03, B-1200 Brussels, Belgium.
EM giulia.jannone@uclouvain.be
OI Jannone, Giulia/0000-0002-7452-8727
FU Fonds National de la Recherche Scientifique et Medicale (FNRS, Belgium)
   through a FRIA grant [FC29559]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   research was supported by the Fonds National de la Recherche
   Scientifique et Medicale (FNRS, Belgium) through a FRIA grant (number
   FC29559).
CR Abu-Tair L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082571
   BODE C, 1982, J CLIN CHEM CLIN BIO, V20, P9
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   HOPWOOD D, 1967, J ANAT, V101, P83
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   LOJDA Z, 1970, HISTOCHEMISTRY, V22, P347
   McDaniel K, 2017, HEPATOLOGY, V65, P544, DOI 10.1002/hep.28831
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Noren Hooten N, 2017, JOVE-J VIS EXP, DOI 10.3791/55533
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pacheco-Rivera R, 2016, TOXICOL LETT, V241, P19, DOI 10.1016/j.toxlet.2015.11.011
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Pearse AGE, 1991, HISTOCHEMISTRY THEOR, V3
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Scouten C., 2006, Micros. Today, V14, P48, DOI [10.1017/S1551929500055218, DOI 10.1017/S1551929500055218]
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   SOKAL EM, 1989, J PEDIATR GASTR NUTR, V8, P522, DOI 10.1097/00005176-198905000-00017
   SOKAL EM, 1992, HEPATOLOGY, V15, P904, DOI 10.1002/hep.1840150525
   SOKAL EM, 1989, J HEPATOL, V9, P42, DOI 10.1016/0168-8278(89)90074-3
   SOKAL EM, 1990, GASTROENTEROLOGY, V99, P785, DOI 10.1016/0016-5085(90)90969-8
   Sokal EM., 1993, ADAPTIVE CHANGES MET
   Takahashi M, 2003, J HISTOCHEM CYTOCHEM, V51, P553, DOI 10.1177/002215540305100419
   Ueberham E, 2015, MOL CANCER RES, V13, P239, DOI 10.1158/1541-7786.MCR-14-0278-T
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Zhao Jing, 2017, Curr Protoc Cytom, V79, DOI 10.1002/cpcy.16
NR 32
TC 12
Z9 13
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0022-1554
EI 1551-5044
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD 2020 APR
PY 2020
VL 68
IS 4
BP 269
EP 278
AR 0022155420913534
DI 10.1369/0022155420913534
EA MAR 2020
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA KZ1QB
UT WOS:000523826600001
PM 32154749
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Vollmar, B
   Pradarutti, S
   Richter, S
   Menger, MD
AF Vollmar, B
   Pradarutti, S
   Richter, S
   Menger, MD
TI <i>In vivo</i> quantification of ageing changes in the rat liver from
   early juvenile to senescent life
SO LIVER
LA English
DT Article
DE ageing; hepatic microcirculation; intravital fluorescence microscopy;
   Ito cell; Kupffer cell
ID WARM ISCHEMIA-REPERFUSION; MARKER PROTEIN-30 SMP30; DRUG-METABOLISM;
   KUPFFER CELLS; INJURY; MATURATION
AB Aims/Method: Using high resolution multifluorescence in vivo microscopy, the present study was undertaken to determine the changes in rat hepatic tissue architecture and microvasculature during the growth associated with juvenile maturation and adult senescence, i.e. the age of 1, 3, 12 and 24 months. Results: By 1 month of age the liver attained its full size and functional capacity, as assessed by relative organ weight and hepatic bile flow. Survey of liver architecture revealed a progressive growth of lobular area with postsinusoidal venules exhibiting a proportional increase in length, diameter and inter-vascular distance up to the age of 12-24 months. In regard to the 3.5-4-fold average increase of lobular units, a minor reduction of sinusoidal density to 87% over life strongly implies the recruitment or formation of new sinusoidal microvessels as contributing mechanism to meet oxygen demand due to overall tissue enlargement. The sinusoidal perfusion rate remained above 98% over the whole lifespan. Leukocytic interaction with the hepatic microvascular endothelium was found within the physiological range in all age groups. Moreover, kinetics of clearance of latex beads as well as lobular distribution of Kupffer cells did not differ between animals of different age. Hepatic stellate cell-associated area of ultraviolet vitamin A-autofluorescence increased with age and significantly correlated with increasing tissue concentrations of vitamin A metabolites. Biochemical parameters serving as measures of tissue integrity did not indicate age-associated tissue alterations. Conclusion: These age-associated physiological changes should be carefully taken into account as a relevant variable in experimental research.
C1 Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
C3 Saarland University
RP Vollmar, B (corresponding author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
CR Baker H. J., 1979, The laboratory rat. Volume I. Biology and diseases., P411
   Blechman MB, 1999, CLIN GERIATR MED, V15, P429
   DRUGAS GT, 1993, J SURG RES, V54, P246, DOI 10.1006/jsre.1993.1039
   DURHAM SK, 1990, J PATHOL, V162, P341, DOI 10.1002/path.1711620412
   Friedman SL, 1999, SEMIN LIVER DIS, V19, P129, DOI 10.1055/s-2007-1007105
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   GEORGE G, 1990, AGE AGEING, V19, P364, DOI 10.1093/ageing/19.6.364
   GROSS J F, 1972, Biorheology, V9, P225
   HENDRIKS HFJ, 1987, MECH AGEING DEV, V41, P241, DOI 10.1016/0047-6374(87)90044-3
   Klinger W., 1996, EXP TOXICOL PATHOL, V48, P1
   RAPPAPORT AM, 1973, MICROVASC RES, V6, P212, DOI 10.1016/0026-2862(73)90021-6
   RIKANS LE, 1984, TOXICOL APPL PHARM, V73, P243, DOI 10.1016/0041-008X(84)90329-6
   Rikans LE, 1999, MECH AGEING DEV, V108, P173, DOI 10.1016/S0047-6374(99)00012-3
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Schoeffner DJ, 1999, J TOXICOL ENV HEAL A, V56, P449, DOI 10.1080/009841099157917
   UNTHANK JL, 1987, CIRC RES, V61, P616, DOI 10.1161/01.RES.61.5.616
   VOLLMAR B, 1994, AM J PHYSIOL-GASTR L, V267, pG786, DOI 10.1152/ajpgi.1994.267.5.G786
   VOLLMAR B, 1994, J HEPATOL, V20, P301, DOI 10.1016/S0168-8278(05)80073-X
   Vollmar B, 1998, HEPATOLOGY, V27, P1544, DOI 10.1002/hep.510270612
   Vollmar B, 1996, SHOCK, V6, P434, DOI 10.1097/00024382-199612000-00008
   VOLLMAR B, 1994, AM J PATHOL, V145, P1421
   Vollmar B, 2000, AM J PHYSIOL-HEART C, V279, pH1591, DOI 10.1152/ajpheart.2000.279.4.H1591
   WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328
   WOODHOUSE KW, 1990, BRIT MED BULL, V46, P22, DOI 10.1093/oxfordjournals.bmb.a072387
   WOODHOUSE KW, 1996, REV CLIN GERONTOL, V6, P215
   WYNNE HA, 1990, BRIT J CLIN PHARMACO, V30, P634, DOI 10.1111/j.1365-2125.1990.tb03826.x
   Yamano T, 1998, TOXICOL APPL PHARM, V151, P9, DOI 10.1006/taap.1998.8401
   Zeintl H, 1986, PROG APPL MICROCIRC, V11, P1
NR 29
TC 35
Z9 38
U1 0
U2 0
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0106-9543
J9 LIVER
JI Liver
PD AUG
PY 2002
VL 22
IS 4
BP 330
EP 341
DI 10.1034/j.1600-0676.2001.01631.x
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 595XP
UT WOS:000178134100007
PM 12296967
DA 2024-02-19
ER

PT J
AU Inoue, H
   Arakawa, K
   Tanaka, M
   Katsumata-Tsuboi, R
   Takahashi, N
   Uehara, M
AF Inoue, Hirofumi
   Arakawa, Kohta
   Tanaka, Miori
   Katsumata-Tsuboi, Rie
   Takahashi, Nobuyuki
   Uehara, Mariko
TI Upregulation and stabilization of senescence marker protein-30 by
   epigallocatechin gallate against <i>tert</i>-butyl hydroperoxide-induced
   liver injury <i>in vitro</i> and <i>in vivo</i>
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE senescence marker protein-30; epigallocatechin gallate; tert-BHP-induced
   liver injury
ID GREEN TEA POLYPHENOLS; OXIDATIVE STRESS; DOWN-REGULATION; KNOCKOUT MICE;
   LIFE-SPAN; SMP30; EGCG; EXPRESSION; CELLS; AGE
AB Senescence marker protein-30 (SMP30), a novel ageing marker, suppresses oxidative stress in the liver. However, studies on phytochemical-mediated regulation of SMP30 expression are lacking. Here, we showed that epigallocatechin gallate (EGCg), a polyphenol abundant in green tea, positively regulates SMP30 expression in the rat hepatoma-derived Fao cells. EGCg maintained SMP30 expression even in the presence of cycloheximide, a protein synthesis inhibitor. Furthermore, treatment of cells with tert-butyl hydroperoxide (tert-BHP), an oxidative promoter, decreased SMP30 expression and ERK1/2 phosphorylation, while EGCg treatment inhibited these effects. Male mice (7-week-old) were divided into 4 groups-Control (saline), tert-BHP (1.5 mmol/kg tert-BHP), EGCg + tert-BHP (30 mg/kg/day of EGCg and 1.5 mmol/kg tert-BHP), and EGCg (30 mg/kg/day). After oral EGCg administration for 6 consecutive days, EGCg + tert-BHP group mice were administered tert-BHP. The tert-BHP-administered mice showed decreased SMP30 expression in the liver and increased aspartate aminotransferase and alanine transaminase (hepatic injury marker enzymes) activities; however, EGCg treatment attenuated these changes. Thus, EGCginduced SMP30 upregulation may alleviate tert-BHP-induced liver injury. The findings of this study offer new perspectives of the anti-ageing properties of EGCg.
C1 [Inoue, Hirofumi; Arakawa, Kohta; Tanaka, Miori; Katsumata-Tsuboi, Rie; Takahashi, Nobuyuki; Uehara, Mariko] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan.
C3 Tokyo University of Agriculture
RP Uehara, M (corresponding author), Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci & Food Safety, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan.
EM mari@nodai.ac.jp
RI Takahashi, Nobuyuki/AAX-8671-2021
OI Takahashi, Nobuyuki/0000-0002-9705-662X; Tanaka,
   Miori/0000-0002-2690-3780
FU JSPS KAKENHI [15H01767]; Grants-in-Aid for Scientific Research
   [15H01767] Funding Source: KAKEN
FX This study was supported in part by JSPS KAKENHI (Grant No. 15H01767).
   The authors thank T. Takagi and S. Fujii (Tokyo University of
   Agriculture) for technical assistance.
CR Abd-ElSalam HAH, 2016, J FOOD SCI, V81, pC1707, DOI 10.1111/1750-3841.13362
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Chen K, 2014, HISTOCHEM CELL BIOL, V142, P285, DOI 10.1007/s00418-014-1194-1
   Choo J, 2018, BBA-MOL BASIS DIS, V1864, P3668, DOI 10.1016/j.bbadis.2018.09.031
   Chung LY, 2001, LIFE SCI, V68, P1207, DOI 10.1016/S0024-3205(00)01020-1
   Du LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135499
   Feng DY, 2004, ANN NY ACAD SCI, V1019, P360, DOI 10.1196/annals.1297.062
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Garcia-Cohen EC, 2000, J PHARMACOL EXP THER, V293, P75
   Han XD, 2017, ONCOTARGET, V8, P65302, DOI 10.18632/oncotarget.18582
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y
   Hosokawa Y, 2010, MOL NUTR FOOD RES, V54, pS151, DOI 10.1002/mnfr.200900549
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Inoue H, 2013, BIOSCI BIOTECH BIOCH, V77, P1223, DOI 10.1271/bbb.121003
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Jung KJ, 2006, ANTIOXID REDOX SIGN, V8, P671, DOI 10.1089/ars.2006.8.671
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2014, FEBS OPEN BIO, V4, P522, DOI 10.1016/j.fob.2014.05.003
   Kuhn DJ, 2004, BBA-MOL CELL BIOL L, V1682, P1, DOI 10.1016/j.bbalip.2003.12.006
   Kwon SM, 2019, BMB REP, V52, P5, DOI 10.5483/BMBRep.2019.52.1.291
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039
   Li YB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/851714
   Li YB, 2011, INT J MOL MED, V27, P205, DOI 10.3892/ijmm.2010.578
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   Nakagawa T, 2004, J AGR FOOD CHEM, V52, P2103, DOI 10.1021/jf030258j
   Nanjo F, 1996, FREE RADICAL BIO MED, V21, P895, DOI 10.1016/0891-5849(96)00237-7
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Pérez-Cano FJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100659
   Quan YY, 2019, INT J BIOCHEM CELL B, V116, DOI 10.1016/j.biocel.2019.105612
   Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107
   Sato Y, 2014, GERIATR GERONTOL INT, V14, P989, DOI 10.1111/ggi.12162
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shinto S, 2018, J CLIN BIOCHEM NUTR, V62, P132, DOI 10.3164/jcbn.17-60
   Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771
   Ushiroda C, 2019, J CLIN BIOCHEM NUTR, V65, P34, DOI 10.3164/jcbn.18-116
NR 40
TC 2
Z9 3
U1 1
U2 10
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD JAN
PY 2021
VL 68
IS 1
BP 51
EP 57
DI 10.3164/jcbn.20-119
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA UE4TU
UT WOS:000687883500011
PM 33536712
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Shibany, KA
   Tötemeyer, S
   Pratt, SL
   Paine, SW
AF Shibany, Khaled A.
   Totemeyer, Sabine
   Pratt, Stefanie L.
   Paine, Stuart W.
TI The effects of aging on hepatic microsomal scaling factor and
   hepatocellularity number in the horse
SO XENOBIOTICA
LA English
DT Article
DE Aging; hepatocellularity; horse; liver; microsomal; scaling factors
ID AGE-RELATED-CHANGES; DRUG-METABOLIZING-ENZYMES; LIVER BLOOD-FLOW;
   IN-VITRO DATA; RAT; PROTEIN; HEPATOCYTES; CLEARANCE; GRAM;
   CYTOCHROME-P450
AB 1.Scaling factor values for the in vitro-in vivo extrapolation of hepatic metabolic clearance for xenobiotics have not yet been determined in horses. Scaling factors were determined by comparing the total protein and or cytochrome (CYP) P450 content in microsomes and cryopreserved hepatocytes against the content in the liver. 2.Microsomal protein per gram of liver (MPPGL) and hepatocellularity number per gram of liver (HPGL) using CYP P450 content method ranged 41-73 mg/gram of liver (mean= 57 mg/gram of liver, n = 39) and 146-320 x 10(6) cells/g of liver (mean = 227x 10(6) cells/g of liver, n = 18), respectively and 156-352 x 10(6) cells/g of liver (mean = 232x 10(6) cells/g of liver) using total protein method. 3.A non-monotonic and inverse relationship between age and MPPGL and HPGL, respectively, was observed. Between one and 20 y of age, the liver cell size decreases as age increases. Subsequently, the cell size increases until the hepatocytes of the oldest horses approached the size found in the youngest horses. Hepatocyte density was inversely related to the size of the hepatocytes. 4.This study provides the first extensive and comprehensive data demonstrating the relationship between the size of hepatocytes and HPGL in any species.
C1 [Shibany, Khaled A.; Totemeyer, Sabine; Pratt, Stefanie L.; Paine, Stuart W.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.
   [Shibany, Khaled A.] Univ Tripoli, Dept Internal Med, Fac Vet Med, Tripoli, Libya.
C3 University of Nottingham; University of Tripoli
RP Paine, SW (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Nottingham LE12 5RD, England.; Paine, SW (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Nottingham LE12 5RD, England.
EM stuart.paine@nottingham.ac.uk
RI Paine, Stuart/G-5848-2011; Pratt, Stefanie/AAP-2700-2020; Totemeyer,
   Sabine/H-1188-2011
OI Totemeyer, Sabine/0000-0001-9781-2475
CR Bakala A, 2003, TOXICOL IN VITRO, V17, P615, DOI 10.1016/S0887-2333(03)00112-7
   Barter ZE, 2008, DRUG METAB DISPOS, V36, P2405, DOI 10.1124/dmd.108.021311
   Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053
   BASU TK, 1971, BIOCHEM J, V124, P19, DOI 10.1042/bj1240019
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   Boyer TD, 2018, ZAKIM BOYERS HEPATOL
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carlile DJ, 1997, DRUG METAB DISPOS, V25, P903
   DELAIGLESIA FA, 1976, AM J PATHOL, V82, P61
   ENGELMANN GL, 1981, MECH AGEING DEV, V16, P385, DOI 10.1016/0047-6374(81)90023-3
   Hakooz N, 2006, PHARM RES-DORDR, V23, P533, DOI 10.1007/s11095-006-9531-2
   HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
   Iwatsubo T, 1997, PHARMACOL THERAPEUT, V73, P147, DOI 10.1016/S0163-7258(96)00184-2
   Lave T, 1996, PHARMACEUT RES, V13, P97, DOI 10.1023/A:1016037519116
   Mahmood I, 2007, ADV DRUG DELIVER REV, V59, P1177, DOI 10.1016/j.addr.2007.05.015
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Nebbia C, 2004, LIFE SCI, V74, P1605, DOI 10.1016/j.lfs.2003.08.028
   Pearce RE, 1996, ARCH BIOCHEM BIOPHYS, V331, P145, DOI 10.1006/abbi.1996.0294
   Riley RJ, 2005, DRUG METAB DISPOS, V33, P1304, DOI 10.1124/dmd.105.004259
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1987, DRUG METAB DISPOS, V15, P225
   SCHMUCKER DL, 1977, SCIENCE, V197, P1005, DOI 10.1126/science.887935
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   Schmucker DL, 1981, AGING DEV, V4, P81
   Schmucker DL, 1980, EXP GERONTOL, P249
   Shibany KA, 2016, PHARMACOL RES PERSPE, V4, P1
   Smith R, 2008, XENOBIOTICA, V38, P1386, DOI 10.1080/00498250802491662
   Sohlenius-Sternbeck AK, 2006, TOXICOL IN VITRO, V20, P1582, DOI 10.1016/j.tiv.2006.06.003
   Stegemann JP, 2000, TISSUE ENG, V6, P253, DOI 10.1089/10763270050044434
   TAUCHI H, 1962, J GERONTOL, V17, P254, DOI 10.1093/geronj/17.3.254
   TAUCHI H, 1961, Nagoya J Med Sci, V24, P97
   TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   Wakabayashi H, 2002, J SURG RES, V106, P246, DOI 10.1006/jsre.2002.6462
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   Wilson ZE, 2003, BRIT J CLIN PHARMACO, V56, P433, DOI 10.1046/j.1365-2125.2003.01881.x
   Worboys PD, 1996, DRUG METAB DISPOS, V24, P676
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
   Zhang H, 2015, SCI REP, V5, P1, DOI DOI 10.9734/JSRR/2015/14076
NR 42
TC 2
Z9 2
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0049-8254
EI 1366-5928
J9 XENOBIOTICA
JI Xenobiotica
PD DEC 2
PY 2018
VL 48
IS 12
BP 1237
EP 1244
DI 10.1080/00498254.2017.1413263
PG 8
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA HB5VQ
UT WOS:000451131600006
PM 29198170
OA Green Submitted, Green Accepted
DA 2024-02-19
ER

PT J
AU Mikula, M
   Fuchs, E
   Huber, H
   Beug, H
   Schulte-Hermann, R
   Mikulits, W
AF Mikula, M
   Fuchs, E
   Huber, H
   Beug, H
   Schulte-Hermann, R
   Mikulits, W
TI Immortalized p19<SUP>ARF null</SUP> hepatocytes restore liver injury and
   generate hepatic progenitors after transplantation
SO HEPATOLOGY
LA English
DT Article
ID STEM-CELLS; BONE-MARROW; DIFFERENTIATION; REPOPULATION; PLASTICITY;
   APOPTOSIS; RAS
AB Primary hepatocytes are blocked in mitotic activity and well-defined culture conditions only allow the limited expansion of these cells. Various genetic modifications have therefore been employed to establish immortalized hepatic cell lines, but, unfortunately, proper hepatocyte cultures conducting a faithful hepatic gene expression program and lacking malignancy are hardly available. Here we report the immortalization of primary hepatocytes isolated from p19(ARF) null mice using the rationale that loss of p19(ARF) lowers growth-suppressive functions of p53 and bypasses cellular senescence without losing genetic stability. The established hepatocytes, called MIM, express liver-specific markers, show a nontumorigenic phenotype, and competence to undergo Fas-mediated apoptosis. Intrasplenic transplantation of GFP-expressing parental MIM cells into Fas-injured livers of SCID mice revealed liver-reconstituting activity. In the regenerated liver, MIM cells localized in small-sized clusters and showed presence in structures comparable to canals of Hering, the site of oval cells. Transplantation of MIM-Bcl-X-L cells, which are protected against apoptosis, and successive Fas-induced liver damage, enhanced donor-derived liver repopulation by showing differentiation into cholangiocytes and cells expressing markers characteristic of both fetal hepatocytes and oval cells. In conclusion, these data indicate that long-term cultivated p19(ARF) null hepatocytes are capable of generating hepatic progenitor cells during liver restoration, and thus represent a highly valuable tool to study the differentiation repertoire of hepatocytes.
C1 Univ Vienna, Inst Canc Res, A-1090 Vienna, Austria.
   Res Inst Mol Pathol, A-1030 Vienna, Austria.
C3 University of Vienna; Vienna Biocenter (VBC); Research Institute of
   Molecular Pathology (IMP)
RP Mikulits, W (corresponding author), Univ Vienna, Inst Canc Res, Borschke Gasse 8A, A-1090 Vienna, Austria.
EM wolfgang.mikulits@univie.ac.at
RI Mikulits, Wolfgang/AAH-4043-2021
OI Mikulits, Wolfgang/0000-0003-4612-7106; Mikula,
   Mario/0000-0001-5782-0681
CR Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Forbes S, 2002, J PATHOL, V197, P510, DOI 10.1002/path.1163
   Gotzmann J, 2002, J CELL SCI, V115, P1189
   Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037
   Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3
   Kanzler S, 2000, SEMIN CANCER BIOL, V10, P173, DOI 10.1006/scbi.2000.0318
   Kieslinger M, 2000, GENE DEV, V14, P232
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8
   Michalopoulos GK, 2003, GENE EXPRESSION, V11, P55, DOI 10.3727/000000003108748964
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mignon A, 1998, NAT MED, V4, P1185, DOI 10.1038/2681
   Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952
   Mitchell C, 2002, AM J PATHOL, V160, P31, DOI 10.1016/S0002-9440(10)64345-3
   Nagy P, 1998, HEPATOLOGY, V28, P423, DOI 10.1002/hep.510280220
   Notenboom RGE, 2003, HEPATOLOGY, V38, P683, DOI 10.1053/jhep.2003.50365
   OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0
   Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168
   Schausberger E, 2003, CARCINOGENESIS, V24, P835, DOI 10.1093/carcin/bgg027
   Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900
   Shafritz DA, 2002, J HEPATOL, V36, P552, DOI 10.1016/S0168-8278(02)00013-2
   Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061
   Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123
   Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038
   Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539
   Vessey CJ, 2001, PATHOLOGY, V33, P130
   Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531
NR 27
TC 32
Z9 38
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD MAR
PY 2004
VL 39
IS 3
BP 628
EP 634
DI 10.1002/hep.20084
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 806IP
UT WOS:000220427900009
PM 14999681
OA Bronze
DA 2024-02-19
ER

PT J
AU Gómez-Santos, B
   de Urturi, DS
   Nuñez-García, M
   Gonzalez-Romero, F
   Buque, X
   Aurrekoetxea, I
   de Juan, VG
   Gonzalez-Rellan, MJ
   García-Monzón, C
   González-Rodríguez, A
   Mosteiro, L
   Errazti, G
   Mifsut, P
   Gaztambide, S
   Castaño, L
   Martin, C
   Nogueiras, R
   Martinez-Chantar, ML
   Syn, WK
   Aspichueta, P
AF Gomez-Santos, Beatriz
   Saenz de Urturi, Diego
   Nunez-Garcia, Maitane
   Gonzalez-Romero, Francisco
   Buque, Xabier
   Aurrekoetxea, Igor
   Gutierrez de Juan, Virginia
   Gonzalez-Rellan, Maria J.
   Garcia-Monzon, Carmelo
   Gonzalez-Rodriguez, Agueda
   Mosteiro, Lorena
   Errazti, Gaizka
   Mifsut, Patricia
   Gaztambide, Sonia
   Castano, Luis
   Martin, Cesar
   Nogueiras, Ruben
   Martinez-Chantar, Maria L.
   Syn, Wing-Kin
   Aspichueta, Patricia
TI Liver osteopontin is required to prevent the progression of age-related
   nonalcoholic fatty liver disease
SO AGING CELL
LA English
DT Article; Early Access
DE aging; lipid metabolism; nonalcoholic fatty liver disease; Osteopontin;
   p53; senescence
ID CELLULAR SENESCENCE; HEPATIC STEATOSIS; ADIPOSE-TISSUE; ER STRESS;
   METABOLISM; EXPRESSION; LIPOTOXICITY; DEFICIENCY; CANCER; P53
AB Osteopontin (OPN), a senescence-associated secretory phenotype factor, is increased in patients with nonalcoholic fatty liver disease (NAFLD). Cellular senescence has been associated with age-dependent hepatosteatosis. Thus, we investigated the role of OPN in the age-related hepatosteatosis. For this, human serum samples, animal models of aging, and cell lines in which senescence was induced were used. Metabolic fluxes, lipid, and protein concentration were determined. Among individuals with a normal liver, we observed a positive correlation between serum OPN levels and increasing age. This correlation with age, however, was absent in patients with NAFLD. In wild-type (WT) mice, serum and liver OPN were increased at 10 months old (m) along with liver p53 levels and remained elevated at 20m. Markers of liver senescence increased in association with synthesis and concentration of triglycerides (TG) in 10m OPN-deficient (KO) hepatocytes when compared to WT hepatocytes. These changes in senescence and lipid metabolism in 10m OPN-KO mice liver were associated with the decrease of 78 kDa glucose-regulated protein (GRP78), induction of ER stress, and the increase in fatty acid synthase and CD36 levels. OPN deficiency in senescent cells also diminished GRP78, the accumulation of intracellular TG, and the increase in CD36 levels. In 20m mice, OPN loss led to increased liver fibrosis. Finally, we showed that OPN expression in vitro and in vivo was regulated by p53. In conclusion, OPN deficiency leads to earlier cellular senescence, ER stress, and TG accumulation during aging. The p53-OPN axis is required to inhibit the onset of age-related hepatosteatosis.
C1 [Gomez-Santos, Beatriz; Saenz de Urturi, Diego; Nunez-Garcia, Maitane; Gonzalez-Romero, Francisco; Buque, Xabier; Aurrekoetxea, Igor; Syn, Wing-Kin; Aspichueta, Patricia] Univ Basque Country, Fac Med & Nursing, Dept Physiol, UPV EHU, Barrio Sarriena S-N, Leioa 48940, Spain.
   [Buque, Xabier; Aurrekoetxea, Igor; Mosteiro, Lorena; Errazti, Gaizka; Mifsut, Patricia; Gaztambide, Sonia; Castano, Luis; Aspichueta, Patricia] Cruces Univ Hosp, Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain.
   [Gutierrez de Juan, Virginia; Martinez-Chantar, Maria L.] Basque Res & Technol Alliance BRTA, Ctr Cooperat Res Biosci CIC BioGUNE, Liver Dis Lab, Derio, Bizkaia, Spain.
   [Gonzalez-Rellan, Maria J.; Nogueiras, Ruben] Univ Santiago de Compostela, Dept Physiol, CIMUS, Inst Invest Sanitaria, Santiago De Compostela, Spain.
   [Gonzalez-Rellan, Maria J.; Nogueiras, Ruben] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain.
   [Garcia-Monzon, Carmelo; Gonzalez-Rodriguez, Agueda] Santa Cristina Univ Hosp, Inst Invest Sanitaria Princesa, Liver Res Unit, Madrid, Spain.
   [Garcia-Monzon, Carmelo; Gonzalez-Rodriguez, Agueda; Martinez-Chantar, Maria L.] Carlos III Natl Hlth Inst, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.
   [Martin, Cesar] Univ Basque Country, CSIC, Biofis Inst, Dept Biochem & Mol Biol, Leioa, Spain.
   [Syn, Wing-Kin] Ralph H Johnson VAMC, Sect Gastroenterol, Charleston, SC USA.
   [Syn, Wing-Kin] Med Univ South Carolina, Div Gastroenterol & Hepatol, Charleston, SC 29425 USA.
C3 University of Basque Country; Hospital Universitario Cruces; CIC
   bioGUNE; Universidade de Santiago de Compostela; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEROBN; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de
   Investigaciones Cientificas (CSIC); University of Basque Country; CSIC -
   UPV EHU - Instituto Biofisika; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center;
   Medical University of South Carolina
RP Aspichueta, P (corresponding author), Univ Basque Country, Fac Med & Nursing, Dept Physiol, UPV EHU, Barrio Sarriena S-N, Leioa 48940, Spain.
EM patricia.aspichueta@ehu.eus
RI Nogueiras, Ruben/AAS-9427-2021; marttin, cesar/GWC-4638-2022; Gonzalez
   Rellan, Maria Jesus/GQR-0377-2022; Chantar, Maria Luz
   Martinez/F-5190-2011; Aspichueta, Patricia/M-3490-2018;
   González-Rodríguez, Águeda/O-6990-2018; martin, cesar/L-1303-2014
OI Nogueiras, Ruben/0000-0002-9976-9930; Gonzalez Rellan, Maria
   Jesus/0000-0001-8986-9244; Chantar, Maria Luz
   Martinez/0000-0002-6446-9911; Aspichueta, Patricia/0000-0002-3553-1755;
   González-Rodríguez, Águeda/0000-0003-2851-2318; Gonzalez-Romero,
   Francisco/0000-0002-7064-3592; Gomez-Santos,
   Beatriz/0000-0001-6607-7973; martin, cesar/0000-0002-4087-8729
FU Ministerio de Economia y Competitividad [SAF2017-87301-R];
   MCIU/AEI/FEDER, UE [RTI2018-095134-B-100, RTI2018-099413-B-I00];
   ISCIII-FEDER [PI17/0053, CP14/00181, PI16/00823]; Eusko Jaurlaritza
   [IT971-16]; Xunta de Galicia [2015-CP080, 2016-PG057]
FX Ministerio de Economia y Competitividad, Grant/Award Number:
   SAF2017-87301-R, MCIU/AEI/FEDER, UE RTI2018-095134-B-100,
   MCIU/AEI/FEDER, UE RTI2018-099413-B-I00, and ISCIII-FEDER PI17/0053,
   ISCIII-FEDER CP14/00181 and PI16/00823; Eusko Jaurlaritza IT971-16,
   Xunta de Galicia (2015-CP080 and 2016-PG057).
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860
   Basseri S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/841362
   Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Chong MY, 2018, EMBO REP, V19, DOI 10.15252/embr.201745274
   Coombes JD, 2015, GUT, V64, P1120, DOI 10.1136/gutjnl-2013-306484
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435
   Flanagan KC, 2018, ONCOTARGET, V9, P21, DOI 10.18632/oncotarget.22940
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Glass O, 2018, HEPATOL COMMUN, V2, P1344, DOI 10.1002/hep4.1237
   Gómez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349
   Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595
   Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007
   Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0
   Kim HS, 2019, FASEB J, V33, P2422, DOI 10.1096/fj.201800836R
   Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lancha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098398
   Lau LN, 2019, EXPERT OPIN THER TAR, V23, P1041, DOI 10.1080/14728222.2019.1565658
   Lazaro R, 2015, HEPATOLOGY, V61, P129, DOI 10.1002/hep.27383
   Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008
   Lee AS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40919
   Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387
   Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Magdaleno F, 2018, HEPATOL COMMUN, V2, P84, DOI 10.1002/hep4.1116
   Malaquin N, 2016, EXP GERONTOL, V82, P39, DOI 10.1016/j.exger.2016.05.010
   Morimoto I, 2002, GENE CHROMOSOME CANC, V33, P270, DOI 10.1002/gcc.10020
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Napoli M, 2017, BRIT J CANCER, V116, P149, DOI 10.1038/bjc.2016.384
   Nuñez-Garcia M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32919-9
   Nuñez-Garcia M, 2017, J LIPID RES, V58, P1903, DOI 10.1194/jlr.M078980
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pavlakis E, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020307
   Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970
   Porteiro B, 2018, MOL METAB, V8, P132, DOI 10.1016/j.molmet.2017.12.005
   Porteiro B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15111
   Rajendran P, 2019, J CELL PHYSIOL, V234, P21485, DOI 10.1002/jcp.28895
   Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 2011, CURR GERONTOL GERIAT, V2011, P1
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wen YK, 2016, INT J BIOL SCI, V12, P1121, DOI 10.7150/ijbs.16445
   Wiley CD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20000-4
   Zheng Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0226-x
   Zhong HH, 2017, ONCOTARGET, V8, P102640, DOI 10.18632/oncotarget.21123
NR 53
TC 14
Z9 16
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2020 AUG
PY 2020
VL 19
IS 8
AR e13183
DI 10.1111/acel.13183
EA JUL 2020
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NF6WG
UT WOS:000545856700001
PM 32638492
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fougère-Deschatrette, C
   Imaizumi-Scherrer, T
   Strick-Marchand, H
   Morosan, S
   Charneau, P
   Kremsdorf, D
   Faust, DM
   Weiss, MC
AF Fougere-Deschatrette, Catherine
   Imaizumi-Scherrer, Tereza
   Strick-Marchand, Helene
   Morosan, Serban
   Charneau, Pierre
   Kremsdorf, Dina
   Faust, Daniela M.
   Weiss, Mary C.
TI Plasticity of hepatic cell differentiation:: Bipotential adult mouse
   liver clonal cell lines competent to differentiate in vitro and in vivo
SO STEM CELLS
LA English
DT Article
DE primary hepatocyte cultures; hepatic stem cells; liver regeneration
   model; karyotype bile duct/oval cell markers; epithelial polarity;
   Matrigel; A6
ID EPIDERMAL GROWTH-FACTOR; RAT HEPATOCYTES; EXTRACELLULAR-MATRIX; PRIMARY
   CULTURES; STEM-CELLS; OVAL CELLS; LENTIVIRAL VECTORS; PROGENITOR CELLS;
   BILE-DUCTS; EXPRESSION
AB In fetal liver, bipotential hepatoblasts differentiate into hepatocytes and bile duct cells (cholangiocytes). The persistence of such progenitor cells in adult mouse liver is still debated. In damaged liver of adult murine animals, when hepatocyte proliferation is compromised, bipotential oval cells emerge, probably from bile ducts, proliferate, and differentiate to regenerate the liver. However, treatment to elicit oval cell proliferation is not necessary to obtain bipotential stem cells from adult mouse liver. Here, we have isolated bipotential clonal cell lines from healthy liver of 8-10-week-old C57BL/6 mice. Primary cultures established from hepatocyte-enriched suspensions were characterized by time-lapse image acquisition, immunocytology, and RNA transcript analysis. Although hepatocytes dedifferentiated with loss of apical polarity and other hepatocyte markers, they rapidly activated expression of bile duct/oval cell markers. Reversibility of these processes was achieved in part by culture under dilute Matrigel or by aging of confluent cultures. Cell lines were obtained at high frequency from mass cultures, from isolated colonies, and by primary cloning of the hepatocyte-enriched suspension. Cells of the clonal cell lines do not grow in soft agar and are nontumorigenic, and they express cytokeratin 19, A6 antigen, and alpha 6 integrin, as well as a large panel of hepatocyte functions. Furthermore, they can participate in liver regeneration in albumin-urokinase-type plasminogen activator/severe combined immune-deficient mice, where they differentiate in clusters of hepatocytes and occasionally bile ducts. These results demonstrate the existence, in normal adult mouse liver, of a significant pool of clonogenic cells that are (or can become) bipotential.
C1 Inst Pasteur, CNRS, Unite Genet Differenciat, Unite Rech Associee 2578, F-75724 Paris, France.
   Inst Pasteur, Lab Virol Mol & Vectorol, F-75724 Paris, France.
   CHU Necker, INSERM, Unite 370, F-75015 Paris, France.
C3 Le Reseau International des Instituts Pasteur (RIIP); Universite Paris
   Cite; Institut Pasteur Paris; Centre National de la Recherche
   Scientifique (CNRS); Le Reseau International des Instituts Pasteur
   (RIIP); Universite Paris Cite; Institut Pasteur Paris; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Necker-Enfants Malades - APHP; Institut National de la
   Sante et de la Recherche Medicale (Inserm)
RP Weiss, MC (corresponding author), Inst Pasteur, CNRS, Unite Genet Differenciat, Unite Rech Associee 2578, 25 Rue Dr Roux, F-75724 Paris, France.
EM mweiss@pasteur.fr
RI CHARNEAU, Pierre/M-1565-2017; Strick-Marchand, Helene/M-6525-2014;
   Morosan, Serban/HZM-3757-2023; Kremsdorf, Dina/O-9797-2017
OI CHARNEAU, Pierre/0000-0003-1184-5773; Strick-Marchand,
   Helene/0000-0002-0519-214X
CR Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751
   Azuma H, 2003, HEPATOLOGY, V37, P1385, DOI 10.1053/jhep.2003.50210
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293
   Blaheta RA, 1998, J HEPATOL, V28, P677, DOI 10.1016/S0168-8278(98)80293-6
   Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133
   Brooling JT, 2005, HEPATOLOGY, V41, P906, DOI 10.1002/hep.20645
   Buzzard JJ, 2004, NAT BIOTECHNOL, V22, P381, DOI 10.1038/nbt0404-381
   Christoffersen T., 2000, HEPATOCYTE REV, P209
   Coleman WB, 1997, AM J PATHOL, V151, P353
   DAVIES C S, 1989, Acta Leidensia, V58, P97
   Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922
   Edwards A, 2000, HEPATOCYTE REV, P73
   ENGELHARDT NV, 1990, DIFFERENTIATION, V45, P29, DOI 10.1111/j.1432-0436.1990.tb00453.x
   EZZELL RM, 1993, EXP CELL RES, V208, P442, DOI 10.1006/excr.1993.1266
   FERACCI H, 1987, DEV BIOL, V123, P73, DOI 10.1016/0012-1606(87)90429-5
   GRISHAM JW, 1974, GENE EXPRESSION CARC, P1
   Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200
   Hamilton GA, 2001, CELL TISSUE RES, V306, P85
   IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761
   INOUE C, 1989, J BIOL CHEM, V264, P4747
   Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001
   JUNGERMANN K, 1982, HEPATOLOGY, V2, P385
   Klocke R, 2002, BIOCHEM BIOPH RES CO, V294, P864, DOI 10.1016/S0006-291X(02)00579-X
   Kofman AV, 2005, HEPATOLOGY, V41, P1252, DOI 10.1002/hep.20696
   Kojima T, 2001, EXP CELL RES, V263, P193, DOI 10.1006/excr.2000.5103
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   Li A.P., 2000, The Hepatocyte Review, P391
   Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600
   Michalopoulos GK, 2002, HEPATOLOGY, V36, P278, DOI 10.1053/jhep.2002.34858
   Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084
   MITAKA T, 1991, HEPATOLOGY, V13, P21, DOI 10.1016/0270-9139(91)90211-D
   MOSHAGE H, 1992, J HEPATOL, V15, P404, DOI 10.1016/0168-8278(92)90078-4
   MUSAT AI, 1993, HEPATOLOGY, V18, P198, DOI 10.1016/0270-9139(93)90525-R
   NADAL C, 1966, EXP CELL RES, V42, P99, DOI 10.1016/0014-4827(66)90324-7
   Nishikawa Y, 2005, AM J PATHOL, V166, P1077, DOI 10.1016/S0002-9440(10)62328-0
   Oertel M, 2003, HEPATOLOGY, V37, P994, DOI 10.1053/jhep.2003.50183
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Paku S, 2004, HEPATOLOGY, V39, P1353, DOI 10.1002/hep.20178
   Petersen BE, 1998, HEPATOLOGY, V27, P1030, DOI 10.1002/hep.510270419
   Sacco MG, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-5
   SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6
   Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shafritz DA, 2002, J HEPATOL, V36, P552, DOI 10.1016/S0168-8278(02)00013-2
   Shiojiri N, 2004, HEPATOLOGY, V40, P346, DOI 10.1002/hep.20303
   Sidhu JS, 2004, EXP CELL RES, V292, P252, DOI 10.1016/j.yexcr.2003.09.001
   Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282
   SMITH MD, 2000, HEPATOCYTE REV, P521
   Spagnoli FM, 1998, J CELL BIOL, V143, P1101, DOI 10.1083/jcb.143.4.1101
   Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101
   Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123
   Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349
   Talamini MA, 1997, HEPATOLOGY, V25, P167, DOI 10.1053/jhep.1997.v25.pm0008985285
   Tateno C, 1996, AM J PATHOL, V148, P383
   Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4
   TOURNIERTHURNEYSSEN I, 1992, BIOL CELL, V75, P61, DOI 10.1016/0248-4900(92)90125-K
   TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9
   VANEYKEN P, 1989, HISTOPATHOLOGY, V15, P125
   VANEYKEN P, 1987, VIRCHOWS ARCH A, V412, P63
   Vassilopoulos G, 2003, CURR OPIN GENET DEV, V13, P480, DOI 10.1016/S0959-437X(03)00110-2
   Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531
   WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674
   Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257
   Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4
   Zito MA, 2001, BRAIN RES, V892, P13, DOI 10.1016/S0006-8993(00)03135-8
NR 67
TC 64
Z9 76
U1 0
U2 4
PU ALPHAMED PRESS
PI DURHAM
PA 318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA
SN 1066-5099
J9 STEM CELLS
JI Stem Cells
PD SEP
PY 2006
VL 24
IS 9
BP 2098
EP 2109
DI 10.1634/stemcells.2006-0009
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 085YG
UT WOS:000240639700012
PM 16946000
OA Bronze
DA 2024-02-19
ER

PT J
AU Rutten, MGS
   Lei, Y
   Hoogerland, JH
   Bloks, VW
   Yang, H
   Bos, T
   Krishnamurthy, KA
   Bleeker, A
   Koster, MH
   Thomas, RE
   Wolters, JC
   van den Bos, H
   Mithieux, G
   Rajas, F
   Mardinoglu, A
   Spierings, DCJ
   de Bruin, A
   van de Sluis, B
   Oosterveer, MH
AF Rutten, Martijn G. S.
   Lei, Yu
   Hoogerland, Joanne H. H.
   Bloks, Vincent W. W.
   Yang, Hong
   Bos, Trijnie
   Krishnamurthy, Kishore A. A.
   Bleeker, Aycha
   Koster, Mirjam H. H.
   Thomas, Rachel E. E.
   Wolters, Justina C. C.
   van den Bos, Hilda
   Mithieux, Gilles
   Rajas, Fabienne
   Mardinoglu, Adil
   Spierings, Diana C. J.
   de Bruin, Alain
   van de Sluis, Bart
   Oosterveer, Maaike H. H.
TI Normalization of hepatic ChREBP activity does not protect against liver
   disease progression in a mouse model for Glycogen Storage Disease type
   Ia
SO CANCER & METABOLISM
LA English
DT Article
DE Glycogen Storage Disease type 1a; Carbohydrate Response Element Binding
   Protein; Hepatomegaly; Yes Associated Protein; Cyclic GMP-AMP
   synthase-stimulator of interferon genes (cGAS-STING)
ID NUCLEAR FACTOR 4-ALPHA; CHROMOSOME INSTABILITY; HIPPO PATHWAY;
   SIZE-CONTROL; ORGAN SIZE; EXPRESSION; PROLIFERATION; REGENERATION;
   SUPPRESSES; ACTIVATION
AB BackgroundGlycogen storage disease type 1a (GSD Ia) is an inborn error of metabolism caused by a defect in glucose-6-phosphatase (G6PC1) activity, which induces severe hepatomegaly and increases the risk for liver cancer. Hepatic GSD Ia is characterized by constitutive activation of Carbohydrate Response Element Binding Protein (ChREBP), a glucose-sensitive transcription factor. Previously, we showed that ChREBP activation limits non-alcoholic fatty liver disease (NAFLD) in hepatic GSD Ia. As ChREBP has been proposed as a pro-oncogenic molecular switch that supports tumour progression, we hypothesized that ChREBP normalization protects against liver disease progression in hepatic GSD Ia.MethodsHepatocyte-specific G6pc knockout (L-G6pc(-/-)) mice were treated with AAV-shChREBP to normalize hepatic ChREBP activity.ResultsHepatic ChREBP normalization in GSD Ia mice induced dysplastic liver growth, massively increased hepatocyte size, and was associated with increased hepatic inflammation. Furthermore, nuclear levels of the oncoprotein Yes Associated Protein (YAP) were increased and its transcriptional targets were induced in ChREBP-normalized GSD Ia mice. Hepatic ChREBP normalization furthermore induced DNA damage and mitotic activity in GSD Ia mice, while gene signatures of chromosomal instability, the cytosolic DNA-sensing cGAS-STING pathway, senescence, and hepatocyte dedifferentiation emerged.ConclusionsIn conclusion, our findings indicate that ChREBP activity limits hepatomegaly while decelerating liver disease progression and protecting against chromosomal instability in hepatic GSD Ia. These results disqualify ChREBP as a therapeutic target for treatment of liver disease in GSD Ia. In addition, they underline the importance of establishing the context-specific roles of hepatic ChREBP to define its therapeutic potential to prevent or treat advanced liver disease.
C1 [Rutten, Martijn G. S.; Lei, Yu; Hoogerland, Joanne H. H.; Bloks, Vincent W. W.; Krishnamurthy, Kishore A. A.; Bleeker, Aycha; Koster, Mirjam H. H.; Wolters, Justina C. C.; de Bruin, Alain; van de Sluis, Bart; Oosterveer, Maaike H. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.
   [Yang, Hong; Mardinoglu, Adil] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.
   [Bos, Trijnie; Oosterveer, Maaike H. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands.
   [Thomas, Rachel E. E.; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Biomol Hlth Sci, Utrecht, Netherlands.
   [van den Bos, Hilda; Spierings, Diana C. J.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing ERIBA, Groningen, Netherlands.
   [Mithieux, Gilles; Rajas, Fabienne] INSERM, U1213 Lyon, Lyon, France.
   [Mithieux, Gilles; Rajas, Fabienne] Univ Lyon, Lyon, France.
   [Mithieux, Gilles; Rajas, Fabienne] Univ Lyon 1, Villeurbanne, France.
C3 University of Groningen; Royal Institute of Technology; University of
   Groningen; Utrecht University; University of Groningen; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Claude Bernard Lyon 1
RP Oosterveer, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.; Oosterveer, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands.
EM m.h.oosterveer@umcg.nl
RI Rutten, Martijn/JFA-5931-2023; Hoogerland, Joanne/JJF-5315-2023; Lei,
   Yu/JVO-6682-2024
OI Rutten, Martijn/0000-0003-4640-1830; Hoogerland,
   Joanne/0000-0002-4334-2946; Lei, Yu/0000-0001-7246-8305; Alagere
   Krishnamurthy, Kishore/0000-0001-5441-1794; van de Sluis, Bart
   (A.J.A.)/0000-0003-3039-4365
CR Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004
   Abdul-Wahed A, 2014, MOL METAB, V3, P531, DOI 10.1016/j.molmet.2014.05.005
   Agius L, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.594041
   Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030
   Atanasovska B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081883
   Biagioni F, 2022, NUCLEIC ACIDS RES, V50, P7959, DOI 10.1093/nar/gkac624
   Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599
   Bricambert J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04361-y
   Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810
   Calderaro J, 2013, J HEPATOL, V58, P350, DOI 10.1016/j.jhep.2012.09.030
   Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006
   Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039
   Chou JY, 2015, J INHERIT METAB DIS, V38, P511, DOI 10.1007/s10545-014-9772-x
   Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019
   Dong X, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00403-5
   Dubois V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102185
   Esposti DD, 2016, ONCOTARGET, V7, P31862, DOI 10.18632/oncotarget.7364
   Evert M, 2012, HEPATOLOGY, V55, P1473, DOI 10.1002/hep.25600
   Gisselsson D, 2003, ADV CANCER RES, V87, P1
   Guo SD, 2019, J CELL BIOCHEM, V120, P519, DOI 10.1002/jcb.27407
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hoogerland JA, 2019, HEPATOLOGY, V70, P2171, DOI 10.1002/hep.30778
   Iizuka K, 2017, BBA-MOL BASIS DIS, V1863, P474, DOI 10.1016/j.bbadis.2016.11.029
   Kalkuhl A, 1996, CARCINOGENESIS, V17, P609, DOI 10.1093/carcin/17.3.609
   Kim GY, 2015, HUM MOL GENET, V24, P5115, DOI 10.1093/hmg/ddv230
   Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155
   Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107
   Lei Y, 2020, HEPATOLOGY, V72, P1638, DOI 10.1002/hep.31198
   Lei Y, 2020, PATHOL ONCOL RES, V26, P1331, DOI 10.1007/s12253-019-00708-y
   Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139
   Liu QX, 2021, CELL, V184, P5559, DOI 10.1016/j.cell.2021.10.001
   Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266
   Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988
   Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824
   Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002
   Pefani DE, 2016, FEBS J, V283, P1392, DOI 10.1111/febs.13604
   Pepe-Mooney BJ, 2019, CELL STEM CELL, V25, P23, DOI 10.1016/j.stem.2019.04.004
   Rajas F, 2021, MOL METAB, V43, DOI 10.1016/j.molmet.2020.101108
   Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI [10.1007/s00431-002-0999-4, 10.1007/BF02679990]
   Ribback S, 2018, CELL CYCLE, V17, P1496, DOI 10.1080/15384101.2018.1489182
   Sargsyan A, 2023, JCI INSIGHT, V8, DOI 10.1172/jci.insight.153740
   Shi JH, 2020, DIABETES, V69, P591, DOI 10.2337/db19-0388
   Shu ZP, 2020, BIOCHEM BIOPH RES CO, V530, P115, DOI 10.1016/j.bbrc.2020.06.105
   Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107
   Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928
   Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106
   van den Bos H, 2019, METHODS MOL BIOL, V1896, P159, DOI 10.1007/978-1-4939-8931-7_15
   Wang HB, 2018, J BIOL CHEM, V293, P14740, DOI 10.1074/jbc.RA118.004099
   Weiler SME, 2017, GASTROENTEROLOGY, V152, P2037, DOI 10.1053/j.gastro.2017.02.018
   Zhang SH, 2017, CANCER CELL, V31, P669, DOI 10.1016/j.ccell.2017.04.004
NR 50
TC 0
Z9 0
U1 3
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2049-3002
J9 CANCER METAB
JI Cancer Metab.
PD APR 21
PY 2023
VL 11
IS 1
AR 5
DI 10.1186/s40170-023-00305-3
PG 11
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA E3IA4
UT WOS:000974501500001
PM 37085901
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Zhang, ZL
   Yao, Z
   Zhao, SF
   Shao, JJ
   Chen, AP
   Zhang, F
   Zheng, SZ
AF Zhang, Zili
   Yao, Zhen
   Zhao, Shifeng
   Shao, Jiangjuan
   Chen, Anping
   Zhang, Feng
   Zheng, Shizhong
TI Interaction between autophagy and senescence is required for
   dihydroartemisinin to alleviate liver fibrosis
SO CELL DEATH & DISEASE
LA English
DT Article
ID HEPATIC STELLATE CELLS; EXTRACELLULAR-MATRIX; ACTIVATION; ROS;
   APOPTOSIS; MEDICINE; PI3K/AKT; CURCUMIN; STRESS; CANCER
AB Autophagy and cellular senescence are stress responses essential for homeostasis. Therefore, they may represent new pharmacologic targets for drug development to treat diseases. In this study, we sought to evaluate the effect of dihydroartemisinin (DHA) on senescence of activated hepatic stellate cells (HSCs), and to further elucidate the underlying mechanisms. We found that DHA treatment induced the accumulation of senescent activated HSCs in rat fibrotic liver, and promoted the expression of senescence markers p53, p16, p21 and Hmga1 in cell model. Importantly, our study identified the transcription factor GATA6 as an upstream molecule in the facilitation of DHA-induced HSC senescence. GATA6 accumulation promoted DHA-induced p53 and p16 upregulation,and contributed to HSC senescence. By contrast, siRNA-mediated knockdown of GATA6 dramatically abolished DHA-induced upregulation of p53 and p16, and in turn inhibited HSC senescence. Interestingly, DHA also appeared to increase autophago some generation and autophagic flux in activated HSCs, which was underlying mechanism for DHA-induced GATA6 accumulation. Autophagy depletion impaired GATA6 accumulation, while autophagy induction showed a synergistic effect with DHA. Attractively, p62 was found to act as a negative regulator of GATA6 accumulation. Treatment of cultured HSCs with various autophagy inhibitors, led to an inhibition of DHA-induced p62 degradation, and in turn, prevented DHA- induced GATA6 accumulation and HSC senescence. Overall, these results provide novel implications to reveal the molecular mechanism of DHA- induced senescence, by which points to the possibility of using DHA based proautophagic drugs for the treatment of liver fibrosis.
C1 [Zhang, Zili; Yao, Zhen; Zhao, Shifeng; Shao, Jiangjuan; Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.
   [Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Jiangsu, Peoples R China.
   [Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Therapeut Mat Chinese Med, Nanjing, Jiangsu, Peoples R China.
C3 Nanjing University of Chinese Medicine; Saint Louis University; Nanjing
   University of Chinese Medicine; Nanjing University of Chinese Medicine
RP Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Dept Pharmacol, Coll Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.
EM nytws@163.com
OI Zheng, Shizhong/0000-0002-7092-7843; zhang, zili/0000-0001-6506-648X
FU National Natural Science Foundation of China [81270514, 31571455,
   31401210, 31600653, 81600483]; Natural Science Foundation of Jiangsu
   Province [BK20140955]; Open Project Program of Jiangsu Key Laboratory
   for Pharmacology and Safety Evaluation of Chinese Materia Medica [JKLPSE
   201502]; Project of the Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD)
FX This work was supported by the National Natural Science Foundation of
   China (81270514, 31571455, 31401210, 31600653 and 81600483), the Natural
   Science Foundation of Jiangsu Province (BK20140955), the Open Project
   Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation
   of Chinese Materia Medica (JKLPSE 201502), and the Project of the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD). Finally, I sincerely thank my wife (Mei Guo) for
   her support and encouragement in a difficult period. I shall love you as
   long as I have breath.
CR Bartneck M, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/417023
   Block Dena Hs, 2015, Worm, V4, pe1118607, DOI 10.1080/21624054.2015.1118607
   Carloni V, 2014, LIVER INT, V34, P834, DOI 10.1111/liv.12465
   Cassidy LD, 2015, SCIENCE, V349, P1448, DOI 10.1126/science.aad2501
   Chen Q, 2016, INT IMMUNOPHARMACOL, V34, P250, DOI 10.1016/j.intimp.2016.03.011
   Chen Q, 2016, IUBMB LIFE, V68, P220, DOI 10.1002/iub.1478
   El Hasasna H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13013
   Fan T, 2016, EUR J PHARMACOL, V791, P157, DOI 10.1016/j.ejphar.2016.08.026
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Kagawa S, 2015, ONCOGENE, V34, P2347, DOI 10.1038/onc.2014.169
   Kang C, 2016, AUTOPHAGY, V12, P898, DOI 10.1080/15548627.2015.1121361
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384
   Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227
   Kim JE, 2008, INT J MOL MED, V22, P651, DOI 10.3892/ijmm_00000068
   Kim KM, 2012, INT J MOL MED, V29, P619, DOI 10.3892/ijmm.2012.892
   Kim KH, 2015, CHEM RES TOXICOL, V28, P71, DOI 10.1021/tx500341z
   Kitano M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030038
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lambrecht J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00209
   Lechuga CG, 2006, AM J PHYSIOL-GASTR L, V291, pG1051, DOI 10.1152/ajpgi.00058.2005
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Lentjes MHFM, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.2
   Levchenko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168518
   Liu H, 2014, AUTOPHAGY, V10, P372, DOI 10.4161/auto.27163
   Maiese K, 2016, BRIT J CLIN PHARMACO, V82, P1245, DOI 10.1111/bcp.12804
   Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Shao AW, 2016, CELL DEATH DIFFER, V23, P865, DOI 10.1038/cdd.2015.150
   Tai X, 2016, ONCOL LETT, V12, P3701, DOI 10.3892/ol.2016.5187
   Tang BL, 2014, FRONT CELL DEV BIOL, V1, P4
   Thompson AI, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0291-5
   Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051
   Vicente R, 2016, AGING CELL, V15, P400, DOI 10.1111/acel.12455
   Wu C, 2013, MOLECULES, V18, P6866, DOI 10.3390/molecules18066866
   Xu WX, 2017, TOXICOL APPL PHARM, V315, P23, DOI 10.1016/j.taap.2016.12.001
   Xu WX, 2016, IUBMB LIFE, V68, P376, DOI 10.1002/iub.1492
   Zhang F, 2014, MOL CELL ENDOCRINOL, V382, P197, DOI 10.1016/j.mce.2013.09.020
   Zhang HL, 2016, TRENDS MOL MED, V22, P671, DOI 10.1016/j.molmed.2016.06.001
   Zhang XG, 2014, PARASITOL RES, V113, P1769, DOI 10.1007/s00436-014-3822-z
   Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021
   Zhang ZL, 2016, FREE RADICAL BIO MED, V101, P272, DOI 10.1016/j.freeradbiomed.2016.10.498
   Zhang ZL, 2013, EUR J PHARMACOL, V721, P133, DOI 10.1016/j.ejphar.2013.09.042
NR 46
TC 79
Z9 82
U1 1
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUN
PY 2017
VL 8
AR e2886
DI 10.1038/cddis.2017.255
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA FB1HT
UT WOS:000405895200038
PM 28617435
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Liu, R
   Cui, JJ
   Sun, YT
   Xu, WT
   Wang, ZM
   Wu, MM
   Dong, HK
   Yang, CC
   Hong, SC
   Yin, S
   Wang, H
AF Liu, Rui
   Cui, Juanjuan
   Sun, Yating
   Xu, Wentao
   Wang, Ziming
   Wu, Miaomiao
   Dong, Huke
   Yang, Congcong
   Hong, Shaocheng
   Yin, Shi
   Wang, Hua
TI Autophagy deficiency promotes M1 macrophage polarization to exacerbate
   acute liver injury via ATG5 repression during aging
SO CELL DEATH DISCOVERY
LA English
DT Article
ID CELL-DEATH; FIBROSIS; REGENERATION; INHIBITION; ACTIVATION; PROTECTS;
   MICE
AB Aging disrupts the maintenance of liver homeostasis, which impairs hepatocyte regeneration and aggravates acute liver injury (ALI), ultimately leading to the development of acute liver failure (ALF), a systemic inflammatory response, and even death. Macrophages influence the progression and outcome of ALI through the innate immune system. However, it is still unclear how macrophages regulate ALI during aging. The variation in macrophage autophagy with aging and the influence on macrophage polarization and cytokine release were assessed in BMDMs in vitro. Then, after BMDMs subjected to several treatments were intravenously or intraperitoneally injected into mice, thioacetamide (TAA)-induced ALI (TAA-ALI) was established, and its effects on inflammation, injury, and mortality were assessed. We found that aging aggravated the liver injury, along with increases in the levels of proinflammatory mediators, presenting a senescence-associated secretory phenotype (SASP), which promoted macrophage polarization to the M1 phenotype. In addition, autophagy levels decreased significantly in aged mice, which was ascribed to ATG5 repression during aging. Notably, enhancing autophagy levels in aged BMDMs restored macrophage polarization to that observed under young conditions. Finally, autophagy restoration in aged BMDMs enhanced the protective effect against TAA-ALI, similar to M2 macrophages induced by IL-4. Overall, we demonstrated that the influence of aging on macrophage polarization is an important aggravating factor in TAA-ALI, and the autophagy in macrophages is associated with the aging phenotype.
C1 [Liu, Rui; Xu, Wentao; Wang, Ziming; Wang, Hua] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Peoples R China.
   [Liu, Rui; Wu, Miaomiao; Wang, Hua] Anhui Med Univ, Inflammat & Immune Mediated Dis Lab, Hefei 230022, Peoples R China.
   [Cui, Juanjuan] Anhui Med Univ, Affiliated Hosp 1, Dept Stomatol, Hefei 230022, Peoples R China.
   [Sun, Yating; Yang, Congcong] Anhui Med Univ, Dept Genet, Sch Life Sci, Hefei 230022, Peoples R China.
   [Xu, Wentao; Dong, Huke; Hong, Shaocheng] Anhui Med Univ, Clin Med Coll 1, Hefei 230036, Peoples R China.
   [Yin, Shi] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Dept Geriatr, Hefei 230001, Anhui, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Anhui Medical
   University; Anhui Medical University; Anhui Medical University; Chinese
   Academy of Sciences; University of Science & Technology of China, CAS
RP Wang, H (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Peoples R China.; Wang, H (corresponding author), Anhui Med Univ, Inflammat & Immune Mediated Dis Lab, Hefei 230022, Peoples R China.
EM wanghua@ahmu.edu.cn
RI Young, Smart/V-7656-2019; Yin, Shi/GPX-3723-2022
CR Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Bai YH, 2018, FREE RADICAL BIO MED, V124, P40, DOI 10.1016/j.freeradbiomed.2018.05.005
   Becker L, 2018, GUT, V67, P827, DOI 10.1136/gutjnl-2016-312940
   Begitt A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04522-z
   Bernsmeier C, 2020, J HEPATOL, V73, P186, DOI 10.1016/j.jhep.2020.03.027
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Chen PW, 2014, AUTOPHAGY, V10, P192, DOI 10.4161/auto.26927
   Chen S, 2016, CELL DEATH DIFFER, V23, P1026, DOI 10.1038/cdd.2016.3
   Chen YT, 2021, CELL METAB, V33, DOI 10.1016/j.cmet.2020.11.019
   Chung TW, 2019, CANCERS, V11, DOI 10.3390/cancers11070963
   Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022
   Escobar KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12876
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Han J, 2016, AUTOPHAGY, V12, P2326, DOI 10.1080/15548627.2016.1235124
   Herd HL, 2015, BIOMATERIALS, V53, P574, DOI 10.1016/j.biomaterials.2015.02.070
   Huleihel L, 2017, SEMIN IMMUNOL, V29, P2, DOI 10.1016/j.smim.2017.04.004
   Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019
   Iwata H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12849
   Jackaman C, 2017, AGEING RES REV, V36, P105, DOI 10.1016/j.arr.2017.03.008
   Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037
   Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999
   Kim SH, 2017, AUTOPHAGY, V13, P1767, DOI 10.1080/15548627.2017.1356977
   Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11
   Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415
   Liu K, 2015, AUTOPHAGY, V11, P271, DOI 10.1080/15548627.2015.1009787
   Locati M, 2020, ANNU REV PATHOL-MECH, V15, P123, DOI 10.1146/annurev-pathmechdis-012418-012718
   Lodder J, 2015, AUTOPHAGY, V11, P1280, DOI 10.1080/15548627.2015.1058473
   Lopez Bryan G, 2011, Comp Hepatol, V10, P2, DOI 10.1186/1476-5926-10-2
   Ma JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15636-8
   Maeso-Díaz R, 2019, AGING DIS, V10, P684, DOI 10.14336/AD.2019.0127
   Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988
   Ni HM, 2016, J HEPATOL, V65, P354, DOI 10.1016/j.jhep.2016.04.025
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Reidy PT, 2019, AM J PHYSIOL-ENDOC M, V317, pE85, DOI 10.1152/ajpendo.00422.2018
   Sergin I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15750
   Shirakabe A, 2016, CIRC RES, V118, P1563, DOI 10.1161/CIRCRESAHA.116.307474
   Shirato T, 2017, ARCH TOXICOL, V91, P1319, DOI 10.1007/s00204-016-1785-9
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Tujios SR, 2018, LIVER INT, V38, P6, DOI 10.1111/liv.13535
   Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022
NR 43
TC 18
Z9 19
U1 0
U2 13
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD DEC 20
PY 2021
VL 7
IS 1
AR 397
DI 10.1038/s41420-021-00797-2
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA XS5PZ
UT WOS:000732962000003
PM 34930917
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Montagner, A
   Polizzi, A
   Fouché, E
   Ducheix, S
   Lippi, Y
   Lasserre, F
   Barquissau, V
   Régnier, M
   Lukowicz, C
   Benhamed, F
   Iroz, A
   Bertrand-Michel, J
   Al Saati, T
   Cano, P
   Mselli-Lakhal, L
   Mithieux, G
   Rajas, F
   Lagarrigue, S
   Pineau, T
   Loiseau, N
   Postic, C
   Langin, D
   Wahli, W
   Guillou, H
AF Montagner, Alexandra
   Polizzi, Arnaud
   Fouche, Edwin
   Ducheix, Simon
   Lippi, Yannick
   Lasserre, Frederic
   Barquissau, Valentin
   Regnier, Marion
   Lukowicz, Celine
   Benhamed, Fadila
   Iroz, Alison
   Bertrand-Michel, Justine
   Al Saati, Talal
   Cano, Patricia
   Mselli-Lakhal, Laila
   Mithieux, Gilles
   Rajas, Fabienne
   Lagarrigue, Sandrine
   Pineau, Thierry
   Loiseau, Nicolas
   Postic, Catherine
   Langin, Dominique
   Wahli, Walter
   Guillou, Herve
TI Liver PPARα is crucial for whole-body fatty acid homeostasis and is
   protective against NAFLD
SO GUT
LA English
DT Article
ID ACTIVATED RECEPTOR-ALPHA; GROWTH-FACTOR 21; ADIPOSE-TISSUE; NONALCOHOLIC
   STEATOHEPATITIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ADAPTIVE
   RESPONSE; LIPID-METABOLISM; FGF21; EXPRESSION
AB Objective Peroxisome proliferator-activated receptor alpha (PPAR alpha) is a nuclear receptor expressed in tissues with high oxidative activity that plays a central role in metabolism. In this work, we investigated the effect of hepatocyte PPAR alpha on non-alcoholic fatty liver disease (NAFLD).
   Design We constructed a novel hepatocyte-specific PPAR alpha knockout (PPAR alpha(hep-/-)) mouse model. Using this novel model, we performed transcriptomic analysis following fenofibrate treatment. Next, we investigated which physiological challenges impact on PPAR alpha. Moreover, we measured the contribution of hepatocytic PPAR alpha activity to whole-body metabolism and fibroblast growth factor 21 production during fasting. Finally, we determined the influence of hepatocyte-specific PPAR alpha deficiency in different models of steatosis and during ageing.
   Results Hepatocyte PPAR alpha deletion impaired fatty acid catabolism, resulting in hepatic lipid accumulation during fasting and in two preclinical models of steatosis. Fasting mice showed acute PPAR alpha-dependent hepatocyte activity during early night, with correspondingly increased circulating free fatty acids, which could be further stimulated by adipocyte lipolysis. Fasting led to mild hypoglycaemia and hypothermia in PPAR alpha(hep-/-) mice when compared with PPAR alpha(-/-) mice implying a role of PPAR alpha activity in non-hepatic tissues. In agreement with this observation, PPAR alpha(-/-) mice became overweight during ageing while PPAR alpha(hep-/-) remained lean. However, like PPAR alpha(-/-) mice, PPAR alpha(hep-/-) fed a standard diet developed hepatic steatosis in ageing.
   Conclusions Altogether, these findings underscore the potential of hepatocyte PPAR alpha as a drug target for NAFLD.
C1 [Montagner, Alexandra; Polizzi, Arnaud; Fouche, Edwin; Ducheix, Simon; Lippi, Yannick; Lasserre, Frederic; Regnier, Marion; Lukowicz, Celine; Cano, Patricia; Mselli-Lakhal, Laila; Pineau, Thierry; Loiseau, Nicolas; Wahli, Walter; Guillou, Herve] Univ Toulouse, ToxAlim, INRA, UMR1331, Toulouse, France.
   [Barquissau, Valentin; Bertrand-Michel, Justine; Langin, Dominique] Inst Metab & Cardiovascular Dis, INSERM, UMR 1048, Toulouse, France.
   [Benhamed, Fadila; Iroz, Alison; Postic, Catherine] Cochin Inst, INSERM, U1016, Paris, France.
   [Benhamed, Fadila; Iroz, Alison; Postic, Catherine] CNRS, UMR 8104, Paris, France.
   [Benhamed, Fadila; Iroz, Alison] Univ Paris 05, Sorbonne Paris Cite, Paris, France.
   [Al Saati, Talal] CHU Purpan, Serv Histopathol, INSERM, UPS US006,CREFRE, Toulouse, France.
   [Mithieux, Gilles; Rajas, Fabienne] Univ Lyon, INSERM, U855, Lyon, France.
   [Lagarrigue, Sandrine] INRA, UMR1348, Saint Gilles, France.
   [Lagarrigue, Sandrine] Agrocampus Ouest, Pegase UMR1348, Rennes, France.
   [Lagarrigue, Sandrine] Univ Europeenne Bretagne, Rennes, France.
   [Langin, Dominique] Toulouse Univ Hosp, Lab Clin Biochem, Toulouse, France.
   [Wahli, Walter] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, Genopode Bldg, Lausanne, Switzerland.
C3 INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de
   Toulouse; Institut National Polytechnique de Toulouse; Universite
   Toulouse III - Paul Sabatier; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse
   III - Paul Sabatier; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Paris Cite; Universite Paris Cite; Centre
   National de la Recherche Scientifique (CNRS); CNRS - National Institute
   for Biology (INSB); Universite Paris Cite; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite
   Toulouse III - Paul Sabatier; CHU de Toulouse; Institut National de la
   Sante et de la Recherche Medicale (Inserm); INRAE; Institut Agro;
   Agrocampus Ouest; Universite de Bretagne Occidentale; Universite de
   Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse;
   Nanyang Technological University; University of Lausanne
RP Guillou, H (corresponding author), ToxAlim, INRA, UMR1331, Chemin Tournefeuille, F-31027 Toulouse, France.; Wahli, W (corresponding author), Nanyang Technol Univ Acad, Chian Sch Med, 20 Coll Rd, Singapore 169856, Singapore.
EM walter.wahli@ntu.edu.sg; herve.guillou@toulouse.inra.fr
RI Guillou, Herve/AAG-2826-2020; RAJAS, Fabienne/P-4091-2016; LOISEAU,
   Nicolas/ADN-2394-2022; Guillou, Hervé/AGL-0750-2022; Benhamed,
   Fadila/HPD-1637-2023; Postic, Catherine/P-2271-2017; lippi,
   yannick/AAG-2774-2019; Wahli, Walter/B-1398-2009; Wahli,
   Walter/I-3194-2019
OI Guillou, Herve/0000-0002-5363-9081; RAJAS, Fabienne/0000-0002-9233-7633;
   LOISEAU, Nicolas/0000-0003-3783-0879; Guillou,
   Hervé/0000-0002-5363-9081; Benhamed, Fadila/0000-0003-4905-6585; Postic,
   Catherine/0000-0002-1875-6960; lippi, yannick/0000-0003-4717-078X;
   Wahli, Walter/0000-0002-5966-9089; Lagarrigue,
   Sandrine/0000-0002-4887-7245; Montagner, Alexandra/0000-0002-4800-5105;
   Ducheix, Simon/0000-0001-6676-4263; Langin,
   Dominique/0000-0002-2669-7825; REGNIER, Marion/0000-0002-5005-0597;
   Gilles, Mithieux/0000-0003-3579-8529
FU Human Frontier Science Program (HFSP); Lee Kong Chian School of
   Medicine, Nanyang Technological University, Singapore; SFN; ANRs
   'Crisalis'; ANRs 'Obelip'; Region Midi-Pyrenees
FX This work was funded by grants from the Human Frontier Science Program
   (HFSP) (WW), by Start-Up Grants from the Lee Kong Chian School of
   Medicine, Nanyang Technological University, Singapore (to WW), by SFN
   (to HG), by ANRs 'Crisalis' (to CP and HG), by 'Obelip' (to DL, CP, AM
   and HG). DL is a member of the Institut Universitaire de France. AM, DL,
   WW and HG were supported by Region Midi-Pyrenees.
CR Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Bünger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006
   Caspar-Bauguil S, 2015, DIABETOLOGIA, V58, P2627, DOI 10.1007/s00125-015-3719-0
   Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036
   Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002
   Chen WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082526
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044
   Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   Hegardt FG, 1998, BIOCHIMIE, V80, P803, DOI 10.1016/S0300-9084(00)88874-4
   Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307
   Jaeger D, 2015, J HEPATOL, V63, P437, DOI 10.1016/j.jhep.2015.02.035
   Jha P, 2014, BBA-MOL BASIS DIS, V1842, P959, DOI 10.1016/j.bbadis.2014.02.012
   Jha P, 2014, HEPATOLOGY, V59, P858, DOI 10.1002/hep.26732
   Jo YS, 2015, HEPATOLOGY, V62, P1606, DOI 10.1002/hep.27907
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002
   Kharitonenkov A, 2014, MOL METAB, V3, P221, DOI 10.1016/j.molmet.2013.12.003
   Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490
   Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581
   Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710
   Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171
   Lu PP, 2015, HEPATOLOGY, V61, P1908, DOI 10.1002/hep.27719
   De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748
   Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595
   Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468
   Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Sahebkar A, 2014, EXPERT OPIN PHARMACO, V15, P493, DOI 10.1517/14656566.2014.876992
   Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09
   Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461
   Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586
   Tanaka N, 2014, BBA-MOL CELL BIOL L, V1841, P1596, DOI 10.1016/j.bbalip.2014.08.015
   Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358
   Uebanso T, 2012, J NUTR BIOCHEM, V23, P785, DOI 10.1016/j.jnutbio.2011.03.023
   Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001
   Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149
   Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100
NR 50
TC 449
Z9 491
U1 9
U2 175
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD JUL
PY 2016
VL 65
IS 7
BP 1202
EP 1214
DI 10.1136/gutjnl-2015-310798
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DN6GE
UT WOS:000377170200018
PM 26838599
OA Green Published, hybrid
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Klein, S
   Klösel, J
   Schierwagen, R
   Körner, C
   Granzow, M
   Huss, S
   Mazar, IGR
   Weber, S
   van den Ven, PFM
   Pieper-Fürst, U
   Fürst, DO
   Nattermann, J
   Lammert, F
   Sauerbruch, T
   Trebicka, J
AF Klein, Sabine
   Kloesel, Jeremias
   Schierwagen, Robert
   Koerner, Christian
   Granzow, Michaela
   Huss, Sebastian
   Mazar, Irela Gretchen Reza
   Weber, Susanne
   van den Ven, Peter F. M.
   Pieper-Fuerst, Ursula
   Fuerst, Dieter O.
   Nattermann, Jacob
   Lammert, Frank
   Sauerbruch, Tilman
   Trebicka, Jonel
TI Atorvastatin inhibits proliferation and apoptosis, but induces
   senescence in hepatic myofibroblasts and thereby attenuates hepatic
   fibrosis in rats
SO LABORATORY INVESTIGATION
LA English
DT Article
DE cytokines; fibrogenesis; hepatic stellate cells; HMG-CoA reductase
   inhibitor; myofibroblasts; senescence
ID STELLATE CELLS; REDUCTASE INHIBITORS; BETA-GALACTOSIDASE; LIVER;
   CULTURE; DEFICIENT; BIOMARKER; PROTEIN
AB Hepatic myofibroblasts (MFB) show increased proliferation, migration and collagen production, which are crucial for hepatic fibrogenesis. Atorvastatin treatment inhibits proliferation, apoptosis and cytokine production of MFB in bile duct-ligated (BDL) rats in vivo. Here, we have further investigated the underlying mechanisms. Primary rat hepatic stellate cells (HSC) were isolated and culture-activated to hepatic MFB. Following 3 days of incubation with atorvastatin (10(-4), 10(-5) and 10(-6) M), transcription levels of profibrotic cytokines (transforming growth factor-beta 1, connective tissue growth factor and TIMP1) and procollagen la were analyzed by real time PCR. Proliferation was investigated by 5'-bromo-2'-deoxyuridine assays. alpha-Smooth muscle actin protein expression was examined by western blotting. Fluorescence-activated cell sorting analysis of Annexin V and propidium iodide were used to measure apoptosis. Furthermore, p21 western blotting and beta-galactosidase staining were investigated in MFB as senescence markers. Subsequently, hepatic expression of desmin and senescence markers were analyzed in the livers of rats receiving atorvastatin (15 mg/kg*d) for 1 week starting 3 and 5 weeks after BDL. Atorvastatin inhibited the activation of HSC to MFB and decreased cytokine and collagen production in MFB in vitro. In addition, proliferation, cytokine and collagen production of MFB were reduced by atorvastatin. Atorvastatin initiated apoptosis at 10(-4) M and attenuated it at 10(-5) M. Atorvastatin induced p21 protein expression and beta-galactosidase staining of MFB in vitro and in vivo. Atorvastatin elicits similiar effects on MFB as previously seen in vivo: it decreases MFB turnover and fibrogenesis. We suggest that a further mechanism explaining these effects is senescence of cells. Laboratory Investigation (2012) 92, 1440-1450; doi:10.1038/labinvest.2012.106; published online 13 August 2012
C1 [Klein, Sabine; Kloesel, Jeremias; Schierwagen, Robert; Koerner, Christian; Granzow, Michaela; Pieper-Fuerst, Ursula; Nattermann, Jacob; Sauerbruch, Tilman; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, D-53105 Bonn, Germany.
   [Huss, Sebastian] Univ Bonn, Dept Pathol, D-53105 Bonn, Germany.
   [Mazar, Irela Gretchen Reza; van den Ven, Peter F. M.; Fuerst, Dieter O.] Univ Bonn, Inst Cell Biol, D-53105 Bonn, Germany.
   [Weber, Susanne; Lammert, Frank] Univ Saarland, Med Ctr, Dept Med 2, D-6650 Homburg, Germany.
C3 University of Bonn; University of Bonn; University of Bonn; Saarland
   University
RP Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Sigmund Freud St 25, D-53105 Bonn, Germany.
EM jonel.trebicka@ukb.uni-bonn.de
RI Schierwagen, Robert/AAE-6305-2019; Fürst, Dieter O./H-8561-2013; Klein,
   Sabine/U-1098-2018; Körner, Christian/ABB-8335-2020
OI Schierwagen, Robert/0000-0002-2195-3666; Fürst, Dieter
   O./0000-0001-8805-6444; Klein, Sabine/0000-0001-6691-2895; Körner,
   Christian/0000-0002-3431-7319; van der Ven, Peter/0000-0002-9750-8913;
   Trebicka, Jonel/0000-0002-7028-3881
FU Deutsche Forschungsgemeinschaft [SFB TRR57]; Bonfor-Stiftung
   [O-107.0084, O-107.0103]
FX The study was supported by grants from the Deutsche
   Forschungsgemeinschaft (SFB TRR57 projects 1,12,18, Q1) and the
   Bonfor-Stiftung (O-107.0084 and O-107.0103). We thank G Hack and S
   Bellinghausen for excellent technical assistance, and S Dentler for
   critical reading.
CR Abraldes JG, 2009, GASTROENTEROLOGY, V136, P1651, DOI 10.1053/j.gastro.2009.01.043
   Aprigliano I, 2008, LIVER INT, V28, P546, DOI 10.1111/j.1478-3231.2008.01682.x
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2001, SEMIN LIVER DIS, V21, P307
   Green MR, 2008, CELL, V134, P562, DOI 10.1016/j.cell.2008.08.003
   Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x
   Huss S, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-10
   Kato M, 1999, J HEPATOL, V31, P91, DOI 10.1016/S0168-8278(99)80168-8
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266
   Laufs U, 1999, J BIOL CHEM, V274, P21926, DOI 10.1074/jbc.274.31.21926
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee J, 2006, BIOCHEM BIOPH RES CO, V339, P748, DOI 10.1016/j.bbrc.2005.11.075
   Mason HR, 2004, MOL HUM REPROD, V10, P181, DOI 10.1093/molehr/gah028
   Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002
   Pinzani M, 2002, FRONT BIOSCI-LANDMRK, V7, pD1720, DOI 10.2741/pinzani
   Ramadori G, 2002, LIVER, V22, P283, DOI 10.1034/j.1600-0676.2002.01726.x
   Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23
   Rombouts K, 2003, J HEPATOL, V38, P564, DOI 10.1016/S0168-8278(03)00051-5
   Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Schuppan D, 1998, DIGESTION, V59, P385, DOI 10.1159/000007494
   Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589
   Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673
   Trebicka J, 2011, LIVER INT, V31, P862, DOI 10.1111/j.1478-3231.2011.02496.x
   Trebicka J, 2010, J HEPATOL, V53, P702, DOI 10.1016/j.jhep.2010.04.025
   WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397
NR 34
TC 77
Z9 80
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD OCT
PY 2012
VL 92
IS 10
BP 1440
EP 1450
DI 10.1038/labinvest.2012.106
PG 11
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA 013RX
UT WOS:000309324600006
PM 22890553
OA hybrid
DA 2024-02-19
ER

PT J
AU Li, JR
   Xian, L
   Zheng, RP
   Wang, Y
   Wan, XQ
   Liu, Y
AF Li, Jiarui
   Xian, Lei
   Zheng, Ruipeng
   Wang, Yue
   Wan, Xiaoqiang
   Liu, Ying
TI Canthaxanthin shows anti-liver aging and anti-liver fibrosis effects by
   down-regulating inflammation and oxidative stress in vivo and in vitro
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article; Early Access
DE Canthaxanthin; Liveraging; Hepaticfibrosis; Livercancer
ID HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; SENESCENCE;
   ACTIVATION; IMPACT
AB The elderly population is growing rapidly all over the world. The aging population has brought great medical pressure to the society. It is found that aging is one of the pathogenic factors of liver fibrosis and liver cancer. Therefore, it is very important to explore functional foods with anti-aging, anti-fibrosis and anti-liver cancer effect. Therefore, in this work, we studied the potential effects of Canthaxanthin on liver aging, liver fibrosis and liver cancer. Firstly, we established the aging modelof liver cells by using H2O2. On this basis, the anti-aging effect of Canthaxanthin was analyzed, and the results showed that Canthaxanthin could significantly alleviate the aging of liver cells through Sa-beta-Gal staining and analysis of the expression of aging related markers. In vivo, aged mice wereused as the animal model for studying the effect of anti-aging of Canthaxanthin. The results showed that Canthaxanthin could significantly alleviate the aging of liver in vivo. Further study show that Canthaxanthin may alleviatethe aging of liver cells by regulating SIRT6; Secondly, we evaluated the effect of Canthaxanthin on liver fibrosis. A model of liver fibrosis was established by CCl4. Masson and Sirius red staining showed that Canthaxanthin could significantly reduce the fibrosis area. Additionally, the level of liver inflammation was also reduced; Thirdly, the effect of Canthaxanthin on hepatoma cells has also been investigated. The resultsshowed that Canthaxanthin could promote the apoptosis of hepatoma cells in vivo and in vitro. To sum up, these results show that canthaxanthin can significantly alleviate liver aging and fibrosis, and Canthaxanthin can also promote the apoptosis of liver cancer cells, indicating that Canthaxanthin can be used as a potential drug or health food for the treatment of liveraging related diseases.
C1 [Li, Jiarui; Xian, Lei; Zheng, Ruipeng; Wang, Yue; Wan, Xiaoqiang; Liu, Ying] First Hosp Jilin Univ, Dept Intervent Therapy, Changchun 130000, Jilin, Peoples R China.
   [Liu, Ying] First Hosp Jilin Univ, Clin Lab, Changchun 130000, Peoples R China.
C3 Jilin University; Jilin University
RP Liu, Y (corresponding author), First Hosp Jilin Univ, Dept Intervent Therapy, Changchun 130000, Jilin, Peoples R China.
EM ljr@jlu.edu.cn
RI he, xi/JXN-3817-2024; wang, KiKi/JFZ-3334-2023
CR Ahmed HA., 2019, Medicine, V47, P119, DOI [DOI 10.1016/J.MPMED.2018.11.007, 10.1016/j.mpmed.2018.11.007]
   Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Chan KC, 2009, J FOOD SCI, V74, pH225, DOI 10.1111/j.1750-3841.2009.01274.x
   Dhar D, 2020, EXP BIOL MED, V245, P96, DOI 10.1177/1535370219898141
   Esatbeyoglu T, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600469
   Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034
   Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A
   Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   [李发钊 Li Fazhao], 2018, [中华肝胆外科杂志, Chinese Journal of Hepatobiliary Surgery], V24, P487
   Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007
   Liu ZW, 2019, CLIN INFECT DIS, V68, P717, DOI 10.1093/cid/ciy530
   Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516
   Mowla SN, 2014, AGING CELL, V13, P773, DOI 10.1111/acel.12242
   Nevzorova YA, 2013, BBA-MOL BASIS DIS, V1832, P1765, DOI 10.1016/j.bbadis.2013.06.001
   Nyandra M, 2018, SSRN ELECT J, DOI [10.2139/ssrn.3394858, DOI 10.2139/SSRN.3394858]
   Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Surai AP, 2003, BRIT POULTRY SCI, V44, P612, DOI 10.1080/00071660310001616200
   Tasselli L, 2016, NAT STRUCT MOL BIOL, V23, P434, DOI 10.1038/nsmb.3202
   Uehara Takeki, 2014, Curr Protoc Pharmacol, V66, DOI 10.1002/0471141755.ph1430s66
   Watanabe S, 2017, CANCER SCI, V108, P563, DOI 10.1111/cas.13184
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Zhang XX, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.728100
NR 27
TC 5
Z9 5
U1 5
U2 26
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD 2022 SEP
PY 2022
VL 110
AR 108942
DI 10.1016/j.intimp.2022.108942
EA JUL 2022
PG 15
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA 2Z2US
UT WOS:000826439400002
PM 35810489
DA 2024-02-19
ER

PT J
AU Acun, A
   Oganesyan, R
   Uygun, K
   Yeh, HD
   Yarmush, ML
   Uygun, BE
AF Acun, Aylin
   Oganesyan, Ruben
   Uygun, Korkut
   Yeh, Heidi
   Yarmush, Martin L.
   Uygun, Basak E.
TI Liver donor age affects hepatocyte function through age-dependent
   changes in decellularized liver matrix
SO BIOMATERIALS
LA English
DT Article; Early Access
DE Extracellular matrix; Aging; Liver; Decellularization
AB The only treatment available for end stage liver diseases is orthotopic liver transplantation. Although there is a big donor scarcity, many donor livers are discarded as they do not qualify for transplantation. Alternatively, decellularization of discarded livers can potentially render them transplantable upon recellularization and functional testing. The success of this approach will heavily depend on the quality of decellularized scaffolds which might show variability due to factors including age. Here we assessed the age-dependent differences in liver extracellular matrix (ECM) using rat and human livers. We show that the liver matrix has higher collagen and glycosaminoglycan content and a lower growth factor content with age. Importantly, these changes lead to deterioration in primary hepatocyte function potentially due to ECM stiffening and integrin-dependent signal transduction. Overall, we show that ECM changes with age and these changes significantly affect cell function thus donor age should be considered as an important factor for bioengineering liver substitutes.
C1 [Acun, Aylin; Oganesyan, Ruben; Uygun, Korkut; Yarmush, Martin L.; Uygun, Basak E.] Harvard Med Sch, Massachusetts Gen Hosp, Shriners Hosp Children, Ctr Engn Med & Surg, Boston, MA 02115 USA.
   [Acun, Aylin; Oganesyan, Ruben; Uygun, Korkut; Yeh, Heidi; Yarmush, Martin L.; Uygun, Basak E.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.
   [Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA.
C3 Harvard University; Massachusetts General Hospital; Harvard Medical
   School; Harvard University; Massachusetts General Hospital; Rutgers
   University System; Rutgers University New Brunswick
RP Uygun, BE (corresponding author), 51 Blossom St, Boston, MA 02118 USA.
EM buygun@mgh.harvard.edu
RI Uygun, Basak/I-1792-2012; uygun, korkut/IUM-2451-2023
OI Uygun, Basak/0000-0002-2600-7900; Yarmush, Martin/0000-0003-4986-8444
FU National Institutes of Health [R01DK084053]; Shriners Hospitals for
   Children [84702]; Shriners Hospitals for Children in Boston Genomics and
   Proteomics and Translational Regenerative Medicine Special Shared
   Facilities
FX We would like to acknowledge Peony Banik, Sonal Nagpal and Yibin Chen at
   Massachusetts General Hospital for procurement of the rat livers. We
   would like to acknowledge Taplin Mass Spectrometry Facility at Harvard
   Medical School for mass spectrometry analysis of rat liver extracellular
   matrices. We would like to acknowledge Cell Resource Core at
   Massachusetts General hospital for providing primary rat and human
   hepatocytes. This study is funded from the National Institutes of Health
   (M.L.Y. and B.E.U.) (grant number R01DK084053) Shriners Hospitals for
   Children (A.A.) (grant number 84702) and the Shriners Hospitals for
   Children in Boston Genomics and Proteomics and Translational
   Regenerative Medicine Special Shared Facilities. Finally, great
   appreciation is extended to New England Donor Services (NEDS) for their
   generous support that enables research with human donor organs.
CR Akamatsu N, 2007, TRANSPL P, V39, P3189, DOI 10.1016/j.transproceed.2007.03.116
   Amenta P.S., 1995, FASEB J PUBL FED AM, V9
   [Anonymous], 2013, TRANSPLANTATION, V19, P798, DOI [10.1002/lt.23697, DOI 10.1002/LT.23697]
   Arriazu E, 2014, ANTIOXID REDOX SIGN, V21, P1078, DOI 10.1089/ars.2013.5697
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Böhm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085
   Chen YB, 2019, TECHNOLOGY, V7, P46, DOI 10.1142/S2339547819500043
   Daneshgar A, 2020, BIOMATERIALS, V257, DOI 10.1016/j.biomaterials.2020.120247
   Delire B, 2017, AGING-US, V9, P112, DOI 10.18632/aging.101124
   Duncan MB, 2013, DIS MODEL MECH, V6, P942, DOI 10.1242/dmm.011577
   Emre S, 2011, TRANSPL P, V43, P884, DOI 10.1016/j.transproceed.2011.02.036
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Fledelius C, 1997, J BIOL CHEM, V272, P9755
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gerecke DR, 2004, MATRIX BIOL, V22, P593, DOI 10.1016/j.matbio.2003.11.004
   Gomi I, 2007, J NUTR SCI VITAMINOL, V53, P37, DOI 10.3177/jnsv.53.37
   Hoshida Y, 1999, J HEPATOL, V31, P860, DOI 10.1016/S0168-8278(99)80287-6
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jaramillo M, 2018, J TISSUE ENG REGEN M, V12, pE1962, DOI 10.1002/term.2627
   Kanta J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00491
   Karsdal MA, 2017, ADV DRUG DELIVER REV, V121, P43, DOI 10.1016/j.addr.2017.07.014
   Karsdal MA, 2016, J HEPATOL, V64, P103, DOI 10.1016/j.jhep.2015.08.014
   Karsdal MA, 2015, AM J PHYSIOL-GASTR L, V308, pG807, DOI 10.1152/ajpgi.00447.2014
   Kelly D.A., LONG TERM MEDICAL MA
   Kular JK, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414557112
   Kurtz A, 2012, PREV MED, V54, pS50, DOI 10.1016/j.ypmed.2012.01.003
   Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988
   Mak KM, 2017, ANAT REC, V300, P1371, DOI 10.1002/ar.23567
   Mao S. A, SUSTAINED IN VIVO PE
   Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079
   Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518
   Naderi J, 2003, APOPTOSIS, V8, P91, DOI 10.1023/A:1021657220843
   Neuberger J, 2016, J AUTOIMMUN, V66, P51, DOI 10.1016/j.jaut.2015.08.021
   Ozcebe SG, 2021, BIOMATERIALS, V268, DOI 10.1016/j.biomaterials.2020.120554
   Parola M, 2016, J HEPATOL, V64, P13, DOI 10.1016/j.jhep.2015.09.017
   Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229
   Rayhill SC, 2007, TRANSPLANTATION, V84, P331, DOI 10.1097/01.tp.0000270313.31328.63
   SAFAR P, 1988, CRIT CARE MED, V16, P919
   Shan Z, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.26
   Spadaccio C, 2015, J GERIATR CARDIOL, V12, P76, DOI 10.11909/j.issn.1671-5411.2015.01.009
   Stearns-Reider KM, 2017, AGING CELL, V16, P518, DOI 10.1111/acel.12578
   Sun K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4485
   Uhl P, 2014, INT J MOL SCI, V15, P7500, DOI 10.3390/ijms15057500
   Uygun BE, 2013, CURR OPIN BIOTECH, V24, P893, DOI 10.1016/j.copbio.2013.05.008
   Uygun BE, 2012, NAT REV GASTRO HEPAT, V9, P738, DOI 10.1038/nrgastro.2012.140
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753
   Verstegen MMA, 2017, STEM CELLS DEV, V26, P1304, DOI 10.1089/scd.2017.0095
   Villesen IF, 2020, ALIMENT PHARM THER, V52, P85, DOI 10.1111/apt.15773
   Willemse J, 2020, MAT SCI ENG C-MATER, V108, DOI 10.1016/j.msec.2019.110200
   Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747
   Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012
   Yazigi NA, 2013, PEDIATR GASTROENTERO, V16, P207, DOI 10.5223/pghn.2013.16.4.207
   Yuan J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0208-9
   Zhang R, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4820-9
NR 56
TC 17
Z9 19
U1 3
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD 2021 MAR
PY 2021
VL 270
AR 120689
DI 10.1016/j.biomaterials.2021.120689
EA JAN 2021
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Materials Science
GA QL6KS
UT WOS:000621193200004
PM 33524812
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Min, EY
   Kim, IH
   Lee, J
   Kim, EY
   Choi, YH
   Nam, TJ
AF Min, Eun-Young
   Kim, In-Hye
   Lee, Jungim
   Kim, Eun-Young
   Choi, Youn-Hee
   Nam, Taek-Jeong
TI The effects of fucodian on senescence are controlled by the
   p16<SUP>INK4a</SUP>-pRb and p14<SUP>Arf</SUP>-p53 pathways in
   hepatocellular carcinoma and hepatic cell lines
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article
DE fucoidan; anti-tumor; anti-senescence; p16(INK4a)-Rb; p14(Arf)-p53;
   alpha M-2
ID TUMOR SUPPRESSION; INDUCED APOPTOSIS; HUMAN FIBROBLASTS; INHIBITOR P16;
   GENE-PRODUCT; EXPRESSION; CANCER; FUCOIDAN; P53; INK4A/ARF
AB Fucoidan is known to have various pharmacological effects, including antitumor activity. Although it has potential as a therapeutic agent for cancer cells, the anti-senescence effects and detailed mechanism of action remain poorly understood in normal hepatic cells. We investigated the anticancer functions of fucoidan using HepG2 cells as well as the mechanisms mediating the anti-senescent actions in Chang liver cells. Fucoidan effectively inhibited HepG2 cell viability and induced apoptosis. Also, fucoidan-induced phase arrest was caused by the activity of the p16(INK4a)-Rb and p14(Arf)-p53 pathways. Furthermore, upregulation of p16(INK4a) was critical to the antitumor activity of HepG2 cells treated with fucoidan and was correlated with inhibition of Cdk4 and pRb and upregulation of p21 expression. Our results suggest that fucoidan upregulates INK4a locus genes to induce apoptosis through p38 MAPK in HepG2 cells. Moreover, it prevents cellular senescence of Chang-L cells, by decreasing p14(Arf) expression as cells enter quiescence, with the reduction of p16(INK4a). Fucoidan treatment also downregulated the expression of alpha M-2. In conclusion, fucoidan can be considered a potential therapeutic agent against liver cancer that does not cause senescence in normal hepatic cells. Thus, it may be possible to use fucoidan therapeutically in both tumor suppression and aging.
C1 [Min, Eun-Young; Kim, In-Hye; Lee, Jungim; Kim, Eun-Young; Choi, Youn-Hee; Nam, Taek-Jeong] Pukyong Natl Univ, Inst Fisheries Sci, Pusan 619911, South Korea.
C3 Pukyong National University
RP Nam, TJ (corresponding author), Pukyong Natl Univ, Inst Fisheries Sci, Pusan 619911, South Korea.
EM namtj@pknu.ac.kr
FU National Research Foundation of Korea (NRF) - Ministry of Education,
   Science and Technology [2012R1A6A1028677]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (2012R1A6A1028677).
CR Alekseyenko TV, 2007, B EXP BIOL MED+, V143, P730, DOI 10.1007/s10517-007-0226-4
   Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2
   Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Deng JF, 2008, LIVER INT, V28, P1458, DOI 10.1111/j.1478-3231.2008.01767.x
   Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000
   Duan JM, 2001, J BIOL CHEM, V276, P48325, DOI 10.1074/jbc.M104814200
   Durig J, 1997, THROMB RES, V85, P479, DOI 10.1016/S0049-3848(97)00037-6
   Fedorov SN, 2007, CANCER RES, V67, P5914, DOI 10.1158/0008-5472.CAN-06-3723
   Fujii H, 2007, BIOCHEM BIOPH RES CO, V362, P773, DOI 10.1016/j.bbrc.2007.08.067
   Haber DA, 1997, CELL, V91, P555, DOI 10.1016/S0092-8674(00)80441-9
   Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007
   Hara E, 1996, MOL CELL BIOL, V16, P859
   Hu TT, 2010, INT J BIOL MACROMOL, V46, P193, DOI 10.1016/j.ijbiomac.2009.12.004
   Huschtscha LI, 1999, CARCINOGENESIS, V20, P921, DOI 10.1093/carcin/20.6.921
   Hyun JH, 2009, BIOL PHARM BULL, V32, P1760, DOI 10.1248/bpb.32.1760
   Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776
   Ishii H, 2008, CANCER SCI, V99, P1871, DOI 10.1111/j.1349-7006.2008.00914.x
   Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425
   Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013
   Kim NY, 2010, CANCER RES TREAT, V42, P203, DOI 10.4143/crt.2010.42.4.203
   Kondo T, 2001, EXP GERONTOL, V36, P487, DOI 10.1016/S0531-5565(00)00256-4
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050624
   Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671
   LI Y, 1994, CANCER RES, V54, P6078
   Ma H, 2004, EXP GERONTOL, V39, P415, DOI 10.1016/j.exger.2003.11.012
   Maruyama H, 2003, IN VIVO, V17, P245
   Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716
   Melzer D, 2008, REJUV RES, V11, P523, DOI 10.1089/rej.2008.0684
   Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174
   Park C, 2006, ONCOL REP, V16, P171
   Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Schumacher M, 2011, BIOTECHNOL ADV, V29, P531, DOI 10.1016/j.biotechadv.2011.02.002
   Schyschka L, 2008, LEUKEMIA, V22, P1737, DOI 10.1038/leu.2008.146
   Serrano M, 2000, CARCINOGENESIS, V21, P865, DOI 10.1093/carcin/21.5.865
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   TAHARA H, 1995, ONCOGENE, V10, P835
   Tsygankov D, 2009, P NATL ACAD SCI USA, V106, P16562, DOI 10.1073/pnas.0904405106
   Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008
   Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
   Wang J, 2008, INT J BIOL MACROMOL, V42, P127, DOI 10.1016/j.ijbiomac.2007.10.003
   Wang YX, 2010, J SURG RES, V161, P119, DOI 10.1016/j.jss.2008.10.030
   Xue ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043483
NR 50
TC 33
Z9 39
U1 2
U2 33
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1019-6439
EI 1791-2423
J9 INT J ONCOL
JI Int. J. Oncol.
PD JUL
PY 2014
VL 45
IS 1
BP 47
EP 56
DI 10.3892/ijo.2014.2426
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA AI5BY
UT WOS:000336881600006
PM 24807532
OA hybrid, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Görg, B
   Karababa, A
   Schütz, E
   Paluschinski, M
   Schrimpf, A
   Shafigullina, A
   Castoldi, M
   Bidmon, HJ
   Häussinger, D
AF Goerg, Boris
   Karababa, Ayse
   Schuetz, Elina
   Paluschinski, Martha
   Schrimpf, Alina
   Shafigullina, Aygul
   Castoldi, Mirco
   Bidmon, Hans J.
   Haeussinger, Dieter
TI O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced
   oxidative stress and senescence in hepatic encephalopathy
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Glutamine; Glucosamine; Ferrous iron; RNA oxidation; Senescence
ID CULTURED RAT ASTROCYTES; HUMAN CEREBRAL-CORTEX; EXPRESSION; BRAIN;
   FERRITIN; MECHANISMS; INDUCTION; CIRRHOSIS; TOXICITY
AB Background & Aims: Cerebral oxidative stress plays an important role in the pathogenesis of hepatic encephalopathy (HE), but the underlying mechanisms are incompletely understood. Herein, we analyzed a role of heme oxygenase (HO)1, iron and NADPH oxidase 4 (Nox4) for the induction of oxidative stress and senescence in HE.
   Methods: Gene and protein expression in human post-mortem brain samples was analyzed by gene array and western blot analysis. Mechanisms and functional consequences of HO1 upregulation were studied in NH4Cl-exposed astrocytes in vitro by western blot, qPCR and super-resolution microscopy.
   Results: HO1 and the endoplasmic reticulum (ER) stress marker grp78 were upregulated, together with changes in the expression of multiple iron metabolism-related genes, in postmortem brain samples from patients with liver cirrhosis and HE. NH4Cl elevated HO1 protein and mRNA in cultured astrocytes through glutamine synthetase (GS)-dependent upregulation of glutamine/fructose amidotransferases 1/2 (GFAT1/2), which blocked the transcription of the HO1-targeting miR326-3p in a O-GlcNAcylation dependent manner. Upregulation of HO1 by NH4Cl triggered ER stress and was associated with elevated levels of free ferrous iron and expression changes in iron metabolism-related genes, which were largely abolished after knockdown or inhibition of GS, GFAT1/2, HO1 or iron chelation. NH4Cl, glucosamine (GlcN) and inhibition of miR326-3p upregulated Nox4, while knockdown of Nox4, GS, GFAT1/2, HO1 or iron chelation prevented NH4Cl-induced RNA oxidation and astrocyte senescence. Elevated levels of grp78 and O-GlcNAcylated proteins were also found in brain samples from patients with liver cirrhosis and HE.
   Conclusion: The present study identified glucosamine synthesis-dependent protein O-GlcNAcylation as a novel mechanism in the pathogenesis of HE that triggers oxidative and ER stress, as well as senescence, through upregulation of HO1 and Nox4.
   Lay summary: Patients with liver cirrhosis frequently exhibit hyperammonemia and suffer from cognitive and motoric dysfunctions, which at least in part involve premature ageing of the astrocytes in the brain. This study identifies glucosamine and an O-GlcNAcylation-dependent disruption of iron homeostasis as novel triggers of oxidative stress, thereby mediating ammonia toxicity in the brain. (C) 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Goerg, Boris; Karababa, Ayse; Schuetz, Elina; Paluschinski, Martha; Schrimpf, Alina; Shafigullina, Aygul; Castoldi, Mirco; Haeussinger, Dieter] Heinrich Heine Univ, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany.
   [Bidmon, Hans J.] Heinrich Heine Univ, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany.
C3 Heinrich Heine University Dusseldorf; Heinrich Heine University
   Dusseldorf
RP Görg, B (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM Boris.Goerg@uni-duesseldorf.de
OI Paluschinski, Martha/0000-0002-6899-3753; Castoldi,
   Mirco/0000-0003-2484-936X; Shafigullina, Aygul/0000-0001-9740-7090;
   Gorg, Boris/0000-0002-4630-9420
FU Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
   (Dusseldorf, Germany) [190586431 - SFB 974]
FX Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation) - Projektnummer 190586431 - SFB 974 "Communication and
   Systems Relevance in Liver Injury and Regeneration", (Dusseldorf,
   Germany).
CR Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015
   Bussian T.J., 2018, NATURE
   Copeland RJ, 2013, PROTEOM CLIN APPL, V7, P597, DOI 10.1002/prca.201300001
   Dang TN, 2011, GLIA, V59, P1540, DOI 10.1002/glia.21198
   Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/S0006-8993(96)00680-4
   Görg B, 2008, HEPATOLOGY, V48, P567, DOI 10.1002/hep.22345
   Görg B, 2015, GLIA, V63, P37, DOI 10.1002/glia.22731
   Görg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010
   Görg B, 2013, HEPATOLOGY, V57, P2436, DOI 10.1002/hep.26265
   Görg B, 2010, HEPATOLOGY, V52, P256, DOI 10.1002/hep.23656
   HAUSSINGER D, 1994, GASTROENTEROLOGY, V107, P1475
   Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200
   Karababa A, 2014, METAB BRAIN DIS, V29, P975, DOI 10.1007/s11011-013-9454-7
   Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008
   Kim HP, 2011, BIOCHEM BIOPH RES CO, V404, P1, DOI 10.1016/j.bbrc.2010.11.067
   Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y
   Kruczek C, 2011, BIOL CHEM, V392, P1155, DOI [10.1515/BC-2011-199, 10.1515/BC.2011.199]
   Lewis BA, 2016, J BIOL CHEM, V291, P14056, DOI 10.1074/jbc.M115.684365
   Li MD, 2012, J BIOL CHEM, V287, P12904, DOI 10.1074/jbc.M111.303792
   Oenarto J, 2016, SCI REP-UK, V6, DOI 10.1038/srep18493
   OGUCHI M, 1975, J BIOCHEM, V77, P1117, DOI 10.1093/oxfordjournals.jbchem.a130812
   Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778
   Rao KVR, 2014, NEUROCHEM RES, V39, P593, DOI 10.1007/s11064-012-0955-2
   Schipper HM, 2019, PROG NEUROBIOL, V172, P40, DOI 10.1016/j.pneurobio.2018.06.008
   Sobczyk K, 2015, NEUROCHEM RES, V40, P274, DOI 10.1007/s11064-014-1389-9
   Surguladze N, 2005, BIOCHEM J, V388, P731, DOI 10.1042/BJ20041853
   Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138
   Thompson KJ, 2002, J CELL SCI, V115, P2165
   Troadec MB, 2010, BLOOD, V116, P4657, DOI 10.1182/blood-2010-04-278614
   Warskulat U, 2002, GLIA, V40, P324, DOI 10.1002/glia.10128
   Yang FMY, 2015, BIOMOLECULES, V5, P2538, DOI 10.3390/biom5042538
   Zhang YH, 2010, ANTIOXID REDOX SIGN, V13, P999, DOI 10.1089/ars.2010.3129
NR 32
TC 35
Z9 39
U1 2
U2 14
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD NOV
PY 2019
VL 71
IS 5
BP 930
EP 941
DI 10.1016/j.jhep.2019.06.020
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA JD7CU
UT WOS:000490139600013
PM 31279900
DA 2024-02-19
ER

PT J
AU Tao, L
   Zhang, W
   Zhang, YX
   Zhang, M
   Zhang, YY
   Niu, X
   Zhao, Q
   Liu, ZX
   Li, YY
   Diao, AP
AF Tao, Li
   Zhang, Wei
   Zhang, Yaxin
   Zhang, Mei
   Zhang, Yueying
   Niu, Xing
   Zhao, Qing
   Liu, Zhenxing
   Li, Yuyin
   Diao, Aipo
TI Caffeine promotes the expression of telomerase reverse transcriptase to
   regulate cellular senescence and aging
SO FOOD & FUNCTION
LA English
DT Article
AB Telomere shortening is one of the main causes of cellular senescence. Caffeine is a natural stimulant most commonly found in coffee and tea. In this study, caffeine was found to promote the expression of telomerase reverse transcriptase (TERT) at both mRNA and protein levels, and consequently extended the telomere length and prevented cellular senescence. Knockdown of TERT eliminated the effect of caffeine on telomere elongation. Moreover, animal studies indicated that caffeine promoted the expression of TERT and extended the telomere length in the thymus and spleen of mice treated with caffeine for a long period of eight months. In addition, caffeine restored the decline of organ index and improved the histological structural change of the thymus, spleen and liver of mice due to aging. These results suggest that caffeine promotes the expression of TERT to delay cellular senescence and aging, which help to understand the mechanism for the beneficial effects of caffeine containing foods on health.
C1 [Tao, Li; Zhang, Wei; Zhang, Yaxin; Zhang, Mei; Zhang, Yueying; Niu, Xing; Zhao, Qing; Liu, Zhenxing; Li, Yuyin; Diao, Aipo] Tianjin Univ Sci & Technol, Sch Biotechnol, Key Lab Ind Fermentat Microbiol, Minist Educ,State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
C3 Tianjin University Science & Technology
RP Li, YY; Diao, AP (corresponding author), Tianjin Univ Sci & Technol, Sch Biotechnol, Key Lab Ind Fermentat Microbiol, Minist Educ,State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.
EM liyuyin@tust.edu.cn; diaoaipo@tust.edu.cn
RI ZHAO, S/IWV-4219-2023; Zhang, Jinfan/JPK-7588-2023; Gu, b/JNS-4761-2023;
   Zhao, Ying-Yong/I-9326-2014; Liu, Zhen/IAQ-0136-2023; wang,
   hongyuan/JWP-2279-2024
OI Zhao, Ying-Yong/0000-0002-0239-7342; 
CR Amano H, 2019, CELL METAB, V29, P1274, DOI 10.1016/j.cmet.2019.03.001
   Arthur R, 2018, CANCER EPIDEMIOL, V56, P75, DOI 10.1016/j.canep.2018.07.013
   de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Brunquell J, 2018, CELL STRESS CHAPERON, V23, P65, DOI 10.1007/s12192-017-0824-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239
   Costa MS, 2008, NEUROSCIENCE, V153, P1071, DOI 10.1016/j.neuroscience.2008.03.038
   El-naseery NI, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117168
   Fang CY, 2019, BBA-MOL CELL BIOL L, V1864, P271, DOI 10.1016/j.bbalip.2018.12.003
   Farahzadi R, 2018, TISSUE CELL, V54, P105, DOI 10.1016/j.tice.2018.08.012
   Flurkey K., 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1
   Garcez ML, 2019, NEUROCHEM RES, V44, P787, DOI 10.1007/s11064-018-02710-3
   Gregg JR, 2019, J UROLOGY, V201, P308, DOI 10.1016/j.juro.2018.08.048
   Guallar E, 2017, ANN INTERN MED, V167, P283, DOI 10.7326/M17-1503
   Guarino MP, 2013, AGE, V35, P1755, DOI 10.1007/s11357-012-9475-x
   Hosoi T, 2014, NEUROSCI LETT, V569, P23, DOI 10.1016/j.neulet.2014.03.053
   Hu SW, 2019, TOXICOLOGY, V418, P11, DOI 10.1016/j.tox.2019.02.015
   Hu SW, 2019, TOXICOLOGY, V417, P23, DOI 10.1016/j.tox.2019.02.008
   Ip FCF, 2014, NEUROSIGNALS, V22, P52, DOI 10.1159/000365290
   Kang C, 2019, MOL CELLS, V42, P821, DOI 10.14348/molcells.2019.0298
   Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924
   Li YF, 2018, THERANOSTICS, V8, P5713, DOI 10.7150/thno.28778
   Li YY, 2018, EUR J MED CHEM, V145, P370, DOI 10.1016/j.ejmech.2017.12.077
   Lisko JG, 2017, NICOTINE TOB RES, V19, P484, DOI 10.1093/ntr/ntw192
   Liu JJ, 2016, J NUTR, V146, P1373, DOI 10.3945/jn.116.230490
   Lublin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027762
   Luo Y, 2019, CELL REP, V26, P1869, DOI 10.1016/j.celrep.2019.01.066
   Ma PK, 2017, XENOBIOTICA, V47, P526, DOI 10.1080/00498254.2016.1204568
   Maguire D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010157
   Mensà E, 2019, AGEING RES REV, V50, P27, DOI 10.1016/j.arr.2019.01.004
   Metro D, 2017, J CLIN TRANSL ENDOCR, V10, P22, DOI 10.1016/j.jcte.2017.10.001
   Murati T, 2017, FOOD CHEM TOXICOL, V99, P17, DOI 10.1016/j.fct.2016.11.014
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3
   O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Oh CC, 2019, J AM ACAD DERMATOL, V81, P395, DOI 10.1016/j.jaad.2019.01.084
   Oh JK, 2015, INT J CANCER, V137, P1979, DOI 10.1002/ijc.29569
   Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160
   Rahman F, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600506
   Rallis C, 2013, AGING CELL, V12, P563, DOI 10.1111/acel.12080
   Ren H, 2010, BIOCHEM BIOPH RES CO, V394, P59, DOI 10.1016/j.bbrc.2010.02.093
   Rosso A, 2008, AM J ALZHEIMERS DIS, V23, P417, DOI 10.1177/1533317508320083
   Saito E, 2015, AM J CLIN NUTR, V101, P1029, DOI 10.3945/ajcn.114.104273
   Salari-Moghaddam A, 2019, J CLIN ENDOCR METAB, V104, P5346, DOI 10.1210/jc.2019-00637
   Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498
   Sharma HW, 1995, P NATL ACAD SCI USA, V92, P12343, DOI 10.1073/pnas.92.26.12343
   Shih CJ, 2013, INFLAMMATION, V36, P616, DOI 10.1007/s10753-012-9583-x
   Siasos G, 2014, J AM COLL CARDIOL, V63, P606, DOI 10.1016/j.jacc.2013.08.1642
   Stefanou N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-442
   Su SJ, 2013, INT J FOOD SCI NUTR, V64, P429, DOI 10.3109/09637486.2012.759184
   SZABO G, 1994, ALCOHOL CLIN EXP RES, V18, P548, DOI 10.1111/j.1530-0277.1994.tb00908.x
   Taka T, 2014, BIOORG MED CHEM LETT, V24, P5242, DOI 10.1016/j.bmcl.2014.09.059
   Takahashi K, 2017, AGING-US, V9, P1863, DOI 10.18632/aging.101287
   Tucker LA, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0162-x
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Wang ZH, 2020, AGING-US, V12, P11386, DOI 10.18632/aging.103186
   Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x
   Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084931
   Zhu YK, 2019, BIOGERONTOLOGY, V20, P1, DOI 10.1007/s10522-018-9769-1
NR 60
TC 9
Z9 10
U1 2
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD APR 7
PY 2021
VL 12
IS 7
BP 2914
EP 2924
DI 10.1039/d0fo03246h
PG 11
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA RM3XC
UT WOS:000639596100007
PM 33720241
DA 2024-02-19
ER

PT J
AU Lamas, CA
   Lenquiste, SA
   Baseggio, AM
   Cuquetto-Leite, L
   Kido, LA
   Aguiar, AC
   Erbelin, MN
   Collares-Buzato, CB
   Marostica, MR
   Cagnon, VHA
AF Lamas, C. A.
   Lenquiste, S. A.
   Baseggio, A. M.
   Cuquetto-Leite, L.
   Kido, L. A.
   Aguiar, A. C.
   Erbelin, M. N.
   Collares-Buzato, C. B.
   Marostica Jr, M. R.
   Cagnon, V. H. A.
TI Jaboticaba extract prevents prediabetes and liver steatosis in
   high-fat-fed aging mice
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Bioactive compounds; Jaboticaba; Obesity; Diabetes; Senescence;
   Functional food
ID INSULIN-RESISTANCE; ANTIOXIDANT PROPERTIES; MYRCIARIA JABOTICABA;
   PHENOLIC-COMPOUNDS; TROPICAL FRUITS; PEEL; INFLAMMATION; METABOLISM;
   CAULIFLORA; ASSAYS
AB We developed a patented jaboticaba peel extract (PJE) aiming to investigate PJE dose-dependent effect in liver and metabolism of high-fat-fed aging mice. Male FVB mice were distributed as follows: YG(young; 3-monthsold), AG(aged; 11-months-old), HfAG(aged + high-fat diet), JAGI(aged + 2.9gPJE/Kg), JAGII(aged + 5.8gPJE/Kg), HfJAGI(aged + high-fat diet + 2.9gPJE/Kg) and HfJAGII(aged + high-fat diet + 5.8gPJE/Kg). PJE showed a potent antioxidant activity and high bioactive compounds content. Both PJE doses prevented weight gain, dyslipidemia, hyperglycemia, reduced COX-2 level and improved HDL-cholesterol, pIRS-1, and PPAR gamma levels in high-fat-fed aging mice. Only HfJAGII showed lower TNF alpha level, insulin resistance, and glucose intolerance relative to HfAG. Taking aging into consideration, PJE prevented dyslipidemia and hyperglycemia, reduced TNF alpha besides increasing pIRS-1 and PPAR gamma levels, and restoring the hepatic structure in aged mice. Thus, PJE anti-inflammatory, hypoglycemic and lipid modulation capacity prevented the pre-diabetes and NAFLD in this model, being indicated as potential therapy to prevent hepatic and metabolic disorders associated to obesity, diabetes, and aging.
C1 [Lamas, C. A.; Cuquetto-Leite, L.; Kido, L. A.; Cagnon, V. H. A.] Univ Estadual Campinas, Dept Struct & Funct Biol, Bertrand Russel Av, BR-13083865 Campinas, SP, Brazil.
   [Lenquiste, S. A.; Baseggio, A. M.; Marostica Jr, M. R.] Univ Estadual Campinas, Dept Food & Nutr, 80 Monteiro Lobato St, BR-13083852 Campinas, SP, Brazil.
   [Aguiar, A. C.; Erbelin, M. N.] Univ Estadual Campinas, Inst Chem, ThoMSon Mass Spectrometry Lab, BR-13083859 Campinas, SP, Brazil.
   [Collares-Buzato, C. B.] Univ Estadual Campinas, Dept Biochem & Tissue Biol, 255 Monteiro Lobato St, BR-13083970 Campinas, SP, Brazil.
C3 Universidade Estadual de Campinas; Universidade Estadual de Campinas;
   Universidade Estadual de Campinas; Universidade Estadual de Campinas
RP Lamas, CA (corresponding author), State Univ Campinas UNICAMP, Dept Struct & Funct Biol, Biol Inst, Block A,Cidade Univ Zeferino Vaz Barao Geraldo, BR-13083865 Campinas, SP, Brazil.
EM celina.lamas@gmail.com
RI Kido, Larissa A/J-4884-2017; Collares-Buzato, Carla/GSO-0074-2022;
   Cagnon, Valéria/B-1638-2013; de A. C. Aguiar, Ana Carolina/P-5153-2014;
   Marostica Junior, Mario Roberto/P-5936-2018
OI Collares-Buzato, Carla/0000-0002-3269-9261; de A. C. Aguiar, Ana
   Carolina/0000-0002-5063-7259; Marostica Junior, Mario
   Roberto/0000-0001-8877-3160; Baseggio, Andressa/0000-0003-0242-0845
FU National Council for Scientific and Technological Development [CNPq -
   141766/2015-8]; Sao Paulo Research Foundation [FAPESP - 2015/25714-1];
   CNPq [301108/2016-1]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [15/25714-1] Funding Source: FAPESP
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq - 141766/2015-8) and the Sao Paulo
   Research Foundation (FAPESP - 2015/25714-1). MRMJ thanks CNPq
   (301108/2016-1) for financial support.
CR Abe LT, 2007, CIENCIA TECNOL ALIME, V27, P394, DOI 10.1590/S0101-20612007000200032
   [Anonymous], 2013, PLOS ONE
   Araújo CRR, 2014, J MED FOOD, V17, P262, DOI 10.1089/jmf.2012.0256
   Bataglion GA, 2015, FOOD CHEM, V180, P280, DOI 10.1016/j.foodchem.2015.02.059
   Batista AG, 2014, J FUNCT FOODS, V6, P450, DOI 10.1016/j.jff.2013.11.011
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Carvalheira José B.C., 2002, Arq Bras Endocrinol Metab, V46, P419
   Chiang WD, 2016, FOOD NUTR RES, V60, DOI [10.3402/fnr.v60.30511, 10.3402/fnr.v60.31417]
   d Oliveira RB, 2014, INT J EXP PATHOL, V95, P296, DOI 10.1111/iep.12084
   Daskalova E, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/717439
   Dávalos A, 2004, J AGR FOOD CHEM, V52, P48, DOI 10.1021/jf0305231
   Dragano NRV, 2013, BRIT J NUTR, V110, P447, DOI 10.1017/S0007114512005090
   Duivenvoorde LPM, 2011, J MOL ENDOCRINOL, V47, P81, DOI 10.1530/JME-11-0001
   Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380
   Ersan S, 2016, J AGR FOOD CHEM, V64, P5334, DOI 10.1021/acs.jafc.6b01745
   Gobal Freij A, 2010, Ther Adv Cardiovasc Dis, V4, P375, DOI 10.1177/1753944710385048
   Gülçin I, 2011, J FOOD SCI, V76, pC585, DOI 10.1111/j.1750-3841.2011.02142.x
   Herald TJ, 2012, J SCI FOOD AGR, V92, P2326, DOI 10.1002/jsfa.5633
   Hofmann T, 2016, IND CROP PROD, V87, P340, DOI 10.1016/j.indcrop.2016.04.037
   Ibrahim RM, 2015, REV BRAS FARMACOGN, V25, P134, DOI 10.1016/j.bjp.2015.02.008
   Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Ky I, 2015, MOLECULES, V20, P2190, DOI 10.3390/molecules20022190
   Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003
   Lenquiste SA, 2015, FOOD RES INT, V77, P162, DOI 10.1016/j.foodres.2015.07.023
   Lenquiste SA, 2012, FOOD RES INT, V49, P153, DOI 10.1016/j.foodres.2012.07.052
   Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
   Luz M. A. M., 2002, HISTOQUIMICA IMUNOCI, P29
   Matsudo S., 2000, Revista Brasileira Ciencia e Movimento, P21
   Mezni A, 2017, BIOMED PHARMACOTHER, V95, P1103, DOI 10.1016/j.biopha.2017.09.027
   Negri G, 2013, REV BRAS FARMACOGN, V23, P851, DOI 10.1590/S0102-695X2013000600001
   Oh Y. S., 2016, PLOS ONE, V11, P1
   Oliveira RB, 2015, ANN ANAT, V200, P88, DOI 10.1016/j.aanat.2015.01.007
   Pepin É, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153017
   Inada KOP, 2015, J FUNCT FOODS, V17, P422, DOI 10.1016/j.jff.2015.06.002
   Plaza M, 2016, FOOD CHEM, V211, P185, DOI 10.1016/j.foodchem.2016.04.142
   Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907
   RODRIGUES H.G., 2003, REV NUTR, V16, P315
   Roesler R, 2007, CIENCIA TECNOL ALIME, V27, P53, DOI 10.1590/S0101-20612007000100010
   Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737
   Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037
   Sahin K, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1353360
   Santos SAO, 2010, IND CROP PROD, V31, P521, DOI 10.1016/j.indcrop.2010.02.001
   Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074
   Seymour EM, 2009, J MED FOOD, V12, P935, DOI 10.1089/jmf.2008.0270
   Song HZ, 2016, NUTR RES, V36, P710, DOI 10.1016/j.nutres.2016.01.011
   Stinkens R, 2015, OBES REV, V16, P715, DOI 10.1111/obr.12298
   Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539
   Tripathy D, 2010, CURR DIABETES REP, V10, P184, DOI 10.1007/s11892-010-0115-5
   Valcheva-Kuzmanova S, 2007, PLANT FOOD HUM NUTR, V62, P19, DOI 10.1007/s11130-006-0036-2
   Wang SM, 2017, EUR J NUTR, V56, P2037, DOI 10.1007/s00394-016-1241-x
   WHO, 2015, WORLD REP AG HLTH, P260
   Wrolstad R. E., 1976, COLOR PIGMENT ANAL F, P17
   Wu SBA, 2012, J AGR FOOD CHEM, V60, P7513, DOI 10.1021/jf301888y
   Wu T., 2013, PLOS ONE, V8
   Yue F, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0280-x
   Zar JH., 1998, BIOSTAT ANAL, V4th
NR 58
TC 35
Z9 36
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD AUG
PY 2018
VL 47
BP 434
EP 446
DI 10.1016/j.jff.2018.06.005
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GN4RH
UT WOS:000439019200047
DA 2024-02-19
ER

PT J
AU Zhang, MF
   Damba, T
   Wu, ZM
   Serna-Salas, S
   Buist-Homan, M
   Faber, KN
   Moshage, H
AF Zhang, Mengfan
   Damba, Turtushikh
   Wu, Zongmei
   Serna-Salas, Sandra
   Buist-Homan, Manon
   Faber, Klaas Nico
   Moshage, Han
TI Bioactive coumarin-derivative esculetin decreases hepatic stellate cell
   activation via induction of cellular senescence via the PI3K-Akt-GSK3B
   pathway
SO FOOD BIOSCIENCE
LA English
DT Article; Early Access
DE Fibrosis; Esculetin; Hepatic stellate cell; Senescence; P21; Akt
ID NONALCOHOLIC FATTY LIVER; BETA-GALACTOSIDASE; FIBROSIS; ROLES;
   MECHANISMS; APOPTOSIS; DISEASE; P21; AKT
AB Background: Activation of hepatic stellate cells (HSC) leads to initiation and progression of hepatic fibrosis. HSC senescence is inversely correlated with HSC proliferation and activation. Therefore, induction of HSC senescence may be a strategy to treat hepatic fibrosis. Coumarin-derivatives like esculetin have been suggested to inhibit proliferation of fibrogenic cells. Therefore, in this study we aimed to investigate the effect of esculetin on HSC activation and senescence.Methods: Primary rat HSC were used in all experiments. Real-time cell analyzer and BrdU incorporation assay were used to determine HSC proliferation. Gene expression of the senescence-associated genes Cdkn1a (p21), P53, activation markers Acta2, Col1a1 and quiescence markers Pparg and Lrat were measured by RT-qPCR. Senescence associated B-Galactosidase (SA -B-Gal) staining was used to identify senescent HSC.Results: Our results demonstrate that esculetin increased markers of senescence and decreased proliferation and activation markers in HSC. Protein expression of P21ap1, accompanied by phosphorylation of Ser473 Akt and Ser9 GSK3B was increased by esculetin. The effect of esculetin was dependent on PI3K-Akt signaling.Conclusion: We conclude that esculetin induces HSC senescence and reverses the activated phenotype of HSC. The induction of senescence depends on PI3K-Akt-GSK3B signaling. Esculetin could be a potential therapeutic drug for the treatment of hepatic fibrosis by inducing stellate cell senescence.
C1 [Zhang, Mengfan; Damba, Turtushikh; Wu, Zongmei; Serna-Salas, Sandra; Buist-Homan, Manon; Faber, Klaas Nico; Moshage, Han] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.
   [Damba, Turtushikh] Mongolian Natl Univ Med Sci, Sch Pharm, Ulaanbaatar, Mongolia.
C3 University of Groningen; Mongolian National University of Medical
   Sciences
RP Moshage, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.
EM a.j.moshage@umcg.nl
RI Damba, Turtushikh/ABD-9709-2020
OI Damba, Turtushikh/0000-0003-3141-249X; Zhang,
   Mengfan/0000-0002-2587-9395; Serna Salas, Sandra A./0000-0002-7116-5844;
   Moshage, Han/0000-0002-4764-0246
CR Bansal MB, 2016, HEPATOL INT, V10, P902, DOI 10.1007/s12072-016-9758-x
   Boehm EM, 2016, ENZYMES, V39, P231, DOI 10.1016/bs.enz.2016.03.003
   Choi RY, 2016, CHEM-BIOL INTERACT, V260, P13, DOI 10.1016/j.cbi.2016.10.013
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Dunning S, 2013, BBA-MOL BASIS DIS, V1832, P2027, DOI 10.1016/j.bbadis.2013.07.008
   Goodlad RA, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.274
   Harris R, 2017, LANCET GASTROENTEROL, V2, P288, DOI 10.1016/S2468-1253(16)30205-9
   Iwagami Y, 2016, HEPATOLOGY, V63, P1213, DOI 10.1002/hep.28411
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2017, CELL SIGNAL, V33, P79, DOI 10.1016/j.cellsig.2017.02.006
   Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008
   Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639
   Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee SH, 2008, BIOMED PHARMACOTHER, V62, P723, DOI 10.1016/j.biopha.2007.12.001
   Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   MOSHAGE H, 1990, HEPATOLOGY, V12, P511, DOI 10.1002/hep.1840120311
   Mosteiro L, 2018, AGING CELL, V17, DOI 10.1111/acel.12711
   Nakhaei-Rad S, 2016, J BIOL CHEM, V291, P8399, DOI 10.1074/jbc.M115.700088
   Pandey A, 2017, PHARMACOL REP, V69, P666, DOI 10.1016/j.pharep.2017.02.005
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Rössig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Saleh T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00164
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Sugihara H, 2018, AGING-US, V10, P747, DOI 10.18632/aging.101425
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Turkekul K, 2018, J CANCER PREV, V23, P10, DOI 10.15430/JCP.2018.23.1.10
   Yang DQ, 2019, EBIOMEDICINE, V47, P114, DOI 10.1016/j.ebiom.2019.08.068
   Yang W, 2021, HEPATOLOGY, V74, P2774, DOI 10.1002/hep.31987
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Yun ES, 2011, TOXICOL IN VITRO, V25, P1335, DOI 10.1016/j.tiv.2011.05.001
   Zhang MF, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111572
NR 38
TC 3
Z9 3
U1 4
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-4292
EI 2212-4306
J9 FOOD BIOSCI
JI Food Biosci.
PD 2022 DEC
PY 2022
VL 50
AR 102164
DI 10.1016/j.fbio.2022.102164
EA NOV 2022
PN B
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 6W3VF
UT WOS:000895658400004
OA Green Published
DA 2024-02-19
ER

PT S
AU Maruyama, N
   Ishigami, A
   Kuramoto, M
   Handa, S
   Kubo, S
   Imasawa, T
   Seyama, K
   Shimosawa, T
   Kasahara, Y
AF Maruyama, N
   Ishigami, A
   Kuramoto, M
   Handa, S
   Kubo, S
   Imasawa, T
   Seyama, K
   Shimosawa, T
   Kasahara, Y
BE DeGrey, ADN
TI Senescence marker protein-30 knockout mouse as an aging model
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE SMP30; SMP30-KO; aging; life span
ID SMP30; AGE
AB A mouse strain lacking SMP30 can be regarded as a strain showing ultimate decrease of the SMP30 molecule. After three months of age, SMP30-KO mice had an increased mortality rate, compared with the SMP30-WT mice, all of which remained alive. Electron microscopic observation of the hepatocytes from 12-month-old SMP30-KO mice revealed many empty vacuoles, presumably lipid droplets, abnormally enlarged mitochondria with indistinct cristae, and exceptionally large lysosomes filled with electron-dense bodies. The total hepatic triglyceride concentration of SMP30-KO mice was approximately 3.6-fold higher than that of the age-matched wild type. Similarly, the total hepatic cholesterol of SMP30-KO mice reached an approximate 3.3-fold greater value than that of the comparative group. Total hepatic phospholipids of SMP30-KO mice achieved an approximately 3.7-fold higher level compared with that of the wild-type mice. The cells from SMP30-KO mice were sensitive to apoptotic reagents. Those results supported the idea that SMP30 has an antiapoptotic function with wide spectrum. These findings indicate that SMP30-KO mice are highly susceptible to various harmful reagents. This strain might be a useful tool for aging and biological monitoring.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Maruyama, N (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.
EM maruyama@center.tmig.or.jp
RI Shimosawa, Tatsuo/A-2920-2015
OI Shimosawa, Tatsuo/0000-0002-8742-5129; Ishigami,
   Akihito/0000-0001-7875-7482
CR FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Huang Q, 2001, TOXICOL SCI, V63, P196, DOI 10.1093/toxsci/63.2.196
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x
   YUMURA W, 1989, EXP GERONTOL, V24, P237, DOI 10.1016/0531-5565(89)90015-6
NR 8
TC 26
Z9 30
U1 0
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 383
EP 387
DI 10.1196/annals.1297.068
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700068
PM 15247050
DA 2024-02-19
ER

PT J
AU Wan, J
   Wu, XS
   Chen, HB
   Xia, XY
   Song, X
   Chen, S
   Lu, XY
   Jin, J
   Su, Q
   Cai, DS
   Liu, B
   Li, B
AF Wan, Jian
   Wu, Xiangsong
   Chen, Hanbei
   Xia, Xinyi
   Song, Xi
   Chen, Song
   Lu, Xinyuan
   Jin, Jie
   Su, Qing
   Cai, Dongsheng
   Liu, Bin
   Li, Bo
TI Aging-induced aberrant RAGE/PPARα axis promotes hepatic steatosis via
   dysfunctional mitochondrial β oxidation
SO AGING CELL
LA English
DT Article; Early Access
DE aging; hepatic steatosis; mitochondria; PPAR alpha; RAGE
ID GLYCATION END-PRODUCTS; FATTY LIVER-DISEASE; INSULIN-RESISTANCE;
   PPAR-ALPHA; TRIBBLES HOMOLOG; LIPID-METABOLISM; DOWN-REGULATION;
   EXPRESSION; RECEPTOR; RAGE
AB Non-alcoholic fatty liver disease (NAFLD), characterized by an increase in hepatic triglyceride (TG) content, is the most common liver disease worldwide. Aging has been shown to increase susceptibility to NAFLD; however, the underlying molecular mechanism remains poorly understood. In the present study, we examined hepatic TG content and gene expression profiles in body weight-matched young (3 months old), middle-aged (10 months old), and old (20 months old) C57BL/6 mice and found that TGs were markedly accumulated while mitochondrial beta-oxidation-related genes, including PPAR alpha, were downregulated in the liver of old mice. In addition, advanced glycation end product receptor (RAGE), a key regulator of glucose metabolism, was upregulated in the old mice. Mechanistically, suppression of RAGE upregulated PPAR alpha and its downstream target genes, which in turn led to reduced TG retention. Finally, we found that hepatic RAGE expression was increased in aging patients, a finding that correlated with decreased PPAR alpha levels. Taken together, our findings demonstrate that the upregulation of RAGE may play a critical role in aging-associated liver steatosis.
C1 [Wan, Jian; Song, Xi; Chen, Song; Lu, Xinyuan] Shanghai Univ Med & Hlth Sci, Shanghai Pudong New Area Peoples Hosp, Dept Emergency & Crit Care Med, Shanghai, Peoples R China.
   [Wu, Xiangsong] Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China.
   [Chen, Hanbei; Jin, Jie; Su, Qing; Li, Bo] Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Dept Endocrinol, Shanghai 200092, Peoples R China.
   [Xia, Xinyi] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai, Peoples R China.
   [Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, Inst Aging, Dept Mol Pharmacol, Bronx, NY 10467 USA.
   [Liu, Bin] Hubei Polytech Univ, Sch Med, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Huangshi, Hubei, Peoples R China.
C3 Shanghai University of Medicine & Health Sciences; Shanghai Jiao Tong
   University; Shanghai Jiao Tong University; Shanghai Jiao Tong
   University; Yeshiva University; Albert Einstein College of Medicine;
   Hubei Polytechnic University
RP Li, B (corresponding author), Shanghai Jiao Tong Univ, XinHua Hosp, Sch Med, Dept Endocrinol, Shanghai 200092, Peoples R China.
EM libo@xinhuamed.com.cn
RI Li, Xiaoli/JVZ-4089-2024; Li, Li Bo/HNP-1044-2023; wang,
   chen/JED-7289-2023; cheng, chen/JHS-9462-2023; liu, Bin/AAP-1252-2020;
   jiang, lei/IWE-1124-2023
OI Wan, Jian/0000-0002-7957-0756; liu, bin/0000-0003-1569-2604
FU Project of Clinical Medical Plateau Discipline Construction in Shanghai
   Pudong New Area [PWYgy2018-07]; National Natural Science Foundation of
   China [81500663]; Shanghai Outstanding Young Doctor Training and Funding
   Program; Project of Excellent Young Scholars from Shanghai Municipal
   Health and Family Planning Commission [2018YQ10, 2018YQ37]; Natural
   Science Foundation of Shanghai [20ZR1471900]
FX This study was supported by Project of Clinical Medical Plateau
   Discipline Construction in Shanghai Pudong New Area (No. PWYgy2018-07)
   by J.W., the National Natural Science Foundation of China (No.
   81500663), the Shanghai Outstanding Young Doctor Training and Funding
   Program, the Project of Excellent Young Scholars from Shanghai Municipal
   Health and Family Planning Commission (No. 2018YQ37) and Natural Science
   Foundation of Shanghai (No. 20ZR1471900) by B.L., the Project of
   Excellent Young Scholars from Shanghai Municipal Health and Family
   Planning Commission (No. 2018YQ10) by X.W. We thank Dr. Meng Liu who
   drew the schematic diagram.
CR Anggayasti WL, 2020, COMPUT STRUCT BIOTEC, V18, P1160, DOI 10.1016/j.csbj.2020.05.012
   Bangert A, 2016, P NATL ACAD SCI USA, V113, pE155, DOI 10.1073/pnas.1522288113
   Bidasee KR, 2004, DIABETES, V53, P463, DOI 10.2337/diabetes.53.2.463
   Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9
   Bijnen M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33661-y
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Chandrashekaran V, 2017, REDOX BIOL, V13, P8, DOI 10.1016/j.redox.2017.05.005
   Chen HB, 2014, MOL CELL ENDOCRINOL, V395, P69, DOI 10.1016/j.mce.2014.07.021
   Cho HJ, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0106-z
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006
   del Pozo CH, 2019, CELL REP, V28, P773, DOI 10.1016/j.celrep.2019.06.061
   Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817
   Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319
   Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042
   Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206
   Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   García-Ruiz C, 2013, FREE RADICAL RES, V47, P854, DOI 10.3109/10715762.2013.830717
   Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Guillory B, 2018, AGING CELL, V17, DOI 10.1111/acel.12688
   Hänfling B, 2016, MOL ECOL, V25, P3101, DOI 10.1111/mec.13660
   Hsieh CC, 2004, MECH AGEING DEV, V125, P785, DOI 10.1016/j.mad.2004.07.008
   Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com
   Jin JL, 2016, CELL REP, V16, P744, DOI 10.1016/j.celrep.2016.06.019
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Leung C, 2016, WORLD J GASTROENTERO, V22, P8026, DOI 10.3748/wjg.v22.i35.8026
   Li B, 2014, J MOL ENDOCRINOL, V53, P393, DOI 10.1530/JME-14-0127
   Loyer X, 2016, GUT, V65, P1882, DOI 10.1136/gutjnl-2014-308883
   Lu Y, 2014, J CLIN INVEST, V124, P3501, DOI 10.1172/JCI74438
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798
   Nassir F, 2014, WORLD J GASTROENTERO, V20, P2136, DOI 10.3748/wjg.v20.i9.2136
   Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448
   Osgood D, 2017, NEUROBIOL AGING, V57, P178, DOI 10.1016/j.neurobiolaging.2017.05.011
   Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Senatus LM, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00187
   Song F, 2014, DIABETES, V63, P1948, DOI 10.2337/db13-1636
   Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774
   Xiao F, 2014, DIABETES, V63, P2631, DOI 10.2337/db13-1689
   Xie DY, 2016, ONCOTARGET, V7, P11609, DOI 10.18632/oncotarget.7018
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Yamagishi S, 2018, REJUV RES, V21, P456, DOI 10.1089/rej.2017.2025
   Yu JJ, 2015, DIABETES, V64, P1591, DOI 10.2337/db14-1368
   Zhang DQ, 2018, HEPATOLOGY, V68, P883, DOI 10.1002/hep.29878
   Zhao ZL, 2018, HEPATOLOGY, V68, P289, DOI 10.1002/hep.29786
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 56
TC 28
Z9 28
U1 4
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2020 OCT
PY 2020
VL 19
IS 10
AR e13238
DI 10.1111/acel.13238
EA SEP 2020
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA OL3DN
UT WOS:000571053300001
PM 32936538
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Satomoto, K
   Suzuki, I
   Mita, K
   Wakita, A
   Yamagata, H
   Mitsumoto, T
   Hamada, S
AF Satomoto, Kensuke
   Suzuki, Isamu
   Mita, Koji
   Wakita, Atsushi
   Yamagata, Hiroshi
   Mitsumoto, Tatsuya
   Hamada, Shuichi
TI The effect of aging on the repeated-dose liver micronucleus assay using
   diethylnitrosamine
SO GENES AND ENVIRONMENT
LA English
DT Article
DE Micronucleus assay; Liver; Rat; Diethylnitrosamine; Ki-67
ID ADULT RATS
AB Background: The repeated-dose liver micronucleus (RDLMN) assay has been well-developed and applied because of its simplicity and the ease of integration into general toxicity studies which is the preferred method from the 3R's point of view. In this assay, we observed micronucleated hepatocytes which accumulated during a rather long-term dosing period. When considering integration into general toxicity studies, the effects of age of the animals used in the micronucleus assay becomes a major issue. The effect of age on the micronucleus induction rate has been reported in bone marrow micronucleus assays, and it is considered that the decrease in cell proliferation rate due to aging is the cause of the decrease in sensitivity. A decrease in sensitivity due to aging was also reported in a liver micronucleus assay using clofibrate and the cause is considered to be a decrease in hepatocyte proliferation activity due to aging. However, no actual decrease in hepatocyte proliferation rate due to aging has been reported. In addition, there are no reports, so far, on whether similar effects of aging appear when other substances were administered. To investigate the effects of aging in the RDLMN assay, this study focused on the effects of 14-day repeated administration of DEN, a well-known genotoxic hepatocarcinogen with the hepatocyte toxicity which should cause an elevation of cell proliferation rate as a reflective regeneration.
   Results: The liver micronuclei induced by DEN were equivalent between the two age groups (i.e., six and eight weeks of age at the start of dosing). In the histopathological examination for the liver, single cell necrosis, karyomegaly, and increased mitosis were observed in the hepatocytes, and the frequency and severity were increased dose-dependently. Ki-67 immunohistochemical analysis which can detect all cells in the cell cycle other than those in the G0 phase revealed dose-dependent increase of cell proliferation activity, and the difference between ages was not observed.
   Conclusion: The effect of aging on the RDLMN assay could not be recognized when DEN was administered for 14 days in rats. Meanwhile, it was supported by the histopathological examination and Ki-67 immunohistochemical analysis that such an effect of aging was masked by the compensatory hepatocyte proliferation which was induced by the hepatocyte toxicity of DEN.
C1 [Satomoto, Kensuke; Suzuki, Isamu; Mita, Koji; Wakita, Atsushi; Yamagata, Hiroshi; Mitsumoto, Tatsuya; Hamada, Shuichi] BoZo Res Ctr Inc, Gotemba Lab, 1284 Kamado, Gotemba, Shizuoka 4120039, Japan.
C3 Bozo Research Center Inc.
RP Satomoto, K (corresponding author), BoZo Res Ctr Inc, Gotemba Lab, 1284 Kamado, Gotemba, Shizuoka 4120039, Japan.
EM satomoto-kensuke@bozo.co.jp
CR Agresti A., 2002, Categorical data analysis. Hoboken, V2, DOI DOI 10.1002/0471249688
   [Anonymous], 1988, Nonparametric Statisticsfor the Behavioral Sciences
   ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775
   COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616
   DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208
   DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490
   Gao J, 2018, J PHARMACOL EXP THER, V365, P398, DOI 10.1124/jpet.117.245555
   GERDES J, 1984, J IMMUNOL, V133, P1710
   Hamada S, 2003, MUTAGENESIS, V18, P273, DOI 10.1093/mutage/18.3.273
   Hamada S, 2015, MUTAT RES-GEN TOX EN, V780, P2, DOI 10.1016/j.mrgentox.2015.01.001
   Narumi K, 2012, MUTAT RES-GEN TOX EN, V747, P234, DOI 10.1016/j.mrgentox.2012.05.012
   OECD Organization for Economic Co-operation and Development (OECD), 2008, OECD GUID TEST CHEM
   Shigano M, 2021, GENES ENVIRON, V43, DOI 10.1186/s41021-021-00212-3
   STEEL RGD, 1959, BIOMETRICS, V15, P560, DOI 10.2307/2527654
   Uno Y, 2015, MUTAT RES-GEN TOX EN, V783, P19, DOI 10.1016/j.mrgentox.2015.03.001
   Xu SF, 2019, PEERJ, V7, DOI 10.7717/peerj.7429
NR 16
TC 2
Z9 2
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1880-7046
EI 1880-7062
J9 GENES ENVIRON
JI Gene Environ.
PD AUG 18
PY 2022
VL 44
IS 1
AR 21
DI 10.1186/s41021-022-00250-5
PG 7
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA 3W2OW
UT WOS:000842191700001
PM 35982479
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Liu, ZN
   Wu, BM
   Liu, XQ
   Wu, X
   Du, JY
   Xia, GQ
   Cai, JN
   Zhu, H
   Sheng, XD
   Zhang, MD
   Xu, JR
   Xu, T
   Lv, XW
AF Liu, Zhenni
   Wu, Baoming
   Liu, Xueqi
   Wu, Xue
   Du, Jiyu
   Xia, Guoqing
   Cai, Junnan
   Zhu, Hong
   Sheng, Xiaodong
   Zhang, Mengda
   Xu, Junrui
   Xu, Tao
   Lv, Xiongwen
TI CD73/NT5E-mediated ubiquitination of AURKA regulates alcohol-related
   liver fibrosis via modulating hepatic stellate cell senescence
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE Alcohol-related liver fibrosis (ALF); CD39-CD73-Adenosine axis; Aurora
   kinase A (AURKA); p53 signaling pathway
ID DISEASE PATHOGENESIS; ADENOSINE; CD73; DEGRADATION; AUTOPHAGY; LYSOSOME;
   PATHWAY; INJURY; TARGET
AB Alcohol-related liver disease (ALD) is the most common chronic liver disease worldwide; however, no effective treatment to prevent the progression of alcohol-related liver fibrosis (ALF) is available. CD73/NT5E, a nucleotidase, controls cellular homeostasis by combining extracellular purinergic signaling with intracellular kinase activity and gene transcription and is associated with cell proliferation, differentiation, and death. In this study, we demonstrated that CD73/NT5E had a more significant regulatory effect on the activation, proliferation, and apoptosis of HSCs compared with that of CD39/ENTPD1. We examined the expression of CD73/NT5E in the normal and fibrotic human livers. The absence of CD73/NT5E was protective in mouse models of ALF. In addition, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses showed that CD73/NT5E overexpression was related to the p53 signaling pathway, which regulates cell senescence. Proteins interacting with p53 were predicted using the STRING database. The overlap between proteomic analysis and STRING databases was for Aurora kinase A (AURKA), a cell cycle-regulated kinase. Coimmunoprecipitation (co-IP) assay and molecular docking confirmed that CD73/NT5E directly interacted with AURKA. We found that overexpression of CD73/NT5E inhibited AURKA ubiquitination, whereas p53 signaling was downregulated. Mechanistically, CD73/NT5E regulated ALF and the activation and senescence of stellate cells by binding to AURKA. These findings indicate that CD73/NT5E is a potential therapeutic target for ALF.
C1 [Liu, Zhenni; Wu, Baoming; Liu, Xueqi; Wu, Xue; Du, Jiyu; Xia, Guoqing; Cai, Junnan; Zhu, Hong; Sheng, Xiaodong; Zhang, Mengda; Xu, Tao; Lv, Xiongwen] Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China.
   [Liu, Zhenni; Wu, Baoming; Liu, Xueqi; Wu, Xue; Du, Jiyu; Xia, Guoqing; Cai, Junnan; Zhu, Hong; Sheng, Xiaodong; Zhang, Mengda; Xu, Tao; Lv, Xiongwen] Anhui Med Univ, Sch Pharm, Hefei, Peoples R China.
   [Liu, Zhenni; Wu, Baoming; Liu, Xueqi; Wu, Xue; Du, Jiyu; Xia, Guoqing; Cai, Junnan; Zhu, Hong; Sheng, Xiaodong; Zhang, Mengda; Xu, Tao; Lv, Xiongwen] Anhui Med Univ, Inst Liver Dis, Hefei, Peoples R China.
   [Xu, Junrui] Anhui Med Univ, Gen Thorac Surg, Affiliated Hosp 1, Hefei, Peoples R China.
C3 Anhui Medical University; Anhui Medical University; Anhui Medical
   University
RP Lv, XW (corresponding author), Anhui Med Univ, Sch Pharm, 81 Mei Shan Rd, Hefei 230032, Anhui, Peoples R China.
EM xiongwen_lv2019@163.com
RI yan, xiao/JVP-0766-2024
FU National Natural Science Foundation of China [81970518]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81970518).
CR Brol MJ, 2019, AM J PHYSIOL-GASTR L, V317, pG182, DOI 10.1152/ajpgi.00361.2018
   Bryazka D, 2022, LANCET, V400, P185, DOI 10.1016/S0140-6736(22)00847-9
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Ciechanover A, 2017, BEST PRACT RES CL HA, V30, P341, DOI 10.1016/j.beha.2017.09.001
   Du RJ, 2021, MOL CANCER, V20, DOI 10.1186/s12943-020-01305-3
   Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014
   Faas MM, 2017, MOL ASPECTS MED, V55, P9, DOI 10.1016/j.mam.2017.01.002
   Fernández P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024
   Ferrari D, 2016, FASEB J, V30, P3, DOI 10.1096/fj.15-274563
   Gao Bin, 2017, Gene Expression, V17, P173, DOI 10.3727/105221617X695519
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Ghalamfarsa G, 2019, EXPERT OPIN THER TAR, V23, P127, DOI 10.1080/14728222.2019.1559829
   Giuliani AL, 2019, IMMUNOL LETT, V205, P16, DOI 10.1016/j.imlet.2018.11.006
   Gnad T, 2020, CELL METAB, V32, P56, DOI 10.1016/j.cmet.2020.06.006
   Goswami S, 2020, NAT MED, V26, P39, DOI 10.1038/s41591-019-0694-x
   He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085
   Jia WQ, 2021, EUR J PHARMACOL, V890, DOI 10.1016/j.ejphar.2020.173667
   Jiang MZ, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166227
   Kazemi MH, 2018, J CELL PHYSIOL, V233, P2032, DOI 10.1002/jcp.25873
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Leone RD, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0360-8
   Li XC, 2018, THERANOSTICS, V8, P1740, DOI 10.7150/thno.22010
   Liu ZN, 2022, J INFLAMM RES, V15, P53, DOI 10.2147/JIR.S341680
   Liu ZN, 2019, INT IMMUNOPHARMACOL, V77, DOI 10.1016/j.intimp.2019.105915
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Ma XL, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0724-7
   Moesta AK, 2020, NAT REV IMMUNOL, V20, P739, DOI 10.1038/s41577-020-0376-4
   Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318
   Pda A, 2019, Clin Liver Dis., V23, P39
   Peacock A, 2018, ADDICTION, V113, P1905, DOI 10.1111/add.14234
   Peng ZW, 2017, HEPATOL COMMUN, V1, P957, DOI 10.1002/hep4.1084
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Sasai K, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00247
   Seitz HK, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0014-7
   Shuai C, 2021, EUR J PHARMACOL, V905, DOI 10.1016/j.ejphar.2021.174198
   Singal AK, 2021, JAMA-J AM MED ASSOC, V326, P165, DOI 10.1001/jama.2021.7683
   Singh S, 2017, WORLD J GASTROENTERO, V23, P6549, DOI 10.3748/wjg.v23.i36.6549
   Testino G, 2018, MINERVA MED, V109, P457, DOI 10.23736/S0026-4806.18.05844-5
   Tsuchida T, 2018, J HEPATOL, V69, P385, DOI 10.1016/j.jhep.2018.03.011
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Verkhratsky A, 2014, BIOESSAYS, V36, P697, DOI 10.1002/bies.201400024
   Wen-Jun, 2019, World J Gastroentero, V25, P12
   Wu CJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05694-4
   Yang JF, 2019, J CELL PHYSIOL, V234, P7587, DOI 10.1002/jcp.27521
   Yang S, 2014, Plos One, V9
   Zhang C, 2019, CANCER RES, V79, P928, DOI 10.1158/0008-5472.CAN-18-0520
NR 50
TC 1
Z9 1
U1 0
U2 0
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2023
VL 19
IS 3
BP 950
EP 966
DI 10.7150/ijbs.80461
PG 17
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA U3JQ4
UT WOS:001083798700009
PM 36778123
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Tsukahara, Y
   Ferran, B
   Minetti, ET
   Chong, BSH
   Gower, AC
   Bachschmid, MM
   Matsui, R
AF Tsukahara, Yuko
   Ferran, Beatriz
   Minetti, Erika T.
   Chong, Brian S. H.
   Gower, Adam C.
   Bachschmid, Markus M.
   Matsui, Reiko
TI Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by
   Aging and Non-Alcoholic Steatohepatitis
SO ANTIOXIDANTS
LA English
DT Article
DE liver fibrosis; aging; non-alcoholic steatohepatitis; glutaredoxin-1;
   immune cells
ID VITAMIN-E; S-GLUTATHIONYLATION; MOUSE MODEL; KAPPA-B; EXPRESSION;
   DISEASE; DIET; APOPTOSIS; CELLS; GENE
AB Liver fibrosis is a sign of non-alcoholic fatty liver disease progression towards steatohepatitis (NASH) and cirrhosis and is accelerated by aging. Glutaredoxin-1 (Glrx) controls redox signaling by reversing protein S-glutathionylation, induced by oxidative stress, and its deletion causes fatty liver in mice. Although Glrx regulates various pathways, including metabolism and apoptosis, the impact of Glrx on liver fibrosis has not been studied. Therefore, we evaluated the role of Glrx in liver fibrosis induced by aging or by a high-fat, high-fructose diet. We found that: (1) upregulation of Glrx expression level inhibits age-induced hepatic apoptosis and liver fibrosis. In vitro studies indicate that Glrx regulates Fas-induced apoptosis in hepatocytes; (2) diet-induced NASH leads to reduced expression of Glrx and higher levels of S-glutathionylated proteins in the liver. In the NASH model, hepatocyte-specific adeno-associated virus-mediated Glrx overexpression (AAV-Hep-Glrx) suppresses fibrosis and apoptosis and improves liver function; (3) AAV-Hep-Glrx significantly inhibits transcription of Zbtb16 and negatively regulates immune pathways in the NASH liver. In conclusion, the upregulation of Glrx is a potential therapeutic for the reversal of NASH progression by attenuating inflammatory and fibrotic processes.
C1 [Tsukahara, Yuko; Ferran, Beatriz; Minetti, Erika T.; Chong, Brian S. H.; Bachschmid, Markus M.; Matsui, Reiko] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect, Boston, MA 02118 USA.
   [Gower, Adam C.] Boston Univ, Sch Med, Clin & Translat Sci Inst, Boston, MA 02118 USA.
C3 Boston University; Boston University
RP Matsui, R (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect, Boston, MA 02118 USA.
EM ytsuka@bu.edu; beatriz-ferranperez@ouhsc.edu; eminetti@bu.edu;
   chongbsh@bu.edu; ctsibio@bu.edu; markus@quintarabio.com; rmatsui@bu.edu
OI Minetti, Erika Teresa/0000-0002-4771-791X; Gower,
   Adam/0000-0002-6122-7511
FU NIH [R01 HL133013, R03 AG 051857, R01 DK103750, T32 HL07224]; NIH CTSI
   [1UL1TR001430]; Whitaker Cardiovascular Institute
FX This work was supported by NIH grants R01 HL133013 and R03 AG 051857
   (RM), R01 DK103750 (MMB), and NIH CTSI award 1UL1TR001430 (RM, ACG),
   Pilot grants from the Whitaker Cardiovascular Institute (RM, YT). BF was
   supported by NIH T32 HL07224 Multidisciplinary Training in
   Cardiovascular Research through the Whitaker Cardiovascular Institute.
CR ALAM T, 1992, J BIOL CHEM, V267, P5021
   Anathy V, 2018, NAT MED, V24, P1128, DOI 10.1038/s41591-018-0090-y
   Anathy V, 2009, J CELL BIOL, V184, P241, DOI 10.1083/jcb.200807019
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Bachschmid MM, 2010, FREE RADICAL BIO MED, V49, P1221, DOI 10.1016/j.freeradbiomed.2010.07.005
   Barrow F, 2021, HEPATOLOGY, V74, P2277, DOI 10.1002/hep.31889
   Boland ML, 2019, WORLD J GASTROENTERO, V25, P4904, DOI 10.3748/wjg.v25.i33.4904
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Carrillo-Carrasco N, 2010, HUM GENE THER, V21, P1147, DOI 10.1089/hum.2010.008
   Chalasani NP, 2009, CONTEMP CLIN TRIALS, V30, P88, DOI 10.1016/j.cct.2008.09.003
   Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013
   Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179
   Delire B, 2017, AGING-US, V9, P112, DOI 10.18632/aging.101124
   Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368
   El Hadi H, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010012
   Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Guo L, 2017, J CLIN INVEST, V127, P4449, DOI 10.1172/JCI96324
   Hagström H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027
   Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x
   Herrero-Cervera A, 2019, DIABETOLOGIA, V62, P2143, DOI 10.1007/s00125-019-4962-6
   Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025
   Hong IH, 2014, J BIOL CHEM, V289, P1106, DOI 10.1074/jbc.M113.526780
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Kanda T, 2018, WORLD J GASTROENTERO, V24, P2661, DOI 10.3748/wjg.v24.i25.2661
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim YH, 2017, J IMMUNOL, V199, P3478, DOI 10.4049/jimmunol.1700567
   Kimura T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49624-w
   Koruk M, 2004, ANN CLIN LAB SCI, V34, P57
   Maeso-Díaz R, 2019, AGING DIS, V10, P684, DOI 10.14336/AD.2019.0127
   Maricic I, 2018, J IMMUNOL, V201, P3017, DOI 10.4049/jimmunol.1800614
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Murdoch CE, 2014, J BIOL CHEM, V289, P8633, DOI 10.1074/jbc.M113.517219
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Pacana T, 2012, CURR OPIN CLIN NUTR, V15, P641, DOI 10.1097/MCO.0b013e328357f747
   Park JY, 2019, CELL REP, V27, P2548, DOI 10.1016/j.celrep.2019.05.012
   Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0
   Qi J, 2020, AM J PATHOL, V190, P68, DOI 10.1016/j.ajpath.2019.09.011
   Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103
   Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929
   Seda O, 2017, PHYSIOL RES, V66, pS357, DOI 10.33549/physiolres.933730
   Shao D, 2017, ANTIOXID REDOX SIGN, V27, P313, DOI 10.1089/ars.2016.6716
   Shao D, 2014, J BIOL CHEM, V289, P7293, DOI 10.1074/jbc.M113.520403
   Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tajiri K, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/850836
   Walenbergh SMA, 2013, J HEPATOL, V58, P801, DOI 10.1016/j.jhep.2012.11.014
   Watanabe Y, 2020, FASEB J, V34, P5827, DOI 10.1096/fj.201902575R
   Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167
   Yan ZH, 2012, GENE, V506, P289, DOI 10.1016/j.gene.2012.07.009
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251
   Zhou Z, 2016, CELL MOL IMMUNOL, V13, P301, DOI 10.1038/cmi.2015.97
NR 54
TC 5
Z9 5
U1 4
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD MAY
PY 2022
VL 11
IS 5
AR 867
DI 10.3390/antiox11050867
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 1Q2XG
UT WOS:000802556400001
PM 35624731
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Yin, KL
   Patten, D
   Gough, S
   Goncalves, SD
   Chan, ADLY
   Olan, I
   Cassidy, L
   Poblocka, M
   Zhu, HR
   Lun, AR
   Schuijs, M
   Young, A
   Martinez-Jimenez, C
   Halim, TYF
   Shetty, S
   Narita, M
   Hoare, M
AF Yin, Kelvin
   Patten, Daniel
   Gough, Sarah
   Goncalves, Susana de Barros
   Chan, Adelyne
   Olan, Ioana
   Cassidy, Liam
   Poblocka, Marta
   Zhu, Haoran
   Lun, Aaron
   Schuijs, Martijn
   Young, Andrew
   Martinez-Jimenez, Celia
   Halim, Timotheus Y. F.
   Shetty, Shishir
   Narita, Masashi
   Hoare, Matthew
TI Senescence-induced endothelial phenotypes underpin immune-mediated
   senescence surveillance
SO GENES & DEVELOPMENT
LA English
DT Article
DE senescence; immune surveillance; SASP; endothelium; liver; NF-kappa B
ID ONCOGENE-INDUCED SENESCENCE; SECRETORY PHENOTYPE; TUMOR SURVEILLANCE;
   CELLS; ACTIVATION; EXPRESSION; RESPONSES; RECEPTOR; LIGAND
AB Senescence is a stress-responsive tumor suppressor mechanism associated with expression of the senescence-associated secretory phenotype (SASP). Through the SASP, senescent cells trigger their own immune-mediated elimination, which if evaded leads to tumorigenesis. Senescent parenchymal cells are separated from circulating immunocytes by the endothelium, which is targeted by microenvironmental signaling. Here we show that SASP induces endothelial cell NF-kappa B activity and that SASP-induced endothelial expression of the canonical NF-kappa B component Rela underpins senescence surveillance. Using human liver sinusoidal endothelial cells (LSECs), we show that SASP-induced endothelial NF-kappa B activity regulates a conserved transcriptional program supporting immunocyte recruitment. Furthermore, oncogenic hepatocyte senescence drives murine LSEC NF-kappa B activity in vivo. Critically, we show two distinct endothelial pathways in senescence surveillance. First, endothelial-specific loss of Rela prevents development of Stat1-expressing CD4(+) T lymphocytes. Second, the SASP up-regulates ICOSLG on LSECs, with the ICOS-ICOSLG axis contributing to senescence cell clearance. Our results show that the endothelium is a nonautonomous SASP target and an organizing center for immune-mediated senescence surveillance.
C1 [Yin, Kelvin; Gough, Sarah; Goncalves, Susana de Barros; Chan, Adelyne; Olan, Ioana; Cassidy, Liam; Poblocka, Marta; Zhu, Haoran; Lun, Aaron; Schuijs, Martijn; Young, Andrew; Halim, Timotheus Y. F.; Narita, Masashi; Hoare, Matthew] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England.
   [Yin, Kelvin; Martinez-Jimenez, Celia] Helmholtz Zentrum Munchen, Helmholtz Pioneer Campus, D-85764 Munich, Germany.
   [Patten, Daniel; Shetty, Shishir] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham B15 2TT, England.
   [Narita, Masashi] Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Yokohama, Kanagawa 2260026, Japan.
   [Hoare, Matthew] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England.
C3 CRUK Cambridge Institute; University of Cambridge; Cancer Research UK;
   Helmholtz Association; Helmholtz-Center Munich - German Research Center
   for Environmental Health; University of Birmingham; Tokyo Institute of
   Technology; University of Cambridge
RP Narita, M; Hoare, M (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England.; Narita, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Tokyo Tech World Res Hub Initiat WRHI, Yokohama, Kanagawa 2260026, Japan.; Hoare, M (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England.
EM masashi.narita@cruk.cam.ac.uk; mwh20@cam.ac.uk
RI Shetty, Shishir/AAU-4047-2021; Martinez, Celia/IVH-7222-2023; Halim,
   Timotheus YF/B-3117-2018; Schuijs, Martijn/GWZ-4285-2022; Martinez,
   Celia/K-8751-2012
OI Shetty, Shishir/0000-0002-4729-2173; Halim, Timotheus
   YF/0000-0001-9773-0023; Schuijs, Martijn/0000-0001-6433-6417; Yin,
   Kelvin/0000-0003-2993-6374; Olan, Ioana/0000-0003-0692-1831; Narita,
   Masashi/0000-0001-7764-577X; Cassidy, Liam/0000-0002-9312-6256;
   Martinez, Celia/0000-0002-9534-6201; Patten, Daniel/0000-0002-8745-0578;
   Chan, Adelyne Sue Li/0000-0003-2214-0306; Lun, Aaron/0000-0002-3564-4813
FU CRUK Advanced Clinician Scientist Fellowship [C53575/A29959,
   65BX18MNIB]; CRUK Accelerator Award [C18873/A26813]; CRUK-Oregon Health
   and Science University (OHSU) [C52489/A29681]; CRUK Cambridge Institute
   core grant [C9545/A29580]; Medical Research Council [MR/R010013/1];
   Biotechnology and Biological Sciences Research Council [BB/T013486/1,
   C52489/A19924]; Diabetes UK via BIRAX (the Britain Israel Research and
   Academic Exchange Partnership); British Council [65BX18MNIB]; British
   Council; CRUK Pioneer; National Institute for Health and Care Research
   (NIHR) Cambridge Biomedical Research Centre [BB/S013466/1]; 
   [C63389/A30462];  [BRC-1215-20014]
FX We thank all members of the Narita laboratory for helpful discussions,
   and staff of the Cancer Research UK (CRUK) Cambridge Institute core
   facilities for technical support. This work was supported by a CRUK
   Advanced Clinician Scientist Fellowship (C52489/A19924), CRUK
   Accelerator Award (C18873/A26813), and CRUK-Oregon Health and Science
   University (OHSU) Joint Award (C52489/A29681) to M.H., and a CRUK
   Cambridge Institute core grant (C9545/A29580) to the Narita laboratory.
   D.P., S.S., M.H., and M.N. are also supported by a Medical Research
   Council project grant (MR/R010013/1). M.N. is also supported by the
   Biotechnology and Biological Sciences Research Council (BB/S013466/1)
   and Diabetes UK via BIRAX (the Britain Israel Research and Academic
   Exchange Partnership) and the British Council (65BX18MNIB). M.N. and
   L.C. are also supported by the Biotechnology and Biological Sciences
   Research Council (BB/T013486/1) and Diabetes UK via BIRAX and the
   British Council (65BX18MNIB). I.O. is also supported by the CRUK Pioneer
   grant (C63389/A30462). S.S. is supported by a CRUK Advanced Clinician
   Scientist Fellowship (C53575/A29959). This research was supported by the
   National Institute for Health and Care Research (NIHR) Cambridge
   Biomedical Research Centre (BRC-1215-20014*). The views expressed are
   those of the authors and not necessarily those of the NIHR or the
   Department of Health and Social Care. Author contributions: M.N. and
   M.H. conceived the study. K.Y., M.N., and M.H. performed the
   methodology. K.Y., D.P., S.G., S.d.B.G., L.C., M.P., H.Z., and A.Y.
   performed the investigation and formal analysis. D.P., I.O., A.L., M.S.,
   C.M.-J., T.Y.F.H., S.S., and M.N. acquired the resources. A.C., I.O.,
   and A.L. were responsible for the software and curated the data. M.H.
   wrote the original draft of the manuscript. K.Y., L.C., T.Y.F.H., M.N.,
   and M.H. reviewed and edited the manuscript. S.S., M.N., and M.H.
   supervised the study, were the project administrators, and acquired the
   funding.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Cao ZW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8710
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Fallarino F, 1999, J IMMUNOL, V163, P4109
   Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138
   Gonçalves S, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108860
   Guilliams M, 2022, CELL, V185, P379, DOI 10.1016/j.cell.2021.12.018
   Hanson A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239595
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Kale A, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00187-9
   Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556
   Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836
   Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699
   Klingenberg R, 2005, EUR J IMMUNOL, V35, P1712, DOI 10.1002/eji.200425727
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lesina M, 2016, J CLIN INVEST, V126, P2919, DOI 10.1172/JCI86477
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Lun ATL, 2017, NAT METHODS, V14, P707, DOI 10.1038/nmeth.4295
   Manicardi N, 2021, CANCERS, V13, DOI 10.3390/cancers13112688
   Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Oubaha M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9440
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Pereira BI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10335-5
   Ruscetti M, 2020, CELL, V181, P424, DOI 10.1016/j.cell.2020.03.008
   Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090
   Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y
   Shetty S, 2012, HEPATOLOGY, V56, P1521, DOI 10.1002/hep.25790
   Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961
   Sim GC, 2016, ONCOTARGET, V7, P36074, DOI 10.18632/oncotarget.8683
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3
   Wiley CD, 2021, CELL METAB, V33, P1124, DOI 10.1016/j.cmet.2021.03.008
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 48
TC 10
Z9 10
U1 4
U2 10
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD MAY 1
PY 2022
VL 36
IS 9-10
BP 533
EP 549
DI 10.1101/gad.349585.122
PG 17
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 3F9CI
UT WOS:000830957700003
PM 35618311
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Fafián-Labora, J
   Carpintero-Fernández, P
   Jordan, SJD
   Shikh-Bahaei, T
   Abdullah, SM
   Mahenthiran, M
   Rodriguez-Navarro, JA
   Niklison-Chirou, MV
   O'Loghlen, A
AF Fafian-Labora, Juan
   Carpintero-Fernandez, Paula
   Jordan, Samuel James Davison
   Shikh-Bahaei, Tamanna
   Abdullah, Sana Mohammad
   Mahenthiran, Midusa
   Antonio Rodriguez-Navarro, Jose
   Niklison-Chirou, Maria Victoria
   O'Loghlen, Ana
TI FASN activity is important for the initial stages of the induction of
   senescence
SO CELL DEATH & DISEASE
LA English
DT Article
ID ACID SYNTHASE INHIBITION; ACTIVATED PROTEIN-KINASE; CELLULAR SENESCENCE;
   ENERGY-METABOLISM; TUMOR SUPPRESSION; MTOR; P53; CELLS; HOMEOSTASIS;
   APOPTOSIS
AB Senescent cells accumulate in several tissues during ageing and contribute to several pathological processes such as ageing and cancer. Senescence induction is a complex process not well defined yet and is characterized by a series of molecular changes acquired after an initial growth arrest. We found that fatty acid synthase (FASN) levels increase during the induction of senescence in mouse hepatic stellate cells and human primary fibroblasts. Importantly, we also observed a significant increase in FASN levels during ageing in mouse liver tissues. To probe the central role of FASN in senescence induction, we used a small-molecule inhibitor of FASN activity, C75. We found that C75 treatment prevented the induction of senescence in mouse and human senescent cells. Importantly, C75 also reduced the expression of the signature SASP factors interleukin 1 alpha (IL-1 alpha), IL-1 beta and IL-6, and suppressed the secretion of small extracellular vesicles. These findings were confirmed using a shRNA targeting FASN. In addition, we find that FASN inhibition induces metabolic changes in senescent cells. Our work underscores the importance of C75 as a pharmacological inhibitor for reducing the impact of senescent cell accumulation.
C1 [Fafian-Labora, Juan; Carpintero-Fernandez, Paula; Jordan, Samuel James Davison; Shikh-Bahaei, Tamanna; Abdullah, Sana Mohammad; Mahenthiran, Midusa; O'Loghlen, Ana] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Epigenet & Cellular Senescence Grp, 4 Newark St, London E1 2AT, England.
   [Fafian-Labora, Juan; Carpintero-Fernandez, Paula; Jordan, Samuel James Davison; Shikh-Bahaei, Tamanna; Abdullah, Sana Mohammad; Mahenthiran, Midusa; Niklison-Chirou, Maria Victoria; O'Loghlen, Ana] Queen Mary Univ London, Ctr Genom & Child Hlth, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.
   [Antonio Rodriguez-Navarro, Jose] Hosp Ramon & Cajal, Neurobiol Invest, Inst Ramon & Cajal Invest Sanitarias, Madrid 28034, Spain.
C3 University of London; Queen Mary University London; University of
   London; Queen Mary University London; Hospital Universitario Ramon y
   Cajal
RP O'Loghlen, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Epigenet & Cellular Senescence Grp, 4 Newark St, London E1 2AT, England.; Niklison-Chirou, MV; O'Loghlen, A (corresponding author), Queen Mary Univ London, Ctr Genom & Child Hlth, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.
EM m.niklison-chirou@qmul.ac.uk; a.ologhlen@qmul.ac.uk
RI Fafian-Labora, Juan/AAB-4877-2019; O'Loghlen, Ana/K-9965-2014;
   Carpintero-Fernandez, Paula/AAA-8043-2020
OI Fafian-Labora, Juan/0000-0003-1510-8666; Carpintero-Fernandez,
   Paula/0000-0002-4495-2332; Jordan, Samuel/0000-0002-5580-9451; Niklison
   Chirou, Maria Victoria/0000-0002-2147-370X; O'Loghlen,
   Ana/0000-0002-8141-1965
FU Children with Cancer UK [14-178]; BBSRC [BB/P000223/1]; Royal Society
   [RG170399]; Nacional Health Institute Carlos IIIMiguel-Servet
   [CP13-00234]; MINECO [SAF2016-78666 R]; Xunta de Galicia Fellowships
   [ED481B 2017/117, IN606B 2017/014]; BBSRC [BB/P000223/1] Funding Source:
   UKRI; Biotechnology and Biological Sciences Research Council
   [BB/P000223/1] Funding Source: researchfish
FX We thank Dr Peter Carmeliet for shFASN plasmid. HSCs were kindly
   provided by Dr Scott Lowe. This work was funded by Children with Cancer
   UK (Number: 14-178) awarded to M.V.N.-C., the BBSRC (BB/P000223/1) and
   The Royal Society (RG170399) awarded to A.O.L., and the Nacional Health
   Institute Carlos IIIMiguel-Servet (CP13-00234) and MINECO (SAF2016-78666
   R) awarded to J.A.R.-N. J.F.-L. and P.C.-F. are funded by the Xunta de
   Galicia Fellowships (ED481B 2017/117 and IN606B 2017/014 respectivelly).
CR Allocati N, 2012, EXP CELL RES, V318, P1285, DOI 10.1016/j.yexcr.2012.01.023
   Borghesan M., 2018, BIORXIV, DOI [10.1101/356238, DOI 10.1101/356238]
   Bruning U, 2018, CELL METAB, V28, P866, DOI 10.1016/j.cmet.2018.07.019
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Carpintero-Fernández P, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00079
   Chakraborty PK, 2015, ONCOTARGET, V6, P37367, DOI 10.18632/oncotarget.5424
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Chirou MN, 2008, FEBS J, V275, P4088, DOI 10.1111/j.1742-4658.2008.06550.x
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017
   Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763
   Ford JH, 2010, AGE, V32, P231, DOI 10.1007/s11357-009-9128-x
   Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107
   Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066
   Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028
   Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724
   Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386
   Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897
   Laezza C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.279
   Landree LE, 2004, J BIOL CHEM, V279, P3817, DOI 10.1074/jbc.M310991200
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Marmisolle I, 2017, ARCH BIOCHEM BIOPHYS, V613, P12, DOI 10.1016/j.abb.2016.10.016
   Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007
   Matsuo S, 2014, MOL MED, V20, P1, DOI 10.2119/molmed.2013.00113
   MEDES G, 1953, CANCER RES, V13, P27
   Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nacarelli T, 2017, MOL CELL ENDOCRINOL, V455, P83, DOI 10.1016/j.mce.2016.08.049
   Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407
   Niklison-Chirou MV, 2017, GENE DEV, V31, P1738, DOI 10.1101/gad.302349.117
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Salin K, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1028
   Schmitz FJ, 1995, HORM METAB RES, V27, P515, DOI 10.1055/s-2007-980016
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shi ZZ, 2019, LIFE SCI, V217, P70, DOI 10.1016/j.lfs.2018.11.037
   Smolina N, 2017, METHODS MOL BIOL, V1601, P79, DOI 10.1007/978-1-4939-6960-9_7
   Takahashi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15287
   Terlecki-Zaniewicz L, 2018, AGING-US, V10, P1103, DOI 10.18632/aging.101452
   Wiley C. D., 2018, SCI REP, V8, P2
   Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wu ZS, 2015, AGING-US, V7, P70, DOI 10.18632/aging.100722
   You JS, 2015, DIS MODEL MECH, V8, P1059, DOI 10.1242/dmm.019414
   Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579
   Zhou WB, 2003, CANCER RES, V63, P7330
NR 53
TC 46
Z9 51
U1 1
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD APR 8
PY 2019
VL 10
AR 318
DI 10.1038/s41419-019-1550-0
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HZ2DA
UT WOS:000468658000004
PM 30962418
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fujita, T
   Shirasawa, T
   Uchida, K
   Maruyama, N
AF Fujita, T
   Shirasawa, T
   Uchida, K
   Maruyama, N
TI Gene regulation of senescence marker protein-30 (SMP30): Coordinated
   up-regulation with tissue maturation and gradual down-regulation with
   aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; calcium binding protein; development; kidney; liver; senescence
   marker protein-30 (SMP30)
ID RAT-LIVER; EXPRESSION
AB Senescence marker protein-30 (SMP30) is a calcium binding protein also called regucalcin. The amounts of SMP30 decrease androgen-independently with aging in the livers of rats. We have studied the expression of SMP30 in livers and kidneys of rats from the embryonic to the senescent stages of life. No transcript was detected in livers or kidneys in day 18 embryos. However, Northern blot analysis showed a marked increase of SMP30 mRNA in livers of neonatal and young rats. The first peak of SMP30 transcript was found in a 5-day-old neonate, in which the amount of mRNA was threefold higher in comparison with 3- to 6.5-month-old adults. The expression of SMP30 protein started to increase from day 7 and rapidly reached a plateau at day 10. The substantial amounts of protein and transcript were maintained in adults up to 3-6.5 months of age. In the kidney, SMP30 mRNA and protein started to increase at day 21 and reached near-maximal levels at day 35. The levels of transcript and protein remained high in adults up to 3 months of age. As the aging process progressed to senescent stages, the levels of transcript and protein decreased significantly in the liver and kidney of aged rats. Therefore, the age-associated decrease of SMP30 in the liver and kidney may be, in a large part, controlled at transcriptional levels. Furthermore, immunohistochemical analysis showed a similar pattern of changes in SMP30 protein expression during neonate, adult and senescent stages in hepatocytes and renal proximal tubular epithelia. The high expression of SMP30 in the tissue-maturing process and adulthood suggests that SMP30 may be required for the maintenance of highly differentiated hepatic and renal functions.
C1 TOKYO METROPOLITAN INST GERONTOL,DEPT MOLEC PATHOL,ITABASHI KU,TOKYO 173,JAPAN.
   YAKULT CENT INST MICROBIOL RES,KUNITACHI,TOKYO 186,JAPAN.
C3 Tokyo Metropolitan Institute of Gerontology; Yakult Honsha Company,
   Limited
RP Fujita, T (corresponding author), TOKYO METROPOLITAN INST GERONTOL,DEPT MOLEC BIOL,ITABASHI KU,35-2 SAKAECHO,TOKYO 173,JAPAN.
CR APERIA A, 1979, ACTA PHYSL SCAND, V104, P11
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P1156
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771
   IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078
   LARSSON L, 1980, KIDNEY INT, V18, P29, DOI 10.1038/ki.1980.107
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   VARGHESE S, 1988, J BIOL CHEM, V263, P9776
   VARGHESE S, 1987, ANAL BIOCHEM, V165, P183, DOI 10.1016/0003-2697(87)90218-1
   Yamaguchi M. A., 1992, CALCIUM INHIBITION, P19
   YAMAKUNI T, 1985, FEBS LETT, V188, P124
NR 13
TC 53
Z9 67
U1 0
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN 25
PY 1996
VL 87
IS 3
BP 219
EP 229
DI 10.1016/0047-6374(96)01711-3
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA UR357
UT WOS:A1996UR35700007
PM 8794449
DA 2024-02-19
ER

PT J
AU Yokozawa, T
   Satoh, A
   Cho, EJ
AF Yokozawa, T
   Satoh, A
   Cho, EJ
TI Ginsenoside-Rd attenuates oxidative damage related to aging in
   senescence-accelerated mice
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
ID SUPEROXIDE-DISMUTASE ACTIVITY; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION;
   REDUCED GLUTATHIONE; FREE-RADICALS; AGE; STRESS; SAPONINS; LIVER; RATS
AB Among the various theories of the aging process, the free radical theory, which proposes that deleterious actions of free radicals are responsible for the functional deterioration associated with aging, has received widespread attention. The theory suggests that enhancement of the antioxidative defence system to attenuate free-radical-induced damage will counteract the aging process. We used senescence-accelerated mice (SAM) to investigate the relationship between aging and the antioxidative defence system and evaluated the effects of ginsenoside-Rd, the saponin from ginseng, by measuring antioxidative defence system parameters, including the glutathione (GSH)/ glutathione disulfide (GSSG) redox status, antioxidative enzyme activity and level of lipid peroxidation. SAM at 11 months of age (old SAM) showed a significantly lower hepatic GSH/GSSG ratio, due to decreased GSH and increased GSSG levels, than SAM at 5 weeks of age (young SAM). However, the administration of ginsenoside-Rd at a dose of 1 or 5 mg kg(-1) daily for 30 days to 10-month-old SAM significantly increased GSH, but decreased GSSG, resulting in elevation of the GSH/GSSG ratio. In addition, ginsenoside-Rd increased the activity of glutathione peroxidase (GSH-Px) and glutathione reductase that were both significantly lower in old SAM than in young SAM. This suggests that ginsenoside-Rd could play a crucial role in enhancing the defence system through regulation of the GSH/GSSG redox status. Moreover, decreases in the superoxide dismutase (SOD) and catalase activity in old SAM compared with young SAM were also revealed, indicating that the aging process resulted in suppression of the antioxidative defence system. However, ginsenoside-Rd did not affect SOD and catalase activity. As catalase is localized in peroxisome granules and GSH-Px is present in the cytoplasm and mitochondrial matrix, the site of ginsenoside-Rd action may be the cytoplasm and mitochondrial matrix. Furthermore, the serum and liver malondialdehyde levels, indicators of lipid peroxidation, were elevated with aging, while ginsenoside-Rd inhibited lipid peroxidation. This study indicates that the aging process leads to suppression of the antioxidative defence system and accumulation of lipid peroxidation products, while ginsenoside-Rd attenuates the oxidative damage, which may be responsible for the intervention of GSH/GSSG redox status.
C1 Toyama Med & Pharmaceut Univ, Inst Nat Med, Sugitani, Toyama 9300194, Japan.
C3 University of Toyama
RP Yokozawa, T (corresponding author), Toyama Med & Pharmaceut Univ, Inst Nat Med, 2630, Sugitani, Toyama 9300194, Japan.
EM yokozawa@ms.toyama-mpu.ac.jp
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   AOYAGI K, 1987, KIDNEY INT, V32, pS229
   Aoyagi K, 2000, FREE RADICAL RES, V32, P487, DOI 10.1080/10715760000300491
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHRISTON R, 1995, J NUTR, V125, P3062
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855
   DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163
   Doctrow S R, 1997, Adv Pharmacol, V38, P247
   Dong Erbo, 1996, Natural Medicines, V50, P128
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7
   Evans P, 1999, ANN NY ACAD SCI, V884, P19, DOI 10.1111/j.1749-6632.1999.tb08633.x
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   Floreani M, 1997, FREE RADICAL RES, V26, P449, DOI 10.3109/10715769709084481
   Fukui K, 2001, ANN NY ACAD SCI, V928, P168
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Hu HL, 2000, MECH AGEING DEV, V121, P217
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   KARIKURA M, 1991, CHEM PHARM BULL, V39, P2357
   Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4
   Keum YS, 2003, MUTAT RES-FUND MOL M, V523, P75, DOI 10.1016/S0027-5107(02)00323-8
   Kim SL, 1998, AM J GASTROENTEROL, V93, P53
   Knight JA, 1998, ANN CLIN LAB SCI, V28, P331
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   Lipman RD, 1998, MECH AGEING DEV, V103, P269, DOI 10.1016/S0047-6374(98)00048-7
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   Liu WK, 2000, LIFE SCI, V67, P1297, DOI 10.1016/S0024-3205(00)00720-7
   Liu ZQ, 2002, BBA-GEN SUBJECTS, V1572, P58, DOI 10.1016/S0304-4165(02)00281-7
   Mecocci P, 2000, FREE RADICAL BIO MED, V28, P1243, DOI 10.1016/S0891-5849(00)00246-X
   Melov S, 2002, ANN NY ACAD SCI, V959, P330, DOI 10.1111/j.1749-6632.2002.tb02104.x
   Miquel J, 2002, ANN NY ACAD SCI, V959, P508, DOI 10.1111/j.1749-6632.2002.tb02120.x
   MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197
   Mori A, 1998, ANN NY ACAD SCI, V854, P239, DOI 10.1111/j.1749-6632.1998.tb09906.x
   NAITO C, 1978, JPN J GERIATR, V15, P187
   OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SHIBATA S, 1966, CHEM PHARM BULL, V14, P595
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   SIES H, 1991, KLIN WOCHENSCHR, V69, P965, DOI 10.1007/BF01645140
   SOEJIMA A, 1992, KEY NOTES NEPHROLOGY, P82
   SOHAL RS, 1992, ANN NY ACAD SCI, V663, P74, DOI 10.1111/j.1749-6632.1992.tb38651.x
   Sverko V, 2002, EXP GERONTOL, V37, P1031, DOI 10.1016/S0531-5565(02)00083-9
   Tahara S, 2001, MECH AGEING DEV, V122, P415, DOI 10.1016/S0047-6374(00)00257-8
   TATEISHI N, 1988, PROTEIN NUCL ACID EN, V33, P1358
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   Tor-Agbidye J, 1999, BRAIN RES, V820, P12, DOI 10.1016/S0006-8993(98)01343-2
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Yokozawa T, 1999, NEPHRON, V81, P200, DOI 10.1159/000045277
   Yokozawa T, 1996, PHYTOTHER RES, V10, P569, DOI 10.1002/(SICI)1099-1573(199611)10:7&lt;569::AID-PTR903&gt;3.0.CO;2-U
   Yokozawa T, 1998, NEPHRON, V78, P201, DOI 10.1159/000044911
   Yokozawa T, 2000, RENAL FAILURE, V22, P115, DOI 10.1081/JDI-100100858
   Yokozawa T, 2001, NEPHRON, V89, P433, DOI 10.1159/000046116
   YOKOZAWA T, 1994, BIOL PHARM BULL, V17, P1485, DOI 10.1248/bpb.17.1485
   YOKOZAWA T, 1988, J MED PHARM SOC WAKA, V5, P50
NR 63
TC 95
Z9 107
U1 1
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD JAN
PY 2004
VL 56
IS 1
BP 107
EP 113
DI 10.1211/0022357022449
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 805WT
UT WOS:000220397100013
PM 14980007
OA Bronze
DA 2024-02-19
ER

PT J
AU Paradis, V
   Youssef, N
   Dargère, D
   Bâ, N
   Bonvoust, F
   Deschatrette, J
   Bedossa, P
AF Paradis, V
   Youssef, N
   Dargère, D
   Bâ, N
   Bonvoust, F
   Deschatrette, J
   Bedossa, P
TI Replicative senescence in normal liver, chronic hepatitis C, and
   hepatocellular carcinomas
SO HUMAN PATHOLOGY
LA English
DT Article
DE chronic hepatitis C; hepatocellular carcinoma; replicative senescence;
   telomere
ID TELOMERE LENGTH; HUMAN-CELLS; PROGRESSION; GENE; INVOLVEMENT; REDUCTION;
   CIRRHOSIS; VITRO
AB There is growing evidence that senescent cells accumulate in vivo and are associated with the aging process in parallel with the progressive erosion of telomeres. Because recent data show that telomere shortening is involved in the pathogenesis of liver cirrhosis, we Looked for replicative senescence cells in normal livers, chronic hepatitis C, and hepatocellular carcinoma (HCC). Replicative senescent cells were detected on liver tissue cryosections using expression of a specific marker, senescence-associated beta -galactosidase, a cytoplasmic enzyme detected at pH 6. A total of 57 frozen liver samples (15 normal liver, 32 chronic hepatitis C, and 10 HCCs) were studied. Replicative senescence was graded as absent in 56% of cases (32 of 57) and present in 44% (25 of 57). Replicative senescence was considered present in 3 of 15 normal livers (20%), 16 of 32 chronic hepatitis cases (50%), and 6 of 10 HCCs (60%), In the group of nontumoral livers, the presence of senescent cells in liver was associated with older age (P = .03). In the group with chronic hepatitis C, fibrosis stage, but not activity grade, was significantly correlated with the accumulation of replicative senescent cells (P < .001). Finally <beta>-Gal staining in nontumoral tissue was strongly correlated with the presence of HCC in the surrounding liver (P < .001). These results suggest that chronic hepatitis C represents a relevant model of accelerated replicative senescence and that accumulation of replicative senescent cells predispose to HCC development. Detection of replicative senescent cells may then serve as a predictive marker of a hepatocellular carcinoma in the surrounding tissue. HUM PATHOL 32: 327-332. Copyright (C) 2001 by W.B. Saunders Company.
C1 Hop Bicetre, Serv Anat Pathol, F-94275 Le Kremlin Bicetre, France.
   Fac Pharm, INSERM, U347, UPRES A 8067, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre
   - APHP; Universite Paris Saclay; Hopital Universitaire Antoine-Beclere -
   APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Paradis, V (corresponding author), Hop Bicetre, Serv Anat Pathol, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.
RI Dargere, Delphine/G-5004-2013; Paradis, Valerie/X-9097-2019
OI Bedossa, Pierre/0000-0002-8487-7322; Paradis,
   Valerie/0000-0003-3142-3762
CR Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213
   BEDOSSA P, 1994, HEPATOLOGY, V20, P15
   BOND JA, 1995, CANCER RES, V55, P2404
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Campisi J, 2000, IN VIVO, V14, P183
   Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5
   Campisi Judith, 1996, P121
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   EDINGTON KG, 1995, MOL CARCINOGEN, V13, P254, DOI 10.1002/mc.2940130408
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hisatomi H, 1997, INT HEPATOL COMMUN, V6, P175, DOI 10.1016/S0928-4346(96)00344-1
   Isokawa O, 1999, HEPATOLOGY, V30, P408, DOI 10.1002/hep.510300211
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303
   Kveiborg M, 1999, MECH AGEING DEV, V106, P261, DOI 10.1016/S0047-6374(98)00114-6
   LIVNI N, 1995, CANCER, V75, P2420, DOI 10.1002/1097-0142(19950515)75:10<2420::AID-CNCR2820751006>3.0.CO;2-6
   MARTIN GM, 1970, LAB INVEST, V23, P86
   Matsunaga H, 1999, INVEST OPHTH VIS SCI, V40, P197
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   NEWBOLD RF, 1982, NATURE, V299, P633, DOI 10.1038/299633a0
   NG IOL, 1994, ONCOGENE, V9, P985
   OBRIEN W, 1986, P NATL ACAD SCI USA, V83, P8659
   OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7
   PARASKEVA C, 1988, INT J CANCER, V41, P908
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   SIGAL SH, 1992, AM J PHYSIOL, V263, pG139, DOI 10.1152/ajpgi.1992.263.2.G139
   WynfordThomas D, 1997, HORM RES, V47, P145, DOI 10.1159/000185458
NR 33
TC 236
Z9 271
U1 0
U2 20
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0046-8177
EI 1532-8392
J9 HUM PATHOL
JI Hum. Pathol.
PD MAR
PY 2001
VL 32
IS 3
BP 327
EP 332
DI 10.1053/hupa.2001.22747
PG 6
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 417DX
UT WOS:000167821100013
PM 11274643
DA 2024-02-19
ER

PT J
AU Chao, C
   Youssef, J
   Rezaiekhaleigh, M
   Birnbaum, LS
   Badr, M
AF Chao, C
   Youssef, J
   Rezaiekhaleigh, M
   Birnbaum, LS
   Badr, M
TI Senescence-associated decline in hepatic peroxisomal enzyme activities
   corresponds with diminished levels of retinoid X receptor <i>alpha</i>,
   but not peroxisome proliferator-activated receptor <i>alpha</i>
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE peroxisome-proliferator activated receptors; retinoid X receptors;
   aging; peroxisomal beta-oxidation; apoptosis
ID RAT-LIVER PEROXISOMES; PPAR-ALPHA; APOPTOSIS; AGE; NAFENOPIN; MICE;
   ACID; SUSCEPTIBILITY; SUPPRESSION; CATALASE
AB Aging is associated with alterations in hepatic peroxisomal metabolism and susceptibility to hepatocarcinogenicity produced by agonists of peroxisome proliferator-activated receptor alpha (PPARalpha). Mechanisms involved in these effects are not well understood. However, as a heterodimer with retinoid X receptor alpha (RXRalpha), PPARalpha regulates transcription of genes involved in oxidative stress, cell proliferation and apoptosis. Modulating these important cell functions as a result of aging may be responsible for altered hepatic peroxisomal responses in the senescent liver. Therefore, we investigated hepatic apoptosis, and peroxisomal P-oxidation activity, a major source of H2O2, as well as the activity of the peroxisomal anti-oxidant enzyme catalase, in male Fischer-344 rats of four age groups (4, 10, 50 and 100 week old). We further quantified protein levels of both PPARalpha and RXRalpha in these animals. Data show that peroxisomal P-oxidation and catalase activities were significantly lower in livers of the 100 week old animals compared with other age groups, while percentage of apoptotic hepatocytes were identical in all animal age groups. However, aging had no effect on hepatic PPARalpha protein levels. In the senescent group, the level of decline in both peroxisomal enzyme activities of 30% was surprisingly similar to the decline observed in the hepatic expression of the RXRalpha protein. Results from this study suggest that alterations in peroxisomal metabolism observed in the senescent liver may be a result of the decline in the availability of RXRalpha receptor, and not the primary PPARalpha receptor. On the other hand, PPARalpha-independent mechanisms appear to play a role in controlling apoptosis in the senescent liver. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Missouri, Kansas City, MO 64108 USA.
   US EPA, Natl Hlth & Envirom Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27709 USA.
C3 University of Missouri System; University of Missouri Kansas City;
   United States Environmental Protection Agency
RP Badr, M (corresponding author), Univ Missouri, 2411 Holmes St,M3-115, Kansas City, MO 64108 USA.
EM badrm@umkc.edu
OI Birnbaum, Linda/0000-0001-5429-5658
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   BADR M, 1991, TOXICOLOGIST, V187, P11
   BAYLY AC, 1994, J CELL BIOL, V125, P197, DOI 10.1083/jcb.125.1.197
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   CATTLEY RC, 1991, CARCINOGENESIS, V12, P469, DOI 10.1093/carcin/12.3.469
   FORNOS P, 1982, FASEB J, V4, pA302
   HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1
   Holden PR, 2000, CELL MOL BIOL, V46, P29
   HUBER W, 1991, CANCER RES, V51, P1789
   KRAUPPGRASL B, 1991, CANCER RES, V51, P666
   LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   Mukherjee R, 1998, ARTERIOSCL THROM VAS, V18, P272, DOI 10.1161/01.ATV.18.2.272
   Pallet V, 1997, MECH AGEING DEV, V99, P123, DOI 10.1016/S0047-6374(97)00098-5
   Perichon R, 1996, MECH AGEING DEV, V87, P115, DOI 10.1016/0047-6374(96)01705-8
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   ROBERTS RA, 1995, CARCINOGENESIS, V16, P1693, DOI 10.1093/carcin/16.8.1693
   Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Wan YJY, 2000, J BIOL CHEM, V275, P28285
   Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000
   Wang C, 1999, MOL CELL BIOCHEM, V201, P25, DOI 10.1023/A:1007024905046
   YAMOTO T, 1995, TOXICOL LETT, V78, P141, DOI 10.1016/0378-4274(94)03247-5
   Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575
   YOUSSEF J, 2001, SAUDI PHARM J, V9, P1
   Youssef Jihan, 2002, ScientificWorldJournal, V2, P1491
NR 28
TC 21
Z9 22
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2002
VL 123
IS 11
BP 1469
EP 1476
AR PII S0047-6374(02)00086-6
DI 10.1016/S0047-6374(02)00086-6
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 618JN
UT WOS:000179415100006
PM 12425954
DA 2024-02-19
ER

PT J
AU Chen, YH
   Wang, MF
   Liao, JW
   Chang, SP
   Hu, ML
AF Chen, Yu-Hsuan
   Wang, Ming-Fu
   Liao, Jiunn-Wang
   Chang, Shih-Pei
   Hu, Miao-Lin
TI Beneficial effects of nicotinamide on alcohol-induced liver injury in
   senescence-accelerated mice
SO BIOFACTORS
LA English
DT Article
DE Senescence-accelerate mice; oxidative stress; nicotinamide
   alcohol-induced liver injury
ID INDUCED OXIDATIVE STRESS; ETHANOL-CONSUMPTION; PROTEIN OXIDATION;
   N-ACETYLCYSTEINE; ANTIOXIDANT; ACID; EXPRESSION; DAMAGE; IMPAIRMENT;
   METABOLISM
AB The deleterious effects of ethanol in senescence-accelerated prone 8 mice (SAMP8) and the protective role of nicotinamide (NAM) against ethanol-induced liver injury were examined. The mice were orally administered 2 g ethanol/kg BW and 200 mg or 500 mg NAM/kg BW three times/week for 10 weeks. Results showed that ethanol elevated activity of alanine aminotransferase (ALT) significantly. Ethanol also enhanced the formation of malondialdehyde (MDA) and protein carbonyls in the liver, whereas ethanol treatment resulted in significantly lower activity of hepatic glutathione peroxidase (GPx), catalase and superoxide dismutase (SOD). Hematoxylin and eosin staining indicated moderate to severe fatty infiltration but not fibrosis. Administration of high NAM (500 mg/kg BW) led to markedly decreased levels of hepatic MDA, protein carbonyls, fatty infiltration and the activity of ALT, and increased activity of GPx, catalase and SOD in the ethanol-fed group. Thus, using SAMP8 as animal model for ethanol-induced liver injury in the aged mice, this study demonstrates that NAM is effective in protecting such damage.
C1 [Chen, Yu-Hsuan; Hu, Miao-Lin] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 402, Taiwan.
   [Chen, Yu-Hsuan] Cent Taiwan Univ Sci & Technol, Dept Med Lab Sci & Biotechnol, Taipei, Taiwan.
   [Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
   [Liao, Jiunn-Wang] Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung, Taiwan.
   [Chang, Shih-Pei] Cent Taiwan Univ Sci & Technol, Dept Phys Educ, Taipei, Taiwan.
C3 National Chung Hsing University; Central Taiwan University Science &
   Technology; Providence University - Taiwan; National Chung Hsing
   University; Central Taiwan University Science & Technology
RP Hu, ML (corresponding author), Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 205 Kuo Kuang Rd, Taichung 402, Taiwan.
EM mlhuhu@nchu.edu.tw
RI wang, ming/HPC-6329-2023; wang, ming/ITV-5378-2023; Liao,
   Jun/JUF-2784-2023
OI Liao, Jiunn-Wang/0000-0001-7374-1203
CR Abraham P, 2002, CLIN CHIM ACTA, V325, P117, DOI 10.1016/S0009-8981(02)00279-6
   ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P1222, DOI 10.1001/jama.270.10.1222
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Bailey SM, 2001, ALCOHOL CLIN EXP RES, V25, P726, DOI 10.1111/j.1530-0277.2001.tb02273.x
   Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8
   Benavente CA, 2008, FREE RADICAL BIO MED, V44, P527, DOI 10.1016/j.freeradbiomed.2007.10.006
   Boucheron C, 2006, NEUROBIOL AGING, V27, P1326, DOI 10.1016/j.neurobiolaging.2005.07.008
   Bujanda L, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-35
   Derave W, 2005, EXP GERONTOL, V40, P562, DOI 10.1016/j.exger.2005.05.005
   Gilat T, 2003, HEPATOLOGY, V38, P436, DOI 10.1053/jhep.2003.50348
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X
   Hosokawa M, 2002, MECH AGEING DEV, V123, P1553, DOI 10.1016/S0047-6374(02)00091-X
   Husain K, 2005, PHARMACOL RES, V51, P337, DOI 10.1016/j.phrs.2004.10.005
   Ieraci A, 2006, PLOS MED, V3, P547, DOI 10.1371/journal.pmed.0030101
   Jurczuk M, 2004, FOOD CHEM TOXICOL, V42, P429, DOI 10.1016/j.fct.2003.10.005
   Kamat JP, 1999, REDOX REP, V4, P179, DOI 10.1179/135100099101534882
   Kanbak G, 2001, CELL BIOCHEM FUNCT, V19, P281, DOI 10.1002/cbf.926
   Kasdallah-Grissa A, 2007, LIFE SCI, V80, P1033, DOI 10.1016/j.lfs.2006.11.044
   Krazem A, 2003, BEHAV BRAIN RES, V147, P17, DOI 10.1016/S0166-4328(03)00113-X
   Kroger H, 1997, GEN PHARMACOL, V28, P257, DOI 10.1016/S0306-3623(96)00181-4
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   LOWRY JR, 1950, ARCH BIOCHEM, V25, P148
   Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6
   Moos RH, 2004, AM J PUBLIC HEALTH, V94, P1985, DOI 10.2105/AJPH.94.11.1985
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Oliveira-Silva IF, 2007, BEHAV BRAIN RES, V180, P226, DOI 10.1016/j.bbr.2007.03.012
   Ozaras R, 2003, WORLD J GASTROENTERO, V9, P125, DOI 10.3748/wjg.v9.i1.125
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Raghavendra V, 2001, FREE RADICAL BIO MED, V30, P595, DOI 10.1016/S0891-5849(00)00447-0
   Ray SD, 2001, FREE RADICAL BIO MED, V31, P277, DOI 10.1016/S0891-5849(01)00562-7
   ROSELLE GA, 1989, J CLIN LAB IMMUNOL, V29, P99
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Vogt BL, 2007, BIOCHEM PHARMACOL, V73, P1613, DOI 10.1016/j.bcp.2007.01.033
   Volpi E, 1997, J NUTR, V127, P2199, DOI 10.1093/jn/127.11.2199
   Wheeler MD, 2001, J BIOL CHEM, V276, P36664, DOI 10.1074/jbc.M105352200
NR 38
TC 11
Z9 11
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-6433
EI 1872-8081
J9 BIOFACTORS
JI Biofactors
PY 2008
VL 34
IS 2
BP 97
EP 107
DI 10.1002/biof.5520340202
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 491PG
UT WOS:000269590700002
PM 19706976
DA 2024-02-19
ER

PT J
AU Zang, JF
   Sha, M
   Zhang, C
   Ye, J
   Zhang, KZ
   Gao, JY
AF Zang, Jinfeng
   Sha, Min
   Zhang, Chi
   Ye, Jun
   Zhang, Kezhi
   Gao, Junye
TI Senescent hepatocyte secretion of matrix metalloproteinases is regulated
   by nuclear factor-κB signaling
SO LIFE SCIENCES
LA English
DT Article
DE Hepatocyte; Senescence; Matrix metalloproteinase; Nuclear factor-kappa B
ID CELLULAR SENESCENCE; PERITONEAL MESOTHELIUM; OXIDATIVE STRESS;
   LIVER-DISEASE; PHENOTYPE; FIBROSIS; PROGRESSION; SIGNATURE; INJURY;
   CELLS
AB Aims: Cellular senescence and matrix metalloproteinases (MMPs) play an important role in liver diseases. The source and regulating factors of MMPs in senescent hepatocytes are not known. We investigated whether senescent hepatocytes secreted MMPs and if this was regulated by nuclear factor (NF)-kappa B.
   Materials and methods: The TGF-a transgenic mouse hepatocyte line AML12 was treated with H2O2 to induce senescence. NF-kappa B signaling was examined by Western blotting and luciferase reporter assays. Quantitative reverse transcription polymerase chain reaction was used to evaluated expression of MMP-2, -9 and -13.
   Key findings: AML12 cells treated with H2O2 showed the characteristic morphology of senescence. The activity of NF-.B and expression of MMP-2, -9 and -13 were increased in senescent AML12 cells. The NF-kappa B inhibitor BAY 11-7082 decreased the levels of MMPs.
   Significance: These results suggest that senescent hepatocytes are involved in the pathology of liver diseases through remodeling the extracellular matrix.
C1 [Zang, Jinfeng; Zhang, Chi; Zhang, Kezhi; Gao, Junye] Nantong Univ, Med Sch, Affiliated Hosp 1, Dept Hepatobiliary Surg,Taizhou Peoples Hosp, 210 Yingchun Rd, Taizhou 225300, Jiangsu, Peoples R China.
   [Sha, Min; Ye, Jun] Nantong Univ, Med Sch, Affiliated Hosp 1, Cent Lab,Taizhou Peoples Hosp, Taizhou, Jiangsu, Peoples R China.
C3 Nantong University; Nantong University
RP Zang, JF (corresponding author), Nantong Univ, Med Sch, Affiliated Hosp 1, Dept Hepatobiliary Surg,Taizhou Peoples Hosp, 210 Yingchun Rd, Taizhou 225300, Jiangsu, Peoples R China.
EM xkfy1979@126.com
FU Science and Technology Bureau of Taizhou [TS201626]; Taizhou People's
   Hospital [ZL201628]
FX This work was supported by Science and Technology Bureau of Taizhou
   [grant No. TS201626]; Taizhou People's Hospital [grant no. ZL201628].
   The funders had No role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aini W, 2014, TRANSPL IMMUNOL, V31, P55, DOI 10.1016/j.trim.2014.06.008
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552
   Byun HO, 2015, BMB REP, V48, P549, DOI 10.5483/BMBRep.2015.48.10.122
   Calabro SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090571
   Chang YJ, 2009, LIFE SCI, V85, P517, DOI 10.1016/j.lfs.2009.08.003
   Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902
   Di GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113572
   Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004
   El Samanoudy A, 2014, GENET MOL RES, V13, P8025, DOI 10.4238/2014.September.29.15
   Gredilla R., 2012, OXID MED CELL LONGEV, V2012, DOI DOI 10.1155/2012/28243823050036
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   León MDG, 2006, EXP MOL PATHOL, V80, P97, DOI 10.1016/j.yexmp.2005.03.008
   Li ZY, 2016, AGING-US, V8, P2337, DOI 10.18632/aging.101050
   Long J, 2016, ONCOTARGET, V7, P45678, DOI 10.18632/oncotarget.10141
   McCarthy DA, 2013, J BIOL CHEM, V288, P32149, DOI 10.1074/jbc.M113.493841
   Mikula-Pietrasik J, 2016, CLIN EXP METASTAS, V33, P15, DOI 10.1007/s10585-015-9753-y
   Mikula-Pietrasik J, 2015, ONCOTARGET, V6, P29178, DOI 10.18632/oncotarget.4932
   Ohtani N, 2013, CANCER SCI, V104, P525, DOI 10.1111/cas.12118
   Robert S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153118
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002
   Tachtatzis PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127511
   Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268
   Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268
   Yada A, 2015, J HEPATOL, V63, P905, DOI 10.1016/j.jhep.2015.05.010
   Yang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065256
NR 38
TC 6
Z9 7
U1 2
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD DEC 15
PY 2017
VL 191
BP 205
EP 210
DI 10.1016/j.lfs.2017.10.023
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA FL6SM
UT WOS:000414376500027
PM 29054454
DA 2024-02-19
ER

PT J
AU Liu, BY
   Zhou, ZW
   Jin, Y
   Lu, JY
   Feng, DJ
   Peng, R
   Sun, H
   Mu, XX
   Li, CX
   Chen, Y
AF Liu, Boyuan
   Zhou, Zewei
   Jin, Yu
   Lu, Jinying
   Feng, Dongju
   Peng, Rui
   Sun, Hua
   Mu, Xiaoxin
   Li, Changxian
   Chen, Yun
TI Hepatic stellate cell activation and senescence induced by intrahepatic
   microbiota disturbances drive progression of liver cirrhosis toward
   hepatocellular carcinoma
SO JOURNAL FOR IMMUNOTHERAPY OF CANCER
LA English
DT Article
DE biomarkers; tumor; inflammation; tumor microenvironment
ID STENOTROPHOMONAS-MALTOPHILIA; CANCER; INFECTIONS
AB Background The significance of the relationship between the microbiota and diseases is increasingly being recognized. However, the characterization of tumor microbiome and their precise molecular mechanisms through which microbiota promotes hepatocellular carcinoma (HCC) development are still unclear. Methods The intrahepatic microbiota was investigated from tumor, normal adjacent tissues in 46 patients with HCC and normal hepatic tissues in 33 patients with hemangioma by 16S rRNA gene sequencing. Taxonomic composition differences in patients were evaluated using Linear discriminant analysis Effect Size (LefSe) and Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) to predict microbial functional pathways. Associations between the most relevant taxa and clinical characteristics of HCC patients were analyzed by Spearman rank correlations. The effects of microbe on hepatic stellate cells (HSCs) activation and HCC progression were examined. Results We observed intrahepatic microbiota disturbances by reduced microbial diversity in HCC. The tumor microbiota of the HCC patients with cirrhosis showed higher abundance of Stenotrophomonas maltophilia (S. maltophilia). S. maltophilia provoked senescence-associated secretory phenotype (SASP) in HSCs by activating TLR-4-mediated NF-kappa B signaling pathway, which in turn induced NLRP3 inflammasome complex formation and secreted various inflammatory factors in the liver, thus facilitating HCC progression in mice. Moreover, signs of SASP were also observed in the HSCs in the area of HCC with higher S. maltophilia enrichment arising in patients with cirrhosis. Conclusions Our analysis of the hepatic microbiota revealed for the first time that patients with HCC exhibited a dysbiotic microbial community with higher S. maltophilia abundance, which induced the expression SASP factors of HSCs and cirrhosis in the liver, concurring in the process of hepatocarcinogenesis.
C1 [Liu, Boyuan; Zhou, Zewei; Jin, Yu; Lu, Jinying; Feng, Dongju; Chen, Yun] Nanjing Med Univ, Dept Immunol, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Peoples R China.
   [Liu, Boyuan; Jin, Yu; Lu, Jinying; Chen, Yun] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China.
   [Peng, Rui; Chen, Yun] Nanjing Med Univ, Affiliated Canc Hosp, Res Ctr Clin Oncol, Jiangsu Canc Hosp,Jiangsu Inst Canc Res,Dept Gen, Nanjing, Peoples R China.
   [Sun, Hua] Univ Texas Hlth Sci Ctr Houston, Dept Immunol, Inst Mol Med, Houston, TX 77030 USA.
   [Mu, Xiaoxin; Li, Changxian] Nanjing Med Univ, Liver Transplantat Ctr, Affiliated Hosp 1, Nanjing, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University; Nanjing Medical
   University; University of Texas System; University of Texas Health
   Science Center Houston; Nanjing Medical University
RP Chen, Y (corresponding author), Nanjing Med Univ, Dept Immunol, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Peoples R China.; Chen, Y (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China.; Chen, Y (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Res Ctr Clin Oncol, Jiangsu Canc Hosp,Jiangsu Inst Canc Res,Dept Gen, Nanjing, Peoples R China.
EM chenyun@njmu.edu.cn
RI Liu, Boyuan/GXV-6469-2022
FU National Natural Science Foundation of China [82071767, 81772602,
   91942309, 81902445]; Jiangsu Provincial Key Research Development Program
   of China [BE2018750]; Key Laboratory of Emergency and Trauma, Ministry
   of Education [KLET-201913]; Natural Science Foundation of Jiangsu Higher
   Education Institutions of China [19KJB310008]; Doctor of Mass
   Entrepreneurship and Innovation Program in Jiangsu Province
   [KY101R202040]; Fund of Development on Science and Technology of Nanjing
   Medical University, China [NMUB2018006]
FX This work was supported by project grants from The National Natural
   Science Foundation of China (82071767, 81772602 and 91942309 to YC;
   81902445 to ZZ), Jiangsu Provincial Key Research Development Program of
   China (BE2018750 to YC), Key Laboratory of Emergency and Trauma,
   Ministry of Education (KLET-201913 to YC). The Natural Science
   Foundation of Jiangsu Higher Education Institutions of China
   (19KJB310008 to ZZ), Doctor of Mass Entrepreneurship and Innovation
   Program in Jiangsu Province (KY101R202040 to ZZ), Fund of Development on
   Science and Technology of Nanjing Medical University, China (NMUB2018006
   to ZZ).
CR Amedei A, 2019, HEPATOBIL SURG NUTR, V8, P527, DOI 10.21037/hbsn.2019.09.04
   An SQ, 2018, TRENDS MICROBIOL, V26, P637, DOI 10.1016/j.tim.2018.04.006
   Ansari SR, 2007, CANCER-AM CANCER SOC, V109, P2615, DOI 10.1002/cncr.22705
   Ateba SB, 2018, CURR MED CHEM, V25, P3162, DOI 10.2174/0929867325666180214110932
   Benbow JH, 2016, AM J PATHOL, V186, P145, DOI 10.1016/j.ajpath.2015.09.015
   de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5
   de Martel C, 2020, LANCET GLOB HEALTH, V8, pE180, DOI 10.1016/S2214-109X(19)30488-7
   Elinav E, 2019, NAT REV CANCER, V19, P371, DOI 10.1038/s41568-019-0155-3
   Figueiredo PMS, 2006, LETT APPL MICROBIOL, V43, P443, DOI 10.1111/j.1472-765X.2006.01965.x
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Garrido A, 2021, TRENDS CANCER, V7, P29, DOI 10.1016/j.trecan.2020.08.005
   Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110
   Isobe Y, 2020, NAT CHEM BIOL, V16, P1189, DOI 10.1038/s41589-020-0557-2
   Jin CC, 2019, CELL, V176, P998, DOI 10.1016/j.cell.2018.12.040
   Kadosh E, 2020, NATURE, V586, P133, DOI 10.1038/s41586-020-2541-0
   Kale P, 2018, SCAND J GASTROENTERO, V53, P1354, DOI 10.1080/00365521.2018.1511826
   Keenan BP, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0749-z
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Liu DL, 2020, CLIN SCI, V134, P2243, DOI 10.1042/CS20191213
   Liu QS, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-018-0281-6
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931
   Methé BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Myojin Y, 2021, GASTROENTEROLOGY, V160, P1741, DOI 10.1053/j.gastro.2020.12.015
   Nejman D, 2020, SCIENCE, V368, P973, DOI 10.1126/science.aay9189
   Parida S, 2021, CANCER DISCOV, V11, P1138, DOI 10.1158/2159-8290.CD-20-0537
   Ponziani FR, 2019, HEPATOLOGY, V69, P107, DOI 10.1002/hep.30036
   Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084
   Ringelhan M, 2018, NAT IMMUNOL, V19, P222, DOI 10.1038/s41590-018-0044-z
   Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Safdar A, 2007, CLIN INFECT DIS, V45, P1602, DOI 10.1086/522998
   Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302
   Vétizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Wang X, 2021, CANCER RES, V81, P2745, DOI 10.1158/0008-5472.CAN-20-3827
   Wu LW, 2021, BIOMED PHARMACOTHER, V136, DOI 10.1016/j.biopha.2021.111255
   Xuan SY, 2006, WORLD J GASTROENTERO, V12, P2335, DOI 10.3748/wjg.v12.i15.2335
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang Q, 2018, MOL IMMUNOL, V94, P27, DOI 10.1016/j.molimm.2017.12.011
   Zhang WJ, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000285
NR 43
TC 28
Z9 30
U1 4
U2 20
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 2051-1426
J9 J IMMUNOTHER CANCER
JI J. Immunother. Cancer
PD JAN
PY 2022
VL 10
IS 1
AR e003069
DI 10.1136/jitc-2021-003069
PG 15
WC Oncology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Immunology
GA YE3OF
UT WOS:000741036700001
PM 34996812
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ichinohe, N
   Ishii, M
   Tanimizu, N
   Kon, J
   Yoshioka, Y
   Ochiya, T
   Mizuguchi, T
   Hirata, K
   Mitaka, T
AF Ichinohe, Norihisa
   Ishii, Masayuki
   Tanimizu, Naoki
   Kon, Junko
   Yoshioka, Yusuke
   Ochiya, Takahiro
   Mizuguchi, Toru
   Hirata, Koichi
   Mitaka, Toshihiro
TI Transplantation of Thy1<SUP>+</SUP> Cells Accelerates Liver Regeneration
   by Enhancing the Growth of Small Hepatocyte-Like Progenitor Cells via
   IL17RB Signaling
SO STEM CELLS
LA English
DT Article
DE Hepatic progenitor cells; Small hepatocytes; Interleukin 17 receptor b;
   Liver regeneration; Sinusoidal endothelial cells; Kupffer cells
ID INTERLEUKIN-17 FAMILY-MEMBERS; RETRORSINE-EXPOSED RATS; HEPATIC
   STEM-CELLS; EXTRACELLULAR VESICLES; GENETIC INFORMATION; MATURE
   HEPATOCYTES; OVAL CELLS; MICROVESICLES; FIBROSIS; INJURY
AB Small hepatocyte-like progenitor cells (SHPCs) transiently form clusters in rat livers treated with retrorsine (Ret)/ 70% partial hepatectomy (PH). When Thy1(+) cells isolated from D-galactosamine-treated rat livers were transplanted into the livers of Ret/ PH-treated rats, the mass of the recipient liver transiently increased during the first 30 days after transplantation, suggesting that liver regeneration was enhanced. Here we addressed how Thy1(+) cell transplantation stimulates liver regeneration. We found that the number and size of SHPC clusters increased in the liver at 14 days after transplantation. GeneChip analysis revealed that interleukin 17 receptor b (IL17rb) expression significantly increased in SHPCs from livers transplanted with Thy1(+) cells. We subsequently searched for ligand-expressing cells and found that sinusoidal endothelial cells (SECs) and Kupffer cells expressed Il17b and Il25, respectively. Moreover, extracellular vesicles (EVs) separated from the conditioned medium of Thy1(+) cell culture induced IL17b and IL25 expression in SECs and Kupffer cells, respectively. Furthermore, EVs enhanced IL17rb expression in small hepatocytes (SHs), which are hepatocytic progenitor cells; in culture, IL17B stimulated the growth of SHs. These results suggest that Thy1-EVs coordinate IL17RB signaling to enhance liver regeneration by targeting SECs, Kupffer cells, and SHPCs. Indeed, the administration of Thy1-EVs increased the number and size of SHPC clusters in Ret/ PH-treated rat livers. Sixty days post-transplantation, most expanded SHPCs entered cellular senescence, and the enlarged liver returned to its normal size. In conclusion, Thy1(+) cell transplantation enhanced liver regeneration by promoting the proliferation of intrinsic hepatic progenitor cells via IL17RB signaling.
C1 [Ichinohe, Norihisa; Ishii, Masayuki; Tanimizu, Naoki; Kon, Junko; Mitaka, Toshihiro] Res Inst Frontier Med, Dept Tissue Dev & Regenerat, Sapporo, Hokkaido, Japan.
   [Ishii, Masayuki; Mizuguchi, Toru; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan.
   [Yoshioka, Yusuke; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo, Japan.
C3 Sapporo Medical University; National Cancer Center - Japan
RP Ichinohe, N; Mitaka, T (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Dev & Regenerat, Sapporo, Hokkaido 0608556, Japan.
EM nichi@sapmed.ac.jp; tmitaka@sapmed.ac.jp
RI Ochiya, Takahiro/AAH-7585-2019; Mitaka, Toshihiro/K-9424-2013
OI Mitaka, Toshihiro/0000-0001-9467-4871; Ichinohe,
   Norihisa/0000-0003-3723-7418
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [26460474, 24790389, 22390259, 25293289, 21390365, 24390304];
   Grants-in-Aid for Scientific Research [22390259, 25293289, 24390304,
   21390365, 24790389, 17K19703, 26461921] Funding Source: KAKEN
FX We thank Minako Kuwano and Yumiko Tsukamoto for technical assistance. We
   would like to thank Enago (www. enago. jp) for the English language
   review. This work was supported by Ministry of Education, Culture,
   Sports, Science and Technology, Japan, Grant-in-Aid for Scientific
   Research (C) for N. Ichinohe (26460474), Grant-in-Aid for Young
   Scientists (B) for N. Ichinohe (24790389), andGrants-in-Aid for
   Scientific Research (B) for K. Hirata (22390259, 25293289) and T. Mitaka
   (21390365, 24390304). J. K. is currently affiliated with Gene Techno
   Science, Co. Ltd., Sapporo, Japan. K. H. is currently affiliated with JR
   Sapporo Hospital, Sapporo, Japan.
CR Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453
   [Anonymous], 2014, CELL TRANSPLANT
   Avril A, 2004, J HEPATOL, V41, P737, DOI 10.1016/j.jhep.2004.07.029
   Best DH, 2007, J HEPATOL, V46, P1055, DOI 10.1016/j.jhep.2007.01.040
   Best DH, 2010, EXP MOL PATHOL, V88, P7, DOI 10.1016/j.yexmp.2009.10.009
   Chen Q, 2007, NAT PROTOC, V2, P1197, DOI 10.1038/nprot.2007.118
   Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6
   Fiegel HC, 2006, J CELL MOL MED, V10, P577, DOI 10.1111/j.1582-4934.2006.tb00422.x
   Forbes S, 2002, J PATHOL, V197, P510, DOI 10.1002/path.1163
   Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040
   Furuta S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001374
   Gao B, 2012, GASTROENTEROLOGY, V143, P536, DOI 10.1053/j.gastro.2012.07.031
   Gordon GJ, 2000, AM J PATHOL, V157, P771, DOI 10.1016/S0002-9440(10)64591-9
   Gordon GJ, 2000, AM J PATHOL, V156, P607, DOI 10.1016/S0002-9440(10)64765-7
   Herrera MB, 2010, J CELL MOL MED, V14, P1605, DOI 10.1111/j.1582-4934.2009.00860.x
   Huang CK, 2014, ONCOGENE, V33, P2968, DOI 10.1038/onc.2013.268
   Huebert RC, 2014, MAYO CLIN PROC, V89, P414, DOI 10.1016/j.mayocp.2013.10.023
   Ichinohe N, 2013, HEPATOLOGY, V57, P1192, DOI 10.1002/hep.26084
   Ichinohe N, 2012, CELL TRANSPLANT, V21, P11, DOI 10.3727/096368911X580626
   Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012
   Kamo N, 2007, AM J PHYSIOL-GASTR L, V292, pG526, DOI 10.1152/ajpgi.00241.2006
   Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018
   Kon J, 2006, J HEPATOL, V45, P90, DOI 10.1016/j.jhep.2006.01.029
   Kon J, 2009, AM J PATHOL, V175, P2362, DOI 10.2353/ajpath.2009.080338
   Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317
   Lemoinne S, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.7
   Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103
   MITAKA T, 1992, HEPATOLOGY, V16, P440, DOI 10.1002/hep.1840160224
   Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335
   Mizuguchi T, 2001, J CELL PHYSIOL, V189, P106, DOI 10.1002/jcp.1136
   Nakamura Y, 2014, CELL TRANSPLANT, V23, P1243, DOI 10.3727/096368913X668645
   Petersen BE, 1998, HEPATOLOGY, V27, P433, DOI 10.1002/hep.510270218
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008
   Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299
   Royo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068693
   Sasaki K, 2008, CELL TRANSPLANT, V17, P1221, DOI 10.3727/096368908787236666
   Sugimoto S, 2002, J CELL BIOCHEM, V87, P16, DOI 10.1002/jcb.10274
   Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465
   Vig P, 2006, HEPATOLOGY, V43, P316, DOI 10.1002/hep.21018
   Wang LY, 2011, INT J MOL MED, V27, P385, DOI 10.3892/ijmm.2011.594
   Wu HH, 2015, J EXP MED, V212, P333, DOI 10.1084/jem.20141702
NR 44
TC 15
Z9 16
U1 2
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD APR
PY 2017
VL 35
IS 4
BP 920
EP 931
DI 10.1002/stem.2548
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA EQ5DM
UT WOS:000398102000008
PM 27925343
OA Bronze
DA 2024-02-19
ER

PT J
AU Bhattarai, KR
   Kim, HK
   Chaudhary, M
   Rashid, MMU
   Kim, J
   Kim, HR
   Chae, HJ
AF Bhattarai, Kashi Raj
   Kim, Hyun-Kyoung
   Chaudhary, Manoj
   Rashid, Mohammad Mamun Ur
   Kim, Jisun
   Kim, Hyung-Ryong
   Chae, Han-Jung
TI TMBIM6 regulates redox-associated posttranslational modifications of
   IRE1α and ER stress response failure in aging mice and humans
SO REDOX BIOLOGY
LA English
DT Article; Early Access
DE TMBIM6/BI-1; Aging; IRE1 alpha modifications; S-nitrosylation;
   Sulfonation; ER stress response failure
ID ENDOPLASMIC-RETICULUM STRESS; BAX INHIBITOR-1; INVOLVEMENT; APOPTOSIS;
   PREVALENCE; INCREASES; OBESITY
AB Age-associated persistent ER stress is the result of declining chaperone systems of the ER that reduces cellular functions, induces apoptosis, and leads to age-related diseases. This study investigated the previously unknown regulatory mechanism of TMBIM6 during age-associated hepatic abnormalities. Wild-type (WT) and the TMBIM6 knockout (TMBIM6(-/-)) mice liver, human liver samples from different age groups were used to demonstrate the effect of physiological aging on liver. For TMBIM6 rescue experiments, TMBIM6(-/)- old mice and stable human hepatic cell lines expressing TMBIM6 were used to study the functional role of TMBIM6 on aging-associated steatosis and its associated mechanisms. In aging humans and mice, we observed declined expression of TMBIM6 and aberrant UPR expression, which were associated with high hepatic lipid accumulation. During aging, TMBIM6-deficient mice had increased senescence than their WT counterparts. We identified redoxmediated posttranslational modifications of IRE1 alpha such as S-nitrosylation and sulfonation were higher in TMBIM6-deficient aging mice and humans, which impaired the ER stress response signaling. Sulfonation of IRE1 alpha enhanced regulated IRE1 alpha-dependent decay (RIDD) activity inducing TMBIM6 decay, whereas S-nitrosylation of IRE1 alpha inhibited XBP1 splicing enhancing the cell death. Moreover, the degradation of miR-338-3p by strong IRE1 alpha cleavage activity enhanced the expression of PTP1B, resulting in diminishing phosphorylation of PERK. The re-expression of TMBIM6 reduced IRE1 alpha modifications, preserved ER homeostasis, reduced senescence and senescence-associated lipid accumulation in human hepatic cells and TMBIM6-depleted mice. Snitrosylation or sulfonation of IRE1 alpha and its controller, the TMBIM6, might be the potential therapeutic targets for maintaining ER homeostasis in aging and aging-associated liver diseases.
C1 [Bhattarai, Kashi Raj; Kim, Hyun-Kyoung; Kim, Jisun; Chae, Han-Jung] Jeonbuk Natl Univ, Sch Pharm, Jeonju 54896, South Korea.
   [Bhattarai, Kashi Raj; Kim, Hyun-Kyoung; Kim, Jisun; Chae, Han-Jung] Jeonbuk Natl Univ, Inst New Drug Dev, Jeonju 54896, South Korea.
   [Chaudhary, Manoj; Rashid, Mohammad Mamun Ur] Jeonbuk Natl Univ, Med Sch, Dept Pharmacol, Jeonju 54896, South Korea.
   [Chaudhary, Manoj; Rashid, Mohammad Mamun Ur] Jeonbuk Natl Univ, Med Sch, Inst New Drug Dev, Jeonju 54896, South Korea.
   [Kim, Hyung-Ryong] Jeonbuk Natl Univ, Coll Dent, Dept Dent Pharmacol, Jeonju 54896, South Korea.
   [Bhattarai, Kashi Raj] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA.
C3 Jeonbuk National University; Jeonbuk National University; Jeonbuk
   National University; Jeonbuk National University; Jeonbuk National
   University; St Jude Children's Research Hospital; University of
   Tennessee System; University of Tennessee Health Science Center
RP Chae, HJ (corresponding author), Jeonbuk Natl Univ, Sch Pharm, Jeonju 54896, South Korea.; Chae, HJ (corresponding author), Jeonbuk Natl Univ, Inst New Drug Dev, Jeonju 54896, South Korea.; Kim, HR (corresponding author), Jeonbuk Natl Univ, Coll Dent, Dept Dent Pharmacol, Jeonju 54896, South Korea.
EM hrkimdp@gmail.com; hjchae@jbnu.ac.kr
RI Bhattarai, Kashi Raj/ABC-9753-2021; Kim, Hyun-Kyoung/AGY-2204-2022;
   Rashid, Mohammad Mamun Ur/KAN-3611-2024; Rashid, Mohammad Mamun
   Ur/IAQ-9667-2023
OI Bhattarai, Kashi Raj/0000-0003-4781-9067; Kim,
   Hyung-Ryong/0000-0002-6710-6964; Chae, Han-Jung/0000-0003-4190-9889
FU National Research Foundation of Korea [2020R1A2B5B03094896,
   2017R1E1A1A01073796, 2017M3A 9G7072719, 2017M3A9E4047243,
   2020R1I1A1A01069205]
FX This work was supported by the National Research Foundation of Korea
   (2020R1A2B5B03094896, 2017R1E1A1A01073796, 2017M3A 9G7072719,
   2017M3A9E4047243, and 2020R1I1A1A01069205).
CR Bakke J, 2015, SEMIN CELL DEV BIOL, V37, P58, DOI 10.1016/j.semcdb.2014.09.020
   Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412
   Bhattarai KR, 2021, EXP MOL MED, V53, P151, DOI 10.1038/s12276-021-00560-8
   Bhattarai KR, 2020, TRENDS CELL BIOL, V30, P672, DOI 10.1016/j.tcb.2020.05.004
   Bhattarai KR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041059
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263
   Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038
   Darling NJ, 2014, BBA-MOL CELL RES, V1843, P2150, DOI 10.1016/j.bbamcr.2014.01.009
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007
   Garawi F, 2014, EUR J CLIN NUTR, V68, P1101, DOI 10.1038/ejcn.2014.86
   Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017
   Kenche H, 2013, FASEB J, V27, P965, DOI 10.1096/fj.12-216234
   Kim HK, 2021, REDOX BIOL, V40, DOI 10.1016/j.redox.2021.101853
   Kim HK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17802-4
   Kim HK, 2021, AUTOPHAGY, V17, P761, DOI 10.1080/15548627.2020.1732161
   Kim HK, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.270
   Kramer PA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00347
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Lavallard VJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/120179
   Le MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173499
   Lee GH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32229
   Lee GH, 2011, J BIOL CHEM, V286, P24743, DOI 10.1074/jbc.M110.167734
   Lee GH, 2010, MOL CELL BIOL, V30, P1800, DOI 10.1128/MCB.01357-09
   Lee HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27799
   Li J, 2004, EXP GERONTOL, V39, P735, DOI 10.1016/j.exger.2004.02.008
   Li YM, 2014, ACTA BIOCH BIOPH SIN, V46, P629, DOI 10.1093/abbs/gmu048
   Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434
   Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017
   Madhusudhan T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7496
   Martínez G, 2018, TRENDS NEUROSCI, V41, P610, DOI 10.1016/j.tins.2018.05.009
   Maurel M, 2013, AM J PHYSIOL-CELL PH, V304, pC1117, DOI 10.1152/ajpcell.00061.2013
   Naidoo N, 2009, REV NEUROSCIENCE, V20, P23
   Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005
   Nakato R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14812
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Sasako T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08591-6
   Segnani C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144630
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sun F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0611-0
   Taylor RC, 2016, BRAIN RES, V1648, P588, DOI 10.1016/j.brainres.2016.04.017
   Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782
   Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191
   Wang JM, 2017, DIABETES, V66, P177, DOI 10.2337/db16-0052
   Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121
   Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9
   Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang ZY, 2021, AUTOPHAGY, V17, P1841, DOI 10.1080/15548627.2020.1788889
NR 54
TC 7
Z9 8
U1 1
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD 2021 NOV
PY 2021
VL 47
AR 102128
DI 10.1016/j.redox.2021.102128
EA SEP 2021
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA WA5FQ
UT WOS:000702911300002
PM 34562874
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kurz, DJ
   Decary, S
   Hong, Y
   Erusalimsky, JD
AF Kurz, DJ
   Decary, S
   Hong, Y
   Erusalimsky, JD
TI Senescence-associated β-galactosidase reflects an increase in lysosomal
   mass during replicative ageing of human endothelial cells
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE cell ageing; biological marker; beta-galactosidase; vascular
   endothelium; flow cytometry; lysosome
ID HUMAN LIVER; ENZYME; HISTOCHEMISTRY; PURIFICATION; TELOMERASE; INVITRO;
   VITRO
AB Senescence-associated beta -galactosidase is widely used as a biomarker of replicative senescence. However, it remains unknown whether this is a distinct enzyme active at pH 6, and differentially expressed in senescence, or a manifestation of an increase in the classic acid lysosomal beta -galactosidase, Here we have investigated the origin of senescence-associated-beta -galactosidase activity by modifying the intracellular and lysosomal pH of young and senescent human umbilical vein endothelial cells and examining the effect of these manipulations on the levels of activity, using a flow cytometric assay, Lysosomal alkalinisation with chloroquine or bafilomycin Al, as well as equilibration of the intracellular milieu to pH 6 with nigericin, caused a profound (92-99%) inhibition of the total intracellular beta -galactosidase activity. However, independent of pH alterations, senescent cells showed levels of beta -galactosidase activity three- to sixfold higher than young cells, This increase in activity occurred in parallel to an increase in beta -galactosidase protein levels, Acridine Orange staining revealed an increase in lysosomal content with replicative age, which correlated with the increase in beta -galactosidase. These findings demonstrate that senescence-associated beta -galactosidase is a manifestation of residual lysosomal activity at a suboptimal pH, which becomes detectable due to the increased lysosomal content in senescent cells.
C1 UCL, Royal Free & Univ Coll Med Sch, Dept Med, Ctr Cardiovasc Biol & Med,Cell Biol Grp, London WC1E 6JJ, England.
C3 University of London; University College London
RP Erusalimsky, JD (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Med, Ctr Cardiovasc Biol & Med,Cell Biol Grp, Torrington Pl, London WC1E 6JJ, England.
EM j.erusalimsky@ucl.ac.uk
OI Erusalimsky, Jorge/0000-0002-4253-5789; Kurz, David/0000-0002-3921-6939
CR [Anonymous], 1990, Longevity, senescence and the genome
   ATHERTON AJ, 1994, J CELL SCI, V107, P2931
   BENYOSEPH Y, 1977, ARCH BIOCHEM BIOPHYS, V184, P373, DOI 10.1016/0003-9861(77)90364-2
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   BOSMANN HB, 1976, NATURE, V261, P499, DOI 10.1038/261499a0
   BRUNK U, 1973, EXP CELL RES, V79, P1, DOI 10.1016/0014-4827(73)90484-9
   BRUNK UT, 1999, OXIDAT STRESS DIS, V2, P229
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   CRISTOFALO VJ, 1975, MECH AGEING DEV, V4, P19, DOI 10.1016/0047-6374(75)90004-4
   DARZYNKIEWICZ Z, 1992, FLOW CYTOMETRY SORTI, P296
   DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   ESCOBALES N, 1990, AM J PHYSIOL, V259, pC640, DOI 10.1152/ajpcell.1990.259.4.C640
   FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402
   GOLDSTEIN S, 1979, FED PROC, V38, P1862
   Hartz PA, 1997, BIOCHEM MOL MED, V60, P8, DOI 10.1006/bmme.1996.2542
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HAYFLICK L, 1980, ANN REV GERONTOLOGY, V1, P26
   HO MW, 1973, BIOCHEM J, V136, P351, DOI 10.1042/bj1360351
   HOEKSEMA HL, 1979, BIOCHIM BIOPHYS ACTA, V566, P72, DOI 10.1016/0005-2744(79)90250-X
   HOOGEVEEN AT, 1983, J BIOL CHEM, V258, P2143
   Krishna DR, 1999, MECH AGEING DEV, V109, P113, DOI 10.1016/S0047-6374(99)00031-7
   Matsunaga H, 1999, INVEST OPHTH VIS SCI, V40, P197
   MEISLER M, 1974, AM J HUM GENET, V26, P683
   Mishima K, 1999, INVEST OPHTH VIS SCI, V40, P1590
   MORREAU H, 1989, J BIOL CHEM, V264, P20655
   NEGULESCU PA, 1990, METHOD ENZYMOL, V192, P38
   NORDEN AGW, 1974, J BIOL CHEM, V249, P7969
   Reznikoff CA, 1996, CANCER RES, V56, P2886
   ROBBINS E, 1970, J EXP MED, V131, P1211, DOI 10.1084/jem.131.6.1211
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Suzuki Y, 1995, METABOLIC MOL BASES, P2801
   Tsukamoto A, 1998, BIOCHEM BIOPH RES CO, V248, P9, DOI 10.1006/bbrc.1998.8902
   TURK B, 1974, ARCH BIOCHEM BIOPHYS, V161, P46, DOI 10.1016/0003-9861(74)90233-1
   van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035
   Yegorov YE, 1998, EXP CELL RES, V243, P207, DOI 10.1006/excr.1998.4169
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
NR 42
TC 624
Z9 728
U1 3
U2 65
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD OCT
PY 2000
VL 113
IS 20
BP 3613
EP 3622
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 372WJ
UT WOS:000165256800009
PM 11017877
DA 2024-02-19
ER

PT J
AU Salamanca, A
   Bárcena, B
   Arribas, C
   Fernández-Agulló, T
   Martínez, C
   Carrascosa, JM
   Ros, M
   Andrés, A
   Gallardo, N
AF Salamanca, Aurora
   Barcena, Brenda
   Arribas, Carmen
   Fernandez-Agullo, Teresa
   Martinez, Carmen
   Carrascosa, Jose Ma.
   Ros, Manuel
   Andres, Antonio
   Gallardo, Nilda
TI Aging impairs the hepatic subcellular distribution of ChREBP in response
   to fasting/feeding in rats: Implications on hepatic steatosis
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Hepatic steatosis; Insulin resistance; ChREBP; Nutritional
   adaptation
ID DE-NOVO LIPOGENESIS; INSULIN-RESISTANCE; FATTY LIVER; ADIPOSE-TISSUE;
   XYLULOSE 5-PHOSPHATE; LIPID-METABOLISM; GENE-EXPRESSION; WISTAR RATS;
   GLUCOSE; TRANSCRIPTION
AB Aging is associated with alterations of lipid metabolism and increased prevalence of non alcoholic hepatic steatosis. Nevertheless, the mechanisms by which fat is accumulated in the liver during aging remain incompletely understood. In the present study, we investigated potential alterations that might contribute to the development of hepatic steatosis with aging. To this end, we analyzed the expression and the subcellular localization of key transcriptional factors involved in lipid metabolism such as ChREBP, Foxo1, Foxa2 and SREBP-1c in the liver of 3-and 24-month old Wistar rats. In addition, we studied the intracellular redistribution of ChREBP in response to fasting/refeeding transition. Old rats were characterized by hepatic steatosis, low serum ketone body levels and postprandial hyperinsulinemia. These observations were paralleled by the cytoplasmic localization and decreased expression of Foxa2, while ChREBP expression was markedly up-regulated and mainly localized in the nucleus. Consequently, the expression of lipogenic and beta-oxidation genes was up-regulated or down-regulated, respectively. Besides, the intracellular redistribution of ChREBP in response to fasting/refeeding transition was also impaired in old animals. Additionally, a negative correlation between serum ketone body levels and the nuclear localization of ChREBP was observed only in adult but not in old rats. Taken together, these data suggest that an age-related dysfunctional adaptation of ChREBP, in response to changes in the nutritional state, might contribute to the development of liver steatosis with aging. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Salamanca, Aurora; Barcena, Brenda; Arribas, Carmen; Andres, Antonio; Gallardo, Nilda] Univ Castilla La Mancha, Biochem Sect, Fac Chem Ciudad Real, Reg Ctr Biomed Res CRIB, E-13071 Ciudad Real, Spain.
   [Salamanca, Aurora; Barcena, Brenda; Arribas, Carmen; Andres, Antonio; Gallardo, Nilda] Univ Castilla La Mancha, Fac Biochem & Environm Sci Toledo, Reg Ctr Biomed Res CRIB, Toledo, Spain.
   [Fernandez-Agullo, Teresa; Martinez, Carmen; Ros, Manuel] Univ Rey Juan Carlos, Fac Hlth Sci, Madrid, Spain.
   [Carrascosa, Jose Ma.] Autonomous Univ Madrid, Ctr Mol Biol Severo Ochoa, E-28049 Madrid, Spain.
C3 Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha;
   Universidad Rey Juan Carlos; Autonomous University of Madrid; Consejo
   Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de
   Biologia Molecular Severo Ochoa (CBM)
RP Andrés, A (corresponding author), Univ Castilla La Mancha, Biochem Sect, Fac Chem, CRIB, E-13071 Ciudad Real, Spain.
EM antonio.andres@uclm.es; nilda.gallardo@uclm.es
RI ANDRES, ANTONIO/G-8794-2015; Martinez, Carmen/P-6661-2017; Gallardo,
   Nilda/AAR-3104-2021; Carrascosa, Jose M/ABE-3526-2021; Arribas,
   Carmen/R-9660-2019
OI ANDRES, ANTONIO/0000-0002-9892-8338; Martinez,
   Carmen/0000-0001-7226-9154; Gallardo, Nilda/0000-0003-3211-569X;
   Carrascosa, Jose M/0000-0002-3574-9076; Ros, Manuel/0000-0003-2982-513X;
   , Teresa/0000-0002-7812-747X
FU Junta de Comunidades de Castilla-La Mancha (JCCM) [PCI08-0136];
   Ministerio de Ciencia e Innovacion [BFU2012-39705-C03-01]; Comunidad de
   Madrid, Spain [S2010/BMC2423]; Ministerio de Educacion y Ciencia (MEC),
   Spain; CONACyT predoctoral fellowship from Mexico
FX This work was supported in part by Research Grants PCI08-0136 from Junta
   de Comunidades de Castilla-La Mancha (JCCM), BFU2012-39705-C03-01 from
   Ministerio de Ciencia e Innovacion, and S2010/BMC2423 from Comunidad de
   Madrid, Spain. A.S. was supported by FPU predoctoral fellowship from
   Ministerio de Educacion y Ciencia (MEC), Spain, and B.B. was supported
   by CONACyT predoctoral fellowship from Mexico. The Centre of Molecular
   Biology "Severo Ochoa" is the recipient of institutional aid from the
   Ramon Areces Foundation. We thank Dr. Perdomo for advice and helpful
   suggestions and Sergio Moreno for the excellent technical assistance.
CR AGIUS L, 1986, DIABETES, V35, P1286, DOI 10.2337/diabetes.35.11.1286
   Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001
   Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280
   Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636
   Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421
   De Solís AJ, 2012, MECH AGEING DEV, V133, P306, DOI 10.1016/j.mad.2012.03.006
   Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200
   Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200
   Dentin R, 2012, J HEPATOL, V56, P199, DOI 10.1016/j.jhep.2011.07.019
   Diaz-Moralli S, 2012, AM J PHYSIOL-ENDOC M, V303, pE234, DOI 10.1152/ajpendo.00675.2011
   Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7
   ERIKSSON S, 1986, ACTA MED SCAND, V220, P83
   Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004
   Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com
   Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206
   Gallardo N, 2007, ENDOCRINOLOGY, V148, P5604, DOI 10.1210/en.2007-0933
   Gan L, 2011, CURR GERONTOL GERIAT, V31536
   Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4
   Horrillo D, 2013, J BIOL REG HOMEOS AG, V27, P377
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   del Pozo CH, 2011, BBA-MOL CELL BIOL L, V1811, P1194, DOI 10.1016/j.bbalip.2011.07.016
   Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111
   Ido-Kitamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047231
   Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101
   Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006
   Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100
   Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JC132914, 10.1172/JCI32914]
   Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009
   Liu HY, 2009, J BIOL CHEM, V284, P14087, DOI 10.1074/jbc.M807992200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200
   Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
   Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017
   Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550
   Otero YF, 2014, J BIOL CHEM, V289, P20462, DOI 10.1074/jbc.R114.576355
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Serrano R, 2009, MECH AGEING DEV, V130, P189, DOI 10.1016/j.mad.2008.11.005
   Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028
   Tamura S, 2005, J CLIN INVEST, V115, P1139, DOI 10.1172/JCI200524930
   Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007
   Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001
   Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047
   Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200
NR 45
TC 13
Z9 13
U1 1
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2015
VL 69
BP 9
EP 19
DI 10.1016/j.exger.2015.05.009
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CQ0XD
UT WOS:000360320200002
PM 26004139
OA Green Published
DA 2024-02-19
ER

PT J
AU Ye, X
   Meeker, HC
   Kozlowski, PB
   Wegiel, J
   Wang, KC
   Imaki, H
   Carp, RI
AF Ye, X
   Meeker, HC
   Kozlowski, PB
   Wegiel, J
   Wang, KC
   Imaki, H
   Carp, RI
TI Pathological changes in the liver of a senescence accelerated mouse
   strain (SAMP8): A mouse model for the study of liver diseases
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE SAMP8; fatty liver; fibrosis; ALT; AST
ID MURINE LEUKEMIA-VIRUS; TUMOR-NECROSIS-FACTOR; LIPID-PEROXIDATION;
   OXIDATIVE STRESS; GENE-EXPRESSION; END-PRODUCT; CELLS; MICE;
   PSEUDOCAPILLARIZATION; TARGET
AB Liver disease is characterized by fatty liver, hepatitis, fibrosis and cirrhosis and is a major cause of illness and death worldwide. The prevalence of liver diseases highlights the need for animal models for research on the mechanism of disease pathogenesis and efficient and cost-effective treatments. Here we show that a senescence-accelerated mouse strain (SAMP8 mice), displays severe liver pathology, which is not seen in senescence-resistant mice (SAMR1). The livers of SAMP8 mice show fatty degeneration, hepatocyte death, fibrosis, cirrhotic changes, inflammatory mononuclear cell infiltration and sporadic neoplastic changes. SAMP8 mice also show abnormal liver function tests: significantly increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Furthermore, titers of murine leukemia virus are higher in livers of SAMP8 than in those of SAMR1 mice. Our observations suggest that SAMP8 mouse strain is a valuable animal model for the study of liver diseases. The possible mechanisms of liver damage in SAMP8 mice are also discussed.
C1 New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA.
C3 Institute for Basic Research in Developmental Disabilities
RP Ye, X (corresponding author), New York State Inst Basic Res Dev Disabil, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.
EM XYE@hotmail.com
CR ADAMSON GM, 1992, ARCH BIOCHEM BIOPHYS, V294, P223, DOI 10.1016/0003-9861(92)90161-O
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Barrera G, 1996, BIOCHEM BIOPH RES CO, V227, P589, DOI 10.1006/bbrc.1996.1550
   Beard M R., 1999, Encyclopedia of Virology, V2nd, P631
   BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620
   Carp RI, 1999, J GEN VIROL, V80, P5, DOI 10.1099/0022-1317-80-1-5
   Carp RI, 2002, MECH AGEING DEV, V123, P575, DOI 10.1016/S0047-6374(01)00377-3
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   CURZIO M, 1985, INT J TISSUE REACT, V7, P137
   CZUB M, 1992, J VIROL, V66, P3298, DOI 10.1128/JVI.66.6.3298-3305.1992
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   FAZIO VM, 1992, CANCER RES, V52, P4866
   FENYVES D, 1993, HEPATOLOGY, V17, P301, DOI 10.1002/hep.1840170222
   FLOOD JF, 1994, INT CONGR SER, V1062, P405
   Fukuda A, 1997, BIOCHEM BIOPH RES CO, V236, P505, DOI 10.1006/bbrc.1997.6585
   GUYTON KZ, 1993, BRIT MED BULL, V49, P523, DOI 10.1093/oxfordjournals.bmb.a072628
   HOFFMAN PM, 1992, LAB INVEST, V67, P314
   Hug H, 1997, J BIOL CHEM, V272, P28191, DOI 10.1074/jbc.272.45.28191
   InayatHussain SH, 1997, HEPATOLOGY, V25, P1516, DOI 10.1002/hep.510250634
   KAY DG, 1991, P NATL ACAD SCI USA, V88, P1281, DOI 10.1073/pnas.88.4.1281
   LANCASTER JR, 1989, FEBS LETT, V248, P169, DOI 10.1016/0014-5793(89)80454-5
   Le Couteur David G, 2002, Rev Environ Health, V17, P51
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Leonarduzzi G, 1997, FASEB J, V11, P851, DOI 10.1096/fasebj.11.11.9285483
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Meeker HC, 1997, NEUROBIOL AGING, V18, P543, DOI 10.1016/S0197-4580(97)00041-9
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   PAROLA M, 1993, BIOCHEM BIOPH RES CO, V194, P1044, DOI 10.1006/bbrc.1993.1927
   PURCELL RH, 1999, ENCY VIROLOGY, P657
   Rao GN, 1996, J BIOL CHEM, V271, P27760, DOI 10.1074/jbc.271.44.27760
   ROBINSON WS, 1999, ENCY VIROLOGY, P640
   ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4
   ROWE WP, 1972, J EXP MED, V136, P1272, DOI 10.1084/jem.136.5.1272
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   SHARPE AH, 1990, NATURE, V346, P181, DOI 10.1038/346181a0
   Spycher S, 1996, BIOCHEM BIOPH RES CO, V226, P512, DOI 10.1006/bbrc.1996.1386
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TEMIN HM, 1992, RETROVIRIDAE, V1, P15
   Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234
   WONG PKY, 1990, CURR TOP MICROBIOL, V160, P29
   Wu J, 2000, J GASTROENTEROL, V35, P665, DOI 10.1007/s005350070045
   Yang MC, 2002, PHARMACOL TOXICOL, V90, P203, DOI 10.1034/j.1600-0773.2002.900406.x
NR 47
TC 24
Z9 28
U1 0
U2 5
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
EI 1699-5848
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD OCT
PY 2004
VL 19
IS 4
BP 1141
EP 1151
PG 11
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA 864NF
UT WOS:000224639500014
PM 15375757
DA 2024-02-19
ER

PT J
AU Larrosa, PNF
   Grecco, MR
   Gómez, DM
   Alvarado, CV
   Panelo, LC
   Rubio, MF
   Alonso, DF
   Gómez, DE
   Costas, MA
AF Fernandez Larrosa, P. N.
   Ruiz Grecco, M.
   Mengual Gomez, D.
   Alvarado, C. V.
   Panelo, L. C.
   Rubio, M. F.
   Alonso, D. F.
   Gomez, D. E.
   Costas, M. A.
TI RAC3 more than a nuclear receptor coactivator: a key inhibitor of
   senescence that is downregulated in aging
SO CELL DEATH & DISEASE
LA English
DT Article
ID CELLULAR SENESCENCE; TELOMERASE ACTIVITY; LEUKEMIA-CELLS; DNA-DAMAGE;
   C-MYC; CANCER; APOPTOSIS; SRC-3; AIB1; AMPLIFICATION
AB Receptor-associated coactivator 3 (RAC3) is a nuclear receptor coactivator usually overexpressed in tumors that exerts oncogenic functions in the cytoplasm and the nucleus. Although as part of its oncogenic actions it was previously identified as an inhibitor of apoptosis and autophagy, its expression is required in order to preserve the pluripotency and embryonic stem cell self-renewal. In this work we investigated its role in cellular senescence. We found that RAC3 overexpression in the nontumoral HEK293 cells inhibits the premature senescence induced by hydrogen peroxide or rapamycin. The mechanism involves not only the inhibition of autophagy early induced by these stimuli in the pathway to senescence, but also the increase in levels and nuclear localization of both the cell cycle suppressors p53/p21 and the longevity promoters FOXO1A, FOXO3A and SIRT1. Furthermore, we found that RAC3 overexpression is required in order to maintain the telomerase activity. In tumoral HeLa cells its activity was inhibited by depletion of RAC3 inducing replicative senescence. Moreover, we demonstrated that in vivo, levels of RAC3 are downregulated in the liver from aged as compared with young rats, whereas the levels of p21 are increased, correlating with the expected senescent cell contents in aged tissues. A similar downregulation of RAC3 was observed in the premature and replicative senescence of human fetal WI-38 cells and premature senescence of hepatocyte HepG2 cell line. Taken together, all these results demonstrate that RAC3 is an inhibitor of senescence whose downregulation in aged individuals could be probably a tumor suppressor mechanism, avoiding the clonal expansion of risky old cells having damaged DNA.
C1 [Fernandez Larrosa, P. N.; Ruiz Grecco, M.; Alvarado, C. V.; Panelo, L. C.; Rubio, M. F.; Costas, M. A.] Univ Buenos Aires, CONICET, Inst Invest Med Alfredo Lanari, Lab Biol Mol & Apoptosis,IDIM,Fac Med, Buenos Aires, DF, Argentina.
   [Mengual Gomez, D.; Alonso, D. F.; Gomez, D. E.] Univ Nacl Quilmes, Lab Oncol Mol, Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET)
RP Costas, MA (corresponding author), Univ Buenos Aires, CONICET, IDIM, Lab Biol Mol & Apoptosis, Combatientes Malvinas 3150,Cuerpo 2,Piso 1, Buenos Aires, DF, Argentina.
EM costas.monica@lanari.fmed.uba.ar
OI Gomez, Daniel E/0000-0002-8629-0787; Costas, Monica/0000-0002-4773-3389;
   Mengual Gomez, Diego Luis/0000-0002-6088-3816; Alonso, Daniel
   F./0000-0002-0601-613X; Alvarado, Cecilia/0000-0003-3147-747X; Fernandez
   Larrosa, Pablo Nicolas/0000-0002-7881-1765
FU Agencia Nacional de Promocion Cientifica y Tecnologica; Argentine
   National Research Council (CONICET); University of Buenos Aires
FX This work has been supported by grants from Agencia Nacional de
   Promocion Cientifica y Tecnologica, the Argentine National Research
   Council (CONICET) and the University of Buenos Aires. We thank Dr.
   Silvia Sookoian (IDIM-CONICET, Bs. As. Argentina), Dr. Matias Blaustein
   and Dr. Alberto Kornblihtt (FCEyN-UBA, Bs. As. Argentina) for kindly
   providing some antibodies used in this work.
CR Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965
   Aravinthan A, 2015, GENE EXPRESSION HEPA
   Bashash D, 2012, CANCER INVEST, V30, P57, DOI 10.3109/07357907.2011.629378
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Chitilian JM, 2014, STEM CELLS, V32, P204, DOI 10.1002/stem.1564
   Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Colo GP, 2008, ONCOGENE, V27, P2430, DOI 10.1038/sj.onc.1210900
   Colo GP, 2007, FEBS LETT, V581, P5075, DOI 10.1016/j.febslet.2007.09.052
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325
   Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886
   Falandry C, 2014, J CLIN ONCOL, V32, P2604, DOI 10.1200/JCO.2014.55.1432
   Larrosa PNF, 2012, CANCER SCI, V103, P2064, DOI 10.1111/cas.12019
   García-Matas S, 2015, AGING CELL, V14, P334, DOI 10.1111/acel.12259
   Henke RT, 2004, CLIN CANCER RES, V10, P6134, DOI 10.1158/1078-0432.CCR-04-0561
   Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004
   Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222
   Kim EJ, 2008, BMB REP, V41, P751, DOI 10.5483/BMBRep.2008.41.11.751
   Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479
   Ma G, 2011, INT J BIOL SCI, V7, P664, DOI 10.7150/ijbs.7.664
   Martin N, 2014, TRENDS MOL MED, V20, P667, DOI 10.1016/j.molmed.2014.09.008
   Milas M, 1998, CLIN CANCER RES, V4, P1573
   Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731
   Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238
   Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651
   Percharde M, 2013, CELL CYCLE, V12, P195, DOI 10.4161/cc.23377
   Percharde M, 2012, GENE DEV, V26, P2286, DOI 10.1101/gad.195545.112
   Piano A, 2015, AGING DIS, V6, P56, DOI 10.14336/AD.2014.0209
   Rubio MF, 2012, BBA-MOL CELL RES, V1823, P1119, DOI 10.1016/j.bbamcr.2012.01.009
   Rubio MF, 2006, ONCOGENE, V25, P1367, DOI 10.1038/sj.onc.1209176
   Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234
   Sakakura C, 2000, INT J CANCER, V89, P217
   Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241
   Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Vergel M, 2010, J AGING RES, V2011
   Vermeij WP, 2014, CURR OPIN GENET DEV, V26, P124, DOI 10.1016/j.gde.2014.06.006
   Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697
   Alvarado CV, 2014, FEBS OPEN BIO, V4, P450, DOI 10.1016/j.fob.2014.04.009
   Wang N, 2014, J CLIN ENDOCR METAB, V99, pE1571, DOI 10.1210/jc.2014-1158
   Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963
   Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003
   Werbajh S, 2000, FEBS LETT, V485, P195, DOI 10.1016/S0014-5793(00)02223-7
   White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309
   WU HY, 1994, J BIOL CHEM, V269, P20067
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116
   Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263
   Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x
   Yin L, 2000, J BIOL CHEM, V275, P36671, DOI 10.1074/jbc.M007378200
   Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003
   Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076
NR 60
TC 15
Z9 15
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD OCT
PY 2015
VL 6
AR e1902
DI 10.1038/cddis.2015.218
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA CZ5NU
UT WOS:000367150100009
PM 26469953
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sabaretnam, T
   O'Reilly, J
   Kritharides, L
   Le Couteur, DG
AF Sabaretnam, Tharani
   O'Reilly, Jennifer
   Kritharides, Leonard
   Le Couteur, David G.
TI The effect of old age on apolipoprotein E and its receptors in rat liver
SO AGE
LA English
DT Article
DE Apolipoprotein E; Liver; Hepatocyte; Ageing; Aging; Low-density
   lipoprotein receptor; Low density-lipoprotein receptor-related protein;
   Heparan sulfate proteoglycan
ID LDL RECEPTOR; PHYSIOLOGICAL RELEVANCE; LIPOPROTEIN METABOLISM; A-I;
   CHOLESTEROL; SECRETION; HYPERCHOLESTEROLEMIA; RESTRICTION; EXPRESSION;
   CLEARANCE
AB Apolipoprotein E (apoE) is associated with aging and some age-related diseases. The majority of apoE is produced by hepatocytes for the receptor-mediated uptake of lipoproteins. Here, the effects of age on the hepatic expression and distribution of apoE and its receptors were determined using immunofluorescence, Western blots, and quantitative PCR in rat liver tissue and isolated hepatocytes. The expression of apoE mRNA and protein was not influenced significantly by aging. Immunofluorescence studies in isolated hepatocytes showed that apoE was more likely to be co-localized with early endosomes, golgi, and microtubules in isolated old hepatocytes. The mRNA expression of the receptor involved in sequestration of apoE, heparan sulfate proteoglycan was reduced in old age, without any significant effect on the expression of either the low-density lipoprotein receptor or low density-lipoprotein receptor-related protein. Old age is associated with changes in hepatic apoE intracellular trafficking and heparan sulfate proteoglycan expression that might contribute to age-related disease.
C1 [Le Couteur, David G.] Concord RG Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
   [Sabaretnam, Tharani; O'Reilly, Jennifer; Kritharides, Leonard; Le Couteur, David G.] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia.
   [Sabaretnam, Tharani; Kritharides, Leonard] Concord Hosp, Dept Cardiol, Sydney, NSW, Australia.
   [Sabaretnam, Tharani; O'Reilly, Jennifer; Le Couteur, David G.] Univ Sydney, CERA, Sydney, NSW 2006, Australia.
   [Kritharides, Leonard] Univ New S Wales, Ctr Vasc Res, Sch Med Sci, Sydney, NSW, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; ANZAC
   Research Institute; Concord Repatriation General Hospital; University of
   Sydney; University of New South Wales Sydney
RP Le Couteur, DG (corresponding author), Concord RG Hosp, Ctr Educ & Res Ageing, Hosp Rd, Sydney, NSW 2139, Australia.
EM dlecouteur@med.usyd.edu.au
RI Kritharides, Leonard/AAQ-2720-2020; Research Institute,
   ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016
OI Kritharides, Leonard/0000-0001-5818-8024; Le Couteur,
   David/0000-0002-4227-5817; Sabaretnam, Tharani/0000-0003-3655-8578
FU Australian National Health and Medical Research Council; Ageing and
   Alzheimer's Research Foundation
FX We acknowledge funding from the Australian National Health and Medical
   Research Council and the Ageing and Alzheimer's Research Foundation.
CR Ang LS, 2008, EXP GERONTOL, V43, P615, DOI 10.1016/j.exger.2008.03.010
   Bose C, 2005, MECH AGEING DEV, V126, P740, DOI 10.1016/j.mad.2005.02.003
   Braeckman L, 1998, J Cardiovasc Risk, V5, P155, DOI 10.1097/00043798-199806000-00003
   Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4
   Chou SC, 1996, BIOCHEM MOL BIOL INT, V38, P847
   Cooper AD, 1997, J LIPID RES, V38, P2173
   Fazio S, 2000, TRENDS CARDIOVAS MED, V10, P23, DOI 10.1016/S1050-1738(00)00033-5
   Field PA, 2000, METABOLISM, V49, P492, DOI 10.1016/S0026-0495(00)80014-1
   Gälman C, 2007, AM J PHYSIOL-ENDOC M, V293, pE737, DOI 10.1152/ajpendo.00166.2007
   Gee JR, 2005, EXP GERONTOL, V40, P409, DOI 10.1016/j.exger.2005.01.010
   Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hilmer SN, 2004, EXP GERONTOL, V39, P53, DOI 10.1016/j.exger.2003.09.016
   Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068
   JI ZS, 1994, J BIOL CHEM, V269, P2764
   Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200
   Kolovou GD, 2007, AGEING RES REV, V6, P94, DOI 10.1016/j.arr.2006.11.001
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   LIEPA GU, 1980, AM J PHYSIOL, V238, pE253, DOI 10.1152/ajpendo.1980.238.3.E253
   Lingelbach LB, 2000, J NUTR, V130, P3077, DOI 10.1093/jn/130.12.3077
   MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154
   MASORO EJ, 1983, J NUTR, V113, P880, DOI 10.1093/jn/113.4.880
   Pallottini V, 2006, J CELL BIOCHEM, V98, P1044, DOI 10.1002/jcb.20951
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   RAO KMK, 1990, EXP GERONTOL, V25, P7, DOI 10.1016/0531-5565(90)90004-L
   Sakurabayashi I, 2001, CLIN CHIM ACTA, V312, P87, DOI 10.1016/S0009-8981(01)00591-5
   Siest G, 2000, CLIN CHEM LAB MED, V38, P841, DOI 10.1515/CCLM.2000.122
   Smith JD, 2002, AGEING RES REV, V1, P345, DOI 10.1016/S1568-1637(02)00005-3
   Swindell WR, 2008, MECH AGEING DEV, V129, P138, DOI 10.1016/j.mad.2007.11.003
   TAYLOR LV, 1992, P SOC EXP BIOL MED, V199, P441
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   WALKER RF, 1994, MECH AGEING DEV, V75, P215, DOI 10.1016/0047-6374(94)90011-6
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   Yu KCW, 2001, FRONT BIOSCI-LANDMRK, V6, pD332, DOI 10.2741/Yu
   Zhu MY, 2005, METABOLISM, V54, P1309, DOI 10.1016/j.metabol.2005.04.019
NR 37
TC 7
Z9 10
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD MAR
PY 2010
VL 32
IS 1
BP 69
EP 77
DI 10.1007/s11357-009-9115-2
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 561GD
UT WOS:000274963000007
PM 19809892
OA Green Published
DA 2024-02-19
ER

PT J
AU Sojoodi, M
   Wei, L
   Erstad, DJ
   Yamada, S
   Fujii, T
   Hirschfield, H
   Kim, RS
   Lauwers, GY
   Lanuti, M
   Hoshida, Y
   Tanabe, KK
   Fuchs, BC
AF Sojoodi, Mozhdeh
   Wei, Lan
   Erstad, Derek J.
   Yamada, Suguru
   Fujii, Tsutomu
   Hirschfield, Hadassa
   Kim, Rosa S.
   Lauwers, Gregory Y.
   Lanuti, Michael
   Hoshida, Yujin
   Tanabe, Kenneth K.
   Fuchs, Bryan C.
TI Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and
   Attenuates Development of Hepatocellular Carcinoma
SO CANCER PREVENTION RESEARCH
LA English
DT Article
ID GREEN TEA CONSUMPTION; LIVER-CANCER RISK; NONALCOHOLIC STEATOHEPATITIS;
   OXIDATIVE STRESS; GENE-EXPRESSION; RAT MODEL; FIBROSIS; INFLAMMATION;
   GROWTH; PREVENTION
AB Hepatocellular carcinoma (HCC) is a highly morbid condition with lack of effective treatment options. HCC arises from chronically inflamed and damaged liver tissue; therefore, chemoprevention may be a useful strategy to reduce HCC incidence. Several reports suggest that epigallocatechin gallate (EGCG), extracted from green tea, can suppress liver inflammation and fibrosis in animal models, but its role in HCC chemoprevention is not well established. In this study, male Wistar rats were injected with diethylnitrosamine at 50 mg/kg for 18 weeks to induce cirrhosis and HCC, and EGCG was given in drinking water at a concentration of 0.02%. Clinically achievable dosing of EGCG was well-tolerated in diethylnitrosamine-injured rats and was associated with improved serum liver markers including alanine transaminase, aspartate transaminase, and total bilirubin, and reduced HCC tumor formation. Transcriptomic analysis of diethylnitrosamine-injured hepatic tissue was notable for increased expression of genes associated with the Hoshida high risk HCC gene signature, which was prevented with EGCG treatment. EGCG treatment also inhibited fibrosis progression, which was associated with inactivation of hepatic stellate cells and induction of the senescence-associated secretory phenotype. In conclusion, EGCG administered at clinically safe doses exhibited both chemopreventive and antifibrotic effects in a rat diethylnitrosamine liver injury model.
C1 [Sojoodi, Mozhdeh; Wei, Lan; Erstad, Derek J.; Yamada, Suguru; Fujii, Tsutomu; Tanabe, Kenneth K.; Fuchs, Bryan C.] Massachusetts Gen Hosp, Div Surg Oncol, Canc Ctr, Boston, MA 02114 USA.
   [Sojoodi, Mozhdeh; Wei, Lan; Erstad, Derek J.; Yamada, Suguru; Fujii, Tsutomu; Lauwers, Gregory Y.; Lanuti, Michael; Tanabe, Kenneth K.; Fuchs, Bryan C.] Harvard Med Sch, Boston, MA 02115 USA.
   [Hirschfield, Hadassa; Kim, Rosa S.; Hoshida, Yujin] Univ Texas Southwestern Med Ctr Dallas, Liver Tumor Translat Res Program, Harold C Simmons Comprehens Canc Ctr, Div Digest & Liver Dis,Dept Internal Med, Dallas, TX 75390 USA.
   [Lauwers, Gregory Y.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
   [Lanuti, Michael] Massachusetts Gen Hosp, Div Thorac Surg, Canc Ctr, Boston, MA 02114 USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Harvard Medical School; University of Texas System; University of Texas
   Southwestern Medical Center Dallas; Harvard University; Massachusetts
   General Hospital; Harvard University; Massachusetts General Hospital
RP Fuchs, BC (corresponding author), Massachusetts Gen Hosp, Div Surg Oncol, Canc Ctr, Boston, MA 02114 USA.; Sojoodi, M (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,W401, Boston, MA 02138 USA.
EM MSOJ00DI@mgh.harvard.edu; BFUCHS@mgh.harvard.edu
OI Lanuti, Michael/0000-0001-6049-1276
FU American Institute for Cancer Research
FX This work was supported by an Investigator-Initiated Grant from the
   American Institute for Cancer Research (to B.C. Fuchs).
CR Ahsan MK, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00069
   Al-Rajabi R, 2015, J GASTROINTEST ONCOL, V6, P259, DOI 10.3978/j.issn.2078-6891.2015.005
   Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096
   Chung MY, 2012, J NUTR BIOCHEM, V23, P361, DOI 10.1016/j.jnutbio.2011.01.001
   Coia H, 2018, CANCER PREV RES, V11, P665, DOI 10.1158/1940-6207.CAPR-18-0160
   Coulouarn C, 2014, J HEPATOL, V60, P1306, DOI 10.1016/j.jhep.2014.02.003
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   Darvesh AS, 2013, NUTR CANCER, V65, P329, DOI 10.1080/01635581.2013.767367
   DePeralta DK, 2016, CANCER-AM CANCER SOC, V122, P1216, DOI 10.1002/cncr.29912
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ding Y, 2015, EUR J PHARMACOL, V761, P405, DOI 10.1016/j.ejphar.2015.05.005
   El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014
   Fu Y, 2018, HEPATOLOGY, V67, P159, DOI 10.1002/hep.29380
   Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898
   Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884
   Geng ZM, 2014, CELL BIOCHEM BIOPHYS, V70, P337, DOI 10.1007/s12013-014-9918-3
   Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018
   Hicks DF, 2017, SCI REP-UK, V7, DOI 10.1038/srep42563
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525
   Huang YQ, 2016, NUTRITION, V32, P3, DOI 10.1016/j.nut.2015.05.021
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kudo M, 2016, LIVER INT, V36, P1196, DOI 10.1111/liv.13096
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020
   Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030
   Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481
   Li S, 2019, J GASTROINTEST SURG, V23, P101, DOI 10.1007/s11605-018-4004-6
   Lujambio A, 2015, AGING-US, V7, P348, DOI 10.18632/aging.100758
   Masuda M, 2001, CLIN CANCER RES, V7, P4220
   Nakagawa S, 2016, CANCER CELL, V30, P879, DOI 10.1016/j.ccell.2016.11.004
   Navarro VJ, 2013, DIGEST DIS SCI, V58, P2682, DOI 10.1007/s10620-013-2687-9
   Ni CX, 2017, NUTR CANCER, V69, P211, DOI 10.1080/01635581.2017.1263754
   Park LS, 2011, CANCER EPIDEM BIOMAR, V20, P2512, DOI 10.1158/1055-9965.EPI-11-0582
   Ramakrishna G, 2013, LIVER CANCER, V2, P367, DOI 10.1159/000343852
   Sah JF, 2004, J BIOL CHEM, V279, P12755, DOI 10.1074/jbc.M312333200
   Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14
   Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332
   Shen KZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126278
   Shimizu M, 2015, INT J MOL SCI, V16, P6124, DOI 10.3390/ijms16036124
   Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014
   Tamura T, 2019, NAGOYA J MED SCI, V81, P143, DOI 10.18999/nagjms.81.1.143
   Tanaka H, 2012, CLIN REV ALLERG IMMU, V43, P220, DOI 10.1007/s12016-012-8323-1
   Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014
   Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361
   Tolba R, 2015, LAB ANIM-UK, V49, P59, DOI 10.1177/0023677215570086
   Tsochatzis EA, 2012, NEW ENGL J MED, V366, P92, DOI 10.1056/NEJMc1112501
   Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205
   Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Yu ZM, 2017, CANCER PREV RES, V10, P571, DOI [10.1158/1940-6207.capr-17-0160, 10.1158/1940-6207.CAPR-17-0160]
   Zhang DY, 2016, GUT, V65, P1754, DOI 10.1136/gutjnl-2015-309655
NR 56
TC 17
Z9 18
U1 0
U2 6
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1940-6207
EI 1940-6215
J9 CANCER PREV RES
JI Cancer Prev. Res.
PD JUN
PY 2020
VL 13
IS 6
BP 497
EP 507
DI 10.1158/1940-6207.CAPR-19-0383
PG 11
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA LU6DE
UT WOS:000537842800002
PM 32253266
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Safwat, MH
   El-Sawalhi, MM
   Mausouf, MN
   Shaheen, AA
AF Safwat, M. H.
   El-Sawalhi, M. M.
   Mausouf, M. N.
   Shaheen, A. A.
TI Ozone ameliorates age-related oxidative stress changes in rat liver and
   kidney: Effects of pre- and post-ageing administration
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE ozone; oxidative stress; liver; kidney; pre-ageing; post-ageing
ID GLYCATION END-PRODUCTS; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION; PROTEIN
   OXIDATION; GLUTATHIONE; DISEASE; PROTECTION; THERAPY; RESTRICTION;
   PROTEASOME
AB The ageing process is known to be accompanied by increased oxidative stress and compromised antioxidant defenses. Controlled ozone administration has been shown to be effective in various pathophysiological conditions with an underlying oxidative burden. However, its effect on the biochemical alterations associated with the ageing process has been rarely studied. Therefore, the present work was carried out to study the role of ozone in counteracting the state of oxidative stress associated with ageing in rat liver and kidneys using two experimental models. In the pre-ageing model, ozone was administered prior to the onset of ageing at adulthood and continued after the start of the ageing process (3-month-old rats until the age of 15 months). While in the post-ageing model, ozone was administered after ageing has begun and lasted for one month (14-month-old rats until the age of 15 months). The pre-ageing ozone administration effectively reduced lipid and protein oxidation markers, namely, malondialdehyde and protein carbonyl levels and decreased lipofuscin pigment deposition in rat liver and kidneys. Moreover, it significantly restored hepatic and renal reduced glutathione (GSH) contents and normalized cytosolic hepatic glutathione peroxidase activity. Similar but less pronounced effects were observed in the post-ageing ozone-treated group. Nevertheless, in the latter model ozone administration failed to significantly affect liver and kidney lipofuscin levels, as well as kidney GSH contents. These data provide evidences for potentially positive effects of pre-ageing ozone therapy in neutralizing chronic oxidative stress associated with ageing in rat liver and kidneys.
C1 [Safwat, M. H.; El-Sawalhi, M. M.; Shaheen, A. A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo 11562, Egypt.
   [Mausouf, M. N.] Cairo Univ, Natl Canc Inst, Ozone Therapy Unit, Cairo 11562, Egypt.
C3 Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank
   (EKB); National Cancer Institute - Egypt; Cairo University
RP Safwat, MH (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Kasr Al Aini St, Cairo 11562, Egypt.
EM maheerasafwat@yahoo.com; mahaelsawalhi@yahoo.com;
   nabil_mawsouf@yahoo.co.uk
OI El-Sawalhi, Maha/0000-0002-6598-4392; Shaheen, Amira/0000-0002-7957-0879
CR Ajamieh HH, 2005, TRANSPL INT, V18, P604, DOI 10.1111/j.1432-2277.2005.00101.x
   Ajamieh HH, 2004, LIVER INT, V24, P55, DOI 10.1111/j.1478-3231.2004.00885.x
   Alabarse PVG, 2011, EXP GERONTOL, V46, P773, DOI 10.1016/j.exger.2011.05.006
   BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Berrougui H, 2009, REJUV RES, V12, P117, DOI 10.1089/rej.2008.0840
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BOCCI V, 2000, INT J MED BIOL ENV, V28, P109
   Bocci V, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/26785
   Bocci V, 2009, MED RES REV, V29, P646, DOI 10.1002/med.20150
   Bocci VA, 2007, ARCH MED RES, V38, P265, DOI 10.1016/j.arcmed.2006.09.011
   Borrego A, 2004, MEDIAT INFLAMM, V13, P13, DOI 10.1080/09629350410001664806
   Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P297, DOI 10.1002/jat.758
   Chen H, 2008, ARCH MED RES, V39, P169, DOI 10.1016/j.arcmed.2007.09.005
   Clark B, 2000, ADV RENAL REPLACE TH, V7, P11, DOI 10.1016/S1073-4449(00)70002-1
   Dröge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x
   El Mohsen MMA, 2005, BIOCHEM BIOPH RES CO, V336, P386, DOI 10.1016/j.bbrc.2005.07.201
   El-Sawalhi MM, 2013, CELL BIOCHEM FUNCT, V31, P518, DOI 10.1002/cbf.2930
   Farout L, 2006, ANTIOXID REDOX SIGN, V8, P205, DOI 10.1089/ars.2006.8.205
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Gemma J., 2007, BRAIN AGEING MODELS, P353
   Gil L, 2011, BIOMED AGEING PATHOL, V1, P1
   Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819
   González R, 2004, MEDIAT INFLAMM, V13, P307, DOI 10.1080/09629350400008836
   GOTO S, 1995, MCBU, P151
   Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444
   Hagen TM, 2003, ANTIOXID REDOX SIGN, V5, P503, DOI 10.1089/152308603770310149
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001
   He XZ, 2011, J SURG RES, V170, pE271, DOI 10.1016/j.jss.2011.06.008
   Höhn A, 2011, FREE RADICAL BIO MED, V50, P585, DOI 10.1016/j.freeradbiomed.2010.12.011
   Höhn A, 2010, FREE RADICAL BIO MED, V48, P1100, DOI 10.1016/j.freeradbiomed.2010.01.030
   Ijichi H, 2006, J HEPATOL, V45, P28, DOI 10.1016/j.jhep.2005.12.021
   Iles KE, 2005, FREE RADICAL BIO MED, V38, P547, DOI 10.1016/j.freeradbiomed.2004.11.012
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a
   Kumar P., 2011, J AGEING RES, V2011
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011
   Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martínez-Sánchez G, 2012, EUR J PHARMACOL, V691, P156, DOI 10.1016/j.ejphar.2012.07.010
   Morsy MD, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-29
   Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pandey KB, 2010, OXID MED CELL LONGEV, V3, P2, DOI 10.4161/oxim.3.1.10476
   Percy CJ, 2009, MECH AGEING DEV, V130, P129, DOI 10.1016/j.mad.2008.10.003
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Ramesh T, 2012, EXP GERONTOL, V47, P979, DOI 10.1016/j.exger.2012.09.003
   Ramesh T, 2012, EXP GERONTOL, V47, P77, DOI 10.1016/j.exger.2011.10.007
   Re L, 2008, ARCH MED RES, V39, P17, DOI 10.1016/j.arcmed.2007.07.005
   Rebrin I, 2008, ADV DRUG DELIVER REV, V60, P1545, DOI 10.1016/j.addr.2008.06.001
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Sharman EH, 2001, NEUROBIOL AGING, V22, P629, DOI 10.1016/S0197-4580(01)00226-3
   Shehata NI, 2012, BIOGERONTOLOGY, V13, P565, DOI 10.1007/s10522-012-9400-9
   Shimizu I, 2007, HEPATOL RES, V37, P239, DOI 10.1111/j.1872-034X.2007.00032.x
   Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Subathra M, 2005, EXP GERONTOL, V40, P707, DOI 10.1016/j.exger.2005.06.001
   Tamburini I, 2004, AGING CLIN EXP RES, V16, P425, DOI 10.1007/BF03327396
   TAPPEL A, 1973, J GERONTOL, V28, P415, DOI 10.1093/geronj/28.4.415
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Toroser D, 2007, BIOCHEM J, V405, P583, DOI 10.1042/BJ20061868
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Uribarri J, 2003, J AM SOC NEPHROL, V14, P728, DOI 10.1097/01.ASN.0000051593.41395.B9
   Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427
   Uribarri J, 2007, DIABETES CARE, V30, P2579, DOI 10.2337/dc07-0320
   Zubkova EV, 2004, BIOL REPROD, V71, P1002, DOI 10.1095/biolreprod.104.028373
NR 69
TC 17
Z9 17
U1 0
U2 8
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD MAY
PY 2014
VL 79
IS 5
BP 450
EP 458
DI 10.1134/S0006297914050095
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AH2MP
UT WOS:000335955900009
PM 24954596
DA 2024-02-19
ER

PT J
AU Zhang, XY
   Zhou, D
   Strakovsky, R
   Zhang, YK
   Pan, YX
AF Zhang, Xiyuan
   Zhou, Dan
   Strakovsky, Rita
   Zhang, Yukun
   Pan, Yuan-Xiang
TI Hepatic cellular senescence pathway genes are induced through histone
   modifications in a diet-induced obese rat model
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE aging; stress; chromatin; cancer; nonalcoholic fatty liver disease
ID HIGH-FAT DIET; PROTEOME ANALYSIS; ACID OXIDATION; EXPRESSION; RESISTANT;
   PRONE; LIVER; SUSCEPTIBILITY; PROGRESSION; PROTEINS
AB Zhang X, Zhou D, Strakovsky R, Zhang Y, Pan Y-X. Hepatic cellular senescence pathway genes are induced through histone modifications in a diet-induced obese rat model. Am J Physiol Gastrointest Liver Physiol 302: G558-G564, 2012. First published December 22, 2011; doi:10.1152/ajpgi.00032.2011.-Overnutrition, such as a high-fat (HF) diet, is a feature followed by some in developed nations that leads to obesity and fatty liver disease. In rats, when fed a fat-high diet, some develop obesity (obesity prone, OP) while others display an obesity-resistant (OR) phenotype. The present study investigated the differences between OP and OR rats on their activation of hepatic cellular senescence pathways on a HF diet. Male OP and OR rats were fed a HF diet containing 45% kcal from fat for 13 wk, and livers were collected for analysis by quantitative real-time PCR, Western blot, and chromatin immunoprecipitation. OP rats were 41% heavier than OR rats, despite consuming the same amount of food. Triacylglycerol levels were increased significantly in both plasma and liver of OP rats. Gene analysis demonstrated a significant increase of both the amount and the transcription rates of p16(INK4a) and p21(Cip1) mRNA in OP rats. The increased p16(INK4a) and p21(Cip1) also caused a significant decrease in the level of phosphorylation of retinoblastoma protein. In OP rats, the increase of p16(INK4a) was associated with the higher acetylation levels of histone H4 at the p16(INK4a) promoter and coding region and lower methylation level of histone H3 lysine-27 in the p16(INK4a) coding region. The increase of p21(Cip1) was associated with increased acetylation of both histone H3 and H4 and decreased trimethylation of histone H3 lysine-27 at the p21(Cip1) promoter. In the p21(Cip1) coding region, dimethylation of histone H3 lysine-4 was significantly higher (P < 0.05) in livers of OP rats compared with OR rats.
C1 [Zhang, Xiyuan; Zhou, Dan; Zhang, Yukun; Pan, Yuan-Xiang] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Strakovsky, Rita; Pan, Yuan-Xiang] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
RP Pan, YX (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, 461 Bevier Hall,MC-182,905 S Goodwin Ave, Urbana, IL 61801 USA.
EM yxpan@illinois.edu
RI Pan, Yuan-Xiang/C-6576-2019
OI Pan, Yuan-Xiang/0000-0003-3219-4367
FU United States Department of Agriculture Cooperative State Research,
   Education, and Extension Service [ILLU-698-374]
FX This project was supported by the United States Department of
   Agriculture Cooperative State Research, Education, and Extension
   Service, Hatch project no. ILLU-698-374.
CR ALMASAN A, 1995, CANCER METAST REV, V14, P59, DOI 10.1007/BF00690212
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   CHANG S, 1990, AM J PHYSIOL, V259, pR1103, DOI 10.1152/ajpregu.1990.259.6.R1103
   Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200
   Choi JW, 2010, PROTEOMICS, V10, P4386, DOI 10.1002/pmic.201000391
   Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245
   Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Feng YP, 2009, FEBS J, V276, P4197, DOI 10.1111/j.1742-4658.2009.07128.x
   Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319
   Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1
   HARA E, 1994, J BIOL CHEM, V269, P2139
   Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251
   Jackman MR, 2006, AM J PHYSIOL-ENDOC M, V291, pE1083, DOI 10.1152/ajpendo.00159.2006
   Ji H, 2008, INT J OBESITY, V32, P1331, DOI 10.1038/ijo.2008.71
   Ji H, 2005, METABOLISM, V54, P421, DOI 10.1016/j.metabol.2004.10.007
   Ji H, 2003, PHYSIOL BEHAV, V78, P767, DOI 10.1016/S0031-9384(03)00078-7
   Ji H, 2007, METABOLISM, V56, P1124, DOI 10.1016/j.metabol.2007.04.006
   Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9
   Kim DH, 2011, J PROTEOME RES, V10, P1281, DOI 10.1021/pr101048q
   Kirpich IA, 2011, J NUTR BIOCHEM, V22, P38, DOI 10.1016/j.jnutbio.2009.11.009
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725
   LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774
   Luyckx VA, 2009, AM J PHYSIOL-RENAL, V297, pF1697, DOI 10.1152/ajprenal.00462.2009
   McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004
   Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9
   MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   PAGLIASSOTTI MJ, 1994, AM J PHYSIOL, V267, pR659, DOI 10.1152/ajpregu.1994.267.3.R659
   Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202
   Pi-Sunyer FX, 2002, OBES SURG, V12, p6S, DOI 10.3810/pgm.2009.11.2074
   Ricci MR, 2003, AM J PHYSIOL-REG I, V285, pR610, DOI 10.1152/ajpregu.00235.2003
   Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197
   ROLLS BJ, 1992, NUTR REV, V50, P283, DOI 10.1111/j.1753-4887.1992.tb02466.x
   SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Taghavi N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-138
   Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796
   Zhang XY, 2011, J NUTR, V141, P1254, DOI 10.3945/jn.111.139576
   Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285
NR 43
TC 39
Z9 41
U1 0
U2 15
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD MAR
PY 2012
VL 302
IS 5
BP G558
EP G564
DI 10.1152/ajpgi.00032.2011
PG 7
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 903KA
UT WOS:000301114200010
PM 22194422
OA Green Published
DA 2024-02-19
ER

PT J
AU Sun, KY
   Sun, YT
   Li, HY
   Han, DY
   Bai, YT
   Zhao, R
   Guo, ZJ
AF Sun, Kaiyue
   Sun, Yingting
   Li, Heyang
   Han, Dongyao
   Bai, Yuting
   Zhao, Rong
   Guo, Zijiao
TI Anti-Ageing Effect of <i>Physalis alkekengi</i> Ethyl Acetate Layer on a
   d-galactose-Induced Mouse Model through the Reduction of Cellular
   Senescence and Oxidative Stress
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Physalis alkekengi; learning and memory; exercise endurance; cellular
   senescence; oxidative stress
ID FRANCHETII MAST. MAKINO; RAT MODEL; BRAIN; CELLS; DISEASES; LUTEOLIN;
   HEALTH; DAMAGE; LIVER
AB We aimed to study the effects of an ethyl acetate fraction of Physalis alkekengi (PAE) on d-galactose (d-gal)-induced senescence and the underlying mechanism. Firstly, analysis of the phytochemical composition revealed total flavonoids, total phenolics, total saponins, rutin, and luteolin contents of 71.72 +/- 2.99 mg rutin equivalents/g, 40.19 +/- 0.47 mg gallic acid equivalents/g, 128.13 +/- 1.04 mg oleanolic acid equivalents/g, 1.67 +/- 0.07 mg/g and 1.61 +/- 0.01 mg/g, respectively. The mice were treated with d-gal for six weeks, and from the fifth week, the mice were administered with PAE by gavage once a day for five weeks. We found significant d-gal-induced ageing-related changes, such as learning and memory impairment in novel object recognition and Y-maze, fatigue in weight-loaded forced swimming, reduced thymus coefficient, and histopathological injury of the liver, spleen, and hippocampus. The PAE effectively protected from such changes. Further evaluation showed that PAE decreased the senescence-associated beta-galactosidase of the liver, spleen, and hippocampus, as well as the oxidative stress of the liver, plasma, and brain. The abundance of flavonoids, phenols, and saponins in PAE may have contributed to the above results. Overall, this study showed the potential application of PAE for the prevention or treatment of ageing-associated disorders.
C1 [Sun, Kaiyue; Sun, Yingting; Li, Heyang; Han, Dongyao; Bai, Yuting; Zhao, Rong; Guo, Zijiao] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China.
C3 Shanxi Agricultural University
RP Sun, KY (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China.
EM sunkaiyue21@163.com; syt09809@163.com; liheyangnongda@163.com;
   handongyaoyao@163.com; 18392788015@163.com; rongzhao9610@163.com;
   zijiaoguo814@163.com
OI Sun, Kaiyue/0000-0003-3642-6970
FU Shanxi Province Science Foundation for Youths [201801D221252]
FX This work was financially supported by the grant from Shanxi Province
   Science Foundation for Youths (Grant No: 201801D221252), China.
CR Araujo JA, 2005, PROG NEURO-PSYCHOPH, V29, P411, DOI 10.1016/j.pnpbp.2004.12.008
   Bellantuono I, 2018, NATURE, V554, P293, DOI 10.1038/d41586-018-01668-0
   Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7
   Burton MD, 2016, REJUV RES, V19, P286, DOI 10.1089/rej.2015.1708
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Chen L, 2019, FOOD CHEM TOXICOL, V133, DOI 10.1016/j.fct.2019.110781
   Chen XY, 2016, NEUROCHEM RES, V41, P3032, DOI 10.1007/s11064-016-2022-x
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Chinta SJ, 2018, CELL REP, V22, P930, DOI 10.1016/j.celrep.2017.12.092
   Duan FF, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3159358
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Figueira I, 2016, MECH AGEING DEV, V160, P69, DOI 10.1016/j.mad.2016.09.009
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hoffman JD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00298
   Hong JM, 2015, IMMUNOBIOLOGY, V220, P1, DOI 10.1016/j.imbio.2014.10.004
   Hu XF, 2018, FITOTERAPIA, V127, P129, DOI 10.1016/j.fitote.2018.02.015
   Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003
   Ittai B.P., 2004, INT J BIOCHEM CELL B, V37, P961
   Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324
   Ji MS, 2017, EXP THER MED, V14, P5881, DOI 10.3892/etm.2017.5327
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Li AL, 2018, J ETHNOPHARMACOL, V210, P260, DOI 10.1016/j.jep.2017.08.022
   Li DD, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109204
   Li Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/562345
   Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048
   Li TY, 2016, FOOD FUNCT, V7, P1147, DOI 10.1039/c5fo01036e
   Li X, 2014, PHYTOCHEM LETT, V10, P95, DOI 10.1016/j.phytol.2014.08.004
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Lou ZX, 2011, J FOOD SCI, V76, pM398, DOI 10.1111/j.1750-3841.2011.02213.x
   Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516
   Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035
   Meng HD, 2010, J AM GERIATR SOC, V58, P2033, DOI 10.1111/j.1532-5415.2010.03088.x
   Moniruzzaman M, 2018, CELL STRESS CHAPERON, V23, P763, DOI 10.1007/s12192-018-0887-0
   Moniruzzaman M, 2016, J ETHNOPHARMACOL, V181, P26, DOI 10.1016/j.jep.2016.01.023
   Nabavi SF, 2015, BRAIN RES BULL, V119, P1, DOI 10.1016/j.brainresbull.2015.09.002
   Norheim KB, 2011, RHEUMATOLOGY, V50, P1009, DOI 10.1093/rheumatology/keq454
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Quan W, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103633
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shakeri H, 2018, AM J PHYSIOL-HEART C, V315, pH448, DOI 10.1152/ajpheart.00287.2018
   Shen CY, 2017, BRIT J PHARMACOL, V174, P1395, DOI 10.1111/bph.13631
   Soefje SA, 2011, TARGET ONCOL, V6, P125, DOI 10.1007/s11523-011-0174-9
   Sun JZ, 2018, INT IMMUNOPHARMACOL, V58, P94, DOI 10.1016/j.intimp.2018.03.017
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   Sun KY, 2019, METAB BRAIN DIS, V34, P173, DOI 10.1007/s11011-018-0335-y
   Tu DG, 2018, FOOD FUNCT, V9, P124, DOI 10.1039/c7fo01210a
   Tung YT, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081715
   Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029
   Venkatachalam G, 2017, NUCLEIC ACIDS RES, V45, P10564, DOI 10.1093/nar/gkx684
   Wang GS, 2019, J INTENSIVE CARE MED, V34, P863, DOI 10.1177/0885066618793385
   Xu H, 2016, J FUNCT FOODS, V22, P278, DOI 10.1016/j.jff.2016.01.028
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Zhang Z, 2019, INT IMMUNOPHARMACOL, V67, P78, DOI 10.1016/j.intimp.2018.11.026
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 55
TC 15
Z9 17
U1 3
U2 26
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2020
VL 21
IS 5
AR 1836
DI 10.3390/ijms21051836
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA LB8VL
UT WOS:000524908500287
PM 32155871
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Jurk, D
   Wilson, C
   Passos, JF
   Oakley, F
   Correia-Melo, C
   Greaves, L
   Saretzki, G
   Fox, C
   Lawless, C
   Anderson, R
   Hewitt, G
   Pender, SLF
   Fullard, N
   Nelson, G
   Mann, J
   van de Sluis, B
   Mann, DA
   von Zglinicki, T
AF Jurk, Diana
   Wilson, Caroline
   Passos, Joao F.
   Oakley, Fiona
   Correia-Melo, Clara
   Greaves, Laura
   Saretzki, Gabriele
   Fox, Chris
   Lawless, Conor
   Anderson, Rhys
   Hewitt, Graeme
   Pender, Sylvia L. F.
   Fullard, Nicola
   Nelson, Glyn
   Mann, Jelena
   van de Sluis, Bart
   Mann, Derek A.
   von Zglinicki, Thomas
TI Chronic inflammation induces telomere dysfunction and accelerates ageing
   in mice
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NF-KAPPA-B; DNA-DAMAGE-RESPONSE; CELLULAR SENESCENCE; LIFE-SPAN;
   SECRETORY PHENOTYPE; P50 LIMITS; LIVER; ACTIVATION; INHIBITION; DEVELOP
AB Chronic inflammation is associated with normal and pathological ageing. Here we show that chronic, progressive low-grade inflammation induced by knockout of the nfkb1 subunit of the transcription factor NF-kappa B induces premature ageing in mice. We also show that these mice have reduced regeneration in liver and gut. nfkb1(-/-) fibroblasts exhibit aggravated cell senescence because of an enhanced autocrine and paracrine feedback through NF-kappa B, COX-2 and ROS, which stabilizes DNA damage. Preferential accumulation of telomere-dysfunctional senescent cells in nfkb1(-/-) tissues is blocked by anti-inflammatory or antioxidant treatment of mice, and this rescues tissue regenerative potential. Frequencies of senescent cells in liver and intestinal crypts quantitatively predict mean and maximum lifespan in both short- and long-lived mice cohorts. These data indicate that systemic chronic inflammation can accelerate ageing via ROS-mediated exacerbation of telomere dysfunction and cell senescence in the absence of any other genetic or environmental factor.
C1 [Jurk, Diana; Passos, Joao F.; Correia-Melo, Clara; Saretzki, Gabriele; Lawless, Conor; Anderson, Rhys; Hewitt, Graeme; Nelson, Glyn; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
   [Wilson, Caroline; Oakley, Fiona; Fox, Chris; Fullard, Nicola; Mann, Jelena; Mann, Derek A.] Newcastle Univ, Inst Cellular Med, Liver Grp, Fibrosis Lab, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Greaves, Laura] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Lawless, Conor] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Pender, Sylvia L. F.] Univ Southampton, Southampton Gen Hosp, Sir Henry Wellcome Labs, Fac Med, Southampton SO16 6YD, Hants, England.
   [van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Mol Genet Lab, NL-9713 AV Groningen, Netherlands.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle University - UK; University of Southampton;
   University of Groningen
RP von Zglinicki, T (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England.
EM t.vonzglinicki@ncl.ac.uk
RI nelson, glyn/A-6346-2009; Saretzki, Gabriele Christine/I-7175-2019;
   Mann, Derek A/E-4765-2011; Wang, Ying/A-1492-2018
OI nelson, glyn/0000-0002-1895-4772; Saretzki, Gabriele
   Christine/0000-0003-2100-8223; van de Sluis, Bart
   (A.J.A.)/0000-0003-3039-4365; Passos, Joao/0000-0001-8765-1890; von
   Zglinicki, Thomas/0000-0002-5939-0248; Oakley,
   Fiona/0000-0001-8692-1836; Correia-Melo, Clara/0000-0001-6062-1472;
   Wang, Ying/0000-0001-8332-8500; Greaves, Laura/0000-0002-8071-5916;
   Mann, Derek/0000-0003-0950-243X; Hewitt, Graeme/0000-0003-2614-6932; ,
   Caroline/0000-0002-9016-6025; Jurk, Diana/0000-0003-4486-0857
FU BBSRC [BB/C008200/1, BB/I020748/1]; UK Medical Research Council (MICA
   Programme) [Grant MK/K001949/1, G0700890, G0900535]; Wellcome Trust
   [WT084961MA]; European Commission FP7 programme 'INFLA-CARE' [223151];
   Newcastle Biomedical Research Centre; National Institute for Health
   Research; BBSRC [BB/H022384/1, BB/I020748/1, BB/K017314/1, BB/F010966/1]
   Funding Source: UKRI; MRC [G0900535, G0700890, MR/L016354/1,
   MR/K001949/1, G0700718] Funding Source: UKRI
FX The study was supported by BBSRC (grants BB/C008200/1 and BB/I020748/1
   to T.v.Z.), the UK Medical Research Council (MICA Programme Grant
   MK/K001949/1 to D.A.M., grants G0700890 to D.A.M. and F.O. and G0900535
   to F.O.), the Wellcome Trust (grant WT084961MA to D.A.M.), a European
   Commission FP7 programme grant 'INFLA-CARE' (EC Contract No. 223151;
   http://inflacare.imbb.forth.gr/) and grants from the Newcastle
   Biomedical Research Centre (T.v.Z. and D.A.M.) and the National
   Institute for Health Research (D.A.M.). We thank Neil Perkins, Patrick
   Chinnery, Chris Day and Tom Kirkwood for critical discussion of the
   manuscript.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Aparicio-Vergara M, 2013, HEPATOLOGY, V57, P566, DOI 10.1002/hep.26046
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781
   Cameron Kerry M, 2012, Longev Healthspan, V1, P3, DOI 10.1186/2046-2395-1-3
   Cameron KM, 2011, MECH AGEING DEV, V132, P202, DOI 10.1016/j.mad.2011.04.004
   Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957
   CHEN TS, 1990, J GERONTOL, V45, pB129, DOI 10.1093/geronj/45.4.B129
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Collerton J, 2012, MECH AGEING DEV, V133, P456, DOI 10.1016/j.mad.2012.05.005
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025
   Fontana L, 2013, AGING CELL, V12, P459, DOI 10.1111/acel.12068
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621
   Hawkins P, 2011, LAB ANIM-UK, V45, P1, DOI 10.1258/la.2010.010031
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506
   Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x
   Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007
   Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018
   Lee YJ, 2010, MICROBIOL IMMUNOL, V54, P542, DOI 10.1111/j.1348-0421.2010.00249.x
   Liao CY, 2011, AGING CELL, V10, P629, DOI 10.1111/j.1474-9726.2011.00702.x
   Martien S, 2013, BBA-MOL CELL BIOL L, V1831, P1217, DOI 10.1016/j.bbalip.2013.04.005
   Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125
   Miyamoto S, 2011, CELL RES, V21, P116, DOI 10.1038/cr.2010.179
   Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857
   Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2
   Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893
   Rainsford K. D., 2007, V42, P3
   Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002
   Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429
   Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001
   Sperka T, 2012, NAT CELL BIOL, V14, P73, DOI 10.1038/ncb2388
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Teeling JL, 2010, BRAIN BEHAV IMMUN, V24, P409, DOI 10.1016/j.bbi.2009.11.006
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Ullman-Culleré MH, 1999, LAB ANIM SCI, V49, P319
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
NR 68
TC 526
Z9 565
U1 8
U2 62
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN
PY 2014
VL 5
AR 4172
DI 10.1038/ncomms5172
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AL0TA
UT WOS:000338838500028
PM 24960204
OA Green Published, hybrid
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Gagliano, N
   Grizzi, F
   Annoni, G
AF Gagliano, Nicoletta
   Grizzi, Fabio
   Annoni, Giorgio
TI Mechanisms of aging and liver functions
SO DIGESTIVE DISEASES
LA English
DT Article
DE aged liver, stress response; aging liver; liver regeneration; mast cells
ID HEPATOCYTE GROWTH-FACTOR; MAST-CELL DENSITY; GENE-EXPRESSION;
   MESSENGER-RNA; FACTOR-ALPHA; REGENERATION; RAT; SURVIVAL; CYCLE; AGE
AB Background/Aims: Morphofunctional studies suggest that the liver, compared with other organs, ages fairly well. Its success is ascribable to its lasting ability to regenerate, even if the potential of the cells to replicate progressively declines with age. The aim of this study was to analyze some aspects of the early phases of liver regeneration, its capacity to mount a stress response, and the inflammatory response in the early stage of an acute injury. Methods: Rats aged 2, 6, 12 and 19 months received a single intraperitoneal injection of CCl 4, and morphological, biochemical and molecular evaluations were done 2 and 24 h later. Results: AST and ALT, starting at age 12 months, were significantly higher than in the younger rats after CCl4. Histological modifications were already detectable after 2 h in rats aged 12 and 19 months, thereafter becoming more diffuse and marked, whereas they become evident only 24 h after the intoxication in rats aged 2 and 6 months. Albumin, c- fos, c- myc, hepatocyte growth factor, transforming growth factor-alpha and HSP70 mRNA levels decreased 24 h after CCl4 starting at age 12 months. Mast cell density was higher in the young rats than the old ones. Conclusion: Our results point to: (a) a basically preserved regenerative response of the aged liver, although somehow weaker and slower, with reduced ability to counteract agents inducing cell necrosis; (b) a decrease in the HSP70 response suggesting a reduction in homeostatic capacity, and (c) a lower inflammatory response during aging. Copyright (C) 2007 S. Karger AG, Basel.
C1 Univ Milan, Dept Human Morphol, I-20122 Milan, Italy.
   IRCCS, Ist Clin Humanitas, Labs Quantitat Med, Rozzano, Italy.
   Univ Milan, Chair Geriatr, I-20122 Milan, Italy.
   Univ Milan, Sch Specializat Geriatr, I-20122 Milan, Italy.
   S Gerardo Hosp, Monza, Italy.
C3 University of Milan; IRCCS Humanitas Research Hospital; University of
   Milan; University of Milan; Fondazione IRCCS San Gerardo dei Tintori
RP Annoni, G (corresponding author), DIMEP, Bldg U8,Via Cadore 48, IT-20054 Monza, Italy.
EM giorgio.annoni@unimib.it
RI Grizzi, Fabio/K-3448-2018; Gagliano, Nicoletta/L-1485-2016
OI Grizzi, Fabio/0000-0003-0925-742X; Gagliano,
   Nicoletta/0000-0002-3393-3144
CR ARMELLES G, 1993, J PHYS IV, V3, P283, DOI 10.1051/jp4:1993556
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   Biondo-Simões Maria de Lourdes Pessole, 2006, Acta Cir. Bras., V21, P197, DOI 10.1590/S0102-86502006000400002
   BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539
   De Martinis M, 2004, IMMUNOL CELL BIOL, V82, P415, DOI 10.1111/j.0818-9641.2004.01242.x
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   FAUSTO N, 1989, LAB INVEST, V60, P4
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschini B, 2006, DIGEST DIS SCI, V51, P2248, DOI 10.1007/s10620-006-9082-8
   Gagliano N, 2002, EXP GERONTOL, V37, P791, DOI 10.1016/S0531-5565(02)00022-0
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Grizzi F, 2003, TOXICOL PATHOL, V31, P173, DOI 10.1080/01926230390183643
   Grizzi F, 2002, ANAL QUANT CYTOL, V24, P63
   Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017
   HEYDARI AR, 1993, MOL CELL BIOL, V13, P2909, DOI 10.1128/MCB.13.5.2909
   KARN J, 1989, ONCOGENE, V4, P773
   Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443
   Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   Nguyen M, 2005, J IMMUNOL, V175, P5701, DOI 10.4049/jimmunol.175.9.5701
   Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97
   PANDURO A, 1987, HEPATOLOGY, V7, pS10, DOI 10.1002/hep.1840070703
   Sakai Y, 1997, HEPATOLOGY, V25, P421
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   SHIOTA G, 1994, HEPATOLOGY, V19, P962, DOI 10.1002/hep.1840190423
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   SORRENTINO V, 1986, P NATL ACAD SCI USA, V83, P8167, DOI 10.1073/pnas.83.21.8167
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   THOMPSON NL, 1986, CANCER RES, V46, P3111
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   Tomiya T, 1998, AM J PATHOL, V153, P955, DOI 10.1016/S0002-9440(10)65637-4
   Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321
   WEBBER EM, 1993, HEPATOLOGY, V18, P1422, DOI 10.1002/hep.1840180622
   WU B, 1993, J GERONTOL, V48, pB50, DOI 10.1093/geronj/48.2.B50
   Zhang HJ, 2006, J APPL PHYSIOL, V100, P1385, DOI 10.1152/japplphysiol.01046.2005
NR 38
TC 70
Z9 77
U1 0
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PY 2007
VL 25
IS 2
BP 118
EP 123
DI 10.1159/000099475
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 165CV
UT WOS:000246282400003
PM 17468546
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU El-Sherbiny, M
   Atef, H
   Helal, GM
   Al-Serwi, RH
   Elkattawy, HA
   Shaker, GA
   Said, E
   Abulfaraj, M
   Albalawi, MA
   Elsherbiny, NM
AF El-Sherbiny, Mohamed
   Atef, Hoda
   Helal, Ghada M.
   Al-Serwi, Rasha Hamed
   Elkattawy, Hany A.
   Shaker, Gehan Ahmed
   Said, Eman
   Abulfaraj, Moaz
   Albalawi, Marzough A.
   Elsherbiny, Nehal M.
TI Vitamin K2 (MK-7) Intercepts Keap-1/Nrf-2/HO-1 Pathway and Hinders
   Inflammatory/Apoptotic Signaling and Liver Aging in Naturally Aging Rat
SO ANTIOXIDANTS
LA English
DT Article
DE aging; vitamin K2; Nrf-2; COX-2; TIMP; apoptosis
ID HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL-CELLS; INJURY; AGE; FIBROSIS;
   ACTIVATION; APOPTOSIS; DISEASES
AB Aging is a naturally occurring physiological process with a deleterious impact on various body organs and humans' well-being. The aging population is increasing worldwide, which imposes the need for the exploration of nutritional options that can intercept the impact of the aging processed on various body organs. Vitamin K2 (VK2) is a fat-soluble vitamin with emerging evidence on its therapeutic merits. In the current study, natural aging induced a significant liver deterioration with a disrupted Keap-1/Nrf-2/HO-1 axis and increased COX-2, iNOS and TNF-alpha expression and apoptotic and fibrotic changes. VK2 administration, on the other hand, improved the biochemical indices of liver function (total protein, albumin, ALT and AST); the suppressed hepatic expression of Keap-1 and increased the hepatic expression of Nrf-2 with a parallel increase in the hepatic activity of HO-1. Subsequently, the liver content and hepatic expression of TNF-alpha, COX-2 and iNOS were significantly retracted. In context, the liver content and hepatic expression of the fibrotic biomarkers TGF beta and TIMP significantly retracted as well. Moreover, the TUNEL assay confirmed the retraction of liver apoptotic changes. Of notice, electron transmission microscope examination confirmed the preservation of mitochondrial functions and preservation of the ultra-microscopical structures. In conclusion, the VK2-mediated interception of aging-induced Keap-1/Nrf-2/HO-1 signaling suppressed the hepatic contents of inflammatory and fibrotic biomarkers, as well as apoptotic changes with preservation of the hepatic architectural and functional status. VK2 can be presumed to be an effective nutritional supplement to the aging population to spare the liver, amongst other body organs, against aging-induced deleterious injury.
C1 [El-Sherbiny, Mohamed; Elkattawy, Hany A.] AlMaarefa Univ, Dept Basic Med Sci, Coll Med, POB 71666, Riyadh 11597, Saudi Arabia.
   [El-Sherbiny, Mohamed] Mansoura Univ, Dept Anat, Fac Med, Mansoura 35516, Egypt.
   [Atef, Hoda] Mansoura Univ, Dept Histol & Cell Biol, Fac Med, Mansoura 35516, Egypt.
   [Helal, Ghada M.] Mansoura Univ, Dept Med Biochem, Fac Med, Mansoura 35516, Egypt.
   [Al-Serwi, Rasha Hamed] Princess Nourah Bint Abdulrahman Univ, Dept Basic Dent Sci, Coll Dent, POB 84428, Riyadh 11671, Saudi Arabia.
   [Elkattawy, Hany A.] Zagazig Univ, Dept Med Physiol, Fac Med, Zagazig 44519, Egypt.
   [Shaker, Gehan Ahmed] Mansoura Univ, Dept Med Physiol, Fac Med, Mansoura 35516, Egypt.
   [Said, Eman] Mansoura Univ, Dept Pharmacol & Toxicol, Fac Pharm, Mansoura 35516, Egypt.
   [Said, Eman] New Mansoura Univ, Dept Pharmacol & Toxicol, Fac Pharm, New Mansoura 35511, Egypt.
   [Abulfaraj, Moaz] King Abdulaziz Univ, Dept Surg, Fac Med, Jeddah 21589, Saudi Arabia.
   [Albalawi, Marzough A.] Univ Tabuk, Dept Chem, Alwajh Coll, Tabuk 71491, Saudi Arabia.
   [Elsherbiny, Nehal M.] Univ Tabuk, Dept Pharmaceut Chem, Fac Pharm, Tabuk 71491, Saudi Arabia.
   [Elsherbiny, Nehal M.] Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura 35516, Egypt.
C3 Almaarefa University; Egyptian Knowledge Bank (EKB); Mansoura
   University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian
   Knowledge Bank (EKB); Mansoura University; Princess Nourah bint
   Abdulrahman University; Egyptian Knowledge Bank (EKB); Zagazig
   University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian
   Knowledge Bank (EKB); Mansoura University; New Mansoura University; King
   Abdulaziz University; University of Tabuk; University of Tabuk; Egyptian
   Knowledge Bank (EKB); Mansoura University
RP Elsherbiny, NM (corresponding author), Univ Tabuk, Dept Pharmaceut Chem, Fac Pharm, Tabuk 71491, Saudi Arabia.; Elsherbiny, NM (corresponding author), Mansoura Univ, Dept Biochem, Fac Pharm, Mansoura 35516, Egypt.
EM drnehal@mans.edu.eg
RI Said, Eman/Q-8322-2019; Abulfaraj, Moaz/JJF-8786-2023; AlSerwi, Rasha
   Hamed/GPX-6567-2022; Albalawi, Dr Marzough Aziz/HSF-1320-2023;
   Elsherbiny, Nehal M./AAF-9206-2019
OI Said, Eman/0000-0001-5529-6994; AlSerwi, Rasha
   Hamed/0000-0002-2121-9269; Albalawi, Dr Marzough
   Aziz/0000-0003-4579-0045; Elsherbiny, Nehal M./0000-0001-5167-3377; El
   kattawy, Hany/0000-0003-1701-9894; El-Sherbiny,
   Mohamed/0000-0002-0814-1743
FU AlMaarefa University, Riyadh, Saudi Arabia [202135]; Princess Nourah
   Bint Abdulrahman University, Riyadh, Saudi Arabia [PNURSP2022R199]
FX The authors deeply acknowledge the Researchers Supporting program (TUMA
   Project-202135), AlMaarefa University, Riyadh, Saudi Arabia, and
   Princess Nourah Bint Abdulrahman University Researchers Supporting
   Project number (PNURSP2022R199), Princess Nourah Bint Abdulrahman
   University, Riyadh, Saudi Arabia, for supporting the steps of this work.
CR Afanas'ev I, 2009, FRONT BIOSCI-LANDMRK, V14, P3899, DOI [10.2735/3499, 10.2741/3499]
   Alisi L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00239
   Alsheblak MM, 2016, EUR CYTOKINE NETW, V27, P6, DOI 10.1684/ecn.2016.0372
   Bellezza I, 2018, BBA-MOL CELL RES, V1865, P721, DOI 10.1016/j.bbamcr.2018.02.010
   Braasch-Turi M, 2020, MOLECULES, V25, DOI 10.3390/molecules25194477
   Capozzi A, 2020, GYNECOL ENDOCRINOL, V36, P285, DOI 10.1080/09513590.2019.1689554
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   Dai L, 2020, NEPHROL DIAL TRANSPL, V35, P31, DOI 10.1093/ndt/gfaa006
   Villa JKD, 2017, CRIT REV FOOD SCI, V57, P3959, DOI 10.1080/10408398.2016.1211616
   El-Sherbiny M, 2021, MOLECULES, V26, DOI 10.3390/molecules26247684
   Elkattawy HA, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11030514
   Elsherbiny NM, 2020, ENVIRON TOXICOL PHAR, V80, DOI 10.1016/j.etap.2020.103494
   Fabregat I, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00357
   Fahmy EK, 2021, NEUROTOXICOLOGY, V82, P167, DOI 10.1016/j.neuro.2020.12.008
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Gong X, 2008, VITAM HORM, V78, P85, DOI 10.1016/S0083-6729(07)00005-2
   Habu D, 2004, JAMA-J AM MED ASSOC, V292, P358, DOI 10.1001/jama.292.3.358
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harshman Stephanie G, 2016, Curr Nutr Rep, V5, P90, DOI 10.1007/s13668-016-0162-x
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Hu SJ, 2019, WORLD J CLIN CASES, V7, P691, DOI 10.12998/wjcc.v7.i6.691
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Joaquin AM, 2001, J AM GERIATR SOC, V49, P1234, DOI 10.1046/j.1532-5415.2001.04990.x
   Kakizaki S, 2007, J GASTROEN HEPATOL, V22, P518, DOI 10.1111/j.1440-1746.2007.04844.x
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kolakowski A, 2021, EUR J CELL BIOL, V100, DOI 10.1016/j.ejcb.2021.151188
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Li JR, 2003, J NEUROSCI, V23, P5816
   Li YJ, 2022, JHEP REP, V4, DOI 10.1016/j.jhepr.2021.100397
   Licata A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13114014
   Lu X, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.757603
   Luo DS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00926
   Lysek-Gladysinska M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030502
   Mahrouf-Yorgov M, 2011, REJUV RES, V14, P353, DOI 10.1089/rej.2010.1146
   Marcos R, 2016, CELL TISSUE RES, V366, P639, DOI 10.1007/s00441-016-2490-y
   MUKAI K, 1992, J BIOL CHEM, V267, P22277
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Omidkhoda Seyedeh Farzaneh, 2020, Iran J Pharm Res, V19, P440, DOI 10.22037/ijpr.2019.15022.12825
   Otsuka M, 2004, HEPATOLOGY, V40, P243, DOI 10.1002/hep.20260
   Popa DS, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040566
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   Rusu ME, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050424
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Simes DC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174150
   Sultana H, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082515
   Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632
   Younis NN, 2020, J PHARM PHARMACOL, V72, P1546, DOI 10.1111/jphp.13340
   Zhang Qing, 2021, J Adv Res, V34, P43, DOI 10.1016/j.jare.2021.06.023
   Zhang YM, 2005, WORLD J GASTROENTERO, V11, P3696, DOI 10.3748/wjg.v11.i24.3696
   Zhang Y, 2014, WORLD J GASTROENTERO, V20, P6523, DOI 10.3748/wjg.v20.i21.6523
NR 52
TC 2
Z9 2
U1 3
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD NOV
PY 2022
VL 11
IS 11
AR 2150
DI 10.3390/antiox11112150
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 6Q3PP
UT WOS:000891526900001
PM 36358523
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lo Re, V
   Lim, JK
   Goetz, MB
   Tate, J
   Bathulapalli, H
   Klein, MB
   Rimland, D
   Rodriguez-Barradas, MC
   Butt, AA
   Gibert, CL
   Brown, ST
   Kidwai, F
   Brandt, C
   Dorey-Stein, Z
   Reddy, KR
   Justice, AC
AF Lo Re, Vincent, III
   Lim, Joseph K.
   Goetz, Matthew Bidwell
   Tate, Janet
   Bathulapalli, Harini
   Klein, Marina B.
   Rimland, David
   Rodriguez-Barradas, Maria C.
   Butt, Adeel A.
   Gibert, Cynthia L.
   Brown, Sheldon T.
   Kidwai, Farah
   Brandt, Cynthia
   Dorey-Stein, Zachariah
   Reddy, K. Rajender
   Justice, Amy C.
TI Validity of diagnostic codes and liver-related laboratory abnormalities
   to identify hepatic decompensation events in the Veterans Aging Cohort
   Study
SO PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
LA English
DT Article
DE hepatic decompensation; end-stage liver disease; epidemiologic methods;
   outcomes; validation studies
ID HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATOCELLULAR-CARCINOMA; C-VIRUS;
   FIBROSIS PROGRESSION; NATURAL-HISTORY; HIV-INFECTION; DRUG-USERS;
   MANAGEMENT; CIRRHOSIS; COINFECTION
AB Purpose The absence of validated methods to identify hepatic decompensation in cohort studies has prevented a full understanding of the natural history of chronic liver diseases and impact of medications on this outcome. We determined the ability of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events within the Veterans Aging Cohort Study (VACS).
   Methods Medical records of patients with hepatic decompensation codes and/or laboratory abnormalities of liver dysfunction (total bilirubin >= 5.0 g/dL, albumin <= 2.0 g/dL, INR >= 1.7) recorded 1 year before through 6 months after VACS entry were reviewed to identify decompensation events (i.e., ascites, spontaneous bacterial peritonitis, variceal hemorrhage, hepatic encephalopathy, hepatocellular carcinoma) at VACS enrollment. Positive predictive values (PPVs) of diagnostic codes, laboratory abnormalities, and their combinations for confirmed outcomes were determined.
   Results Among 137 patients with a hepatic decompensation code and 197 with a laboratory abnormality, the diagnosis was confirmed in 57 (PPV, 42%; 95%CI, 33%-50%) and 56 (PPV, 28%; 95%CI, 22%-35%) patients, respectively. The combination of any code plus laboratory abnormality increased PPV (64%; 95%CI, 47%-79%). One inpatient or >= 2 outpatient diagnostic codes for ascites, spontaneous bacterial peritonitis, or variceal hemorrhage had high PPV (91%; 95%CI, 77%-98%) for confirmed hepatic decompensation events.
   Conclusion An algorithm of 1 inpatient or >= 2 outpatient codes for ascites, peritonitis, or variceal hemorrhage has sufficiently high PPV for hepatic decompensation to enable its use for epidemiologic research in VACS. This algorithm may be applicable to other cohorts. Copyright (C) 2011 John Wiley & Sons, Ltd.
C1 [Lo Re, Vincent, III; Dorey-Stein, Zachariah] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III; Dorey-Stein, Zachariah] Philadelphia VA Med Ctr, Philadelphia, PA USA.
   [Lim, Joseph K.; Tate, Janet; Bathulapalli, Harini; Kidwai, Farah; Brandt, Cynthia; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA.
   [Lim, Joseph K.; Tate, Janet; Bathulapalli, Harini; Kidwai, Farah; Brandt, Cynthia; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA.
   [Goetz, Matthew Bidwell] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Goetz, Matthew Bidwell] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Klein, Marina B.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada.
   [Rimland, David] Atlanta VA Med Ctr, Atlanta, GA USA.
   [Rimland, David] Emory Univ, Sch Med, Atlanta, GA USA.
   [Rodriguez-Barradas, Maria C.] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Houston, TX 77030 USA.
   [Butt, Adeel A.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA.
   [Butt, Adeel A.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
   [Gibert, Cynthia L.] Washington DC VA Med Ctr, Washington, DC USA.
   [Gibert, Cynthia L.] George Washington Univ, Med Ctr, Washington, DC 20037 USA.
   [Brown, Sheldon T.] James J Peters VA Med Ctr, New York, NY USA.
   [Brown, Sheldon T.] Mt Sinai Sch Med, New York, NY USA.
C3 University of Pennsylvania; University of Pennsylvania; Pennsylvania
   Medicine; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Philadelphia Veterans Affairs Medical Center; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   Connecticut Healthcare System; Yale University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los
   Angeles Healthcare System; University of California System; University
   of California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA; McGill University;
   Royal Victoria Hospital; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA
   Medical Center; Emory University; Baylor College of Medicine; Baylor
   College of Medicine; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; George Washington University; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); James J. Peters VA
   Medical Center; Icahn School of Medicine at Mount Sinai
RP Lo Re, V (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
EM vincentl@mail.med.upenn.edu
RI Re, Vincent Lo/N-7817-2015; Bathulapalli, Harini/B-7451-2015; Brown,
   Stephen/A-2513-2016; Goetz, Matthew Bidwell/GPX-4090-2022
OI Bathulapalli, Harini/0000-0002-2531-0238; Brown,
   Stephen/0000-0002-0210-4562; Goetz, Matthew/0000-0003-4542-992X; Klein,
   Marina/0000-0002-3063-8430
FU National Institute of Allergy and Infectious Diseases [K01-AI070001];
   National Institute on Alcohol Abuse and Alcoholism [U10-AA13566]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases (grant number K01-AI070001 to Dr. Lo Re) and the
   National Institute on Alcohol Abuse and Alcoholism (U10-AA13566). The
   contents do not represent the views of the Department of Veterans
   Affairs or the United States Government.
CR Bagchi A, 2004, SCHIZOPHR RES, V71, P435, DOI 10.1016/j.schres.2004.02.021
   Balasubramanian Sripriya, 2005, Clin Liver Dis, V9, P83, DOI 10.1016/j.cld.2004.10.004
   BEASLEY RP, 1981, LANCET, V2, P1129
   Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409
   Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933
   Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1
   Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789
   COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002
   DAMICO G, 1986, DIGEST DIS SCI, V31, P468, DOI 10.1007/BF01320309
   Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201
   Fleming KM, 2010, ALIMENT PHARM THER, V32, P1343, DOI 10.1111/j.1365-2036.2010.04473.x
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Fultz SL, 2003, CLIN INFECT DIS, V36, P1039, DOI 10.1086/374049
   Fuster D, 2004, AIDS RES HUM RETROV, V20, P1293, DOI 10.1089/aid.2004.20.1293
   Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907
   GarciaSamaniego J, 1997, AM J GASTROENTEROL, V92, P1130
   GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124
   Giordano TP, 2004, ARCH INTERN MED, V164, P2349, DOI 10.1001/archinte.164.21.2349
   Gordon AJ, 2001, J FAM PRACTICE, V50, P313
   HOEFS JC, 1982, HEPATOLOGY, V2, P399
   Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66
   Lamoreaux J, 1996, MED CARE, V34, pMS31
   Lockwood AH, 2004, METAB BRAIN DIS, V19, P345, DOI 10.1023/B:MEBR.0000043980.74574.eb
   LURIE N, 1992, HOSP COMMUNITY PSYCH, V43, P69
   Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3
   Preneta E, 1998, HEPATOLOGY, V28, p453A
   Riordan SM, 1997, NEW ENGL J MED, V337, P473, DOI 10.1056/NEJM199708143370707
   Romeo R, 2000, J VIRAL HEPATITIS, V7, P297
   Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853
   Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3
   Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9
   Tradati F, 1998, BLOOD, V91, P1173
   Walkup J, 2001, J CLIN PSYCHIAT, V62, P174, DOI 10.4088/JCP.v62n0307
   Walkup JT, 2004, MED CARE, V42, P756, DOI 10.1097/01.mlr.0000132749.20897.46
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
NR 35
TC 121
Z9 129
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1053-8569
EI 1099-1557
J9 PHARMACOEPIDEM DR S
JI Pharmacoepidemiol. Drug Saf.
PD JUL
PY 2011
VL 20
IS 7
BP 689
EP 699
DI 10.1002/pds.2148
PG 11
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA 800PE
UT WOS:000293374600003
PM 21626605
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Malatesta, M
   Biggiogera, M
   Cisterna, B
   Balietti, M
   Bertoni-Freddari, C
   Fattoretti, P
AF Malatesta, Manuela
   Biggiogera, Marco
   Cisterna, Barbara
   Balietti, Marta
   Bertoni-Freddari, Carlo
   Fattoretti, Patrizia
TI Perichromatin Fibrils Accumulation in Hepatocyte Nuclei Reveals
   Alterations of Pre-mRNA Processing During Aging
SO DNA AND CELL BIOLOGY
LA English
DT Article
ID VITAMIN-E-DEFICIENCY; WISTAR RAT-LIVER; ACTIN CYTOSKELETON; HUMAN
   FIBROBLASTS; XENOPUS-OOCYTES; MYOSIN-I; TRANSCRIPTION; PROTEIN; CELLS;
   SUBUNITS
AB We previously described an unusual accumulation of perichromatin fibrils (PF)-the in situ form of pre-mRNA transcription and early splicing-in hepatocyte nuclei of old rats. Here we have investigated, by immunoelectron microscopy, the nature of such PF, analyzing the presence of transcription, splicing and cleavage factors, polyadenylated RNA, and the incorporation of bromouridine in adult and old rats. Our observations revealed alterations in amount and/or distribution of pre-mRNA transcription, splicing and cleavage factors, as well as of polyadenylated RNA, together with lower bromouridine incorporation in newly transcribed RNA in the hepatocyte nucleoplasm of old rats. Therefore, our data indicate both a decrease in pre-mRNA transcription and a slow down of PF processing and transport during aging.
C1 [Biggiogera, Marco; Cisterna, Barbara] Univ Pavia, Dept Anim Biol, Lab Cell Biol & Neurobiol, I-27100 Pavia, Italy.
   [Malatesta, Manuela] Univ Verona, Dept Morphol & Biomed Sci, Anat & Histol Sect, I-37100 Verona, Italy.
   [Balietti, Marta; Bertoni-Freddari, Carlo; Fattoretti, Patrizia] Natl Inst Hospitalizat & Care Elderly INRCA, Neurobiol Aging Lab, Ancona, Italy.
C3 University of Pavia; University of Verona; IRCCS INRCA
RP Biggiogera, M (corresponding author), Univ Pavia, Lab Biol Cellulare & Neurobiol, Dipartimento Biol Anim, Piazza Botta 10, I-27100 Pavia, Italy.
EM marcobig@unipv.it
RI Fattoretti, Patrizia/A-8152-2011; Biggiogera, Marco/AAH-3543-2019;
   Balietti, Marta/AAD-9098-2020
OI Balietti, Marta/0000-0002-3123-7903; MALATESTA,
   Manuela/0000-0001-8196-9232; Fattoretti, Patrizia/0000-0003-1998-0080
CR BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X
   Bertoni-Freddari C, 2004, ANN NY ACAD SCI, V1030, P289, DOI 10.1196/annals.1329.036
   Biggiogera M, 2008, DIFFERENTIATION, V76, P57, DOI 10.1111/j.1432-0436.2007.00211.x
   Björk P, 2009, J CELL BIOL, V184, P555, DOI 10.1083/jcb.200806156
   Bogolyubov D, 2009, BIOESSAYS, V31, P400, DOI 10.1002/bies.200800100
   Cardinale S, 2007, MOL BIOL CELL, V18, P1282, DOI 10.1091/mbc.E06-09-0846
   Cisterna B, 2006, FASEB J, V20, P1901, DOI 10.1096/fj.05-5278fje
   Cmarko D, 1999, MOL BIOL CELL, V10, P211, DOI 10.1091/mbc.10.1.211
   Fakan S, 2004, HISTOCHEM CELL BIOL, V122, P83, DOI 10.1007/s00418-004-0681-1
   Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5
   Frasca D, 2003, J IMMUNOL, V170, P719, DOI 10.4049/jimmunol.170.2.719
   FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0
   Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   Gourlay CW, 2005, FEMS YEAST RES, V5, P1193, DOI 10.1016/j.femsyr.2005.08.001
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Hallén A, 2002, BIOGERONTOLOGY, V3, P307, DOI 10.1023/A:1020155502734
   Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182
   Jameson CW, 2004, MED HYPOTHESES, V63, P83, DOI 10.1016/j.mehy.2004.01.021
   JENSEN PO, 1993, CYTOMETRY, V14, P455
   KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F
   Kim JH, 2001, ANN NY ACAD SCI, V928, P65
   Kyselá K, 2005, HISTOCHEM CELL BIOL, V124, P347, DOI 10.1007/s00418-005-0042-8
   LAFARGA M, 1993, ANAT EMBRYOL, V187, P363
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461
   LUHRMANN R, 1990, BIOCHIM BIOPHYS ACTA, V1087, P265, DOI 10.1016/0167-4781(90)90001-I
   MA HJ, 1990, CELL MOL BIOL, V36, P589
   Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878
   Malatesta M, 2005, MICROSC RES TECHNIQ, V68, P45, DOI 10.1002/jemt.20221
   Malatesta M, 2004, ANN NY ACAD SCI, V1019, P379, DOI 10.1196/annals.1297.067
   Malatesta M, 2003, MECH AGEING DEV, V124, P175, DOI 10.1016/S0047-6374(02)00117-3
   Malatesta M, 2008, MICROSC RES TECHNIQ, V71, P564, DOI 10.1002/jemt.20587
   MARBAIX G, 1975, P NATL ACAD SCI USA, V72, P3065, DOI 10.1073/pnas.72.8.3065
   Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x
   MONNERON A, 1969, J ULTRA MOL STRUCT R, V27, P266, DOI 10.1016/S0022-5320(69)80017-1
   Nagata Tetsuji, 2003, Medical Electron Microscopy, V36, P263, DOI 10.1007/s00795-003-0224-1
   NUDEL U, 1976, EUR J BIOCHEM, V64, P115, DOI 10.1111/j.1432-1033.1976.tb10279.x
   PARK GH, 1990, GERONTOLOGY, V36, P61
   PARK GH, 1990, GERONTOLOGY, V36, P76
   Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190
   Pujol G, 2002, BIOCHEM BIOPH RES CO, V294, P354, DOI 10.1016/S0006-291X(02)00492-8
   PUVION E, 1977, BIOL CELLULAIRE, V29, P81
   Puvion E, 1996, EXP CELL RES, V229, P217, DOI 10.1006/excr.1996.0363
   PUVIONDUTILLEUI F, 1981, J ULTRA MOL STRUCT R, V74, P341, DOI 10.1016/S0022-5320(81)80125-6
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511
   Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8
   Schul W, 1996, EMBO J, V15, P2883, DOI 10.1002/j.1460-2075.1996.tb00649.x
   Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490
   SOREQ H, 1974, J MOL BIOL, V88, P233, DOI 10.1016/0022-2836(74)90307-6
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341
   Thompson WF, 1997, PLANT J, V12, P571, DOI 10.1046/j.1365-313X.1997.00571.x
   Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001
   Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1111/j.1574-6976.1999.tb00400.x
   ZANCANARO C, 1993, BIOL CELL, V79, P55, DOI 10.1016/0248-4900(93)90263-E
NR 57
TC 14
Z9 15
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD FEB
PY 2010
VL 29
IS 2
BP 49
EP 57
DI 10.1089/dna.2009.0880
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA 546ZZ
UT WOS:000273855700001
PM 20025533
DA 2024-02-19
ER

PT J
AU Lorbek, G
   Perse, M
   Jeruc, J
   Juvan, P
   Gutierrez-Mariscal, FM
   Lewinska, M
   Gebhardt, R
   Keber, R
   Horvat, S
   Björkhem, I
   Rozman, D
AF Lorbek, Gregor
   Perse, Martina
   Jeruc, Jera
   Juvan, Peter
   Gutierrez-Mariscal, Francisco M.
   Lewinska, Monika
   Gebhardt, Rolf
   Keber, Rok
   Horvat, Simon
   Bjorkhem, Ingemar
   Rozman, Damjana
TI Lessons from Hepatocyte-Specific <i>Cyp51</i> Knockout Mice: Impaired
   Cholesterol Synthesis Leads to Oval Cell-Driven Liver Injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51; NONALCOHOLIC STEATOHEPATITIS;
   GENE-EXPRESSION; RECEPTOR-ALPHA; PPAR-ALPHA; BILE-ACID; DISEASE;
   METABOLISM; MOUSE; SENESCENCE
AB We demonstrate unequivocally that defective cholesterol synthesis is an independent determinant of liver inflammation and fibrosis. We prepared a mouse hepatocyte-specific knockout (LKO) of lanosterol 14 alpha-demethylase (CYP51) from the part of cholesterol synthesis that is already committed to cholesterol. LKO mice developed hepatomegaly with oval cell proliferation, fibrosis and inflammation, but without steatosis. The key trigger was reduced cholesterol esters that provoked cell cycle arrest, senescence-associated secretory phenotype and ultimately the oval cell response, while elevated CYP51 substrates promoted the integrated stress response. In spite of the oval cell-driven fibrosis being histologically similar in both sexes, data indicates a female-biased down-regulation of primary metabolism pathways and a stronger immune response in males. Liver injury was ameliorated by dietary fats predominantly in females, whereas dietary cholesterol rectified fibrosis in both sexes. Our data place defective cholesterol synthesis as a focus of sex-dependent liver pathologies.
C1 [Lorbek, Gregor; Juvan, Peter; Gutierrez-Mariscal, Francisco M.; Lewinska, Monika; Rozman, Damjana] Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Inst Biochem, Ljubljana, Slovenia.
   [Perse, Martina] Univ Ljubljana, Fac Med, Ctr Med Expt, Inst Pathol, Ljubljana, Slovenia.
   [Jeruc, Jera] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia.
   [Jeruc, Jera] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany.
   [Keber, Rok; Horvat, Simon] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Ljubljana, Slovenia.
   [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia.
   [Bjorkhem, Ingemar] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Chem, Huddinge, Sweden.
C3 University of Ljubljana; University of Ljubljana; University of
   Ljubljana; Leipzig University; University of Ljubljana; National
   Institute of Chemistry - Slovenia; Karolinska Institutet; Karolinska
   University Hospital
RP Rozman, D (corresponding author), Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Inst Biochem, Ljubljana, Slovenia.
EM damjana.rozman@mf.uni-lj.si
RI Mariscal, Francisco Miguel Gutierrez/AAH-3689-2020; Lewinska,
   Monika/N-9919-2017; Perse, Martina/AAS-2898-2020; Mariscal, Francisco M
   Gutierrez/F-9804-2016; Gutierrez-Mariscal, Francisco M M/AAX-3185-2021;
   Jeruc, Jera/AAL-5258-2021
OI Mariscal, Francisco Miguel Gutierrez/0000-0003-3353-2188; Mariscal,
   Francisco M Gutierrez/0000-0003-3353-2188; Bjorkhem,
   Ingemar/0000-0002-0575-9425; Lewinska, Monika/0000-0002-5275-992X
FU Slovenian Research Agency (ARRS) program grant [P1-0104, J7-4053]; ARRS;
   FP7 FightingDrugFailure ITN Marie Curie grant [238132]
FX We thank K. Kodra, M. Kuznik, H. Klavzar and dr. R. Kosir for their help
   with the experiments. We acknowledge Z. Urlep's contribution to the
   immunohistochemistry and excellent technical assistance of ddr. J.
   Acimovic and A. Lovgren-Sandblom with the gas chromatography/mass
   spectrometry analyses. We also thank dr. K. Ryckman for careful
   proofreading of the manuscript. This work was supported by the Slovenian
   Research Agency (ARRS) program grants P1-0104 and J7-4053. G. Lorbek was
   supported by the graduate fellowship of ARRS. M. Lewinska and F.M.
   Gutierrez-Mariscal were supported by the FP7 FightingDrugFailure ITN
   Marie Curie grant #238132.
CR Acimovic J, 2013, MOLECULES, V18, P4002, DOI 10.3390/molecules18044002
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Aravinthan A, 2012, J CLIN PATHOL, V65, P557, DOI 10.1136/jclinpath-2011-200641
   Carpino G, 2013, INT J MOL SCI, V14, P20112, DOI 10.3390/ijms141020112
   Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002
   Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006
   Conforto TL, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-9
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Desmarchelier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-84
   Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949
   Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158
   Ducheix S, 2011, CHEM PHYS LIPIDS, V164, P500, DOI 10.1016/j.chemphyslip.2011.06.004
   Erker L, 2008, STEM CELL RES, V1, P90, DOI 10.1016/j.scr.2008.01.002
   Fink M, 2005, ENDOCRINOLOGY, V146, P5321, DOI 10.1210/en.2005-0781
   Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699
   Harding HP, 2005, CELL METAB, V2, P361, DOI 10.1016/j.cmet.2005.11.005
   Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580
   Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336
   Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245
   Knight B, 2005, IMMUNOL CELL BIOL, V83, P364, DOI 10.1111/j.1440-1711.2005.01346.x
   Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417
   Lorbek G, 2013, MOLECULES, V18, P11067, DOI 10.3390/molecules180911067
   Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x
   Malisch JL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P146, DOI 10.1086/508828
   Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004
   Musso G, 2013, PROG LIPID RES, V52, P175, DOI 10.1016/j.plipres.2012.11.002
   Nagashima S, 2012, ARTERIOSCL THROM VAS, V32, P1824, DOI 10.1161/ATVBAHA.111.240754
   Nagoshi S, 2008, HEPATOL RES, V38, P219, DOI 10.1111/j.1872-034X.2007.00301.x
   Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763
   Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937
   Rossi M, 2005, AM J MED GENET A, V132A, P144, DOI 10.1002/ajmg.a.30426
   Saito K, 2006, BBA-MOL CELL BIOL L, V1761, P709, DOI 10.1016/j.bbalip.2006.04.016
   Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151
   Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808
   Sheikh K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1157, DOI 10.1152/ajpendo.00254.2006
   Simonen P, 2011, J HEPATOL, V54, P153, DOI 10.1016/j.jhep.2010.05.037
   Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058833
   Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001
   Thompson MD, 2011, HEPATOLOGY, V54, P1333, DOI 10.1002/hep.24506
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365
   Turley SD, 1998, HEPATOLOGY, V28, P1088, DOI 10.1002/hep.510280425
   Villa A, 2012, P NATL ACAD SCI USA, V109, P11806, DOI 10.1073/pnas.1205797109
   Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200
   Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776
   Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
NR 47
TC 25
Z9 26
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 5
PY 2015
VL 5
AR 8777
DI 10.1038/srep08777
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CC6CV
UT WOS:000350453200004
PM 25739789
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU FUJITA, T
   UCHIDA, K
   MARUYAMA, N
AF FUJITA, T
   UCHIDA, K
   MARUYAMA, N
TI PURIFICATION OF SENESCENCE MARKER PROTEIN-30 (SMP30) AND ITS
   ANDROGEN-INDEPENDENT DECREASE WITH AGE IN THE RAT-LIVER
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE AGING; SENESCENCE; PROTEIN; 2-DIMENSIONAL ELECTROPHORESIS; SMP30; (RAT
   LIVER)
ID MESSENGER-RNA; CLONING; ANTIGEN; SMP-2; CDNA
AB Age-associated changes in the soluble proteins from rat liver were examined by a newly developed two-dimensional cellulose acetate membrane electrophoresis (2D-CAME). We detected and isolated a novel rat liver protein, the amounts of which decreased androgen-independently with aging. We designated this protein, whose molecular mass was 30 kDa and pI value was 4.9, as senescence marker protein-30 (SMP30). The expression of SMP30 was not modified by castration or treatment with testosterone propionate after castration. Age-associated decrease of SMP30 level was also recognized in aged female. We noted another protein with a pI value of 7.3 that decreased with aging. Its expression seemed to be androgen-dependent and it was markedly expressed only in young and adult male rat livers. We then purified SMP30 and prepared an anti-serum to SMP30. Immunohistochemical analysis showed that the localization of SMP30 was restricted to liver and kidney among numerous organs tested. Although the amount of SMP30 in the liver was relatively large and the tissue distribution was characteristic, no known protein corresponds to this protein.
C1 TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT MOLEC PATHOL,TOKYO 173,JAPAN.
C3 Tokyo Metropolitan Institute of Gerontology
RP FUJITA, T (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT MOLEC BIOL,35-2 SAKAECHO,ZTABASHI KU,TOKYO 173,JAPAN.
CR BUTLER JA, 1989, J CELL PHYSIOL, V141, P400, DOI 10.1002/jcp.1041410222
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   CHATTERJEE B, 1984, FEBS LETT, V170, P114, DOI 10.1016/0014-5793(84)81380-0
   DANNER DB, 1990, HDB BIOL AGING, V3, P97
   ENGVALL E, 1972, J IMMUNOL, V109, P129
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1986, ANAL BIOCHEM, V159, P8, DOI 10.1016/0003-2697(86)90299-X
   HORBACH GJM, 1987, REV BIOL RES AGING, V3, P485
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANNS MP, 1989, J CLIN INVEST, V83, P1066, DOI 10.1172/JCI113949
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R
   RICHARDSON A, 1987, REV BIOL RES AGING, V3, P467
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   RIZZETTO M, 1973, CLIN EXP IMMUNOL, V15, P331
   ROY AK, 1983, J BIOL CHEM, V258, P123
   SHIGEMOTO K, 1992, IN PRESS MOL IMMUNOL
   TODA T, 1984, ELECTROPHORESIS, V5, P42, DOI 10.1002/elps.1150050108
   TODA T, 1984, ANAL BIOCHEM, V119, P167
NR 22
TC 157
Z9 174
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD APR 22
PY 1992
VL 1116
IS 2
BP 122
EP 128
DI 10.1016/0304-4165(92)90108-7
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA HT307
UT WOS:A1992HT30700006
PM 1581340
DA 2024-02-19
ER

PT J
AU Rey, S
   Quintavalle, C
   Burmeister, K
   Calabrese, D
   Schlageter, M
   Quagliata, L
   Cathomas, G
   Diebold, J
   Molinolo, A
   Heim, MH
   Terracciano, LM
   Matter, MS
AF Rey, Silvia
   Quintavalle, Cristina
   Burmeister, Katharina
   Calabrese, Diego
   Schlageter, Manuel
   Quagliata, Luca
   Cathomas, Gieri
   Diebold, Joachim
   Molinolo, Alfredo
   Heim, Markus H.
   Terracciano, Luigi M.
   Matter, Matthias S.
TI Liver damage and senescence increases in patients developing
   hepatocellular carcinoma
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE hepatocellular carcinoma; senescence; telomeres
ID CELLULAR SENESCENCE; P21(WAF1/CIP1); INACTIVATION; RISK
AB Background and Aim: Most patients with a hepatocellular carcinoma (HCC) have an underlying chronic liver inflammation, which causes a continuous damage leading to liver cirrhosis and eventually HCC. However, only a minority of cirrhotic patients develop HCC. To assess a possible differential impact of liver inflammation in patients developing HCC versus patients remaining tumor-free, we designed a longitudinal study and analysed liver tissue of the same patients (n = 33) at two points in time: once when no HCC was present and once several years later when an HCC was present. As a control group, we followed cirrhotic patients (n = 37) remaining tumor-free over a similar time frame.
   Methods: We analysed cell damage and senescence of hepatocytes by measuring gamma-H2AX positivity, p16(INK4) and p21(WAF/Cip1) expression, nuclear size, and telomere length.
   Results: gamma-H2AX positivity, p16(INK4) and p21(WAF/Cip1) expression, in the first liver biopsy was similar in patients developing HCC later on and cirrhotic patients remaining tumor free. In contrast, gamma-H2AX positivity, p16(INK4) and p21(WAF/Cip1) expression, was significantly higher in the second non-tumoral liver biopsy of HCC patients than in the control patients. Consequently, the individual increase in gamma-H2AX positivity, p16(INK4) and p21(WAF/Cip1) expression, from the first biopsy to the second biopsy was significantly higher in patients developing HCC than in patients remaining tumor free. In addition, changes in nuclear size and telomere length revealed a more pronounced cell aging in patients developing HCC than in patients remaining tumor free.
   Conclusions: Hepatocytes from patients developing HCC go through more pronounced cell damage and senescence in contrast to cirrhotic patients remaining tumor free.
C1 [Rey, Silvia; Quintavalle, Cristina; Burmeister, Katharina; Schlageter, Manuel; Quagliata, Luca; Terracciano, Luigi M.; Matter, Matthias S.] Univ Hosp Basel, Inst Pathol, Schoenbeinstr 40, CH-4031 Basel, Switzerland.
   [Calabrese, Diego; Heim, Markus H.] Univ Hosp Basel, Dept Gastroenterol & Hepatol, Basel, Switzerland.
   [Cathomas, Gieri] Kantonsspital Baselland, Inst Pathol, Liestal, Switzerland.
   [Diebold, Joachim] Luzerner Kantonsspital, Inst Pathol, Luzern, Switzerland.
   [Molinolo, Alfredo] NIDCR NIH, Oral & Pharyngeal Canc Branch, Bethesda, MD USA.
C3 University of Basel; University of Basel; Kantonsspital Baselland;
   Lucerne Cantonal Hospital
RP Matter, MS (corresponding author), Univ Hosp Basel, Inst Pathol, Schoenbeinstr 40, CH-4031 Basel, Switzerland.
EM matthias.matter@usb.ch
RI Quagliata, Luca/HKE-2640-2023; Heim, Markus/A-7526-2008; Quintavalle,
   Cristina/AHH-9379-2022; Terracciano, Luigi M./AAB-5335-2022;
   Quintavalle, Cristina/O-1317-2015
OI Quagliata, Luca/0000-0001-8249-9914; Heim, Markus/0000-0002-7523-4894;
   Terracciano, Luigi M./0000-0002-9393-9660; Marston,
   Katharina/0000-0002-7431-3531; Matter, Matthias/0000-0002-2005-5266;
   Calabrese, Diego/0000-0002-0259-8611; Quintavalle,
   Cristina/0000-0002-7432-9170
FU Swiss Cancer League (Oncosuisse) [KFS-3302-08-2013, KLS-2867-08-2011];
   Forschungsfond Universitat Basel [DMS 2286]
FX The study was supported by grants of Swiss Cancer League (Oncosuisse)
   grant no. KFS-3302-08-2013 and Forschungsfond Universitat Basel (DMS
   2286) to M. S. M. and Swiss Cancer League (Oncosuisse) grant
   KLS-2867-08-2011 to L. M. T.
CR BEDOSSA P, 1994, HEPATOLOGY, V20, P15
   Behrns K E, 1998, J Gastrointest Surg, V2, P292, DOI 10.1016/S1091-255X(98)80025-5
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65
   El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   Lee YH, 2009, MODERN PATHOL, V22, P1121, DOI 10.1038/modpathol.2009.76
   Matsuda Y, 2013, SCI WORLD J, DOI 10.1155/2013/597095
   Mehta IS, 2007, ANN NY ACAD SCI, V1100, P250, DOI 10.1196/annals.1395.027
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Pinyol R, 2014, J HEPATOL, V61, P685, DOI 10.1016/j.jhep.2014.05.028
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Singal AG, 2015, CLIN GASTROENTEROL H, V13, P2140, DOI 10.1016/j.cgh.2015.08.014
   Tarao K, 2002, CANCER-AM CANCER SOC, V94, P1787, DOI 10.1002/cncr.10391
   Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035
   Wagayama H, 2002, HUM PATHOL, V33, P429, DOI 10.1053/hupa.2002.124724
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
NR 23
TC 12
Z9 12
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD AUG
PY 2017
VL 32
IS 8
BP 1480
EP 1486
DI 10.1111/jgh.13717
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FB9SD
UT WOS:000406478400014
PM 28052383
DA 2024-02-19
ER

PT J
AU White, RR
   Milholland, B
   MacRae, SL
   Lin, MY
   Zheng, DY
   Vijg, J
AF White, Ryan R.
   Milholland, Brandon
   MacRae, Sheila L.
   Lin, Mingyan
   Zheng, Deyou
   Vijg, Jan
TI Comprehensive transcriptional landscape of aging mouse liver
SO BMC GENOMICS
LA English
DT Article
DE Gene expression; Aging; RNA-seq; Transcriptome; Non-coding RNA;
   Variation; Liver
ID GENE-EXPRESSION PROFILES; DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; RNA;
   INDUCTION; CANCER; CELLS; BRAIN; LONG; MICE
AB Background: Mammalian aging is a highly complex process, a full mechanistic understanding of which is still lacking. One way to help understand the molecular changes underlying aging is through a comprehensive analysis of the transcriptome, the primary determinant of age-related phenotypic diversity. Previous studies have relied on microarray analysis to examine gene expression profiles in different tissues of aging organisms. However, studies have shown microarray-based transcriptional profiling is less accurate and not fully capable of capturing certain intricacies of the global transcriptome.
   Methods: Here, using directional whole transcriptome RNA-sequencing of aged mouse liver we have identified a comprehensive high-resolution profile of differentially expressed liver transcripts comprised of canonical protein-coding transcripts, transcript isoforms, and non-coding RNA transcripts, including pseudogenes, long non-coding RNAs and small RNA species.
   Results: Results show extensive age-related changes in every component of the mouse liver transcriptome and a pronounced increase in inter-individual variation. Functional annotation of the protein-coding mRNAs and isoforms indicated broad alterations in immune response, cell activation, metabolic processes, and RNA modification. Interestingly, multiple lncRNAs (Meg3, Rian, Mirg) from the Dlk-Dio3 microRNA locus were found up-regulated in aging liver, classifying this locus as a putative regulatory hotspot locus in aging liver. Moreover, integration of the altered non-coding RNAs and protein-coding transcripts into interaction networks of age-related change revealed inflammation, cellular proliferation, and metabolism as the dominant aging phenotypes in mouse liver.
   Conclusions: Our analyses provide the first comprehensive dissection of the transcriptional landscape in aging mouse liver.
C1 [White, Ryan R.; Milholland, Brandon; MacRae, Sheila L.; Lin, Mingyan; Zheng, Deyou; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.
   [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.
   [White, Ryan R.; Vijg, Jan] Albert Einstein Coll Med, Michael F Price Ctr Genet & Translat Res, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine
RP White, RR (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.
EM ryan.white@phd.einstein.yu.edu; jan.vijg@einstein.yu.edu
RI lin, mingyan/HDL-9420-2022
OI Zheng, Deyou/0000-0003-4354-5337; White, Ryan/0000-0001-8344-2549
FU National Institutes of Health [AG17242]; Glenn Foundation for Medical
   Research
FX This work was supported by the National Institutes of Health grant
   AG17242 and the Glenn Foundation for Medical Research. We would like to
   thank the Epigenomics Core and the Computational Genomics Core of the
   Albert Einstein College of Medicine for sequencing and computational
   suggestions. We would also like to thank Dr. Masako Suzuki and Dr.
   Yousin Suh for helpful comments and suggestions.
CR Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875
   Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008
   Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027
   CHENG YK, 1992, PROG BIOPHYS MOL BIO, V58, P225, DOI 10.1016/0079-6107(92)90007-S
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Gombar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-353
   Guo ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-403
   Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352
   Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569
   Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kim JY, 2014, AGING-US, V6, P524, DOI 10.18632/aging.100677
   Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223
   Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124
   Mazin P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.67
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Somel M, 2006, CURR BIOL, V16, pR359, DOI 10.1016/j.cub.2006.04.024
   Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   White RR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7790
   Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
   Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011
   Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307
NR 62
TC 81
Z9 91
U1 1
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD NOV 5
PY 2015
VL 16
AR 899
DI 10.1186/s12864-015-2061-8
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA CW8WW
UT WOS:000365281100002
PM 26541291
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Höhn, A
   Weber, D
   Jung, T
   Ott, C
   Hugo, M
   Kochlik, B
   Kehm, R
   König, J
   Grune, T
   Castro, JP
AF Hoehn, Annika
   Weber, Daniela
   Jung, Tobias
   Ott, Christiane
   Hugo, Martin
   Kochlik, Bastian
   Kehm, Richard
   Koenig, Jeannette
   Grune, Tilman
   Castro, Jose Pedro
TI Happily (n)ever after: Aging in the context of oxidative stress,
   proteostasis loss and cellular senescence
SO REDOX BIOLOGY
LA English
DT Article
DE Aging; Senescence; Protein oxidation; Proteostasis; Trace elements;
   Antioxidants; Micronutrients
ID METHIONINE SULFOXIDE REDUCTASES; PARKIN-MEDIATED MITOPHAGY; PROTEIN
   CARBONYL GROUPS; AGE-RELATED DECLINE; LIFE-SPAN; VITAMIN-E;
   SKELETAL-MUSCLE; RAT-LIVER; MITOCHONDRIAL DYSFUNCTION; REPLICATIVE
   SENESCENCE
AB Aging is a complex phenomenon and its impact is becoming more relevant due to the rising life expectancy and because aging itself is the basis for the development of age-related diseases such as cancer, neurodegenerative diseases and type 2 diabetes. Recent years of scientific research have brought up different theories that attempt to explain the aging process. So far, there is no single theory that fully explains all facets of aging. The damage accumulation theory is one of the most accepted theories due to the large body of evidence found over the years. Damage accumulation is thought to be driven, among others, by oxidative stress. This condition results in an excess attack of oxidants on biomolecules, which lead to damage accumulation over time and contribute to the functional involution of cells, tissues and organisms. If oxidative stress persists, cellular senescence is a likely outcome and an important hallmark of aging. Therefore, it becomes crucial to understand how senescent cells function and how they contribute to the aging process. This review will cover cellular senescence features related to the protein pool such as morphological and molecular hallmarks, how oxidative stress promotes protein modifications, how senescent cells cope with them by proteostasis mechanisms, including antioxidant enzymes and proteolytic systems. We will also highlight the nutritional status of senescent cells and aged organisms (including human clinical studies) by exploring trace elements and micronutrients and on their importance to develop strategies that might increase both, life and health span and postpone aging onset.
C1 [Hoehn, Annika; Weber, Daniela; Jung, Tobias; Ott, Christiane; Hugo, Martin; Kochlik, Bastian; Kehm, Richard; Koenig, Jeannette; Grune, Tilman; Castro, Jose Pedro] German Inst Human Nutr DTFE, Dept Mol Toxicol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
   [Hoehn, Annika; Kehm, Richard; Grune, Tilman; Castro, Jose Pedro] German Ctr Diabet Res DZD, D-85764 Munich, Germany.
   [Jung, Tobias; Ott, Christiane; Grune, Tilman] German Ctr Cardiovasc Res DZHK, D-10117 Berlin, Germany.
   [Weber, Daniela; Kochlik, Bastian; Grune, Tilman] NutriAct Comp Cluster Nutr Res, D-14558 Nuthetal, Germany.
   [Castro, Jose Pedro] Univ Porto, Fac Med, Dept Biomed, P-4200319 Oporto, Portugal.
   [Castro, Jose Pedro] Inst Innovat & Hlth Res I3S, Aging & Stress Grp, P-4200135 Oporto, Portugal.
C3 Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE);
   German Centre for Cardiovascular Research; Universidade do Porto;
   Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em
   Saude, Universidade do Porto
RP Castro, JP (corresponding author), German Inst Human Nutr DTFE, Dept Mol Toxicol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.; Castro, JP (corresponding author), Inst Innovat & Hlth Res I3S, Aging & Stress Grp, P-4200135 Oporto, Portugal.
EM jose.castro@dife.de
RI Hugo, Martín/AAW-8351-2020
OI Hugo, Martín/0000-0003-3430-6457; Konig, Jeannette/0000-0003-3217-573X;
   Kochlik, Bastian/0000-0003-0214-7092; Jung, Tobias/0000-0002-9159-8444;
   Castro, Jose Pedro/0000-0002-2627-5331; Grune,
   Tilman/0000-0003-4775-9973; Hohn, Annika/0000-0003-1306-2668; Kehm,
   Richard/0000-0002-2993-4291; Ott, Christiane/0000-0002-3199-0655; Weber,
   Daniela/0000-0002-2054-6233
CR Abu-Zidan FM, 2002, EUR J SURG, V168, P119, DOI 10.1080/11024150252884359
   Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825
   AHLBERG J, 1985, EXP MOL PATHOL, V42, P78, DOI 10.1016/0014-4800(85)90020-6
   Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301
   Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x
   Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7
   Alam ZI, 1997, J NEUROCHEM, V69, P1326
   [Anonymous], 1998, DIETARY REFERENCE IN
   [Anonymous], ONCOTARGET
   [Anonymous], EXP PHYSL
   Anraku M, 2009, FOOD CHEM TOXICOL, V47, P104, DOI 10.1016/j.fct.2008.10.015
   Ashoori M, 2014, BRIT J NUTR, V111, P1985, DOI 10.1017/S0007114514000178
   Bakondi E, 2011, FREE RADICAL BIO MED, V50, P86, DOI 10.1016/j.freeradbiomed.2010.10.700
   Baraibar MA, 2013, EXP GERONTOL, V48, P620, DOI 10.1016/j.exger.2012.10.007
   Baraibar MA, 2012, PROG MOL BIOL TRANSL, V109, P249, DOI 10.1016/B978-0-12-397863-9.00007-9
   Baraibar MA, 2011, FREE RADICAL BIO MED, V51, P1522, DOI 10.1016/j.freeradbiomed.2011.06.032
   Barja G, 2014, PROG MOL BIOL TRANSL, V127, P1, DOI 10.1016/B978-0-12-394625-6.00001-5
   Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   BERGAMINI CM, 1991, INT J BIOCHEM, V23, P123, DOI 10.1016/0020-711X(91)90018-I
   Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075
   Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3
   Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977
   Boscia F, 2000, INVEST OPHTH VIS SCI, V41, P2461
   Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942
   Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663
   Bulvik BE, 2012, AGE, V34, P693, DOI 10.1007/s11357-011-9268-7
   Buss IH, 2000, PEDIATR RES, V47, P640, DOI 10.1203/00006450-200005000-00014
   Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3
   Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006
   Cai TJ, 2007, BRAIN RES, V1185, P359, DOI 10.1016/j.brainres.2007.09.075
   Çakatay U, 2000, ENDOCR RES, V26, P365, DOI 10.3109/07435800009066174
   Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957
   Caramés B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305
   Carty JL, 2000, BIOCHEM BIOPH RES CO, V273, P729, DOI 10.1006/bbrc.2000.3014
   Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x
   Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0
   Castro J. P., 2016, FREE RADIC BIOL MED
   Castro JP, 2013, J PROTEOMICS, V92, P171, DOI 10.1016/j.jprot.2013.05.006
   Castro JP, 2012, FREE RADICAL BIO MED, V53, P916, DOI 10.1016/j.freeradbiomed.2012.06.005
   Castro JP, 2016, BIOL CHEM
   Catalgol B, 2010, FREE RADICAL BIO MED, V48, P673, DOI 10.1016/j.freeradbiomed.2009.12.010
   Catalgol B, 2009, J BIOL CHEM, V284, P30076, DOI 10.1074/jbc.M109.044503
   Cazanave S, 2007, J HEPATOL, V46, P858, DOI 10.1016/j.jhep.2006.11.015
   Chapman KM, 1996, J GERONTOL A-BIOL, V51, pB261, DOI 10.1093/gerona/51A.4.B261
   Chawla Jasvinder, 2014, Handb Clin Neurol, V120, P891, DOI 10.1016/B978-0-7020-4087-0.00059-0
   Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048
   Chen X, 2016, WIRES SYST BIOL MED, V8, P300, DOI 10.1002/wsbm.1340
   Cho SH, 2004, FEBS LETT, V560, P7, DOI 10.1016/S0014-5793(04)00112-7
   Choi JG, 2002, BIOCHEM BIOPH RES CO, V293, P1566, DOI 10.1016/S0006-291X(02)00420-5
   Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200
   Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200
   Chondrogianni N, 2007, EXP GERONTOL, V42, P899, DOI 10.1016/j.exger.2007.01.012
   Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045
   Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890
   Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557
   Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Conrad CC, 2000, BIOCHEM BIOPH RES CO, V275, P678, DOI 10.1006/bbrc.2000.3356
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105
   da Silva SL, 2014, ALZHEIMERS DEMENT, V10, P485, DOI 10.1016/j.jalz.2013.05.1771
   Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2
   Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5
   DAS BS, 1990, AM J CLIN NUTR, V51, P859, DOI 10.1093/ajcn/51.5.859
   David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450
   de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187
   Dellon AL, 2001, ANN PLAS SURG, V47, P153, DOI 10.1097/00000637-200108000-00008
   Diot A, 2015, PHARMACOL RES, V100, P24, DOI 10.1016/j.phrs.2015.07.014
   Dixit S, 2015, ACS CHEM NEUROSCI, V6, P570, DOI 10.1021/cn500308h
   Dominguez C, 1998, DIABETES CARE, V21, P1736, DOI 10.2337/diacare.21.10.1736
   Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fabian E, 2012, J NUTR HEALTH AGING, V16, P206, DOI 10.1007/s12603-011-0159-5
   Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Fischer DF, 2009, NEUROBIOL AGING, V30, P847, DOI 10.1016/j.neurobiolaging.2008.06.009
   Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008
   Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148
   Flohé L, 2016, FREE RADICAL RES, V50, P126, DOI 10.3109/10715762.2015.1046858
   Floor E, 1998, J NEUROCHEM, V70, P268
   Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397
   Freese R, 2008, EUR J CLIN NUTR, V62, P1151, DOI 10.1038/sj.ejcn.1602865
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   Frohnert BI, 2013, ADV NUTR, V4, P157, DOI 10.3945/an.112.003319
   GALE CR, 1995, BRIT MED J, V310, P1563, DOI 10.1136/bmj.310.6994.1563
   Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203
   Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29
   GARFINKEL S, 1994, P NATL ACAD SCI USA, V91, P1559, DOI 10.1073/pnas.91.4.1559
   Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105
   Gaziano JM, 2004, ANN NY ACAD SCI, V1031, P280, DOI 10.1196/annals.1331.028
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gibson GE, 2013, MOL CELL NEUROSCI, V55, P17, DOI 10.1016/j.mcn.2012.09.001
   Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962
   GLADSTONE IM, 1994, PEDIATRICS, V93, P764
   Gohlke S, 2014, AGE, V36, P57, DOI 10.1007/s11357-013-9543-x
   Granado-Lorencio F, 2013, EUR J CLIN NUTR, V67, P1325, DOI 10.1038/ejcn.2013.198
   Granzotto A, 2015, NEUROBIOL DIS, V81, P25, DOI 10.1016/j.nbd.2015.04.010
   Grattagliano I, 1998, FREE RADICAL BIO MED, V25, P369, DOI 10.1016/S0891-5849(98)00059-8
   Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200
   Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X
   Gutiérrez-Fernández A, 2015, EMBO J, V34, P1875, DOI 10.15252/embj.201490594
   GUTTERIDGE JMC, 1984, MECH AGEING DEV, V25, P205, DOI 10.1016/0047-6374(84)90141-6
   Hanzén S, 2016, CELL, V166, P140, DOI 10.1016/j.cell.2016.05.006
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hashimoto T, 2010, NEUROSCI LETT, V469, P273, DOI 10.1016/j.neulet.2009.12.015
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054
   HENSLEY K, 1995, J NEUROCHEM, V65, P2146
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   Hepple RT, 2016, FREE RADICAL BIO MED, V98, P177, DOI 10.1016/j.freeradbiomed.2016.03.017
   Himmelfarb J, 2001, KIDNEY INT, V60, P358, DOI 10.1046/j.1523-1755.2001.00807.x
   Himmelfarb J, 2000, KIDNEY INT, V58, P2571, DOI 10.1046/j.1523-1755.2000.00443.x
   Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003
   Höhn A, 2014, FREE RADICAL BIO MED, V71, P70, DOI 10.1016/j.freeradbiomed.2014.02.028
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Höhn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004
   Höhn A, 2012, FREE RADICAL BIO MED, V53, P1760, DOI 10.1016/j.freeradbiomed.2012.08.591
   Höhn A, 2011, FREE RADICAL BIO MED, V50, P585, DOI 10.1016/j.freeradbiomed.2010.12.011
   Höhn A, 2010, FREE RADICAL BIO MED, V48, P1100, DOI 10.1016/j.freeradbiomed.2010.01.030
   Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124
   HORNSBY PJ, 1987, EXP CELL RES, V168, P203, DOI 10.1016/0014-4827(87)90429-0
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Hsu CY, 2014, EXP GERONTOL, V50, P128, DOI 10.1016/j.exger.2013.12.003
   Hughes CF, 2013, ANN CLIN BIOCHEM, V50, P315, DOI 10.1177/0004563212473279
   Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9
   Hwang JS, 2007, J GERONTOL A-BIOL, V62, P490, DOI 10.1093/gerona/62.5.490
   Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057
   IKEDA H, 1985, MECH AGEING DEV, V31, P139, DOI 10.1016/S0047-6374(85)80024-5
   IKEDA H, 1985, MECH AGEING DEV, V33, P77, DOI 10.1016/0047-6374(85)90110-1
   Jacob K, 2008, BRIT J NUTR, V99, P137, DOI 10.1017/S0007114507791894
   Jacob RA, 2003, J NUTR, V133, P740, DOI 10.1093/jn/133.3.740
   JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415
   Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002
   Jiang QA, 2011, MOL BIOL CELL, V22, P1167, DOI 10.1091/mbc.E10-10-0860
   Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849
   Johnson EJ, 2012, AM J CLIN NUTR, V96, p1161S, DOI 10.3945/ajcn.112.034611
   Johnston-Carey HK, 2016, CRIT REV BIOCHEM MOL, V51, P268, DOI 10.3109/10409238.2016.1172554
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Jung T, 2014, REDOX BIOL, V2, P99, DOI 10.1016/j.redox.2013.12.008
   Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029
   Jung T, 2013, REDOX BIOL, V1, P178, DOI 10.1016/j.redox.2013.01.004
   Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13
   Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001
   Kästle M, 2012, FREE RADICAL BIO MED, V53, P2092, DOI 10.1016/j.freeradbiomed.2012.09.023
   Kästle M, 2011, CURR PHARM DESIGN, V17, P4007, DOI 10.2174/138161211798764898
   Kang JH, 2005, ANN NEUROL, V57, P713, DOI 10.1002/ana.20476
   Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191
   Kang YA, 2012, MOL CELL BIOL, V32, P226, DOI 10.1128/MCB.06166-11
   Kapeta S, 2010, J BIOL CHEM, V285, P8171, DOI 10.1074/jbc.M109.031575
   Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Kedziora-Kornatowska K, 2004, CELL MOL BIOL LETT, V9, P635
   Keisala T, 2009, J STEROID BIOCHEM, V115, P91, DOI 10.1016/j.jsbmb.2009.03.007
   KENESSEY A, 1989, J NEUROSCI RES, V23, P454, DOI 10.1002/jnr.490230412
   Khanna S, 2010, J NEUROCHEM, V112, P1249, DOI 10.1111/j.1471-4159.2009.06550.x
   Killilea DW, 2004, ANN NY ACAD SCI, V1019, P365, DOI 10.1196/annals.1297.063
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356
   König J, 2016, BIOFACTORS, V42, P307, DOI 10.1002/biof.1274
   KOISTINAHO J, 1989, ADV EXP MED BIOL, V266, P49
   Korolainen MA, 2002, ELECTROPHORESIS, V23, P3428, DOI 10.1002/1522-2683(200210)23:19<3428::AID-ELPS3428>3.0.CO;2-5
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009
   Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246
   Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955
   LeBrasseur NK, 2015, NESTLE NUTR WORKS SE, V83, P11, DOI 10.1159/000382054
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee JH, 2010, AGING-US, V2, P369, DOI 10.18632/aging.100157
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Lee S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-8
   Legrain Y, 2014, J BIOL CHEM, V289, P6299, DOI 10.1074/jbc.M113.526863
   Lenz AG, 1999, EUR RESPIR J, V13, P169, DOI 10.1034/j.1399-3003.1999.13a31.x
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   Li HY, 2011, J APPL TOXICOL, V31, P690, DOI 10.1002/jat.1654
   LihBrody L, 1996, DIGEST DIS SCI, V41, P2078, DOI 10.1007/BF02093613
   Lim PS, 2002, FREE RADICAL RES, V36, P295, DOI 10.1080/10715760290019318
   Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105
   Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107
   Liu Q, 2004, BIOL TRACE ELEM RES, V100, P215, DOI 10.1385/BTER:100:3:215
   Liuzzi JP, 2013, BIOL TRACE ELEM RES, V156, P350, DOI 10.1007/s12011-013-9816-3
   Lopez-Otin C., CELL, V153, P1194
   Lyras L, 1998, J NEUROCHEM, V71, P302
   MADARIC A, 1994, PHYSIOL RES, V43, P107
   Maggini S, 2007, BRIT J NUTR, V98, pS29, DOI 10.1017/S0007114507832971
   Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013
   Mangialasche F, 2013, J INTERN MED, V273, P602, DOI 10.1111/joim.12037
   Mangialasche F, 2012, NEUROBIOL AGING, V33, P2282, DOI 10.1016/j.neurobiolaging.2011.11.019
   Mangialasche F, 2010, J ALZHEIMERS DIS, V20, P1029, DOI 10.3233/JAD-2010-091450
   Mantle D, 1999, CLIN CHIM ACTA, V284, P45, DOI 10.1016/S0009-8981(99)00055-8
   Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6
   Martínez-Vega R, 2015, FASEB J, V29, P418, DOI 10.1096/fj.14-259283
   Maruyama J, 2009, CURR MED CHEM, V16, P1229, DOI 10.2174/092986709787846613
   Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010
   Matos L, 2012, AGE, V34, P783, DOI 10.1007/s11357-011-9276-7
   McCord MC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00077
   McGrath LT, 1999, THORAX, V54, P518, DOI 10.1136/thx.54.6.518
   Mecocci P, 2000, FREE RADICAL BIO MED, V28, P1243, DOI 10.1016/S0891-5849(00)00246-X
   Mehta R, 2011, TOXICOL IN VITRO, V25, P1114, DOI 10.1016/j.tiv.2011.03.015
   Menardo J, 2012, ANTIOXID REDOX SIGN, V16, P263, DOI 10.1089/ars.2011.4037
   Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   Mirzaei H, 2007, J CHROMATOGR A, V1141, P22, DOI 10.1016/j.chroma.2006.11.009
   Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x
   Miyata T, 2000, NEPHROL DIAL TRANSPL, V15, P25, DOI 10.1093/oxfordjournals.ndt.a027959
   Mizuno Y, 2006, J NEUROL SCI, V249, P13, DOI 10.1016/j.jns.2006.05.060
   Mocchegiani E, 2013, CURR PHARM DESIGN, V19, P1753
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004
   Morris MC, 2002, ARCH NEUROL-CHICAGO, V59, P1125, DOI 10.1001/archneur.59.7.1125
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Murata H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142438
   Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002
   Nacarelli T, 2015, EXP GERONTOL, V68, P66, DOI 10.1016/j.exger.2014.11.004
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819
   Nezich CL, 2015, J CELL BIOL, V210, P435, DOI 10.1083/jcb.201501002
   Nielsen GP, 1999, LAB INVEST, V79, P1137
   Nowotny K, 2014, EXP GERONTOL, V59, P3, DOI 10.1016/j.exger.2014.10.001
   Nyström T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599
   Nyström T, 2012, GENE DEV, V26, P2001, DOI 10.1101/gad.200006.112
   O'Byrne DJ, 2002, AM J CLIN NUTR, V76, P1367, DOI 10.1093/ajcn/76.6.1367
   Okura T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05663
   Ott C., 2016, FREE RADIC BIOL MED
   Ott C, 2016, REDOX BIOL, V10, P266, DOI 10.1016/j.redox.2016.10.015
   Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200
   Pantke U, 1999, FREE RADICAL BIO MED, V27, P1080, DOI 10.1016/S0891-5849(99)00144-6
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211
   Pedro CJ, 2014, FREE RADICAL BIO MED, V75, pS24, DOI 10.1016/j.freeradbiomed.2014.10.743
   Pernodet N, 2016, J COSMET SCI, V67, P13
   Petrov D, 2011, J AM CHEM SOC, V133, P7016, DOI 10.1021/ja110577e
   Pickering AM, 2015, J CLIN INVEST, V125, P2059, DOI 10.1172/JCI80514
   Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878
   Picot CR, 2004, FEBS LETT, V558, P74, DOI 10.1016/S0014-5793(03)01530-8
   Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972
   Puissant A, 2012, J MOL CELL BIOL, V4, P207, DOI 10.1093/jmcb/mjs010
   Pusceddu I, 2015, CLIN CHEM LAB MED, V53, P1661, DOI 10.1515/cclm-2014-1184
   Qi L, 2014, ACTA BIOCH BIOPH SIN, V46, P83, DOI 10.1093/abbs/gmt133
   QUINLAN GJ, 1994, FREE RADICAL RES, V20, P289, DOI 10.3109/10715769409145628
   Ramsay PL, 2001, AM J RESP CRIT CARE, V164, P155, DOI 10.1164/ajrccm.164.1.2008022
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9
   Range SP, 1999, EUR RESPIR J, V13, P560, DOI 10.1183/09031936.99.13356099
   Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172
   Reeg S., 2016, FREE RADIC BIOL MED
   Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062
   Renke J, 2000, FREE RADICAL BIO MED, V29, P101, DOI 10.1016/S0891-5849(00)00288-4
   Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026
   Rinaldi P, 2003, NEUROBIOL AGING, V24, P915, DOI 10.1016/S0197-4580(03)00031-9
   Robinson K, 1998, CIRCULATION, V97, P437
   Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890
   Rodríguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517
   Rodriguez-Navarro JA, 2007, J NEUROCHEM, V103, P98, DOI 10.1111/j.1471-4159.2007.04762.x
   Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027
   Rudolf E, 2015, APOPTOSIS, V20, P1651, DOI 10.1007/s10495-015-1182-5
   Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344
   Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658
   Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004
   Saretzki G, 1998, J GERONTOL A-BIOL, V53, pB438, DOI 10.1093/gerona/53A.6.B438
   SATO I, 1993, BIOCHEM BIOPH RES CO, V195, P1070, DOI 10.1006/bbrc.1993.2153
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Schock BC, 2001, AM J PHYSIOL-LUNG C, V281, pL1386, DOI 10.1152/ajplung.2001.281.6.L1386
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sheng Z, 2011, BLOOD, V118, P2840, DOI 10.1182/blood-2010-12-322537
   Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787
   Siciliano G, 2007, J NEUROL, V254, P575, DOI 10.1007/s00415-006-0301-1
   Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   Singh R, 2011, CELL MOL NEUROBIOL, V31, P83, DOI 10.1007/s10571-010-9557-1
   Sirotkin AV, 2014, CELL TISSUE RES, V358, P627, DOI 10.1007/s00441-014-1940-7
   Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490
   Sitte N, 2000, FASEB J, V14, P2503, DOI 10.1096/fj.00-0210com
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   Sosulski ML, 2015, AGING CELL, V14, P774, DOI 10.1111/acel.12357
   Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Sun T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-161
   Szabó É, 2011, ALLERGY, V66, P811, DOI 10.1111/j.1398-9995.2011.02551.x
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Tank EMH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000382
   Tavana O, 2010, CELL CYCLE, V9, P3328, DOI 10.4161/cc.9.16.12688
   Telci A, 2000, HORM METAB RES, V32, P40, DOI 10.1055/s-2007-978584
   Telci A, 2000, DIABETES RES CLIN PR, V50, P213, DOI 10.1016/S0168-8227(00)00197-2
   Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197
   Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009
   Terman Alexei, 2005, Heart Lung Circ, V14, P107, DOI 10.1016/j.hlc.2004.12.023
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Totan Y, 2009, CURR EYE RES, V34, P1089, DOI 10.3109/02713680903353772
   Touyarot K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072101
   Troesch B, 2012, J NUTR, V142, P979, DOI 10.3945/jn.112.157826
   Tsakiri EN, 2015, INT REV CEL MOL BIO, V314, P171, DOI 10.1016/bs.ircmb.2014.09.002
   Tsakiri EN, 2013, FREE RADICAL BIO MED, V65, P1155, DOI 10.1016/j.freeradbiomed.2013.08.186
   Tsakiri EN, 2013, AGING CELL, V12, P802, DOI 10.1111/acel.12111
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van der Loo B, 2004, J CARDIOVASC PHARM, V43, P26, DOI 10.1097/00005344-200401000-00005
   Voellmy R, 2007, ADV EXP MED BIOL, V594, P89
   Voss P, 2007, BIOL CHEM, V388, P583, DOI 10.1515/BC.2007.068
   Wang GG, 2011, HEART INT, V6, P75, DOI 10.4081/hi.2011.e21
   Wang SJ, 1996, J ENG GEOL, V4, P1
   Warner TA, 2015, EPILEPSY RES, V110, P20, DOI 10.1016/j.eplepsyres.2014.11.017
   Wesselborg S, 2015, CELL MOL LIFE SCI, V72, P4721, DOI 10.1007/s00018-015-2034-8
   WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8
   Winterbourn CC, 2000, CRIT CARE MED, V28, P143, DOI 10.1097/00003246-200001000-00024
   Woodside JV, 2015, MATURITAS, V80, P63, DOI 10.1016/j.maturitas.2014.10.012
   Wu G., 2004, J NUTR, V134, P3
   Wu M, 2011, J AGR FOOD CHEM, V59, P11882, DOI 10.1021/jf203012a
   Xiao Y, 2010, INT J ONCOL, V37, P81, DOI 10.3892/ijo_00000655
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   ZAMAN Z, 1992, AGE AGEING, V21, P91, DOI 10.1093/ageing/21.2.91
   Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003
   Zhang YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146797
   Zhang YG, 2016, EXP BIOL MED, V241, P1395, DOI 10.1177/1535370216642039
   Zhao H, 2011, CELL MOL LIFE SCI, V68, P3963, DOI 10.1007/s00018-011-0861-9
   Zheng TY, 2011, CURR EYE RES, V36, P449, DOI 10.3109/02713683.2011.559301
   Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997
NR 337
TC 209
Z9 228
U1 6
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD APR
PY 2017
VL 11
BP 482
EP 501
DI 10.1016/j.redox.2016.12.001
PG 20
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biochemistry & Molecular Biology
GA EQ6RY
UT WOS:000398212000047
PM 28086196
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ki, MR
   Lee, HR
   Park, JK
   Hong, IH
   Han, SY
   You, SY
   Lee, EM
   Kim, AY
   Lee, SS
   Jeong, KS
AF Ki, Mi-Ran
   Lee, Hye-Rim
   Park, Jin-Kyu
   Hong, Il-Hwa
   Han, Seon-Young
   You, Sang-Young
   Lee, Eun-Mi
   Kim, Ah-Young
   Lee, Seung-Sook
   Jeong, Kyu-Shik
TI Ascorbate promotes carbon tetrachloride-induced hepatic injury in
   senescence marker protein 30-deficient mice by enhancing inflammation
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Ascorbate-deficient animal; Inflammation; Liver injury; Pro-oxidant;
   Senescence; SMP30
ID NECROSIS-FACTOR-ALPHA; VITAMIN-C; STELLATE CELLS; CELLULAR SENESCENCE;
   KINASE ACTIVATION; OXIDATIVE STRESS; LIVER FIBROSIS; KNOCKOUT MICE;
   DNA-DAMAGE; APOPTOSIS
AB The genetic deletion of the senescence marker protein 30 (SMP30) gene results in ascorbate deficiency and the premature aging processes in mice. Apparent liver injury of SMP30(-/-) mice was less severe than those of wild type (WT) mice, upon chronic CCl(4) injection. The purpose of this study was to investigate the pathophysiology underlying the mild CCl(4) toxicity in SMP30(-/-) mice. Along with the lower level of serum alanine aminotransferase, the livers of SMP30(-/-) mice revealed a lesser glycogen depletion, a decrease in c-Jun N-terminal kinase (JNK)-mediated inflammatory signaling in parallel with tumor necrosis factor-alpha and interleukin-1 beta, inducible nitric oxide synthase and glutathione peroxidase, and the lower lipid peroxidation as compared to those of WT mice. CCl(4)-induced proliferation, measured by the expression of proliferating cell nuclear antigen, was low in SMP30(-/-) mice as compared with that of WT mice whereas the levels of p21 and Bax were comparable to those of the CCl(4)-treated WT mice. Moreover, CCl(4) toxicity in ascorbate-fed SMP30(-/-) mice was comparable to that of the CCl(4)-alone treated WT mice, accompanied by an increase in the above mentioned factors. Conversely, ascorbate partly compensated for the CCl(4)-induced oxidative stress in WT mice, indicating that sufficient ascorbate may be required for an antioxidant function under severe levels of oxidative stress. Our data suggest that the restoration of ascorbate-deficiency reverses a sluggish immune system into an activated condition by an increase in JNK-mediated inflammation and free radical cascade; thus leading to accelerated hepatic damage in SMP30(-/-) mice. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Ki, Mi-Ran; Lee, Hye-Rim; Park, Jin-Kyu; Hong, Il-Hwa; Han, Seon-Young; You, Sang-Young; Lee, Eun-Mi; Kim, Ah-Young; Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
   [Lee, Seung-Sook] Korea Inst Radiol & Med Sci, Dept Pathol, Seoul, South Korea.
C3 Kyungpook National University; Korea Institute of Radiological & Medical
   Sciences
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
EM jeongks@knu.ac.kr
FU Health and Korea Health Industry Development Institute in Republic of
   Korea [A081039]
FX This work was supported by Health and Medical Technology R and D program
   (A081039), Health and Korea Health Industry Development Institute in
   Republic of Korea.
CR Ashcroft M, 1999, MOL CELL BIOL, V19, P1751
   BANHEGYI G, 1996, FEBS LETT, V38, P139
   Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099
   Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036
   Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271
   Calvino Nick, 2003, J Chiropr Med, V2, P25, DOI 10.1016/S0899-3467(07)60070-6
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chatterjee M, 2008, FREE RADICAL BIO MED, V45, P1084, DOI 10.1016/j.freeradbiomed.2008.06.028
   Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037
   Cotran RS, 1999, ROBBINS PATHOLOGIC B
   Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010
   Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Gallo O, 2003, AM J PATHOL, V163, P723, DOI 10.1016/S0002-9440(10)63699-1
   GELLER DA, 1993, P NATL ACAD SCI USA, V90, P522, DOI 10.1073/pnas.90.2.522
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045
   Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027
   Haidara K, 2002, BBA-MOL CELL RES, V1542, P173, DOI 10.1016/S0167-4889(01)00178-1
   Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0
   Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200
   Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263
   Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   KONDO Y, 2008, CELL, V34, P657
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee CW, 2008, INT J CANCER, V122, P1068, DOI 10.1002/ijc.23228
   Lei XG, 2005, J NUTR, V135, P2295, DOI 10.1093/jn/135.10.2295
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754
   Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841
   Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365
   McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X
   Miquel J, 2002, ANN NY ACAD SCI, V959, P508, DOI 10.1111/j.1749-6632.2002.tb02120.x
   Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006
   Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548
   Naumann M, 1998, J EXP MED, V188, P1277, DOI 10.1084/jem.188.7.1277
   Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   PARK JK, 2008, GUT, V57, pA285
   Premkumar K, 2004, J NUTR, V134, P435, DOI 10.1093/jn/134.2.435
   Rancourt RC, 2002, J CELL PHYSIOL, V193, P26, DOI 10.1002/jcp.10146
   Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7
   Rivera A, 2005, J BIOL CHEM, V280, P29346, DOI 10.1074/jbc.M504852200
   RUBBO H, 1994, J BIOL CHEM, V269, P26066
   Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320
   SANCHEZMORENO C, 2004, J NUTR, V134, P3201
   Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Ulicná O, 2003, PHYSIOL RES, V52, P461, DOI 10.33549/physiolres.930340
   Victor VM, 2001, FREE RADICAL RES, V35, P907, DOI 10.1080/10715760100301401
   Vissers MCM, 2001, J BIOL CHEM, V276, P46835, DOI 10.1074/jbc.M107664200
   Xu J, 1999, MOL CELL BIOL, V19, P12
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 56
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JUN
PY 2011
VL 22
IS 6
BP 535
EP 542
DI 10.1016/j.jnutbio.2010.04.008
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 770GP
UT WOS:000291075300004
PM 20801630
DA 2024-02-19
ER

PT J
AU Kuhla, A
   Blei, T
   Jaster, R
   Vollmar, B
AF Kuhla, Angela
   Blei, Tina
   Jaster, Robert
   Vollmar, Brigitte
TI Aging Is Associated With a Shift of Fatty Metabolism Toward Lipogenesis
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Senescence; Nuclear receptors; Hepatic steatosis
ID PROLIFERATOR-ACTIVATED RECEPTORS; SENESCENCE-ACCELERATED MICE;
   UNION-OF-PHARMACOLOGY; LIVER-DISEASE; CHOLESTEROL HOMEOSTASIS; DEPENDENT
   REGULATION; HEPATIC STEATOSIS; NUCLEAR RECEPTORS; OXIDATIVE STRESS;
   GENE-EXPRESSION
AB The incidence of nonalcoholic fatty liver disease is steadily increasing among the elderly population. Lipid metabolism is transcriptionally controlled by the nuclear receptors retinoid acid receptor alpha, liver-X-receptor alpha, and peroxisome proliferator-activated receptor alpha and their target genes ABCA1, sterol regulatory element-binding protein-1c, and fatty acid synthase. Using senescence-accelerated prone mice (SAMP8), we addressed the question as to whether age-related increase of oxidative stress affects nuclear receptor gene expression. In contrast to SAMR1 control mice, young SAMP8 mice exhibit hepatic steatosis with increased hepatic cholesterol content, plasma triglyceride, and aspartate aminotransferase levels. This is accompanied by an increase of liver-X-receptor alpha and retinoid acid receptor alpha expression, whereas peroxisome proliferator-activated receptor alpha expression is found diminished. SAMP8 mice further reveal a lower expression of ABCA1 as well as of sterol regulatory element-binding protein-1c and higher expression of fatty acid synthase. The dysbalance between the nuclear receptors and their target genes most probably mediates hepatic steatosis and underlines the pathological relevance of nuclear receptor shift toward lipogenesis in fat metabolism of the elderly patient.
C1 [Kuhla, Angela; Blei, Tina; Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18057 Rostock, Germany.
   [Jaster, Robert] Univ Rostock, Div Gastroenterol, Dept Med 2, D-18057 Rostock, Germany.
C3 University of Rostock; University of Rostock
RP Vollmar, B (corresponding author), Univ Rostock, Inst Expt Surg, Schillingallee 69A, D-18057 Rostock, Germany.
EM brigitte.vollmar@med.uni-rostock.de
CR Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Caballero B, 2009, J PINEAL RES, V46, P106, DOI 10.1111/j.1600-079X.2008.00637.x
   Chiba Y, 2009, NEUROCHEM RES, V34, P679, DOI 10.1007/s11064-008-9812-8
   Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116
   Dancygier H, 2006, DTSCH ARZTEBL, V103, P1301
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1
   Feng YM, 2010, CARDIOVASC RES, V88, P376, DOI 10.1093/cvr/cvq204
   Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002
   Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7
   HOYUMPA AM, 1975, AM J DIG DIS, V20, P1142, DOI 10.1007/BF01070758
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406
   Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5
   Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698
   Ouvrier A, 2009, J LIPID RES, V50, P1766, DOI 10.1194/jlr.M800657-JLR200
   Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839
   Rebrin I, 2004, EXP GERONTOL, V39, P1513, DOI 10.1016/j.exger.2004.08.014
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Sanal MG, 2008, WORLD J GASTROENTERO, V14, P831, DOI 10.3748/wjg.14.831
   Santamarina-Fojo S, 2001, J LIPID RES, V42, P1339
   Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400
   Song C, 2000, ENDOCRINOLOGY, V141, P4180, DOI 10.1210/en.141.11.4180
   TAKEDA T, 1994, ARCH GERONTOL GERIAT, V19, P185, DOI 10.1016/0167-4943(94)90039-6
   Teramoto S, 1996, LUNG, V174, P119
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   Wang Y, 2004, J LIPID RES, V45, P972, DOI 10.1194/jlr.M400011-JLR200
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
NR 37
TC 46
Z9 50
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2011
VL 66
IS 11
BP 1192
EP 1200
DI 10.1093/gerona/glr124
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 836HN
UT WOS:000296102100007
PM 21835806
OA Bronze
DA 2024-02-19
ER

PT J
AU Sokhi, RP
   Rajvanshi, P
   Gupta, S
AF Sokhi, RP
   Rajvanshi, P
   Gupta, S
TI Transplanted reporter cells help in defining onset of hepatocyte
   proliferation during the life of F344 rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE hepatocyte transplantation; dipeptidyl peptidase IV; liver;
   regeneration; aging
ID LIVER-REGENERATION; PARTIAL-HEPATECTOMY; GENE-EXPRESSION; STEM-CELLS;
   REPLACEMENT; GROWTH; DIFFERENTIATION; REPOPULATION; REPLICATION; LOBULE
AB Transplanted hepatocytes integrate in the liver parenchyma and exhibit gene expression patterns that are similar to adjacent host hepatocytes. To determine the fate of genetically marked hepatocytes in the context of hepatocellular proliferation throughout the rodent life span, we transplanted Fischer 344 (F344) rat hepatocytes into syngeneic dipeptidyl peptidase IV-deficient rats. The proliferative activity in transplanted hepatocytes was studied in animals ranging in age from a few days to 2 yr. Transplanted hepatocytes proliferated during liver development between 1 and 6 wk of age, each dividing an estimated two to five times. DNA synthesis in occasional cells was demonstrated by localizing bromodeoxyuridine incorporation. There was no evidence for transplanted cell proliferation between 6 wk and 1 yr of age. Subsequently, transplanted cells proliferated again, with increased sizes of transplanted cell clusters at 18 and 24 mo of age. The proliferative activity of transplanted cells was greater in rats entering senescence compared with during postnatal liver development. In old rats, some liver lobules were composed entirely of transplanted cells. We conclude that hepatocyte proliferation in the livers of very young and old F344 rats is regulated in a temporally determined, biphasic manner. The findings will be relevant to mechanisms concerning liver development, senescence, and oncogenesis, as well as to cell and gene therapy.
C1 Yeshiva Univ Albert Einstein Coll Med, Ctr Canc Res, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine
RP Gupta, S (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Ctr Canc Res, Marion Bessin Liver Res Ctr, Ullmann 625,1300 Morris Pk Ave, Bronx, NY 10461 USA.
FU NIDDK NIH HHS [P33-DK-41296, R01-DK-46952] Funding Source: Medline
CR Alison M, 1997, J HEPATOL, V26, P343, DOI 10.1016/S0168-8278(97)80051-7
   ALISON MR, 1985, BIOL EPITHELIAL CELL
   ARBER N, 1988, LIVER, V8, P80
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BEYER HS, 1992, J LAB CLIN MED, V119, P38
   BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5
   DABEVA MD, 1995, AM J PATHOL, V147, P1633
   EUSTIS SL, 1990, PATHOLOGY FISCHER RA, P71
   Fausto Nelson, 1994, P1501
   Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   GRISHAM JW, 1962, CANCER RES, V22, P842
   GROSSMAN M, 1995, NAT MED, V1, P1148, DOI 10.1038/nm1195-1148
   Gupta S, 1999, J BIOL CHEM, V274, P2157, DOI 10.1074/jbc.274.4.2157
   Gupta S, 1999, AM J PHYSIOL-GASTR L, V276, pG629, DOI 10.1152/ajpgi.1999.276.3.G629
   Gupta S, 1999, J HEPATOL, V30, P162, DOI 10.1016/S0168-8278(99)80022-1
   GUPTA S, 1995, P NATL ACAD SCI USA, V92, P5860, DOI 10.1073/pnas.92.13.5860
   KENNEDY S, 1995, HEPATOLOGY, V22, P160, DOI 10.1016/0270-9139(95)90369-0
   KOZURKOVA M, 1993, MECH AGEING DEV, V72, P37, DOI 10.1016/0047-6374(93)90129-F
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   LEBOUTON AV, 1974, DEV BIOL, V41, P22, DOI 10.1016/0012-1606(74)90279-6
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mignon A, 1998, NAT MED, V4, P1185, DOI 10.1038/2681
   Overturf K, 1997, AM J PATHOL, V151, P1273
   PANDURO A, 1987, GENE DEV, V1, P1172, DOI 10.1101/gad.1.10.1172
   Rajvanshi P, 1996, HEPATOLOGY, V23, P482
   RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734
   ROSS M H, 1969, Journal of Nutrition, V97, P563
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   SCHAPIRO H, EXPERIENTIA, V38, P1075
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   SELL S, 1994, MODERN PATHOL, V7, P105
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
NR 34
TC 35
Z9 35
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD SEP
PY 2000
VL 279
IS 3
BP G631
EP G640
DI 10.1152/ajpgi.2000.279.3.G631
PG 10
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA 347UB
UT WOS:000088946600021
PM 10960364
DA 2024-02-19
ER

PT J
AU SPIERING, AL
   SMITH, JR
AF SPIERING, AL
   SMITH, JR
TI NEGATIVE GROWTH EFFECTORS AND CELLULAR SENESCENCE
SO MUTATION RESEARCH
LA English
DT Article
DE NEGATIVE GROWTH FACTORS; SENESCENCE; INHIBITORS
ID HUMAN-DIPLOID FIBROBLASTS; REPLICATIVE LIFE-SPAN; DNA-SYNTHESIS;
   HUMAN-CELLS; S-PHASE; SURFACE-MEMBRANES; MESSENGER-RNA; ONCOSTATIN-M;
   WI-38 CELLS; INHIBITION
AB Current studies suggest a genetic program governs the lifespan of each organism. Using cellular senescence as a model system, components of this program for aging have been sought. Human diploid fibroblasts, upon reaching senescence, express active inhibitors of DNA synthesis. It is believed that such inhibitors could be members of a new family of negative growth effectors involved in the pathway to senescence. Factors capable of inhibiting DNA synthesis in a similar manner have also been identified from human quiescent fibroblasts and liver cells as well as from quiescent rodent liver cells. The relationship of these inhibitors to previously identified negative growth effectors and aging are discussed.
C1 BAYLOR COLL MED,HUFFINGTON CTR AGING,HOUSTON,TX 77030.
   BAYLOR COLL MED,DIV MOLEC VIROL,HOUSTON,TX 77030.
   BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030.
   BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine
CR BRUNETTE DM, 1971, J MEMBRANE BIOL, V5, P215, DOI 10.1007/BF01870550
   BURMER GC, 1983, EXP CELL RES, V145, P79, DOI 10.1016/S0014-4827(83)80010-X
   DRESCHERLINCOLN CK, 1984, EXP CELL RES, V153, P208, DOI 10.1016/0014-4827(84)90462-2
   FELTHAM N, 1987, J BIOL CHEM, V262, P2176
   FRIESEL R, 1987, J CELL BIOL, V104, P689, DOI 10.1083/jcb.104.3.689
   GERHARD GS, 1991, EXP CELL RES, V193, P87, DOI 10.1016/0014-4827(91)90541-2
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HOLLIDAY R, 1972, HUMANGENETIK, V16, P83, DOI 10.1007/BF00393991
   HOWE P H, 1989, Journal of Cell Biology, V109, p243A
   HSU YM, 1986, J CELL BIOL, V102, P362, DOI 10.1083/jcb.102.2.362
   KIRKWOOD TBL, 1975, J THEOR BIOL, V53, P481, DOI 10.1016/S0022-5193(75)80018-X
   LINSLEY PS, 1989, J BIOL CHEM, V264, P4282
   LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407
   LUMPKIN CK, 1985, EXP CELL RES, V160, P544, DOI 10.1016/0014-4827(85)90201-0
   MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924
   MARTIN GM, 1974, AM J PATHOL, V74, P137
   MARTIN GM, 1970, LAB INVEST, V23, P86
   MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121
   MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5
   MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8
   NAMBA M, 1988, ANTICANCER RES, V8, P947
   Namba M, 1981, GANN MONOGR CANCER R, V27, P221
   NORWOOD TH, 1974, P NATL ACAD SCI USA, V71, P2231, DOI 10.1073/pnas.71.6.2231
   NORWOOD TH, 1985, HDB BIOL AGING, P291
   NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372
   ORGEL LE, 1970, P NATL ACAD SCI USA, V67, P1476, DOI 10.1073/pnas.67.3.1476
   ORGEL LE, 1973, NATURE, V243, P441
   PEPPERKOK R, 1988, P NATL ACAD SCI USA, V85, P6748, DOI 10.1073/pnas.85.18.6748
   PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042
   PEREIRASMITH OM, 1985, EXP CELL RES, V160, P297, DOI 10.1016/0014-4827(85)90177-6
   PEREIRASMITH OM, 1989, CRC GROWTH CONTROL C, V8, P123
   Phillips P D, 1990, Annu Rev Gerontol Geriatr, V10, P43
   PHILLIPS PD, 1983, J CELL PHYSIOL, V114, P311, DOI 10.1002/jcp.1041140309
   PHILLIPS PD, 1987, J CELL PHYSIOL, V133, P135, DOI 10.1002/jcp.1041330117
   RABINOVITCH PS, 1980, EXP CELL RES, V130, P101, DOI 10.1016/0014-4827(80)90046-4
   REICH NC, 1990, P NATL ACAD SCI USA, V87, P8761, DOI 10.1073/pnas.87.22.8761
   ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009
   ROWLEY DR, 1987, CANCER RES, V47, P2955
   SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3
   SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528
   SMITH JR, 1980, MECH AGEING DEV, V13, P387, DOI 10.1016/0047-6374(80)90080-9
   SPIERING AL, 1988, EXP CELL RES, V179, P159, DOI 10.1016/0014-4827(88)90355-2
   SPIERING AL, 1991, IN PRESS EXP CELL RE, V195
   STALLCUP KC, 1986, J IMMUNOL, V136, P2723
   STEIN GH, 1986, EXP CELL RES, V162, P255, DOI 10.1016/0014-4827(86)90443-X
   STEIN GH, 1979, EXP CELL RES, V120, P155, DOI 10.1016/0014-4827(79)90546-9
   STEIN GH, 1982, P NATL ACAD SCI-BIOL, V79, P5287, DOI 10.1073/pnas.79.17.5287
   STEIN GH, 1986, P NATL ACAD SCI USA, V83, P9030, DOI 10.1073/pnas.83.23.9030
   VILCEK J, 1991, J BIOL CHEM, V266, P7313
   WEIR ML, 1986, AM J PATHOL, V125, P546
   WELLS V, 1983, J CELL PHYSIOL, V117, P148, DOI 10.1002/jcp.1041170203
   WELLS V, 1991, CELL, V64, P91, DOI 10.1016/0092-8674(91)90211-G
   WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8
   WHITTENBERGER B, 1978, P NATL ACAD SCI USA, V75, P5457, DOI 10.1073/pnas.75.11.5457
   YANISHEVSKY RM, 1980, EXP CELL RES, V126, P469, DOI 10.1016/0014-4827(80)90290-6
   ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739
NR 57
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD MAR-NOV
PY 1991
VL 256
IS 2-6
BP 263
EP 269
DI 10.1016/0921-8734(91)90017-6
PG 7
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA GX496
UT WOS:A1991GX49600017
PM 1722016
DA 2024-02-19
ER

PT J
AU Thomann, S
   Tóth, M
   Sprengel, SD
   Liermann, J
   Schirmacher, P
AF Thomann, Stefan
   Toth, Marcell
   Sprengel, Simon David
   Liermann, Jakob
   Schirmacher, Peter
TI Digital Staging of Hepatic Hemangiomas Reveals Spatial Heterogeneity in
   Endothelial Cell Composition and Vascular Senescence
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article; Early Access
DE continuous endothelial cells; endothelial cell heterogeneity; lymphatic
   endothelial cells; vascular senescence; vascular tumors
ID POSSIBLE ASSOCIATION; LIVER
AB Hepatic hemangioma (HH) is the most common benign primary liver tumor; however, despite its high prevalence, a stage-specific classification of this tumor is currently missing. For a spatial stage-specific classification, a tissue microarray (TMA) consisting of 98 HHs and 80 hemangioma margins and 78 distant liver tissues was digitally analyzed for the expression of 16 functional and vascular niche-specific markers. For cross-correlation of histopathology and functional characteristics, computed tomography/MRI imaging data of 28 patients were analyzed. Functional and morphological analyses revealed a high level of intra- and interpatient heterogeneity, and morphological heterogeneity was observed with regard to cellularity, vascular diameter, and endothelial cell subtype composition. While regressed hemangiomas were characterized by low blood vessel density, low beta-catenin levels, and a microvascular phenotype, non-regressed HHs showed a pronounced cellular and architectural heterogeneity. Functionally, cellular senescence-associated p16 expression identified an HH subgroup with high vascular density and increased lymphatic endothelial cell content. Histological HH regions may be grouped into spatially defined morphological compartments that may reflect the current region-specific disease stage. The stage-specific classification of HHs with signs of regression and vascular senescence may allow a better disease course-based and cell state-based subtyping of these benign vascular lesions.
C1 [Thomann, Stefan; Toth, Marcell; Schirmacher, Peter] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany.
   [Sprengel, Simon David; Liermann, Jakob] Univ Hosp Heidelberg, Dept Radiat Oncol, Heidelberg, Germany.
   [Thomann, Stefan] Univ Wurzburg, Inst Syst Immunol, Wurzburg, Germany.
C3 Ruprecht Karls University Heidelberg; Ruprecht Karls University
   Heidelberg; University of Wurzburg
RP Thomann, S (corresponding author), Heidelberg Univ, Inst Pathol, Neuenheimer Feld 224, D-69120 Heidelberg, Germany.
EM stefan.thomann@med.uni-heidelberg.de
OI Thomann, Stefan/0000-0002-3500-0014; Toth, Marcell/0000-0002-6946-8192
CR Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Aydin O, 2021, EUR J GASTROEN HEPAT, V33, P1436, DOI 10.1097/MEG.0000000000002069
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346
   Birdsey GM, 2015, DEV CELL, V32, P82, DOI 10.1016/j.devcel.2014.11.016
   CHOI BI, 1989, AM J ROENTGENOL, V152, P1221, DOI 10.2214/ajr.152.6.1221
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008
   FARGES O, 1995, WORLD J SURG, V19, P19, DOI 10.1007/BF00316974
   Furumaya A, 2019, CARDIOVASC INTER RAD, V42, P800, DOI 10.1007/s00270-019-02169-x
   Glinkova V, 2004, GUT, V53, P1352, DOI 10.1136/gut.2003.038646
   Gracia-Sancho J, 2021, NAT REV GASTRO HEPAT, V18, P411, DOI 10.1038/s41575-020-00411-3
   Isik FF, 1996, J SURG RES, V61, P71, DOI 10.1006/jsre.1996.0083
   Janardhan HP, 2020, J EXP MED, V217, DOI 10.1084/jem.20192205
   Klotz T, 2013, Diagn Interv Imaging, V94, P849, DOI 10.1016/j.diii.2013.04.008
   Léauté-Labrèze C, 2017, LANCET, V390, P85, DOI 10.1016/S0140-6736(16)00645-0
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Mahajan D, 2008, J HEPATOL, V49, P867, DOI 10.1016/j.jhep.2008.06.028
   Mamone G, 2019, ABDOM RADIOL, V44, P2327, DOI 10.1007/s00261-019-01964-x
   Mocchegiani F, 2016, DIGEST LIVER DIS, V48, P309, DOI 10.1016/j.dld.2015.09.016
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Ritter Matthew R, 2003, Lymphat Res Biol, V1, P291, DOI 10.1089/153968503322758094
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Shah AV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16002
   Sheppard KE, 2013, CLIN CANCER RES, V19, P5320, DOI 10.1158/1078-0432.CCR-13-0259
   TAKAHASHI K, 1994, J CLIN INVEST, V93, P2357, DOI 10.1172/JCI117241
   Testini C, 2020, EMBO REP, V21, DOI 10.15252/embr.202050409
   Thomann S, 2021, LIVER INT, V41, P3011, DOI 10.1111/liv.15048
   Thomann S, 2020, CANCER RES, V80, P5502, DOI 10.1158/0008-5472.CAN-20-0242
   Thomann S, 2015, ONCOTARGET, V6, P39960, DOI 10.18632/oncotarget.5662
   Toro A, 2014, ANN HEPATOL, V13, P327, DOI 10.1016/S1665-2681(19)30839-7
   Vilgrain V, 2000, RADIOGRAPHICS, V20, P379, DOI 10.1148/radiographics.20.2.g00mc01379
   Wang ZJ, 2012, J CLIN PATHOL, V65, P146, DOI 10.1136/jclinpath-2011-200365
   Wu KQ, 2017, AM J PATHOL, V187, P2102, DOI 10.1016/j.ajpath.2017.05.014
NR 35
TC 2
Z9 2
U1 1
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0022-1554
EI 1551-5044
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD 2022 JUL
PY 2022
VL 70
IS 7
BP 531
EP 541
DI 10.1369/00221554221112701
EA JUL 2022
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 3A0ML
UT WOS:000822451600001
PM 35815421
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Hsu, YW
   Chen, WK
   Tsai, CF
AF Hsu, Yu-Wen
   Chen, Wen-Kang
   Tsai, Chia-Fang
TI Senescence-Mediated Redox Imbalance in Liver and Kidney: Antioxidant
   Rejuvenating Potential of Green Tea Extract
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE aging; antioxidant enzyme; catechins; green tea; oxidative stress
ID OXIDATIVE STRESS; CAMELLIA-SINENSIS; RATS; POLYPHENOLS; TOXICITY;
   GALLATE; PLASMA; CANCER; HEPATOTOXICITY; METABOLISM
AB This study investigates the catechin composition and protective effect of green tea extract on senescence-mediated redox imbalance in the livers and kidneys of aged mice. The results showed that the seven catechins in the green tea extract analyzed in this study could be completely separated within 30 min and the main components of catechins in green tea extract were EGCG, EGC and ECG. In terms of the anti-senescence effects of green tea extract, green tea extract supplementation at doses of 125, 625 and 1250 mg/kg for 4 weeks significantly alleviated the senescence-mediated redox imbalance, as exhibited from significantly (p < 0.05) reduced thiobarbituric acid-reactive substances (TBARS) and protein carbonyls levels in the serum, and increased glutathione (GSH) and total thiols contents in the plasma. Additionally, hepatic and renal protein carbonyls levels were significantly diminished (p < 0.05) and the activities of superoxide dismutase (SOD), catalase, glucose-6-phosphate dehydrogenase (G6PD), glutathione peroxidase (GSH-Px) and glutathione reductase (GSH-Rd) in the liver and kidney were remarkably elevated (p < 0.05). Overall, these results clearly show that green tea extract exhibits extremely potent protective effects against senescence-mediated redox imbalance in the livers and kidneys of mice by inhibiting oxidative damage of lipids and proteins and increasing the activities of antioxidant enzymes in organs.
C1 [Hsu, Yu-Wen] Dayeh Univ, Dept Optometry, Changhua 515006, Taiwan.
   [Chen, Wen-Kang; Tsai, Chia-Fang] Natl Tainan Jr Coll Nursing, Dept Appl Cosmetol, Tainan 700007, Taiwan.
RP Tsai, CF (corresponding author), Natl Tainan Jr Coll Nursing, Dept Appl Cosmetol, Tainan 700007, Taiwan.
EM yuwen@mail.dyu.edu.tw; yayen0619@gmail.com; tsaicf@ntin.edu.tw
RI Zhou, heng/JCN-6493-2023
CR Rojo MA, 2020, TOXINS, V12, DOI 10.3390/toxins12090542
   Assunçao M, 2010, FREE RADICAL BIO MED, V48, P831, DOI 10.1016/j.freeradbiomed.2010.01.003
   Boehm K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005004.pub2
   Dobrzynska L, 2005, CHEM-BIOL INTERACT, V156, P41, DOI 10.1016/j.cbi.2005.07.002
   Dufresne C, 2000, FOOD RES INT, V33, P409, DOI 10.1016/S0963-9969(00)00067-3
   Forester SC., 2011, Mol Nutr Food Res, V55, P844, DOI DOI 10.1002/MNFR.201000641
   Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173
   Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014
   Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hofer T, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081159
   Hong JT, 2000, BRAIN RES BULL, V53, P743, DOI 10.1016/S0361-9230(00)00348-8
   Hsu YW, 2014, J FUNCT FOODS, V7, P471, DOI 10.1016/j.jff.2014.01.009
   Hsu YW, 2011, FOOD CHEM TOXICOL, V49, P2624, DOI 10.1016/j.fct.2011.07.007
   Hsu YW, 2009, FOOD CHEM TOXICOL, V47, P2281, DOI 10.1016/j.fct.2009.06.015
   Jian L, 2004, INT J CANCER, V108, P130, DOI 10.1002/ijc.11550
   Jimenez P., 2014, Food and Nutrition Sciences, V5, P466, DOI 10.4236/fns.2014.55055
   Khan SA, 2007, NUTRITION, V23, P687, DOI 10.1016/j.nut.2007.06.007
   Kohri T, 2001, J AGR FOOD CHEM, V49, P4102, DOI 10.1021/jf001491+
   KOIZUMI M, 1992, CHEM PHARM BULL, V40, P1864
   Kumaran VS, 2008, EXP GERONTOL, V43, P176, DOI 10.1016/j.exger.2007.10.017
   Kumaran VS, 2009, NUTRITION, V25, P847, DOI 10.1016/j.nut.2009.02.005
   Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030
   LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393
   Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024
   Li ZY, 2006, CLIN CHIM ACTA, V366, P209, DOI 10.1016/j.cca.2005.10.011
   Mahesh R, 2009, CELL BIOCHEM FUNCT, V27, P358, DOI 10.1002/cbf.1581
   Miquel J, 2006, ARCH GERONTOL GERIAT, V42, P289, DOI 10.1016/j.archger.2005.08.005
   Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X
   NOBERASCO G, 1991, BIOMED PHARMACOTHER, V45, P193, DOI 10.1016/0753-3322(91)90107-5
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   Schmidt M, 2005, FOOD CHEM TOXICOL, V43, P307, DOI 10.1016/j.fct.2004.11.001
   Skrzydlewska E, 2002, PHYTOMEDICINE, V9, P232, DOI 10.1078/0944-7113-00119
   Sperker B, 1997, CLIN PHARMACOKINET, V33, P18, DOI 10.2165/00003088-199733010-00003
   Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771
   Sun K, 2013, FOOD CHEM TOXICOL, V52, P36, DOI 10.1016/j.fct.2012.10.038
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Tsai CF, 2013, FOOD CHEM, V136, P1337, DOI 10.1016/j.foodchem.2012.09.063
   Vitaglione P, 2004, CRIT REV FOOD SCI, V44, P575, DOI 10.1080/10408690490911701
   Wang HF, 2003, FOOD CHEM, V81, P307, DOI 10.1016/S0308-8146(02)00510-1
   Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489
   WINTER J, 1989, APPL ENVIRON MICROB, V55, P1203, DOI 10.1128/AEM.55.5.1203-1208.1989
   Wu J, 1999, Expert Opin Investig Drugs, V8, P585, DOI 10.1517/13543784.8.5.585
   Yokozawa T, 1996, BIOSCI BIOTECH BIOCH, V60, P1000, DOI 10.1271/bbb.60.1000
NR 44
TC 6
Z9 6
U1 3
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JAN
PY 2022
VL 19
IS 1
AR 260
DI 10.3390/ijerph19010260
PG 15
WC Environmental Sciences; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA YS9ZO
UT WOS:000751029900001
PM 35010518
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Huang, YH
   Chen, MH
   Guo, QL
   Chen, YX
   Zhang, LJ
   Chen, ZX
   Wang, XZ
AF Huang, Yue-Hong
   Chen, Ming-Hua
   Guo, Qi-Lan
   Chen, Yun-Xin
   Zhang, Li-Juan
   Chen, Zhi-Xin
   Wang, Xiao-Zhong
TI Interleukin-10 promotes primary rat hepatic stellate cell senescence by
   upregulating the expression levels of p53 and p21
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE interleukin-10; hepatic stellate cells; senescence; p53; p21; cytokine
ID INDUCED LIVER FIBROSIS; ACTIVATION; MECHANISMS; REGRESSION; CULTURE;
   NETWORK
AB Liver fibrosis is characterized by the excessive deposition of extracellular matrix (ECM) components, and activated hepatic stellate cells (HSCs) are a primary source of ECM. Several studies have revealed that the induction of HSC senescence may reduce liver fibrosis. The effect of interleukin-10 (IL-10) on the senescence of activated HSCs is not fully understood. Therefore, the present study examined its effects and potential mechanisms in activated primary rat HSCs. Collagenase perfusion and density gradient centrifugation methods were used to isolate rat HSCs. HSCs were identified by autofluorescence, Oil Red O staining and immunocytochemical analysis. Activated HSCs were treated with 0, 10, 20 or 40 ng/ml IL-10 for 24 h. Senescence-associated -galactosidase (SA--Gal) staining, flow cytometry analysis and a cell counting kit-8 assay were performed to detect the senescence, apoptosis and viability of rat HSCs, respectively. Reverse transcription-quantitative polymerase chain reaction, western blot analysis and enzyme linked immunosorbent assays were used to detect the expression of senescence-associated proteins and cytokines. Freshly isolated rat HSCs exhibited a striking blue-green autofluorescence and HSC retinoid droplets were stained bright red by Oil Red O. Immunocytochemical analysis demonstrated the cytoplasmic expression of HSC markers desmin and -smooth muscle actin. The number of SA--Gal positive HSCs, the apoptotic rate and the expression levels of p53, p21 and tumor necrosis factor- were significantly increased following IL-10 treatment. HSC viability and IL-6 and IL-8 expression levels were significantly decreased compared with the control group. In summary, primary rat HSCs were successfully isolated and IL-10 was demonstrated to promote the senescence of activated primary rat HSCs through the upregulation of p53 and p21 expression.
C1 [Huang, Yue-Hong; Chen, Ming-Hua; Guo, Qi-Lan; Chen, Yun-Xin; Zhang, Li-Juan; Chen, Zhi-Xin; Wang, Xiao-Zhong] Fujian Med Univ Union Hosp, Dept Gastroenterol, 29 Xingquan Rd, Fuzhou 350001, Fujian, Peoples R China.
   [Huang, Yue-Hong] Fujian Med Univ Union Hosp, Dept Geriatr, Fuzhou 350001, Fujian, Peoples R China.
RP Wang, XZ (corresponding author), Fujian Med Univ Union Hosp, Dept Gastroenterol, 29 Xingquan Rd, Fuzhou 350001, Fujian, Peoples R China.
EM drwangxz@sina.com
RI Chen, Ming/GVU-8412-2022
OI HUANG, Yue-Hong/0000-0001-7134-719X
FU National Natural Science Foundation of China [81600486]; Fujian Province
   Nature Scientific Foundation of China [2016J01462]; Key Clinical
   Specialty Discipline Construction Program of Fujian and Nation, P.R.
   China
FX The present study was supported by the National Natural Science
   Foundation of China (grant no. 81600486), the Fujian Province Nature
   Scientific Foundation of China (grant no. 2016J01462) and the Key
   Clinical Specialty Discipline Construction Program of Fujian and Nation,
   P.R. China.
CR Ahsan MK, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00069
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Chang WJ, 2014, ACTA BIOCH BIOPH SIN, V46, P291, DOI 10.1093/abbs/gmt143
   Chen JL, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.228
   He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232
   Huang YH, 2014, INT J MOL MED, V34, P677, DOI 10.3892/ijmm.2014.1831
   Hung KS, 2005, BIOCHEM BIOPH RES CO, V336, P324, DOI 10.1016/j.bbrc.2005.08.085
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kojima H, 2014, JAK STAT, V2
   Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Li P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42938
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Ramachandran P, 2015, SEMIN LIVER DIS, V35, P119, DOI 10.1055/s-0035-1550057
   Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245
   Shi MN, 2006, WORLD J GASTROENTERO, V12, P2357, DOI 10.3748/wjg.v12.i15.2357
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Huang YH, 2006, WORLD J GASTROENTERO, V12, P1386, DOI 10.3748/wjg.v12.i9.1386
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
NR 25
TC 24
Z9 28
U1 2
U2 12
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD APR
PY 2018
VL 17
IS 4
BP 5700
EP 5707
DI 10.3892/mmr.2018.8592
PG 8
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA GA9PA
UT WOS:000428672100107
PM 29436649
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU MULLERHOCKER, J
AF MULLERHOCKER, J
TI MITOCHONDRIA AND AGING
SO BRAIN PATHOLOGY
LA English
DT Article
ID LIVER SUPEROXIDE-DISMUTASE; INNER MEMBRANE-PROTEINS; HUMAN
   SKELETAL-MUSCLE; PARKINSONS-DISEASE; RAT-LIVER; ULTRASTRUCTURAL-CHANGES;
   DEPENDENT CHANGES; OXIDASE ACTIVITY; CHAIN FUNCTION; NUCLEAR-DNA
AB This work reviews the role of mitochondria in the ageing process and summarizes pathomorphological biochemical and molecular genetic data. The pathophysiological mechanisms underlying the phenomenon of ageing are only partly understood. There is, however, increasing evidence that mitochondria are essentially involved. In various tissues of various species a decline in the respiratory chain capacity is seen with ageing. Enzyme histochemistry of cytochrome c oxidase (complex IV of the respiratory chain) has revealed an age-related increase of randomly distributed defective fibres/cells in the skeletal and heart muscle the random pattern probably indicating cellular heterogeneity of the ageing process. Observed deletions of mitochondrial DNA during ageing may represent one causative factor. Similar to primary mitochondrial myopathies point mutations and depletion of the mtDNA are probably also involved. There is some evidence that damage of the mitochondrial genome and of other mitochondrial structures might be due to increased oxygen radical production during ageing. The role of nuclear influences on the degeneration of mitochondrial function remains, however, also to be determined. Nevertheless, the decline of respiratory chain function with ageing represents an important factor for the decline of functional organ reserve capacity in senescence.
RP MULLERHOCKER, J (corresponding author), UNIV MUNICH, INST PATHOL, W-8000 MUNICH 2, GERMANY.
CR AKERSTROM G, 1986, HUM PATHOL, V17, P520, DOI 10.1016/S0046-8177(86)80043-0
   ANGQUIST KA, 1980, ULTRASTRUCT PATHOL, V1, P461
   BERTONIFREDDARI C, 1991, ARCH GERONTOL GERIAT, V12, P253, DOI 10.1016/0167-4943(91)90032-L
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   BURCH GE, 1970, ARCH PATHOL, V89, P128
   BYRNE E, 1991, MECH AGEING DEV, V60, P295, DOI 10.1016/0047-6374(91)90042-X
   CANO J, 1983, CARDIOLOGY AGEING, P25
   CARDELLACH F, 1989, LANCET, V2, P44
   CHEN JC, 1972, J CELL PHYSIOL, V80, P141, DOI 10.1002/jcp.1040800115
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   COLEMAN R, 1988, ACTA HISTOCHEM, V83, P81, DOI 10.1016/S0065-1281(88)80075-8
   CORBISIER P, 1990, EUR J CELL BIOL, V51, P173
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   CURTI D, 1990, MECH AGEING DEV, V55, P171, DOI 10.1016/0047-6374(90)90024-A
   DE AK, 1991, MECH AGEING DEV, V59, P123, DOI 10.1016/0047-6374(91)90078-E
   FELDMAN ML, 1981, J ANAT, V133, P7
   FERNANDEZSILVA P, 1991, BIOCHEM BIOPH RES CO, V176, P645, DOI 10.1016/S0006-291X(05)80233-5
   FLANNERY GR, 1989, ANN HUM BIOL, V16, P259, DOI 10.1080/03014468900000372
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   FRENZEL H, 1985, Z KARDIOL, V74, P17
   FRENZEL H, 1984, MECH AGEING DEV, V27, P29, DOI 10.1016/0047-6374(84)90080-0
   FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304
   FUKUNAGA M, 1979, BIOCHEM BIOPH RES CO, V90, P582, DOI 10.1016/0006-291X(79)91275-0
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GOREN P, 1977, FEBS LETT, V84, P83, DOI 10.1016/0014-5793(77)81062-4
   GORINI A, 1989, BASIC APPL HISTOCHEM, V33, P139
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   HAMMERSEN F, 1980, ACTA NEUROPATHOL, V49, P35, DOI 10.1007/BF00692217
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5
   HARE JF, 1982, J BIOL CHEM, V257, P3575
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   HRUSZKEWYCZ AM, 1988, BIOCHEM BIOPH RES CO, V153, P191, DOI 10.1016/S0006-291X(88)81207-5
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   JENNEKENS FG, 1971, J NEUROL SCI, V14, P259, DOI 10.1016/0022-510X(71)90216-4
   JENNEKENS FGI, 1981, MITOCHONDRIA MUSCULA, P19
   KADENBACH B, 1990, NATURWISSENSCHAFTEN, V77, P221, DOI 10.1007/BF01138485
   KIESSLING KH, 1973, CLIN SCI, V44, P547, DOI 10.1042/cs0440547
   KOLL F, 1986, NATURE, V324, P597, DOI 10.1038/324597a0
   KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608
   LAUBER J, 1991, NUCLEIC ACIDS RES, V19, P1393, DOI 10.1093/nar/19.7.1393
   LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LITOSHENKO AY, 1981, EXP GERONTOL, V16, P213, DOI 10.1016/0531-5565(81)90015-2
   MACHADO A, 1991, ARCH GERONTOL GERIAT, V12, P187, DOI 10.1016/0167-4943(91)90027-N
   MARCUS DL, 1982, EXP GERONTOL, V17, P333, DOI 10.1016/0531-5565(82)90033-X
   MASSIE HR, 1981, AGE, V4, P42, DOI 10.1007/BF02431982
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1991, IN PRESS PATHOL RES
   MURFITT RR, 1978, MECH AGEING DEV, V8, P197, DOI 10.1016/0047-6374(78)90018-0
   MUSCARI C, 1990, BIOCHIM BIOPHYS ACTA, V1015, P200, DOI 10.1016/0005-2728(90)90021-U
   MYERS KA, 1988, CARCINOGENESIS, V9, P285, DOI 10.1093/carcin/9.2.285
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   NOHL H, 1979, Z GERONTOL, V12, P9
   NOHL H, 1980, MECH AGEING DEV, V14, P137, DOI 10.1016/0047-6374(80)90112-8
   NOHL H, 1986, MODERN AGING RES, V8, P77
   Nohl H., 1982, ADV STUDIES HEART ME, P413
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   POGGI P, 1987, ANAT RECORD, V217, P30, DOI 10.1002/ar.1092170106
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROTHSTEIN M, 1977, MECH AGEING DEV, V6, P241, DOI 10.1016/0047-6374(77)90025-2
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   SHAY JW, 1990, MECHANISMS DIFFERENT, V1, P135
   SHEARMAN CW, 1977, ARCH BIOCHEM BIOPHYS, V182, P573, DOI 10.1016/0003-9861(77)90539-2
   SHIMA A, 1975, EXP GERONTOL, V10, P171, DOI 10.1016/0531-5565(75)90028-5
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   TOMONAGA M, 1977, J AM GERIATR SOC, V25, P125, DOI 10.1111/j.1532-5415.1977.tb00274.x
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   WILSON PD, 1973, GERONTOLOGY, V19, P79, DOI 10.1159/000211964
   WRIGHT RM, 1983, NATURE, V302, P86, DOI 10.1038/302086a0
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 90
TC 89
Z9 91
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1015-6305
EI 1750-3639
J9 BRAIN PATHOL
JI Brain Pathol.
PD APR
PY 1992
VL 2
IS 2
BP 149
EP 158
DI 10.1111/j.1750-3639.1992.tb00683.x
PG 10
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA HK664
UT WOS:A1992HK66400007
PM 1341956
DA 2024-02-19
ER

PT J
AU Wang, YM
   Xiong, YL
   Zhang, AP
   Zhao, NN
   Zhang, JS
   Zhao, DM
   Yu, ZH
   Xu, N
   Yin, YC
   Luan, XY
   Xiong, YL
AF Wang, Yueming
   Xiong, Yanlei
   Zhang, Aiping
   Zhao, Nannan
   Zhang, Jiashen
   Zhao, Dongmei
   Yu, Zhenhai
   Xu, Ning
   Yin, Yancun
   Luan, Xiying
   Xiong, Yanlian
TI Oligosaccharide attenuates aging-related liver dysfunction by activating
   Nrf2 antioxidant signaling
SO FOOD SCIENCE & NUTRITION
LA English
DT Article; Early Access
DE anti-aging; chitosan oligosaccharide; D-galactose; liver; Nrf2 pathway
ID D-GALACTOSE; CHITOSAN OLIGOSACCHARIDE; EXPRESSION; ENHANCE; PATHWAY
AB Chitosan oligosaccharide (COS) is the depolymerized product of chitosan possessing various biological activities and protective effects against inflammation and oxidative injury. The aim of the present study was to investigate the antioxidant effects of COS supplements on aging-related liver dysfunction. We found that COS treatment significantly attenuated elevated liver function biomarkers and oxidative stress biomarkers and decreased antioxidative enzyme activities in liver tissues in D-galactose (D-gal)-treated mice. Furthermore, COS treatment significantly upregulated the expression of Nrf2 and its downstream target genes HO-1, NQO1, and CAT. Moreover, in vitro experiments showed that COS treatment played a vital role in protecting H2O2-exposed L02 cells against oxidative stress by activating Nrf2 antioxidant signaling. These data indicate that COS could protect against D-gal-induced hepatic aging by activating Nrf2 antioxidant signaling, which may provide novel applications for the prevention and treatment of aging-related hepatic dysfunction.
C1 [Wang, Yueming; Zhang, Jiashen; Zhao, Dongmei; Yu, Zhenhai; Xu, Ning; Yin, Yancun; Xiong, Yanlian] Binzhou Med Univ, Sch Basic Med, Dept Anat, Yantai 264003, Shandong, Peoples R China.
   [Xiong, Yanlei] Capital Med Univ, Xuanwu Hosp, Dept Pathol, Beijing, Peoples R China.
   [Zhang, Aiping; Zhao, Nannan; Luan, Xiying] Binzhou Med Univ, Sch Basic Med, Dept Immunol, Yantai 264003, Shandong, Peoples R China.
C3 Binzhou Medical University; Capital Medical University; Binzhou Medical
   University
RP Xiong, YL (corresponding author), Binzhou Med Univ, Sch Basic Med, Dept Anat, Yantai 264003, Shandong, Peoples R China.; Luan, XY (corresponding author), Binzhou Med Univ, Sch Basic Med, Dept Immunol, Yantai 264003, Shandong, Peoples R China.
EM xiying_luan@163.com; xyl8807@sina.com
OI Xiong, Yanlian/0000-0001-5178-8932; Xiong, Yanlei/0000-0001-8555-494X;
   Wang, Yueming/0000-0003-1375-8737
FU Shandong Provincial Natural Science Foundation [ZR2018QH002]; Shandong
   Medical and Health Science and Technology Development Plan [2017WS042,
   2016WS062]; Key R&D Program of Shandong Province [2019GSF107069];
   Introduction Cultivation Project for Young Creative Talents of Higher
   Education of Shandong Province
FX Shandong Provincial Natural Science Foundation, Grant/Award Number:
   ZR2018QH002; Shandong Medical and Health Science and Technology
   Development Plan, Grant/Award Number: 2017WS042 and 2016WS062; Key R&D
   Program of Shandong Province, Grant/Award Number: 2019GSF107069;
   Introduction Cultivation Project for Young Creative Talents of Higher
   Education of Shandong Province: to Yancun Yin
CR Ahmed SMU, 2017, BBA-MOL BASIS DIS, V1863, P585, DOI 10.1016/j.bbadis.2016.11.005
   Ambrozewicz E, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100159
   Azuma K, 2015, J FUNCT BIOMATER, V6, P33, DOI 10.3390/jfb6010033
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Boland BS, 2014, J CLIN EXP HEPATOL, V4, P1, DOI 10.1016/j.jceh.2014.01.003
   Bruns DR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732596
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Han YQ, 2019, INT J BIOL MACROMOL, V131, P769, DOI 10.1016/j.ijbiomac.2019.03.033
   Hollenbach M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112466
   Huang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/275431
   Hyung JH, 2016, EUR J PHARMACOL, V793, P43, DOI 10.1016/j.ejphar.2016.11.002
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003
   Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200
   Liu J, 2019, FOOD SCI NUTR, V7, P969, DOI 10.1002/fsn3.907
   Lodovici M, 2007, FREE RADICAL BIO MED, V43, P415, DOI 10.1016/j.freeradbiomed.2007.04.018
   Luceri C, 2018, TOXICOL REP, V5, P141, DOI 10.1016/j.toxrep.2017.12.017
   Mizoue T, 2007, CANCER SCI, V98, P1254, DOI 10.1111/j.1349-7006.2007.00511.x
   Morroni F, 2018, AGING DIS, V9, P605, DOI 10.14336/AD.2017.0903
   Muanprasat C, 2017, PHARMACOL THERAPEUT, V170, P80, DOI 10.1016/j.pharmthera.2016.10.013
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Vasconcelos AR, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00033
   Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014
   Xiao MH, 2018, EXP THER MED, V16, P4100, DOI 10.3892/etm.2018.6727
   Xiong YL, 2017, REJUV RES, V20, P85, DOI 10.1089/rej.2016.1835
   Xiong YL, 2016, CELL PHYSIOL BIOCHEM, V40, P1410, DOI 10.1159/000453193
   Xu MC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8549035
   Yang JCZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040872
   Zhang XQ, 2019, FOOD SCI NUTR, V7, P3403, DOI 10.1002/fsn3.1154
   Zhang YT, 2019, CHEM-BIOL INTERACT, V305, P54, DOI 10.1016/j.cbi.2019.03.027
   Zhu K, 2019, FOOD SCI NUTR, V7, P4105, DOI 10.1002/fsn3.1278
NR 33
TC 23
Z9 25
U1 6
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD 2020 JUL
PY 2020
VL 8
IS 7
BP 3872
EP 3881
DI 10.1002/fsn3.1681
EA JUN 2020
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA MP3LO
UT WOS:000537896900001
PM 32724648
OA Green Published
DA 2024-02-19
ER

PT J
AU Le Couteur, DG
   Tay, SS
   Solon-Biet, S
   Bertolino, P
   McMahon, AC
   Cogger, VC
   Colakoglu, F
   Warren, A
   Holmes, AJ
   Pichaud, N
   Horan, M
   Correa, C
   Melvin, RG
   Turner, N
   Ballard, JWO
   Ruohonen, K
   Raubenheimer, D
   Simpson, SJ
AF Le Couteur, David G.
   Tay, Szun S.
   Solon-Biet, Samantha
   Bertolino, Patrick
   McMahon, Aisling C.
   Cogger, Victoria C.
   Colakoglu, Feyza
   Warren, Alessandra
   Holmes, Andrew J.
   Pichaud, Nicolas
   Horan, Martin
   Correa, Carolina
   Melvin, Richard G.
   Turner, Nigel
   Ballard, J. William O.
   Ruohonen, Kari
   Raubenheimer, David
   Simpson, Stephen J.
TI The Influence of Macronutrients on Splanchnic and Hepatic Lymphocytes in
   Aging Mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Liver; Lymphocytes; Macronutrients
ID REGULATORY T-CELLS; GENETICALLY HETEROGENEOUS MICE; LIFE-SPAN; CALORIC
   RESTRICTION; DIETARY RESTRICTION; OXIDATIVE STRESS; IMMUNOLOGICAL
   FUNCTION; PROTEIN-LEVERAGE; FOOD RESTRICTION; IMMUNE FUNCTIONS
AB There is a strong association between aging, diet, and immunity. The effects of macronutrients and energy intake on splanchnic and hepatic lymphocytes were studied in 15 month old mice. The mice were ad-libitum fed 1 of 25 diets varying in the ratios and amounts of protein, carbohydrate, and fat over their lifetime. Lymphocytes in liver, spleen, Peyers patches, mesenteric lymph nodes, and inguinal lymph nodes were evaluated using flow cytometry. Low protein intake reversed aging changes in splenic CD4 and CD8 T cells, CD4: CD8 T cell ratio, memory/effector CD4 T cells and naive CD4 T cells. A similar influence of total caloric intake in these ad-libitum fed mice was not apparent. Protein intake also influenced hepatic NK cells and B cells, while protein to carbohydrate ratio influenced hepatic NKT cells. Hepatosteatosis was associated with increased energy and fat intake and changes in hepatic Tregs, effector/memory T, and NK cells. Hepatic NK cells were also associated with body fat, glucose tolerance, and leptin levels while hepatic Tregs were associated with hydrogen peroxide production by hepatic mitochondria. Dietary macronutrients, particularly protein, influence splanchnic lymphocytes in old age, with downstream associations with mitochondrial function, liver pathology, and obesity-related phenotype.
C1 [Le Couteur, David G.; Solon-Biet, Samantha; McMahon, Aisling C.; Cogger, Victoria C.; Colakoglu, Feyza; Warren, Alessandra; Holmes, Andrew J.; Raubenheimer, David; Simpson, Stephen J.] Concord Hosp, Charles Perkins Ctr, Sydney, NSW 2139, Australia.
   [Le Couteur, David G.; Solon-Biet, Samantha; McMahon, Aisling C.; Cogger, Victoria C.; Warren, Alessandra] Concord Hosp, Ageing & Alzheimers Inst, Sydney, NSW 2139, Australia.
   [Le Couteur, David G.; Solon-Biet, Samantha; McMahon, Aisling C.; Cogger, Victoria C.; Warren, Alessandra] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
   [Le Couteur, David G.; Solon-Biet, Samantha; McMahon, Aisling C.; Cogger, Victoria C.; Warren, Alessandra] Univ Sydney, ANZAC Res Inst, Concord Hosp, Sydney, NSW 2006, Australia.
   [Tay, Szun S.; Bertolino, Patrick] Royal Prince Alfred Hosp, Centenary Inst, Liver Immunol Grp, Sydney, NSW, Australia.
   [Tay, Szun S.; Bertolino, Patrick] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia.
   [Tay, Szun S.; Bertolino, Patrick] Univ Sydney, Sydney, NSW 2006, Australia.
   [Pichaud, Nicolas; Horan, Martin; Correa, Carolina] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
   [Melvin, Richard G.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland.
   [Turner, Nigel] Univ New S Wales, Sydney, NSW, Australia.
   [Ruohonen, Kari] EWOS Innovat, Dirdal, Norway.
   [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.
   [Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; Concord
   Repatriation General Hospital; Concord Repatriation General Hospital;
   Concord Repatriation General Hospital; University of Sydney; ANZAC
   Research Institute; NSW Health; Royal Prince Alfred Hospital; University
   of Sydney; Centenary Institute; University of Sydney; NSW Health; Royal
   Prince Alfred Hospital; University of Sydney; University of New South
   Wales Sydney; University of Helsinki; University of New South Wales
   Sydney; University of Sydney; University of Sydney
RP Le Couteur, DG (corresponding author), Concord Hosp, AAAI, Sydney, NSW 2139, Australia.
EM david.lecouteur@sydney.edu.au
RI Holmes, Andrew/AAI-2845-2020; Research Institute, ANZAC/CAE-9030-2022;
   Bertolino, Patrick/JQI-3345-2023; Melvin, Richard George/AGH-4179-2022;
   Turner, Nigel/H-7176-2013; Ballard, John William O./ABB-2743-2020;
   Solon-Biet, Samantha/R-6551-2017
OI Bertolino, Patrick/0000-0001-8244-7057; Melvin, Richard
   George/0000-0001-6428-6763; Turner, Nigel/0000-0002-0119-9328; Ballard,
   John William O./0000-0002-2358-6003; Solon-Biet,
   Samantha/0000-0003-0608-958X; Tay, Szun S/0000-0003-0186-8154; Le
   Couteur, David/0000-0002-4227-5817; Simpson, Stephen
   J./0000-0003-0256-7687; Raubenheimer, David/0000-0001-9050-1447;
   Pichaud, Nicolas/0000-0002-2820-8124
FU National Health and Medical Research Council (NHMRC) of Australia
   [571328, 571408]; Ageing and Alzheimers Institute (AAAI); Ageing and
   Alzheimers Research Foundation (AARF) of the Concord Hospital; NHMRC
   Senior Research Fellowship [511903]
FX This work was supported by the National Health and Medical Research
   Council (NHMRC) of Australia (Project grant 571328, Program grant
   571408), and the Ageing and Alzheimers Institute (AAAI) and the Ageing
   and Alzheimers Research Foundation (AARF) of the Concord Hospital. P.B.
   was supported by an NHMRC Senior Research Fellowship (511903).
CR Avula CPR, 1999, FEBS LETT, V458, P231, DOI 10.1016/S0014-5793(99)01163-1
   Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x
   CALLAHAN JE, 1993, J IMMUNOL, V151, P6657
   Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13
   Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6
   Fanson BG, 2009, AGING CELL, V8, P514, DOI 10.1111/j.1474-9726.2009.00497.x
   FERNANDES G, 1978, P NATL ACAD SCI USA, V75, P1500, DOI 10.1073/pnas.75.3.1500
   FERNANDES G, 1984, Pharmacological Reviews, V36, p123S
   Fernandes G, 1997, J CLIN IMMUNOL, V17, P85, DOI 10.1023/A:1027344730553
   FERNANDES G, 1976, J IMMUNOL, V116, P782
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franko A, 2014, J HEPATOL, V60, P816, DOI 10.1016/j.jhep.2013.11.020
   Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]
   GROSSMANN A, 1990, CELL IMMUNOL, V131, P191, DOI 10.1016/0008-8749(90)90246-N
   Harper JM, 2004, MECH AGEING DEV, V125, P381, DOI 10.1016/j.mad.2004.03.003
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Le Couteur DG, 2014, J GERONTOL A-BIOL, V69, P1, DOI 10.1093/gerona/glt130
   Le Couteur DG, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P191, DOI 10.1007/978-90-481-8556-6_11
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105
   Lustig A, 2009, INT J MED SCI, V6, P51
   Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823
   Miller RA, 1997, FASEB J, V11, P775, DOI 10.1096/fasebj.11.10.9271362
   Miller RA, 2001, J GERONTOL A-BIOL, V56, pB180, DOI 10.1093/gerona/56.4.B180
   Mougiakakos D, 2011, BLOOD, V117, P857, DOI 10.1182/blood-2010-09-307041
   Mougiakakos D, 2009, BLOOD, V113, P3542, DOI 10.1182/blood-2008-09-181040
   Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013
   Simpson S.J., 2012, NATURE NUTR UNIFYING
   Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x
   Simpson SJ, 2007, J GERONTOL A-BIOL, V62, P707, DOI 10.1093/gerona/62.7.707
   Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Sun DX, 2004, CELL IMMUNOL, V228, P54, DOI 10.1016/j.cellimm.2004.04.001
   Troyer DA, 1998, AGE, V21, P175, DOI 10.1007/s11357-998-0026-4
   WALFORD RL, 1973, MECH AGEING DEV, V2, P447, DOI 10.1016/0047-6374(73)90035-3
   Wang L, 2010, BIOMED ENVIRON SCI, V23, P327, DOI 10.1016/S0895-3988(10)60072-4
   WEINDRUCH RH, 1979, FED PROC, V38, P2007
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
NR 42
TC 27
Z9 28
U1 0
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD DEC
PY 2015
VL 70
IS 12
BP 1499
EP 1507
DI 10.1093/gerona/glu196
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA DB2UB
UT WOS:000368364100006
PM 25335766
OA Bronze
DA 2024-02-19
ER

PT J
AU Chu, XG
   Wen, J
   Raju, RP
AF Chu, Xiaogang
   Wen, Jin
   Raju, Raghavan Pillai
TI Rapid senescence-like response after acute injury
SO AGING CELL
LA English
DT Article; Early Access
DE acute senescence; aging; cell cycle; senescence-associated secretory
   phenotype
ID CELLULAR SENESCENCE; CELLS
AB Cellular senescence is a state of irreversible growth arrest. Short-term programmed senescence such as in embryonic development and slowly progressing senescence as in aging are both well described. However, acute senescence in living organisms is not well understood. We hypothesized that hemorrhagic shock injury (HI) caused by whole body hypoxia and nutrient deprivation, resulting in organ dysfunction due to severe blood loss, could lead to acute senescence in vivo. Our experiments, for the first time, demonstrate a rapidly emerged, senolytics-responsive, senescence-like response in the rat liver in less than five hr following hemorrhagic shock. We conclude that the senescence, or pseudosenescence, observed is necessary to maintain tissue homeostasis following the injury.
C1 [Chu, Xiaogang; Wen, Jin; Raju, Raghavan Pillai] Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA.
C3 University System of Georgia; Augusta University
RP Raju, RP (corresponding author), Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, Augusta, GA 30912 USA.
EM RRaju@augusta.edu
RI Raju, Raghavan/E-9219-2011; WEN, JIN/HMO-7894-2023
OI WEN, JIN/0000-0002-8883-8443; Raju, Raghavan/0000-0002-4516-8654
FU National Institute of General Medical Sciences [R01 GM 122059]
FX National Institute of General Medical Sciences, Grant/Award Number: R01
   GM 122059
CR Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649
   Chu XG, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00281
   Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Pignolo RJ, 2020, TRENDS MOL MED, V26, P630, DOI 10.1016/j.molmed.2020.03.005
   Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Gerdes EOW, 2020, FEBS J, V287, P2418, DOI 10.1111/febs.15264
   Wu DY, 2018, CELL DEATH DIFFER, V25, P169, DOI 10.1038/cdd.2017.187
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 20
TC 15
Z9 15
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2020 SEP
PY 2020
VL 19
IS 9
AR e13201
DI 10.1111/acel.13201
EA AUG 2020
PG 5
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA NW7UG
UT WOS:000554388400001
PM 32741083
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Nakahara, H
   Kanno, T
   Inai, Y
   Utsumi, K
   Hiramatsu, M
   Mori, A
   Packer, L
AF Nakahara, H
   Kanno, T
   Inai, Y
   Utsumi, K
   Hiramatsu, M
   Mori, A
   Packer, L
TI Mitochondrial dysfunction in the senescence accelerated mouse (SAM)
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE aging; senescence accelerated mouse (SAM); mitochondria; mitochondrial
   dysfunction; free radicals; hydrogen peroxide; Bcl-x
ID LIPID PEROXIDE LEVELS; OXIDATIVE DAMAGE; HYDROGEN-PEROXIDE; SUPEROXIDE
   ANIONS; MURINE MODEL; CYTOCHROME-C; QUANTITATION; GENERATION; APOPTOSIS;
   RELEASE
AB Oxidative damage to DNA, proteins, and lipids in mitochondria caused by free radicals may be one factor in aging. Oxidative phosphorylation was estimated in liver mitochondria from senescence accelerated mice (SAMP8) and a senescence resistant substrain (SAMR1). The respiratory control ratio decreased in liver mitochondria of SAMP8 during aging, and it was estimated that at 18 months of age this respiratory control value suggested that it might be insufficient to provide ATP synthesis necessary for normal cell metabolism. In addition, the ADP/O, an index of efficiency of ATP synthesis, was depressed at 18 months of age. Dinitrophenol-dependent uncoupled respiration in liver mitochondria of SAMP8 mice was markedly decreased with aging, suggesting a dysfunctional energy transfer mechanism in mitochondria of aged SAMP8 mice. Active uptake of calcium in liver mitochondria was markedly dysfunctional in SAMP8 mice with aging, and uncoupling of respiration was induced more easily in aged mitochondria. Milder effects on these functional parameters were observed in SAMR1 mice. A similar dysfunction was also observed in heart mitochondria of SAMP8 mice at 12 months of age. The amount of Bcl-x in liver mitochondria was slightly decreased in SAMP8. We suggest that these changes in mitochondrial function may be related to the shorter life span of the senescence accelerated mouse. Published by Elsevier Science Inc.
C1 UNIV CALIF BERKELEY,DEPT MOL & CELL BIOL,BERKELEY,CA 94720.
   CTR ADULT DIS,INST MED SCI,KURASHIKI,OKAYAMA 710,JAPAN.
   YAMAGATA TECHNOPOLIS FDN,INST LIFE SUPPORT TECHNOL,YAMAGATA 990,JAPAN.
C3 University of California System; University of California Berkeley
CR AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BHUYAN KC, 1986, LIFE SCI, V38, P1463, DOI 10.1016/0024-3205(86)90559-X
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   GELDER VBF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593
   GREENAWALT JW, 1966, J CELL BIOL, V29, P37, DOI 10.1083/jcb.29.1.37
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V178, P1023
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   HOGEBOOM GH, 1955, METHOD ENZYMOL, V1, P16, DOI 10.1016/0076-6879(55)01007-0
   KOMURA S, 1988, J CLIN BIOCHEM NUTR, V5, P255
   KRAJEWSKI S, 1994, CANCER RES, V54, P5501
   Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PACKER L, 1966, ARCH BIOCHEM BIOPHYS, V117, P381, DOI 10.1016/0003-9861(66)90426-7
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P64655
   ROOT RK, 1975, J CLIN INVEST, V55, P945, DOI 10.1172/JCI108024
   SCHARF J, 1986, OPHTHALMIC RES, V18, P332, DOI 10.1159/000265459
   SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   Tyler D. D., 1967, Methods in Enzymology, V10, P75
   YAGI K, 1988, J CLIN BIOCHEM NUTR, V5, P21
NR 35
TC 106
Z9 112
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JAN 1
PY 1998
VL 24
IS 1
BP 85
EP 92
DI 10.1016/S0891-5849(97)00164-0
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA YK775
UT WOS:A1998YK77500010
PM 9436617
DA 2024-02-19
ER

PT J
AU Zeeh, J
AF Zeeh, J
TI The aging liver: consequences for drug treatment in old age
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE aging of liver; drug; metabolization in old liver; hepatic
   detoxification
ID BLOOD-FLOW; THERAPY; CLEARANCE; RISK
AB Numerous age-related changes in hepatic structure and function have been described although liver function seems to be quite well maintained in old age. Few consistent and reproducible observations and a lack of correlation between structural and functional data characterize the present state of our knowledge. However, a decline in liver volume and blood flow has been shown in older subjects, which is the physiologic basis of reduced hepatic drug clearance in this age group. In contrast to renal clearance, no reliable method exists to estimate hepatic drug clearance, The contribution of age to altered drug clearance in the elderly is difficult to assess as drug interactions, numbers and types of drugs taken at a time, underlying disease and increased interindividual variability are superimposed to the aging process. Therefore after decades of research into the matter; the old and well known aphorism 'start lower - go slower' is valid more than ever in the field of geriatric prescribing, Not only renally excreted drugs but also substances metabolized and excreted by the liver should be used in a starting dose which is 30-40% smaller than the average dose used in middle aged adults. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
C1 Geriatr Fachklin Georgenhaus, D-98617 Meiningen, Germany.
RP Zeeh, J (corresponding author), Geriatr Fachklin Georgenhaus, D-98617 Meiningen, Germany.
EM georgenhaus@t-online.de
CR COLT HG, 1989, J AM GERIATR SOC, V37, P323, DOI 10.1111/j.1532-5415.1989.tb05498.x
   DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002
   GREENBLATT DJ, 1986, THER DRUG MONIT, V8, P249, DOI 10.1097/00007691-198609000-00001
   GURWITZ JH, 1991, ANN INTERN MED, V114, P956, DOI 10.7326/0003-4819-114-11-956
   HAEFELI WE, 1995, SCHWEIZ RUNDSCH MED, V84, P619
   Hämmerlein A, 1998, CLIN PHARMACOKINET, V35, P49
   HURWITZ N, 1969, BRIT MED J, V1, P536, DOI 10.1136/bmj.1.5643.536
   IBER FL, 1994, DRUG AGING, V5, P34, DOI 10.2165/00002512-199405010-00004
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   LEVY DW, 1987, J ROY COLL PHYS LOND, V21, P148
   LINDEMAN RD, 1992, DRUG AGING, V2, P423, DOI 10.2165/00002512-199202050-00006
   MONTAMAT SC, 1989, NEW ENGL J MED, V321, P303
   NOLAN L, 1988, J AM GERIATR SOC, V36, P142, DOI 10.1111/j.1532-5415.1988.tb01785.x
   PLATT D, 1986, DRUGS AGING
   RAY WA, 1987, NEW ENGL J MED, V316, P363, DOI 10.1056/NEJM198702123160702
   Ray WA, 2000, J AM GERIATR SOC, V48, P682, DOI 10.1111/j.1532-5415.2000.tb04729.x
   SABANATHAN K, 1987, EUR J CLIN PHARMACOL, V32, P53, DOI 10.1007/BF00609957
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   ZEEH J, 1988, GASTROENTEROLOGY, V95, P749, DOI 10.1016/S0016-5085(88)80024-6
   Zeeh J, 1990, Fortschr Med, V108, P651
   ZEEH J, 1993, FORTSCHR MED, V111, P23
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 25
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAY-JUN
PY 2001
VL 32
IS 3
BP 255
EP 263
DI 10.1016/S0167-4943(01)00090-5
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 444GH
UT WOS:000169391400008
PM 11395171
DA 2024-02-19
ER

PT J
AU Sousa-Victor, P
   Neves, J
   Cedron-Craft, W
   Ventura, PB
   Liao, CY
   Riley, RR
   Soifer, I
   van Bruggen, N
   Kolumam, GA
   Villeda, SA
   Lamba, DA
   Jasper, H
AF Sousa-Victor, Pedro
   Neves, Joana
   Cedron-Craft, Wendy
   Ventura, P. Britten
   Liao, Chen-Yu
   Riley, Rebeccah R.
   Soifer, Ilya
   van Bruggen, Nicholas
   Kolumam, Ganesh A.
   Villeda, Saul A.
   Lamba, Deepak A.
   Jasper, Heinrich
TI MANF regulates metabolic and immune homeostasis in ageing and protects
   against liver damage
SO NATURE METABOLISM
LA English
DT Article
ID NF-KAPPA-B; NEUROTROPHIC FACTOR; ALTERNATIVE ACTIVATION; COGNITIVE
   FUNCTION; EXPRESSION; MICROGLIA; PROMOTES; CELLS; DIFFERENTIATION;
   REJUVENATION
AB Ageing is accompanied by altered intercellular communication, deregulated metabolic function, and inflammation. Interventions that restore a youthful state delay or reverse these processes, prompting the search for systemic regulators of metabolic and immune homeostasis. Here, we identified mesencephalic-astrocyte-derived neurotrophic factor (MANF), a secreted stressresponse protein with immune modulatory properties, as an evolutionarily conserved regulator of systemic and, in particular, liver metabolic homeostasis. We show that MANF levels declined with age in flies, mice, and humans, and MANF overexpression extends lifespan in flies. MANF-deficient flies exhibit enhanced inflammation and shorter lifespans, and MANF heterozygous mice exhibit inflammatory phenotypes in various tissues, as well as progressive liver damage, fibrosis, and steatosis. We show that immune-cell-derived MANF protects against liver inflammation and fibrosis, whereas hepatocyte-derived MANF prevents hepatosteatosis. Liver rejuvenation by heterochronic parabiosis in mice further depends on MANF, whereas MANF supplementation ameliorates several hallmarks of liver ageing, prevents hepatosteatosis induced by diet, and improves agerelated metabolic dysfunction. Our findings identify MANF as a systemic regulator of homeostasis in young animals, suggesting a therapeutic application for MANF in age-related metabolic diseases.
C1 [Sousa-Victor, Pedro; Neves, Joana; Cedron-Craft, Wendy; Liao, Chen-Yu; Riley, Rebeccah R.; Lamba, Deepak A.; Jasper, Heinrich] Buck Inst Res Aging, Paul F Glenn Ctr Biol Aging Res, Novato, CA 94945 USA.
   [Ventura, P. Britten; Villeda, Saul A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
   [Ventura, P. Britten; Villeda, Saul A.; Lamba, Deepak A.] Univ Calif San Francisco, Eli & Edythe Broad, Ctr Regenerat Med & Stem Cell Res, San Francisco, CA 94143 USA.
   [Soifer, Ilya; van Bruggen, Nicholas; Kolumam, Ganesh A.] Calico Life Sci LLC, San Francisco, CA USA.
   [Lamba, Deepak A.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA.
   [Jasper, Heinrich] Genentech Inc, Immunol Discovery, San Francisco, CA 94080 USA.
C3 Buck Institute for Research on Aging; University of California System;
   University of California San Francisco; University of California System;
   University of California San Francisco; University of California System;
   University of California San Francisco; Roche Holding; Genentech
RP Jasper, H (corresponding author), Buck Inst Res Aging, Paul F Glenn Ctr Biol Aging Res, Novato, CA 94945 USA.; Jasper, H (corresponding author), Genentech Inc, Immunol Discovery, San Francisco, CA 94080 USA.
EM jasperh@gene.com
RI Sousa-Victor, Pedro/AER-5744-2022
OI Neves, Joana/0000-0002-1027-3489
FU NIH [AG052989, AG050104, AG047497, EY025779, AG055797]; Calico Labs;
   Glenn Foundation for Medical Research
FX We thank M. Konjikusic for technical help with the mouse colony, A.
   Ireland and M. Ray from Calico Labs for help with library preparation
   and RNA sequencing, and H. Liu for providing an expert pathologist
   evaluation of liver sections. Work in H.J.'s laboratory is supported by
   NIH grant nos. AG052989, AG050104, and AG047497, and some work was
   supported by Calico Labs. Work in D.A.L.'s laboratory is supported by
   NIH grant no. EY025779. Work in S.A.V.'s lab is supported by NIH grant
   no. AG055797. P.S.-V. and J.N. are supported by the Glenn Foundation for
   Medical Research.
CR Asher V, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-6
   Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883
   Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067
   Chen LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08133
   Clark RI, 2018, CELL MOL LIFE SCI, V75, P93, DOI 10.1007/s00018-017-2671-1
   Clark RI, 2014, AGING-US, V6, P3, DOI 10.18632/aging.100626
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Galli E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29058
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735
   Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016
   Higami Y, 1997, AM J PATHOL, V151, P659
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956
   Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Le Couteur D. G., 2010, CALORIE RESTRICTION
   Li HJ, 2016, CELL HOST MICROBE, V19, P240, DOI 10.1016/j.chom.2016.01.008
   Lindahl M, 2017, NEUROBIOL DIS, V97, P90, DOI 10.1016/j.nbd.2016.07.009
   Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023
   Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016
   Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760
   Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005
   Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Neves J, 2017, CELL STEM CELL, V20, P161, DOI 10.1016/j.stem.2017.01.008
   Neves J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3646
   Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18
   Palgi M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-134
   Park JH, 2014, AGING CELL, V13, P709, DOI 10.1111/acel.12224
   Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030
   RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Stahl EC, 2016, J IMMUNOL, V196
   Sugaya Y, 2017, J DIABETES, V9, P754, DOI 10.1111/1753-0407.12482
   Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009
   Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9
   Wang YP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057085, 10.1371/journal.pone.0065634]
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Wu T, 2017, ENDOCR J, V64, P403, DOI 10.1507/endocrj.EJ16-0472
   Yang L, 2018, IMMUNOL RES, V66, P414, DOI 10.1007/s12026-018-9002-y
   Yang S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00750-x
   Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002
   Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003
   Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
NR 76
TC 76
Z9 81
U1 4
U2 21
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2522-5812
J9 NAT METAB
JI Nat. Metab.
PD FEB
PY 2019
VL 1
IS 2
BP 276
EP 290
DI 10.1038/s42255-018-0023-6
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA JT0ZN
UT WOS:000500728400011
PM 31489403
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Fujita, T
AF Fujita, T
TI Senescence marker protein-30 (SMP30): Structure and biological function
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE aging; Ca2+-binding protein; Ca2+ homeostasis; calbindin-D 28 kDa; cDNA;
   kidney; hepatocyte; liver; plasma membrane Ca2+-pumping activity; renal
   tubular epithelium; regucalcin; SMP30; senescence marker protein-30
ID RAT-LIVER; GENE-EXPRESSION; AGE
AB Senescence marker protein-30 (SMP30), which we previously identified, is notable for its androgen-independent decrease in the livers of aging rats. Hepatocytes and renal tubular epithelia express large amounts of SMP30 in their cytosol throughout the tissue-maturing process and adulthood, but its level decreases thereafter. Upon cloning cDNAs that encode SMP30 in rats, mice, and humans, we found that the amino acid sequence of SMP30 is well conserved with remarkable homology among these species. However, this gene, which is so strongly conserved in these higher animals, does not appear in yeast. We also determined the genome organization and 5' flanking region of SMP30 in mouse genome. In the meantime, SMP30 turned out be identical to a Ca2+-binding protein called regucalcin (RC). To learn how this protein functions, we transfected Hep G2 cells with human SMP30 cDNA so that these cells stably express large amounts of SMP30. The results suggest that SMP30 regulates Ca2+ homeostasis by enhancing Ca2+-pumping activity in the plasma membranes. Thus, SMP30 seems to play a critical role in the highly differentiated functions of the liver and kidney and to exert a major impact on Ca2+ homeostasis. If so, down-regulation of SMP30 with aging would attribute greatly to the related deterioration of these organs, as indicated in this brief overview of the structure, expression, and function Of SMP30. (C) 1999 Academic Press.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Fujita, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 1730015, Japan.
CR AMMENDOLA R, 1992, J BIOL CHEM, V267, P17994
   DOWD DR, 1992, MOL ENDOCRINOL, V6, P1843, DOI 10.1210/me.6.11.1843
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078
   LEDDACOLUMBANO GM, 1991, APOPTOSIS MOL BASIS, P101
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   VARGHESE S, 1988, J BIOL CHEM, V263, P9776
NR 14
TC 46
Z9 52
U1 0
U2 1
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 8
PY 1999
VL 254
IS 1
BP 1
EP 4
DI 10.1006/bbrc.1998.9841
PG 4
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 158XB
UT WOS:000078141800001
PM 9920722
DA 2024-02-19
ER

PT J
AU Kristensen, CM
   Brandt, CT
   Ringholm, S
   Pilegaard, H
AF Kristensen, Caroline M.
   Brandt, Christina T.
   Ringholm, Stine
   Pilegaard, Henriette
TI PGC-1α in aging and lifelong exercise training-mediated regulation of
   UPR in mouse liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE PGC-1 alpha; Aging; Exercise; Liver; ER stress; UPR
ID ENDOPLASMIC-RETICULUM STRESS; HUMAN SKELETAL-MUSCLE; HEPATIC
   GLUCONEOGENESIS; GENE-EXPRESSION; AMPK ACTIVATION; STEATOSIS; MICE;
   SUPPLEMENTATION; ACCUMULATION; CHAPERONES
AB Aging is associated with changes in several metabolic pathways affecting liver function including the adaptive unfolded protein response (UPR). On the other hand, exercise training has been shown to exert beneficial effects on metabolism in the liver and exercise training has been reported to affect hepatic UPR. PGC-1 alpha is a transcriptional coactivator involved in exercise training-induced adaptations in skeletal muscle and liver. Therefore, the aim of the present study was to examine the impact of PGC-1 alpha in aging and lifelong exercise training-induced hepatic UPR in mice. Liver was obtained from young (3 months old), aged (15 months old) and lifelong exercise trained aged wild-type (WT) and whole-body PGC-1 alpha knockout (KO) mice. Hepatic BiP, IRE1 alpha and cleaved ATF6 protein content increased, whereas PERK protein content was reduced with aging indicating both increased and decreased capacity of specific UPR pathways and increased activity of the ATF6 pathway in the liver with aging. Lifelong exercise training prevented the age-associated change in BiP and IRE1 alpha protein, but not cleaved ATF6 protein and resulted in further decreased PERK protein. Taken together, the present study provides evidence that the capacity and activity of the three UPR pathways are differentially regulated in the liver with aging and lifelong exercise training. In addition, PGC-1 alpha does not seem to regulate the activity of hepatic UPR in response to exercise training, but to influence the capacity of the liver to induce UPR in a pathway specific manner.
C1 [Kristensen, Caroline M.; Brandt, Christina T.; Ringholm, Stine; Pilegaard, Henriette] Univ Copenhagen, Dept Biol, Copenhagen, Denmark.
C3 University of Copenhagen
RP Pilegaard, H (corresponding author), Dept Biol, Univ Sparken 13,4th Floor, DK-2100 Copenhagen, Denmark.
EM hpilegaard@bio.ku.dk
RI Pilegaard, Henriette/M-2315-2014
OI Pilegaard, Henriette/0000-0002-1071-0327
FU Danish Medical Research Council [4004-00134]; Novo Nordisk Foundation
   [1015389]; Danish Diabetes Academy - Novo Nordisk Foundation
FX The present study was supported by the Danish Medical Research Council
   4004-00134, Novo Nordisk Foundation 1015389 and by the Danish Diabetes
   Academy funded by the Novo Nordisk Foundation. The authors would like to
   thank Jesper Olesen for contributing to performing the mouse
   experiments.
CR Alex S, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0026-1
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014
   Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972
   Chapados NA, 2010, CELL BIOCHEM FUNCT, V28, P202, DOI 10.1002/cbf.1643
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Cintra DE, 2012, LIFE SCI, V91, P395, DOI 10.1016/j.lfs.2012.08.002
   da Luz G, 2011, EUR J APPL PHYSIOL, V111, P2015, DOI 10.1007/s00421-010-1802-2
   Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435
   ESSENGUSTAVSSON B, 1984, ACTA PHYSIOL SCAND, V120, P505, DOI 10.1111/j.1748-1716.1984.tb07414.x
   Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007
   Gauthier MS, 2003, J APPL PHYSIOL, V94, P2127, DOI 10.1152/japplphysiol.01164.2002
   Haase TN, 2011, AM J PHYSIOL-REG I, V301, pR1501, DOI 10.1152/ajpregu.00775.2010
   Halling JF, 2017, EXP GERONTOL, V96, P1, DOI 10.1016/j.exger.2017.05.020
   Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156
   Kim Y, 2010, BRAIN RES, V1317, P13, DOI 10.1016/j.brainres.2009.12.062
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007
   Li HL, 2014, BBA-MOL BASIS DIS, V1842, P1844, DOI 10.1016/j.bbadis.2014.07.002
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lowry OH., 1972, FLEXIBLE SYSTEM ENZY
   Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Nuss JE, 2008, BIOCHEM BIOPH RES CO, V365, P355, DOI 10.1016/j.bbrc.2007.10.194
   Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06
   Olesen J, 2013, EXP GERONTOL, V48, P1274, DOI 10.1016/j.exger.2013.07.015
   Pagliassotti MJ, 2017, J NUTR BIOCHEM, V45, P15, DOI 10.1016/j.jnutbio.2017.02.022
   Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X
   Ringholm S, 2013, EXP GERONTOL, V48, P1311, DOI 10.1016/j.exger.2013.08.012
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570
   Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
NR 43
TC 17
Z9 19
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD NOV
PY 2017
VL 98
BP 124
EP 133
DI 10.1016/j.exger.2017.08.006
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FM8XL
UT WOS:000415375500016
PM 28801170
DA 2024-02-19
ER

PT J
AU Sun, KY
   Yang, PY
   Zhao, R
   Bai, YT
   Guo, ZJ
AF Sun, Kaiyue
   Yang, Pengyu
   Zhao, Rong
   Bai, Yuting
   Guo, Zijiao
TI Matrine Attenuates D-Galactose-Induced Aging-Related Behavior in Mice
   <i>via</i> Inhibition of Cellular Senescence an Oxidative Stress
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID CHOLINERGIC HYPOTHESIS; BRAIN; INJURY; CELLS; IMPAIRMENT; DISEASE; LIFE;
   SCOPOLAMINE; APOPTOSIS; COGNITION
AB The present study was designed to evaluate the effects of matrine (MAT) on D-galactose- (D-gal-) induced aging and relative mechanism. Vitamin E at the dose of 100 mg/kg was used as a standard positive control. MAT significantly improved the D-gal-induced recognition and spatial memory impairment in novel object recognition and Y maze tests, and exercise endurance decreased in the weight-loaded swimming test at 2 and 10 mg/kg. We found that D-gal treatment induced noticeably aging-related changes such as reducing thymus coefficients, increasing the pathological injury and cellular senescence of liver, spleen, and hippocampus, as well as an increase in cyclin-dependent kinase inhibitor p16, p19, and p21 gene expression and the interleukin-1 beta expression in the liver and hippocampus. MAT showed effective protection on such changes. Furthermore, MAT decreased the oxidative stress of the liver, plasma, and brain, as evidenced by increased total antioxidant capacity, total superoxide dismutase, and catalase activities and decreased the malondialdehyde level. Additionally, there was a significant positive correlation between swimming time in weight-loaded swimming time and thymus index. MAT ameliorated aging-related disorder caused by D-gal through the inhibition of both cellular senescence and oxidative stress. The study provides further evidence for drug development of MAT for prevention or treatment of the aging-associated disorder.
C1 [Sun, Kaiyue; Yang, Pengyu; Zhao, Rong; Bai, Yuting; Guo, Zijiao] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China.
C3 Shanxi Agricultural University
RP Sun, KY (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China.
EM sunkaiyue21@163.com
OI Sun, Kaiyue/0000-0003-3642-6970
FU Shanxi Agricultural University Science and Technology Innovation Fund
   [2014YJ04]
FX This work was supported by the grant from Shanxi Agricultural University
   Science and Technology Innovation Fund (2014YJ04), China.
CR Maciel-Barón LA, 2018, ANTIOXID REDOX SIGN, V28, P1704, DOI 10.1089/ars.2017.7112
   [Anonymous], BIOMED RES INT
   Araujo JA, 2005, PROG NEURO-PSYCHOPH, V29, P411, DOI 10.1016/j.pnpbp.2004.12.008
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   Botton PH, 2010, BEHAV BRAIN RES, V214, P254, DOI 10.1016/j.bbr.2010.05.034
   Chen XY, 2016, NEUROCHEM RES, V41, P3032, DOI 10.1007/s11064-016-2022-x
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Chinta SJ, 2018, CELL REP, V22, P930, DOI 10.1016/j.celrep.2017.12.092
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Li HJ, 2015, INT J CLIN EXP PATHO, V8, P14793
   Li XB, 2012, J PHARM PHARMACOL, V64, P1107, DOI 10.1111/j.2042-7158.2012.01502.x
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Liu X, 2016, CELL MOL BIOL, V62, P38, DOI 10.14715/cmb/2016.62.11.7
   Liu ZW, 2017, EUR J PHARMACOL, V804, P21, DOI 10.1016/j.ejphar.2017.03.061
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Meng FH, 2017, ONCOL LETT, V13, P296, DOI 10.3892/ol.2016.5383
   Meng HD, 2010, J AM GERIATR SOC, V58, P2033, DOI 10.1111/j.1532-5415.2010.03088.x
   Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Norheim KB, 2011, RHEUMATOLOGY, V50, P1009, DOI 10.1093/rheumatology/keq454
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020
   SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843
   Shichiri M, 2013, BIOL PSYCHOL, V94, P527, DOI 10.1016/j.biopsycho.2013.10.002
   Shinmura K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/528935
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029
   Wang DL, 2012, BIOL PHARM BULL, V35, P2128, DOI 10.1248/bpb.b12-00238
   Wang W, 2009, LIFE SCI, V85, P127, DOI 10.1016/j.lfs.2009.05.003
   [张晶 Zhang Jing], 2015, [基础医学与临床, Basic & Clinical Medicine], V35, P1308
   Zhang Y, 2018, EUR J PHARMACOL, V822, P207, DOI 10.1016/j.ejphar.2018.01.029
   Zhao P, 2015, INT J MOL MED, V36, P633, DOI 10.3892/ijmm.2015.2260
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
NR 44
TC 81
Z9 87
U1 2
U2 29
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2018
VL 2018
AR 7108604
DI 10.1155/2018/7108604
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HE0WY
UT WOS:000452991800001
PM 30598725
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Ritschka, B
   Knauer-Meyer, T
   Gonçalves, DS
   Mas, A
   Plassat, JL
   Durik, M
   Jacobs, H
   Pedone, E
   Di Vicino, U
   Cosma, MP
   Keyes, WM
AF Ritschka, Birgit
   Knauer-Meyer, Tania
   Sampaio Goncalves, Daniel
   Mas, Alba
   Plassat, Jean-Luc
   Durik, Matej
   Jacobs, Hugues
   Pedone, Elisa
   Di Vicino, Umberto
   Pia Cosma, Maria
   Keyes, William M.
TI The senotherapeutic drug ABT-737 disrupts aberrant p21 expression to
   restore liver regeneration in adult mice
SO GENES & DEVELOPMENT
LA English
DT Article
DE senescence; senolytic; liver regeneration; p21; p16(Ink4a); ABT-737;
   hepatocyte; aging
ID CELLULAR SENESCENCE; PARTIAL-HEPATECTOMY; GENE-EXPRESSION; CELLS
AB Young mammals possess a limited regenerative capacity in some tissues, which is lost upon maturation. We inves-tigated whether cellular senescence might play a role in such loss during liver regeneration. We found that fol- lowing partial hepatectomy, the senescence-associated p21, p16(Ink4a), genes and p19(Arf) become dynamically ex- pressed in different cell types when regenerative capacity decreases, but without a full senescent response. Howev-er, we show that treatment with a senescence-inhibiting drug improves regeneration, by disrupting aberrantly pro-longed p21 expression. This work suggests that senes-cence may initially develop from heterogeneous cellular responses, and that senotherapeutic drugs might be useful in promoting organ regeneration.
C1 [Ritschka, Birgit; Knauer-Meyer, Tania; Sampaio Goncalves, Daniel; Mas, Alba; Plassat, Jean-Luc; Durik, Matej; Jacobs, Hugues; Keyes, William M.] IGBMC, F-67404 Illkirch Graffenstaden, France.
   [Ritschka, Birgit; Knauer-Meyer, Tania; Sampaio Goncalves, Daniel; Mas, Alba; Plassat, Jean-Luc; Durik, Matej; Jacobs, Hugues; Keyes, William M.] CNRS, UMR7104, F-67404 Illkirch Graffenstaden, France.
   [Ritschka, Birgit; Knauer-Meyer, Tania; Sampaio Goncalves, Daniel; Mas, Alba; Plassat, Jean-Luc; Durik, Matej; Jacobs, Hugues; Keyes, William M.] INSERM, U1258, F-67404 Illkirch Graffenstaden, France.
   [Ritschka, Birgit; Knauer-Meyer, Tania; Sampaio Goncalves, Daniel; Mas, Alba; Plassat, Jean-Luc; Durik, Matej; Jacobs, Hugues; Keyes, William M.] Univ Strasbourg, F-67404 Illkirch Graffenstaden, France.
   [Ritschka, Birgit; Mas, Alba; Pedone, Elisa; Di Vicino, Umberto; Pia Cosma, Maria; Keyes, William M.] Barcelona Inst Sci & Technol, CRG, Barcelona 08003, Spain.
   [Pia Cosma, Maria; Keyes, William M.] UPF, Barcelona 08003, Spain.
   [Pia Cosma, Maria] Inst Catalana Invest & Estudios Avanzados ICREA, Barcelona 08010, Spain.
   [Ritschka, Birgit] ViennaBioctr VBC, Res Inst Mol Pathol IMP, Campus Vienna Bioctr 1, A-1030 Vienna, Austria.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universites de Strasbourg Etablissements
   Associes; Universite de Strasbourg; Barcelona Institute of Science &
   Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG);
   Pompeu Fabra University; ICREA; Vienna Biocenter (VBC); Research
   Institute of Molecular Pathology (IMP)
RP Keyes, WM (corresponding author), IGBMC, F-67404 Illkirch Graffenstaden, France.; Keyes, WM (corresponding author), CNRS, UMR7104, F-67404 Illkirch Graffenstaden, France.; Keyes, WM (corresponding author), INSERM, U1258, F-67404 Illkirch Graffenstaden, France.; Keyes, WM (corresponding author), Univ Strasbourg, F-67404 Illkirch Graffenstaden, France.; Keyes, WM (corresponding author), Barcelona Inst Sci & Technol, CRG, Barcelona 08003, Spain.; Keyes, WM (corresponding author), UPF, Barcelona 08003, Spain.
EM bill.keyes@igbmc.fr
RI Cosma, Maria Pia/E-8731-2015; Pedone, Elisa/AAP-7448-2020
OI Cosma, Maria Pia/0000-0003-4207-5097; Pedone, Elisa/0000-0001-9467-8207;
   Sampaio Goncalves, Daniel/0000-0001-6634-4699; Keyes, William
   M./0000-0002-8917-2268
FU Spanish Ministry for Economy and Competitiveness [SAF2013-49082-P];
   Fondation Recherche Medicale (FRM) [AJE20160635985]; Fondation ARC
   [PJA20181208104]; IDEX Attractivite-University of Strasbourg (IDEX2017);
   Fondation Schlumberger pour l'Education et la Recherche (FSER) (FSER
   19-Year 2018); ANR [ANR-19-CE13-0023-03]; French State fund
   [ANR-10LABX-0030-INRT, ANR10-IDEX-0002-02]; Spanish Ministry of Science
   and Innovation; Centro de Excelencia Severo Ochoa; CERCA
   Programme/Generalitat de Catalunya
FX We thank Muriel Rhinn for help with procedures. We thank the mouse
   facility at the Mouse Clinical Institute (ICS), the Histology Facilities
   at the Centre for Genomic Regulation and the Institut de Genetique et de
   Biologie Moleculaire et Cellulaire/ICS, and the phenotyping platform at
   the ICS for excellent technical support. Work in the Keyes lab wasfunded
   in part by grants from the Spanish Ministry for Economy and
   Competitiveness (SAF2013-49082-P), La Fondation Recherche Medicale (FRM)
   (AJE20160635985), Fondation ARC (PJA20181208104), IDEX
   Attractivite-University of Strasbourg (IDEX2017), and La Fondation
   Schlumberger pour l'Education et la Recherche (FSER) (FSER 19-Year
   2018), and ANR (ANR-19-CE13-0023-03). Work was also supported by grant
   ANR-10LABX-0030-INRT, a French State fund managed by the Agence
   Nationale de la Recherche under the frame program Investissements
   d'Avenir (ANR10-IDEX-0002-02). Weacknowledge the support of the Spanish
   Ministry of Science and Innovation to the EMBL partnership, the Centro
   de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de
   Catalunya. Author contributions: B.R., M.P.C., andW.M.K. conceived and
   designed the study. B.R. performed most of the experiments. T.K.-M.,
   A.M., J.-L.P., D.S.G., M.D., U.D.V., and E.P. performed additional
   experiments and techniques. H.J. performed histopathological analysis.
   B.R. and W.M.K. wrote the manuscript. M.P.C. and W.M.K. supervised the
   project and secured funding. All authors approved the manuscript.
CR Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bassat E, 2017, NATURE, V547, P179, DOI 10.1038/nature22978
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Buitrago-Molina LE, 2013, HEPATOLOGY, V58, P1143, DOI 10.1002/hep.26412
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Chang  J., 2015, NAT MED, V22, P1
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Enkhbold C, 2015, J GASTROEN HEPATOL, V30, P1217, DOI 10.1111/jgh.12930
   Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lehmann K, 2012, GASTROENTEROLOGY, V143, P1609, DOI 10.1053/j.gastro.2012.08.043
   Liu JY, 2019, P NATL ACAD SCI USA, V116, P2603, DOI 10.1073/pnas.1818313116
   Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Payzin-Dogru D, 2018, INT J DEV BIOL, V62, P393, DOI 10.1387/ijdb.180002jw
   Pedone E, 2017, CELL REP, V18, P107, DOI 10.1016/j.celrep.2016.12.008
   Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506
   Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Zou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030675
NR 33
TC 50
Z9 50
U1 0
U2 14
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD APR 1
PY 2020
VL 34
IS 7-8
BP 489
EP 494
DI 10.1101/gad.332643.119
PG 6
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA KY8AS
UT WOS:000522794600003
PM 32139422
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Wang, EQ
   Liao, ZY
   Wang, LH
   Liao, Y
   Xu, XD
   Liu, P
   Wang, X
   Hou, J
   Jiang, HJ
   Wu, XW
   Chen, XL
AF Wang, Erqiang
   Liao, Zhenyu
   Wang, Lianghai
   Liao, Yuan
   Xu, Xiaodan
   Liu, Ping
   Wang, Xian
   Hou, Jun
   Jiang, Huijiao
   Wu, Xiangwei
   Chen, Xueling
TI A combination of pirfenidone and TGF-β inhibition mitigates cystic
   echinococcosis-associated hepatic injury
SO PARASITOLOGY
LA English
DT Article
DE Cystic echinococcosis; Echinococcus granulosus; hepatocyte senescence;
   liver fibrosis; natural killer cell
ID LIVER FIBROSIS; CELL ACTIVATION; STELLATE CELLS; MECHANISMS; SENESCENCE;
   RESPONSES; MATRIX; GAMMA
AB Cystic echinococcosis (CE) occurs in the intermediate host's liver, assuming a bladder-like structure surrounded by the host-derived collagen capsule mainly derived from activated hepatic stellate cells (HSCs). However, the effect of CE on liver natural killer (NK) cells and the potential of transforming growth factor-beta (TGF-beta) signalling inhibition on alleviating CE-related liver damage remain to be explored. Here, by using the CE-mouse model, we revealed that the inhibitory receptors on the surface of liver NK cells were up-regulated, whereas the activating receptors were down-regulated over time. TGF-beta 1 secretion was elevated in liver tissues and mainly derived from macrophages. A combination of TGF-beta signalling inhibitors SB525334 and pirfenidone could reduce the expression of TGF-beta 1 signalling pathway-related proteins and collagen production. Based on the secretion of TGF-beta 1, only the pirfenidone group showed a depressing effect. Also, the combination of SB525334 and pirfenidone exhibited a higher potential in effectively alleviating the senescence of the hepatocytes and restoring liver function. Together, TGF-beta 1 may be a potential target for the treatment of CE-associated liver fibrosis.
C1 [Wang, Erqiang; Liao, Zhenyu; Wang, Lianghai; Liao, Yuan; Xu, Xiaodan; Liu, Ping; Wang, Xian; Hou, Jun; Jiang, Huijiao; Chen, Xueling] Shihezi Univ, Dept Basic Med Sci, Sch Med, Shihezi 832002, Xinjiang, Peoples R China.
   [Wang, Erqiang] Hunan Childrens Hosp, Hunan Childrens Res Inst, Changsha, Peoples R China.
   [Wu, Xiangwei] Shihezi Univ, Sch Med, Dept Hepatobiliary Surg, Affiliated Hosp 1, Shihezi 832002, Xinjiang, Peoples R China.
C3 Shihezi University; Shihezi University
RP Chen, XL (corresponding author), Shihezi Univ, Dept Basic Med Sci, Sch Med, Shihezi 832002, Xinjiang, Peoples R China.; Wu, XW (corresponding author), Shihezi Univ, Sch Med, Dept Hepatobiliary Surg, Affiliated Hosp 1, Shihezi 832002, Xinjiang, Peoples R China.
EM wxwshz@126.com; chenxueling@shzu.edu.cn
FU National Natural Science Foundation of China [82060297, 81760371,
   81760570]; XPCC youth science and technology innovation leading talent
   project [2018CB017]; XPCC science and technology key project [2019AB031]
FX This work was supported by the `National Natural Science Foundation of
   China' (Grant/Award Number: 82060297, 81760371 and 81760570), the `XPCC
   youth science and technology innovation leading talent project'
   (Grant/Award Number: 2018CB017), and `XPCC science and technology key
   project' (Grant/Award Number: 2019AB031).
CR Albright CD, 2003, J CELL BIOCHEM, V89, P254, DOI 10.1002/jcb.10498
   Lopez-de La Mora DA, 2015, INT J MED SCI, V12, P840, DOI 10.7150/ijms.11579
   Amri M, 2007, J INTERF CYTOK RES, V27, P781, DOI 10.1089/jir.2007.0003
   André P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014
   Anton OM, 2020, P NATL ACAD SCI USA, V117, P522, DOI 10.1073/pnas.1911678117
   Atmaca Hasan Tarik, 2019, J Parasit Dis, V43, P576, DOI 10.1007/s12639-019-01129-z
   Beschin A, 2013, J PATHOL, V229, P186, DOI 10.1002/path.4112
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Cheng YQ, 2015, IMMUNOLOGY, V145, P485, DOI 10.1111/imm.12463
   Cordero-Espinoza L, 2018, J CLIN INVEST, V128, P85, DOI 10.1172/JCI93562
   Dewidar B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111419
   Distler JHW, 2019, NAT REV RHEUMATOL, V15, P705, DOI 10.1038/s41584-019-0322-7
   Fasbender F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00019
   Flores-Contreras L, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-131
   Gandhi CR, 2017, J HEPATOL, V67, P1104, DOI 10.1016/j.jhep.2017.06.001
   Guo M, 2017, BIOMED PHARMACOTHER, V96, P1527, DOI 10.1016/j.biopha.2017.11.075
   Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200
   Jiao JJ, 2016, J HEPATOL, V65, P344, DOI 10.1016/j.jhep.2016.04.020
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415
   Lembarki G, 2018, NEW ENGL J MED, V379, P181, DOI 10.1056/NEJMicm1702005
   Li YH, 2016, CELL MOL IMMUNOL, V13, P73, DOI 10.1038/cmi.2014.126
   Liu YM, 2016, KOREAN J PARASITOL, V54, P519, DOI 10.3347/kjp.2016.54.4.519
   Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005
   Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799
   Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951
   Pareek A, 2013, J ETHNOPHARMACOL, V150, P973, DOI 10.1016/j.jep.2013.09.048
   Peng H, 2016, CELL MOL IMMUNOL, V13, P328, DOI 10.1038/cmi.2015.96
   Roeb E, 2018, MATRIX BIOL, V68-69, P463, DOI 10.1016/j.matbio.2017.12.012
   Schrader Jorg, 2009, Hepatology, V49, P1045, DOI 10.1002/hep.22832
   Seniutkin O, 2018, TOXICOL APPL PHARM, V339, P1, DOI 10.1016/j.taap.2017.11.024
   Tamarozzi F, 2016, PARASITE IMMUNOL, V38, P170, DOI 10.1111/pim.12301
   Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884
   Wen H, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00075-18
   Zhang K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00204-4
   Zheng MJ, 2018, FRONT MED-PRC, V12, P269, DOI 10.1007/s11684-018-0621-4
   Zhou J, 2019, IMMUNITY, V50, P403, DOI 10.1016/j.immuni.2018.12.024
NR 44
TC 4
Z9 6
U1 0
U2 8
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD JUN
PY 2021
VL 148
IS 7
BP 767
EP 778
DI 10.1017/S0031182021000287
PG 12
WC Parasitology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Parasitology
GA SD0WO
UT WOS:000651084600001
PM 33583470
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Lagnado, A
   Leslie, J
   Ruchaud-Sparagano, MH
   Victorelli, S
   Hirsova, P
   Ogrodnik, M
   Collins, AL
   Vizioli, MG
   Habiballa, L
   Saretzki, G
   Evans, SA
   Salmonowicz, H
   Hruby, A
   Geh, D
   Pavelko, KD
   Dolan, D
   Reeves, HL
   Grellscheid, S
   Wilson, CH
   Pandanaboyana, S
   Doolittle, M
   von Zglinicki, T
   Oakley, F
   Gallage, S
   Wilson, CL
   Birch, J
   Carroll, B
   Chapman, J
   Heikenwalder, M
   Neretti, N
   Khosla, S
   Masuda, CA
   Tchkonia, T
   Kirkland, JL
   Jurk, D
   Mann, DA
   Passos, JF
AF Lagnado, Anthony
   Leslie, Jack
   Ruchaud-Sparagano, Marie-Helene
   Victorelli, Stella
   Hirsova, Petra
   Ogrodnik, Mikolaj
   Collins, Amy L.
   Vizioli, Maria Grazia
   Habiballa, Leena
   Saretzki, Gabriele
   Evans, Shane A.
   Salmonowicz, Hanna
   Hruby, Adam
   Geh, Daniel
   Pavelko, Kevin D.
   Dolan, David
   Reeves, Helen L.
   Grellscheid, Sushma
   Wilson, Colin H.
   Pandanaboyana, Sanjay
   Doolittle, Madison
   von Zglinicki, Thomas
   Oakley, Fiona
   Gallage, Suchira
   Wilson, Caroline L.
   Birch, Jodie
   Carroll, Bernadette
   Chapman, James
   Heikenwalder, Mathias
   Neretti, Nicola
   Khosla, Sundeep
   Masuda, Claudio Akio
   Tchkonia, Tamar
   Kirkland, James L.
   Jurk, Diana
   Mann, Derek A.
   Passos, Joao F.
TI Neutrophils induce paracrine telomere dysfunction and senescence in
   ROS-dependent manner
SO EMBO JOURNAL
LA English
DT Article; Early Access
DE aging; neutrophils; senescence; telomeres
ID DNA-DAMAGE-RESPONSE; CELLULAR SENESCENCE; LIFE-SPAN; CELLS;
   ACCUMULATION; SURVEILLANCE; RECRUITMENT; EXTENSION; SEQUENCE; SHORTEN
AB Cellular senescence is characterized by an irreversible cell cycle arrest as well as a pro-inflammatory phenotype, thought to contribute to aging and age-related diseases. Neutrophils have essential roles in inflammatory responses; however, in certain contexts their abundance is associated with a number of age-related diseases, including liver disease. The relationship between neutrophils and cellular senescence is not well understood. Here, we show that telomeres in non-immune cells are highly susceptible to oxidative damage caused by neighboring neutrophils. Neutrophils cause telomere dysfunction both in vitro and ex vivo in a ROS-dependent manner. In a mouse model of acute liver injury, depletion of neutrophils reduces telomere dysfunction and senescence. Finally, we show that senescent cells mediate the recruitment of neutrophils to the aged liver and propose that this may be a mechanism by which senescence spreads to surrounding cells. Our results suggest that interventions that counteract neutrophil-induced senescence may be beneficial during aging and age-related disease.
C1 [Lagnado, Anthony; Victorelli, Stella; Ogrodnik, Mikolaj; Vizioli, Maria Grazia; Habiballa, Leena; Salmonowicz, Hanna; Hruby, Adam; Masuda, Claudio Akio; Jurk, Diana; Passos, Joao F.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.
   [Lagnado, Anthony; Victorelli, Stella; Ogrodnik, Mikolaj; Vizioli, Maria Grazia; Habiballa, Leena; Salmonowicz, Hanna; Hruby, Adam; Doolittle, Madison; Khosla, Sundeep; Masuda, Claudio Akio; Tchkonia, Tamar; Kirkland, James L.; Jurk, Diana; Passos, Joao F.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA.
   [Leslie, Jack; Collins, Amy L.; Geh, Daniel; Oakley, Fiona; Wilson, Caroline L.; Mann, Derek A.] Newcastle Univ, Biosci Inst, Newcastle Fibrosis Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Ruchaud-Sparagano, Marie-Helene] Newcastle Univ, Translat Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.
   [Hirsova, Petra] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA.
   [Habiballa, Leena] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
   [Habiballa, Leena] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.
   [Saretzki, Gabriele; Salmonowicz, Hanna; von Zglinicki, Thomas; Birch, Jodie; Chapman, James] Newcastle Univ, Biosci Inst, Fac Med Sci, Ageing Res Labs, Newcastle Upon Tyne, Tyne & Wear, England.
   [Evans, Shane A.; Neretti, Nicola] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.
   [Pavelko, Kevin D.] Mayo Clin, Dept Immunol & Immune Monitoring Core, Rochester, MN USA.
   [Dolan, David; Grellscheid, Sushma] Univ Bergen, Computat Biol Unit, Bergen, Norway.
   [Reeves, Helen L.] Newcastle Univ, Translat & Clin Res Inst, Liver Unit, Newcastle Upon Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.
   [Grellscheid, Sushma] Univ Durham, Dept Biosci, Durham, England.
   [Wilson, Colin H.; Pandanaboyana, Sanjay] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Hepatobiliary Surg, Newcastle Upon Tyne, Tyne & Wear, England.
   [Gallage, Suchira; Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany.
   [Carroll, Bernadette] Univ Bristol, Sch Biochem, Bristol, Avon, England.
   [Masuda, Claudio Akio] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
C3 Mayo Clinic; Mayo Clinic; Newcastle University - UK; Newcastle
   University - UK; Mayo Clinic; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Brown
   University; Mayo Clinic; University of Bergen; Newcastle Upon Tyne
   Hospitals NHS Foundation Trust; Newcastle University - UK; Durham
   University; Newcastle Upon Tyne Hospitals NHS Foundation Trust;
   Helmholtz Association; German Cancer Research Center (DKFZ); University
   of Bristol; Universidade Federal do Rio de Janeiro
RP Passos, JF (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.; Passos, JF (corresponding author), Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA.; Mann, DA (corresponding author), Newcastle Univ, Biosci Inst, Newcastle Fibrosis Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
EM Derek.Mann@ncl.ac.uk; Passos.Joao@mayo.edu
RI Mann, Derek A/E-4765-2011; Masuda, Claudio A/F-7214-2014; Doolittle,
   Madison/AAB-3047-2022; Saretzki, Gabriele Christine/I-7175-2019;
   Kirkland, James/F-9159-2016; Pavelko, Kevin D./K-7072-2019; Khosla,
   Sundeep/AAE-6170-2020; Salmonowicz, Hanna/ABD-2086-2021
OI Masuda, Claudio A/0000-0002-0310-7108; Doolittle,
   Madison/0000-0003-0912-0095; Saretzki, Gabriele
   Christine/0000-0003-2100-8223; Pavelko, Kevin D./0000-0001-7555-1315;
   Khosla, Sundeep/0000-0002-2936-4372; Salmonowicz,
   Hanna/0000-0002-9444-1039; Hruby, Adam/0000-0002-1970-1312; Geh,
   Daniel/0000-0002-3592-7469; leslie, jack/0000-0001-6443-2396; Jurk,
   Diana/0000-0003-4486-0857; Pandanaboyana, Sanjay/0000-0003-3099-2197;
   Chapman, James/0000-0002-2841-282X; Reeves, Helen/0000-0003-0359-9795;
   Carroll, Bernadette/0000-0001-5673-9371; Mann,
   Derek/0000-0003-0950-243X; Passos, Joao/0000-0001-8765-1890; Oakley,
   Fiona/0000-0001-8692-1836; Gallage, Suchira/0000-0002-1956-3597
FU NIH [R01 AG068048, R01 AG068182-01, R37 AG013925, R01 AG050582, P01
   AG062413]; Connor Fund; Noaber Foundation; MRC program [MR/K0019494/1,
   MR/R023026/1]; CRUK program grant [C18342/A23390]; National Centre for
   Advancing Translational Sciences (NCATS) [UL1 TR0002377]; BBSRC
   [BB/L502066/1, BB/K017314/1]; Newcastle CRUK Clinical Academic Training
   Programme; W.E. Harker Foundation; AASLD Foundation; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (Capes) [001]; 
   [P30DK084567]; BBSRC [BB/L502066/1] Funding Source: UKRI; MRC [G0900535,
   MR/R023026/1, MR/K001949/1] Funding Source: UKRI
FX The authors acknowledge support from NIH grants: R01 AG068048 (JFP), R01
   AG068182-01 (DJ), R37 AG013925 (JLK, TT), R01 AG050582 (NN) and P01
   AG062413 (SK, JLK, DJ, TT, JFP), the Connor Fund (JLK, TT), Robert J.
   and Theresa W. Ryan (JLK, TT), and the Noaber Foundation (JLK, TT). F.O
   and D.A.M are supported by MRC program Grants MR/K0019494/1 and
   MR/R023026/1. D.A.M is supported by a CRUK program grant, reference
   C18342/A23390. JFP, DJ, AL, and SV would like to thank the Ted Nash Long
   Life Foundation, UL1 TR0002377 from the National Centre for Advancing
   Translational Sciences (NCATS) and BBSRC [grants BB/L502066/1;
   BB/K017314/1]. DG is supported by the Newcastle CRUK Clinical Academic
   Training Programme. AC is funded by the W.E. Harker Foundation. PH is
   supported by the AASLD Foundation. DJ and PH are supported by
   P30DK084567. CAM was supported by a fellowship from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior-Brasil (Capes)-Finance Code
   001. MCAT mice were a kind gift from Prof. Owen Samson at the Cancer
   Research UK Beatson Institute. We also thank the technical support
   provided by Dr. Glyn Nelson and the Newcastle University Bioimaging
   unit.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Anderson R, 2019, EMBO J, V38, DOI 10.15252/embj.2018100492
   Ariazi J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00333
   Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Cassidy LD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14187-x
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Fouquerel E, 2019, MOL CELL, V75, P117, DOI 10.1016/j.molcel.2019.04.024
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guo QQ, 2019, J HEPATOL, V71, P1193, DOI 10.1016/j.jhep.2019.07.019
   Hari P, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0254
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Jin H, 2020, AM J PATHOL, V190, P176, DOI 10.1016/j.ajpath.2019.09.013
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Ma S, 2020, CELL, V180, P984, DOI 10.1016/j.cell.2020.02.008
   Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005
   Moles A, 2014, J HEPATOL, V60, P782, DOI 10.1016/j.jhep.2013.12.005
   Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Németh T, 2020, NAT REV DRUG DISCOV, V19, P253, DOI 10.1038/s41573-019-0054-z
   Ogrodnik M, 2019, TRENDS BIOCHEM SCI, V44, P996, DOI 10.1016/j.tibs.2019.06.011
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g
   Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Paish HL, 2019, HEPATOLOGY, V70, P1377, DOI 10.1002/hep.30651
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Peiseler M, 2019, J CLIN INVEST, V129, P2629, DOI 10.1172/JCI124616
   Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893
   Razdan N, 2018, AGING CELL, V17, DOI 10.1111/acel.12838
   Sawant KV, 2016, SCI REP-UK, V6, DOI 10.1038/srep33123
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653
   Victorelli S, 2019, EMBO J, V38, DOI 10.15252/embj.2019101982
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wilson CL, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms7818, 10.1038/ncomms9901]
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 58
TC 79
Z9 82
U1 3
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD 2021 MAY 3
PY 2021
VL 40
IS 9
AR e106048
DI 10.15252/embj.2020106048
EA MAR 2021
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA RV9UY
UT WOS:000632466400001
PM 33764576
OA hybrid, Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Satoh, A
   Yokozawa, T
   Cho, EJ
   Okamoto, T
   Sei, Y
AF Satoh, A
   Yokozawa, T
   Cho, EJ
   Okamoto, T
   Sei, Y
TI Antioxidative effects related to the potential anti-aging properties of
   the Chinese prescription Kangen-karyu and Carthami Flos in
   senescence-accelerated mice
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Kangen-karyu; Carthami Flos; aging; senescence-accelerated mice;
   oxidative stress; antioxidative effect
ID SUPEROXIDE-DISMUTASE; RENAL-FAILURE; MOUSE SAM; PERIPHERAL ORGANS;
   INHIBITION; METHYLGUANIDINE; CREATININE; NITRITE; MODEL; ASSAY
AB The popular oxidative stress theory predicts that enhancement of the antioxidative defense system to attenuate free radical-induced damage counteracts the aging process. We used senescence-accelerated mice (SAM) because SAM has been shown to suppress the antioxidative defense system and mitochondrial dysfunction induced by oxidative stress. We investigated the antioxidative effects of the Chinese prescription Kangen-karyu and its crude drug component Carthami Flos. The administration of Kangen-karyu extract at 100mg/kg body weight per day for 10 weeks inhibited generation of nitric oxide, superoxide and the hydroxyl radical ((OH)-O-.), while Carthami Flos extract showed only (OH)-O-.-scavenging activity. Diet supplemented with Kangen-karyu and Carthami Flos extracts enhanced the activities of the antioxidative enzymes superoxide dismutase in hepatic tissue and glutathione peroxidase in renal tissue, and reduced the hepatic lipid peroxidation level which increased with aging, indicating the protective action against oxidative stress by enhancing the antioxidative status. Hepatic and renal dysfunction with aging was also ameliorated by the administration of Kangen-karyu and Carthami Flos supplements. Furthermore, the observed antioxidative properties of the Chinese prescription Kangen-karyu were more evident than those of Carthami Flos. These findings suggest that the protective activity of Kangen-karyu against the oxidative tissue damages during aging may be due partly to synergistic and/or additive effects of its crude preparation. The present study strongly indicates that Kangen-karyu Counteract the oxidative stress and ameliorating tissue damage possibly associated with aging in SAM. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Toyama Med & Pharmaceut Univ, Inst Nat Med, Toyama 9300194, Japan.
   Iskra Ind Co Ltd, Chuo Ku, Tokyo 1030027, Japan.
C3 University of Toyama
RP Yokozawa, T (corresponding author), Toyama Med & Pharmaceut Univ, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.
EM yokozawa@ms.toyama-mpu.ac.jp
CR Aebi H., 1974, Methods of enzymatic analysis, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bodyrev AA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1157, DOI 10.1023/A:1012441215506
   Chang LY, 2002, FREE RADICAL BIO MED, V33, P379, DOI 10.1016/S0891-5849(02)00919-X
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7
   Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014
   Gao Ming, 2001, Journal of Traditional Medicines, V18, P245
   GREENBLATT S, 1982, GENRE, V15, P3
   HARANAKA K, 1985, CANCER IMMUNOL IMMUN, V20, P1
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HIGASHIDATE S, 1984, BUNSEKI KAGAKU, V33, P366
   Ho JCM, 2001, CANCER RES, V61, P8578
   Hosokawa M, 1997, EXP GERONTOL, V32, P111, DOI 10.1016/S0531-5565(96)00078-2
   Husain K, 2001, ALCOHOL, V25, P89, DOI 10.1016/S0741-8329(01)00176-8
   IENAGA K, 1991, J CHEM SOC CHEM COMM, P509, DOI 10.1039/c39910000509
   INOUE M, 1990, FEBS LETT, V269, P89, DOI 10.1016/0014-5793(90)81126-9
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   Jacob RA, 2003, J NUTR, V133, P740, DOI 10.1093/jn/133.3.740
   Kim JM, 1998, CARCINOGENESIS, V19, P81, DOI 10.1093/carcin/19.1.81
   KONDO K, 1994, LANCET, V344, P1152, DOI 10.1016/S0140-6736(94)90656-4
   Kuro-o M, 2001, TRENDS MOL MED, V7, P179, DOI 10.1016/S1471-4914(01)01921-9
   Lee SMY, 2002, LIFE SCI, V71, P2267, DOI 10.1016/S0024-3205(02)01962-8
   Makino T, 2002, BIOL PHARM BULL, V25, P523, DOI 10.1248/bpb.25.523
   Makino T, 2002, J ETHNOPHARMACOL, V82, P35, DOI 10.1016/S0378-8741(02)00175-7
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449
   MORIGUCHI T, 1994, BIOL PHARM BULL, V17, P1589, DOI 10.1248/bpb.17.1589
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   NAKAMURA K, 1991, NEPHRON, V58, P42, DOI 10.1159/000186376
   OBOSOVA IG, 2003, FREE RADIC BIOL MED, V34, P186
   Okubo T, 2000, BIOL PHARM BULL, V23, P199, DOI 10.1248/bpb.23.199
   OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290
   Rahman K, 2003, AGEING RES REV, V2, P39, DOI 10.1016/S1568-1637(02)00049-1
   RECKELHOFF JF, 1994, LIFE SCI, V55, P1895, DOI 10.1016/0024-3205(94)00521-4
   Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704
   Scapagnini G, 2002, INT J TISSUE REACT, V24, P89
   Schindowski K, 2001, J NEURAL TRANSM, V108, P969, DOI 10.1007/s007020170016
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   TAKAHASHI H, 1991, CLIN J CHINESE MED, V12, P145
   TAKAHASHI M, 1992, JPN J PHARMACOL, V60, P307, DOI 10.1254/jjp.60.307
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Toprakçi M, 2000, INT J CLIN LAB RES, V30, P83
   Troen BR, 2003, MT SINAI J MED, V70, P3
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Yao HW, 2003, WORLD J GASTROENTERO, V9, P320, DOI 10.3748/wjg.v9.i2.320
   Yokozawa T, 1998, NEPHRON, V78, P201, DOI 10.1159/000044911
   YOKOZAWA T, 1995, NEPHRON, V70, P382, DOI 10.1159/000188627
   Yokozawa T, 1997, NEPHRON, V75, P103, DOI 10.1159/000189510
   YOKOZAWA T, 1991, NEPHRON, V58, P90, DOI 10.1159/000186384
   YOKOZAWA T, 1990, NEPHRON, V56, P249, DOI 10.1159/000186149
   Yoshikawa T, 1999, ANTIOXID REDOX SIGN, V1, P469, DOI 10.1089/ars.1999.1.4-469
NR 53
TC 31
Z9 32
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JUL-AUG
PY 2004
VL 39
IS 1
BP 69
EP 82
DI 10.1016/j.archger.2004.01.001
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 829RC
UT WOS:000222066300007
PM 15158582
DA 2024-02-19
ER

PT J
AU Dupressoir, A
   Puech, A
   Heidmann, T
AF Dupressoir, A
   Puech, A
   Heidmann, T
TI IAP retrotransposons in the mouse liver as reporters of ageing
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
LA English
DT Article
DE IAP; retrotransposon; ageing; gene tagging; (mouse liver)
ID INTRACISTERNAL-A-PARTICLES; CELL LINE WEHI-3B; X-LINKED GENE;
   NUCLEOTIDE-SEQUENCE; EXPRESSION; LEUKEMIA; GENOME; VIRUS; RNA;
   INTERLEUKIN-3
AB IAP are endogenous retrovirus-like elements present at a thousand copies in the murine genome. They can modulate the level of expression of the tagged genes into which they have inserted, and conversely their activity could be influenced by the level of activity of the genes and/or DNA sequences into which they are embedded. In this report, we have analysed by Northern blots the pattern of expression of the IAP-related transcripts in the organs of young and ageing mice. We show that IAP transcripts of unexpected size (namely 10 kb and 6 kb) are induced in the liver of ageing mice from all inbred and hybrid strains tested. These transcripts are not detected in young mice, and their intensity disclose variations depending on the strain, as those observed for the two canonical 7.2 and 5.4 kb IAP transcripts. It is suggested that these age-dependent IAP transcripts originate from unique sites within the mouse genome that are 'tagged' by an IAP sequence, which would be sensitive both to strain-dependent cellular factors acting at the level of all IAPs, and to an age-dependent liver-specific cellular factor and/or DNA state, responsible for the position-dependent effect. These age-dependent transcripts should allow the identification of putative genes or factors of 'senescence'.
C1 INST GUSTAVE ROUSSY, CNRS URA 147, UNITE PHYSICHIMIE & PHARMACOL MACROMOLEC BIOL, F-94805 VILLEJUIF, FRANCE.
C3 UNICANCER; Gustave Roussy
RI PUECH, Anne/A-7470-2013; Dupressoir, Anne/M-5280-2018
OI Dupressoir, Anne/0000-0002-3464-8513
CR [Anonymous], MOBILE DNA
   ASCH BB, 1990, CANCER RES, V50, P2404
   AUGENLICHT LH, 1984, J BIOL CHEM, V259, P1842
   BROWN S, 1988, GENET RES, V52, P151, DOI 10.1017/S0016672300027531
   CHANGYEH A, 1991, NUCLEIC ACIDS RES, V19, P3667, DOI 10.1093/nar/19.13.3667
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   DEAN RG, 1985, ARCH GERONTOL GERIAT, V4, P43, DOI 10.1016/0167-4943(85)90017-2
   DEOCA FHM, 1984, BIOL CELL, V52, P199
   DUPRESSOIR A, UNPUB
   FEENSTRA A, 1986, NUCLEIC ACIDS RES, V14, P4343, DOI 10.1093/nar/14.10.4343
   FLORINE DL, 1980, CANCER RES, V40, P519
   GAUBATZ JW, 1991, MECH AGEING DEV, V57, P71, DOI 10.1016/0047-6374(91)90025-U
   HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M
   Kanungo MS, 1994, GENES AGING, P167
   KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881
   KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7
   KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474
   KUFF EL, 1990, CANCER CELL-MON REV, V2, P398
   LATCHMAN DS, 1991, EUKARYOTIC TRANSCRIP
   LUEDERS KK, 1993, MOL CELL BIOL, V13, P7439, DOI 10.1128/MCB.13.12.7439
   LUEDERS KK, 1977, CELL, V12, P963, DOI 10.1016/0092-8674(77)90161-1
   MAYHOOPES LL, 1983, MOL CELL BIOL, V3, P1371
   MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463
   MIETZ JA, 1992, MOL CELL BIOL, V12, P220, DOI 10.1128/MCB.12.1.220
   MIETZ JA, 1987, J VIROL, V61, P3020, DOI 10.1128/JVI.61.10.3020-3029.1987
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431
   WAREHAM KA, 1987, NATURE, V327, P725, DOI 10.1038/327725a0
   Yeivin A, 1993, EXS, V64, P523
   YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0
   YMER S, 1986, NUCLEIC ACIDS RES, V14, P5901, DOI 10.1093/nar/14.14.5901
   [No title captured]
NR 33
TC 14
Z9 14
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4781
J9 BBA-GENE STRUCT EXPR
JI Biochim. Biophys. Acta-Gene Struct. Expression
PD DEC 27
PY 1995
VL 1264
IS 3
BP 397
EP 402
DI 10.1016/0167-4781(95)00181-6
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA TP083
UT WOS:A1995TP08300024
PM 8547329
DA 2024-02-19
ER

PT J
AU Novoa, B
   Pereiro, P
   López-Muñoz, A
   Varela, M
   Forn-Cuní, G
   Anchelin, M
   Dios, S
   Romero, A
   Martinez-López, A
   Medina-Gali, RM
   Collado, M
   Coll, J
   Estepa, A
   Cayuela, ML
   Mulero, V
   Figueras, A
AF Novoa, Beatriz
   Pereiro, Patricia
   Lopez-Munoz, Azucena
   Varela, Monica
   Forn-Cuni, Gabriel
   Anchelin, Monique
   Dios, Sonia
   Romero, Alejandro
   Martinez-Lopez, Alicia
   Maria Medina-Gali, Regla
   Collado, Manuel
   Coll, Julio
   Estepa, Amparo
   Luisa Cayuela, Maria
   Mulero, Victoriano
   Figueras, Antonio
TI Rag1 immunodeficiency-induced early aging and senescence in zebrafish
   are dependent on chronic inflammation and oxidative stress
SO AGING CELL
LA English
DT Article; Early Access
DE aging; DNA damage; inflammation; oxidative stress; rag1; senescence
ID ACETYL-L-HISTIDINE; DNA-DAMAGE; CELLULAR SENESCENCE; HUMAN-DISEASE;
   INHIBITION; ARREST; CELLS; MODEL; P53; RECOMBINASE
AB In mammals, recombination activating gene 1 (RAG1) plays a crucial role in adaptive immunity, generating a vast range of immunoglobulins. Rag1(-/-) zebrafish (Danio rerio) are viable and reach adulthood without obvious signs of infectious disease in standard nonsterile conditions, suggesting that innate immunity could be enhanced to compensate for the lack of adaptive immunity. By using microarray analysis, we confirmed that the expression of immunity- and apoptosis-related genes was increased in the rag1(-/-) fish. This tool also allows us to notice alterations of the DNA repair and cell cycle mechanisms in rag1(-/-) zebrafish. Several senescence and aging markers were analyzed. In addition to the lower lifespan of rag1(-/-) zebrafish compared to their wild-type (wt) siblings, rag1(-/-) showed a higher incidence of cell cycle arrest and apoptosis, a greater amount of phosphorylated histone H2AX, oxidative stress and decline of the antioxidant mechanisms, an upregulated expression and activity of senescence-related genes and senescence-associated beta-galactosidase, respectively, diminished telomere length, and abnormal self-renewal and repair capacities in the retina and liver. Metabolomic analysis also demonstrated clear differences between wt and rag1(-/-) fish, as was the deficiency of the antioxidant metabolite l-acetylcarnitine (ALCAR) in rag1(-/-) fish. Therefore, Rag1 activity does not seem to be limited to V(D)J recombination but is also involved in senescence and aging. Furthermore, we confirmed the senolytic effect of ABT-263, a known senolytic compound and, for the first time, the potential in vivo senolytic activity of the antioxidant agent ALCAR, suggesting that this metabolite is essential to avoid premature aging.
C1 [Novoa, Beatriz; Pereiro, Patricia; Varela, Monica; Forn-Cuni, Gabriel; Dios, Sonia; Romero, Alejandro; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain.
   [Lopez-Munoz, Azucena; Mulero, Victoriano] Univ Murcia, IMIB Arrixaca, Fac Biol, Dept Biol Celular & Histol, Murcia, Spain.
   [Anchelin, Monique; Luisa Cayuela, Maria] Hosp Clin Univ Virgen de la Arrixaca, IMIB Arrixaca, Grp Telomerasa Canc & Envejecimiento, Murcia, Spain.
   [Martinez-Lopez, Alicia; Maria Medina-Gali, Regla; Estepa, Amparo] UMH, IBMC, Elche, Spain.
   [Collado, Manuel] Complexo Hosp Univ Santiago de Compostela CHUS, SERGAS, Inst Invest Sanitaria Santiago de Compostela IDIS, Santiago De Compostela, Spain.
   [Coll, Julio] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Investigaciones Marinas (IIM); University of Murcia; Hospital Clinico
   Universitario Virgen de la Arrixaca; Hospital Clinico Universitario
   Virgen de la Arrixaca; Universidad Miguel Hernandez de Elche; Complexo
   Hospitalario Universitario de Santiago de Compostela; Instituto Nacional
   Investigacion Tecnologia Agraria Alimentaria (INIA)
RP Novoa, B (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.
EM beatriznovoa@iim.csic.es
RI Pereiro, Patricia/AAS-9514-2020; Forn-Cuní, Gabriel/M-8498-2016;
   Figueras, Antonio/B-5133-2015; Martinez Lopez, Alicia/HSI-3331-2023;
   Mulero, Victoriano/L-2730-2014; Collado, Manuel/K-8140-2014; Dios,
   Sonia/M-4201-2018; Novoa, Beatriz/K-3785-2014; Figueras,
   Antonio/AAB-8921-2019; Romero, Alejandro/R-4565-2019; Gali, Regla María
   Medina/AAH-9742-2020
OI Pereiro, Patricia/0000-0002-8734-3334; Forn-Cuní,
   Gabriel/0000-0001-5976-4759; Figueras, Antonio/0000-0002-0617-0030;
   Mulero, Victoriano/0000-0001-9527-0211; Collado,
   Manuel/0000-0002-0330-0880; Dios, Sonia/0000-0002-2126-991X; Novoa,
   Beatriz/0000-0003-4888-8419; Figueras, Antonio/0000-0002-0617-0030;
   Romero, Alejandro/0000-0002-9343-3352; Gali, Regla María
   Medina/0000-0001-9401-8292; Varela, Monica/0000-0003-0215-9173; Martinez
   Lopez, Alicia/0000-0003-3347-0394
FU Spanish Ministry of Economy and Competitiveness [AGL2014-51773-C3,
   BIO2017-828, 51-C3-1-R, PIE 201230E057]; Agencia Estatal Consejo
   Superior de Investigaciones Cientificas (CSIC) [BIO2011-23400,
   BIO2014-52655-R, PI13/0234]; Fondos Europeos de Desarrollo
   Regional/European Regional Development Funds; Fundacion Seneca-Murcia
   [19400/PI/14]; Conselleria de Economia, Emprego e Industria (GAIN),
   Xunta de Galicia [IN607B 2016/12]
FX Spanish Ministry of Economy and Competitiveness, Grant/Award Number:
   AGL2014-51773-C3, BIO2017-828, 51-C3-1-R and PIE 201230E057; Agencia
   Estatal Consejo Superior de Investigaciones Cientificas (CSIC),
   Grant/Award Number: BIO2011-23400, BIO2014-52655-R and PI13/0234; Fondos
   Europeos de Desarrollo Regional/European Regional Development Funds;
   Fundacion Seneca-Murcia, Grant/Award Number: 19400/PI/14; Conselleria de
   Economia, Emprego e Industria (GAIN), Xunta de Galicia, Grant/Award
   Number: IN607B 2016/12
CR Baslow MH, 1997, J NEUROCHEM, V68, P1335
   Baslow MH, 2015, BIOMOLECULES, V5, P635, DOI 10.3390/biom5020635
   Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Blagosklonny MV, 2012, AGING-US, V4, P159, DOI 10.18632/aging.100443
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040
   CAMPBELL PW, 1995, PEDIATR PULM, V20, P44, DOI 10.1002/ppul.1950200109
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   COSTELL M, 1989, BIOCHEM BIOPH RES CO, V161, P1135, DOI 10.1016/0006-291X(89)91360-0
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024
   Forn-Cuní G, 2017, SCI REP-UK, V7, DOI 10.1038/srep41905
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   García-Valtanen P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00121
   Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134
   Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184
   Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214
   Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124
   Hohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044451
   Jima DD, 2009, MOL IMMUNOL, V46, P1505, DOI 10.1016/j.molimm.2008.12.021
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026
   KASTAN MB, 1991, CANCER RES, V51, P6304
   Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047
   Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152
   KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491
   Lescale C, 2017, MECH AGEING DEV, V165, P3, DOI 10.1016/j.mad.2016.11.003
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   MACCARI F, 1990, EXP GERONTOL, V25, P127, DOI 10.1016/0531-5565(90)90043-2
   Masud S, 2019, AUTOPHAGY, V15, P796, DOI 10.1080/15548627.2019.1569297
   Mathias JR, 2009, DEV COMP IMMUNOL, V33, P1212, DOI 10.1016/j.dci.2009.07.003
   McDade TW, 2016, EVOL MED PUBLIC HLTH, P1, DOI 10.1093/emph/eov033
   Mobarak H, 2017, VET RES COMMUN, V41, P41, DOI 10.1007/s11259-016-9670-9
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL
   Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579
   Pan J, 2017, INT J RADIAT ONCOL, V99, P353, DOI 10.1016/j.ijrobp.2017.02.216
   Pereiro P, 2015, DEV COMP IMMUNOL, V51, P148, DOI 10.1016/j.dci.2015.03.009
   Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Råberg L, 2002, P ROY SOC B-BIOL SCI, V269, P817, DOI 10.1098/rspb.2001.1953
   Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434
   Savitha S, 2005, CLIN CHIM ACTA, V355, P173, DOI 10.1016/j.cccn.2004.12.005
   Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045
   Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Singh S, 2016, MOL NEUROBIOL, V53, P4286, DOI 10.1007/s12035-015-9361-5
   Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b
   STEIN GH, 1995, BIOESSAYS, V17, P537, DOI 10.1002/bies.950170610
   Stöckl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Surendran S, 2011, INT J NEUROSCI, V121, P305, DOI 10.3109/00207454.2011.558225
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Tort L., 2003, Inmunologia, V22, P277
   Tsai SB, 2007, AGING CELL, V6, P209, DOI 10.1111/j.1474-9726.2007.00278.x
   Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836
   Walters KB, 2010, BLOOD, V116, P2803, DOI 10.1182/blood-2010-03-276972
   Westerfield M., 2000, The Zebrafish Book. A guide for the laboratory use of zebrafish (danio rerio), V4th ed.
   Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762
   Willett CE, 1997, IMMUNOGENETICS, V45, P394, DOI 10.1007/s002510050221
   Williams AB, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026070
   Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810
   Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yu QJ, 2015, CELL REP, V11, P785, DOI 10.1016/j.celrep.2015.03.069
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
NR 78
TC 17
Z9 18
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2019 OCT
PY 2019
VL 18
IS 5
AR e13020
DI 10.1111/acel.13020
EA JUL 2019
PG 17
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA IU6IX
UT WOS:000479719300001
PM 31348603
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Koudelkova, P
   Weber, G
   Mikulits, W
AF Koudelkova, Petra
   Weber, Gerhard
   Mikulits, Wolfgang
TI Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF
SO PLOS ONE
LA English
DT Article
ID PHENOTYPIC HETEROGENEITY; EXPRESSION; CULTURE; PECAM-1
AB Liver sinusoidal endothelial cells (LSECs) represent a highly differentiated cell type that lines hepatic sinusoids. LSECs form a discontinuous endothelium due to fenestrations under physiological conditions, which are reduced upon chronic liver injury. Cultivation of rodent LSECs associates with a rapid onset of stress-induced senescence a few days post isolation, which limits genetic and biochemical studies ex vivo. Here we show the establishment of LSECs isolated from p19(ARF-/-) mice which undergo more than 50 cell doublings in the absence of senescence. Isolated p19(ARF-/-) LSECs display a cobblestone-like morphology and show the ability of tube formation. Analysis of DNA content revealed a stable diploid phenotype after long-term passaging without a gain of aneuploidy. Notably, p19(ARF-/-) LSECs express the endothelial markers CD31, vascular endothelial growth factor receptor (VEGFR)-2, VE-cadherin, von Willebrand factor, stabilin-2 and CD146 suggesting that these cells harbor and maintain an endothelial phenotype. In line, treatment with small molecule inhibitors against VEGFR-2 caused cell death, demonstrating the sustained ability of p19(ARF-/-) LSECs to respond to anti-angiogenic therapeutics. From these data we conclude that loss of p19(ARF) overcomes senescence of LSECs, allowing immortalization of cells without losing endothelial characteristics. Thus, p19(ARF-/-) LSECs provide a novel cellular model to study endothelial cell biology.
C1 [Koudelkova, Petra; Weber, Gerhard; Mikulits, Wolfgang] Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria.
C3 Medical University of Vienna
RP Mikulits, W (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Div Inst Canc Res, Dept Med 1, Vienna, Austria.
EM wolfgang.mikulits@meduniwien.ac.at
RI Mikulits, Wolfgang/AAH-4043-2021
OI Mikulits, Wolfgang/0000-0003-4612-7106
FU People Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme, Spain (FP7) under Research Executive Agency Grant
   [PITN-GA-2012-316549-(IT-LIVER)]
FX People Programme (Marie Curie Actions) of the European Union's Seventh
   Framework Programme, Spain (FP7/2007-2013) under Research Executive
   Agency Grant agreement no. PITN-GA-2012-316549-(IT-LIVER) to WM. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   Angst BD, 2001, J CELL SCI, V114, P629
   Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6
   Bian Chang, 2005, J Zhejiang Univ Sci B, V6, P631, DOI 10.1631/jzus.2005.B0631
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Daneker GW, 1998, IN VITRO CELL DEV-AN, V34, P370, DOI 10.1007/s11626-998-0018-9
   Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111
   DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006
   DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025
   Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377
   Géraud C, 2013, LIVER INT, V33, P1428, DOI 10.1111/liv.12262
   Géraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618
   Gotzmann J, 2002, J CELL SCI, V115, P1189
   Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429
   March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085
   Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084
   NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x
   Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3
   Oommen S, 2011, J BIOL CHEM, V286, P1083, DOI 10.1074/jbc.M110.175158
   Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870
   Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717
   Ponnuchamy B, 2008, CIRC RES, V102, P1139, DOI 10.1161/CIRCRESAHA.108.177394
   Proell V, 2005, BBA-MOL CELL RES, V1744, P76, DOI 10.1016/j.bbamcr.2004.12.009
   QUELLE DE, 1995, CELL, V83, P993
   Sano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089830
   Schneider GP, 2002, CLIN CANCER RES, V8, P3955
   Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x
   Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004
   Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5
   Siow RCM, 2012, METHODS MOL BIOL, V806, P265, DOI 10.1007/978-1-61779-367-7_18
   Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603
   Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456
   Wu WC, 2003, ONCOGENE, V22, P3361, DOI 10.1038/sj.onc.1206285
   Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494
NR 39
TC 12
Z9 16
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 3
PY 2015
VL 10
IS 11
AR e0142134
DI 10.1371/journal.pone.0142134
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CV1QH
UT WOS:000364032600106
PM 26528722
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Cheng, X
   Ali, MSSH
   Moran, M
   Viana, MP
   Schlichte, SL
   Zimmerman, MC
   Khalimonchuk, O
   Feinberg, MW
   Sun, XH
AF Cheng, Xiao
   Ali, Mohamed Sham Shihabudeen Haider
   Moran, Matthew
   Viana, Martonio Ponte
   Schlichte, Sarah L.
   Zimmerman, Matthew C.
   Khalimonchuk, Oleh
   Feinberg, Mark W.
   Sun, Xinghui
TI Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and
   insulin signaling by inducing cellular senescence of hepatic endothelium
   in obesity
SO REDOX BIOLOGY
LA English
DT Article; Early Access
DE Long noncoding RNAs; Cellular senescence; Obesity; Hepatic endothelium;
   Glucose homeostasis
ID DIFFERENTIAL EXPRESSION ANALYSIS; DIET-INDUCED OBESITY; GENE-EXPRESSION;
   CELLS; MOUSE; INFLAMMATION; MECHANISMS; P53; SUPEROXIDE; PHYSIOLOGY
AB Obesity-induced insulin resistance is a risk factor for diabetes and cardiovascular disease. However, the mechanisms underlying endothelial senescence in obesity, and how it impacts obesity-induced insulin resistance remain incompletely understood. In this study, transcriptome analysis revealed that the long non-coding RNA (lncRNA) Maternally expressed gene 3 (Meg3) is one of the top differentially expressed lncRNAs in the vascular endothelium in diet-induced obese mice. Meg3 knockdown induces cellular senescence of endothelial cells characterized by increased senescence-associated beta-galactosidase activity, increased levels of endogenous superoxide, impaired mitochondrial structure and function, and impaired autophagy. Moreover, Meg3 knockdown causes cellular senescence of hepatic endothelium in diet-induced obese mice. Furthermore, Meg3 expression is elevated in human nonalcoholic fatty livers and nonalcoholic steatohepatitis livers, which positively correlates with the expression of CDKN2A encoding p16, an important hallmark of cellular senescence. Meg3 knockdown potentiates obesity-induced insulin resistance and impairs glucose homeostasis. Insulin signaling is reduced by Meg3 knockdown in the liver and, to a lesser extent, in the skeletal muscle, but not in the visceral fat of obese mice. We found that the attenuation of cellular senescence of hepatic endothelium by ablating p53 expression in vascular endothelium can restore impaired glucose homeostasis and insulin signaling in obesity. In conclusion, our data demonstrate that cellular senescence of hepatic endothelium promotes obesity-induced insulin resistance, which is tightly regulated by the expression of Meg3. Our results suggest that manipulation of Meg3 expression may represent a novel approach to managing obesity-associated hepatic endothelial senescence and insulin resistance.
C1 [Cheng, Xiao; Ali, Mohamed Sham Shihabudeen Haider; Moran, Matthew; Viana, Martonio Ponte; Khalimonchuk, Oleh; Sun, Xinghui] Univ Nebraska, Beadle Ctr, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA.
   [Schlichte, Sarah L.; Zimmerman, Matthew C.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, 985850 Nebraska Med Ctr, Omaha, NE 68198 USA.
   [Zimmerman, Matthew C.; Khalimonchuk, Oleh] Univ Nebraska, Nebraska Redox Biol Ctr, Lincoln, NE 68588 USA.
   [Khalimonchuk, Oleh; Sun, Xinghui] Univ Nebraska, Nebraska Ctr Integrated Biomol Commun, Lincoln, NE 68588 USA.
   [Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA.
   [Sun, Xinghui] Univ Nebraska, Nebraska Ctr Prevent Obes Dis Dietary Mol, Lincoln, NE 68588 USA.
C3 University of Nebraska System; University of Nebraska Lincoln;
   University of Nebraska System; University of Nebraska Medical Center;
   University of Nebraska System; University of Nebraska Lincoln;
   University of Nebraska System; University of Nebraska Lincoln; Harvard
   University; Brigham & Women's Hospital; Harvard Medical School;
   University of Nebraska System; University of Nebraska Lincoln
RP Sun, XH (corresponding author), Univ Nebraska, Dept Biochem, Beadle N158,1901 Vine St, Lincoln, NE 68588 USA.
EM xsun17@unl.edu
RI Cheng, Xiao/AAV-2712-2021; Khalimonchuk, Oleh/AAM-1194-2021
OI Khalimonchuk, Oleh/0000-0002-3972-8678; Zimmerman,
   Matthew/0000-0001-5658-9051; sun, xinghui/0000-0002-1156-0375; Feinberg,
   Mark/0000-0001-9523-3859; Schlichte, Sarah/0000-0002-2506-3599; Moran,
   Matthew/0000-0003-3739-4536
FU National Institute of General Medical Sciences of the National
   Institutes of Health [P30GM103335]; National Institutes of Health
   [P30GM103335, 1P20GM104320, HL150536, HL115141, HL134849, HL148207,
   HL148355, HL153356, GM108975, GM131701-01, HSN276201200017C]; American
   Heart Association SDG [15SDG25400012, 18SFRN33900144]; National
   Institutes of Health Funded T32 grant [5T32GM10700104]; Boston Nutrition
   Obesity Research Center - NIH grant [P30DK046200]; National Institutes
   of Health
FX We thank Dr. Reinier Boon and Dr. Stefanie Dimmeler for providing the
   target sequence of human and mouse Meg3 gapmeRs, Dr. Jason C. Kovacic
   for providing Cdh5CreERT2 Cre mice, Dr. Mi-Jeong Lee and Dr. Susan K.
   Fried for providing unidentified human white adipose tissues, and
   technologists Emily Barber and Mengna Xia at the Biomedical and Obesity
   Research Core of the Nebraska Center for Prevention of Obesity Diseases
   for assisting with mouse metabolic cage studies. Proteomics experiments
   in Fig. S7 were carried out by the Proteomics and Mass Spectrometry Core
   facility at Princeton University. EPR Spectroscopy data (Fig. 2C) was
   collected in the University of Nebraska's EPR Spectroscopy Core, which
   was established, in part, by a grant from the National Institute of
   General Medical Sciences of the National Institutes of Health
   (P30GM103335) awarded to the University of Nebraska's Redox Biology
   Center. This work was supported by the National Institutes of Health
   Funded COBRE grant 1P20GM104320 [X.S. through the Nebraska Center for
   the Prevention of Obesity-related Diseases through Dietary Molecules],
   the American Heart Association SDG#15SDG25400012 [to X.S.] and
   18SFRN33900144 [to M.W.F.], and the National Institutes of Health Funded
   T32 grant 5T32GM10700104 [to M.M.]. This work was also supported by the
   National Institutes of Health [HL150536 to X.S.; HL115141, HL134849,
   HL148207, HL148355, and HL153356 to M.W.F.; GM108975 and GM131701-01 to
   O.K.; P30GM103335 to the University of Nebraska's Redox Biology Center;
   and NIH Contract #HSN276201200017C to the Liver Tissue Cell Distribution
   System.]; and the Pilot and Feasibility Program [to X. S.] from Boston
   Nutrition Obesity Research Center funded by NIH grant P30DK046200.
   Funding for open access charge: National Institutes of Health.
CR Ali MSSH, 2019, NUCLEIC ACIDS RES, V47, P1505, DOI 10.1093/nar/gky1190
   An YA, 2019, NAT METAB, V1, P1243, DOI 10.1038/s42255-019-0149-1
   Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099
   Baker DJ, 2018, J CLIN INVEST, V128, P1208, DOI 10.1172/JCI95145
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Boon RA, 2016, J AM COLL CARDIOL, V68, P2589, DOI 10.1016/j.jacc.2016.09.949
   Brodsky SV, 2004, CIRC RES, V94, P377, DOI 10.1161/01.RES.0000111802.09964.EF
   Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Case AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164609
   Case AJ, 2013, AM J PHYSIOL-HEART C, V305, pH19, DOI 10.1152/ajpheart.00974.2012
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Chou CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122060
   Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105
   Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006
   Crowe EP, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00208
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530
   Flach RJR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9995
   Fuschi P, 2017, AGING-US, V9, P2559, DOI 10.18632/aging.101341
   Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Haemmig S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw1868
   Hammoutene A, 2020, J HEPATOL, V72, P528, DOI 10.1016/j.jhep.2019.10.028
   Hernandez-Segura A, 2019, AGING CELL, V18, DOI 10.1111/acel.12911
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Issitt T, 2019, ISCIENCE, V11, P205, DOI 10.1016/j.isci.2018.12.005
   Jaé N, 2019, VASC PHARMACOL, V114, P13, DOI 10.1016/j.vph.2018.03.003
   Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028
   Kauffman Megan E, 2016, React Oxyg Species (Apex), V2, P361, DOI 10.20455/ros.2016.865
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim YM, 2018, CELL REP, V23, P3565, DOI 10.1016/j.celrep.2018.05.054
   Kirkin V, 2019, MOL CELL, V76, P268, DOI 10.1016/j.molcel.2019.09.005
   Kleinert M, 2018, NAT REV ENDOCRINOL, V14, P140, DOI 10.1038/nrendo.2017.161
   Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886
   Konishi M, 2017, P NATL ACAD SCI USA, V114, pE8478, DOI 10.1073/pnas.1710625114
   Kopacz A, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101572
   Koval OM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav1439
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007
   Lan Y, 2019, AM J PHYSIOL-CELL PH, V316, pC830, DOI 10.1152/ajpcell.00262.2018
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lecot P, 2016, BRIT J CANCER, V114, P1180, DOI 10.1038/bjc.2016.115
   Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025
   Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161
   Leung A, 2019, VASC PHARMACOL, V114, P139, DOI 10.1016/j.vph.2018.01.007
   Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139
   Li XR, 2020, P NATL ACAD SCI USA, V117, P32584, DOI 10.1073/pnas.1922169117
   Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9
   Liu J.Y., 2019, P NATL ACAD SCI USA, V116
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042
   Merrill RA, 2017, NEUROMETHODS, V123, P31, DOI 10.1007/978-1-4939-6890-9_2
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Natarelli L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05065-z
   Neumann P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02431-1
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Payne S, 2018, ARTERIOSCL THROM VAS, V38, P2550, DOI 10.1161/ATVBAHA.118.309669
   Pedersen DJ, 2015, MOL METAB, V4, P507, DOI 10.1016/j.molmet.2015.04.003
   Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017
   Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Ruart M, 2019, J HEPATOL, V70, P458, DOI 10.1016/j.jhep.2018.10.015
   Sarig R, 2019, CIRCULATION, V139, P2491, DOI 10.1161/CIRCULATIONAHA.119.040125
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Simion V, 2019, VASC PHARMACOL, V114, P145, DOI 10.1016/j.vph.2018.01.003
   Sörensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508
   Stein CS, 2018, CELL REP, V23, P3710, DOI 10.1016/j.celrep.2018.06.002
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Sun XH, 2020, AM J PHYSIOL-CELL PH, V318, pC1200, DOI 10.1152/ajpcell.00062.2020
   Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166
   SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163
   Tang YF, 2010, GENESIS, V48, P563, DOI 10.1002/dvg.20654
   Team RC, 2020, R: A Language and Environment for Statistical
   Tencerova M, 2019, CELL REP, V27, P2050, DOI 10.1016/j.celrep.2019.04.066
   Thompson PJ, 2019, CELL METAB, V29, P1045, DOI 10.1016/j.cmet.2019.01.021
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71
   Vasileiou PVS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070686
   Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27
   Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143
   Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002
   Weirick T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00522
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Williams LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106159
   Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215
   Yokoyama M, 2014, CELL REP, V7, P1691, DOI 10.1016/j.celrep.2014.04.046
   Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 102
TC 23
Z9 26
U1 1
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD 2021 APR
PY 2021
VL 40
AR 101863
DI 10.1016/j.redox.2021.101863
EA JAN 2021
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA QL5GS
UT WOS:000621105900004
PM 33508742
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Chiang, WD
   Huang, CY
   Paul, CR
   Lee, ZY
   Lin, WT
AF Chiang, Wen-Dee
   Huang, Chih Yang
   Paul, Catherine Reena
   Lee, Zong-Yan
   Lin, Wan-Teng
TI Lipolysis stimulating peptides of potato protein hydrolysate effectively
   suppresses high-fat-diet-induced hepatocyte apoptosis and fibrosis in
   aging rats
SO FOOD & NUTRITION RESEARCH
LA English
DT Article
DE apoptosis; fibrosis; high fat diet; lipolysis stimulating protein
   hydrolysates; obesity; APPH
ID LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; PROBUCOL; OBESITY;
   SECRETION
AB Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common outcomes of obesity and is characterized by the accumulation of triglycerides, increased tissue apoptosis, and fibrosis. NAFLD is more common among elderly than in younger age groups, and it causes serious hepatic complications.
   Objective: In this study, alcalase treatment derived potato protein hydrolysate (APPH) with lipolysis-stimulating property has been evaluated for its efficiency to provide hepato-protection in a high-fat-diet (HFD)-fed aging rats.
   Design: Twenty-four-month-old SD rats were randomly divided into six groups (n = 8): aged rats fed with standard chow, HFD-induced aged obese rats, HFD with low-dose (15 mg/kg/day) APPH treatment, HFD with moderate (45 mg/kg/day) APPH treatment, HFD with high (75 mg/kg/day) APPH treatment, and HFD with probucol.
   Results: APPH was found to reduce the NAFLD-related effects in rat livers induced by HFD and all of the HFD-fed rats exhibited heavier body weight than those with control chow diet. However, the HFD-induced hepatic fat accumulation was effectively attenuated in rats administered with low (15 mg/kg/day), moderate (45 mg/kg/day), and high (75 mg/kg/day) doses of APPH. APPH oral administration also suppressed the hepatic apoptosis-and fibrosis-related proteins induced by HFD.
   Conclusions: Our results thus indicate that APPH potentially attenuates hepatic lipid accumulation and antiapoptosis and fibrosis effects in HFD-induced rats. APPH may have therapeutic potential in the amelioration of NAFLD liver damage.
C1 [Chiang, Wen-Dee] Tunghai Univ, Dept Food Sci, Coll Agr, Taichung, Taiwan.
   [Huang, Chih Yang; Paul, Catherine Reena] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.
   [Huang, Chih Yang] China Med Univ, Sch Chinese Med, Taichung, Taiwan.
   [Huang, Chih Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.
   [Paul, Catherine Reena; Lee, Zong-Yan; Lin, Wan-Teng] Tunghai Univ, Dept Hospitality Management, Coll Agr, 1727,Sec 4,Taiwan Blvd, Taichung 40704, Taiwan.
C3 Tunghai University; China Medical University Taiwan; China Medical
   University Taiwan; Asia University Taiwan; Tunghai University
RP Lin, WT (corresponding author), Tunghai Univ, Dept Hospitality Management, Coll Agr, 1727,Sec 4,Taiwan Blvd, Taichung 40704, Taiwan.
EM 040770@thu.edu.tw
RI Chiang, Wen-Dee/AAP-5049-2020; Huang, Kevin Chih-Yang/O-5170-2015
OI Lin, Wan-Teng/0000-0001-7700-3398; Huang, Kevin
   Chih-Yang/0000-0002-0266-3233
FU Ministry of Science and Technology of Taiwan [MOST103-2410-H-029-037,
   MOST104-2410-H-029-033-MY2]
FX The authors declare no conflict of financial interest. This Research was
   financially supported by a grant from the Ministry of Science and
   Technology of Taiwan (MOST103-2410-H-029-037 and
   MOST104-2410-H-029-033-MY2).
CR Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996
   Ambigaipalan P, 2015, J AGR FOOD CHEM, V63, P864, DOI 10.1021/jf505327b
   Valiñas MA, 2015, J AGR FOOD CHEM, V63, P4902, DOI 10.1021/jf505777p
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bogdanova Katerina, 2006, Biomedical Papers (Olomouc), V150, P101, DOI 10.5507/bp.2006.014
   Bouziana Stella D, 2013, World J Gastrointest Pharmacol Ther, V4, P4, DOI 10.4292/wjgpt.v4.i1.4
   Bravo E, 1996, J BIOCHEM-TOKYO, V119, P240, DOI 10.1093/oxfordjournals.jbchem.a021229
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Chakraborty JB, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/648915
   Elahi D, 2002, NOVART FDN SYMP, V242, P222
   Elahi D, 2002, NOVART FDN SYMP, V242
   Goto M, 2009, REPRODUCTION, V137, P835, DOI 10.1530/REP-08-0315
   Hu WS, 2015, INT J MOL SCI, V16, P10158, DOI 10.3390/ijms160510158
   Huang CY, 2015, J FUNCT FOODS, V12, P389, DOI 10.1016/j.jff.2014.11.027
   Huang CY, 2012, BIOMEDICINE-TAIWAN, V2, P36, DOI 10.1016/j.biomed.2011.12.004
   Jiang Y, 2011, J MOL MED, V89, P1207, DOI 10.1007/s00109-011-0790-y
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Lee J, 2014, NUTR RES PRACT, V8, P284, DOI 10.4162/nrp.2014.8.3.284
   Lin WT, 2016, TAIWANESE J AGR CHEM, V54, P53
   Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432
   Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404
   Merat S, 2003, J CLIN GASTROENTEROL, V36, P266, DOI 10.1097/00004836-200303000-00015
   Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030
   Ou HC, 2010, J AGR FOOD CHEM, V58, P10347, DOI [10.1021/jf101606s, 10.1021/Jf101606s]
   Park MT, 2003, CLIN CANCER RES, V9, P878
   Sundaram Sneha, 2013, J Carcinog, V12, P19, DOI 10.4103/1477-3163.119606
   TAWARA K, 1986, JPN J PHARMACOL, V40, P123, DOI 10.1254/jjp.40.123
   Tokushige K, 2007, HEPATOL RES, V37, P872, DOI 10.1111/j.1872-034X.2007.00128.x
   Tsou MJ, 2013, FOOD CHEM, V138, P1454, DOI 10.1016/j.foodchem.2012.10.149
   van Koningsveld GA, 2006, J AGR FOOD CHEM, V54, P6419, DOI 10.1021/jf061278z
   Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603
   Xiao J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/642920
   Yamashita S, 2015, CURR OPIN LIPIDOL, V26, P304, DOI 10.1097/MOL.0000000000000199
   Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046
NR 34
TC 52
Z9 52
U1 1
U2 13
PU SWEDISH NUTRITION FOUNDATION-SNF
PI LUND
PA IDEON SCIENCE PARK, BESOK SCHEELEV 17 BETA 5, 3V, LUND, 223 70, SWEDEN
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PY 2016
VL 60
AR 31417
DI 10.3402/fnr.v60.31417
PG 8
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA DS9XF
UT WOS:000381136100001
PM 27415158
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Duan, XL
   Zhao, TJ
   Wang, JR
   Wang, JH
   Zheng, Y
AF Duan, Xuelin
   Zhao, Tiejian
   Wang, Jiaru
   Wang, Jiahui
   Zheng, Yang
TI Curcumol targets glutaminase 1 to regulate glutamine metabolism and
   induce senescence of hepatic stellate cells
SO EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE
LA English
DT Article; Early Access
DE Curcumol; Senescence; Glutamine; GLS1; HSC
ID ACTIVATION; MECHANISMS
AB Introduction: Curcuma is used as an herbal remedy for the treatment of chronic liver diseases, and its main active ingredient is curcumol. This study explored the molecular mechanism of curcumol in regulating glutamine metabolism.Methods: The current investigation used lipopolysaccharide (LPS) to activate hepatic stellate cells (HSCs) and then analyzed the effects of curcumol on glutamine metabolism and cell proliferation. The effects of curcumol on glutaminase 1 (GLS1), senescence-related proteins, and extracellular matrix (ECM) expression were examined by western blotting and reverse transcription-quantitative polymerase chain reaction (RT-PCR). The effect of curcumol on the cell cycle was detected by flow cytometry. Furthermore, after overexpression of GLS1, we observed the effects of curcumol on glutamine metabolism, the expression of related molecules, and the cell cycle.Results: Curcumol significantly inhibited cell proliferation, glutamine metabolism, and GLS1 and ECM expression, and also significantly promoted cell senescence. With GLS1 overexpression, the inhibitory effects of curcumol on glutamine metabolism and on promoting cell senescence were rescued.Conclusion: Curcumol targets GLS1, inhibits glutamine metabolism, and induces senescence in HSCs. GLS1 may be an important target for the pharmacological effects of curcumol.
C1 [Duan, Xuelin] Guangxi Univ Chinese Med, Coll Zhuang Med, Nanning 530222, Guangxi, Peoples R China.
   [Zhao, Tiejian; Wang, Jiaru] Guangxi Univ Chinese Med, Coll Basic Med, Dept Physiol, Nanning 530222, Guangxi, Peoples R China.
   [Wang, Jiahui; Zheng, Yang] Guangxi Univ Chinese Med, Fac Chinese Med Sci, Dept Med, Nanning 530222, Guangxi, Peoples R China.
C3 Guangxi University of Chinese Medicine; Guangxi University of Chinese
   Medicine; Guangxi University of Chinese Medicine
RP Wang, JH; Zheng, Y (corresponding author), Guangxi Univ Chinese Med, Fac Chinese Med Sci, Dept Med, Nanning 530222, Guangxi, Peoples R China.
EM wangjh@gxtcmu.edu.cn; zhengy@gxtcmu.edu.cn
OI zheng, yang/0000-0001-7646-511X
FU National Natural Science Foundation of China [81960751, 81960761,
   81660705, 2022KY1667]; Guangxi Young and Middle-Aged Teachers' Research
   Ability Improvement Project [GXZYZZ2019-1]; Guangxi Zhuangyao
   Pharmaceutical Key Laboratory [GXZYZZ2020-07, 2020GXNSFBA297094];
   Guangxi Natural Science Foundation Youth Project [2020GXNSFAA297119,
   2023GXNSFBA026274, 2022QN008]; Guangxi University of Traditional Chinese
   Medicine School-level Project Youth Fund [2022MS008]; Faculty of Chinese
   Medicine Science Guangxi University of Chinese Medicine Research Project
   [2022QJ001];  [82204755]
FX This study was funded by the National Natural Science Foundation of
   China (Grant Nos. 82204755, 81960751, 81960761, and 81660705) , the
   Guangxi Young and Middle-Aged Teachers' Research Ability Improvement
   Project (Grant No. 2022KY1667) , the Guangxi Zhuangyao Pharmaceutical
   Key Laboratory (Grant Nos. GXZYZZ2019-1 and GXZYZZ2020-07) , the Guangxi
   Natural Science Foundation Youth Project (Grant Nos. 2020GXNSFBA297094,
   2020GXNSFAA297119, and 2023GXNSFBA026274) , the Guangxi University of
   Traditional Chinese Medicine School-level Project Youth Fund (Grant No.
   2022QN008) , and the Faculty of Chinese Medicine Science Guangxi
   University of Chinese Medicine Research Project (2022MS008 and
   2022QJ001) .
CR Chen QZ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02921-z
   Chen XiaoJun, 2018, Journal of Pharmaceutical Research, V37, P664
   Czarkwiani A, 2018, CURR OPIN CELL BIOL, V55, P74, DOI 10.1016/j.ceb.2018.05.014
   Dai WQ, 2020, J HEPATOL, V72, P909, DOI 10.1016/j.jhep.2019.12.015
   Dewidar B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111419
   Du K, 2020, CELL MOL GASTROENTER, V10, P1, DOI 10.1016/j.jcmgh.2019.12.006
   Du K, 2018, GASTROENTEROLOGY, V154, P1465, DOI 10.1053/j.gastro.2017.12.022
   Fabregat I, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00357
   Ferguson G, 2016, ARCH BIOCHEM BIOPHYS, V593, P12, DOI 10.1016/j.abb.2016.01.017
   Fu Jia, 2019, Zhongguo Zhong Yao Za Zhi, V44, P3672, DOI 10.19540/j.cnki.cjcmm.20190415.201
   Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823
   Kawakami I, 2022, BIOCHEM BIOPH RES CO, V611, P99, DOI 10.1016/j.bbrc.2022.04.068
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Krenkel O, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050503
   Li GY, 2020, PHYTOTHER RES, V34, P1421, DOI 10.1002/ptr.6616
   Li J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182679
   Lu WQ, 2010, CANCER CELL, V18, P199, DOI 10.1016/j.ccr.2010.08.017
   Lv J, 2016, ACTA BIOCH BIOPH SIN, V48, P17, DOI 10.1093/abbs/gmv102
   National Pharmacopoeia Commission, 2020, Pharmacopoeia of the people's republic of China (Part 1)
   [聂添情 Nie Tianqing], 2020, [中草药, Chinese Traditional and Herbal Drugs], V51, P5613
   Nwosu ZC, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00191
   Parola M, 2019, MOL ASPECTS MED, V65, P37, DOI 10.1016/j.mam.2018.09.002
   Ren M., 2013, CHIN J EXP TRADIT ME, V19, P155, DOI [10.11653/syfj2013210155, DOI 10.11653/SYFJ2013210155]
   Rezzani R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102498
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Shao Jing-wei, 2008, Zhongguo Yaolixue Tongbao, V24, P504
   Song J, 2018, J PHARM PHARMACOL, V70, P393, DOI 10.1111/jphp.12877
   Sun SM, 2022, PEERJ, V10, DOI 10.7717/peerj.13376
   Sun Y, 2023, BIOMED PHARMACOTHER, V162, DOI 10.1016/j.biopha.2023.114653
   Trivedi P, 2021, CELL METAB, V33, P242, DOI 10.1016/j.cmet.2020.10.026
   Tsuchida Takuma, 2019, Folia Pharmacologica Japonica, V154, P203, DOI 10.1254/fpj.154.203
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Xie H, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.01.045
   Yang F, 2018, J PROTEOME RES, V17, P1091, DOI 10.1021/acs.jproteome.7b00761
   Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08759-0
   Yoo HC, 2020, EXP MOL MED, V52, P1496, DOI 10.1038/s12276-020-00504-8
   Yu W, 2021, CLIN TRANSL ONCOL, V23, P2253, DOI 10.1007/s12094-021-02645-2
   Yuan SY, 2022, CELL PROLIFERAT, V55, DOI 10.1111/cpr.13158
   Zhang F, 2014, MOL CELL ENDOCRINOL, V382, P197, DOI 10.1016/j.mce.2013.09.020
   Zhang XY, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0595-5
   Zheng Y, 2022, FASEB J, V36, DOI 10.1096/fj.202200933RR
   Zheng Y, 2022, BIOMED PHARMACOTHER, V152, DOI 10.1016/j.biopha.2022.113204
   Zheng Y, 2021, J ETHNOPHARMACOL, V280, DOI 10.1016/j.jep.2021.114480
   郑洋, 2021, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V32, P58
NR 44
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1876-3820
EI 1876-3839
J9 EUR J INTEGR MED
JI Eur. J. Integr. Med.
PD 2023 SEP
PY 2023
VL 62
AR 102278
DI 10.1016/j.eujim.2023.102278
EA AUG 2023
PG 9
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA Q1CG8
UT WOS:001054958900001
DA 2024-02-19
ER

PT J
AU Kaushal, D
   Kansal, VK
AF Kaushal, Deepti
   Kansal, Vinod K.
TI Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium
   bifidum alleviates age-inflicted oxidative stress and improves
   expression of biomarkers of ageing in mice
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE L. acidophilus; B. bifidum; Probiotic Dahi; Antioxidant enzymes; Ageing;
   Peroxisome proliferators activated receptor-alpha; Senescence marker
   protein-30; Klotho
ID SUPEROXIDE-DISMUTASE; ANTIOXIDANT ENZYMES; PROTEIN CARBONYL;
   GENE-EXPRESSION; LIFE-SPAN; RATS; LIVER; INCREASES; DIET;
   HYPERCHOLESTEROLEMIA
AB The potential benefiting effects of probiotic Dahi on age-inflicted accumulation of oxidation products, antioxidant enzymes and expression of biomarkers of ageing were evaluated in mice. Probiotic Dahi were prepared by co-culturing in buffalo milk (3% fat) Dahi bacteria (Lactococcus lactis ssp. cremoris NCDC-86 and Lactococcus lactis ssp. lactis biovar diacetylactis NCDC-60) along with selected strain of Lactobacillus acidophilus LaVK2 (La-Dahi) or combined L. acidophilus and Bifidobacterium bifidum BbVK3 (LaBb-Dahi). Four groups of 12 months old mice (6 each) were fed for 4 months supplements (5 g/day) of buffalo milk (3% fat), Dahi, La-Dahi and LaBb-Dahi, respectively, with basal diet. The activities of catalase (CAT) and glutathione peroxidase (GPx) declined and the contents of oxidation products, thiobarbituric acid reactive substances (TBARS) and protein carbonyls, increased in red blood corpuscles (RBCs), liver, kidney and heart tissues and superoxide dismutase (SOD) activity increased in RBCs and hepatic tissues during ageing of mice. Feeding ageing mice with La-Dahi or LaBb-Dahi increased CAT activity in all the four tissues, and GPx activity in RBCs and hepatic tissue, and a significant decline in TBARS in plasma, kidney and hepatic tissues and protein carbonyls in plasma. Feeding mice with probiotic Dahi also reversed age related decline in expression of biomarkers of ageing, peroxisome proliferators activated receptor-alpha, senescence marker protein-30 (SMP-30) and klotho in hepatic and kidney tissues. The present study suggests that probiotic Dahi containing selected strains of bacteria can be used as a potential nutraceutical intervention to combat oxidative stress and molecular alterations associated with ageing.
C1 [Kaushal, Deepti; Kansal, Vinod K.] Natl Dairy Res Inst, Div Anim Biochem, Karnal 132001, Haryana, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - National Dairy
   Research Institute
RP Kansal, VK (corresponding author), Natl Dairy Res Inst, Div Anim Biochem, Karnal 132001, Haryana, India.
EM vkk49karnal@yahoo.com
RI Kansal, Vinod/AAK-3249-2021
FU Council of Scientific and Industrial Research (CSIR), New Delhi
FX The authors thankfully acknowledge the Council of Scientific and
   Industrial Research (CSIR), New Delhi, for awarding fellowship grants to
   one of the authors (Deepti Kaushal).
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Akhter T, 2007, INT J MOL MED, V19, P653
   AOAC, 2005, OFF METH AN AOAC INT, V45, P75
   Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18
   Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   CHIPALKATTI S, 1983, J NUTR, V113, P944, DOI 10.1093/jn/113.5.944
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   DRABKIN DL, 1950, J BIOL CHEM, V185, P231
   Fukushima M, 1996, BRIT J NUTR, V76, P857, DOI 10.1079/BJN19960092
   GEMANT A, 1979, MOL BIOL REP, V4, P203
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Jung KJ, 2006, ANTIOXID REDOX SIGN, V8, P671, DOI 10.1089/ars.2006.8.671
   Korpela R, 1997, MILCHWISSENSCHAFT, V52, P503
   Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2
   Kumar A, 2010, MOL BIOL REP, V37, P1373, DOI 10.1007/s11033-009-9519-1
   Kumar A, 2010, MOL BIOL REP, V37, P621, DOI 10.1007/s11033-009-9649-5
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lutgendorff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004512
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Metchnikoff E, 1908, PROLONGATION LIFE
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   Muchová J, 2001, FREE RADICAL BIO MED, V31, P499, DOI 10.1016/S0891-5849(01)00609-8
   Mutlu-Türkoglu Ü, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro-Arévalo A, 1998, MECH AGEING DEV, V104, P91, DOI 10.1016/S0047-6374(98)00061-X
   Niho N, 2005, P NATL ACAD SCI USA, V102, P2970, DOI 10.1073/pnas.0500153102
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pallottini V, 2005, MECH AGEING DEV, V126, P845, DOI 10.1016/j.mad.2005.02.009
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Rajpal S, 2008, MILCHWISSENSCHAFT, V63, P122
   Rajpal S, 2009, MILCHWISSENSCHAFT, V64, P147
   Rajpal S, 2009, MILCHWISSENSCHAFT, V64, P21
   Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Sobocanec S, 2005, PHYSIOL RES, V54, P97, DOI 10.33549/physiolres.930585
   SOHAL RS, 1992, ANN NY ACAD SCI, V663, P74, DOI 10.1111/j.1749-6632.1992.tb38651.x
   Suhara W, 2009, J DAIRY SCI, V92, P4180, DOI 10.3168/jds.2009-2186
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Wang Y, 2007, CHIN J GERONTOL, V27, DOI CNKI: SUN: ZLXZ.0.2007-13-012
   Wu S, 2007, CLIN EXP PHARMACOL P, V34, P81, DOI 10.1111/j.1440-1681.2007.04540.x
   Yadav H, 2007, NUTRITION, V23, P62, DOI 10.1016/j.nut.2006.09.002
   Yadav H, 2008, J DAIRY RES, V75, P189, DOI 10.1017/S0022029908003129
   Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
   Zommara M, 1996, NUTR RES, V16, P293, DOI 10.1016/0271-5317(96)00013-9
   Zommara M, 1998, BIOSCI BIOTECH BIOCH, V62, P710, DOI 10.1271/bbb.62.710
NR 53
TC 48
Z9 50
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD FEB
PY 2012
VL 39
IS 2
BP 1791
EP 1799
DI 10.1007/s11033-011-0920-1
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 871PX
UT WOS:000298751300117
PM 21625850
DA 2024-02-19
ER

PT J
AU Grosse, L
   Bulavin, DV
AF Grosse, Laurent
   Bulavin, Dmitry V.
TI LSEC model of aging
SO AGING-US
LA English
DT Article
DE aging; liver sinusoid endothelial cells; senescence; lifespan
ID SINUSOIDAL ENDOTHELIAL-CELLS; AGE-RELATED-CHANGES; GLYCATION
   END-PRODUCTS; INTESTINAL PERMEABILITY; SCAVENGER RECEPTORS; SENESCENT
   CELLS; LIVER; PSEUDOCAPILLARIZATION; MICROCIRCULATION; ATHEROSCLEROSIS
AB Data obtained from genetically modified mouse models suggest a detrimental role for p16(High) senescent cells in physiological aging and age-related pathologies. Our recent analysis of aging mice revealed a continuous and noticeable accumulation of liver sinusoid endothelial cells (LSECs) expressing numerous senescence markers, including p16. At early stage, senescent LSECs show an enhanced ability to clear macromolecular waste and toxins including oxidized LDL (oxLDL). Later in life, however, the efficiency of this important detoxifying function rapidly declines potentially due to increased endothelial thickness and senescence-induced silencing of scavenger receptors and endocytosis genes. This inability to detoxify toxins and macromolecular waste, which can be further exacerbated by increased intestinal leakiness with age, might be an important contributing factor to animal death. Here, we propose how LSEC senescence could serve as an endogenous clock that ultimately controls longevity and outline some of the possible approaches to extend the lifespan.
C1 [Grosse, Laurent; Bulavin, Dmitry V.] Univ Cote Azur, CNRS, INSERM, IRCAN, Nice, France.
C3 Centre National de la Recherche Scientifique (CNRS); Universite Cote
   d'Azur; Institut National de la Sante et de la Recherche Medicale
   (Inserm)
RP Bulavin, DV (corresponding author), Univ Cote Azur, CNRS, INSERM, IRCAN, Nice, France.
EM Dmitry.Bulavin@unice.fr
RI Bulavin, Dmitry/G-9650-2011
CR Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1
   Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7
   Bowe B, 2016, CLIN J AM SOC NEPHRO, V11, P1784, DOI 10.2215/CJN.00730116
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Criscione SW, 2016, TRENDS GENET, V32, P751, DOI 10.1016/j.tig.2016.09.005
   DeLeve LD, 2017, SEMIN LIVER DIS, V37, P377, DOI 10.1055/s-0037-1617455
   Duong LL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00526
   Duryee MJ, 2005, MOL PHARMACOL, V68, P1423, DOI 10.1124/mol.105.016121
   Fishman SL, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0060-3
   Fraser R, 2012, PATHOLOGY, V44, P181, DOI 10.1097/PAT.0b013e328351bcc8
   Fukui H, 2015, WORLD J HEPATOL, V7, P425, DOI 10.4254/wjh.v7.i3.425
   Ganesan LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20646
   Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281
   Gao Shen, 2017, Chronic Dis Transl Med, V3, P89, DOI 10.1016/j.cdtm.2017.02.008
   Pereira ENGD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179654
   Graves SI, 2020, BASIC CLIN PHARMACOL, V127, P102, DOI 10.1111/bcpt.13403
   Grosse Laurent, 2020, Cell Metab, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Hansen B, 2002, DIABETOLOGIA, V45, P1379, DOI 10.1007/s00125-002-0912-8
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hunt NJ, 2020, J GERONTOL A-BIOL, V75, P278, DOI 10.1093/gerona/glz153
   Hunt NJ, 2019, AM J PHYSIOL-GASTR L, V316, pG144, DOI 10.1152/ajpgi.00179.2018
   Hunt NJ, 2018, ADV DRUG DELIVER REV, V135, P39, DOI 10.1016/j.addr.2018.09.006
   Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Iwafuchi-Doi M, 2019, WIRES SYST BIOL MED, V11, DOI 10.1002/wsbm.1427
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324
   Jia GH, 2019, BBA-MOL BASIS DIS, V1865, P1802, DOI 10.1016/j.bbadis.2018.08.008
   Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018
   Klenerman P, 2015, GASTROENTEROLOGY, V148, P288, DOI 10.1053/j.gastro.2014.12.010
   Knolle PA, 2014, GASTROENTEROLOGY, V146, P1193, DOI 10.1053/j.gastro.2013.12.036
   Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523
   Labbé A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184
   Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Man AL, 2015, CLIN SCI, V129, P515, DOI 10.1042/CS20150046
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Martinez-Zamudio RI, 2019, EUROPE PMC
   Mayran A, 2018, J BIOL CHEM, V293, P13795, DOI 10.1074/jbc.R117.001232
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Mohar Dilbahar S, 2012, J Clin Exp Cardiolog, V3
   Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, pH251, DOI 10.1152/ajpheart.00197.2013
   Mosteiro L, 2018, AGING CELL, V17, DOI 10.1111/acel.12711
   Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001
   OH ST, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/6487825
   Oteiza A, 2011, AM J PHYSIOL-GASTR L, V301, pG684, DOI 10.1152/ajpgi.00347.2010
   Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009
   Qi Y, 2017, J AM MED DIR ASSOC, V810, pe1
   Rhee SY, 2018, DIABETES METAB J, V42, P188, DOI 10.4093/dmj.2017.0105
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Rossman MJ, 2017, AM J PHYSIOL-HEART C, V313, pH890, DOI 10.1152/ajpheart.00416.2017
   Sati S, 2020, MOL CELL, V78, P522, DOI 10.1016/j.molcel.2020.03.007
   Sayej WN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7867852
   Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740
   Sen P, 2019, MOL CELL, V73, P684, DOI 10.1016/j.molcel.2019.01.021
   Simon-Santamaria J, 2010, J GERONTOL A-BIOL, V65, P951, DOI 10.1093/gerona/glq108
   Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078
   Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011
   Svistounov D, 2013, EXP GERONTOL, V48, P549, DOI 10.1016/j.exger.2013.03.005
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Terpstra V, 2000, ARTERIOSCL THROM VAS, V20, P1860, DOI 10.1161/01.ATV.20.8.1860
   Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378
   Wang L, 2012, GASTROENTEROLOGY, V143, P1555, DOI 10.1053/j.gastro.2012.08.008
   Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789
   Xiao YZ, 2020, CELL METAB, V31, P534, DOI 10.1016/j.cmet.2020.01.002
   Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yamagishi S, 2005, CURR PHARM DESIGN, V11, P2279, DOI 10.2174/1381612054367300
   Yamazaki Y, 2016, STROKE, V47, P1068, DOI 10.1161/STROKEAHA.115.010835
   Yao ZL, 2016, J IMMUNOL, V197, P2390, DOI 10.4049/jimmunol.1600702
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 80
TC 9
Z9 10
U1 2
U2 10
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN 15
PY 2020
VL 12
IS 11
BP 11152
EP 11160
DI 10.18632/aging.103492
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Geriatrics & Gerontology
GA LY5PF
UT WOS:000540580800076
PM 32535553
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Liu, R
   Xu, WT
   Zhu, H
   Dong, ZJ
   Dong, HK
   Yin, S
AF Liu, Rui
   Xu, Wentao
   Zhu, He
   Dong, Zijian
   Dong, Huke
   Yin, Shi
TI Aging aggravates acetaminophen-induced acute liver injury and
   inflammation through inordinate C/EBPα-BMP9 crosstalk
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Aging; Macrophage; Bone morphogenetic protein 9; CCAAT; enhancer binding
   protein alpha; Autophagy; Inflammation
ID C/EBP-ALPHA; UP-REGULATION; REGENERATION; AUTOPHAGY;
   TRANSDIFFERENTIATION; MECHANISMS; CELLS; MICE
AB Background Previous studies have shown that bone morphogenetic protein 9 (BMP9) is almost exclusively produced in the liver and reaches tissues throughout the body as a secreted protein. However, the mechanism of BMP9 action and its role in aging-associated liver injury and inflammation are still unclear. Results Aging significantly aggravates acetaminophen (APAP)-induced acute liver injury (ALI). Increased expression of CCAAT/enhancer binding protein a (C/EBPa) and BMP9 was identified in aged livers and in hepatocytes and macrophages (M phi s) isolated from aged mice. Further analysis revealed that excess BMP9 was directly related to APAPinduced hepatocyte injury and death, as evidenced by activated drosophila mothers against decapentaplegic protein 1/5/9 (SMAD1/5/9) signaling, an increased dead cell/total cell ratio, decreased levels of ATG3 and ATG7, blocked autophagy, increased senescence-associated beta-galactosidase (SA-beta-Gal) activity, and a higher rate of senescenceassociated secretory phenotype (SASP) acquisition. In contrast, Bmp9 knockout (Bmp9(-/-)) partially alleviated the aforementioned manifestations of BMP9 overexpression. Moreover, BMP9 expression was found to be regulated by C/EBPa in vitro and in vivo. Notably, BMP9 also downregulated autophagy through its effect on autophagy-related genes (ATG3 and ATG7) in MFs, which was associated with aggravated liver injury and SASP acquisition. Conclusions In summary, the present study highlights the crucial roles played by C/EBPa-BMP9 crosstalk and provides insights into the interrelationship between hepatocytes and MFs during acute liver injury.
C1 [Liu, Rui; Zhu, He; Yin, Shi] Anhui Med Univ, Affiliated Prov Hosp, Dept Geriatr, Hefei 230001, Peoples R China.
   [Yin, Shi] Univ Sci & Technol China, Affiliated Hosp 1, Dept Geriatr, Div Life Sci & Med,USTC, Hefei 230001, Anhui, Peoples R China.
   [Liu, Rui; Xu, Wentao] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Peoples R China.
   [Dong, Zijian; Dong, Huke] Anhui Med Univ, Clin Med Coll, Hefei 230036, Peoples R China.
C3 Anhui Medical University; Chinese Academy of Sciences; University of
   Science & Technology of China, CAS; Anhui Medical University; Anhui
   Medical University
RP Yin, S (corresponding author), Anhui Med Univ, Affiliated Prov Hosp, Dept Geriatr, Hefei 230001, Peoples R China.; Yin, S (corresponding author), Univ Sci & Technol China, Affiliated Hosp 1, Dept Geriatr, Div Life Sci & Med,USTC, Hefei 230001, Anhui, Peoples R China.
EM drshiyin@ustc.edu.cn
FU National Natural Science Foundation of China [81870450]
FX This research is funded by the National Natural Science Foundation of
   China (81870450).
CR ALPINI G, 1994, HEPATOLOGY, V20, P494, DOI 10.1002/hep.1840200231
   Aman Y, 2021, NATURE AGING, V1, P634, DOI 10.1038/s43587-021-00098-4
   Avellino R, 2017, BLOOD, V129, P2083, DOI 10.1182/blood-2016-09-687822
   Berry MN, 1997, CELL BIOL TOXICOL, V13, P223, DOI 10.1023/A:1007402505482
   Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1
   Breitkopf-Heinlein K, 2017, GUT, V66, P939, DOI 10.1136/gutjnl-2016-313314
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108
   Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Frudd K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02352-z
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079
   Hashimoto A, 2021, CLIN CANCER RES, V27, P5961, DOI 10.1158/1078-0432.CCR-21-0986
   Huang XY, 2022, CELL MOL GASTROENTER, V14, P1, DOI 10.1016/j.jcmgh.2022.03.006
   Ji J, 2018, AGING CELL, V17, DOI 10.1111/acel.12774
   Jiang QQ, 2021, INT IMMUNOPHARMACOL, V96, DOI 10.1016/j.intimp.2021.107591
   Kopec AK, 2017, J HEPATOL, V66, P787, DOI 10.1016/j.jhep.2016.12.004
   Liu R, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00797-2
   Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014
   Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937
   Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690
   Nie YZ, 2022, HEPATOLOGY, V76, P1030, DOI 10.1002/hep.32443
   Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248
   Pinto C, 2020, SEMIN LIVER DIS, V40, P225, DOI 10.1055/s-0039-3402033
   Puchalska P, 2019, CELL METAB, V29, P383, DOI 10.1016/j.cmet.2018.10.015
   Pundhir S, 2018, CELL REP, V23, P2744, DOI 10.1016/j.celrep.2018.05.012
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Schinaman JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44106-5
   Sun XJ, 2022, J HEPATOL, V77, P436, DOI 10.1016/j.jhep.2022.02.028
   van Oevelen C, 2015, STEM CELL REP, V5, P232, DOI 10.1016/j.stemcr.2015.06.007
   Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9
   Wible DJ, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0110-1
   Yang YJ, 2022, J NANOBIOTECHNOL, V20, DOI 10.1186/s12951-021-01203-w
   Yang Z, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5022
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
   Zhao HY, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00627-y
NR 42
TC 3
Z9 3
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD MAR 21
PY 2023
VL 13
IS 1
AR 61
DI 10.1186/s13578-023-01014-6
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA A7UA2
UT WOS:000957120600001
PM 36945064
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Li, RL
   Li, Y
   Tian, MM
   Zhang, HH
   Lou, LJ
   Liu, K
   Zhang, JH
   Zhao, Y
   Zhang, J
   Le, SS
   Fu, X
   Zhou, Y
   Li, WJ
   Gao, XC
   Nie, YZ
AF Li, Renlong
   Li, Yan
   Tian, Miaomiao
   Zhang, Haohao
   Lou, Lijun
   Liu, Kun
   Zhang, Jiehao
   Zhao, Yu
   Zhang, Jing
   Le, Shuangshuang
   Fu, Xin
   Zhou, Yao
   Li, Wenjiao
   Gao, Xianchun
   Nie, Yongzhan
TI Comparative proteomic profiling reveals a pathogenic role for the
   O-GlcNAcylated AIMP2-PARP1 complex in aging-related hepatic steatosis in
   mice
SO FEBS LETTERS
LA English
DT Article; Early Access
DE aging; AIMP2; hepatic steatosis; O-GlcNAcylation; PARP1; proteomics
ID FATTY LIVER-DISEASE; N-ACETYLGLUCOSAMINE; AGE; AUTOPHAGY; TRANSFERASE;
   DEFICIENCY; METABOLISM; NAD(+); ACID; EPIGENETICS
AB The prevalence of non-alcoholic fatty liver disease (NAFLD) increases with aging. However, the mechanism of aging-related NAFLD remains unclear. Herein, we constructed an aging-related hepatic steatosis model and analyzed the differentially expressed proteins (DEPs) in livers from young and old mice using liquid chromatography-mass spectrometry. Five hundred and eighty-eight aging-related DEPs and novel pathways were identified. Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2), the most significantly upregulated protein, promoted poly(ADP-ribose) polymerase 1 (PARP1) activation in aging-related hepatic steatosis. Additionally, mice liver-specific O-GlcNAcase knockout promoted AIMP2 and PARP1 expression. O-GlcNAc transferase (OGT) overexpression and O-GlcNAcase inhibition by genetic or pharmaceutical manipulations increased AIMP2 and PARP1 levels in vitro. Mechanistically, O-GlcNAcylation increased AIMP2 protein stability, leading to its aggregation. Our study reveals O-GlcNAcylated AIMP2 as a novel pathogenic regulator of aging-related hepatic steatosis.
C1 [Li, Renlong; Li, Yan; Tian, Miaomiao; Zhang, Haohao; Lou, Lijun; Liu, Kun; Zhang, Jiehao; Zhao, Yu; Zhang, Jing; Le, Shuangshuang; Fu, Xin; Zhou, Yao; Li, Wenjiao; Gao, Xianchun; Nie, Yongzhan] Air Force Mil Med Univ, State Key Lab Canc Biol, Natl Clin Res Ctr Digest Dis, 127 West Changle Rd, Xian 710032, Peoples R China.
   [Li, Renlong; Li, Yan; Tian, Miaomiao; Zhang, Haohao; Lou, Lijun; Liu, Kun; Zhang, Jiehao; Zhao, Yu; Zhang, Jing; Le, Shuangshuang; Fu, Xin; Zhou, Yao; Li, Wenjiao; Gao, Xianchun; Nie, Yongzhan] Air Force Mil Med Univ, Xijing Hosp Digest Dis, 127 West Changle Rd, Xian 710032, Peoples R China.
C3 Air Force Military Medical University
RP Nie, YZ (corresponding author), Air Force Mil Med Univ, State Key Lab Canc Biol, Natl Clin Res Ctr Digest Dis, 127 West Changle Rd, Xian 710032, Peoples R China.; Nie, YZ (corresponding author), Air Force Mil Med Univ, Xijing Hosp Digest Dis, 127 West Changle Rd, Xian 710032, Peoples R China.
EM yongznie@fmmu.edu.cn
RI wu, yi/JEP-1581-2023; LI, XIAO/IQV-9318-2023; cheng, chen/JHS-9462-2023;
   Zhang, Yiyang/HZI-3668-2023; Zhang, Zhentao/JQV-7389-2023; zhang,
   xu/JEO-4879-2023; zhan, y/ISA-2807-2023; liang, shuang/JOK-5869-2023;
   Zhang, Jiehao/GWV-0440-2022; He, Chen/JLM-5059-2023; Jiang,
   Yuan/JED-3759-2023; JIN, LIYING/JFB-1980-2023; Gao,
   Xianchun/IKJ-2737-2023; LU, Li/JFJ-9011-2023; Wang,
   Xuezhen/IUN-6267-2023
OI Gao, Xianchun/0000-0001-6162-2434
FU National Natural Science Foundation of China [81730016, 81972761]
FX The authors thank Michal Bell, PhD, from Liwen Bianji (Edanz) () for
   editing the English text of a draft of this manuscript. The authors
   thank Shanghai Ouyi Biotech Company for proteomics analysis. This work
   was supported by the National Natural Science Foundation of China (Grant
   NO. 81730016, 81972761).
CR Alexander CC, 2022, J GERONTOL A-BIOL, V77, P268, DOI 10.1093/gerona/glab296
   Bai B, 2020, NEURON, V105, P975, DOI 10.1016/j.neuron.2019.12.015
   Brown GT, 2016, METABOLISM, V65, P1080, DOI 10.1016/j.metabol.2015.11.008
   Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030
   Cornelissen T, 2018, ELIFE, V7, DOI 10.7554/eLife.35878
   El Ouarrat D, 2020, CELL METAB, V31, P162, DOI 10.1016/j.cmet.2019.10.003
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117
   Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452
   Guo ES, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02318-7
   Haidar M, 2019, AUTOPHAGY, V15, P1051, DOI 10.1080/15548627.2019.1569930
   Ham SW, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax0091
   Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334
   Hardy T, 2016, GUT, V65, P1895, DOI 10.1136/gutjnl-2015-311292
   Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Huang K, 2017, J HEPATOL, V66, P962, DOI 10.1016/j.jhep.2016.11.020
   Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020
   Jiang MZ, 2019, THERANOSTICS, V9, P5359, DOI 10.7150/thno.34024
   Jiang MZ, 2019, ONCOGENE, V38, P301, DOI 10.1038/s41388-018-0435-5
   Jiang Y, 2019, NATURE, V567, P257, DOI 10.1038/s41586-019-0987-8
   Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442
   Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008
   Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500
   Leidal AM, 2018, NAT CELL BIOL, V20, P1338, DOI 10.1038/s41556-018-0235-8
   Li RL, 2017, OBESITY, V25, P561, DOI 10.1002/oby.21757
   Lin L, 2020, FEBS LETT, V594, P2965, DOI 10.1002/1873-3468.13879
   Liu B, 2018, BIOCHEM BIOPH RES CO, V507, P286, DOI 10.1016/j.bbrc.2018.11.023
   Liu YS, 2008, MOL CELL PROTEOMICS, V7, P1737, DOI 10.1074/mcp.M800109-MCP200
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006
   Mao KM, 2020, AGING CELL, V19, DOI 10.1111/acel.13163
   Martini-Stoica H, 2016, TRENDS NEUROSCI, V39, P221, DOI 10.1016/j.tins.2016.02.002
   McLaughlin T, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0250-z
   Moaddel R, 2021, AGING CELL, V20, DOI 10.1111/acel.13325
   Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023
   Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985
   Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Nguyen P, 2018, CELL REP, V24, P1597, DOI 10.1016/j.celrep.2018.07.014
   Plumel MI, 2016, J PROTEOMICS, V135, P181, DOI 10.1016/j.jprot.2015.09.008
   Roberts SB, 2006, PHYSIOL REV, V86, P651, DOI 10.1152/physrev.00019.2005
   Saito T, 2013, CIRCULATION, V127, P104, DOI 10.1161/CIRCULATIONAHA.112.135608
   Saran AR, 2020, GASTROENTEROLOGY, V158, P1948, DOI 10.1053/j.gastro.2020.01.050
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Sun-Wang JL, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101203
   Tang ZY, 2019, AUTOPHAGY, V15, P2165, DOI 10.1080/15548627.2019.1666594
   Tuttle CSL, 2021, AGEING RES REV, V68, DOI 10.1016/j.arr.2021.101334
   Ulgherait M, 2021, NATURE, V598, P353, DOI 10.1038/s41586-021-03934-0
   Valverde DP, 2019, J CELL BIOL, V218, P1787, DOI 10.1083/jcb.201811139
   van der Laarse SAM, 2018, FEBS J, V285, P3152, DOI 10.1111/febs.14491
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Wree A, 2018, HEPATOLOGY, V67, P438, DOI 10.1002/hep.29495
   Xiao HP, 2020, CELL, V180, P968, DOI 10.1016/j.cell.2020.02.012
   Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017
   Xu XH, 2013, J HEPATOL, V59, P308, DOI 10.1016/j.jhep.2013.03.037
   Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633
   Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470
   Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22
   Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3
   Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998
   Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x
   Yun SP, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.157
   Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
   Zhou Z, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02794-2
NR 74
TC 1
Z9 2
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD 2022 JAN
PY 2022
VL 596
IS 1
BP 128
EP 145
DI 10.1002/1873-3468.14242
EA DEC 2021
PG 18
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA YD9NA
UT WOS:000725550400001
PM 34817071
OA hybrid
DA 2024-02-19
ER

PT J
AU Ranhotra, HS
   Sharma, R
AF Ranhotra, HS
   Sharma, R
TI Modulation of hepatic and renal glucocorticoid receptors during aging of
   mice
SO BIOGERONTOLOGY
LA English
DT Article
DE activation modulation; aging; glucocorticoid receptor; mice
ID UNSATURATED FATTY-ACIDS; BINDING; RATS; CHROMATIN; PROTEIN; BRAIN
AB The regulation of hepatic and renal glucocorticoid receptors (GRs) in young (4 weeks) and senescent (120 weeks) mice was studied. Significant changes in the level of GRs from liver and kidney were detected, whereas the affinity (K-d) for the hormone [H-3]dexamethasone did not change in young and old mice. The concentration of GRs was markedly decreased in liver (25%) and kidney (33%) of old mice as compared to young ones. The magnitude of heat activation of GR complexes was more pronounced in both the tissues at young age compared to old. In addition, we have found changes in the heat activation-inhibition studies of GRs, using polyunsaturated fatty acids (PUFAs) as measured by binding to DNA-cellulose and purified nuclei. Linoleic acid (Cl 8:2) exhibited significant decrease in heat activation of both hepatic and renal hormone-bound GR, with higher magnitude of inhibition in young, liver (64%) and kidney (68%) as compared to old (41 % and 43 %, respectively). Arachidonic acid (C20:4) was also found to be an inhibitor of activation causing significant decrease in hepatic GR activation, with greater inhibition in young liver with respect to old, however, without any such difference in the kidney of young and old mice. Furthermore, DNase I digestion and extraction of nuclear-bound GR-complexes from both the tissues reveal lesser extraction in old liver (26%) and kidney (24%) compared to young tissues, indicating chromatin condensation with aging, thereby controlling the accessibility to such transcription factors as GRs. These findings indicate that the changes in the GR concentration, activation-modulation by PUFAs and chromatin organization, that take place during aging, may contribute to functional changes in glucocorticoid action mechanisms in senescent animals.
C1 NE Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
C3 North Eastern Hill University
RP Sharma, R (corresponding author), NE Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
EM rsharma@nehu.ac.in
CR BELISLE S, 1986, ENDOCRINOLOGY, V118, P750, DOI 10.1210/endo-118-2-750
   Biola A, 2000, PRESSE MED, V29, P215
   Borbhuiya MA, 1995, BIOCHEM MOL BIOL INT, V37, P645
   BORHUIYA MA, 1995, IND J BIOCH BIOPHYS, V32, P125
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CHATURVEDI MM, 1983, BIOCHEM INT, V6, P357
   Chaurasia P, 1997, MECH AGEING DEV, V95, P63, DOI 10.1016/S0047-6374(96)01843-X
   CHUKNYISKA RS, 1985, ENDOCRINOLOGY, V116, P547, DOI 10.1210/endo-116-2-547
   Djordjevic-Markovic R, 1999, EXP GERONTOL, V34, P971, DOI 10.1016/S0531-5565(99)00067-4
   HAOURIGUI M, 1994, STEROIDS, V59, P46, DOI 10.1016/0039-128X(94)90044-2
   KALIMI M, 1981, MECH AGEING DEV, V17, P19, DOI 10.1016/0047-6374(81)90125-1
   KALIMI M, 1984, MECH AGEING DEV, V24, P129, DOI 10.1016/0047-6374(84)90065-4
   KALIMI M, 1988, ANN NY ACAD SCI, V521, P149
   KANUNGO MS, 1994, GENES AGING
   Kellendonk C, 1999, J STEROID BIOCHEM, V69, P253, DOI 10.1016/S0960-0760(99)00041-2
   KONOPLYA EF, 1986, MECH AGEING DEV, V35, P95, DOI 10.1016/0047-6374(86)90001-1
   LEE PC, 1992, COMP BIOCHEM PHYS B, V102, P707, DOI 10.1016/0305-0491(92)90067-2
   Luckinbill LS, 2000, BIOGERONTOLOGY, V1, P3, DOI 10.1023/A:1010033807151
   Martin R, 1999, Z GERONTOL GERIATR, V32, P76, DOI 10.1007/s003910050087
   McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262
   MESHINCHI S, 1990, J BIOL CHEM, V265, P4863
   Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306
   Prima V, 2000, J STEROID BIOCHEM, V72, P1, DOI 10.1016/S0960-0760(99)00146-6
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438
   SINGH LS, 1995, MECH AGEING DEV, V80, P85, DOI 10.1016/0047-6374(94)01560-9
   SUMIDA C, 1993, ACTA ENDOCRINOL-COP, V129, P348, DOI 10.1530/acta.0.1290348
   TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315
NR 30
TC 13
Z9 14
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2001
VL 2
IS 4
BP 245
EP 251
DI 10.1023/A:1013218528102
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 516NF
UT WOS:000173558800003
PM 11868899
DA 2024-02-19
ER

PT J
AU Tomobe, K
   Shinozuka, T
   Kawashima, T
   Kawashima-Ohya, Y
   Nomura, Y
AF Tomobe, Koji
   Shinozuka, Tatsuo
   Kawashima, Tsuyoshi
   Kawashima-Ohya, Yoshie
   Nomura, Yasuyuki
TI Age-related changes of forkhead transcription factor FOXO1 in the liver
   of senescence-accelerated mouse SAMP8
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE FOXO1; IGF-1R; SAMP8; Antioxidant enzyme; Longevity; Senescence
ID EXTENDS LIFE-SPAN; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; SURVIVAL
   SIGNALS; FAMILY-MEMBER; C-ELEGANS; KAPPA-B; PHOSPHORYLATION; LONGEVITY;
   JNK
AB SAMP8 exhibits accelerated aging and a short lifespan. Insulin-like growth factor-1 receptor (IGF-1R)/FOXO pathway is associated with aging. Phosphorylation of IGF-1R, Akt, and FOXO1 was found to be increased during aging in the liver of SAMR1 normal aging mice. However, significant decreases in the phosphorylation of IGF-1R and Akt were observed in the liver of SAMP8 during aging compared with that in SAMR1, whereas phosphorylation of FOXO1 was markedly increased with age in SAMP8. In addition, the protein level of FOXO1 was decreased with age in SAMP8. Protein phosphatase 2A (PP2A) directly dephosphorylates FOXO1. Significant reduction of PP2A activity was observed in the liver nucleus of SAMP8. These results suggest the possibility that the increased FOXO1 phosphorylation might occur by the decreased activity of PP2A, resulting in the decrease in the protein level of FOXO1 in SAMP8. Furthermore, FOXO1 regulates longevity and the expression of antioxidant enzymes such as Mn-SOD and catalase. The expression of Mn-SOD and catalase was significantly decreased in the liver of SAMP8. Therefore, it is possible that the elevation of phosphorylated FOXO1 level with age causes a short lifespan in SAMP8. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Tomobe, Koji; Shinozuka, Tatsuo] Yokohama Coll Pharm, Dept Pathophysiol, Yokohama, Kanagawa 2450066, Japan.
   [Kawashima, Tsuyoshi] Yokohama Coll Pharm, Dept Mol Biol, Yokohama, Kanagawa 2450066, Japan.
   [Kawashima-Ohya, Yoshie] Yokohama Coll Pharm, Dept Immunol, Yokohama, Kanagawa 2450066, Japan.
   [Nomura, Yasuyuki] Yokohama Coll Pharm, Dept Pharmacotheraput, Yokohama, Kanagawa 2450066, Japan.
RP Tomobe, K (corresponding author), Yokohama Coll Pharm, Dept Pathophysiol, Totsuka Ku, Matano Cho 601, Yokohama, Kanagawa 2450066, Japan.
EM k.tomobe@hamayaku.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX This study was supported by Grants-in-Aid from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan (K. T., Y.
   N.).
CR Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8
   Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010
   Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891
   Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059
   Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Chávez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587
   Daitoku H, 2007, J BIOCHEM, V141, P769, DOI 10.1093/jb/mvm104
   Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476
   Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200
   Friedman DB, 1996, J CELL BIOL, V132, P903, DOI 10.1083/jcb.132.5.903
   Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Honda Y, 2010, GERIATR GERONTOL INT, V10, pS59, DOI 10.1111/j.1447-0594.2010.00591.x
   Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2
   Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512
   HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0
   Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kurokawa T, 2001, NEUROSCI LETT, V298, P135, DOI 10.1016/S0304-3940(00)01755-9
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   Malik AI, 2011, GENE, V485, P114, DOI 10.1016/j.gene.2011.06.014
   Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100
   Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4
   Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179
   SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cb.10.110194.000415
   Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117
   Sureda FX, 2006, EXP GERONTOL, V41, P360, DOI 10.1016/j.exger.2006.01.015
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167
   Venkatesan B, 2007, J CELL PHYSIOL, V211, P457, DOI 10.1002/jcp.20953
   Verdaguer E, 2012, EXPERT OPIN DRUG DIS, V7, P217, DOI 10.1517/17460441.2012.660144
   Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030
   Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X
   Yagi H, 1998, BRAIN RES, V791, P90, DOI 10.1016/S0006-8993(98)00070-5
   Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200
NR 43
TC 14
Z9 16
U1 0
U2 25
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD NOV-DEC
PY 2013
VL 57
IS 3
BP 417
EP 422
DI 10.1016/j.archger.2013.06.004
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 213AE
UT WOS:000324024300027
PM 23806789
DA 2024-02-19
ER

PT J
AU Carr, SK
   Chen, JH
   Cooper, WN
   Constância, M
   Yeo, GSH
   Ozanne, SE
AF Carr, Sarah K.
   Chen, Jian-Hua
   Cooper, Wendy N.
   Constancia, Miguel
   Yeo, Giles S. H.
   Ozanne, Susan E.
TI Maternal diet amplifies the hepatic aging trajectory of Cidea in male
   mice and leads to the development of fatty liver
SO FASEB JOURNAL
LA English
DT Article
DE developmental programming; maternal low protein; catch-up growth; lipid
   accumulation; epigenetic
ID POSTNATAL-GROWTH LEADS; LIFE-SPAN; PRENATAL EXPOSURE; DEFENSE CAPACITY;
   GENE-EXPRESSION; ADIPOSE-TISSUE; DNA-DAMAGE; EFFECTOR-A; RESTRICTION;
   PROTEIN
AB The importance of the early environment on long-term heath and life span is well documented. However, the molecular mechanisms mediating these effects remain poorly understood. Male offspring from a maternal protein restriction model, in which animals are exposed to a low-protein diet while in utero and then are cross-fostered to normally fed dams, demonstrate low birth weight, catch-up growth, and reduced life span (recuperated offspring). In the current study, we used microarray analysis to identify hepatic genes that changed with age. Cell death-inducing DNA fragmentation factor, subunit-like effector A (Cidea), a transcriptional coactivator that has been implicated in lipid accumulation demonstrated one of the largest age-associated increases in expression (200-fold, P<0.001). This increase was exaggerated approximate to 3-fold in recuperated offspring. These demonstrated increased hepatic lipid accumulation, higher levels of transcription factors important in lipid regulation, and greater oxidative stress. In vitro analysis revealed that Cidea expression was regulated by oxidative stress and DNA methylation. These findings suggest that maternal diet modulates the age-associated changes in Cidea expression through several mechanisms. This expression affects hepatic lipid metabolism in these animals and thus provides a mechanism by which maternal diet can contribute to the metabolic health and ultimately the life span of the offspring.Carr, S. K., Chen, J.-H., Cooper, W. N., Constancia, M., Yeo, G. S. H., Ozanne, S. E. Maternal diet amplifies the hepatic ageing trajectory of Cidea in male mice and leads to the development of fatty liver.
C1 [Carr, Sarah K.; Chen, Jian-Hua; Cooper, Wendy N.; Constancia, Miguel; Yeo, Giles S. H.; Ozanne, Susan E.] Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, MRC Metab Dis Unit, Metab Res Labs,Addenbrookes Hosp, Cambridge CB2 OQQ, England.
   [Constancia, Miguel] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 OQQ, England.
C3 Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's
   Hospital; University of Cambridge; University of Cambridge
RP Carr, SK (corresponding author), Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, MRC Metab Dis Unit, Metab Res Labs,Addenbrookes Hosp, Level 4,Box 289, Cambridge CB2 OQQ, England.
EM sb716@cam.ac.uk
RI Constancia, Miguel/F-6654-2013; Cooper, Wendy/JZE-5930-2024
OI Cooper, Wendy/0000-0003-3416-9982; Ozanne, Susan/0000-0001-8753-5144;
   Constancia, Miguel/0000-0002-8976-1679; Yeo, Giles See
   How/0000-0001-8823-3615
FU UK Biotechnology and Biological Science Research Council; Biotechnology
   and Biological Sciences Research Council [BB/D01235X/2, BB/D01235X/1,
   BB/E002161/1] Funding Source: researchfish; British Heart Foundation
   [FS/09/029/27902] Funding Source: researchfish; Medical Research Council
   [MC_UU_12012/1, MC_UU_12012/4, G0600717, MC_UU_12012/5/B, G0600717B,
   MC_UU_12012/5] Funding Source: researchfish; BBSRC [BB/D01235X/1,
   BB/E002161/1, BB/D01235X/2] Funding Source: UKRI; MRC [MC_UU_12012/5,
   MC_UU_12012/4, MC_UU_12012/1, G0600717] Funding Source: UKRI
FX This work was supported by the UK Biotechnology and Biological Science
   Research Council. S.E.O. is a British Heart Foundation Senior Fellow.
CR ANDERSON JM, 1972, J CLIN PATHOL, V25, P867, DOI 10.1136/jcp.25.10.867
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Berends LM, 2013, INT J OBESITY, V37, P1051, DOI 10.1038/ijo.2012.196
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703
   Chen JH, 2004, J BIOL CHEM, V279, P49439, DOI 10.1074/jbc.M409153200
   Chen JH, 2010, CLIN SCI, V119, P373, DOI 10.1042/CS20100230
   Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950
   Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009
   Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb
   Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291
   HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835
   Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526
   Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1
   Kelder Bruce, 2007, Comp Hepatol, V6, P4, DOI 10.1186/1476-5926-6-4
   Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812
   Li D, 2008, NUCLEIC ACIDS RES, V36, P330, DOI 10.1093/nar/gkm1028
   Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385
   Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064
   Nathanielsz PW, 2003, J PHYSIOL-LONDON, V548, P333, DOI 10.1113/jphysiol.2003.040527
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Okamoto Y, 2002, HEPATOL RES, V23, P138, DOI 10.1016/S1386-6346(01)00172-3
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b
   Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008
   Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9
   Roseboom TJ, 2000, BRIT J HAEMATOL, V111, P112, DOI 10.1046/j.1365-2141.2000.02268.x
   Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500
   Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523
   Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796
   Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685
   Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890
   Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200
   Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y
   Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611
   Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225
NR 37
TC 13
Z9 15
U1 0
U2 9
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAY
PY 2014
VL 28
IS 5
BP 2191
EP 2201
DI 10.1096/fj.13-242727
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA AG3RA
UT WOS:000335336000022
PM 24481968
DA 2024-02-19
ER

PT J
AU Kwan, R
   Brady, GF
   Brzozowski, M
   Weerasinghe, SV
   Martin, H
   Park, MJ
   Brunt, MJ
   Menon, RK
   Tong, X
   Yin, L
   Stewart, CL
   Omary, MB
AF Kwan, Raymond
   Brady, Graham F.
   Brzozowski, Maria
   Weerasinghe, Sujith V.
   Martin, Hope
   Park, Min-Jung
   Brunt, Makayla J.
   Menon, Ram K.
   Tong, Xin
   Yin, Lei
   Stewart, Colin L.
   Omary, M. Bishr
TI Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective
   Steatohepatitis
SO CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE Nonalcoholic Fatty Liver Disease; Laminopathy; Growth Hormone Signaling;
   Lipodystrophy; Fibrosis
ID FAMILIAL PARTIAL LIPODYSTROPHY; FATTY LIVER-DISEASE;
   GROWTH-HORMONE-SECRETION; A-TYPE LAMINS; HEPATIC STEATOSIS;
   GENE-EXPRESSION; STRUCTURAL ORGANIZATION; INSULIN SENSITIVITY;
   MUSCULAR-DYSTROPHY; HEART FUNCTION
AB BACKGROUND & AIMS: Lamins are nuclear intermediate filament proteins that comprise the major components of the nuclear lamina. Mutations in LMNA, which encodes lamins A/C, cause laminopathies, including lipodystrophy, cardiomyopathy, and premature aging syndromes. However, the role of lamins in the liver is unknown, and it is unclear whether laminopathy-associated liver disease is caused by primary hepatocyte defects or systemic alterations.
   METHODS: To address these questions, we generated mice carrying a hepatocyte-specific deletion of Lmna (knockout [KO] mice) and characterized the KO liver and primary hepatocyte phenotypes by immunoblotting, immunohistochemistry, microarray analysis, quantitative real-time polymerase chain reaction, and Oil Red O and Picrosirius red staining.
   RESULTS: KO hepatocytes manifested abnormal nuclear morphology, and KO mice showed reduced body mass. KO mice developed spontaneous male-selective hepatosteatosis with increased susceptibility to high-fat diet-induced steatohepatitis and fibrosis. The hepatosteatosis was associated with up-regulated transcription of genes encoding lipid transporters, lipid biosynthetic enzymes, lipid droplet-associated proteins, and interferon-regulated genes. Hepatic Lmna deficiency led to enhanced signal transducer and activator of transcription 1 (Stat1) expression and blocked growth hormone-mediated Janus kinase 2 (Jak2), signal transducer and activator of transcription 5 (Stat5), and extracellular signal-regulated kinase (Erk) signaling.
   CONCLUSIONS: Lamin A/C acts cell-autonomously to maintain hepatocyte homeostasis and nuclear shape and buffers against male-selective steatohepatitis by positively regulating growth hormone signaling and negatively regulating Stat1 expression. Lamins are potential genetic modifiers for predisposition to steatohepatitis and liver fibrosis. The microarray data can be found in the Gene Expression Omnibus repository (accession number: GSE93643).
C1 [Kwan, Raymond; Brady, Graham F.; Brzozowski, Maria; Weerasinghe, Sujith V.; Martin, Hope; Park, Min-Jung; Brunt, Makayla J.; Tong, Xin; Yin, Lei; Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, 7720 Med Sci 2, Ann Arbor, MI 48109 USA.
   [Brady, Graham F.; Menon, Ram K.; Yin, Lei; Omary, M. Bishr] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
   [Stewart, Colin L.] Immunos, Inst Med Biol, Dev & Regenerat Biol Grp, Singapore, Singapore.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; Agency for Science Technology &
   Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)
RP Kwan, R (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, 7720 Med Sci 2, Ann Arbor, MI 48109 USA.
EM raykwan@umich.edu
RI Brady, Graham/HLQ-7520-2023
OI Brady, Graham/0000-0002-8376-5871; TONG, XIN/0000-0002-4832-8940; Omary,
   Bishr/0000-0002-8624-2347
FU National Institutes of Health [R01 DK47918, R01 DK099593, T32 DK094775];
   institutional National Institutes of Health grant to the University of
   Michigan [P30 DK34933]
FX This work was supported by National Institutes of Health grants R01
   DK47918 (M.B.O.); R01 DK099593 (L.Y.); National Institutes of Health
   training grant T32 DK094775 (G.F.B.); and an institutional National
   Institutes of Health grant (P30 DK34933) to the University of Michigan.
CR Agarwal AK, 2016, J LIPID RES, V57, P616, DOI 10.1194/jlr.M065896
   Ajluni N, 2017, CLIN ENDOCRINOL, V86, P698, DOI 10.1111/cen.13311
   Anstee QM, 2016, GASTROENTEROLOGY, V150, P1728, DOI 10.1053/j.gastro.2016.01.037
   Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x
   Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537
   Barclay JL, 2010, MOL ENDOCRINOL, V24, P204, DOI 10.1210/me.2009-0233
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BIAMONTI G, 1992, MOL CELL BIOL, V12, P3499, DOI 10.1128/MCB.12.8.3499
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Burke B, 2014, CURR TOP DEV BIOL, V109, P1, DOI 10.1016/B978-0-12-397920-9.00006-8
   Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001
   Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489
   Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713
   Cutler DA, 2002, BIOCHEM BIOPH RES CO, V291, P522, DOI 10.1006/bbrc.2002.6466
   Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844
   Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308
   Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261
   Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115
   Gruenbaum Y, 2015, CURR OPIN CELL BIOL, V32, P7, DOI 10.1016/j.ceb.2014.09.009
   Guénantin AC, 2014, SEMIN CELL DEV BIOL, V29, P148, DOI 10.1016/j.semcdb.2013.12.015
   Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502
   Harr JC, 2015, J CELL BIOL, V208, P33, DOI 10.1083/jcb.201405110
   Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Jaffe CA, 1998, J CLIN INVEST, V102, P153, DOI 10.1172/JCI2908
   Jaffe CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE1008, DOI 10.1152/ajpendo.00513.2001
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036
   LIN F, 1993, J BIOL CHEM, V268, P16321
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lüdtke A, 2005, AM J GASTROENTEROL, V100, P2218, DOI 10.1111/j.1572-0241.2005.00234.x
   MACLEOD JN, 1991, J ENDOCRINOL, V131, P395, DOI 10.1677/joe.0.1310395
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027
   Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042
   Muchir A, 2010, TRENDS CARDIOVAS MED, V20, P217, DOI 10.1016/j.tcm.2011.11.002
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105
   ROBER RA, 1990, J CELL SCI, V95, P587
   ROBER RA, 1989, DEVELOPMENT, V105, P365
   Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807
   Shi SY, 2012, J BIOL CHEM, V287, P10277, DOI 10.1074/jbc.M111.317453
   Singla A, 2013, J CELL SCI, V126, P3105, DOI 10.1242/jcs.123026
   Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009
   Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894
   Speckman RA, 2000, AM J HUM GENET, V66, P1192, DOI 10.1086/302836
   STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9
   Strnad P, 2008, GASTROENTEROLOGY, V134, P1169, DOI 10.1053/j.gastro.2008.01.035
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913
   Tassiulas I, 2004, NAT IMMUNOL, V5, P1181, DOI 10.1038/ni1126
   Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239
   Vigouroux C, 2000, DIABETES, V49, P1958, DOI 10.2337/diabetes.49.11.1958
   Wang AS, 2015, DIFFERENTIATION, V89, P11, DOI 10.1016/j.diff.2014.12.002
   WAXMAN DJ, 1995, MOL PHARMACOL, V48, P790
   WAXMAN DJ, 1991, P NATL ACAD SCI USA, V88, P6868, DOI 10.1073/pnas.88.15.6868
   Weerasinghe SVW, 2014, J CELL SCI, V127, P1464, DOI 10.1242/jcs.138479
   Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866
   Wojtanik KM, 2009, J LIPID RES, V50, P1068, DOI 10.1194/jlr.M800491-JLR200
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
   Wu W, 2011, CIRCULATION, V123, P53, DOI 10.1161/CIRCULATIONAHA.110.970673
   Xu CF, 2013, AM J GASTROENTEROL, V108, P1299, DOI 10.1038/ajg.2013.104
   Xu J, 2006, J BIOL CHEM, V281, P982, DOI 10.1074/jbc.M505484200
   Younossi Z, 2016, GASTROENTEROLOGY, V150, P1778, DOI 10.1053/j.gastro.2016.03.005
   Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611
   Zhu T, 2002, J BIOL CHEM, V277, P45592, DOI 10.1074/jbc.M201385200
NR 68
TC 22
Z9 22
U1 0
U2 5
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 2352-345X
J9 CELL MOL GASTROENTER
JI Cell. Mol. Gastroenterol. Hepatol.
PD NOV
PY 2017
VL 4
IS 3
BP 365
EP 383
DI 10.1016/j.jcmgh.2017.06.005
PG 19
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FQ5LW
UT WOS:000418402900003
PM 28913408
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Mostofinejad, Z
   Akheruzzaman, M
   Siddik, MA
   Patkar, P
   Dhurandhar, NV
   Hegde, V
AF Mostofinejad, Zahra
   Akheruzzaman, Md
   Abu Bakkar Siddik, Md
   Patkar, Presheet
   Dhurandhar, Nikhil, V
   Hegde, Vijay
TI Antidiabetic E4orf1 protein prevents hepatic steatosis and reduces
   markers of aging-related cellular damage in high fat fed older mice
SO BMJ OPEN DIABETES RESEARCH & CARE
LA English
DT Article; Proceedings Paper
CT 38th Annual Meeting of the Obesity-Society at Obesity Week (R)
   Interactive
CY NOV 02-06, 2020
CL ELECTR NETWORK
SP Obes Soc
DE hyperglycemia; hyperinsulinism; ageing
ID GLYCEMIC CONTROL; LIVER-DISEASE; OBESITY; MITOCHONDRIA; RESTRICTION;
   METABOLISM; ADENOVIRUS; ADIPOSITY; HALLMARKS; METFORMIN
AB Introduction Older age is associated with greater prevalence of hyperinsulinemia, type 2 diabetes, and fatty liver disease. These metabolic conditions and aging are bidirectionally linked to mitochondrial dysfunction and telomere attrition. Although effectively addressing these conditions is important for influencing the health and the lifespan, it is particularly challenging in older age. We reported that E4orf1, a protein derived from human adenovirus Ad36, reduces hyperinsulinemia, improves glucose clearance, and protects against hepatic steatosis in younger mice exposed to high fat diet (HFD). Here, we tested if E4orf1 will improve glycemic control, liver fat accumulation, mitochondrial integrity, and reduce telomere attrition in older mice.
   Research design and methods We used 9-month-old mice that inducibly expressed E4orf1 in adipose tissue and non-E4orf1 expressing control mice. Mice were maintained on a 60% (kcal) HFD for 20 weeks and glycemic control was determined by intraperitoneal glucose tolerance test at week 20. Following 20 weeks of HF-feeding, mice were sacrificed and liver tissues collected to determine the expression of aging genes using qRT-PCR based RT2 Profiler PCR array.
   Results Compared with the control mice, E4orf1 significantly improved glycemic control and reduced hepatic steatosis and fibrosis. Additionally, E4orf1 maintained markers of mitochondrial integrity and telomere attrition.
   Conclusion E4orf1 has the potential to improve glycemic control in older mice, and the improvement persists even after longer term exposure. E4orf1 expression also maintains mitochondrial integrity and telomere attrition, thus delaying age-associated diseases. This provides strong evidence for therapeutic utility of E4orf1 in improving age-associated metabolic and cellular changes that occur with aging in humans.
C1 [Mostofinejad, Zahra; Akheruzzaman, Md; Abu Bakkar Siddik, Md; Patkar, Presheet; Dhurandhar, Nikhil, V; Hegde, Vijay] Texas Tech Univ, Dept Nutr Sci, Lubbock, TX 79409 USA.
   [Mostofinejad, Zahra] Univ Calif Davis, Dept Nutr & Environm Toxicol, Davis, CA 95616 USA.
C3 Texas Tech University System; Texas Tech University; University of
   California System; University of California Davis
RP Hegde, V (corresponding author), Texas Tech Univ, Dept Nutr Sci, Lubbock, TX 79409 USA.
EM vijay.hegde@ttu.edu
OI Akheruzzaman, Md/0000-0003-4639-5581; Hegde, Vijay/0000-0003-4160-2764;
   SIDDIK, MD ABU BAKKAR/0000-0002-3550-946X
FU Texas Tech University, College of Human Sciences; Department of
   Nutritional Sciences; American Heart Association AIREA [20AIREA35170031]
FX This work was supported in part by startup funds from Texas Tech
   University, College of Human Sciences and Department of Nutritional
   Sciences and by American Heart Association AIREA grant (20AIREA35170031)
   to VH.
CR Akheruzzaman M, 2020, NUTR DIABETES, V10, DOI 10.1038/s41387-020-0114-9
   Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bannister CA, 2014, DIABETES OBES METAB, V16, P1165, DOI 10.1111/dom.12354
   Barzilai N, 2018, JAMA-J AM MED ASSOC, V320, P1321, DOI 10.1001/jama.2018.9562
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Bluhm A, 2019, NUCLEIC ACIDS RES, V47, P1896, DOI 10.1093/nar/gky1289
   Brewer Rachel A, 2016, Nutr Healthy Aging, V4, P31, DOI 10.3233/NHA-160007
   Bril F, 2016, ENDOCRIN METAB CLIN, V45, P765, DOI 10.1016/j.ecl.2016.06.005
   Chen KQ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004078
   Dassanayaka S, 2015, BIOCHEM J, V467, P115, DOI 10.1042/BJ20141018
   De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111
   Dhurandhar NV, 2011, LANCET INFECT DIS, V11, P963, DOI 10.1016/S1473-3099(11)70274-2
   Dye L, 2017, P NUTR SOC, V76, P443, DOI 10.1017/S0029665117002014
   Feizy Z, 2020, INT J OBESITY, V44, P1607, DOI 10.1038/s41366-020-0526-6
   Frescas D, 2014, J BIOL CHEM, V289, P24180, DOI 10.1074/jbc.M114.592592
   Hegde V., 1865, BIOCH BIOPHYS ACTA M, V2019
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]
   Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321
   Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010
   Kusminski CM, 2015, MOL METAB, V4, P653, DOI 10.1016/j.molmet.2015.07.004
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115922
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   McMurphy TB, 2017, DIABETES, V66, P358, DOI 10.2337/db16-0876
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Na HN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161275
   Na HN, 2016, BIOCHIMIE, V124, P3, DOI 10.1016/j.biochi.2014.11.005
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015
   Palmeira CM, 2007, TOXICOL APPL PHARM, V225, P214, DOI 10.1016/j.taap.2007.07.015
   Papavagelis C, 2018, MATURITAS, V110, P79, DOI 10.1016/j.maturitas.2018.02.001
   Park JS, 2018, BIOCHEM BIOPH RES CO, V495, P1775, DOI 10.1016/j.bbrc.2017.12.045
   Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222
   Pérez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691
   Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001
   Robin JD, 2020, AGING CELL, V19, DOI 10.1111/acel.13097
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Srinivas N, 2020, CANCERS, V12, DOI 10.3390/cancers12030558
   Tamura Y, 2014, J CLIN ENDOCR METAB, V99, P2771, DOI 10.1210/jc.2014-1222
   Tchkonia T, 2018, JAMA-J AM MED ASSOC, V320, P1319, DOI 10.1001/jama.2018.12440
   Trovato GM, 2010, LIVER INT, V30, P184, DOI 10.1111/j.1478-3231.2009.02127.x
   Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034
   Wang GE, 2018, METABOLISM, V85, P227, DOI 10.1016/j.metabol.2018.04.011
   Xia Xian, 2017, F1000Res, V6, P860, DOI 10.12688/f1000research.10692.1
   Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056
   Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012
NR 50
TC 7
Z9 7
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
EI 2052-4897
J9 BMJ OPEN DIAB RES CA
JI BMJ Open Diab. Res. Care
PY 2021
VL 9
IS 1
AR e002096
DI 10.1136/bmjdrc-2020-002096
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Endocrinology & Metabolism
GA ZM0ZB
UT WOS:000764093800002
PM 33941552
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lunz, JG
   Tsuji, H
   Nozaki, I
   Murase, N
   Demetris, AJ
AF Lunz, JG
   Tsuji, H
   Nozaki, I
   Murase, N
   Demetris, AJ
TI An inhibitor of cyclin-dependent kinase, stress-induced
   p21<SUP>Waf-1/Cip-1</SUP>, mediates hepatocyte mitoinhibition during the
   evolution of cirrhosis
SO HEPATOLOGY
LA English
DT Article
ID OXIDATIVE-STRESS; REPLICATIVE SENESCENCE; PROLIFERATIVE ACTIVITY;
   LIVER-TRANSPLANTATION; HEPATITIS-C; EXPRESSION; P21; P21(WAF1/CIP1);
   DISEASE; ARREST
AB During the evolution of cirrhosis, there is a relative decrease in volume percentage of hepatocytes and a relative increase in biliary epithelial cells and myofibroblasts. This is recognized histopathologically as a ductular reaction and leads to gradual distortion of the normal hepatic architecture. The final or decompensated stage of cirrhosis is characterized by a further decline in hepatocyte proliferation and loss of functional liver mass that manifests clinically as ascites, encephalopathy, and other signs of liver failure. In this report, we tested the hypothesis that p21-mediated hepatocyte mito-inhibition accelerates the evolution of cirrhosis using an established mouse model of decompensated biliary cirrhosis, p21-deficient mice, and liver tissue from humans awaiting liver replacement. Despite the same insult of long-term (12-week) bile duct ligation, mice prone to decompensation showed significantly more oxidative stress and hepatocyte nuclear p21 expression, which resulted in less hepatocyte proliferation, an exaggerated ductular reaction, and more advanced disease compared with compensation-prone controls. Mice deficient in p21 were better able than wild-type controls to compensate for long-term bile duct ligation because of significantly greater hepatocyte proliferation, which led to a larger liver mass and less architectural distortion. Mito-inhibitory hepatocyte nuclear p21 expression in humans awaiting liver replacement directly correlated with pathological disease stage and model of end-stage liver disease scoring. In conclusion, stress-induced upregulation of hepatocyte p21 inhibits hepatocyte proliferation during the evolution of cirrhosis. These findings have implications for understanding the evolution of cirrhosis and associated carcinogenesis.
C1 Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Div Transplantat, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Med Ctr, Dept Pathol, Div Transplantat, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Med Ctr, Dept Surg, Div Transplantat, Pittsburgh, PA 15213 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh
RP Demetris, AJ (corresponding author), Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Div Transplantat, UPMC Montefiore E-741,200 Lothrop St, Pittsburgh, PA 15213 USA.
EM demetrisaj@upmc.edu
FU NIDDK NIH HHS [R01 DK49615] Funding Source: Medline
CR Aboutwerat A, 2003, BBA-MOL BASIS DIS, V1637, P142, DOI 10.1016/S0925-4439(02)00225-9
   Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728
   Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311
   Barnouin K, 2002, J BIOL CHEM, V277, P13761, DOI 10.1074/jbc.M111123200
   Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497
   Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Crary GS, 1998, HEPATOLOGY, V28, P738, DOI 10.1002/hep.510280320
   Delhaye M, 1996, HEPATOLOGY, V23, P1003, DOI 10.1002/hep.510230510
   Delhaye M, 1999, J HEPATOL, V30, P461, DOI 10.1016/S0168-8278(99)80106-8
   Demetris AJ, 2004, MED INTELL UNIT, P167
   Demetris AJ, 1999, FALK SYMP, V103C, P141
   DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X
   Desmet V. J., 1994, P425
   Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6
   Ezure T, 2000, AM J PATHOL, V156, P1627, DOI 10.1016/S0002-9440(10)65034-1
   Freeman RB, 2004, AM J TRANSPLANT, V4, P114, DOI 10.1111/j.1600-6135.2004.00403.x
   Huang YT, 2003, J BIOMED SCI, V10, P170, DOI 10.1159/000068715
   Kaido T, 1998, J SURG RES, V74, P173, DOI 10.1006/jsre.1997.5243
   Kinoshita A, 2002, CARCINOGENESIS, V23, P341, DOI 10.1093/carcin/23.2.341
   Kobayashi S, 2001, CANCER-AM CANCER SOC, V91, P2096, DOI 10.1002/1097-0142(20010601)91:11<2096::AID-CNCR1237>3.0.CO;2-9
   Koteish A, 2002, ALCOHOL CLIN EXP RES, V26, P1710, DOI 10.1097/01.ALC.0000036923.77613.59
   Kwon YH, 2003, J BIOL CHEM, V278, P30348, DOI 10.1074/jbc.M300996200
   Li R, 1996, CURR BIOL, V6, P189, DOI 10.1016/S0960-9822(02)00452-9
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Martin KR, 2002, HUM EXP TOXICOL, V21, P71, DOI 10.1191/0960327102ht213oa
   Merion RM, 2003, LIVER TRANSPLANT, V9, P12, DOI 10.1053/jlts.2003.50009
   Nozaki I, 2004, AM J PATHOL, V165, P1907, DOI 10.1016/S0002-9440(10)63243-9
   Omori M, 1997, HEPATOLOGY, V25, P1115, DOI 10.1002/hep.510250512
   Papakyriakou P, 2002, APOPTOSIS, V7, P133, DOI 10.1023/A:1014472430976
   Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101
   Sawada N, 1996, JPN J CANCER RES, V87, P1102, DOI 10.1111/j.1349-7006.1996.tb03117.x
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   SHIBATA M, 1994, J GASTROENTEROL, V29, P56, DOI 10.1007/BF01229074
   Simpson DM, 2004, PROTEOMICS, V4, P524, DOI 10.1002/pmic.200300557
   Stell DA, 2004, LIVER TRANSPLANT, V10, P898, DOI 10.1002/lt.20138
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Trautwein C, 1999, ONCOGENE, V18, P6443, DOI 10.1038/sj.onc.1203045
   Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593
   Videla LA, 2003, BIOMETALS, V16, P103, DOI 10.1023/A:1020707811707
   Wagayama H, 2001, DIGEST DIS SCI, V46, P2074, DOI 10.1023/A:1011977923941
   Wang VS, 2004, LIVER INT, V24, P1, DOI 10.1111/j.1478-3231.2004.00888.x
   Weiss RH, 2000, CELL SIGNAL, V12, P413, DOI 10.1016/S0898-6568(00)00081-4
   Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8
   Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750
NR 50
TC 46
Z9 46
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 2005
VL 41
IS 6
BP 1262
EP 1271
DI 10.1002/hep.20709
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 931WX
UT WOS:000229517300008
PM 15880761
DA 2024-02-19
ER

PT J
AU Horvath, S
   Erhart, W
   Brosch, M
   Ammerpohl, O
   von Schönfels, W
   Ahrens, M
   Heits, N
   Bell, JT
   Tsai, PC
   Spector, TD
   Deloukas, P
   Siebert, R
   Sipos, B
   Becker, T
   Röcken, C
   Schafmayer, C
   Hampe, J
AF Horvath, Steve
   Erhart, Wiebke
   Brosch, Mario
   Ammerpohl, Ole
   von Schoenfels, Witigo
   Ahrens, Markus
   Heits, Nils
   Bell, Jordana T.
   Tsai, Pei-Chien
   Spector, Tim D.
   Deloukas, Panos
   Siebert, Reiner
   Sipos, Bence
   Becker, Thomas
   Roecken, Christoph
   Schafmayer, Clemens
   Hampe, Jochen
TI Obesity accelerates epigenetic aging of human liver
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE obesity; epigenetics; aging; biological age; DNA methylation
ID DNA METHYLATION CHANGES; TELOMERE LENGTH; CELLULAR SENESCENCE; AGE;
   DISEASE; NORMALIZATION; CANCER; ASSOCIATION; SIGNATURES; QUANTILE
AB Because of the dearth of biomarkers of aging, it has been difficult to test the hypothesis that obesity increases tissue age. Here we use a novel epigenetic biomarker of aging (referred to as an "epigenetic clock") to study the relationship between high body mass index (BMI) and the DNA methylation ages of human blood, liver, muscle, and adipose tissue. A significant correlation between BMI and epigenetic age acceleration could only be observed for liver (r = 0.42, P = 6.8 x 10(-4) in dataset 1 and r = 0.42, P = 1.2 x 10(-4) in dataset 2). On average, epigenetic age increased by 3.3 y for each 10 BMI units. The detected age acceleration in liver is not associated with the Nonalcoholic Fatty Liver Disease Activity Score or any of its component traits after adjustment for BMI. The 279 genes that are underexpressed in older liver samples are highly enriched (1.2 x 10(-9)) with nuclear mitochondrial genes that play a role in oxidative phosphorylation and electron transport. The epigenetic age acceleration, which is not reversible in the short term after rapid weight loss induced by bariatric surgery, may play a role in liver-related comorbidities of obesity, such as insulin resistance and liver cancer.
C1 [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Horvath, Steve] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA.
   [Erhart, Wiebke] Univ Kiel, Inst Human Genet, Dept Internal Med 1, D-24015 Kiel, Germany.
   [von Schoenfels, Witigo; Ahrens, Markus; Heits, Nils; Becker, Thomas; Schafmayer, Clemens] Univ Kiel, Inst Human Genet, Dept Visceral & Thorac Surg, D-24015 Kiel, Germany.
   [Roecken, Christoph] Univ Hosp Schleswig Holstein, Inst Pathol, D-24015 Kiel, Germany.
   [Brosch, Mario; Hampe, Jochen] Tech Univ Dresden, Univ Hosp Dresden, D-01307 Dresden, Germany.
   [Bell, Jordana T.; Tsai, Pei-Chien; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.
   [Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.
   [Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England.
   [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah 21589, Saudi Arabia.
   [Sipos, Bence] Univ Tubingen Hosp, Inst Pathol, D-72074 Tubingen, Germany.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of Kiel; University of Kiel;
   University of Kiel; Schleswig Holstein University Hospital; Technische
   Universitat Dresden; Carl Gustav Carus University Hospital; University
   of London; King's College London; University of London; Queen Mary
   University London; Wellcome Trust Sanger Institute; King Abdulaziz
   University; Eberhard Karls University of Tubingen; Eberhard Karls
   University Hospital
RP Horvath, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
EM shorvath@mednet.ucla.edu
RI Siebert, Reiner/A-8049-2010; Hampe, Jochen/A-2555-2010; Deloukas,
   Panos/B-2922-2013; Ammerpohl, Ole/G-2691-2010; Heits,
   Nils/AAL-9780-2020; Röcken, Christoph/A-9239-2010; Bell,
   Jordana/AAH-7312-2019; Ahrens, Markus/AAA-2615-2022
OI Hampe, Jochen/0000-0002-2421-6127; Deloukas, Panos/0000-0001-9251-070X;
   Röcken, Christoph/0000-0002-6989-8002; Brosch,
   Mario/0000-0001-8983-6557; TSAI, PEI-CHIEN/0000-0003-1575-9020; Bell,
   Jordana/0000-0002-3858-5986
FU National Institutes of Health (NIA/NIH) [5R01AG042511-02]; German
   ministry of education and research (BmBF) through the Virtual Liver
   Network (VLN) [0315763]; Christian-Albrechts-University Kiel; University
   Hospitals Schleswig-Holstein and Dresden in Germany
FX This study was supported by the National Institutes of Health (NIA/NIH
   5R01AG042511-02), the German ministry of education and research (BmBF)
   through the Virtual Liver Network (VLN, #0315763), and through
   institutional funds from the Christian-Albrechts-University Kiel and the
   University Hospitals Schleswig-Holstein and Dresden in Germany.
CR Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027
   Berdasco M, 2012, AGING CELL, V11, P181, DOI 10.1111/j.1474-9726.2012.00806.x
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Day K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r102
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4
   Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85
   Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336
   Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   García-Calzón S, 2014, INT J OBESITY, V38, P177, DOI 10.1038/ijo.2013.68
   Grönniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971
   Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109
   Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44
   Nordfjäll K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413
   Rönn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572
   Teschendorff AE, 2013, HUM MOL GENET, V22, pR7, DOI 10.1093/hmg/ddt375
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109
   Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5
   Vanni E, 2014, CLIN LIVER DIS, V18, P191, DOI 10.1016/j.cld.2013.09.001
   Yousefi P, 2013, EPIGENETICS-US, V8, P1141, DOI 10.4161/epi.26037
   Zykovich A, 2014, AGING CELL, V13, P360, DOI 10.1111/acel.12180
NR 39
TC 473
Z9 514
U1 9
U2 103
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 28
PY 2014
VL 111
IS 43
BP 15538
EP 15543
DI 10.1073/pnas.1412759111
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AR6ZL
UT WOS:000343729500068
PM 25313081
OA Green Published, Bronze
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Munroe, M
   Niero, EL
   Fok, WC
   Vessoni, AT
   Jeong, HC
   Brenner, KA
   Batista, LFZ
AF Munroe, Michael
   Niero, Evandro Luis
   Fok, Wilson Chun
   Vessoni, Alexandre Teixeira
   Jeong, Ho-Chang
   Brenner, Kirsten Ann
   Batista, Luis Francisco Zirnberger
TI Telomere Dysfunction Activates p53 and Represses HNF4α Expression
   Leading to Impaired Human Hepatocyte Development and Function
SO HEPATOLOGY
LA English
DT Article; Early Access
ID NUCLEAR FACTOR 4-ALPHA; LIVER; CELLS; DIFFERENTIATION; PROLIFERATION;
   HEMATOPOIESIS; ELONGATION; MUTATIONS; CIRRHOSIS; PROMOTER
AB Background and Aims Telomere attrition is a major risk factor for end-stage liver disease. Due to a lack of adequate models and intrinsic difficulties in studying telomerase in physiologically relevant cells, the molecular mechanisms responsible for liver disease in patients with telomere syndromes remain elusive. To circumvent that, we used genome editing to generate isogenic human embryonic stem cells (hESCs) harboring clinically relevant mutations in telomerase and subjected them to anin vitro, stage-specific hepatocyte differentiation protocol that resembles hepatocyte developmentin vivo. Approach and Results Using this platform, we observed that while telomerase is highly expressed in hESCs, it is quickly silenced, specifically due to telomerase reverse transcriptase component (TERT) down-regulation, immediately after endoderm differentiation and completely absent inin vitro-derived hepatocytes, similar to what is observed in human primary hepatocytes. While endoderm derivation is not impacted by telomere shortening, progressive telomere dysfunction impaired hepatic endoderm formation. Consequently, hepatocyte derivation, as measured by expression of specific hepatic markers as well by albumin expression and secretion, is severely compromised in telomerase mutant cells with short telomeres. Interestingly, this phenotype was not caused by cell death induction or senescence. Rather, telomere shortening prevents the up-regulation and activation of human hepatocyte nuclear factor 4 alpha (HNF4 alpha) in a p53-dependent manner. Both reactivation of telomerase and silencing of p53 rescued hepatocyte formation in telomerase mutants. Likewise, the conditional expression (doxycycline-controlled) ofHNF4 alpha, even in cells that retained short telomeres, accrued DNA damage, and exhibited p53 stabilization, successfully restored hepatocyte formation from hESCS. Conclusions Our data show that telomere dysfunction acts as a major regulator ofHNF4 alpha during hepatocyte development, pointing to a target in the treatment of liver disease in telomere-syndrome patients.
C1 [Brenner, Kirsten Ann] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.
   [Munroe, Michael; Niero, Evandro Luis; Fok, Wilson Chun; Vessoni, Alexandre Teixeira; Jeong, Ho-Chang; Brenner, Kirsten Ann; Batista, Luis Francisco Zirnberger] Washington Univ, Dept Med, St Louis, MO 63110 USA.
   [Batista, Luis Francisco Zirnberger] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA.
   [Batista, Luis Francisco Zirnberger] Washington Univ, Ctr Regenerat Med, St Louis, MO 63110 USA.
C3 University of Michigan System; University of Michigan; Washington
   University (WUSTL); Washington University (WUSTL); Washington University
   (WUSTL)
RP Batista, LFZ (corresponding author), Washington Univ, Sch Med, Hematol Div, Campus Box 8125,660 South Euclid Ave, St Louis, MO 63110 USA.
EM lbatista@wustl.edu
RI Jeong, Hochang/C-9070-2019
OI Jeong, Hochang/0000-0002-5379-8314
FU CNPq, Brazil; Phillip Majerus Postdoctoral Fellowship; National Heart,
   Lung, and Blood Institute's T32 Training Grant in Molecular Hematology
   [HL007088-41]; National Fellowship Foundation; National Heart, Lung, and
   Blood Institute [1R01HL137793-01]; Department of Defense [BM160054];
   Siteman Cancer Center at Washington University in St. Louis; American
   Cancer Society; V Foundation for Cancer Research; Edward Mallinckrodt
   Jr. Foundation; Concern Foundation; American Federation for Aging
   Research; Longer Life Foundation; Washington University DDRCC program
   [NIDDK P30 DK052574]
FX Supported by CNPq, Brazil (E.L. N.); the Phillip Majerus Postdoctoral
   Fellowship (A.T. V.); the National Heart, Lung, and Blood Institute's
   T32 Training Grant in Molecular Hematology (HL007088-41, to M.M. and
   W.C.F.); the National Fellowship Foundation (K.A.B.); the National
   Heart, Lung, and Blood Institute (1R01HL137793-01, to L.F.Z.B.); the
   Department of Defense (BM160054); and grants from the Siteman Cancer
   Center at Washington University in St. Louis, the American Cancer
   Society, the V Foundation for Cancer Research, the Edward Mallinckrodt
   Jr. Foundation, the Concern Foundation, the American Federation for
   Aging Research, and the Longer Life Foundation. This project was also
   supported by a pilot grant from the Washington University DDRCC program
   (NIDDK P30 DK052574, to L.F.Z.B.).
CR Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792
   Alder JK, 2018, P NATL ACAD SCI USA, V115, pE2358, DOI 10.1073/pnas.1720427115
   Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246
   Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P52, DOI 10.1016/j.mrfmmm.2011.10.013
   Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046
   Babeu JP, 2014, WORLD J GASTROENTERO, V20, P22, DOI 10.3748/wjg.v20.i1.22
   Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084
   Bertuch AA, 2016, RNA BIOL, V13, P696, DOI 10.1080/15476286.2015.1094596
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287
   Chiba K, 2017, SCIENCE, V357, P1416, DOI 10.1126/science.aao0535
   Corbett JL, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00265
   Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606
   Donaires FS, 2019, STEM CELL RES, V40, DOI 10.1016/j.scr.2019.101540
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   Fok WC, 2019, BLOOD, V133, P1308, DOI 10.1182/blood-2018-11-885368
   Fok WC, 2017, STEM CELL REP, V9, P409, DOI 10.1016/j.stemcr.2017.06.015
   Hanawa M, 2017, STEM CELL REV REP, V13, P542, DOI 10.1007/s12015-016-9709-x
   Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   Jing R, 2018, CELL REP, V25, P1469, DOI 10.1016/j.celrep.2018.10.036
   Kapuria D, 2019, HEPATOLOGY, V69, P2579, DOI 10.1002/hep.30578
   Krstic J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030921
   Laptenko O, 2017, GENE DEV, V31, P955, DOI 10.1101/gad.302364.117
   Lau HH, 2018, J HEPATOL, V68, P1033, DOI 10.1016/j.jhep.2017.11.026
   Lazarevich N. L., 2010, Experimental Oncology, V32, P167
   Lazzerini-Denchi E, 2016, NAT REV MOL CELL BIO, V17, P364, DOI 10.1038/nrm.2016.43
   Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7
   Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614
   Mallanna Sunil K, 2013, Curr Protoc Stem Cell Biol, V26, DOI 10.1002/9780470151808.sc01g04s26
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3
   Niewisch MR, 2019, EXPERT REV HEMATOL, V12, P1037, DOI 10.1080/17474086.2019.1662720
   Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280
   Savage Sharon A, 2018, F1000Res, V7, DOI 10.12688/f1000research.14068.1
   Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1
   Sim XL, 2016, METHODS MOL BIOL, V1353, P13, DOI 10.1007/7651_2014_179
   Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047
   Smith EM, 2020, CELL MOL LIFE SCI, V77, P61, DOI 10.1007/s00018-019-03369-x
   Takayama K, 2017, HEPATOL COMMUN, V1, P1058, DOI [10.1002/hep4.1111, 10.1002/Hep4.1111]
   Walesky C, 2015, GENE EXPRESSION, V16, P101, DOI 10.3727/105221615X14181438356292
   Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x
   Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Winkler T, 2013, J CLIN INVEST, V123, P1952, DOI 10.1172/JCI67146
   Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019
   Yan ZB, 2018, LIFE SCI, V215, P64, DOI 10.1016/j.lfs.2018.10.051
   Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904
NR 52
TC 10
Z9 10
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2020 OCT
PY 2020
VL 72
IS 4
BP 1412
EP 1429
DI 10.1002/hep.31414
EA AUG 2020
PG 18
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA OA2QV
UT WOS:000562542500001
PM 32516515
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Kim, JS
   Na, CS
   Pak, SC
   Kim, YG
AF Kim, JS
   Na, CS
   Pak, SC
   Kim, YG
TI Effects of Yukmi, an herbal formula, on the liver of senescence
   accelerated mice (SAM) exposed to oxidative stress
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
ID LIPID-PEROXIDATION; ANTIOXIDANTS; PARAQUAT; DAMAGE; MOUSE; DNA
AB The effects of Yukmi (Decoction of six plants including rehmannia), an herbal formula, were studied on liver oxidant damage induced by paraquat (PQ) administered intravenously in the senescence accelerated mice (SAM-Pls). The activities of superoxide dismutase (SOD) and catalase as two major antioxidant enzymes and lipid peroxidation levels were determined for six days. Data show that the activities of hepatic SODs and catalase were increased by oral administration of Yukmi extracts following PQ pretreatment. Herbal medicine effectively blocked the PQ-induced effects on liver malondialdehyde (MDA) levels. For the histopathological changes in SAM-P/8 liver, Yukmi extracts inhibited PQ-induced damage to the hepatic mitochondria and their membranes. Data suggest that Yukmi extracts may be useful in protecting against oxidative damage.
C1 Chosun Univ, Coll Nat Sci, Dept Biol Sci, Dong Ku, Kwangju 501759, South Korea.
C3 Chosun University
RP Kim, YG (corresponding author), Chosun Univ, Coll Nat Sci, Dept Biol Sci, Dong Ku, 375 Seosuk DOng, Kwangju 501759, South Korea.
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   [Anonymous], 1991, OXIDATIVE STRESS OXI
   ARUROMA OI, 1990, FREE RADICAL RES COM, V10, P143
   Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   BAST A, 1984, TRENDS BIOCHEM SCI, V9, P510, DOI 10.1016/0968-0004(84)90273-1
   Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245
   Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3
   FABISIAK JP, 1997, AM J PHYSIOL, V272, P6675
   FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377
   GROOTVELD M, 1987, BIOCHEM J, V243, P803, DOI 10.1042/bj2430803
   HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X
   Holzinger F, 1999, ANN ONCOL, V10, P122, DOI 10.1023/A:1008321710719
   Kim YG, 1997, FREE RADICAL RES, V26, P1, DOI 10.3109/10715769709097779
   KIM YG, 1998, KOR J GERONTOL, V8, P14
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MINAKATA K, 1995, J TOXICOL ENV HEALTH, V44, P29, DOI 10.1080/15287399509531941
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MOODY CS, 1982, P NATL ACAD SCI-BIOL, V79, P2855, DOI 10.1073/pnas.79.9.2855
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0
   STORZ GM, 1987, P NATL ACAD SCI USA, V86, P4474
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Yang MK, 1999, J TOXICOL ENV HEAL A, V58, P289, DOI 10.1080/009841099157250
   YUWEN EY, 1996, CHINESE ENGLISH DICT
NR 28
TC 16
Z9 16
U1 0
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0192-415X
EI 1793-6853
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PY 2000
VL 28
IS 3-4
BP 343
EP 350
DI 10.1142/S0192415X00000404
PG 8
WC Integrative & Complementary Medicine; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; General & Internal Medicine
GA 387LR
UT WOS:000166124500005
PM 11154047
DA 2024-02-19
ER

PT J
AU Tang, XM
   Yin, XY
   Al-Wraikat, M
   Zhang, YQ
   Zhou, SP
   Tang, YX
   Zhang, YY
   Fan, JF
AF Tang, Xiaomin
   Yin, Xiaoyu
   Al-Wraikat, Majida
   Zhang, Yaqiong
   Zhou, Saiping
   Tang, Yingxue
   Zhang, Yanyan
   Fan, Junfeng
TI Formation of Maillard Reaction Products in Aged Sorghum Vinegar during
   Ageing and Protective Effects of Pure Vinegar Melanoidin Against
   CCl4-Induced Rat Hepatic Damage
SO FOOD TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE food safety; 5-HMF; advanced glycation end products; hepatoprotective
   ef-fect; oxidative damage; reactive oxygen species
ID APPROVED RECOMMENDATION 1985; ACETIC-ACID; 2-OXOGLUTARATE
   AMINOTRANSFERASE; CATALYTIC CONCENTRATION; OXIDATIVE STRESS; IFCC
   METHODS; L-ALANINE; IN-VITRO; ANTIOXIDANT; GLUTATHIONE
AB Research background. The processing method generally affects the toxicity and bio-logical activity of aged sorghum vinegar. This study investigates the changes in the inter-mediate Maillard reaction products of sorghum vinegar during ageing and the in vivo hepatoprotective effects of pure melanoidin obtained from it. Experimental approach. High-performance liquid chromatography (HPLC) and fluores-cence spectrophotometry were utilized to quantify intermediate Maillard reaction prod-ucts. The CCl4-induced liver damage in rats was used to evaluate the protective role of pure melanoidin in rat liver.Results and conclusions. Compared with the initial concentration, the 18-month ageing process caused a 1.2-to 3.3-fold increase in the concentrations of intermediate Maillard reaction products, i.e. 5-hydroxymethylfurfural (HMF), 5-methylfurfural (MF), methygly-oxal (MGO), glyoxal (GO) and advanced glycation end products (AGEs). The concentrations of HMF in the aged sorghum vinegar were 6.1-fold higher than the 450 mu M limit standard for honey, implying the need for shortening the ageing of the vinegar in practice for safe-ty concerns. Pure melanoidin (Mr>3.5 kDa) demonstrated significant protective effects against CCl4-induced rat liver damage, as evidenced by normalized serum biochemical parameters (transaminases and total bilirubin), suppressing hepatic lipid peroxidation and reactive oxygen species, as well as increasing glutathione amount and restoring antioxi-dant enzyme activities. Histopathological analysis revealed that melanoidin in vinegar reduced cell infiltration and vacuolar hepatocyte necrosis in rat liver. The findings demon-strated that a shortened ageing process should be considered in practice to ensure the safety of aged sorghum vinegar. Vinegar melanoidin is a potential alternative for the pre-vention of hepatic oxidative damage.Novelty and scientific contribution. This study demonstrates that the manufacturing process had a profound influence on the generation of vinegar intermediate Maillard re-action products. In particular, it revealed the in vivo hepatoprotective effect of pure mel-anoidin from aged sorghum vinegar, and provides insight into the in vivo biological activ-ity of melanoidin.
C1 [Tang, Xiaomin; Yin, Xiaoyu; Al-Wraikat, Majida; Zhang, Yaqiong; Zhou, Saiping; Tang, Yingxue; Fan, Junfeng] Beijing Forestry Univ, Coll Biol Sci & Technol, Dept Food Sci & Engn, Beijing Key Lab Forest Food Proc & Safety, 35 Qinghua Rd, Beijing 100083, Peoples R China.
   [Zhang, Yanyan] Beijing Univ Agr, Coll Food Sci & Engn, 7 Beinong Rd, Beijing 102206, Peoples R China.
C3 Beijing Forestry University; Beijing University of Agriculture
RP Fan, JF (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Dept Food Sci & Engn, Beijing Key Lab Forest Food Proc & Safety, 35 Qinghua Rd, Beijing 100083, Peoples R China.; Zhang, YY (corresponding author), Beijing Univ Agr, Coll Food Sci & Engn, 7 Beinong Rd, Beijing 102206, Peoples R China.
EM zhangyanyan@bac.edu.cn; fanjunfeng@bjfu.edu.cn
RI Zhang, Yanyan/JFA-9161-2023; Zhang, Han/JMR-0670-2023; Yang,
   Mei/JNS-2225-2023; Wang, Han/JJF-2614-2023; li, yurong/JMQ-8540-2023
OI Al-Wraikat, Majida/0000-0001-5510-9925; Zhou,
   Saiping/0000-0002-0211-9748
CR Alvarez-Suarez JM, 2013, CURR MED CHEM, V20, P621, DOI 10.2174/092986713804999358
   [Anonymous], 2021, OR V 2021
   [Anonymous], 2016, National Food Safety Standard-Determination of Protein in Foods
   [Anonymous], 2019, SPSS STAT, V26.0
   BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P497
   BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P481
   Crapo J D, 1978, Methods Enzymol, V53, P382
   EBIHARA K, 1988, AGR BIOL CHEM TOKYO, V52, P1311
   Fan JF, 2011, JARQ-JPN AGR RES Q, V45, P445, DOI 10.6090/jarq.45.445
   Fan JF, 2009, J AGR FOOD CHEM, V57, P8683, DOI 10.1021/jf901680y
   Guo L, 2013, THESIS SHANXI U
   Kondo S, 2001, BIOSCI BIOTECH BIOCH, V65, P2690, DOI 10.1271/bbb.65.2690
   KROH LW, 1994, FOOD CHEM, V51, P373, DOI 10.1016/0308-8146(94)90188-0
   Lan MY, 2020, J FUNCT FOODS, V71, DOI 10.1016/j.jff.2020.103976
   Li J, 2015, FOOD FUNCT, V6, P2845, DOI [10.1039/c5fo00327j, 10.1039/C5FO00327J]
   Liu DC, 2021, FOOD CHEM, V342, DOI 10.1016/j.foodchem.2020.128319
   Liu JY, 2017, J FUNCT FOODS, V37, P632, DOI 10.1016/j.jff.2017.08.009
   Liu JY, 2016, J FUNCT FOODS, V21, P75, DOI 10.1016/j.jff.2015.11.041
   Lu X, 2015, THESIS SHANXI U TAIY
   Luevano-Contreras C, 2010, NUTRIENTS, V2, P1247, DOI 10.3390/nu2121247
   Mohsin GF, 2018, FOOD CHEM, V245, P761, DOI 10.1016/j.foodchem.2017.11.115
   Morales FJ, 2004, EUR FOOD RES TECHNOL, V218, P515, DOI 10.1007/s00217-004-0896-3
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Mukherjee Pulok K, 2003, Adv Food Nutr Res, V47, P277, DOI 10.1016/S1043-4526(03)47005-8
   Nooshkam M, 2019, FOOD CHEM, V275, P644, DOI 10.1016/j.foodchem.2018.09.083
   Ouyang Yu, 2021, Shipin Kexue / Food Science, V42, P350, DOI 10.7506/spkx1002-6630-20200610-135
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Qiu J, 2010, J SCI FOOD AGR, V90, P1951, DOI 10.1002/jsfa.4040
   Ren LP, 2017, J FUNCT FOODS, V33, P227, DOI 10.1016/j.jff.2017.03.053
   Rufián-Henares JA, 2007, FOOD RES INT, V40, P995, DOI 10.1016/j.foodres.2007.05.002
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Su D, 2020, PHYTOMEDICINE, V76, DOI 10.1016/j.phymed.2020.153265
   Sumner JB, 1937, J BIOL CHEM, V121, P417
   Suzuki E, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104046
   Tagliazucchi D, 2010, J AGR FOOD CHEM, V58, P2513, DOI 10.1021/jf903701h
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0
   Wang TT, 2022, J ETHNOPHARMACOL, V290, DOI 10.1016/j.jep.2022.115112
   Wang Y, 2008, LISHIZHEN MED MATERI, V19, P1778
   Xia T, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103448
   Xu QP, 2007, FOOD CHEM, V102, P841, DOI 10.1016/j.foodchem.2006.06.013
   Ye XS, 2009, J ETHNOPHARMACOL, V124, P130, DOI 10.1016/j.jep.2009.04.003
   [张锦华 Zhang Jinhua], 2016, [食品与发酵工业, Food and Fermentation Industries], V42, P141
NR 44
TC 0
Z9 0
U1 7
U2 12
PU FACULTY FOOD TECHNOLOGY BIOTECHNOLOGY
PI ZAGREB
PA UNIV ZAGREB, KACIECEVA 23, 41000 ZAGREB, CROATIA
SN 1330-9862
EI 1334-2606
J9 FOOD TECHNOL BIOTECH
JI Food Technol. Biotechnol.
PD JAN-MAR
PY 2023
VL 61
IS 1
BP 27
EP 38
DI 10.17113/ftb.61.01.23.7537
PG 12
WC Biotechnology & Applied Microbiology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA D1ZC3
UT WOS:000966761900003
PM 37200790
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Shi, Y
   Shu, ZJ
   Xue, XL
   Yeh, CK
   Katz, MS
   Kamat, A
AF Shi, Yun
   Shu, Zhen-Ju
   Xue, Xiaoling
   Yeh, Chih-Ko
   Katz, Michael S.
   Kamat, Amrita
TI β<sub>2</sub>-Adrenergic receptor ablation modulates hepatic lipid
   accumulation and glucose tolerance in aging mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Lipid; Hepatocytes; Cide; Triglycerides; Metabolism; Nonalcoholic fatty
   liver disease
ID SYMPATHETIC-NERVOUS-SYSTEM; BETA-ADRENERGIC-RECEPTORS; FATTY
   LIVER-DISEASE; RAT-LIVER; INSULIN-RESISTANCE; ADENYLATE-CYCLASE;
   GLYCOGENOLYSIS; EPINEPHRINE; METABOLISM; ACTIVATION
AB Catecholamines acting through beta-adrenergic receptors (beta(1)-, beta(2)-, beta(3)-AR subtypes) modulate important biological responses in various tissues. Our previous studies suggest a role for increased hepatic beta-AR-mediated signaling during aging as a mediator of hepatic steatosis, liver glucose output, and insulin resistance in rodents. In the current study, we have utilized beta(2)-AR knockout (KO) and wildtype (WT) control mice to define further the role of beta(2)-AR signaling during aging on lipid and glucose metabolism. Our results demonstrate for the first time that age-related increases in hepatic triglyceride accumulation and body weight are attenuated upon beta(2)-AR ablation. Although no differences in plasma triglyceride, non-esterified fatty acids or insulin levels were detected between old WT and KO animals, an age-associated increase in hepatic expression of lipid homeostasis regulator Cidea was significantly reduced in old KO mice. Interestingly, we also observed a shift from reduced glucose tolerance in young adult KO animals to significantly improved glucose tolerance in old KO when compared to age-matched WT mice. These results provide evidence for an important role played by beta(2)-ARs in the regulation of lipid and glucose metabolism during aging. The effect of beta(2)-AR ablation on caloric intake during aging is currently not known and requires investigation. Future studies are also warranted to delineate the beta(2)-AR-mediated mechanisms involved in the control of lipid and glucose homeostasis, especially in the context of a growing aging population. Published by Elsevier Inc.
C1 [Shi, Yun; Shu, Zhen-Ju; Xue, Xiaoling; Yeh, Chih-Ko; Katz, Michael S.; Kamat, Amrita] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Audie L Murphy Div, San Antonio, TX 78229 USA.
   [Shi, Yun; Shu, Zhen-Ju; Xue, Xiaoling; Katz, Michael S.; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Yeh, Chih-Ko; Katz, Michael S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, San Antonio, TX 78229 USA.
   [Yeh, Chih-Ko; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
C3 Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy
   Memorial Veterans Hospital; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio
RP Kamat, A (corresponding author), South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr 182, Audie L Murphy Div, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.
EM shiy@uthscsa.edu; shuz2@uthscsa.edu; xue@uthscsa.edu; yeh@uthscsa.edu;
   katz@uthscsa.edu; Amrita.Kamat@va.gov
RI wang, KiKi/JFZ-3334-2023
OI Yeh, Chih-Ko/0000-0001-6611-9942
FU VA Merit Review Award [1I01BX001744-01]; Kronos Longevity Research
   Institute Award
FX This work was supported by VA Merit Review Award (1I01BX001744-01 to AK)
   and Kronos Longevity Research Institute Award (to MSK).
CR ARNER P, 1990, J CLIN ENDOCR METAB, V71, P1119, DOI 10.1210/jcem-71-5-1119
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Boyda HN, 2013, J NEUROENDOCRINOL, V25, P217, DOI 10.1111/jne.12002
   Chen ZJ, 2010, J BIOL CHEM, V285, P25996, DOI 10.1074/jbc.M110.141598
   Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   DEIBERT DC, 1980, J CLIN INVEST, V65, P717, DOI 10.1172/JCI109718
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398
   Erraji-Benchekroun L, 2005, AM J PHYSIOL-ENDOC M, V288, pE715, DOI 10.1152/ajpendo.00113.2004
   Esler M, 2002, AM J PHYSIOL-REG I, V282, pR909, DOI 10.1152/ajpregu.00335.2001
   Fernandes GW, 2014, J ENDOCRINOL, V221, P381, DOI 10.1530/JOE-13-0526
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   Grassi G, 2010, HYPERTENSION, V56, P338, DOI 10.1161/HYPERTENSIONAHA.110.156596
   Gruenewald D. A., 2003, PRINCIPLES GERIATRIC, P819
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   Hu AH, 2008, REJUV RES, V11, P215, DOI 10.1089/rej.2007.0609
   Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659
   Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756
   Jin ES, 2015, J CLIN ENDOCR METAB, V100, P235, DOI 10.1210/jc.2014-2404
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   Kelder Bruce, 2007, Comp Hepatol, V6, P4, DOI 10.1186/1476-5926-6-4
   KRIEF S, 1993, J CLIN INVEST, V91, P344, DOI 10.1172/JCI116191
   LONNQVIST F, 1990, J CLIN INVEST, V85, P1614, DOI 10.1172/JCI114612
   Ma Y, 2011, ENDOCRINOLOGY, V152, P1412, DOI 10.1210/en.2010-0881
   Muscogiuri G, 2011, ENDOCR RES, V36, P74, DOI 10.3109/07435800.2010.539993
   Nonogaki K, 2000, DIABETOLOGIA, V43, P533, DOI 10.1007/s001250051341
   Park SY, 2006, LIFE SCI, V79, P2228, DOI 10.1016/j.lfs.2006.07.014
   Reynolds TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130259
   RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714
   SANGHANI MP, 1994, J GERONTOL, V49, pB60, DOI 10.1093/geronj/49.2.B60
   Santulli G, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-10
   Santulli G, 2012, DIABETES, V61, P692, DOI 10.2337/db11-1027
   SCARPACE P J, 1991, Drugs and Aging, V1, P116
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   SUPIANO MA, 1993, J GERONTOL, V48, pB173, DOI 10.1093/geronj/48.5.B173
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   TROISI RJ, 1991, HYPERTENSION, V17, P669, DOI 10.1161/01.HYP.17.5.669
   Vilà-Brau A, 2013, J LIPID RES, V54, P592, DOI 10.1194/jlr.M028472
   Wang DY, 2013, J BIOL CHEM, V288, P10298, DOI 10.1074/jbc.M112.415141
   Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009
   Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489
   Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013
NR 50
TC 15
Z9 15
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN 1
PY 2016
VL 78
BP 32
EP 38
DI 10.1016/j.exger.2016.03.005
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DJ6OR
UT WOS:000374333300004
PM 26952573
DA 2024-02-19
ER

PT J
AU Horrillo, D
   Gallardo, N
   Lauzurica, N
   Barrús, MT
   San Frutos, MG
   Andrés, A
   Ros, M
   Fernández-Agulló, T
AF Horrillo, D.
   Gallardo, N.
   Lauzurica, N.
   Barrus, M. T.
   San Frutos, M. G.
   Andres, A.
   Ros, M.
   Fernandez-Agullo, T.
TI DEVELOPMENT OF LIVER FIBROSIS DURING AGING: EFFECTS OF CALORIC
   RESTRICTION
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE elderly; steatosis; hepatic stellate cells; lipid droplets;
   non-alcoholic fatty liver disease
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; FIBRILLARY ACIDIC PROTEIN;
   INSULIN-RESISTANCE; HEPATIC STEATOSIS; MICE; STEATOHEPATITIS;
   INFLAMMATION; DISEASE; MATRIX
AB Liver is the central metabolic organ of the body and diet is considered one of the main environmental factors that can impact on aging liver. In the elderly stage liver function is relatively well conserved although there are a variety of not well defined morphological changes related to liver fibrosis which is commonly associated with an inflammatory state. The aim of this paper is to study these alterations during the physiological process of aging in Wistar rats and also test if caloric restriction (CR) could ameliorate them. As fibrosis is associated to hepatic stellate cell (HSC) function we also analyzed these cells during aging. Livers from five groups of male Wistar rats (3-, 8-, 24-months old ad libitum and 8- and 24-months caloric restricted rats) were used in this study. Histological analysis, expression of genes implicated in liver fibrosis and the status of inflammatory step-pathways as p38 mitogen-activated protein kinase (p38-MAPK), c-Jun N-terminal kinase (INK) and the nuclear factor kappa B (NF kappa beta) isoforms, p50 and p65, in cytosolic and nuclear fractions were performed. During elderly, associated with morphological change of HSC, there is a progressive increase in collagen deposition due to an inhibition in collagen degradation. Higher expression of cytokines and the activation of inflammatory pathways are associated with aging. CR ameliorates these circumstances being more effective when it started in middle age. In conclusion elderly stage is associated to a mild fibrotic and inflammatory state in the liver which could be ameliorated after CR.
C1 [Horrillo, D.; Lauzurica, N.; Barrus, M. T.; San Frutos, M. G.; Ros, M.; Fernandez-Agullo, T.] Univ Rey Juan Carlos, Fac Hlth Sci, Dept Biochem Physiol & Mol Genet, Alcorcon, Spain.
   [Gallardo, N.; Andres, A.] Univ Castilla La Mancha, Biochem Sect, Fac Chem, E-13071 Ciudad Real, Spain.
   [Gallardo, N.; Andres, A.] Univ Castilla La Mancha, Reg Ctr Biomed Res CRIB, E-13071 Ciudad Real, Spain.
C3 Universidad Rey Juan Carlos; Universidad de Castilla-La Mancha;
   Universidad de Castilla-La Mancha
RP Fernández-Agulló, T (corresponding author), Fac Ciencias Salud, Dept Bioquim Fisiol & Genet Mol, Av Atenas S-N, Madrid 28922, Spain.
EM teresa.fernandez.agullo@urjc.es
RI García-San Frutos, Miriam/C-1592-2015; Gallardo, Nilda/AAR-3104-2021;
   Barrús, Mª Teresa/AAA-7466-2019; ANDRES, ANTONIO/G-8794-2015
OI García-San Frutos, Miriam/0000-0001-7097-3498; Gallardo,
   Nilda/0000-0003-3211-569X; ANDRES, ANTONIO/0000-0002-9892-8338; Ros,
   Manuel/0000-0003-2982-513X; Lauzurica, Nuria/0000-0001-5937-9965
FU Ministerio de Ciencia y Tecnologia, Spain [BFU2005.07647- C03-02];
   Comunidad de Madrid [S2010/BMC24-23]; Junta de Comuidades de Castilla-La
   Mancha, Spain [FISCAM-PI-2007/60]; Universidad Rey Juan Carlos-Comunidad
   de Madrid, Spain [URJC-CM-2008-CSH-3484]
FX This work was supported by grants BFU2005.07647- C03-02 (Ministerio de
   Ciencia y Tecnologia, Spain), S2010/BMC24-23 (Comunidad de Madrid),
   FISCAM-PI-2007/60 (Junta de Comuidades de Castilla-La Mancha, Spain) and
   URJC-CM-2008-CSH-3484 (Universidad Rey Juan Carlos-Comunidad de Madrid,
   Spain). We would like to thank to Maria Conejero Moreno for her help in
   electron microscopy, Jose Mas for the RT-PCR experiments and Eva
   Oliveros for her technical assistance.
CR Allman M, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/738620
   ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270
   Beier JI, 2011, ARCH BIOCHEM BIOPHYS, V510, P19, DOI 10.1016/j.abb.2011.04.001
   Bergheim I, 2006, J PHARMACOL EXP THER, V316, P592, DOI 10.1124/jpet.105.095042
   Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001
   Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Fernández-Galaz C, 2002, DIABETOLOGIA, V45, P997, DOI 10.1007/s00125-002-0851-4
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Fortuna VA, 2001, J NUTR BIOCHEM, V12, P610, DOI 10.1016/S0955-2863(01)00179-6
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   García-San Frutos M, 2012, MECH AGEING DEV, V133, P489, DOI 10.1016/j.mad.2012.06.001
   GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4
   Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166
   Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354
   Horrillo Daniel, 2011, Archives of Physiology and Biochemistry, V117, P140, DOI 10.3109/13813455.2011.577435
   Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995
   Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551
   Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4
   Leyland H, 1996, HEPATOLOGY, V24, P1172, DOI 10.1002/hep.510240532
   Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039
   Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1
   Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007
   Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655
NR 30
TC 16
Z9 16
U1 0
U2 9
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD APR-JUN
PY 2013
VL 27
IS 2
BP 377
EP 388
PG 12
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA 189TH
UT WOS:000322290700010
PM 23830388
DA 2024-02-19
ER

PT J
AU Liu, YS
   Xiao, JQ
   Cai, JY
   Li, R
   Sui, X
   Zhang, JB
   Lu, TY
   Chen, HT
   Chen, GH
   Li, HB
   Jiang, CH
   Zhao, XG
   Xiao, CC
   Lei, YG
   Yao, J
   Lv, G
   Liang, JL
   Zhang, YC
   Yang, JR
   Zheng, J
   Yang, Y
AF Liu, Yasong
   Xiao, Jiaqi
   Cai, Jianye
   Li, Rong
   Sui, Xin
   Zhang, Jiebin
   Lu, Tongyu
   Chen, Haitian
   Chen, Guihua
   Li, Haibo
   Jiang, Chenhao
   Zhao, Xuegang
   Xiao, Cuicui
   Lei, Yunguo
   Yao, Jia
   Lv, Guo
   Liang, Jinliang
   Zhang, Yingcai
   Yang, Jian-Rong
   Zheng, Jun
   Yang, Yang
TI Single-cell immune profiling of mouse liver aging reveals
   <i>Cxcl2</i><SUP>+</SUP> macrophages recruit neutrophils to aggravate
   liver injury
SO HEPATOLOGY
LA English
DT Article; Early Access
ID SENESCENCE; INFLAMMATION; DISTINCT; DISEASE; FUTURE
AB Background and Aims: Immune cells play a crucial role in liver aging. However, the impact of dynamic changes in the local immune microenvironment on age-related liver injury remains poorly understood. We aimed to characterize intrahepatic immune cells at different ages to investigate key mechanisms associated with liver aging. Approach and Results: We carried out single-cell RNA sequencing on mouse liver tissues at 4 different ages, namely, the newborn, suckling, young, and aged stages. The transcriptomic landscape, cellular classification, and intercellular communication were analyzed. We confirmed the findings by multiplex immunofluorescence staining, flow cytometry, in vitro functional experiments, and chimeric animal models. Nine subsets of 89,542 immune cells with unique properties were identified, of which Cxcl2 + macrophages within the monocyte/macrophage subset were preferentially enriched in the aged liver. Cxcl2 (+) macrophages presented a senescence-associated secretory phenotype and recruited neutrophils to the aged liver through the CXCL2-CXCR2 axis. Through the secretion of IL-1 beta and TNF-alpha, Cxcl2 (+) macrophages stimulated neutrophil extracellular traps formation. Targeting the CXCL2-CXCR2 axis limited the neutrophils migration toward the liver and attenuated age-related liver injury. Moreover, the relationship between Cxcl2 + macrophages and neutrophils in age-related liver injury was further validated by human liver transplantation samples. Conclusions: This in-depth study illustrates that the mechanism of Cxcl2 + macrophage-driven neutrophil activation involves the CXCL2-CXCR2 axis and provides a potential therapeutic strategy for age-related liver injury.
C1 [Liu, Yasong; Xiao, Jiaqi; Cai, Jianye; Zhang, Jiebin; Lu, Tongyu; Chen, Haitian; Chen, Guihua; Li, Haibo; Jiang, Chenhao; Lei, Yunguo; Yao, Jia; Zhang, Yingcai; Zheng, Jun; Yang, Yang] Sun Yat sen Univ, Dept Hepat Surg, Organ Transplantat Res Ctr Guangdong Prov, Guangdong Prov Engn Lab Transplantat Med,Affiliate, Guangzhou 510630, Peoples R China.
   [Liu, Yasong; Xiao, Jiaqi; Cai, Jianye; Zhang, Jiebin; Lu, Tongyu; Chen, Haitian; Chen, Guihua; Li, Haibo; Jiang, Chenhao; Lei, Yunguo; Yao, Jia; Zhang, Yingcai; Zheng, Jun; Yang, Yang] Sun Yat sen Univ, Affiliated Hosp 3, Organ Transplantat Res Ctr ofGuangdong Prov, Guangdong Prov Engn Lab Transplantat Med,Liver Tra, Guangzhou, Peoples R China.
   [Liu, Yasong; Xiao, Jiaqi; Cai, Jianye; Li, Rong; Zhang, Jiebin; Lu, Tongyu; Chen, Haitian; Chen, Guihua; Li, Haibo; Jiang, Chenhao; Lei, Yunguo; Yao, Jia; Zhang, Yingcai; Zheng, Jun; Yang, Yang] Sun Yat Sen Univ, Affiliated Hosp 3, Key Lab Liver Dis Biotherapy Translat Med Guangdon, Guangdong Key Lab Liver Dis Res, Guangzhou, Peoples R China.
   [Sui, Xin; Zhao, Xuegang] Sun Yat Sen Univ, Affiliated Hosp 3, Surg ICU, Guangzhou, Peoples R China.
   [Xiao, Cuicui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou, Peoples R China.
   [Lv, Guo] Sun Yat sen Univ, Affiliated Hosp 3, Biol Treatment Ctr, Guangzhou, Peoples R China.
   [Liang, Jinliang] Sun Yat sen Univ, Affiliated Hosp 3, Organ Transplantat Res Ctr, Guangdong Prov Key Lab Liver Dis Biotherapy & Tran, Guangzhou, Peoples R China.
   [Yang, Jian-Rong] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Genet & Biomed Informat, Guangzhou 510080, Peoples R China.
   [Yang, Jian-Rong] Sun Yat Sen Univ, Affiliated Hosp 1, Adv Med Technol Ctr, Zhongshan Sch Med, Guangzhou, Peoples R China.
   [Zhang, Yingcai; Zheng, Jun; Yang, Yang] Sun Yat sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510630, Peoples R China.
   [Zhang, Yingcai; Zheng, Jun; Yang, Yang] Sun Yat sen Univ, Liver Transplantat Ctr, Affiliated Hosp 3, Guangzhou 510630, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University;
   Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University;
   Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University;
   Sun Yat Sen University; Sun Yat Sen University
RP Yang, JR (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Genet & Biomed Informat, Guangzhou 510080, Peoples R China.; Zhang, YC; Zheng, J; Yang, Y (corresponding author), Sun Yat sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510630, Peoples R China.; Zhang, YC; Zheng, J; Yang, Y (corresponding author), Sun Yat sen Univ, Liver Transplantat Ctr, Affiliated Hosp 3, Guangzhou 510630, Peoples R China.
EM liuys3@mail2.sysu.edu.cn; xiaojq5@mail2.sysu.edu.cn;
   caijianyeah@163.com; tsfnlr@163.com; drsuixin@126.com;
   zhjieb@mail2.sysu.edu.cn; lutongyu@mail2.sysu.edu.cn;
   chenht3@mail2.sysu.edu.cn; chghua@mail.sysu.edu.cn;
   lihb9@mail.sysu.edu.cn; jiangchh7@mail2.sysu.edu.cn;
   zhaoxg7@mail2.sysu.edu.cn; xiaocc@mail2.sysu.edu.cn;
   leiyg@mail2.sysu.edu.cn; yaojia6@mail.sysu.edu.cn; 564787306@qq.com;
   ljlj73094@126.com; zhangyc3@mail.sysu.edu.cn;
   yangjianrong@mail.sysu.edu.cn; zhengj67@mail2.sysu.edu.cn;
   yysysu@163.com
OI Liu, yasong/0000-0002-9919-2051
FU National Key Research and Development Program of China [2017YFA0104304,
   2021YFF1200904, 2021YFA1302500]; National Natural Science Foundation of
   China [82073171, 81900597, 81802897, 81901943, 81970567, 82100693,
   82170631, 81972286]; Science andTechnology Program of Guangdong Province
   [2019B020236003, 2020B1212060019]; Science and Technology Program of
   Guangzhou City [201803040005]; Natural Science Foundation of Guangdong
   Province [2019A1515011698, 2021A1515012136, 2021A1515011156,
   2021A1515010571, 2022A1515012331]; Medical Scientific Research
   Foundation of Guangdong Province [A2020120]; Guangdong Basicand Applied
   Basic Research Foundation [2020A1515110687, 2021A1515111058,
   2022A1515110316]; Guangzhou Basic and Applied Basic Research Foundation
   [202102020237]; China Post-doctoral Science Foundation [2022M713617,
   2022M713621]
FX This work was supported by the grants from the National Key Research and
   Development Program of China(2017YFA0104304, 2021YFF1200904,
   2021YFA1302500), the National Natural Science Foundation of
   China(82073171, 81900597, 81802897, 81901943, 81970567, 82100693,
   82170631, and 81972286), the Science andTechnology Program of Guangdong
   Province (2019B020236003, 2020B1212060019), the Science and Technology
   Program of Guangzhou City (201803040005), the Natural Science Foundation
   of Guangdong Province (2019A1515011698, 2021A1515012136,
   2021A1515011156, 2021A1515010571 and 2022A1515012331), the Medical
   Scientific Research Foundation of Guangdong Province (A2020120), the
   Guangdong Basicand Applied Basic Research Foundation (2020A1515110687,
   2021A1515111058, 2022A1515110316),the Guangzhou Basic and Applied Basic
   Research Foundation (202102020237), and the China Post-doctoral Science
   Foundation (2022M713617, 2022M713621)
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225
   Bilkei-Gorzo A, 2017, NAT MED, V23, P782, DOI 10.1038/nm.4311
   Brazhnik K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax2659
   Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5
   Chen M, 2019, PROG RETIN EYE RES, V69, P159, DOI 10.1016/j.preteyeres.2018.10.003
   Chun SK, 2018, AGING CELL, V17, DOI 10.1111/acel.12761
   Comen E, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2016.9
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217
   Dinallo V, 2019, J CROHNS COLITIS, V13, P772, DOI 10.1093/ecco-jcc/jjy215
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Guilliams M, 2022, CELL, V185, P379, DOI 10.1016/j.cell.2021.12.018
   Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054
   Jeon OH, 2022, NAT METAB, V4, P995, DOI 10.1038/s42255-022-00609-6
   Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Konishi T, 2019, AM J PHYSIOL-GASTR L, V317, pD773, DOI 10.1152/ajpgi.00080.2019
   Kuboki S, 2008, HEPATOLOGY, V48, P1213, DOI 10.1002/hep.22471
   Lagnado A, 2021, EMBO J, V40, DOI 10.15252/embj.2020106048
   Li L, 2023, CELL STEM CELL, V30, P283, DOI 10.1016/j.stem.2023.01.009
   Liang Y, 2022, DEV CELL, V57, P398, DOI 10.1016/j.devcel.2022.01.004
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Liu GH, 2021, NUCLEIC ACIDS RES, V49, pD825, DOI 10.1093/nar/gkaa894
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma S, 2020, CELL, V180, P984, DOI 10.1016/j.cell.2020.02.008
   Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005
   Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011
   Nakashima H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34466
   Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105
   Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052
   Phillips BE, 2022, CARDIOVASC DIABETOL, V21, DOI 10.1186/s12933-022-01564-y
   Prince LR, 2004, AM J PATHOL, V165, P1819, DOI 10.1016/S0002-9440(10)63437-2
   Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Remmerie A, 2020, IMMUNITY, V53, P641, DOI 10.1016/j.immuni.2020.08.004
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Tabula Muris Consortium, 2020, Nature, V583, P590, DOI 10.1038/s41586-020-2496-1
   Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406
   Wang LW, 2023, GUT, V72, P958, DOI 10.1136/gutjnl-2021-326070
   Wang S, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117242
   Yao JH, 2023, INT J BIOL SCI, V19, P1564, DOI 10.7150/ijbs.82352
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Zheng J, 2020, ADV SCI, V7, DOI 10.1002/advs.201903746
NR 47
TC 1
Z9 1
U1 6
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2023 SEP 9
PY 2023
DI 10.1097/HEP.0000000000000590
EA SEP 2023
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HI0O9
UT WOS:001158750200001
PM 37695548
OA hybrid
DA 2024-02-19
ER

PT J
AU Nagata, T
   Ma, HJ
AF Nagata, T
   Ma, HJ
TI Electron microscopic radioautographic study of RNA synthesis in
   hepatocyte mitochondria of aging mouse
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE mitochondria; EM radioautography; RNA syntheses; mouse hepatocytes;
   aging
ID DRY-MOUNTING AUTORADIOGRAPHY; RAT-LIVER MITOCHONDRIA; NUCLEIC-ACID
   SYNTHESIS; DNA-SYNTHESIS; MACROMOLECULAR-SYNTHESIS; RIBONUCLEIC-ACID;
   IN-VIVO; CELLS; MICE; RIBOSOMES
AB In order to study the aging changes of intramitochondrial RNA synthesis in mouse hepatocytes, 10 groups of aging mice, each consisting of three individuals (total 30) from fetal day 19 to postnatal month 24 were injected with H-3-uridine, an RNA precursor, sacrificed 1 hour later, and the liver tissues processed for electron microscopic radioautography. On EM radioautograms obtained from each animal the number of mitochondria, the number of labeled mitochondria, and the mitochondrial labeling index labeled with H-3-uridine showing RNA synthesis in each hepatocytes, both mononucleate and binucleate cells, were counted and the averages in respective aging groups were compared. From the results it was demonstrated that the numbers of mitochondria, the numbers of labeled mitochondria, and the labeling indices of intramitochondrial RNA syntheses in both mononucleate and binucleate hepatocytes of mice at various ages increased and decreased according to the age of the animals.
C1 Shinshu Univ, Sch Med, Dept Anat & Cell Biol, Matsumoto, Nagano 3908621, Japan.
   Hebei Med Univ, Electron Microscopy Res Ctr, Shijiazhuang, Hebei Province, Peoples R China.
C3 Shinshu University; Hebei Medical University
RP Nagata, T (corresponding author), 1361 Matsuoka, Matsumoto, Nagano 3900313, Japan.
EM nagatas@po.cnet.ne.jp
CR ANDRE J, 1968, CR SOC BIOL, V162, P7
   ANDRE J, 1965, J MICROSC-PARIS, V4, P615
   CHEVREMONT M, 1963, CELL GROWTH CELL DIV, V2, P323
   CHI JCH, 1970, J MOL BIOL, V53, P531, DOI 10.1016/0022-2836(70)90082-3
   Cui H, 1996, P 4 CHIN JAP JOINT H, P111
   CURGY JJ, 1968, J MICROSC-PARIS, V7, P849
   CURGY JJ, 1970, EXP CELL RES, V62, P359, DOI 10.1016/0014-4827(70)90566-5
   GAHAN P. B., 1965, INT REV CYTOL, V18, P223, DOI 10.1016/S0074-7696(08)60555-0
   GAO FL, 1995, CELL MOL BIOL, V41, P145
   Gao Fulu, 1994, Medical Electron Microscopy, V27, P360, DOI 10.1007/BF02349697
   Gibbs S.P., 1968, J CELL SCI, V81, P227
   Gunarso W, 1997, CELL MOL BIOL, V43, P189
   Gunarso W, 1996, ACTA HISTOCHEM, V98, P309, DOI 10.1016/S0065-1281(96)80024-9
   Gunarso W., 1984, SHINSHU MED J, V32, P241
   GUTTES E, 1964, SCIENCE, V145, P1057, DOI 10.1126/science.145.3636.1057
   Hanai Toru, 1994, Medical Electron Microscopy, V27, P355, DOI 10.1007/BF02349695
   Ito Masayuki, 1996, Medical Electron Microscopy, V29, P145, DOI 10.1007/BF02348068
   KNIGHT E, 1969, BIOCHIM BIOPHYS ACTA, V182, P562, DOI 10.1016/0005-2787(69)90208-1
   Kong Yongli, 1994, Medical Electron Microscopy, V27, P366, DOI 10.1007/BF02349699
   Korr H, 1997, ACTA NEUROPATHOL, V94, P557, DOI 10.1007/s004010050750
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   LEDUC EH, 1966, EXP CELL RES, V42, P597, DOI 10.1016/0014-4827(66)90272-2
   Liang Yan, 1999, Acta Anatomica Nipponica, V74, P291
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P335
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P715
   Ma H., 2005, ANN MICROSC, V5, P4
   Ma H, 1994, MED ELECT MICROSC, V27, P349
   MA HJ, 1990, CELL MOL BIOL, V36, P73
   MEYER RR, 1966, J CELL BIOL, V31, pA151
   Nadler NJ, 1971, J CELL BIOL, V49, P377
   NAGATA T, 1969, Acta Anatomica Nipponica, V44, P126
   Nagata T, 1997, HISTOL HISTOPATHOL, V12, P1091
   Nagata T, 1996, J ELECTRON MICROSC, V45, P258, DOI 10.1093/oxfordjournals.jmicro.a023442
   Nagata T, 2003, CELL MOL BIOL, V49, P591
   Nagata T, 2002, PROG HISTOCHEM CYTO, V37, P67, DOI 10.1016/S0079-6336(02)80003-1
   Nagata T, 1977, J Electron Microsc (Tokyo), V26 Suppl, P347
   NAGATA T, 1972, Acta Histochemica et Cytochemica, V5, P201
   NAGATA T, 1977, ACTA PHARMACOL TOX, V41, P64
   Nagata T, 2001, INT REV CYTOL, V211, P33, DOI 10.1016/S0074-7696(01)11017-X
   NAGATA T, 1979, ACTA HISTOCHEM CYTOC, V12, P610
   NAGATA T, 1977, HISTOCHEMISTRY, V54, P75, DOI 10.1007/BF00493331
   NAGATA T, 1977, ACTA PHARMACOL TOX, V41, P62
   NAGATA T, 1982, HISTOCHEM J, V14, P197, DOI 10.1007/BF01041214
   NAGATA T, 1972, HISTOCHEMISTRY, V32, P163, DOI 10.1007/BF00303731
   NAGATA T, 1967, HISTOCHEMISTRY, V10, P305, DOI 10.1007/BF00304312
   NAGATA T, 1992, RECENT ADVANCES IN CELLULAR AND MOLECULAR BIOLOGY, VOL 6, V6, P9
   NAGATA T, 1976, P 5 INT C HIST CYT B, P242
   Nagata T, 2000, ANN MICROSC, V1, P13
   Nagata T., 1984, J CLIN ELECT MICROSC, V17, P589
   NAGATA T, 1974, P 8 INT C EL MICR CA, V2, P346
   NAGATA T, 1984, P 11 INT C EL MICR, V3, P2281
   Nagata T., 1967, ARCH HISTOL JAPON, V28, P540
   Nagata T., 1982, P 10 INT C EL MICR, V2, P305
   Nagata T., 2003, ANN MICROSC, V3, P53
   NAGATA T, 1972, P 4 INT C HIST CYT J, P223
   NAGATA T, 1972, JPN SOC HISTOCHEM CY, P43
   NAGATA T, 1975, P 10 INT C AN TOK, P474
   Nagata Tetsuji, 2003, Medical Electron Microscopy, V36, P263, DOI 10.1007/s00795-003-0224-1
   NAGATA TETSUJI, 1962, MED JOUR SHINSHU UNIV, V7, P17
   NUSSDORFER GG, 1971, Z ZELLFORSCH MIK ANA, V118, P35, DOI 10.1007/BF00331765
   OBRIEN TW, 1967, J BIOL CHEM, V242, P2172
   OBRIEN TW, 1967, J BIOL CHEM, V242, P2180
   SALPETER MM, 1969, J CELL BIOL, V41, P1, DOI 10.1083/jcb.41.1.1
   SCHATZ G, 1970, MEMBRANES MITOCHONDR, P251
   Schmitz C, 1999, ACTA NEUROPATHOL, V97, P71, DOI 10.1007/s004010050957
   Schmitz Christoph, 1999, J Alzheimers Dis, V1, P387
   SCHUSTER FL, 1965, EXP CELL RES, V39, P329, DOI 10.1016/0014-4827(65)90038-8
   SINCLAIR JH, 1966, P NATL ACAD SCI USA, V56, P508, DOI 10.1073/pnas.56.2.508
   STONE GE, 1965, J EXP ZOOL, V159, P33, DOI 10.1002/jez.1401590104
   Sun L, 1997, ACTA HISTOCHEM CYTOC, V30, P211, DOI 10.1267/ahc.30.211
   SWIFT HEWSON, 1965, AMER NATUR, V99, P201, DOI 10.1086/282368
   Tandler B., 1972, ULTRASTRUCTURE CELLS, P1
   UCHIDA K, 1971, ARCH HISTOL JAPON, V31, P291
   VANBRUGGEN EF, 1966, BIOCHIM BIOPHYS ACTA, V119, P437, DOI 10.1016/0005-2787(66)90210-3
   VOGEL FS, 1967, EXP CELL RES, V47, P209, DOI 10.1016/0014-4827(67)90224-8
   Yamada Aureo T., 1994, Medical Electron Microscopy, V27, P363, DOI 10.1007/BF02349698
   Yamada Aureo T., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P763
NR 77
TC 8
Z9 11
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD JUN 1
PY 2005
VL 67
IS 2
BP 55
EP 64
DI 10.1002/jemt.20183
PG 10
WC Anatomy & Morphology; Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 954CU
UT WOS:000231132500001
PM 16037977
OA Bronze
DA 2024-02-19
ER

PT J
AU Correia-Melo, C
   Marques, FDM
   Anderson, R
   Hewitt, G
   Hewitt, R
   Cole, J
   Carroll, BM
   Miwa, S
   Birch, J
   Merz, A
   Rushton, MD
   Charles, M
   Jurk, D
   Tait, SWG
   Czapiewski, R
   Greaves, L
   Nelson, G
   Bohlooly-Y, M
   Rodriguez-Cuenca, S
   Vidal-Puig, A
   Mann, D
   Saretzki, G
   Quarato, G
   Green, DR
   Adams, PD
   von Zglinicki, T
   Korolchuk, VI
   Passos, JF
AF Correia-Melo, Clara
   Marques, Francisco D. M.
   Anderson, Rhys
   Hewitt, Graeme
   Hewitt, Rachael
   Cole, John
   Carroll, Bernadette M.
   Miwa, Satomi
   Birch, Jodie
   Merz, Alina
   Rushton, Michael D.
   Charles, Michelle
   Jurk, Diana
   Tait, Stephen W. G.
   Czapiewski, Rafal
   Greaves, Laura
   Nelson, Glyn
   Bohlooly-Y, Mohammad
   Rodriguez-Cuenca, Sergio
   Vidal-Puig, Antonio
   Mann, Derek
   Saretzki, Gabriele
   Quarato, Giovanni
   Green, Douglas R.
   Adams, Peter D.
   von Zglinicki, Thomas
   Korolchuk, Viktor I.
   Passos, Joao F.
TI Mitochondria are required for pro-ageing features of the senescent
   phenotype
SO EMBO JOURNAL
LA English
DT Article
DE ageing; inflammation; mitochondria; mTOR; senescence
ID TERM CALORIE RESTRICTION; CELL SENESCENCE; SECRETORY PHENOTYPE;
   COMPLEX-I; LIFE-SPAN; DAMAGE; BIOGENESIS; PROMOTES; DYSFUNCTION;
   ACTIVATION
AB Cell senescence is an important tumour suppressor mechanism and driver of ageing. Both functions are dependent on the development of the senescent phenotype, which involves an overproduction of pro-inflammatory and pro-oxidant signals. However, the exact mechanisms regulating these phenotypes remain poorly understood. Here, we show the critical role of mitochondria in cellular senescence. In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis. Global transcriptomic analysis by RNA sequencing revealed that a vast number of senescent-associated changes are dependent on mitochondria, particularly the pro-inflammatory phenotype. Mechanistically, we show that the ATM, Akt and mTORC1 phosphorylation cascade integrates signals from the DNA damage response (DDR) towards PGC-1 beta-dependent mitochondrial biogenesis, contributing to a ROS-mediated activation of the DDR and cell cycle arrest. Finally, we demonstrate that the reduction in mitochondrial content in vivo, by either mTORC1 inhibition or PGC-1 beta deletion, prevents senescence in the ageing mouse liver. Our results suggest that mitochondria are a candidate target for interventions to reduce the deleterious impact of senescence in ageing tissues.
C1 [Correia-Melo, Clara; Marques, Francisco D. M.; Anderson, Rhys; Hewitt, Graeme; Carroll, Bernadette M.; Miwa, Satomi; Birch, Jodie; Merz, Alina; Rushton, Michael D.; Charles, Michelle; Jurk, Diana; Czapiewski, Rafal; Nelson, Glyn; Saretzki, Gabriele; von Zglinicki, Thomas; Korolchuk, Viktor I.; Passos, Joao F.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Univ Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Correia-Melo, Clara] Univ Porto, Abel Salazar Biomed Sci Inst, GABBA Program, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
   [Hewitt, Rachael; Cole, John; Tait, Stephen W. G.; Adams, Peter D.] Univ Glasgow, Inst Canc Sci, CR UK Beatson Inst, Glasgow, Lanark, Scotland.
   [Greaves, Laura] Newcastle Univ, Newcastle Univ Ctr Brain Ageing & Vital, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Bohlooly-Y, Mohammad] AstraZeneca, Discovery Sci, Transgen RAD, Molndal, Sweden.
   [Rodriguez-Cuenca, Sergio; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England.
   [Mann, Derek] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Quarato, Giovanni; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.
C3 Newcastle University - UK; Universidade do Porto; Beatson Institute;
   University of Glasgow; Newcastle University - UK; AstraZeneca;
   University of Cambridge; Cambridge University Hospitals NHS Foundation
   Trust; Addenbrooke's Hospital; Newcastle University - UK; St Jude
   Children's Research Hospital
RP Passos, JF (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Univ Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM joao.passos@ncl.ac.uk
RI nelson, glyn/A-6346-2009; Green, Douglas R/N-8083-2018; Korhonen,
   Laura/AAW-3256-2020; Mann, Derek A/E-4765-2011; Saretzki, Gabriele
   Christine/I-7175-2019; Quarato, Giovanni/F-8272-2016
OI nelson, glyn/0000-0002-1895-4772; Green, Douglas R/0000-0002-7332-1417;
   Korhonen, Laura/0000-0002-1837-5930; Saretzki, Gabriele
   Christine/0000-0003-2100-8223; Quarato, Giovanni/0000-0003-1167-3422;
   Greaves, Laura/0000-0002-8071-5916; Jurk, Diana/0000-0003-4486-0857; von
   Zglinicki, Thomas/0000-0002-5939-0248; Hewitt,
   Graeme/0000-0003-2614-6932; Carroll, Bernadette/0000-0001-5673-9371;
   Miwa, Satomi/0000-0002-1239-1198; Czapiewski, Rafal/0000-0003-0211-8435;
   Correia-Melo, Clara/0000-0001-6062-1472; Adams,
   Peter/0000-0002-0684-1770; Tait, Stephen/0000-0001-7697-132X;
   Vidal-Puig, Antonio/0000-0003-4220-9577; Mann,
   Derek/0000-0003-0950-243X; Passos, Joao/0000-0001-8765-1890; Korolchuk,
   Viktor/0000-0002-4071-592X; Madeira Marques,
   Francisco/0000-0001-7521-6955
FU FP7-MITIN [HEALTH-F4-2008-223450]; Medical Research Council Centre for
   Obesity and Related Metabolic Diseases; BBSRC [BB/I020748/1,
   BB/K019260/1, BB/H022384/1, BB/K017314/1]; Royal Society University
   Fellowship; Foundation for Science and Technology (FCT), Portugal
   studentship through the GABBA Program; University of Porto; Newcastle
   University; BBSRC [BB/K017314/1, BB/J007803/1, BB/K017233/1,
   BB/K019260/1, BB/I020748/1, BB/H022384/1, BB/F010966/1, BB/M023389/1]
   Funding Source: UKRI; MRC [G0700718, MR/K001949/1, MR/L016354/1,
   MC_UU_12012/2, G0400192, MC_G0802535, MR/K006312/1] Funding Source:
   UKRI; Biotechnology and Biological Sciences Research Council
   [BB/K017314/1, BB/K019260/1, BB/K017233/1, BB/M023389/1, BB/H022384/1,
   BB/F010966/1, BB/I020748/1, BB/J007803/1] Funding Source: researchfish;
   Medical Research Council [G0700718, G0400192, MC_UU_12012/5/B,
   MR/K001949/1, MR/L016354/1, MR/K006312/1, MC_UU_12012/2, MC_G0802535]
   Funding Source: researchfish
FX We would like to thank Rebecca Faill and Jayne Kelleher for technical
   assistance. PGC-1 beta<SUP>-/-</SUP> mice were generated and provided by
   Transgenic RAD, Discovery Science, Astrazeneca. AV-P was funded by
   FP7-MITIN (HEALTH-F4-2008-223450) and Medical Research Council Centre
   for Obesity and Related Metabolic Diseases; SM is funded by a BBSRC
   grant BB/I020748/1, GN by a BBSRC grant BB/K019260/1 and VIK by BBSRC;
   SWGT is supported by a Royal Society University Fellowship, GH is
   supported by a case studentship from BBSRC, CCM is supported by
   Foundation for Science and Technology (FCT), Portugal studentship
   through the GABBA Program, University of Porto and Newcastle University,
   and JFP is supported by a David Phillips Fellowship provided by BBSRC
   BB/H022384/1 and a BBSRC grant BB/K017314/1.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272
   Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200
   Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897
   Chappell JB, 1972, Subcellular Components, V2nd, P77, DOI DOI 10.1016/B978-0-408-70360-4.50009-2
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Correia-Melo Clara, 2014, Longev Healthspan, V3, P1, DOI 10.1186/2046-2395-3-1
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Hancock CR, 2011, FASEB J, V25, P785, DOI 10.1096/fj.10-170415
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Hickey FB, 2011, J AM SOC NEPHROL, V22, P1475, DOI 10.1681/ASN.2010111154
   Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106
   Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x
   Ning YC, 2013, MECH AGEING DEV, V134, P570, DOI 10.1016/j.mad.2013.11.006
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523
   Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pospelova TV, 2012, CELL CYCLE, V11, P2402, DOI 10.4161/cc.20882
   Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746
   Romanino K, 2011, P NATL ACAD SCI USA, V108, P20808, DOI 10.1073/pnas.1111448109
   Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014
   Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2
   Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132
   Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
   Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196
   Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006
NR 66
TC 430
Z9 461
U1 16
U2 100
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD APR 1
PY 2016
VL 35
IS 7
BP 724
EP 742
DI 10.15252/embj.201592862
PG 19
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA DI7XC
UT WOS:000373714300005
PM 26848154
OA Green Published, Green Accepted, hybrid
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Garbarino, O
   Lambroia, L
   Basso, G
   Marrella, V
   Franceschini, B
   Soldani, C
   Pasqualini, F
   Giuliano, D
   Costa, G
   Peano, C
   Barbarossa, D
   Annarita, D
   Salvati, A
   Terracciano, L
   Torzilli, G
   Donadon, M
   Faggioli, F
AF Garbarino, Ombretta
   Lambroia, Luca
   Basso, Gianluca
   Marrella, Veronica
   Franceschini, Barbara
   Soldani, Cristiana
   Pasqualini, Fabio
   Giuliano, Desiree
   Costa, Guido
   Peano, Clelia
   Barbarossa, Davide
   Annarita, Destro
   Salvati, Andreina
   Terracciano, Luigi
   Torzilli, Guido
   Donadon, Matteo
   Faggioli, Francesca
TI Spatial resolution of cellular senescence dynamics in human colorectal
   liver metastasis
SO AGING CELL
LA English
DT Article; Early Access
DE cellular senescence; colorectal cancer liver metastasis; EMT; prognostic
   role; senescence-associated secretory phenotype; spatial transcriptomics
ID ONCOGENE-INDUCED SENESCENCE; CANCER CELLS; TGF-BETA; ACTIVATION;
   MECHANISM; P53; PROGRESSION; PHENOTYPE; SURVIVAL; INSIGHTS
AB Hepatic metastasis is a clinical challenge for colorectal cancer (CRC). Senescent cancer cells accumulate in CRC favoring tumor dissemination. Whether this mechanism progresses also in metastasis is unexplored. Here, we integrated spatial transcriptomics, 3D-microscopy, and multicellular transcriptomics to study the role of cellular senescence in human colorectal liver metastasis (CRLM). We discovered two distinct senescent metastatic cancer cell (SMCC) subtypes, transcriptionally located at the opposite pole of epithelial (e) to mesenchymal (m) transition. SMCCs differ in chemotherapy susceptibility, biological program, and prognostic roles. Mechanistically, epithelial (e)SMCC initiation relies on nucleolar stress, whereby c-myc dependent oncogene hyperactivation induces ribosomal RPL11 accumulation and DNA damage response. In a 2D pre-clinical model, we demonstrated that RPL11 co-localized with HDM2, a p53-specific ubiquitin ligase, leading to senescence activation in (e)SMCCs. On the contrary, mesenchymal (m)SMCCs undergo TGF beta paracrine activation of NOX4-p15 effectors. SMCCs display opposing effects also in the immune regulation of neighboring cells, establishing an immunosuppressive environment or leading to an active immune workflow. Both SMCC signatures are predictive biomarkers whose unbalanced ratio determined the clinical outcome in CRLM and CRC patients. Altogether, we provide a comprehensive new understanding of the role of SMCCs in CRLM and highlight their potential as new therapeutic targets to limit CRLM progression.
C1 [Garbarino, Ombretta; Lambroia, Luca; Basso, Gianluca; Marrella, Veronica; Pasqualini, Fabio; Giuliano, Desiree; Barbarossa, Davide; Annarita, Destro; Faggioli, Francesca] IRCCS Humanitas Res Hosp, Milan, Italy.
   [Lambroia, Luca] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.
   [Marrella, Veronica; Peano, Clelia; Faggioli, Francesca] Inst Genet & Biomed Res, Natl Res Council, UoS Milan, Milan, Italy.
   [Franceschini, Barbara; Soldani, Cristiana; Costa, Guido; Torzilli, Guido; Donadon, Matteo] IRCCS Humanitas Res Hosp, Dept Hepatobiliary & Gen Surg, Milan, Italy.
   [Pasqualini, Fabio; Costa, Guido; Terracciano, Luigi; Torzilli, Guido; Donadon, Matteo] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, MI, Italy.
   [Peano, Clelia] Fdn Humanitas Technopole, Milan, Italy.
   [Annarita, Destro; Salvati, Andreina; Terracciano, Luigi] IRCCS Humanitas Res Hosp, Dept Pathol, Milan, Italy.
   [Faggioli, Francesca] IRCCS Humanitas Res Hosp, Italy Inst Genet & Biomed Res, Natl Res Council, UoS Milan, via Manzoni 56, I-20089 Milan, Italy.
C3 University of Brescia; Consiglio Nazionale delle Ricerche (CNR);
   Istituto di Ricerca Genetica e Biomedica (IRGB-CNR)
RP Faggioli, F (corresponding author), IRCCS Humanitas Res Hosp, Italy Inst Genet & Biomed Res, Natl Res Council, UoS Milan, via Manzoni 56, I-20089 Milan, Italy.
EM francesca.faggioli@humanitasresearch.it
RI soldani, cristiana/C-2401-2008; Faggioli, Francesca/K-1592-2016;
   Giuliano, Desiree/HKE-2887-2023; Lambroia, Luca/AAA-6953-2022
OI soldani, cristiana/0000-0001-5041-9588; Faggioli,
   Francesca/0000-0001-8030-3674; Giuliano, Desiree/0000-0003-0576-4125;
   Lambroia, Luca/0000-0002-8724-1485; Barbarossa,
   Davide/0009-0001-3512-9870
FU Italian Ministry of Health [GR-2016-02363222]
FX ACKNOWLEDGMENTS We thank Dr. A. Doni and Dr. F. Grizzi for their help in
   imaging with SP8 STED3x SMD, Dr. A. Felicetta for providing antibodies
   and Axio scan and Dr. Micheal Latroniko for English editing. We also
   thank the Genomics Facility at IRCCS Humanitas Research Hospital for the
   technical support. The research leading to these results has received
   funding from the Italian Ministry of Health, Ricerca Finalizzata (FF;
   GR-2016-02363222).
CR Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Ark AV, 2018, CELL SIGNAL, V52, P112, DOI 10.1016/j.cellsig.2018.09.002
   Baba AB, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.791272
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Birkbak NJ, 2020, CANCER CELL, V37, P8, DOI 10.1016/j.ccell.2019.12.004
   Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024
   Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006
   BURRI N, 2001, METHYLATION SILENCIN
   Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109
   Cagnoni AJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102950118
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Celià-Terrassa T, 2018, NAT CELL BIOL, V20, P868, DOI 10.1038/s41556-018-0145-9
   Che LH, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00312-y
   Chen CF, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020042
   Chen HA, 2023, CANCER DISCOV, V13, P432, DOI 10.1158/2159-8290.CD-22-0528
   Chiavarina B, 2021, THERANOSTICS, V11, P1626, DOI 10.7150/thno.51507
   Chiesa M, 2018, BIOINFORMATICS, V34, P1416, DOI 10.1093/bioinformatics/btx795
   Choi YW, 2021, ADV SCI, V8, DOI 10.1002/advs.202002497
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Desai LP, 2014, J BIOL CHEM, V289, P18270, DOI 10.1074/jbc.M114.562249
   Destefanis F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114037
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Doppler W, 2019, FEBS J, V286, P456, DOI 10.1111/febs.14746
   Faggioli F, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12060860
   Giessler KM, 2017, J EXP MED, V214, P2073, DOI 10.1084/jem.20162017
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784
   Havel JJ, 2015, ONCOGENE, V34, P1487, DOI 10.1038/onc.2014.91
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Hu Z, 2019, NAT GENET, V51, P1113, DOI 10.1038/s41588-019-0423-x
   Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kim YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15208
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Li DW, 2021, EMBO REP, V22, DOI 10.15252/embr.202051644
   Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114
   Liu JF, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0713-7
   Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7
   Lohrum M. A. E., 2000, REGULATION HDM2 ACTI
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Luca BA, 2021, CELL, V184, P5482, DOI 10.1016/j.cell.2021.09.014
   Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3
   Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650
   Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716
   Marin I, 2023, CANCER DISCOV, V13, P410, DOI 10.1158/2159-8290.CD-22-0523
   Massagué J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001
   Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Morgado-Palacin L, 2014, CARCINOGENESIS, V35, P2822, DOI 10.1093/carcin/bgu220
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193
   Ou HL, 2021, MOL ONCOL, V15, P2634, DOI 10.1002/1878-0261.12807
   Ovadya Y, 2018, J CLIN INVEST, V128, P1247, DOI 10.1172/JCI95149
   Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3
   Patry M, 2015, DIABETES, V64, P4212, DOI 10.2337/db15-0638
   Petrova NV, 2016, AGING CELL, V15, P999, DOI 10.1111/acel.12518
   Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161
   Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270
   Russo A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010140
   Saleh T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041427
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Seoane J, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022277
   Sieben CJ, 2018, TRENDS CELL BIOL, V28, P723, DOI 10.1016/j.tcb.2018.04.006
   SMIT MA, 2010, EPITHELIAL MESENCHYM
   Sonzogni SV, 2014, BBA-GEN SUBJECTS, V1840, P2171, DOI 10.1016/j.bbagen.2014.03.015
   Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469
   Tauriello DVF, 2022, NAT REV CANCER, V22, P25, DOI 10.1038/s41568-021-00413-6
   Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501
   Vasaikar SV, 2021, BRIT J CANCER, V124, P259, DOI 10.1038/s41416-020-01178-9
   Waldman AD, 2020, NAT REV IMMUNOL, V20, P651, DOI 10.1038/s41577-020-0306-5
   Was H, 2018, CANCER BIOL THER, V19, P63, DOI 10.1080/15384047.2017.1385675
   Winkler J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18794-x
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang K, 2018, CELL STRESS, V2, P125, DOI 10.15698/cst2018.06.139
   Yang LX, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.49
   Zhou H, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-00922-2
NR 82
TC 2
Z9 2
U1 5
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 JUL
PY 2023
VL 22
IS 7
AR e13853
DI 10.1111/acel.13853
EA MAY 2023
PG 20
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA M6VN8
UT WOS:000984474600001
PM 37157887
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Serra, MP
   Marongiu, F
   Marongiu, M
   Contini, A
   Laconi, E
AF Serra, Maria Paola
   Marongiu, Fabio
   Marongiu, Michela
   Contini, Antonella
   Laconi, Ezio
TI Cell-autonomous decrease in proliferative competitiveness of the aged
   hepatocyte
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Aging; Liver regeneration; Cell competition; Hepatocyte transplantation;
   Retrorsine
ID LIVER-REGENERATION; IN-VIVO; HEPATOCELLULAR-CARCINOMA; RAT-LIVER; RNA
   LEVELS; GROWTH; TRANSPLANTATION; PATHWAY; REPOPULATION; SENESCENCE
AB Background & Aims: The regenerative potential of the liver declines with age, this might be dependent on a decrease in the intensity of the stimulus and/or an increased refractoriness of the target. In the present study, we compared the in vivo growth capacity of young and old hepatocytes transplanted into the same host.
   Methods: We utilized the retrorsine (RS)-based model for liver repopulation, which provides a specific and effective stimulus for transplanted hepatocytes. Rats of the dipeptidyl-peptidase type IV (DPP-IV)-deficient strain were given RS and were injected with a mix of hepatocytes isolated from either a 2-month old or an 18-month old donor. To follow the fate of transplanted cells, they were each identified through a specific tag: young hepatocytes expressed the green fluorescent protein (GFP(+)), while those from old donors were DPP-IV-positive.
   Results: At 1 month post-transplantation, DPP-IV-positive clusters (derived from old donor) were consistently smaller than those GFP(+) (young donor); the cross sectional area of clusters was decreased by 50%, while the mean volume was reduced to 1/3. Furthermore, when 2/3 partial hepatectomy (PH) was performed, the S-phase response of old hepatocyte-derived clusters was only 30-40% compared to that observed in cluster originating from young hepatocytes. No markers of cell senescence were expressed in clusters of transplanted hepatocytes.
   Conclusions: This is the first direct evidence in vivo that hepatocytes in the aged liver express a cell-autonomous decline in their replicative capacity and in their regenerative response to PH compared to those from a young animal. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Serra, Maria Paola; Marongiu, Fabio; Marongiu, Michela; Contini, Antonella; Laconi, Ezio] Univ Cagliari, Dept Biomed Sci, Unit Expt Med, I-09124 Cagliari, Italy.
C3 University of Cagliari
RP Laconi, E (corresponding author), Univ Cagliari, Dept Biomed Sci, Unit Expt Med, Via Porcell 4,3rd Floor, I-09124 Cagliari, Italy.
EM elaconi@unica.it
RI Marongiu, Fabio/E-6294-2016
OI Marongiu, Fabio/0000-0001-5860-4227
FU AIRC (Italian Association for Cancer Research) [IG 14640]; Sardinian
   Regional Government (RAS - Italy)
FX This work was supported by AIRC (Italian Association for Cancer
   Research, grant No. IG 14640) and by Sardinian Regional Government (RAS
   - Italy).
CR BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   Gambato M, 2013, TRANSPLANTATION, V95, P1528, DOI 10.1097/TP.0b013e318292827f
   Gielchinsky Y, 2010, GENE DEV, V24, P543, DOI 10.1101/gad.563110
   Grijalva JL, 2014, AM J PHYSIOL-GASTR L, V307, pG196, DOI 10.1152/ajpgi.00077.2014
   Helling TS, 2006, HPB, V8, P165, DOI 10.1080/13651820510035712
   Henry CJ, 2010, P NATL ACAD SCI USA, V107, P21713, DOI 10.1073/pnas.1005486107
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880
   Huang JS, 2014, AM J PATHOL, V184, P309, DOI 10.1016/j.ajpath.2013.04.034
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kawano Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093749
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Laconi S, 2001, P NATL ACAD SCI USA, V98, P7806, DOI 10.1073/pnas.131210498
   Laconi S, 2001, AM J PATHOL, V158, P771, DOI 10.1016/S0002-9440(10)64019-9
   Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403
   Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107
   Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107
   Monga SS, 2014, GENE EXPRESSION, V16, P51, DOI 10.3727/105221614X13919976902138
   Ohtake Y, 2008, J HEPATOL, V48, P246, DOI 10.1016/j.jhep.2007.08.009
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   Shirabe K, 2013, SCAND J SURG, V102, P101, DOI 10.1177/1457496913482250
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Tanemura A, 2012, WORLD J SURG, V36, P1102, DOI 10.1007/s00268-012-1496-1
   THOMPSON NL, 1991, BIOCHEM J, V273, P497, DOI 10.1042/bj2730497
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Walldorf J, 2004, SCAND J GASTROENTERO, V39, P584, DOI 10.1080/00365520410005586
   Wang C, 2012, MOL MED REP, V5, P410, DOI 10.3892/mmr.2011.640
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
   Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3
   Yang J, 2014, HEPATOLOGY, V60, P964, DOI 10.1002/hep.27082
   Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060
NR 46
TC 18
Z9 18
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD JUN
PY 2015
VL 62
IS 6
BP 1341
EP 1348
DI 10.1016/j.jhep.2015.01.015
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CI2KA
UT WOS:000354574800017
PM 25617502
DA 2024-02-19
ER

PT J
AU Haramizu, S
   Ota, N
   Hase, T
   Murase, T
AF Haramizu, Satoshi
   Ota, Noriyasu
   Hase, Tadashi
   Murase, Takatoshi
TI Aging-Associated Changes in Physical Performance and Energy Metabolism
   in the Senescence-Accelerated Mouse
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Aging; Fatty acid oxidation; Peroxisome proliferator-activated
   receptor-gamma-coactivator-1-Physical performance
ID ACTIVATED-RECEPTOR-GAMMA; MUSCLE PROTEIN-DEGRADATION;
   TUMOR-NECROSIS-FACTOR; SKELETAL-MUSCLE; OXIDATIVE STRESS;
   INSULIN-RESISTANCE; GASTROCNEMIUS-MUSCLE; CALORIC RESTRICTION; 3T3-L1
   ADIPOCYTES; FAT OXIDATION
AB The aim of the study was to clarify the aging-associated changes in physical performance and energy metabolism in senescence-accelerated prone mouse (SAMP1). The endurance of aged SAMP1 was significantly lower by 28% than the age-matched senescence-resistant mouse (SAMR1). Oxygen consumption and fat oxidation in aged SAMP1 were lower by 19% and 22%, respectively. Peroxisome proliferator activated receptor-gamma-coactivator-1 beta and medium-chain acyl coenzyme A dehydrogenase messenger RNA expression was significantly lower in aged SAMP1. Aged SAMP1 exhibited higher plasma glucose, insulin, leptin, and lower adiponectin concentrations. Aged SAMP1 also had higher malondialdehyde levels in plasma and tissues and lower peroxisome proliferator activated receptor-gamma messenger RNA and protein levels in adipose tissue. These results indicate that physical performance and energy expenditure decrease earlier with aging in SAMP1, accompanied by decreased fatty acid catabolism in muscle and liver and increased inflammation and oxidative stress in adipose tissue. SAMP1 could thus be a useful accelerated functional depression model for studying physical performance and energy metabolism.
C1 [Haramizu, Satoshi; Ota, Noriyasu; Hase, Tadashi; Murase, Takatoshi] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation
RP Murase, T (corresponding author), Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
EM murase.takatoshi@kao.co.jp
CR BARZILAI N, 1996, AM J PHYSIOL, V270, P930
   Bolster DR, 2004, P NUTR SOC, V63, P351, DOI 10.1079/PNS2004355
   Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092
   Cannon C. M. A., 2005, V41, P116
   Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050
   Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002
   DAW CK, 1988, J APPL PHYSIOL, V64, P2428, DOI 10.1152/jappl.1988.64.6.2428
   DELUCA A, 1992, PFLUG ARCH EUR J PHY, V420, P407, DOI 10.1007/BF00374477
   Derave W, 2005, EXP GERONTOL, V40, P562, DOI 10.1016/j.exger.2005.05.005
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Fukushima J, 2009, HEPATOL RES, V39, P724, DOI 10.1111/j.1872-034X.2009.00509.x
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Haramizu S, 2009, J APPL PHYSIOL, V106, P871, DOI 10.1152/japplphysiol.90804.2008
   Hawley JA, 1998, SPORTS MED, V25, P241, DOI 10.2165/00007256-199825040-00003
   Helge JW, 2002, MED SCI SPORT EXER, V34, P1499, DOI [10.1249/01.MSS.0000027691.95763.B5, 10.1097/00005768-200209000-00016]
   Hirofuji C, 2000, NEUROREPORT, V11, P823, DOI 10.1097/00001756-200003200-00033
   Hosokawa M, 2002, MECH AGEING DEV, V123, P1553, DOI 10.1016/S0047-6374(02)00091-X
   Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100
   Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745
   Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kuwahara H, 2010, FREE RADICAL BIO MED, V48, P1252, DOI 10.1016/j.freeradbiomed.2010.02.011
   Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Levadoux E, 2001, INT J OBESITY, V25, P39, DOI 10.1038/sj.ijo.0801530
   LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809
   Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581
   Matsunaga S, 2008, EXP PHYSIOL, V93, P426, DOI 10.1113/expphysiol.2007.040477
   Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028
   Matzel LD, 2008, LEARN MEMORY, V15, P733, DOI 10.1101/lm.954808
   Miyasaka K, 2003, MECH AGEING DEV, V124, P183, DOI 10.1016/S0047-6374(02)00118-5
   Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494
   Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631
   Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x
   Okatani Y, 2002, J PINEAL RES, V33, P127, DOI 10.1034/j.1600-079X.2002.02109.x
   PERONNET F, 1991, CAN J SPORT SCI, V16, P23
   Piers LS, 1998, J APPL PHYSIOL, V85, P2196, DOI 10.1152/jappl.1998.85.6.2196
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Rebrin I, 2004, EXP GERONTOL, V39, P1513, DOI 10.1016/j.exger.2004.08.014
   Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002
   Rodríguez-Calvo R, 2006, J GERONTOL A-BIOL, V61, P773, DOI 10.1093/gerona/61.8.773
   ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380
   Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200
   Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562
   Sakakima H, 2004, J GERONTOL A-BIOL, V59, P1015
   Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100
   Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8
   Siu PM, 2008, J APPL PHYSIOL, V105, P1695, DOI 10.1152/japplphysiol.90800.2008
   Sohal RS, 2009, J NUTR, V139, P533, DOI 10.3945/jn.108.100313
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595
   Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202
   Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251
   Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829
   Ye P, 2006, GERONTOLOGY, V52, P69, DOI 10.1159/000090951
   Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111
   Zangarelli A, 2006, FASEB J, V20, P2439, DOI 10.1096/fj.05-4544com
NR 67
TC 29
Z9 31
U1 1
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUN
PY 2011
VL 66
IS 6
BP 646
EP 655
DI 10.1093/gerona/glr037
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 780XA
UT WOS:000291892900005
PM 21415262
OA Bronze
DA 2024-02-19
ER

PT J
AU Lushchak, O
   Schosserer, M
   Grillari, J
AF Lushchak, Oleh
   Schosserer, Markus
   Grillari, Johannes
TI Senopathies-Diseases Associated with Cellular Senescence
SO BIOMOLECULES
LA English
DT Article
DE cellular senescence; aging; senopathy; senolytic; senomorphic;
   senotherapy; geroscience; senescence-associated secretory phenotype
   (SASP); pathology; age-related disease
ID SECRETORY PHENOTYPE; CELLS; FIBROSIS; MECHANISMS; CLEARANCE; METFORMIN;
   SHORTEN; CANCER; SASP
AB Cellular senescence describes a stable cell cycle arrest state with a characteristic phenotype. Senescent cells accumulate in the human body during normal aging, limiting the lifespan and promoting aging-related, but also several non-related, pathologies. We propose to refer to all diseases whose pathogenesis or progression is associated with cellular senescence as "senopathies". Targeting senescent cells with senolytics or senomorphics is likely to mitigate these pathologies. Examples of senopathies include cardiovascular, metabolic, musculoskeletal, liver, kidney, and lung diseases and neurodegeneration. For all these pathologies, animal studies provide clear mechanistic evidence for a connection between senescent cell accumulation and disease progression. The major persisting challenge in developing novel senotherapies is the heterogeneity of senescence phenotypes, causing a lack of universal biomarkers and difficulties in discriminating senescent from non-senescent cells.
C1 [Lushchak, Oleh; Grillari, Johannes] Ludwig Boltzmann Inst Traumatol, Res Ctr Cooperat AUVA, A-1200 Vienna, Austria.
   [Lushchak, Oleh] Precarpathian Natl Univ, Dept Biochem & Biotechnol, UA-76000 Ivano Frankivsk, Ukraine.
   [Lushchak, Oleh] Res & Dev Univ, UA-76018 Ivano Frankivsk, Ukraine.
   [Schosserer, Markus] Med Univ Vienna, Inst Med Genet, Ctr Pathobiochem & Genet, A-1090 Vienna, Austria.
   [Schosserer, Markus; Grillari, Johannes] Austrian Cluster Tissue Regenerat, A-1200 Vienna, Austria.
   [Grillari, Johannes] Univ Nat Resources & Life Sci, Inst Mol Biotechnol, Dept Biotechnol, A-1190 Vienna, Austria.
C3 Ludwig Boltzmann Institute; Ministry of Education & Science of Ukraine;
   Vasyl Stefanyk Precarpathian National University; Medical University of
   Vienna; Vienna Biocenter (VBC); Institute of Molecular Biotechnology
   (IMBA); University of Natural Resources & Life Sciences, Vienna
RP Grillari, J (corresponding author), Ludwig Boltzmann Inst Traumatol, Res Ctr Cooperat AUVA, A-1200 Vienna, Austria.; Grillari, J (corresponding author), Austrian Cluster Tissue Regenerat, A-1200 Vienna, Austria.; Grillari, J (corresponding author), Univ Nat Resources & Life Sci, Inst Mol Biotechnol, Dept Biotechnol, A-1190 Vienna, Austria.
EM oleh.lushchak@pnu.edu.ua; markus.schosserer@meduniwien.ac.at;
   johannes.grillari@trauma.lbg.ac.at
RI Schosserer, Markus/A-5966-2010; Grillari, Johannes/B-2967-2011
OI Schosserer, Markus/0000-0003-2025-0739; Grillari,
   Johannes/0000-0001-5474-6332
FU Austrian Science Fund (FWF); Herzfelder'sche Familienstiftung [FG
   2400-B]; FEBS Ukrainian Short-Term Fellowship;  [P35268-B]
FX We kindly acknowledge support by the Austrian Science Fund (FWF) and
   Herzfelder'sche Familienstiftung: P35268-B and FG 2400-B. OL is
   supported by a FEBS Ukrainian Short-Term Fellowship. This research was
   conducted while MS was a Hevolution/AFAR New Investigator Awardee in
   Aging Biology and Geroscience Research. The APC was funded by Open
   Access Funding by the Austrian Science Fund (FWF): P35268-B.
CR Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12
   Al-Naggar Iman M A, 2020, Curr Mol Biol Rep, V6, P161, DOI 10.1007/s40610-020-00140-1
   Anderson R, 2019, EMBO J, V38, DOI 10.15252/embj.2018100492
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2017, ONCOTARGET, V8, P27661, DOI 10.18632/oncotarget.15742
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Borghesan M, 2020, TRENDS CELL BIOL, V30, P777, DOI 10.1016/j.tcb.2020.07.002
   Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Currais A, 2018, J GERONTOL A-BIOL, V73, P299, DOI 10.1093/gerona/glx104
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Doolittle ML, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111565
   Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010
   Fafián-Labora JA, 2021, AGING CELL, V20, DOI 10.1111/acel.13426
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Feng MX, 2019, FASEB BIOADV, V1, P579, DOI 10.1096/fba.2019-00041
   Fischer BM, 2013, AM J PHYSIOL-LUNG C, V304, pL394, DOI 10.1152/ajplung.00091.2012
   Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018
   Giorgi C, 2018, INT REV CEL MOL BIO, V340, P209, DOI 10.1016/bs.ircmb.2018.05.006
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hopp W.J., 2011, PREC MED BUILD KNOWL, VVolume 27
   Hybiak J, 2020, EUR J PHARMACOL, V866, DOI 10.1016/j.ejphar.2019.172762
   Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324
   Khosla S, 2020, NAT REV ENDOCRINOL, V16, P263, DOI 10.1038/s41574-020-0335-y
   Kritsilis M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102937
   Loaiza N, 2016, BBA-REV CANCER, V1865, P155, DOI 10.1016/j.bbcan.2016.01.007
   Lopes-Paciencia S, 2019, CYTOKINE, V117, P15, DOI 10.1016/j.cyto.2019.01.013
   Lushchak O, 2020, GEROSCIENCE, V42, P117, DOI 10.1007/s11357-019-00116-9
   Majewska J, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111550
   Marin I, 2023, CANCER DISCOV, V13, P410, DOI 10.1158/2159-8290.CD-22-0523
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Matias I, 2022, AGING CELL, V21, DOI 10.1111/acel.13521
   Mehdizadeh M, 2022, NAT REV CARDIOL, V19, P250, DOI 10.1038/s41569-021-00624-2
   Mertens J, 2021, CELL STEM CELL, V28, P1533, DOI 10.1016/j.stem.2021.04.004
   Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Owens WA, 2021, MECH AGEING DEV, V198, DOI 10.1016/j.mad.2021.111540
   Pan J, 2017, INT J RADIAT ONCOL, V99, P353, DOI 10.1016/j.ijrobp.2017.02.216
   Piskovatska Veronika, 2019, Subcell Biochem, V91, P339, DOI 10.1007/978-981-13-3681-2_13
   Ring NAR, 2022, DEV CELL, V57, P1083, DOI 10.1016/j.devcel.2022.04.005
   Robbins PD, 2021, ANNU REV PHARMACOL, V61, P779, DOI 10.1146/annurev-pharmtox-050120-105018
   Saul D, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32552-1
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Schmitt CA, 2023, NAT REV IMMUNOL, V23, P251, DOI 10.1038/s41577-022-00785-2
   Schosserer M, 2022, MECH AGEING DEV, V202, DOI 10.1016/j.mad.2022.111629
   Schosserer M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00278
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Sikora E, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100941
   Sreekumar PG, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2583601
   Tanaka Y, 2021, J BIOCHEM, V169, P147, DOI 10.1093/jb/mvaa109
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Terlecki-Zaniewicz L, 2018, AGING-US, V10, P1103, DOI 10.18632/aging.101452
   Thompson PJ, 2019, CELL METAB, V29, P1045, DOI 10.1016/j.cmet.2019.01.021
   Toussaint O, 2002, BIOCHEM PHARMACOL, V64, P1007, DOI 10.1016/S0006-2952(02)01170-X
   Vaiserman A, 2021, MED RES REV, V41, P1676, DOI 10.1002/med.21773
   Vaiserman A, 2020, MECH AGEING DEV, V189, DOI 10.1016/j.mad.2020.111259
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wang LQ, 2022, NAT REV CANCER, V22, P340, DOI 10.1038/s41568-022-00450-9
   Weilner S, 2013, EXP GERONTOL, V48, P626, DOI 10.1016/j.exger.2012.11.017
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Zhang CM, 2020, MED SCI MONIT BASIC, V26, DOI 10.12659/MSMBR.923391
   Zhang L, 2023, FEBS J, V290, P1362, DOI 10.1111/febs.16350
   Zhang L, 2021, AGING CELL, V20, DOI 10.1111/acel.13486
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 84
TC 1
Z9 1
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD JUN
PY 2023
VL 13
IS 6
AR 966
DI 10.3390/biom13060966
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA K5TC5
UT WOS:001017054500001
PM 37371545
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU El-Din, SHS
   Hammam, OA
   Ezzat, SM
   Saleh, S
   Safar, MM
   El-Maadawy, WH
   El-Lakkany, NM
AF el-Din, Sayed H. Seif
   Hammam, Olfat A.
   Ezzat, Shahira M.
   Saleh, Samira
   Safar, Marwa M.
   El-Maadawy, Walaa H.
   El-Lakkany, Naglaa M.
TI Hydroxysafflor yellow A protects against thioacetamide-induced liver
   fibrosis in rats <i>via</i> suppressing proinflammatory/fibrogenic
   mediators and promoting hepatic stellate cell senescence and apoptosis
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Article
ID CARBON-TETRACHLORIDE; CARTHAMUS-TINCTORIUS; INJURY; PROLIFERATION;
   ATORVASTATIN; ATTENUATE; CIRRHOSIS; DISEASE; TISSUE; DEATH
AB Objective: To evaluate the effect of hydroxysafflor yellow A (HSYA) on thioacetamide-induced liver fibrosis.
   Methods: Thioacetamide was administered to rats intraperitoneally in doses of 200 mg/kg twice a week for 12 weeks. Thioacetamide-intoxicated rats were given silymarin (50 mg/kg) or HSYA (5 mg/kg) orally every day for 8 weeks. Liver enzymes, fibrosis markers, histological changes as well as immunohistochemistry of TNF-alpha, IL-6, p21, alpha-SMA, and caspase-3 were examined. The effect of HSYA on HSC-T6 activation/proliferation and apoptosis was also determined in vitro.
   Results: HSYA decreased liver enzymes, TNF-alpha, IL-6, and p21 expressions, hepatic PDGF-B, TIMP-1, TGF-beta 1, and hydroxyproline levels, as well as fibrosis score (S2 vs. S4) compared to the thioacetamide group. HSYA also downregulated alpha-SMA while increasing caspase-3 expression. Surprisingly, at 500 mu g/mL, HSYA had only a slightly suppressive effect on HSC proliferation, with a 9.5% reduction. However, it significantly reduced TGF-beta 1, inhibited alpha-SMA expression, induced caspase-3 expression, and promoted cell senescence.
   Conclusions: HSYA may be a potential therapeutic agent for delaying and reversing the progression of liver fibrosis. More research on HSYA at higher doses and for a longer period is warranted.
C1 [el-Din, Sayed H. Seif; El-Maadawy, Walaa H.; El-Lakkany, Naglaa M.] Theodor Bilharz Res Inst, Dept Pharmacol, Imbaba POB 30, Giza 12411, Egypt.
   [Hammam, Olfat A.] Theodor Bilharz Res Inst, Pathol Dept, Imbaba POB 30, Giza 12411, Egypt.
   [Ezzat, Shahira M.] Cairo Univ, Dept Pharmacognosy, Fac Pharm, Cairo 11562, Egypt.
   [Ezzat, Shahira M.] October Univ Modern Sci & Arts, Dept Pharmacognosy, Fac Pharm, Giza, Egypt.
   [Saleh, Samira; Safar, Marwa M.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo 11562, Egypt.
   [Safar, Marwa M.] British Univ Egypt, Pharmacol & Biochem Dept, Fac Pharm, Cairo, Egypt.
C3 Egyptian Knowledge Bank (EKB); Theodor Bilharz Research Institute
   (TBRI); Egyptian Knowledge Bank (EKB); Theodor Bilharz Research
   Institute (TBRI); Egyptian Knowledge Bank (EKB); Cairo University;
   Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA);
   Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank
   (EKB); British University in Egypt
RP El-Din, SHS (corresponding author), Theodor Bilharz Res Inst, Dept Pharmacol, Imbaba POB 30, Giza 12411, Egypt.
EM s.seifeldin@tbri.gov.eg
RI El-Lakkany, Naglaa/N-8249-2019
OI El-Lakkany, Naglaa/0000-0002-5783-9945
FU Theodore Bilharz Research Institute [ID-MS-99/A]
FX This investigation is part of a project funded by Theodore Bilharz
   Research Institute (grant number: ID-MS-99/A, Principal investigator:
   Naglaa M. El-Lakkany).
CR Al-Attar AM, 2016, SAUDI J BIOL SCI, V23, P363, DOI 10.1016/j.sjbs.2015.08.011
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bai J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27217-3
   Bai YH, 2012, MOLECULES, V17, P14918, DOI 10.3390/molecules171214918
   Basso BD, 2021, J ETHNOPHARMACOL, V280, DOI 10.1016/j.jep.2021.114433
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120713
   Choi JH, 2011, ENVIRON TOXICOL PHAR, V31, P212, DOI 10.1016/j.etap.2010.10.011
   Federico A, 2017, MOLECULES, V22, DOI 10.3390/molecules22020191
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Ghosh S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00481
   González-Gualda E, 2021, FEBS J, V288, P56, DOI 10.1111/febs.15570
   He YH, 2015, J PHYSIOL BIOCHEM, V71, P69, DOI 10.1007/s13105-015-0382-3
   Huang YH, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109445
   Jiang SJ, 2014, INT J CLIN EXP PATHO, V7, P2595
   Kadir FA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/739850
   Klein S, 2012, LAB INVEST, V92, P1440, DOI 10.1038/labinvest.2012.106
   Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819
   Li CC, 2012, EUR J PHARM SCI, V46, P397, DOI 10.1016/j.ejps.2012.03.003
   Li L, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/560345
   Liu Q, 2014, PHARM BIOL, V52, P1085, DOI 10.3109/13880209.2013.877491
   Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Nascimento M, 2018, LIFE SCI, V212, P168, DOI 10.1016/j.lfs.2018.09.051
   Neha, 2016, ADV EXP MED BIOL, V929, P25, DOI 10.1007/978-3-319-41342-6_2
   Park EJ, 2007, EUR J PHARMACOL, V559, P115, DOI 10.1016/j.ejphar.2007.01.024
   Prakash J, 2017, ADV DRUG DELIVER REV, V121, P1, DOI 10.1016/j.addr.2017.11.008
   Salama SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-56
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shay Jessica E S, 2018, Clin Liver Dis (Hoboken), V11, P111, DOI 10.1002/cld.702
   Shirin H, 2013, WORLD J GASTROENTERO, V19, P241, DOI 10.3748/wjg.v19.i2.241
   Wadhwa K, 2022, MOLECULES, V27, DOI 10.3390/molecules27165327
   Wan SZ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01321
   Wang CY, 2013, PHYTOMEDICINE, V20, P592, DOI 10.1016/j.phymed.2013.02.001
   Wang FD, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.787748
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yang CC, 2013, INT IMMUNOPHARMACOL, V15, P106, DOI 10.1016/j.intimp.2012.10.017
   Yu HX, 2019, MOL IMMUNOL, V107, P29, DOI 10.1016/j.molimm.2019.01.004
   Zhang CY, 2023, WORLD J HEPATOL, V15, P755, DOI 10.4254/wjh.v15.i6.755
   Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015
   Zhao F, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.579332
   Zoubek ME, 2017, BEST PRACT RES CL GA, V31, P129, DOI 10.1016/j.bpg.2017.04.005
NR 44
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD AUG
PY 2023
VL 13
IS 8
BP 348
EP 358
DI 10.4103/2221-1691.383689
PG 11
WC Tropical Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Tropical Medicine
GA T8SD3
UT WOS:001080619700003
OA gold
DA 2024-02-19
ER

PT J
AU Fuhrmeister, J
   Zota, A
   Sijmonsma, TP
   Seibert, O
   Cingir, S
   Schmidt, K
   Vallon, N
   de Guia, RM
   Niopek, K
   Diaz, MB
   Maida, A
   Blüher, M
   Okun, JG
   Herzig, S
   Rose, AJ
AF Fuhrmeister, Jessica
   Zota, Annika
   Sijmonsma, Tjeerd P.
   Seibert, Oksana
   Cingir, Sahika
   Schmidt, Kathrin
   Vallon, Nicola
   de Guia, Roldan M.
   Niopek, Katharina
   Diaz, Mauricio Berriel
   Maida, Adriano
   Blueher, Matthias
   Okun, Juergen G.
   Herzig, Stephan
   Rose, Adam J.
TI Fasting-induced liver GADD45 restrains hepatic fatty acid uptake and
   improves metabolic health
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE FABP1; hormesis; lipid; metabolism; stress
ID BINDING PROTEIN GENE; DIET-INDUCED OBESITY; ACYL-COA ESTERS;
   INSULIN-RESISTANCE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ACETAMINOPHEN
   HEPATOTOXICITY; LIPID-METABOLISM; STRESS-RESPONSE; MURINE LIVER
AB Recent studies have demonstrated that repeated short-term nutrient withdrawal (i.e. fasting) has pleiotropic actions to promote organismal health and longevity. Despite this, the molecular physiological mechanisms by which fasting is protective against metabolic disease are largely unknown. Here, we show that, metabolic control, particularly systemic and liver lipid metabolism, is aberrantly regulated in the fasted state in mouse models of metabolic dysfunction. Liver transcript assays between lean/healthy and obese/diabetic mice in fasted and fed states uncovered growth arrest and DNA damage-inducible GADD45 as a dysregulated gene transcript during fasting in several models of metabolic dysfunction including ageing, obesity/pre-diabetes and type 2 diabetes, in both mice and humans. Using whole-body knockout mice as well as liver/hepatocyte-specific gain- and loss-of-function strategies, we revealed a role for liver GADD45 in the coordination of liver fatty acid uptake, through cytoplasmic retention of FABP1, ultimately impacting obesity-driven hyperglycaemia. In summary, fasting stress-induced GADD45 represents a liver-specific molecular event promoting adaptive metabolic function.
C1 [Fuhrmeister, Jessica; Zota, Annika; Sijmonsma, Tjeerd P.; Seibert, Oksana; Cingir, Sahika; Vallon, Nicola; de Guia, Roldan M.; Niopek, Katharina; Diaz, Mauricio Berriel; Maida, Adriano; Herzig, Stephan; Rose, Adam J.] Heidelberg Univ, German Canc Res Ctr, Ctr Mol Biol, Joint Res Div Mol Metab Control, Heidelberg, Germany.
   [Fuhrmeister, Jessica; Zota, Annika; Sijmonsma, Tjeerd P.; Seibert, Oksana; Cingir, Sahika; Vallon, Nicola; de Guia, Roldan M.; Niopek, Katharina; Diaz, Mauricio Berriel; Maida, Adriano; Herzig, Stephan; Rose, Adam J.] Univ Heidelberg Hosp, Heidelberg, Germany.
   [Zota, Annika; Niopek, Katharina; Diaz, Mauricio Berriel; Maida, Adriano; Herzig, Stephan] Helmholtz Ctr Munich, IDC, Neuherberg, Germany.
   [Zota, Annika; Niopek, Katharina; Diaz, Mauricio Berriel; Maida, Adriano; Herzig, Stephan] Univ Heidelberg Hosp, Inner Med 1, Joint Heidelberg IDC Translat Diabet Program, Neuherberg, Germany.
   [Schmidt, Kathrin; Okun, Juergen G.] Univ Childrens Hosp, Div Inherited Metab Dis, Heidelberg, Germany.
   [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany.
C3 Ruprecht Karls University Heidelberg; Helmholtz Association; German
   Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg;
   Helmholtz Association; Helmholtz-Center Munich - German Research Center
   for Environmental Health; Ruprecht Karls University Heidelberg; Ruprecht
   Karls University Heidelberg; University of Hamburg; University Medical
   Center Hamburg-Eppendorf; Leipzig University
RP Herzig, S; Rose, AJ (corresponding author), Heidelberg Univ, German Canc Res Ctr, Ctr Mol Biol, Joint Res Div Mol Metab Control, Heidelberg, Germany.; Herzig, S (corresponding author), Univ Heidelberg Hosp, Heidelberg, Germany.; Herzig, S (corresponding author), Helmholtz Ctr Munich, IDC, Neuherberg, Germany.
EM stephan.herzig@helmholtz-muenchen.de; a.rose@dkfz.de
RI Rose, Adam John/AAC-6274-2019; Díaz, Mauricio/JXX-4543-2024; Diaz,
   Mauricio Berriel/AAF-8285-2021; de Guia, Roldan/AAF-2823-2020; De Guia,
   Roldan/AAL-8529-2020
OI Rose, Adam John/0000-0001-9132-8244; De Guia,
   Roldan/0000-0002-4239-2407; Herzig, Stephan/0000-0003-3950-3652; Berriel
   Diaz, Mauricio/0000-0003-4670-919X
FU Helmholtz Association (ICEMED, Cross-Program Topic Metabolic
   Dysfunction); Deutsche Forschungsgemeinschaft [He3260/4-2]
FX We thank Prof. Christof Niehrs (IMB, Mainz, DEU) and his colleagues Dr.
   Matthias Gierl and Dr. Andrea Schafer for providing the Gadd45 mouse
   breeding pairs as well as experimental support and advice. Furthermore,
   we appreciate the experimental support of Emil Karaulanov (IMB, Mainz),
   Prachiti Narvekar, Astrid Wendler, Katharina Sowodniok, Yvonne Feuchter
   (A170, DKFZ) and Marcus Jabs (A270, DKFZ) for helpful advice regarding
   the LC-Acyl-CoA assay. This work was supported by grants from the
   Helmholtz Association (ICEMED, Cross-Program Topic Metabolic
   Dysfunction) and the Deutsche Forschungsgemeinschaft (He3260/4-2) to
   S.H.
CR Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018
   Antonenkov VD, 2006, BIOCHEM J, V394, P475, DOI 10.1042/BJ20051058
   Argmann Carmen A, 2006, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a03s75
   Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005
   Aubert J, 2012, J PHARMACOL EXP THER, V342, P676, DOI 10.1124/jpet.112.193813
   Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239
   BARBER ED, 1971, BIOCHIM BIOPHYS ACTA, V250, P361, DOI 10.1016/0005-2744(71)90192-6
   Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003
   Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258
   Cai Q, 2006, AM J PHYSIOL-RENAL, V291, pF341, DOI 10.1152/ajprenal.00518.2005
   Calabrese V, 2011, MOL ASPECTS MED, V32, P279, DOI 10.1016/j.mam.2011.10.007
   CHEN MT, 1992, METABOLISM, V41, P564, DOI 10.1016/0026-0495(92)90221-U
   Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883
   Connor T, 2015, CLIN EXP PHARMACOL P, V42, P109, DOI 10.1111/1440-1681.12315
   Cooney GJ, 2002, ANN NY ACAD SCI, V967, P196
   Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273
   de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111
   Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200
   Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777
   Faergeman NJ, 1997, BIOCHEM J, V323, P1
   Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gantner ML, 2014, P NATL ACAD SCI USA, V111, P11870, DOI 10.1073/pnas.1406638111
   Glatz JFC, 2002, MOL CELL BIOCHEM, V239, P3, DOI 10.1023/A:1020529918782
   Golovko MY, 2004, J LIPID RES, V45, P1777, DOI 10.1194/jlr.D400004-JLR200
   Graham Tracey, 2008, Genet Vaccines Ther, V6, P9, DOI 10.1186/1479-0556-6-9
   Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847
   Hakvoort TBM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216986
   Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106
   Hoene M, 2010, EXERC IMMUNOL REV, V16, P163
   Kamath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027617
   Kanasaki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197636
   Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010
   Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129
   Kim JH, 2014, HEPATOLOGY, V59, P695, DOI 10.1002/hep.26683
   Kim YH, 2015, J HEPATOL, V63, P75, DOI [10.1016/j.jhep.2015.02.050, 10.1016/j.jhep.2015.02.008]
   Klöting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009
   Kolb H, 2012, NAT REV ENDOCRINOL, V8, P183, DOI 10.1038/nrendo.2011.158
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013
   Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093
   Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007
   Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024
   Liebermann DA, 2002, LEUKEMIA, V16, P527, DOI 10.1038/sj.leu.2402477
   Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15
   Lindén D, 2002, J BIOL CHEM, V277, P23044, DOI 10.1074/jbc.M110416200
   Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157
   Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008
   Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500
   Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200
   Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200
   Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019
   Mittelman SD, 1997, J CLIN INVEST, V100, P3121, DOI 10.1172/JCI119867
   Morris EM, 2012, AM J PHYSIOL-GASTR L, V303, pG979, DOI 10.1152/ajpgi.00169.2012
   Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010
   Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473
   Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200
   Oakes ND, 1999, J LIPID RES, V40, P1155
   Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913
   Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Rose AJ, 2011, CELL METAB, V14, P123, DOI 10.1016/j.cmet.2011.04.010
   ROSS BD, 1967, BIOCHEM J, V105, P869, DOI 10.1042/bj1050869
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x
   Schupp M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-758
   Sokolovic M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-528
   Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   Tian JM, 2013, ADV EXP MED BIOL, V793, P69, DOI 10.1007/978-1-4614-8289-5_5
   Tian JM, 2011, J CLIN INVEST, V121, P4491, DOI 10.1172/JCI38760
   Tschöp MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]
   VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914
   Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011
   Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898
   Yang Z, 2009, CURR CANCER DRUG TAR, V9, P915, DOI 10.2174/156800909790192383
   Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027553
   Zhang YKJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059122
NR 84
TC 25
Z9 26
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JUN
PY 2016
VL 8
IS 6
BP 654
EP 669
DI 10.15252/emmm.201505801
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA DR5SZ
UT WOS:000379964000008
PM 27137487
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Park, S
   Chung, MJ
   Son, JY
   Yun, HH
   Park, JM
   Yim, JH
   Jung, SJ
   Lee, SH
   Jeong, KS
AF Park, SunYoung
   Chung, Myung-Jin
   Son, Ji-Yoon
   Yun, Hyun Ho
   Park, Jae-Min
   Yim, Jae-Hyuk
   Jung, Seung-Jun
   Lee, Sang-Han
   Jeong, Kyu-Shik
TI The role of Sirtuin 2 in sustaining functional integrity of the liver
SO LIFE SCIENCES
LA English
DT Article; Early Access
DE SIRT2; NAFLD; Lipid metabolism; Cellular senescence; Fibrosis; High-fat
   diet
ID GLUCOSE; PROTEIN; MUSCLE; CELLS; ATHEROSCLEROSIS; ASSOCIATION;
   ACTIVATION; SENESCENCE; PROMOTES; GLUT4
AB Aim: Sirtuin 2 (SIRT2) is a NAD+-dependent deacetylase involved in various biological functions via deacetylation of proteins, including histone protein. Hepatic fat accumulation from aging and excess caloric intake contribute to development of non-alcoholic fatty liver disease. The study aim was to elucidate the role of SIRT2 in lipid metabolism homeostasis.
   Materials and methods: SIRT2(+/+) (C57BL/6) and SIRT2(-/-) were randomly assigned to normal diet or high-fat diet (HFD) groups and fed for 6 weeks. Histological features of the livers were evaluated by hematoxylin and eosin and Masson's trichrome staining, and the levels of selected factors were determined by quantitative reverse transcription-polymerase chain reaction and western blot analysis.
   Key findings: Although the SIRT2(-/-) mice were viable, their livers exhibited higher glycogen accumulation, and skeletal muscle showed features of increased metabolic demand. The SIRT2(-/-) mice attenuated HFD-induced weight gain, visceral adipose tissue formation, and fat accumulation in the liver in which the expressions of genes involved in metabolic substrate transport were modified. Additionally, the hepatocellular senescence and upregulated cell-cycle factors upon HFD intake in SIRT2(-/-) livers suggested a role of SIRT2 in gene expression during abnormal metabolism. Moreover, the fibrotic phenotype of liver tissue without fat accumulation and the increased expression of genes involved in liver fibrosis in the HFD-fed SIRT2(-/)- mice indicated that SIRT2 had a role in hepatocyte and hepatic stellate cell activation.
   Significance: Our results indicated that SIRT2 has a critical role in regulating lipid metabolic homeostasis and in sustaining liver integrity by modulating related gene expression.
C1 [Park, SunYoung; Chung, Myung-Jin; Son, Ji-Yoon; Yun, Hyun Ho; Park, Jae-Min; Yim, Jae-Hyuk; Jung, Seung-Jun; Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Daegu 41566, South Korea.
   [Park, SunYoung; Jeong, Kyu-Shik] Kyungpook Natl Univ, Stem Cell Therapeut Res Inst, Daegu 41566, South Korea.
   [Lee, Sang-Han] Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Daegu 41566, South Korea.
C3 Kyungpook National University; Kyungpook National University; Kyungpook
   National University
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Stem Cell Therapeut Res Inst, Dept Pathol, Daegu 41566, South Korea.
EM jeongks@knu.ac.kr
FU Kyungpook National University Development Project Research Fund
FX This research was supported by the Kyungpook National University
   Development Project Research Fund, 2019.
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Belman JP, 2015, J BIOL CHEM, V290, P4447, DOI 10.1074/jbc.M114.603977
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Bonder A, 2015, CLIN LIVER DIS, V19, P123, DOI 10.1016/j.cld.2014.09.007
   Bouché C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chen J, 2013, HEPATOLOGY, V57, P2287, DOI 10.1002/hep.26278
   CLARK SA, 1988, LANCET, V2, P1225
   DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351
   Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681
   Gomes P, 2015, TRENDS PHARMACOL SCI, V36, P756, DOI 10.1016/j.tips.2015.08.001
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Herrnberger L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115005
   Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002
   Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003
   Kim AY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0920-3
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Majeed Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87759-x
   Mashek DG, 2013, ADV NUTR, V4, P697, DOI 10.3945/an.113.004648
   Maslak E, 2015, PHARMACOL REP, V67, P689, DOI 10.1016/j.pharep.2015.04.010
   Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001
   North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Ramakrishnan G, 2014, J BIOL CHEM, V289, P6054, DOI 10.1074/jbc.M113.537266
   Ren HH, 2021, HEPATOLOGY, V74, P723, DOI [10.1002/htp.31773, 10.1002/hep.31773]
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012
   Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y
   Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019
   Xiao M, 2018, ONCOTARGET, V9, P8772, DOI [10.18632/oncotarget.23622, DOI 10.18632/ONCOTARGET.23622]
   Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x
   Zhou YF, 2016, ONCOTARGET, V7, P77707, DOI 10.18632/oncotarget.12774
   ZORZANO A, 1986, AM J PHYSIOL, V251, pE664, DOI 10.1152/ajpendo.1986.251.6.E664
NR 39
TC 7
Z9 7
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD 2021 NOV 15
PY 2021
VL 285
AR 119997
DI 10.1016/j.lfs.2021.119997
EA OCT 2021
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA YO0FR
UT WOS:000747624900002
PM 34597608
DA 2024-02-19
ER

PT J
AU Kitsugi, K
   Noritake, H
   Matsumoto, M
   Hanaoka, T
   Umemura, M
   Yamashita, M
   Takatori, S
   Ito, J
   Ohta, K
   Chida, T
   Ulmasov, B
   Neuschwander-Tetri, BA
   Suda, T
   Kawata, K
AF Kitsugi, Kensuke
   Noritake, Hidenao
   Matsumoto, Moe
   Hanaoka, Tomohiko
   Umemura, Masahiro
   Yamashita, Maho
   Takatori, Shingo
   Ito, Jun
   Ohta, Kazuyoshi
   Chida, Takeshi
   Ulmasov, Barbara
   Neuschwander-Tetri, Brent A.
   Suda, Takafumi
   Kawata, Kazuhito
TI Inhibition of integrin binding to ligand arg-gly-asp motif induces
   AKT-mediated cellular senescence in hepatic stellate cells
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article; Early Access
DE Cell cycle arrest; Focal adhesion kinase; Liver fibrosis; Murine
   double-minute clone 2; Senescence-associated secretory phenotype
ID PATHWAY; TISSUE; EXPRESSION; INDUCTION; APOPTOSIS; FIBROSIS
AB Background & aimsHepatic stellate cells (HSCs) play an essential role in liver fibrogenesis. The induction of cellular senescence has been reported to inhibit HSC activation. Previously, we demonstrated that CWHM12, a small molecule arginine-glycine-aspartic acid (RGD) peptidomimetic compound, inhibits HSC activation. This study investigated whether the inhibitory effects of CWHM12 on HSCs affected cellular senescence.MethodsThe immortalized human HSC lines, LX-2 and TWNT-1, were used to evaluate the effects of CWHM12 on cellular senescence via the disruption of RGD-mediated binding to integrins.ResultsCWHM12 induces cell cycle arrest, senescence-associated beta-galactosidase activity, acquisition of senescence-associated secretory phenotype (SASP), and expression of senescence-associated proteins in HSCs. Further experiments revealed that the phosphorylation of AKT and murine double minute 2 (MDM2) was involved in the effects of CWHM12, and the inhibition of AKT phosphorylation reversed these effects of CWHM12 on HSCs.ConclusionsPharmacological inhibition of RGD-mediated integrin binding induces senescence in activated HSCs.
C1 [Kitsugi, Kensuke; Noritake, Hidenao; Matsumoto, Moe; Hanaoka, Tomohiko; Umemura, Masahiro; Yamashita, Maho; Takatori, Shingo; Ito, Jun; Ohta, Kazuyoshi; Chida, Takeshi; Kawata, Kazuhito] Hamamatsu Univ, Dept Internal Med, Div Hepatol, Sch Med, Hamamatsu, Shizuoka, Japan.
   [Ulmasov, Barbara; Neuschwander-Tetri, Brent A.] St Louis Univ, Div Gastroenterol & Hepatol, St Louis, MO 63105 USA.
   [Suda, Takafumi] Hamamatsu Univ, Sch Med, Dept Internal Med, Div Resp Med, Hamamatsu, Shizuoka, Japan.
C3 Hamamatsu University School of Medicine; Saint Louis University;
   Hamamatsu University School of Medicine
RP Noritake, H (corresponding author), Hamamatsu Univ, Dept Internal Med, Div Hepatol, Sch Med, Hamamatsu, Shizuoka, Japan.
EM noritake@hama-med.ac.jp
RI 木次, 健介/ISB-7685-2023
FU JSPS KAKENHI [JP19K17428]
FX This work was supported by JSPS KAKENHI (grant number JP19K17428).
CR Alza L, 2020, CANCERS, V12, DOI 10.3390/cancers12051086
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Buj R, 2021, AGING-US, V13, P3290, DOI 10.18632/aging.202640
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen J, 2013, TISSUE ENG PART B-RE, V19, P516, DOI [10.1089/ten.teb.2012.0672, 10.1089/ten.TEB.2012.0672]
   Chen YX, 2017, ONCOTARGET, V8, P31065, DOI 10.18632/oncotarget.16075
   Chibaya L, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2003193118
   Chuang HH, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00022
   Conroy KP, 2016, CELL TISSUE RES, V365, P511, DOI 10.1007/s00441-016-2407-9
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cuollo L, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9120485
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Doura T, 2016, ANGEW CHEM INT EDIT, V55, P9620, DOI 10.1002/anie.201603328
   Fang DD, 2016, AGING-US, V8, P571, DOI 10.18632/aging.100946
   Franovic A, 2015, CANCER RES, V75, P4466, DOI 10.1158/0008-5472.CAN-15-0988
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Fujita M, 2021, AM J CANCER RES, V11, P4364
   Gao JH, 2020, J HEPATOL, V73, P1144, DOI 10.1016/j.jhep.2020.04.044
   Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4
   Guo QL, 2021, EXP BIOL MED, V246, P447, DOI 10.1177/1535370220960391
   Hara E, 1996, MOL CELL BIOL, V16, P859
   HAYMAN EG, 1979, J CELL BIOL, V83, P255, DOI 10.1083/jcb.83.1.255
   Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ito Y, 2017, TRENDS CELL BIOL, V27, P830, DOI 10.1016/j.tcb.2017.07.004
   Jia LL, 2018, INT J MED SCI, V15, P1241, DOI 10.7150/ijms.25115
   Kawada N, 2006, GUT, V55, P1073, DOI 10.1136/gut.2005.090449
   Kitsugi K, 2022, CELL SIGNAL, V99, DOI 10.1016/j.cellsig.2022.110437
   Klungsaeng S, 2020, AM J CHINESE MED, V48, P1475, DOI 10.1142/S0192415X2050072X
   Kong CH, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/1200602
   Korbecki J, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23084205
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Liao ZH, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9121769
   Liu S, 2011, AGING CELL, V10, P661, DOI 10.1111/j.1474-9726.2011.00704.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ludwig BS, 2021, CANCERS, V13, DOI 10.3390/cancers13071711
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   Mijit M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030420
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Niu HT, 2021, CANCER MANAG RES, V13, P489, DOI 10.2147/CMAR.S286866
   Okamura K, 2022, TOXICOL APPL PHARM, V454, DOI 10.1016/j.taap.2022.116231
   Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011
   Rahman SR, 2022, LIVER INT, V42, P507, DOI 10.1111/liv.15157
   Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Saga K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103043
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Topacio BR, 2019, MOL CELL, V74, P758, DOI 10.1016/j.molcel.2019.03.020
   Ulmasov B, 2019, HEPATOL COMMUN, V3, P246, DOI 10.1002/hep4.1298
   Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013
   Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wijayasiri P, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11142221
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhao KL, 2018, EMBO REP, V19, P305, DOI 10.15252/embr.201744465
   Zheng KL, 2017, ONCOTARGET, V8, P14978, DOI 10.18632/oncotarget.14785
   Zhou J, 2022, J INFLAMM RES, V15, P3689, DOI 10.2147/JIR.S358470
NR 63
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD 2023 OCT 30
PY 2023
DI 10.1007/s11010-023-04883-0
EA OCT 2023
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA W2BJ4
UT WOS:001089733500002
PM 37902885
DA 2024-02-19
ER

PT J
AU Kim, SM
   Lee, B
   An, HJ
   Kim, DH
   Park, KC
   Noh, SG
   Chung, KW
   Lee, EK
   Kim, KM
   Kim, DH
   Kim, SJ
   Chun, P
   Lee, HJ
   Moon, HR
   Chung, HY
AF Kim, Seong Min
   Lee, Bonggi
   An, Hye Jin
   Kim, Dae Hyun
   Park, Kyung Chul
   Noh, Sang-Gyun
   Chung, Ki Wung
   Lee, Eun Kyeong
   Kim, Kyung Mok
   Kim, Do Hyun
   Kim, Su Jeong
   Chun, Pusoon
   Lee, Ho Jeong
   Moon, Hyung Ryong
   Chung, Hae Young
TI Novel PPARa agonist MHY553 alleviates hepatic steatosis by increasing
   fatty acid oxidation and decreasing inflammation during aging
SO ONCOTARGET
LA English
DT Article
DE MHY553; PPARa agonist; hepatic steatosis; fatty acid oxidation; aging
ID NF-KAPPA-B; LIVER-DISEASE; GENE-REGULATION; ALPHA; EXPRESSION;
   DEFICIENCY; METABOLISM; MOUSE
AB Hepatic steatosis is frequently observed in obese and aged individuals. Because hepatic steatosis is closely associated with metabolic syndromes, including insulin resistance, dyslipidemia, and inflammation, numerous efforts have been made to develop compounds that ameliorate it. Here, a novel peroxisome proliferator-activated receptor (PPAR) a agonist, 4-(benzo[d] thiazol-2-yl) benzene-1,3-diol (MHY553) was developed, and investigated its beneficial effects on hepatic steatosis using young and old Sprague-Dawley rats and HepG2 cells.
   Docking simulation and Western blotting confirmed that the activity of PPARa, but not that of the other PPAR subtypes, was increased by MHY553 treatment. When administered orally, MHY553 markedly ameliorated aging-induced hepatic steatosis without changes in body weight and serum levels of liver injury markers. Consistent with in vivo results, MHY553 inhibited triglyceride accumulation induced by a liver X receptor agonist in HepG2 cells. Regarding underlying mechanisms, MHY553 stimulated PPARa translocation into the nucleus and increased mRNA levels of its downstream genes related to fatty acid oxidation, including CPT-1A and ACOX1, without apparent change in lipogenesis signaling. Furthermore, MHY553 significantly suppresses inflammatory mRNA expression in old rats. In conclusion, MHY553 is a novel PPARa agonist that improved aged-induced hepatic steatosis, in part by increasing beta-oxidation signaling and decreasing inflammation in the liver. MHY553 is a potential pharmaceutical agent for treating hepatic steatosis in aging.
C1 [Kim, Seong Min; Lee, Bonggi; An, Hye Jin; Kim, Dae Hyun; Park, Kyung Chul; Noh, Sang-Gyun; Chung, Ki Wung; Lee, Eun Kyeong; Kim, Kyung Mok; Kim, Do Hyun; Kim, Su Jeong; Moon, Hyung Ryong; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan 46241, South Korea.
   [Kim, Seong Min; Lee, Ho Jeong] Gyeongsang Natl Univ, Res Inst Life Sci, Jinju 52828, South Korea.
   [Lee, Bonggi] Korea Inst Oriental Med, Korean Med KM Applicat Ctr, Daegu 41062, South Korea.
   [Chun, Pusoon] Inje Univ, Coll Pharm, Gimhae 621749, South Korea.
C3 Pusan National University; Gyeongsang National University; Korea
   Institute of Oriental Medicine (KIOM); Inje University
RP Moon, HR; Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Mol Inflammat Res Ctr Aging Intervent MRCA, Busan 46241, South Korea.
EM mhr108@pusan.ac.kr; hyjung@pusan.ac.kr
RI Lee, Ho-jeong/S-4934-2019
FU National Research Foundation of Korea (NRF) grant - Korea Government
   (MSIP) [2009-0083538]
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant funded by the Korea Government (MSIP) (No. 2009-0083538). We also
   take this opportunity to thank the Aging Tissue Bank (Busan, Korea) for
   supplying research materials.
CR Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048
   Fernández-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973
   Hebbachi AM, 2008, J BIOL CHEM, V283, P4866, DOI 10.1074/jbc.M709471200
   Intano GW, 2003, J GERONTOL A-BIOL, V58, P205
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067
   Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200
   Louet JF, 2001, BIOCHEM J, V354, P189, DOI 10.1042/0264-6021:3540189
   Méndez-Sánchez N, 2007, LIVER INT, V27, P423, DOI 10.1111/j.1478-3231.2007.01483.x
   MENTHA G, 1992, BRIT J SURG, V79, P557, DOI 10.1002/bjs.1800790627
   Park MH, 2016, J GERONTOL A-BIOL, V71, P300, DOI 10.1093/gerona/glv043
   Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003
   Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181
   Zámbó V, 2013, WORLD J HEPATOL, V5, P550, DOI 10.4254/wjh.v5.i10.550
NR 21
TC 16
Z9 17
U1 0
U2 5
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JUL 11
PY 2017
VL 8
IS 28
BP 46273
EP 46285
DI 10.18632/oncotarget.17695
PG 13
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA FA5SS
UT WOS:000405504600108
PM 28545035
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Patriarca, S
   Furfaro, AL
   Cosso, L
   Maineri, EP
   Balbis, E
   Domenicotti, C
   Nitti, M
   Cottalasso, D
   Marinari, UM
   Pronzato, MA
   Traverso, N
AF Patriarca, Stefania
   Furfaro, Anna Lisa
   Cosso, Luana
   Maineri, Elena Pesce
   Balbis, Emanuela
   Domenicotti, Cinzia
   Nitti, Mariapaola
   Cottalasso, Damiano
   Marinari, Umberto Maria
   Pronzato, Maria Adelaide
   Traverso, Nicola
TI Heme oxygenase 1 expression in rat liver during ageing and ethanol
   intoxication
SO BIOGERONTOLOGY
LA English
DT Article
DE heme oxygenase 1; development; ageing; ethanol; liver; lipid
   peroxidation
ID LIFE-SPAN; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; GENE-EXPRESSION;
   PROTEIN OXIDATION; REDOX REGULATION; HEAT-SHOCK-PROTEIN-70;
   OVEREXPRESSION; MECHANISMS; INDUCTION
AB Heme oxygenase 1 (HO-1) expression is recognized as a marker of cellular response to oxidative stress; since ageing is believed to be related to oxidative "wear and tear", HO-1 may represent a candidate biomarker of ageing. In our study, the hepatic expression of HO-1 mRNA, evaluated by RT-PCR in 2.5-24 month-old rats, was higher at 6 months than at 2.5 months of age, but thereafter increased no further: on the contrary, a declining trend was observed. However, while 2.5 month-old rats responded to acute ethanol intoxication by displaying increased expression of liver HO-1 mRNA, and 6 month-old rats exhibited a mild response, 18 month-old rats did not show any response; this phenomenon suggests that during development and ageing the transcriptional response to oxidative stress decreases. In our view, the finding that HO-1 expression did not increase progressively during ageing may be explained by a decreased transcriptional ability to respond to stress in older animals, rather than by a reduction in oxidative stress.
C1 Univ Genoa, Sect Gen Pathol, Dept Expt Med, I-16132 Genoa, Italy.
C3 University of Genoa
RP Traverso, N (corresponding author), Univ Genoa, Sect Gen Pathol, Dept Expt Med, Via LB Alberti 2, I-16132 Genoa, Italy.
EM stefaniapatriarca@virgilio.it; annalisa.furfaro@virgilio.it;
   lcosso@hotmail.com; elenapm@hotmail.com; ebalbis76@hotmail.com;
   cdomeni@medicina.unige.it; paonit@medicina.unige.it;
   dcottalasso@medicina.unige.it; umm@medicina.unige.it;
   maidep@medicina.unige.it; ntravers@medicina.unige.it
RI Nitti, Mariapaola/ABB-1067-2020; Domenicotti, Cinzia/C-7786-2011
CR Albano E, 2002, FREE RADICAL BIO MED, V32, P110, DOI 10.1016/S0891-5849(01)00773-0
   Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891
   BLAKE MJ, 1991, AM J PHYSIOL, V260, pR663, DOI 10.1152/ajpregu.1991.260.4.R663
   Calabrese V, 2004, MECH AGEING DEV, V125, P325, DOI 10.1016/j.mad.2004.01.003
   Calabrese V, 2004, ANTIOXID REDOX SIGN, V6, P895, DOI 10.1089/ars.2004.6.895
   Chen J, 2006, J GERONTOL A-BIOL, V61, P20, DOI 10.1093/gerona/61.1.20
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   CHOI SY, 1996, J PARODONTOL IMPLANT, V15, P19
   ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HEYDARI AR, 1994, EXPERIENTIA, V50, P1092, DOI 10.1007/BF01923466
   Hoetzel A, 2006, ANESTHESIOLOGY, V104, P101, DOI 10.1097/00000542-200601000-00016
   Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5
   Jin XF, 2004, CELL STRESS CHAPERON, V9, P69, DOI 10.1379/477.1
   KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99
   Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   Locke M, 1996, CELL STRESS CHAPERON, V1, P251, DOI 10.1379/1466-1268(1996)001<0251:DHSRIT>2.3.CO;2
   MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025
   MOORADIAN AD, 1990, J GERONTOL, V45, pB183, DOI 10.1093/geronj/45.6.B183
   Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862
   Nakanishi Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1302, DOI 10.1271/bbb.61.1302
   Njemini R, 2004, BIOGERONTOLOGY, V5, P31, DOI 10.1023/B:BGEN.0000017684.15626.29
   OKUNO F, 1991, ALCOHOL, V8, P449, DOI 10.1016/S0741-8329(91)90102-3
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Poon HF, 2004, J GERONTOL A-BIOL, V59, P478
   Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3
   Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865
   SOHAL RS, 1992, ANN NY ACAD SCI, V663, P74, DOI 10.1111/j.1749-6632.1992.tb38651.x
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Soti C, 2000, BIOGERONTOLOGY, V1, P225, DOI 10.1023/A:1010082129022
   Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22
   Terry DF, 2004, ANN NY ACAD SCI, V1019, P502, DOI 10.1196/annals.1297.092
   van der Loo B, 2005, BIOGERONTOLOGY, V6, P325, DOI 10.1007/s10522-005-4807-1
   Vasilaki A, 2003, BIOCHEM SOC T, V31, P455, DOI 10.1042/BST0310455
   Wei YH, 2001, CHINESE J PHYSIOL, V44, P1
NR 39
TC 26
Z9 26
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD JUN
PY 2007
VL 8
IS 3
BP 365
EP 372
DI 10.1007/s10522-006-9079-x
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 163QP
UT WOS:000246177800012
PM 17221286
DA 2024-02-19
ER

PT J
AU Honma, T
   Yanaka, M
   Tsuduki, T
   Ikeda, I
AF Honma, Taro
   Yanaka, Miyuki
   Tsuduki, Tsuyoshi
   Ikeda, Ikuo
TI Increased Lipid Accumulation in Liver and White Adipose Tissue in Aging
   in the SAMP10 Mouse
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE aging; DNA microarray; Hsd11b1; hyperinsulinemia; SAMP10
ID CONJUGATED TRIENE SYSTEM; ALPHA-ELEOSTEARIC-ACID; INSULIN-RESISTANCE;
   MURINE MODEL; SENESCENCE; PEROXIDATION; SUPPRESSION; PATHWAY; OBESITY;
   ISOMER
AB The population of elderly persons has increased worldwide. However, few studies have examined age-dependent changes in lipid and carbohydrate metabolism related to age-related diseases. The number of cases of metabolic syndrome is increasing worldwide and prevention of lifestyle diseases may lead to prolongation of lifespan. In this study, we examined age-dependent changes in lipid and carbohydrate metabolism in the senescence-accelerated (SAM) P10 mouse. Tissue weights and biochemical parameters in plasma and liver were examined in SAMP10 mice aged 3, 6, 9 and 12 mo. White adipose tissue weight and the levels of liver triacylglycerol, plasma free fatty acids, and plasma insulin all showed increases with aging of the mice. To examine this mechanism in detail, aging-related changes in mRNA expression of genes related to lipid and carbohydrate metabolism were examined by DNA microarray analysis. The mRNA level for Hsd11b1 (hydroxysteroid 11-beta dehydrogenase 1), which increases insulin secretion and resistance, was elevated with aging in the liver of SAMP10 mice. These results show that lipid accumulation in liver and white adipose tissue is promoted by aging in SAMP10 mice through an increase in plasma insulin levels.
C1 [Honma, Taro; Yanaka, Miyuki; Tsuduki, Tsuyoshi; Ikeda, Ikuo] Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi 9818555, Japan.
C3 Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi 9818555, Japan.
EM tsuzukit@biochem.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/E-4717-2012; Tsuduki, Tsuyoshi/T-2697-2019; Tsuduki,
   Tsuyoshi/C-2254-2016
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528; 
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [20780099]; Grants-in-Aid for Scientific Research [20780099] Funding
   Source: KAKEN
FX This study was supported by a Grant-in-Aid for Young Scientists (B)
   (20780099) from the Ministry of Education, Culture, Sports, Science and
   Technology, Japan.
CR Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18
   Bjorntorp Per, 1997, Human Reproduction (Oxford), V12, P21
   Chen N, 2008, BRIT J PHARMACOL, V153, P1364, DOI 10.1038/bjp.2008.15
   Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Ekuni D, 2010, LAB INVEST, V90, P348, DOI 10.1038/labinvest.2009.141
   Enns LC, 2009, J GERONTOL A-BIOL, V64, P1221, DOI 10.1093/gerona/glp133
   Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x
   Hosokawa M, 2002, MECH AGEING DEV, V123, P1553, DOI 10.1016/S0047-6374(02)00091-X
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MATSUZAWA Y, 1994, DIABETES RES CLIN PR, V24, pS111, DOI 10.1016/0168-8227(94)90236-4
   Mendoza-Nunez Victor Manuel, 2009, BMC Geriatr, V9, P40, DOI 10.1186/1471-2318-9-40
   Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x
   Nogués MR, 2006, J PINEAL RES, V41, P142, DOI 10.1111/j.1600-079X.2006.00344.x
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Oswal A, 2007, OBES REV, V8, P293, DOI 10.1111/j.1467-789X.2007.00378.x
   Park SY, 2006, LIFE SCI, V79, P2228, DOI 10.1016/j.lfs.2006.07.014
   Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101
   Petursdottir AL, 2007, NEUROBIOL AGING, V28, P1170, DOI 10.1016/j.neurobiolaging.2006.05.033
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   Sango K, 2006, J NEUROCHEM, V98, P446, DOI 10.1111/j.1471-4159.2006.03885.x
   Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x
   Shannon J, 2007, PUBLIC HEALTH NUTR, V10, P810, DOI 10.1017/S1368980007258604
   SHIMOMURA I, 1992, BIOCHIM BIOPHYS ACTA, V1124, P112, DOI 10.1016/0005-2760(92)90086-B
   Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583
   Sugawara M, 2009, DRUG METAB DISPOS, V37, P2244, DOI 10.1124/dmd.109.028571
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAMURA T, 2005, BIOCHIM BIOPHYS ACTA, V18, P73
   Tsuzuki T, 2005, LIPIDS, V40, P1117, DOI 10.1007/s11745-005-1475-0
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298
   Tsuzuki T, 2007, BBA-MOL CELL BIOL L, V1771, P20, DOI 10.1016/j.bbalip.2006.11.006
   Tsuzuki T, 2006, J NUTR BIOCHEM, V17, P518, DOI 10.1016/j.jnutbio.2005.09.006
   Ueda T, 2007, GENES CELLS, V12, P581, DOI 10.1111/j.1365-2443.2007.01080.x
   YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
NR 38
TC 29
Z9 31
U1 0
U2 4
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
EI 1881-7742
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD APR
PY 2011
VL 57
IS 2
BP 123
EP 129
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 757ZR
UT WOS:000290129100001
PM 21697630
OA gold
DA 2024-02-19
ER

PT J
AU Wang, MJ
   Chen, JJ
   Song, SH
   Su, J
   Zhao, LH
   Liu, QG
   Yang, T
   Chen, ZW
   Liu, C
   Fu, ZR
   Hu, YP
   Chen, F
AF Wang, Min-Jun
   Chen, Jia-Jia
   Song, Shao-Hua
   Su, Jing
   Zhao, Ling-Hao
   Liu, Qing-Gui
   Yang, Tao
   Chen, Zhiwen
   Liu, Chang
   Fu, Zhi-Ren
   Hu, Yi-Ping
   Chen, Fei
TI Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing
   Senescence of Liver Cancer Stem Cells
SO JOURNAL OF HEPATOCELLULAR CARCINOMA
LA English
DT Article
DE SIRT1; hepatocellular carcinoma; liver cancer stem cells; cellular
   senescence; stemness; self-renewal
ID TUMOR-INITIATING CELLS; CELLULAR SENESCENCE; PROMOTES; DISEASE;
   CHEMORESISTANCE; MAINTENANCE; ACTIVATION; RESISTANCE; TARGET; AXIS
AB Purpose: Cancer stem cells (CSCs) have been considered involving in tumorigenesis, local recurrence, and therapeutic drug resistance of hepatocellular carcinoma (HCC). To investi-gate novel and effective methods for targeting hepatic CSCs is crucial for a permanent cure of liver cancer.
   Methods: The expression level of SIRT1 was detected in CSCs of HCC tissues and cancer cell lines. Expression of CSC markers, the self-renewal and tumorigenic ability of liver CSCs were analyzed with SIRT1 inhibition. Cellular senescence-related markers were used to detect CSCs senescence after inhibition of SIRT1.
   Results: SIRT1 was highly expressed in CSCs of HCC cell lines and human HCC tissues. In vitro study revealed that decreasing of SIRT1 level significantly downregulated the stemness-associated genes of liver CSCs and reduced the CSC stemness properties. Also, down-regulated SIRT1 suppressed liver CSCs proliferation by decreasing their self-renewal abil-ities. Furthermore, CSCs with decreased SIRT1 expression showed limited tumorigenicity and formed smaller HCC tumor in vivo. And SIRT1 decreased CSCs became more suscep-tible to chemotherapeutic drugs. Mechanistically, SIRT1 decreased CSCs became senescence through the activation of p53-p21 and p16 pathway. The data further indicated that the tumor formed from SIRT1-knockdown CSCs exhibited higher senescence-associated beta-galactosidase (SA-beta-Gal) activity but lower proliferative capacity.
   Conclusion: Taken together, these findings pointed that induction of senescence in liver CSCs is an effective tumor suppression method for HCC, and SIRT1 may be served as a promising target for HCC treatment.
C1 [Wang, Min-Jun; Chen, Jia-Jia; Su, Jing; Liu, Qing-Gui; Yang, Tao; Hu, Yi-Ping; Chen, Fei] Second Mil Med Univ, Dept Cell Biol, Ctr Stem Cell & Med, Navy Med Univ, Shanghai, Peoples R China.
   [Song, Shao-Hua; Fu, Zhi-Ren] Shanghai Jiao Tong Univ, Dept Gen Surg, Liver Transplantat Ctr, Ruijin Hosp,Sch Med, Shanghai, Peoples R China.
   [Zhao, Ling-Hao] Second Mil Med Univ, Natl Ctr Liver Canc, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.
   [Chen, Zhiwen; Liu, Chang] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai, Peoples R China.
C3 Naval Medical University; Shanghai Jiao Tong University; Naval Medical
   University; Fudan University
RP Hu, YP; Chen, F (corresponding author), Second Mil Med Univ, Dept Cell Biol, Ctr Stem Cell & Med, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.
EM yphu9@yeah.net; feelchen@smmu.edu.cn
RI Li, Wei/JLL-4365-2023; Fu, zr/JHT-6152-2023
FU National Key R&D Program of China [2018YFA0107500]; National Natural
   Science Foundation of China [31601101, 31701186, 32070732, 31970753];
   Medical Science Youth Development Plan of PLA [17QNP011]; Open Research
   Fund of State Key Laboratory of Genetic Engineering, Fudan University
   [SKLGE1901]
FX This work was supported by the National Key R&D Program of China
   (2018YFA0107500) , National Natural Science Foundation of China
   (31601101, 31701186, 32070732, 31970753) , Medical Science Youth
   Development Plan of PLA (17QNP011) , Open Research Fund of State Key
   Laboratory of Genetic Engineering, Fudan University (No. SKLGE1901) .
CR Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3
   Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen CL, 2016, CELL METAB, V23, P206, DOI 10.1016/j.cmet.2015.12.004
   Chen HY, 2017, CANCER SCI, V108, P1310, DOI 10.1111/cas.13275
   Chen J, 2015, CANCER LETT, V367, P1, DOI 10.1016/j.canlet.2015.06.019
   Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274
   Chen XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07481
   Chen XJ, 2019, CANCER LETT, V463, P1, DOI 10.1016/j.canlet.2019.07.021
   Chiba T, 2016, HEPATOL RES, V46, P50, DOI 10.1111/hepr.12548
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Clara JA, 2020, NAT REV CLIN ONCOL, V17, P204, DOI 10.1038/s41571-019-0293-2
   Di Mitri D, 2016, TRENDS CELL BIOL, V26, P215, DOI 10.1016/j.tcb.2015.10.005
   Gravitz L, 2014, NATURE, V516, pS1, DOI 10.1038/516S1a
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hu B, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.233
   Iwagami Y, 2016, HEPATOLOGY, V63, P1213, DOI 10.1002/hep.28411
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005
   Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001
   Li YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070
   Liu LM, 2016, HEPATOLOGY, V64, P814, DOI 10.1002/hep.28690
   Liu XB, 2014, J HEART LUNG TRANSPL, V33, P1083, DOI 10.1016/j.healun.2014.05.008
   Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010
   Ma W, 2015, ONCOTARGET, V6, P10432, DOI 10.18632/oncotarget.3394
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Mvunta DH, 2017, TRANSL ONCOL, V10, P621, DOI 10.1016/j.tranon.2017.05.005
   Nio K, 2015, J HEPATOL, V63, P1164, DOI 10.1016/j.jhep.2015.06.009
   Ong ALC, 2018, AGEING RES REV, V43, P64, DOI 10.1016/j.arr.2018.02.004
   Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396
   Rajendran V, 2018, METHODS MOL BIOL, V1692, P89, DOI 10.1007/978-1-4939-7401-6_8
   Rimmelé P, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.015
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shah C, 2017, J GASTROINTEST ONCOL, V8, P789, DOI 10.21037/jgo.2017.06.16
   Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745
   Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608
   Tordella L, 2016, GENE DEV, V30, P2187, DOI 10.1101/gad.286112.116
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Uyar B, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101156
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wörns MA, 2014, NAT REV GASTRO HEPAT, V11, P447, DOI 10.1038/nrgastro.2014.10
   Xu CY, 2020, NAT CELL BIOL, V22, P1170, DOI 10.1038/s41556-020-00579-5
   Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004
   Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013
   Zhang S, 2017, ONCOTARGET, V8, P18848, DOI 10.18632/oncotarget.14473
   Zhou G, 2021, CANCER LETT, V501, P124, DOI 10.1016/j.canlet.2020.12.022
   Zhou G, 2017, THERANOSTICS, V7, P3948, DOI 10.7150/thno.20725
NR 52
TC 9
Z9 9
U1 1
U2 9
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
EI 2253-5969
J9 J HEPATOCELL CARCINO
JI J. HEPATOCELL. CARCINOMA
PY 2021
VL 8
BP 685
EP 699
DI 10.2147/JHC.S296234
PG 15
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA TD9IC
UT WOS:000669630100001
PM 34235106
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tang, CM
   Zhang, Z
   Sun, Y
   Ding, WJ
   Yang, XC
   Song, YP
   Ling, MY
   Li, XH
   Yan, R
   Zheng, YJ
   Yu, N
   Zhang, WH
   Wang, Y
   Wang, SP
   Gao, HQ
   Zhao, CL
   Xing, YQ
AF Tang, Cong-Min
   Zhang, Zhen
   Sun, Yan
   Ding, Wen-Jing
   Yang, Xue-Chun
   Song, Yi-Ping
   Ling, Ming-Ying
   Li, Xue-Hui
   Yan, Rong
   Zheng, Yu-Jing
   Yu, Na
   Zhang, Wen-Hua
   Wang, Yong
   Wang, Shao-Peng
   Gao, Hai-Qing
   Zhao, Chuan-Li
   Xing, Yan-Qiu
TI Multi-omics reveals aging-related pathway in natural aging mouse liver
SO HELIYON
LA English
DT Article; Early Access
DE aging; Mouse; liver; metabolomics; Phosphoproteomics
ID MECHANISMS; CANCER
AB Aging is associated with gradual changes in liver structure, altered metabolites and other physiological/pathological functions in hepatic cells. However, its characterized phenotypes based on altered metabolites and the underlying biological mechanism are unclear. Advancements in high throughput omics technology provide new opportunities to understand the pathological process of aging. Here, in our present study, both metabolomics and phosphoproteomics were applied to identify the altered metabolites and phosphorylated proteins in liver of young (the WTY group) and naturally aged (the WTA group) mice, to find novel biomarkers and pathways, and uncover the biological mechanism. Analysis showed that the body weights, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increased in the WTA group. The grips decreased with age, while the triglyceride (TG) and cholesterol (TC) did not change significantly. The increase of fibrosis, accumulation of inflammatory cells, hepatocytes degeneration, the deposition of lipid droplets and glycogen, the damaged mitochondria, and deduction of endoplasmic reticulum were observed in the aging liver under optical and electron microscopes. In addition, a network of metabolites and phosphorylated proteomes of the aging liver was established. Metabolomics detected 970 metabolites in the positive ion mode and 778 metabolites in the negative ion mode. A total of 150 pathways were pooled. Phosphoproteomics identified 2618 proteins which contained 16621 phosphosites. A total of 164 pathways were detected. 65 common pathways were detected in two omics. Phosphorylated protein heat shock protein HSP 90 alpha (HSP90A) and v-raf murine viral oncogene homolog B1(BRAF), related to cancer pathway, were significantly upregulated in aged mice liver. Western blot verified that protein expression of MEK and ERK, downstream of BRAF pathway were elevated in the liver of aging mice. However, the protein expression of BRAF was not a significant difference. Overall, these findings revealed a close link between aging and cancer and contributed to our understanding of the multi-omics changes in natural aging.
C1 [Tang, Cong-Min; Zhang, Zhen; Sun, Yan; Ding, Wen-Jing; Yang, Xue-Chun; Song, Yi-Ping; Ling, Ming-Ying; Li, Xue-Hui; Yan, Rong; Gao, Hai-Qing; Xing, Yan-Qiu] Shandong Univ, Dept Geriatr Med, Qilu Hosp, Jinan 250012, Shandong Provin, Peoples R China.
   [Zhang, Zhen; Song, Yi-Ping; Ling, Ming-Ying; Li, Xue-Hui; Gao, Hai-Qing; Xing, Yan-Qiu] Shandong Univ, Key Lab Cardiovasc Prote Shandong Prov, Qilu Hosp, Jinan 250012, Shandong Provin, Peoples R China.
   [Tang, Cong-Min; Ding, Wen-Jing; Yang, Xue-Chun; Ling, Ming-Ying] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250012, Shandong Provin, Peoples R China.
   [Zheng, Yu-Jing; Yu, Na; Zhang, Wen-Hua; Wang, Yong; Wang, Shao-Peng] Shandong Precis Med Engn Lab Bacterial Antitumor D, Jinan 250101, Shandong, Peoples R China.
   [Zhao, Chuan-Li] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Shandong Provin, Peoples R China.
   [Tang, Cong-Min] Shandong Prov Third Hosp, Dept Ultrasound, Jinan 250031, Shandong Provin, Peoples R China.
   [Xing, Yan-Qiu] Shandong Univ, Dept Geriatr Med, Qilu Hosp, Cheeloo Coll Med, West Culture Rd 107, Jinan 250012, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong
   University; Shandong University
RP Xing, YQ (corresponding author), Shandong Univ, Dept Geriatr Med, Qilu Hosp, Jinan 250012, Shandong Provin, Peoples R China.; Zhao, CL (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Shandong Provin, Peoples R China.
EM chuanlizhao@email.sdu.edu.cn; xingyanqiu@sina.com
FU Key Technology Research and Development Program of Shandong
   [2022CXGC010510]; National Natural Science Foundation of China
   [81700725]; Natural Science Foundation of Shandong Province
   [ZR20222M193]
FX This research was funded by the Key Technology Research and Development
   Program of Shandong [grant number 2017GSF218101] ; the National Natural
   Science Foundation of China [grant number 81700725] ; the Natural
   Science Foundation of Shandong Province [grant number ZR2017BH003] ; the
   Natural Science Foundation of Shandong Province [grant number
   ZR2021MH008] ; the Key Technology Research and Development Program of
   Shandong [grant number 2022CXGC010510] and the Natural Science
   Foundation of Shandong Province [grant number ZR20222M193] .
CR Adav SS, 2021, AGING DIS, V12, P646, DOI 10.14336/AD.2020.0909
   Adav SS, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0430-y
   Amin B, 2020, MECH AGEING DEV, V187, DOI 10.1016/j.mad.2020.111227
   Ando A, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0324-9
   Azman KF, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111372
   Bao HN, 2023, SCI CHINA LIFE SCI, DOI 10.1007/s11427-023-2305-0
   Bareja A, 2021, MECH AGEING DEV, V195, DOI 10.1016/j.mad.2021.111443
   Bellantuono I, 2020, NAT PROTOC, V15, P540, DOI 10.1038/s41596-019-0256-1
   Blagosklonny MV, 2009, CELL CYCLE, V8, P1883, DOI 10.4161/cc.8.12.8815
   Blasl AT, 2022, BIOL CHEM, V403, P151, DOI 10.1515/hsz-2021-0139
   Bohannon RW, 2019, CLIN INTERV AGING, V14, P1681, DOI 10.2147/CIA.S194543
   Braithwaite SP, 2012, NEUROCHEM INT, V61, P899, DOI 10.1016/j.neuint.2012.01.031
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Campbell MD, 2022, GEROSCIENCE, V44, P2913, DOI 10.1007/s11357-022-00679-0
   Chatsirisupachai K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22560-y
   Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871
   Dabravolski SA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020649
   Ding W.J., 2023, Mol. Cell. Proteomics, V22
   Fan XJ, 2021, EXP EYE RES, V210, DOI 10.1016/j.exer.2021.108705
   Gat-Yablonski G, 2016, AGING-US, V8, P1735, DOI 10.18632/aging.101009
   Hoffman JM, 2014, AGING CELL, V13, P596, DOI 10.1111/acel.12215
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Isaev NK, 2019, REV NEUROSCIENCE, V30, P573, DOI 10.1515/revneuro-2018-0084
   Ishizuka K, 2020, J GASTROEN HEPATOL, V35, P1437, DOI 10.1111/jgh.15006
   Jové M, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00052
   Kim D, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23021006
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim JW, 2019, EXP GERONTOL, V126, DOI 10.1016/j.exger.2019.110691
   Kim Y, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700240
   Kudryashova KS, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201900408
   L'Hôte V, 2021, AGING CELL, V20, DOI 10.1111/acel.13447
   Le Couteur DG, 2021, CELL METAB, V33, P2367, DOI 10.1016/j.cmet.2021.10.016
   Li JR, 2022, INT IMMUNOPHARMACOL, V110, DOI 10.1016/j.intimp.2022.108942
   Ling MY, 2023, EXP CELL RES, V427, DOI 10.1016/j.yexcr.2023.113566
   Liu GH, 2021, NUCLEIC ACIDS RES, V49, pD825, DOI 10.1093/nar/gkaa894
   Luo DS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00926
   Lysek-Gladysinska M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030502
   Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094
   Moaddel R, 2021, AGING CELL, V20, DOI 10.1111/acel.13325
   Mohammed S, 2021, AGING CELL, V20, DOI 10.1111/acel.13512
   Ni Lochlainn M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070929
   Fakhruddin NNINM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102900
   Parkhitko AA, 2016, GENE DEV, V30, P1409, DOI 10.1101/gad.282277.116
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   Ping LY, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00650-8
   Preuss HG, 2019, J AM COLL NUTR, V38, P661, DOI 10.1080/07315724.2019.1580169
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409
   Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Serrano M, 2016, CARCINOGENESIS, V37, P107, DOI 10.1093/carcin/bgv100
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shoji Hirotaka, 2019, Neuropsychopharmacology Reports, V39, P100, DOI 10.1002/npr2.12052
   Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023
   Slaoui M, 2017, METHODS MOL BIOL, V1641, P101, DOI 10.1007/978-1-4939-7172-5_4
   Son N, 2012, J PROTEOME RES, V11, P2551, DOI 10.1021/pr201263q
   Song J, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110843
   Srivastava S, 2019, METABOLITES, V9, DOI 10.3390/metabo9120301
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Tabibzadeh S, 2021, FRONT BIOSCI-LANDMRK, V26, P50, DOI 10.2741/4889
   Takemon Y, 2021, ELIFE, V10, DOI 10.7554/eLife.62585
   Takeshita H, 2017, SCI REP-UK, V7, DOI 10.1038/srep42323
   Tizro P, 2019, METHODS MOL BIOL, V1897, P417, DOI 10.1007/978-1-4939-8935-5_33
   UniProt Consortium, 2021, Nucleic Acids Res, V49, pD480, DOI 10.1093/nar/gkaa1100
   Vanhooren V, 2015, MECH AGEING DEV, V151, P71, DOI 10.1016/j.mad.2015.03.009
   Wiley CD, 2021, NAT METAB, V3, P1290, DOI 10.1038/s42255-021-00483-8
   Williams EG, 2022, CELL SYST, V13, DOI 10.1016/j.cels.2021.09.005
   Wu L, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12010039
   Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x
   Zaman A, 2019, CANCERS, V11, DOI 10.3390/cancers11081197
   Zhang FR, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020235
   Zhao FF, 2018, METAB BRAIN DIS, V33, P1401, DOI 10.1007/s11011-018-0229-z
NR 73
TC 0
Z9 0
U1 2
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2405-8440
J9 HELIYON
JI Heliyon
PD 2023 NOV
PY 2023
VL 9
IS 11
AR e21011
DI 10.1016/j.heliyon.2023.e21011
EA OCT 2023
PG 19
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA Z2OK0
UT WOS:001110519600001
PM 37920504
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kawahara, T
   Kita, T
   Ueno, Y
   Yamasaki, S
   Kimura, G
   Nakanishi, M
   Hosokawa, T
   Kurasaki, M
   Sikder, T
   Saito, T
AF Kawahara, Tae
   Kita, Tomomi
   Ueno, Yukako
   Yamasaki, Shojiro
   Kimura, Goh
   Nakanishi, Miki
   Hosokawa, Toshiyuki
   Kurasaki, Masaaki
   Sikder, Tajuddin
   Saito, Takeshi
TI Elucidation of the mechanism of changes in the antioxidant function with
   the aging in the liver of the senescence-accelerated mouse P10 (SAMP10)
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Senescence-accelerated mice prone 10; Catalase; Glutathione peroxidase;
   Manganese superoxide dismutase; Forkhead box class O-1a
ID OXIDATIVE STRESS; CEREBRAL-CORTEX; FREE-RADICALS; DEFICIENCY; OXIDASE;
   GENE; MITOCHONDRIA; GENERATION; MUTATIONS; BRAIN
AB Senescence-accelerated mice are known to display a variety of deficits and signs of accelerated aging, but the specific mechanisms involved in this process are still unclear. In this study, we examined the expression levels of antioxidant enzymes, transcription factors responsible for the regulation of expression of these enzymes, and mitochondrial proteins in the liver of SAMP10 and SAMR1 mice at 3 and 12 months of age using western blotting analysis. To investigate the amount of oxidative damage to DNA, levels of 8-OHdG were measured in the liver of these mice. At 3 months of age, the levels of catalase, Mn-SOD, GPx, UQCRC2 and COXIV were significantly upregulated in SAMP10 mice compared with that in SAMR1 mice. However, NDUFS3 levels were not significantly different at this young age. In contrast, the expression level of catalase was significantly lower, and the levels of phosphorylated FoxO-1a and UQCRC2 were significantly higher in SAMP10 mice compared to those in SAMR1 mice; however, at 12 months of age, there were no significant differences in Mn-SOD, GPx, total -FoxO-1a, COXIV, and NDUFS3 expression between the two groups of mice. The levels of 8-OHdG in the liver were markedly higher in 12-month-old SAMP10 mice than those in 3-month-old SAMP10 and SAMR1 mice. These results suggest that an increase in number of mitochondria or a collapse in the balance between the levels of complexes I and III results in an increase in the amount of ROS and induces the expression of antioxidant enzymes in the liver of SAMP10 mice at 3 months of age. Although young SAMP10 mice produce a large amount of ROS, they also produce suitable levels of antioxidant enzymes that decompose ROS; consequently accelerated aging does not occur in young SAMP10 mice. In addition to excessive ROS production which is an important cause of aging, the level of catalase was significantly lower in SAMP10 than that in SAMR1 mice. These results suggested that overexpression of ROS and a decrease in the levels of catalase resulted in the accelerated aging observed in older SAMP10 mice. Moreover, the level of phosphorylated FoxO-1a was increased in SAMP10 compared to that in SAMR1 mice though the total amount of FoxO-1a was not significantly different between the two groups in old age. These results suggest that some impairment in the regulation mechanism of FoxO-1a phosphorylation is responsible for abnormal catalase expression and that a significant decrease in the level of catalase with aging decisively affects the metabolic balance of ROS; thus, ROS that cannot be metabolized contributes to the accelerated aging of SAMP10 mice.
C1 [Kawahara, Tae] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka, Japan.
   [Kawahara, Tae; Kita, Tomomi; Ueno, Yukako; Yamasaki, Shojiro; Kimura, Goh] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan.
   [Nakanishi, Miki] Shinoro Elementary Sch, Sapporo, Hokkaido, Japan.
   [Hosokawa, Toshiyuki] Hokkaido Univ, Inst Adv Higher Educ, Sapporo, Hokkaido, Japan.
   [Kurasaki, Masaaki] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan.
   [Sikder, Tajuddin] Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh.
   [Sikder, Tajuddin; Saito, Takeshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan.
C3 Osaka University; Hokkaido University; Hokkaido University; Hokkaido
   University; Jahangirnagar University; Hokkaido University
RP Saito, T (corresponding author), Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan.
EM taksaito@med.hokudai.ac.jp
RI , 細川敏幸/A-3851-2012; Sikder, Tajuddin/AAK-4868-2020; SAITO,
   TAKESHI/E-5950-2012; k, t/IQS-6456-2023; Kurasaki, Masaaki/B-8207-2012
OI , 細川敏幸/0000-0002-4818-8968; Sikder, Tajuddin/0000-0002-5717-2263;
   Kurasaki, Masaaki/0000-0003-2125-095X
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [16K15366, 16F16116]; Grants-in-Aid for Scientific Research [16F16116,
   16K15366] Funding Source: KAKEN
FX This work was supported in part by a Grant-in-Aid for Scientific
   Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan: Project Number 16K15366 and 16F16116.
CR Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bartholome A, 2010, ARCH BIOCHEM BIOPHYS, V501, P58, DOI 10.1016/j.abb.2010.05.024
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bjorklund G, 2017, NUTRITION, V33, P311, DOI 10.1016/j.nut.2016.07.018
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brunyanszki A, 2016, FREE RADICAL BIO MED, V100, P257, DOI 10.1016/j.freeradbiomed.2016.02.024
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Fernández-Vizarra E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00134
   Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021
   Kishido T, 2007, BIOGERONTOLOGY, V8, P423, DOI 10.1007/s10522-007-9085-7
   Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019
   Kurokawa T, 2001, NEUROSCI LETT, V298, P135, DOI 10.1016/S0304-3940(00)01755-9
   Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295
   LOMAX MI, 1992, P NATL ACAD SCI USA, V89, P5266, DOI 10.1073/pnas.89.12.5266
   Mata-Greenwood E, 2006, AM J PHYSIOL-LUNG C, V290, pL232, DOI 10.1152/ajplung.00393.2004
   Miyajima M, 2013, ARCH GERONTOL GERIAT, V56, P68, DOI 10.1016/j.archger.2012.05.013
   Münzel T, 1999, ANN NY ACAD SCI, V874, P386, DOI 10.1111/j.1749-6632.1999.tb09253.x
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934
   Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x
   Sato E, 1996, MECH AGEING DEV, V92, P175, DOI 10.1016/S0047-6374(96)01832-5
   Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Takahashi R, 2010, YAKUGAKU ZASSHI, V130, P11, DOI 10.1248/yakushi.130.11
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Unno K, 2004, EXP GERONTOL, V39, P1027, DOI 10.1016/j.exger.2004.03.033
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   VARANASI U, 1994, P NATL ACAD SCI USA, V91, P3107, DOI 10.1073/pnas.91.8.3107
   Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153
   Yakunin E, 2014, ANN CLIN TRANSL NEUR, V1, P145, DOI 10.1002/acn3.38
NR 33
TC 3
Z9 4
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 2018
VL 106
BP 46
EP 53
DI 10.1016/j.exger.2018.02.025
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GD4JI
UT WOS:000430469000007
PM 29477336
DA 2024-02-19
ER

PT J
AU Odagiri, N
   Matsubara, T
   Higuchi, M
   Takada, S
   Urushima, H
   Sato-Matsubara, M
   Teranishi, Y
   Yoshizato, K
   Kawada, N
   Ikeda, K
AF Odagiri, Naoshi
   Matsubara, Tsutomu
   Higuchi, Moe
   Takada, Sayuri
   Urushima, Hayato
   Sato-Matsubara, Misako
   Teranishi, Yuga
   Yoshizato, Katsutoshi
   Kawada, Norifumi
   Ikeda, Kazuo
TI Involvement of ERK1/2 activation in the gene expression of
   senescence-associated secretory factors in human hepatic stellate cells
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE Hepatic stellate cell; Senescence; Secretory factor; ERK1; 2; Fibroblast
ID CELLULAR SENESCENCE; CANCER; FIBROBLASTS; GROWTH; INTERLEUKIN-8;
   ANGIOGENESIS; PHENOTYPE; INVASION
AB Senescent hepatic stellate cells (senescent HSCs) are found in patients with liver cirrhosis and have been thought to be involved in the development of hepatocellular carcinoma (HCC) in mice via the senescence-associated secretory proteins. However, in humans, which secretory proteins are involved and what regulate their expression remain unclear. In the current study, we characterized senescence-associated -galactosidase-positive senescent human HSCs (hHSCs) induced by repetitive passaging. They exhibited enhanced expression of 14 genes for secretory protein and persistent phosphorylation of ERK1/2 protein but not JNK or p38 MAPK proteins. Enhanced nuclear ERK1/2 phosphorylation was observed in senescent hHSCs. Treatment of the senescent hHSCs with ERK1/2 inhibitor, SCH772984, significantly decreased the levels of angiopoietin like 4 (ANGPTL4), C-C motif chemokine ligand 7 (CCL7), Interleukin-8 (IL-8), platelet factor 4 variant 1 (PF4V1), and TNF superfamily member 15 (TNFSF15) mRNA levels in a dose-dependent manner. The enhanced phosphorylation of ERK1/2 and expression of ANGPTL4, IL-8 and PF4V1 genes were observed in both of senescent human dermal fibroblasts and X-ray-induced senescent hHSCs. However, transient ERK1/2 activation induced by epidermal growth factor could not mimic the gene profile of the senescent hHSCs. These results revealed involvement of ERK1/2 signaling in the regulation of senescence-associated secretory factors, suggesting that simultaneous induction of ANGPTL4, IL-8, and PF4V1 genes is a marker of hHSC senescence. This study will contribute to understanding roles of senescent hHSCs in liver diseases.
C1 [Odagiri, Naoshi; Matsubara, Tsutomu; Higuchi, Moe; Takada, Sayuri; Urushima, Hayato; Ikeda, Kazuo] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 5458585, Japan.
   [Odagiri, Naoshi; Takada, Sayuri; Sato-Matsubara, Misako; Teranishi, Yuga; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan.
   [Sato-Matsubara, Misako; Yoshizato, Katsutoshi] Osaka City Univ, Grad Sch Med, Endowed Lab Synthet Biol, Osaka 5458585, Japan.
   [Yoshizato, Katsutoshi] PhoenixBio Co Ltd, Acad Advisors Off, Higashihiroshima 7390046, Japan.
C3 Osaka Metropolitan University; Osaka Metropolitan University; Osaka
   Metropolitan University; PHOENIXBIO CO. LTD.
RP Matsubara, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 5458585, Japan.
EM matsu335@med.osaka-cu.ac.jp
RI kawada, norifumi/AAS-1367-2020
FU Uehara Memorial Foundation; Osaka Medical Research Foundation for
   Intractable Diseases; Tokyo Biochemical Research Foundation; JSPS
   KAKENHI [JP26870501, JP17K18012]; Japan Agency for Medical Research and
   Development (AMED) [16fk0210104h0001]; Osaka City University
FX This work was supported by The Uehara Memorial Foundation, The Osaka
   Medical Research Foundation for Intractable Diseases, The Tokyo
   Biochemical Research Foundation, The Osaka City University Strategic
   Research Grant 2016 for young researchers, JSPS KAKENHI Grant Number
   JP26870501 and JP17K18012, and a Grant for Research Program on Hepatitis
   from the Japan Agency for Medical Research and Development (AMED) Grant
   Number 16fk0210104h0001.
CR Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppe JP, 2008, MOL CANCER RES, V6, P1085, DOI 10.1158/1541-7786.MCR-08-0062
   Ebert R, 2015, STEM CELL RES, V15, P231, DOI 10.1016/j.scr.2015.06.008
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Johmura Y, 2014, MOL CELL, V55, P73, DOI 10.1016/j.molcel.2014.05.003
   Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee YS, 2012, BRIT J CANCER, V106, P1833, DOI 10.1038/bjc.2012.177
   Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479
   Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Nakayama T, 2011, ONCOL REP, V25, P929, DOI 10.3892/or.2011.1176
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Quemener C, 2016, CANCER RES, V76, P6507, DOI 10.1158/0008-5472.CAN-15-2864
   Saito N, 2017, BBA-GEN SUBJECTS, V1861, P2261, DOI 10.1016/j.bbagen.2017.06.019
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhu B, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0730-7
NR 31
TC 7
Z9 7
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD MAY
PY 2019
VL 455
IS 1-2
BP 7
EP 19
DI 10.1007/s11010-018-3466-x
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA HR6CM
UT WOS:000463236000002
PM 30426301
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Enkhbold, C
   Morine, Y
   Utsunomiya, T
   Imura, S
   Ikemoto, T
   Arakawa, Y
   Saito, Y
   Yamada, S
   Ishikawa, D
   Shimada, M
AF Enkhbold, Chinbold
   Morine, Yuji
   Utsunomiya, Tohru
   Imura, Satoru
   Ikemoto, Tetsuya
   Arakawa, Yusuke
   Saito, Yu
   Yamada, Shinichiro
   Ishikawa, Daichi
   Shimada, Mitsuo
TI Dysfunction of liver regeneration in aged liver after partial
   hepatectomy
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE aging; autophagy; ER stress; liver regeneration; partial hepatectomy
ID ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; AUTOPHAGY; APOPTOSIS;
   PROLIFERATION; SENESCENCE; GROWTH; EXPRESSION; CANCER
AB Background and AimA remarkable feature of the liver is its regenerative capacity following partial hepatectomy. However, the regenerative capacity of many organs and tissues loses its natural ability to divide with aging. In this study, we investigated the association of aging with endoplasmic reticulum stress, the cell cycle, autophagy, and apoptosis-related genes during liver regeneration after hepatectomy.
   MethodsBalb/c 4-week and 40-week-old male mice were subjected to 70% hepatectomy. Animals were sacrificed at 24, 48, and 72h after hepatectomy. Immunohistochemical stainings for proliferating cell nuclear antigen, LC3, Atg5, and caspase-3 were used to quantify protein expression. Real-time reverse transcription-polymerase chain reaction was used to detect p16, CHOP, LC3, Atg5, hepatocyte growth factor, cMet, cyclin D1, cyclin A2, and caspase-3 expression.
   ResultsAfter hepatectomy, old group showed a lower survival rate and significantly lower expression of hepatocyte growth factor, cMet, cyclin D1, cyclin A2, proliferating cell nuclear antigen labeling index, and SMP30 compared with young group. The liver weight/body weight ratio was significantly lower at 48h and 72h after hepatectomy and was accompanied by markedly elevated levels of the liver cell injury markers, LC3 and caspase-3. Immunohistochemical results showed that LC3, Atg5, and caspase-3 protein expression were higher in old group than in young group.
   ConclusionThese results revealed that impaired liver regeneration was due to aging, which was expressed by decreased cell cycle and increased autophagy and apoptosis. Therefore, understanding the molecular basis for aged liver regeneration might provide a new therapeutic option for old patients.
C1 [Enkhbold, Chinbold; Morine, Yuji; Utsunomiya, Tohru; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Saito, Yu; Yamada, Shinichiro; Ishikawa, Daichi; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan.
C3 Tokushima University
RP Morine, Y (corresponding author), Univ Tokushima, Grad Sch, Dept Surg, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.
EM ymorine@tokushima-u.ac.jp
OI Ikemoto, Tetsuya/0000-0001-9800-1359
FU Japan Society for the Promotion of Science [21462091, 23390324];
   Grants-in-Aid for Scientific Research [26108007, 23390324] Funding
   Source: KAKEN
FX This work was supported in part by Grants-in-Aid for Scientific Research
   (C) (21462091) and Scientific Research (B) (23390324) from the Japan
   Society for the Promotion of Science.
CR Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423
   Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012
   Capparelli C, 2012, CELL CYCLE, V11, P3599, DOI 10.4161/cc.21884
   Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Ito M, 2009, ARCH TOXICOL, V83, P151, DOI 10.1007/s00204-008-0341-7
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390
   Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Sánchez-Hidalgo JM, 2012, J SURG RES, V175, pE1, DOI 10.1016/j.jss.2011.11.1022
   Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060
   Nejak-Bowen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059836
   Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06
   Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150
   Passegué E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969
   Patijn GA, 1998, HEPATOLOGY, V28, P707, DOI 10.1002/hep.510280317
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374
   Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523
   Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025
   Suzuki A, 2012, J SURG RES, V173, P267, DOI 10.1016/j.jss.2010.10.012
   Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479
   Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380
   ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K
   Zhang JL, 2013, J SURG RES, V183, P929, DOI 10.1016/j.jss.2013.02.043
NR 35
TC 47
Z9 51
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD JUL
PY 2015
VL 30
IS 7
BP 1217
EP 1224
DI 10.1111/jgh.12930
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CL0BP
UT WOS:000356603800020
PM 25682855
DA 2024-02-19
ER

PT J
AU Perveen, R
   Ozaki, I
   Manirujjaman, M
   Mine, K
   Murata, Y
   Tanaka, K
   Xia, JH
   Takahashi, H
   Anzai, K
   Matsuhashi, S
AF Perveen, Rasheda
   Ozaki, Iwata
   Manirujjaman, M.
   Mine, Keiichiro
   Murata, Yuzo
   Tanaka, Kenichi
   Xia, Jinghe
   Takahashi, Hirokazu
   Anzai, Keizo
   Matsuhashi, Sachiko
TI Induction of premature senescence and a less-fibrogenic phenotype by
   programmed cell death 4 knockdown in the human hepatic stellate cell
   line Lieming Xu-2
SO HUMAN CELL
LA English
DT Article; Early Access
DE PDCD4; p21; Hepatic stellate cell; alpha-SMA; Senescence; Fibrosis
ID PDCD4 EXPRESSION; REPLICATIVE SENESCENCE; EXTRACELLULAR-MATRIX; FIBROTIC
   LIVER; HUMAN SKIN; RAT-LIVER; CANCER; CARCINOMA; PROTEIN; MYOFIBROBLASTS
AB Although programmed cell death 4 (PDCD4) was initially reported as a tumor suppressor and has been shown to inhibit cancer cell growth and metastasis, recent studies have demonstrated that loss of PDCD4 expression also induces growth inhibition by inducing apoptosis and/or cellular senescence. At present, the roles of PDCD4 in the activation and profibrogenic properties of myofibroblasts, which are critically involved in organ fibrosis, such as that in the liver, are unclear. We, therefore, investigated the roles of PDCD4 in myofibroblasts using human hepatic stellate cell line Lieming Xu-2 (LX-2). PDCD4 knockdown inhibited LX-2 proliferation and induced a senescent phenotype with increased beta-galactosidase staining and p21 expression in a p53-independent manner together with downregulation of the notch signaling mediator RBJ-kappa/CSL. During PDCD4 knockdown, alpha smooth muscle actin (alpha-SMA; an activation marker of myofibroblasts), matrix metalloproteinases MMP-1 and MMP-9, and collagen IV were upregulated, but the expression of collagen1 alpha 1 and collagen III was markedly downregulated without any marked change in the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1). These results demonstrated that knockdown of PDCD4 induced the cellular senescence phenotype and activated myofibroblasts while suppressing the profibrogenic phenotype, suggesting roles of PDCD4 in cellular senescence and fibrogenesis in the liver.
C1 [Perveen, Rasheda; Ozaki, Iwata; Manirujjaman, M.; Mine, Keiichiro; Tanaka, Kenichi; Xia, Jinghe; Takahashi, Hirokazu; Anzai, Keizo; Matsuhashi, Sachiko] Saga Univ, Saga Med Sch, Dept Internal Med, Div Hepatol Diabetol & Endocrinol, 5-1-1 Nabeshima, Saga, Saga 8498501, Japan.
   [Ozaki, Iwata] Saga Univ, Hlth Adm Ctr, Saga Med Sch, 5-1-1 Nabeshima, Saga, Saga 8498501, Japan.
   [Murata, Yuzo] Int Univ Hlth & Welf, Sch Pharm Fukuoka, Dept Pharmaceut Sci, 137-1 Enokizu, Ohkawa, Fukuoka 8318501, Japan.
   [Takahashi, Hirokazu] Saga Univ, Saga Univ Hosp, Liver Dis Ctr, Saga Med Sch, 5-1-1 Nabeshima, Saga, Saga 8498501, Japan.
C3 Saga University; Saga University; International University of Health &
   Welfare; Saga University
RP Ozaki, I (corresponding author), Saga Univ, Saga Med Sch, Dept Internal Med, Div Hepatol Diabetol & Endocrinol, 5-1-1 Nabeshima, Saga, Saga 8498501, Japan.; Ozaki, I (corresponding author), Saga Univ, Hlth Adm Ctr, Saga Med Sch, 5-1-1 Nabeshima, Saga, Saga 8498501, Japan.
EM ozaki@cc.saga-u.ac.jp
RI Mine, Keiichiro/JFB-6397-2023
OI Mine, Keiichiro/0000-0001-9759-4148
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [16590606]
FX This work was supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan (No. 16590606). The funders had no role in the study design,
   investigation, and preparation of this article
CR BACHEM MG, 1993, VIRCHOWS ARCH B, V63, P123, DOI 10.1007/BF02899251
   Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3
   Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552
   Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378
   Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276
   Duan P, 2020, MOL THER-NUCL ACIDS, V20, P242, DOI 10.1016/j.omtn.2020.02.001
   Eto K, 2012, CELL DEATH DIFFER, V19, P573, DOI 10.1038/cdd.2011.126
   Furuya S, 2017, FEBS OPEN BIO, V7, P1586, DOI 10.1002/2211-5463.12300
   Galanos P, 2016, NAT CELL BIOL, V18, P777, DOI 10.1038/ncb3378
   Gao F, 2007, ONCOL REP, V17, P123
   Guo J, 2019, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00661
   Guo Xiaoling, 2011, Genes Cancer, V2, P818, DOI 10.1177/1947601911431082
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Hwang SK, 2014, CARCINOGENESIS, V35, P1469, DOI 10.1093/carcin/bgu008
   Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111
   Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Jo SH, 2016, ONCOTARGET, V7, P58717, DOI 10.18632/oncotarget.11227
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lachowski D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43759-6
   Lee S, 2006, ONCOL REP, V16, P747
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Li LY, 2019, EXP THER MED, V17, P4536, DOI 10.3892/etm.2019.7475
   Lochner K, 2007, BIOGERONTOLOGY, V8, P269, DOI 10.1007/s10522-006-9070-6
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lujambio A, 2016, BIOESSAYS, V38, pS56, DOI 10.1002/bies.201670910
   Ma Gang, 2005, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V27, P597
   Matsuhashi S, 2007, EXP DERMATOL, V16, P179, DOI 10.1111/j.1600-0625.2006.00531.x
   Matsuhashi S, 2014, CELL SIGNAL, V26, P603, DOI 10.1016/j.cellsig.2013.11.038
   McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X
   Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685
   Nakano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080411
   Ordoñez R, 2014, J PINEAL RES, V56, P20, DOI 10.1111/jpi.12092
   Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Rahmaniah R, 2018, DRUG RES, V68, P153, DOI 10.1055/s-0043-119074
   RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   SCHUPPAN D, 1990, SEMIN LIVER DIS, V10, P1, DOI 10.1055/s-2008-1040452
   Tajhya RB, 2017, METHODS MOL BIOL, V1579, P231, DOI 10.1007/978-1-4939-6863-3_12
   TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965
   Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6
   Wang Q, 2017, ONCOGENE, V36, P6225, DOI 10.1038/onc.2017.228
   Wang Q., 2012, BIOPHYS ACTA MOL CEL, V1823
   Wen YH, 2007, ONCOL REP, V18, P1387
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
   Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu SH, 2021, HUM EXP TOXICOL, V40, P231, DOI 10.1177/0960327120943935
   Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634
   Zhang L, 2021, MECH AGEING DEV, V200, DOI 10.1016/j.mad.2021.111587
NR 57
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 0914-7470
EI 1749-0774
J9 HUM CELL
JI Hum. Cell
PD 2023 MAR
PY 2023
VL 36
IS 2
BP 583
EP 601
DI 10.1007/s13577-022-00844-9
EA DEC 2022
PG 19
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 9X2TE
UT WOS:000899455800001
PM 36522523
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Wu, QM
   Shuang, E
   Yamamoto, K
   Tsuduki, T
AF Wu, Qiming
   Shuang, E.
   Yamamoto, Kazushi
   Tsuduki, Tsuyoshi
TI RETRACTED: Carbohydrate-restricted diet promotes skin senescence in
   senescence-accelerated prone mice (Retracted Article)
SO BIOGERONTOLOGY
LA English
DT Article; Retracted Publication
DE Aging; Autophagy; Carbohydrate-restricted diet; IL-6; mTOR;
   Senescence-accelerated mice
ID AGE-RELATED-CHANGES; EXTENDS LIFE-SPAN; JAPANESE DIET;
   STRUCTURAL-CHANGES; LIPID ABSORPTION; MURINE MODEL; FAT DIET; AUTOPHAGY;
   CELLS; LIVER
AB This study used senescence-accelerated prone mice (SAMP8) to examine the effects of a carbohydrate-restricted diet on aging and skin senescence, to determine how long-term carbohydrate restriction affects the aging process. Three-week-old male SAMP8 mice were divided into three groups after 1week of preliminary feeding: one was given a controlled diet, the other was given a high-fat diet, and the third was given a carbohydrate-restricted diet. Ad libitum feeding was administered until the mice reached 50weeks of age. Before the end of the test period, a grading test was used to evaluate visible aging in the mice. After the test period, serum and skin samples in mice were obtained and submitted for analysis. As a result, the grading test demonstrated that there was significant progression of visible aging in the carbohydrate-restricted group, as well as a decreased survival rate. Histological examination of the skin revealed that the epidermis and dermis in the carbohydrate-restricted group had become thinner. Analysis of the mechanisms involved demonstrated an increase in serum interleukin-6, aggravated skin senescence, inhibition of skin autophagy and activation of skin mTOR. Therefore, this study proved that a carbohydrate-restricted diet promoted skin senescence in senescence-accelerated mice.
C1 [Wu, Qiming; Shuang, E.; Yamamoto, Kazushi; Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Aoba Ku, 468-1 Aoba, Sendai, Miyagi 9800845, Japan.
C3 Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Aoba Ku, 468-1 Aoba, Sendai, Miyagi 9800845, Japan.
EM tsudukit@m.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/T-2697-2019
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528
FU Project of the NARO Bio-oriented Technology Research Advancement
   Institution
FX This research was supported by grants from the Project of the NARO
   Bio-oriented Technology Research Advancement Institution (Advanced
   integration research for agriculture and interdisciplinary fields).
CR [Anonymous], 2011, PAT SURV
   [Anonymous], 2011, FOOD SUPPL DEM FIG 2
   Asano M, 2019, NUTRITION, V57, P173, DOI 10.1016/j.nut.2018.05.023
   Bedarida T, 2014, AM J PHYSIOL-HEART C, V307, pH649, DOI 10.1152/ajpheart.00291.2014
   BHAWAN J, 1992, AM J DERMATOPATH, V14, P224, DOI 10.1097/00000372-199206000-00008
   Bringhenti I, 2011, J NUTR BIOCHEM, V22, P1009, DOI 10.1016/j.jnutbio.2010.08.013
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/S0140-6736(17)32252-3, 10.1016/s0140-6736(17)32252-3]
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6
   Fromentin G, 2012, NUTR RES REV, V25, P29, DOI 10.1017/S0954422411000175
   GILCHREST BA, 1982, J INVEST DERMATOL, V79, P85, DOI 10.1111/1523-1747.ep12500031
   GILCHREST BA, 1979, J INVEST DERMATOL, V73, P141, DOI 10.1111/1523-1747.ep12581580
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Honma T, 2013, J JPN SOC FOOD SCI, V60, P541, DOI 10.3136/nskkk.60.541
   Hosokawa M, 2013, SENESCENCE ACCELERAT, P561
   Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031
   Ishikawa H, 2018, NUTRITION
   Ishikawa H, 2018, BIOSCI BIOTECH BIOCH, V82, P515, DOI 10.1080/09168451.2018.1428788
   Iwagaki Y, 2018, BIOSCI BIOTECH BIOCH, V82, P709, DOI 10.1080/09168451.2017.1417022
   Iwagaki Y, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700430
   JACOBSEN E, 1985, J INVEST DERMATOL, V85, P483, DOI 10.1111/1523-1747.ep12277224
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Kitano Y., 2014, Journal of Japanese Society of Nutrition and Food Science, V67, P73, DOI 10.4327/jsnfs.67.73
   KLIGMAN AM, 1979, J INVEST DERMATOL, V73, P39, DOI 10.1111/1523-1747.ep12532758
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   KURBAN RS, 1993, GERIATRICS, V48, P30
   Kushida M, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201701054
   LONGAS MO, 1987, CARBOHYD RES, V159, P127, DOI 10.1016/S0008-6215(00)90010-7
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Mizowaki Y, 2017, J OLEO SCI, V66, P507, DOI 10.5650/jos.ess16241
   MONTAGNA W, 1979, J INVEST DERMATOL, V73, P47, DOI 10.1111/1523-1747.ep12532761
   PROCACCI P, 1970, GERONTOL CLIN, V12, P213, DOI 10.1159/000245281
   Rebrin I, 2005, FREE RADICAL BIO MED, V39, P549, DOI 10.1016/j.freeradbiomed.2005.04.008
   Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681
   Shimizu T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050610
   SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Srividhya R, 2008, INT J DEV NEUROSCI, V26, P217, DOI 10.1016/j.ijdevneu.2007.12.003
   Sugawara S, 2018, J OLEO SCI, V67, P599, DOI 10.5650/jos.ess17259
   Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Terman A, 1995, GERONTOLOGY, V41, P319
   Tsuduki T., 2008, Journal of Japanese Society of Nutrition and Food Science, V61, P255
   Tsuduki T, 2013, J OLEO SCI, V62, P825, DOI 10.5650/jos.62.825
   Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   Yamamoto K, 2018, NUTRITION, V50, P26, DOI 10.1016/j.nut.2017.10.015
   Yamamoto K, 2016, NUTRITION, V32, P122, DOI 10.1016/j.nut.2015.07.002
   Yamamoto K, 2015, J CLIN BIOCHEM NUTR, V57, P204, DOI 10.3164/jcbn.15-60
NR 56
TC 10
Z9 10
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2019
VL 20
IS 1
BP 71
EP 82
DI 10.1007/s10522-018-9777-1
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HG2FK
UT WOS:000454778400005
PM 30284122
DA 2024-02-19
ER

PT J
AU Ogawa, T
   Ohira, A
   Amemiya, T
   Kubo, N
   Sato, H
AF Ogawa, T
   Ohira, A
   Amemiya, T
   Kubo, N
   Sato, H
TI Superoxide dismutase in senescence-accelerated mouse retina
SO HISTOCHEMICAL JOURNAL
LA English
DT Article
ID RAT-BRAIN; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION; PIGMENT EPITHELIUM;
   COPPER-ZINC; AGE; LIVER; SAM; MANGANESE; MEMORY
AB To examine the relationship between retinal ageing and superoxide dismutase, we studied the dismutase, with immunohistochemistry and immunoquantitative analysis, in the retina of senescence-accelerated mice P8/Ta (SAMP8/Ta) 3 and 12 months after birth. Accelerated senescence-resistant mice R1TA (SAMR1TA), which show no acceleration of senescence, were used as controls. In SAMP8/Ta, copper-zinc superoxide dismutase and manganese superoxide dismutase immunoreactivity in the photoreceptor inner segments, the outer nuclear layer and the inner nuclear layer increased earlier than in the controls. The increase in both superoxide dismutases with age occurred not only in SAMP8/Ta retinas but also in the controls. In conclusion, we propose the possibility that SAMP8/Ta undergo deterioration not only of learning and memory but also acceleration of senescence in the retina. The dismutases also appear to increase with normal ageing in the retina.
C1 Nagasaki Univ, Sch Med, Lab Anim Ctr Biomed Res, Nagasaki 8528501, Japan.
   Nagasaki Univ, Sch Med, Dept Ophthalmol, Nagasaki 8528501, Japan.
C3 Nagasaki University; Nagasaki University
RP Ogawa, T (corresponding author), Shimane Med Univ, Dept Ophthalmol, 89-1 Enya, Izumo, Shimane 6938501, Japan.
RI ohira, akihiro/G-8352-2017
OI ohira, akihiro/0000-0002-1307-5592
CR AMEMIYA T, 1994, INT CONGR SER, V1062, P243
   Barber A A, 1967, Adv Gerontol Res, V2, P355
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   DeLaPaz MA, 1996, CURR EYE RES, V15, P273, DOI 10.3109/02713689609007621
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   Gompertz B., 1825, PHILOS T ROY SOC LON, V115, P513, DOI DOI 10.1098/RSTL.1825.0026
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HIRAMATSU M, 1992, J NEUROCHEM, V58, P1160, DOI 10.1111/j.1471-4159.1992.tb09375.x
   HOGAN MJ, 1971, HISTOLOGY HUMAN EYE, P424
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   JI LL, 1991, GERONTOLOGY, V37, P317
   KAGAN VE, 1973, BIOCHIM BIOPHYS ACTA, V330, P76, DOI 10.1016/0005-2736(73)90285-X
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   MARKLUND SL, 1985, J NEUROL SCI, V67, P319, DOI 10.1016/0022-510X(85)90156-X
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   Noell W K, 1966, Invest Ophthalmol, V5, P450
   Ogawa T, 1998, HISTOCHEM J, V30, P325, DOI 10.1023/A:1003228326884
   Ogawa T, 1997, ACTA HISTOCHEM, V99, P1
   OLIVER PD, 1992, INVEST OPHTH VIS SCI, V33, P1909
   ROY D, 1983, EXP GERONTOL, V18, P185, DOI 10.1016/0531-5565(83)90031-1
   SCARPA M, 1987, P SOC EXP BIOL MED, V185, P129
   SLOT JW, 1986, LAB INVEST, V55, P363
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TANIGUCHI N, 1992, ADV CLIN CHEM, V29, P1, DOI 10.1016/S0065-2423(08)60221-8
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   YAMASHITA H, 1992, RETINA-J RET VIT DIS, V12, P59, DOI 10.1097/00006982-199212010-00012
NR 37
TC 4
Z9 6
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0018-2214
J9 HISTOCHEM J
JI Histochem.J.
PD JAN
PY 2001
VL 33
IS 1
BP 43
EP 50
DI 10.1023/A:1017591813823
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 417UV
UT WOS:000167853300007
PM 11352400
DA 2024-02-19
ER

PT J
AU Zhou, TH
   Wu, N
   Meng, FY
   Venter, J
   Giang, TK
   Francis, H
   Kyritsi, K
   Wu, CD
   Franchitto, A
   Alvaro, D
   Marzioni, M
   Onori, P
   Mancinelli, R
   Gaudio, E
   Glaser, S
   Alpini, G
AF Zhou, Tianhao
   Wu, Nan
   Meng, Fanyin
   Venter, Julie
   Giang, Thao K.
   Francis, Heather
   Kyritsi, Konstantina
   Wu, Chaodong
   Franchitto, Antonio
   Alvaro, Domenico
   Marzioni, Marco
   Onori, Paolo
   Mancinelli, Romina
   Gaudio, Eugenio
   Glaser, Shannon
   Alpini, Gianfranco
TI Knockout of secretin receptor reduces biliary damage and liver fibrosis
   in Mdr2<SUP>-/-</SUP> mice by diminishing senescence of cholangiocytes
SO LABORATORY INVESTIGATION
LA English
DT Article
ID PRIMARY SCLEROSING CHOLANGITIS; ENDOTHELIAL GROWTH-FACTOR; HEPATIC
   STELLATE CELLS; BILE-DUCT LIGATION; FUNCTIONAL-HETEROGENEITY; CELLULAR
   SENESCENCE; HYPERPLASIA; PROLIFERATION; MODEL; RATS
AB Secretin receptor (SR), only expressed by cholangiocytes, plays a key role in the regulation of biliary damage and liver fibrosis. The aim of this study was to determine the effects of genetic depletion of SR in Mdr2(-/-)mice on intrahepatic biliary mass, liver fibrosis, senescence, and angiogenesis. 12 wk SR-/-, Mdr2(-/-), and SR-/-/Mdr2(-/-)mice with corresponding wild-type mice were used for the in vivo studies. Immunohistochemistry or immunofluorescence was performed in liver sections for (i) biliary expression of SR; (ii) hematoxylin and eosin; (iii) intrahepatic biliary mass by CK-19; (iv) fibrosis by Col1a1 and alpha-SMA; (v) senescence by SA-beta-gal and p16; and (vi) angiogenesis by VEGF-A and CD31. Secretin (Sct) and TGF-beta 1 levels were measured in serum and cholangiocyte supernatant by ELISA. In total liver, isolated cholangiocytes or HSCs, we evaluated the expression of fibrosis markers (FN-1 and Col1a1); senescence markers (p16 and CCL2); microRNA 125b and angiogenesis markers (VEGF-A, VEGFR-2, CD31, and vWF) by immunoblots and/or qPCR. In vitro, we measured the paracrine effect of cholangiocyte supernatant on the expression of senescent and fibrosis markers in human hepatic stellate cells (HHSteCs). The increased level of ductular reaction, fibrosis, and angiogenesis in Mdr2-/-mice was reduced in SR-/-/ Mdr2(-/-)mice. Enhanced senescence levels in cholangiocytes from Mdr2(-/-)mice were reversed to normal in SR-/-/ Mdr2(-/-)mice. However, senescence was decreased in HSCs from Mdr2(-/-)mice but returned to normal values in SR-/-/Mdr2(-/-)mice. In vitro treatment of HHSteCs with supernatant from cholangiocyte lacking SR (containing lower biliary levels of Sct-dependent TGF-beta 1) have decreased fibrotic reaction and increased cellular senescence. Sct-induced TGF-beta 1 secretion was mediated by microRNA 125b. Our data suggest that differential modulation of angiogenesisdependent senescence of cholangiocytes and HSCs may be important for the treatment of liver fibrosis in cholangiopathies.
C1 [Zhou, Tianhao; Wu, Nan; Venter, Julie; Giang, Thao K.; Francis, Heather; Kyritsi, Konstantina; Glaser, Shannon; Alpini, Gianfranco] Texas A&M Univ, Dept Med Physiol, Coll Med, Temple, TX 76504 USA.
   [Meng, Fanyin; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res, Temple, TX 76504 USA.
   [Meng, Fanyin; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White Hlth, Baylor Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA.
   [Meng, Fanyin] Baylor Scott & White Healthcare, Acad Res Integrat, Temple, TX 76504 USA.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77840 USA.
   [Franchitto, Antonio; Onori, Paolo; Mancinelli, Romina; Gaudio, Eugenio] Sapienza, Dept Anat Histol Forens Med & Orthopaed Sci, Rome, Italy.
   [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy.
   [Alvaro, Domenico] Sapienza, Dept Med, Gastroenterol, Rome, Italy.
   [Marzioni, Marco] Univ Politecn Marche, Osped Riuniti Univ Hosp, Clin Gastroenterol & Hepatol, Ancona, Italy.
C3 Texas A&M University System; Baylor Health Care System; Baylor Health
   Care System; Texas A&M University System; Texas A&M University College
   Station; Sapienza University Rome; Sapienza University Rome; Marche
   Polytechnic University
RP Glaser, S; Alpini, G (corresponding author), Texas A&M Univ, Dept Med Physiol, Coll Med, Temple, TX 76504 USA.; Glaser, S; Alpini, G (corresponding author), Cent Texas Vet Hlth Care Syst, Res, Temple, TX 76504 USA.; Glaser, S; Alpini, G (corresponding author), Baylor Scott & White Hlth, Baylor Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA.
EM sglaser@medicine.tamhsc.edu; galpini@tamu.edu
RI Onori, Paolo/J-9394-2013; Franchitto, Antonio/C-8095-2009; Marzioni,
   Marco/A-8153-2011; Zhou, Tianhao/AAO-3542-2021; ALVARO,
   Domenico/J-8600-2018; Mancinelli, Romina/Y-4540-2018
OI Onori, Paolo/0000-0002-7195-3760; Marzioni, Marco/0000-0001-6014-6165;
   Zhou, Tianhao/0000-0002-5722-6954; ALVARO, Domenico/0000-0003-3771-9644;
   Mancinelli, Romina/0000-0003-2040-0581
FU VA Research Career Scientist Award, a VA Merit award from the United
   States [5I01BX000574]; VA Merit Award from the United States
   [5I01BX002192, 1I01BX001724]; University of Rome "La Sapienza"
   [1I01BX003031]; NIH [DK058411, DK110035, DK076898, DK108959, DK062975,
   DK095862]; American Diabetes Association [1-17-IBS-145]
FX This work was supported partly by the Dr. Nicholas C. Hightower
   Centennial Chair of Gastroenterology from Scott & White, a VA Research
   Career Scientist Award, a VA Merit award to GA (5I01BX000574), a VA
   Merit Award (5I01BX002192) to SG, a VA Merit Award (1I01BX001724) to FM
   from the United States and a VA Merit Award (1I01BX003031) to HF,
   Department of Veterans Affairs Biomedical Laboratory Research and
   Development Service, by University of Rome "La Sapienza" to PO, and the
   NIH grants DK058411, DK110035, DK076898, DK108959, and DK062975 to GA,
   FM, and SG. CW is supported by grants from American Diabetes Association
   (1-17-IBS-145) and the NIH grant DK095862. The content is the
   responsibility of the author(s) alone and does not necessarily reflect
   the views or policies of the Department of Veterans Affairs or the
   United States Government.
CR Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG1064, DOI 10.1152/ajpgi.1997.272.5.G1064
   ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   ALPINI G, 1994, AM J PHYSIOL, V266, pG922, DOI 10.1152/ajpgi.1994.266.5.G922
   Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073
   Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023
   Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537
   Boissart C, 2012, DEVELOPMENT, V139, P1247, DOI 10.1242/dev.073627
   Chung BK, 2018, BBA-MOL BASIS DIS, V1864, P1390, DOI 10.1016/j.bbadis.2017.08.020
   Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034
   Gaudio E, 2006, AM J PHYSIOL-GASTR L, V291, pG307, DOI 10.1152/ajpgi.00507.2005
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Guerrier Micheleine, 2014, Hepatobiliary Surg Nutr, V3, P118, DOI 10.3978/j.issn.2304-3881.2014.04.04
   Hall Chad, 2017, Gene Expression, V17, P155, DOI 10.3727/105221616X692568
   Han YY, 2014, AM J PHYSIOL-GASTR L, V307, pG894, DOI 10.1152/ajpgi.00288.2014
   Han YY, 2013, EXP BIOL MED, V238, P549, DOI 10.1177/1535370213489926
   Ikenaga N, 2015, AM J PATHOL, V185, P325, DOI 10.1016/j.ajpath.2014.10.013
   Kanno N, 2001, AM J PHYSIOL-GASTR L, V281, pG612, DOI 10.1152/ajpgi.2001.281.3.G612
   Kennedy LL, 2016, LAB INVEST, V96, P1256, DOI 10.1038/labinvest.2016.112
   Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006
   Lazaridis KN, 2015, MAYO CLIN PROC, V90, P791, DOI 10.1016/j.mayocp.2015.03.017
   Loarca L, 2017, LAB INVEST, V97, P1385, DOI 10.1038/labinvest.2017.63
   Maroni L, 2015, CELL MOL GASTROENTER, V1, P368, DOI 10.1016/j.jcmgh.2015.05.005
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Puche JE, 2013, HEPATOLOGY, V57, P340, DOI 10.1002/hep.26053
   Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012
   Ren XF, 2015, EUR REV MED PHARMACO, V19, P1182
   Sato K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10694-3
   Shimizu R, 2015, J HEPATO-BIL-PAN SCI, V22, P675, DOI 10.1002/jhbp.256
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yan C, 2016, INFECT GENET EVOL, V43, P321, DOI 10.1016/j.meegid.2016.06.009
   Yin H, 2015, EXP CELL RES, V339, P252, DOI 10.1016/j.yexcr.2015.09.015
   Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
   Zhao Y, 2012, MOL CELL BIOCHEM, V359, P217, DOI 10.1007/s11010-011-1016-x
NR 39
TC 40
Z9 42
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0023-6837
EI 1530-0307
J9 LAB INVEST
JI Lab. Invest.
PD NOV
PY 2018
VL 98
IS 11
BP 1449
EP 1464
DI 10.1038/s41374-018-0093-9
PG 16
WC Medicine, Research & Experimental; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pathology
GA GY9KY
UT WOS:000448964900008
PM 29977037
OA hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU Helenius, M
   Hanninen, M
   Lehtinen, SK
   Salminen, A
AF Helenius, M
   Hanninen, M
   Lehtinen, SK
   Salminen, A
TI Changes associated with aging and replicative senescence in the
   regulation of transcription factor nuclear factor-kappa B
SO BIOCHEMICAL JOURNAL
LA English
DT Article
ID FACTOR-BINDING ACTIVITIES; DNA-BINDING; ACTIVATION; CELLS; GENE;
   EXPRESSION; STRESS
AB Both the aging of animals and the senescence of cultured cells involve an altered pattern of gene expression, suggesting changes in transcription factor regulation. We studied age-related changes in transcription factors nuclear factor (NF)-kappa B, activator protein factor-1 (AP-1) and Sp-1 by using electrophoretic mobility shift binding assays; we also analysed changes in the protein components of NF-kappa B complex with Western blot assays. Nuclear and cytoplasmic extracts were prepared from heart, liver, kidney and brain of young adult and old NMRI mice and Wistar rats as well as from presenescent, senescent and simian virus 40-immortalized human WI-38 fibroblasts. Aging of both mice and rats induced a strong and consistent increase in the nuclear binding activity of NF-kappa B factor in all tissues studied, whereas those of AP-1 and Sp-1 decreased, e.g. in liver. Protein levels of p50, p52 and p65 components of the NF-kappa B complex did not show any age-associated changes in the cytoplasmic fraction but in the nuclear fraction the level of p52 strongly increased in heart and liver during aging. The protein levels of inhibitory I kappa B-alpha and Bcl-3 components were not affected by aging in any of the tissues studied. Replicative cellular senescence of human WI-38 fibroblasts induced a strong decrease in nuclear NF-kappa B, AP-1 and Sp-1 binding activities. Protein levels of p50 and p52 components of NF-kappa B complex were decreased in the nuclear fraction of senescent WI-38 fibroblasts but in the cytoplasm of senescent fibroblasts the level of p65 protein was increased. Cellular senescence also slightly decreased the protein levels of I kappa B-alpha and Bcl-3. Transfection assays with NF-kappa B-enhancer-driven chloramphenicol acetyltransferase reporter gene showed a significant down-regulation of NF-kappa B promoter activity in senescent WI-38 fibroblasts. Results suggest that the aging process might be regulated differently in tissues and cultured fibroblasts, perhaps reflecting differences between mitotic and post-mitotic cells. In tissues, aging seems to involve specific changes in the regulation of NF-kappa B components and perhaps also changes in the DNA-binding affinities of the NF-kappa B complex.
C1 UNIV KUOPIO,DEPT NEUROSCI & NEUROL,FIN-70211 KUOPIO,FINLAND.
   UNIV JYVASKYLA,DEPT CELL BIOL,FIN-40351 JYVASKYLA,FINLAND.
C3 University of Eastern Finland; University of Jyvaskyla
CR ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944
   ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527
   ATADJA PW, 1994, MOL CELL BIOL, V14, P4991, DOI 10.1128/MCB.14.7.4991
   BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0
   CALLEJA M, 1993, J BIOL CHEM, V268, P18891
   CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617
   DAVIDSON EH, 1994, BIOESSAYS, V16, P603, DOI 10.1002/bies.950160903
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   DIMRI GP, 1994, EXP CELL RES, V212, P132, DOI 10.1006/excr.1994.1127
   FAWCETT TW, 1994, J BIOL CHEM, V269, P32272
   GHODOSH LA, 1989, CURRENT PROTOCOLS MO
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   LI CCH, 1994, J BIOL CHEM, V269, P30089
   MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136
   MUKHOPADHYAY T, 1995, ONCOGENE, V11, P999
   NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35
   SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   THAKUR MK, 1993, MECH AGEING DEV, V66, P283, DOI 10.1016/0047-6374(93)90015-J
NR 28
TC 196
Z9 216
U1 0
U2 2
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD SEP 1
PY 1996
VL 318
BP 603
EP 608
DI 10.1042/bj3180603
PN 2
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA VH412
UT WOS:A1996VH41200033
PM 8809053
OA Green Published
DA 2024-02-19
ER

PT J
AU Meijnikman, AS
   Van Olden, CC
   Aydin, O
   Herrema, H
   Kaminska, D
   Lappa, D
   Männistö, V
   Tremaroli, V
   Olofsson, LE
   De Brauw, M
   Van de Laar, A
   Verheij, J
   Gerdes, VEA
   Schwartz, TW
   Nielsen, J
   Bäckhed, F
   Pajukanta, P
   Pihlajamäki, J
   Tchkonia, T
   Kirkland, JL
   Kuipers, F
   Nieuwdorp, M
   Groen, AK
AF Meijnikman, Abraham S.
   van Olden, Casper C.
   Aydin, Omrum
   Herrema, Hilde
   Kaminska, Dorota
   Lappa, Dimitra
   Mannisto, Ville
   Tremaroli, Valentina
   Olofsson, Louise E.
   de Brauw, Maurits
   van de Laar, Arnold
   Verheij, Joanne
   Gerdes, Victor E. A.
   Schwartz, Thue W.
   Nielsen, Jens
   Backhed, Fredrik
   Pajukanta, Paivi
   Pihlajamaki, Jussi
   Tchkonia, Tamar
   Kirkland, James L.
   Kuipers, Folkert
   Nieuwdorp, Max
   Groen, Albert K.
TI Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic
   Senescence in Two Independent Cohorts
SO DIABETES
LA English
DT Article
ID PROGRESSION
AB Cellular senescence is an essentially irreversible growth arrest that occurs in response to various cellular stressors and may contribute to development of type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD). In this article, we investigated whether chronically elevated insulin levels are associated with cellular senescence in the human liver. In 107 individuals undergoing bariatric surgery, hepatic senescence markers were assessed by immunohistochemistry as well as transcriptomics. A subset of 180 participants from the ongoing Finnish Kuopio OBesity Surgery (KOBS) study was used as validation cohort. We found plasma insulin to be highly associated with various markers of cellular senescence in liver tissue. The liver transcriptome of individuals with high insulin revealed significant upregulation of several genes associated with senescence: p21, TGF beta, PI3K, HLA-G, IL8, p38, Ras, and E2F. Insulin associated with hepatic senescence independently of NAFLD and plasma glucose. By using transcriptomic data from the KOBS study, we could validate the association of insulin with p21 in the liver. Our results support a potential role for hyperinsulinemia in induction of cellular senescence in the liver. These findings suggest possible benefits of lowering insulin levels in obese individuals with insulin resistance.
C1 [Meijnikman, Abraham S.; van Olden, Casper C.; Aydin, Omrum; Herrema, Hilde; Gerdes, Victor E. A.; Nieuwdorp, Max; Groen, Albert K.] Univ Amsterdam, Dept Internal, Locat AMC, Med Ctr, Amsterdam, Netherlands.
   [Meijnikman, Abraham S.; van Olden, Casper C.; Aydin, Omrum; Herrema, Hilde; Gerdes, Victor E. A.; Nieuwdorp, Max; Groen, Albert K.] Univ Amsterdam, Dept Expt Vasc Med, Locat AMC, Med Ctr, Amsterdam, Netherlands.
   [Meijnikman, Abraham S.; Aydin, Omrum; de Brauw, Maurits; van de Laar, Arnold; Gerdes, Victor E. A.] Spaarne Hosp, Dept Surg, Hoofddorp, Netherlands.
   [Kaminska, Dorota; Pihlajamaki, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Lappa, Dimitra; Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Syst & Synthet Biol, Gothenburg, Sweden.
   [Mannisto, Ville; Pihlajamaki, Jussi] Kuopio Univ Hosp, Dept Med Endocrinol & Clin Nutr, Kuopio, Finland.
   [Tremaroli, Valentina; Olofsson, Louise E.; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.
   [Verheij, Joanne] Univ Amsterdam, Univ Med Ctr, Canc Ctr Amsterdam, Dept Pathol, Amsterdam, Netherlands.
   [Schwartz, Thue W.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Lab Mol Pharmacol, Copenhagen, Denmark.
   [Backhed, Fredrik] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark.
   [Backhed, Fredrik] Sahlgrens Univ Hosp, Dept Clin Physiol, Reg Vastra Gotaland, Gothenburg, Sweden.
   [Pajukanta, Paivi] UCLA, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA USA.
   [Pajukanta, Paivi] UCLA, Inst Precis Hlth, David Geffen Sch Med, Los Angeles, CA USA.
   [Tchkonia, Tamar; Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA.
   [Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.
   [Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands.
C3 University of Amsterdam; University of Amsterdam; Spaarne Hospital;
   University of Eastern Finland; Chalmers University of Technology;
   University of Eastern Finland; Kuopio University Hospital; University of
   Gothenburg; Vrije Universiteit Amsterdam; University of Amsterdam;
   University of Copenhagen; Novo Nordisk Foundation; University of
   Copenhagen; Sahlgrenska University Hospital; University of California
   System; University of California Los Angeles; University of California
   Los Angeles Medical Center; David Geffen School of Medicine at UCLA;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; Mayo Clinic; University of Groningen; University of
   Groningen
RP Groen, AK (corresponding author), Univ Amsterdam, Dept Internal, Locat AMC, Med Ctr, Amsterdam, Netherlands.; Groen, AK (corresponding author), Univ Amsterdam, Dept Expt Vasc Med, Locat AMC, Med Ctr, Amsterdam, Netherlands.; Groen, AK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.; Groen, AK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands.
EM a.k.groen@amsterdamumc.nl
RI Kirkland, James/F-9159-2016; Kaminska, Dorota/AAE-9192-2022; Nielsen,
   Jens Bo/C-7632-2015; Tremaroli, Valentina/AAE-8001-2019; Kaminska,
   Dorota/P-7874-2017; Kuipers, Folkert/JZD-2819-2024
OI Kaminska, Dorota/0000-0003-1829-576X; Nielsen, Jens
   Bo/0000-0001-5568-2916; Tremaroli, Valentina/0000-0002-9150-4233;
   Kaminska, Dorota/0000-0003-1829-576X; Backhed,
   Fredrik/0000-0002-4871-8818; Kuipers, Folkert/0000-0003-2518-737X;
   Schwartz, Thue W./0000-0002-0261-6904; Verheij,
   Joanne/0000-0003-1283-630X
FU Leducq consortium [CVD01]; Novo Nordisk Foundation [NNF15OC0016798];
   Academy of Finland [138,006, 316458]; Kuopio University Hospital Project
   grants (EVO/VTR grants) [2005-2019]; EFSD/Lilly; Noaber Foundation;
   National Institutes of Health [AG013925, AG062413, AG061456]; Robert and
   Arlene Kogod Center on Aging; Connor Group; Robert J. and Theresa W.
   Ryan Foundation; Ted Nash Long Life and Noaber Foundation; Academy of
   Finland (AKA) [316458] Funding Source: Academy of Finland (AKA)
FX This study was funded by Leducq consortium grant CVD01 and the Novo
   Nordisk Foundation (NNF15OC0016798). D.K. was supported by Academy of
   Finland grant (contract 316458). The KOBS study (principal investigator
   J.P.) was supported by Kuopio University Hospital Project grants
   (EVO/VTR grants 2005-2019) and an Academy of Finland grant (contract no.
   138,006). A.S.M. is supported by EFSD/Lilly. F.K. is supported by the
   Noaber Foundation. T.T. and J.L.K. were supported by National Institutes
   of Health grants AG013925 and AG062413 and the Translational Geroscience
   Network (AG061456), Robert and Arlene Kogod Center on Aging, the Connor
   Group, Robert J. and Theresa W. Ryan, and the Ted Nash Long Life and
   Noaber Foundations.
CR American Diabetes Association, 2020, Diabetes Care, V43, pS14, DOI 10.2337/dc20-S002
   Arab JP, 2018, ANNU REV PATHOL-MECH, V13, P321, DOI 10.1146/annurev-pathol-020117-043617
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173
   Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483
   GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549
   Gustafson B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10688-x
   Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429
   Li Q, 2021, NAT MED, V27, P1941, DOI 10.1038/s41591-021-01501-8
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Männistö V, 2021, HEPATOL COMMUN, V5, P244, DOI 10.1002/hep4.1630
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Ogrodnik M, 2019, AGING CELL, V18, DOI 10.1111/acel.12841
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Palmer AK, 2019, DIABETOLOGIA, V62, P1835, DOI 10.1007/s00125-019-4934-x
   Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044
   Simonen M, 2013, HEPATOLOGY, V58, P976, DOI 10.1002/hep.26342
   Van Olden CC, 2021, J INTERN MED, V289, P340, DOI 10.1111/joim.13157
   Wiegman CH, 2003, DIABETES, V52, P1081, DOI 10.2337/diabetes.52.5.1081
NR 22
TC 7
Z9 7
U1 1
U2 3
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD SEP
PY 2022
VL 71
IS 9
BP 1929
EP 1936
DI 10.2337/db21-1076
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 7K3KS
UT WOS:000905185400015
PM 35713877
OA Green Published, Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Ruan, QW
   Liu, F
   Gao, ZJ
   Kong, DQ
   Hu, XN
   Shi, DM
   Bao, ZJ
   Yu, ZW
AF Ruan, Qingwei
   Liu, Fang
   Gao, Zhanjuan
   Kong, Deqiu
   Hu, Xiaona
   Shi, Dongmei
   Bao, Zhijun
   Yu, Zhuowei
TI The anti-inflamm-aging and hepatoprotective effects of huperzine A in
   D-galactose-treated rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE D-Galactose; Huperzine A; Inflamm-aging; Inflammation and
   anti-inflammation; Cholinergic anti-inflammatory pathway; Nuclear
   factor-kappa B
ID KAPPA-B ACTIVATION; OXIDATIVE STRESS; ACETYLCHOLINESTERASE INHIBITORS;
   REPLICATIVE SENESCENCE; IMMUNE-SYSTEM; LIFE-SPAN; PERSPECTIVE;
   P16(INK4A); MECHANISMS; EXPRESSION
AB Oxidative stress contributes to a chronic inflammatory process referred to as "inflamm-aging". Acetylcholinesterase inhibitors (AChEI) can enhance cholinergic transmission and act as anti-inflammatory agents via immunocompetent cells expressing alpha-7 acetylcholine receptors (AChR). The present study explores the possible role of huperzine A, a reversible and selective AChEI, against D-gal-induced oxidative damage, cell toxicity and inflamm-aging in rat livers. In two-month-old rats with normal liver function, an 8-week administration of D-gal (300 mg/kg subcutaneously (s.c.) injected), significantly increased hepatic impairment, ROS generation and oxidative damage, hepatic senescence, nuclear factor-kappa B (NF-kappa B) activation and inflammatory responses. An 8-week co-administration of both D-gal (300 mg/kg s.c.) and huperzine A (0.1 mg/kg s.c.) not only significantly decreased hepatic function impairment, ROS generation, oxidative damage, but also suppressed inflamm-aging by inhibiting hepatic replicative senescence, AChE activity, I kappa B alpha degradation, NF-kappa B p65 nuclear translocation and inflammatory responses. The expression levels of pro-inflammatory cytokine mRNA and proteins, such as TNF alpha, IL-1 beta and IL-6 decrease significantly, and the protein levels of the anti-inflammatory cytokine IL-10 display an obvious increase. These findings indicated that D-gal-induced hepatic injury and inflamm-aging in the rat liver was associated with the development of a pro-inflammatory phenotype in this organ. D-gal induced damage-associated molecular patterns (DAMPs) because oxidative damages might play an important role in D-gal-induced hepatic sterile inflammation. Huperzine A exhibited protective effects against D-gal-induced hepatotoxicity and inflamm-aging by inhibiting AChE activity and via the activation of the cholinergic anti-inflammatory pathway. The huperzine A mechanism might be involved in the inhibition of DAMPs-mediated NF-kappa B nuclear localization and activation. (c) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Ruan, Qingwei; Bao, Zhijun; Yu, Zhuowei] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Shanghai Inst Geriatr,Cent Lab, Shanghai 200040, Peoples R China.
   [Liu, Fang; Gao, Zhanjuan; Hu, Xiaona; Shi, Dongmei; Bao, Zhijun] Fudan Univ, Shanghai Med Coll, Huadong Hosp, Shanghai Inst Geriatr,Dept Gastroenterol, Shanghai 200040, Peoples R China.
   [Kong, Deqiu] Shanghai Jiao Tong Univ, Affiliated Hosp 3, Dept Otolaryngol, Shanghai 201900, Peoples R China.
C3 Fudan University; Fudan University; Shanghai Jiao Tong University
RP Bao, ZJ (corresponding author), Fudan Univ, Shanghai Med Coll, Huadong Hosp, 221 West Yan An Rd, Shanghai 200040, Peoples R China.
EM xinyi8681@sina.com; qingweir@yahoo.com.cn
RI ruan, qingwei/IUN-3847-2023
OI Bao, Zhijun/0000-0002-0900-7204; Yu, Zhuowei/0000-0002-9152-6491
FU Fudan university 985 platform [985III-YFX0603]; Shanghai medical key
   subject construction [05III015]; Natural Science Foundation of Shanghai
   in China [11ZR1411600]
FX This work was supported by Fudan university 985 platform (No.
   985III-YFX0603), Shanghai medical key subject construction (No.
   05III015), and the Natural Science Foundation of Shanghai in China (No.
   11ZR1411600).
CR Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3
   Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643
   Best TM, 1999, J APPL PHYSIOL, V87, P74, DOI 10.1152/jappl.1999.87.1.74
   Brenner T, 2008, J NEUROIMMUNOL, V201, P121, DOI 10.1016/j.jneuroim.2008.05.022
   Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Cannizzo ES, 2011, J PROTEOMICS, V74, P2313, DOI 10.1016/j.jprot.2011.06.005
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Chen QM, 2000, ANN NY ACAD SCI, V908, P111
   Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008
   Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Gallowitsch-Puerta M, 2007, LIFE SCI, V80, P2325, DOI 10.1016/j.lfs.2007.01.002
   Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615
   Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006
   Gordon RK, 2001, J APPL TOXICOL, V21, pS47, DOI 10.1002/jat.805
   Grando SA, 2003, LIFE SCI, V72, P2009, DOI 10.1016/S0024-3205(03)00063-8
   Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x
   Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003
   Kumar Anil, 2011, Int J Alzheimers Dis, V2011, P347569, DOI 10.4061/2011/347569
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma XC, 2003, ACTA PHARMACOL SIN, V24, P247
   Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168
   Nizri E, 2006, NEUROPHARMACOLOGY, V50, P540, DOI 10.1016/j.neuropharm.2005.10.013
   Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146
   Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011
   Pollak Y, 2005, ANN NEUROL, V57, P741, DOI 10.1002/ana.20454
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092
   Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378
   Singh SP, 2000, TOXICOL APPL PHARM, V164, P65, DOI 10.1006/taap.2000.8897
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tabet N, 2006, AGE AGEING, V35, P336, DOI 10.1093/ageing/afl027
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369
   Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x
   Wang ZF, 2008, J NEUROCHEM, V106, P1594, DOI 10.1111/j.1471-4159.2008.05504.x
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
   Zhang HY, 2008, CELL MOL NEUROBIOL, V28, P173, DOI 10.1007/s10571-007-9163-z
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
NR 50
TC 51
Z9 63
U1 1
U2 35
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR-APR
PY 2013
VL 134
IS 3-4
BP 89
EP 97
DI 10.1016/j.mad.2012.12.005
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 120DH
UT WOS:000317150500003
PM 23313706
DA 2024-02-19
ER

PT J
AU Qian, L
   Zhang, H
   Gu, YT
   Li, DC
   He, SB
   Wang, H
   Cheng, YJ
   Yang, WL
   Yu, HS
   Zhao, XN
   Cai, W
   Meng, LJ
   Jin, M
   Wang, YN
   Zhang, YY
AF Qian, Liu
   Zhang, Hui
   Gu, Yuting
   Li, Dechun
   He, Songbing
   Wang, Hui
   Cheng, Yiji
   Yang, Wanlin
   Yu, Hongshuang
   Zhao, Xiaonan
   Cai, Wei
   Meng, Lijun
   Jin, Min
   Wang, Yanan
   Zhang, Yanyun
TI Reduced production of laminin by hepatic stellate cells contributes to
   impairment in oval cell response to liver injury in aged mice
SO AGING-US
LA English
DT Article
DE oval cells; hepatic stellate cells; aging; niche; DNA-dependent protein
   kinase
ID PROGENITOR CELLS; CLONAL HEMATOPOIESIS; GROWTH-FACTOR; REGENERATION;
   EXPRESSION; NICHE; SENESCENCE; CANCER
AB Aged liver is usually impaired in response to hepatic injury. Tissue-specific stem cells participate in the repair of tissue injury. However, how oval cells (OCs) respond to injury and how the process is regulated by tissue microenvironment in aged mice have not been fully understood. In this study, taking advantage of well-established murine OC activation model, we demonstrated that OCs were less activated upon injury in aged mice and the impairment was mainly attributed to dysfunction in their niche. Through analyzing global gene expression, we found that the genes differentially expressed in damaged young and aged mouse liver tissues were predominantly those required for the formation and remodeling of extracellular matrix. As one of the most important extracellular matrix components in the OC niche, laminin was shown to promote the proliferation of OCs. Not surprisingly, laminin was downregulated with aging. Consistent with the downregulation of genes encoding DNA-dependent protein kinase (DNA-PK) proteins in aged hepatic stellate cells (HSCs), inhibition of DNA-PK also led to reduced expression of laminin in HSCs. Moreover, impairment in OC activation caused by less supporting from DNA-damaged HSCs could be rescued by laminin. This study reveals a new cellular mechanism underlying impaired OCs functionality during aging.
C1 [Qian, Liu; Li, Dechun; He, Songbing; Wang, Hui; Yang, Wanlin; Meng, Lijun; Wang, Yanan; Zhang, Yanyun] Soochow Univ, Affiliated Hosp 1, Inst Translat Med, Dept Gen Surg, Suzhou, Peoples R China.
   [Qian, Liu; Zhang, Hui] Shanghai Univ Med & Hlth Sci, Jiading Dist Cent Hosp, Dept Gen Surg, Shanghai, Peoples R China.
   [Gu, Yuting; Wang, Hui; Cheng, Yiji; Yu, Hongshuang; Zhao, Xiaonan; Cai, Wei; Jin, Min; Zhang, Yanyun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.
   [Gu, Yuting; Wang, Hui; Cheng, Yiji; Yu, Hongshuang; Zhao, Xiaonan; Cai, Wei; Jin, Min; Zhang, Yanyun] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.
C3 Soochow University - China; Shanghai University of Medicine & Health
   Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences;
   Chinese Academy of Sciences
RP Wang, YN; Zhang, YY (corresponding author), Soochow Univ, Affiliated Hosp 1, Inst Translat Med, Dept Gen Surg, Suzhou, Peoples R China.; Jin, M; Zhang, YY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China.; Jin, M; Zhang, YY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.
EM mjin@sibs.ac.cn; ynwang@fudan.edu.cn; yyzhang@sibs.ac.cn
RI meng, li/GVT-2063-2022; cai, wei/JPY-3260-2023; liu, qian/HDM-2936-2022;
   Qian, Liu/GYU-5886-2022; Zhao, Xiaonan/S-3139-2016; meng,
   li/HTQ-7341-2023
FU Ministry of Science and Technology of China [2015CB943300, 2011CB966200,
   2014CB943300]; National Natural Science Foundation of China [81670540,
   81700656, 81470867, 81700170, 81130057]; China Postdoctoral Science
   Foundation [2017M611458]; Seed Fund Program of Shanghai University of
   Medicine & Health Sciences [SFP-18-20-16-004]; Shanghai Medical Key
   Specialist Construction Plans [ZK2015B10]; Scientific & Technological
   Commission of Jiading District in Shanghai [JDKW-2018-W01]
FX This work was supported by the Ministry of Science and Technology of
   China (2015CB943300, 2011CB966200, 2014CB943300), National Natural
   Science Foundation of China (81670540, 81700656, 81470867, 81700170,
   81130057), China Postdoctoral Science Foundation (2017M611458), The Seed
   Fund Program of Shanghai University of Medicine & Health Sciences
   (SFP-18-20-16-004), The Shanghai Medical Key Specialist Construction
   Plans (ZK2015B10), the Seed Fund Program of Shanghai University of
   Medicine & Health Sciences (SFP-18-20-16-004), the Scientific &
   Technological Commission of Jiading District in Shanghai
   (JDKW-2018-W01).
CR Ambrosi TH, 2017, CELL STEM CELL, V20, P771, DOI 10.1016/j.stem.2017.02.009
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Cheng YJ, 2017, AGING-US, V9, P1359, DOI 10.18632/aging.101232
   Couvelard A, 1998, HEPATOLOGY, V27, P839, DOI 10.1002/hep.510270328
   Durant S, 2003, NUCLEIC ACIDS RES, V31, P5501, DOI 10.1093/nar/gkg753
   FARBER E, 1956, CANCER RES, V16, P142
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   García-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221
   Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405
   HU ZY, 1993, AM J PATHOL, V142, P1823
   Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796
   Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617
   Kallis YN, 2011, GUT, V60, P525, DOI 10.1136/gut.2010.224436
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Leite AR, 2007, CELL TISSUE RES, V327, P529, DOI 10.1007/s00441-006-0340-z
   Liang Shuang, 2014, Gastroenterology, V146, P1823, DOI 10.1053/j.gastro.2014.04.010
   Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258
   Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602
   Maschmeyer Patrick, 2011, J Vis Exp, DOI 10.3791/2710
   Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0
   Pintilie DG, 2010, LAB INVEST, V90, P1199, DOI 10.1038/labinvest.2010.88
   Preisegger KH, 1999, LAB INVEST, V79, P103
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Shen KT, 2011, ACTA BIOCH BIOPH SIN, V43, P307, DOI 10.1093/abbs/gmr005
   Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112
   Turányi E, 2010, HISTOPATHOLOGY, V57, P607, DOI 10.1111/j.1365-2559.2010.03668.x
   Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770
   Zhang W, 2009, WORLD J GASTROENTERO, V15, P552, DOI 10.3748/wjg.15.552
NR 35
TC 3
Z9 4
U1 2
U2 17
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC
PY 2018
VL 10
IS 12
BP 3713
EP 3735
DI 10.18632/aging.101665
PG 23
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HG0KM
UT WOS:000454633200018
PM 30513510
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Görg, B
   Karababa, A
   Shafigullina, A
   Bidmon, HJ
   Häussinger, D
AF Goerg, Boris
   Karababa, Ayse
   Shafigullina, Aygul
   Bidmon, Hans J.
   Haeussinger, Dieter
TI Ammonia-Induced Senescence in Cultured Rat Astrocytes and in Human
   Cerebral Cortex in Hepatic Encephalopathy
SO GLIA
LA English
DT Article
DE ammonia; astrocytes; senescence; glutamine
ID OXIDATIVE STRESS; TRUNCATED TRKB; BRAIN; PROLIFERATION; PHOSPHORYLATION;
   INHIBITION; CIRRHOSIS
AB Hepatic encephalopathy (HE) is a frequent complication of liver cirrhosis and is due to a low-grade cerebral edema associated with oxidative/nitrosative stress. Recent reports suggest that cognitive impairment in cirrhotic patients may not resolve completely after an attack of manifest HE. As astrocyte dysfunction is central to the pathogenesis of HE and astrocytes are critically involved in synaptic plasticity, we tested for sustained impairment of astrocyte function by analyzing expression levels of senescence biomarkers in ammonia-treated cultured rat astrocytes and in postmortem brain samples from cirrhotic patients with or without HE. NH4Cl time- and dose-dependently inhibited proliferation of cultured astrocytes by up to 45% (5 mmol/L, 72 h) and strongly increased senescence-associated -galactosidase activity. Inhibition of astrocyte proliferation by ammonia was mediated by a l-methionine sulfoximine-, oxidative stress-, and p38(MAPK)-dependent activation of p53 associated with enhanced transcription of cell cycle inhibitory genes GADD45 and p21. Mitochondria and the nucleus were identified as sources of oxygen radical formation after prolonged NH4Cl exposure. Concurrently, NH4Cl (5 mmol/L) treatment inhibited both epidermal growth factor- and brain-derived neurotrophic factor (BDNF)-induced proliferation as well as BDNF-mediated astrocyte morphology changes through downregulation of the respective growth factor receptors epidermal growth factor receptor and truncated tyrosine receptor kinase B. Increased mRNA expression levels of senescence-associated genes were also found in post mortem brain samples from patients with liver cirrhosis with HE, but not in those without HE. The data suggest that ammonia toxicity and HE are associated with premature astrocyte senescence, which may impair neurotransmission and contribute to persistence of cognitive disturbances after resolution of episodes of overt HE.
C1 [Goerg, Boris; Karababa, Ayse; Shafigullina, Aygul; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany.
   [Bidmon, Hans J.] Univ Dusseldorf, C&O Vogt Inst Brain Res, Dusseldorf, Germany.
C3 Heinrich Heine University Dusseldorf; Heinrich Heine University
   Dusseldorf
RP Häussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM haeussin@uni-duesseldorf.de
OI Gorg, Boris/0000-0002-4630-9420
FU Deutsche Forschungsgemeinschaft (through Sonderforschungsbereich) [SFB
   974]
FX Grant sponsor: Deutsche Forschungsgemeinschaft (through
   Sonderforschungsbereich); Grant number: SFB 974.
CR Aravamudan B, 2012, J CELL MOL MED, V16, P812, DOI 10.1111/j.1582-4934.2011.01356.x
   Bai G, 2001, J NEUROSCI RES, V66, P981, DOI 10.1002/jnr.10056
   Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015
   Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069
   Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200
   Butz M, 2013, ARCH BIOCHEM BIOPHYS, V536, P197, DOI 10.1016/j.abb.2013.04.004
   CAVANAGH JB, 1971, J NEUROL SCI, V12, P63, DOI 10.1016/0022-510X(71)90252-8
   Chen JR, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-15
   Chen QM, 2000, ANN NY ACAD SCI, V908, P111
   Cox ML, 2010, CELL SIGNAL, V22, P564, DOI 10.1016/j.cellsig.2009.11.014
   Dennis CV, METAB BRAIN IN PRESS
   Fenner BM, 2012, CYTOKINE GROWTH F R, V23, P15, DOI 10.1016/j.cytogfr.2012.01.002
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Görg B, 2008, HEPATOLOGY, V48, P567, DOI 10.1002/hep.22345
   Görg B, 2013, HEPATOLOGY, V57, P2436, DOI 10.1002/hep.26265
   Görg B, 2010, HEPATOLOGY, V52, P256, DOI 10.1002/hep.23656
   Häussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829
   HAUSSINGER D, 1994, GASTROENTEROLOGY, V107, P1475
   Häussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5
   Haussinger D, 2007, OXFORD TXB HEPATOLOG, P728
   Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006
   Jayakumar AR, 2004, NEUROCHEM RES, V29, P2051, DOI 10.1007/s11064-004-6878-9
   Jayakumar AR, 2004, GLIA, V46, P296, DOI 10.1002/glia.20003
   Kawano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048034
   Kruczek C, 2009, GLIA, V57, P79, DOI 10.1002/glia.20737
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lachmann V, 2013, ARCH BIOCHEM BIOPHYS, V536, P143, DOI 10.1016/j.abb.2013.05.004
   Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98
   Midgley AC, 2014, AGING CELL, V13, P235, DOI 10.1111/acel.12167
   Murthy CRK, 2001, J NEUROSCI RES, V66, P282, DOI 10.1002/jnr.1222
   Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883
   NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599
   Ohira K, 2007, EUR J NEUROSCI, V25, P406, DOI 10.1111/j.1460-9568.2007.05282.x
   OKEEFE EJ, 1983, MOL CELL ENDOCRINOL, V31, P167, DOI 10.1016/0303-7207(83)90147-8
   Oria M, 2014, J HEPATOL, V60, pS101, DOI 10.1016/S0168-8278(14)60268-3
   Panickar KS, 2009, NEUROCHEM INT, V55, P98, DOI 10.1016/j.neuint.2008.12.022
   RAGO R, 1990, ANAL BIOCHEM, V191, P31
   Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504
   RICHARDS WL, 1985, EXP CELL RES, V159, P235, DOI 10.1016/S0014-4827(85)80052-5
   Riggio O, 2011, CLIN GASTROENTEROL H, V9, P181, DOI 10.1016/j.cgh.2010.10.002
   Schliess F, 2002, FASEB J, V16, P739, DOI 10.1096/fj.01-0862fje
   Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015
   Shah NJ, 2008, NEUROIMAGE, V41, P706, DOI 10.1016/j.neuroimage.2008.02.057
   Tervonen TA, 2006, EUR J NEUROSCI, V24, P1277, DOI 10.1111/j.1460-9568.2006.05010.x
   Zhao RB, 2000, GENE DEV, V14, P981
   Zhou BG, 1999, NEUROSCI LETT, V276, P145, DOI 10.1016/S0304-3940(99)00816-2
NR 46
TC 70
Z9 73
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0894-1491
EI 1098-1136
J9 GLIA
JI Glia
PD JAN
PY 2015
VL 63
IS 1
BP 37
EP 50
DI 10.1002/glia.22731
PG 14
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AU0XC
UT WOS:000345344500003
PM 25092802
DA 2024-02-19
ER

PT J
AU MANTEIFEL, VM
   ROMANENKO, EB
   BABADZHANYAN, DP
   ZELENIN, AV
   VANYUSHIN, BF
AF MANTEIFEL, VM
   ROMANENKO, EB
   BABADZHANYAN, DP
   ZELENIN, AV
   VANYUSHIN, BF
TI ELECTRON-MICROSCOPY OF CHROMATIN IN RAT HEPATOCYTE NUCLEUS IN RELATION
   TO GENOME AGING
SO MOLECULAR BIOLOGY
LA English
DT Article
C1 AN BELOZERSKII MOLEC BIOL & BIOORGAN CHEM LAB,MOSCOW 119899,USSR.
C3 Lomonosov Moscow State University
RP MANTEIFEL, VM (corresponding author), ACAD SCI USSR,INST MOLEC BIOL,MOSCOW 117984,USSR.
CR BECHELLERIE JP, 1976, EUR J BIOCHEM, V58, P327
   BERDYSHEV GD, 1986, MOL GENET BIOFIZ, V11, P112
   Brodsky V.Y., 1985, GENOME MULTIPLICATIO
   CHENTSOV YS, 1974, ULTRASTRUCTURE CELL
   COLLINS JM, 1978, J BIOL CHEM, V253, P5769
   DERENZINI M, 1978, EXP CELL RES, V112, P443, DOI 10.1016/0014-4827(78)90226-4
   DERENZINI M, 1981, J ULTRA MOL STRUCT R, V75, P229, DOI 10.1016/S0022-5320(81)80138-4
   ERSHOV YV, 1979, MOL BIOL, V13, P1312
   FAKAN S, 1971, EXP CELL RES, V67, P129, DOI 10.1016/0014-4827(71)90628-8
   HADJILOV A, 1985, CELL BIOL MONOGRAPHS
   KHILOBOCK IY, 1986, VEST AKAD MED NAUK S, V10, P20
   Manteifel' V M, 1982, Mol Biol (Mosk), V16, P1051
   MANTEIFEL V M, 1977, Molekulyarnaya Biologiya (Moscow), V11, P677
   MEDVEDEV ZA, 1984, MECH AGEING DEV, V28, P139, DOI 10.1016/0047-6374(84)90014-9
   MEINDERS.J, 1971, Z ZELLFORSCH MIK ANA, V114, P165, DOI 10.1007/BF00333998
   MILLER JK, 1980, BIOCHEM J, V188, P55, DOI 10.1042/bj1880055
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   PROKOFEVABELGOV.AA, 1986, HETEROCHROMIC CHROMO
   RICHARDSON A, 1982, J GERONTOL, V37, P666, DOI 10.1093/geronj/37.6.666
   TAS S, 1982, J GERONTOL, V37, P673, DOI 10.1093/geronj/37.6.673
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   TOKUYASU K, 1968, J CELL BIOL, V39, P630, DOI 10.1083/jcb.39.3.630
   URVYAEVA IV, 1976, TSITOLOGIYA+, V21, P1427
   ZHELABOVSKAYA SM, 1972, EXP GERONTOL, V7, P321
NR 24
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 0026-8933
J9 MOL BIOL+
JI Mol. Biol.
PD JUL-AUG
PY 1988
VL 22
IS 4
BP 876
EP 883
PN 2
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA U7667
UT WOS:A1988U766700009
DA 2024-02-19
ER

PT J
AU Kumar, VB
   Vyas, K
   Buddhiraju, M
   Alshaher, M
   Flood, JF
   Morley, JE
AF Kumar, VB
   Vyas, K
   Buddhiraju, M
   Alshaher, M
   Flood, JF
   Morley, JE
TI Changes in membrane fatty acids and delta-9 desaturase in senescence
   accelerated (SAMP8) mouse hippocampus with aging
SO LIFE SCIENCES
LA English
DT Article
DE delta-9 desaturase; aging; mice; senescence acceleration; hippocampus
ID STEAROYL-COA DESATURASE; AGE-RELATED-CHANGES; LIVER-MICROSOMES; RAT;
   GENE; TEMPERATURE; PLASMA; INVIVO; BRAIN
AB Senescence accelerated mice (SAMP8) exhibit age induced impairments such as loss of memory and learning disabilities by the age of 8 - 10 months. Analysis of hippocampus of SAMP8 mice revealed that delta 9-desaturase (Delta(9)desaturase) activity reduced up to 44-50% with age. Correspondingly, levels of unsaturated fatty acids are also lowered in the aged animals approximately to the same level. RNase protection assay showed that Delta(9)specific message decreased similarly with age. As such a decrease is known to cause alterations in membrane fluidity and affect cellular signaling pathways, these results suggest that lowering of Delta(9)gene expression may be partly involved in age induced impairments.
C1 VA Med Ctr, Geriatr Res & Clin Ctr, St Louis, MO 63110 USA.
   St Louis Univ, Sch Med, St Louis, MO 63110 USA.
C3 Saint Louis University
RP Kumar, VB (corresponding author), VA Med Ctr, Geriatr Res & Clin Ctr, St Louis, MO 63110 USA.
RI Morley, John Edward/K-1570-2019; morley, john e/F-9177-2011
OI morley, john e/0000-0001-6444-2965; Shaher, Motaz/0000-0003-3248-708X
CR BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347
   Carratu L, 1996, P NATL ACAD SCI USA, V93, P3870, DOI 10.1073/pnas.93.9.3870
   COSTA E, 1983, LIFE SCI, V32, P165, DOI 10.1016/0024-3205(83)90028-0
   CRAWFORD M A, 1981, Progress in Lipid Research, V20, P31, DOI 10.1016/0163-7827(81)90011-4
   CUNNANE SC, 1984, BRIT J NUTR, V51, P209, DOI 10.1079/BJN19840025
   DEANTUENNO RJ, 1993, LIPIDS, V163, P285
   FLOOD JF, 1992, J GERONTOL, V47, pB52, DOI 10.1093/geronj/47.2.B52
   Folch J., J BIOL CHEM
   HABIB NA, 1987, BRIT J CANCER, V56, P455, DOI 10.1038/bjc.1987.223
   HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3
   HORROBIN DF, 1984, LIPIDS, V19, P806, DOI 10.1007/BF02534476
   JEFFCOAT R, 1977, LIPIDS, V12, P480, DOI 10.1007/BF02535446
   KAESTNER KH, 1989, J BIOL CHEM, V264, P14755
   KHOO DE, 1991, BRIT J CANCER, V63, P97, DOI 10.1038/bjc.1991.20
   KUMAR BV, 1989, BIOCH ACS, V28, P4042
   LEIKIN AI, 1988, BIOCHIM BIOPHYS ACTA, V963, P311, DOI 10.1016/0005-2760(88)90296-2
   MANDON EC, 1988, ACTA PHYSIOL PHARM L, V38, P49
   MANIONGUI C, 1993, LIPIDS, V28, P291, DOI 10.1007/BF02536313
   MIHARA K, 1990, J BIOCHEM-TOKYO, V108, P1022, DOI 10.1093/oxfordjournals.jbchem.a123301
   MORLEY JE, 1995, LIFE SCI, V57, P1327, DOI 10.1016/0024-3205(95)02089-2
   NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505
   Nishida S, 1998, LIPIDS, V33, P251, DOI 10.1007/s11745-998-0203-0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Tosco A, 1997, BIOCHEM BIOPH RES CO, V230, P457, DOI 10.1006/bbrc.1996.5984
   UMEKI S, 1983, J THERM BIOL, V8, P353, DOI 10.1016/0306-4565(83)90022-0
NR 29
TC 44
Z9 45
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PD SEP 10
PY 1999
VL 65
IS 16
BP 1657
EP 1662
DI 10.1016/S0024-3205(99)00414-2
PG 6
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 236UU
UT WOS:000082618200006
PM 10573183
DA 2024-02-19
ER

PT J
AU Zhao, DL
   Gao, YY
   Su, Y
   Zhou, YY
   Yang, T
   Li, Y
   Wang, YQ
   Sun, Y
   Chen, L
   Zhang, F
   Zhang, ZL
   Wang, FX
   Shao, JJ
   Zheng, SZ
AF Zhao, Danli
   Gao, Yuanyuan
   Su, Ying
   Zhou, Yuanyuan
   Yang, Ting
   Li, Yang
   Wang, Yingqian
   Sun, Ying
   Chen, Li
   Zhang, Feng
   Zhang, Zili
   Wang, Feixia
   Shao, Jiangjuan
   Zheng, Shizhong
TI Oroxylin A regulates cGAS DNA hypermethylation induced by methionine
   metabolism to promote HSC senescence
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article; Early Access
DE Hepatic fibrosis; Cell senescence; cGAS-STING; DNA methylation;
   Methionine cyclic metabolism; Oroxylin A
ID HEPATIC STELLATE CELLS; METHYLATION; INHIBITION; ACTIVATION; EXPRESSION;
   CANCER; SENSOR; ROS
AB Relevant studies have recognized the important role of hepatic stellate cell (HSC) senescence in anti-liver fibrosis. Cellular senescence is believed to be regulated by the cGAS-STING signaling pathway. However, underlying exact mechanisms of cGAS-STING pathway in hepatic stellate cell senescence are still unclear. Here, we found that Oroxylin A could promote senescence in HSC by activating the cGAS-STING pathway. Moreover, activation of the cGAS-STING pathway was dependent on DNMT3A downregulation, which suppressed cGAS gene DNA methylation. Interestingly, the attenuation of DNMT activity relied on the reduction of methyl donor SAM level. Noteworthy, the downregulation of SAM levels implied the imbalance of methionine cycle metabolism, and MAT2A was considered to be an important regulatory enzyme in metabolic processes. In vivo experiments also indicated that Oroxylin A induced senescence of HSCs in mice with liver fibrosis, and DNMT3A overexpression partly offset this effect. In conclusion, we discovered that Oroxylin A prevented the methylation of the cGAS gene by preventing the production of methionine metabolites, which promoted the senescence of HSCs. This finding offers a fresh hypothesis for further research into the anti-liver fibrosis mechanism of natural medicines.
C1 [Zhao, Danli; Gao, Yuanyuan; Zhou, Yuanyuan; Yang, Ting; Li, Yang; Wang, Yingqian; Sun, Ying; Chen, Li; Zhang, Feng; Zhang, Zili; Wang, Feixia; Shao, Jiangjuan; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing, Peoples R China.
   [Su, Ying] Anhui Med Univ, Hefei, Anhui, Peoples R China.
C3 Nanjing University of Chinese Medicine; Anhui Medical University
RP Shao, JJ; Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chinese, Nanjing, Peoples R China.
EM jjshao@njucm.edu.cn; nytws@njucm.edu.cn
RI JIN, LIYING/JFB-1980-2023; li, jiaxin/JNT-5073-2023; 王,
   娅冰/JGE-0541-2023; sun, jiamin/JPY-2155-2023; liu, sha/JXL-6600-2024;
   zhang, lin/IZQ-4870-2023; li, yansong/JXL-5023-2024; zhang,
   lm/JWP-8874-2024
OI Zheng, Shizhong/0000-0002-7092-7843
FU National Natural Science Foundation of China [82274185, 82073914,
   82173874, 82000572]; Natural Science Foundation of Jiangsu Province
   [BK20200840]; Major Project of the Natural Science Research of Jiangsu
   Higher Education Institutions [19KJA310005, 20KJB310003]; Joint Project
   of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of
   Chinese Materia Medica and Yangtze River Pharmaceutical [JKLPSE202005];
   Open Project of Chinese Materia Medica First -Class Discipline of
   Nanjing University of Chinese Medicine [2020YLKX023, 2020YLKX022];
   Jiangsu Graduate Research and Practice Innovation Program [KYCX22_2004]
FX The work was supported by the National Natural Science Foundation of
   China (82274185, 82073914, 82173874, 82000572) , the Natural Science
   Foundation of Jiangsu Province (BK20200840) , the Major Project of the
   Natural Science Research of Jiangsu Higher Education Institutions
   (19KJA310005, 20KJB310003) , the Joint Project of Jiangsu Key Laboratory
   for Pharmacology and Safety Evaluation of Chinese Materia Medica and
   Yangtze River Pharmaceutical (JKLPSE202005) , the Open Project of
   Chinese Materia Medica First -Class Discipline of Nanjing University of
   Chinese Medicine (2020YLKX023, 2020YLKX022) , and Jiangsu Graduate
   Research and Practice Innovation Program (KYCX22_2004) . We are very
   grateful for the help provided by the experiment center for science and
   technology of Nanjing University of Chinese Medicine.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Beck MA, 2021, EMBO J, V40, DOI 10.15252/embj.2021108234
   Bian EB, 2013, CELL SIGNAL, V25, P355, DOI 10.1016/j.cellsig.2012.10.007
   Bian ML, 2019, APOPTOSIS, V24, P905, DOI 10.1007/s10495-019-01568-2
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dasari S, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031532
   DiNardo CD, 2019, BLOOD, V133, P7, DOI 10.1182/blood-2018-08-868752
   Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050
   Du K, 2018, GASTROENTEROLOGY, V154, P1465, DOI 10.1053/j.gastro.2017.12.022
   Hao F, 2023, COMB CHEM HIGH T SCR, V26, P224, DOI 10.2174/1386207325666220517095503
   Haque N, 2022, MAR DRUGS, V20, DOI 10.3390/md20080528
   Härtlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012
   Hu CH, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-021-01154-x
   Hu X, 2020, EUR J PHARMACOL, V886, DOI 10.1016/j.ejphar.2020.173424
   Jia Y, 2018, REDOX BIOL, V19, P375, DOI 10.1016/j.redox.2018.09.007
   Jin C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03048-x
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Jin HH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12431
   Jin HH, 2018, CHEM-BIOL INTERACT, V285, P14, DOI 10.1016/j.cbi.2018.02.025
   Kai J, 2020, FREE RADICAL BIO MED, V153, P89, DOI 10.1016/j.freeradbiomed.2020.03.031
   Kim H, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz5683
   Lai JZ, 2021, MOL THER, V29, P1758, DOI 10.1016/j.ymthe.2021.02.005
   Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Li ZH, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00349-7
   Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266
   Martinez-Zamudio RI, 2021, AGING CELL, V20, DOI 10.1111/acel.13344
   Mentch SJ, 2016, ANN NY ACAD SCI, V1363, P91, DOI 10.1111/nyas.12956
   Noureddin M, 2015, EXP BIOL MED, V240, P809, DOI 10.1177/1535370215579161
   Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024
   Pascale RM, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030409
   Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003
   Ramani Komal, 2017, Liver Res, V1, P103, DOI 10.1016/j.livres.2017.07.002
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Shen M, 2021, REDOX BIOL, V47, DOI 10.1016/j.redox.2021.102151
   Shen M, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106637
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Takahashi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15287
   Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Tumburu L, 2021, BLOOD, V137, P3116, DOI 10.1182/blood.2020009063
   Wang FX, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0324-8
   Wang KF, 2019, EBIOMEDICINE, V42, P458, DOI 10.1016/j.ebiom.2019.03.058
   Werge MP, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051081
   Wu P, 2016, CHIN J NAT MEDICINES, V14, P255, DOI 10.1016/S1875-5364(16)30025-5
   Wu YT, 2017, TOXICOL APPL PHARM, V315, P35, DOI 10.1016/j.taap.2016.12.002
   Xu WX, 2017, FEBS J, V284, P114, DOI 10.1111/febs.13956
   Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941
   Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang MF, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111572
   Zhang NF, 2018, ANIM NUTR, V4, P11, DOI 10.1016/j.aninu.2017.08.009
   Zhang ZL, 2019, LIFE SCI, V238, DOI 10.1016/j.lfs.2019.116934
   Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021
   Zhu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071612
   Zhu XF, 2020, J PATHOL, V252, P423, DOI 10.1002/path.5536
   Zhu YY, 2022, ACTA PHARM SIN B, V12, P4011, DOI 10.1016/j.apsb.2022.08.022
NR 60
TC 2
Z9 2
U1 6
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD 2023 JAN
PY 2023
VL 187
AR 106590
DI 10.1016/j.phrs.2022.106590
EA DEC 2022
PG 19
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 7Y5CG
UT WOS:000914896600002
PM 36464146
OA hybrid
DA 2024-02-19
ER

PT J
AU Muraca, M
   Burlina, AB
AF Muraca, M
   Burlina, AB
TI Liver and liver cell transplantation for glycogen storage disease type
   IA
SO ACTA GASTRO-ENTEROLOGICA BELGICA
LA English
DT Article; Proceedings Paper
CT Consensus Conference on Liver and Liver Cell Transplantation in Inborn
   Errors of Metabolism
CY JAN 26-27, 2006
CL Brussels, BELGIUM
ID GLUCOSE-METABOLISM; HEPATIC ADENOMAS; THERAPY; PATIENT; TUMORS; 1A; IV;
   IB
AB Glycogen storage disease type Ia (GSDIa) is an inherited disorder of glucose metabolism, due to the selective deficiency of the hepatic enzyme glucose-6-phosphatase. Clinical manifestations include severe hypoglycaemia three to four hours post-prandially, increased production of lactic acid, triglycerides and uric acid, hepatic glycogen storage disease with development of multiple adenomas and kidney disease with proteinuria. Liver transplantation is frequently performed in order to achieve metabolic control and when malignant transformation of adenomas is suspected. Long term outcome following transplantation is good, but immunosuppressive therapy can worsen the progression of associated kidney disease. Hepatocyte transplantation could be considered as a less invasive procedure in such patients. Our experience with hepatocyte transplantation in a 47 year-old woman affected by glycogen storage disease type la and suffering of severe fasting hypoglycaemia indicates that the procedure can partially correct some metabolic abnormalities and improve the quality of life in this disease. However, the metabolic improvement was reduced and finally abolished during long term follow-up, probably due to rejection or to senescence of transplanted cells. Moreover, the portal and pulmonary hypertension associated with the disease need to be evaluated for their possible influence on haemodynamic changes associated with cell infusion. Finally, hepatic adenomas need careful monitoring because of the possible risk of malignant transformation.
C1 Osped Pediat Bambino Gesu, IRCCS, Dept Labs, Lab Anal, I-00165 Rome, Italy.
   Azienda Osped Univ, Dept Pediat, Div Inborn Metab Dis, Padua, Italy.
C3 IRCCS Bambino Gesu; University of Padua; Azienda Ospedaliera -
   Universita di Padova
RP Muraca, M (corresponding author), Osped Pediat Bambino Gesu, IRCCS, Dept Labs, Lab Anal, Piazza St Onofrio 4, I-00165 Rome, Italy.
EM muraca@opbg.net
RI burlina, alberto/AHE-6095-2022; Muraca, Maurizio/G-3063-2012
OI MURACA, MAURIZIO/0000-0003-1218-097X
CR Bhattacharya K, 2004, J INHERIT METAB DIS, V27, P539, DOI 10.1023/B:BOLI.0000037400.49488.20
   BIANCHI L, 1993, EUR J PEDIATR, V152, pS63
   Charny CK, 2001, BRIT J SURG, V88, P808, DOI 10.1046/j.0007-1323.2001.01771.x
   CHEN YT, 1991, PEDIATR NEPHROL, V5, P71, DOI 10.1007/BF00852851
   CHEN YT, 1991, J INHERIT METAB DIS, V14, P80, DOI 10.1007/BF01804394
   CHEN YT, 2001, METABOLIC MOL BASES, P121
   EMMETT M, 1978, JAMA-J AM MED ASSOC, V239, P1642, DOI 10.1001/jama.239.16.1642
   Faivre L, 1999, J INHERIT METAB DIS, V22, P723, DOI 10.1023/A:1005544117285
   GROMPE MG, 2002, LANCET, V359, P317
   IBANEZ VM, 1987, TRANSPLANT P, V19, P3803
   KHARSA G, 1990, GASTROEN CLIN BIOL, V14, P84
   KIRSCHNER BS, 1991, GASTROENTEROLOGY, V101, P238, DOI 10.1016/0016-5085(91)90483-2
   Koestinger A, 2000, TRANSPLANTATION, V69, P2205, DOI 10.1097/00007890-200005270-00045
   Labrune P, 1997, J PEDIATR GASTR NUTR, V24, P276, DOI 10.1097/00005176-199703000-00008
   LABRUNE P, 2002, TRANSPLANTATION EUR, V161, pS53
   Lee PJ, 2002, EUR J PEDIATR, V161, pS46
   LEONARD J, 2002, EUR J PEDIATR, V161, pS112
   Lerut JP, 2003, TRANSPL INT, V16, P879, DOI 10.1111/j.1432-2277.2003.tb00258.x
   MALATACK JJ, 1983, LANCET, V1, P1073
   Martinez Ibanez V, 1987, Transplant Proc, V19, P3803
   Matern D, 1999, EUR J PEDIATR, V158, pS43, DOI 10.1007/PL00014320
   Muraca M, 2002, LANCET, V359, P317, DOI 10.1016/S0140-6736(02)07529-3
   PARKER P, 1981, GASTROENTEROLOGY, V81, P534
   POE R, 1988, AM J SURG PATHOL, V12, P477, DOI 10.1097/00000478-198806000-00008
   Reding R, 2004, ACTA GASTRO-ENT BELG, V67, P176
   SELBY R, 1993, EUR J PEDIATR, V152, pS71
   Visser G, 2000, J PEDIATR-US, V137, P187, DOI 10.1067/mpd.2000.105232
   Weinstein DA, 2002, EUR J PEDIATR, V161, pS35, DOI [10.1007/BF02679991, 10.1007/s00431-002-1000-2]
   Yoshikawa M, 2001, J GASTROENTEROL, V36, P52, DOI 10.1007/s005350170155
NR 29
TC 19
Z9 19
U1 0
U2 1
PU ACTA MEDICAL BELGICA
PI BRUSSELS
PA AVENUE CIRCULAIRE 138 A, B-1180 BRUSSELS, BELGIUM
SN 0001-5644
J9 ACTA GASTRO-ENT BELG
JI Acta Gastro-Enterol. Belg.
PD OCT-DEC
PY 2005
VL 68
IS 4
BP 469
EP 472
PG 4
WC Gastroenterology & Hepatology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 011XO
UT WOS:000235302300017
PM 16433006
DA 2024-02-19
ER

PT J
AU Kong, LN
   Dong, RC
   Huang, K
   Wang, XH
   Wang, DL
   Yue, N
   Wang, CY
   Sun, PY
   Gu, JN
   Luo, HF
   Liu, KX
   Wu, JJ
   Sun, HJ
   Meng, Q
AF Kong, Lina
   Dong, Renchao
   Huang, Kai
   Wang, Xiaohui
   Wang, Dalong
   Yue, Nan
   Wang, Changyuan
   Sun, Pengyuan
   Gu, Jiangning
   Luo, Haifeng
   Liu, Kexin
   Wu, Jingjing
   Sun, Huijun
   Meng, Qiang
TI Yangonin modulates lipid homeostasis, ameliorates cholestasis and
   cellular senescence in alcoholic liver disease via activating nuclear
   receptor FXR
SO PHYTOMEDICINE
LA English
DT Article; Early Access
DE Alcoholic liver injury; Farnesoid X receptor; Yangonin; Lipid
   homeostasis; Cellular senescence
ID INJURY; INFLAMMATION
AB Background: : Alcoholic liver disease (ALD) is a progressive disease beginning with simple steatosis but can progress to alcoholic steatohepatitis, fibrosis, cirrhosis, and even hepatocellular carcinoma. The morbidity of ALD is on the rise and has been a large burden on global healthcare system. It is unfortunately that there are currently no approved therapeutic drugs against ALD. Hence, it is of utmost urgency to develop the efficacious therapies. The ability of many molecular targets against ALD is under investigation. Farnesoid X receptor (FXR), a member of the ligand-activated transcription factor superfamily, has been recently demonstrated to have a crucial role in the pathogenesis and progression of ALD.
   Purpose: : The purpose of the study is to determine whether Yangonin (YAN), a FXR agonist previously demonstrated by us, exerts the hepatoprotective effects against ALD and further to clarify the mechanisms in vitro and in vivo.
   Study design: : The alcoholic liver disease model induced by Lieber-Decarli liquid diet was established with or without Yan treatment.
   Methods: : We determined the liver to body weight ratios, the body weight, serum and hepatic biochemical indicators. The alleviation of the liver histopathological progression was evaluated by H&E and immunohistochemical staining. Western blot and quantitative real-time PCR were used to demonstrate YAN treatment-mediated alleviation mechanisms of ALD.
   Results: : The data indicated that YAN existed hepatoprotective activity against ALD via FXR activation. YAN improved the lipid homeostasis by decreasing hepatic lipogenesis and increasing fatty acid beta-oxidation and lipoprotein lipolysis through modulating the related protein. Also, YAN ameliorated ethanol-induced cholestasis via inhibiting bile acid uptake transporter Ntcp and inducing bile acid efflux transporter Bsep and Mrp2 expression. Besides, YAN improved bile acid homeostasis via inducing Sult2a1 expression and inhibiting Cyp7a1 and Cyp8b1 expression. Furthermore, YAN attenuated ethanol-triggered hepatocyte damage by inhibiting cellular senescence marker P16, P21 and Hmga1 expression. Also, YAN alleviated ethanol-induced inflammation by down-regulating the inflammation-related gene IL-6, IL-1 beta and TNF-alpha expression. Notably, the protective effects of YAN were cancelled by FXR siRNA in vitro and FXR antagonist GS in vivo.
   Conclusions: : YAN exerted significant hepatoprotective effects against liver injury triggered by ethanol via FXR-mediated target gene modulation.
C1 [Kong, Lina; Dong, Renchao; Wang, Xiaohui; Wang, Dalong; Yue, Nan; Wang, Changyuan; Sun, Pengyuan; Liu, Kexin; Wu, Jingjing; Sun, Huijun; Meng, Qiang] Dalian Med Univ, Dept Clin Pharmacol, Coll Pharm, 9 West Sect,Lvshun South Rd, Dalian 116044, Peoples R China.
   [Huang, Kai] Nanjing Med Univ, Drug Clin Trial Inst, Affiliated Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China.
   [Gu, Jiangning; Luo, Haifeng] Dalian Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Dalian 116011, Peoples R China.
C3 Dalian Medical University; Nanjing Medical University; Dalian Medical
   University
RP Meng, Q (corresponding author), Dalian Med Univ, Dept Clin Pharmacol, Coll Pharm, 9 West Sect,Lvshun South Rd, Dalian 116044, Peoples R China.
EM qiangmeng@dmu.edu.cn
RI Liu, Kexin/GQH-0970-2022; Wang, dalong/HDN-9881-2022; Huang,
   Kai/JVO-5066-2024; zhao, weiwei/JUU-6585-2023; zhou, wei/JQJ-0490-2023
FU National Natural Science Foundation of China [81302826, 81874324];
   Dalian Science, technology innovation fund [2018J12SN065]; Basic
   research project of Education Department of Liaoning Province
   [LZ2019037]; Project of Liaoning BaiQianWan Talents Program
FX This present study was financially supported by a grant from the
   National Natural Science Foundation of China (Nos. 81302826, 81874324),
   Dalian Science, technology innovation fund (No. 2018J12SN065), Basic
   research project of Education Department of Liaoning Province
   (LZ2019037) and the Project of Liaoning BaiQianWan Talents Program.
CR Bai T, 2016, PHARMACOL RES, V105, P1, DOI 10.1016/j.phrs.2015.12.022
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Blaya D, 2016, GUT, V65, P1535, DOI 10.1136/gutjnl-2015-311314
   Cohen JI, 2011, ANTIOXID REDOX SIGN, V15, P523, DOI 10.1089/ars.2010.3746
   Dong RC, 2019, PHYTOMEDICINE, V53, P134, DOI 10.1016/j.phymed.2018.09.006
   Dong RC, 2019, EUR J PHARMACOL, V857, DOI 10.1016/j.ejphar.2019.172461
   Gadaleta RM, 2017, MOL ASPECTS MED, V56, P66, DOI 10.1016/j.mam.2017.04.002
   Gao XG, 2018, TOXICOL APPL PHARM, V348, P105, DOI 10.1016/j.taap.2018.04.015
   Garton M, 2013, J MOL BIOL, V425, P2910, DOI 10.1016/j.jmb.2013.05.005
   Giannone RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012407
   Hartmann P, 2018, HEPATOLOGY, V67, P2150, DOI 10.1002/hep.29676
   Hu S., 2019, PHARMACOL RES, V150
   Huanhuan J., 2018, CELL PROLIFERAT, V51
   Iracheta-Vellve A, 2018, HEPATOL COMMUN, V2, P1379, DOI 10.1002/hep4.1256
   Jadhav K, 2018, MOL METAB, V9, P131, DOI 10.1016/j.molmet.2018.01.005
   Kong B, 2019, DIGEST LIVER DIS, V51, P570, DOI 10.1016/j.dld.2018.12.026
   Li JSZ, 2017, SCIENCE, V355, P638, DOI 10.1126/science.aah6752
   Li TG, 2020, HEPATOBIL SURG NUTR, V9, P152, DOI 10.21037/hbsn.2019.09.03
   LIEBER CS, 1994, METHOD ENZYMOL, V233, P585
   Ligresti A, 2012, PHARMACOL RES, V66, P163, DOI 10.1016/j.phrs.2012.04.003
   Liu JX, 2020, PHARMACOL RES, V152, DOI 10.1016/j.phrs.2020.104631
   Liu ZB, 2017, J BIOMED RES, V31, P408, DOI 10.7555/JBR.31.20160160
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   Lu CF, 2015, IUBMB LIFE, V67, P645, DOI 10.1002/iub.1409
   Mads I., 2020, CLIN GASTROENTEROL H, V20, P1542
   Meng Q, 2015, TOXICOL APPL PHARM, V283, P178, DOI 10.1016/j.taap.2015.01.020
   Schumacher JD, 2019, HANDB EXP PHARMACOL, V256, P325, DOI 10.1007/164_2019_228
   Singh S, 2017, WORLD J GASTROENTERO, V23, P6549, DOI 10.3748/wjg.v23.i36.6549
   Stickel F, 2017, GUT LIVER, V11, P173, DOI 10.5009/gnl16477
   Tan XY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900257
   Tung B Y, 1999, Clin Liver Dis, V3, P585, DOI 10.1016/S1089-3261(05)70086-6
   Voican CS, 2015, LIVER INT, V35, P967, DOI 10.1111/liv.12575
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wang J, 2015, J FOOD SCI TECH MYS, V52, P1164, DOI 10.1007/s13197-013-1047-2
   Wang M, 2019, CRIT REV FOOD SCI, V59, pS116, DOI 10.1080/10408398.2018.1544542
   White CM, 2018, J CLIN PHARMACOL, V58, P1396, DOI 10.1002/jcph.1263
   Wruck CJ, 2008, MOL PHARMACOL, V73, P1785, DOI 10.1124/mol.107.042499
   Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057
   Xu LN, 2020, PHYTOMEDICINE, V67, DOI 10.1016/j.phymed.2019.153139
   Zeng T, 2018, REDOX BIOL, V14, P295, DOI 10.1016/j.redox.2017.09.018
   Zhang LJ, 2017, INT J BIOL MACROMOL, V99, P63, DOI 10.1016/j.ijbiomac.2017.01.125
   Zhang YM, 2017, TOXICOLOGY, V378, P53, DOI 10.1016/j.tox.2017.01.007
   Zheng LL, 2018, BIOMED PHARMACOTHER, V97, P481, DOI 10.1016/j.biopha.2017.10.153
NR 43
TC 13
Z9 13
U1 2
U2 17
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD 2021 SEP
PY 2021
VL 90
AR 153629
DI 10.1016/j.phymed.2021.153629
EA JUL 2021
PG 13
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA UA5RO
UT WOS:000685219400011
PM 34304130
DA 2024-02-19
ER

PT J
AU Tammen, SA
   Park, LK
   Dolnikowski, GG
   Ausman, LM
   Friso, S
   Choi, SW
AF Tammen, Stephanie A.
   Park, Lara K.
   Dolnikowski, Gregory G.
   Ausman, Lynne M.
   Friso, Simonetta
   Choi, Sang-Woon
TI Hepatic DNA hydroxymethylation is site-specifically altered by chronic
   alcohol consumption and aging
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Alcohol; Aging; DNA hydroxymethylation; hmeDIP-Chip; Liver
ID GLUCOCORTICOID-RECEPTOR; HEPATOCELLULAR-CARCINOMA; EPIGENETIC
   REGULATION; LEPTIN RESISTANCE; GROWTH-HORMONE; GENOMIC DNA; FATTY LIVER;
   METHYLATION; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION
AB Global DNA hydroxymethylation is markedly decreased in human cancers, including hepatocellular carcinoma, which is associated with chronic alcohol consumption and aging. Because gene-specific changes in hydroxymethylcytosine may affect gene transcription, giving rise to a carcinogenic environment, we determined genome-wide site-specific changes in hepatic hydroxymethylcytosine that are associated with chronic alcohol consumption and aging.
   Young (4 months) and old (18 months) male C57Bl/6 mice were fed either an ethanol-containing Lieber-DeCarli liquid diet or an isocaloric control diet for 5 weeks. Genomic and gene-specific hydroxymethylcytosine patterns were determined through hydroxymethyl DNA immunoprecipitation array in hepatic DNA.
   Hydroxymethylcytosine patterns were more perturbed by alcohol consumption in young mice than in old mice (431 differentially hydroxymethylated regions, DhMRs, in young vs 189 DhMRs in old). A CpG island similar to 2.5 kb upstream of the glucocorticoid receptor gene, Nr3c1, had increased hydroxymethylation as well as increased mRNA expression (p = 0.015) in young mice fed alcohol relative to the control group. Aging alone also altered hydroxymethylcytosine patterns, with 331 DhMRs, but alcohol attenuated this effect. Aging was associated with a decrease in hydroxymethylcytosine similar to 1 kb upstream of the leptin receptor gene, Lepr, and decreased transcription of this gene (p = 0.029). Nr3c1 and Lepr are both involved in hepatic lipid homeostasis and hepatosteatosis, which may create a carcinogenic environment.
   These results suggest that the location of hydroxymethylcytosine in the genome is site specific and not random, and that changes in hydroxymethylation may play a role in the liver's response to aging and alcohol.
C1 [Tammen, Stephanie A.; Park, Lara K.; Dolnikowski, Gregory G.; Ausman, Lynne M.; Choi, Sang-Woon] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Tammen, Stephanie A.; Park, Lara K.; Dolnikowski, Gregory G.; Ausman, Lynne M.; Choi, Sang-Woon] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
   [Friso, Simonetta] Univ Verona, Sch Med, Verona, Italy.
   [Choi, Sang-Woon] CHA Univ, Chaum Life Ctr, Sch Med, 442 Dosan Daero, Seoul 135948, South Korea.
C3 United States Department of Agriculture (USDA); Tufts University; Tufts
   University; University of Verona; Pochon Cha University
RP Choi, SW (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.; Choi, SW (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.; Choi, SW (corresponding author), CHA Univ, Chaum Life Ctr, Sch Med, 442 Dosan Daero, Seoul 135948, South Korea.
EM sang.choi@cha.ac.kr
RI Friso, Simonetta/K-4715-2016; Dolnikowski, G/C-4354-2008
OI Dolnikowski, G/0000-0001-5886-2656
FU U.S. Department of Agriculture-Agricultural Research Service (ARS)
   [58-1950-0-014]; Korean Food Research Institute
FX This work is based upon work supported by the U.S. Department of
   Agriculture-Agricultural Research Service (ARS) under Agreement No.
   58-1950-0-014. Any opinions, findings, conclusion, or recommendations
   expressed in this publication are those of the author(s) and do not
   necessarily reflect the view of the U.S. Dept of Agriculture. This work
   is also supported in part by the Korean Food Research Institute
   (S.W.C.). All authors participated in the design of the research
   project. S.A.T. and L.K.P. adapted the microarray methods and
   computational analysis for use in this study. S.A.T. and S.W.C.
   conducted the research and drafted manuscript. G.G.D., L.M.A., and S.F.
   designed the research, interpreted the results of experiment, and
   revised manuscript.
CR Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938
   Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206
   Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602
   Clément K, 1998, NATURE, V392, P398, DOI 10.1038/32911
   Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002
   de Rooij SR, 2012, PSYCHONEUROENDOCRINO, V37, P782, DOI 10.1016/j.psyneuen.2011.09.010
   DECARLI LM, 1967, J NUTR, V91, P331, DOI 10.1093/jn/91.3_Suppl.331
   Diehl AM, 2005, HEPATOL RES, V33, P138, DOI 10.1016/j.hepres.2005.09.022
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008
   Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963
   Gabriely I, 2002, DIABETES, V51, P1016, DOI 10.2337/diabetes.51.4.1016
   Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508
   Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023
   Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223
   Leclercq IA, 2002, J HEPATOL, V37, P206, DOI 10.1016/S0168-8278(02)00102-2
   Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726
   Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008
   LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417
   Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X
   Liu Chunhua, 2013, P 2013 IEEE INT S IN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0062828
   Mandrekar P, 2011, WORLD J GASTROENTERO, V17, P2456, DOI 10.3748/wjg.v17.i20.2456
   McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020
   Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026
   Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509
   Münzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547
   Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110
   Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034
   PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776
   Radtke KM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.21
   Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005
   Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004
   Sauer J, 2010, BRIT J NUTR, V104, P24, DOI 10.1017/S0007114510000322
   Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135
   Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462
   Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109
   Tammen SA, 2014, ALCOHOL CLIN EXP RES, V38, P2178, DOI 10.1111/acer.12477
   Udali S, 2015, HEPATOLOGY, V62, P496, DOI 10.1002/hep.27823
   Uygun A, 2000, AM J GASTROENTEROL, V95, P3584
   Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739
   Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com
   Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731
   Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011
   YEHUDA R, 1991, AM J PSYCHIAT, V148, P499
   Yudt MR, 2002, MOL ENDOCRINOL, V16, P1719, DOI 10.1210/me.2002-0106
NR 49
TC 7
Z9 7
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD MAR
PY 2017
VL 56
IS 2
BP 535
EP 544
DI 10.1007/s00394-015-1098-4
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EN5IR
UT WOS:000396039300008
PM 26578530
DA 2024-02-19
ER

PT J
AU Jannone, G
   de Magnée, C
   Tambucci, R
   Evraerts, J
   Ravau, J
   Najimi, M
   Sokal, EM
AF Jannone, Giulia
   de Magnee, Catherine
   Tambucci, Roberto
   Evraerts, Jonathan
   Ravau, Joachim
   Najimi, Mustapha
   Sokal, Etienne Marc
TI Premature senescence of the liver in Alagille patients
SO PLOS ONE
LA English
DT Article
ID HEPATOCYTES
AB IntroductionAlagille syndrome (ALGS) is an autosomal dominant disease characterized by a multisystem involvement including bile duct paucity and cholestasis, caused by JAG1 or NOTCH2 mutations in most of the cases. Jagged1-Notch2 interactions are known to be crucial for intrahepatic biliary tract development, but the Notch signaling pathway is also involved in the juxtacrine transmission of senescence and in the induction and modulation of the senescence-associated secretory phenotype (SASP). AimOur aim was to investigate premature senescence and SASP in ALGS livers. MethodsLiver tissue from ALGS patients was prospectively obtained at the time of liver transplantation (n = 5) and compared to control livers (n = 5). ResultsWe evidenced advanced premature senescence in the livers of five JAG1 mutated ALGS pediatric patients through increased senescence-associated beta-galactosidase activity (p<0.05), increased p16 and p21 gene expression (p<0.01), and increased p16 and gamma H2AX protein expression (p<0.01). Senescence was located in hepatocytes of the whole liver parenchyma as well as in remaining bile ducts. The classical SASP markers TGF-beta 1, IL-6, and IL-8 were not overexpressed in the livers of our patients. ConclusionsWe demonstrate for the first time that ALGS livers display important premature senescence despite Jagged1 mutation, underlying the complexity of senescence and SASP development pathways.
C1 [Jannone, Giulia; Evraerts, Jonathan; Ravau, Joachim; Najimi, Mustapha; Sokal, Etienne Marc] UCLouvain, Inst Rech Expt & Clin IREC, Lab Pediat Hepatol & Cell Therapy, Brussels, Belgium.
   [de Magnee, Catherine; Tambucci, Roberto] UCLouvain, Dept Surg, Pediat Surg & Transplantat Unit, Clin Univ St Luc, Brussels, Belgium.
C3 Universite Catholique Louvain; Universite Catholique Louvain; Cliniques
   Universitaires Saint-Luc
RP Jannone, G (corresponding author), UCLouvain, Inst Rech Expt & Clin IREC, Lab Pediat Hepatol & Cell Therapy, Brussels, Belgium.
EM giulia.jannone@uclouvain.be
OI NAJIMI, Mustapha/0000-0002-7329-9635
FU Fonds National de la Recherche Scientifique et Medicale (FNRS, Belgium)
   through a FRIA grant [FC29559]
FX This research was supported by the Fonds National de la Recherche
   Scientifique et Me'dicale (FNRS, Belgium) through a FRIA grant (number
   FC29559). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Andersson ER, 2018, GASTROENTEROLOGY, V154, P1080, DOI 10.1053/j.gastro.2017.11.002
   Ayoub MD, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10110907
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gilbert MA, 2019, HUM MUTAT, V40, P2197, DOI 10.1002/humu.23879
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Ito Y, 2017, TRENDS CELL BIOL, V27, P830, DOI 10.1016/j.tcb.2017.07.004
   Jannone G, 2020, J HISTOCHEM CYTOCHEM, V68, P269, DOI 10.1369/0022155420913534
   Kamath BM, 2020, HEPATOL COMMUN, V4, P387, DOI 10.1002/hep4.1468
   Lemaigre FP, 2020, ANNU REV PATHOL-MECH, V15, P1, DOI 10.1146/annurev-pathmechdis-012418-013013
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Meadows V, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.803098
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Zhao CJ, 2022, HEPATOLOGY, V75, P567, DOI 10.1002/hep.32173
NR 21
TC 1
Z9 1
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 26
PY 2023
VL 18
IS 4
AR e0285019
DI 10.1371/journal.pone.0285019
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA F8KJ7
UT WOS:000984779900063
PM 37099537
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ow, JR
   Cadez, MJ
   Zafer, G
   Foo, JC
   Li, HY
   Ghosh, S
   Wollmann, H
   Cazenave-Gassiot, A
   Ong, CB
   Wenk, MR
   Han, WP
   Choi, H
   Kaldis, P
AF Ow, Jin Rong
   Cadez, Matias J.
   Zafer, Gozde
   Foo, Juat Chin
   Li, Hong Yu
   Ghosh, Soumita
   Wollmann, Heike
   Cazenave-Gassiot, Amaury
   Ong, Chee Bing
   Wenk, Markus R.
   Han, Weiping
   Choi, Hyungwon
   Kaldis, Philipp
TI Remodeling of whole-body lipid metabolism and a diabetic-like phenotype
   caused by loss of CDK1 and hepatocyte division
SO ELIFE
LA English
DT Article
ID FATTY-ACID OXIDATION; GENE-EXPRESSION; INSULIN-RESISTANCE;
   ADIPOSE-TISSUE; LIVER-DISEASE; CELL-CYCLE; NONALCOHOLIC STEATOHEPATITIS;
   DEFICIENCY PROTECTS; GLUCOSE-METABOLISM; HEPATIC STEATOSIS
AB Cell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid metabolism and the consequent impact on whole-body physiology, we performed lipidomics, metabolomics, and RNA-seq analyses on a mouse model. We observed reduced triacylglycerides in liver of young mice, caused by oxidative stress that activated FOXO1 to promote expression of Pnpla2/ATGL. Additionally, we discovered that hepatocytes displayed malfunctioning beta-oxidation, reflected by increased acylcarnitines (ACs) and reduced beta-hydroxybutyrate. This led to elevated plasma free fatty acids (FFAs), which were transported to the adipose tissue for storage and triggered greater insulin secretion. Upon aging, chronic hyperinsulinemia resulted in insulin resistance and hepatic steatosis through activation of LXR. Here, we demonstrate that loss of hepatocyte proliferation is not only an outcome but also possibly a causative factor for liver pathology.
C1 [Ow, Jin Rong; Cadez, Matias J.; Zafer, Gozde; Wollmann, Heike; Han, Weiping; Kaldis, Philipp] ASTAR, Inst Mol & Cell Biol IMCB, Singapore, Singapore.
   [Cadez, Matias J.; Zafer, Gozde; Cazenave-Gassiot, Amaury; Wenk, Markus R.; Han, Weiping; Kaldis, Philipp] Natl Univ Singapore NUS, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
   [Foo, Juat Chin; Cazenave-Gassiot, Amaury; Wenk, Markus R.] Natl Univ Singapore NUS, Life Sci Inst, Singapore Lipid Incubator SLING, Singapore, Singapore.
   [Li, Hong Yu; Han, Weiping] ASTAR, Singapore Bioimaging Consortium SBIC, Lab Metab Med, Singapore, Singapore.
   [Ghosh, Soumita; Choi, Hyungwon] Natl Univ Singapore NUS, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Ong, Chee Bing] ASTAR, Biol Resource Ctr BRC, Singapore, Singapore.
   [Kaldis, Philipp] Lund Univ, Clin Res Ctr CRC, Dept Clin Sci, Malmo, Sweden.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Institute of
   Molecular & Cell Biology (IMCB); National University of Singapore;
   National University of Singapore; Agency for Science Technology &
   Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging
   (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National
   University of Singapore; Agency for Science Technology & Research
   (A*STAR); Lund University
RP Kaldis, P (corresponding author), ASTAR, Inst Mol & Cell Biol IMCB, Singapore, Singapore.; Kaldis, P (corresponding author), Natl Univ Singapore NUS, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Kaldis, P (corresponding author), Lund Univ, Clin Res Ctr CRC, Dept Clin Sci, Malmo, Sweden.
EM philipp.kaldis@med.lu.se
RI Wenk, Markus Rene/D-1441-2014; Kaldis, Philipp/G-2714-2010;
   Cazenave-Gassiot, Amaury/E-4536-2014
OI Kaldis, Philipp/0000-0002-7247-7591; Ow, Jin Rong/0000-0002-7468-691X;
   Ong, Chee Bing/0000-0002-0521-1646; Cazenave-Gassiot,
   Amaury/0000-0002-3050-634X; foo, juat chin/0000-0002-9189-4585
FU Agency for Science, Technology and Research [IAF-ICP I1901E0040];
   Singapore International Graduate Award; National Research Foundation
   Singapore [NRF2016-CRP001-103]; National Medical Research Council
   [NMRC-CG-M009]; National University of Singapore; Swedish Foundation for
   Strategic Environmental Research [Dnr IRC15-0067]; Swedish Research
   Council [2009-1039]
FX Agency for Science, Technology and Research IAF-ICP I1901E0040 Amaury
   Cazenave-Gassiot Markus R Wenk; Singapore International Graduate Award
   Gozde Zafer; National Research Foundation Singapore NRF2016-CRP001-103
   Philipp Kaldis; National Medical Research Council NMRC-CG-M009 Hyungwon
   Choi; National University of Singapore Life Sciences Institute Juat Chin
   Foo Amaury Cazenave-Gassiot Markus R Wenk; Swedish Foundation for
   Strategic Environmental Research Dnr IRC15-0067 Philipp Kaldis; Swedish
   Research Council Dnr 2009-1039 Philipp Kaldis; The funders had no role
   in study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a
   Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419
   Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053
   Barbato DL, 2014, CELL DEATH DIFFER, V21, P113, DOI 10.1038/cdd.2013.137
   Becher I, 2018, CELL, V173, P1495, DOI 10.1016/j.cell.2018.03.053
   Benoit RM, 2010, J MOL BIOL, V397, P1231, DOI 10.1016/j.jmb.2010.02.043
   Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12
   Caldez MJ, 2018, DEV CELL, V47, P425, DOI 10.1016/j.devcel.2018.09.020
   Catalano KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108693
   Cen J, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0119-5
   Chakrabarti P, 2011, J LIPID RES, V52, P1693, DOI 10.1194/jlr.M014647
   Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200
   Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398
   Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007
   Christinat N, 2016, J PROTEOME RES, V15, P2228, DOI 10.1021/acs.jproteome.6b00198
   Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06
   Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120
   Cui Y, 2016, DIABETOLOGIA, V59, P2229, DOI 10.1007/s00125-016-4043-z
   Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5
   Dewhurst MR, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009084
   Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200
   Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104
   Gentric G, 2015, J CLIN INVEST, V125, P981, DOI 10.1172/JCI73957
   Grabacka M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122093
   Habelhah H, 2004, J BIOL CHEM, V279, P53782, DOI 10.1074/jbc.M410315200
   Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200
   Harbauer AB, 2014, SCIENCE, V346, P1109, DOI 10.1126/science.1261253
   Hennig EE, 2014, J CELL MOL MED, V18, P1762, DOI 10.1111/jcmm.12328
   Herbig U, 2003, AGING CELL, V2, P295, DOI 10.1046/j.1474-9728.2003.00067.x
   Hou Chao, 2018, Gene Expression, V19, P25, DOI 10.3727/105221618X15341831737687
   Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045
   Huang SZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25658-4
   Ieronymaki E, 2019, J IMMUNOL, V202, P1786, DOI 10.4049/jimmunol.1800065
   Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478
   Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258
   Jensen T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30267-2
   Jiang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep22193
   Jiang ZG, 2018, CLIN GASTROENTEROL H, V16, P1170, DOI 10.1016/j.cgh.2017.11.028
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019
   Knuever J, 2015, J IMMUNOL, V195, P5296, DOI 10.4049/jimmunol.1501237
   Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Kurauti MA, 2019, J CELL PHYSIOL, V234, P9802, DOI 10.1002/jcp.27667
   Kurtul Naciye, 2004, Acta Medica (Hradec Kralove), V47, P33
   Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899
   Lackner C, 2011, EXPERT REV GASTROENT, V5, P223, DOI [10.1586/egh.11.8, 10.1586/EGH.11.8]
   Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062
   Lee YS, 2012, J GASTROEN HEPATOL, V27, P75, DOI 10.1111/j.1440-1746.2011.07007.x
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li YB, 2013, ONCOL LETT, V6, P156, DOI 10.3892/ol.2013.1352
   Liu L, 2020, DEV CELL, V52, P196, DOI 10.1016/j.devcel.2019.11.012
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009
   Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686
   MACDONALD R, 1961, ARCH INTERN MED, V107, P335, DOI 10.1001/archinte.1961.03620030023003
   Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343
   Manoli I, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124351
   Marín-Juez R, 2014, J ENDOCRINOL, V222, P229, DOI 10.1530/JOE-14-0178
   McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X
   Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468
   Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449
   Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8
   Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200
   Mlettinen TP, 2014, CURR BIOL, V24, P598, DOI 10.1016/j.cub.2014.01.071
   Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040
   Morita Ippei, 2017, Am J Physiol Endocrinol Metab, V312, pE264, DOI 10.1152/ajpendo.00342.2016
   Moylan CA, 2014, HEPATOLOGY, V59, P471, DOI 10.1002/hep.26661
   Narayanaswamy P, 2020, MOL OMICS, V16, P436, DOI 10.1039/d0mo00030b
   Niska-Blakie J, 2020, CELL MOL LIFE SCI, V77, P3423, DOI 10.1007/s00018-019-03359-z
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Omori S, 2020, CELL METAB, V32, P814, DOI 10.1016/j.cmet.2020.09.006
   Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575
   Papandreou C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39441-6
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016
   Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017
   Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700
   Quadri RA, 1998, J IMMUNOL, V161, P5203
   Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190
   RONNETT GV, 1982, J BIOL CHEM, V257, P4285
   Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017
   Ryaboshapkina M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10930-w
   Scaglia N, 2014, CELL CYCLE, V13, P859, DOI 10.4161/cc.27767
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068
   Senokuchi T, 2008, DIABETES, V57, P2967, DOI 10.2337/db08-0520
   Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761
   Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9
   SHILLABEER G, 1990, J LIPID RES, V31, P623
   Srivastava A, 2018, J MOL MED, V96, P315, DOI 10.1007/s00109-018-1623-z
   STEIN GH, 1991, P NATL ACAD SCI USA, V88, P11012, DOI 10.1073/pnas.88.24.11012
   Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346
   Sun L, 2017, ONCOL LETT, V13, P2599, DOI 10.3892/ol.2017.5788
   Taddeo EP, 2020, DIABETES, V69, P131, DOI 10.2337/db19-0379
   TERCE F, 1994, J LIPID RES, V35, P2130
   Tovar AR, 2011, ARCH MED RES, V42, P540, DOI 10.1016/j.arcmed.2011.10.004
   Usui R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52048-1
   van Koppen A, 2018, CELL MOL GASTROENTER, V5, P83, DOI 10.1016/j.jcmgh.2017.10.001
   Varadaiah YGC, 2022, ARCH PHYSIOL BIOCHEM, V128, P87, DOI 10.1080/13813455.2019.1663219
   Veteläinen R, 2007, ANN SURG, V245, P44, DOI 10.1097/01.sla.0000225253.84501.0e
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033
   Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73
   Wong H, 1996, EXP GERONTOL, V31, P311, DOI 10.1016/0531-5565(95)00025-9
   Xu CF, 2015, J HEPATOL, V62, P1412, DOI 10.1016/j.jhep.2015.01.019
   Xu G, 2017, LAB INVEST, V97, P1201, DOI 10.1038/labinvest.2017.84
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yang SQ, 2001, HEPATOLOGY, V34, P694, DOI 10.1053/jhep.2001.28054
   Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645
   Yin X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0119-3
   Yokoo T, 2016, WORLD J GASTROENTERO, V22, P8862, DOI 10.3748/wjg.v22.i40.8862
   Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021
   Zhao G, 2002, BIOCHEM BIOPH RES CO, V292, P474, DOI 10.1006/bbrc.2002.6630
   Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747
NR 131
TC 12
Z9 12
U1 1
U2 10
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD DEC 21
PY 2020
VL 9
AR e63835
DI 10.7554/eLife.63835
PG 34
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA PO0QV
UT WOS:000604877500001
PM 33345777
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Giri, S
   Nieber, K
   Acikgöz, A
   Pavlica, S
   Keller, M
   Bader, A
AF Giri, Shibashish
   Nieber, Karen
   Acikgoez, Ali
   Pavlica, Sanja
   Keller, Mario
   Bader, Augustinus
TI Telomerase activity and hepatic functions of rat embryonic liver
   progenitor cell in nanoscaffold-coated model bioreactor
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article; Proceedings Paper
CT Symposium on Perspectives of Cell Signaling and Molecular Medicine
CY NOV 27-29, 2008-2009
CL Bose Inst, Kolkata, INDIA
HO Bose Inst
DE Albumin secretion; Bioreactor; Telomerase; RLC-18 cell line; Urea
   synthesis
ID SELF-COMPLEMENTARY OLIGOPEPTIDE; SMALL-SCALE BIOREACTOR; IN-VITRO;
   BIOARTIFICIAL LIVER; HEPATOCYTE CULTURE; PEPTIDE HYDROGEL; STEM-CELLS;
   PHASE-I; DIFFERENTIATION; TISSUE
AB Presently, there is growing interest on telomerase activity in all cells (somatic cells, stem cells, cancerous cells and others) since this activity is associated with cellular changes such as proliferation, differentiation, immortalization, cell injury and ageing. Telomerase activity is absent in most of the somatic cells but present in over 90% of cancerous cells and other immortalized cell lines. In our present study, we cultured a rat embryonal liver progenitor cell line RLC-18 in a self-assembly nanostructured scaffold-coated bioreactor (NCB), collagen-coated plates (CCP) and uncoated plates (UP), and evaluated changes of telomerase activity by non radioactive techniques (Telo TAGGG Telomerase PCR ELISA, cell proliferation based on mitochondria number by MTT assay and hepatic functions such as albumin secretion, urea metabolism, Cytochrome P450 activity like ethoxyresorufin-O-deethylase (EROD) activity. We found less telomerase activity and less cell proliferation, but more hepatic functions on the NCB than on the CCP and UP. Our data support the concept that cell-scaffold interaction may play a significant in controlling the telomerase activity as well as enhanced hepatic functions. Although our present study does not focus on the exact mechanism of telomerase regulation, our result may provide basic clues on cell differentiation whereby telomerase activity inhibits differentiation of cells as in the rat embryonic liver cell line, may be regulated by cell-scaffold interaction and where there is less proliferation, cells perform enhanced hepatic functions, thereby implying that bioartificial liver support may be possible.
C1 [Giri, Shibashish; Acikgoez, Ali; Pavlica, Sanja; Keller, Mario; Bader, Augustinus] Biomed Biotechnol Ctr BBZ, Dept Cell Technol & Appl Stem Cell Biol, D-04103 Leipzig, Germany.
   [Nieber, Karen] Univ Leipzig, Inst Pharm, D-04103 Leipzig, Germany.
C3 Leipzig University
RP Bader, A (corresponding author), Biomed Biotechnol Ctr BBZ, Dept Cell Technol & Appl Stem Cell Biol, Deutsch Pl 5, D-04103 Leipzig, Germany.
EM Augustinus.Bader@bbz.uni-leipzig.de
CR BADER A, 1995, ARTIF ORGANS, V19, P368, DOI 10.1111/j.1525-1594.1995.tb02343.x
   Bader A, 1998, XENOBIOTICA, V28, P815, DOI 10.1080/004982598239074
   Bader A, 1999, EXP CELL RES, V246, P221, DOI 10.1006/excr.1998.4295
   BADER A, 1992, BIOTECHNOL PROGR, V8, P219, DOI 10.1021/bp00015a007
   Bader A, 1999, ESA SP PUBL, V433, P499
   Balis UJ, 1999, METAB ENG, V1, P49, DOI 10.1006/mben.1998.0105
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Brezden CB, 1996, ONCOGENE, V12, P201
   BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   De Bartolo L, 2001, Ann Transplant, V6, P40
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Flendrig LM, 1998, INT J ARTIF ORGANS, V21, P467
   Frühauf NR, 2004, SURGERY, V136, P47, DOI 10.1016/j.surg.2003.12.017
   Fu WM, 1999, J BIOL CHEM, V274, P7264, DOI 10.1074/jbc.274.11.7264
   Genové E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   GERLACH J, 1994, ARTIF ORGANS, V18, P226, DOI 10.1111/j.1525-1594.1994.tb02181.x
   GraslKraupp B, 1997, HEPATOLOGY, V25, P906, DOI 10.1002/hep.510250420
   Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933
   Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780
   Hamada K, 2008, J BIOMED MATER RES A, V84A, P128, DOI 10.1002/jbm.a.31439
   HIYAMA E, 1995, NAT MED, V1, P249, DOI 10.1038/nm0395-249
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   JASMUND I, 2002, ADV BIOCHEM ENG BIOT, V74, P100
   Kaito K, 2007, CELL TECHNOLOGY FOR CELL PRODUCTS, P233, DOI 10.1007/978-1-4020-5476-1_37
   Kanai H, 2007, ARTIF ORGANS, V31, P148, DOI 10.1111/j.1525-1594.2007.00354.x
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kisiday JD, 2005, TISSUE ENG, V11, P141, DOI 10.1089/ten.2005.11.141
   Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005
   Kondo S, 1998, FASEB J, V12, P801, DOI 10.1096/fasebj.12.10.801
   Kondo Y, 2000, ONCOGENE, V19, P2205, DOI 10.1038/sj.onc.1203538
   Langsch A, 2001, BIOTECHNOL BIOENG, V76, P115, DOI 10.1002/bit.1151
   Machaj EK, 2005, FOLIA HISTOCHEM CYTO, V43, P217
   McKane BW, 2003, HUM IMMUNOL, V64, P708, DOI 10.1016/S0198-8859(03)00081-8
   Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   NYBERG SL, 1994, ANN SURG, V220, P59
   Oren R, 2005, LIVER TRANSPLANT, V11, P929, DOI 10.1002/lt.20481
   Park YN, 2001, CANCER, V92, P2733, DOI 10.1002/1097-0142(20011201)92:11<2733::AID-CNCR10126>3.0.CO;2-5
   RHYU S, 1995, J NATL CANCER I, V87, P884
   ROZGA J, 1993, LANCET, V342, P898, DOI 10.1016/0140-6736(93)91947-K
   Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9
   SARKAR G, 1995, SCIENCE, V268, P1115, DOI 10.1126/science.7761821
   Schafer DF, 1997, NEW ENGL J MED, V336, P1173, DOI 10.1056/NEJM199704173361609
   Schmitmeier S, 2006, BIOTECHNOL BIOENG, V95, P1198, DOI 10.1002/bit.21089
   Schneider H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001718
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sharma HW, 1995, P NATL ACAD SCI USA, V92, P12343, DOI 10.1073/pnas.92.26.12343
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   SUSSMAN NL, 1992, HEPATOLOGY, V16, P60, DOI 10.1002/hep.1840160112
   TAHARA H, 1995, CANCER RES, V55, P2734
   TAKAOKA T, 1975, JPN J EXP MED, V45, P317
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Thorgeirsson SS, 2003, SEMIN LIVER DIS, V23, P303
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Watanabe FD, 1997, ANN SURG, V225, P484, DOI 10.1097/00000658-199705000-00005
   Yoshida D, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4618
   Zhang S., 2013, Scaffolding Tissue Eng, P1, DOI DOI 10.1201/9781420027563.CH15
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 68
TC 15
Z9 16
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD MAR
PY 2010
VL 336
IS 1-2
SI SI
BP 137
EP 149
DI 10.1007/s11010-009-0266-3
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology
GA 560LP
UT WOS:000274904500014
PM 19816756
DA 2024-02-19
ER

PT J
AU Bramlage, KS
   Bhattacharjee, J
   Kirby, M
   Myronovych, A
   Gupta, R
   Gonzalez, RMS
   Xanthakos, S
   Bove, K
   Kohli, R
AF Bramlage, Kristin S.
   Bhattacharjee, Jashdeep
   Kirby, Michelle
   Myronovych, Andriy
   Gupta, Rohun
   Gonzalez, Rosa-Maria Salazar
   Xanthakos, Stavra
   Bove, Kevin
   Kohli, Rohit
TI A Diet High in Fat and Fructose Induces Early Hepatic Mitochondrial
   Aging
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Article
DE fatty liver; NAFLD; NASH; obesity; steatohepatitis
ID NONALCOHOLIC STEATOHEPATITIS; LIVER; STEATOSIS
AB To investigate the effect of high fructose diet on ultrastructure and content of hepatic mitochondria, we randomized 6-8 weeks old male C57Bl6/J mice to ad lib chow or high-fat-high-fructose (HF2) diet for 32 weeks. HF2-fed mice gained more weight, had higher plasma alanine aminotransferase, and fasting glucose levels and increased hepatic triglyceride content at all time points compared to chow-fed mice. HF2-fed mice had lower mitochondrial to nuclear DNA ratio compared to chow-fed mice. HF2-fed mice had lower average mitochondrial surface area and the number of mitochondria compared to chow-fed mice. HF2-fed mice had higher expression of the hepatic endoplasmic reticulum stress marker Chop, compared to chow-fed mice. A diet high in fat and fructose leads to enhanced hepatic mitochondrial aging, depletion, and dysfunction, which may be important determinants of nonalcoholic steatohepatitis pathogenesis.
C1 [Bramlage, Kristin S.; Kirby, Michelle; Myronovych, Andriy; Xanthakos, Stavra] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA.
   [Bhattacharjee, Jashdeep; Gupta, Rohun; Gonzalez, Rosa-Maria Salazar; Kohli, Rohit] Childrens Hosp Los Angeles, Div Gastroenterol Hepatol & Nutr, Los Angeles, CA 90027 USA.
   [Bove, Kevin] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pathol, Cincinnati, OH USA.
C3 Cincinnati Children's Hospital Medical Center; Children's Hospital Los
   Angeles; Cincinnati Children's Hospital Medical Center; University
   System of Ohio; University of Cincinnati
RP Kohli, R (corresponding author), Childrens Hosp Los Angeles, Div Gastroenterol Hepatol & Nutr, Los Angeles, CA 90027 USA.
EM rokohli@chla.usc.edu
RI Gupta, Rohun/HQY-7933-2023; Bhattacharjee, Jashdeep/AAH-4088-2019
OI Bhattacharjee, Jashdeep/0000-0003-2196-3079; Myronovych,
   Andriy/0000-0003-1361-0644
FU NIH [R01DK100314, T32 DK007727 18]; Cincinnati Digestive Health Center
   PHS Grant [P30 DK078392]; NASPGHAN Foundation Mentored Summer Student
   Research Program
FX This work was supported by NIH R01DK100314 (R.K.), T32 DK007727 18
   (K.S.B.), Cincinnati Digestive Health Center PHS Grant P30 DK078392,
   NASPGHAN Foundation Mentored Summer Student Research Program (R.G.).
CR Bozaykut P, 2016, MECH AGEING DEV, V157, P17, DOI 10.1016/j.mad.2016.07.001
   Cedikova M, 2016, PHYSIOL RES, V65, pS519, DOI 10.33549/physiolres.933538
   Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306
   Eisinger K, 2014, EXP MOL PATHOL, V97, P37, DOI 10.1016/j.yexmp.2014.05.002
   Golabi P, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011518
   Guimaraes EL, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-68
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kim JY, 2018, CELL, V175, P133, DOI 10.1016/j.cell.2018.08.020
   Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797
   Léveillé M, 2019, METABOLITES, V9, DOI 10.3390/metabo9100233
   Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004
   Lotowska JM, 2014, WORLD J GASTROENTERO, V20, P4335, DOI 10.3748/wjg.v20.i15.4335
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   McDonald CM, 2021, MUSCLE NERVE, V63, P239, DOI 10.1002/mus.27108
   Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74
NR 19
TC 2
Z9 2
U1 2
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-2116
EI 1536-4801
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD JUL
PY 2021
VL 73
IS 1
BP 99
EP 102
DI 10.1097/MPG.0000000000003068
PG 4
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA SS8YT
UT WOS:000662040300029
PM 34135298
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Orge, ID
   Gadd, VL
   Barouh, JL
   Rossi, EA
   Carvalho, RH
   Smith, I
   Allahdadi, KJ
   Paredes, BD
   Silva, DN
   Damasceno, PKF
   Sampaio, GL
   Forbes, SJ
   Soares, MBP
   Souza, BSD
AF Orge, Iasmim Diniz
   Gadd, Victoria L.
   Barouh, Judah Leao
   Rossi, Erik Aranha
   Carvalho, Rejane Hughes
   Smith, Ian
   Allahdadi, Kyan James
   Paredes, Bruno Diaz
   Silva, Daniela Nascimento
   Damasceno, Patricia Kauanna F.
   Sampaio, Gabriela Louise
   Forbes, Stuart J.
   Pereira Soares, Milena Botelho
   de Freitas Souza, Bruno Solano
TI Phenotype instability of hepatocyte-like cells produced by direct
   reprogramming of mesenchymal stromal cells
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Hepatocyte-like cells; Direct reprogramming; Mesenchymal stromal cells
ID MOUSE FIBROBLASTS; DIRECT CONVERSION; GENERATION
AB Background Hepatocyte-like cells (iHEPs) generated by transcription factor-mediated direct reprogramming of somatic cells have been studied as potential cell sources for the development of novel therapies targeting liver diseases. The mechanisms involved in direct reprogramming, stability after long-term in vitro expansion, and safety profile of reprogrammed cells in different experimental models, however, still require further investigation. Methods iHEPs were generated by forced expression of Foxa2/Hnf4a in mouse mesenchymal stromal cells and characterized their phenotype stability by in vitro and in vivo analyses. Results The iHEPs expressed mixed hepatocyte and liver progenitor cell markers, were highly proliferative, and presented metabolic activities in functional assays. A progressive loss of hepatic phenotype, however, was observed after several passages, leading to an increase in alpha-SMA(+) fibroblast-like cells, which could be distinguished and sorted from iHEPs by differential mitochondrial content. The resulting purified iHEPs proliferated, maintained liver progenitor cell markers, and, upon stimulation with lineage maturation media, increased expression of either biliary or hepatocyte markers. In vivo functionality was assessed in independent pre-clinical mouse models. Minimal engraftment was observed following transplantation in mice with acute acetaminophen-induced liver injury. In contrast, upon transplantation in a transgenic mouse model presenting host hepatocyte senescence, widespread engraftment and uncontrolled proliferation of iHEPs was observed, forming islands of epithelial-like cells, adipocyte-like cells, or cells presenting both morphologies. Conclusion The results have significant implications for cell reprogramming, suggesting that iHEPs generated by Foxa2/Hnf4a expression have an unstable phenotype and depend on transgene expression for maintenance of hepatocyte-like characteristics, showing a tendency to return to the mesenchymal phenotype of origin and a compromised safety profile.
C1 [Orge, Iasmim Diniz; Barouh, Judah Leao; Rossi, Erik Aranha; Silva, Daniela Nascimento; Damasceno, Patricia Kauanna F.; Sampaio, Gabriela Louise; Pereira Soares, Milena Botelho; de Freitas Souza, Bruno Solano] Fiocruz MS, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Orge, Iasmim Diniz; Barouh, Judah Leao; Rossi, Erik Aranha; Allahdadi, Kyan James; Paredes, Bruno Diaz; Sampaio, Gabriela Louise; de Freitas Souza, Bruno Solano] Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, Salvador, BA, Brazil.
   [Gadd, Victoria L.; Smith, Ian; Forbes, Stuart J.] MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.
   [Rossi, Erik Aranha; Allahdadi, Kyan James; Paredes, Bruno Diaz; de Freitas Souza, Bruno Solano] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Carvalho, Rejane Hughes] Univ Fed Bahia, Inst Hlth Sci, Salvador, BA, Brazil.
   [Silva, Daniela Nascimento; Pereira Soares, Milena Botelho; de Freitas Souza, Bruno Solano] Natl Inst Sci & Technol Regenerat Med, Rio De Janeiro, RJ, Brazil.
   [de Freitas Souza, Bruno Solano] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
C3 Fundacao Oswaldo Cruz; IDOR - Instituto D'Or de Ensino e Pesquisa;
   Universidade Federal da Bahia; Fundacao Oswaldo Cruz
RP Souza, BSD (corresponding author), Fiocruz MS, Goncalo Moniz Inst, Salvador, BA, Brazil.; Souza, BSD (corresponding author), Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, Salvador, BA, Brazil.; Souza, BSD (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.; Souza, BSD (corresponding author), Natl Inst Sci & Technol Regenerat Med, Rio De Janeiro, RJ, Brazil.; Souza, BSD (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM bruno.solano@fiocruz.br
RI Soares, Milena/O-3771-2018; Souza, Bruno/AAO-4601-2021; Paredes,
   Bruno/ABE-6217-2021; Barouh, Judah Leão/AAK-7070-2020
OI Soares, Milena/0000-0001-7549-2992; Souza, Bruno/0000-0003-3771-0439;
   Paredes, Bruno/0000-0001-5711-0604; Barouh, Judah
   Leão/0000-0002-5309-1175; Orge, Iasmim/0000-0001-5935-0177; Nascimento
   Silva, Daniela/0000-0003-2165-4989; Rossi, Erik/0000-0001-8540-5258;
   Smith, Ian/0000-0001-7918-6415; Gadd, Victoria/0000-0003-1819-8660
FU CNPq; FAPESB; FINEP; UKRMP; Print/CAPES/Fiocruz; MRC [MR/K017047/1]
   Funding Source: UKRI
FX This work was supported by grants from CNPq, FAPESB,
   Print/CAPES/Fiocruz, FINEP, and UKRMP.
CR Burtscher I, 2009, DEVELOPMENT, V136, P1029, DOI 10.1242/dev.028415
   Cabral F, 2018, JOVE-J VIS EXP, V132, P1
   Chijiiwa K, 2000, AM J SURG, V179, P161, DOI 10.1016/S0002-9610(00)00274-9
   DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X
   Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44
   Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008
   Gonçalves GVM, 2018, CYTOTECHNOLOGY, V70, P577, DOI 10.1007/s10616-017-0131-2
   Guo R, 2017, STEM CELL REP, V9, P499, DOI 10.1016/j.stemcr.2017.06.013
   Heslop JA, 2017, ARCH TOXICOL, V91, P439, DOI 10.1007/s00204-016-1694-y
   Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003
   Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116
   Hwang SI, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/6937257
   Katayama H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44498
   Kim J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15706
   Lau HH, 2018, J HEPATOL, V68, P1033, DOI 10.1016/j.jhep.2017.11.026
   Lim KT, 2016, CELL REP, V15, P814, DOI 10.1016/j.celrep.2016.03.071
   Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021
   Nakamori D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16856-7
   Park S, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1127-3
   Pournasr B, 2015, EUR J CELL BIOL, V94, P603, DOI 10.1016/j.ejcb.2015.10.003
   Rastegar-Pouyani S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167081
   Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263
   Shi XL, 2016, CELL RES, V26, P206, DOI 10.1038/cr.2016.6
   Simeonov KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100134
   Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622
   Tanaka M, 2012, METHODS MOL BIOL, V826, P25, DOI 10.1007/978-1-61779-468-1_3
   Tang W, 2019, ACTA PHARMACOL SIN, V40, P620, DOI 10.1038/s41401-018-0170-z
   VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122
   Viganò M, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/3038565
   Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273
   Xie BQ, 2019, CELL RES, V29, P696, DOI 10.1038/s41422-019-0196-x
   Zakikhan K, 2016, BIOCHEM BIOPH RES CO, V474, P97, DOI 10.1016/j.bbrc.2016.04.076
NR 34
TC 12
Z9 13
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD APR 10
PY 2020
VL 11
IS 1
AR 154
DI 10.1186/s13287-020-01665-z
PG 15
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA LC9QX
UT WOS:000525670000001
PM 32276654
OA Green Published, Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Kang, TW
   Yevsa, T
   Woller, N
   Hoenicke, L
   Wuestefeld, T
   Dauch, D
   Hohmeyer, A
   Gereke, M
   Rudalska, R
   Potapova, A
   Iken, M
   Vucur, M
   Weiss, S
   Heikenwalder, M
   Khan, S
   Gil, J
   Bruder, D
   Manns, M
   Schirmacher, P
   Tacke, F
   Ott, M
   Luedde, T
   Longerich, T
   Kubicka, S
   Zender, L
AF Kang, Tae-Won
   Yevsa, Tetyana
   Woller, Norman
   Hoenicke, Lisa
   Wuestefeld, Torsten
   Dauch, Daniel
   Hohmeyer, Anja
   Gereke, Marcus
   Rudalska, Ramona
   Potapova, Anna
   Iken, Marcus
   Vucur, Mihael
   Weiss, Siegfried
   Heikenwalder, Mathias
   Khan, Sadaf
   Gil, Jesus
   Bruder, Dunja
   Manns, Michael
   Schirmacher, Peter
   Tacke, Frank
   Ott, Michael
   Luedde, Tom
   Longerich, Thomas
   Kubicka, Stefan
   Zender, Lars
TI Senescence surveillance of pre-malignant hepatocytes limits liver cancer
   development
SO NATURE
LA English
DT Article
ID MOUSE; RAS; FIBROBLASTS; SUPPRESSION; EXPRESSION; PATHWAY; MODELS; MICE;
   P53
AB Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo(1). Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro-as well as anti-tumorigenic effects(2-5). Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance by mounting specific immune responses against antigens expressed in pre-malignant senescent cells.
C1 [Kang, Tae-Won; Yevsa, Tetyana; Hoenicke, Lisa; Wuestefeld, Torsten; Dauch, Daniel; Hohmeyer, Anja; Gereke, Marcus; Rudalska, Ramona; Potapova, Anna; Weiss, Siegfried; Bruder, Dunja; Zender, Lars] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
   [Yevsa, Tetyana; Woller, Norman; Wuestefeld, Torsten; Hohmeyer, Anja; Manns, Michael; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.
   [Iken, Marcus; Ott, Michael] Twincore Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany.
   [Vucur, Mihael; Tacke, Frank; Luedde, Tom] Univ Hosp Aachen, Dept Internal Med 3, D-52074 Aachen, Germany.
   [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland.
   [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Ctr Munich, Inst Virol, D-81675 Munich, Germany.
   [Khan, Sadaf; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London W12 0NN, England.
   [Schirmacher, Peter; Longerich, Thomas] Univ Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany.
   [Kubicka, Stefan] Dist Hosp Reutlingen, Clin Internal Med, D-72764 Reutlingen, Germany.
C3 Helmholtz Association; Helmholtz-Center for Infection Research; Hannover
   Medical School; Helmholtz Association; Helmholtz-Center for Infection
   Research; RWTH Aachen University; RWTH Aachen University Hospital;
   University of Zurich; University Zurich Hospital; Technical University
   of Munich; Helmholtz Association; Helmholtz-Center Munich - German
   Research Center for Environmental Health; Imperial College London;
   Ruprecht Karls University Heidelberg
RP Zender, L (corresponding author), Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38124 Braunschweig, Germany.
EM Lars.Zender@helmholtz-hzi.de
RI Woller, Norman/AAU-2803-2021; Heikenwalder, Mathias/AAA-2269-2020; Kang,
   Tae Won/S-4864-2019; Luedde, Tom/AAE-9135-2022; Gil, Jesus/C-7739-2012;
   Tacke, Frank/ABF-2212-2020
OI Woller, Norman/0000-0002-4928-0117; Kang, Tae Won/0000-0003-1497-8926;
   Luedde, Tom/0000-0002-6288-8821; Gil, Jesus/0000-0002-4303-6260; Yevsa,
   Tetyana/0000-0003-0377-9198; Vucur, Mihael/0000-0003-4078-1668;
   /0000-0002-2430-4397; Hoenicke, Lisa/0000-0003-0613-8337
FU Helmholtz Association of German Research Centres [VH-NG-424]; German
   Research Foundation, DFG [ZE 545/2-1, SFB/TRR77]; Wilhelm Sander
   Stiftung; Bear Necessities Pediatric Cancer Foundation; Federal German
   Ministry for Education and Research (BMBF); European Commission; MRC
   [MC_U120085810] Funding Source: UKRI; Medical Research Council
   [MC_U120085810] Funding Source: researchfish
FX We thank D. Largaespada and M. Kay for providing transposon vectors and
   transposase encoding vectors. We thank L. Grobe, A. Rinkel, N. Struever,
   H. Riedesel, the team of the Helmholtz Centre for Infection Research
   (HZI) animal facility, M. Rothe, K. Schulze, A. Kobold, F. Heinzmann, N.
   Jedicke, C. Schneider, M. Pesic, H. Klimek and A. Samuels for technical
   assistance and assistance with animal work, and F. Alves, S. Kimmina, C.
   Dullin and S. Greco for assistance with flat panel-volumetric computer
   tomography. We thank the tissue bank of the National Center for Tumor
   Diseases Heidelberg for providing liver explant tissues. We thank S.
   Lowe, H. Tillmann, F. Greten and members of the Lowe and Zender
   laboratory for advice and discussions. This work was supported by the
   Helmholtz Association of German Research Centres (VH-NG-424 to L.Z.),
   the German Research Foundation, DFG (Emmy Noether Programme ZE 545/2-1
   to L.Z., SFB/TRR77 and the 'Rebirth' Cluster of Excellence), the Wilhelm
   Sander Stiftung, the Bear Necessities Pediatric Cancer Foundation, the
   Federal German Ministry for Education and Research (BMBF) (ARCHES AWARD
   to L.Z.) and the European Commission (project 'Heptromic'). L.Z. holds
   an adjunct assistant Professorship with the Cold Spring Harbor
   Laboratory, Cold Spring Harbor, New York, USA. This work is dedicated to
   J. Wehland.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021
   Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008
   Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102
   Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200
   Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599
   Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123
   Hensel M, 2011, DTSCH ARZTEBL INT, V108, P117, DOI 10.3238/arztebl.2010.0117
   HICKMAN MA, 1994, HUM GENE THER, V5, P1477, DOI 10.1089/hum.1994.5.12-1477
   Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001
   Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3
   Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920
   Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764
   SARMA DSR, 1986, CANCER SURV, V5, P781
   Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549
   Tannour-Louet M, 2002, HEPATOLOGY, V35, P1072, DOI 10.1053/jhep.2002.33164
   Thomsen M, 2008, TOXICOLOGY, V246, P18, DOI 10.1016/j.tox.2007.10.017
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 21
TC 1045
Z9 1150
U1 3
U2 169
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD NOV 24
PY 2011
VL 479
IS 7374
BP 547
EP 551
DI 10.1038/nature10599
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 851QI
UT WOS:000297285600055
PM 22080947
DA 2024-02-19
ER

PT J
AU Tang, P
   Low, HB
   Png, CW
   Torta, F
   Kumar, JK
   Lim, HY
   Zhou, Y
   Yang, H
   Angeli, V
   Shabbir, A
   Tai, ES
   Flavell, RA
   Dong, C
   Wenk, MR
   Yang, DY
   Zhang, YL
AF Tang, Peng
   Low, Heng Boon
   Png, Chin Wen
   Torta, Federico
   Kumar, Jaspal Kaur
   Lim, Hwee Ying
   Zhou, Yi
   Yang, Henry
   Angeli, Veronique
   Shabbir, Asim
   Tai, E. Shyong
   Flavell, Richard A.
   Dong, Chen
   Wenk, Markus R.
   Yang, Dan Yock
   Zhang, Yongliang
TI Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in
   Aging- and Diet-Induced Hepatic Steatosis and Steatohepatitis
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article
ID LEPTIN-DEFICIENT MICE; PPAR-GAMMA; FATTY LIVER; ADIPOSE-TISSUE;
   PROLIFERATION; ROSIGLITAZONE; INFLAMMATION; MECHANISMS; HEPATOCYTE;
   RESISTANCE
AB Nonalcoholic fatty liver disease is currently the most common liver disease and is a leading cause of liver-related morbidity and mortality. However, its pathogenesis remains largely unclear. We previously showed that mice deficient in mitogen-activated protein kinase (MAPK) phosphatase 5 (MKP5) spontaneously developed insulin resistance and glucose intolerance, which are associated with visceral obesity and adipose tissue inflammation. In this study, we discovered that mice deficient in MKP5 developed more severe hepatic steatosis and steatohepatitis with age or with feeding on a high-fat diet (HFD) compared to wild-type (WT) mice, and this was associated with increased expression of proinflammatory cytokines and collagen genes. Increased p38 activation in MKP5 knockout (KO) liver compared to that in WT liver was detected, which contributed to increased expression of lipid droplet-associated protein cell death-inducing DFF45-like effector A (CIDEA) and CIDEC/fat-specific protein 27 but not CIDEB through activating transcription factor 2 (ATF2). In addition, MKP5 KO liver had higher peroxisome proliferator-activated receptor gamma (PPAR) expression compared with WT liver. On the other hand, overexpression of MKP5 or inhibition of p38 activation in hepatocytes resulted in reduced expression of PPAR. Inhibition of p38 resulted in alleviation of hepatic steatosis in KO liver in response to HFD feeding, and this was associated with reduced expression of CIDEA, CIDEC, and proinflammatory cytokines. Conclusion: MKP5 prevents the development of nonalcoholic steatohepatitis by suppressing p38-ATF2 and p38-PPAR to reduce hepatic lipid accumulation, inflammation, and fibrosis.
C1 [Tang, Peng; Low, Heng Boon; Png, Chin Wen; Lim, Hwee Ying; Angeli, Veronique; Zhang, Yongliang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
   [Tang, Peng; Low, Heng Boon; Png, Chin Wen; Lim, Hwee Ying; Angeli, Veronique; Zhang, Yongliang] Natl Univ Singapore, Inst Life Sci, Program Immunol, Singapore, Singapore.
   [Torta, Federico; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
   [Torta, Federico; Kumar, Jaspal Kaur; Wenk, Markus R.] Natl Univ Singapore, Singapore Lipid Incubator, Inst Life Sci, Singapore, Singapore.
   [Zhou, Yi; Yang, Henry] Natl Univ Singapore, Canc Sci Inst Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Shabbir, Asim; Tai, E. Shyong; Yang, Dan Yock] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06511 USA.
   [Dong, Chen] Tsinghua Univ, Beijing, Peoples R China.
C3 National University of Singapore; National University of Singapore;
   National University of Singapore; National University of Singapore;
   National University of Singapore; National University of Singapore;
   Howard Hughes Medical Institute; Yale University; Tsinghua University
RP Zhang, YL (corresponding author), Ctr Life Sci, 03-06 28 Med Dr, Singapore 117456, Singapore.
EM miczy@nus.edu.sg
RI Wenk, Markus Rene/D-1441-2014; Yang, Henry Chong-heng/HLG-0902-2023;
   Yang, Yaoyuan/JGL-8841-2023; dong, chen/B-3181-2009
OI dong, chen/0000-0002-0084-9130; Tai, E Shyong/0000-0003-2929-8966
FU National University Health System of Singapore [T1-NUHS O-CRG2016
   Oct-21]; Singapore National Medical Research Council
   [NMRC/OFIRG/0059/2017]; A*STAR-NHMRC [NHMRC2017-SG006]; National
   Research Foundation, Prime Minister's Office, Singapore, under its
   Campus of Research Excellence and Technological Enterprise program
FX Supported by the National University Health System of Singapore (T1-NUHS
   O-CRG2016 Oct-21 to Y.Z.), Singapore National Medical Research Council
   (NMRC/OFIRG/0059/2017 to Y.Z.), A*STAR-NHMRC (bilateral grant
   NHMRC2017-SG006 to Y.Z.), and National Research Foundation, Prime
   Minister's Office, Singapore, under its Campus of Research Excellence
   and Technological Enterprise program.
CR Abdelmegeed MA, 2011, J NUTR, V141, P603, DOI 10.3945/jn.110.135210
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021
   Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006
   Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323
   Feng B, 2014, DIABETES, V63, P2924, DOI 10.2337/db14-0066
   García-Ruiz I, 2007, HEPATOLOGY, V46, P414, DOI 10.1002/hep.21687
   Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941
   Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033
   Ikura Y, 2015, INT J CLIN EXP PATHO, V8, P8699
   Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070
   Kang YJ, 2015, J IMMUNOL, V194, P4759, DOI 10.4049/jimmunol.1402954
   Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839
   Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223
   Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003
   Morán-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716
   Okumura T, 2011, J PHYSIOL BIOCHEM, V67, P629, DOI 10.1007/s13105-011-0110-6
   Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129
   Reddy ST, 2004, ARTERIOSCL THROM VAS, V24, P1676, DOI 10.1161/01.ATV.0000138342.94314.64
   Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016
   Sakurai T, 2013, CANCER RES, V73, P215, DOI 10.1158/0008-5472.CAN-12-1602
   Tamura S, 2005, J CLIN INVEST, V115, P1139, DOI 10.1172/JCI200524930
   Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829
   Tormos AM, 2013, HEPATOLOGY, V57, P1950, DOI 10.1002/hep.26174
   Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200
   Wang C, 2015, HEPATOLOGY, V61, P870, DOI 10.1002/hep.27409
   Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010
   Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200
   Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489
   Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371
   Ye P, 2019, HEPATOLOGY, V69, P76, DOI 10.1002/hep.30198
   Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3
   Zhang YL, 2015, J BIOL CHEM, V290, P14875, DOI 10.1074/jbc.M115.660969
   Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611
NR 34
TC 20
Z9 23
U1 2
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD JUN
PY 2019
VL 3
IS 6
BP 748
EP 762
DI 10.1002/hep4.1324
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA IB1KD
UT WOS:000470023200004
PM 31168510
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU KUDRYAVTSEV, BN
   KUDRYAVTSEVA, MV
   SAKUTA, GA
   STEIN, GI
AF KUDRYAVTSEV, BN
   KUDRYAVTSEVA, MV
   SAKUTA, GA
   STEIN, GI
TI HUMAN HEPATOCYTE POLYPLOIDIZATION KINETICS IN THE COURSE OF LIFE-CYCLE
SO VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY
LA English
DT Article
DE CYTOPHOTOMETRY; LIVER CELLS; POSTNATAL GROWTH; AGING; CELL TRANSITION
   RATES
ID LIVER CELLS
AB The processes of polyploidization in normal human liver parenchyma from 155 individuals aged between 1 day and 92 years were investigated by Feulgen-DNA cytophotometry. It was shown that polyploid hepatocytes appear in individuals from 1 to 5 years old. Up to the age of 50 years the accumulation rate of binucleate and polyploid cells is very slow, but subsequently hepatocyte polyploidization is intensified, and in patients aged 86-92 years the relative number of cells with polyploid nuclei is about 27%. Only a few hepatocytes in the normal human liver reach 16C and 8C x 2 ploidy levels for mononucleate and binucleate cells respectively. Using a mathematical modeling method, it was shown that during postnatal liver growth the polyploidization process in human liver is similar to that in the rat, and that polyploid cells are formed mainly from binucleate cells. As in rats, prior to an increase in ploidy level, diploid human hepatocytes can pass several times through the usual mitotic cycles maintaining their initial ploidy level. After birth, only one in ten hepatocytes starting DNA synthesis enters the polyploidization process. At maturity about 60% of 2C-hepatocytes starting DNA synthesis divide by conventional mitosis, the rest dividing by acytokinetic mitosis leading to the formation of binucleate cells. During ageing the probability of hepatocyte polyploidization increases and in this period there are two polyploid or binucleate cells for every diploid dividing by conventional mitosis.
RP KUDRYAVTSEV, BN (corresponding author), RUSSIAN ACAD SCI,INST CYTOL,ST PETERSBURG 194064,RUSSIA.
RI Stein, Grigory/AAF-1454-2021; Kudryavtsev, Boris N/B-2899-2018
OI Stein, Grigory/0000-0003-0455-9031; Kudryavtsev,
   Boris/0000-0002-1236-822X
CR ADLER CP, 1981, PATHOL RES PRACT, V172, P25, DOI 10.1016/S0344-0338(81)80120-3
   ALTMANN HW, 1966, VIRCHOWS ARCH A, V341, P85, DOI 10.1007/BF00958971
   [Anonymous], 1978, ENDOPOLYPLOIDY POLYT
   ASHWORTH CT, 1947, AM J PATHOL, V23, P269
   BELOV LN, 1975, TSITOLOGIYA+, V17, P1332
   BLUGER AF, 1977, SUCSESSES HEPATOL, V6, P120
   Boyd E, 1933, ARCH PATHOL, V16, P350
   BOYD E, 1941, OUTLINE PHYSICAL GRO
   Brodsky V.Y., 1985, GENOME MULTIPLICATIO
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   CARRIERE R, 1962, ANAT REC, V142, P443, DOI 10.1002/ar.1091420402
   CAVALLI G, 1960, Z Mikrosk Anat Forsch, V66, P428
   EPSTEIN CJ, 1967, P NATL ACAD SCI USA, V57, P327, DOI 10.1073/pnas.57.2.327
   GAHAN PB, 1984, EXP GERONTOL, V19, P355, DOI 10.1016/0531-5565(84)90044-5
   GERHARD H, 1971, EXP CELL RES, V69, P223, DOI 10.1016/0014-4827(71)90330-2
   GRABNER W, 1974, VIRCHOWS ARCH B, V15, P279
   GRISHAM JW, 1969, NORMAL MALIGNANT CEL, P28
   Kanungo M.S., 1980, BIOCH AGEING
   KASTEN FH, 1961, J HISTOCHEM CYTOCHEM, V9, P599
   KITAMURA O, 1979, JAP J GASTROENTEROL, V76, P223
   KOIKE Y, 1982, HISTOCHEMISTRY, V73, P549, DOI 10.1007/BF00493368
   KORENCHEVSKY V, 1961, PHYSL PATHOLOGICAL A
   KUDRYAVTSEV BN, 1982, TSITOLOGIYA+, V24, P436
   KUDRYAVTSEV BN, 1979, TSITOLOGIYA+, V21, P218
   KUDRYAVTSEV BN, 1986, TSITOLOGIYA+, V28, P828
   KUDRYAVTSEV BN, 1974, METODY BIOL RAZVITIY, P497
   KUDRYAVTSEVA MV, 1983, LAB DELO, V9, P21
   Leevy C M, 1967, Adv Intern Med, V13, P97
   LEEVY CM, 1963, J LAB CLIN MED, V61, P761
   LEUCHTENBERGER C, 1954, AM J PATHOL, V30, P65
   Munzer FT, 1923, ARCH MIKROSK ANAT EN, V98, P249, DOI 10.1007/BF02109231
   NADAL C, 1966, EXP CELL RES, V42, P99, DOI 10.1016/0014-4827(66)90324-7
   POLISCHUK AM, 1983, SUCSESS MOD BIOL, V96, P451
   RANEK L, 1976, ACTA CYTOL, V20, P151
   RANEK L, 1975, ACTA PATH MICRO IM A, V83, P467
   SCHULTZE B, 1978, CELL TISSUE KINET, V11, P241, DOI 10.1111/j.1365-2184.1978.tb00892.x
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   STEIN GI, 1992, J THEOR BIOL, V156, P349, DOI 10.1016/S0022-5193(05)80680-0
   SWARTZ FJ, 1956, CHROMOSOMA, V8, P53, DOI 10.1007/BF01259493
   TAKEHARA K, 1975, JPN J GASTROENTEROL, V72, P527
   TAUCHI H, 1961, Nagoya J Med Sci, V24, P97
   Tauchi H., 1978, LIVER AGING 1978, P3
   TAUCHI HISASHI, 1954, NAGOYA MED JOUR, V2, P1
   URYVAEVA IV, 1969, CYTOLOGY, V10, P1252
   URYVAEVA IV, 1974, CYTOLOGY, V16, P1100
   WATANABE M, 1970, J MED SCI, V33, P1
   WATANABE T, 1978, VIRCHOWS ARCH B, V27, P307
   WHEATLEY DN, 1972, EXP CELL RES, V74, P455, DOI 10.1016/0014-4827(72)90401-6
   ZAVARZIN AA, 1967, DNA SYNTHESIS CELL P
NR 49
TC 118
Z9 129
U1 0
U2 8
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-6075
J9 VIRCHOWS ARCH B
JI Virchows Arch. B-Cell Molec. Pathol.
PD DEC
PY 1993
VL 64
IS 6
BP 387
EP 393
DI 10.1007/BF02915139
PG 7
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA MU788
UT WOS:A1993MU78800009
PM 8148960
DA 2024-02-19
ER

PT J
AU Covarrubias, AJ
   Kale, A
   Perrone, R
   Lopez-Dominguez, JA
   Pisco, AO
   Kasler, HG
   Schmidt, MS
   Heckenbach, I
   Kwok, R
   Wiley, CD
   Wong, HS
   Gibbs, E
   Iyer, SS
   Basisty, N
   Wu, QX
   Kim, IJ
   Silva, E
   Vitangcol, K
   Shin, KO
   Lee, YM
   Riley, R
   Ben-Sahra, I
   Ott, M
   Schilling, B
   Scheibye-Knudsen, M
   Ishihara, K
   Quake, SR
   Newman, J
   Brenner, C
   Campisi, J
   Verdin, E
AF Covarrubias, Anthony J.
   Kale, Abhijit
   Perrone, Rosalba
   Lopez-Dominguez, Jose Alberto
   Pisco, Angela Oliveira
   Kasler, Herbert G.
   Schmidt, Mark S.
   Heckenbach, Indra
   Kwok, Ryan
   Wiley, Christopher D.
   Wong, Hoi-Shan
   Gibbs, Eddy
   Iyer, Shankar S.
   Basisty, Nathan
   Wu, Qiuxia
   Kim, Ik-Jung
   Silva, Elena
   Vitangcol, Kaitlyn
   Shin, Kyong-Oh
   Lee, Yong-Moon
   Riley, Rebeccah
   Ben-Sahra, Issam
   Ott, Melanie
   Schilling, Birgit
   Scheibye-Knudsen, Morten
   Ishihara, Katsuhiko
   Quake, Stephen R.
   Newman, John
   Brenner, Charles
   Campisi, Judith
   Verdin, Eric
TI Senescent cells promote tissue NAD<SUP>+</SUP> decline during ageing via
   the activation of CD38<SUP>+</SUP> macrophages
SO NATURE METABOLISM
LA English
DT Article
ID MITOCHONDRIAL DYSFUNCTION; METABOLIC DYSFUNCTION; NICOTINAMIDE RIBOSIDE;
   CELLULAR SENESCENCE; IMMUNE CELLS; ADP-RIBOSE; PROLIFERATION;
   INFLAMMATION; ACQUISITION; HOMEOSTASIS
AB Declining tissue nicotinamide adenine dinucleotide (NAD) levels are linked to ageing and its associated diseases. However, the mechanism for this decline is unclear. Here, we show that pro-inflammatory M1-like macrophages, but not naive or M2 macrophages, accumulate in metabolic tissues, including visceral white adipose tissue and liver, during ageing and acute responses to inflammation. These M1-like macrophages express high levels of the NAD-consuming enzyme CD38 and have enhanced CD38-dependent NADase activity, thereby reducing tissue NAD levels. We also find that senescent cells progressively accumulate in visceral white adipose tissue and liver during ageing and that inflammatory cytokines secreted by senescent cells (the senescence-associated secretory phenotype, SASP) induce macrophages to proliferate and express CD38. These results uncover a new causal link among resident tissue macrophages, cellular senescence and tissue NAD decline during ageing and offer novel therapeutic opportunities to maintain NAD levels during ageing.
   Senescent cells in fat and liver are shown to attract M1-like macrophages with increased expression of the NAD-consuming enzyme CD38, leading to their local accumulation and providing a mechanism for the age-associated decline in tissue NAD(+) levels.
C1 [Covarrubias, Anthony J.; Kale, Abhijit; Perrone, Rosalba; Lopez-Dominguez, Jose Alberto; Kasler, Herbert G.; Heckenbach, Indra; Kwok, Ryan; Wiley, Christopher D.; Wong, Hoi-Shan; Gibbs, Eddy; Basisty, Nathan; Wu, Qiuxia; Kim, Ik-Jung; Silva, Elena; Vitangcol, Kaitlyn; Riley, Rebeccah; Schilling, Birgit; Newman, John; Campisi, Judith; Verdin, Eric] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Covarrubias, Anthony J.; Newman, John; Verdin, Eric] UCSF Dept Med, San Francisco, CA 94143 USA.
   [Pisco, Angela Oliveira; Quake, Stephen R.] Chan Zuckerberg Biohub, San Francisco, CA USA.
   [Schmidt, Mark S.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.
   [Heckenbach, Indra; Scheibye-Knudsen, Morten] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.
   [Iyer, Shankar S.] Harvard Med Sch, Div Gastroenterol Hepatol & Endoscopy, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.
   [Shin, Kyong-Oh; Lee, Yong-Moon] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea.
   [Ben-Sahra, Issam] Northwestern Univ, Dept Biochem & Mol Genet, Chicago, IL 60611 USA.
   [Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA USA.
   [Ishihara, Katsuhiko] Kawasaki Med Sch, Immunol & Mol Genet, Kurashiki, Okayama, Japan.
   [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
   [Shin, Kyong-Oh] Hallym Univ, Dept Food Sci & Nutr, Chunchon, South Korea.
   [Brenner, Charles] City Hope Natl Med Ctr, Dept Diabet & Canc Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA.
C3 Buck Institute for Research on Aging; University of Iowa; University of
   Copenhagen; Harvard University; Harvard Medical School; Brigham &
   Women's Hospital; Chungbuk National University; Northwestern University;
   University of California System; University of California San Francisco;
   The J David Gladstone Institutes; Kawasaki Medical School; Stanford
   University; Hallym University; City of Hope
RP Verdin, E (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Verdin, E (corresponding author), UCSF Dept Med, San Francisco, CA 94143 USA.
EM everdin@buckinstitute.org
RI Brenner, Charles/D-6339-2014; Wiley, C/JDD-3366-2023; Covarrubias,
   Anthony/AAR-7214-2020; Kim, Ik-jung/AGZ-5587-2022; Newman,
   John/L-8112-2013; Kale, Abhijit/I-3787-2019; Ishihara,
   Katsuhiko/AAL-8175-2021; López-Domínguez, José Alberto/AAA-9275-2020
OI Brenner, Charles/0000-0002-4955-3226; Covarrubias,
   Anthony/0000-0002-7884-652X; Newman, John/0000-0002-8455-0100; Kale,
   Abhijit/0000-0002-1105-6953; López-Domínguez, José
   Alberto/0000-0001-8733-3294; Wiley, Christopher/0000-0002-7699-6866;
   Schmidt, Mark/0000-0003-4593-4096; Perrone, Rosalba/0000-0001-8894-4548;
   WONG, Hoi Shan/0000-0002-9846-7842
FU NIH [R24DK085610, U01AG060906, 1S10OD016281, R01HL147545]; Gladstone
   Institute intramural funds; Buck Institute intramural funds; UC
   President's Postdoctoral Fellowship at UCSF; NIH training grant
   [T32AG000266]; SENS Research Foundation; Roy J. Carver Trust
FX This project was supported by NIH grant R24DK085610 (E.V.), Gladstone
   Institute intramural funds (E.V.) and Buck Institute intramural funds
   (E.V. and J.C.). A.J.C. is a recipient of the UC President's
   Postdoctoral Fellowship at UCSF and was supported by NIH training grant
   T32AG000266 (Buck Institute). A.K. was supported by the SENS Research
   Foundation and NIH grant R01AG051729 (J.C.). B.S. and N.B. were
   supported by NIH grant U01AG060906 (B.S., principal investigator) and
   NIH Shared Instrumentation Grant 1S10OD016281 (Buck Institute). M.S.S.
   and C.B. were supported by NIH grant R01HL147545 and the Roy J. Carver
   Trust to C.B. We thank M. Walter for help with imaging cells, and P.
   Dighe for help optimizing Seahorse assay conditions. We thank R.
   Camarda, V. Byles and D. Powell for reviewing the manuscript and helpful
   discussions.
CR Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443
   Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305
   Buford TW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0296-0
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Cameron AM, 2019, NAT IMMUNOL, V20, P420, DOI 10.1038/s41590-019-0336-y
   Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964
   Chatterjee S, 2018, CELL METAB, V27, P85, DOI 10.1016/j.cmet.2017.10.006
   Cho KW, 2014, METHOD ENZYMOL, V537, P297, DOI 10.1016/B978-0-12-411619-1.00016-1
   Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050
   Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004
   Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109
   Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342
   JACKSON DG, 1990, J IMMUNOL, V144, P2811
   Jager J, 2016, J INTERN MED, V280, P209, DOI 10.1111/joim.12483
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010
   Langston PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00061
   Lischke T, 2013, INFECT IMMUN, V81, P4091, DOI 10.1128/IAI.00340-13
   Liu J, 2017, P NATL ACAD SCI USA, V114, P8283, DOI 10.1073/pnas.1703718114
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   Mitchell SJ, 2018, CELL METAB, V27, P667, DOI 10.1016/j.cmet.2018.02.001
   Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827
   Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012
   Preugschat F, 2014, ARCH BIOCHEM BIOPHYS, V564, P156, DOI 10.1016/j.abb.2014.09.008
   RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827
   Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103
   Real AM, 2013, DRUG METAB DISPOS, V41, P550, DOI 10.1124/dmd.112.049734
   Regdon Z, 2019, FREE RADICAL BIO MED, V131, P184, DOI 10.1016/j.freeradbiomed.2018.11.034
   Savarino A, 2000, AIDS, V14, P1079, DOI 10.1097/00002030-200006160-00004
   Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304
   Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4
   Schilling B, 2017, METHODS MOL BIOL, V1550, P223, DOI 10.1007/978-1-4939-6747-6_16
   Shrimp JH, 2014, J AM CHEM SOC, V136, P5656, DOI 10.1021/ja411046j
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Ströbele S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134770
   Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Trammell SA, 2016, NAT COMMUN, V7
   Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012
   Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906
   Velarde MC, 2015, P NATL ACAD SCI USA, V112, P10407, DOI 10.1073/pnas.1505675112
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Virág L, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101261
   Wei Wenjie, 2014, World J Biol Chem, V5, P58, DOI 10.4331/wjbc.v5.i1.58
   Weiss R, 2015, INNATE IMMUN-LONDON, V21, P813, DOI 10.1177/1753425915602545
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhang ZQ, 2018, J GENET GENOMICS, V45, P25, DOI 10.1016/j.jgg.2018.01.002
   Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700
NR 74
TC 148
Z9 157
U1 17
U2 85
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2522-5812
J9 NAT METAB
JI Nat. Metab.
PD NOV
PY 2020
VL 2
IS 11
DI 10.1038/s42255-020-00305-3
PG 34
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA PA9EZ
UT WOS:000595931800001
PM 33199924
OA Green Accepted
HC Y
HP N
DA 2024-02-19
ER

PT J
AU FERLAND, G
   TUCHWEBER, B
   BHAT, PV
   LACROIX, A
AF FERLAND, G
   TUCHWEBER, B
   BHAT, PV
   LACROIX, A
TI EFFECT OF DIETARY RESTRICTION ON HEPATIC VITAMIN-A CONTENT IN AGING RATS
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
ID INTESTINAL-ABSORPTION INVIVO; FAT-STORING CELLS; CALORIE RESTRICTION;
   FOOD RESTRICTION; SURFACE-AREA; LIVER; MICE; HEPATOCYTES; LONGEVITY;
   RODENTS
AB The size and number of fat-storing cells (FSC), considered to be the main liver storage site of vitamin A, as well as hepatic vitamin A content, were studied in aging female Sprague-Dawley rats subjected soon after weaning to dietary restriction (R), that is, 60% of food consumed by their ad libitum-fed controls (A).  In A or R rats, the FSC index (number of cells per 1000 hepatocytes) and volume density (% of hepatic volume) were increased significantly at 24-27 months compared with the younger age groups.  The lipocyte index and volume density were also found to be significantly higher, after the first year, in R rats when compared to corresponding age-matched A controls.  An increase in total vitamin A content was also noted with age in both groups.  R rats exhibited higher retinol, retinyl ester, and total retinoid content than their corresponding controls, but the differences were statistically significant only at 12-14 and 24-27 months.  These results indicate that, during aging, dietary restriction markedly increases vitamin A content in liver tissue, a change that may be relevant to the beneficial effect of this dietary manipulation on liver function.
C1 UNIV MONTREAL,DEPT NUTR,POB 6128,STN A,MONTREAL H3C 3J7,QUEBEC,CANADA.
   CLIN RES INST MONTREAL,NUTR & CANC LAB,MONTREAL H2W 1R7,QUEBEC,CANADA.
C3 Universite de Montreal; Universite de Montreal; Institut de Recherche
   Clinique de Montreal (IRCM)
CR BALES CW, 1988, EXP GERONTOL, V23, P189, DOI 10.1016/0531-5565(88)90006-X
   BATRES RO, 1987, J NUTR, V117, P77, DOI 10.1093/jn/117.1.77
   BHAT PV, 1983, J CHROMATOGR, V272, P269, DOI 10.1016/S0378-4347(00)86129-0
   DELEEUW AM, 1983, P NUTR SOC, V42, pA8
   EARNEST DL, 1986, CELLS HEPATIC SINUSO, V1, P277
   FAHIMI HD, 1982, SINUSOIDAL ENDOTHELI, P502
   FERLAND G, 1989, LIPIDS, V24, P842, DOI 10.1007/BF02535757
   FERLAND G, 1990, MECH AGEING DEV, V56, P143, DOI 10.1016/0047-6374(90)90005-Z
   FLEMING BB, 1982, EXP GERONTOL, V17, P115, DOI 10.1016/0531-5565(82)90044-4
   HENDRIKS HFJ, 1987, MECH AGEING DEV, V41, P241, DOI 10.1016/0047-6374(87)90044-3
   HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   HOLLANDER D, 1983, CAN J PHYSIOL PHARM, V61, P1501, DOI 10.1139/y83-215
   HOLLANDER D, 1977, AM J PHYSIOL, V232, pE471, DOI 10.1152/ajpendo.1977.232.5.E471
   HOLLANDER D, 1979, EXP GERONTOL, V14, P301, DOI 10.1016/0531-5565(79)90041-X
   HOLLANDER D, 1986, AGE, V9, P57, DOI 10.1007/BF02432262
   Ikejiri N, 1977, KUPFFER CELLS OTHER, P83
   IWASAKI K, 1988, J GERONTOL, V43, pB13, DOI 10.1093/geronj/43.1.B13
   KNOOK DL, 1989, CELLS HEPATIC SINUSO, V2, P16
   KOBAYASHI K, 1973, NATURE-NEW BIOL, V243, P186, DOI 10.1038/newbio243186a0
   KRASINSKI SD, 1985, GASTROENTEROLOGY, V88, P1715
   KUBO C, 1984, J NUTR, V114, P1884, DOI 10.1093/jn/114.10.1884
   LEE BC, 1985, BIOL TRACE ELEM RES, V8, P1, DOI 10.1007/BF02917598
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   MESHKINPOUR H, 1981, EXP GERONTOL, V16, P399, DOI 10.1016/0531-5565(81)90061-9
   MORIGUCHI S, 1985, IMMUNOLOGY, V56, P169
   PITT GAJ, 1985, FAT SOLUBLE VITAMINS, P1
   SALAS M, 1980, PATHOL RES PRACT, V167, P217, DOI 10.1016/S0344-0338(80)80052-5
   SUNBOOM J, 1984, EXP GERONTOL, V19, P257
   TACHIBANA K, 1984, BRIT J CANCER, V49, P343, DOI 10.1038/bjc.1984.54
   TUCHWEBER B, 1987, LIFE SCI, V41, P2091, DOI 10.1016/0024-3205(87)90526-1
   Wake K, 1980, Int Rev Cytol, V66, P303
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   WISS O, 1963, LIVER MORPHOLOGY BIO, P133
   YOUNG VR, 1979, FED PROC, V38, P1994
NR 36
TC 9
Z9 9
U1 0
U2 1
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD JAN
PY 1992
VL 47
IS 1
BP B3
EP B8
DI 10.1093/geronj/47.1.B3
PG 6
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GY680
UT WOS:A1992GY68000006
PM 1730846
DA 2024-02-19
ER

PT J
AU Jiang, WX
   Zhang, YJ
   Huang, Y
   Cheng, YF
   Liu, ZG
AF Jiang, Wenxiao
   Zhang, Yijun
   Huang, Ye
   Cheng, Yunfeng
   Liu, Zhigang
TI Effect of Hepatic Kinase B1 (LKB1) on Osteogenic Differentiation of Bone
   Marrow Mesenchymal Stem Cells During Senescence
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Aging; BMSCs; Osteogenic Differentiation; LKB1; Zempster24
ID FRACTURE; PATHWAY
AB Hepatic kinase B1 (LKB1) is a tumor suppressor and regulates cell proliferation and apoptosis. However, whether LKB1 affects bone marrow mesenchymal stem cells (BMSCs) osteogenic differentiation of during aging remains unclear. Two BMSCs derived from Zempster24-/- (aging) and Zempster24+/+ (normal) mice were cultured in vitro followed by measurement of LKB1 expression by real-time quantitative PCR and Western blot. LKB1 siRNA was transfected into Zempster24-/-BMSCs and LKB1 expression was measured. 14 days after osteogenic induction, mineralized nodule formation was evaluated by alizarin red staining, expression of Calcin, type I collagen, RUNX2 and OPN mRNA expression was measured, together with alkaline phosphatase (ALP) activity and the PI3K/mTOR pathway activity. Compared with normal BMSCs, LKB1 expression was significantly increased, calcified nodules were decreased, with reduced expression of osteocalcin, type I collagen, RUNX2 and OPN mRNA as well as decreased ALP activity and PI3K/mTOR signaling protein expression (P < 0.05). LKB1 siRNA transfection into senescent BMSCs down-regulated LKB1 expression, increased calcification nodule formation, expression of osteocalcin, type I collagen, RUNX2 and OPN mRNA, as well as increased ALP activity and PI3K/mTOR pathway protein expression (P < 0.05). Aging can promote the increase of LKB1 expression and inhibit the osteogenic differentiation of BMSCs. Down-regulation of LKB1 expression in BMSCs during senescence can promote osteogenic differentiation through regulating PI3K/mTOR pathway.
C1 [Jiang, Wenxiao; Zhang, Yijun] Shandong Univ Qingdao, Qilu Hosp, Dept Sports Med, Qingdao 266000, Shandong, Peoples R China.
   [Huang, Ye] Shinan Dist Peoples Hosp, Dept Tradit Chinese Med, Qingdao 266000, Shandong, Peoples R China.
   [Cheng, Yunfeng] Haiyang Tradit Chinese Med Hosp, Dept Orthopaed, Qingdao 266000, Shandong, Peoples R China.
   [Liu, Zhigang] Shandong Univ Qingdao, Quit Hosp, Dept Rehabil, Qingdao 266000, Shandong, Peoples R China.
C3 Shandong University; Shandong University
RP Jiang, WX (corresponding author), Shandong Univ Qingdao, Qilu Hosp, Dept Sports Med, Qingdao 266000, Shandong, Peoples R China.
RI Cheng, Yunfeng/ISS-0527-2023
CR Alzahrani FA, 2019, AM J TRANSL RES, V11, P2887
   Aronson LI, 2013, LEUKEMIA, V27, P2397, DOI 10.1038/leu.2013.150
   Bruna F, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0878-1
   Darcy J, 2019, GEROSCIENCE, V41, P285, DOI 10.1007/s11357-019-00076-0
   Di X, 2019, SPIRIT RELIG EDUC, P19, DOI 10.1007/978-3-030-13356-6_2
   Ju XA, 2018, CARDIOVASC TOXICOL, V18, P471, DOI 10.1007/s12012-018-9460-4
   Kasap B, 2019, GENE, V711, DOI 10.1016/j.gene.2019.06.027
   Lee JH, 2018, CHEM-BIOL INTERACT, V289, P68, DOI 10.1016/j.cbi.2018.04.023
   Lloret A, 2016, CLIN CASES MINER BON, V13, P123, DOI 10.11138/ccmbm/2016.13.2.123
   Long QF, 2017, AGING DIS, V8, P301, DOI 10.14336/AD.2016.1018
   Herrera ML, 2019, BEHAV BRAIN RES, V372, DOI 10.1016/j.bbr.2019.112050
   Ma J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25563-w
   Mahzoon S, 2019, ANN BIOMED ENG, V47, P2308, DOI 10.1007/s10439-019-02306-0
   Saito T, 2019, HUM MOL GENET, V28, P3062, DOI 10.1093/hmg/ddz120
   Sun ZZ, 2020, J CELL BIOCHEM, V121, P371, DOI 10.1002/jcb.29188
   Tian Y, 2017, ONCOTARGET, V8, P88308, DOI 10.18632/oncotarget.19015
   Vyas AK, 2018, LIVER INT, V38, P2149, DOI 10.1111/liv.13871
   Wang FK, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190502
   Wu T, 2018, BONE JOINT RES, V7, P179, DOI 10.1302/2046-3758.72.BJR-2017-0229.R1
   Xiao J, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0254-y
   Yang SM, 2019, J TISSUE ENG REGEN M, V13, P2055, DOI 10.1002/term.2915
   Yogui FC, 2018, J APPL ORAL SCI, V26, DOI 10.1590/1678-7757-2017-0329
   Zhang JK, 2018, INT J BIOL SCI, V14, P449, DOI 10.7150/ijbs.24158
   Zhu B, 2019, J CELL MOL MED, V23, P5782, DOI 10.1111/jcmm.14503
   Zhu XF, 2019, AIDS BEHAV, V10, P1
NR 25
TC 0
Z9 0
U1 1
U2 6
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD FEB
PY 2020
VL 10
IS 2
BP 246
EP 251
DI 10.1166/jbt.2020.2247
PG 6
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA ML4MC
UT WOS:000549441100017
DA 2024-02-19
ER

PT J
AU Chen, ZW
   Yao, L
   Liu, YY
   Pan, Z
   Peng, S
   Wan, GG
   Cheng, JX
   Wang, JW
   Cao, WF
AF Chen, Zhiwei
   Yao, Ling
   Liu, Yuanyuan
   Pan, Zheng
   Peng, Shuang
   Wan, Guoguo
   Cheng, Junxiong
   Wang, Jianwei
   Cao, Wenfu
TI Astragaloside IV regulates NF-κB-mediated cellular senescence and
   apoptosis of hepatic stellate cells to suppress PDGF-BB-induced
   activation
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE astragaloside IV; hepatic stellate cells; cellular senescence;
   apoptosis; nuclear factor-kappa B pathway
ID ATTENUATES LIVER FIBROSIS; IN-VIVO; SIGNALING PATHWAY; OXIDATIVE STRESS;
   PORCINE-SERUM; PHENOTYPE; PROLIFERATION; MEMBRANACEUS; PATHOGENESIS;
   INDUCTION
AB Activated hepatic stellate cells (HSCs) are the principal effectors during hepatic fibrosis, which is characterized by the accumulation of extracellular matrix. Therefore, present therapies and investigations into hepatic fibrosis mainly focus on the suppression of activated HSCs. Astragaloside IV (ASIV) is an effective constituent extracted from the plant Astragalus membranaceus and has exhibited anti-fibrotic properties in hepatic fibrosis. However, its protective mechanism against hepatic fibrosis is not fully understood. The present study aimed to investigate the mechanistic role of ASIV on rat HSC-T6 cells activated with platelet-derived growth factor (PDGF)-BB. HSC-T6 cells were activated using PDGF-BB and subsequently treated with ASIV (final concentrations of 20 and 40 mu g/ml) for 48 h. ASIV treatment decreased the expression of alpha 1 type I collagen, alpha-smooth muscle actin and fibronectin on mRNA and protein levels, suggesting that ASIV suppresses PDGF-BB-induced HSC-T6 activation. Senescence-associated beta-galactosidase activity, p21, high-mobility group AT-hook 1 and p53, common biomarkers of senescence, were upregulated by ASIV treatment. In addition, the expression of telomerase reverse transcriptase was reduced. ASIV promoted apoptosis of PDGF-BB-activated HSC-T6 cells. The NF-kappa B signaling pathway, which controls cellular senescence and apoptosis, was demonstrated to be stimulated by ASIV by increasing p65, p52, p50 and inhibitor of NF-kappa B kinase alpha expression levels, and by suppressing the expression of NF-kappa B inhibitor alpha. Taken together, these results demonstrated that ASIV promoted cellular senescence and apoptosis by activating the NF-kappa B pathway to suppress PDGF-BB-induced HSC-T6 activation; with potential implications for the treatment of hepatic fibrosis.
C1 [Chen, Zhiwei; Yao, Ling; Pan, Zheng; Wan, Guoguo; Cheng, Junxiong; Wang, Jianwei; Cao, Wenfu] Chongqing Med Univ, Coll Tradit Chinese Med, Chongqing Key Lab Tradit Chinese Med Prevent & Cu, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.
   [Liu, Yuanyuan] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Hematol, Chongqing 400038, Peoples R China.
   [Peng, Shuang] Chongqing Tradit Chinese Med Hosp, Dept Intens Care Unit, Chongqing 400021, Peoples R China.
   [Cao, Wenfu] Chongqing Med Univ, Affiliated Hosp 1, Dept Chinese Tradit Med, Chongqing 400016, Peoples R China.
C3 Chongqing Medical University; Army Medical University; Chongqing Medical
   University
RP Cao, WF (corresponding author), Chongqing Med Univ, Coll Tradit Chinese Med, Chongqing Key Lab Tradit Chinese Med Prevent & Cu, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.
EM 13883658367@163.com
RI chen, zhiwei/AAP-5465-2020; Wang, Guanhua/JXM-6373-2024; liu,
   yuanyuan/HSG-8372-2023; li, Li/JPA-0218-2023; wen, Wen/KBB-1727-2024;
   liu, yuanyuan/IQS-2755-2023; liu, 园园/HJI-4438-2023; liu,
   yuanyuan/GWZ-5838-2022
FU National Natural Science Foundation of China [81573860]; Science and
   Technology Research Program of Chongqing Municipal Education Commission
   [KJQN201800432]; China Postdoctoral Science Foundation [2018M633330]
FX This research project was supported by grants from The National Natural
   Science Foundation of China(grant no. 81573860), Science and Technology
   Research Program of Chongqing Municipal Education Commission (grant no.
   KJQN201800432) and China Postdoctoral Science Foundation (grant no.
   2018M633330).
CR Albanis E, 2001, Clin Liver Dis, V5, P315, DOI 10.1016/S1089-3261(05)70168-9
   Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X
   Bitto N, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7080085
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Chen P, 2011, EUR J PHARMACOL, V658, P168, DOI 10.1016/j.ejphar.2011.02.040
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   da Silva BD, 2017, CELL BIOL INT, V41, P946, DOI 10.1002/cbin.10790
   Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004
   Duci SB, 2015, WORLD J PLAST SURG, V4, P153
   Duval F, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/373295
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Hao M, 2018, NEURAL REGEN RES, V13, P1081, DOI 10.4103/1673-5374.233452
   Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Hu TZ, 2017, PHARMACOL REP, V69, P1159, DOI 10.1016/j.pharep.2017.07.001
   Huang Y, 2017, EXP CELL RES, V352, P420, DOI 10.1016/j.yexcr.2017.02.038
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kim CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152591
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuo LM, 2018, MAR DRUGS, V16, DOI 10.3390/md16010019
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee JJ, 2018, ANTICANCER RES, V38, P2771, DOI 10.21873/anticanres.12520
   Leontieva OV, 2013, CELL CYCLE, V12, P3063, DOI 10.4161/cc.26130
   Li LC, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00513
   Li XM, 2013, FREE RADICAL BIO MED, V60, P168, DOI 10.1016/j.freeradbiomed.2013.02.027
   Liu H, 2009, J ETHNOPHARMACOL, V122, P502, DOI 10.1016/j.jep.2009.01.035
   Liu Y, 2018, J CHROMATOGR B, V1085, P110, DOI 10.1016/j.jchromb.2018.03.044
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mallat A, 2013, J HEPATOL, V59, P383, DOI 10.1016/j.jhep.2013.03.031
   Mei M, 2015, ENVIRON TOXICOL PHAR, V40, P764, DOI 10.1016/j.etap.2015.09.007
   Meng DX, 2018, BIOMED PHARMACOTHER, V108, P1617, DOI 10.1016/j.biopha.2018.10.005
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Osorio FG, 2012, AGING-US, V4, P726, DOI 10.18632/aging.100502
   Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420
   Ping J, 2011, EUR J PHARMACOL, V650, P656, DOI 10.1016/j.ejphar.2010.10.057
   Qian WB, 2018, J CELL MOL MED, V22, P4354, DOI 10.1111/jcmm.13725
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Senoo T, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0761-7
   Sun MX, 2015, CLIN RES HEPATOL GAS, V39, pS60, DOI 10.1016/j.clinre.2015.06.015
   Sun WY, 2012, INT J MOL MED, V29, P491, DOI 10.3892/ijmm.2011.844
   Thirukkumaran C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168233
   Trappoliere M, 2009, J HEPATOL, V50, P1102, DOI 10.1016/j.jhep.2009.02.023
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wan Y, 2018, EUR J PHARMACOL, V833, P545, DOI 10.1016/j.ejphar.2018.06.016
   Wang L, 2014, EXP BIOL MED, V239, P1310, DOI 10.1177/1535370214532597
   Wang PP, 2017, MOL MED REP, V16, P2761, DOI 10.3892/mmr.2017.6924
   Wang SX, 2018, BIOMED PHARMACOTHER, V102, P1037, DOI 10.1016/j.biopha.2018.03.127
   WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497
   Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112
   Xu WJ, 2014, J PHARMACOL EXP THER, V350, P552, DOI 10.1124/jpet.114.214205
   Yilmaz B, 2018, MOLECULES, V23, DOI 10.3390/molecules23040723
   Ying HZ, 2017, MOL MED REP, V16, P7879, DOI 10.3892/mmr.2017.7641
   Yuan W, 2008, PLANTA MED, V74, P1259, DOI 10.1055/s-2008-1081290
   Zhang ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.255
   Zhao ZR, 2014, J CELL PHYSIOL, V229, P1323, DOI 10.1002/jcp.24537
   Zoubek ME, 2017, BEST PRACT RES CL GA, V31, P129, DOI 10.1016/j.bpg.2017.04.005
NR 60
TC 13
Z9 15
U1 2
U2 12
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD NOV
PY 2019
VL 18
IS 5
BP 3741
EP 3750
DI 10.3892/etm.2019.8047
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA JW7GX
UT WOS:000503217400058
PM 31641375
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU FROLKIS, VV
   SHKAPENKO, AL
AF FROLKIS, VV
   SHKAPENKO, AL
TI SYNTHESIS OF INSULIN-DEPENDENT ACTIVATOR OF HEPATOCYTE PLASMATIC
   MEMBRANE NA,K-ATPASE DECREASES IN AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; HEPATOCYTE; INSULIN; HYPERPOLARIZATION; NA,K-ATPASE
AB The experiments on Wistar rats of different age-groups have shown that insulin (1.6 units/kg) provokes hyperpolarization of hepatocyte plasmatic membranes in adult rats, but not in old ones.  The hyperpolarization can be prevented by actinomycin D and ouabain, while 2-aminopyridine is ineffective in this case.  The appearance of hyperpolarization correlates with the activation of Na,K-ATPase in hepatocyte plasmatic membrane.  It is shown that insulin injection provokes the appearance of Na,K-ATPase activation factor in the hepatocyte cytosol.  The synthesis of this factor reduces with age.
RP FROLKIS, VV (corresponding author), ACAD MED SCI UKSSR,INST GERONTOL,VYSHGORODSKAYA ST 67,KIEV 252655,UKRAINE,USSR.
CR FROLKIS V, 1981, EXPERIENTIA, V37, P1076, DOI 10.1007/BF02085019
   FROLKIS VV, 1972, EXPERIENTIA, V28, P151, DOI 10.1007/BF01935723
   FROLKIS VV, 1981, B EXP BIOL MED, V3, P362
   FROLKIS VV, 1975, MECHANISMEN ALTERNS, P438
   KOSTYUK PG, 1960, MICROELECTRODE TECHN
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MICHELL RH, 1965, BIOCHEM BIOPH RES CO, V21, P333, DOI 10.1016/0006-291X(65)90198-1
   POTAPENKO RI, 1986, NEUROCHEM, V5, P56
   YAMAMOTO K, 1973, CANCER RES, V3, P567
NR 9
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP
PY 1991
VL 60
IS 1
BP 55
EP 60
DI 10.1016/0047-6374(91)90109-D
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GH764
UT WOS:A1991GH76400006
PM 1660552
DA 2024-02-19
ER

PT J
AU Ding, M
   Huang, WJ
   Liu, GF
   Zhai, B
   Yan, HX
   Zhang, Y
AF Ding, Min
   Huang, Weijian
   Liu, Guifen
   Zhai, Bo
   Yan, Hexin
   Zhang, Yong
TI Integration of ATAC-Seq and RNA-Seq reveals FOSL2 drives human liver
   progenitor-like cell aging by regulating inflammatory factors
SO BMC GENOMICS
LA English
DT Article
DE HepLPCs; ATAC-seq; RNA-seq; Aging; Inflammatory response
ID TRANSCRIPTION; HEPATOCYTES; PLURIPOTENT; SENESCENCE; EXPRESSION;
   STRATEGIES; CHROMATIN; PACKAGE; DISEASE; BINDING
AB BackgroundHuman primary hepatocytes (PHCs) are considered to be the best cell source for cell-based therapies for the treatment of end-stage liver disease and acute liver failure. To obtain sufficient and high-quality functional human hepatocytes, we have established a strategy to dedifferentiate human PHCs into expandable hepatocyte-derived liver progenitor-like cells (HepLPCs) through in vitro chemical reprogramming. However, the reduced proliferative capacity of HepLPCs after long-term culture still limits their utility. Therefore, in this study, we attempted to explore the potential mechanism related to the proliferative ability of HepLPCs in vitro culture.ResultsIn this study, analysis of assay for transposase accessible chromatin using sequencing (ATAC-seq) and RNA sequencing (RNA-seq) were performed for PHCs, proliferative HepLPCs (pro-HepLPCs) and late-passage HepLPCs (lp-HepLPCs). Genome-wide transcriptional and chromatin accessibility changes during the conversion and long-term culture of HepLPCs were studied. We found that lp-HepLPCs exhibited an aged phenotype characterized by the activation of inflammatory factors. Epigenetic changes were found to be consistent with our gene expression findings, with promoter and distal regions of many inflammatory-related genes showing increased accessibility in the lp-HepLPCs. FOSL2, a member of the AP-1 family, was found to be highly enriched in the distal regions with increased accessibility in lp-HepLPCs. Its depletion attenuated the expression of aging- and senescence-associated secretory phenotype (SASP)-related genes and resulted in a partial improvement of the aging phenotype in lp-HepLPCs.ConclusionsFOSL2 may drive the aging of HepLPCs by regulating inflammatory factors and its depletion may attenuate this phenotypic shift. This study provides a novel and promising approach for the long-term in vitro culture of HepLPCs.
C1 [Ding, Min; Liu, Guifen; Zhang, Yong] Tongji Univ, Frontier Sci Ctr Stem Cell Res, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res,Shanghai East, Shanghai 200092, Peoples R China.
   [Ding, Min; Zhai, Bo; Yan, Hexin] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Intervent Oncol, Shanghai 200127, Peoples R China.
   [Huang, Weijian; Yan, Hexin] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Anesthesiol & Crit Care Med, Shanghai 200127, Peoples R China.
   [Zhai, Bo] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China.
   [Yan, Hexin] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Sch Med, Shanghai 200127, Peoples R China.
C3 Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong
   University; Shanghai Jiao Tong University; Shanghai Jiao Tong University
RP Zhang, Y (corresponding author), Tongji Univ, Frontier Sci Ctr Stem Cell Res, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res,Shanghai East, Shanghai 200092, Peoples R China.; Zhai, B; Yan, HX (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Intervent Oncol, Shanghai 200127, Peoples R China.; Yan, HX (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Anesthesiol & Crit Care Med, Shanghai 200127, Peoples R China.; Zhai, B (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China.; Yan, HX (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Sch Med, Shanghai 200127, Peoples R China.
EM zhaiboshi@sina.com; hexinyw@163.com; yzhang@tongji.edu.cn
CR Alwahsh SM, 2018, CELL MOL LIFE SCI, V75, P1307, DOI 10.1007/s00018-017-2713-8
   Avelar RA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01990-9
   Basu SK, 2011, EMBO J, V30, P3714, DOI 10.1038/emboj.2011.250
   Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937
   Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590
   Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]
   Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024
   Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607
   Dhawan A, 2010, NAT REV GASTRO HEPAT, V7, P288, DOI 10.1038/nrgastro.2010.44
   Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009
   Fu GB, 2019, CELL RES, V29, P8, DOI 10.1038/s41422-018-0103-x
   Gao X, 2015, J CELL BIOL, V211, P669, DOI 10.1083/jcb.201506014
   Grossman SR, 2018, P NATL ACAD SCI USA, V115, pE7222, DOI 10.1073/pnas.1804663115
   Han BY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17304-3
   Hannoun Z, 2016, J HEPATOL, V65, P182, DOI 10.1016/j.jhep.2016.02.025
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hu HL, 2018, CELL, V175, P1591, DOI 10.1016/j.cell.2018.11.013
   Huang M, 2022, HEPATOLOGY, V76, P1706, DOI 10.1002/hep.32458
   Huggins CJ, 2013, MOL CELL BIOL, V33, P3242, DOI 10.1128/MCB.01674-12
   Huh HD, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060600
   Iansante V, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0229
   Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873
   Katsuda T, 2019, ELIFE, V8, DOI 10.7554/eLife.47313
   Kim CL, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050468
   Kim Y, 2019, J HEPATOL, V70, P97, DOI 10.1016/j.jhep.2018.09.007
   Kuzmichev AN, 2012, CURR BIOL, V22, P1705, DOI 10.1016/j.cub.2012.07.013
   Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014
   Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437
   Li LL, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110313
   Liu YT, 2021, CELL MOL LIFE SCI, V78, P5847, DOI 10.1007/s00018-021-03883-x
   Martínez-Zamudio RI, 2020, NAT CELL BIOL, V22, P842, DOI 10.1038/s41556-020-0529-5
   Moon S, 2018, CELL MOL LIFE SCI, V75, P2303, DOI 10.1007/s00018-018-2804-1
   Park JH, 2018, MOL CELLS, V41, P83
   Ramboer E, 2014, J HEPATOL, V61, P925, DOI 10.1016/j.jhep.2014.05.046
   Ramírez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365
   Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730
   Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441
   Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145
   Stelekati E, 2018, CELL REP, V23, P2142, DOI 10.1016/j.celrep.2018.04.038
   Stravitz RT, 2019, LANCET, V394, P869, DOI 10.1016/S0140-6736(19)31894-X
   Stravitz RT, 2009, NAT REV GASTRO HEPAT, V6, P542, DOI 10.1038/nrgastro.2009.127
   Struecker B, 2014, NAT REV GASTRO HEPAT, V11, P166, DOI 10.1038/nrgastro.2013.204
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun XX, 2016, CELL STEM CELL, V18, P456, DOI 10.1016/j.stem.2016.03.001
   Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074
   Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796
   Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33
   Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154
   Wang AW, 2020, CELL MOL GASTROENTER, V9, P121, DOI 10.1016/j.jcmgh.2019.09.006
   Wang CH, 2022, HEPATOLOGY, V76, P1690, DOI 10.1002/hep.32436
   Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406
   Wang S, 2019, DEV CELL, V50, P43, DOI 10.1016/j.devcel.2019.05.034
   Wang YQ, 2017, GENOM PROTEOM BIOINF, V15, P14, DOI 10.1016/j.gpb.2017.01.001
   Wu H, 2017, CELL RES, V27, P709, DOI 10.1038/cr.2017.47
   Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang K, 2018, CELL STEM CELL, V23, P806, DOI 10.1016/j.stem.2018.10.018
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 58
TC 0
Z9 0
U1 5
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD MAY 13
PY 2023
VL 24
IS 1
AR 260
DI 10.1186/s12864-023-09349-7
PG 17
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA F9WA5
UT WOS:000985765300001
PM 37173651
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Marongiu, F
   Serra, MP
   Fanti, M
   Cadoni, E
   Serra, M
   Laconi, E
AF Marongiu, Fabio
   Serra, Maria Paola
   Fanti, Maura
   Cadoni, Erika
   Serra, Monica
   Laconi, Ezio
TI Regenerative Medicine: Shedding Light on the Link between Aging and
   Cancer
SO CELL TRANSPLANTATION
LA English
DT Article
DE aging; cancer; regenerative medicine; hepatocyte transplantation; tissue
   fitness
ID IN-VIVO; LIVER REPOPULATION; CELL COMPETITION; SENESCENCE; DNA;
   MICROENVIRONMENT; HEPATOCYTES; MECHANISMS; FITNESS; DAMAGE
AB The evidence linking aging and cancer is overwhelming. Findings emerging from the field of regenerative medicine reinforce the notion that aging and cancer are profoundly interrelated in their pathogenetic pathways. We discuss evidence to indicate that age-associated alterations in the tissue microenvironment contribute to the emergence of a neoplastic-prone tissue landscape, which is able to support the selective growth of preneoplastic cell populations. Interestingly, tissue contexts that are able to select for the growth of preneoplastic cells, including the aged liver microenvironment, are also supportive for the clonal expansion of normal, homotypic, transplanted cells. This suggests that the growth of normal and preneoplastic cells is possibly driven by similar mechanisms, implying that strategies based on principles of regenerative medicine might be applicable to modulate neoplastic disease.
C1 [Marongiu, Fabio; Serra, Maria Paola; Fanti, Maura; Cadoni, Erika; Serra, Monica; Laconi, Ezio] Univ Cagliari, Dept Biomed Sci, Unit Expt Med, Cagliari, Italy.
C3 University of Cagliari
RP Laconi, E (corresponding author), Univ Cagliari, Dept Biomed Sci, Unit Expt Med, Sch Med, Via Porcell 4,3rd Floor, I-09124 Cagliari, Italy.
EM elaconi@unica.it
RI Marongiu, Fabio/E-6294-2016
OI Marongiu, Fabio/0000-0001-5860-4227; Fanti, Maura/0000-0002-8627-666X
FU AIRC (Italian Association for Cancer Research) [10604]; Sardinian
   Regional Government (RAS)
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Part of
   the work referred to in this review was supported by AIRC (Italian
   Association for Cancer Research, Grant No. IG 10604) and by Sardinian
   Regional Government (RAS).
CR Biran A, 2015, GENE DEV, V29, P791, DOI 10.1101/gad.259341.115
   Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085
   Di Gregorio A, 2016, DEV CELL, V38, P621, DOI 10.1016/j.devcel.2016.08.012
   Effenberger T, 2014, FASEB J, V28, P4847, DOI 10.1096/fj.14-254565
   FARBER E, 1991, CANCER RES, V51, P2751
   Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5
   Fleenor CJ, 2015, RADIAT RES, V184, P341, DOI 10.1667/RR14147.1
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Fougere B., 2016, J GERONTOL A
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Fulop T, 2014, CURR OPIN IMMUNOL, V29, P105, DOI 10.1016/j.coi.2014.05.007
   Galun E, 2016, HEPATOLOGY, V63, P354, DOI 10.1002/hep.28344
   GENSLER HL, 1981, Q REV BIOL, V56, P279, DOI 10.1086/412317
   Gladyshev VN, 2016, AGING CELL, V15, P594, DOI 10.1111/acel.12480
   Gravina S, 2016, AGING CELL, V15, P398, DOI 10.1111/acel.12454
   Henry CJ, 2015, J CLIN INVEST, V125, P4666, DOI 10.1172/JCI83024
   Henry CJ, 2010, P NATL ACAD SCI USA, V107, P21713, DOI 10.1073/pnas.1005486107
   Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002
   Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   Horvath S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0649-6
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Huang JS, 2014, AM J PATHOL, V184, P309, DOI 10.1016/j.ajpath.2013.04.034
   Kaeberlein M, 2015, SCIENCE, V350, P1191, DOI 10.1126/science.aad3267
   Kajita M, 2015, J BIOCHEM, V158, P15, DOI 10.1093/jb/mvv050
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Laconi S, 2001, P NATL ACAD SCI USA, V98, P7806, DOI 10.1073/pnas.131210498
   Laconi S, 1999, J HEPATOL, V31, P1069, DOI 10.1016/S0168-8278(99)80320-1
   Laconi S, 2006, TRANSPLANTATION, V82, P1319, DOI 10.1097/01.tp.0000228239.78290.13
   Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538
   Lenart P, 2016, MUTAT RES-FUND MOL M, V788, P25, DOI 10.1016/j.mrfmmm.2016.04.002
   Lizée G, 2006, CLIN CANCER RES, V12, P4794, DOI 10.1158/1078-0432.CCR-06-0944
   Loaiza N, 2016, BBA-REV CANCER, V1865, P155, DOI 10.1016/j.bbcan.2016.01.007
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Ma YN, 2015, COMPR PHYSIOL, V5, P667, DOI 10.1002/cphy.c140041
   Madia F, 2009, J CELL BIOL, V186, P509, DOI 10.1083/jcb.200906011
   Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676
   Marongiu F, 2008, AM J PATHOL, V172, P857, DOI 10.2353/ajpath.2008.070910
   Marongiu F, 2016, AGING-US, V8, P3390, DOI 10.18632/aging.101128
   Marongiu F, 2014, AGING-US, V6, P26, DOI 10.18632/aging.100631
   MARTIN GM, 1977, AM J PATHOL, V89, P513
   Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082
   Marusyk A, 2009, CANCER RES, V69, P7262, DOI 10.1158/0008-5472.CAN-09-0604
   MATTOCKS AR, 1968, NATURE, V217, P723, DOI 10.1038/217723a0
   MCCULLOUGH KD, 1994, CANCER RES, V54, P3668
   Menthena A, 2011, GASTROENTEROLOGY, V140, P1009, DOI 10.1053/j.gastro.2010.12.003
   Merino MM, 2016, TRENDS CELL BIOL, V26, P776, DOI 10.1016/j.tcb.2016.05.009
   Monti D, 2016, MECH AGEING DEV, V12, P27
   O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   Pasero C, 2016, CANCER RES, V76, P2153, DOI 10.1158/0008-5472.CAN-15-1965
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Serra MP, 2015, J HEPATOL, V62, P1341, DOI 10.1016/j.jhep.2015.01.015
   Serra MP, 2012, HEPATOLOGY, V56, P760, DOI 10.1002/hep.25698
   Serrano M, 2016, CARCINOGENESIS, V37, P107, DOI 10.1093/carcin/bgv100
   Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113
   Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111
   Soskic V, 2008, EXP GERONTOL, V43, P247, DOI 10.1016/j.exger.2007.12.001
   Sousounis K, 2014, CURR TOP DEV BIOL, V108, P217, DOI 10.1016/B978-0-12-391498-9.00008-5
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Vanhooren V, 2015, MECH AGEING DEV, V151, P71, DOI 10.1016/j.mad.2015.03.009
   Vijg J, 2014, BIOESSAYS, V36, P282, DOI 10.1002/bies.201300127
   Wang Yu-Ping, 2005, Int J Environ Res Public Health, V2, P74, DOI 10.3390/ijerph2005010074
   White RR, 2016, MOL CELL, V63, P729, DOI 10.1016/j.molcel.2016.08.004
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yin DZ, 2005, EXP GERONTOL, V40, P455, DOI 10.1016/j.exger.2005.03.012
   Zhang R, 2015, CELL SYST, V1, P180, DOI 10.1016/j.cels.2015.09.002
   Zhu L, 2017, ARCH TOXICOL, V91, P949, DOI 10.1007/s00204-016-1713-z
NR 74
TC 5
Z9 6
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PD SEP
PY 2017
VL 26
IS 9
SI SI
BP 1530
EP 1537
DI 10.1177/0963689717721224
PG 8
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA FM3LJ
UT WOS:000414907000005
PM 29113461
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kodama, T
   Takehara, T
   Hikita, H
   Shimizu, S
   Shigekawa, M
   Tsunematsu, H
   Li, W
   Miyagi, T
   Hosui, A
   Tatsumi, T
   Ishida, H
   Kanto, T
   Hiramatsu, N
   Kubota, S
   Takigawa, M
   Tomimaru, Y
   Tomokuni, A
   Nagano, H
   Doki, Y
   Mori, M
   Hayashi, N
AF Kodama, Takahiro
   Takehara, Tetsuo
   Hikita, Hayato
   Shimizu, Satoshi
   Shigekawa, Minoru
   Tsunematsu, Hinako
   Li, Wei
   Miyagi, Takuya
   Hosui, Atsushi
   Tatsumi, Tomohide
   Ishida, Hisashi
   Kanto, Tatsuya
   Hiramatsu, Naoki
   Kubota, Satoshi
   Takigawa, Masaharu
   Tomimaru, Yoshito
   Tomokuni, Akira
   Nagano, Hiroaki
   Doki, Yuichiro
   Mori, Masaki
   Hayashi, Norio
TI Increases in p53 expression induce CTGF synthesis by mouse and human
   hepatocytes and result in liver fibrosis in mice
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID TISSUE GROWTH-FACTOR; HEPATIC STELLATE CELLS; MIR-17-92 CLUSTER;
   MICRORNA CLUSTER; TARGET GENE; APOPTOSIS; INHIBITION; MDM2;
   DIFFERENTIATION; STEATOHEPATITIS
AB The tumor suppressor p53 has been implicated in the pathogenesis of non-cancer-related conditions such as insulin resistance, cardiac failure, and early aging. In addition, accumulation of p53 has been observed in the hepatocytes of individuals with fibrotic liver diseases, but the significance of this is not known. Herein, we have mechanistically linked p53 activation in hepatocytes to liver fibrosis. Hepatocyte-specific deletion in mice of the gene encoding Mchm2, a protein that promotes p53 degradation, led to hepatocyte synthesis of connective tissue growth factor (CTGF; the hepatic fibrogenic master switch), increased hepatocyte apoptosis, and spontaneous liver fibrosis; concurrent removal of p53 completely abolished this phenotype. Compared with wild-type controls, mice with hepatocyte-specific p53 deletion exhibited similar levels of hepatocyte apoptosis but decreased liver fibrosis and hepatic CTGF expression in two models of liver fibrosis. The clinical significance of these data was highlighted by two observations. First, p53 upregulated CTGF in a human hepatocellular carcinoma cell line by repressing miR-17-92. Second, human liver samples showed a correlation between CTGF and p53-regulated gene expression, which were both increased in fibrotic livers. This study reveals that p53 induces CTGF expression and promotes liver fibrosis, suggesting that the p53/CTGF pathway may be a therapeutic target in the treatment of liver fibrosis.
C1 [Kodama, Takahiro; Takehara, Tetsuo; Hikita, Hayato; Shimizu, Satoshi; Shigekawa, Minoru; Tsunematsu, Hinako; Li, Wei; Miyagi, Takuya; Hosui, Atsushi; Tatsumi, Tomohide; Ishida, Hisashi; Kanto, Tatsuya; Hiramatsu, Naoki] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Kubota, Satoshi; Takigawa, Masaharu] Okayama Univ, Dept Biochem & Mol Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.
   [Tomimaru, Yoshito; Tomokuni, Akira; Nagano, Hiroaki; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Surg, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Hayashi, Norio] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan.
C3 Osaka University; Okayama University; Osaka University; Kansai Rosai
   Hospital
RP Takehara, T (corresponding author), Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.
EM takehara@gh.med.osaka-u.ac.jp
RI Tomimaru, Yoshito/IQS-7856-2023; Kodama, Takahiro/AAW-9605-2021; Hosui,
   Atsushi/AAC-1771-2020
OI Tomimaru, Yoshito/0000-0002-4432-060X; Kodama,
   Takahiro/0000-0002-6250-1324; Hosui, Atsushi/0000-0003-0777-8045
FU Grants-in-Aid for Scientific Research [19109008, 21590845, 21592360,
   23390197] Funding Source: KAKEN
CR Abou-Shady M, 2000, LIVER, V20, P296, DOI 10.1034/j.1600-0676.2000.020004296.x
   Akyol G, 1999, PATHOL INT, V49, P214, DOI 10.1046/j.1440-1827.1999.00849.x
   Attallah AM, 2009, CLIN BIOCHEM, V42, P455, DOI 10.1016/j.clinbiochem.2008.11.004
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036
   Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189
   Canbay A, 2003, LAB INVEST, V83, P655, DOI 10.1097/01.LAB.0000069036.63405.5C
   Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30
   Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034
   Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855
   Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535
   Eguchi T, 2001, J BIOCHEM, V130, P79, DOI 10.1093/oxfordjournals.jbchem.a002965
   Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Gao R, 2006, GUT, V55, P856, DOI 10.1136/gut.2005.079178
   George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929
   Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x
   Gressner OA, 2007, J HEPATOL, V47, P699, DOI 10.1016/j.jhep.2007.05.015
   Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006
   Haydont V, 2008, AM J PHYSIOL-CELL PH, V294, pC1332, DOI 10.1152/ajpcell.90626.2007
   Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836
   Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207
   Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126
   Hora C, 2008, LIVER INT, V28, P370, DOI 10.1111/j.1478-3231.2007.01608.x
   Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Kodama T, 2011, J BIOL CHEM, V286, P13905, DOI 10.1074/jbc.M110.195370
   Kodama T, 2010, GASTROENTEROLOGY, V138, P2487, DOI 10.1053/j.gastro.2010.02.054
   Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733
   Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050
   Ku JL, 2002, BRIT J CANCER, V87, P187, DOI 10.1038/sj.bjc.6600440
   Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x
   Li GM, 2006, J GENE MED, V8, P889, DOI 10.1002/jgm.894
   Lin Y., 1996, Annals Academy of Medicine Singapore, V25, P22
   Loguercio C, 2003, J VIRAL HEPATITIS, V10, P266, DOI 10.1046/j.1365-2893.2003.00432.x
   LUNA RMD, 1995, NATURE, V378, P203
   Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Ohgawara T, 2009, FEBS LETT, V583, P1006, DOI 10.1016/j.febslet.2009.02.025
   Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020
   Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198
   Papakyriakou P, 2002, APOPTOSIS, V7, P133, DOI 10.1023/A:1014472430976
   Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055
   Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425
   Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062
   Sakamori R, 2007, HEPATOLOGY, V46, P1564, DOI 10.1002/hep.21837
   Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602
   Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850
   Suzuki T, 2003, BIOCHEM BIOPH RES CO, V300, P784, DOI 10.1016/S0006-291X(02)02889-9
   Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019
   Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065
   Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102
   Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864
   Vozenin-Brotons MC, 2003, INT J RADIAT ONCOL, V56, P561, DOI 10.1016/S0360-3016(02)04601-1
   Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806
   Williams EJ, 2000, J HEPATOL, V32, P754, DOI 10.1016/S0168-8278(00)80244-5
   Xiong SB, 2006, P NATL ACAD SCI USA, V103, P3226, DOI 10.1073/pnas.0508500103
   Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214
NR 61
TC 130
Z9 140
U1 2
U2 18
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA
SN 0021-9738
J9 J CLIN INVEST
JI J. Clin. Invest.
PD AUG
PY 2011
VL 121
IS 8
BP 3343
EP 3356
DI 10.1172/JCI44957
PG 14
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 802FU
UT WOS:000293495500040
PM 21747166
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Huang, Y
   Deng, X
   Liang, J
AF Huang, Yu
   Deng, Xin
   Liang, Jian
TI Modulation of hepatic stellate cells and reversibility of hepatic
   fibrosis
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE Modulation; Hepatic stellate cells; Reversibility; Hepatic fibrosis;
   Mechanism
ID RAT-LIVER FIBROSIS; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; CELLULAR
   SENESCENCE; NATURAL-KILLER; MESSENGER-RNA; APOPTOSIS; REGRESSION;
   EXPRESSION; ACTIVATION
AB Hepatic fibrosis (HF) is the pathological component of a variety of chronic liver diseases. Hepatic stellate cells (HSC) are the main collagen-producing cells in the liver and their activation promotes HF. If HSC activation and proliferation can be inhibited, HF occurrence and development can theoretically be reduced and even reversed. Over the past ten years, a number of studies have addressed this process, and here we present a review of HSC modulation and HF reversal.
C1 [Huang, Yu] Guangxi Univ Chinese Med, Fac Grad Studies, Nanning 530001, Guangxi Zhuang, Peoples R China.
   [Deng, Xin] Guangxi Univ Chinese Med, Ruikang Hosp, 10 East China Rd, Nanning 530001, Guangxi Zhuang, Peoples R China.
   [Liang, Jian] Guangxi Univ Chinese Med, Nanning 530001, Guangxi Zhuang, Peoples R China.
C3 Guangxi University of Chinese Medicine; Guangxi University of Chinese
   Medicine; Guangxi University of Chinese Medicine
RP Deng, X (corresponding author), Guangxi Univ Chinese Med, Ruikang Hosp, 10 East China Rd, Nanning 530001, Guangxi Zhuang, Peoples R China.
EM 1293363632@QQ.com; Hendly@163.com; lj99669@163.com
FU National Natural Science Foundation of China [81360595, 81160433];
   Guangxi Natural Science Foundation [2013GXNSFBA019188]; Guangxi
   Provincial Medicine and Health Industry; Guangxi Bagui scholars and
   Guangxi distinguished experts
FX This study was supported by grants from the National Natural Science
   Foundation of China (81360595 and 81160433) and Guangxi Natural Science
   Foundation (2013GXNSFBA019188). This study was funded by the Guangxi
   Provincial Medicine and Health Industry, Guangxi Bagui scholars and
   Guangxi distinguished experts.
CR Abu-Elsaad NM, 2016, CAN J PHYSIOL PHARM, V94, P554, DOI 10.1139/cjpp-2015-0284
   Agiasotelli D, 2016, HEPATOL RES, V46, P514, DOI 10.1111/hepr.12582
   Albanis E, 2001, Clin Liver Dis, V5, P315, DOI 10.1016/S1089-3261(05)70168-9
   Andrade CMB, 2008, LIFE SCI, V82, P21, DOI 10.1016/j.lfs.2007.10.003
   Atta HM, 2015, WORLD J GASTROENTERO, V21, P5138, DOI 10.3748/wjg.v21.i17.5138
   Bansal MB, 2016, HEPATOL INT, V10, P902, DOI 10.1007/s12072-016-9758-x
   Bedossa Pierre, 2003, Clin Liver Dis, V7, P195, DOI 10.1016/S1089-3261(02)00076-4
   Bennett RG, 2003, BIOCHEM PHARMACOL, V66, P867, DOI 10.1016/S0006-2952(03)00403-9
   Benyon RC, 2000, GUT, V46, P443, DOI 10.1136/gut.46.4.443
   Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892
   Che XH, 2010, BASIC CLIN PHARMACOL, V106, P30, DOI 10.1111/j.1742-7843.2009.00465.x
   Chen JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30957
   Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405
   Cho JJ, 2000, GASTROENTEROLOGY, V118, P1169, DOI 10.1016/S0016-5085(00)70370-2
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   de Mesquita FC, 2013, EUR J PHARMACOL, V720, P320, DOI 10.1016/j.ejphar.2013.09.067
   Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675
   Duseja A, 2013, J CLIN EXP HEPATOL, V3, P167, DOI 10.1016/j.jceh.2013.05.007
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Fasbender F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00019
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828
   FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681
   Fu YM, 2008, MOL PHARMACOL, V73, P399, DOI 10.1124/mol.107.039818
   Gao B, 2013, BBA-MOL BASIS DIS, V1832, P1061, DOI 10.1016/j.bbadis.2012.09.008
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Glässner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54
   Gonzalez SA, 2009, J VIRAL HEPATITIS, V16, P141, DOI 10.1111/j.1365-2893.2008.01052.x
   Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604
   Hansen T., 2015, UGESKRIFT LAEGER, V177
   Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182
   Iredale JP, 2013, BBA-MOL BASIS DIS, V1832, P876, DOI 10.1016/j.bbadis.2012.11.002
   Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1053/jhep.1996.v24.pm0008707259
   Iredale JP, 1997, INT J BIOCHEM CELL B, V29, P43, DOI 10.1016/S1357-2725(96)00118-5
   Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548
   Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Karthikeyan S, 2016, BIOCHEM BIOPH RES CO, V469, P463, DOI 10.1016/j.bbrc.2015.10.101
   Kawada N, 2006, GUT, V55, P1073, DOI 10.1136/gut.2005.090449
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Liu Xiao, 2013, Curr Pathobiol Rep, V1, P209
   Lu Guangming, 2002, Journal of Medical Investigation, V49, P172
   MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886
   Maher JJ, 2001, SEMIN LIVER DIS, V21, P417, DOI 10.1055/s-2001-17555
   MAK KM, 1988, HEPATOLOGY, V8, P1027, DOI 10.1002/hep.1840080508
   Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013
   Mallat A, 2013, J HEPATOL, V59, P383, DOI 10.1016/j.jhep.2013.03.031
   Manne V, 2014, J CLIN GASTROENTEROL, V48, pE76, DOI 10.1097/MCG.0000000000000162
   MILANI S, 1989, HEPATOLOGY, V10, P84, DOI 10.1002/hep.1840100117
   Mitra A, 2014, HEPATOLOGY, V60, P2027, DOI 10.1002/hep.27392
   Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200
   Ng VL, 2001, J HEPATOL, V35, P781, DOI 10.1016/S0168-8278(01)00212-4
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701
   Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003
   Pan TL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/734987
   Panebianco C., 2016, CLIN EXP MED
   Park EJ, 2005, PLANTA MED, V71, P885, DOI 10.1055/s-2005-871280
   Park EJ, 2005, PLANTA MED, V71, P82, DOI 10.1055/s-2005-837757
   Pellicoro A, 2012, HEPATOLOGY, V55, P1965, DOI 10.1002/hep.25567
   Roldán FP, 2010, GASTROENT HEPAT-BARC, V33, P498, DOI 10.1016/j.gastrohep.2010.04.007
   Ping J, 2011, J PHARMACOL EXP THER, V339, P694, DOI 10.1124/jpet.111.179820
   Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Ray Katrina, 2014, Nat Rev Gastroenterol Hepatol, V11, P74, DOI 10.1038/nrgastro.2013.244
   Reifart J, 2015, TRANSPLANTATION, V99, P41, DOI 10.1097/TP.0000000000000461
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   SCHUPPAN D, 1994, ANN NY ACAD SCI, V733, P87, DOI 10.1111/j.1749-6632.1994.tb17259.x
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   Sun MX, 2015, CLIN RES HEPATOL GAS, V39, pS60, DOI 10.1016/j.clinre.2015.06.015
   Taghdouini E. I., 2015, TISSUE REPAIR, V8, P14
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Viñas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392
   Wu L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7478650
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
NR 82
TC 79
Z9 105
U1 2
U2 60
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAR 15
PY 2017
VL 352
IS 2
BP 420
EP 426
DI 10.1016/j.yexcr.2017.02.038
PG 7
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA EO8TY
UT WOS:000396964600027
PM 28238836
DA 2024-02-19
ER

PT J
AU Gutierrez-Reyes, G
   de Leon, MDG
   Varela-Fascinetto, G
   Valencia, P
   Tamayo, RP
   Rosado, CG
   Labonne, BF
   Rochilin, NM
   Garcia, RM
   Valadez, JA
   Latour, GT
   Corona, DL
   Diaz, GR
   Zlotnik, A
   Kershenobich, D
AF Gutierrez-Reyes, Gabriela
   del Carmen Garcia de Leon, Maria
   Varela-Fascinetto, Gustavo
   Valencia, Pedro
   Perez Tamayo, Ruy
   Gonzalez Rosado, Claudia
   Farfan Labonne, Blanca
   Morales Rochilin, Norma
   Martinez Garcia, Rosalinda
   Aguirre Valadez, Jonathan
   Togno Latour, Gabriela
   Lau Corona, Dana
   Robles Diaz, Guillermo
   Zlotnik, Albert
   Kershenobich, David
TI Cellular Senescence in Livers from Children with End Stage Liver Disease
SO PLOS ONE
LA English
DT Article
ID REPLICATIVE SENESCENCE; DNA-DAMAGE; HEPATITIS-C; CELLS; EXPRESSION;
   HEPATOCYTES; P16(INK4A); BIOMARKER; MARKERS; REPAIR
AB Background: Senescent cells occur in adults with cirrhotic livers independent of the etiology. Aim: Investigate the presence rate of cellular senescence and expression of cell cycle check points in livers from children with end stage disease.
   Methodology/Principal Findings: Livers of five children aged three years or less undergoing liver transplantation due to tyrosinemia (n = 1), biliary atresia (n = 2), or fulminant hepatitis (n = 2) were analyzed for senescence associated beta-galactosidase (SA-beta gal) activity and p16INK4a, p21cip1 and p53. All livers displayed positive cellular staining for SA-beta gal in the canals of Hering and interlobular biliary ducts. In the presence of cirrhosis (3/5 cases) SA-beta gal was found at the cholangioles and hepatocytes surrounding the regenerative nodules. Children with fulminant hepatic failure without cirrhosis had significant ductular transformation with intense SA-beta gal activity. No SA-beta gal activity was evident in the fibrous septa. Staining for p53 had a similar distribution to that observed for SA-beta gal. Staining for p16(INK4a) and p21(cip1) was positive in the explanted liver of the patient with tyrosinemia, in the hepatocytes, the canals of Hering, cholangioles and interlobular bile ducts. In the livers with fulminant hepatitis, p21(cip1) staining occurred in the areas of ductular transformation and in the interlobular bile ducts.
   Conclusions/Significance: Cellular senescence in livers of children with end stage disease is associated with damage rather than corresponding to an age dependent phenomenon. Further studies are needed to support the hypothesis that these senescence markers correlate with disease progression.
C1 [Gutierrez-Reyes, Gabriela; del Carmen Garcia de Leon, Maria; Perez Tamayo, Ruy; Gonzalez Rosado, Claudia; Farfan Labonne, Blanca; Morales Rochilin, Norma; Martinez Garcia, Rosalinda; Aguirre Valadez, Jonathan; Togno Latour, Gabriela; Lau Corona, Dana; Robles Diaz, Guillermo; Kershenobich, David] Univ Nacl Autonoma Mexico, Sch Med, Dept Expt Med, Mexico City 04510, DF, Mexico.
   [Varela-Fascinetto, Gustavo; Valencia, Pedro] Hosp Infantil Mexico Dr Federico Gomez, Dept Surg & Pathol, Mexico City, DF, Mexico.
   [Zlotnik, Albert] Univ Calif Irvine, Irvine, CA USA.
C3 Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico
   Federico Gomez; University of California System; University of
   California Irvine
RP Gutierrez-Reyes, G (corresponding author), Univ Nacl Autonoma Mexico, Sch Med, Dept Expt Med, Mexico City 04510, DF, Mexico.
EM kesdhipa@yahoo.com
RI Zlotnik, Albert/C-3791-2011
OI Varela-Fascinetto, Gustavo/0000-0001-8836-8448; Lau Corona,
   Dana/0000-0002-8743-6346
FU CONACYT-SALUD (Mexico) [2004-C01-175]; Universidad Nacional Autonoma de
   Mexico (UNAM) [SDI.PTID.05.6.]
FX This study was supported by CONACYT-SALUD (Mexico), grant (2004-C01-175)
   and Universidad Nacional Autonoma de Mexico (UNAM) grant (NEEGPSP
   SDI.PTID.05.6.) The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8
   Campisi J, 2000, IN VIVO, V14, P183
   Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005
   Chen Jian-Hua, 2007, Methods Mol Biol, V371, P179
   Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919
   Ju YJ, 2006, EXP MOL MED, V38, P686, DOI 10.1038/emm.2006.81
   Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064
   Kiss A, 2001, LIVER, V21, P237, DOI 10.1034/j.1600-0676.2001.021004237.x
   Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x
   Maier AB, 2007, ANN NY ACAD SCI, V1100, P323, DOI 10.1196/annals.1395.035
   Martien S, 2007, ANN NY ACAD SCI, V1119, P51, DOI 10.1196/annals.1404.010
   Obata M, 2001, MOL CARCINOGEN, V32, P9, DOI 10.1002/mc.1059
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007
   Seki S, 2003, HEPATOL RES, V25, P149, DOI 10.1016/S1386-6346(02)00205-X
   Shawi M, 2008, MECH AGEING DEV, V129, P3, DOI 10.1016/j.mad.2007.11.007
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Trak-Smayra V, 2004, TRANSPLANTATION, V77, P1755, DOI 10.1097/01.TP.0000131172.75294.A9
   Watanabe H, 2008, PATHOLOGY, V40, P272, DOI 10.1080/00313020801911546
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816
NR 26
TC 35
Z9 36
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 21
PY 2010
VL 5
IS 4
AR e10231
DI 10.1371/journal.pone.0010231
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 586YS
UT WOS:000276952500009
PM 20422055
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bilson, J
   Sethi, JK
   Byrne, CD
AF Bilson, Josh
   Sethi, Jaswinder K.
   Byrne, Christopher D.
TI Non-alcoholic fatty liver disease: a multi-system disease influenced by
   ageing and sex, and affected by adipose tissue and intestinal function
SO PROCEEDINGS OF THE NUTRITION SOCIETY
LA English
DT Article; Early Access
DE Non-alcoholic fatty liver disease; Adipose tissue dysfunction; Gut
   microbiota; Diabetes; CVD; Age; Sex
ID NECROSIS-FACTOR-ALPHA; HEPATIC STELLATE CELLS; CHRONIC KIDNEY-DISEASE;
   INSULIN-RESISTANCE; GUT MICROBIOTA; VISCERAL FAT; CIRCULATING
   ADIPONECTIN; METABOLIC SYNDROME; GENE-EXPRESSION; FIBROSIS STAGE
AB In recent years, a wealth of factors are associated with increased risk of developing non-alcoholic fatty liver disease (NAFLD) and NAFLD is now thought to increase the risk of multiple extra-hepatic diseases. The aim of this review is first to focus on the role of ageing and sex as key, poorly understood risk factors in the development and progression of NAFLD. Secondly, we aim to discuss the roles of white adipose tissue (WAT) and intestinal dysfunction, as producers of extra-hepatic factors known to further contribute to the pathogenesis of NAFLD. Finally, we aim to summarise the role of NAFLD as a multi-system disease affecting other organ systems beyond the liver. Both increased age and male sex increase the risk of NAFLD and this may be partly driven by alterations in the distribution and function of WAT. Similarly, changes in gut microbiota composition and intestinal function with ageing and chronic overnutrition are likely to contribute to the development of NAFLD both directly (i.e. by affecting hepatic function) and indirectly via exacerbating WAT dysfunction. Consequently, the presence of NAFLD significantly increases the risk of various extra-hepatic diseases including CVD, type 2 diabetes mellitus, chronic kidney disease and certain extra-hepatic cancers. Thus changes in WAT and intestinal function with ageing and chronic overnutrition contribute to the development of NAFLD - a multi-system disease that subsequently contributes to the development of other chronic cardiometabolic diseases.
C1 [Bilson, Josh; Sethi, Jaswinder K.; Byrne, Christopher D.] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England.
   [Bilson, Josh; Sethi, Jaswinder K.; Byrne, Christopher D.] Univ Southampton, Natl Inst Hlth Res Southampton Biomed Res Ctr, Southampton, Hants, England.
   [Bilson, Josh; Sethi, Jaswinder K.; Byrne, Christopher D.] Univ Hosp Southampton Natl Hlth Serv Fdn Trust, Southampton, Hants, England.
   [Sethi, Jaswinder K.] Univ Southampton, Inst Life Sci, Southampton, Hants, England.
C3 University of Southampton; University of Southampton; University of
   Southampton
RP Byrne, CD (corresponding author), Univ Southampton, Fac Med, Human Dev & Hlth, Southampton, Hants, England.; Byrne, CD (corresponding author), Univ Southampton, Natl Inst Hlth Res Southampton Biomed Res Ctr, Southampton, Hants, England.; Byrne, CD (corresponding author), Univ Hosp Southampton Natl Hlth Serv Fdn Trust, Southampton, Hants, England.
EM C.D.Byrne@soton.ac.uk
RI ; Sethi, Jaswinder K./B-1413-2008
OI Byrne, Christopher D/0000-0001-6322-7753; Bilson,
   Josh/0000-0003-4665-3886; Sethi, Jaswinder K./0000-0003-4157-0475
FU National Institution for Health Research through the NIHR Southampton
   Biomedical Research Centre - Wellcome Trust [206453/Z/17/Z]; Wellcome
   Trust [206453/Z/17/Z] Funding Source: Wellcome Trust
FX J. B., J. K. S. and C. B. are supported by the National Institution for
   Health Research through the NIHR Southampton Biomedical Research Centre;
   J. K. S. is funded by the Wellcome Trust (grant number 206453/Z/17/Z).
CR Abdulnour J, 2012, MENOPAUSE, V19, P760, DOI 10.1097/gme.0b013e318240f6f3
   Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991
   Adamczak M, 2005, CLIN ENDOCRINOL, V62, P114, DOI 10.1111/j.1365-2265.2004.02182.x
   Ajmera V, 2017, HEPATOLOGY, V65, P65, DOI 10.1002/hep.28776
   Aktas B, 2011, METABOLISM, V60, P544, DOI 10.1016/j.metabol.2010.05.008
   Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Aron-Wisnewsky J, 2020, NAT REV GASTRO HEPAT, V17, P279, DOI 10.1038/s41575-020-0269-9
   Azzu V, 2020, GASTROENTEROLOGY, V158, P1899, DOI 10.1053/j.gastro.2019.12.054
   Babaei Parvin, 2010, Menopause Int, V16, P100, DOI 10.1258/mi.2010.010028
   Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Bäckhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Bäckhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104
   Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067
   Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264
   Baranova A, 2006, OBES SURG, V16, P1118, DOI 10.1381/096089206778392149
   Bedogni G, 2007, HEPATOLOGY, V46, P1387, DOI 10.1002/hep.21827
   Bekaert M, 2016, OBES REV, V17, P68, DOI 10.1111/obr.12333
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bilson J, 2021, NUTR DIABETES, V11, DOI 10.1038/s41387-021-00170-3
   Blühre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044
   Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
   Boutari C, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154028
   Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801
   Byrne CD, 2020, J HEPATOL, V72, P785, DOI 10.1016/j.jhep.2020.01.013
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Byrne CD, 2013, P NUTR SOC, V72, P412, DOI 10.1017/S0029665113001249
   Camarillo-Guerrero LF, 2021, CELL, V184, P1098, DOI 10.1016/j.cell.2021.01.029
   Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048
   Cao Q, 2004, J BIOL CHEM, V279, P4292, DOI 10.1074/jbc.M308351200
   Cao Q, 2007, J HEPATOL, V46, P124, DOI 10.1016/j.jhep.2006.07.027
   Cariou B, 2021, DIABETES OBES METAB, V23, P1069, DOI 10.1111/dom.14322
   Carpino G, 2020, HEPATOLOGY, V72, P470, DOI 10.1002/hep.31056
   Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601
   Caso G, 2013, METABOLISM, V62, P337, DOI 10.1016/j.metabol.2012.08.007
   Castracane VD, 1998, FERTIL STERIL, V70, P472, DOI 10.1016/S0015-0282(98)00187-3
   Caussy C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09455-9
   Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Chang CC, 2019, INT J MED SCI, V16, P167, DOI 10.7150/ijms.24068
   Chen JZ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155214
   Chen X, 2020, J GASTROEN HEPATOL, V35, P2009, DOI 10.1111/jgh.15027
   Chen XC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45100
   Chen YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19076
   Cheng YL, 2020, FRONT MATER, V7, DOI 10.3389/fmats.2020.00086
   Clemente-Postigo M, 2019, AM J PHYSIOL-ENDOC M, V316, pE319, DOI 10.1152/ajpendo.00277.2018
   Cooke PS, 2004, EXP BIOL MED, V229, P1127, DOI 10.1177/153537020422901107
   Dai WJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008179
   De Carvalho FG, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112553
   Dendi VSR, 2015, AM J GASTROENTEROL, V110, pS896, DOI 10.14309/00000434-201510001-02149
   DiStefano JK, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa134
   Douhara A, 2015, MOL MED REP, V11, P1693, DOI 10.3892/mmr.2014.2995
   Durkin LA, 2021, FOODS, V10, DOI 10.3390/foods10010199
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   Eaton SA, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010008
   Eddowes PJ, 2019, GASTROENTEROLOGY, V156, P1717, DOI 10.1053/j.gastro.2019.01.042
   Eguchi Y, 2006, J GASTROENTEROL, V41, P462, DOI 10.1007/s00535-006-1790-5
   Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8
   Frank AP, 2019, J LIPID RES, V60, P1710, DOI 10.1194/jlr.R086975
   Funcke JB, 2019, J LIPID RES, V60, P1648, DOI 10.1194/jlr.R094060
   Gao X, 2015, FOOD FUNCT, V6, P1117, DOI 10.1039/c5fo00007f
   Gao X, 2014, J BIOSCI BIOENG, V118, P476, DOI 10.1016/j.jbiosc.2014.03.001
   Gastaldelli A, 2017, CLIN SCI, V131, P2701, DOI 10.1042/CS20170987
   Godoy-Matos AF, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00570-y
   Grabherr F, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00611
   Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12
   Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09
   Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x
   Hu HM, 2020, J GASTROENTEROL, V55, P142, DOI 10.1007/s00535-019-01649-8
   Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475
   Isidori AM, 2000, J CLIN ENDOCR METAB, V85, P1954, DOI 10.1210/jc.85.5.1954
   Item F, 2012, OBES REV, V13, P30, DOI 10.1111/j.1467-789X.2012.01035.x
   Jamali R, 2016, WORLD J GASTROENTERO, V22, P5096, DOI 10.3748/wjg.v22.i21.5096
   Jarvis H, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003100
   Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585
   Jiménez-Cortegana C, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9070762
   Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004
   Kanwar P, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000114
   Kaps L, 2020, UNITED EUR GASTROENT, V8, P942, DOI 10.1177/2050640620944098
   Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kema VH, 2015, ADIPOCYTE, V4, P225, DOI 10.1080/21623945.2015.1017170
   Khalid YS, 2020, AM J CARDIOVASC DIS, V10, P258
   Kim D, 2016, CLIN GASTROENTEROL H, V14, P132, DOI 10.1016/j.cgh.2015.07.024
   Kim YS, 2020, WORLD J MENS HEALTH, V38, P48, DOI 10.5534/wjmh.190009
   Kitabatake H, 2017, WORLD J GASTROENTERO, V23, P712, DOI 10.3748/wjg.v23.i4.712
   Kizer JR, 2010, J GERONTOL A-BIOL, V65, P1208, DOI 10.1093/gerona/glq122
   Kleiner DE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12565
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kolodziejczyk AA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809302
   Koukias N, 2017, MINERVA ENDOCRINOL, V42, P184, DOI 10.23736/S0391-1977.16.02567-0
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Kukla M, 2010, SCAND J GASTROENTERO, V45, P235, DOI 10.3109/00365520903443852
   Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Leeners B, 2017, HUM REPROD UPDATE, V23, P300, DOI 10.1093/humupd/dmw045
   Lefebvre P, 2021, NAT REV ENDOCRINOL, V17, P662, DOI 10.1038/s41574-021-00538-6
   Leon-Mimila P, 2021, Diabetes Metab, V47, P101183, DOI 10.1016/j.diabet.2020.07.010
   Li K, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1482109
   Li YR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174291
   Liu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47687-3
   Liu Y, 2016, J CLIN ENDOCR METAB, V101, P4338, DOI 10.1210/jc.2016-1320
   Lizcano Fernando, 2014, Biomed Res Int, V2014, P757461, DOI 10.1155/2014/757461
   Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005
   Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626
   Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004
   Longo M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092358
   Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001
   Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25
   Lundgren P, 2020, AM J PHYSIOL-GASTR L, V318, pG717, DOI 10.1152/ajpgi.00304.2019
   Luther J, 2015, CELL MOL GASTROENTER, V1, P222, DOI 10.1016/j.jcmgh.2015.01.001
   Lv SY, 2017, ONCOTARGET, V8, P112145, DOI 10.18632/oncotarget.22841
   Ma LQ, 2020, HEPATOLOGY, V72, P1191, DOI 10.1002/hep.31115
   Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054
   Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724
   Maggi A, 2018, MOL METAB, V15, P3, DOI 10.1016/j.molmet.2018.02.012
   Man AL, 2015, CLIN SCI, V129, P515, DOI 10.1042/CS20150046
   Mancuso P, 2019, FRONT ENDOCRINOL, V10, DOI [10.3389/fendo.2019.00137, 10.3389/fendo.019.00137]
   Mantovani A, 2022, GUT, V71, P778, DOI 10.1136/gutjnl-2021-324191
   Mantovani A, 2022, GUT, V71, P156, DOI 10.1136/gutjnl-2020-323082
   Mantovani A, 2021, GUT, V70, P962, DOI 10.1136/gutjnl-2020-322572
   Mantovani A, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154170
   Mantovani A, 2018, METABOLISM, V79, P64, DOI 10.1016/j.metabol.2017.11.003
   Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902
   Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367
   Mells JE, 2013, SEMIN LIVER DIS, V33, P343, DOI 10.1055/s-0033-1358527
   Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848
   Mohamed-Ali V, 2001, J CLIN ENDOCR METAB, V86, P5864, DOI 10.1210/jc.86.12.5864
   Mok JKW., 2019, CURR OPIN ENDOCR MET, V4, P4, DOI DOI 10.1016/J.COEMR.2018.09.005
   Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Montazerifar F, 2017, J RES MED SCI, V22, DOI 10.4103/jrms.JRMS_788_16
   Morrison AE, 2019, LIVER INT, V39, P557, DOI 10.1111/liv.13994
   Motamed N, 2017, EXP CLIN ENDOCR DIAB, V125, P202, DOI 10.1055/s-0042-119032
   Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319
   Musso G, 2005, HEPATOLOGY, V42, P1175, DOI 10.1002/hep.20896
   Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680
   Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Oh TG, 2020, CELL METAB, V32, P878, DOI 10.1016/j.cmet.2020.06.005
   Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065
   Ohki T, 2009, GUT, V58, P839, DOI 10.1136/gut.2008.164053
   Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018
   Ota T, 2013, DIABETES METAB J, V37, P165
   Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473
   Paik JM, 2020, HEPATOLOGY, V72, P1605, DOI 10.1002/hep.31173
   Paik JM, 2019, HEPATOL COMMUN, V3, P1459, DOI 10.1002/hep4.1419
   Palmer AK, 2016, EXP GERONTOL, V86, P97, DOI 10.1016/j.exger.2016.02.013
   Phillips GB, 2008, METABOLISM, V57, P838, DOI 10.1016/j.metabol.2008.01.029
   Polyzos SA, 2019, METABOLISM, V96, P66, DOI 10.1016/j.metabol.2019.05.001
   Polyzos SA, 2016, DIABETOLOGIA, V59, P30, DOI 10.1007/s00125-015-3769-3
   Polyzos SA, 2015, METABOLISM, V64, P60, DOI 10.1016/j.metabol.2014.10.012
   Polyzos SA, 2011, METABOLISM, V60, P313, DOI 10.1016/j.metabol.2010.09.003
   Polyzos SA, 2011, J CLIN GASTROENTEROL, V45, P50, DOI 10.1097/MCG.0b013e3181ec5c66
   Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x
   Polyzos SA, 2010, J CLIN GASTROENTEROL, V44, P229, DOI 10.1097/MCG.0b013e3181b5ce68
   Przybyszewski Eric M, 2021, Clin Liver Dis (Hoboken), V17, P19, DOI 10.1002/cld.1017
   Qiu Y, 2019, ANN NUTR METAB, V74, P44, DOI 10.1159/000495215
   Rau M, 2018, UNITED EUR GASTROENT, V6, P1496, DOI 10.1177/2050640618804444
   Rea MC, 2012, J CLIN MICROBIOL, V50, P867, DOI 10.1128/JCM.05176-11
   Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405
   Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063
   Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579
   Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001
   Schipper BM, 2008, ANN PLAS SURG, V60, P538, DOI 10.1097/SAP.0b013e3181723bbe
   Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200
   Sethi JK, 2021, NAT METAB, V3, P1302, DOI 10.1038/s42255-021-00470-z
   Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9
   Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202
   Simon TG, 2021, HEPATOLOGY, V74, P2410, DOI 10.1002/hep.31845
   Simon TG, 2021, GUT, V70, P1375, DOI 10.1136/gutjnl-2020-322786
   Sohara N, 2005, LIVER INT, V25, P28, DOI 10.1111/j.1478-3231.2004.0986.x
   Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644
   Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170
   Souza CO, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158776
   Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007
   Tan XY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900257
   Targher G, 2021, LANCET GASTROENTEROL, V6, pS78, DOI 10.1016/S2468-1253(21)00020-0
   Targher G, 2021, NAT REV GASTRO HEPAT, V18, P599, DOI 10.1038/s41575-021-00448-y
   Targher G, 2021, DIABETES METAB, V47, DOI 10.1016/j.diabet.2020.101215
   Targher G, 2020, GUT, V69, P1691, DOI 10.1136/gutjnl-2020-320622
   Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013
   Taylor RS, 2020, GASTROENTEROLOGY, V158, P1611, DOI 10.1053/j.gastro.2020.01.043
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003
   Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054
   Tsochatzis EA, 2018, LANCET GASTROENTEROL, V3, P509, DOI 10.1016/S2468-1253(18)30077-3
   Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179
   Valeri F, 2021, FRONT NEUROENDOCRIN, V61, DOI 10.1016/j.yfrne.2021.100912
   Virtue AT, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1892
   Vlassopoulos A, 2014, INT J OBESITY, V38, P857, DOI 10.1038/ijo.2013.216
   Volynets V, 2012, DIGEST DIS SCI, V57, P1932, DOI 10.1007/s10620-012-2112-9
   Wang X, 2020, DIABETES METAB, V46, P119, DOI 10.1016/j.diabet.2019.04.009
   Wang XK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12676
   Wang Y, 2019, MOL CELL BIOCHEM, V460, P205, DOI 10.1007/s11010-019-03581-0
   WHO Consultation, 2000, WHO TECH REP SER, V894, P1
   Wong VWS, 2006, CLIN GASTROENTEROL H, V4, P1154, DOI 10.1016/j.cgh.2006.06.011
   Xia M, 2013, HEPATOLOGY, V58, P564, DOI 10.1002/hep.26227
   Xu MQ, 2015, ECS ELECTROCHEM LETT, V4, DOI 10.1149/2.0021508eel
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Ye Q, 2020, LANCET GASTROENTEROL, V5, P739, DOI 10.1016/S2468-1253(20)30077-7
   Yilmaz Y, 2011, SCAND J GASTROENTERO, V46, P91, DOI 10.3109/00365521.2010.516452
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021
   Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Yu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002159
   Zhang JH, 2021, BMC GASTROENTEROL, V21, DOI 10.1186/s12876-021-01721-9
   Zhou D, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0183-1
   Zhou D, 2017, WORLD J GASTROENTERO, V23, P60, DOI 10.3748/wjg.v23.i1.60
   Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093
   Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2
NR 220
TC 18
Z9 19
U1 1
U2 8
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0029-6651
EI 1475-2719
J9 P NUTR SOC
JI Proc. Nutr. Soc.
PD 2022 MAY
PY 2022
VL 81
IS 2
BP 146
EP 161
AR PII S0029665121003815
DI 10.1017/S0029665121003815
EA NOV 2021
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 6M1JJ
UT WOS:000741757200001
PM 35934688
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU SASTRE, J
   RODRIGUEZ, JV
   PALLARDO, FV
   GASCO, E
   ASENSI, M
   FERRER, JV
   MIQUEL, J
   VINA, J
AF SASTRE, J
   RODRIGUEZ, JV
   PALLARDO, FV
   GASCO, E
   ASENSI, M
   FERRER, JV
   MIQUEL, J
   VINA, J
TI EFFECT OF AGING ON METABOLIC ZONATION IN RAT-LIVER - ACINAR DISTRIBUTION
   OF GSH METABOLISM
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE GLUTATHIONE METABOLISM; AGING; HEPATIC ZONATION
ID GLUTATHIONE-S-TRANSFERASE; LIFE-SPAN; TISSUES; AGE; HEPATOCYTES;
   PEROXIDASE; ENZYMES; CELLS
AB The effect of age on the glutathione antioxidant system and its acinar distribution in rat liver was studied. GSH/GSSG ratio in blood and liver was lower in old than in young rats. Hepatic glutathione peroxidase and glutathione S-transferase activities were higher in old than in young rats, whereas hepatic gamma-glutamyl transpeptidase activity was lower in old than in young rats. Glutathione reductase and glucose-6-phosphate dehydrogenase activities did not change with age in rat liver. Total glutathione levels and glutathione peroxidase activity were higher in periportal than in perivenous areas of young rats, but this heterogeneous distribution did not occur in old rats. No change with age was found in hepatic zonation of glutathione reductase and glucose-6-phosphate dehydrogenase.
C1 UNIV VALENCIA, FAC MED, DEPT FISIOL, AV BLASCO IBANEZ 17, E-46010 VALENCIA, SPAIN.
   UNIV NACL ROSARIO, FAC CIENCIAS BIOQUIM & FARMACEUT, INST FISIOL EXPTL, RA-2000 ROSARIO, ARGENTINA.
   UNIV ALICANTE, FAC MED, DEPT NEUROQUIM, ALICANTE, SPAIN.
C3 University of Valencia; National University of Rosario; Universitat
   d'Alacant
RI Pallardo, Federico V./T-1156-2017; Asensi Miralles, Miguel/I-2756-2015;
   Vina, Jose/AAB-3069-2021
OI Pallardo, Federico V./0000-0003-3715-1980; Asensi Miralles,
   Miguel/0000-0003-1922-7777; Vina, Jose/0000-0001-9709-0089
CR ALLEN RG, 1985, COMP BIOCHEM PHYS C, V82, P399, DOI 10.1016/0742-8413(85)90181-1
   Bergmeyer H. U., 1974, METHODS ENZYMATIC AN
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BLANCO P, 1987, MECH AGEING DEV, V39, P11, DOI 10.1016/0047-6374(87)90082-0
   Buege J A, 1978, Methods Enzymol, V52, P302
   CHASSEAUD LF, 1974, 6 P C GERM SOC BIOL
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   GAFNI A, 1981, J BIOL CHEM, V256, P8875
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HARISCH G, 1985, RES COMMUN CHEM PATH, V47, P399
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HONDA S, 1988, EXP GERONTOL, V23, P81, DOI 10.1016/0531-5565(88)90072-1
   JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708
   KERA Y, 1987, BIOCHEM PHARMACOL, V36, P2003
   KERA Y, 1988, BIOCHEM J, V254, P411, DOI 10.1042/bj2540411
   KITAHARA A, 1982, LIVER AGING 1982, P135
   KNOOK DL, 1980, P SOC EXP BIOL MED, V165, P170
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASSEY V, 1965, J BIOL CHEM, V240, P4470
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MEISTER A, 1985, METHOD ENZYMOL, V113, P185
   MEISTER A, 1989, METABOLISM FUNCTION
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIQUEL J, 1979, EXP GERONTOL, V14, P279, DOI 10.1016/0531-5565(79)90039-1
   QUISTORFF B, 1987, BIOCHEM J, V243, P87, DOI 10.1042/bj2430087
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   ROMERO FJ, 1983, BIOCHEM EDUC, V11, P135, DOI 10.1016/0307-4412(83)90093-6
   SASTRE J, 1989, LIFE SCI, V45, P183, DOI 10.1016/0024-3205(89)90293-2
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   STOHS SJ, 1986, LIVER AGING 1986 LIV, P59
   TATE SS, 1974, J BIOL CHEM, V249, P7593
   THURMAN RG, 1985, HEPATOLOGY, V5, P144, DOI 10.1002/hep.1840050128
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   WALS PA, 1988, J BIOL CHEM, V263, P4876
   YOSHIMURA S, 1980, BIOCHIM BIOPHYS ACTA, V621, P130, DOI 10.1016/0005-2795(80)90068-9
NR 39
TC 22
Z9 23
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 1992
VL 62
IS 2
BP 181
EP 190
DI 10.1016/0047-6374(92)90054-H
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HF590
UT WOS:A1992HF59000008
PM 1569787
DA 2024-02-19
ER

PT J
AU Li, Y
   Ruan, DY
   Jia, CC
   Zheng, J
   Wang, GY
   Zhao, H
   Yang, Q
   Liu, W
   Yi, SH
   Li, H
   Wang, GS
   Yang, Y
   Chen, GH
   Zhang, Q
AF Li, Yang
   Ruan, Dan-yun
   Jia, Chang-chang
   Zheng, Jun
   Wang, Guo-ying
   Zhao, Hui
   Yang, Qing
   Liu, Wei
   Yi, Shu-hong
   Li, Hua
   Wang, Gen-shu
   Yang, Yang
   Chen, Gui-hua
   Zhang, Qi
TI Aging aggravates hepatic ischemia-reperfusion injury in mice by
   impairing mitophagy with the involvement of the EIF2α-parkin pathway
SO AGING-US
LA English
DT Article
DE aged graft; hepatic ischemia reperfusion injury; mitophagy; graft
   evaluation; parkin
ID ENDOPLASMIC-RETICULUM STRESS; LIVER ISCHEMIA/REPERFUSION INJURY;
   CEREBRAL-ISCHEMIA; PARK2-DEPENDENT MITOPHAGY; MITOCHONDRIAL PRODUCTION;
   RAT-LIVER; AUTOPHAGY; PROTECTS; AGE; BRAIN
AB Hepatic ischemia-reperfusion (I/R) injury fundamentally influences the performance of aged liver grafts. The significance of mitophagy in the age dependence of sensitivity to I/R injury remains poorly understood. Here, we show that aging aggravated hepatic I/R injury with decreased mitophagy in mice. The enhancement of mitophagy resulted in significant protection against hepatic I/R injury. Parkin, an E3 ubiquitin ligase, was found depleted by I/R in aged livers. In oxygen-glucose deprivation reperfusion (OGD-Rep.)-treated L02 cells, parkin silencing impaired mitophagy and aggravated cell damage through a relative large mitochondrial membrane potential transition. The phosphorylation of the endoplasmic reticulum stress response protein EIF2 alpha, which was also reduced in the aged liver, induced parkin expression both in vivo and vitro. Forty-six hepatic biopsy specimens from liver graft were collected 2 hours after complete revascularization, followed by immunohistochemical analyses. Parkin expression was negatively correlated to donor age and the peak level of aspartate aminotransferase within first week after liver transplantation. Our translational study demonstrates that aging aggravated hepatic I/R injury by impairing the age-dependent mitophagy function via an insufficient parkin expression and identifies a new strategy to evaluate the capacity of an aged liver graft in the process of I/R through the parkin expression.
C1 [Li, Yang; Zheng, Jun; Wang, Guo-ying; Zhao, Hui; Yang, Qing; Liu, Wei; Yi, Shu-hong; Li, Hua; Wang, Gen-shu; Yang, Yang; Chen, Gui-hua] Sun Yat Sen Univ, Guangzhou Clin Res & Translat Ctr Liver Dis, Dept Liver Surg & Liver Transplantat, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.
   [Ruan, Dan-yun] Sun Yat Sen Univ, Dept Med Oncol, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.
   [Jia, Chang-chang; Zhang, Qi] Sun Yat Sen Univ, Dept Biotherapy, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.
   [Li, Yang; Jia, Chang-chang; Zheng, Jun; Liu, Wei; Zhang, Qi] Sun Yat Sen Univ, Guangdong Key Lab Liver Dis Res, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University;
   Sun Yat Sen University
RP Chen, GH (corresponding author), Sun Yat Sen Univ, Guangzhou Clin Res & Translat Ctr Liver Dis, Dept Liver Surg & Liver Transplantat, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.; Zhang, Q (corresponding author), Sun Yat Sen Univ, Dept Biotherapy, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.; Zhang, Q (corresponding author), Sun Yat Sen Univ, Guangdong Key Lab Liver Dis Res, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China.
EM chgh1955@263.net; Zhangq27@mail.sysu.edu.cn
RI Liu, Wei/AAH-5037-2020; Li, Yang/GWM-7879-2022; Li, Yang/HPC-4054-2023;
   li, yong/HDN-3885-2022; Li, Yuan/GXV-1310-2022; Wang,
   Guoying/GQQ-7956-2022
OI Liu, Wei/0000-0002-4935-7591; Zhang, Qi/0000-0001-9916-8919
FU National Natural Science Foundation of China [81600505, 81770648,
   81670601, 81570593, 81370555]; National Key RD Plan [2017YFA0104304];
   Key Scientific and Technological Projects of Guangdong Province
   [2015B020226004, 2017A020215178]; Guangdong Natural Science Foundation
   [2015A030312013, 2017A030311034]; Guangdong Natural Science Fund for
   Distinguished Young Scholars [S20120011190]; Science and Technology
   Planning Project of Guangdong Province [2017B030314027, 2017B020209004];
   Science and Technology Planning Project of Guangzhou [2014Y200544,
   201604020001]; Guangdong Province
FX This work is supported by the National Natural Science Foundation of
   China (81600505, 81770648, 81670601, 81570593, 81370555); National Key
   R&D Plan (2017YFA0104304); Key Scientific and Technological Projects of
   Guangdong Province(2015B020226004, 2017A020215178), Guangdong Natural
   Science Foundation (2015A030312013, 2017A030311034), Guangdong Natural
   Science Fund for Distinguished Young Scholars (S20120011190), Science
   and Technology Planning Project of Guangdong Province (2017B030314027,
   2017B020209004), Science and Technology Planning Project of Guangzhou
   (2014Y200544, 201604020001) and 2017 Pearl River Scholar of Guangdong
   Province.
CR Ali JM, 2015, LIVER TRANSPLANT, V21, P487, DOI 10.1002/lt.24072
   Anuncibay-Soto B, 2016, J NEUROCHEM, V138, P295, DOI 10.1111/jnc.13651
   Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Castellaneta A, 2014, HEPATOLOGY, V60, P267, DOI 10.1002/hep.27037
   Cursio R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/417590
   de Rougemont O, 2009, LIVER TRANSPLANT, V15, P1172, DOI 10.1002/lt.21876
   Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Detry O, 2014, BRIT J SURG, V101, P784, DOI 10.1002/bjs.9488
   Domingo Aloysius, 2018, Handb Clin Neurol, V147, P211, DOI 10.1016/B978-0-444-63233-3.00014-2
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008
   Gao B, 2013, ACTA PHARMACOL SIN, V34, P657, DOI 10.1038/aps.2013.34
   Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200
   JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355
   Jiang SJ, 2013, HUM GENE THER, V24, P443, DOI 10.1089/hum.2012.219
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984
   Kubli Dieter A, 2013, Commun Integr Biol, V6, pe24511, DOI 10.4161/cib.24511
   Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363
   Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156
   Liu AD, 2013, LIVER TRANSPLANT, V19, P762, DOI 10.1002/lt.23666
   Liu Y, 2016, Zhonghua Xin Xue Guan Bing Za Zhi, V44, P494, DOI 10.3760/cma.j.issn.0253-3758.2016.06.008
   Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   SCHWEIGER H, 1988, BIOCHEM MED METAB B, V40, P162, DOI 10.1016/0885-4505(88)90117-X
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Shen Z, 2017, AUTOPHAGY, V13, P473, DOI 10.1080/15548627.2016.1274596
   Shin JK, 2017, TOXICOL APPL PHARM, V328, P25, DOI 10.1016/j.taap.2017.05.002
   Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947
   Tang CY, 2018, AUTOPHAGY, V14, P880, DOI 10.1080/15548627.2017.1405880
   Tran TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023660
   Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005
   Wang KW, 2015, CELL CYCLE, V14, P1631, DOI 10.1080/15384101.2015.1038685
   Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098834
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
   Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200
   Zhang XN, 2014, AUTOPHAGY, V10, P1801, DOI 10.4161/auto.32136
   Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132
   Zhou HM, 2016, TRANSPLANTATION, V100, P365, DOI 10.1097/TP.0000000000001032
NR 46
TC 24
Z9 28
U1 2
U2 24
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD AUG
PY 2018
VL 10
IS 8
BP 1902
EP 1920
DI 10.18632/aging.101511
PG 19
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GS1RN
UT WOS:000443308900012
PM 30089704
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU De Cecco, M
   Jeyapalan, J
   Zhao, XA
   Tamamori-Adachi, M
   Sedivy, JM
AF De Cecco, Marco
   Jeyapalan, Jessie
   Zhao, Xiaoai
   Tamamori-Adachi, Mimi
   Sedivy, John M.
TI Nuclear protein accumulation in cellular senescence and organismal aging
   revealed with a novel single-cell resolution fluorescence microscopy
   assay
SO AGING-US
LA English
DT Article
DE Aging; cellular senescence; quantitative protein assay; fluorescence
   microscopy; NanoOrange (R) reagent
ID REPLICATIVE SENESCENCE; HUMAN-FIBROBLASTS; PICOMOLE RANGE; PRIMARY
   AMINES; CULTURE; FLUORESCAMINE; QUANTITATION; REAGENT; ARREST; WI-38
AB Replicative cellular senescence was discovered some 50 years ago. The phenotypes of senescent cells have been investigated extensively in cell culture, and found to affect essentially all aspects of cellular physiology. The relevance of cellular senescence in the context of age-associated pathologies as well as normal aging is a topic of active and ongoing interest. Considerable effort has been devoted to biomarker discovery to enable the microscopic detection of single senescent cells in tissues. One characteristic of senescent cells documented very early in cell culture studies was an increase in cell size and total protein content, but whether this occurs in vivo is not known. A limiting factor for studies of protein content and localization has been the lack of suitable fluorescence microscopy tools. We have developed an easy and flexible method, based on the merocyanine dye known as NanoOrange, to visualize and quantitatively measure total protein levels by high resolution fluorescence microscopy. NanoOrange staining can be combined with antibody-based immunofluorescence, thus providing both specific target and total protein information in the same specimen. These methods are optimally combined with automated image analysis platforms for high throughput analysis. We document here increasing protein content and density in nuclei of senescent human and mouse fibroblasts in vitro, and in liver nuclei of aged mice in vivo. Additionally, in aged liver nuclei NanoOrange revealed protein-dense foci that colocalize with centromeric heterochromatin.
C1 [De Cecco, Marco; Jeyapalan, Jessie; Zhao, Xiaoai; Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA.
   [De Cecco, Marco] Univ Bologna, Dept Vet Sci, Bologna, Italy.
   [Tamamori-Adachi, Mimi] Teikyo Univ, Sch Med, Dept Biochem, Tokyo 1738605, Japan.
C3 Brown University; University of Bologna; Teikyo University
RP Sedivy, JM (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA.
EM madachi@med.teikyo-u.ac.jp; john_sedivy@brown.edu
FU NIH/NIA [R37 AG016694]; Bologna University; Glenn Award for Research in
   Biological Mechanisms of Aging
FX The microscopic analysis presented in this work was performed in the
   Leduc Bioimaging Facility at Brown University. We gratefully acknowledge
   the generous help and advice of Nicola Neretti. We thank Peter D. Adams,
   Beatson Institute, for providing the mH2A antibody. This work was
   supported by NIH/NIA grant R37 AG016694 to J.M.S. M. D. C. was supported
   in part by Dottorato di Ricerca in "Biotecnologie, Farmacologia e
   Tossicologia", PFDR in "Biotecnologie Cellulari e Molecolari" fellowship
   of Bologna University. J.M.S. is a Senior Scholar of the Ellison Medical
   Foundation and a recipient of the Glenn Award for Research in Biological
   Mechanisms of Aging.
CR BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112
   BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Campisi J, 2011, SEMIN CANC IN PRESS
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039
   Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06
   CRISTOFA.VJ, 1969, MED EXP, V19, P313
   CRISTOFALO VJ, 1988, EXP GERONTOL, V23, P297, DOI 10.1016/0531-5565(88)90032-0
   Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010
   CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617
   DICE JF, 1989, EXP GERONTOL, V24, P451
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Jones LJ, 2003, BIOTECHNIQUES, V34, P850, DOI 10.2144/03344pt03
   Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482
   Jun JI, 2011, AGING ALBANY NY, V2, P627
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   KAFTORY A, 1978, J CELL PHYSIOL, V94, P147, DOI 10.1002/jcp.1040940204
   KALIMI M, 1979, BIOCHIM BIOPHYS ACTA, V583, P352, DOI 10.1016/0304-4165(79)90459-8
   Kikis EA, 2010, ADV EXP MED BIOL, V694, P138
   Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x
   MEDVEDEV ZA, 1980, MECH AGEING DEV, V14, P1, DOI 10.1016/0047-6374(80)90102-5
   MITSUI Y, 1976, EXP CELL RES, V100, P147, DOI 10.1016/0014-4827(76)90336-0
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1
   OUTTERIDGE PM, 1988, VET IMMUNOL IMMUNOP, V19, P141, DOI 10.1016/0165-2427(88)90005-0
   PARRY G, 1982, CYTOMETRY, V3, P97, DOI 10.1002/cyto.990030206
   Sakagami H, 1979, CELL STRUCT FUNCT, V4, P11
   SCHNEIDER EL, 1975, CELL, V6, P179, DOI 10.1016/0092-8674(75)90008-2
   Sedivy JM, 2008, MOL BIOL AGING
   SHAKESPEARE VA, 1979, GERONTOLOGY, V25, P305, DOI 10.1159/000212358
   Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296
   Smith J, 1985, CRC HDB CELL BIOL, P375
   STANULISPRAEGER BM, 1987, MECH AGEING DEV, V38, P1, DOI 10.1016/0047-6374(87)90109-6
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   YANISHEVSKY R, 1974, J CELL PHYSIOL, V84, P165, DOI 10.1002/jcp.1040840202
   You WW, 1997, ANAL BIOCHEM, V244, P277, DOI 10.1006/abio.1996.9920
NR 42
TC 32
Z9 36
U1 0
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT
PY 2011
VL 3
IS 10
BP 955
EP 967
DI 10.18632/aging.100372
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 845CC
UT WOS:000296799500006
PM 22006542
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Turola, E
   Petta, S
   Vanni, E
   Milosa, F
   Valenti, L
   Critelli, R
   Miele, L
   Maccio, L
   Calvaruso, V
   Fracanzani, AL
   Bianchini, M
   Raos, N
   Bugianesi, E
   Mercorella, S
   Di Giovanni, M
   Craxì, A
   Fargion, S
   Grieco, A
   Cammà, C
   Cotelli, F
   Villa, E
AF Turola, Elena
   Petta, Salvatore
   Vanni, Ester
   Milosa, Fabiola
   Valenti, Luca
   Critelli, Rosina
   Miele, Luca
   Maccio, Livia
   Calvaruso, Vincenza
   Fracanzani, Anna L.
   Bianchini, Marcello
   Raos, Nazarena
   Bugianesi, Elisabetta
   Mercorella, Serena
   Di Giovanni, Marisa
   Craxi, Antonio
   Fargion, Silvia
   Grieco, Antonio
   Camma, Calogero
   Cotelli, Franco
   Villa, Erica
TI Ovarian senescence increases liver fibrosis in humans and zebrafish with
   steatosis
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Fibrosis; Menopause; Non-alcoholic fatty liver disease; Ovarian
   senescence; Zebrafish
ID NONALCOHOLIC FATTY LIVER; HOMEOSTASIS MODEL ASSESSMENT; AROMATASE
   KNOCKOUT MOUSE; HEPATIC STEATOSIS; RISK-FACTORS; INSULIN-RESISTANCE;
   CARDIOVASCULAR-DISEASE; IMAGE-ANALYSIS; VISCERAL FAT; EXPRESSION
AB Contrasting data exist on the effect of gender and menopause on the susceptibility, development and liver damage progression in nonalcoholic fatty liver disease (NAFLD). Our aim was to assess whether menopause is associated with the severity of liver fibrosis in individuals with NAFLD and to explore the issue of ovarian senescence in experimental liver steatosis in zebrafish. In 244 females and age-matched males with biopsy-proven NAFLD, we assessed anthropometric, biochemical and metabolic features, including menopausal status (self-reported); liver biopsy was scored according to 'The Pathology Committee of the NASH Clinical Research Network'. Young and old male and female zebrafish were fed for 24 weeks with a high-calorie diet. Weekly body mass index (BMI), histopathological examination and quantitative real-time PCR analysis on genes involved in lipid metabolism, inflammation and fibrosis were performed. In the entire cohort, at multivariate logistic regression, male gender [odds ratio (OR): 1.408, 95% confidence interval (95% CI): 0.779-2.542, P=0.25] vs women at reproductive age was not associated with F2-F4 fibrosis, whereas a trend was observed for menopause (OR: 1.752, 95% CI: 0.956-3.208, P=0.06). In women, menopause (OR: 2.717, 95% CI: 1.020-7.237, P=0.04) was independently associated with F2-F4 fibrosis. Similarly, in overfed zebrafish, old female fish with failing ovarian function [as demonstrated by extremely low circulating estradiol levels (1.4 +/- 0.1 pg/mu l) and prevailing presence of atretic follicles in the ovaries] developed massive steatosis and substantial fibrosis (comparable with that occurring in males), whereas young female fish developed less steatosis and were totally protected from the development of fibrosis. Ovarian senescence significantly increases the risk of fibrosis severity both in humans with NAFLD and in zebrafish with experimental steatosis.
C1 [Turola, Elena; Milosa, Fabiola; Critelli, Rosina; Bianchini, Marcello; Raos, Nazarena; Mercorella, Serena; Villa, Erica] Univ Modena & Reggio Emilia, Dept Internal Med, Gastroenterol Unit, I-41124 Modena, Italy.
   [Petta, Salvatore; Calvaruso, Vincenza; Craxi, Antonio; Camma, Calogero] Univ Palermo, Div Gastroenterol, DiBiMIS, I-90128 Palermo, Italy.
   [Vanni, Ester; Bugianesi, Elisabetta] Univ Turin, Dept Med Sci, Div Gastroenterol & Hepatol, I-10126 Turin, Italy.
   [Valenti, Luca; Fracanzani, Anna L.; Fargion, Silvia] Fdn Ca Granda IRCCS Osped Maggiore Policlin, Sect Internal Med, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy.
   [Miele, Luca; Grieco, Antonio] Univ Cattolica Sacro Cuore, Inst Internal Med, Sch Med, I-00168 Rome, Italy.
   [Maccio, Livia; Di Giovanni, Marisa] Univ Modena & Reggio Emilia, Dept Pathol, I-41124 Modena, Italy.
   [Cotelli, Franco] Univ Milan, Dept Biosci, I-20122 Milan, Italy.
C3 Universita di Modena e Reggio Emilia; University of Palermo; University
   of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; Catholic
   University of the Sacred Heart; IRCCS Policlinico Gemelli; Universita di
   Modena e Reggio Emilia; University of Milan
RP Villa, E (corresponding author), Univ Modena & Reggio Emilia, Dept Internal Med, Gastroenterol Unit, I-41124 Modena, Italy.
EM erica.villa@unimore.it
RI Villa, Erica/A-7576-2012; Bianchini, Marcello/AGE-2988-2022; Miele,
   Luca/C-2255-2015; maccio, livia/AAA-5092-2020; Valenti,
   Luca/B-3695-2009; Bianchini, Marcello/AAA-8503-2019; Calvaruso,
   Vincenza/K-8973-2016
OI Villa, Erica/0000-0001-6388-7022; Miele, Luca/0000-0003-3464-0068;
   Valenti, Luca/0000-0001-8909-0345; Bianchini,
   Marcello/0000-0003-4615-3777; grieco, antonio/0000-0002-0544-8993;
   Elena, Turola/0000-0002-1810-8648; Calvaruso,
   Vincenza/0000-0002-0287-1059
FU PRIN [2010C4JJWB_001]
FX This study was funded by grants from the PRIN 2010-2011 [number Prot. N.
   2010C4JJWB_001].
CR Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535
   Agh N, 2008, Pak J Biol Sci, V11, P164, DOI 10.3923/pjbs.2008.164.172
   American Diabetes Association, 2000, DIABETES CARE, V2000, P23
   [Anonymous], 1992, SAS STAT SOFTW CHANG
   Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019
   Asaoka Y, 2013, DIS MODEL MECH, V6, P905, DOI 10.1242/dmm.011981
   Bayer EM, 1998, J HEPATOL, V28, P803, DOI 10.1016/S0168-8278(98)80230-4
   Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608
   Bugianesi E, 2006, HEPATOLOGY, V44, P1648, DOI 10.1002/hep.21429
   Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001
   Calvaruso V, 2009, HEPATOLOGY, V49, P1236, DOI 10.1002/hep.22745
   Castranova D, 2011, ZEBRAFISH, V8, P141, DOI 10.1089/zeb.2011.0688
   Chow JDY, 2011, J ENDOCRINOL, V210, P323, DOI 10.1530/JOE-10-0462
   Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0
   Dongiovanni P, 2013, CURR PHARM DESIGN, V19, P5219, DOI 10.2174/13816128113199990381
   Erkan G, 2013, PATHOL RES PRACT, V209, P429, DOI 10.1016/j.prp.2013.04.010
   Gopalakrishnan S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-78
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19
   Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369
   Hölttä-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293
   Hsu SC, 2006, J NUTR, V136, P1779, DOI 10.1093/jn/136.7.1779
   Ikeda Y, 2001, ENDOCR J, V48, P81, DOI 10.1507/endocrj.48.81
   Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278
   Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Koc ND, 2008, BRAZ ARCH BIOL TECHN, V51, P513
   Kuroda H, 2012, WORLD J GASTROENTERO, V18, P3889, DOI 10.3748/wjg.v18.i29.3889
   Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Marlow FL, 2008, DEV BIOL, V321, P40, DOI 10.1016/j.ydbio.2008.05.557
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McKenzie J, 2006, CLIN ENDOCRINOL, V65, P40, DOI 10.1111/j.1365-2265.2006.02543.x
   Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Persson L, 2012, ARTERIOSCL THROM VAS, V32, P810, DOI 10.1161/ATVBAHA.111.242461
   Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x
   Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787
   Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004
   Petta S, 2011, DIGEST LIVER DIS, V43, P404, DOI 10.1016/j.dld.2010.12.013
   Rogers A, 2001, BONE, V29, P30, DOI 10.1016/S8756-3282(01)00468-9
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shao JP, 2011, DEV DYNAM, V240, P1271, DOI 10.1002/dvdy.22603
   Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016
   Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4
   Tehrani FR, 2014, CLIMACTERIC, V17, P164, DOI 10.3109/13697137.2013.828197
   van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350
   Villa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044624
   Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027
   Völzke H, 2007, GUT, V56, P594, DOI 10.1136/gut.2006.115345
   Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761
   Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307
   Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200
   Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783
NR 59
TC 47
Z9 51
U1 1
U2 20
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD SEP
PY 2015
VL 8
IS 9
BP 1037
EP 1046
DI 10.1242/dmm.019950
PG 10
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA CV0UO
UT WOS:000363969100004
PM 26183212
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Jannone, G
   Riani, EB
   de Magnée, C
   Tambucci, R
   Evraerts, J
   Ravau, J
   Baldin, P
   Bouzin, C
   Loriot, A
   Gatto, L
   Decottignies, A
   Najimi, M
   Sokal, EM
AF Jannone, Giulia
   Riani, Eliano Bonaccorsi
   de Magnee, Catherine
   Tambucci, Roberto
   Evraerts, Jonathan
   Ravau, Joachim
   Baldin, Pamela
   Bouzin, Caroline
   Loriot, Axelle
   Gatto, Laurent
   Decottignies, Anabelle
   Najimi, Mustapha
   Sokal, Etienne Marc
TI Senescence and senotherapies in biliary atresia and biliary cirrhosis
SO AGING-US
LA English
DT Article
DE senescence; senotherapy; liver; biliary cirrhosis; biliary atresia
ID CELLS; TRANSPLANTATION; PATHOGENESIS
AB Background: Premature senescence occurs in adult hepatobiliary diseases and worsens the prognosis through deleterious liver remodeling and hepatic dysfunction. Senescence might also arises in biliary atresia (BA), the first cause of pediatric liver transplantation. Since alternatives to transplantation are needed, our aim was to investigate premature senescence in BA and to assess senotherapies in a preclinical model of biliary cirrhosis. Methods: BA liver tissues were prospectively obtained at hepatoportoenterostomy (n=5) and liver transplantation (n=30) and compared to controls (n=10). Senescence was investigated through spatial whole transcriptome analysis, SA-& beta;-gal activity, p16 and p21 expression, & gamma;-H2AX and senescence-associated secretory phenotype (SASP). Human allogenic liver-derived progenitor cells (HALPC) or dasatinib and quercetin (D+Q) were administrated to two-month-old Wistar rats after bile duct ligation (BDL). Results: Advanced premature senescence was evidenced in BA livers from early stage and continued to progress until liver transplantation. Senescence and SASP were predominant in cholangiocytes, but also present in surrounding hepatocytes. HALPC but not D+Q reduced the early marker of senescence p21 in BDL rats and improved biliary injury (serum & gamma;GT and Sox9 expression) and hepatocytes mass loss (Hnf4a). Conclusions: BA livers displayed advanced cellular senescence at diagnosis that continued to progress until liver transplantation. HALPC reduced early senescence and improved liver disease in a preclinical model of BA, providing encouraging preliminary results regarding the use of senotherapies in pediatric biliary cirrhosis.
C1 [Jannone, Giulia; Evraerts, Jonathan; Ravau, Joachim; Najimi, Mustapha; Sokal, Etienne Marc] UCLouvain, Inst Rech Expt & Clin, Pediat Hepatol & Cell Therapy Unit, Brussels, Belgium.
   [Riani, Eliano Bonaccorsi] UCLouvain, Clin Univ St Luc, Abdominal Transplantat Unit, Dept Surg, Brussels, Belgium.
   [de Magnee, Catherine; Tambucci, Roberto] UCLouvain, Dept Surg, Pediat Surg & Transplantat Unit, Clin Univ St Luc, Brussels, Belgium.
   [Baldin, Pamela] UCLouvain, Dept Anatomopathol, Clin Univ St Luc, Brussels, Belgium.
   [Bouzin, Caroline] UCLouvain, Inst Rech Expt & Clin, IREC Imaging Platform 2IP, Brussels, Belgium.
   [Loriot, Axelle; Gatto, Laurent] UCLouvain, de Duve Inst, Computat Biol & Bioinformat Unit, Brussels, Belgium.
   [Decottignies, Anabelle] UCLouvain, de Duve Inst, Genet & Epigenet Alterat Genomes Grp, Brussels, Belgium.
C3 Universite Catholique Louvain; Universite Catholique Louvain; Cliniques
   Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques
   Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques
   Universitaires Saint-Luc; Universite Catholique Louvain; Universite
   Catholique Louvain; Universite Catholique Louvain
RP Jannone, G (corresponding author), UCLouvain, Inst Rech Expt & Clin, Pediat Hepatol & Cell Therapy Unit, Brussels, Belgium.
EM giulia.jannone@uclouvain.be
FU Fonds National de la Recherche Scientifique et Medicale (FNRS, Belgium)
   through a FRIA grant [FC29559]
FX This research was supported by the Fonds National de la Recherche
   Scientifique et Medicale (FNRS, Belgium) through a FRIA grant (number
   FC29559).
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Alsuraih M, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100250
   Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y
   Berardis S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086137
   Bezerra JA, 2018, HEPATOLOGY, V68, P1163, DOI 10.1002/hep.29905
   Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8
   Cazzagon N, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100286
   Chardot C, 2013, J HEPATOL, V58, P1209, DOI 10.1016/j.jhep.2013.01.040
   Cheng NY, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.158207
   Khuu DN, 2011, CELL TRANSPLANT, V20, P287, DOI 10.3727/096368910X516655
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Gurevich M, 2015, ANN SURG, V262, P1141, DOI 10.1097/SLA.0000000000001094
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Herrero A, 2017, CELL TRANSPLANT, V26, P351, DOI 10.3727/096368916X692960
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Irvine KM, 2014, WORLD J GASTROENTERO, V20, P17851, DOI 10.3748/wjg.v20.i47.17851
   Iskusnykh IY, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/870628
   Jannone G, 2020, J HISTOCHEM CYTOCHEM, V68, P269, DOI 10.1369/0022155420913534
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lai XF, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-021-02688-w
   Lendahl U, 2021, EBIOMEDICINE, V74, DOI 10.1016/j.ebiom.2021.103689
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Meadows V, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.803098
   Morsli S, 2022, MECH AGEING DEV, V202, DOI 10.1016/j.mad.2021.111618
   Nagano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31758
   Najimi M, 2007, CELL TRANSPLANT, V16, P717, DOI 10.3727/000000007783465154
   Najimi M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0575-5
   Nakajima Y, 2022, MED MOL MORPHOL, V55, P131, DOI 10.1007/s00795-022-00314-z
   Nakanuma Y, 2015, J HEPATOL, V62, P934, DOI 10.1016/j.jhep.2014.11.027
   Nana FA, 2019, CANCERS, V11, DOI 10.3390/cancers11101526
   Nevens F, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100291
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Okamura A, 2013, CLIN EXP IMMUNOL, V173, P268, DOI 10.1111/cei.12103
   Raffaele M, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-021-00731-0
   Rodrigues CE, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0475-8
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sana G, 2014, CELL TRANSPLANT, V23, P1127, DOI 10.3727/096368913X666421
   Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z
   Sasaki M, 2018, HISTOPATHOLOGY, V72, P1164, DOI 10.1111/his.13476
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   SOKAL EM, 1992, HEPATOLOGY, V15, P904, DOI 10.1002/hep.1840150525
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang MY, 2015, STEM CELL TRANSL MED, V4, P494, DOI 10.5966/sctm.2014-0206
   Zhao M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.414
NR 55
TC 2
Z9 2
U1 1
U2 3
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN 15
PY 2023
VL 15
IS 11
BP 4576
EP 4599
PG 24
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA K8QG1
UT WOS:001019021700005
PM 37204430
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Xing, BP
   Lan, HA
   Li, HF
AF Xing, Baopeng
   Lan, Hainan
   Li, Haifeng
TI HBO1 as an Important Target for the Treatment of CCL4-Induced Liver
   Fibrosis and Aged-Related Liver Aging and Fibrosis
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID HEPATIC STELLATE CELLS; ACTIVATION
AB The liver is the largest digestive organ in the human body. The increasing incidence of chronic liver fibrosis is one of the major health challenges in the world. Liver fibrosis is a wound-healing response to acute or chronic cellular damage of liver tissue. At present, despite a series of research progress on the pathophysiological mechanism of fibrosis that has been made, there is still a gap in identifying antifibrotic targets and converting them into effective treatments. Therefore, it is extremely important to seek a molecular target that can alleviate or reverse liver fibrosis, which has important scientific and clinical significance. In the current study, to evaluate the therapeutic effect of HBO1 as a molecular target on liver aging and fibrosis, naturally-aged mice and CCL4-induced liver fibrosis mice were used as animal models, and multiple experiments were performed. Experimental results showed that HBO1 knockdown could strongly mitigate the accumulation of hepatic collagen by Masson and Sirius Red staining. Further study showed that HBO1 knockdown reduced the expression of fibrosis-related marker molecules (alpha-SMA, collagen type I (ColI), and fibronectin). Further work showed that HBO1 knockdown could significantly alleviate HSC activation. On this basis, we analyzed the underlying mechanism by which HBO1 alleviates liver fibrosis. It was found that HBO1 knockdown may modulate liver fibrosis by regulating the processes of EMT, inflammation, and oxidative stress. We further studied the effect of HBO1 knockdown on liver aging and aging-related liver fibrosis, and the results showed that HBO1 knockdown could significantly reduce the level of aging-related liver fibrosis and relieve liver aging. In conclusion, we systematically investigated the potential of HBO1 as a therapeutic target to attenuate liver fibrosis and liver aging. The current study found a crucial target for liver fibrosis and liver-aging therapy, which has laid a solid foundation for the liver fibrosis-related research.
C1 [Xing, Baopeng; Li, Haifeng] First Hosp Jilin Univ, Emergency Med Dept, Changchun 130031, Peoples R China.
   [Lan, Hainan] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Peoples R China.
C3 Jilin University; Jilin Agricultural University
RP Li, HF (corresponding author), First Hosp Jilin Univ, Emergency Med Dept, Changchun 130031, Peoples R China.
EM xbp2020@jlu.edu.cn; lanhainan@sina.com; hfli@jlu.edu.cn
FU Guizhou Ruihe Pharmaceutical Co., Ltd.;  [320.6750.1323]
FX AcknowledgmentsThis study was supported by the Guizhou Ruihe
   Pharmaceutical Co., Ltd., "Clinical Observation of Shuganning Injection
   on Liver Poisoning Injury" (grant no. 320.6750.1323).
CR Allaire M, 2020, CLIN RES HEPATOL GAS, V44, P6, DOI 10.1016/j.clinre.2019.07.011
   Bai ZJ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919241
   Berumen J, 2021, WIRES MECH DIS, V13, DOI 10.1002/wsbm.1499
   Budi EH, 2021, J PATHOL, V254, P358, DOI 10.1002/path.5680
   Campana L, 2017, SEMIN LIVER DIS, V37, P1, DOI 10.1055/s-0036-1597816
   Chen SR, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0036-y
   Chilvery S, 2020, INT IMMUNOPHARMACOL, V88, DOI [10.1016/j.intimp.2020.106909, 10.1016/J.intimp.2020.106909]
   El-Emam SZ, 2020, N-S ARCH PHARMACOL, V393, P1849, DOI 10.1007/s00210-020-01887-1
   Feng Yibin, 2009, Chin Med, V4, P16, DOI 10.1186/1749-8546-4-16
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Gao SD, 2017, BIOCHEM BIOPH RES CO, V489, P235, DOI 10.1016/j.bbrc.2017.05.143
   Nguyen G, 2018, BIOCHEM BIOPH RES CO, V495, P2649, DOI 10.1016/j.bbrc.2017.12.143
   Han J, 2018, J BIOL CHEM, V293, P4498, DOI 10.1074/jbc.RA117.000677
   Jie MM, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01160-2
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kueh AJ, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00506-19
   Liang Y, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00323-w
   Liu Y, 2020, AGING-US, V12, P6058, DOI 10.18632/aging.103002
   Ozawa Shogo, 2021, Drug Metab Lett, V14, P25, DOI 10.2174/1872312814666201202112610
   Ramos-Tovar E, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121279
   Roehlen N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040875
   Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028
   Wan JH, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw8523
   Wang B., 2022, CELL CYCLE, V21, P1
   Wang T, 2021, J PHARM PHARMACOL, V73, P338, DOI 10.1093/jpp/rgaa042
   Xiao YH, 2021, NUCLEIC ACIDS RES, V49, P8037, DOI 10.1093/nar/gkab607
   Yao X, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01891-5
   Yu HX, 2019, MOL IMMUNOL, V107, P29, DOI 10.1016/j.molimm.2019.01.004
   Zhao Z, 2019, TRANSL RES, V214, P17, DOI 10.1016/j.trsl.2019.07.007
NR 29
TC 1
Z9 1
U1 2
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD DEC 6
PY 2022
VL 2022
AR 1881519
DI 10.1155/2022/1881519
PG 25
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 7A8ZK
UT WOS:000898736800001
PM 36524217
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Li, Y
   Zhang, DD
   Li, L
   Han, YL
   Dong, XA
   Yang, L
   Li, XW
   Li, WZ
   Li, WP
AF Li, Yan
   Zhang, Duoduo
   Li, Lan
   Han, Yuli
   Dong, Xianan
   Yang, Liu
   Li, Xuewang
   Li, Weizu
   Li, Weiping
TI Ginsenoside Rg1 ameliorates aging-induced liver fibrosis by inhibiting
   the NOX4/NLRP3 inflammasome in SAMP8 mice
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE ginsenoside Rg1; liver aging; NLR family pyrin domain containing 3
   inflammasome; NADPH oxidase 4; oxidative stress
ID OXIDATIVE STRESS; NADPH OXIDASE; ACTIVATION; SENESCENCE; PATHWAY;
   DISEASE; MECHANISMS; INJURY; INDUCTION; APOPTOSIS
AB Aging is often accompanied by liver injury and fibrosis, eventually leading to the decline in liver function. However, the mechanism of aging-induced liver injury and fibrosis is still not fully understood, to the best of our knowledge, and there are currently no effective treatment options available for liver aging. Ginsenoside Rg1 (Rg1) has been reported to exert potent anti-aging effects due to its potential antioxidant and anti-inflammatory activity. The present study aimed to investigate the protective effect and underlying mechanism of action of Rg1 in aging-induced liver injury and fibrosis in senescence-accelerated mouse prone 8 (SAMP8) mice treated for 9 weeks. The histopathological results showed that the arrangement of hepatocytes was disordered, vacuole-like degeneration occurred in the majority of cells, and collagen IV and TGF-beta 1 expression levels, that were detected via immunohistochemistry, were also significantly upregulated in the SAMP8 group. Rg1 treatment markedly improved aging-induced liver injury and fibrosis, and significantly downregulated the expression levels of collagen IV and TGF-beta 1. In addition, the dihydroethylene staining and western blotting results showed that Rg1 treatment significantly reduced the levels of reactive oxygen species (ROS) and IL-1 beta, and downregulated the expression levels of NADPH oxidase 4 (NOX4), p47phox, p22phox, phosphorylated-NF-kappa B, caspase-1, apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain and the NLR family pyrin domain containing 3 (NLRP3) inflammasome, which were significantly upregulated in the liver tissues of elderly SAMP8 mice. In conclusion, the findings of the present study suggested that Rg1 may attenuate aging-induced liver injury and fibrosis by reducing NOX4-mediated ROS oxidative stress and inhibiting NLRP3 inflammasome activation.
C1 [Li, Yan; Zhang, Duoduo; Li, Lan; Han, Yuli; Dong, Xianan; Yang, Liu; Li, Xuewang; Li, Weizu; Li, Weiping] Anhui Med Univ, Basic Med Coll, Key Lab Antiinflammatory & Immunopharmacol, Dept Pharmacol,Minist Educ, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
   [Li, Weiping] Anqing Med & Pharmaceut Coll, Dept Pharmacol, Anqing 246052, Anhui, Peoples R China.
C3 Anhui Medical University
RP Li, WZ; Li, WP (corresponding author), Anhui Med Univ, Basic Med Coll, Key Lab Antiinflammatory & Immunopharmacol, Dept Pharmacol,Minist Educ, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.
EM liweizu@126.com; lwp19@126.com
RI zhang, xu/JEO-4879-2023; zhou, wei/JQJ-0490-2023; LI,
   Xiang/JBJ-8387-2023; ZHAO, S/IWV-4219-2023; chen, chen/JGD-3057-2023;
   LI, WEI/ISS-1208-2023; zhang, yuyang/IVV-5089-2023; Zhang,
   Duo/GYU-8678-2022
FU National Natural Science Foundation of China [81970630]; Major Science
   and Technology Projects in Anhui Province [201903a07020025]
FX The present study was supported by grants from the National Natural
   Science Foundation of China (grant no. 81970630) and the Major Science
   and Technology Projects in Anhui Province (grant no. 201903a07020025).
CR Aydin MM, 2018, TURK J GASTROENTEROL, V29, P14, DOI 10.5152/tjg.2018.17330
   Baltanás A, 2013, J PHYSIOL BIOCHEM, V69, P927, DOI 10.1007/s13105-013-0271-6
   Cao ZW, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12389
   Chen Y, 2020, J FUNCT FOODS, V65, DOI 10.1016/j.jff.2019.103713
   Chen YX, 2019, BIOMED PHARMACOTHER, V116, DOI 10.1016/j.biopha.2019.108923
   Cheng Q, 2019, CHEM-BIOL INTERACT, V299, P131, DOI 10.1016/j.cbi.2018.12.006
   Cheng YC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9091948
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Cuesta S, 2010, EXP GERONTOL, V45, P950, DOI 10.1016/j.exger.2010.08.016
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9
   Dumeus S, 2018, CELL PHYSIOL BIOCHEM, V48, P1942, DOI 10.1159/000492518
   Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022
   Fernández-García C, 2019, EUR J NUTR, V58, P653, DOI 10.1007/s00394-018-1657-6
   Fougère B, 2017, J GERONTOL A-BIOL, V72, P1218, DOI 10.1093/gerona/glw240
   Gallego P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102148
   Gao Y, 2019, J ASIAN NAT PROD RES, V21, P782, DOI 10.1080/10286020.2018.1504024
   Ghosh R, 2017, J CLIN DIAGN RES, V11, pBC9, DOI 10.7860/JCDR/2017/25276.9315
   Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893
   Hou LY, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101134
   Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com
   Huang CK, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00431
   Iezzoni JC, 2018, SEMIN DIAGN PATHOL, V35, P381, DOI 10.1053/j.semdp.2018.10.003
   Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Jin CJ, 2020, AM J PHYSIOL-GASTR L, V318, pG736, DOI 10.1152/ajpgi.00345.2018
   Jones-Bolin Susan, 2012, Curr Protoc Pharmacol, VAppendix 4, p4B, DOI 10.1002/0471141755.pha04bs59
   Kang RF, 2019, ENVIRON POLLUT, V251, P689, DOI 10.1016/j.envpol.2019.05.026
   Kim DH, 2012, J GINSENG RES, V36, P1, DOI 10.5142/jgr.2012.36.1.1
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190
   Koh EJ, 2017, J GINSENG RES, V41, P23, DOI 10.1016/j.jgr.2015.12.005
   Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821
   Lan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129743
   Langley M, 2017, ANTIOXID REDOX SIGN, V27, P1048, DOI 10.1089/ars.2016.6905
   Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651
   Lefkowitch JH, 2006, SEMIN DIAGN PATHOL, V23, P190, DOI 10.1053/j.semdp.2006.11.006
   Li JP, 2014, ACTA PHARMACOL SIN, V35, P1031, DOI 10.1038/aps.2014.41
   Liu Q, 2017, THERANOSTICS, V7, P4001, DOI 10.7150/thno.18788
   Luangmonkong T, 2018, REV PHYSIOL BIOCH P, V175, P71, DOI 10.1007/112_2018_10
   Malik A, 2017, J CELL SCI, V130, P3955, DOI 10.1242/jcs.207365
   Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]
   Maroni L, 2019, HEPATOLOGY, V70, P883, DOI 10.1002/hep.30466
   Mo C, 2021, PHYTOMEDICINE, V84, DOI 10.1016/j.phymed.2021.153524
   Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022
   Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703
   Neves J, 2020, FEBS J, V287, P43, DOI 10.1111/febs.15061
   Pinto C, 2020, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00332
   Qin QJ, 2019, DIABETES METAB SYNDR, V12, P1091, DOI 10.2147/DMSO.S208989
   Ralston JC, 2017, ANNU REV NUTR, V37, P77, DOI 10.1146/annurev-nutr-071816-064836
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shen XY, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106339
   Sho T, 2019, BIOTECHNOL APPL BIOC, V66, P4, DOI 10.1002/bab.1700
   Song AQ, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01848-8
   Soysal P, 2020, ADV EXP MED BIOL, V1216, P55, DOI 10.1007/978-3-030-33330-0_7
   Stahl EC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02795
   Stakos DA, 2020, J AM COLL CARDIOL, V75, P952, DOI 10.1016/j.jacc.2019.12.033
   Stancu IC, 2019, ACTA NEUROPATHOL, V137, P599, DOI 10.1007/s00401-018-01957-y
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Sun LB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1761-4
   Sun XT, 2020, SEMIN CELL DEV BIOL, V101, P78, DOI 10.1016/j.semcdb.2019.10.015
   Tao Y, 2021, J CELL PHYSIOL, V236, P1469, DOI 10.1002/jcp.29952
   Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002
   Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wang Y, 2016, INT J BIOL SCI, V12, P1341, DOI 10.7150/ijbs.15992
   Wei XY, 2018, BIOFACTORS, V44, P327, DOI 10.1002/biof.1432
   Wick MR, 2019, SEMIN DIAGN PATHOL, V36, P303, DOI 10.1053/j.semdp.2019.06.003
   Wojtovich AP, 2014, REDOX BIOL, V2, P368, DOI 10.1016/j.redox.2014.01.019
   Wree A, 2018, HEPATOLOGY, V67, P736, DOI 10.1002/hep.29523
   Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592
   Xiong X, 2017, BIOMED PHARMACOTHER, V96, P1292, DOI 10.1016/j.biopha.2017.11.083
   Xu FY, 2016, J HISTOCHEM CYTOCHEM, V64, P157, DOI 10.1369/0022155415627681
   Xu TZ, 2019, INT J MOL MED, V43, P717, DOI 10.3892/ijmm.2018.4005
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127
   Yu HT, 2016, J CELL MOL MED, V20, P623, DOI 10.1111/jcmm.12739
   Yu X, 2017, J HEPATOL, V66, P693, DOI 10.1016/j.jhep.2016.12.018
   Zhang M, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1806234
   Zhao JQ, 2021, INT J MED SCI, V18, P1382, DOI 10.7150/ijms.50919
   Zhou DH, 2020, J CELL MOL MED, V24, P6008, DOI 10.1111/jcmm.15108
   Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358
NR 81
TC 19
Z9 19
U1 3
U2 14
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD NOV
PY 2021
VL 24
IS 5
AR 801
DI 10.3892/mmr.2021.12441
PG 14
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA UT2CN
UT WOS:000697929100001
PM 34523690
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Honma, T
   Shinohara, N
   Ito, J
   Kijima, R
   Sugawara, S
   Arai, T
   Tsuduki, T
   Ikeda, I
AF Honma, Taro
   Shinohara, Nahoko
   Ito, Junya
   Kijima, Ryo
   Sugawara, Soko
   Arai, Tatsuya
   Tsuduki, Tsuyoshi
   Ikeda, Ikuo
TI High-fat diet intake accelerates aging, increases expression of Hsd11b1,
   and promotes lipid accumulation in liver of SAMP10 mouse
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; High-fat diet; Hsd11b1; Hyperinsulinemia; Lipid metabolism;
   SAMP10
ID CONJUGATED TRIENE SYSTEM; ALPHA-ELEOSTEARIC-ACID; ADIPOSE-TISSUE; MURINE
   MODEL; LIFE-SPAN; SENESCENCE; GENE; SUPPRESSION; OBESITY; ISOMER
AB An understanding of the mechanisms of aging is important for prevention of age-related diseases. In this study, we examined age-dependent changes in lipid metabolism in the senescence-accelerated mouse (SAM)P10 fed a high-fat diet to investigate the effects of high-fat intake and aging. Tissue weights and biological parameters in plasma and liver were measured at 6 and 12 months old in SAMP10 mice fed a high-fat diet. These mice showed marked increases in liver triacylglycerol and plasma insulin levels with intake of a high-fat diet intake and aging. Lipid ahypertrophy ccumulation in hepatocytes and morphological aberrations and in pancreatic islets were also promoted by a high-fat diet and aging. To investigate the underlying mechanisms, the activities and mRNA levels for enzymes associated with lipid metabolism in liver were measured. The results indicated that the lipid metabolic system was activated by a high-fat diet and aging. Liver mRNA level for hydroxysteroid 11-beta dehydrogenase 1 (Hsd11b1), which exhibit age-dependent increases and promote insulin secretion, was also markedly increased. These results suggest that a high-fat diet accelerated aging in the liver of SAMP10 mice by increasing liver mRNA level for Hsd11b1, increasing insulin secretion, and promoting lipid accumulation in the liver.
C1 [Honma, Taro; Shinohara, Nahoko; Ito, Junya; Kijima, Ryo; Sugawara, Soko; Arai, Tatsuya; Tsuduki, Tsuyoshi; Ikeda, Ikuo] Tohoku Univ, Lab Food & Biomol Sci, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan.
C3 Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Lab Food & Biomol Sci, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.
EM tsuzukit@biochem.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/T-2697-2019; Tsuduki, Tsuyoshi/C-2254-2016; Tsuduki,
   Tsuyoshi/E-4717-2012
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528; 
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [20780099]; Grants-in-Aid for Scientific Research [20780099] Funding
   Source: KAKEN
FX This study was supported by Grant-in-Aid for Young Scientists (B)
   (20780099) from the Ministry of Education, Culture, Sports, Science and
   Technology, Japan.
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Chen GH, 2007, NEUROBIOL AGING, V28, P611, DOI 10.1016/j.neurobiolaging.2006.03.001
   de Cavanagh EMV, 2008, EXP GERONTOL, V43, P919, DOI 10.1016/j.exger.2008.08.007
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Ide T, 2000, BBA-MOL CELL BIOL L, V1485, P23, DOI 10.1016/S1388-1981(00)00026-3
   Lin H, 2006, COMP BIOCHEM PHYS A, V143, P400, DOI 10.1016/j.cbpa.2005.12.030
   Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   Mendoza-Nunez Victor Manuel, 2009, BMC Geriatr, V9, P40, DOI 10.1186/1471-2318-9-40
   Miard S, 2009, AGING CELL, V8, P449, DOI 10.1111/j.1474-9726.2009.00490.x
   Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101
   ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316
   Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x
   Shannon J, 2007, PUBLIC HEALTH NUTR, V10, P810, DOI 10.1017/S1368980007258604
   Shibata A, 2008, BIOCHEM PHARMACOL, V76, P330, DOI 10.1016/j.bcp.2008.05.017
   Shimada A, 2006, NEUROPATH APPL NEURO, V32, P1, DOI 10.1111/j.1365-2990.2006.00632.x
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017
   Tsuduki T, 2009, J AGR FOOD CHEM, V57, P11024, DOI 10.1021/jf903132r
   Tsuzuki T, 2005, LIPIDS, V40, P1117, DOI 10.1007/s11745-005-1475-0
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298
   Tsuzuki T, 2007, BBA-MOL CELL BIOL L, V1771, P20, DOI 10.1016/j.bbalip.2006.11.006
   Tsuzuki T, 2006, J NUTR BIOCHEM, V17, P518, DOI 10.1016/j.jnutbio.2005.09.006
   Unno K, 2007, BIOGERONTOLOGY, V8, P89, DOI 10.1007/s10522-006-9036-8
   Wang J, 2000, J GERONTOL A-BIOL, V55, pB432, DOI 10.1093/gerona/55.9.B432
   Yanaka M, 2011, BIOSCI BIOTECH BIOCH, V75, P1098, DOI 10.1271/bbb.100909
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
NR 33
TC 33
Z9 36
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD APR
PY 2012
VL 13
IS 2
BP 93
EP 103
DI 10.1007/s10522-011-9363-2
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 922TM
UT WOS:000302571100001
PM 22033707
DA 2024-02-19
ER

PT J
AU Sorensen, KK
   Simon-Santamaria, J
   McCuskey, RS
   Smedsrod, B
AF Sorensen, Karen Kristine
   Simon-Santamaria, Jaione
   McCuskey, Robert S.
   Smedsrod, Bard
TI Liver Sinusoidal Endothelial Cells
SO COMPREHENSIVE PHYSIOLOGY
LA English
DT Article
ID RECEPTOR-MEDIATED ENDOCYTOSIS; LOW-DENSITY-LIPOPROTEIN;
   AGE-RELATED-CHANGES; GLYCATION END-PRODUCTS; HEPATIC MICROVASCULAR
   INJURY; FC-GAMMA-RIIB; PATTERN-RECOGNITION RECEPTORS; ANTIGEN-ANTIBODY
   COMPLEXES; RAT-LIVER; MANNOSE RECEPTOR
AB The liver sinusoidal endothelial cell (LSEC) forms the fenestrated wall of the hepatic sinusoid and functions as a control post regulating and surveying the trafficking of molecules and cells between the liver parenchyma and the blood. The cell acts as a scavenger cell responsible for removal of potential dangerous macromolecules from blood, and is increasingly acknowledged as an important player in liver immunity. This review provides an update of the major functions of the LSEC, including its role in plasma ultrafiltration and regulation of the hepatic microcirculation, scavenger functions, immune functions, and role in liver aging, as well as issues that are either undercommunicated or confusingly dealt with in the literature. These include metabolic functions, including energy metabolic interplay between the LSEC and the hepatocyte, and adequate ways of identifying and distinguishing the cells. (C) 2015 American Physiological Society.
C1 [Sorensen, Karen Kristine; Simon-Santamaria, Jaione; Smedsrod, Bard] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway.
   [McCuskey, Robert S.] Univ Arizona, Coll Med, Dept Mol & Cellular Med, Tucson, AZ USA.
C3 UiT The Arctic University of Tromso; University of Arizona
RP Smedsrod, B (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway.
EM bard.smedsrod@uit.no
OI Smedsrod, Bard/0000-0002-3308-8948
FU Tromso Research Foundation; National Institutes of Health [AA-08037,
   AA-12436, HD-26013, AG-02582]
FX We thank Ana Oteiza for skilled assistance with illustrations. This work
   was supported in parts by a grant from the Tromso Research Foundation,
   and National Institutes of Health grants AA-08037, AA-12436, HD-26013,
   and AG-02582.
CR Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200
   AHMED SS, 1995, HEPATOLOGY, V22, P316, DOI 10.1002/hep.1840220143
   Allen Peter J, 2003, Adv Surg, V37, P29
   AREND WP, 1971, J IMMUNOL, V107, P63
   Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x
   Arimoto J, 2010, J GASTROENTEROL, V45, P317, DOI 10.1007/s00535-009-0152-5
   Arteta B, 2010, HEPATOLOGY, V51, P2172, DOI 10.1002/hep.23590
   Asumendi A, 1996, HEPATOLOGY, V23, P1521, DOI 10.1002/hep.510230632
   ATERMAN K., 1964, P61
   Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789
   Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671
   BATTISTO JR, 1962, P SOC EXP BIOL MED, V111, P111
   BENACERRAF B, 1959, J IMMUNOL, V82, P131
   Berg M, 2006, EUR J IMMUNOL, V36, P2960, DOI 10.1002/eji.200636033
   BLOMHOFF R, 1984, BIOCHEM J, V218, P81, DOI 10.1042/bj2180081
   BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   Boaru SG, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-49
   BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V86, P328
   Braet F, 1998, P NATL ACAD SCI USA, V95, P13635, DOI 10.1073/pnas.95.23.13635
   Braet F, 1996, SCANNING MICROSCOPY SUPPLEMENT 10, 1996, P225
   Braet F, 2004, LIVER INT, V24, P532, DOI 10.1111/j.1478-3231.2004.0974.x
   Braet F, 2012, MICRON, V43, P1252, DOI 10.1016/j.micron.2012.02.010
   Braet F, 2003, J MICROSC-OXFORD, V212, P175, DOI 10.1046/j.1365-2818.2003.01229.x
   Braet F, 2001, J ELECTRON MICROSC, V50, P283, DOI 10.1093/jmicro/50.4.283
   BRAET F, 1995, HEPATOLOGY, V21, P180, DOI 10.1002/hep.1840210130
   Braet F, 1996, SCANNING MICROSCOPY, V10, P235
   Braet F, 2007, MICROSC RES TECHNIQ, V70, P230, DOI 10.1002/jemt.20408
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Braet F, 2009, LIVER INT, V29, P603, DOI 10.1111/j.1478-3231.2008.01836.x
   Breiner KM, 2001, HEPATOLOGY, V34, P803, DOI 10.1053/jhep.2001.27810
   Brinkley TE, 2009, HYPERTENSION, V53, P846, DOI 10.1161/HYPERTENSIONAHA.108.127043
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255
   CANTOR HM, 1967, NATURE, V215, P744, DOI 10.1038/215744a0
   CAPERNA TJ, 1982, MECH AGEING DEV, V20, P205, DOI 10.1016/0047-6374(82)90088-4
   Carreira CM, 2001, CANCER RES, V61, P8079
   Chung KW, 2013, EXP GERONTOL, V48, P1049, DOI 10.1016/j.exger.2012.11.007
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   COGGER VC, 2009, LIVER BIOL PATHOBIOL
   Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001
   COHN JS, 1988, J LIPID RES, V29, P469
   Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x
   Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005
   Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629
   Deaciuc IV, 1999, J HEPATOL, V30, P213, DOI 10.1016/S0168-8278(99)80064-6
   DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006
   DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025
   DeLeve LD, 1997, BIOCHEM PHARMACOL, V53, P1339, DOI 10.1016/S0006-2952(97)00048-8
   DeLeve LD, 1999, HEPATOLOGY, V29, P1779, DOI 10.1002/hep.510290615
   DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004
   DELEVE LD, 1994, J PHARMACOL EXP THER, V268, P1261
   DeLeve LD, 2003, GASTROENTEROLOGY, V125, P882, DOI 10.1016/S0016-5085(03)01056-4
   DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204
   DeLeve LD, 1996, HEPATOLOGY, V23, P589
   DeLeve LD, 1997, MUTAT RES-GEN TOX EN, V389, P291, DOI 10.1016/S1383-5718(96)00159-3
   DeLeve LD, 1996, HEPATOLOGY, V24, P830, DOI 10.1002/hep.510240414
   DeLeve LD, 2014, HEPATOLOGY
   DERIJKE YB, 1994, BIOCHEM J, V304, P69, DOI 10.1042/bj3040069
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Duryee MJ, 2005, MOL PHARMACOL, V68, P1423, DOI 10.1124/mol.105.016121
   Ebrahimkhani MR, 2011, HEPATOLOGY, V54, P1379, DOI 10.1002/hep.24508
   EGUCHI H, 1991, HEPATOLOGY, V13, P751, DOI 10.1016/0270-9139(91)92575-S
   Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007
   Elvevold K, 2008, HEPATOLOGY, V48, P2007, DOI 10.1002/hep.22527
   Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4
   ESKILD W, 1986, INT J BIOCHEM, V18, P647, DOI 10.1016/0020-711X(86)90295-8
   Falkowska-Hansen B, 2007, EXP CELL RES, V313, P1745, DOI 10.1016/j.yexcr.2007.02.026
   Falkowska-Hansen B, 2006, MOL CELL BIOCHEM, V287, P43, DOI 10.1007/s11010-005-9024-3
   Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5
   FAWCETT DW, 1955, J NATL CANCER I, V15, P1475
   FINBLOOM DS, 1979, J IMMUNOL, V123, P1594
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRASER R, 1986, PATHOLOGY, V18, P5, DOI 10.3109/00313028609090821
   FRASER R, 1978, ATHEROSCLEROSIS, V29, P113, DOI 10.1016/0021-9150(78)90001-1
   Fraser R, 2012, PATHOLOGY, V44, P181, DOI 10.1097/PAT.0b013e328351bcc8
   Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200
   Gamble Jennifer, 2011, Hepatology, V54, P731, DOI 10.1002/hep.24455
   Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017
   Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281
   Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100
   Géraud C, 2013, LIVER INT, V33, P1428, DOI 10.1111/liv.12262
   Géraud C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034206
   Géraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618
   GOERDT S, 1991, J CELL BIOL, V113, P1425, DOI 10.1083/jcb.113.6.1425
   GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333
   HAMPTON J. C., 1958, ACTA ANAT, V32, P262
   Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017
   Hansen B, 2002, MOL CELL BIOCHEM, V229, P63, DOI 10.1023/A:1017919800347
   Hansen B, 2002, DIABETOLOGIA, V45, P1379, DOI 10.1007/s00125-002-0912-8
   Harb R, 2009, GASTROENTEROLOGY, V137, P704, DOI 10.1053/j.gastro.2009.05.009
   Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045
   Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200
   HEIL MF, 1984, MECH AGEING DEV, V26, P327, DOI 10.1016/0047-6374(84)90104-0
   Hellevik T, 1996, EXP CELL RES, V223, P39, DOI 10.1006/excr.1996.0056
   HENRIKSEN JH, 1984, LIVER, V4, P221
   Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47
   Irjala H, 2003, CANCER RES, V63, P4671
   ISAKSSON A, 1983, ENZYME, V30, P230, DOI 10.1159/000469582
   Ito Y, 2005, TOXICOL SCI, V83, P190, DOI 10.1093/toxsci/kfh291
   Ito Y, 2004, AM J PHYSIOL-GASTR L, V286, pG60, DOI 10.1152/ajpgi.00217.2003
   Ito Y, 2003, MICROCIRCULATION, V10, P391, DOI 10.1038/sj.mn.7800204
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Ito Y, 2006, AM J PHYSIOL-GASTR L, V291, pG211, DOI 10.1152/ajpgi.00312.2005
   Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136
   Jamieson HA, 2007, DIABETOLOGIA, V50, P1969, DOI 10.1007/s00125-007-0739-4
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691
   Juvet LK, 1997, HEPATOLOGY, V25, P1204, DOI 10.1002/hep.510250524
   Katz SC, 2004, J IMMUNOL, V173, P230, DOI 10.4049/jimmunol.173.1.230
   KAWADA N, 1993, EUR J BIOCHEM, V213, P815, DOI 10.1111/j.1432-1033.1993.tb17824.x
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kjeken R, 2001, CELL TISSUE RES, V304, P221, DOI 10.1007/s004410100348
   Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427
   Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x
   KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4
   KNOOK DL, 1980, BIOCHEM BIOPH RES CO, V96, P250, DOI 10.1016/0006-291X(80)91207-3
   KNOOK DL, 1977, EXP CELL RES, V109, P317, DOI 10.1016/0014-4827(77)90011-8
   KOSUGI I, 1993, CELLS OF THE HEPATIC SINUSOID, VOL 4, P434
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   Krause P, 2000, J HEPATOL, V32, P718, DOI 10.1016/S0168-8278(00)80239-1
   Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x
   Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825
   Lai WK, 2006, AM J PATHOL, V169, P200, DOI 10.2353/ajpath.2006.051191
   Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429
   LAURENT TC, 1986, CONNECT TISSUE RES, V15, P33, DOI 10.3109/03008208609001971
   LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 2007, ANN NY ACAD SCI, V1114, P79, DOI 10.1196/annals.1396.003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LEBAIL B, 1990, J ELECTRON MICR TECH, V14, P257, DOI 10.1002/jemt.1060140307
   Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010
   Li RM, 2009, MICROCIRCULATION, V16, P640, DOI 10.1080/10739680903133185
   Li Y, 2009, MOL CELL BIOCHEM, V327, P183, DOI 10.1007/s11010-009-0056-y
   Licastro Federico, 2005, Immun Ageing, V2, P8
   Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161
   Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961
   Linehan SA, 2005, HISTOCHEM CELL BIOL, V123, P365, DOI 10.1007/s00418-005-0767-4
   Liu YL, 2013, EXP MOL PATHOL, V94, P160, DOI 10.1016/j.yexmp.2012.10.015
   Lohmann R, 1999, AM J PHYSIOL-GASTR L, V276, pG743, DOI 10.1152/ajpgi.1999.276.3.G743
   MACPHEE PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG692, DOI 10.1152/ajpgi.1995.269.5.G692
   MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651
   MAGNUSSON S, 1993, BIOCHEM J, V291, P749, DOI 10.1042/bj2910749
   Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639
   March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085
   Martens JH, 2006, J PATHOL, V208, P574, DOI 10.1002/path.1921
   Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020
   MARTINEZ I, 1995, BIOCHEM BIOPH RES CO, V212, P235, DOI 10.1006/bbrc.1995.1961
   Martinez Inigo, 2008, Comp Hepatol, V7, P4, DOI 10.1186/1476-5926-7-4
   Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046
   Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   May D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021478
   McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521
   McCuskey P.A., 1986, CELLS HEPATIC SINUSO, P489
   McCuskey RS, 2008, ANAT REC, V291, P661, DOI 10.1002/ar.20663
   McCuskey RS, 2006, CLIN HEMORHEOL MICRO, V34, P5
   McCuskey RS, 2005, J HEPATOL, V42, P371, DOI 10.1016/j.jhep.2004.11.033
   McCuskey RS, 2000, LIVER, V20, P3, DOI 10.1034/j.1600-0676.2000.020001003.x
   MCCUSKEY RS, 1966, AM J ANAT, V119, P455, DOI 10.1002/aja.1001190307
   MCCUSKEY RS, 1993, SEMIN LIVER DIS, V13, P1, DOI 10.1055/s-2007-1007333
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MELKKO J, 1994, J EXP MED, V179, P405, DOI 10.1084/jem.179.2.405
   MODIS L, 1991, LAB INVEST, V65, P661
   Moniaux N, 2011, J HEPATOL, V55, P488, DOI 10.1016/j.jhep.2011.02.005
   Monkemoller V, 2014, PHYS CHEM CHEM PHYS
   MORI T, 1993, HEPATOLOGY, V17, P891
   Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748
   Müller AM, 2002, EXP GERONTOL, V37, P713, DOI 10.1016/S0531-5565(02)00010-4
   MURO H, 1993, AM J PATHOL, V143, P105
   NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221
   NAITO M, 1978, CELL TISSUE RES, V190, P371
   NAKATA K, 1960, AM J PHYSIOL, V199, P1181, DOI 10.1152/ajplegacy.1960.199.6.1181
   NAKATA K, 1967, ACTA PATHOL JAPON, V17, P361
   Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027
   Nedredal GI, 2007, AM J PHYSIOL-GASTR L, V293, pG75, DOI 10.1152/ajpgi.00245.2006
   Nedredal GI, 2009, HEPATOLOGY, V50, P900, DOI 10.1002/hep.23076
   Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4
   NIESEN TE, 1984, J LEUKOCYTE BIOL, V36, P307, DOI 10.1002/jlb.36.3.307
   NISHIDA J, 1994, SHOCK, V1, P413, DOI 10.1097/00024382-199406000-00004
   Nonaka H, 2007, DEV DYNAM, V236, P2258, DOI 10.1002/dvdy.21227
   ODA M, 1990, PROGR APPL MICR, V17, P103
   Oda M, 2000, CLIN HEMORHEOL MICRO, V23, P85
   Ohtani O, 2008, ANAT REC, V291, P643, DOI 10.1002/ar.20681
   Oie CI, 2008, AM J PHYSIOL-GASTR L, V294, pG520, DOI 10.1152/ajpgi.00489.2007
   Oie CI, 2011, J HEPATOL, V55, P1346, DOI 10.1016/j.jhep.2011.03.013
   OSTGAARD G, 1995, ACTA PHYSIOL SCAND, V153, P51, DOI 10.1111/j.1748-1716.1995.tb09833.x
   Oteiza A, 2011, AM J PHYSL GASTROINT
   Oynebråten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183
   PINZANI M, 1992, J CLIN INVEST, V90, P642, DOI 10.1172/JCI115905
   Pipirou Z, 2011, GLYCOBIOLOGY, V21, P806, DOI 10.1093/glycob/cwr008
   Pöhlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398
   Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155
   PRAANINGVANDALEN DP, 1987, HEPATOLOGY, V7, P672
   PrabhuDas M, 2014, J IMMUNOL, V192, P1997, DOI 10.4049/jimmunol.1490003
   Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   PULFORD K, 1981, CLIN EXP IMMUNOL, V46, P581
   Qian H, 2009, BIOCHEM BIOPH RES CO, V390, P883, DOI 10.1016/j.bbrc.2009.10.068
   ROCKEY DC, 1993, J CLIN INVEST, V92, P1795, DOI 10.1172/JCI116769
   Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551
   RUBINSTEIN D, 1986, J IMMUNOL, V137, P1803
   Samarasinghe DA, 2000, HEPATOLOGY, V31, P160, DOI 10.1002/hep.510310124
   Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942
   Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740
   Schönhaar K, 2014, INT J CLIN EXP PATHO, V7, P1625
   SCOAZEC JY, 1991, HEPATOLOGY, V14, P789, DOI 10.1002/hep.1840140508
   Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299
   Shahani T, 2014, J THROMB HAEMOST, V12, P36, DOI 10.1111/jth.12412
   SHECHTER I, 1981, J LIPID RES, V22, P63
   Simon-Santamaria J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111762
   Simon-Santamaria J, 2010, J GERONTOL A-BIOL, V65, P951, DOI 10.1093/gerona/glq108
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   SKOGH T, 1985, IMMUNOLOGY, V55, P585
   SKOSKIEWICZ MJ, 1985, J EXP MED, V162, P1645, DOI 10.1084/jem.162.5.1645
   SMEDSROD B, 1990, SCAND J CLIN LAB INV, V50, P148
   SMEDSROD B, 1985, BIOCHEM J, V228, P415, DOI 10.1042/bj2280415
   SMEDSROD B, 1985, BIOCHEM J, V229, P63, DOI 10.1042/bj2290063
   SMEDSROD B, 1988, COLLAGEN REL RES, V8, P375
   SMEDSROD B, 1990, BIOCHEM J, V271, P345, DOI 10.1042/bj2710345
   SMEDSROD B, 1984, BIOCHEM J, V223, P617, DOI 10.1042/bj2230617
   SMEDSROD B, 1985, CELL TISSUE RES, V241, P639
   SMEDSROD B, 1990, BIOCHEM J, V266, P313, DOI 10.1042/bj2660313
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   SMEDSROD B, 1988, THROMB HAEMOSTASIS, V59, P480
   SMEDSROD B, 1989, BIOCHEM J, V261, P37, DOI 10.1042/bj2610037
   SMEDSROD B, 1991, ADV DRUG DELIVER REV, V7, P265, DOI 10.1016/0169-409X(91)90006-X
   SMEDSROD B, 1991, IMMUNOPHARMACOLOGY, V21, P149, DOI 10.1016/0162-3109(91)90020-Y
   Smedsrod B., 1982, SINUSOIDAL LIVER CEL, P263
   Smedsrod Bard, 2004, Comp Hepatol, V3 Suppl 1, pS22, DOI 10.1186/1476-5926-2-S1-S22
   Smith KGC, 2010, NAT REV IMMUNOL, V10, P328, DOI 10.1038/nri2762
   Snoeys J, 2007, GENE THER, V14, P604, DOI 10.1038/sj.gt.3302899
   Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011
   Sorensen KK, 1998, J EXP BIOL, V201, P1707
   SPEILBERG L, 1994, ANAT RECORD, V240, P291, DOI 10.1002/ar.1092400302
   SPOLARICS Z, 1991, AM J PHYSIOL, V261, pG185, DOI 10.1152/ajpgi.1991.261.2.G185
   Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9
   STEFFAN AM, 1987, HEPATOLOGY, V7, P1230, DOI 10.1002/hep.1840070610
   STEFFAN AM, 1986, HEPATOLOGY, V6, P830, DOI 10.1002/hep.1840060505
   STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1
   Straub AC, 2008, J CLIN INVEST, V118, P3980, DOI 10.1172/JCI35092
   SUEMATSU M, 1995, J CLIN INVEST, V96, P2431, DOI 10.1172/JCI118300
   Svistounov D, 2013, EXP GERONTOL, V48, P549, DOI 10.1016/j.exger.2013.03.005
   Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134
   TAIRA K, 1994, J SUBMICR CYTOL PATH, V26, P271
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200
   Tang L, 2009, GASTROENTEROLOGY, V137, P1498, DOI 10.1053/j.gastro.2009.07.051
   Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858
   TRIGER DR, 1973, IMMUNOLOGY, V25, P941
   Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332
   Van Berkel TJC, 1998, BIOCHEM J, V331, P29, DOI 10.1042/bj3310029
   VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282
   VANDERSLUIJS P, 1986, HEPATOLOGY, V6, P723, DOI 10.1002/hep.1840060431
   VANOOSTEN N, 1995, HEPATOLOGY, V22, P1538
   VIDALVANACLOCHA F, 1985, J ULTRA MOL STRUCT R, V90, P115, DOI 10.1016/0889-1605(85)90102-8
   Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032
   VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034
   WAKE K, 1989, INT REV CYTOL, V118, P173
   WAKE K, 1988, CELL TISSUE RES, V253, P563
   Wake K, 1980, INT REV CYTOL, P303
   WALKER RM, 1983, AM J PATHOL, V113, P321
   Wang L, 2012, GASTROENTEROLOGY, V143, P1555, DOI 10.1053/j.gastro.2012.08.008
   Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789
   Wang XD, 2000, HEPATOLOGY, V31, P428, DOI 10.1002/hep.510310224
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Warren A, 2008, MICROCIRCULATION, V15, P191, DOI 10.1080/10739680701600856
   Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   WIDMANN JJ, 1976, LAB INVEST, V34, P141
   Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109
   WISSE E, 1983, SCAN ELECTRON MICROS, P1441
   WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Wisse E, 1996, TOXICOL PATHOL, V24, P100, DOI 10.1177/019262339602400114
   WISSE E, 1972, J ULTRA MOL STRUCT R, V38, P528, DOI 10.1016/0022-5320(72)90089-5
   Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468
   Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x
   Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017
   Xie GH, 2010, AM J PHYSIOL-GASTR L, V299, pG1204, DOI 10.1152/ajpgi.00302.2010
   Xu B, 2003, AM J PATHOL, V163, P1275, DOI 10.1016/S0002-9440(10)63487-6
   Yajima K, 2003, EUR J IMMUNOL, V33, P1020, DOI 10.1002/eji.200323794
   Yokomori H, 2012, MICRON, V43, P129, DOI 10.1016/j.micron.2011.08.002
   Yoshida M, 2007, CELL TISSUE RES, V329, P273, DOI 10.1007/s00441-007-0387-5
   ZHANG JX, 1994, AM J PHYSIOL, V266, pG624, DOI 10.1152/ajpgi.1994.266.4.G624
   Zhao DY, 2013, IMMUNOBIOLOGY, V218, P602, DOI 10.1016/j.imbio.2012.07.017
   Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200
   Zuo YF, 2013, GUT, V62, P1169, DOI 10.1136/gutjnl-2011-300593
NR 294
TC 175
Z9 184
U1 2
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 2040-4603
J9 COMPR PHYSIOL
JI Compr. Physiol.
PD OCT
PY 2015
VL 5
IS 4
BP 1751
EP 1774
DI 10.1002/cphy.c140078
PG 24
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA CT1KL
UT WOS:000362557100006
PM 26426467
OA Bronze
DA 2024-02-19
ER

PT J
AU Chen, Q
   Song, YT
   Yang, NL
   Ai, XM
   Pu, LY
   Kong, LB
AF Chen, Qi
   Song, Yating
   Yang, Ningli
   Ai, Xiaoming
   Pu, Liyong
   Kong, Lianbao
TI Aging deteriorated liver Ischemia and reperfusion injury by suppressing
   Tribble's proteins 1 mediated macrophage polarization
SO BIOENGINEERED
LA English
DT Article
DE Liver ischemia; reperfusion injury; inflammation; macrophage; TRIB1;
   polarization
ID KUPFFER CELLS; ISCHEMIA/REPERFUSION INJURY; MECHANISM; GRAFTS; TRIB1;
   OLDER
AB Aggravated liver injury has been reported in aged ischemia/reperfusion-stressed livers; however, the mechanism of aged macrophage inflammatory regulation is not well understood. Here, we found that the adaptor protein TRIB1 plays a critical role in the differentiation of macrophages and the inflammatory response in the liver after ischemia/reperfusion injury. In the present study, we determined that aging promoted macrophage-mediated liver injury and that inflammation was mainly responsible for lower M2 polarization in liver transplantation-exposed humans post I/R. Young and aged mice were subjected to hepatic I/R modeling and showed that aging aggravated liver injury and suppressed macrophage TRIB1 protein expression and anti-inflammatory function in I/R-stressed livers. Restoration of TRIB1 is mediated by lentiviral infection-induced macrophage anti-inflammatory M2 polarization and alleviated hepatic I/R injury. Moreover, TRIB1 overexpression in macrophages facilitates M2 polarization and anti-inflammation by activating MEK1-ERK1/2 signaling under IL-4 stimulation. Taken together, our results demonstrated that aging promoted hepatic I/R injury by suppressing TRIB1-mediated MEK1-induced macrophage M2 polarization and anti-inflammatory function.
C1 [Chen, Qi; Ai, Xiaoming; Pu, Liyong; Kong, Lianbao] Nanjing Med Univ, Hepatobiliary Ctr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.
   [Chen, Qi] Nanjing Med Univ, Sir Run Run Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.
   [Song, Yating; Yang, Ningli] Nanjing Med Univ, Dept Bariatr & Metab Surg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.
   [Kong, Lianbao] Nanjing Med Univ, Hepatobiliary Ctr, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University; Nanjing Medical
   University; Nanjing Medical University
RP Kong, LB (corresponding author), Nanjing Med Univ, Hepatobiliary Ctr, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.
EM lianbaokong_njmu@163.com
FU National Natural Science Foundation of China [81871260]; Science and
   Technology Development Foundation of Nanjing Medical University
   [2020326]
FX This study was supported by the National Natural Science Foundation of
   China #1 under grant [number 81871260], Science and Technology
   Development Foundation of Nanjing Medical University #2 under grant
   [number 2020326] [].
CR Arndt L, 2018, J BIOL CHEM, V293, P11527, DOI 10.1074/jbc.RA117.000703
   Bhogal RH, 2011, LIVER TRANSPLANT, V17, P95, DOI 10.1002/lt.22205
   Cheng MX, 2019, TRANSPL IMMUNOL, V54, P59, DOI 10.1016/j.trim.2019.02.004
   Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002
   Haugen CE, 2019, JAMA SURG, V154, P441, DOI 10.1001/jamasurg.2018.5568
   He LZ, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109955
   Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010
   Jadhav KS, 2019, ARTERIOSCL THROM VAS, V39, P998, DOI 10.1161/ATVBAHA.118.311573
   Jiang T, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105711
   Jung KW, 2020, ANN SURG, V271, P646, DOI 10.1097/SLA.0000000000003498
   Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7
   Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999
   Kapoor N, 2015, J IMMUNOL, V194, P6011, DOI 10.4049/jimmunol.1402797
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Lee LY, 2011, LIVER TRANSPLANT, V17, P1457, DOI 10.1002/lt.22415
   Li XF, 2017, BIOMED PHARMACOTHER, V89, P1392, DOI 10.1016/j.biopha.2017.03.022
   Li YK, 2017, TRANSPLANTATION, V101, P1600, DOI 10.1097/TP.0000000000001765
   Liu Z, 2022, REDOX BIOL, V52, DOI 10.1016/j.redox.2022.102305
   Liu ZZ., 2019, CELL SIGNAL, V59, P1873
   Lu L, 2016, TRANSPLANTATION, V100, P2601, DOI 10.1097/TP.0000000000001411
   Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2
   Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3
   Miyajima C, 2015, BIOL PHARM BULL, V38, P618, DOI 10.1248/bpb.b15-00003
   Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339
   Ohkura T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00017
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Park Y, 2007, J SURG RES, V137, P96, DOI 10.1016/j.jss.2006.08.013
   Qiu Z, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9743280
   Raptis DA, 2014, J HEPATOL, V60, P625, DOI 10.1016/j.jhep.2013.11.006
   Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930
   Selzner M, 2009, LIVER TRANSPLANT, V15, P1594, DOI 10.1002/lt.21864
   Shi Y, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.609060
   Sun K, 2012, AM J SURG, V204, P389, DOI 10.1016/j.amjsurg.2011.10.020
   Sun Y, 2019, APMIS, V127, P468, DOI 10.1111/apm.12944
   Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200
   VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83
   Wan PX, 2020, CELL DEATH DIFFER, V27, P176, DOI 10.1038/s41418-019-0351-4
   Wang Q, 2022, J HEPATOL, V77, P312, DOI 10.1016/j.jhep.2022.02.031
   Wang ZL, 2019, TRENDS IMMUNOL, V40, P825, DOI 10.1016/j.it.2019.07.002
   Ai XM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.582347
   Xie XC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00473
   Yang FJ, 2018, FREE RADICAL BIO MED, V124, P395, DOI 10.1016/j.freeradbiomed.2018.06.043
   Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264
   Zhong WZ, 2020, AGING CELL, V19, DOI 10.1111/acel.13186
   Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004
   Zhou HM, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106580
   Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036
NR 49
TC 0
Z9 0
U1 3
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2165-5979
EI 2165-5987
J9 BIOENGINEERED
JI Bioengineered
PD JUN 1
PY 2022
VL 13
IS 6
BP 14519
EP 14533
DI 10.1080/21655979.2022.2090218
PG 15
WC Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology
GA 8D6FI
UT WOS:000918386200001
PM 36694470
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Marongiu, F
   Serra, MP
   Doratiotto, S
   Sini, M
   Fanti, M
   Cadoni, E
   Serra, M
   Laconi, E
AF Marongiu, Fabio
   Serra, Maria Paola
   Doratiotto, Silvia
   Sini, Marcella
   Fanti, Maura
   Cadoni, Erika
   Serra, Monica
   Laconi, Ezio
TI Aging promotes neoplastic disease through effects on the tissue
   microenvironment
SO AGING-US
LA English
DT Article
DE aging; microenvironment; selection; pre-neoplastic hepatocytes; liver
   carcinogenesis
ID LIVER EPITHELIAL-CELLS; HEMATOPOIETIC STEM; CANCER; SENESCENCE;
   TRANSPLANTATION; PATHWAYS; PROTEIN; OBESITY; IMPACT; REPAIR
AB A better understanding of the complex relationship between aging and cancer will provide important tools for the prevention and treatment of neoplasia. In these studies, the hypothesis was tested that aging may fuel carcinogenesis via alterations imposed in the tissue microenvironment. Preneoplastic hepatocytes isolated from liver nodules were orthotopically injected into either young or old syngeneic rats and their fate was followed over time using the dipeptidyl-peptidase type IV (DPPIV) system to track donor-derived-cells. At 3 months post-Tx, the mean size of donor-derived clusters was 11 +/- 3 cells in young vs. 42 +/- 8 in old recipients. At 8 months post-Tx, no visible lesion were detected in any of 21 young recipients, while 17/18 animals transplanted at old age displayed hepatic nodules, including 7 large tumors. All tumors expressed the DPPIV marker enzyme, indicating that they originated from transplanted cells. Expression of senescence-associated beta-galactosidase was common in liver of 18-month old animals, while it was a rare finding in young controls. Finally, both mRNA and IL6 protein were found to be increased in the liver of aged rats compared to young controls. These results are interpreted to indicate that the microenvironment of the aged liver promotes the growth of pre-neoplastic hepatocytes.
C1 [Marongiu, Fabio; Serra, Maria Paola; Doratiotto, Silvia; Sini, Marcella; Fanti, Maura; Cadoni, Erika; Serra, Monica; Laconi, Ezio] Univ Cagliari, Dept Biomed Sci, Unit Expt Med, I-09124 Cagliari, Italy.
C3 University of Cagliari
RP Laconi, E (corresponding author), Univ Cagliari, Dept Biomed Sci, Unit Expt Med, I-09124 Cagliari, Italy.
EM elaconi@unica.it
RI Marongiu, Fabio/E-6294-2016
OI Marongiu, Fabio/0000-0001-5860-4227; Fanti, Maura/0000-0002-8627-666X;
   Serra, Monica/0000-0001-8434-9522
FU AIRC (Italian Association for Cancer Research) [IG 10604]; Sardinian
   Regional Government (RAS)
FX This work was supported by AIRC (Italian Association for Cancer
   Research, grant No. IG 10604) and by Sardinian Regional Government
   (RAS).
CR BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013
   Biswas S, 2015, J PATHOL, V237, P135, DOI 10.1002/path.4563
   Blagosklonny MV, 2008, CANCER BIOL THER, V7, P1520, DOI 10.4161/cbt.7.10.6663
   Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002
   Cantor DJ, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.969167
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337
   Gil J, 2016, CURR BIOL, V26, pR164, DOI 10.1016/j.cub.2016.01.006
   Hakim FT, 2004, CURR OPIN IMMUNOL, V16, P151, DOI 10.1016/j.coi.2004.01.009
   Henry CJ, 2015, J CLIN INVEST, V125, P4666, DOI 10.1172/JCI83024
   Henry CJ, 2011, AGING-US, V3, P643, DOI 10.18632/aging.100351
   Henry CJ, 2010, P NATL ACAD SCI USA, V107, P21713, DOI 10.1073/pnas.1005486107
   Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Laconi E, 2000, Lancet Oncol, V1, P235, DOI 10.1016/S1470-2045(00)00154-6
   Laconi E, 2007, BIOESSAYS, V29, P738, DOI 10.1002/bies.20606
   Laconi S, 2001, P NATL ACAD SCI USA, V98, P7806, DOI 10.1073/pnas.131210498
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lutz CT, 2012, AGING-US, V4, P535, DOI 10.18632/aging.100482
   Mantovani A, 2010, ANN MED, V42, P161, DOI 10.3109/07853890903405753
   Marongiu F, 2014, AGING-US, V6, P26, DOI 10.18632/aging.100631
   Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082
   MCCULLOUGH KD, 1994, CANCER RES, V54, P3668
   McCullough KD, 1997, CANCER RES, V57, P1807
   Merino MM, 2016, TRENDS CELL BIOL, V26, P776, DOI 10.1016/j.tcb.2016.05.009
   MILLER DG, 1980, CANCER, V46, P1307, DOI 10.1002/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6
   Nicolai S, 2015, AGING-US, V7, P1050, DOI 10.18632/aging.100858
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036
   SEMPLEROBERTS E, 1987, INT J CANCER, V40, P643, DOI 10.1002/ijc.2910400512
   Serra MP, 2015, J HEPATOL, V62, P1341, DOI 10.1016/j.jhep.2015.01.015
   Shackel NA, 2014, HEPATOLOGY, V59, P2413, DOI 10.1002/hep.26932
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SOLT DB, 1983, CANCER RES, V43, P188
   Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132
   THOMPSON NL, 1991, BIOCHEM J, V273, P497, DOI 10.1042/bj2730497
   Vas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031523
   Wong C, 2013, CURR OPIN IMMUNOL, V25, P535, DOI 10.1016/j.coi.2013.05.016
   Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200
   Zhang HL, 2016, TRENDS MOL MED, V22, P671, DOI 10.1016/j.molmed.2016.06.001
NR 43
TC 19
Z9 21
U1 1
U2 3
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC
PY 2016
VL 8
IS 12
BP 3390
EP 3399
DI 10.18632/aging.101128
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EI5IP
UT WOS:000392527800020
PM 27929382
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Jeong, DH
   Hwang, M
   Park, JK
   Goo, MJ
   Hong, IH
   Ki, MR
   Ishigami, A
   Kim, AY
   Lee, EM
   Lee, EJ
   Jeong, KS
AF Jeong, Da-Hee
   Hwang, Meeyul
   Park, Jin-Kyu
   Goo, Moon-Jung
   Hong, Il-Hwa
   Ki, Mi-Ran
   Ishigami, Akihito
   Kim, Ah-Young
   Lee, Eun-Mi
   Lee, Eun-Joo
   Jeong, Kyu-Shik
TI <i>Smad3</i> Deficiency Ameliorates Hepatic Fibrogenesis through the
   Expression of Senescence Marker Protein-30, an Antioxidant-Related
   Protein
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE liver fibrosis; Smad3; SMP-30; antioxidant
ID RAT-LIVER; MICE; DISEASE; SMP30; BETA
AB Smad3 is a key mediator of the transforming growth factor (TGF)-1 signaling pathway that plays central role in inflammation and fibrosis. In present study, we evaluated the effect of Smad3 deficiency in Smad3(-/-) mice with carbon tetrachloride (CCl4)-induced liver fibrosis. The animals were received CCl4 or olive oil three times a week for 4 weeks. Histopathological analyses were performed to evaluate the fibrosis development in the mice. Alteration of protein expression controlled by Smad3 was examined using a proteomic analysis. CCl4-induced liver fibrosis was rarely detected in Smad3(-/-) mice compared to Smad3(+/+). Proteomic analysis revealed that proteins related to antioxidant activities such as senescence marker protein-30 (SMP30), selenium-binding proteins (SP56) and glutathione S-transferases (GSTs) were up-regulated in Smad3(-/-) mice. Western blot analysis confirmed that SMP30 protein expression was increased in Smad3(-/-) mice. And SMP30 levels were decreased in CCl4-treated Smad3(+/+) and Smad3(-/-) mice. These results indicate that Smad3 deficiency influences the proteins level related to antioxidant activities during early liver fibrosis. Thus, we suggest that Smad3 deteriorate hepatic injury by inhibitor of antioxidant proteins as well as mediator of TGF-1 signaling.
C1 [Jeong, Da-Hee; Hwang, Meeyul; Park, Jin-Kyu; Goo, Moon-Jung; Hong, Il-Hwa; Ki, Mi-Ran; Kim, Ah-Young; Lee, Eun-Mi; Lee, Eun-Joo; Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
   [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
C3 Kyungpook National University; Tokyo Metropolitan Institute of
   Gerontology
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
EM daheej.kr@gmail.com; meeyulh@gmail.com; 820jinkyu@hanmail.net;
   goomoonj@hotmail.com; ihhong@gnu.ac.kr; mrgee@hanmail.net;
   ishigami@phar.toho-u.ac.jp; pretersensual@hanmail.net;
   nikeun@hanmail.net; miffy525@hanmail.net; jeongks@knu.ac.kr
OI Ishigami, Akihito/0000-0001-7875-7482
FU Bio-industry Technology Development Program of iPET (Korea Institute of
   Planning and Evaluation for Technology in Food, Agriculture, Forestry
   and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries,
   Korea [312062-5]
FX This research was supported by the Bio-industry Technology Development
   Program (312062-5) of iPET (Korea Institute of Planning and Evaluation
   for Technology in Food, Agriculture, Forestry and Fisheries), Ministry
   for Food, Agriculture, Forestry and Fisheries, Korea.
CR Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1
   Fountoulakis M, 2002, TOXICOL APPL PHARM, V183, P71, DOI 10.1006/taap.2002.9460
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Görg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V
   Han G., 2011, CELL BIOSCI, V28, P1
   Haschek W. M., 2002, HDB TOXICOLOGIC PATH, P72
   Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011
   Low TY, 2004, PROTEOMICS, V4, P3960, DOI 10.1002/pmic.200400852
   Matsuzaki K, 2012, CELL TISSUE RES, V347, P225, DOI 10.1007/s00441-011-1178-6
   Megiorni F, 2013, J CYST FIBROS, DOI S1569-1993(13) 00043-X
   Mendler MH, 2005, LIVER INT, V25, P294, DOI 10.1111/j.1478-3231.2005.01052.x
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Stramer BM, 2005, J CELL PHYSIOL, V203, P226, DOI 10.1002/jcp.20215
   Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280
NR 20
TC 7
Z9 11
U1 0
U2 19
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2013
VL 14
IS 12
BP 23700
EP 23710
DI 10.3390/ijms141223700
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 296XX
UT WOS:000330219800034
PM 24304543
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Mansouri, A
   Gaou, I
   Fromenty, B
   Berson, A
   Letteron, P
   Degott, C
   Erlinger, S
   Pessayre, D
AF Mansouri, A
   Gaou, I
   Fromenty, B
   Berson, A
   Letteron, P
   Degott, C
   Erlinger, S
   Pessayre, D
TI Premature oxidative aging of hepatic mitochondrial DNA in Wilson's
   disease
SO GASTROENTEROLOGY
LA English
DT Article
ID RAT-LIVER MITOCHONDRIA; DEGENERATIVE DISEASES; COPPER; HEMOCHROMATOSIS;
   DELETION; MUTATIONS; SPECTRUM; ETHANOL; CELLS
AB Background & Aims: Aging is associated with and may be caused by acquired somatic mutations of the mitochondrial genome, In Wilson's disease, inherited mutations of a nuclear gene encoding a copper transporter cause accumulation of copper in the liver, particularly within mitochondria, Because copper has prooxidant properties and the mitochondrial genome is particularly susceptible to oxidative damage, we hypothesized that Wilson's disease may cause premature oxidative aging of mitochondrial DNA. Methods: Hepatic DNA was screened for large mitochondrial DNA deletion(s) in 16 patients with Wilson's disease and 67 control subjects, Deleted mitochondrial DNA copies were amplified by polymerase chain reaction and were sequenced, Results: Although 15 of the 16 patients with Wilson's disease were 30 years old or younger, 8 of them (50%), including the 6 patients with cirrhosis (100%), had diverse mitochondrial DNA deletions, whereas only 2 controls (3%), aged 39 and 45 years, showed a mitochondrial DNA deletion, Conclusions: Wilson's disease is associated with frequent, diverse, and early deletions of mitochondrial DNA. Accumulation of prooxidant copper within hepatic mitochondria may cause this premature oxidative aging of mitochondrial DNA, Thus, inherited mutations of a nuclear gene may cause somatic mutations of the mitochondrial genome in this condition.
C1 HOP BEAUJON,INSERM,U24,F-92118 CLICHY,FRANCE.
   HOP BEAUJON,ASSOC CLAUDE BERNARD,CTR RECH PHYSIOPATHOL HEPAT,CLICHY,FRANCE.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Beaujon - APHP; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP
RI Abdellah, Mansouri/B-3002-2017; Fromenty, Bernard/E-5052-2016; Fromenty,
   Bernard/Y-8621-2019
OI Abdellah, Mansouri/0000-0003-3856-5771; Fromenty,
   Bernard/0000-0003-2994-5465; 
CR ALI M, 1993, Q J MED, V86, P25
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
   CARMICHAEL PL, 1992, CARCINOGENESIS, V13, P1127, DOI 10.1093/carcin/13.7.1127
   CARMICHAEL PL, 1995, MUTAT RES-FUND MOL M, V326, P235, DOI 10.1016/0027-5107(94)00177-7
   CASADEMONT J, 1994, HUM MOL GENET, V3, P1945, DOI 10.1093/hmg/3.11.1945
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R
   FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6
   FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1
   GRABSKE RJ, 1967, J CELL BIOL, V35, pA48
   GREGORIA.G, 1967, CAN J BIOCHEM CELL B, V45, P1841, DOI 10.1139/o67-217
   GROSOVSKY AJ, 1988, P NATL ACAD SCI USA, V85, P185, DOI 10.1073/pnas.85.1.185
   KADIISKA MB, 1995, J CLIN INVEST, V96, P1653, DOI 10.1172/JCI118205
   KATSUMATA K, 1994, BIOCHEM BIOPH RES CO, V202, P102, DOI 10.1006/bbrc.1994.1899
   KUKIELKA E, 1994, ARCH BIOCHEM BIOPHYS, V309, P377, DOI 10.1006/abbi.1994.1127
   Lithgow GJ, 1996, SCIENCE, V273, P80, DOI 10.1126/science.273.5271.80
   MANSOURI A, IN PRESS J HEPATOL
   Nair J, 1996, CANCER RES, V56, P1267
   OKAWA S, 1996, BIOCHEMISTRY-US, V35, P4584
   POWELL LW, 1980, GASTROENTEROLOGY, V78, P374
   Scheinberg I. Herbert, 1996, American Journal of Clinical Nutrition, V63, p842S
   SCHON EA, 1996, CELLULAR AGING CELL, P19
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOKOL RJ, 1993, GASTROENTEROLOGY, V105, P178, DOI 10.1016/0016-5085(93)90024-7
   SOKOL RJ, 1994, GASTROENTEROLOGY, V107, P1788, DOI 10.1016/0016-5085(94)90822-2
   STERNLIEB I, 1980, GASTROENTEROLOGY, V78, P1615
   TANGERAS A, 1983, BIOCHIM BIOPHYS ACTA, V757, P59, DOI 10.1016/0304-4165(83)90152-6
   THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210
   TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401
   Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P859, DOI 10.1016/0891-5849(95)02184-1
   TRINH TQ, 1993, GENETICS, V134, P409
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WIELAND P, 1995, BIOCHEM BIOPH RES CO, V213, P815, DOI 10.1006/bbrc.1995.2202
   YAMAMOTO F, 1993, JPN J CANCER RES, V84, P508, DOI 10.1111/j.1349-7006.1993.tb00168.x
   ZABA BN, 1976, BIOCHEM J, V160, P707, DOI 10.1042/bj1600707
NR 38
TC 82
Z9 87
U1 0
U2 4
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD AUG
PY 1997
VL 113
IS 2
BP 599
EP 605
DI 10.1053/gast.1997.v113.pm9247482
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA XQ410
UT WOS:A1997XQ41000043
PM 9247482
OA Bronze
DA 2024-02-19
ER

PT J
AU Shi, Y
   Pizzini, J
   Wang, HZ
   Das, F
   Azees, PAA
   Choudhury, GG
   Barnes, JL
   Zang, MW
   Weintraub, ST
   Yeh, CK
   Katz, MS
   Kamat, A
AF Shi, Yun
   Pizzini, Jason
   Wang, Hanzhou
   Das, Falguni
   Azees, Parveez Ahamed Abdul
   Choudhury, Goutam Ghosh
   Barnes, Jeffrey L.
   Zang, Mengwei
   Weintraub, Susan T.
   Yeh, Chih-Ko
   Katz, Michael S.
   Kamat, Amrita
TI β<sub>2</sub>-Adrenergic receptor agonist induced hepatic steatosis in
   mice: modeling nonalcoholic fatty liver disease in hyperadrenergic
   states
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE aging; lipogenesis; liver; obesity; triglycerides
ID CATECHOLAMINE-INDUCED LIPOLYSIS; BETA-ADRENERGIC-RECEPTORS;
   INSULIN-RESISTANCE; ADIPOSE-TISSUE; LIPID DROPLETS; PHOSPHATIDATE
   PHOSPHOHYDROLASE; SUBCELLULAR-DISTRIBUTION; METABOLIC DYSFUNCTION;
   GENE-EXPRESSION; VLDL SECRETION
AB Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disorders ranging from hepatic steatosis [excessive accumulation of triglycerides (TG)] to nonalcoholic steatohepatitis, which can progress to cirrhosis and hepatocellular carcinoma. The molecular pathogenesis of steatosis and progression to more severe NAFLD remains unclear. Obesity and aging, two principal risk factors for NAFLD, are associated with a hyperadrenergic state. beta-Adrenergic responsiveness in liver increases in animal models of obesity and aging, and in both is linked to increased hepatic expression of beta(2)-adrenergic receptors (beta(2)-ARs). We previously showed that in aging rodents intracellular signaling from elevated hepatic levels of beta(2)-ARs may contribute to liver steatosis. In this study we demonstrate that injection of formoterol, a highly selective beta(2)-AR agonist, to mice acutely results in hepatic TG accumulation. Further, we have sought to define the intrahepatic mechanisms underlying beta(2)-AR mediated steatosis by investigating changes in hepatic expression and cellular localization of enzymes, transcription factors, and coactivators involved in processes of lipid accrual and disposition-and also functional aspects thereof-in livers of formoterol-treated animals. Our results suggest that beta(2)-AR activation by formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, increased but incomplete beta-oxidation of fatty acids with accumulation of potentially toxic long-chain acylcarnitine intermediates, and reduced TG secretion-all previously invoked as contributors to fatty liver disease. Experiments are ongoing to determine whether sustained activation of hepatic beta(2)-AR signaling by formoterol might be utilized to model fatty liver changes occurring in hyperadrenergic states of obesity and aging, and thereby identify novel molecular targets for the prevention or treatment of NAFLD.
   NEW & NOTEWORTHY Results of our study suggest that beta(2)-adrenergic receptor (beta(2)-AR) activation by agonist formoterol leads to increased hepatic TG synthesis and de novo lipogenesis, incomplete beta-oxidation of fatty acids with accumulation of long-chain acylcarnitine intermediates, and reduced TG secretion. These findings may, for the first time, implicate a role for beta(2)-AR responsive dysregulation of hepatic lipid metabolism in the pathogenetic processes underlying NAFLD in hyperadrenergic states such as obesity and aging.
C1 [Shi, Yun; Pizzini, Jason; Das, Falguni; Azees, Parveez Ahamed Abdul; Choudhury, Goutam Ghosh; Barnes, Jeffrey L.; Katz, Michael S.; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.
   [Wang, Hanzhou; Azees, Parveez Ahamed Abdul; Yeh, Chih-Ko] Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, San Antonio, TX 78229 USA.
   [Zang, Mengwei] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.
   [Weintraub, Susan T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA.
   [Zang, Mengwei; Yeh, Chih-Ko; Kamat, Amrita] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Choudhury, Goutam Ghosh; Zang, Mengwei; Yeh, Chih-Ko; Katz, Michael S.; Kamat, Amrita] South Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; University of
   Texas System; University of Texas Health Science Center at San Antonio;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital; Geriatric Research Education
   & Clinical Center
RP Kamat, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.; Kamat, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.; Kamat, A (corresponding author), South Texas Vet Hlth Care Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.
EM Amrita.Kamat@va.gov
FU Department of Veterans Affairs Biomedical Laboratory Research and
   Development Service Merit Review Awards [1I01BX001744, 2I01 BX000926];
   National Center for Advancing Translational Sciences [UL1TR002645];
   National Institutes of Health [R21 AA026922, R01 DK100603, R01
   DK121527]; Department of Veterans Affairs Biomedical Laboratory Research
   and Development Service [IK6BX00361]; UTHSCSA; NIH [1S10RR03158601]
FX This work was partially supported by Department of Veterans Affairs
   Biomedical Laboratory Research and Development Service Merit Review
   Awards (1I01BX001744 to A.K.; 2I01 BX000926 to G.G-C.), Translation
   Technology Resources pilot award to A.K. (Award Number UL1TR002645 from
   the National Center for Advancing Translational Sciences), and by the
   National Institutes of Health Grants R21 AA026922, R01 DK100603, and R01
   DK121527 to M.Z. G.G-C. is also a recipient of Research Career Scientist
   Award IK6BX00361 from the Department of Veterans Affairs Biomedical
   Laboratory Research and Development Service. Mass spectrometry analyses
   were conducted in the University of Texas Health Science Center at San
   Antonio (UTHSCSA) Institutional Mass Spectrometry Laboratory, supported
   in part by UTHSCSA and by NIH grant 1S10RR03158601 (to S.T.W.) for
   purchase of the mass spectrometer. The technical assistance of Xiaoli
   Gao is gratefully acknowledged.
CR Ahmed M, 2015, WORLD J HEPATOL, V7, P1450, DOI 10.4254/wjh.v7.i11.1450
   Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012
   Arner P, 1999, INT J OBESITY, V23, P10, DOI 10.1038/sj.ijo.0800789
   Baidal JAW, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8390
   BEGINHEICK N, 1994, AM J PHYSIOL, V266, pC1664, DOI 10.1152/ajpcell.1994.266.6.C1664
   BJORNSSON OG, 1994, EUR J CLIN INVEST, V24, P137, DOI 10.1111/j.1365-2362.1994.tb00979.x
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x
   BUTTERWITH SC, 1984, BIOCHEM J, V222, P487, DOI 10.1042/bj2220487
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527
   Chen DT, 2012, ANN SURG ONCOL, V19, P3556, DOI 10.1245/s10434-012-2396-1
   Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538
   Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Das F, 2019, J BIOL CHEM, V294, P9440, DOI 10.1074/jbc.RA118.007023
   DEIBERT DC, 1980, J CLIN INVEST, V65, P717, DOI 10.1172/JCI109718
   DiStefano MT, 2015, J BIOL CHEM, V290, P15175, DOI 10.1074/jbc.M115.650184
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Enns LC, 2009, J GERONTOL A-BIOL, V64, P1221, DOI 10.1093/gerona/glp133
   Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Frühbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X
   Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069
   Grefhorst A, 2005, AM J PHYSIOL-GASTR L, V289, pG592, DOI 10.1152/ajpgi.00063.2005
   GREGERMAN RI, 1994, J GERONTOL, V49, pB135, DOI 10.1093/geronj/49.4.B135
   Gross DA, 2014, CRIT REV BIOCHEM MOL, V49, P304, DOI 10.3109/10409238.2014.931337
   Hall AM, 2010, J LIPID RES, V51, P554, DOI 10.1194/jlr.M000976
   Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200
   Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006
   Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199
   Heijboer AC, 2005, J LIPID RES, V46, P582, DOI 10.1194/jlr.M400440-JLR200
   Higashida K, 2008, BIOCHEM BIOPH RES CO, V374, P587, DOI 10.1016/j.bbrc.2008.07.079
   Hurr C, 2019, J PHYSIOL-LONDON, V597, P4565, DOI 10.1113/JP277994
   Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510
   Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659
   Kalinovich A, 2020, DIABETOLOGIA, V63, P1603, DOI 10.1007/s00125-020-05171-y
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KAWAI Y, 1986, J CLIN ENDOCR METAB, V62, P827, DOI 10.1210/jcem-62-5-827
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200
   Kohjima M, 2007, INT J MOL MED, V20, P351
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001
   Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9
   Lee P, 2013, INT J OBESITY, V37, P593, DOI 10.1038/ijo.2012.90
   London E, 2014, ENDOCRINOLOGY, V155, P3397, DOI 10.1210/en.2014-1122
   LONNQVIST F, 1990, J CLIN INVEST, V85, P1614, DOI 10.1172/JCI114612
   Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200
   Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839
   Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466
   Muscogiuri G, 2011, ENDOCR RES, V36, P74, DOI 10.3109/07435800.2010.539993
   Patterson RE, 2016, AM J PHYSIOL-ENDOC M, V310, pE484, DOI 10.1152/ajpendo.00492.2015
   Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202
   Peng KY, 2018, J LIPID RES, V59, P1977, DOI 10.1194/jlr.M085613
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Rasouli M, 2006, EUR J PHARMACOL, V545, P109, DOI 10.1016/j.ejphar.2006.06.066
   REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015
   Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   Ryall JG, 2006, BRIT J PHARMACOL, V147, P587, DOI 10.1038/sj.bjp.0706669
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382
   Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466
   Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276
   Shi Y, 2018, AM J PHYSIOL-REG I, V314, pR574, DOI 10.1152/ajpregu.00372.2017
   Shi Y, 2016, EXP GERONTOL, V78, P32, DOI 10.1016/j.exger.2016.03.005
   Simon J, 2020, CELL METAB, V31, P605, DOI 10.1016/j.cmet.2020.01.013
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   TAYLOR SJ, 1986, BIOCHEM J, V239, P275, DOI 10.1042/bj2390275
   Thorp AA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/341583
   Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587
   Wu FQ, 2016, J HEPATOL, V65, P314, DOI 10.1016/j.jhep.2016.04.019
   Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489
   Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655
NR 81
TC 11
Z9 11
U1 1
U2 6
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JUL
PY 2021
VL 321
IS 1
BP E90
EP E104
DI 10.1152/ajpendo.00651.2020
PG 15
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA UX3UT
UT WOS:000700769100002
PM 34029162
OA Green Published
DA 2024-02-19
ER

PT J
AU Park, JK
   Ki, MR
   Lee, HR
   Hong, IH
   Ji, AR
   Ishigami, A
   Park, SI
   Kim, JM
   Chung, HY
   Yoo, SE
   Jeong, KS
AF Park, Jin-Kyu
   Ki, Mi-Ran
   Lee, Hye-Rim
   Hong, Il-Hwa
   Ji, Ae-Ri
   Ishigami, Akihito
   Park, Se-Il
   Kim, Ji-Min
   Chung, Hae-Young
   Yoo, Sung-Eun
   Jeong, Kyu-Shik
TI Vitamin C Deficiency Attenuates Liver Fibrosis by Way of Up-regulated
   Peroxisome Proliferator-Activated Receptor-gamma Expression in
   Senescence Marker Protein 30 Knockout Mice
SO HEPATOLOGY
LA English
DT Article
ID HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; NECROSIS-FACTOR-ALPHA;
   PPAR-GAMMA; OXIDATIVE STRESS; TGF-BETA; INDUCED APOPTOSIS; SMP30
   DEFICIENCY; RAT-LIVER; LIFE-SPAN
AB Senescence marker protein 30 (SMP30), an important aging marker molecule that is highly expressed in the liver, has been known to protect hepatocytes from apoptosis by the synthesis of vitamin C. To explore the function of SMP30 in liver fibrosis, the effect of SMP30 deficiency on liver fibrosis was investigated in SMP30 knockout (KO) mice. Moreover, the in vivo results were further confirmed by way of hepatic stellate cell (HSC) isolation. We demonstrated that carbon tetrachloride (CCl(4)) -induced liver fibrosis and the nuclear translocation of p-Smad2/3, the immediate downstream of transforming growth factor beta (TGF-beta), were significantly inhibited in the liver of SMP30 KO mice compared with wild-type (WT) mice. We also confirmed that both WT and SMP30 KO HSCs did not express SMP30. Finally, we further confirmed that up-regulation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) caused by a lack of vitamin C was the pivotal factor in the mechanisms for attenuated liver fibrosis of SMP30 KO mice, and feeding with vitamin C restored CCl(4)-induced liver fibrosis in SMP30 KO mice. Conclusion: Vitamin C deficiency by SMP30 depletion attenuated liver fibrosis by way of up-regulated PPAR-gamma expression in SMP30 KO mice. Our results provide, for the first time, the possible mechanisms underlying inhibition of HSC activation associated with vitamin C and PPAR-gamma up-regulation in liver fibrosis of SMP30 KO mice. (HEPATOLOGY 2010;51:1766-1777.)
C1 [Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
   [Ishigami, Akihito] Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
   [Kim, Ji-Min; Chung, Hae-Young] Pusan Natl Univ, Coll Pharm, Dept Pharm, Pusan, South Korea.
   [Yoo, Sung-Eun] Korea Res Inst Chem Technol, Taejon 305606, South Korea.
C3 Kyungpook National University; Toho University; Pusan National
   University; Korea Research Institute of Chemical Technology (KRICT)
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
EM jeongks@knu.ac.kr
RI Jeong, Kyu-Shik/D-6740-2011
OI Ishigami, Akihito/0000-0001-7875-7482; Park, seil/0000-0002-4949-8976
FU Health & Korea Health Industry Development Institute in Republic of
   Korea [A081039]; Grants-in-Aid for Scientific Research [21590974]
   Funding Source: KAKEN
FX This work was supported by a grant (A081039)from Health & Medical
   Technology R&D program, Health & Korea Health Industry Development
   Institute in Republic of Korea.
CR Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807
   Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374
   Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912
   Dooley S, 2001, FEBS LETT, V502, P4, DOI 10.1016/S0014-5793(01)02656-4
   Ferguson HE, 2009, AM J RESP CELL MOL, V41, P722, DOI 10.1165/rcmb.2009-0006OC
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Gan Q, 2008, J CELL SCI, V121, P2235, DOI 10.1242/jcs.026633
   Gao Bin, 2007, Expert Rev Gastroenterol Hepatol, V1, P173, DOI 10.1586/17474124.1.1.173
   Ghosh AK, 2009, FASEB J, V23, P2968, DOI 10.1096/fj.08-128736
   Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050
   Guo JS, 2007, SEMIN LIVER DIS, V27, P413, DOI 10.1055/s-2007-991517
   Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200
   Henneberger C, 2000, J NEUROSCI METH, V100, P123, DOI 10.1016/S0165-0270(00)00241-7
   Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Jeong DH, 2008, J RADIAT RES, V49, P653, DOI 10.1269/jrr.08042
   Jeong WI, 2004, LIVER INT, V24, P658, DOI 10.1111/j.1478-3231.2004.0961.x
   Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184
   Kaul D, 2005, EUR J CLIN NUTR, V59, P978, DOI 10.1038/sj.ejcn.1602203
   Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104
   Kim JY, 2009, AGE, V31, P127, DOI 10.1007/s11357-009-9089-0
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257
   Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x
   Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200
   Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365
   Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3
   Park JK, 2008, TOXICOLOGY, V246, P132, DOI 10.1016/j.tox.2008.01.006
   Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7
   Saika S, 2007, AM J PHYSIOL-CELL PH, V293, pC75, DOI 10.1152/ajpcell.00332.2006
   Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Sung BY, 2006, EXP GERONTOL, V41, P590, DOI 10.1016/j.exger.2006.04.005
   Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003
   Yang L, 2006, AM J PHYSIOL-GASTR L, V291, pG902, DOI 10.1152/ajpgi.00124.2006
   Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069
NR 46
TC 42
Z9 46
U1 3
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD MAY
PY 2010
VL 51
IS 5
BP 1766
EP 1777
DI 10.1002/hep.23499
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 590XJ
UT WOS:000277261400034
PM 20162732
DA 2024-02-19
ER

PT J
AU Stahl, EC
   Delgado, ER
   Alencastro, F
   LoPresti, ST
   Wilkinson, PD
   Roy, N
   Haschak, MJ
   Skillen, CD
   Monga, SP
   Duncan, AW
   Brown, BN
AF Stahl, Elizabeth C.
   Delgado, Evan R.
   Alencastro, Frances
   LoPresti, Samuel T.
   Wilkinson, Patrick D.
   Roy, Nairita
   Haschak, Martin J.
   Skillen, Clint D.
   Monga, Satdarshan P.
   Duncan, Andrew W.
   Brown, Bryan N.
TI Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is
   Influenced by CCR2
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID NONALCOHOLIC STEATOHEPATITIS; KUPFFER CELLS; OXIDATIVE STRESS; DISEASE;
   MACROPHAGES; RECRUITMENT; FIBROSIS; PROMOTES; TISSUE; HEPATOCYTES
AB Aging is associated with inflammation and metabolic syndrome, which manifests in the liver as nonalcoholic fatty liver disease (NAFLD). NAFLD can range in severity from steatosis to fibrotic steatohepatitis and is a major cause of hepatic morbidity. However, the pathogenesis of NAFLD in naturally aged animals is unclear. Herein, we performed a comprehensive study of lipid content and inflammatory signature of livers in 19-month-old aged female mice. These animals exhibited increased body and liver weight, hepatic triglycerides, and inflammatory gene expression compared with 3-month-old young controls. The aged mice also had a significant increase in F4/80(+) hepatic macrophages, which coexpressed CD11b, suggesting a circulating monocyte origin. A global knockout of the receptor for monocyte chemoattractant protein (CCR2) prevented excess steatosis and inflammation in aging livers but did not reduce the number of CD11b(+) macrophages, suggesting changes in macrophage accumulation precede or are independent from chemokine (C-C motif) ligand-CCR2 signaling in the development of age-related NAFLD. RNA sequencing further elucidated complex changes in inflammatory and metabolic gene expression in the aging liver. In conclusion, we report a previously unknown accumulation of CD11b(+) macrophages in aged livers with robust inflammatory and metabolic transcriptomic changes. A better understanding of the hallmarks of aging in the liver will be crucial in the development of preventive measures and treatments for end-stage liver disease in elderly patients.
C1 [Stahl, Elizabeth C.; Delgado, Evan R.; Alencastro, Frances; LoPresti, Samuel T.; Wilkinson, Patrick D.; Roy, Nairita; Haschak, Martin J.; Skillen, Clint D.; Monga, Satdarshan P.; Duncan, Andrew W.; Brown, Bryan N.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
   [LoPresti, Samuel T.; Haschak, Martin J.; Brown, Bryan N.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA.
   [Monga, Satdarshan P.; Duncan, Andrew W.; Brown, Bryan N.] Univ Pittsburgh, Pittsburgh Liver Res Ctr, Pittsburgh, PA USA.
   [Stahl, Elizabeth C.; Delgado, Evan R.; Alencastro, Frances; Wilkinson, Patrick D.; Roy, Nairita; Monga, Satdarshan P.; Duncan, Andrew W.; Brown, Bryan N.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA.
   [Stahl, Elizabeth C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.
   [LoPresti, Samuel T.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.
   [Wilkinson, Patrick D.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; University of California System; University of California
   Berkeley; Carnegie Mellon University; Harvard University; Brigham &
   Women's Hospital; Harvard Medical School
RP Brown, BN (corresponding author), Univ Pittsburgh, Pittsburgh Liver Res Ctr, McGowan Inst Regenerat Med, Dept Bioengn, 450 Technol Dr,Ste 300, Pittsburgh, PA 15219 USA.; Duncan, AW (corresponding author), Univ Pittsburgh, Pittsburgh Liver Res Ctr, McGowan Inst Regenerat Med, Dept Pathol, 450 Technol Dr,Ste 300, Pittsburgh, PA 15219 USA.
EM duncana@pitt.edu; brownb@upmc.edu
OI LoPresti, Samuel/0000-0002-9941-7935; Duncan,
   Andrew/0000-0003-4962-4191; Delgado, Evan/0000-0003-2706-0946;
   Wilkinson, Patrick/0000-0001-6643-8599
FU NIH [R01-AG055564, R01-DK103645, F31-DK112633, U24-DK059637,
   P30-DK020593]; Cellular Approaches to Tissue Engineering and
   Regeneration T32 training grant [T32-EB001026]; Pittsburgh Liver
   Research Center Pilot and Feasibility Award [P30-DK120531]
FX Supported by NIH grants R01-AG055564 (B.N.B.), R01-DK103645 (A.W.D.),
   F31-DK112633 (E.C.S.), U24-DK059637, and P30-DK020593; the Cellular
   Approaches to Tissue Engineering and Regeneration T32 training grant
   T32-EB001026 (E.C.S., S.T.L., and M.J.H.); the Pittsburgh Liver Research
   Center Pilot and Feasibility Award P30-DK120531 (B.N.B.).
CR Arner P, 2019, NAT MED, V25, P1385, DOI 10.1038/s41591-019-0565-5
   Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1
   Bieghs V, 2012, ATHEROSCLEROSIS, V220, P287, DOI 10.1016/j.atherosclerosis.2011.08.041
   Cameron Kerry M, 2012, Longev Healthspan, V1, P3, DOI 10.1186/2046-2395-1-3
   Chinenov Y, 2013, MOL CELL ENDOCRINOL, V380, P55, DOI 10.1016/j.mce.2013.04.006
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   Friedman S, 2016, CONTEMP CLIN TRIALS, V47, P356, DOI 10.1016/j.cct.2016.02.012
   Friedman SL, 2018, HEPATOLOGY, V67, P1754, DOI 10.1002/hep.29477
   Galastri S, 2012, CLIN SCI, V123, P459, DOI 10.1042/CS20110515
   González-Rodríguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173
   Ibrahim SH, 2018, GUT, V67, P963, DOI 10.1136/gutjnl-2017-315691
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008
   Kim SJ, 2019, HEPATOLOGY, V69, P1965, DOI 10.1002/hep.30525
   Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037
   Kumar A, 2013, J CLIN EXP HEPATOL, V3, P12, DOI 10.1016/j.jceh.2012.10.009
   Lanthier N, 2015, WORLD J HEPATOL, V7, P2184, DOI 10.4254/wjh.v7.i19.2184
   Li L, 2011, HEPATOLOGY, V54, P1620, DOI 10.1002/hep.24552
   Lim SY, 2016, ONCOTARGET, V7, P28697, DOI 10.18632/oncotarget.7376
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Mikolasevic I, 2018, WORLD J GASTROENTERO, V24, P1491, DOI 10.3748/wjg.v24.i14.1491
   Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Nakashima H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34466
   Norris CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096053
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   Palikaras K, 2017, J LIPID RES, V58, P72, DOI 10.1194/jlr.M069385
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179
   Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321
   Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952
   Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200
   Tacke F, 2017, J HEPATOL, V66, P1300, DOI 10.1016/j.jhep.2017.02.026
   Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025
   Takano M, 2012, J PERIODONTAL RES, V47, P89, DOI 10.1111/j.1600-0765.2011.01408.x
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919
   Turola E, 2015, DIS MODEL MECH, V8, P1037, DOI 10.1242/dmm.019950
   Valencia AP, 2016, EXP GERONTOL, V73, P14, DOI 10.1016/j.exger.2015.11.011
   Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039
   Yeung OWH, 2015, J HEPATOL, V62, P607, DOI 10.1016/j.jhep.2014.10.029
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhao L, 2013, HEPATOLOGY, V57, P829, DOI 10.1002/hep.26094
NR 55
TC 20
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD FEB
PY 2020
VL 190
IS 2
BP 372
EP 387
DI 10.1016/j.ajpath.2019.10.016
PG 16
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA KF7SB
UT WOS:000509437800009
PM 31843499
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Lv, J
   Hu, YM
   Li, LL
   He, Y
   Wang, JJ
   Guo, NN
   Fang, Y
   Chen, Q
   Cai, CG
   Tong, JJ
   Tang, LX
   Wang, ZH
AF Lv, Jian
   Hu, Yimeng
   Li, Lili
   He, Yuan
   Wang, Jingjing
   Guo, Ningning
   Fang, Yu
   Chen, Qin
   Cai, Cheguo
   Tong, Jingjing
   Tang, Lixu
   Wang, Zhihua
TI Targeting FABP4 in elderly mice rejuvenates liver metabolism and
   ameliorates aging-associated metabolic disorders
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article; Early Access
DE Aging; Metabolic disorders; FABP4; Senescence; Rejuvenation; Biomarkers
ID ACID-BINDING PROTEIN; YOUNG; BIOMARKER; GLUCOSE; RESTRICTION;
   SUPPRESSION; RESISTANCE; HEALTH; POTENT
AB Introduction: Aging is characterized by progressive metabolic dyshomeostasis that increases morbidity and mortality. Solutions for optimizing healthy aging are challenged by lacking appropriate biomarkers. Moreover, druggable targets to rejuvenate the aging-associated metabolic phenotypes remain unavailable. Methods: Proteomics analysis was performed in a cohort of young and elderly adults. Circulating levels of insulin -like growth factor 1 (IGF-1) and fatty acid binding protein 4 (FABP4) were evaluated by ELISA. FABP4 was silenced in elderly mice by adeno-associated virus. Metabolic activities were measured by metabolic cages. Cognitive function was evaluated by Morris water maze. Glucose and lipid metabolism were evaluated by biochemistry assays with blood samples. RNA-seq in mouse liver was performed for transcriptome analysis. Results: Among 9 aging-sensitive proteins shared by both male and female, FABP4 was identified as a reliable aging biomarker in both human and mouse. Silencing FABP4 in elderly mice significantly rejuvenated the aging -associated decline in metabolic activities. FABP4 knockdown reversed the aging-associated metabolic disorders by promoting degradation of cholesterol and fatty acids, while suppressing gluconeogenesis. Transcriptome analysis revealed a restoration of the pro-aging gene reprogramming towards inflammation and metabolic dis-orders in the liver after FABP4 knockdown. FABP4 overexpression promoted human LO2 cell senescence. Moreover, administration of an FABP4 inhibitor BMS309403 delivered metabolic benefits in elderly mice. Conclusion: Our findings demonstrate FABP4 as a reliable aging biomarker as well as a practicable target to improve healthy aging in the elderly.
C1 [Lv, Jian; Wang, Zhihua] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
   [Lv, Jian; Guo, Ningning; Fang, Yu; Wang, Zhihua] Chinese Acad Med Sci, Fuwai Hosp, Shenzhen Key Lab Cardiovasc Dis, Shenzhen 518057, Peoples R China.
   [Lv, Jian; Guo, Ningning; Fang, Yu; Wang, Zhihua] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing, Peoples R China.
   [Hu, Yimeng] Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Dept Endocrinol, Zhengzhou 450003, Henan, Peoples R China.
   [Hu, Yimeng] Wuhan Univ, Renmin Hosp, Dept Endocrinol, Wuhan 430060, Peoples R China.
   [Li, Lili; He, Yuan] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan 430060, Peoples R China.
   [Wang, Jingjing; Tang, Lixu] Wuhan Sports Univ, Sch Martial Arts, Wuhan 430079, Peoples R China.
   [Chen, Qin; Tong, Jingjing] Cent China Normal Univ, Sch Life Sci, Wuhan 430079, Peoples R China.
   [Cai, Cheguo] Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Key Lab Syst Hlth Sci Zhejiang Prov, Hangzhou 310024, Peoples R China.
   [Wang, Zhihua] Chinese Acad Med Sci, Fuwai Hosp, Shenzhen 518057, Peoples R China.
C3 Wuhan University; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking
   Union Medical College; Zhengzhou University; Wuhan University; Wuhan
   University; Wuhan Sports University; Central China Normal University;
   Chinese Academy of Sciences; University of Chinese Academy of Sciences,
   CAS; Chinese Academy of Medical Sciences - Peking Union Medical College;
   Fu Wai Hospital - CAMS
RP Hu, YM (corresponding author), Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Dept Endocrinol, Zhengzhou 450003, Henan, Peoples R China.; Tang, LX (corresponding author), Wuhan Sports Univ, Sch Martial Arts, Wuhan 430079, Peoples R China.; Tong, JJ (corresponding author), Cent China Normal Univ, Sch Life Sci, Wuhan 430079, Peoples R China.; Cai, CG (corresponding author), Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Life Sci, Key Lab Syst Hlth Sci Zhejiang Prov, Hangzhou 310024, Peoples R China.; Wang, ZH (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Shenzhen 518057, Peoples R China.
EM huyimeng1992@zzu.edu.cn; ccheguo@126.com; tongjj@mail.ccnu.edu.cn;
   tanglixu@126.com; wangzhihua@fuwaihospital.org
OI Lixu, Tang/0000-0002-8146-9999
FU National Natural Science Foundation of China [32170763, 81722007,
   82070231]; National Health Commission of China [2017ZX10304402001-008];
   National Key~Ramp;D Program of China [2022YFA1104500]; CAMS Innovation
   Fund for Medical Sciences [2022-I2M-1-007, 2022-I2M-2-001]; National
   High Level Hospital Clinical Research Funding of China [2022-GSP-GG-7];
   State Key Laboratory of Cardiovascular Disease of China [2022-ZD-03];
   Shenzhen Fundamental Research Program [ZDSYS20200923172000001]; Shenzhen
   Science and Technology Innovation Commission [RCJC20210706091947009];
   Guangdong Basic and Applied Basic Research Foundation [2022A1515012517]
FX This study was supported by funds from National Natural Science
   Foundation of China (32170763; 81722007; 82070231), National Health
   Commission of China (2017ZX10304402001-008), National Key & nbsp;R &
   amp;D Program of China (2022YFA1104500), CAMS Innovation Fund for
   Medical Sciences (2022-I2M-1-007; 2022-I2M-2-001), National High Level
   Hospital Clinical Research Funding of China (2022-GSP-GG-7), State Key
   Laboratory of Cardiovascular Disease of China (2022-ZD-03), Shenzhen
   Fundamental Research Program (ZDSYS20200923172000001), Shenzhen Science
   and Technology Innovation Commission (RCJC20210706091947009), and
   Guangdong Basic and Applied Basic Research Foundation (2022A1515012517).
CR Ader I, 2021, J FRALITY AGING, V10, P313, DOI 10.14283/jfa.2021.15
   Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a
   Baht GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8131
   Beard JR, 2016, GERONTOLOGIST, V56, pS163, DOI 10.1093/geront/gnw037
   Cai ZH, 2023, METABOLISM, V138, DOI 10.1016/j.metabol.2022.155328
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Catala R, 2013, SLEEP MED, V14, P38
   Chang L, 2017, J NEUROIMMUNOL, V311, P29, DOI 10.1016/j.jneuroim.2017.07.011
   Charles KN, 2017, CELL REP, V21, P393, DOI 10.1016/j.celrep.2017.09.051
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Deutz NEP, 2018, METABOLISM, V78, P167, DOI 10.1016/j.metabol.2017.09.015
   Dunston CR, 2012, PROTEOMICS, V12, P3147, DOI 10.1002/pmic.201100506
   Floresta G, 2022, EUR J MED CHEM, V240, DOI 10.1016/j.ejmech.2022.114604
   Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589
   Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844
   Furuhashi M, 2016, AM J CARDIOL, V118, P198, DOI 10.1016/j.amjcard.2016.04.037
   Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067
   Green S, 2021, HIST PHIL LIFE SCI, V43, DOI 10.1007/s40656-021-00367-w
   Griffiths HR, 2015, MECH AGEING DEV, V151, P114, DOI 10.1016/j.mad.2015.05.010
   Holm S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028785
   Honka MJ, 2016, J APPL PHYSIOL, V120, P633, DOI 10.1152/japplphysiol.00950.2015
   Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377
   Hu YM, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.602529
   Huang Q, 2018, J GERONTOL A-BIOL, V73, P421, DOI 10.1093/gerona/glx183
   Iram T, 2023, NATURE, V613, pE1, DOI 10.1038/s41586-022-05630-z
   Iram T, 2022, NATURE, V605, P509, DOI 10.1038/s41586-022-04722-0
   Johnson AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13048
   Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9
   Li LL, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02196-9
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Luo J, 2020, NAT REV MOL CELL BIO, V21, P225, DOI 10.1038/s41580-019-0190-7
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Palikaras K, 2017, J LIPID RES, V58, P72, DOI 10.1194/jlr.M069385
   Parkhitko AA, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101188
   Piskovatska V, 2020, ADV EXP MED BIOL, V1260, P319, DOI 10.1007/978-3-030-42667-5_13
   Prentice KJ, 2019, J LIPID RES, V60, P734, DOI [10.1194/jlr.S091793, 10.1194/jlr.s091793]
   Reiser H, 2015, ARTERIOSCL THROM VAS, V35, P1872, DOI 10.1161/ATVBAHA.115.305365
   Rizza W, 2014, AGEING RES REV, V13, P38, DOI 10.1016/j.arr.2013.11.002
   Rodríguez-Calvo R, 2019, METABOLISM, V96, P12, DOI 10.1016/j.metabol.2019.04.007
   Saraswat K, 2017, EXPERT OPIN DRUG DIS, V12, P955, DOI 10.1080/17460441.2017.1349750
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Shintani H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121821
   Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044
   Tanaka T, 2020, ELIFE, V9, DOI 10.7554/eLife.61073
   Tanaka T, 2018, AGING CELL, V17, DOI 10.1111/acel.12799
   Tang LX, 2021, J NUTR, V151, P2175, DOI 10.1093/jn/nxab123
   Todoric J, 2020, NAT METAB, V2, P1034, DOI 10.1038/s42255-020-0261-2
   Triggle CR, 2022, METABOLISM, V133, DOI 10.1016/j.metabol.2022.155223
   Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413
   Umbarawan Y, 2017, METABOLISM, V77, P47, DOI 10.1016/j.metabol.2017.09.003
   Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388
   van den Hoek AM, 2021, METABOLISM, V124, DOI 10.1016/j.metabol.2021.154873
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Walenna NF, 2020, J BIOL CHEM, V295, P2713, DOI 10.1074/jbc.RA119.010683
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
   Zong Z, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00537
NR 59
TC 0
Z9 0
U1 4
U2 10
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD 2023 MAY
PY 2023
VL 142
AR 155528
DI 10.1016/j.metabol.2023.155528
EA MAR 2023
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA M4DZ9
UT WOS:001029732300001
PM 36842611
DA 2024-02-19
ER

PT J
AU Saleh, DO
   Mansour, DF
   Hashad, IM
   Bakeer, RM
AF Saleh, Dalia O.
   Mansour, Dina F.
   Hashad, Ingy M.
   Bakeer, Rofanda M.
TI Effects of sulforaphane on D-galactose-induced liver aging in rats: Role
   of keap-1/nrf-2 pathway
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Aging; Sulforaphane; D-galactose; Nrf-2; Fibrosis; Rats
ID OXIDATIVE DAMAGE; BLOOD-FLOW; SHORT-TERM; INJURY; NRF2; AGE; INHIBITION;
   PROTECTS; ACID; ACTIVATION
AB Aging; a biological phenomenon characterized by progressive decline in cellular functions, is considered as a major risk factor of various liver diseases that plays as an adverse prognostic role, thus increasing mortality rate. However, diet is the main environmental factor that has a major impact on the aging process whereas; sulforaphane (SFN), an isothiocyanate organosulfur compound in cruciferous vegetables, has been reported with myriad biological effects. In the present study, SFN antiaging properties were evaluated on D-galactose (D-GaI)induced liver aging in rats. For this purpose, forty adult male Wistar rats were divided into five groups. All animals, except the normal control, were intraperitoneally injected with D-Gal (300 mg/kg/day for 5 days a week) for six consecutive weeks. In the hepatoprotective groups, animals received oral SFN (0.5, 1.0 and 2.0 mg/kg) for 6 weeks concurrently with D-GAL. SFN administration improved liver biomarkers through decreasing serum levels of AST, ALT, total and direct bilirubin when compared to D-Gal-aging group. SFN significantly increased hepatic GSH level as well as catalase and glutathione-S-transferase activities while counteracted the elevation in hepatic oxidative stress markers; MDA, NO and protein carbonyl in aged rats. SFN abrogated the dysregulation in hepatic Keap-1, Nrf-2 and HO-land limited the elevation of TNF-alpha and TGF-beta concentrations in aging liver. Histopathologically, SFN decreased the intensity of hepatic fibrous proliferation in D-Gal-induced aging. In conclusion, SFN has shown hepatic anti-aging potential through promoting the antioxidant machinery via regulating Keap-1, Nrf-2 and HO-1 and antioxidant enzyme activities as well as ameliorating oxidative stress, hampering the inflammatory cytokines; TNF-alpha and TGF-beta, and limiting hepatic fibrosis in a dose dependent manner.
C1 [Saleh, Dalia O.; Mansour, Dina F.] Natl Res Ctr, Dept Pharmacol, Med Res Div, 33 EL Bohouth St,EL Tahrir St,PO 12622, Giza, Egypt.
   [Mansour, Dina F.] Ahram Canadian Univ, Fac Pharm, Dept Clin Pharm & Pharm Practice, Giza Governorate, Egypt.
   [Hashad, Ingy M.] German Univ Cairo, Fac Pharm & Biotechnol, Clin Biochem Unit, Cairo, Egypt.
   [Bakeer, Rofanda M.] Helwan Univ, Fac Med, Dept Pathol, Helwan, Egypt.
   [Bakeer, Rofanda M.] October Univ Modern Sci & Arts MSA Univ, Pathol, Cairo, Egypt.
C3 Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian
   Knowledge Bank (EKB); German University in Cairo; Egyptian Knowledge
   Bank (EKB); Helwan University; Egyptian Knowledge Bank (EKB); Modern
   Sciences & Arts University (MSA)
RP Saleh, DO (corresponding author), Natl Res Ctr, Dept Pharmacol, Med Res Div, 33 EL Bohouth St,EL Tahrir St,PO 12622, Giza, Egypt.
EM do.saleh@nrc.eg
RI Bakeer, Rofanda/AAY-9280-2020
OI Bakeer, Rofanda/0000-0001-8202-2999; Mansour, Dina/0000-0002-5656-2462
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Amjad Ali I, 2015, Curr Pharmacol Rep, V1, P382
   Andrews GR, 2002, EXP GERONTOL, V37, P1303, DOI 10.1016/S0531-5565(02)00097-9
   Aruoma OI, 2002, NAHRUNG, V46, P381, DOI 10.1002/1521-3803(20021101)46:6<381::AID-FOOD381>3.0.CO;2-T
   Astegiano M, 2004, Eur Rev Med Pharmacol Sci, V8, P3
   Aydin AF, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12939
   Aydin S, 2018, JCPSP-J COLL PHYSICI, V28, P501, DOI 10.29271/jcpsp.2018.07.501
   Baek SH, 2008, BIOSCI BIOTECH BIOCH, V72, P1176, DOI 10.1271/bbb.70545
   Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5
   Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Bloomer SA, 2009, J GERONTOL A-BIOL, V64, P419, DOI 10.1093/gerona/gln056
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Boland BS, 2014, J CLIN EXP HEPATOL, V4, P1, DOI 10.1016/j.jceh.2014.01.003
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007
   Clarke JD, 2011, PHARM RES-DORDR, V28, P3171, DOI 10.1007/s11095-011-0500-z
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Cooper DA, 1997, J NUTR, V127, pS1699, DOI 10.1093/jn/127.8.1699S
   Corssac GB, 2018, BIOMED PHARMACOTHER, V104, P165, DOI 10.1016/j.biopha.2018.05.031
   Dinkova-Kostova AT, 2017, TRENDS FOOD SCI TECH, V69, P257, DOI 10.1016/j.tifs.2017.02.002
   Dinkova-Kostova AT, 2017, ARCH BIOCHEM BIOPHYS, V617, P84, DOI 10.1016/j.abb.2016.08.005
   Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296
   El-Baz FK, 2018, ADV PHARM BULL, V8, P523, DOI 10.15171/apb.2018.061
   Guerrero-Beltrán CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005
   Fahey JW, 1999, FOOD CHEM TOXICOL, V37, P973, DOI 10.1016/S0278-6915(99)00082-4
   Flicker L, 2000, MED J AUSTRALIA, V173, P77, DOI 10.5694/j.1326-5377.2000.tb139247.x
   Gao JQ, 2018, CLIN INTERV AGING, V13, P1859, DOI 10.2147/CIA.S173838
   Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014
   Gomes AS, 2010, EUR J PHARMACOL, V642, P140, DOI 10.1016/j.ejphar.2010.05.023
   Greaney AJ, 2016, J LEUKOCYTE BIOL, V99, P189, DOI 10.1189/jlb.3A0415-155RR
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Hong IH, 2014, J BIOL CHEM, V289, P1106, DOI 10.1074/jbc.M113.526780
   Hu R, 2006, LIFE SCI, V79, P1944, DOI 10.1016/j.lfs.2006.06.019
   Huang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/275431
   Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563
   Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339
   Kikuchi M, 2015, WORLD J GASTROENTERO, V21, P12457, DOI 10.3748/wjg.v21.i43.12457
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim JK, 2016, EXCLI J, V15, DOI 10.17179/excli2016-485
   Kim JY, 2012, VASC PHARMACOL, V56, P131, DOI 10.1016/j.vph.2011.11.007
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Kubo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14520-8
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418
   López-Diazguerrero NE, 2005, LIFE SCI, V77, P2840, DOI 10.1016/j.lfs.2005.05.034
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257
   Mahrouf-Yorgov M, 2011, REJUV RES, V14, P353, DOI 10.1089/rej.2010.1146
   Marrazzo P, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5263985
   MONTGOMERY H, 1961, ANALYST, V86, P414
   Moustafa PE, 2018, INFLAMMATION, V41, P1460, DOI 10.1007/s10753-018-0792-9
   Mu XY, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3508907
   Nam Y, 2018, J GINSENG RES, V42, P540, DOI 10.1016/j.jgr.2017.07.007
   Nazmy EA, 2017, CAN J PHYSIOL PHARM, V95, P420, DOI 10.1139/cjpp-2016-0447
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Oh CJ, 2012, FREE RADICAL BIO MED, V52, P671, DOI 10.1016/j.freeradbiomed.2011.11.012
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Roller J, 2010, LANGENBECK ARCH SURG, V395, P387, DOI 10.1007/s00423-010-0603-8
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Sánchez-Font MF, 2003, CELL MOL LIFE SCI, V60, P1513, DOI 10.1007/s00018-003-3048-1
   Sayed RH, 2014, NUTR RES, V34, P982, DOI 10.1016/j.nutres.2014.10.003
   Shubin AV, 2016, ONCOTARGET, V7, P55863, DOI 10.18632/oncotarget.10150
   Struck MB, 2011, J AM ASSOC LAB ANIM, V50, P344
   Sun XY, 2011, TOXICOL APPL PHARM, V255, P9, DOI 10.1016/j.taap.2011.05.011
   Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3
   Tarozzi A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/415078
   Veeranki OL, 2013, BRIT J NUTR, V109, P25, DOI 10.1017/S0007114512000657
   Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666
   Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378
   Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018
   Winiwarter S, 1998, J MED CHEM, V41, P4939, DOI 10.1021/jm9810102
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yu C, 2017, INT IMMUNOPHARMACOL, V45, P74, DOI 10.1016/j.intimp.2017.01.034
   Zhang Y, 2015, FOOD FUNCT, V6, P927, DOI [10.1039/c4fo01051e, 10.1039/C4FO01051E]
   Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zhou R, 2014, BBA-GEN SUBJECTS, V1840, P209, DOI 10.1016/j.bbagen.2013.09.018
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 89
TC 41
Z9 43
U1 2
U2 48
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD JUL 15
PY 2019
VL 855
BP 40
EP 49
DI 10.1016/j.ejphar.2019.04.043
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA HZ5CW
UT WOS:000468869300005
PM 31039346
DA 2024-02-19
ER

PT J
AU Sanada, F
   Taniyama, Y
   Azuma, J
   Iekushi, K
   Dosaka, N
   Yokoi, T
   Koibuchi, N
   Kusunoki, H
   Aizawa, Y
   Morishita, R
AF Sanada, Fumihiro
   Taniyama, Yoshiaki
   Azuma, Junya
   Iekushi, Kazuma
   Dosaka, Norio
   Yokoi, Toyohiko
   Koibuchi, Nobutaka
   Kusunoki, Hiroshi
   Aizawa, Yoshifusa
   Morishita, Ryuichi
TI Hepatocyte Growth Factor, but not Vascular Endothelial Growth Factor,
   Attenuates Angiotensin II-Induced Endothelial Progenitor Cell Senescence
SO HYPERTENSION
LA English
DT Article
DE HGF; VEGF; angiotensin II; EPC; senescence; oxidative stress
ID ACUTE MYOCARDIAL-INFARCTION; CRITICAL LIMB ISCHEMIA; NAD(P)H OXIDASE;
   OXIDATIVE STRESS; KAPPA-B; ANGIOGENESIS; DISEASE; PROLIFERATION; VEGF;
   HYPERTENSION
AB Although both hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) are potent angiogenic growth factors in animal models of ischemia, their characteristics are not the same in animal experiments and clinical trials. To elucidate the discrepancy between HGF and VEGF, we compared the effects of HGF and VEGF on endothelial progenitor cells under angiotensin II stimulation, which is a well-known risk factor for atherosclerosis. Here, we demonstrated that HGF, but not VEGF, attenuated angiotensin II-induced senescence of endothelial progenitor cells through a reduction of oxidative stress by inhibition of the phosphatidylinositol-3,4,5-triphosphate/rac1 pathway. Potent induction of neovascularization of endothelial progenitor cells by HGF, but not VEGF, under angiotensin II was also confirmed by in vivo experiments using several models, including HGF transgenic mice. (Hypertension. 2009; 53: 77-82.)
C1 [Sanada, Fumihiro; Taniyama, Yoshiaki; Azuma, Junya; Iekushi, Kazuma; Dosaka, Norio; Kusunoki, Hiroshi; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan.
   [Taniyama, Yoshiaki; Azuma, Junya; Iekushi, Kazuma; Dosaka, Norio; Yokoi, Toyohiko; Kusunoki, Hiroshi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan.
   [Taniyama, Yoshiaki; Azuma, Junya; Iekushi, Kazuma; Dosaka, Norio; Yokoi, Toyohiko; Kusunoki, Hiroshi] Osaka Univ, Grad Sch Med, Dept Nephrol, Suita, Osaka 5650871, Japan.
   [Sanada, Fumihiro; Aizawa, Yoshifusa] Niigata Univ, Grad Sch Med, Dept Cardiol, Niigata, Japan.
   [Koibuchi, Nobutaka] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Tokyo, Japan.
C3 Osaka University; Osaka University; Osaka University; Niigata
   University; University of Tokyo
RP Morishita, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM morishit@cgt.med.osaka-u.ac.jp
FU Organization for Pharmaceutical Safety and Research; Ministry of Public
   Health and Welfare; Japan Promotion of Science; Ministry of Education,
   Culture, Sports, Science and Technology, of the Japanese government
FX This work was partially supported by a Grant-in-Aid from the
   Organization for Pharmaceutical Safety and Research, a Grant-in-Aid from
   the Ministry of Public Health and Welfare, a Grant-in-Aid from Japan
   Promotion of Science, and through special coordination funds of the
   Ministry of Education, Culture, Sports, Science and Technology, of the
   Japanese government.
CR Abid MR, 2007, J BIOL CHEM, V282, P35373, DOI 10.1074/jbc.M702175200
   Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C
   Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114
   Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1729, DOI 10.1152/ajpheart.01103.2005
   Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Feugier P, 2002, J HEMATOTH STEM CELL, V11, P127, DOI 10.1089/152581602753448595
   Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027
   Gong RJ, 2006, J AM SOC NEPHROL, V17, P2464, DOI 10.1681/ASN.2006020185
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Iekushi K, 2007, HYPERTENSION, V49, P1409, DOI 10.1161/HYPERTENSIONAHA.106.080994
   Imanishi T, 2005, J HYPERTENS, V23, P97, DOI 10.1097/00004872-200501000-00018
   Imanishi T, 2004, HYPERTENS RES, V27, P101, DOI 10.1291/hypres.27.101
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Li H, 2006, AM J NEPHROL, V26, P519, DOI 10.1159/000097368
   Lucerna M, 2007, BLOOD, V109, P122, DOI 10.1182/blood-2006-07-031773
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE
   Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045
   Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347
   Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9
   RALEVIC V, 1991, CIRCULATION, V84, P1, DOI 10.1161/01.CIR.84.1.1
   Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
   Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI17712
   Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16
   Szöcs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189
   Takayama H, 1997, LAB INVEST, V77, P131
   Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, pC494, DOI 10.1152/ajpcell.00439.2003
   Taniyama Y, 2001, CIRCULATION, V104, P2344, DOI 10.1161/hc4401.098470
   Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93
   Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14
   Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8
   Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   Yao EH, 2007, HYPERTENS RES, V30, P1119, DOI 10.1291/hypres.30.1119
   Yu Y, 2008, AM J HYPERTENS, V21, P72, DOI 10.1038/ajh.2007.5
NR 38
TC 50
Z9 55
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0194-911X
EI 1524-4563
J9 HYPERTENSION
JI Hypertension
PD JAN
PY 2009
VL 53
IS 1
BP 77
EP U137
DI 10.1161/HYPERTENSIONAHA.108.120725
PG 20
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 385EE
UT WOS:000261795400013
PM 19047582
OA Bronze
DA 2024-02-19
ER

PT J
AU Capel, F
   Delmotte, MH
   Brun, M
   Lonchampt, M
   De Fanti, B
   Xuereb, L
   Baschet, L
   Rolland, G
   Galizzi, JP
   Lockhart, B
   Ktorza, A
   Dacquet, C
AF Capel, F.
   Delmotte, M. H.
   Brun, M.
   Lonchampt, M.
   De Fanti, B.
   Xuereb, L.
   Baschet, L.
   Rolland, G.
   Galizzi, J. P.
   Lockhart, B.
   Ktorza, A.
   Dacquet, C.
TI Aging and Obesity Induce Distinct Gene Expression Adaptation in the
   Liver of C57BL/6J Mice
SO JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS
LA English
DT Article
DE Aging; Genes; High-fat diet; Liver; Metabolism; Obesity
ID DIET-INDUCED OBESITY; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE;
   NUCLEAR RECEPTORS; LIFE-SPAN; TRANSCRIPTION; METABOLISM; MOUSE
AB Background: Aging and obesity induce complex transcriptomic changes in the liver, promoting the development of insulin resistance and type 2 diabetes. In spite of an increasing amount of studies on the role of aging and nutrient excess in metabolic disorders, the specific molecular events leading to insulin resistance are still poorly understood. Methods: This study presents a comparative analysis of hepatic gene expression profiles between young adult C57BL/6J mice fed with a low- or a high-fat diet for 1 and 12 months. We evaluated the expression of a defined set of genes implicated in glucose and lipid metabolism as well as key nuclear receptors and their target genes, IGF1 signaling and clock genes. Results: Aging and short-term high-fat consumption induced insulin resistance, albeit through two distinct processes. Hepatic gene expression changes were more pronounced in the context of aging. We further analyzed expression profiles together with plasma parameters by principal component analysis with regard to diet condition. Conclusions: Our results suggest that in the liver of C57BL/6J mice, the molecular mechanisms underlying high-fat feeding or aging which mediated insulin resistance were not identical. Copyright (C) 2011 S. Karger AG, Basel
C1 [Xuereb, L.; Baschet, L.] Inst Rech Servier, Dept Biostat, F-92150 Suresnes, France.
   [Capel, F.; Rolland, G.; Galizzi, J. P.; Lockhart, B.] Inst Rech Servier, Croissy Sur Seine, France.
C3 Servier; Institut de Recherches Internationales Servier; Servier;
   Institut de Recherches Internationales Servier
RP Capel, F (corresponding author), Lipid & Energy Metab Team, Human Nutr Unit, BP 321,58 Rue Montalembert, FR-63009 Clermont Ferrand 1, France.
EM frederic.capel@clermont.inra.fr
OI Capel, Frederic/0000-0002-0133-0277
FU EU [018652]
FX This work was supported by the EU contract No. 018652 'CRESCENDO'.
CR Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Chalkley SM, 2002, AM J PHYSIOL-ENDOC M, V282, pE1231, DOI 10.1152/ajpendo.00173.2001
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Dröge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x
   Everitt B, 1974, CLUSTER ANAL, P122
   Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022
   Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232
   Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358
   Hill JO, 2000, NUTRITION, V16, P385, DOI 10.1016/S0899-9007(00)00264-1
   Hoffler U, 2009, ENDOCRINE, V36, P311, DOI 10.1007/s12020-009-9224-9
   Jolliffe I, 2002, PRINCIPAL COMPONENT, P487, DOI DOI 10.1007/B98835
   Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015
   Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006
   Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morgan K, 2008, EUR J GASTROEN HEPAT, V20, P843, DOI 10.1097/MEG.0b013e3282f9b203
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133
   Ringnér M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36
   Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533
   Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5
   Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216
   Wilson Peter W F, 2002, Am J Geriatr Cardiol, V11, P119
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 32
TC 5
Z9 5
U1 0
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-6499
EI 1661-6758
J9 J NUTRIGENET NUTRIGE
JI J. Nutrigenet. Nutrigenomics
PY 2011
VL 4
IS 3
BP 154
EP 164
DI 10.1159/000328190
PG 11
WC Genetics & Heredity; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Nutrition & Dietetics
GA 818OV
UT WOS:000294763700004
PM 21757924
OA gold
DA 2024-02-19
ER

PT J
AU Szlezak, D
   Bronowicka-Adamska, P
   Hutsch, T
   Ufnal, M
   Wróbel, M
AF Szlezak, Dominika
   Bronowicka-Adamska, Patrycja
   Hutsch, Tomasz
   Ufnal, Marcin
   Wrobel, Maria
TI Hypertension and Aging Affect Liver Sulfur Metabolism in Rats
SO CELLS
LA English
DT Article
DE liver; hypertension; aging; hydrogen sulfide; cystathionine gamma-lyase;
   3-mercaptopyruvate sulfurtransferase; thiosulfate sulfurtransferase
   (rhodanese)
ID HYDROGEN-SULFIDE FORMATION; RP-HPLC; CYSTATHIONINE; H2S; GLUTATHIONE;
   DETOXIFICATION; VASORELAXANT; HALLMARKS; CYSTEINE; KIDNEY
AB Hypertension and age are key risk factors for cardiovascular morbidity and mortality. Hydrogen sulfide (H2S), a gaseous transmitter, contributes significantly to regulating arterial blood pressure and aging processes. This study evaluated the effects of hypertension and aging on the hepatic metabolism of sulfur-containing compounds, the activity of the enzymes involved in sulfur homeostasis, and the liver's ability to generate H2S. Livers isolated from 16- and 60-week-old normotensive Wistar Kyoto rats (WKY) and Spontaneously Hypertensive Rats (SHR) were used to evaluate gene expression using RT-PCR, and the activity of enzymes participating in H2S metabolism, including thiosulfate sulfurtransferase (rhodanese; TST), cystathionine gamma-lyase (CTH), and 3-mercaptopyruvate sulfurtransferase (MPST). The levels of cysteine, cystine, reduced and oxidized glutathione were measured using RP-HPLC. SHR livers from both age groups showed a higher capacity to generate H2S than livers from WKY. The gene expression and activity of enzymes involved in sulfur metabolism differed between WKY and SHR, and between the age groups. For example, 16-week-old SHR had significantly higher activity of TST than 16-week-old WKY. Furthermore, differences between younger and older WKY rats in the expression and/or activity of TST and MPST were present. In conclusion, our study shows that arterial hypertension and aging affect hepatic sulfur metabolism and H2S production in rats. These findings pave the way for interventional studies evaluating a potential causal relation between liver sulfur metabolism, hypertension and aging.
C1 [Szlezak, Dominika; Bronowicka-Adamska, Patrycja; Wrobel, Maria] Jagiellonian Univ Med Coll, Fac Med, Chair Med Biochem, 7 Kopernika St, PL-31034 Krakow, Poland.
   [Hutsch, Tomasz; Ufnal, Marcin] Med Univ Warsaw, Dept Physiol & Expt Pathophysiol, Lab Ctr Preclin Res, 1B Banacha St, PL-02097 Warsaw, Poland.
   [Hutsch, Tomasz] ALAB Plus Sp Z Oo, Vet Diagnost Lab ALAB Biosci, 13 Krucza St, PL-05090 Rybie, Poland.
C3 Jagiellonian University; Collegium Medicum Jagiellonian University;
   Medical University of Warsaw
RP Wróbel, M (corresponding author), Jagiellonian Univ Med Coll, Fac Med, Chair Med Biochem, 7 Kopernika St, PL-31034 Krakow, Poland.
EM dominika.szlezak@uj.edu.pl; patrycja.bronowicka-adamska@uj.edu.pl;
   t.hutsch@yahoo.com; mufnal@wum.edu.pl; mtk.wrobel@uj.edu.pl
RI Szlęzak, Dominika/T-9916-2018; Szlęzak, Dominika/AAJ-7405-2020; Wróbel,
   Maria/ABC-4547-2021
OI Szlęzak, Dominika/0000-0002-7188-5630; Szlęzak,
   Dominika/0000-0002-7188-5630; Wróbel, Maria/0000-0001-7919-2778; Ufnal,
   Marcin/0000-0003-0088-8284; Bronowicka-Adamska,
   Patrycja/0000-0001-7167-8685
FU Polish Ministry of Science and Higher Education of the Jagiellonian
   University Medical College [N41/DBS/000435]
FX This work was supported by the Polish Ministry of Science and Higher
   Education, grant N41/DBS/000435 of the Jagiellonian University Medical
   College.
CR Bronowicka-Adamska P, 2019, ACTA BIOCHIM POL, V66, P611, DOI 10.18388/abp.2019_2900
   Bronowicka-Adamska P, 2017, MOLECULES, V22, DOI 10.3390/molecules22040530
   Bronowicka-Adamska P, 2015, NITRIC OXIDE-BIOL CH, V46, P186, DOI 10.1016/j.niox.2014.09.159
   Bronowicka-Adamska P, 2011, J CHROMATOGR B, V879, P2005, DOI 10.1016/j.jchromb.2011.05.026
   Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367
   Czubak Jerzy, 2002, Acta Biologica Cracoviensia Series Zoologia, V44, P113
   Dominick PK, 2001, J CHROMATOGR B, V761, P1, DOI 10.1016/S0378-4347(01)00298-5
   Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817
   Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109
   Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752
   Gkretsi V, 2007, HEPATOLOGY, V45, P1025, DOI 10.1002/hep.21540
   Goodman Z.D., 2006, SURG PATHOLOGY CYTOP, VVolume 2, P1465
   Guo W, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/878052
   HANDLER JA, 1994, HEPATOLOGY, V19, P1496, DOI 10.1002/hep.1840190627
   Huc T, 2018, AM J PHYSIOL-HEART C, V315, pH1805, DOI 10.1152/ajpheart.00536.2018
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ibdah J.A., 2015, HEPATOL, V11, P175
   Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781
   Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI 10.1002/lt.21810
   Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kimura H, 2015, P JPN ACAD B-PHYS, V91, P131, DOI 10.2183/pjab.91.131
   Kjeldsen SE, 2018, PHARMACOL RES, V129, P95, DOI 10.1016/j.phrs.2017.11.003
   Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu SC., 2020, LIVER RES, V4, P64, DOI DOI 10.1016/J.LIVRES.2020.05.003
   Mani S, 2014, NITRIC OXIDE-BIOL CH, V41, P62, DOI 10.1016/j.niox.2014.02.006
   Mard SA, 2016, IRAN J BASIC MED SCI, V19, P172
   Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613
   MATSUO Y, 1958, J BIOL CHEM, V230, P545
   Nakajima T, 2015, MED SCI MONITOR, V21, P1721, DOI 10.12659/MSM.893234
   Olson KR, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13368
   Paul BD, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101772
   Percy D.H., 2007, PATHOLOGY LAB RODENT, V3rd ed., P356
   Predmore BL, 2010, AGE, V32, P467, DOI 10.1007/s11357-010-9150-z
   Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   SORBO BH, 1955, METHOD ENZYMOL, V2, P334, DOI 10.1016/S0076-6879(55)02207-6
   STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267
   Tan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025943
   Toohey JI, 2001, MED HYPOTHESES, V56, P259, DOI 10.1054/mehy.2000.1209
   VALENTINE WN, 1974, CLIN CHIM ACTA, V51, P205, DOI 10.1016/0009-8981(74)90031-X
   Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp
   Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011
   WOOD JL, 1987, METHOD ENZYMOL, V143, P25
   World Health Organization, 2009, 2008 2013 ACTION PLA, P5
   Wróbel M, 2004, TOXICOL MECH METHOD, V14, P331, DOI 10.1080/15376520490434683
   Wu DD, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3831713
   Wu DD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05457-z
   Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.10.2783S
   Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667
   Yang Wei, 2015, EXCLI J, V14, P1273, DOI 10.17179/excli2015-734
   Yu XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30033
   Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008
NR 55
TC 9
Z9 10
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAY
PY 2021
VL 10
IS 5
AR 1238
DI 10.3390/cells10051238
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA SI3MT
UT WOS:000654730800001
PM 34069923
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Mimura, S
   Iwama, H
   Kato, K
   Nomura, K
   Kobayashi, M
   Yoneyama, H
   Miyoshii, H
   Tani, J
   Morishita, A
   Himoto, T
   Deguchi, A
   Nomura, T
   Sakamoto, T
   Fujita, K
   Maeda, E
   Izuishi, K
   Okano, K
   Suzuki, Y
   Masaki, T
AF Mimura, Shima
   Iwama, Hisakazu
   Kato, Kiyohito
   Nomura, Kei
   Kobayashi, Mitsuyoshi
   Yoneyama, Hirohito
   Miyoshii, Hisaaki
   Tani, Joji
   Morishita, Asahiro
   Himoto, Takashi
   Deguchi, Akihiro
   Nomura, Takako
   Sakamoto, Teppei
   Fujita, Koji
   Maeda, Emiko
   Izuishi, Kunihiko
   Okano, Keiichi
   Suzuki, Yasuyuki
   Masaki, Tsutomu
TI Profile of microRNAs associated with aging in rat liver
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE microRNA; fetal liver; cell cycle; aging
ID CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; HOLOCARBOXYLASE SYNTHETASE;
   REGULATE EXPRESSION; PROMOTES APOPTOSIS; CANCER; PROLIFERATION; PROTEIN;
   TUMORIGENICITY; METHYLATION
AB Recent studies suggest that small non-coding microRNAs (miRNAs or miRs) play an important role in the regulation of genes involved in various cellular and developmental processes. However, the expression of miRNAs during the aging process remains largely unknown. The aim of the present study was to analyze miRNA expression profiles in rat livers during the aging process. The livers of male Wistar rats at different stages of development (fetal, aged 3 days, and 1, 2, 4, 8 and 36 weeks of age) were used. Total RNA was extracted from the livers. We analyzed the expression levels of 679 rat miRNA probes. In addition, immunohistochemical staining for proliferating cell nuclear antigen (PCNA) was performed. Several up- and downregulated miRNAs were identified in the rat livers at 7 different fetal developmental stages and at 36 weeks of age. We observed the upregulation of miR-29a, miR-29c, miR-195 and miR-497, whereas miR-301a, miR-148b-3p, miR-7a, miR-93, miR-106b, miR-185, miR-450a, miR-539 and miR-301b were downregulated in the aging rat livers. The number of PCNA-positive hepatocytes was decreased with age. In conclusion, our findings suggest that these up- and downregulated miRNAs play an important role in aging by regulating cell cycles that are involved in liver senescence. Further investigation is required to reveal additional target genes of the miRNAs expressed in the liver and the roles of miRNAs in the developmental process of aging in the liver.
C1 [Mimura, Shima; Kato, Kiyohito; Nomura, Kei; Kobayashi, Mitsuyoshi; Yoneyama, Hirohito; Miyoshii, Hisaaki; Tani, Joji; Morishita, Asahiro; Himoto, Takashi; Deguchi, Akihiro; Nomura, Takako; Sakamoto, Teppei; Fujita, Koji; Maeda, Emiko; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 7610793, Japan.
   [Iwama, Hisakazu; Okano, Keiichi; Suzuki, Yasuyuki] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Takamatsu, Kagawa 7610793, Japan.
   [Izuishi, Kunihiko] Kagawa Univ, Fac Med, Dept Gastroenterol Surg, Takamatsu, Kagawa 7610793, Japan.
C3 Kagawa University; Kagawa University; Kagawa University
RP Mimura, S (corresponding author), Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, 1750-1 Ikenobe,Miki Cho, Takamatsu, Kagawa 7610793, Japan.
EM shimamimura@hotmail.com
RI Fujita, Koji/X-4478-2019
OI Fujita, Koji/0000-0001-9390-7565
CR Aw S, 2012, CELL RES, V22, P1218, DOI 10.1038/cr.2012.59
   Bao BL, 2012, J NUTR BIOCHEM, V23, P635, DOI 10.1016/j.jnutbio.2011.03.007
   Bao BL, 2010, J NUTR, V140, P1546, DOI 10.3945/jn.110.126359
   Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x
   Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737
   Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73
   Chen YQ, 2011, AM J NEPHROL, V34, P549, DOI 10.1159/000333809
   Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692
   Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025872
   Ding DP, 2011, CARCINOGENESIS, V32, P1025, DOI 10.1093/carcin/bgr078
   Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507
   Dumortier O, 2012, DIABETES OBES METAB, V14, P22, DOI 10.1111/j.1463-1326.2012.01656.x
   Eda A, 2011, GENE, V485, P46, DOI 10.1016/j.gene.2011.05.034
   Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104
   Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465
   Funamizu N, 2014, INT J ONCOL, V44, P725, DOI 10.3892/ijo.2014.2243
   Hu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016221
   Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233
   Inukai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040028
   Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07
   Kim BM, 2011, DEVELOPMENT, V138, P1081, DOI 10.1242/dev.056317
   Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002
   Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lakner AM, 2011, WORLD J GASTROENTERO, V17, P2536, DOI 10.3748/wjg.v17.i20.2536
   Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272
   Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800
   Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004
   Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020
   Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027
   Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006
   Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046
   Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009
   Ma LM, 2013, J GENET GENOMICS, V40, P143, DOI 10.1016/j.jgg.2013.03.002
   Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Milewicz DM, 2012, J CLIN INVEST, V122, P490, DOI 10.1172/JCI62204
   Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585
   Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613
   Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006
   Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10
   Rao YS, 2013, ENDOCRINOLOGY, V154, P2795, DOI 10.1210/en.2013-1230
   Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922
   Salminen A, 2011, CELL MOL LIFE SCI, V68, P1021, DOI 10.1007/s00018-010-0597-y
   SCHNEIDER EL, 1979, MECH AGEING DEV, V9, P313, DOI 10.1016/0047-6374(79)90108-8
   Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511
   Ugalde AP, 2011, NUCLEUS-PHILA, V2, P549, DOI 10.4161/nucl.2.6.17986
   Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124
   Ungvari Z, 2013, J GERONTOL A-BIOL, V68, P877, DOI 10.1093/gerona/gls242
   Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055
   Wang CM, 2011, BIOCHEM BIOPH RES CO, V411, P586, DOI 10.1016/j.bbrc.2011.06.191
   Wang Y, 2011, INT J RADIAT ONCOL, V81, P839, DOI 10.1016/j.ijrobp.2010.09.048
   Weng ZH, 2011, EXP THER MED, V2, P951, DOI 10.3892/etm.2011.288
   Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172
   Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380
   Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919
   Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531
   Zhang QQ, 2012, NEURO-ONCOLOGY, V14, P278, DOI 10.1093/neuonc/nor216
   Zhang ZP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-124
   Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T
   Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145
   Zhu W, 2012, MED ONCOL, V29, P384, DOI 10.1007/s12032-010-9797-4
   Zong YY, 2011, BRAIN RES, V1395, P108, DOI 10.1016/j.brainres.2011.04.035
NR 72
TC 28
Z9 29
U1 0
U2 10
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD OCT
PY 2014
VL 34
IS 4
BP 1065
EP 1072
DI 10.3892/ijmm.2014.1892
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA AQ4AL
UT WOS:000342734500019
PM 25118807
OA Bronze
DA 2024-02-19
ER

PT J
AU Wege, H
   Chui, MS
   Le, HT
   Strom, SC
   Zern, MA
AF Wege, H
   Chui, MS
   Le, HT
   Strom, SC
   Zern, MA
TI In vitro expansion of human hepatocytes is restricted by
   telomere-dependent replicative aging
SO CELL TRANSPLANTATION
LA English
DT Article
DE hepatocyte; immortality; proliferation; senescence; telomerase
ID REPEAT AMPLIFICATION PROTOCOL; ENDOGENOUS RETROVIRUS; BIOARTIFICIAL
   LIVER; HUMAN FIBROBLASTS; HUMAN-CELLS; IMMORTALIZATION; TRANSPLANTATION;
   QUANTIFICATION; CULTIVATION; SENESCENCE
AB Currently, different techniques to expand human hepatocytes in vitro are being investigated to generate enough cells for liver-directed cell therapies. However, based on observations in fibroblasts and other cell types, telomere attrition limits the proliferative capacity of normal somatic cells. Therefore, we explored whether telomere-dependent replicative aging restricts the in vitro proliferation of human hepatocytes. Subpopulations of cells isolated from a neonatal Ever and characterized as hepatocyte derived by RT-PCR and flow cytometry started to proliferate 5-7 days after plating and were termed proliferating human hepatocytes (PHH). Following retroviral-mediated transduction of the catalytic telornerase subunit, telomerase reverse transcriptase (hTERT), telomerase activity increased from almost undetectable levels to levels as high as in HepG2 and other telomerase-positive cell lines. As expected, untransduced PHH progressively lost telomeric repeats and arrested after 30-35 cell divisions with telomeres of less than 5 kilo bases. In comparison, telomerase-reconstituted PHH maintained elongated telomeres and continued to proliferate as shown by colorimetric assays and cell counts. In this study, telomere stabilization extended the proliferative capacity of in vitro proliferating human neonatal hepatocytes. Therefore, telomere attrition needs to be addressed when developing techniques to expand human hepatocytes.
C1 Univ Calif Davis, Davis Med Ctr, Transplant Res Inst, Sacramento, CA 95817 USA.
   Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15261 USA.
C3 University of California System; University of California Davis;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Zern, MA (corresponding author), Univ Calif Davis, Davis Med Ctr, Transplant Res Inst, Res Bldg 1,Suite 1001,4635 2nd Ave, Sacramento, CA 95817 USA.
EM mazern@ucdavis.edu
OI Strom, Stephen/0000-0002-2889-3387
CR Allen KJ, 2000, J GASTROEN HEPATOL, V15, P1325, DOI 10.1046/j.1440-1746.2000.02328.x
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Amicone L, 1997, EMBO J, V16, P495, DOI 10.1093/emboj/16.3.495
   Avilion AA, 1996, CANCER RES, V56, P645
   Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133
   Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271
   Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5
   Cerni C, 2000, MUTAT RES-REV MUTAT, V462, P31, DOI 10.1016/S1383-5742(99)00091-5
   CLARK GJ, 1995, METHOD ENZYMOL, V255, P395
   CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191
   Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625
   Fisher RA. SS, 2000, The Hepatocyte Review, P475
   Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592
   Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056
   Kamohara Y, 1998, J Hepatobiliary Pancreat Surg, V5, P273, DOI 10.1007/s005340050046
   Kim BH, 2000, EXP MOL MED, V32, P29, DOI 10.1038/emm.2000.6
   Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595
   Kobayashi N, 2001, CELL TRANSPLANT, V10, P383
   KONO Y, 1995, EXP CELL RES, V221, P478, DOI 10.1006/excr.1995.1399
   Li ZY, 2002, MOL THER, V5, P420, DOI 10.1006/mthe.2002.0565
   Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063
   Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996
   Nichols WS, 1999, SCAND J IMMUNOL, V49, P302, DOI 10.1046/j.1365-3083.1999.00505.x
   NYBERG SL, 1994, ANN SURG, V220, P59
   Nyberg SL, 1999, TRANSPLANTATION, V67, P1251, DOI 10.1097/00007890-199905150-00009
   Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282
   Piatyszek Mieczyslaw A., 1995, Methods in Cell Science, V17, P1, DOI 10.1007/BF00981880
   Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295
   Reddel RR, 2001, RADIAT RES, V155, P194, DOI 10.1667/0033-7587(2001)155[0194:ALOTIH]2.0.CO;2
   Strom SC, 1996, METHOD ENZYMOL, V272, P388, DOI 10.1016/S0076-6879(96)72044-X
   Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096
   Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769
   Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064
   Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003
   Werner A, 2000, BIOTECHNOL BIOENG, V68, P59, DOI 10.1002/(SICI)1097-0290(20000405)68:1<59::AID-BIT7>3.0.CO;2-N
NR 41
TC 42
Z9 46
U1 0
U2 5
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2003
VL 12
IS 8
BP 897
EP 906
DI 10.3727/000000003771000138
PG 10
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 762VA
UT WOS:000188001800010
PM 14763510
DA 2024-02-19
ER

PT J
AU Handa, S
   Maruyama, N
   Ishigami, A
AF Handa, Setsuko
   Maruyama, Naoki
   Ishigami, Akihito
TI Over-expression of Senescence Marker Protein-30 Decreases Reactive
   Oxygen Species in Human Hepatic Carcinoma Hep G2 Cells
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE senescence marker protein-30; gluconolactonase; reactive oxygen species;
   glutathione; superoxide dismutase
ID SMP30/GNL KNOCKOUT MICE; MOUSE; LIVER
AB Senescence Marker Protein-30 (SMP30) is an androgen-independent factor that decreases with aging. We recently characterized SMP30 as a gluconolactonase (GNL) involved in the biosynthetic pathway of vitamin C and established that SMP30 knockout mice could not synthesize vitamin C in vivo. Although mice normally synthesize vitamin C, humans are prevented from doing so by mutations that have altered the gluconolactone oxidase gene during evolution. Even the SMP30/GNL present abundantly in the human liver does not synthesize vitamin C in vivo. To clarify the functions of this SMP30/GNL, we transfected the human SMP30/CNL gene into the human liver carcinoma cell line, Hep G2. The resulting Hep G2/SMP30 cells expressed approximately 10.9-fold more SMP30/GNL than Hep G2/pcDNA3 mock-transfected control cells. Examination of SMP30/GNL's impact on the state of oxidative stress in these cells revealed that formation of the reactive oxygen species (ROS) of mitochondrial and post-mitochondrial fractions from Hep G2/SMP30 cells decreased by a significant 24.0% and 18.1%, respectively, compared to those from Hep G2/pcDNA3 cells. Lipid peroxidation levels in Hep G2/SMP30 cells similarly decreased. Moreover, levels of the antioxidants superoxide dismutase (SOD) and glutathione (GSH) in Hep G2/SMP30 cells were a significant 42.6% and 62.4% lower than those in Hep G2/pcDNA3 cells, respectively. Thus, over-expression of SMP30/GNL in Hep G2 cells contributed to a decrease of ROS formation accompanied by decreases of lipid peroxidation, SOD activity and GSH levels.
C1 [Handa, Setsuko; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
   [Ishigami, Akihito] Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Toho University
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
EM ishigami@phar.toho-u.ac.jp
OI Ishigami, Akihito/0000-0001-7875-7482
FU Ministry of Education, Science, and Culture, Japan; Smoking Research
   Foundation, Japan
FX This study is supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Science, and Culture, Japan (to S.H. and
   A.L), and a Grant-in-Aid for Smoking Research Foundation, Japan (to
   A.I.). We thank Ms. P. Minick for the excellent editorial assistance.
CR FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Ishigami A, 2005, CELL TISSUE RES, V320, P243, DOI 10.1007/s00441-004-1073-5
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Sato Y, 2008, BIOCHEM BIOPH RES CO, V375, P346, DOI 10.1016/j.bbrc.2008.08.020
   Sjaastad MD, 1997, BIOESSAYS, V19, P47, DOI 10.1002/bies.950190109
   TAKATSU H, 2009, NAT MED TOKYO, V63, P364
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 20
TC 34
Z9 49
U1 1
U2 3
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD OCT
PY 2009
VL 32
IS 10
BP 1645
EP 1648
DI 10.1248/bpb.32.1645
PG 4
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 502GP
UT WOS:000270444500002
PM 19801822
DA 2024-02-19
ER

PT J
AU Jourdan, M
   Vaubourdolle, M
   Cynober, L
   Aussel, C
AF Jourdan, M
   Vaubourdolle, M
   Cynober, L
   Aussel, C
TI Effect of aging on liver functions - an experimental study in a perfused
   rat liver model
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; liver; indocyanine green; clearance; isolated perfused liver; rat
ID HEPATIC BLOOD-FLOW; AGE-RELATED-CHANGES; INDOCYANINE GREEN; BIOSYNTHETIC
   FUNCTION; OXYGEN-CONSUMPTION; DRUG-METABOLISM; ACID-METABOLISM;
   AMINO-ACIDS; BILE-FLOW; IN-VIVO
AB Background. Aging is associated with marked changes in the physiology of many organs. Aging of the liver has been little studied and findings are inconclusive. The purpose of this work was to determine the effect of aging on transport and metabolic functions of the liver as assessed by extraction ratio of indocyanine green (ICG) and urea flux respectively. Bile flow was also recorded. As ICG is removed exclusively by the liver without bioconversion, its clearance reflects hepatic functional mass.
   Methods. Livers from adult (3-month old) or old (24-month old) rats were perfused in a recirculating system for 90 min. At time 30 min, a bolus of 0.125 mg of indocyanine green was introduced in the perfusion buffer. At least every 10 minutes, the perfusion buffer was sampled for the measurements of ICG and urea. Bile flow was closely monitored throughout the experiment.
   Results. Extraction ratio of ICG was increased in livers from old rats (9.49 +/- 2,84 vs 3.70 +/- 1.56% of ICG extracted), whereas urea flux was diminished (0.33 +/- 0.06 vs 1.33 +/- 0.65 mumol/min/% of ICD extracted) and bile flow was unchanged (4.03 +/- 1.02 vs 3.57 +/- 1.34 d/min).
   Conclusions. Aging does not affect the different functions of the liver in the same way. It increases hepatocellular uptake function, but decreases the metabolic function of hepatocytes and does not change excretion function. These discrepancies are likely to be of some importance in the study of drug metabolism and action, and so we suggest that results should be corrected for ICG extraction. (C) 2004 Elsevier Inc. All rights reserved.
C1 Lab Biol Nutr, EA 2498, F-75270 Paris 06, France.
   Hop St Antoine, Biochem A Lab, F-75571 Paris, France.
   Hop Hotel Dieu, Biochem A Lab, F-75181 Paris, France.
   Emile Roux Hosp, Biochem Lab, Limeil Brevannes, France.
C3 Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital
   Universitaire Saint-Antoine - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP;
   Assistance Publique Hopitaux Paris (APHP); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Emile-Roux
   - APHP
RP Jourdan, M (corresponding author), Lab Biol Nutr, EA 2498, 4 Ave Observ, F-75270 Paris 06, France.
EM marion.jourdan@wanadoo.fr
RI Cynober, Luc/ABB-2368-2020
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BLONDECYNOBER F, 1995, AM J PHYSIOL-ENDOC M, V268, pE298, DOI 10.1152/ajpendo.1995.268.2.E298
   BRODY DH, 1979, MED CLIN N AM, V63, P621, DOI 10.1016/S0025-7125(16)31692-3
   CAESAR J, 1961, CLIN SCI, V21, P43
   De Bandt JP, 1999, J HEPATOL, V30, P843
   DEBANDT JP, 1990, J SURG RES, V49, P8, DOI 10.1016/0022-4804(90)90102-8
   DEBANDT JP, 1995, BRIT J NUTR, V73, P227, DOI 10.1079/BJN19950025
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Gagliano N, 2002, EXP GERONTOL, V37, P791, DOI 10.1016/S0531-5565(02)00022-0
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Handler JA, 1997, BIOCHEM PHARMACOL, V54, P159, DOI 10.1016/S0006-2952(97)00159-7
   Horn DB, 1997, METABOLISM, V46, P414, DOI 10.1016/S0026-0495(97)90058-5
   KITANI K, 1978, EXP GERONTOL, V13, P9, DOI 10.1016/0531-5565(78)90024-4
   LEEVY CM, 1967, J AMER MED ASSOC, V200, P236, DOI 10.1001/jama.200.3.236
   LEEVY CM, 1962, ANN NY ACAD SCI, P161
   Mollica MP, 1998, CELL MOL LIFE SCI, V54, P1277, DOI 10.1007/s000180050253
   Mollica MP, 2001, CELL MOL LIFE SCI, V58, P477, DOI 10.1007/PL00000871
   MONTGOMERY PR, 1988, CAN J PHYSIOL PHARM, V66, P592, DOI 10.1139/y88-091
   MOODY FG, 1974, ANN SURG, V180, P592, DOI 10.1097/00000658-197410000-00024
   Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068
   Neveux N, 2000, J HEPATOL, V33, P68, DOI 10.1016/S0168-8278(00)80161-0
   NIELSEN NC, 1963, SCAND J CLIN LAB INV, V15, P613, DOI 10.3109/00365516309051344
   ROWLAND M, 1973, J PHARMACOKINET BIOP, V1, P123, DOI 10.1007/BF01059626
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   SHATTUCK KE, 1993, JPEN-PARENTER ENTER, V17, P171, DOI 10.1177/0148607193017002171
   UCHIDA K, 1978, J LIPID RES, V19, P544
   VAUBOURDOLLE M, 1989, SCAND J GASTROENTERO, V24, P467, DOI 10.3109/00365528909093076
   VILLENEUVE JP, 1982, AM J GASTROENTEROL, V77, P233
   VILSTRUP H, 1980, GUT, V21, P990, DOI 10.1136/gut.21.11.990
   Wang P, 1996, AM J PHYSIOL-REG I, V270, pR927, DOI 10.1152/ajpregu.1996.270.5.R927
   WOODHOUSE K, 1992, BIOPHARM DRUG DISPOS, V13, P311, DOI 10.1002/bdd.2510130502
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   WYNNE HA, 1990, BRIT J CLIN PHARMACO, V30, P634, DOI 10.1111/j.1365-2125.1990.tb03826.x
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 36
TC 8
Z9 9
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2004
VL 39
IS 9
BP 1341
EP 1346
DI 10.1016/j.exger.2004.07.004
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 857UM
UT WOS:000224144000010
PM 15489057
DA 2024-02-19
ER

PT J
AU Wang, XH
   Krupczak-Hollis, K
   Tan, YJ
   Dennewitz, MB
   Adami, GR
   Costa, RH
AF Wang, XH
   Krupczak-Hollis, K
   Tan, YJ
   Dennewitz, MB
   Adami, GR
   Costa, RH
TI Increased hepatic forkhead box M1B (FoxM1B) levels in old-aged mice
   stimulated liver regeneration through diminished p27<SUP>KiP1</SUP>
   protein levels and increased Cdc25B expression
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TRANSCRIPTION FACTOR HFH-11B; CELL-CYCLE REGULATION; HEPATOCYTE ENTRY;
   S-PHASE; GROWTH; HEAD; PHOSPHORYLATION; ENDODERM; LACKING; INJURY
AB Recent liver regeneration studies indicate that maintaining hepatic Forkhead Box M1B (FoxM1B) expression in 12-month-old (old-aged) Transthyretin-FoxM1B transgenic mice increases hepatocyte proliferation and expression of cell cycle regulatory genes. Because these transgenic CD-1 mice maintain FoxM1B levels during the aging process, we conducted the current study to determine whether adenovirus delivery of the FoxM1B gene (AdFoxM1B) is sufficient to stimulate liver regeneration in old-aged Balb/c mice. Here we show that AdFoxM1B infection of old-aged mice caused a significant increase in FoxM1B expression, hepatocyte DNA replication, and mitosis following partial hepatectomy. This stimulation in hepatocyte S-phase progression was associated with diminished protein expression and perinuclear localization of cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) (p27) protein following partial hepatectomy. In contrast, old-aged mice infected with control virus displayed high hepatocyte levels of p27 protein, which had been localized to the nucleus prior to S-phase. Furthermore, we found that restoring FoxM1B expression did not influence p27 mRNA levels, and this new finding implicates FoxM1B in regulation of p27 protein levels. Likewise, AdFoxM1B-infected regenerating livers displayed elevated S-phase levels of Cdk2 kinase activity compared with old-aged mice infected with control virus. Furthermore, restoring FoxM1B expression in old-aged mice caused elevated levels of Cyclin B1, Cyclin B2, Cdc25B, Cdk1, and p55CDC mRNA as well as stimulating Cdc25B nuclear localization during liver regeneration, all of which are required for mitosis. These studies indicated that an acute delivery of the FoxM1B gene in old-aged mice is sufficient to re-establish proliferation of regenerating hepatocytes, suggesting that FoxM1B can be used for therapeutic intervention to alleviate the reduction in cellular proliferation observed in the elderly.
C1 Univ Illinois, Coll Med & Dent, Dept Mol Genet, Chicago, IL 60607 USA.
   Univ Illinois, Coll Med & Dent, Dept Oral Med & Diagnost Sci, Chicago, IL 60607 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital
RP Costa, RH (corresponding author), Univ Illinois, Dept Mol Genet MC699, Coll Med, 900 S Ashland Ave,Rm 2220 MBRB, Chicago, IL 60607 USA.
FU NIDDK NIH HHS [R01 DK 54687-04] Funding Source: Medline
CR Benihoud K, 2000, J GENE MED, V2, P194, DOI 10.1002/(SICI)1521-2254(200005/06)2:3<194::AID-JGM102>3.0.CO;2-5
   Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0
   Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x
   Duncan SA, 2000, DEV DYNAM, V219, P131, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1051>3.3.CO;2-E
   Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184
   Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200
   Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200
   Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X
   Kaestner KH, 2000, GENE DEV, V14, P142
   Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573
   Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4
   Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Nilsson I, 2000, Prog Cell Cycle Res, V4, P107
   Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000
   Rausa FM, 1998, METHODS, V16, P29, DOI 10.1006/meth.1998.0642
   Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672
   SCHWARZ JK, 1995, P NATL ACAD SCI USA, V92, P483, DOI 10.1073/pnas.92.2.483
   SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Tan YJ, 2002, HEPATOLOGY, V35, P30, DOI 10.1053/jhep.2002.30317
   Tan YJ, 2001, GENE EXPRESSION, V9, P237, DOI 10.3727/000000001783992542
   Taub R, 1999, SEMIN LIVER DIS, V19, P117, DOI 10.1055/s-2007-1007104
   Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230
   Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200
   Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666
   Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441
   Ye HG, 1999, MOL CELL BIOL, V19, P8570
   Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626
   Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039
   Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228
NR 39
TC 133
Z9 155
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 15
PY 2002
VL 277
IS 46
BP 44310
EP 44316
DI 10.1074/jbc.M207510200
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 615XE
UT WOS:000179272000101
PM 12221098
OA hybrid
DA 2024-02-19
ER

PT J
AU Dasuri, K
   Zhang, L
   Ebenezer, P
   Liu, Y
   Fernandez-Kim, SO
   Keller, JN
AF Dasuri, Kalavathi
   Zhang, Le
   Ebenezer, Philip
   Liu, Ying
   Fernandez-Kim, Sun Ok
   Keller, Jeffrey N.
TI Aging and dietary restriction alter proteasome biogenesis and
   composition in the brain and liver
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Hepatocyte; Neuron; Oxidative stress; Ubiquitin proteasome pathway
ID PROTEIN OXIDATION; 20S PROTEASOME; RAT-LIVER; OXIDIZED PROTEINS; 26-S
   PROTEASOME; DEGRADATION; INHIBITION; AGE; INACTIVATION; DECLINE
AB Interventions such as dietary restriction (DR) have been reported to ameliorate age-related proteasome inhibition in some tissues. Currently it is not known what effects aging and DR have on proteasome biogenesis in the liver and brain, nor have previous studies identified the links between changes in proteasome composition, biogenesis, and activity in the aging brain and liver. In the present study we demonstrate that the brain and liver exhibit age-dependent decreases in 26S and 20S proteasome activity. Additionally, our studies demonstrate that the brain and liver undergo selective changes in proteasome biology, including increases in proteasome biogenesis in response to aging and DR, with the liver exhibit more robust plasticity as compared to the brain. Lastly, studies demonstrated that aging and DR alter the interaction of Hsp90 with the 20S proteasome complex in the brain and liver. These studies affirm the dynamic nature of the proteasome complexes in both the liver and brain following aging and DR. Additionally, these data indicate that the relationship between proteasome composition/biogenesis and proteasome activity in tissues is extremely complex and tissue specific. These data have implications for understanding the effects of tissue specific effects of aging and DR on protein turnover and proteotoxicity. (C) 2009 Published by Elsevier Ireland Ltd.
C1 [Dasuri, Kalavathi; Zhang, Le; Ebenezer, Philip; Liu, Ying; Fernandez-Kim, Sun Ok; Keller, Jeffrey N.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center
RP Keller, JN (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM jeffrey.keller@pbrc.edu
RI Keller, Jeffrey N/N-1975-2017; DASURI, KALAVATHI/E-7381-2012
OI keller, jeffrey/0000-0002-9892-7423
FU NIA [AG029885, AG025771]
FX This work was generously supported by grants from the NIA (AG029885 and
   AG025771) to J.N.K. The authors thank Dr. Rafael De Cabo at the National
   Institutes of Health for supplying some of the tissue for these studies.
CR Aksenova MV, 1998, MECH AGEING DEV, V100, P157, DOI 10.1016/S0047-6374(97)00133-4
   Ali RE, 2006, ANN NY ACAD SCI, V1067, P394, DOI 10.1196/annals.1354.056
   Amici M, 2003, FREE RADICAL BIO MED, V34, P987, DOI 10.1016/S0891-5849(02)01369-2
   Beedholm R, 2004, CELL STRESS CHAPERON, V9, P49, DOI 10.1379/1466-1268(2004)009<0049:MHSSSP>2.0.CO;2
   Bose S, 2001, BIOCHEM J, V353, P291, DOI 10.1042/0264-6021:3530291
   Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029
   Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155
   Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4
   Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039
   Ciechanover A, 2000, J CELL BIOCHEM, P40
   Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   DAHLMANN B, 1995, BIOCHEM J, V309, P195, DOI 10.1042/bj3090195
   Dasuri K, 2009, FREE RADICAL RES, V43, P28, DOI 10.1080/10715760802534812
   de Vrij FMS, 2004, PROG NEUROBIOL, V74, P249, DOI 10.1016/j.pneurobio.2004.10.001
   Ding QX, 2004, FREE RADICAL BIO MED, V36, P445, DOI 10.1016/j.freeradbiomed.2003.10.025
   Ding QX, 2003, FEBS LETT, V546, P228, DOI 10.1016/S0014-5793(03)00582-9
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323
   Goto S, 2007, ANN NY ACAD SCI, V1100, P431, DOI 10.1196/annals.1395.048
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X
   Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8
   Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106
   Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015
   Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002
   Keller JN, 2006, AGEING RES REV, V5, P1, DOI 10.1016/j.arr.2005.06.002
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025
   Li F, 2008, MECH AGEING DEV, V129, P515, DOI 10.1016/j.mad.2008.04.007
   Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200
   PETERS JM, 1994, J BIOL CHEM, V269, P7709
   Petropoulos I, 2006, FREE RADICAL RES, V40, P1269, DOI 10.1080/10715760600917144
   Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503
   Radák Z, 2002, EXP GERONTOL, V37, P1423, DOI 10.1016/S0531-5565(02)00116-X
   Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001
   Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3
   Rattan Suresh I. S., 2005, Dose-Response, V3, P533, DOI 10.2203/dose-response.003.04.008
   Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB175, DOI 10.1093/gerona/51A.2.B175
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200
   van Tijn P, 2008, PROG NEUROBIOL, V85, P176, DOI 10.1016/j.pneurobio.2008.03.001
   Widmer R, 2006, FREE RADICAL RES, V40, P1259, DOI 10.1080/10715760600911154
   Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959
   Zhang L, 2007, FEBS LETT, V581, P5543, DOI 10.1016/j.febslet.2007.10.054
NR 50
TC 54
Z9 64
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV-DEC
PY 2009
VL 130
IS 11-12
BP 777
EP 783
DI 10.1016/j.mad.2009.10.003
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 547DD
UT WOS:000273864900009
PM 19896962
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Yokozawa, T
   Cho, EJ
   Okamoto, T
   Sei, Y
AF Yokozawa, Takako
   Cho, Eun Ju
   Okamoto, Takuya
   Sei, Yasuo
TI Effects of the Chinese prescription Kangen-karyu and its crude drug
   Tanjin on ageing process in rats
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
ID GLYCATION END-PRODUCTS; AGE-RELATED-CHANGES; KAPPA-B ACTIVATION;
   DEPENDENT INCREASE; MAILLARD REACTION; GENE-EXPRESSION; SERUM-PROTEINS;
   CROSS-LINK; SENESCENCE; APOPTOSIS
AB The effects of the Chinese prescription Kangen-karyu and its crude drug Tanjin on the ageing process were investigated in rats. Diets supplemented with Kangen-karyu and Tanjin extracts decreased glycosylated protein levels in serum, a risk marker of ageing and ageing-related diseases. In addition, they inhibited the levels of thiobarbituric acid reactive substance in the serum and liver; Kangen-karyu in particular led to a strong decrease in hepatic mitochondrial thiobarbituric acid reactive substance. The decline in the reduced glutathione/oxidized glutathione ratio in the liver observed with ageing was ameliorated by Kangen-karyu and Tanjin, while these groups attenuated the increase in glutathione peroxidase activity of hepatic tissue against ageing. This suggests that Kangen-karyu and Tanjin regulate the glutathione redox cycle that maintains the cellular redox condition against age-related oxidative stress. Moreover, the overexpression of cytoplasmic cytochrome c observed with ageing was attenuated by Kangen-karyu and Tanjin. This provides new evidence that Kangen-karyu and Tanjin inhibit leakage of superoxide in mitochondria and attenuate cellular oxidative damage. Furthermore, Kangen-karyu and Tanjin would maintain mitochondrial function with ageing through the regulation of related protein expression such as bax and bcl-2 proteins. In addition, Kangen-karyu reduced the expression of nuclear factor kappa B; Kangen-karyu and Tanjin did not affect the expression of inhibitor kappa B. The present study demonstrated that Kangen-karyu prevented oxidative damage and mitochondrial dysfunction with ageing. Furthermore, Kangen-karyu showed a stronger protective effect against ageing by oxidative stress than Tanjin, probably through synergistic and/or additive effects.
C1 Toyama Univ, Inst Nat Med, Toyama 9300194, Japan.
   Pusan Natl Univ, Dept Food Sci & Nutr, Pusan 609735, South Korea.
   Iskra Ind Co Ltd, Chuo Ku, Tokyo 1030027, Japan.
C3 University of Toyama; Pusan National University
RP Yokozawa, T (corresponding author), Toyama Univ, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.
EM yokozawa@inm.u-toyama.ac.jp
CR Alway SE, 2003, J GERONTOL A-BIOL, V58, P687
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x
   BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569
   Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Chung L, 2006, BBA-MOL BASIS DIS, V1762, P103, DOI 10.1016/j.bbadis.2005.08.003
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FENG JF, 1995, NEURAL PROCESS LETT, V2, P9, DOI 10.1007/BF02309009
   Floreani M, 1997, FREE RADICAL RES, V26, P449, DOI 10.3109/10715769709084481
   FLUCKIGER R, 1976, FEBS LETT, V71, P356, DOI 10.1016/0014-5793(76)80969-6
   Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714
   Gao Ming, 2001, Journal of Traditional Medicines, V18, P245
   Ginn-Pease ME, 1998, FREE RADICAL BIO MED, V25, P346, DOI 10.1016/S0891-5849(98)00067-7
   GOPPELTSTRUEBE M, 1995, PROSTAG LEUKOTR ESS, V52, P213, DOI 10.1016/0952-3278(95)90039-X
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   HUNT JV, 1994, ATHEROSCLEROSIS, V111, P255, DOI 10.1016/0021-9150(94)90100-7
   INOUE M, 1990, FEBS LETT, V269, P89, DOI 10.1016/0014-5793(90)81126-9
   ITZHAKI RF, 1964, ANAL BIOCHEM, V9, P401, DOI 10.1016/0003-2697(64)90200-3
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   JUNG K, 1985, FEBS LETT, V183, P167, DOI 10.1016/0014-5793(85)80977-7
   Kasper M, 2001, ARCH GERONTOL GERIAT, V32, P233, DOI 10.1016/S0167-4943(01)00103-0
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   Kim JM, 1998, CARCINOGENESIS, V19, P81, DOI 10.1093/carcin/19.1.81
   Kim JW, 2002, ARCH GERONTOL GERIAT, V34, P9, DOI 10.1016/S0167-4943(01)00178-9
   KONDO K, 1994, LANCET, V344, P1152, DOI 10.1016/S0140-6736(94)90656-4
   Lavrovsky Y, 2000, MECH AGEING DEV, V114, P49, DOI 10.1016/S0047-6374(00)00087-7
   Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015
   Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697
   Makino T, 2002, BIOL PHARM BULL, V25, P523, DOI 10.1248/bpb.25.523
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   MCFARLAND KF, 1979, DIABETES, V28, P1011, DOI 10.2337/diabetes.28.11.1011
   Miquel J, 2002, ANN NY ACAD SCI, V959, P508, DOI 10.1111/j.1749-6632.2002.tb02120.x
   Nagaraj RH, 1996, J BIOL CHEM, V271, P19338, DOI 10.1074/jbc.271.32.19338
   NAITO C, 1978, JPN J GERIATR, V15, P187
   NOMURA, 1997, FOLIA PHARM JPN S1, V110, P142
   Odani H, 2001, BIOCHEM BIOPH RES CO, V285, P1232, DOI 10.1006/bbrc.2001.5322
   Ono Y, 1998, DIABETES RES CLIN PR, V41, P131, DOI 10.1016/S0168-8227(98)00074-6
   Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704
   Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0
   Sastre J, 2002, ANN NY ACAD SCI, V959, P448, DOI 10.1111/j.1749-6632.2002.tb02114.x
   Satoh A, 2005, J PHARM PHARMACOL, V57, P1335, DOI 10.1111/j.2042-7158.2005.tb01609.x
   Satoh A, 2004, ARCH GERONTOL GERIAT, V39, P69, DOI 10.1016/j.archger.2004.01.001
   SELL DR, 1989, J BIOL CHEM, V264, P21597
   Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1
   SMITH WL, 1994, ANN NY ACAD SCI, V714, P136, DOI 10.1111/j.1749-6632.1994.tb12037.x
   TAKAHASHI H, 1991, CLIN J CHINESE MED, V12, P145
   TAKAHASHI M, 1992, JPN J PHARMACOL, V60, P307, DOI 10.1254/jjp.60.307
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Yokozawa T, 1998, NEPHRON, V78, P201, DOI 10.1159/000044911
   Youssef JA, 2003, MECH AGEING DEV, V124, P333, DOI 10.1016/S0047-6374(02)00189-6
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 53
TC 6
Z9 6
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD DEC
PY 2006
VL 58
IS 12
BP 1591
EP 1599
DI 10.1211/jpp.58.12.0005
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 126BY
UT WOS:000243488400005
PM 17331322
OA Bronze
DA 2024-02-19
ER

PT J
AU Merker, K
   Grune, T
AF Merker, K
   Grune, T
TI Proteolysis of oxidised proteins and cellular senescence
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT Biological Aging - Euroconference on Molecular, Cellular and Tissue
   Gerontology
CY MAY 06-10, 2000
CL SPA, BELGIUM
SP Int Assoc Gerontol, UN Programme Ageing
DE protein oxidation; proteolysis; proteasome; ageing; cellular senescence
ID MODIFIED GLUTAMINE-SYNTHETASE; OXIDATIVE DAMAGE; CALORIE RESTRICTION;
   OXIDIZED PROTEINS; EPITHELIAL-CELLS; EMORY MICE; PROTEASOME; LIVER;
   DEGRADATION; UBIQUITIN
AB Aerobe living is consequently connected with a permanent oxidation of cellular proteins. Free radicals and other oxidants damage the normal intracellular protein pool. Therefore. the prevention of accumulation of oxidised cellular proteins is one of the major functions of the proteolytic machinery of mammalian cells. It is known that the multicatalytic proteinase complex, the proteasome, is the major protease that is able to recognise and degrade oxidised proteins.
   Cellular models are most useful to investigate biochemical changes of protein catabolism during senescence. Unfortunately, little is known about the protein turnover and the regulation of the proteasomal system as well as under oxidative stress conditions as during senescence. The proteasomal regulation during oxidative stress, protein oxidation and the changes of these processes during the ageing process are highlighted in this review. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Humboldt Univ, Fac Med Charite, Clin Phys Med, D-10098 Berlin, Germany.
   Humboldt Univ, Fac Med Charite, Clin Rehabil, D-10098 Berlin, Germany.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin
RP Grune, T (corresponding author), Humboldt Univ, Fac Med Charite, Clin Phys Med, Schumannstr 20-21, D-10098 Berlin, Germany.
OI Grune, Tilman/0000-0003-4775-9973
CR Agarwal S, 1995, MECH AGEING DEV, V85, P55, DOI 10.1016/0047-6374(95)01655-4
   AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8
   AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   AGARWAL S, 1996, EXP GERONTOL, V31, P3387
   BRADLEY MO, 1976, J BIOL CHEM, V251, P3521
   BRUNK UT, 1998, UNDERSTANDING PROCES, P229
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   PACIFICI RE, 1993, J BIOL CHEM, V268, P15405
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   RIVETT AJ, 1993, BIOCHEM J, V291, P1
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   Scrofano MM, 1998, MECH AGEING DEV, V101, P277, DOI 10.1016/S0047-6374(97)00178-4
   SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297
   Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086
   Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STARKEREED PE, 1989, J BIOL CHEM, V272, P20313
   Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
NR 29
TC 55
Z9 57
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2000
VL 35
IS 6-7
SI SI
BP 779
EP 786
DI 10.1016/S0531-5565(00)00140-6
PG 8
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 367ZQ
UT WOS:000090093100014
PM 11053668
DA 2024-02-19
ER

PT J
AU Lee, R
   Lee, WY
   Park, HJ
AF Lee, Ran
   Lee, Won-Yong
   Park, Hyun-Jung
TI Effects of Melatonin on Liver of D-Galactose-Induced Aged Mouse Model
SO CURRENT ISSUES IN MOLECULAR BIOLOGY
LA English
DT Article
DE melatonin; hepatic steatosis; D-Galactose; aging model; inflammation
ID GENE-EXPRESSION; AGING MODEL; DISEASE; INFLAMMATION; METABOLISM; INJURY;
   MICE; STEATOSIS; APOPTOSIS; DAMAGE
AB Melatonin, a hormone secreted by the pineal gland of vertebrates, regulates sleep, blood pressure, and circadian and seasonal rhythms, and acts as an antioxidant and anti-inflammatory agent. We investigated the protective effects of melatonin against markers of D-galactose (D-Gal)-induced hepatocellular aging, including liver inflammation, hepatocyte structural damage, and non-alcoholic fatty liver. Mice were divided into four groups: phosphate-buffered saline (PBS, control), D-Gal (200 mg/kg/day), melatonin (20 mg/kg), and D-Gal (200 mg/kg) and melatonin (20 mg) cotreatment. The treatments were administered once daily for eight consecutive weeks. Melatonin treatment alleviated D-Gal-induced hepatocyte impairment. The AST level was significantly increased in the D-Gal-treated groups compared to that in the control group, while the ALT level was decreased compared to the melatonin and D-Gal cotreated group. Inflammatory genes, such as IL1-beta, NF-kappa B, IL-6, TNF alpha, and iNOS, were significantly increased in the D-Gal aging model, whereas the expression levels of these genes were low in the D-Gal and melatonin cotreated group. Interestingly, the expression levels of hepatic steatosis-related genes, such as LXR alpha, C/EBP alpha, PPAR alpha, ACC, ACOX1, and CPT-1, were markedly decreased in the D-Gal and melatonin cotreated group. These results suggest that melatonin suppresses hepatic steatosis and inflammation in a mouse model of D-Gal-induced aging.
C1 [Lee, Ran; Lee, Won-Yong] Korea Natl Univ Agr & Fisheries, Dept Livestock, Jeonju 54874, South Korea.
   [Lee, Ran; Park, Hyun-Jung] Sangji Univ, Coll Life Sci, Dept Anim Biotechnol, Wonju 26339, South Korea.
C3 Sangji University
RP Park, HJ (corresponding author), Sangji Univ, Coll Life Sci, Dept Anim Biotechnol, Wonju 26339, South Korea.
EM ranran2424@gmail.com; leewy81@korea.kr; parkhj02@sangji.ac.kr
OI Park, Hyun Jung/0000-0002-4589-2052
FU "Regional Innovation Strategy (RIS)" of the National Research Foundation
   of Korea (NRF) - Ministry of Education (MOE) [2022RIS-005]; National
   Research Foundation of Korea (NRF) - Korean Government (MIST)
   [2021R1G1A1091690]
FX This research was supported by "Regional Innovation Strategy (RIS)" of
   the National Research Foundation of Korea (NRF), funded by the Ministry
   of Education (MOE) (2022RIS-005). This study was supported by the
   National Research Foundation of Korea (NRF) grant, funded by the Korean
   Government (MIST) (No. 2021R1G1A1091690).
CR Alberts A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.596103
   Azman KF, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111372
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Cariou B, 2021, DIABETES OBES METAB, V23, P1069, DOI 10.1111/dom.14322
   Chen HC, 2020, J NUTR BIOCHEM, V77, DOI 10.1016/j.jnutbio.2019.108319
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Chen X, 2011, J PINEAL RES, V51, P416, DOI 10.1111/j.1600-079X.2011.00905.x
   Cisneros B, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1059173
   Coelho AI, 2015, CURR OPIN CLIN NUTR, V18, P422, DOI 10.1097/MCO.0000000000000189
   Cordero AIH, 2022, AM J RESP CRIT CARE, V206, P150, DOI 10.1164/rccm.202106-1440OC
   Cordero P, 2013, GENES NUTR, V8, P105, DOI 10.1007/s12263-012-0300-z
   Cordero P, 2013, MOL GENET METAB, V110, P388, DOI 10.1016/j.ymgme.2013.08.022
   Cortes-Canteli M, 2020, J AM COLL CARDIOL, V75, P942, DOI 10.1016/j.jacc.2019.10.062
   Crespo E, 1999, FASEB J, V13, P1537, DOI 10.1096/fasebj.13.12.1537
   Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662
   Escribano BM, 2014, CNS NEUROL DISORD-DR, V13, P1096, DOI 10.2174/1871527313666140806160400
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Ferramosca A, 2014, ADV NUTR, V5, P217, DOI 10.3945/an.113.004762
   Ferramosca A, 2014, WORLD J GASTROENTERO, V20, P1746, DOI 10.3748/wjg.v20.i7.1746
   Ferreira DMS, 2014, FEBS J, V281, P2503, DOI 10.1111/febs.12806
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gao JQ, 2018, CLIN INTERV AGING, V13, P1859, DOI 10.2147/CIA.S173838
   Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952
   Guo J, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01251-0
   Gusarov A. A., 2016, Sudebno-Meditsinskaya Ekspertiza, V59, P61, DOI 10.17116/sudmed201659461-64
   Hall Philip, 2012, Ulster Med J, V81, P30
   Heo JI, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12493
   HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427
   Homolak J, 2023, J RADIAT RES, V64, P743, DOI 10.1093/jrr/rrad046
   Hritcu L, 2015, NEUROCHEM RES, V40, P1799, DOI 10.1007/s11064-015-1662-6
   Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012
   Jing ZT, 2019, AM J PHYSIOL-GASTR L, V316, pG387, DOI 10.1152/ajpgi.00350.2018
   KAUFMAN P, 1950, ANN INTERN MED, V32, P889, DOI 10.7326/0003-4819-32-5-889
   Kennaway DJ, 2017, CRIT REV FOOD SCI, V57, P958, DOI 10.1080/10408398.2014.962686
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   KOTLYAROV P M, 1990, Meditsinskaya Radiologiya, V35, P14
   Lee WY, 2023, THERIOGENOLOGY, V206, P181, DOI 10.1016/j.theriogenology.2023.05.001
   Li C, 2022, J INFLAMM RES, V15, DOI [10.2147/JIR.S369176Journalof, 10.2147/JIR.S369176]
   Liu C, 2021, ADV SCI, V8, DOI 10.1002/advs.202004433
   Liu W, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/4927403
   Liu YX, 2021, HEPATOB PANCREAT DIS, V20, P409, DOI 10.1016/j.hbpd.2021.08.004
   Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002
   Meynial-Denis D, 2016, NUTR REV, V74, P225, DOI 10.1093/nutrit/nuv052
   Mi Y, 2018, CELL BIOCHEM BIOPHYS, V76, P463, DOI 10.1007/s12013-018-0859-0
   Mooli RGR, 2022, CELL MOL GASTROENTER, V13, P1267, DOI 10.1016/j.jcmgh.2022.01.007
   Morava E, 2014, MOL GENET METAB, V112, P275, DOI 10.1016/j.ymgme.2014.06.002
   Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001
   Ou TH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040748
   Park HJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103491
   Park HJ, 2020, TOXICOL SCI, V173, P53, DOI 10.1093/toxsci/kfz212
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Reiter RJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040843
   Rezaeejam H, 2018, J CANCER RES THER, V14, pS1070, DOI 10.4103/0973-1482.196758
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Sato K, 2020, J PINEAL RES, V68, DOI 10.1111/jpi.12639
   Sehgal R, 2023, CLIN EPIGENETICS, V15, DOI 10.1186/s13148-023-01431-x
   Seif M, 2021, ENVIRON SCI POLLUT R, V28, P62943, DOI 10.1007/s11356-021-15142-4
   Sha JY, 2021, PHYTOTHER RES, V35, P4411, DOI 10.1002/ptr.7142
   Shahroudi MJ, 2017, J PHARMACOPUNCT, V20, P29, DOI 10.3831/KPI.2017.20.006
   Sun LY, 2020, BIOCHEM BIOPH RES CO, V521, P113, DOI 10.1016/j.bbrc.2019.10.088
   Tan DX, 2015, MOLECULES, V20, P18886, DOI 10.3390/molecules201018886
   Tarocco A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1556-7
   Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033
   Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270
   Tryndyak VP, 2011, MOL NUTR FOOD RES, V55, P411, DOI 10.1002/mnfr.201000300
   Wang HY, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106445
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   WILKERSON HLC, 1947, AM J PUBLIC HEALTH, V37, P177
   Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang JQ, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1055-y
   Zhang JJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040673
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
   Zhao D, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00249
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 77
TC 0
Z9 0
U1 8
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1467-3037
EI 1467-3045
J9 CURR ISSUES MOL BIOL
JI Curr. Issues Mol. Biol.
PD OCT
PY 2023
VL 45
IS 10
BP 8412
EP 8426
DI 10.3390/cimb45100530
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA W8EF4
UT WOS:001093896600001
PM 37886973
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fukui, M
   Senmaru, T
   Hasegawa, G
   Yamazaki, M
   Asano, M
   Kagami, Y
   Ishigami, A
   Maruyama, N
   Iwasa, K
   Kitawaki, J
   Itoh, Y
   Okanoue, T
   Ohta, M
   Obayashi, H
   Nakamura, N
AF Fukui, Michiaki
   Senmaru, Takafumi
   Hasegawa, Goji
   Yamazaki, Masahiro
   Asano, Mai
   Kagami, Yayoi
   Ishigami, Akihito
   Maruyama, Naoki
   Iwasa, Koichi
   Kitawaki, Jo
   Itoh, Yoshito
   Okanoue, Takeshi
   Ohta, Mitsuhiro
   Obayashi, Hiroshi
   Nakamura, Naoto
TI 17β-Estradiol attenuates saturated fatty acid diet-induced liver injury
   in ovariectomized mice by up-regulating hepatic senescence marker
   protein-30
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Senescence marker protein-30; 17 beta-Estradiol; Endoplasmic reticulum
   stress; Apoptosis; Saturated fatty acids; Nonalcoholic steatohepatitis
ID ENDOPLASMIC-RETICULUM STRESS; TERM EZETIMIBE THERAPY; INDUCED APOPTOSIS;
   GENE-EXPRESSION; DISEASE; SMP30; STEATOSIS; CALCIUM; ALPHA; CELLS
AB Senescence marker protein-30 (SMP30) plays an important role in intracellular Ca2+ homeostasis. The aim of the present study was to investigate the effects of estrogens on liver apoptotic damage and changes in SMP30 expression induced by a high saturated fatty acid diet (HSFD). Ovariectomized mice (OVX) and sham-operated mice (SHAM) were randomly divided into five groups: SHAM fed a normal diet (SHAM/ND). SHAM fed HSFD (SHAM/HSFD), OVX fed ND (OVX/ND), OVX fed HSFD (OVX/HSFD) and OVX fed HSFD with 17 beta-estradiol (E2) supplementation using an implanted slow-release pellet (OVX/ HSFD + E2). After 8 weeks, markers of endoplasmic reticulum (ER) stress and apoptosis, and levels of tumor necrosis factor-alpha (TNF alpha and SMP30 expression were investigated. Compared with SHAM/ND, OVX/HSFD mice showed significantly increased spliced X-box protein-1 (s-XBP1), phosphorylated eukaryotic initiation factor-2 alpha (p-eIF2 alpha), glucose-regulated protein 78 (GPR78), C/EBP homologous protein (CHOP), cytosolic cytochrome c, caspase-3 activity, and TNF alpha, and significantly decreased SMP30. These differences in OVX/HSFD mice were restored to the levels of SHAM/ND mice by E2 supplementation. These results suggest that E2 supplementation attenuates HSFD-induced liver apoptotic death in ovariectomized mice by up-regulating SMP30. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Fukui, Michiaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, Kyoto 6028566, Japan.
   [Iwasa, Koichi; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto 6028566, Japan.
   [Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan.
   [Kagami, Yayoi; Ishigami, Akihito; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
   [Okanoue, Takeshi] Saiseikai Salta Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan.
   [Ohta, Mitsuhiro] Kobe Pharmaceut Univ, Dept Med Biochem, Kobe, Hyogo 658, Japan.
   [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto, Japan.
C3 Kyoto Prefectural University of Medicine; Kyoto Prefectural University
   of Medicine; Kyoto Prefectural University of Medicine; Tokyo
   Metropolitan Institute of Gerontology; Kobe Pharmaceutical University
RP Fukui, M (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kamikyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM michiaki@koto.kpu-m.ac.jp
OI Fukui, Michiaki/0000-0003-0903-1797; Ishigami,
   Akihito/0000-0001-7875-7482
FU Japan Society for the Promotion of Science [23591317, 18590355];
   Ministry of Labor and Welfare Japan [H20-Hepatitis-general-008];
   Grants-in-Aid for Scientific Research [21592104, 23591317, 18590355]
   Funding Source: KAKEN
FX This work was supported by Grants-in-Aid for Scientific Research
   (23591317 to G.H. and 18590355 to Aid.) from the Japan Society for the
   Promotion of Science., and the Ministry of Labor and Welfare Japan (TO.,
   H20-Hepatitis-general-008).
CR Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200
   Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5
   Clark JM, 2003, JAMA-J AM MED ASSOC, V289, P3000, DOI 10.1001/jama.289.22.3000
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0
   Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283
   Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7
   Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4
   Festi D, 2004, Obes Rev, V5, P27, DOI 10.1111/j.1467-789X.2004.00126.x
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kimura M, 2007, J IMMUNOL, V178, P3316, DOI 10.4049/jimmunol.178.5.3316
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282
   Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200
   Pagliassotti MJ, 2007, ENDOCRINOLOGY, V148, P3338, DOI 10.1210/en.2006-1710
   Park H, 2011, J GASTROENTEROL, V46, P101, DOI 10.1007/s00535-010-0291-8
   Park H, 2010, CLIN CHIM ACTA, V411, P1735, DOI 10.1016/j.cca.2010.07.012
   Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3
   Ruhl Constance E, 2004, Clin Liver Dis, V8, P501, DOI 10.1016/j.cld.2004.04.008
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Srivastava S, 2007, FREE RADICAL RES, V41, P38, DOI 10.1080/10715760600943900
   Völzke H, 2007, GUT, V56, P594, DOI 10.1136/gut.2006.115345
   Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570
   Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005
   YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V143, P137, DOI 10.1007/BF01816947
   Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25
   Yatsuji S, 2007, HEPATOL RES, V37, P1034, DOI 10.1111/j.1872-034X.2007.00156.x
   Zhang KZ, 2008, METHOD ENZYMOL, V442, P395, DOI 10.1016/S0076-6879(08)01420-1
NR 35
TC 20
Z9 24
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 18
PY 2011
VL 415
IS 2
BP 252
EP 257
DI 10.1016/j.bbrc.2011.10.025
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 855AB
UT WOS:000297534800008
PM 22037452
DA 2024-02-19
ER

PT J
AU Choi, WG
   Han, J
   Kim, JH
   Kim, MJ
   Park, JW
   Song, B
   Cha, HJ
   Choi, HS
   Chung, HT
   Lee, IK
   Park, TS
   Hatzoglou, M
   Choi, HS
   Yoo, HJ
   Kaufman, RJ
   Back, SH
AF Choi, Woo-Gyun
   Han, Jaeseok
   Kim, Ji-Hyeon
   Kim, Mi-Jeong
   Park, Jae-Woo
   Song, Benbo
   Cha, Hee-Jeong
   Choi, Hye-Seon
   Chung, Hun-Taeg
   Lee, In-Kyu
   Park, Tae-Sik
   Hatzoglou, Maria
   Choi, Hueng-Sik
   Yoo, Hyun Ju
   Kaufman, Randal J.
   Back, Sung Hoon
TI eIF2α phosphorylation is required to prevent hepatocyte death and liver
   fibrosis in mice challenged with a high fructose diet
SO NUTRITION & METABOLISM
LA English
DT Article
DE Nonalcoholic fatty liver disease; Fibrosis; High fructose diet; eIF2
   alpha phosphorylation; Aging; Oxidative stress; Antioxidant enzymes;
   NADPH; Glutathione
ID ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEPATIC
   INSULIN-RESISTANCE; OXIDATIVE STRESS; TRANSLATIONAL CONTROL; CELL-DEATH;
   ER-STRESS; MESSENGER-RNA; GLUTATHIONE SYNTHESIS; LIPID-ACCUMULATION
AB Background: Dietary fructose can rapidly cause fatty liver in animals through de novo lipogenesis (DNL) and contribute to the development and severity of nonalcoholic fatty liver disease (NAFLD). In response to diverse cellular insults including endoplasmic reticulum (ER) and oxidative stress, phosphorylation of the eukaryotic translation initiation factor 2 alpha subunit (eIF2 alpha) attenuates general translation initiation, allowing cells to conserve resources and initiate adaptive gene expression to restore homeostasis. The present study aimed to investigate the role of eIF2 alpha phosphorylation in protecting against NAFLD induced by high fructose ingestion in a hepatocyte-specific eIF2 alpha-phosphorylation-deficient mouse model.
   Methods: Hepatocyte-specific non-phosphorylatable (S51A) eIF2 alpha knock-in (A/A;fTg/0;Cre(Hep)/0, A/A(Hep)) mice were generated by crossing A/A;fTg/fTg mice with the floxed WT eIF2 alpha transgene (fTg) with Alfp-Cre recombinase transgenic S/A;Cre(Hep)/0 (S/A-Cre(Hep)) mice. Hepatocyte-specific eIF2 alpha-phosphorylation-deficient 3-month-old mice or 12-month-old mice were fed a 60% high fructose diet (HFrD) for 16 or 5 wks, and the effects of eIF2 alpha-phosphorylation deficiency on NADP/NADPH and GSSG/GSH levels, ROS-defense gene expression, oxidative damage, cell death, and fibrosis were observed.
   Results: Prolonged fructose feeding to mice caused dysregulation of the unfolded protein response (UPR) sensor activation and UPR gene expression, and then led to decreased expression of several ROS defense genes including glutathione biogenesis genes. Nonetheless, these changes were not sufficient to induce the death of eIF2 alpha phosphorylation-sufficient hepatocytes. However, there was a substantial increase in hepatocyte death and liver fibrosis in fructose-fed middle-aged mice deficient in hepatocyte-specific eIF2 alpha phosphorylation because of diminished antioxidant capacity due to reduced expression of antioxidant enzymes (GPX1 and HO-1) and lower NADPH and glutathione levels, as well as a possible increase in ROS-induced damage from infiltrating NOX2-expressing leukocytes; all this led to a vicious cycle of hepatocyte death and leukocyte infiltration.
   Conclusion: Our findings suggest that eIF2 alpha phosphorylation maintains NADPH and GSH levels and controls the expression of ROS-defense genes, thereby protecting hepatocytes from oxidative stresses induced by fructose metabolism.
C1 [Choi, Woo-Gyun; Kim, Ji-Hyeon; Park, Jae-Woo; Choi, Hye-Seon; Chung, Hun-Taeg; Back, Sung Hoon] Univ Ulsan, Sch Biol Sci, Ulsan 44610, South Korea.
   [Han, Jaeseok; Kaufman, Randal J.] Soonchunhyang Univ, Soonchunhyang Inst Med Bio Sci SIMS, Cheonan Si 31151, Choongchungnam, South Korea.
   [Han, Jaeseok] Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Song, Benbo] NGM Biopharmaceut Inc, 333 Oyster Point Blvd, San Francisco, CA 94080 USA.
   [Cha, Hee-Jeong] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Pathol, Ulsan 44043, South Korea.
   [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med & Biochem & Cell Biol, Daegu 41944, South Korea.
   [Park, Tae-Sik] Gachon Univ, Dept Life Sci, Seongnam, South Korea.
   [Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA.
   [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea.
   [Kim, Ji-Hyeon; Yoo, Hyun Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Biomed Res Ctr, Seoul 05505, South Korea.
C3 University of Ulsan; Soonchunhyang University; Sanford Burnham Prebys
   Medical Discovery Institute; University of Ulsan; Ulsan University
   Hospital; Kyungpook National University; Gachon University; University
   System of Ohio; Case Western Reserve University; Chonnam National
   University; University of Ulsan
RP Back, SH (corresponding author), Univ Ulsan, Sch Biol Sci, Ulsan 44610, South Korea.; Kaufman, RJ (corresponding author), Soonchunhyang Univ, Soonchunhyang Inst Med Bio Sci SIMS, Cheonan Si 31151, Choongchungnam, South Korea.; Yoo, HJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Biomed Res Ctr, Seoul 05505, South Korea.
EM yoohyunju@amc.seoul.kr; rkaufman@sanfordburnham.org; shback@ulsan.ac.kr
RI Lee, In-Kyu/AAR-6374-2021; Kim, Mi-Jeong/AAK-3053-2021; Han,
   Jaeseok/AAE-6872-2020
OI Kim, Mi-Jeong/0000-0002-7887-3309; Choi, Hye-Seon/0000-0003-2992-2677
FU Basic Science Research Program [2011-0011433, 2014R1A1A4A01004329]; Bio
   & Medical Technology Development Program [2012M3A9C3050632]; Priority
   Research Centers Program of the National Research Foundation of Korea
   (NRF) - Korean government [2014R1A6A1030318]; National Institutes of
   Health (NIH) [DK042394, DK110973, DK103185, CA198103]
FX This work was supported by the Basic Science Research Program
   (2011-0011433 and 2014R1A1A4A01004329 to S.H.B), the Bio & Medical
   Technology Development Program (2012M3A9C3050632 to S.H.B), and the
   Priority Research Centers Program (2014R1A6A1030318 to S.H.B) of the
   National Research Foundation of Korea (NRF) funded by the Korean
   government. Portions of this work were supported by National Institutes
   of Health (NIH) grants (DK042394, DK110973, DK103185, and CA198103 to
   R.J.K.).
CR Abraham NG, 2007, CURR GENE THER, V7, P89, DOI 10.2174/156652307780363134
   Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044
   Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200
   Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002
   Balakumar M, 2016, MOL CELL BIOCHEM, V423, P93, DOI 10.1007/s11010-016-2828-5
   Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625
   Bose T, 2008, BBA-GEN SUBJECTS, V1780, P800, DOI 10.1016/j.bbagen.2008.02.001
   BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669
   Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a
   Cao SS, 2014, INFLAMM BOWEL DIS, V20, P712, DOI 10.1097/MIB.0000000000000010
   Castro MC, 2013, BBA-GEN SUBJECTS, V1830, P2226, DOI 10.1016/j.bbagen.2012.10.010
   Castro MC, 2012, CLIN SCI, V123, P681, DOI 10.1042/CS20110665
   Chan SMH, 2013, DIABETES, V62, P2095, DOI 10.2337/db12-1397
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528
   Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010
   Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018
   Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754
   Diggle CP, 2009, J HISTOCHEM CYTOCHEM, V57, P763, DOI 10.1369/jhc.2009.953190
   Dong QA, 2010, CHEM-BIOL INTERACT, V188, P31, DOI 10.1016/j.cbi.2010.06.006
   Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Francini F, 2010, LIFE SCI, V86, P965, DOI 10.1016/j.lfs.2010.05.005
   Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107
   FUKUDA H, 1983, J NUTR SCI VITAMINOL, V29, P691, DOI 10.3177/jnsv.29.691
   Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738
   Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Hine CM, 2012, J CLIN EXP PATHOL S, VS4
   Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542
   Jaiswal N, 2015, APOPTOSIS, V20, P930, DOI 10.1007/s10495-015-1128-y
   Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760
   Kavanagh K, 2013, AM J CLIN NUTR, V98, P349, DOI 10.3945/ajcn.112.057331
   Korsmeyer SJ, 1999, CANCER RES, V59, p1693S
   Lee O, 2009, CHEM-BIOL INTERACT, V178, P332, DOI 10.1016/j.cbi.2008.10.011
   Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200
   Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41
   Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743
   Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11
   Montgomery MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18474
   Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058
   Muaddi H, 2010, MOL BIOL CELL, V21, P3220, DOI 10.1091/mbc.E10-01-0023
   Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513
   Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011
   Paik YH, 2014, ANTIOXID REDOX SIGN, V20, P2854, DOI 10.1089/ars.2013.5619
   Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281
   Parviz F, 2002, GENESIS, V32, P130, DOI 10.1002/gene.10058
   Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004
   Rajesh K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.554
   Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Rouschop KM, 2013, P NATL ACAD SCI USA, V110, P4622, DOI 10.1073/pnas.1210633110
   Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003
   Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9
   Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4
   Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Suzuki A, 2000, HEPATOLOGY, V32, P796, DOI 10.1053/jhep.2000.17738
   Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184
   Takahashi T, 2004, CURR MED CHEM, V11, P1545, DOI 10.2174/0929867043365080
   Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009
   Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510
   Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132
   Vos MB, 2013, HEPATOLOGY, V57, P2525, DOI 10.1002/hep.26299
   Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007
   Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764
   Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526
   Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2
   YARNAMOTO K, 2007, DEV CELL, V13, P365, DOI DOI 10.1016/J.DEVCEL.2007.07.018
   Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81
   Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007
   Zhang C, 2012, TOXICOL LETT, V212, P229, DOI 10.1016/j.toxlet.2012.06.002
   Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52
   Zhang X, 2015, ANTIOXID REDOX SIGN, V22, P848, DOI 10.1089/ars.2014.5868
NR 79
TC 22
Z9 25
U1 1
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD AUG 1
PY 2017
VL 14
AR 48
DI 10.1186/s12986-017-0202-6
PG 21
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA FC6NA
UT WOS:000406955900001
PM 28781602
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU van der Bilt, JDW
   Kranenburg, O
   Borren, A
   van Hillegersberg, R
   Rinkes, IHMB
AF van der Bilt, Jarmila D. W.
   Kranenburg, Onno
   Borren, Alie
   van Hillegersberg, Richard
   Rinkes, Inne H. M. Borel
TI Ageing and hepatic steatosis exacerbate ischemia/reperfusion-accelerated
   outgrowth of colorectal micrometastases
SO ANNALS OF SURGICAL ONCOLOGY
LA English
DT Article
DE ischemia; reperfusion; vascular clamping; residual tumor growth;
   colorectal liver metastases; prognosis; ageing; steatosis; gender
ID MAJOR LIVER RESECTION; PORTAL TRIAD; METASTASES; ISCHEMIA; INJURY;
   HYPOXIA; CANCER; CHEMOTHERAPY; HEPATECTOMY; RECURRENCE
AB Background: Ischemia/reperfusion (I/R) injury is frequently encountered during hepatic surgery. We recently showed that I/R accelerates the outgrowth of pre-established colorectal micrometastases. The aim of this study was to assess the influence of ischemia time, gender, age, and liver steatosis on the accelerated outgrowth of colorectal metastases following I/R.
   Methods: Five days after tumor cell inoculation, mice were subjected to 20, 30 or 45 min of left lobar I/R. To assess the influence of age, gender, and liver steatosis on I/R-accelerated tumor growth, we compared old with young mice, male with female mice, and mice with healthy livers with mice with steatotic livers. Endpoints were extent of tissue necrosis and tumor growth.
   Results: With increasing ischemia times, tissue necrosis and I/R-accelerated tumor growth increased, with a significant stimulatory effect at 30 and 45 min of ischemia. I/R-stimulated outgrowth of micrometastases was further increased by 33% in aged mice and by 42% in steatotic livers and was associated with increased tissue necrosis. In female mice tissue necrosis had decreased by 47% and tumor growth was reduced in both control and clamped liver lobes. The stimulatory effect of I/R on metastasis outgrowth was similar in male and female mice.
   Conclusions: I/R-accelerated outgrowth of colorectal micrometastases largely depends on the duration of the ischemic period, with a safe upper limit of 20 min in mice. The stimulatory effects of I/R on tumor growth are exacerbated in aged mice and in steatotic livers.
C1 [van der Bilt, Jarmila D. W.; Kranenburg, Onno; Borren, Alie; van Hillegersberg, Richard; Rinkes, Inne H. M. Borel] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands.
   [Rinkes, Inne H. M. Borel] Dept Surg G04 228, NL-3508 GA Utrecht, Netherlands.
C3 Utrecht University; Utrecht University Medical Center
RP Rinkes, IHMB (corresponding author), Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands.
EM i.h.m.borelrinkes@umcutrecht.nl
RI Kranenburg, Onno/K-4115-2015
OI Kranenburg, Onno/0000-0002-2112-4390; Borren, Alie/0000-0002-6118-0899
CR Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
   Behrns K E, 1998, J Gastrointest Surg, V2, P292, DOI 10.1016/S1091-255X(98)80025-5
   Belghiti J, 1999, ANN SURG, V229, P369, DOI 10.1097/00000658-199903000-00010
   Benoist S, 2006, SURGERY, V140, P396, DOI 10.1016/j.surg.2006.03.023
   Brahimi-Horn C, 2001, TRENDS CELL BIOL, V11, pS32, DOI 10.1016/S0962-8924(01)82185-1
   Brand MI, 2000, AM SURGEON, V66, P412
   Cescon M, 2003, ARCH SURG-CHICAGO, V138, P547, DOI 10.1001/archsurg.138.5.547
   Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d
   DELVA E, 1989, ANN SURG, V209, P211, DOI 10.1097/00000658-198902000-00012
   Eckhoff DE, 2002, SURGERY, V132, P302, DOI 10.1067/msy.2002.125718
   ELIAS D, 1991, BRIT J SURG, V78, P42, DOI 10.1002/bjs.1800780115
   Fong Y, 1997, BRIT J SURG, V84, P1386
   Gasbarrini A, 1998, SCAND J GASTROENTERO, V33, P1107
   Harada H, 2001, J APPL PHYSIOL, V91, P2816, DOI 10.1152/jappl.2001.91.6.2816
   Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704
   Hines IN, 2003, AM J PHYSIOL-GASTR L, V284, pG536, DOI 10.1152/ajpgi.00400.2002
   HUGUET C, 1994, J AM COLL SURGEONS, V178, P454
   Ijaz S, 2003, MICROCIRCULATION, V10, P447, DOI 10.1038/sj.mn.7800206
   KAHN D, 1986, EUR SURG RES, V18, P277, DOI 10.1159/000128536
   Karoui M, 2006, ANN SURG, V243, P1, DOI 10.1097/01.sla.0000193603.26265.c3
   LECOUTEUR DG, 1994, TRANSPLANTATION, V58, P531, DOI 10.1097/00007890-199409150-00001
   Leporrier J, 2006, BRIT J SURG, V93, P465, DOI 10.1002/bjs.5278
   Liu DL, 1996, ARCH SURG-CHICAGO, V131, P442
   Lü P, 2005, WORLD J GASTROENTERO, V11, P3441
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Nakajima Y, 2002, SURG TODAY, V32, P48
   NORDLINGER B, 1980, SURG GYNECOL OBSTET, V150, P859
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Quan D, 1996, Liver Transpl Surg, V2, P99, DOI 10.1002/lt.500020203
   Ratto C, 1998, DIS COLON RECTUM, V41, P1033, DOI 10.1007/BF02237397
   Sakamoto Y, 1999, HEPATO-GASTROENTEROL, V46, P457
   Scheele J, 1999, LANGENBECK ARCH SURG, V384, P313, DOI 10.1007/s004230050209
   SELZNER M, 2004, MALIGNANT LIVER TUMO, P153
   Selzner N, 2006, J HEPATOL, V44, P694, DOI 10.1016/j.jhep.2005.07.032
   Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033
   van der Bilt JDW, 2007, DIGEST SURG, V24, P423, DOI 10.1159/000108325
   van der Bilt JDW, 2006, BRIT J SURG, V93, P1015, DOI 10.1002/bjs.5382
   van der Bilt JDW, 2007, AM J PATHOL, V170, P1379, DOI 10.2353/ajpath.2007.061028
   van der Bilt JDW, 2005, HEPATOLOGY, V42, P165, DOI 10.1002/hep.20739
   Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074
   Wang JY, 1996, DIS COLON RECTUM, V39, P847, DOI 10.1007/BF02053981
   Yokoyama N, 2002, CANCER, V94, P1642, DOI 10.1002/cncr.10422
NR 42
TC 32
Z9 32
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-9265
J9 ANN SURG ONCOL
JI Ann. Surg. Oncol.
PD MAY
PY 2008
VL 15
IS 5
BP 1392
EP 1398
DI 10.1245/s10434-007-9758-0
PG 7
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA 283FW
UT WOS:000254623100020
PM 18335279
DA 2024-02-19
ER

PT J
AU Duan, JL
   Liu, JJ
   Ruan, B
   Ding, J
   Fang, ZQ
   Xu, H
   Song, P
   Xu, C
   Li, ZW
   Du, W
   Xu, M
   Ling, YW
   He, F
   Wang, L
AF Duan, Juan-Li
   Liu, Jing-Jing
   Ruan, Bai
   Ding, Jian
   Fang, Zhi-Qiang
   Xu, Hao
   Song, Ping
   Xu, Chen
   Li, Zhi-Wen
   Du, Wei
   Xu, Ming
   Ling, Yu-Wei
   He, Fei
   Wang, Lin
TI Age-related liver endothelial zonation triggers steatohepatitis by
   inactivating pericentral endothelium-derived C-kit
SO NATURE AGING
LA English
DT Article; Early Access
ID EXPRESSION; CELLS; ATLAS; AXIS
AB The authors show that liver sinusoidal endothelial cell (LSEC) senescence promotes steatosis by reprogramming liver endothelial zonation and inhibiting C-kit, a type III receptor tyrosine kinase. Infusing C-kit-expressing LSECs in aged or diet-induced NASH mice counteracts senescence and steatosis.
   Aging leads to systemic metabolic disorders, including steatosis. Here we show that liver sinusoidal endothelial cell (LSEC) senescence accelerates liver sinusoid capillarization and promotes steatosis by reprogramming liver endothelial zonation and inactivating pericentral endothelium-derived C-kit, which is a type III receptor tyrosine kinase. Specifically, inhibition of endothelial C-kit triggers cellular senescence, perturbing LSEC homeostasis in male mice. During diet-induced nonalcoholic steatohepatitis (NASH) development, Kit deletion worsens hepatic steatosis and exacerbates NASH-associated fibrosis and inflammation. Mechanistically, C-kit transcriptionally inhibits chemokine (C-X-C motif) receptor (CXCR)4 via CCAAT enhancer-binding protein alpha (CEBPA). Blocking CXCR4 signaling abolishes LSEC-macrophage-neutrophil cross-talk and leads to the recovery of C-kit-deficient mice with NASH. Of therapeutic relevance, infusing C-kit-expressing LSECs into aged mice or mice with diet-induced NASH counteracts age-associated senescence and steatosis and improves the symptoms of diet-induced NASH by restoring metabolic homeostasis of the pericentral liver endothelium. Our work provides an alternative approach that could be useful for treating aging- and diet-induced NASH.
C1 [Duan, Juan-Li; Liu, Jing-Jing; Ruan, Bai; Ding, Jian; Fang, Zhi-Qiang; Xu, Hao; Song, Ping; Xu, Chen; Li, Zhi-Wen; Du, Wei; Xu, Ming; Ling, Yu-Wei; He, Fei; Wang, Lin] Fourth Mil Med Univ, Xi Jing Hosp, Dept Hepatobiliary Surg, Xian, Peoples R China.
   [Ruan, Bai] Fourth Mil Med Univ, Ctr Clin Aerosp Med, Xian, Peoples R China.
   [Ruan, Bai] Fourth Mil Med Univ, Dept Aviat Med, Xian, Peoples R China.
C3 Air Force Military Medical University; Air Force Military Medical
   University; Air Force Military Medical University
RP Wang, L (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, Dept Hepatobiliary Surg, Xian, Peoples R China.
EM fierywang@163.com
RI LI, Jing/HNB-5575-2023
FU National Key Research and Development Program of China [2016YFA0102100,
   2021YFA1100500]; NSFC [81422009, 81770560, 81870430, 82270637]
FX We thank H. Han from the Fourth Military Medical University for
   technical assistance. This work was supported by grants from the
   National Key Research and Development Program of China (2016YFA0102100,
   2021YFA1100500) and NSFC 81422009, 81770560, 81870430 and 82270637.
CR Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1
   Cao YW, 2017, AGING DIS, V8, P314, DOI 10.14336/AD.2016.1101
   Dimova I, 2019, J CELL MOL MED, V23, P3916, DOI 10.1111/jcmm.14269
   Duan JL, 2022, CELL MOL GASTROENTER, V13, P1741, DOI 10.1016/j.jcmgh.2022.01.019
   Duan JL, 2022, HEPATOLOGY, V75, P584, DOI 10.1002/hep.32209
   Duan JL, 2018, HEPATOLOGY, V68, P677, DOI 10.1002/hep.29834
   Fang ZQ, 2022, HEPATOLOGY, V76, P742, DOI 10.1002/hep.32332
   Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Fujio K, 1996, EXP CELL RES, V224, P243, DOI 10.1006/excr.1996.0134
   Furuta K, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143690
   Grunewald M, 2021, SCIENCE, V373, P533, DOI 10.1126/science.abc8479
   Halpern KB, 2017, NATURE, V543, DOI 10.1038/nature21729
   Hammoutene A, 2019, J HEPATOL, V70, P1278, DOI 10.1016/j.jhep.2019.02.012
   Hamrick MW, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101175
   Harvey BE, 2022, ACTA PHARMACOL SIN, V43, P1210, DOI 10.1038/s41401-021-00832-z
   Hennigs JK, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102712
   Honda M, 2018, NAT REV GASTRO HEPAT, V15, P206, DOI 10.1038/nrgastro.2017.183
   Ibrahim SH, 2018, GUT, V67, P963, DOI 10.1136/gutjnl-2017-315691
   Inverso D, 2021, DEV CELL, V56, P1677, DOI 10.1016/j.devcel.2021.05.001
   Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kus E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00006
   Luna G, 2004, STEM CELLS DEV, V13, P528, DOI 10.1089/scd.2004.13.528
   Ma RH, 2020, ELIFE, V9, DOI 10.7554/eLife.46206
   MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7
   Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22
   Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95
   Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007
   Qing J, 2022, J HEPATOL, V76, P394, DOI 10.1016/j.jhep.2021.09.032
   Regina C, 2016, MECH AGEING DEV, V159, P14, DOI 10.1016/j.mad.2016.05.003
   Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049
   Sadri F, 2022, MOL BIOL REP, V49, P3307, DOI 10.1007/s11033-021-07069-3
   Su TT, 2021, CELL MOL GASTROENTER, V11, P1139, DOI 10.1016/j.jcmgh.2020.12.007
   Sun XH, 2020, AM J PHYSIOL-CELL PH, V318, pC1200, DOI 10.1152/ajpcell.00062.2020
   Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638
   van der Windt DJ, 2018, HEPATOLOGY, V68, P1347, DOI 10.1002/hep.29914
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Wang WN, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.598855
   Xu XL, 2017, AGING DIS, V8, P590, DOI 10.14336/AD.2017.0430
   Zhang H, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd1206
   Zhu SC, 2022, CELL MOL GASTROENTER, V13, P1757, DOI [10.1016/j.jcmgh.2022.02.010), 10.1016/j.jcmgh.2022.02.010]
NR 43
TC 7
Z9 7
U1 5
U2 9
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD 2023 MAR
PY 2023
VL 3
IS 3
BP 258
EP +
DI 10.1038/s43587-022-00348-z
EA DEC 2022
PG 33
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA 9X4FT
UT WOS:000946124000001
PM 37118422
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Haridoss, S
   Yovchev, MI
   Schweizer, H
   Megherhi, S
   Beecher, M
   Locker, J
   Oertel, M
AF Haridoss, Srividyameena
   Yovchev, Mladen I.
   Schweizer, Hannah
   Megherhi, Sabreen
   Beecher, Maria
   Locker, Joseph
   Oertel, Michael
TI Activin A Is a Prominent Autocrine Regulator of Hepatocyte Growth Arrest
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article
ID FACTOR-BETA; GENE-EXPRESSION; CELL COMPETITION; DNA-SYNTHESIS; IN-VIVO;
   LIVER; FOLLISTATIN; PROLIFERATION; TRANSCRIPTION; SENESCENCE
AB Activin A, a multifunctional cytokine, plays an important role in hepatocyte growth suppression and is involved in liver size control. The present study was aimed to determine the cell location of activin A in the normal rat liver microenvironment and the contribution of activin A signaling to the hepatocyte phenotype to obtain insight into molecular mechanisms. Immunohistochemical and in situ hybridization analyses identified hepatocytes as the major activin A-positive cell population in normal liver and identified mast cells as an additional activin A source. To investigate paracrine and autocrine activin A-stimulated effects, hepatocytes were cocultured with engineered activin A-secreting cell lines (RF1, TL8) or transduced with an adeno-associated virus vector encoding activin bA, which led to strikingly altered expression of cell cycle-related genes (Ki-67, E2F transcription factor 1 [E2F1], minichromosome maintenance complex component 2 [Mcm2], forkhead box M1 [FoxM1]) and senescence-related genes (cyclin-dependent kinase inhibitor 2B [p15(INK4b)/CDKN2B], differentiated embryo-chondrocyte expressed gene 1 [DEC1]) and reduced proliferation and induction of senescence. Microarray analyses identified 453 differentially expressed genes, many of which were not yet recognized as activin A downstream targets (e.g., ADAM metallopeptidase domain 12 [Adam12], semaphorin 7A [Sema7a], LIM and cysteine-rich domains-1 [Lmcd1], DAB2, clathrin adaptor protein [Dab2]). Among the main activin A-mediated molecular/cellular functions are cellular growth/proliferation and movement, molecular transport, and metabolic processes containing highly down-regulated genes, such as cytochrome P450, subfamily 2, polypeptide 11 (Cyp2C11), sulfotransferase family 1A, member 1 (Sult1a1), glycine-N-acyltransferase (Glyat), and bile acid-CoA:amino acid N-acyltransferase (Baat). Moreover, Ingenuity Pathway Analyses identified particular gene networks regulated by hepatocyte nuclear factor (HNF)-4 alpha and peroxisome proliferator-activated receptor gamma (PPAR gamma) as key targets of activin Asignaling. Conclusion: Our in vitro models demonstrated that activin A-stimulated growth inhibition and cellular senescence is mediated through p15(INK4b)/CDKN2B and is associated with up-and down-regulation of numerous target genes involved in multiple biological processes performed by hepatocytes, suggesting that activin A fulfills a critical role in normal liver function.
C1 [Haridoss, Srividyameena; Yovchev, Mladen I.; Schweizer, Hannah; Megherhi, Sabreen; Beecher, Maria; Locker, Joseph; Oertel, Michael] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.
   [Locker, Joseph; Oertel, Michael] Univ Pittsburgh, Pittsburgh Liver Res Ctr, Pittsburgh, PA USA.
   [Oertel, Michael] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh
RP Oertel, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St,BST S-404, Pittsburgh, PA 15261 USA.
EM mio19@pitt.edu
OI Locker, Joseph/0000-0002-4190-188X; , Maria/0000-0002-7672-0157
FU National Institutes of Health [R01 DK090325]
FX Supported by National Institutes of Health grant R01 DK090325 (to M.O.).
CR Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Ashida Y, 2017, GENES CELLS, V22, P189, DOI 10.1111/gtc.12467
   Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046
   Bak B, 2009, J ENDOCRINOL, V201, P89, DOI 10.1677/JOE-08-0460
   Bale SS, 2015, TISSUE ENG PART C-ME, V21, P413, DOI [10.1089/ten.tec.2014.0152, 10.1089/ten.TEC.2014.0152]
   Brennan EP, 2012, BBA-MOL BASIS DIS, V1822, P589, DOI 10.1016/j.bbadis.2012.01.008
   Chen YG, 2006, EXP BIOL MED, V231, P534
   DABEVA MD, 1993, AM J PATHOL, V143, P1606
   Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59
   De Minicis S, 2013, AM J PATHOL, V183, P820, DOI 10.1016/j.ajpath.2013.05.030
   DeBleser PJ, 1997, HEPATOLOGY, V26, P905
   Du LT, 2016, CANCER MED-US, V5, P1962, DOI 10.1002/cam4.719
   Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009
   Freeman A, 2003, J VIRAL HEPATITIS, V10, P345, DOI 10.1046/j.1365-2893.2003.00454.x
   Funaba M, 2003, CELL SIGNAL, V15, P605, DOI 10.1016/S0898-6568(02)00150-X
   Gold EJ, 2005, J MOL ENDOCRINOL, V34, P505, DOI 10.1677/jme.1.01657
   Gressner OA, 2008, LIVER INT, V28, P1207, DOI 10.1111/j.1478-3231.2008.01729.x
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789
   Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435
   Hughes RD, 2003, EUR J GASTROEN HEPAT, V15, P127, DOI 10.1097/00042737-200302000-00004
   Iber H, 1998, DRUG METAB DISPOS, V26, P1042
   Ichikawa T, 2001, HEPATOLOGY, V34, P918, DOI 10.1053/jhep.2001.29132
   KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369
   Kang Liang-I, 2012, Cells, V1, P1261, DOI 10.3390/cells1041261
   KANZAKI M, 1995, MOL CELL ENDOCRINOL, V108, P11, DOI 10.1016/0303-7207(94)03451-X
   Kogure K, 2000, HEPATOLOGY, V31, P916, DOI 10.1053/he.2000.6100
   Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Link AS, 2016, MOL NEUROBIOL, V53, P4210, DOI 10.1007/s12035-015-9363-3
   Loomans HA, 2015, CANCERS, V7, P70, DOI 10.3390/cancers7010070
   Menthena A, 2011, GASTROENTEROLOGY, V140, P1009, DOI 10.1053/j.gastro.2010.12.003
   Miki Y, 2012, J STEROID BIOCHEM, V131, P68, DOI 10.1016/j.jsbmb.2011.12.004
   Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Patella S, 2001, J HEPATOL, V34, P576, DOI 10.1016/S0168-8278(00)00029-5
   Pellicoro A, 2007, HEPATOLOGY, V45, P340, DOI 10.1002/hep.21528
   Penzo-Méndez AI, 2014, WIRES DEV BIOL, V3, P419, DOI 10.1002/wdev.148
   SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Sinicropi D, 2006, MICRO NANOTECHNOLOGY, VII, P23
   Takabe K, 2003, HEPATOLOGY, V38, P1107, DOI 10.1053/jhep.2003.50483
   Takamura K, 2005, J SURG RES, V126, P3, DOI 10.1016/j.jss.2005.01.002
   TSUJII H, 1993, GASTROENTEROLOGY, V105, P495, DOI 10.1016/0016-5085(93)90725-R
   Voumvouraki A, 2012, EUR J CLIN INVEST, V42, P815, DOI 10.1111/j.1365-2362.2012.02647.x
   Walesky C, 2013, AM J PHYSIOL-GASTR L, V304, pG26, DOI 10.1152/ajpgi.00064.2012
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727
   Yovchev MI, 2016, J HEPATOL, V64, P1348, DOI 10.1016/j.jhep.2016.01.036
NR 50
TC 10
Z9 12
U1 1
U2 4
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD NOV
PY 2017
VL 1
IS 9
BP 852
EP 870
DI 10.1002/hep4.1106
PG 19
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HE2SC
UT WOS:000453177400002
PM 29404498
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hopkinson, BM
   Desler, C
   Kalisz, M
   Vestentoft, PS
   Rasmussen, LJ
   Bisgaard, HC
AF Hopkinson, Branden M.
   Desler, Claus
   Kalisz, Mark
   Vestentoft, Peter Siig
   Rasmussen, Lene Juel
   Bisgaard, Hanne Cathrine
TI Bioenergetic Changes during Differentiation of Human Embryonic Stem
   Cells along the Hepatic Lineage
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID MITOCHONDRIAL; LIVER; GLYCOLYSIS; EXPRESSION; GENERATION; PHENOTYPES;
   MUSCLE
AB Mitochondrial dysfunction has been demonstrated to result in premature aging due to its effects on stem cells. Nevertheless, a full understanding of the role of mitochondrial bioenergetics through differentiation is still lacking. Here we show the bioenergetics profile of human stem cells of embryonic origin differentiating along the hepatic lineage. Our study reveals especially the transition between hepatic specification and hepatic maturation as dependent on mitochondrial respiration and demonstrates that even though differentiating cells are primarily dependent on glycolysis until induction of hepatocyte maturation, oxidative phosphorylation is essential at all stages of differentiation.
C1 [Hopkinson, Branden M.; Desler, Claus; Vestentoft, Peter Siig; Rasmussen, Lene Juel; Bisgaard, Hanne Cathrine] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.
   [Desler, Claus; Rasmussen, Lene Juel] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth Sci, Copenhagen, Denmark.
   [Kalisz, Mark] Hagedorn Res Inst, Dept Dev Biol, DK-2820 Gentofte, Denmark.
C3 University of Copenhagen; University of Copenhagen; Novo Nordisk;
   Hagedorn Research Institute
RP Desler, C (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.; Desler, C (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Fac Hlth Sci, Copenhagen, Denmark.
EM cdesler@sund.ku.dk
RI Vestentoft, Peter Siig/I-2951-2018; Bisgaard, Hans/N-4761-2016;
   Vestentoft, Peter/V-6032-2019
OI Vestentoft, Peter Siig/0000-0002-9281-433X; Bisgaard,
   Hans/0000-0003-4131-7592; Rasmussen, Lene Juel/0000-0001-6864-963X;
   desler, claus/0000-0002-0125-004X
FU Vera and Carl Michaelsen's Legat (Hanne Cathrine Bisgaard); Nordeafonden
   (Lene Juel Rasmussen and Claus Desler)
FX This work is supported by grants from Vera and Carl Michaelsen's Legat
   (Hanne Cathrine Bisgaard) and Nordeafonden (Lene Juel Rasmussen and
   Claus Desler). The authors would like to thank Dr. Palle Serup, The
   Danish Stem Cell Center, Faculty of Health and Medical Sciences,
   University of Copenhagen, for his valuable help regarding the culture of
   human embryonic stem cells. Furthermore, they would like to acknowledge
   the Core Facility for Integrated Microscopy, Faculty of Health and
   Medical Sciences, University of Copenhagen, for help with the confocal
   microscopy.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509
   Desler C, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701518
   Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972
   Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011
   Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827
   Khiati S, 2015, P NATL ACAD SCI USA, V112, P11282, DOI 10.1073/pnas.1511016112
   Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023
   Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641
   Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105
   Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237
   Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036
   Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011
   Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje
   Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vestentoft PS, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-56
   Wilding M, 2005, ZYGOTE, V13, P317, DOI 10.1017/S0967199405003382
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
   Zhang LH, 2014, PULM CIRC, V4, P387, DOI 10.1086/677353
NR 25
TC 17
Z9 18
U1 0
U2 3
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2017
VL 2017
AR 5080128
DI 10.1155/2017/5080128
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EL9IH
UT WOS:000394933400001
PM 28265337
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Choi, YJ
   Yun, SH
   Yu, J
   Mun, Y
   Lee, W
   Park, CJ
   Han, BW
   Lee, BH
AF Choi, You-Jin
   Yun, Sung Ho
   Yu, Jihyeon
   Mun, Yewon
   Lee, Wonseok
   Park, Cheon Jun
   Han, Byung Woo
   Lee, Byung-Hoon
TI Chaperone-mediated autophagy dysregulation during aging impairs hepatic
   fatty acid oxidation via accumulation of NCoR1
SO MOLECULAR METABOLISM
LA English
DT Article
DE Aging; Chaperone-mediated autophagy; PPARa; NCoR1; Fatty acid oxidation
ID NUCLEAR RECEPTOR COREPRESSOR; LIVER; PROTEIN; ROLES; IDENTIFICATION;
   DEGRADATION; DEFICIENCY; DISEASE; ALPHA
AB Objective: Alterations in lipid metabolism are associated with aging and age-related diseases. Chaperone-mediated autophagy (CMA) is a lysosome-dependent process involved in specific protein degradation. Heat shock cognate 71 kDa protein (Hsc70) recognizes cytosolic proteins with KFERQ motif and allows them to enter the lysosome via lysosome-associated membrane glycoprotein 2 isoform A (LAMP2A). CMA deficiency is associated with dysregulated lipid metabolism in the liver. In this study, we examined the effect of CMA on lipid metabolism in the aged liver. Methods: 12-week-old and 88-week-old mice were employed to assess the effect of aging on hepatic CMA activity. We generated CMA-deficient mouse primary hepatocytes using siRNA for Lamp2a and liver-specific LAMP2A knockdown mice via adeno-associated viruses expressing short hairpin RNAs to investigate the influence of CMA on lipid metabolism. Results: We noted aging-induced progression toward fatty liver and a decrease in LAMP2A levels in total protein and lysosomes. The expression of genes associated with fatty acid oxidation was markedly downregulated in the aged liver, as verified in CMA-deficient mouse primary hepatocytes. In addition, the aged liver accumulated nuclear receptor corepressor 1 (NCoR1), a negative regulator of peroxisome proliferator-activated receptor a (PPARa). We found that Hsc70 binds to NCoR1 via the KFERQ motif. Lamp2a siRNA treatment accumulated NCoR1 and decreased the fatty acid oxidation rate. Pharmacological activation of CMA by AR7 treatment increased LAMP2A expression, leading to NCoR1 degradation. A liver-specific LAMP2A knockdown via adeno-associated viruses expressing short hairpin RNAs caused NCoR1 accumulation, inactivated PPARa, downregulated the expression of fatty acid oxidation-related genes and significantly increased liver triglyceride levels. Conclusions: Our results elucidated a novel PPARa regulatory mechanism involving CMA-mediated NCoR1 degradation during aging. These findings demonstrate that CMA dysregulation is crucial for the progression of aging-related fatty liver diseases.
C1 [Choi, You-Jin; Yun, Sung Ho; Mun, Yewon; Lee, Wonseok; Park, Cheon Jun; Han, Byung Woo; Lee, Byung-Hoon] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.
   [Choi, You-Jin; Yun, Sung Ho; Mun, Yewon; Lee, Wonseok; Park, Cheon Jun; Han, Byung Woo; Lee, Byung-Hoon] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul 08826, South Korea.
   [Yu, Jihyeon] Korea Polar Res Inst, Div Life Sci, Incheon 21990, South Korea.
   [Lee, Byung-Hoon] 1 Gwanak Ro, Seoul 08826, South Korea.
C3 Seoul National University (SNU); Seoul National University (SNU); Korea
   Polar Research Institute (KOPRI)
RP Lee, BH (corresponding author), 1 Gwanak Ro, Seoul 08826, South Korea.
EM lee@snu.ac.kr
RI Yu, Jihyeon/U-4150-2019
OI Yu, Jihyeon/0000-0003-0247-7753; Choi, You-Jin/0009-0008-5544-8116; Lee,
   Byung-Hoon/0000-0002-0348-4675
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2021R1C1C2004529,
   NRF-2022R1A6A1A03046247, NRF-2023R1A2C2004929]
FX This study was supported by the Basic Science Research Program through
   the National Research Foundation of Korea (NRF) , funded by the Ministry
   of Education [NRF-2021R1C1C2004529, NRF-2022R1A6A1A03046247,
   NRF-2023R1A2C2004929] .
CR Aman Y, 2021, NATURE AGING, V1, P634, DOI 10.1038/s43587-021-00098-4
   Bin Ali A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025268
   Boylston WH, 2006, AGE, V28, P125, DOI 10.1007/s11357-006-9008-6
   Cave MC, 2016, BBA-GENE REGUL MECH, V1859, P1083, DOI 10.1016/j.bbagrm.2016.03.002
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153
   Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901
   Du QQ, 2019, CANCER SCI, V110, P2050, DOI 10.1111/cas.14011
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Huang J, 2012, CLIN BIOCHEM, V45, P1229, DOI 10.1016/j.clinbiochem.2012.06.016
   Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613
   Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9
   Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280
   Kaushik S, 2016, AUTOPHAGY, V12, P432, DOI 10.1080/15548627.2015.1124226
   Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166
   Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073
   Kirchner P, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000301
   Li Y, 2022, AGING DIS, V13, P1239, DOI 10.14336/AD.2022.0318
   Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107
   Ma SY, 2020, LIVER INT, V40, P2427, DOI 10.1111/liv.14492
   Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2
   Milot M, 2021, bioRxiv
   Mizushima N, 2020, TRENDS BIOCHEM SCI, V45, P1080, DOI 10.1016/j.tibs.2020.07.006
   Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798
   Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113
   Nguyen D, 2013, AGING CELL, V12, P415, DOI 10.1111/acel.12073
   Ott C, 2016, REDOX BIOL, V10, P266, DOI 10.1016/j.redox.2016.10.015
   Ou-Yang Q, 2018, HEPATOLOGY, V67, P1071, DOI 10.1002/hep.29562
   Röhrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89
   Saito T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08829-3
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310
   Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009
   Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b
   Singh BK, 2020, AGING-US, V12, P13958, DOI 10.18632/aging.103740
   Takahashi S, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900513
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Wan J, 2020, AGING CELL, V19, DOI 10.1111/acel.13238
   Wang YJ, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-021-00729-8
   Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535
   Xu JH, 2018, AGING DIS, V9, P1031, DOI 10.14336/AD.2018.0221
   Xu XH, 2013, J HEPATOL, V59, P308, DOI 10.1016/j.jhep.2013.03.037
   Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
NR 45
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-8778
J9 MOL METAB
JI Mol. Metab.
PD OCT
PY 2023
VL 76
AR 101784
DI 10.1016/j.molmet.2023.101784
EA AUG 2023
PG 12
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA X3VV9
UT WOS:001097774600001
PM 37524243
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Mohammed, S
   Thadathil, N
   Selvarani, R
   Nicklas, EH
   Wang, DW
   Miller, BF
   Richardson, A
   Deepa, SS
AF Mohammed, Sabira
   Thadathil, Nidheesh
   Selvarani, Ramasamy
   Nicklas, Evan H.
   Wang, Dawei
   Miller, Benjamin F.
   Richardson, Arlan
   Deepa, Sathyaseelan S.
TI Necroptosis contributes to chronic inflammation and fibrosis in aging
   liver
SO AGING CELL
LA English
DT Article; Early Access
DE aging; fibrosis; inflammation; liver; necroptosis; necrostatin-1s
ID CELL-DEATH; EXPRESSION
AB Inflammaging, characterized by an increase in low-grade chronic inflammation with age, is a hallmark of aging and is strongly associated with various age-related diseases, including chronic liver disease (CLD) and hepatocellular carcinoma (HCC). Because necroptosis is a cell death pathway that induces inflammation through the release of DAMPs, we tested the hypothesis that age-associated increase in necroptosis contributes to chronic inflammation in aging liver. Phosphorylation of MLKL and MLKL oligomers, markers of necroptosis, as well as phosphorylation of RIPK3 and RIPK1 were significantly upregulated in the livers of old mice relative to young mice and this increase occurred in the later half of life (i.e., after 18 months of age). Markers of M1 macrophages, expression of pro-inflammatory cytokines (TNF alpha, IL6 and IL1 beta), and markers of fibrosis were all significantly upregulated in the liver with age and the change in necroptosis paralleled the changes in inflammation and fibrosis. Hepatocytes and liver macrophages isolated from old mice showed elevated levels of necroptosis markers as well as increased expression of pro-inflammatory cytokines relative to young mice. Short-term treatment with the necroptosis inhibitor, necrostatin-1s (Nec-1s), reduced necroptosis, markers of M1 macrophages, fibrosis, and cell senescence as well as reducing the expression of pro-inflammatory cytokines in the livers of old mice. Thus, our data show for the first time that liver aging is associated with increased necroptosis and necroptosis contributes to chronic inflammation in the liver, which in turn appears to contribute to liver fibrosis and possibly CLD.
C1 [Mohammed, Sabira; Richardson, Arlan; Deepa, Sathyaseelan S.] Stephenson Canc Ctr, Oklahoma City, OK USA.
   [Thadathil, Nidheesh; Selvarani, Ramasamy; Nicklas, Evan H.; Wang, Dawei; Miller, Benjamin F.; Richardson, Arlan; Deepa, Sathyaseelan S.] Dept Biochem & Mol Biol, Oklahoma City, OK USA.
   [Miller, Benjamin F.; Richardson, Arlan; Deepa, Sathyaseelan S.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Gerosci & Brain Aging, Oklahoma City, OK 73104 USA.
   [Miller, Benjamin F.] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.
   [Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center; University of Oklahoma System; University of Oklahoma Health
   Sciences Center; Oklahoma Medical Research Foundation; University of
   Oklahoma System; University of Oklahoma Health Sciences Center
RP Deepa, SS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Gerosci & Brain Aging, Dept Biochem & Mol Biol,Stephenson Canc Ctr, 975 NE 10th St,BRC-1368B, Oklahoma City, OK 73104 USA.
EM Deepa-Sathyaseelan@ouhsc.edu
RI Thadathil, Nidheesh/IWE-4992-2023
OI Miller, Benjamin/0000-0003-3283-0685; Jazir, Sabira
   Mohammed/0000-0002-0332-3660; T, Nidheesh/0000-0003-2168-8337
FU NIH [R01AG059718, R01AG057424, R01 AG064951, R56 AG067754, R21
   AR077387]; Oklahoma Center for the Advancement of Science and Technology
   research [HR18-053]; Presbyterian Health Foundation (OUHSC) Seed; Senior
   Career Research Award [I01BX004538]; Merit [I01BX004538]; Department of
   Veterans Affairs
FX NIH, Grant/Award Number: R01AG059718 and R01AG057424; Oklahoma Center
   for the Advancement of Science and Technology research, Grant/Award
   Number: HR18--053; Presbyterian Health Foundation (OUHSC) Seed; Senior
   Career Research Award (AR) and a Merit, Grant/Award Number: I01BX004538;
   Department of Veterans Affairs, and NIH, Grant/Award Number: R01
   AG064951, R56 AG067754 and R21 AR077387
CR Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2
   Deepa SS, 2018, AGING CELL, V17, DOI 10.1111/acel.12770
   Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711
   Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004
   Fabregat I, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00357
   Faure-Dupuy S, 2018, J INNATE IMMUN, V10, P339, DOI 10.1159/000489966
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fritsch M, 2019, NATURE, V575, P683, DOI 10.1038/s41586-019-1770-6
   Fulda S, 2018, CELL CYCLE, V17, P829, DOI 10.1080/15384101.2018.1442626
   Gautheron J, 2014, EMBO MOL MED, V6, P1062, DOI 10.15252/emmm.201403856
   Gong YT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1029-8
   Higgins SJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-105
   Huang DL, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00497-16
   Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803
   Kale A, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00187-9
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lee HW, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-01921-7
   Liu J, 2017, METHODS MOL BIOL, V1540, P249, DOI 10.1007/978-1-4939-6700-1_21
   Majdi A, 2020, J HEPATOL, V72, P627, DOI 10.1016/j.jhep.2019.11.008
   Mancuso P, 2019, FRONT ENDOCRINOL, V10, DOI [10.3389/fendo.2019.00137, 10.3389/fendo.019.00137]
   Meng YX, 2021, CELL DEATH DIFFER, V28, P861, DOI 10.1038/s41418-020-00722-7
   Mifflin L, 2020, NAT REV DRUG DISCOV, V19, P553, DOI 10.1038/s41573-020-0071-y
   Mohammed S, 2021, FREE RADICAL BIO MED, V164, P315, DOI 10.1016/j.freeradbiomed.2020.12.449
   Mohammed S, 2019, FASEB J, V33, P7061, DOI 10.1096/fj.201802535R
   Mohar I, 2015, METHODS MOL BIOL, V1325, P3, DOI 10.1007/978-1-4939-2815-6_1
   Newton K, 2016, ANNU REV BIOCHEM, V85, P743, DOI 10.1146/annurev-biochem-060815-014830
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Saeed WK, 2014, WORLD J GASTROENTERO, V20, P12526, DOI 10.3748/wjg.v20.i35.12526
   Shojaie L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249682
   Smith LR, 2016, MUSCLE NERVE, V54, P71, DOI 10.1002/mus.24998
   Stahl EC, 2020, AM J PATHOL, V190, P372, DOI 10.1016/j.ajpath.2019.10.016
   Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176
   Thadathil N, 2021, GEROSCIENCE, V43, P2345, DOI 10.1007/s11357-021-00448-5
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Wang XK, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.655557
   Wen SH, 2020, FASEB J, V34, P4384, DOI 10.1096/fj.201900817R
   Wu XQ, 2020, J HEPATOL, V73, P617, DOI 10.1016/j.jhep.2020.03.023
   Zelic M, 2018, J CLIN INVEST, V128, P2064, DOI 10.1172/JCI96147
   Zhang ST, 2019, P NATL ACAD SCI USA, V116, P5675, DOI 10.1073/pnas.1819917116
   Zhong WZ, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2822
NR 44
TC 54
Z9 57
U1 3
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2021 DEC
PY 2021
VL 20
IS 12
AR e13512
DI 10.1111/acel.13512
EA NOV 2021
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA XO6QH
UT WOS:000716883500001
PM 34761505
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Ledda-Columbano, GM
   Pibiri, M
   Cossu, C
   Molotzu, F
   Locker, J
   Columbano, A
AF Ledda-Columbano, GM
   Pibiri, M
   Cossu, C
   Molotzu, F
   Locker, J
   Columbano, A
TI Aging does not reduce the hepatocyte proliferative response of mice to
   the primary mitogen TCPOBOP
SO HEPATOLOGY
LA English
DT Article
ID TRANSCRIPTION FACTOR HFH-11B; LIVER-REGENERATION; EXPRESSION; PROTEIN;
   INDUCTION; GROWTH; ALPHA; ENTRY; AGE; DNA
AB It has been shown that the magnitude of DNA synthesis and the time at which maximal DNA synthesis occurs after two-thirds partial hepatectomy (PH) is greatly reduced in the liver of aged rodents compared to young animals. This reduction could represent an intrinsic defect in proliferation or a more specialized change in the response to PH. We therefore evaluated the proliferative capacity of hepatocytes in aged animals, following treatment with primary liver mitogens. We show that treatment of 12-month-old CD-1 mice with the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) caused an increase in hepatocyte proliferation similar to that seen in young (8-week-old) mice. The labeling index was 82% in the livers of aged mice versus 76% in young animals. Histological observation demonstrated that the number of hepatocytes entering mitoses was similar in both groups; the mitotic indices were 2.5 per thousand and 2.7 per thousand, respectively. Additional experiments showed that the timing of DNA synthesis and M phase were nearly identical in both aged and young mice. Stimulation of hepatocyte DNA synthesis was associated with increased expression of several cell cycle-associated proteins (cyclin D1, cyclin A, cyclin B1, E2F, pRb, and p107); all were comparable in aged mice and young mice. TCPOBOP treatment also increased expression of the Forkhead Box transcription factor m1b (Foxm1b) to a similar degree in both groups. In conclusion, hepatocytes retain their proliferative capacity in old age despite impaired liver regeneration. These findings suggest that therapeutic use of mitogens would alleviate the reduction in hepatocyte proliferation observed in the elderly.
C1 Univ Cagliari, Dipartimento Tossicol, Sez Oncol & Patol Mol, I-09124 Cagliari, Italy.
   Univ Cagliari, Oncol & Mol Pathol Unit, I-09124 Cagliari, Italy.
   Albert Einstein Med Ctr, Dept Pathol, Bronx, NY USA.
C3 University of Cagliari; University of Cagliari; Yeshiva University
RP Columbano, A (corresponding author), Univ Cagliari, Dipartimento Tossicol, Sez Oncol & Patol Mol, Via Porcell 4, I-09124 Cagliari, Italy.
EM columbano@unica.it
RI Columbano, Amedeo/C-7463-2011
OI Columbano, Amedeo/0000-0002-6956-9030; PIBIRI,
   MONICA/0000-0002-9660-9616
FU NCI NIH HHS [R01-CA104292-01] Funding Source: Medline
CR AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Calbó J, 2002, J BIOL CHEM, V277, P50263, DOI 10.1074/jbc.M209181200
   Columbano A, 2003, CELL DEATH DIFFER, V10, pS19, DOI 10.1038/sj.cdd.4401113
   Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714
   Columbano A, 1997, ONCOGENE, V14, P857, DOI 10.1038/sj.onc.1200891
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Honkakoski P, 1998, MOL PHARMACOL, V53, P597, DOI 10.1124/mol.53.4.597
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Ledda-Columbano GM, 2000, AM J PATHOL, V156, P91, DOI 10.1016/S0002-9440(10)64709-8
   Ledda-Columbano GM, 1998, ONCOGENE, V17, P1039, DOI 10.1038/sj.onc.1202018
   Locker J, 2003, HEPATOLOGY, V38, P314, DOI 10.1053/jhep.2003.50299
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Stocker E, 1971, Beitr Pathol, V144, P400
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804
   Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666
   Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441
   Ye HG, 1999, MOL CELL BIOL, V19, P8570
NR 30
TC 34
Z9 39
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2004
VL 40
IS 4
BP 981
EP 988
DI 10.1002/hep.20403
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 857AX
UT WOS:000224088800026
PM 15382178
DA 2024-02-19
ER

PT J
AU Han, X
   Bao, XG
   Lou, Q
   Xie, X
   Zhang, M
   Zhou, SS
   Guo, HG
   Jiang, GJ
   Shi, QJ
AF Han, Xue
   Bao, Xiaogang
   Lou, Qi
   Xie, Xian
   Zhang, Meng
   Zhou, Shasang
   Guo, Honggang
   Jiang, Guojun
   Shi, Qiaojuan
TI Nicotinamide riboside exerts protective effect against aging-induced
   NAFLD-like hepatic dysfunction in mice
SO PEERJ
LA English
DT Article
DE Non-alcoholic fatty liver disease; Nicotinamide adenine dinucleotide;
   Nicotinamide riboside; Aged mice; Inflammatory infiltration
ID FATTY LIVER-DISEASE; RISK-FACTORS; NAD(+); PREVALENCE; SIRTUINS;
   FIBROSIS; PROMOTES; GENES; NMN
AB Background & Aims. Aging is one of the risk factors of non-alcoholic fatty liver disease (NAFLD). Yet, the mechanism underlying the aging-associated NAFLD-like syndrome is not fully understood. Nicotinamide adenine dinucleotide (NAD), a ubiquitous coenzyme, has protective effects against aging. Here, we investigated the actions of NAD precursors nicotinamide riboside (NR) on the development of aging-induced NAFLD.
   Methods. NR supplemented food (2.5 g/kg food) was applied to aged mice for three months while normal chow to the other groups. Body weight, food intake, liver weight and fat pat mass were measured. The serum concentrations of lipid content, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and NAD were determined by biochemical assays. Pathological assessment and immunohistochemistry analysis of hepatic tissues were used to evaluate the effect of NR on NAFLD development and inflammatory infiltration.
   Results. NR repletion significantly reduced fat pat mass in aged mice, while not altered the body weight, food intake, and liver weight. NR repletion significantly rescued the NAD reduction in aged mice. The total cholesterol and triglyceride levels could be lowered by NR repletion in aged mice. The AST level was also significantly reduced by NR repletion in aged group, while the ALT level lowered but without significance. Notably, moderate NAFLD phenotypes, including steatosis and hepatic fibrosis could be markedly corrected by NR repletion. In addition, Kupffer cells accumulated and inflammatory infiltration could also be remarkably reversed by NR repletion in aged mice.
   Conclusion. Aging was associated with NAFLD-like phenotypes in mice, which could be reversed by oral NR repletion. Therefore, oral NR uptake might be a promising strategy to halt the progression of NAFLD.
C1 [Han, Xue; Lou, Qi; Zhou, Shasang; Guo, Honggang; Shi, Qiaojuan] Zhejiang Acad Med Sci, Lab Anim Ctr, Hangzhou, Zhejiang, Peoples R China.
   [Bao, Xiaogang] Second Mil Med Univ, Changzheng Hosp, Spine Ctr, Dept Orthoped Surg, Shanghai, Peoples R China.
   [Xie, Xian] Zhejiang Univ, Hosp Stomatol, Sch Med, Hangzhou, Zhejiang, Peoples R China.
   [Zhang, Meng] Tongde Hosp Zhejiang Prov, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China.
   [Jiang, Guojun] Zhejiang Xiaoshan Hosp, Hangzhou, Zhejiang, Peoples R China.
C3 Zhejiang Academy of Medical Sciences; Naval Medical University; Zhejiang
   University
RP Shi, QJ (corresponding author), Zhejiang Acad Med Sci, Lab Anim Ctr, Hangzhou, Zhejiang, Peoples R China.; Jiang, GJ (corresponding author), Zhejiang Xiaoshan Hosp, Hangzhou, Zhejiang, Peoples R China.
EM jguojun999@163.com; shiqiaojuan@163.com
FU Natural Science Foundation of Zhejiang [LGJ18H310002, LQY19H090001,
   LY18H310009, LQY18C040001]; Shanghai Committee of Science and
   Technology, China [15411951000, 2018QN13]
FX This study was supported by the Natural Science Foundation of Zhejiang
   (Grants LGJ18H310002, LQY19H090001, LY18H310009 and LQY18C040001) and
   the Shanghai Committee of Science and Technology, China (Grant No.
   15411951000 and 2018QN13). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Andreani C, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8936251
   Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Chi HC, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0517-x
   Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164
   Fan R, 2018, BIOCHEM BIOPH RES CO, V500, P476, DOI 10.1016/j.bbrc.2018.04.107
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Hoxhaj G, 2019, SCIENCE, V363, P1088, DOI 10.1126/science.aau3903
   Jadeja RN, 2019, AGING-US, V11, P386, DOI 10.18632/aging.101743
   Jesko H, 2017, NEUROCHEM RES, V42, P876, DOI 10.1007/s11064-016-2110-y
   Jiang R, 2019, LIFE SCI, V225, P20, DOI 10.1016/j.lfs.2019.03.064
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Karpe F, 2004, LANCET, V363, P1892, DOI 10.1016/S0140-6736(04)16359-9
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3
   Moon J, 2018, ANN LAB MED, V38, P395
   Ooi GJ, 2018, OBES REV, V19, P281, DOI 10.1111/obr.12628
   Phimister EG, 2019, NEW ENGL J MED, V380, P681, DOI 10.1056/NEJMcibr1815636
   Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906
   Wan XY, 2016, J HEPATOL, V64, P925, DOI 10.1016/j.jhep.2015.11.022
   Watroba M, 2017, AGEING RES REV, V40, P11, DOI 10.1016/j.arr.2017.08.001
   Wu FH, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-018-1541-0
   Xie X, 2019, METAB BRAIN DIS, V34, P353, DOI 10.1007/s11011-018-0346-8
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
   Zhou XH, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3156
NR 37
TC 22
Z9 25
U1 1
U2 8
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD AUG 28
PY 2019
VL 7
AR e7568
DI 10.7717/peerj.7568
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IT5IE
UT WOS:000482895100009
PM 31523515
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sato, S
   Solanas, G
   Peixoto, FO
   Bee, L
   Symeonidi, A
   Schmidt, MS
   Brenner, C
   Masri, S
   Benitah, SA
   Sassone-Corsi, P
AF Sato, Shogo
   Solanas, Guiomar
   Oliveira Peixoto, Francisca
   Bee, Leonardo
   Symeonidi, Aikaterini
   Schmidt, Mark S.
   Brenner, Charles
   Masri, Selma
   Aznar Benitah, Salvador
   Sassone-Corsi, Paolo
TI Circadian Reprogramming in the Liver Identifies Metabolic Pathways of
   Aging
SO CELL
LA English
DT Article
ID LIFE-SPAN EXTENSION; CALORIE RESTRICTION; NICOTINAMIDE RIBOSIDE;
   ACETYL-COENZYME; GENE-EXPRESSION; CLOCK; MITOCHONDRIAL; NAD(+);
   SIRTUINS; EXTENDS
AB The process of aging and circadian rhythms are intimately intertwined, but how peripheral clocks involved in metabolic homeostasis contribute to aging remains unknown. Importantly, caloric restriction (CR) extends lifespan in several organisms and rewires circadian metabolism. Using young versus old mice, fed ad libitum or under CR, we reveal reprogramming of the circadian transcriptome in the liver. These age-dependent changes occur in a highly tissue-specific manner, as demonstrated by comparing circadian gene expression in the liver versus epidermal and skeletal muscle stem cells. Moreover, de novo oscillating genes under CR show an enrichment in SIRT1 targets in the liver. This is accompanied by distinct circadian hepatic signatures in NAD(+)-related metabolites and cyclic global protein acetylation. Strikingly, this oscillation in acetylation is absent in old mice while CR robustly rescues global protein acetylation. Our findings indicate that the clock operates at the crossroad between protein acetylation, liver metabolism, and aging.
C1 [Sato, Shogo; Bee, Leonardo; Masri, Selma; Sassone-Corsi, Paolo] Univ Calif Irvine, INSERM U1233, Ctr Epigenet & Metab, Irvine, CA 92607 USA.
   [Solanas, Guiomar; Oliveira Peixoto, Francisca; Symeonidi, Aikaterini; Aznar Benitah, Salvador] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona 08028, Spain.
   [Schmidt, Mark S.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.
   [Aznar Benitah, Salvador] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain.
C3 University of California System; University of California Irvine;
   Barcelona Institute of Science & Technology; Institute for Research in
   Biomedicine - IRB Barcelona; University of Iowa; ICREA
RP Sassone-Corsi, P (corresponding author), Univ Calif Irvine, INSERM U1233, Ctr Epigenet & Metab, Irvine, CA 92607 USA.; Benitah, SA (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona 08028, Spain.; Benitah, SA (corresponding author), Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain.
EM salvador.aznar-benitah@irbbarcelona.org; psc@uci.edu
RI Aznar-Benitah, Salvador/F-4761-2016; Brenner, Charles/D-6339-2014
OI Aznar-Benitah, Salvador/0000-0002-9059-5049; Brenner,
   Charles/0000-0002-4955-3226; Solanas, Guiomar/0000-0001-8388-8647; Sato,
   Shogo/0000-0002-2874-7072; Schmidt, Mark/0000-0003-4593-4096; Masri,
   Selma/0000-0002-8619-8331
FU Della Martin Foundation; Italian Association for Cancer Research;
   National Institutes of Health; INSERM (Institut National de la Sante et
   Recherche Medicale, France); Roy J. Carver Trust; Novo Nordisk
   Foundation; European Research Council (ERC); Spanish Ministry of Economy
   and Development; Institute for Research in Biomedicine (IRB-Barcelona);
   La Caixa International PhD fellowship; MINECO (Government of Spain)
FX We thank all members of the Sassone-Corsi laboratory for help and
   critical discussions. S.S. is supported by the Della Martin Foundation;
   L. B. by Italian Association for Cancer Research; this work was possible
   through support by the National Institutes of Health, INSERM (Institut
   National de la Sante et Recherche Medicale, France), the Roy J. Carver
   Trust, and a Novo Nordisk Foundation Challenge Grant. Research for this
   project in the lab of S.A.B. was supported by the European Research
   Council (ERC), the Spanish Ministry of Economy and Development, and the
   Institute for Research in Biomedicine (IRB-Barcelona). F.O.P. is
   supported by a La Caixa International PhD fellowship. IRB Barcelona is
   the recipient of a Severo Ochoa Award of Excellence from MINECO
   (Government of Spain).
CR [Anonymous], SCIENCE, V350, P1208
   [Anonymous], TITLE ERROR
   Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015
   Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Cartee GD, 2016, CELL METAB, V23, P1034, DOI 10.1016/j.cmet.2016.05.007
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500
   Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Masri S, 2016, CELL, V165, P896, DOI 10.1016/j.cell.2016.04.039
   Masri S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005685
   Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050
   Masri S, 2013, P NATL ACAD SCI USA, V110, P3339, DOI 10.1073/pnas.1217632110
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   Ocampo A, 2016, TRENDS MOL MED, V22, P725, DOI 10.1016/j.molmed.2016.06.005
   Orozco-Solis R, 2014, CURR OPIN GENET DEV, V26, P66, DOI 10.1016/j.gde.2014.06.003
   Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108
   Patel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25970
   Patel SA, 2016, FASEB J, V30, P1634, DOI 10.1096/fj.15-282475
   Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111
   Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417
   Peleg S, 2016, TRENDS BIOCHEM SCI, V41, P700, DOI 10.1016/j.tibs.2016.05.008
   Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014
   Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641
   Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191
   Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497
   Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012
   SEUFERT CD, 1974, BIOCHEM BIOPH RES CO, V57, P901, DOI 10.1016/0006-291X(74)90631-7
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917
   Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490
   Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948
   Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012
   Ulgherait M, 2016, CELL METAB, V24, P763, DOI 10.1016/j.cmet.2016.11.002
   Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931
   Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011
NR 69
TC 218
Z9 248
U1 2
U2 68
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 10
PY 2017
VL 170
IS 4
BP 664
EP +
DI 10.1016/j.cell.2017.07.042
PG 25
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA FD3PU
UT WOS:000407445700008
PM 28802039
OA Green Accepted, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Bertolotti, M
   Gabbi, C
   Anzivino, C
   Crestani, M
   Mitro, N
   Del Puppo, M
   Godio, C
   De Fabiani, E
   Macchioni, D
   Carulli, L
   Rossi, A
   Ricchi, M
   Loria, P
   Carulli, N
AF Bertolotti, M.
   Gabbi, C.
   Anzivino, C.
   Crestani, M.
   Mitro, N.
   Del Puppo, M.
   Godio, C.
   De Fabiani, E.
   Macchioni, D.
   Carulli, L.
   Rossi, A.
   Ricchi, M.
   Loria, P.
   Carulli, N.
TI Age-related changes in bile acid synthesis and hepatic nuclear receptor
   expression
SO EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
DE ageing; bile acid synthesis; cholesterol 7 alpha-hydroxylase; hepatocyte
   nuclear factor-4; insulin-like growth factor-I; nuclear receptors
ID GROWTH-FACTOR-I; MICROSOMAL CHOLESTEROL 7-ALPHA-HYDROXYLASE; NEGATIVE
   FEEDBACK-REGULATION; GENE CYP7A1; HUMAN LIVER; HORMONE; TRANSCRIPTION;
   BIOSYNTHESIS; HUMANS; PATHWAYS
AB Background Recent data highlighted the role of nuclear receptors in the transcriptional regulation of the limiting enzyme of bile acid synthesis, cholesterol 7 alpha-hydroxylase, in cellular and animal models. This study was designed to analyze the effects of age on cholesterol 7 alpha-hydroxylase and related nuclear receptor expression in human livers.
   Design Surgical liver biopsies were obtained in 23 patients requiring operation on the gastrointestinal tract. mRNA levels of cholesterol 7 alpha-hydroxylase and related nuclear receptors and co-activators were assayed by quantitative real-time RT-PCR. Serum levels of 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis, were assayed by gas-liquid chromatography:mass spectrometry.
   Results Ageing was inversely correlated with serum 7 alpha-hydroxy-4-cholesten-3-one and with cholesterol 7 alpha-hydroxylase mRNA levels (r = -0.44 and r = -0.45 on a semi-log scale, respectively, P < 0.05). Among different nuclear factors, cholesterol 7 alpha-hydroxylase mRNA best correlated with hepatocyte nuclear factor-4 (r = 0.55 on a log scale, P < 0.05); hepatocyte nuclear factor-4 levels were also inversely correlated with age (r = -0.64 on a semi-log scale, P < 0.05). Age was inversely correlated with serum insulin-like growth factor-I levels, which were directly correlated with hepatocyte nuclear factor-4 and cholesterol 7 alpha-hydroxylase expression. No suppressive effect of short heterodimer partner expression on cholesterol 7 alpha-hydroxylase was observed.
   Conclusions Ageing associates with reduced bile acid synthesis, possibly related to decreased hepatic expression of hepatocyte nuclear factor-4 and consequently of cholesterol 7 alpha-hydroxylase. Age-related modifications of the growth hormone/insulin-like growth factor axis might play a role. These findings may help to elucidate the pathophysiology of age-related modifications of cholesterol metabolism.
C1 Univ Modena & Reggio Emilia, Modena, Italy.
   Univ Milan, I-20122 Milan, Italy.
   Univ Milano Bicocca, Monza, Italy.
C3 Universita di Modena e Reggio Emilia; University of Milan; University of
   Milano-Bicocca
RP Bertolotti, M (corresponding author), Nuovo Osped Civile, Dipartimento Med Endocrinol Metab & Geriatr, Via Giardini 1355, I-41040 Modena, Italy.
EM bertolotti.marco@unimore.it
RI Gabbi, Chiara/AAB-9677-2022; Matteo, Ricchi/A-3538-2013; Bertolotti,
   Marco/P-6040-2015; Carulli, Lucia/G-3783-2016; Carulli,
   Lucia/AAA-4358-2019; De Fabiani, Emma/B-6936-2015; gabbi,
   chiara/F-4481-2012
OI Gabbi, Chiara/0000-0002-9764-4771; Matteo, Ricchi/0000-0002-4923-0216;
   Bertolotti, Marco/0000-0001-6908-1820; Carulli,
   Lucia/0000-0001-7792-8542; De Fabiani, Emma/0000-0003-2406-1468; Mitro,
   Nico/0000-0002-5000-3619; Godio, Cristina/0000-0003-2639-6368; Crestani,
   Maurizio/0000-0001-9230-1078
CR Abrahamsson A, 2005, BIOCHEM BIOPH RES CO, V330, P395, DOI 10.1016/j.bbrc.2005.02.170
   AXELSON M, 1991, FEBS LETT, V284, P216, DOI 10.1016/0014-5793(91)80688-Y
   BARBARA L, 1995, AM J EPIDEMIOL, V141, P158, DOI 10.1093/oxfordjournals.aje.a117403
   Bertolotti M, 2006, EUR J CLIN INVEST, V36, P170, DOI 10.1111/j.1365-2362.2006.01607.x
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   Bertolotti M, 2003, HEPATOLOGY, V38, P939, DOI 10.1053/jhep.2003.50377
   BERTOLOTTI M, 1991, HEPATOLOGY, V14, P830, DOI 10.1002/hep.1840140515
   Ceda GP, 1998, J CLIN ENDOCR METAB, V83, P499, DOI 10.1210/jc.83.2.499
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006
   Crestani M, 1998, J LIPID RES, V39, P2192
   De Fabiani E, 2004, BIOCHIMIE, V86, P771, DOI 10.1016/j.biochi.2004.09.027
   De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200
   De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   Eleswarapu S, 2005, J ENDOCRINOL, V184, P95, DOI 10.1677/joe.1.05821
   FRIEDMAN GD, 1966, J CHRON DIS, V19, P273, DOI 10.1016/0021-9681(66)90132-9
   Goodwin B, 2002, AM J PHYSIOL-GASTR L, V282, pG926, DOI 10.1152/ajpgi.00044.2002
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   HEISS G, 1980, CIRCULATION, V61, P302, DOI 10.1161/01.CIR.61.2.302
   HEUBI JE, 1983, J CLIN ENDOCR METAB, V57, P885, DOI 10.1210/jcem-57-5-885
   Honda A, 2005, J LIPID RES, V46, P287, DOI 10.1194/jlr.M400256-JLR200
   Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200
   Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5
   Lahuna O, 1997, P NATL ACAD SCI USA, V94, P12309, DOI 10.1073/pnas.94.23.12309
   Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285
   Laron Z, 1997, EUR J ENDOCRINOL, V136, P377, DOI 10.1530/eje.0.1360377
   Lind S, 2004, ARTERIOSCL THROM VAS, V24, P349, DOI 10.1161/01.ATV.0000110657.67317.90
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Matasconi M, 2005, BBA-MOL CELL BIOL L, V1736, P221, DOI 10.1016/j.bbalip.2005.08.012
   Metón I, 1999, FEBS LETT, V444, P155, DOI 10.1016/S0014-5793(99)00064-2
   Miyake JH, 2000, J BIOL CHEM, V275, P21805, DOI 10.1074/jbc.C000275200
   Paré JF, 2001, J BIOL CHEM, V276, P13136, DOI 10.1074/jbc.M010737200
   Princen HMG, 1997, CURR PHARM DESIGN, V3, P59
   REIHNER E, 1989, GASTROENTEROLOGY, V97, P1498, DOI 10.1016/0016-5085(89)90395-8
   Rudling M, 1997, J CLIN INVEST, V99, P2239, DOI 10.1172/JCI119398
   Rudling M, 1996, J CLIN INVEST, V97, P292, DOI 10.1172/JCI118415
   Rudling M, 2002, J CLIN ENDOCR METAB, V87, P4307, DOI 10.1210/jc.2002-012041
   Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712
   Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129
   Stroup D, 2000, J LIPID RES, V41, P1
   Vlahcevic ZR, 1999, GASTROENTEROL CLIN N, V28, P1, DOI 10.1016/S0889-8553(05)70041-8
   Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9
   Yang Q, 2002, DIABETES, V51, P1785, DOI 10.2337/diabetes.51.6.1785
NR 45
TC 47
Z9 51
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2972
EI 1365-2362
J9 EUR J CLIN INVEST
JI Eur. J. Clin. Invest.
PD JUN
PY 2007
VL 37
IS 6
BP 501
EP 508
DI 10.1111/j.1365-2362.2007.01808.x
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA 172GU
UT WOS:000246792900008
PM 17537158
DA 2024-02-19
ER

PT J
AU Kondo, Y
   Masutomi, H
   Noda, Y
   Ozawa, Y
   Takahashi, K
   Handa, S
   Maruyama, N
   Shimizu, T
   Ishigami, A
AF Kondo, Yoshitaka
   Masutomi, Hirofumi
   Noda, Yoshihiro
   Ozawa, Yusuke
   Takahashi, Keita
   Handa, Setsuko
   Maruyama, Naoki
   Shimizu, Takahiko
   Ishigami, Akihito
TI Senescence marker protein-30/superoxide dismutase 1 double knockout mice
   exhibit increased oxidative stress and hepatic steatosis
SO FEBS OPEN BIO
LA English
DT Article
DE Ascorbic acid; Non-alcoholic fatty liver disease; Reactive oxygen
   species; SMP30; SOD1
ID ASCORBIC-ACID DEFICIENCY; VITAMIN-C DEPLETION; SMP30 DEFICIENCY; FATTY
   LIVER; CELL-DEATH; PROTEIN-30; DEGRADATION; DYSFUNCTION; BIOSYNTHESIS;
   ACCUMULATION
AB Superoxide dismutase 1 (SOD1) is an antioxidant enzyme that converts superoxide anion radicals into hydrogen peroxide and molecular oxygen. The senescence marker protein-30 (SMP30) is a gluconolactonase that functions as an antioxidant protein in mammals due to its involvement in ascorbic acid (AA) biosynthesis. SMP30 also participates in Ca2+ efflux by activating the calmodulin-dependent Ca2+-pump. To reveal the role of oxidative stress in lipid metabolism defects occurring in non-alcoholic fatty liver disease pathogenesis, we generated SMP30/SOD1-double knockout (SMP30/SOD1-DKO) mice and investigated their survival curves, plasma and hepatic lipid profiles, amounts of hepatic oxidative stress, and hepatic protein levels expressed by genes related to lipid metabolism. While SMP30/SOD1-DKO pups had no growth retardation by 14 days of age, they did have low plasma and hepatic AA levels. Thereafter, 39% and 53% of male and female pups died by 15-24 and 89 days of age, respectively. Compared to wild type, SMP30-KO and SOD1-KO mice, by 14 days SMP30/SOD1-DKO mice exhibited: (1) higher plasma levels of triglyceride and aspartate aminotransferase; (2) severe accumulation of hepatic triglyceride and total cholesterol; (3) higher levels of superoxide anion radicals and thiobarbituric acid reactive substances in livers; and (4) decreased mRNA and protein levels of Apolipoprotein B (ApoB) in livers - ApoB is an essential component of VLDL secretion. These results suggest that high levels of oxidative stress due to concomitant deficiency of SMP30 and/or AA, and SOD1 cause abnormal plasma lipid metabolism, hepatic lipid accumulation and premature death resulting from impaired VLDL secretion. (C) 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This is an open access article under the CC BY-NC-ND license.
C1 [Kondo, Yoshitaka; Masutomi, Hirofumi; Noda, Yoshihiro; Takahashi, Keita; Handa, Setsuko; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan.
   [Ozawa, Yusuke; Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chuo Ku, Chiba 2608670, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Chiba University
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami,
   Akihito/0000-0001-7875-7482; Noda, Yoshihiro/0000-0002-2657-2555
FU Japan Society for the Promotion of Science [23790122, 23590441,
   24380073]; Grants-in-Aid for Scientific Research [23790122, 23590441]
   Funding Source: KAKEN
FX This study was supported by the Japan Society for the Promotion of
   Science (http://www.jsps.go.jp/english/e-grants/index.html) KAKENHI
   Grant Number 23790122 (Y.K.), 23590441 (N.M.), and 24380073 (A.I.).
CR Aizawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053706
   Amano A, 2014, EUR J NUTR, V53, P177, DOI 10.1007/s00394-013-0515-9
   Amano A, 2013, J NUTR SCI VITAMINOL, V59, P489, DOI 10.3177/jnsv.59.489
   Andreo U, 2011, FASEB J, V25, P3554, DOI 10.1096/fj.11-182725
   Arai KY, 2009, BIOCHEM BIOPH RES CO, V385, P478, DOI 10.1016/j.bbrc.2009.05.104
   Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Guturu P, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/212865
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730
   Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043
   Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Ishikawa Y, 2012, EXP EYE RES, V94, P85, DOI 10.1016/j.exer.2011.11.010
   Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386
   Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010
   Kashio A, 2009, BIOCHEM BIOPH RES CO, V390, P394, DOI 10.1016/j.bbrc.2009.09.003
   Kim HS, 2013, NEUROBIOL AGING, V34, P1177, DOI 10.1016/j.neurobiolaging.2012.10.008
   Koike K, 2010, AM J PHYSIOL-LUNG C, V298, pL784, DOI 10.1152/ajplung.00256.2009
   Kojima T, 2012, AM J PATHOL, V180, P1879, DOI 10.1016/j.ajpath.2012.01.019
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Kondo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065698
   Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Mizukami H, 2013, INT J MOL SCI, V14, P9408, DOI 10.3390/ijms14059408
   Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036
   Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208
   Murakami K, 2009, BIOCHEM BIOPH RES CO, V382, P457, DOI 10.1016/j.bbrc.2009.03.053
   Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x
   Noda Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092999
   Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489
   Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Olofsson EM, 2012, CLIN EXP OPHTHALMOL, V40, P813, DOI 10.1111/j.1442-9071.2012.02794.x
   Pohanka M, 2012, MINI-REV MED CHEM, V12, P35, DOI 10.2174/138955712798868986
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   Senmaru T, 2012, J CLIN BIOCHEM NUTR, V50, P114, DOI 10.3164/jcbn.11-52
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Uchiyama S, 2006, J BIOL CHEM, V281, P31713, DOI 10.1074/jbc.M603422200
   Yamada S, 2013, ANTIOXID REDOX SIGN, V19, P1063, DOI 10.1089/ars.2012.4903
NR 46
TC 37
Z9 40
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2211-5463
J9 FEBS OPEN BIO
JI FEBS Open Bio
PY 2014
VL 4
BP 522
EP 532
DI 10.1016/j.fob.2014.05.003
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AW4WL
UT WOS:000346278200063
PM 25003023
OA Green Published
DA 2024-02-19
ER

PT J
AU Arif, M
   Matyas, C
   Mukhopadhyay, P
   Yokus, B
   Trojnar, E
   Paloczi, J
   Paes-Leme, B
   Zhao, SX
   Lohoff, FW
   Haskó, G
   Pacher, P
AF Arif, Muhammad
   Matyas, Csaba
   Mukhopadhyay, Partha
   Yokus, Burhan
   Trojnar, Eszter
   Paloczi, Janos
   Paes-Leme, Bruno
   Zhao, Suxian
   Lohoff, Falk W.
   Hasko, Gyorgy
   Pacher, Pal
TI Data-driven transcriptomics analysis identifies PCSK9 as a novel key
   regulator in liver aging
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Systems biology; Network biology; Transcriptomics; PCSK9; Liver;
   Metabolism; Aging; Rat model
ID GENE-EXPRESSION; AGE; MITOCHONDRIA; HALLMARKS; ENRICHR; OMICS
AB The liver, as a crucial metabolic organ, undergoes significant pathological changes during the aging process, which can have a profound impact on overall health. To gain a comprehensive understanding of these alterations, we employed data-driven approaches, along with biochemical methods, histology, and immunohistochemistry techniques, to systematically investigate the effects of aging on the liver. Our study utilized a well-established rat aging model provided by the National Institute of Aging. Systems biology approaches were used to analyze genome-wide transcriptomics data from liver samples obtained from young (4-5 months old) and aging (20-21 months old) Fischer 344 rats. Our findings revealed pathological changes occurring in various essential biological processes in aging livers. These included mitochondrial dysfunction, increased oxidative/nitrative stress, decreased NAD + content, impaired amino acid and protein synthesis, heightened inflammation, disrupted lipid metabolism, enhanced apoptosis, senescence, and fibrosis. These results were validated using independent datasets from both human and rat aging studies. Furthermore, by employing co-expression network analysis, we identified novel driver genes responsible for liver aging, confirmed our findings in human aging subjects, and pointed out the cellular localization of the driver genes using single-cell RNA-sequencing human data. Our study led to the discovery and validation of a liver-specific gene, proprotein convertase subtilisin/kexin type 9 (PCSK9), as a potential therapeutic target for mitigating the pathological processes associated with aging in the liver. This finding envisions new possibilities for developing interventions aimed to improve liver health during the aging process.
C1 [Arif, Muhammad; Matyas, Csaba; Mukhopadhyay, Partha; Yokus, Burhan; Trojnar, Eszter; Paloczi, Janos; Paes-Leme, Bruno; Zhao, Suxian; Pacher, Pal] Natl Inst Alcohol Abuse & Alcoholism, NIH, Lab Cardiovasc Physiol & Tissue Injury, Bethesda, MD 20892 USA.
   [Arif, Muhammad] Natl Inst Alcohol Abuse & Alcoholism, NIH, Sect Fibrot Disorders, Bethesda, MD USA.
   [Lohoff, Falk W.] Natl Inst Alcohol Abuse, Alcoholism Natl Inst Hlth, Sect Clin Genom & Expt Therapeut, Bethesda, MD USA.
   [Hasko, Gyorgy] Columbia Univ, Dept Anesthesiol, New York, NY USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH)
   - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA);
   National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); Columbia University
RP Pacher, P (corresponding author), Natl Inst Alcohol Abuse & Alcoholism, NIH, Lab Cardiovasc Physiol & Tissue Injury, Bethesda, MD 20892 USA.
EM pacher@mail.nih.gov
RI liu, yuhao/JWP-0475-2024; chen, si/JPK-4258-2023; Matyas,
   Csaba/K-6053-2016
OI Matyas, Csaba/0000-0001-6095-7611; Paes-Leme, Bruno/0000-0002-2976-6523
FU Common Fund of the Office of the Director of the National Institutes of
   Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; Intramural Program of the
   Intramural Program of the National Institute on Alcohol Abuse and
   Alcoholism, National Institutes of Health
FX The Genotype-Tissue Expression (GTEx) Project was supported by the
   Common Fund of the Office of the Director of the National Institutes of
   Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The research
   was funded by Intramural Program of the Intramural Program of the
   National Institute on Alcohol Abuse and Alcoholism, National Institutes
   of Health to P.P.
CR Arif M, 2021, Elife, P10
   Arif M, 2021, NUCLEIC ACIDS RES, V49, pW271, DOI 10.1093/nar/gkab254
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Ballantyne CM, 2023, J AM COLL CARDIOL, V81, P1553, DOI 10.1016/j.jacc.2023.02.018
   Benfeitas R, 2019, EBIOMEDICINE, V40, P471, DOI 10.1016/j.ebiom.2018.12.057
   Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Ding J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26310-y
   Dodson R.J., 2021, NUCLEIC ACIDS RES, V49, pD325, DOI 10.1093/nar/gkaa1113
   Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74
   He Y, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141513
   Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2021, NUCLEIC ACIDS RES, V49, pD545, DOI 10.1093/nar/gkaa970
   Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715
   Karczewski KJ, 2018, NAT REV GENET, V19, P299, DOI 10.1038/nrg.2018.4
   Katzmann JL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.595819
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lee JS, 2021, J CLIN MED, V10, DOI 10.3390/jcm10081758
   Lee JS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53603-6
   Lee S, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177703
   Lohoff FW, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.168
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7
   Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005
   Matyas C, 2023, J Am Coll Cardiol Basic Trans Science
   Matyas C, 2021, NAT REV CARDIOL, V18, P117, DOI 10.1038/s41569-020-0433-5
   Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Ray KK, 2020, NEW ENGL J MED, V382, P1507, DOI 10.1056/NEJMoa1912387
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schreiter T, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13122009
   Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Shavlakadze T, 2018, J GERONTOL A-BIOL, V73, P845, DOI 10.1093/gerona/glx249
   Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0
   Spolitu S, 2019, CURR OPIN LIPIDOL, V30, P186, DOI 10.1097/MOL.0000000000000601
   Tanaka T, 2020, ELIFE, V9, DOI 10.7554/eLife.61073
   Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z
   Turanli B, 2019, EBIOMEDICINE, V42, P386, DOI 10.1016/j.ebiom.2019.03.009
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Ungvari Z, 2018, CIRC RES, V123, P849, DOI 10.1161/CIRCRESAHA.118.311378
   United Nations, 2020, World Population Ageing 2020 Highlights
   Väremo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111
   Wang H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102344118
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   World Health Organization, 2012, World Health Organ Tech Rep Ser, P1
   Xie K, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.602887
   You M, 2019, J HEPATOL, V70, P237, DOI 10.1016/j.jhep.2018.10.037
   Zeybel M, 2022, ADV SCI, V9, DOI 10.1002/advs.202104373
   Zhang C, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.209495
NR 56
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 SEP 20
PY 2023
DI 10.1007/s11357-023-00928-w
EA SEP 2023
PG 19
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA R8GL6
UT WOS:001066685300001
PM 37726433
OA Green Published
DA 2024-02-19
ER

PT J
AU Wang, W
   Liu, F
   Xu, C
   Liu, ZJ
   Ma, JG
   Gu, LY
   Jiang, ZM
   Hou, JC
AF Wang, Wan
   Liu, Fei
   Xu, Cong
   Liu, Zhijing
   Ma, Jiage
   Gu, Liya
   Jiang, Zhanmei
   Hou, Juncai
TI <i>Lactobacillus plantarum</i> 69-2 Combined with
   Galacto-Oligosaccharides Alleviates D-Galactose-Induced Aging by
   Regulating the AMPK/SIRT1 Signaling Pathway and Gut Microbiota in Mice
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article; Early Access
DE Lactobacillus plantarum; galacto-oligosaccharide; gut microbiota;
   AMPK/SIRT signaling pathway; aging model
ID OXIDATIVE STRESS; IN-VITRO; SURVIVAL; GALACTOOLIGOSACCHARIDES;
   ANTIOXIDANTS; SENESCENCE; HEALTH; INJURY; INULIN
AB Probiotics and prebiotics for preventing and alleviating the degenerative changes associated with aging have received extensive attention. In the present work, Lactobacillus plantarum (L. plantarum) 69-2 with the highest antioxidant capacity combined with galacto-oligosaccharide (GOS) was used in aging model mice to evaluate the effect on aging and the regulation of gut microbiota. The combination of L. plantarum 69-2 and GOS supplementation could significantly (P < 0.05) improve liver function, antioxidant capacity, and inflammation accompanied by regulating the gut microbiota, increasing the short chain fatty acid (SCFA) levels, and activating the hepatic AMPK/SIRT1 regulatory pathway. The results showed that L. plantarum 69-2 and GOS could activate the hepatic AMPK/SIRT1 signaling pathway by regulating the gut microbiota and metabolites through the liver-gut axis to restore hepatic antioxidant activity to alleviate aging. The study provided a new insight for targeting the gut microbiota to relieve aging through the gut-liver axis.
C1 [Wang, Wan; Liu, Fei; Xu, Cong; Liu, Zhijing; Ma, Jiage; Gu, Liya; Jiang, Zhanmei; Hou, Juncai] Northeast Agr Univ, Coll Food Sci, Minist Educ, Harbin 150030, Peoples R China.
   [Wang, Wan; Liu, Fei; Xu, Cong; Liu, Zhijing; Ma, Jiage; Gu, Liya; Jiang, Zhanmei; Hou, Juncai] Northeast Agr Univ, Coll Food Sci, Key Lab Dairy Sci, Minist Educ, Harbin 150030, Peoples R China.
C3 Northeast Agricultural University - China; Northeast Agricultural
   University - China
RP Jiang, ZM; Hou, JC (corresponding author), Northeast Agr Univ, Coll Food Sci, Minist Educ, Harbin 150030, Peoples R China.; Jiang, ZM; Hou, JC (corresponding author), Northeast Agr Univ, Coll Food Sci, Key Lab Dairy Sci, Minist Educ, Harbin 150030, Peoples R China.
EM zhanmeijiang@neau.edu.cn; jchou@neau.edu.cn
OI Xu, Cong/0000-0002-7467-2083
FU National Key Research and Development Program of China [2016YFD0400605]
FX The present work was financially supported by the National Key Research
   and Development Program of China (Grant no. 2016YFD0400605).
CR Alliet P, 2007, NUTRITION, V23, P719, DOI 10.1016/j.nut.2007.06.011
   An R, 2018, GUT, V67, P2213, DOI 10.1136/gutjnl-2017-315542
   Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213
   Burokas A, 2017, BIOL PSYCHIAT, V82, P472, DOI 10.1016/j.biopsych.2016.12.031
   Celik O, 2004, EUR J OBSTET GYN R B, V117, P183, DOI 10.1016/j.ejogrb.2004.05.007
   Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004
   Das D, 2014, FOOD FUNCT, V5, P2453, DOI 10.1039/c4fo00481g
   Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07
   Fernandes L.M., 2020, FOOD HYDROCOLLOID, V104, DOI DOI 10.1016/j.jfoodeng.2007.10.004
   Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01385
   Frey N, 2018, NAT REV GASTRO HEPAT, V15, P81, DOI 10.1038/nrgastro.2017.146
   Goto Y, 2016, NAT IMMUNOL, V17, P1244, DOI 10.1038/ni.3587
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1992, ANN NY ACAD SCI, V673, P126, DOI 10.1111/j.1749-6632.1992.tb27444.x
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hou YC, 2019, J DAIRY SCI, V102, P7684, DOI 10.3168/jds.2019-16332
   Hu XB, 2019, AUTOPHAGY, V15, P453, DOI 10.1080/15548627.2018.1520548
   Krause KH, 2018, FREE RADICAL BIO MED, V120, pS7, DOI 10.1016/j.freeradbiomed.2018.04.033
   Li BL, 2018, FOOD FUNCT, V9, P6587, DOI 10.1039/c8fo01768a
   Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162604
   Liu ZJ, 2020, FOOD FUNCT, V11, P3823, DOI [10.1039/c9fo02992c, 10.1039/C9FO02992C]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luo JM, 2019, J AGR FOOD CHEM, V67, P7040, DOI 10.1021/acs.jafc.9b02434
   Manoharan S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8590578
   Mishra V, 2015, J AGR FOOD CHEM, V63, P3615, DOI 10.1021/jf506326t
   Mu GQ, 2018, J DAIRY SCI, V101, P10792, DOI 10.3168/jds.2018-14989
   Nazzaro F, 2012, PHARMACEUTICALS-BASE, V5, P481, DOI 10.3390/ph5050481
   Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016
   Paneni F, 2013, CIRCULATION, V127, P1229, DOI 10.1161/CIRCULATIONAHA.112.000826
   Patel JR, 2008, EXP NEUROL, V213, P93, DOI 10.1016/j.expneurol.2008.05.007
   Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638
   Pietraforte D, 2014, ANTIOXID REDOX SIGN, V21, P52, DOI 10.1089/ars.2014.5914
   Prattichizzo F, 2018, AGEING RES REV, V48, P87, DOI 10.1016/j.arr.2018.10.003
   Sangwan V, 2015, J DAIRY RES, V82, P70, DOI 10.1017/S0022029914000582
   Tang W, 2016, APPL MICROBIOL BIOT, V100, P7193, DOI 10.1007/s00253-016-7581-x
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132
   Wang YG, 2016, SCI REP-UK, V6, DOI 10.1038/srep32771
   Xing JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04453-9
   Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176
   Zhang J, 2017, J DAIRY SCI, V100, P6025, DOI 10.3168/jds.2016-12480
   Zhao HJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30104-6
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zhao X, 2019, J DAIRY SCI, V102, P5899, DOI 10.3168/jds.2018-16033
   Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6
   Zhu SQ, 2019, SEMIN CANCER BIOL, V57, P59, DOI 10.1016/j.semcancer.2018.11.003
NR 50
TC 34
Z9 39
U1 13
U2 114
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD 2021 MAR 10
PY 2021
VL 69
IS 9
BP 2745
EP 2757
DI 10.1021/acs.jafc.0c06730
EA FEB 2021
PG 13
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA QX1CR
UT WOS:000629087500010
PM 33565862
DA 2024-02-19
ER

PT J
AU Higgins, CB
   Mayer, AL
   Zhang, YM
   Franczyk, M
   Ballentine, S
   Yoshino, J
   DeBosch, BJ
AF Higgins, Cassandra B.
   Mayer, Allyson L.
   Zhang, Yiming
   Franczyk, Michael
   Ballentine, Samuel
   Yoshino, Jun
   DeBosch, Brian J.
TI SIRT1 selectively exerts the metabolic protective effects of hepatocyte
   nicotinamide phosphoribosyltransferase
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NAD(+) BIOSYNTHESIS; HEPATIC STEATOSIS; GLUCOSE; THERMOGENESIS;
   SIRTUINS; MICE; HOMEOSTASIS; DEFICIENCY; DELETION; DISEASE
AB Calorie restriction abates aging and cardiometabolic disease by activating metabolic signaling pathways, including nicotinamide adenine dinucleotide (NAD(+)) biosynthesis and salvage. Nicotinamide phosphoribosyltransferase (NAMPT) is rate-limiting in NAD(+) salvage, yet hepatocyte NAMPT actions during fasting and metabolic duress remain unclear. We demonstrate that hepatocyte NAMPT is upregulated in fasting mice, and in isolated hepatocytes subjected to nutrient withdrawal. Mice lacking hepatocyte NAMPT exhibit defective FGF21 activation and thermal regulation during fasting, and are sensitized to diet-induced glucose intolerance. Hepatocyte NAMPT overexpression induced FGF21 and adipose browning, improved glucose homeostasis, and attenuated dyslipidemia in obese mice. Hepatocyte SIRT1 deletion reversed hepatocyte NAMPT effects on dark-cycle thermogenesis, and hepatic FGF21 expression, but SIRT1 was dispensable for NAMPT insulin-sensitizing, anti-dyslipidemic, and light-cycle thermogenic effects. Hepatocyte NAMPT thus conveys key aspects of the fasting response, which selectively dissociate through hepatocyte SIRT1. Modulating hepatocyte NAD(+) is thus a potential mechanism through which to attenuate fasting-responsive disease.
   NAD + metabolism is potential target to treat metabolic disorders, in part due to the effects of the NAD + dependent enzyme Sirt1. Here the authors report that hepatic nicotinamide phosphoribosyltransferase, a rate-limiting step in the NAD + salvage pathway, regulates dark-cycle thermogenesis in a Sirt1-dependent but light-cycle thermogenesis and glucose homeostasis in a Sirt1-independent manner.
C1 [Higgins, Cassandra B.; Zhang, Yiming; DeBosch, Brian J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.
   [Mayer, Allyson L.] Biogenerator, St Louis, MO 63110 USA.
   [Franczyk, Michael; Yoshino, Jun] Keio Univ, Dept Med, Sch Med, Minato Ku, Tokyo, Japan.
   [Ballentine, Samuel] Washington Univ, Dept Anat & Mol Pathol, Sch Med, St Louis, MO 63110 USA.
   [DeBosch, Brian J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Keio University; Washington University
   (WUSTL); Washington University (WUSTL)
RP DeBosch, BJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.; DeBosch, BJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
EM deboschb@wustl.edu
RI Mayer, Allyson/GWV-5430-2022
OI Zhang, Yiming/0000-0002-6020-0237; Yoshino, Jun/0000-0001-9833-4356;
   DeBosch, Brian/0000-0002-9924-7921
FU Office of the Assistant Secretary of Defense for Health Affairs through
   NHLBI [1R01HL147968]; NIDDK [1R01DK126622, DK104995]; AASLD; NCCIH
   [1R21AT010520-01]; NIH/National Center for Advancing Translational
   Sciences (NCATS) [UL1TR002345]; NIH [DK115764]; AGA-Gilead Sciences
   Research Scholar Award in Liver Disease; AGA-Allergan Foundation Pilot
   Research Award in Non-Alcoholic Fatty Liver Disease; Washington
   University Digestive Disease Research Core Center [P30DK052574];
   Washington University Diabetes Research Center [P30DK020579]; Robert
   Wood Johnson Foundation; Longer Life Foundation; Nutrition & Obesity
   Research Center [P30DK056341]
FX This work was supported by the Office of the Assistant Secretary of
   Defense for Health Affairs, through grants from the NHLBI
   (1R01HL147968), NIDDK (1R01DK126622), AASLD (Pilot Research Award),
   NCCIH (1R21AT010520-01), NIH/National Center for Advancing Translational
   Sciences (NCATS, #UL1TR002345), NIH R56 (DK115764), AGA-Gilead Sciences
   Research Scholar Award in Liver Disease, the AGA-Allergan Foundation
   Pilot Research Award in Non-Alcoholic Fatty Liver Disease, the
   Washington University Digestive Disease Research Core Center
   (P30DK052574), Washington University Diabetes Research Center
   (P30DK020579), and the Robert Wood Johnson Foundation and the Longer
   Life Foundation. J.Y. is supported by NIDDK DK104995 and Nutrition &
   Obesity Research Center (P30DK056341). We thank Michael Wallendorf, PhD
   (Washington University Division of Biostatistics) for providing
   statistical consultations and review in preparing this paper.
CR Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225
   Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001
   Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100
   Danielson ND, 2019, CHEM COMMUN, V55, P5009, DOI 10.1039/c9cc01300h
   DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472
   DeBosch BJ, 2014, J BIOL CHEM, V289, P10989, DOI 10.1074/jbc.M113.527002
   DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137
   Flippo KH, 2021, NAT METAB, V3, P309, DOI 10.1038/s42255-021-00354-2
   Franczyk MP, 2021, ENDOCRINOLOGY, V162, DOI 10.1210/endocr/bqab006
   Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117
   Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005
   Helsley RN, 2020, CURR DIABETES REP, V20, DOI 10.1007/s11892-020-01342-8
   Higgins CB, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120794
   Hintze KJ, 2018, ADV NUTR, V9, P263, DOI 10.1093/advances/nmy002
   Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171
   Imai S, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.18
   Kading J, 2021, FEBS J, V288, P3784, DOI 10.1111/febs.15482
   Kane AE, 2018, CIRC RES, V123, P868, DOI 10.1161/CIRCRESAHA.118.312498
   Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059
   Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492
   Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Madeo F, 2019, CELL METAB, V29, P592, DOI 10.1016/j.cmet.2019.01.018
   Mardones P, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1937
   Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005
   Mayer AL, 2018, ENDOCRINOLOGY, V159, P2110, DOI 10.1210/en.2017-03150
   Mayer AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38586
   MILNER RE, 1989, AM J PHYSIOL, V256, pR42, DOI 10.1152/ajpregu.1989.256.1.R42
   Mitchell SJ, 2018, CELL METAB, V27, P667, DOI 10.1016/j.cmet.2018.02.001
   Najt CP, 2020, MOL CELL, V77, P810, DOI 10.1016/j.molcel.2019.12.003
   Nielsen KN, 2018, MOL METAB, V11, P178, DOI 10.1016/j.molmet.2018.02.014
   North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224
   Patterson RE, 2015, J ACAD NUTR DIET, V115, P1203, DOI 10.1016/j.jand.2015.02.018
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Potthoff MJ, 2017, NAT REV ENDOCRINOL, V13, P74, DOI 10.1038/nrendo.2016.206
   Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Ren J, 2018, TRENDS PHARMACOL SCI, V39, P1064, DOI 10.1016/j.tips.2018.10.005
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685
   Seyer P, 2013, J CLIN INVEST, V123, P1662, DOI 10.1172/JCI65538
   Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027
   Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061
   Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243
   Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700
   Yamaguchi S, 2019, P NATL ACAD SCI USA, V116, P23822, DOI 10.1073/pnas.1909917116
   Yamaguchi S, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600227
   Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhang YM, 2020, GUT MICROBES, V11, P1475, DOI 10.1080/19490976.2020.1750273
   Zhang YM, 2020, GASTROENTEROLOGY, V158, P1402, DOI 10.1053/j.gastro.2019.11.295
   Zhang YM, 2019, CURR OPIN CLIN NUTR, V22, P303, DOI 10.1097/MCO.0000000000000568
   Zhang YM, 2018, AUTOPHAGY, V14, P1959, DOI 10.1080/15548627.2018.1493044
   Zhang YL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09783-w
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 64
TC 12
Z9 11
U1 2
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 28
PY 2022
VL 13
IS 1
AR 1074
DI 10.1038/s41467-022-28717-7
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA ZJ6UQ
UT WOS:000762439700015
PM 35228549
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Chiang, CH
   Li, SJ
   Lin, YH
   Wang, PY
   Hsu, PS
   Lin, SP
   Chiang, TC
   Chen, CY
AF Chiang, Chun-Hsien
   Li, Sin-Jin
   Lin, Yu-Han
   Wang, Pei-Yu
   Hsu, Pu-Sheng
   Lin, Shau-Ping
   Chiang, Ting-Chia
   Chen, Ching-Yi
TI Early-onset caloric restriction alleviates ageing-associated
   steatohepatitis in male mice via restoring mitochondrial homeostasis
SO BIOGERONTOLOGY
LA English
DT Article; Early Access
DE Ageing; Caloric restriction; Energy deficit; Mitochondrial functions;
   Steatohepatitis
ID ADIPOSE-TISSUE; SLEEVE GASTRECTOMY; ENERGY RESTRICTION; WEIGHT-LOSS;
   LIVER; MODEL; SEX; METABOLISM; HALLMARKS; RESPONSES
AB Non-alcoholic fatty liver disease is associated with ageing, and impaired mitochondrial homeostasis is the main cause for hepatic ageing. Caloric restriction (CR) is a promising therapeutic approach for fatty liver. The purpose of the present study was to investigate the possibility of early-onset CR in decelerating the progression of ageing-related steatohepatitis. The putative mechanism associated with mitochondria was further determined. C57BL/6 male mice at 8 weeks of age were randomly assigned to one of three treatments: Young-AL (AL, ad libitum), Aged-AL, or Aged-CR (60% intake of AL). Mice were sacrificed when they were 7 months old (Young) or 20 months old (Aged). Aged-AL mice displayed the greatest body weight, liver weight, and liver relative weight among treatments. Steatosis, lipid peroxidation, inflammation, and fibrosis coexisted in the aged liver. Mega mitochondria with short, randomly organized crista were noticed in the aged liver. The CR ameliorated these unfavourable outcomes. The level of hepatic ATP decreased with ageing, but this was reversed by CR. Ageing caused a decrease in mitochondrial-related protein expressions of respiratory chain complexes (NDUFB8 and SDHB) and fission (DRP1), but an increase in proteins related to mitochondrial biogenesis (TFAM), and fusion (MFN2). CR reversed the expression of these proteins in the aged liver. Both Aged-CR and Young-AL revealed a comparable pattern of protein expression. To summarize, this study demonstrated the potential of early-onset CR in preventing ageing-associated steatohepatitis, and maintaining mitochondrial functions may contribute to CR's protection during hepatic ageing.
C1 [Chiang, Chun-Hsien; Lin, Yu-Han; Chiang, Ting-Chia; Chen, Ching-Yi] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.
   [Li, Sin-Jin] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA USA.
   [Wang, Pei-Yu] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Coll Med, Taipei, Taiwan.
   [Hsu, Pu-Sheng; Lin, Shau-Ping] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.
   [Chen, Ching-Yi] Natl Taiwan Univ, Dept Anim Sci & Technol, 50,Lane 155,Sec 3,Keelung Rd, Taipei 10672, Taiwan.
C3 National Taiwan University; Stanford University; National Taiwan
   University; National Taiwan University; National Taiwan University
RP Chen, CY (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Chen, CY (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, 50,Lane 155,Sec 3,Keelung Rd, Taipei 10672, Taiwan.
EM ronichen@ntu.edu.tw
RI zhang, hao/JOJ-7093-2023; Zhang, Yunyi/JHS-3626-2023; zhang,
   xiao/JCN-8822-2023; Li, Yan/JRW-0176-2023; Li, J N/JXL-5833-2024; YI,
   J/JJE-7713-2023; Liu, Yang/JVD-6777-2023; wang, yixuan/JGM-3893-2023;
   Wang, Xuechun/JRX-6509-2023; zhang, ying/JQX-1479-2023; li,
   li/JVP-2971-2024; zhao, lin/JJF-0406-2023; yang, xiao/JLL-7721-2023;
   Wang, Jing/JRW-1512-2023; li, yifan/JHU-9272-2023; Li,
   Wen/JQI-4757-2023; wang, xiaoxuan/JMP-6531-2023; yuanyuan,
   Li/JEZ-6497-2023; Wang, yl/JNR-4963-2023; zhao, yan/JNT-6961-2023;
   zheng, yan/JKJ-3632-2023
FU Ministry of Science and Technology, Taiwan [MOST
   110-2320-B-002-039-MY3]; Academia Sinica Core Facility and Innovative
   Instrument Project [AS-CFII-108- 119]
FX This work was supported by the Research Grant MOST
   110-2320-B-002-039-MY3 (from Ministry of Science and Technology,
   Taiwan). We thank Academia Sinica Biological Electron Microscopy Core
   Facility for TEM technical support. The core facility is funded by
   Academia Sinica Core Facility and Innovative Instrument Project
   (AS-CFII-108- 119). The authors are grateful to Dr. Harry J. Mersmann
   for reviewing the manuscript and English proofreading.
CR Astafev AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09289-9
   Berardo C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249646
   Cameron Kerry M, 2012, Longev Healthspan, V1, P3, DOI 10.1186/2046-2395-1-3
   Chaix A, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109543
   Chien MJ, 2023, ARCH PHYSIOL BIOCHEM, V129, P1289, DOI 10.1080/13813455.2021.1949022
   Chimienti G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041665
   Chuang HL, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13525
   Chung KW, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040880
   Dohmen J, 2020, INT J SURG, V75, P139, DOI 10.1016/j.ijsu.2020.01.139
   Fernández A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081865
   Fujii N, 2019, EXP GERONTOL, V118, P55, DOI 10.1016/j.exger.2019.01.001
   Fujii N, 2017, AGING CELL, V16, P508, DOI 10.1111/acel.12576
   Gibbs VK, 2018, J GERONTOL A-BIOL, V73, P157, DOI 10.1093/gerona/glx127
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hernández-Alvarez MI, 2019, CELL, V177, P881, DOI 10.1016/j.cell.2019.04.010
   Izquierdo AG, 2020, FASEB J, V34, P2312, DOI 10.1096/fj.201901147RR
   Johnson-Henry KC, 2014, J NUTR, V144, P1725, DOI 10.3945/jn.114.195081
   Kobayashi M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072054
   Lee MB, 2021, SCIENCE, V374, P953, DOI 10.1126/science.abe7365
   Li LZ, 2019, J BIOL CHEM, V294, P12581, DOI 10.1074/jbc.RA119.007601
   Li SJ, 2019, BBA-MOL CELL BIOL L, V1864, P957, DOI 10.1016/j.bbalip.2019.03.004
   López-Lluch G, 2017, MECH AGEING DEV, V162, P108, DOI 10.1016/j.mad.2016.12.005
   Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161
   Martínez-Cisuelo V, 2016, EXP GERONTOL, V83, P130, DOI 10.1016/j.exger.2016.08.002
   Mitchell SJ, 2019, CELL METAB, V29, P221, DOI 10.1016/j.cmet.2018.08.011
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Poekes L, 2019, LAB INVEST, V99, P4, DOI 10.1038/s41374-018-0120-x
   Selman Colin, 2012, Longev Healthspan, V1, P2, DOI 10.1186/2046-2395-1-2
   Shabalina IG, 2017, AGING-US, V9, P315, DOI 10.18632/aging.101174
   Sumida Y, 2018, J GASTROENTEROL, V53, P362, DOI 10.1007/s00535-017-1415-1
   Swiatkiewicz I, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010221
   Takeichi Y, 2021, DIABETOLOGIA, V64, P2092, DOI 10.1007/s00125-021-05488-2
   Talavera-Urquijo E, 2018, OBES SURG, V28, P142, DOI 10.1007/s11695-017-2805-4
   Tulsian R, 2018, AGING-US, V10, P1640, DOI 10.18632/aging.101498
   Ulgherait M, 2021, NATURE, V598, P353, DOI 10.1038/s41586-021-03934-0
   Valle A, 2007, AM J PHYSIOL-CELL PH, V293, pC1302, DOI 10.1152/ajpcell.00203.2007
   Velingkaar N, 2020, AGING CELL, V19, DOI 10.1111/acel.13138
   Wan J, 2020, AGING CELL, V19, DOI 10.1111/acel.13238
   Wang Q, 2011, ATHEROSCLEROSIS, V219, P100, DOI 10.1016/j.atherosclerosis.2011.07.025
NR 42
TC 2
Z9 2
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD 2023 JUN
PY 2023
VL 24
IS 3
BP 391
EP 401
DI 10.1007/s10522-023-10023-4
EA FEB 2023
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA E3HP8
UT WOS:000935052600001
PM 36802043
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Gagliano, N
   Arosio, B
   Grizzi, F
   Masson, S
   Tagliabue, J
   Dioguardi, N
   Vergani, C
   Annoni, G
AF Gagliano, N
   Arosio, B
   Grizzi, F
   Masson, S
   Tagliabue, J
   Dioguardi, N
   Vergani, C
   Annoni, G
TI Reduced collagenolytic activity of matrix metalloproteinases and
   development of liver fibrosis in the aging rat
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE liver; aging; fibrosis; matrix metalloproteinases
ID HEPATIC EXTRACELLULAR-MATRIX; AGE-RELATED-CHANGES; TISSUE INHIBITOR;
   TRANSFORMING GROWTH-FACTOR-BETA-1; FIBROTIC LIVER; GENE-EXPRESSION;
   IN-VIVO; COLLAGENASE; DEGRADATION; LIPOCYTES
AB Although moderate fibrosis is a histological hallmark of the aging liver. the molecular mechanisms underlying this phenomenon are little known. Here we provide a comprehensive description of hepatic collagen expression and metabolism during natural aging in rats, Interstitial collagen accumulated significantly in the oldest animals, mainly in the periportal area (P < 0.05, 19- vs, 2-month-old rats). This was ascribed to COL-III protein deposition (P < 0.05 vs. 2-month-old rats), rather than COL-I. Conversely the transcription activity of COL-III gene decreased (P < 0.05) during the considered lifespan (2-19-months). whereas COL-I and transforming growth fator-beta1 (TGF-beta1) mRNA content was substantially unchanged. In the aged rats, hepatic matrix metalloproteinases (NIMP) activity (both MMP-1 and MMP-2) dropped significantly (P < 0.05). with a concomitant increase of the inactive tissue inhibitor of MNIP (TIMP-1)/MMP-1 complex (P < 0.05). MMP-2 and TIMP-1 levels were bleakly affected. All together, these results suggest that during natural aging, (i) COL III is the protein that accumulates preferentially in the liver: (ii) liver fibrosclerosis is mainly explained by a reduced proteolytic activity of matrix MMP in which TIMP-1 seems to be a major regulating factor. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Milan, Dept Internal Med & Geriatr, I-20122 Milan, Italy.
   IRCCS, Osped Maggiore, I-20122 Milan, Italy.
   Univ Milano Bicocca, Milan, Italy.
   Ist Clin Humanitias, Sci Direct, Milan, Italy.
   Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy.
C3 University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   University of Milano-Bicocca; IRCCS Humanitas Research Hospital;
   Istituto di Ricerche Farmacologiche Mario Negri IRCCS
RP Annoni, G (corresponding author), Univ Milan, Dept Internal Med & Geriatr, Via Pace 9, I-20122 Milan, Italy.
EM giorgio.annoni@unimib.it
RI Gagliano, Nicoletta/L-1485-2016; Grizzi, Fabio/K-3448-2018
OI Gagliano, Nicoletta/0000-0002-3393-3144; Grizzi,
   Fabio/0000-0003-0925-742X; Arosio, Beatrice/0000-0002-0615-3580
CR ABRASS CK, 1995, AM J PATHOL, V146, P742
   ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256
   ANNONI G, 1992, J HEPATOL, V14, P259, DOI 10.1016/0168-8278(92)90168-O
   Annoni G, 1998, MECH AGEING DEV, V101, P57, DOI 10.1016/S0047-6374(97)00165-6
   ARTHUR MJP, 1990, SEMIN LIVER DIS, V10, P47, DOI 10.1055/s-2008-1040456
   ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270
   ARTHUR MJP, 1992, BIOCHEM J, V287, P701, DOI 10.1042/bj2870701
   BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1002/hep.1840210325
   Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892
   BIAGINI G, 1989, J HEPATOL, V8, P115, DOI 10.1016/0168-8278(89)90170-0
   BRADLEY KH, 1974, J BIOL CHEM, V249, P2674
   Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4
   BRINCKERHOFF CE, 1986, BIOCHEMISTRY-US, V25, P6378, DOI 10.1021/bi00369a006
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477
   DENHARDT DT, 1993, PHARMACOL THERAPEUT, V59, P329, DOI 10.1016/0163-7258(93)90074-N
   Dioguardi N, 1999, ANAL QUANT CYTOL, V21, P262
   Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365
   GRASEDYCK K, 1980, MECH AGEING DEV, V14, P435, DOI 10.1016/0047-6374(80)90014-7
   Herbst H, 1997, AM J PATHOL, V150, P1647
   HERRON GS, 1986, J BIOL CHEM, V261, P2814
   Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1053/jhep.1996.v24.pm0008707259
   IREDALE JP, 1992, J CLIN INVEST, V90, P282, DOI 10.1172/JCI115850
   KANUNGO MS, 1980, BIOCH AGEING, P129
   KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186
   KUCHARZ EJ, 1987, CONNECT TISSUE RES, V16, P143, DOI 10.3109/03008208709002002
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1
   MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57
   MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P1, DOI 10.1007/BF01606425
   MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307
   MAYS PK, 1991, HEPATOLOGY, V14, P1224
   MILANI S, 1991, AM J PATHOL, V139, P1221
   MILANI S, 1994, AM J PATHOL, V144, P528
   RAUTERBERG J, 1981, KLIN WOCHENSCHR, V59, P767, DOI 10.1007/BF01724682
   ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710
   SAKAI T, 1967, BIOCHEMISTRY-US, V6, P518, DOI 10.1021/bi00854a021
   Sakai Y, 1997, HEPATOLOGY, V25, P421
   SAMBROOK J, 1989, MOL CLONING LAB MANU, P739
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHALEGER LL, 1963, ADV PHYS ORG CHEM, V1, P1, DOI 10.1016/S0065-3160(08)60276-2
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   SCHUPPAN D, 1990, SEMIN LIVER DIS, V10, P1, DOI 10.1055/s-2008-1040452
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   TAKAHARA T, 1995, HEPATOLOGY, V21, P787
   Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708
   TIETZ NW, 1992, CLIN CHEM, V38, P1167
   WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705
   Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521
NR 51
TC 41
Z9 52
U1 1
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 2002
VL 123
IS 4
BP 413
EP 425
AR PII S0047-6374(01)00398-0
DI 10.1016/S0047-6374(01)00398-0
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 578NR
UT WOS:000177125000014
PM 11744051
DA 2024-02-19
ER

PT J
AU Cano, M
   Guerrero-Castilla, A
   Nabavi, SM
   Ayala, A
   Argüelles, S
AF Cano, Mercedes
   Guerrero-Castilla, Angelica
   Nabavi, Seyed Mohammad
   Ayala, Antonio
   Arguelles, Sandro
TI Targeting pro-senescence mitogen activated protein kinase (Mapk) enzymes
   with bioactive natural compounds
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Aging; Senescence; Bioactive compounds; Anti-senescence compounds; MAPK
   pathway
ID NF-KAPPA-B; LIFE-SPAN EXTENSION; ACACETIN INHIBITS EXPRESSION;
   CHLOROGENIC ACID PROTECTS; FULMINANT HEPATIC-FAILURE; P38 MAPK; GALLIC
   ACID; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; SIGNALING PATHWAY
AB Aging is a multifactorial universal process characterized by a gradual decrease in physiological and biochemical functions. Given that life expectancy is on the rise, a better understanding of molecular mechanisms of the aging process is necessary in order to develop anti-aging interventions. Uncontrolled cellular senescence promotes persistent inflammation and accelerates the aging process by decreasing tissue renewal, repair and regeneration. Senescence of immune cells, immunesenescence, is another hallmark of aging. Targeting pro-senescent enzymes increases survival and therefore the lifespan. Although the upregulation of Mitogen Activated Protein Kinases (MAPK) enzymes in aging is still controversial, increasing evidence shows that dysregulation of those enzymes are associated with biological processes that contribute to aging such as irreversible senescence. In this manuscript components of the MAPK pathway will be summarized, including extracellular signal-regulated kinase 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK) and p38, as well as natural flavonoids, phenolic and diterpenoids with anti-senescence activity that shows positive effects on longevity and MAPK inhibition. Although more studies using additional aging models are needed, we suggest that these selected natural bioactive compounds that regulate MAPK enzymes and reduce senescent cells can be potentially used to improve longevity and prevent/treat age-related diseases.
C1 [Cano, Mercedes; Arguelles, Sandro] Univ Seville, Dept Physiol, Fac Pharm, C Prof Garcia Gonzalez 241012, Seville, Spain.
   [Guerrero-Castilla, Angelica] Univ Arturo Prat, Fac Ciencias Salud, Quim & Farm, Iquique, Chile.
   [Nabavi, Seyed Mohammad] Baqiyatallah Univ Med Sci, Appl Biotechnol Res Ctr, Tehran, Iran.
   [Ayala, Antonio] Univ Seville, Fac Pharm, Dept Biochem & Mol Biol, Seville, Spain.
C3 University of Sevilla; Universidad Arturo Prat; Baqiyatallah University
   of Medical Sciences (BMSU); University of Sevilla
RP Argüelles, S (corresponding author), Univ Seville, Dept Physiol, Fac Pharm, C Prof Garcia Gonzalez 241012, Seville, Spain.
RI Nabavi, Seyed Mohammad/G-5335-2010; Arguelles, Sandro/Y-6343-2019; Cano,
   Mercedes/L-1129-2014
OI Nabavi, Seyed Mohammad/0000-0001-8859-5675; Arguelles,
   Sandro/0000-0001-8450-3227; Ayala, Antonio/0000-0001-9711-3711;
   Guerrero-Castilla, Angelica/0000-0002-2061-5200; Cano,
   Mercedes/0000-0002-7710-0072
FU V Plan Propio US-Acceso [USE-14793-G]
FX S.A was supported by V Plan Propio US-Acceso USE-14793-G.
CR Ahad A, 2015, CHEM-BIOL INTERACT, V240, P292, DOI 10.1016/j.cbi.2015.08.026
   Alimbetov D, 2016, BIOGERONTOLOGY, V17, P305, DOI 10.1007/s10522-015-9610-z
   Altieri P, 2017, BRIT J PHARMACOL, V174, P3713, DOI 10.1111/bph.13725
   [Anonymous], J GERONTOL SER A BIO
   [Anonymous], 2016, J GERONTOL A
   [Anonymous], INT J MOL SCI
   [Anonymous], PROSTATE
   Asthana J, 2016, J GERONTOL A-BIOL, V71, P1160, DOI 10.1093/gerona/glv173
   Asthana J, 2016, FREE RADICAL RES, V50, P861, DOI 10.1080/10715762.2016.1187268
   Bar Christian, 2016, F1000Res, V5, DOI 10.12688/f1000research.7020.1
   Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492
   Bartholome A, 2010, ARCH BIOCHEM BIOPHYS, V501, P58, DOI 10.1016/j.abb.2010.05.024
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023
   Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003
   Blazanin N, 2017, P NATL ACAD SCI USA, V114, P9900, DOI 10.1073/pnas.1701757114
   Tung BT, 2015, EXP GERONTOL, V64, P1, DOI 10.1016/j.exger.2015.02.004
   Buzzi N, 2007, BIOGERONTOLOGY, V8, P189, DOI 10.1007/s10522-006-9068-0
   Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x
   Cano M, 2017, CURR PHARM DESIGN, V23, P4351, DOI 10.2174/1381612823666170714143426
   Cao T, 2018, BIOCHEM BIOPH RES CO, V495, P693, DOI 10.1016/j.bbrc.2017.11.006
   Castello L, 2011, MECH AGEING DEV, V132, P305, DOI 10.1016/j.mad.2011.06.006
   Chan YC, 2009, INT J NANOMED, V4, P27
   Chang SS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/683872
   Chang W, 2017, J PHARMACOL SCI, V135, P156, DOI 10.1016/j.jphs.2017.11.009
   Chen HM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-233
   Chen JM, 2017, MECH AGEING DEV, V164, P1, DOI 10.1016/j.mad.2017.03.007
   Chen WP, 2015, J CELL MOL MED, V19, P1910, DOI 10.1111/jcmm.12564
   Chen YJ, 2014, J AGR FOOD CHEM, V62, P3422, DOI 10.1021/jf500210p
   Cho HI, 2014, J NAT PROD, V77, P2497, DOI 10.1021/np500537x
   Cho YH, 2016, J FOOD SCI, V81, pC2447, DOI 10.1111/1750-3841.13497
   Chou RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071983
   Cieslik KA, 2017, J MOL CELL CARDIOL, V111, P81, DOI 10.1016/j.yjmcc.2017.08.003
   Cieslik KA, 2013, FASEB J, V27, P1761, DOI 10.1096/fj.12-220145
   Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001
   Cui YQ, 2016, CURR ALZHEIMER RES, V13, P288, DOI 10.2174/156720501303160217122803
   Currais A, 2018, J GERONTOL A-BIOL, V73, P299, DOI 10.1093/gerona/glx104
   Danilov A, 2015, ONCOTARGET, V6, P19428, DOI 10.18632/oncotarget.5118
   Davis T, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9020023
   Dong FX, 2017, BIOCHEM BIOPH RES CO, V491, P636, DOI 10.1016/j.bbrc.2017.07.151
   Duan DD, 2017, REJUV RES, V20, P506, DOI 10.1089/rej.2017.1919
   Dueñas M, 2013, PHARMACOL RES, V76, P41, DOI 10.1016/j.phrs.2013.07.001
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Ganai AA, 2015, TOXICOL APPL PHARM, V283, P139, DOI 10.1016/j.taap.2015.01.012
   Gao L, 2018, ACS CHEM NEUROSCI, V9, P1714, DOI 10.1021/acschemneuro.8b00074
   Gao YL, 2016, CARDIOVASC TOXICOL, V16, P130, DOI 10.1007/s12012-015-9321-3
   Ghosh S, 2015, J GERONTOL A-BIOL, V70, P232, DOI 10.1093/gerona/glu067
   Gray AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109208
   Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059
   Gu YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150954
   Guo R, 2014, CELL PHYSIOL BIOCHEM, V34, P603, DOI 10.1159/000363026
   Gurau F, 2018, AGEING RES REV, V46, P14, DOI 10.1016/j.arr.2018.05.001
   Gutiérrez-Venegas G, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0047-z
   Gutiérrez-Venegas G, 2014, J ASIAN NAT PROD RES, V16, P1009, DOI 10.1080/10286020.2014.932351
   Ha SK, 2012, NEUROCHEM RES, V37, P1560, DOI 10.1007/s11064-012-0751-z
   Han SY, 2015, AM J CHINESE MED, V43, P1605, DOI 10.1142/S0192415X15500913
   Harada G, 2014, J BIOCHEM, V156, P283, DOI 10.1093/jb/mvu040
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Havermann S, 2016, FITOTERAPIA, V113, P123, DOI 10.1016/j.fitote.2016.06.018
   Havermann S, 2013, J AGR FOOD CHEM, V61, P2158, DOI 10.1021/jf304553g
   He XX, 2015, INT IMMUNOPHARMACOL, V28, P470, DOI 10.1016/j.intimp.2015.07.012
   Hekimi S, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00161
   Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051
   Heo JR, 2018, PHYTOMEDICINE, V39, P100, DOI 10.1016/j.phymed.2017.12.006
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194
   Hu S, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/973524
   Huang HL, 2012, J AGR FOOD CHEM, V60, P2328, DOI 10.1021/jf203709q
   Hwang E, 2014, PHYTOTHER RES, V28, P1778, DOI 10.1002/ptr.5198
   Jang IA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111741
   Ji GY, 2011, INT IMMUNOPHARMACOL, V11, P762, DOI 10.1016/j.intimp.2011.01.036
   Ji LL, 2013, J NUTR BIOCHEM, V24, P1911, DOI 10.1016/j.jnutbio.2013.05.007
   Jin Y, 2008, ACTA PHARMACOL SIN, V29, P1399, DOI 10.1111/j.1745-7254.2008.00848.x
   Jones SA, 2015, MECH AGEING DEV, V146, P72, DOI 10.1016/j.mad.2015.05.001
   Joo SY, 2012, GUT LIVER, V6, P188, DOI 10.5009/gnl.2012.6.2.188
   Kang SW, 2016, MECH AGEING DEV, V153, P7, DOI 10.1016/j.mad.2015.12.002
   Kim CD, 2015, ARCH ORAL BIOL, V60, P1283, DOI 10.1016/j.archoralbio.2015.05.009
   Kim DH, 2014, INT J MOL MED, V34, P1669, DOI 10.3892/ijmm.2014.1956
   Kim HJ, 2014, J PHARMACOL EXP THER, V349, P518, DOI 10.1124/jpet.114.213769
   Kim JM, 2011, BIOGERONTOLOGY, V12, P537, DOI 10.1007/s10522-011-9345-4
   Kim KH, 2015, CHEM RES TOXICOL, V28, P71, DOI 10.1021/tx500341z
   Kim MC, 2014, INT J MOL MED, V33, P1657, DOI 10.3892/ijmm.2014.1704
   Kim M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161247
   Kim SM, 2017, BIOORG MED CHEM LETT, V27, P5207, DOI 10.1016/j.bmcl.2017.10.048
   Kim SJ, 2014, ARCH PHARM RES, V37, P1079, DOI 10.1007/s12272-013-0309-x
   Kim SJ, 2017, J FOOD SCI, V82, P1484, DOI 10.1111/1750-3841.13720
   Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177
   Kuroyanagi G, 2015, EXP THER MED, V9, P2303, DOI 10.3892/etm.2015.2389
   Kwak SC, 2013, BIOL PHARM BULL, V36, P1779
   Kwong J, 2013, MOL CELL BIOL, V33, P3780, DOI 10.1128/MCB.00784-13
   Lai CC, 2016, PLANTA MED, V82, P181, DOI 10.1055/s-0035-1558114
   Lanna A, 2017, NAT IMMUNOL, V18, P354, DOI 10.1038/ni.3665
   Lee CH, 2012, MOL MED, V18, P1437, DOI 10.2119/molmed.2012.00279
   Lee EB, 2015, BIOMOL THER, V23, P77, DOI 10.4062/biomolther.2014.075
   Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355
   Lee M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112497
   Lei L, 2017, MOL MED REP, V15, P3977, DOI 10.3892/mmr.2017.6532
   Li L, 2005, LIFE SCI, V77, P230, DOI 10.1016/j.lfs.2004.12.024
   Li Y, 2018, PHARMACOL RES, V130, P110, DOI 10.1016/j.phrs.2018.01.006
   Li ZL, 2011, EXP GERONTOL, V46, P694, DOI 10.1016/j.exger.2011.04.005
   Lian WW, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00409
   Liao ZY, 2017, EXP GERONTOL, V98, P177, DOI 10.1016/j.exger.2017.08.032
   Lin FY, 2015, J ORAL PATHOL MED, V44, P699, DOI 10.1111/jop.12288
   Lin WH, 2015, IRAN J BASIC MED SCI, V18, P555
   Ling QZ, 2014, J CELL PHYSIOL, V229, P108, DOI 10.1002/jcp.24425
   Liu M, 2015, PHARMAZIE, V70, P244, DOI 10.1691/ph.2015.4799
   Liu Y, 2016, INT J OPHTHALMOL-CHI, V9, P9, DOI 10.18240/ijo.2016.01.02
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lorenzini A, 2002, EXP GERONTOL, V37, P1149, DOI 10.1016/S0531-5565(02)00133-X
   Lu Y, 2010, EUR J PHARMACOL, V641, P102, DOI 10.1016/j.ejphar.2010.05.043
   Luo XP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12562-6
   Sabogal-Guáqueta AM, 2015, NEUROPHARMACOLOGY, V93, P134, DOI 10.1016/j.neuropharm.2015.01.027
   Marmisolle I, 2017, ARCH BIOCHEM BIOPHYS, V613, P12, DOI 10.1016/j.abb.2016.10.016
   Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Mei XY, 2018, VASC PHARMACOL, V101, P29, DOI 10.1016/j.vph.2017.11.002
   Meng Y, 2019, HERZ, V44, P247, DOI 10.1007/s00059-017-4635-5
   Monti D, 2017, MECH AGEING DEV, V165, P129, DOI 10.1016/j.mad.2016.12.008
   Navarro-Cruz AR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8510761
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Noh EM, 2015, EUR J PHARMACOL, V764, P79, DOI 10.1016/j.ejphar.2015.06.038
   Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102
   Okuyama T, 2010, J BIOL CHEM, V285, P30274, DOI 10.1074/jbc.M110.146274
   Onishi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195753
   Pal HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086338
   Pan W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147034
   Pang JHS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071354
   Park WH, 2013, ONCOL REP, V30, P513, DOI 10.3892/or.2013.2447
   Patwardhan RS, 2014, FREE RADICAL BIO MED, V68, P52, DOI 10.1016/j.freeradbiomed.2013.11.004
   Pauli JR, 2010, MECH AGEING DEV, V131, P323, DOI 10.1016/j.mad.2010.03.004
   Peng ZX, 2017, INT IMMUNOPHARMACOL, V52, P281, DOI 10.1016/j.intimp.2017.09.022
   Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6
   Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012
   Proshkina E, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00505
   Qian YS, 2015, PHARM BIOL, V53, P1124, DOI 10.3109/13880209.2014.962057
   Rascón B, 2012, AGING-US, V4, P499, DOI 10.18632/aging.100474
   Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166
   Sahu BD, 2016, J NUTR BIOCHEM, V28, P171, DOI 10.1016/j.jnutbio.2015.10.004
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Sánchez-González PD, 2017, FOOD CHEM TOXICOL, V107, P226, DOI 10.1016/j.fct.2017.06.047
   Sarubbo F, 2018, J NEUROIMMUNE PHARM, V13, P24, DOI 10.1007/s11481-017-9759-0
   Saul N, 2011, J NAT PROD, V74, P1713, DOI 10.1021/np200011a
   Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005
   Shi HT, 2016, CLIN NUTR, V35, P1366, DOI 10.1016/j.clnu.2016.03.002
   Shi RZ, 2018, PULM PHARMACOL THER, V48, P124, DOI 10.1016/j.pupt.2017.11.003
   Shim HY, 2007, MOL CELLS, V24, P95
   Shimada N, 2009, RNA BIOL, V6, P293, DOI 10.4161/rna.6.3.8497
   Si HW, 2019, FASEB J, V33, P965, DOI [10.1096/fj.201800554RR, 10.1096/fj.201800554rr]
   Singh S, 2018, LIFE SCI, V193, P171, DOI 10.1016/j.lfs.2017.11.004
   Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023
   Solas M, 2013, BBA-MOL BASIS DIS, V1832, P2332, DOI 10.1016/j.bbadis.2013.09.013
   Su P, 2016, NEUROTOXICOLOGY, V53, P153, DOI 10.1016/j.neuro.2015.12.019
   Sun GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141509
   Sun YN, 2014, EXP GERONTOL, V50, P57, DOI 10.1016/j.exger.2013.11.020
   Tajes M, 2010, EXP GERONTOL, V45, P702, DOI 10.1016/j.exger.2010.04.010
   Tanigawa N, 2013, IMMUNOPHARM IMMUNOT, V35, P471, DOI 10.3109/08923973.2013.811596
   Toniolo L, 2018, EXP GERONTOL, V111, P170, DOI 10.1016/j.exger.2018.07.012
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Vatner SF, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/250310
   Vrailas-Mortimer A, 2011, DEV CELL, V21, P783, DOI 10.1016/j.devcel.2011.09.002
   Wang F, 2016, SCI CHINA LIFE SCI, V59, P940, DOI 10.1007/s11427-015-0277-8
   Wang F, 2014, MOL MED REP, V9, P1085, DOI 10.3892/mmr.2014.1909
   Wang LH, 2017, ADV EXP MED BIOL, V1024, P213, DOI 10.1007/978-981-10-5987-2_10
   Wang N, 2017, INT J MOL MED, V39, P783, DOI 10.3892/ijmm.2017.2890
   Wang Q, 2014, DIS MODEL MECH, V7, P1385, DOI 10.1242/dmm.018218
   Wang T, 2014, INT J MOL MED, V33, P994, DOI 10.3892/ijmm.2014.1635
   Wang W, 2015, J MOL HISTOL, V46, P283, DOI 10.1007/s10735-015-9621-8
   Wang Z, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0223-0
   Warnsmann V, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00160
   Wiley CD, 2016, CELL METAB, V23, P1013, DOI 10.1016/j.cmet.2016.05.010
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Wu HQ, 2017, J MOL NEUROSCI, V61, P449, DOI 10.1007/s12031-017-0885-1
   Wu ZS, 2015, AGING-US, V7, P70, DOI 10.18632/aging.100722
   Xu H, 2015, INFLAMMATION, V38, P327, DOI 10.1007/s10753-014-0036-6
   Yang YL, 2016, INT IMMUNOPHARMACOL, V41, P8, DOI 10.1016/j.intimp.2016.10.005
   Yeung YT, 2018, CURR PHARM DESIGN, V24, P1449, DOI 10.2174/1381612824666180327165604
   Youngman MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002082
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Yu BW, 2016, ACTA PHARMACOL SIN, V37, P1413, DOI 10.1038/aps.2016.79
   Yu XP, 2012, MED ONCOL, V29, P349, DOI 10.1007/s12032-010-9770-2
   Zhan XL, 2018, MOL CELL BIOCHEM, V439, P131, DOI 10.1007/s11010-017-3142-6
   Zhang L, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027874
   Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041
   Zhang Q, 2015, INT IMMUNOPHARMACOL, V28, P578, DOI 10.1016/j.intimp.2015.07.027
   Zhang X, 2017, MICROB PATHOGENESIS, V107, P462, DOI 10.1016/j.micpath.2017.04.002
   Zhao B, 2013, ONCOL LETT, V6, P1749, DOI 10.3892/ol.2013.1632
   Zhao L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/425705
   Zheng ZY, 2016, ENVIRON TOXICOL PHAR, V46, P80, DOI 10.1016/j.etap.2016.07.002
   Zhou L, 2015, J PINEAL RES, V59, P190, DOI 10.1111/jpi.12250
   Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043
   Zhu B, 2014, ONCOGENE, V33, P5348, DOI 10.1038/onc.2013.477
   Zou Y, 2016, J VET MED SCI, V78, P1487, DOI 10.1292/jvms.16-0090
NR 197
TC 14
Z9 16
U1 4
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD SEP
PY 2019
VL 131
AR 110544
DI 10.1016/j.fct.2019.05.052
PG 18
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Food Science & Technology; Toxicology
GA IS6FB
UT WOS:000482246600035
PM 31201898
DA 2024-02-19
ER

PT J
AU Gelson, W
   Hoare, M
   Vowler, S
   Shankar, A
   Gibbs, P
   Akbar, AN
   Alexander, GJM
AF Gelson, William
   Hoare, Matthew
   Vowler, Sarah
   Shankar, Arun
   Gibbs, Paul
   Akbar, Arne N.
   Alexander, Graeme J. M.
TI Features of Immune Senescence in Liver Transplant Recipients with
   Established Grafts
SO LIVER TRANSPLANTATION
LA English
DT Article
ID T-CELL; TELOMERE LENGTH; PROLIFERATIVE CAPACITY; FLOW-CYTOMETRY;
   RECEPTOR G1; IMMUNOSENESCENCE; MORTALITY; AGE; COMPLICATIONS; DISEASE
AB Immune senescence is the normal process whereby the human immune system ages, but becomes less effective. We investigated whether liver transplant recipients have features of immune senescence. Lymphocytes from 97 liver transplant recipients with established grafts and 41 age-matched and sex-matched controls were subjected to an 8-color flow cytometry assay that measured expression of killer cell lectin-like receptor subfamily G member 1, cluster of differentiation 127 (CD127), CD45RO, CD27, CD28, CD4, CD8, and CD57. Lymphocyte telomere length was assessed by flow-fluorescence in situ hybridization. Cases were compared with controls for each marker of immune senescence using a Mann-Whitney U test. For liver transplant recipients, linear regression analyses identified associations between markers of immune senescence and clinical or demographic characteristics. Lymphocytes from liver transplant recipients expressed more phenotypic markers of maturity than did lymphocytes from controls. Lymphocyte telomeres were shorter in liver transplant recipients than in controls. Age, hepatocellular carcinoma at transplantation, and skin malignancy developing after transplantation were associated independently with shortened lymphocyte telomeres. Increasing age and previous cytomegalovirus infection were associated independently with phenotypic markers of lymphocyte maturity. Thus, lymphocytes from liver transplant recipients are older "biologically" than lymphocytes from age-matched and sex-matched controls. Hepatocellular carcinoma at transplantation, subsequent skin malignancy, and previous cytomegalovirus infection are associated with lymphocyte senescence in liver transplant recipients. Liver Transpl 16:577-587, 2010. (C) 2010 AASLD.
C1 [Gelson, William; Hoare, Matthew; Shankar, Arun; Alexander, Graeme J. M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.
   [Vowler, Sarah] Univ Cambridge, Ctr Appl Med Stat, Cambridge CB2 2QQ, England.
   [Gibbs, Paul] Univ Cambridge, Dept Surg, Cambridge CB2 2QQ, England.
   [Akbar, Arne N.] UCL, Dept Immunol, London, England.
C3 University of Cambridge; University of Cambridge; University of
   Cambridge; University of London; University College London
RP Alexander, GJM (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Med, Box 157, Cambridge CB0 2QQ, England.
EM gja1000@doctors.org.uk
OI Hoare, Matthew/0000-0001-5990-9604; Shankar, Arun/0000-0003-1293-2502;
   Akbar, Arne/0000-0002-3763-9380
FU British Transplantation Society; Wellcome Trust; Frank Litchfield
   Charitable Trust; Cambridge Hepatology Endowment Fund
FX The British Transplantation Society supported Dr. William Gelson; The
   Wellcome Trust, supported Dr. Matthew Hoare. The Frank Litchfield
   Charitable Trust and Cambridge Hepatology Endowment Fund provided
   financial support for the running costs of the study.
CR Åberg F, 2008, LIVER TRANSPLANT, V14, P1428, DOI 10.1002/lt.21475
   Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003
   Akbar AN, 2005, CURR OPIN IMMUNOL, V17, P480, DOI 10.1016/j.coi.2005.07.019
   Akbar AN, 2004, NAT REV IMMUNOL, V4, P737, DOI 10.1038/nri1440
   Akbar AN, 2000, MECH AGEING DEV, V121, P69
   Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x
   Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5
   Canzanello V J, 1997, Liver Transpl Surg, V3, P1
   CAREY WD, 1995, TRANSPLANTATION, V59, P859, DOI 10.1097/00007890-199503270-00010
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249
   Eaton SM, 2004, J EXP MED, V200, P1613, DOI 10.1084/jem.20041395
   Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218
   Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020
   Guan JZ, 2007, J GERONTOL A-BIOL, V62, P1199, DOI 10.1093/gerona/62.11.1199
   Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013
   Haynes L, 2006, IMMUNITY, V24, P663, DOI 10.1016/j.immuni.2006.06.003
   Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890
   Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651
   Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088
   Johnston SD, 2002, TRANSPLANTATION, V73, P901, DOI 10.1097/00007890-200203270-00012
   Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984
   Kizilisik A Tarik, 2003, Prog Transplant, V13, P278
   Kniepeiss D, 2004, CLIN TRANSPLANT, V18, P642, DOI 10.1111/j.1399-0012.2004.00253.x
   Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043
   Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869
   MEYER TD, 2008, FRONT BIOSCI, V13, P2960
   Neal DAJ, 2004, TRANSPLANTATION, V77, P93, DOI 10.1097/01.TP.0000100685.70064.90
   Ohyashiki JH, 2002, ONCOGENE, V21, P680, DOI 10.1038/sj.onc.1205075
   Pawelec G, 2004, TRENDS IMMUNOL, V25, P406, DOI 10.1016/j.it.2004.05.006
   Pawelec G, 1996, EXP GERONTOL, V31, P655, DOI 10.1016/S0531-5565(96)00097-6
   PERILLO NL, 1993, EXP CELL RES, V207, P131, DOI 10.1006/excr.1993.1171
   Pommier JP, 1997, VIROLOGY, V231, P148, DOI 10.1006/viro.1997.8512
   Rabkin JM, 2002, AM J SURG, V183, P595, DOI 10.1016/S0002-9610(02)00826-7
   Sheiner PA, 2000, TRANSPLANTATION, V69, P781
   Singh N, 2001, LIVER TRANSPLANT, V7, P884, DOI 10.1053/jlts.2001.27864
   Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007
   Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x
   Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5
   Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657
   Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001
   Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011
NR 44
TC 21
Z9 22
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD MAY
PY 2010
VL 16
IS 5
BP 577
EP 587
DI 10.1002/lt.22033
PG 11
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 594HH
UT WOS:000277526500006
PM 20440767
DA 2024-02-19
ER

PT J
AU Wang, M
   Lan, LH
   Yang, F
   Jiang, S
   Xu, HJ
   Zhang, CF
   Zhou, GR
   Xia, HP
   Xia, JL
AF Wang, Mei
   Lan, Linhua
   Yang, Fan
   Jiang, Shan
   Xu, Haojun
   Zhang, Chengfei
   Zhou, Guoren
   Xia, Hongping
   Xia, Jinglin
TI Hepatic SIRT6 deficit promotes liver tumorigenesis in the mice models
SO GENES & DISEASES
LA English
DT Article
DE ERK1/2 pathway; HCC; Liver carcinogenesis; Mouse model; SIRT6
ID HISTONE DEACETYLASE SIRT6; HEPATOCELLULAR-CARCINOMA; DNA-DAMAGE; CANCER;
   INHIBITION; HEPATOCARCINOGENESIS; DISRUPTION; EXPRESSION; MUTATIONS;
   FIBROSIS
AB SIRT6 belongs to class III sirtuin family with NAD+-dependent histone deacetylase activities and controls multiple processes including aging, metabolism and inflammation. In recent years, increasing studies showed tumor suppressor role of SIRT6 in HCC development. We established a two-stage DEN followed CCE4 induced liver carcinogenesis in the hepatic-specific SIRT6 HKO mice models and found that hepatic SIRT6 deficit significantly promotes liver injury and liver cancer through inhibition of the ERK1/2 pathway. SIRT6 was compensatory up-regulated in mice tumor tissues and human HCC cells and overexpressed SIRT6 inhibits tumor growth both in vitro and in vivo. Taken together, we provide a useful mouse model for delineating the molecular pathways involved in chronic liver diseases and primary liver cancer and suggest that SIRT6 can be a promising target for HCC therapies. Copyright (C) 2020, Chongqing Medical University. Production and hosting by Elsevier B.V.
C1 [Wang, Mei; Xu, Haojun; Zhang, Chengfei; Xia, Hongping] Nanjing Med Univ, Dept Pathol, Sch Basic Med Sci, Nanjing 211166, Jiangsu, Peoples R China.
   [Wang, Mei; Xu, Haojun; Zhang, Chengfei; Xia, Hongping] Nanjing Med Univ, Sir Run Run Hosp, Nanjing 211166, Jiangsu, Peoples R China.
   [Wang, Mei; Xu, Haojun; Zhang, Chengfei; Xia, Hongping] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.
   [Wang, Mei; Xu, Haojun; Zhang, Chengfei; Xia, Hongping] Nanjing Med Univ, Key Lab Antibody Tech, Natl Hlth Commiss, Nanjing 211166, Jiangsu, Peoples R China.
   [Wang, Mei; Xia, Hongping] Southeast Univ, Dept Immunol, Med Sch, Nanjing 210009, Jiangsu, Peoples R China.
   [Lan, Linhua; Xia, Jinglin] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China.
   [Yang, Fan; Jiang, Shan] Chongqing Med Univ, Affiliated Hosp 1, Chongqing 400016, Peoples R China.
   [Zhou, Guoren; Xia, Hongping] Nanjing Med Univ, Jiangsu Canc Hosp, Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China.
   [Zhou, Guoren; Xia, Hongping] Nanjing Med Univ, Jiangsu Inst Canc Res, Affiliated Canc Hosp, Nanjing 210009, Jiangsu, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University; Nanjing Medical
   University; Nanjing Medical University; Southeast University - China;
   Wenzhou Medical University; Chongqing Medical University; Nanjing
   Medical University; Nanjing Medical University
RP Xia, HP (corresponding author), Nanjing Med Univ, Dept Pathol, Sch Basic Med Sci, Nanjing 211166, Jiangsu, Peoples R China.; Zhou, GR (corresponding author), Jiangsu Canc Hosp, Dept Oncol, Nanjing 210009, Jiangsu, Peoples R China.; Xia, JL (corresponding author), Wenzhou Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China.
EM zhouguoren888@126.com; xiahongping@njmu.edu.cn; xiajinglin@wzhospital.cn
RI zhang, cl/JDW-6549-2023; Zhang, Cheng/GRS-8698-2022; Zhang,
   Cheng/JAD-2236-2023
OI Xia, Jinglin/0000-0001-9443-7075; Wang, Mei/0009-0001-4916-3789
FU National Natural Science Foundation of China [81902803, 81972233];
   Overseas Young Talents Project of China [(2018)2015]; Science and
   Technology Grant [BE2019758]; Natural Science Foundation of Jiangsu
   Province [BK20190657]; Southeast University-Nanjing Medical University
   Cooperative Research Project [2242018K3DN33]; Fund of Nanjing Medical
   University; China Scholarship Council [201906090247]
FX This study was supported grants from the National Natural Science
   Foundation of China (No. 81902803, 81972233), the Overseas Young Talents
   Project of China, "Innovative and Entrepreneurial Team" (No.
   (2018)2015), Science and Technology Grant (No. BE2019758) and the
   Natural Science Foundation (No. BK20190657) of Jiangsu Province,
   Southeast University-Nanjing Medical University Cooperative Research
   Project (No. 2242018K3DN33), Fund of Nanjing Medical University and the
   China Scholarship Council (No. 201906090247).
CR Cea M, 2016, BLOOD, V127, P1138, DOI 10.1182/blood-2015-06-649970
   Chen HJ., 2018, Hepatoma Res, V4, P29, DOI [10.20517/2394-5079.2018.18, DOI 10.20517/2394, DOI 10.20517/2394-5079.2018.18]
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608
   Feng J, 2016, ONCOL REP, V35, P1395, DOI 10.3892/or.2015.4477
   Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898
   Geng CH, 2018, J CELL BIOCHEM, V119, P3957, DOI 10.1002/jcb.26539
   Han ZJ, 2014, INT J CLIN EXP PATHO, V7, P4774
   Huang ZM, 2018, NAT CHEM BIOL, V14, P1118, DOI 10.1038/s41589-018-0150-0
   Irminger-Finger I, 2007, J CLIN ONCOL, V25, P1844, DOI 10.1200/JCO.2007.10.8928
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Ka SO, 2017, FASEB J, V31, P3999, DOI 10.1096/fj.201700098RR
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kim EJ, 2015, J BIOL CHEM, V290, P9604, DOI 10.1074/jbc.M114.633198
   Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009
   Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033
   Kugel S, 2015, CELL REP, V13, P479, DOI 10.1016/j.celrep.2015.09.022
   Lerrer B, 2013, EMBO J, V32, P7, DOI 10.1038/emboj.2012.332
   Li ZC, 2018, KIDNEY INT, V93, P881, DOI 10.1016/j.kint.2017.10.021
   Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Min LH, 2011, SEMIN CANCER BIOL, V21, P10, DOI 10.1016/j.semcancer.2010.10.011
   Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]
   Müller M, 2020, J HEPATOL, V72, P990, DOI 10.1016/j.jhep.2020.01.019
   Park TJ, 2008, HEPATOLOGY, V47, P1533, DOI 10.1002/hep.22212
   Rabachini T, 2018, CELL DEATH DIFFER, V25, P706, DOI 10.1038/s41418-017-0008-0
   Ran LK, 2016, CLIN CANCER RES, V22, P3372, DOI 10.1158/1078-0432.CCR-15-1638
   Santos-Barriopedro I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02586-x
   Sebastián C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047
   STOWELL RE, 1951, CANCER RES, V11, P345
   Tang CF, 2019, J CELL PHYSIOL, V234, P18615, DOI 10.1002/jcp.28500
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Uehara Takeki, 2014, Curr Protoc Pharmacol, V66, DOI 10.1002/0471141755.ph1430s66
   Uehara T, 2013, TOXICOL SCI, V132, P53, DOI 10.1093/toxsci/kfs342
   VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253
   Vitiello M, 2017, AGEING RES REV, V35, P301, DOI 10.1016/j.arr.2016.10.008
   Wang ZY, 2013, AUTOPHAGY, V9, P925, DOI 10.4161/auto.24229
   Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006
   Zhang ZG, 2014, MOL MED REP, V9, P882, DOI 10.3892/mmr.2013.1879
   Zhu BJ, 2018, J INT MED RES, V46, P1517, DOI 10.1177/0300060517750298
NR 40
TC 3
Z9 3
U1 0
U2 15
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG
   DISTRICT 100009, PEOPLES R CHINA
SN 2352-4820
EI 2352-3042
J9 GENES DIS
JI Genes Dis.
PD MAY
PY 2022
VL 9
IS 3
BP 789
EP 796
DI 10.1016/j.gendis.2020.08.007
PG 8
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA VL2AS
UT WOS:000805331400019
PM 35782983
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Langley-Evans, SC
   Sculley, DV
AF Langley-Evans, SC
   Sculley, DV
TI Programming of hepatic antioxidant capacity and oxidative injury in the
   ageing rat
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE ageing; fetal programming; rat; undernutrition; antioxidants; protein
   carbonyls
ID LOW-PROTEIN-DIET; FETAL EXPOSURE; ADULT-RATS; LIFE-SPAN; RESTRICTION;
   GLUTATHIONE; STRESS; APOPTOSIS; GROWTH; AGE
AB Exposure to undernutrition in fetal life increases the susceptibility of humans and animals to major disease states in adult life. Studies of rodents exposed to protein restriction during fetal life indicate that lifespan is reduced, a finding that is the opposite of the well-documented improvement in longevity noted with post-weaning caloric restriction. The maternal low-protein (MLP) model of rat pregnancy therefore provides a suitable vehicle to consider how nutrition in fetal life may programme mechanisms of ageing. Pregnant rats were fed control (n = 7) or MLP diet (n = 7) throughout pregnancy. At birth, increased oxidation of hepatic proteins was noted, and this appeared related to activity of glutathione reductase. Older offspring were studied at 4, 16, 30 and 44 weeks of age and analyses revealed that MLP exposure in utero produced sex-specific differences in oxidant: antioxidant balance. In male offspring, MLP increased protein carbonyl concentrations in the liver (P = 0.013) and increased glutathione peroxidase activity (P = 0.018). These programmed changes were absent in the female offspring. The data support the hypothesis that reduced lifespan in rats subject to prenatal protein restriction is a consequence of enhanced oxidative processes promoting apoptosis and loss of tissue function. Mechanisms of ageing appear to be subject to nutritional programming during early development. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Nottingham, Sch Biosci, Ctr Reprod & Early Life, Loughborough LE12 5RD, Leics, England.
C3 University of Nottingham
RP Langley-Evans, SC (corresponding author), Univ Nottingham, Sch Biosci, Ctr Reprod & Early Life, Loughborough LE12 5RD, Leics, England.
EM Simon.Langley-Evans@Nottingham.ac.uk
RI Langley-Evans, Simon/AAR-4181-2020; Sculley, Dean Vincent/ABD-4789-2021;
   Langley-Evans, Simon C/F-3564-2012
OI Sculley, Dean Vincent/0000-0003-3972-8309; Langley-Evans, Simon
   C/0000-0002-1969-8416
CR AEBI H, 1984, METHOD ENZYMOL, V105, P114
   Barker DJP, 2004, J EPIDEMIOL COMMUN H, V58, P114, DOI 10.1136/jech.58.2.114
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brandes RP, 1997, LIFE SCI, V60, P391, DOI 10.1016/S0024-3205(96)00663-7
   CHOW BF, 1964, J NUTR, V82, P10, DOI 10.1093/jn/82.1.10
   Evans JR, 1998, INVEST OPHTH VIS SCI, V39, P1740
   Franco MD, 2002, J CARDIOVASC PHARM, V40, P501, DOI 10.1097/00005344-200210000-00002
   Gasbarrini A, 2001, DIGEST DIS SCI, V46, P1305, DOI 10.1023/A:1010679716435
   Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292
   Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633
   Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1
   Jennings BJ, 2000, MOL GENET METAB, V71, P32, DOI 10.1006/mgme.2000.3077
   Jüngst C, 2004, HEPATOLOGY, V39, P1663, DOI 10.1002/hep.20241
   LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217
   LANGLEY SC, 1992, AM J PHYSIOL, V263, pL357, DOI 10.1152/ajplung.1992.263.3.L357
   LANGLEY SC, 1992, BIOCHEM PHARMACOL, V44, P1489, DOI 10.1016/0006-2952(92)90462-R
   LANGLEY SC, 1994, J NUTR, V124, P1588, DOI 10.1093/jn/124.9.1588
   Langley-Evans S. C., 2004, Fetal nutrition and adult disease: programming of chronic disease through fetal exposure to undernutrition, P1, DOI 10.1079/9780851998213.0001
   Langley-Evans SC, 2001, P NUTR SOC, V60, P505, DOI 10.1079/PNS2001111
   Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3
   LangleyEvans SC, 1997, J NUTR, V127, P202, DOI 10.1093/jn/127.2.202
   LANGLEYEVANS SC, 1995, ANN NUTR METAB, V39, P28, DOI 10.1159/000177839
   LANGLEYEVANS SC, 2005, IN PRESS EARLY LIFE
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Lopez SG, 2004, FREE RADICAL BIO MED, V36, P1366, DOI 10.1016/j.freeradbiomed.2004.02.067
   McMullen S, 2004, BRIT J NUTR, V91, P133, DOI 10.1079/BJN20031029
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   MERRY BJ, 1991, REV CLIN GERONTOL, V1, P203
   Nanji AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1348, DOI 10.1152/ajpgi.2001.281.6.G1348
   Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b
   Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582
   Renehan AG, 2001, BMJ-BRIT MED J, V322, P1536, DOI 10.1136/bmj.322.7301.1536
   ROEDER LM, 1973, NUTR REP INT, V7, P271
   ROTH GS, 1995, NAT MED, V1, P414, DOI 10.1038/nm0595-414
   Sayer AA, 2001, GERONTOLOGY, V47, P9, DOI 10.1159/000052764
   Sibley C, 1997, EXP PHYSIOL, V82, P389, DOI 10.1113/expphysiol.1997.sp004034
   SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sullivan JC, 2004, J APPL PHYSIOL, V97, P1268, DOI 10.1152/japplphysiol.00242.2004
   Takeuchi A, 2000, J NEUROBIOL, V45, P39, DOI 10.1002/1097-4695(200010)45:1<39::AID-NEU4>3.0.CO;2-A
   TANIGUCHI M, 1986, J BIOCHEM-TOKYO, V100, P1457, DOI 10.1093/oxfordjournals.jbchem.a121851
   Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337
   Wyllie AH, 1999, BRIT J CANCER, V80, P34
   Zhu ZL, 2004, J NEUROSCI RES, V78, P837, DOI 10.1002/jnr.20338
NR 48
TC 44
Z9 47
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUN-JUL
PY 2005
VL 126
IS 6-7
BP 804
EP 812
DI 10.1016/j.mad.2005.03.003
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 932EC
UT WOS:000229536000022
PM 15888335
DA 2024-02-19
ER

PT J
AU Zhu, QN
   Hou, WY
   Xu, SF
   Lu, YF
   Liu, J
AF Zhu, Qiong-Ni
   Hou, Wei-Yu
   Xu, Shang-Fu
   Lu, Yuan-Fu
   Liu, Jie
TI Ontogeny, aging, and gender-related changes in hepatic multidrug
   resistant protein genes in rats
SO LIFE SCIENCES
LA English
DT Article
DE Mrp transporters; Abcg2; Rat liver; Development; Aging; Sex-difference
ID DRUG-METABOLIZING-ENZYMES; HEPATOCELLULAR-CARCINOMA; BILE-ACID; EFFLUX
   TRANSPORTERS; HORMONAL-REGULATION; TISSUE DISTRIBUTION; EXPRESSION;
   MICE; LIVER; ABCG2
AB Multidrug resistance proteins (Mrps) are efflux transporters playing important roles in endogenous substances and xenobiotics transport out of the liver. Children, elderly, gender and physio-pathological conditions could influence their expression and result in changes in drug disposition.
   Aim: This study was aimed to examine the development-, aging-, and sex-dependent changes in Mrp1-4 and ATP-binding cassette sub-family G member 2 (Abcg2) gene expressions in livers of rats.
   Main methods: The livers from male and female SD rats at development (-2,1,7,14,21,28,35, and 60 d) and aging (28, 60, 180 and 540 d) were collected and total RNA was isolated, purified and subjected to real-time RT-PCR analysis.
   Key findings: Results showed that expression of Mrp1 was low, while Abcg2 and Mrp2 were the high in the liver. Mrp1 expression decreased with maturity but remained constant to 540 d, while Mrp3 and 4 increased with liver development, reached the peak with maturity at 35-60 days of age, and slightly reduced with aging. Mrp2 and Abcg2 were high at 7 days of age and maintained at relative high levels till maturity, while Abcg2 was reduced during aging. Females had higher Mrp3 and Abcg2 mRNA expression than male rats, while male rats had higher Mrp2 and Mrp4 mRNA expression.
   Significance: The expression of hepatic Mrp1-4 and Abcg2 mRNA during development, aging in male and female rats was characterized, which could be fundamental to our understanding of age- and sex-associated variations in drug disposition in children, elderly, and women. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Zhu, Qiong-Ni; Hou, Wei-Yu; Xu, Shang-Fu; Lu, Yuan-Fu; Liu, Jie] Zunyi Med Coll, Minist Educ, Key Lab Pharmacol, Zunyi 563003, Peoples R China.
   [Zhu, Qiong-Ni] Cent S Univ, Xiangya Hosp, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet,Dept Clin Pharmacol, Changsha, Hunan, Peoples R China.
C3 Zunyi Medical University; Central South University
RP Liu, J (corresponding author), Zunyi Med Coll, Zunyi 563003, Peoples R China.
EM Jieliu@zmc.edu.cn
RI Xu, Shangfu/JLG-2773-2023; zhu, Qiong Ni/IZE-3502-2023
FU Guizhou Science and Technology [TZJF2009-41]; Foundation of Zunyi
   Medical College [QK023]; Chinese Natural Science Foundation [81374063]
FX This study was supported by Guizhou Science and Technology (TZJF2009-41)
   and Foundation of Zunyi Medical College (QK023), as well as by the
   Chinese Natural Science Foundation (81374063).
CR Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587
   Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9
   Chai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120055
   Chai J, 2011, J GASTROINTEST SURG, V15, P996, DOI 10.1007/s11605-011-1473-2
   Chen C, 2004, BIOCHEM BIOPH RES CO, V317, P46, DOI 10.1016/j.bbrc.2004.03.014
   Chen HL, 2008, PEDIATR RES, V63, P667, DOI 10.1203/PDR.0b013e318170a6b5
   Chen YL, 2016, ANTICANCER RES, V36, P2983
   Cherrington NJ, 2013, AM J PHYSIOL-GASTR L, V304, pG48, DOI 10.1152/ajpgi.00317.2012
   Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023
   Cu X., 2010, DRUG METAB REV, V42, P482
   Cui JY, 2012, TOXICOL SCI, V127, P592, DOI 10.1093/toxsci/kfs107
   de Zwart L, 2008, REPROD TOXICOL, V26, P220, DOI 10.1016/j.reprotox.2008.09.010
   Devgun MS, 2012, ANN CLIN BIOCHEM, V49, P609, DOI 10.1258/acb.2012.011279
   Dzierlenga AL, 2016, J PHARMACOL EXP THER, V358, P246, DOI 10.1124/jpet.116.234310
   Fernández-Barrena MG, 2012, J HEPATOL, V56, P367, DOI 10.1016/j.jhep.2011.05.031
   Fu ZD, 2012, DRUG METAB DISPOS, V40, P1216, DOI 10.1124/dmd.111.044461
   Gradhand U, 2008, PHARMACOGENOMICS J, V8, P42, DOI 10.1038/sj.tpj.6500451
   Hill CR, 2013, BIOCHEM PHARMACOL, V85, P29, DOI 10.1016/j.bcp.2012.10.004
   Hou WY, 2014, TOXICOL APPL PHARM, V280, P370, DOI 10.1016/j.taap.2014.08.020
   Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741
   Johnson DR, 2002, TOXICOLOGY, V178, P209, DOI 10.1016/S0300-483X(02)00231-7
   Kawase A, 2015, EUR J DRUG METAB PH, V40, P239, DOI 10.1007/s13318-014-0208-7
   Keppler D, 2014, DRUG METAB DISPOS, V42, P561, DOI 10.1124/dmd.113.055772
   Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014
   Köck K, 2014, DRUG METAB DISPOS, V42, P665, DOI 10.1124/dmd.113.054304
   Li CY, 2016, DRUG METAB DISPOS, V44, P1038, DOI 10.1124/dmd.115.066639
   Li N, 2009, DRUG METAB DISPOS, V37, P66, DOI 10.1124/dmd.108.023234
   Maher JM, 2006, BIOCHEM PHARMACOL, V71, P1470, DOI 10.1016/j.bcp.2006.02.005
   Maher JM, 2005, DRUG METAB DISPOS, V33, P947, DOI 10.1124/dmd.105.003780
   Mao QC, 2015, AAPS J, V17, P65, DOI 10.1208/s12248-014-9668-6
   Mooij MG, 2014, DRUG METAB DISPOS, V42, P1268, DOI 10.1124/dmd.114.056929
   Morgan JA, 2012, J BIOL CHEM, V287, P14456, DOI 10.1074/jbc.M111.319681
   Namisaki T, 2014, DRUG METAB DISPOS, V42, P2033, DOI 10.1124/dmd.114.059832
   Riches Z, 2015, CHEM-BIOL INTERACT, V242, P203, DOI 10.1016/j.cbi.2015.10.007
   Ros JE, 2003, J PATHOL, V200, P553, DOI 10.1002/path.1379
   Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006
   Sane RS, 2014, J PHARMACOL EXP THER, V351, P403, DOI 10.1124/jpet.114.218081
   Tanaka Y, 2005, BIOCHEM BIOPH RES CO, V326, P181, DOI 10.1016/j.bbrc.2004.11.012
   Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235
   van der Schoor LWE, 2015, EXPERT OPIN DRUG MET, V11, P273, DOI 10.1517/17425255.2015.981152
   Vlaming MLH, 2014, MOL PHARMACOL, V85, P520, DOI 10.1124/mol.113.088823
   Wang L, 2016, DRUG METAB DISPOS, V19
   Xu QH, 2015, EUR J PHARM SCI, V71, P73, DOI 10.1016/j.ejps.2015.02.010
   Xu Y.J., 2016, MOL MED REP IN PRESS
   Yang Z, 2012, DRUG METAB DISPOS, V40, P1883, DOI 10.1124/dmd.111.043901
   Zhao J, 2010, WORLD J GASTROENTERO, V16, P6104, DOI 10.3748/wjg.v16.i48.6104
   Zhu QN, 2013, J ETHNOPHARMACOL, V147, P215, DOI 10.1016/j.jep.2013.03.005
NR 47
TC 14
Z9 14
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD FEB 1
PY 2017
VL 170
BP 108
EP 114
DI 10.1016/j.lfs.2016.11.022
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EL1VR
UT WOS:000394410000014
PM 27913103
DA 2024-02-19
ER

PT J
AU Borghesan, M
   Fusilli, C
   Rappa, F
   Panebianco, C
   Rizzo, G
   Oben, JA
   Mazzoccoli, G
   Faulkes, C
   Pata, I
   Agodi, A
   Rezaee, F
   Minogue, S
   Warren, A
   Peterson, A
   Sedivy, JM
   Douet, J
   Buschbeck, M
   Cappello, F
   Mazza, T
   Pazienza, V
   Vinciguerra, M
AF Borghesan, Michela
   Fusilli, Caterina
   Rappa, Francesca
   Panebianco, Concetta
   Rizzo, Giovanni
   Oben, Jude A.
   Mazzoccoli, Gianluigi
   Faulkes, Chris
   Pata, Illar
   Agodi, Antonella
   Rezaee, Farhad
   Minogue, Shane
   Warren, Alessandra
   Peterson, Abigail
   Sedivy, John M.
   Douet, Julien
   Buschbeck, Marcus
   Cappello, Francesco
   Mazza, Tommaso
   Pazienza, Valerio
   Vinciguerra, Manlio
TI DNA Hypomethylation and Histone Variant macroH2A1 Synergistically
   Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular
   Carcinoma Progression
SO CANCER RESEARCH
LA English
DT Article
ID CELLS; 5-AZA-2'-DEOXYCYTIDINE; HEPATOCYTES; METHYLATION; ACTIVATION;
   EXPRESSION; REGULATOR; BINDING; PROTEIN; GROWTH
AB Aging is a major risk factor for progression of liver diseases to hepatocellular carcinoma (HCC). Cellular senescence contributes to age-related tissue dysfunction, but the epigenetic basis underlying drug-induced senescence remains unclear. macroH2A1, a variant of histone H2A, is a marker of senescence-associated heterochromatic foci that synergizes with DNA methylation to silence tumor-suppressor genes in human fibroblasts. In this study, we investigated the relationship between macroH2A1 splice variants, macroH2A1.1 and macroH2A1.2, and liver carcinogenesis. We found that protein levels of both macroH2A1 isoforms were increased in the livers of very elderly rodents and humans, and were robust immunohistochemical markers of human cirrhosis and HCC. In response to the chemotherapeutic and DNA-demethylating agent 5-aza-deoxycytidine (5-aza-dC), transgenic expression of macroH2A1 isoforms in HCC cell lines prevented the emergence of a senescent-like phenotype and induced synergistic global DNA hypomethylation. Conversely, macroH2A1 depletion amplified the antiproliferative effects of 5-aza-dC in HCC cells, but failed to enhance senescence. Senescence-associated secretory phenotype and whole-transcriptome analyses implicated the p38 MAPK/IL8 pathway in mediating macroH2A1-dependent escape of HCC cells from chemotherapy-induced senescence. Furthermore, chromatin immunoprecipitation sequencing revealed that this hepatic antisenescence state also required active transcription that could not be attributed to genomic occupancy of these histones. Collectively, our findings reveal a new mechanism by which drug-induced senescence is epigenetically regulated by macroH2A1 and DNA methylation and suggest macroH2A1 as a novel biomarker of hepatic senescence that could potentially predict prognosis and disease progression. (C) 2016 AACR.
C1 [Borghesan, Michela; Rizzo, Giovanni; Oben, Jude A.; Minogue, Shane; Warren, Alessandra; Vinciguerra, Manlio] UCL, Royal Free Hosp, Inst Liver & Digest Hlth, London, England.
   [Borghesan, Michela; Mazzoccoli, Gianluigi] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Div Internal Med, San Giovanni Rotondo, Italy.
   [Fusilli, Caterina; Mazza, Tommaso] IRCCS Casa Sollievo Sofferenza, Mendel Lab, Bioinformat Unit, Rome, Italy.
   [Rappa, Francesca; Cappello, Francesco] Univ Palermo, Sect Human Anat, Dept Expt Biomed & Clin Neurosci, Palermo, Italy.
   [Panebianco, Concetta; Pazienza, Valerio; Vinciguerra, Manlio] IRCCS Casa Sollievo Sofferenza, Gastroenterol Unit, San Giovanni Rotondo, Italy.
   [Faulkes, Chris] Queen Mary Univ London, Sch Biol & Chem Sci, London, England.
   [Pata, Illar] Tallinn Univ Technol, IVEX Lab, Dept Gene Technol, EE-19086 Tallinn, Estonia.
   [Agodi, Antonella] Univ Catania, Dept GF Ingrassia, Catania, Italy.
   [Rezaee, Farhad] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.
   [Warren, Alessandra] Univ Sydney, Concord RG Hosp, CERA, Sydney, NSW 2006, Australia.
   [Warren, Alessandra] Univ Sydney, Concord RG Hosp, ANZAC Res Inst, Sydney, NSW 2006, Australia.
   [Peterson, Abigail; Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.
   [Douet, Julien; Buschbeck, Marcus] Inst Predict & Personalized Med Canc, Campus Can Ruti, Badalona, Spain.
   [Douet, Julien; Buschbeck, Marcus] Josep Carreras Inst Leukaemia Res, Campus ICO HGTP,Campus Can Ruti, Badalona, Spain.
   [Cappello, Francesco; Vinciguerra, Manlio] Euromediterranean Inst Sci & Technol IEMEST, Palermo, Italy.
   [Vinciguerra, Manlio] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.
C3 University of London; University College London; Royal Free London NHS
   Foundation Trust; UCL Medical School; IRCCS Casa Sollievo Della
   Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel;
   University of Palermo; IRCCS Casa Sollievo Della Sofferenza; University
   of London; Queen Mary University London; Tallinn University of
   Technology; University of Catania; University of Groningen; University
   of Sydney; Concord Repatriation General Hospital; University of Sydney;
   ANZAC Research Institute; Concord Repatriation General Hospital; Brown
   University; Institut de Recerca Contra la Leucemia Josep Carreras (IJC);
   Nottingham Trent University
RP Vinciguerra, M (corresponding author), UCL, Rowland Hill St, London NW3 2PF, England.
EM m.vinciguerra@ucl.ac.uk
RI Vinciguerra, Manlio/N-1309-2015; Faulkes, Chris/O-8101-2019; Panebianco,
   Concetta/K-6380-2016; Buschbeck, Marcus/J-8204-2017; Cappello,
   Francesco/F-9153-2012; Research Institute, ANZAC/CAE-9030-2022;
   Mazzoccoli, Gianluigi/H-2447-2016; Pata, Illar/HLH-7992-2023; Agodi,
   Antonella/AIF-3938-2022; Francesca, Rappa/ADW-8431-2022; Fiorucci,
   Stefano/I-1251-2012; Mazza, Tommaso/I-4531-2019; Pazienza,
   Valerio/K-5073-2012; Agodi, Antonella/B-3501-2011; OBEN, JUDE
   A/K-4331-2013; Fusilli, Caterina/K-3016-2016; Mazza, Tommaso/H-6414-2016
OI Vinciguerra, Manlio/0000-0002-1768-3894; Panebianco,
   Concetta/0000-0003-2819-3505; Buschbeck, Marcus/0000-0002-3218-4567;
   Cappello, Francesco/0000-0001-9288-1148; Mazzoccoli,
   Gianluigi/0000-0003-3535-7635; Agodi, Antonella/0000-0002-4405-8162;
   Mazza, Tommaso/0000-0003-0434-8533; Pazienza,
   Valerio/0000-0002-3492-1153; Agodi, Antonella/0000-0002-4405-8162;
   Fusilli, Caterina/0000-0001-7497-0657; Mazza,
   Tommaso/0000-0003-0434-8533; rappa, francesca/0000-0001-6610-5268; Oben,
   Jude/0000-0003-3350-8356
FU Italian Ministry of Health, Bando [GR 2010 2311017]; My First
   Associazione Italiana Ricerca sul Cancro (AIRC) Grant-AIRC Grant
   [13419]; UCL; Juan de la Cierva Fellowship [JCI-2011-10831]; Ramon y
   Cajal Fellowship [RYC2010-07337]; MINECO [SAF2012-39749]; NIH [R37
   AG016694]
FX V. Pazienza and M. Vinciguerra are supported by Italian Ministry of
   Health, Bando GR 2010 2311017. M. Vinciguerra is supported by a My First
   Associazione Italiana Ricerca sul Cancro (AIRC) Grant-AIRC Grant no.
   13419 and by UCL; J. Douet by the Juan de la Cierva Fellowship
   JCI-2011-10831; and M. Buschbeck by the Ramon y Cajal Fellowship
   RYC2010-07337 and the grant SAF2012-39749 (MINECO). J.M. Sedivy was
   supported by grant R37 AG016694 from the NIH.
CR Barzily-Rokni M, 2011, NUCLEIC ACIDS RES, V39, P1326, DOI 10.1093/nar/gkq994
   Benegiamo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060527
   Benegiamo G, 2012, DIGEST DIS SCI, V57, P1598, DOI 10.1007/s10620-012-2160-1
   Bolasco G, 2012, AGING-US, V4, P402, DOI 10.18632/aging.100464
   Borghesan M, 2014, BIOCHEM SOC T, V42, P1409, DOI 10.1042/BST20140119
   Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8
   Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457
   Cantariño N, 2013, CANCER LETT, V336, P247, DOI 10.1016/j.canlet.2013.03.022
   Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06
   Changolkar LN, 2006, MOL CELL BIOL, V26, P4410, DOI 10.1128/MCB.02258-05
   Changolkar LN, 2010, MOL CELL BIOL, V30, P5473, DOI 10.1128/MCB.00518-10
   Chen HS, 2015, MOL CELL, V59, P719, DOI 10.1016/j.molcel.2015.07.011
   Cong R, 2014, NUCLEIC ACIDS RES, V42, P181, DOI 10.1093/nar/gkt863
   Creppe C, 2012, EPIGENOMICS-UK, V4, P221, DOI [10.2217/EPI.12.8, 10.2217/epi.12.8]
   Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11
   D'Aronzo M, 2015, ONCOTARGET, V6, P18545, DOI 10.18632/oncotarget.4186
   Feng YM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1137-9
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110
   Gores GJ, 2014, NAT REV GASTRO HEPAT, V11, P645, DOI 10.1038/nrgastro.2014.157
   Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486
   Huang WJ, 2015, GASTROENTEROLOGY, V149, P1053, DOI 10.1053/j.gastro.2015.05.058
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Jueliger SL, 2012, EORTC AACR NCI S MOL
   Karimi M, 2006, EPIGENETICS-US, V1, P45
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x
   Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956
   Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534
   Marongiu F, 2014, AGING-US, V6, P26, DOI 10.18632/aging.100631
   McKee C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08812
   Mossman D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-366
   Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11
   Pazienza V, 2014, AGING-US, V6, P35, DOI 10.18632/aging.100632
   Podrini C, 2015, FASEB J, V29, P1676, DOI 10.1096/fj.14-262717
   Pogribny IP, 2010, EPIGENETICS OF AGING, P11, DOI 10.1007/978-1-4419-0639-7_2
   Posavec M, 2013, CELL MOL LIFE SCI, V70, P1509, DOI 10.1007/s00018-013-1294-4
   Rai TS, 2012, BBA-GENE REGUL MECH, V1819, P322, DOI 10.1016/j.bbagrm.2011.07.014
   Rappa F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054458
   Ripoli M, 2011, VIRUS RES, V160, P74, DOI 10.1016/j.virusres.2011.05.014
   Sheedfar F, 2015, INT J OBESITY, V39, P331, DOI 10.1038/ijo.2014.91
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Venturelli S, 2007, CANCER, V109, P2132, DOI 10.1002/cncr.22652
   Venturelli S, 2013, MOL CANCER THER, V12, P2226, DOI 10.1158/1535-7163.MCT-13-0137
   Venturelli S, 2011, GUT, V60, P156, DOI 10.1136/gut.2010.208041
   Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001
NR 49
TC 65
Z9 67
U1 0
U2 29
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD FEB 1
PY 2016
VL 76
IS 3
BP 594
EP 606
DI 10.1158/0008-5472.CAN-15-1336
PG 13
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA DC2YL
UT WOS:000369084600011
PM 26772755
OA Bronze, Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU KITANI, K
AF KITANI, K
TI LIVER AND AGING
SO GASTROENTEROLOGIA JAPONICA
LA English
DT Article
RP KITANI, K (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT CLIN PHYSIOL,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN.
NR 0
TC 9
Z9 9
U1 0
U2 1
PU JAPAN SOC GASTROENTEROL
PI TOKYO
PA GINZA ORIENT BLDG 8TH FLOOR CHUO-KU 8-9-13 GINZA, TOKYO, JA 104
SN 0435-1339
J9 GASTROENTEROL JPN
PD APR
PY 1992
VL 27
IS 2
BP 276
EP 285
DI 10.1007/BF02777737
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA JE625
UT WOS:A1992JE62500020
PM 1577235
DA 2024-02-19
ER

PT J
AU WILLIAMS, D
   WOODHOUSE, K
AF WILLIAMS, D
   WOODHOUSE, K
TI AGE-RELATED-CHANGES IN NADPH CYTOCHROME-C REDUCTASE-ACTIVITY IN MOUSE
   SKIN AND LIVER-MICROSOMES
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE CUTANEOUS; HEPATIC; AGING; NADPH CYTOCHROME C; REDUCTASE
ID DRUG-METABOLIZING-ENZYMES; P-450 REDUCTASE; STEREOLOGICAL ANALYSIS;
   RAT-LIVER; INDUCTION; YOUNG
AB In this study, the effect of ageing on the activity of cutaneous and hepatic NADPH cytochrome c reductase, a component of the mixed function mono-oxygenase system, was studied in young adult and senescent male C57B1/6J mice. Horse heart cytochrome c was used as substrate and its reduction by Skin and liver microsomes was measured spectrophotometrically. Statistical analysis of our results show a significant decrease in cutaneous enzyme activity with age. This, however, was not the case in liver where no significant difference was seen, consistent with previous studies on mixed function mono-oxygenase activity in mouse liver. This suggests that the ageing process may have a tissue specific effect on the monooxygenase system in the C57B1/6J strain of mouse. However, further work in other rodent species and humans is required to fully characterize the effect of ageing on the drug metabolizing capacity of skin as compared to liver.
C1 UNIV CARDIFF,CARDIFF ROYAL INFIRM,DEPT GERIATR MED,CARDIFF CF2 1SZ,S GLAM,WALES.
C3 Cardiff Royal Infirmary; Cardiff University
CR ADELMAN RC, 1971, EXP GERONTOL, V6, P75, DOI 10.1016/0531-5565(71)90051-9
   ANTHONY LE, 1978, J LIPID RES, V19, P154
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   FRENCH JS, 1979, ARCH BIOCHEM BIOPHYS, V195, P565, DOI 10.1016/0003-9861(79)90383-7
   HALES DB, 1986, ENDOCRINOLOGY, V119, P811, DOI 10.1210/endo-119-2-811
   KAO J, 1980, BIOCHEM PHARMACOL, V29, P1191, DOI 10.1016/0006-2952(80)90417-7
   KATO R, 1968, JPN J PHARMACOL, V18, P389, DOI 10.1254/jjp.18.389
   KATO R, 1970, JPN J PHARMACOL, V20, P572, DOI 10.1254/jjp.20.572
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU AYH, 1969, J BIOL CHEM, V244, P3714
   LU AYH, 1968, J BIOL CHEM, V243, P1331
   MARIA CS, 1987, MECH AGEING DEV, V37, P183
   MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8
   MASTERS BSS, 1971, J BIOL CHEM, V246, P4143
   MCMARTIN DN, 1980, TOXICOL APPL PHARM, V54, P411, DOI 10.1016/0041-008X(80)90168-4
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MUKHTAR H, 1983, DRUG METAB DISPOS, V11, P562
   PIERI C, 1978, EXP GERONTOL, V10, P291
   RIKANS LE, 1981, EXP GERONTOL, V16, P253, DOI 10.1016/0531-5565(81)90021-8
   SCHMUCKER DL, 1983, EXP GERONTOL, V18, P313, DOI 10.1016/0531-5565(83)90043-8
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P321, DOI 10.1016/0531-5565(80)90037-6
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   VENKATESH K, 1992, PESTIC BIOCHEM PHYS, V43, P53, DOI 10.1016/0048-3575(92)90019-V
   VERMILION JL, 1978, J BIOL CHEM, V253, P2694
   VONBAHR C, 1980, CLIN PHARMACOL THER, V27, P711, DOI 10.1038/clpt.1980.102
   WEXLER BC, 1964, J ATHEROSCLER RES, V4, P131, DOI 10.1016/S0368-1319(64)80033-8
NR 27
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD SEP-OCT
PY 1995
VL 21
IS 2
BP 191
EP 197
DI 10.1016/0167-4943(95)00638-2
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA RW599
UT WOS:A1995RW59900007
PM 15374214
DA 2024-02-19
ER

PT J
AU Luo, ZX
   Wang, YQ
   Xue, MZ
   Xia, FQ
   Zhu, LQ
   Li, YY
   Jia, DK
   Chen, SL
   Xu, GF
   Lei, Y
AF Luo, Zhixiao
   Wang, Yaqi
   Xue, Mengzhen
   Xia, Fangqi
   Zhu, Leiqi
   Li, Yuanyang
   Jia, Dengke
   Chen, Silong
   Xu, Guangfu
   Lei, Yan
TI Astragaloside IV ameliorates fat metabolism in the liver of ageing mice
   through targeting mitochondrial activity
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article; Early Access
DE ageing; Astragaloside IV; energy metabolism; fat catabolism;
   mitochondria; respiratory quotient; beta-oxidation
ID DISEASE; SAPONINS; HEALTH
AB Astragaloside IV (AST) is a major bioactive compound of Radix Astragali with medical and health benefits. Previous studies have found that AST can reduce the body weights of high-fat diet fed mice. However, the effect of AST on fat metabolism of ageing mice is unclear. In this study, naturally ageing mice were administered intragastrically with AST at 30 mg/kg/day (ageing + AST-L group) and 90 mg/kg/day (ageing + AST-H group) for 16-20 months. Adult (4 months old) and ageing mice were given 1% sodium carboxyl methylcellulose as vehicle. Energy metabolism-related biological parameters of living mice were examined. Moreover, mRNA and protein levels of key enzymes/proteins involved in triglyceride (TG) lipolysis, fatty acid beta-oxidation (FAO), ketone body (KB) production and mitochondrial respiratory chain were also examined after sacrifice. Results demonstrated that treatment with AST significantly reduced body weight, white fat and liver/body weight ratio of ageing mice, significantly reduced serum/hepatic TG levels, respiratory quotient, promoted fatty acid mobilization in white adipose tissue, mitochondrial FAO and KB production and mitochondrial biosynthesis/functions in the liver of ageing mice. AST also up-regulated the expression of phosphorylated AMP-activated protein kinase, acetyl-CoA carboxylase, acetyl-coenzyme A synthetase, carnitine palmitoyltransferase 1a/1b, enoyl coenzyme A hydratase-short chain, acyl-CoA dehydrogenase medium chain and mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase-2 involved in fat metabolism. These results indicated that mitochondrial activity could be the target of AST to treat abnormal fat metabolism during ageing.
C1 [Luo, Zhixiao] Chongqing Med Univ, Affiliated Hosp 1, Hlth Management Ctr, Chongqing, Peoples R China.
   [Wang, Yaqi; Xue, Mengzhen; Xia, Fangqi; Zhu, Leiqi; Li, Yuanyang; Jia, Dengke; Chen, Silong; Xu, Guangfu] China Three Gorges Univ, Coll Med Sci, Yichang, Peoples R China.
   [Lei, Yan] Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing 400016, Peoples R China.
C3 Chongqing Medical University; China Three Gorges University; Chongqing
   Medical University
RP Lei, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing 400016, Peoples R China.
EM yanlei46@126.com
CR Bonzón-Kulichenko E, 2018, J GERONTOL A-BIOL, V73, P1139, DOI 10.1093/gerona/gly081
   Bu Y, 2018, DIABETES, V67, P1761, DOI 10.2337/db17-1201
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6
   Dong ZW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02360-5
   Du CYQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078622
   Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042
   Filip R, 2018, CLIN INTERV AGING, V13, P1879, DOI 10.2147/CIA.S170533
   Forni C, 2019, BIOMED RES INT-UK, V2019, DOI 10.1155/2019/8748253
   Frank AP, 2019, J LIPID RES, V60, P1710, DOI 10.1194/jlr.R086975
   Gai HY, 2020, J FOOD SCI, V85, P4050, DOI 10.1111/1750-3841.15482
   Ganzera M, 2001, J PHARM SCI, V90, P1752, DOI 10.1002/jps.1124
   García-Ruiz C, 2013, FREE RADICAL RES, V47, P854, DOI 10.3109/10715762.2013.830717
   GARDNER ID, 1980, REV INFECT DIS, V2, P801
   Gimeno-Mallench L, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109130
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824
   Hänfling B, 2016, MOL ECOL, V25, P3101, DOI 10.1111/mec.13660
   He YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076495
   Holzem KM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12489
   Jin KL, 2015, AGING DIS, V6, P1, DOI 10.14336/AD.2014.1210
   Lau KM, 2012, J ETHNOPHARMACOL, V141, P250, DOI 10.1016/j.jep.2012.02.025
   Liu HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19137
   Longo KA, 2010, AM J PHYSIOL-REG I, V298, pR747, DOI 10.1152/ajpregu.00476.2009
   Lv L, 2010, PHYTOTHER RES, V24, P219, DOI 10.1002/ptr.2915
   Movafeghi A, 2010, NAT PROD RES, V24, P703, DOI 10.1080/14786410802361446
   Nassir F, 2014, WORLD J GASTROENTERO, V20, P2136, DOI 10.3748/wjg.v20.i9.2136
   O'Toole PW, 2018, CELL MOL LIFE SCI, V75, P119, DOI 10.1007/s00018-017-2673-z
   Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004
   Pu WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13914
   Schweiger M, 2014, METHOD ENZYMOL, V538, P171, DOI 10.1016/B978-0-12-800280-3.00010-4
   Titchenell PM, 2017, TRENDS ENDOCRIN MET, V28, P497, DOI 10.1016/j.tem.2017.03.003
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Wan J, 2020, AGING CELL, V19, DOI 10.1111/acel.13238
   Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774
   Wang SY, 2018, PROG CARDIOVASC DIS, V61, P182, DOI 10.1016/j.pcad.2018.07.011
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yang ZG, 2005, VACCINE, V23, P5196, DOI 10.1016/j.vaccine.2005.06.016
   Zhang WD, 2006, LIFE SCI, V79, P808, DOI 10.1016/j.lfs.2006.02.032
   Zhao MM, 2013, BIOL PHARM BULL, V36, P515, DOI 10.1248/bpb.b12-00655
NR 40
TC 8
Z9 8
U1 4
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-1838
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD 2021 SEP
PY 2021
VL 25
IS 18
BP 8863
EP 8876
DI 10.1111/jcmm.16847
EA AUG 2021
PG 14
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA UP1DY
UT WOS:000685944400001
PM 34402182
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU HE, PM
   YASUMOTO, K
AF HE, PM
   YASUMOTO, K
TI DIETARY BUTYLATED HYDROXYTOLUENE COUNTERACTS WITH PARAQUAT TO REDUCE THE
   RATE OF HEPATIC DNA SINGLE-STRAND BREAKS IN SENESCENCE-ACCELERATED MICE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; BUTYLATED HYDROXYTOLUENE; DNA DAMAGE; OXIDATIVE DAMAGE; PARAQUAT;
   SENESCENCE-ACCELERATED MOUSE
ID OXIDATIVE STRESS; FREE-RADICALS; DAMAGE; TOXICITY; INJURY; URINE; CELLS
AB The present study was designed to assess the age-related changes of DNA single strand breaks (SSB) in the liver of senescence-resistant and senescence-prone mice, SAMR1/Fky and SAMP1//Fky. In the first series of experiments, the animals were fed a commercial diet for 12-18 months. The mice were killed and the livers were excised at 3- or 6-month intervals for the analysis of the rate of DNA SSB by the ethidium bromide fluorescence method. With advancing age, the rate of DNA SSB was increased in both strains of mice but the increase was significantly higher in SAMP1//Fky than in SAMR1/Fky. In the second series of experiments, the mice were fed one of the following diets for 12 weeks: 20% casein diet (basal diet), basal diet with 300 ppm butylated hydroxytoluene (BHT) added, basal diet with 200 ppm paraquat (PQ) added, and basal diet with 200 ppm PQ plus 300 ppm BHT added. Added dietary PQ increased the rate of DNA SSB in both SAMP1//Fky and SAMR1/Fky. The increases were offset by co-administration of BHT. Dietary BHT, therefore, may suppress the oxidative stress developed by paraquat administration.
C1 KYOTO UNIV, FOOD SCI RES INST, UJI, KYOTO 611, JAPAN.
C3 Kyoto University
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   BELLOMO G, 1992, ANN NY ACAD SCI, V663, P97, DOI 10.1111/j.1749-6632.1992.tb38653.x
   BIRNBOIM HC, 1990, METHOD ENZYMOL, V186, P550
   BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X
   CANTONI O, 1992, ANN NY ACAD SCI, V663, P71, DOI 10.1111/j.1749-6632.1992.tb38650.x
   CATHCART R, 1984, P NATL ACAD SCI-BIOL, V81, P5633, DOI 10.1073/pnas.81.18.5633
   Epstein J, 1972, MECH AGEING DEV, V1, P257, DOI 10.1016/0047-6374(72)90092-9
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 1968, FREE RADICAL AGING D, P3
   HASSAN HM, 1978, J BIOL CHEM, V253, P8143
   HE PM, 1994, BIOSCI BIOTECH BIOCH, V58, P146, DOI 10.1271/bbb.58.146
   JACKSON JH, 1987, J CLIN INVEST, V80, P1090, DOI 10.1172/JCI113165
   MIQUEL J, 1975, GERONTOLOGIST, V15, P25
   MONTI D, 1992, ANN NY ACAD SCI, V663, P250, DOI 10.1111/j.1749-6632.1992.tb38668.x
   MOODY CS, 1982, P NATL ACAD SCI-BIOL, V79, P2855, DOI 10.1073/pnas.79.9.2855
   MORGAN AR, 1974, BIOCHEM BIOPH RES CO, V61, P396
   MUIRAS ML, 1992, ANN NY ACAD SCI, V663, P447, DOI 10.1111/j.1749-6632.1992.tb38697.x
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHRAUFSTATTER IU, 1986, J CLIN INVEST, V77, P1312, DOI 10.1172/JCI112436
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
NR 22
TC 16
Z9 16
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD OCT 1
PY 1994
VL 76
IS 1
BP 43
EP 48
DI 10.1016/0047-6374(94)90006-X
PG 6
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PH481
UT WOS:A1994PH48100005
PM 7845061
DA 2024-02-19
ER

PT J
AU Taketani, H
   Nishikawa, T
   Nakajima, H
   Kodo, K
   Sugimoto, S
   Aoi, W
   Horike, S
   Meguro-Horike, M
   Ishiba, H
   Seko, Y
   Umemura, A
   Yamaguchi, K
   Moriguchi, M
   Yasui, K
   Itoh, Y
AF Taketani, Hiroyoshi
   Nishikawa, Taichiro
   Nakajima, Hisakazu
   Kodo, Kazuki
   Sugimoto, Satoru
   Aoi, Wataru
   Horike, Shin-ichi
   Meguro-Horike, Makiko
   Ishiba, Hiroshi
   Seko, Yuya
   Umemura, Atsushi
   Yamaguchi, Kanji
   Moriguchi, Michihisa
   Yasui, Kohichiroh
   Itoh, Yoshito
TI Aging-associated impairment in metabolic compensation by subcutaneous
   adipose tissue promotes diet-induced fatty liver disease in mice
SO DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
LA English
DT Article
DE nonalcoholic fatty liver disease; obesity; scenescence; brown adipocyte;
   mesenchymal stem cells; cell transplantation
ID NONALCOHOLIC STEATOHEPATITIS; BROWN ADIPOCYTES; BEIGE; METAANALYSIS;
   SEVERITY; OBESITY; MOUSE; CELL
AB Background and aims: Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome, and its progression is associated with aging-associated impairment in metabolic homeostasis. Recently, energy metabolism in adipose tissue has been the subject of renewed interest, because significant energy expenditure can be induced in cells derived from white adipose tissue progenitors, in addition to brown adipose tissue (BAT). Here we evaluated whether aging-associated change in various adipose tissue depots affects the progression of NAFLD.
   Methods: Six-week-old male C57BL/6NCrSlc mice were fed control chow (C) or high-fat diet (60% fat; HF) for 12 or 24 weeks (12w/C, 12w/HF, 24w/C and 24w/HF groups, respectively) or switched from C to HF diet at 18 weeks of age (24w/C/HF group) and fed for a further 24 weeks. Some 24w/HF mice received a subcutaneous transplantation of adipose progenitors (10(6) cells/ mouse) from young donor mice. Basal energy expenditure, glucose tolerance, and liver and adipose tissue histology were then evaluated. In addition, features of senescence and the capacity of adipose progenitors to "brown" were compared in mice of various ages.
   Results: 12w/HF mice demonstrated compensation in the forms of hypertrophy of interscapular classical BAT and the appearance of subcutaneous beige adipocytes, consistent with improved metabolic homeostasis. In contrast, 24w/HF and 24w/C/HF mice developed obesity, glucose intolerance, and severe NAFLD, with accelerated senescence and loss of adipose progenitors in subcutaneous fat tissues. Recruitment of adipose progenitors ameliorated these findings in 24w/HF mice.
   Conclusion: Impaired metabolic compensation in adipose tissue resulted in the progression of NAFLD, which was associated with aging-related deterioration in adipose progenitors. A new approach targeting adipose tissue progenitors might represent a potential strategy for the prevention of NAFLD.
C1 [Taketani, Hiroyoshi; Nishikawa, Taichiro; Ishiba, Hiroshi; Seko, Yuya; Umemura, Atsushi; Yamaguchi, Kanji; Moriguchi, Michihisa; Yasui, Kohichiroh; Itoh, Yoshito] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.
   [Nakajima, Hisakazu; Kodo, Kazuki; Sugimoto, Satoru] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto, Japan.
   [Aoi, Wataru] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Kyoto, Japan.
   [Horike, Shin-ichi; Meguro-Horike, Makiko] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan.
C3 Kyoto Prefectural University of Medicine; Kyoto Prefectural University
   of Medicine; Kyoto Prefectural University; Kanazawa University
RP Nishikawa, T (corresponding author), Kyoto Prefectural Univ Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM taichi@koto.kpu-m.ac.jp
RI Nakajima, Hisakazu/AAH-7764-2021; Horike, Shin-ichi/C-4319-2015
OI Nakajima, Hisakazu/0000-0002-3678-9918; Ishiba,
   Hiroshi/0000-0002-1516-5938; taketani, hiroyoshi/0000-0003-1033-2642;
   Umemura, Atsushi/0000-0002-7433-8501; Horike,
   Shin-ichi/0000-0002-4256-9129; Meguro-Horike, Makiko/0000-0001-9371-8852
FU Shionogi Co., Ltd.; Takeda Chemical Industries, Ltd
FX This work was supported by the Research Encouragement Donations from MSD
   K.K., Shionogi & Co., Ltd. and Takeda Chemical Industries, Ltd (to TN).
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Cholankeril G, 2017, DIGEST DIS SCI, V62, P2915, DOI 10.1007/s10620-017-4684-x
   Croci I, 2013, GUT, V62, P1625, DOI 10.1136/gutjnl-2012-302789
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Ezquer M, 2011, J HEPATOL, V55, P1112, DOI 10.1016/j.jhep.2011.02.020
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Franssens BT, 2017, J MAGN RESON IMAGING, V46, P497, DOI 10.1002/jmri.25594
   Graja A, 2015, GERONTOLOGY, V61, P211, DOI 10.1159/000366557
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Hashida R, 2017, J HEPATOL, V66, P142, DOI 10.1016/j.jhep.2016.08.023
   Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kodo K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173661
   Koopman KE, 2014, HEPATOLOGY, V60, P545, DOI 10.1002/hep.27149
   Lee CW, 2017, TRANSL RES, V182, P61, DOI 10.1016/j.trsl.2016.11.003
   Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nishikawa T, 2006, J HEPATOL, V44, P1074, DOI 10.1016/j.jhep.2005.11.045
   Nishikawa T, 2015, J CLIN INVEST, V125, P1533, DOI 10.1172/JCI73137
   Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014
   Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   Okada Y, 2013, LIVER INT, V33, P301, DOI 10.1111/liv.12033
   Paschos P, 2009, HIPPOKRATIA, V13, P9
   Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283
   Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363
   Wong VWS, 2013, J GASTROEN HEPATOL, V28, P18, DOI 10.1111/jgh.12011
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Youssef A, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9453108
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
NR 39
TC 4
Z9 4
U1 1
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7007
J9 DIABET METAB SYND OB
JI Diabetes Metab. Syndr. Obes.
PY 2019
VL 12
BP 1473
EP 1492
DI 10.2147/DMSO.S214093
PG 20
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA IU2YC
UT WOS:000483444900001
PM 31692556
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   NOKUBO, M
   KANAI, S
   KITANI, K
AF RIKANS, LE
   NOKUBO, M
   KANAI, S
   KITANI, K
TI DIURNAL-VARIATION IN HEPATIC GLUTATHIONE CONTENT AS A FUNCTION OF AGE
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Article
DE CIRCADIAN RHYTHM; SENESCENCE; SEXUAL DIMORPHISM
ID TRANSFERASE ACTIVITIES; RATS; LIVER; MICE; TISSUES; ANTIOXIDANTS;
   METABOLISM; TOXICITY; ENZYMES; RHYTHM
AB The purpose of this study was to investigate the influence of aging on the diurnal variation in glutathione (GSH) content of mouse liver. Young (7 months) and old (27 months) C57BL mice were housed under standarized conditions with lighting from 0800 to 2000 and free access to food and water. GSH was determined in acid extracts of liver homogenates by HPLC separation and fluorometric detection of the o-phthaldialdehyde derivative. A diurnal rhythm in hepatic GSH concentration was evident in young and old mice of both sexes. Peak levels of GSH occurred at 1 000 and were unaffected by age or gender; however, age and sex-dependent differences were observed in the lowest concentration of GSH and in the amplitude of the GSH cycle. Hepatic GSH levels at 2200 and 0600 were 30-35% lower in old males than in young males and 25-40% lower in young females than in young males. The results may provide an explanation for the inconsistencies in previous findings about the influence of aging on hepatic GSH concentrations.
C1 TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT CLIN PHYSIOL,TOKYO 173,JAPAN.
C3 Tokyo Metropolitan Institute of Gerontology
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA,HLTH SCI CTR,COLL MED,DEPT PHARMACOL,BMSB 753,POB 26901,OKLAHOMA CITY,OK 73190, USA.
CR ABBOTT WA, 1986, P NATL ACAD SCI USA, V83, P1246, DOI 10.1073/pnas.83.5.1246
   BAUMAN PF, 1988, J NUTR, V118, P1048, DOI 10.1093/jn/118.8.1048
   BECK LV, 1958, P SOC EXP BIOL MED, V97, P229
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   DELEVE LD, 1990, SEMIN LIVER DIS, V10, P251, DOI 10.1055/s-2008-1040481
   DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HIRAYAMA K, 1987, BIOCHEM PHARMACOL, V36, P1919
   JAEGER RJ, 1973, RES COMMUN CHEM PATH, V6, P465
   JAESCHKE H, 1985, BIOCHEM PHARMACOL, V34, P1029, DOI 10.1016/0006-2952(85)90606-9
   KITANI K, 1990, PROGR LIVER DISEASES, P603
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAUTERBURG BH, 1980, J PHARMACOL EXP THER, V213, P54
   NEUSCHWANDERTETRI BA, 1989, ANAL BIOCHEM, V179, P236, DOI 10.1016/0003-2697(89)90121-8
   OOHTENS M, 1987, BIOCHEM PHARMACOL, V36, P4015
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   RIKANS LE, 1987, ALCOHOL CLIN EXP RES, V11, P562, DOI 10.1111/j.1530-0277.1987.tb00175.x
   SCHNELL RC, 1983, TOXICOL APPL PHARM, V71, P353
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   WHITE BP, 1987, TOXICOL LETT, V35, P217, DOI 10.1016/0378-4274(87)90209-8
NR 25
TC 2
Z9 2
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0272-4391
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PY 1992
VL 26
IS 4
BP 461
EP 465
DI 10.1002/ddr.430260409
PG 5
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA JJ782
UT WOS:A1992JJ78200008
DA 2024-02-19
ER

PT J
AU Hayashi, T
   Kotani, H
   Yamaguchi, T
   Taguchi, K
   Iida, M
   Ina, K
   Maeda, M
   Kuzuya, M
   Hattori, Y
   Ignarro, LJ
AF Hayashi, Toshio
   Kotani, Hitoshi
   Yamaguchi, Tomoe
   Taguchi, Kumiko
   Iida, Mayu
   Ina, Koichiro
   Maeda, Morihiko
   Kuzuya, Masafumi
   Hattori, Yuichi
   Ignarro, Louis J.
TI Endothelial cellular senescence is inhibited by liver X receptor
   activation with an additional mechanism for its atheroprotection in
   diabetes
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE T0901317; cholesterol efflux transporter
ID NUCLEAR RECEPTOR; THERAPEUTIC-TARGET; BETA-GALACTOSIDASE; NITRIC-OXIDE;
   FATTY LIVER; LXR; ATHEROSCLEROSIS; CELLS; METABOLISM; PATHWAY
AB Senescence of vascular endothelial cells leads to endothelial dysfunction and contributes to the progression of atherosclerosis. Liver X receptors (LXRs) are nuclear receptors whose activation protects against atherosclerosis by transcriptional regulation of genes important in promoting cholesterol efflux and inhibiting inflammation. Here we found that LXR activation with specific ligands reduced the increase in senescence-associated (SA) beta-gal activity, a senescence marker, and reversed the decrease in telomerase activity, a replicative senescence marker, in human endothelial cells under high glucose. This effect of LXR activation was associated with reduced reactive oxygen species and increased endothelial NO synthase activity. A series of experiments that used siRNAs indicated that LXR beta mediates the prevention of endothelial cellular senescence, and that sterol regulatory element binding protein-1, which was up-regulated as a direct LXR beta target gene, may act as a brake of endothelial cellular senescence. Although oral administration of the LXR ligand led to severe fatty liver in diabetic rats, concomitant therapy with metformin avoided the development of hepatic steatosis. However, the preventive effect of the LXR ligand on SA beta-gal-stained cells in diabetic aortic endothelium was preserved even if metformin was coadministered. Taken together, our studies demonstrate that an additional mechanism, such as the regulation of endothelial cellular senescence, is related to the antiatherogenic properties of LXRs, and concomitant treatment with metformin may provide a clinically useful therapeutic strategy to alleviate an LXR activation-mediated adverse effects on liver triglyceride metabolism.
C1 [Hayashi, Toshio; Kotani, Hitoshi; Yamaguchi, Tomoe; Iida, Mayu; Ina, Koichiro; Maeda, Morihiko; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan.
   [Taguchi, Kumiko; Hattori, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 9300194, Japan.
   [Ignarro, Louis J.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Hlth Sci, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
C3 Nagoya University; University of Toyama; University of California
   System; University of California Los Angeles; University of California
   Los Angeles Medical Center; David Geffen School of Medicine at UCLA
RP Hayashi, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan.
EM hayashi@med.nagoya-u.ac.jp; lignarro@mednet.ucla.edu
RI Kuzuya, Masafumi/I-1583-2012; Hayashi, Toshio/I-7346-2014
OI Hayashi, Toshio/0000-0002-7711-2700
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Grants-in-Aid for Scientific Research [24590881, 24406003] Funding
   Source: KAKEN
FX We thank Toshio Fujimori for his technical assistance. This work was
   supported by a Grant-in-Aid for Scientific Research from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan.
CR Boyle JG, 2010, DIABETIC MED, V27, P1097, DOI 10.1111/j.1464-5491.2010.03098.x
   Brodsky SV, 2004, CIRC RES, V94, P377, DOI 10.1161/01.RES.0000111802.09964.EF
   BURRIG KF, 1991, ARTERIOSCLER THROMB, V11, P1678, DOI 10.1161/01.ATV.11.6.1678
   Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289
   Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008
   Faulds MH, 2010, CURR OPIN PHARMACOL, V10, P692, DOI 10.1016/j.coph.2010.07.003
   Hansen MK, 2008, CURR OPIN INVEST DR, V9, P247
   Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103
   Hayashi T, 2008, PHARMACOL THERAPEUT, V120, P333, DOI 10.1016/j.pharmthera.2008.09.002
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Hwahng SH, 2009, HEPATOLOGY, V49, P1913, DOI 10.1002/hep.22887
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820
   Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299
   Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584
   Parikh N, 2010, CARDIOL REV, V18, P269, DOI 10.1097/CRD.0b013e3181e8067a
   Parks JS, 2012, CURR OPIN LIPIDOL, V23, P196, DOI 10.1097/MOL.0b013e328352dd1a
   Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075
   van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035
   WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033
   Woods CG, 2007, TOXICOL PATHOL, V35, P474, DOI 10.1080/01926230701311351
   Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024
   Yap F, 2011, INT J BIOL SCI, V7, P645, DOI 10.7150/ijbs.7.645
   Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607
   Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883
   Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974
NR 34
TC 53
Z9 60
U1 1
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 21
PY 2014
VL 111
IS 3
BP 1168
EP 1173
DI 10.1073/pnas.1322153111
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 292UQ
UT WOS:000329928400068
PM 24398515
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU SAHAKIAN, JA
   SZWEDA, LI
   FRIGUET, B
   KITANI, K
   LEVINE, RL
AF SAHAKIAN, JA
   SZWEDA, LI
   FRIGUET, B
   KITANI, K
   LEVINE, RL
TI AGING OF THE LIVER - PROTEOLYSIS OF OXIDATIVELY MODIFIED
   GLUTAMINE-SYNTHETASE
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
ID MIXED-FUNCTION OXIDATION; METAL-CATALYZED OXIDATION;
   AGE-RELATED-CHANGES; PROTEIN OXIDATION; ESCHERICHIA-COLI; CYSTEINE
   PROTEINASE; RATS; DEGRADATION; TURNOVER; ENZYMES
AB During aging cells accumulate altered forms of proteins, notably oxidatively modified proteins. The multicatalytic protease selectively degrades oxidized proteins, suggesting that the age-related accumulation of oxidized proteins might be a consequence of decreased activity of this protease, The protease activity of liver homogenates was assayed with an improved fluorimetric method, using oxidatively modified glutamine synthetase as substrate, Application of this assay to extracts from liver of Fischer 344 rats from both Japan and the United States demonstrated a marked preference for the oxidized substrate, as expected. Extracts from animals ages 8 to 26 months maintain both total proteolytic activity and the ability to distinguish between native and oxidized substrates. Oxidatively modified hepatocyte extracts were also employed as substrate, and older animals again maintained proteolytic activity. The multicatalytic protease was purified from liver of young and old rats, and the specific activity of the preparations were comparable when assayed with oxidatively modified glutamine synthetase. We conclude that the intrinsic neutral or alkaline proteolytic activity of rat liver is maintained during aging,
C1 UNIV TOKYO, FAC MED, RADIOISOTOPE RES INST, TOKYO 113, JAPAN.
C3 University of Tokyo
RP SAHAKIAN, JA (corresponding author), NHLBI, BIOCHEM LAB, BLDG 3, ROOM 106, BETHESDA, MD 20892 USA.
RI Levine, Rodney L/D-9885-2011
OI Friguet, Bertrand/0000-0001-8085-1961
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2
   BOSMANN HB, 1976, NATURE, V261, P499, DOI 10.1038/261499a0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   DE BERNARDO S, 1974, ARCH BIOCHEM BIOPHYS, V163, P390, DOI 10.1016/0003-9861(74)90490-1
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   FARMER KJ, 1989, FREE RADICAL BIO MED, V7, P23, DOI 10.1016/0891-5849(89)90096-8
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   GARLAND D, 1990, EXP EYE RES, V50, P677, DOI 10.1016/0014-4835(90)90113-9
   GRANT AJ, 1992, BIOCHIM BIOPHYS ACTA, V1134, P203, DOI 10.1016/0167-4889(92)90177-D
   GRANT AJ, 1993, FREE RADICAL RES COM, V18, P259, DOI 10.3109/10715769309147493
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   IVY GO, 1991, ARCH GERONTOL GERIAT, V12, P119, DOI 10.1016/0167-4943(91)90023-J
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   KITANI K, 1993, LIFE SCI, V52, P281, DOI 10.1016/0024-3205(93)90219-S
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P133, DOI 10.1016/0167-4943(91)90024-K
   LEVINE RL, 1983, J BIOL CHEM, V258, P1828
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   RIVETT AJ, 1985, J BIOL CHEM, V260, P2600
   RIVETT AJ, 1986, CURR TOP CELL REGUL, V28, P291
   RIVETT AJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P26, DOI 10.1016/0003-9861(90)90226-O
   RIVETT AJ, 1987, ARCH BIOCHEM BIOPHYS, V259, P423, DOI 10.1016/0003-9861(87)90508-X
   RIVETT AJ, 1985, ARCH BIOCHEM BIOPHYS, V243, P624, DOI 10.1016/0003-9861(85)90540-5
   ROSEMAN JE, 1987, J BIOL CHEM, V262, P2101
   ROTH GS, 1993, J GERONTOL, V48, pB213, DOI 10.1093/geronj/48.6.B213
   Rothstein M., 1982, BIOCH APPROACHES AGI
   SEGLEN PO, 1976, METHOD CELL BIOL, V13, P24
   SIERRA F, 1992, J BIOL CHEM, V267, P10665
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   STADTMAN ER, 1979, ANAL BIOCHEM, V95, P275, DOI 10.1016/0003-2697(79)90217-3
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   WANG RKJ, 1977, EXP GERONTOL, V12, P117, DOI 10.1016/0531-5565(77)90019-5
NR 43
TC 49
Z9 51
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 20
PY 1995
VL 318
IS 2
BP 411
EP 417
DI 10.1006/abbi.1995.1248
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA QV624
UT WOS:A1995QV62400022
PM 7733671
DA 2024-02-19
ER

PT J
AU Pantasis, S
   Friemel, J
   Brütsch, SM
   Hu, ZH
   Krautbauer, S
   Liebisch, G
   Dengjel, J
   Weber, A
   Werner, S
   Bordoli, MR
AF Pantasis, Sophia
   Friemel, Juliane
   Bruetsch, Salome Mirjam
   Hu, Zehan
   Krautbauer, Sabrina
   Liebisch, Gerhard
   Dengjel, Joern
   Weber, Achim
   Werner, Sabine
   Bordoli, Mattia Renato
TI Vertebrate Ionesome kinase modulates the hepatocyte secretome to prevent
   perivascular liver fibrosis and inflammation
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Collagen; Fibrosis; Liver; Secreted kinase; VLK; Pkdcc
ID PROGENITOR CELLS; BILE-ACIDS; HOMEOSTASIS; VLK; QUANTIFICATION;
   MECHANISM; BACTERIA; INJURY; GENE
AB Vertebrate lonesome kinase (VLK) is the only known extracellular tyrosine kinase, but its physiological functions are largely unknown. We show that VLK is highly expressed in hepatocytes of neonatal mice, but downregulated during adulthood. To determine the role of VLK in liver homeostasis and regeneration, we generated mice with a hepatocyte-specific knockout of the VLK gene (Pkdcc). Cultured progenitor cells established from primary hepatocytes of Pkdcc knockout mice produced a secretome, which promoted their own proliferation in 3D spheroids and proliferation of cultured fibroblasts. In vivo, Pkdcc knockout mice developed liver steatosis with signs of inflammation and perivascular fibrosis upon aging, combined with expansion of liver progenitor cells. In response to chronic CCI4-induced liver injury, the pattern of deposited collagen was significantly altered in these mice. The liver injury marker alpha-fetoprotein (AFP) was increased in the secretome of VLK-deficient cultured progenitor cells and in liver tissues of aged or CCI4-treated knockout mice. These results support a key role for VLK and extracellular protein phosphorylation in liver homeostasis and repair through paracrine control of liver cell function and regulation of appropriate collagen deposition.
   This article has an associated First Person interview with the first author of the paper.
C1 [Pantasis, Sophia; Bruetsch, Salome Mirjam; Werner, Sabine; Bordoli, Mattia Renato] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Otto Stern Weg 7, CH-8093 Zurich, Switzerland.
   [Friemel, Juliane; Weber, Achim] Univ Zurich, Dept Pathol & Mol Pathol, Ramistr 100, CH-8091 Zurich, Switzerland.
   [Friemel, Juliane; Weber, Achim] Univ Hosp Zurich, Ramistr 100, CH-8091 Zurich, Switzerland.
   [Hu, Zehan; Dengjel, Joern] Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland.
   [Krautbauer, Sabrina; Liebisch, Gerhard] Univ Hosp Regensburg, Dept Clin Chem & Lab Med, Franz Josef Strauss Allee 11, DE-93053 Regensburg, Germany.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich; University of
   Zurich; University of Zurich; University Zurich Hospital; University of
   Fribourg; University of Regensburg
RP Werner, S; Bordoli, MR (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Otto Stern Weg 7, CH-8093 Zurich, Switzerland.
EM sabine.werner@biol.ethz.ch; mattia.bordoli@novartis.com
RI Liebisch, Gerhard/G-6130-2010; Dengjel, Joern/AAI-3682-2020
OI Liebisch, Gerhard/0000-0003-4886-0811; Dengjel,
   Joern/0000-0002-9453-4614; Pantasis, Sophia/0000-0003-4221-8246; Weber,
   Achim/0000-0003-0073-3637; Werner, Sabine/0000-0001-7397-8710; Brutsch,
   Salome/0000-0002-6209-0019; Friemel, Juliane/0000-0002-1408-0406
FU Swiss National Science Foundation (Schweizerischer Nationalfonds zur
   Forderung der Wissenschaftlichen Forschung) [PZ00P3_161512]; ETH Zurich
   (Eidgenossische Technische Hochschule Zurich) [ETH-25 17-1]; Novartis
   Foundation for Medical-Biological Research (Novartis Stiftung fur
   Medizinisch-Biologische Forschung) [18B106]; Eidgenossische Technische
   Hochschule Zurich; Swiss National Science Foundation (SNF)
   [PZ00P3_161512] Funding Source: Swiss National Science Foundation (SNF)
FX This study was supported by the Swiss National Science Foundation
   (Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen
   Forschung, grant PZ00P3_161512 to M.R.B.), ETH Zurich (Eidgenossische
   Technische Hochschule Zurich, grant ETH-25 17-1 to M.R.B. and core
   funding to S.W.) and the Novartis Foundation for Medical-Biological
   Research (Novartis Stiftung fur Medizinisch-Biologische Forschung, grant
   18B106 to M.R.B.). Open Access funding provided by Eidgenossische
   Technische Hochschule Zurich. Deposited in PMC for immediate release.
CR Alison MR, 2009, CURR OPIN MOL THER, V11, P364
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   BIAGINI G, 1989, J HEPATOL, V8, P115, DOI 10.1016/0168-8278(89)90170-0
   Bordoli MR, 2014, CELL, V158, P1033, DOI 10.1016/j.cell.2014.06.048
   Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2
   Cannon MV, 2016, G3-GENES GENOM GENET, V6, P3701, DOI 10.1534/g3.116.034785
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022
   Ding C, 2016, MOL CELL PROTEOMICS, V15, P3190, DOI 10.1074/mcp.M116.060145
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Gadd VL, 2020, CELL STEM CELL, V27, P557, DOI 10.1016/j.stem.2020.08.016
   HALL MJ, 1960, AM J CLIN PATHOL, V34, P313
   Harada H, 2019, NAT CHEM BIOL, V15, P1035, DOI 10.1038/s41589-019-0345-z
   HEROVICI C, 1963, REV FR ETUD CLIN BIO, V8, P88
   Imuta Y, 2009, DEV DYNAM, V238, P210, DOI 10.1002/dvdy.21822
   Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001
   JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4
   Katsuda T, 2017, CELL STEM CELL, V20, P41, DOI 10.1016/j.stem.2016.10.007
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kim JM, 2020, BIOCHEM J, V477, P121, DOI 10.1042/BCJ20190784
   Kinoshita M, 2009, DEVELOPMENT, V136, P2069, DOI 10.1242/dev.026435
   Krautbauer S, 2016, ANAL CHEM, V88, P10957, DOI 10.1021/acs.analchem.6b02596
   Lee YA, 2015, GUT, V64, P830, DOI 10.1136/gutjnl-2014-306842
   Li MS, 2002, CELL RES, V12, P151, DOI 10.1038/sj.cr.7290121
   Li Y, 2017, AUTOIMMUN REV, V16, P885, DOI 10.1016/j.autrev.2017.07.002
   LUNDGREN B, 1981, OIKOS, V36, P17, DOI 10.2307/3544373
   Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261
   March S, 2015, NAT PROTOC, V10, P2027, DOI 10.1038/nprot.2015.128
   Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968
   Mohar I, 2015, METHODS MOL BIOL, V1325, P3, DOI 10.1007/978-1-4939-2815-6_1
   Pose E, 2019, METHODS MOL BIOL, V1981, P249, DOI 10.1007/978-1-4939-9420-5_16
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Probst S, 2013, DIFFERENTIATION, V85, P121, DOI 10.1016/j.diff.2013.03.002
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Revollo L, 2022, BLOOD, V139, P104, DOI 10.1182/blood.2020010342
   Scherer M, 2009, J CHROMATOGR B, V877, P3920, DOI 10.1016/j.jchromb.2009.09.038
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Soderdahl G, 1998, Transpl Int, V11 Suppl 1, pS231, DOI 10.1007/s001470050467
   Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255
   Teuscher AC, 2019, METHODS MOL BIOL, V1944, P169, DOI 10.1007/978-1-4939-9095-5_13
   Trivedi P, 2021, CELL METAB, V33, P242, DOI 10.1016/j.cmet.2020.10.026
   Vizcaíno JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   WANNAGAT FJ, 1978, J CLIN INVEST, V61, P297, DOI 10.1172/JCI108939
   Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034
   Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568
   WILSON W., 1950, BULL INTERNAT ASSOC MED MUS, V31, P216
NR 50
TC 2
Z9 2
U1 0
U2 2
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD APR
PY 2022
VL 135
IS 7
AR jcs259243
DI 10.1242/jcs.259243
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 0O9JT
UT WOS:000783840400011
PM 35293576
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Gal, H
   Majewska, J
   Krizhanovsky, V
AF Gal, Hilah
   Majewska, Julia
   Krizhanovsky, Valery
TI The intricate nature of senescence in development and cell plasticity
SO SEMINARS IN CANCER BIOLOGY
LA English
DT Article; Early Access
DE Cellular senescence; Embryonic development; Placenta; Regeneration
ID PLURIPOTENT STEM-CELLS; DNA-DAMAGE RESPONSE; SECRETORY PHENOTYPE;
   LIVER-CANCER; IMMUNOSURVEILLANCE; FIBROBLASTS; GENERATION; GROWTH
AB Cellular senescence, a stable form of cell cycle arrest, accompanied by pronounced secretory activity, has functional roles in both physiological and pathological conditions. Although senescence has been linked for a long time with cancer and ageing, recent studies have revealed a functional role of senescence in development, regeneration and reprogramming. Notably, the transient presence of senescent cells may be beneficial, in contrast to the potential deleterious effects of persistent senescence in aged or chronically damaged tissues. We will discuss how senescence contributes to embryonic development, cell plasticity and tissue regeneration, as a highly coordinated and programmed cellular state.
C1 [Gal, Hilah; Majewska, Julia; Krizhanovsky, Valery] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.
C3 Weizmann Institute of Science
RP Krizhanovsky, V (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.
EM valery.krizhanovsky@weizmann.ac.il
RI Krizhanovsky, Valery/D-1336-2010
OI Krizhanovsky, Valery/0000-0002-3977-5482
FU European Research Council [856487]; Israel Science Foundation [634-15,
   2633-17, 1626-20]; Israel Ministry of Health; Minerva Center "Aging,
   from Physical Materials to Human Tissues" and Sagol Institute for
   Longevity Research; European Research Council (ERC) [856487] Funding
   Source: European Research Council (ERC)
FX V.K. is supported by grants from the European Research Council under
   Horizon 2020 (856487), from the Israel Science Foundation (634- 15;
   2633-17; 1626-20), Israel Ministry of Health, Minerva Center "Aging,
   from Physical Materials to Human Tissues" and Sagol Institute for
   Longevity Research.
CR Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586
   Achuthan S, 2011, J BIOL CHEM, V286, P37813, DOI 10.1074/jbc.M110.200675
   Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006
   Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884
   Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609
   Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592
   Burton DGA, 2014, CELL MOL LIFE SCI, V71, P4373, DOI 10.1007/s00018-014-1691-3
   Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chuprin A, 2013, GENE DEV, V27, P2356, DOI 10.1101/gad.227512.113
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Cox LS, 2017, PLACENTA, V52, P139, DOI 10.1016/j.placenta.2017.01.116
   Da Silva-Alvarez S, 2020, AGING CELL, V19, DOI 10.1111/acel.13052
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530
   Gal H, 2019, EMBO J, V38, DOI 10.15252/embj.2018100849
   Gal H, 2014, AGING-US, V6, P353, DOI 10.18632/aging.100670
   Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738
   Goldman-Wohl D, 2014, PLACENTA, V35, P341, DOI 10.1016/j.placenta.2014.03.012
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kobayashi Y, 2020, NAT CELL BIOL, V22, P934, DOI 10.1038/s41556-020-0542-8
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290
   Marión RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052
   Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005
   Ortiz-Montero P, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0172-3
   Ovadya Y, 2014, BIOGERONTOLOGY, V15, P627, DOI 10.1007/s10522-014-9529-9
   Plaks V, 2011, MOL IMAGING BIOL, V13, P481, DOI 10.1007/s11307-010-0390-1
   Plaks V, 2011, BIOL REPROD, V84, P537, DOI 10.1095/biolreprod.110.085951
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Sagiv A, 2016, AGING-US, V8, P328, DOI 10.18632/aging.100897
   Sagiv A, 2013, BIOGERONTOLOGY, V14, P617, DOI 10.1007/s10522-013-9473-0
   Sarig R, 2019, CIRCULATION, V139, P2491, DOI 10.1161/CIRCULATIONAHA.119.040125
   Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Wiley CD, 2017, AGING CELL, V16, P1043, DOI 10.1111/acel.12632
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Yosef R, 2017, EMBO J, V36, P2280, DOI 10.15252/embj.201695553
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yun MH, 2015, ELIFE, V4, DOI 10.7554/eLife.05505
   Zhu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074535
   Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038
NR 69
TC 5
Z9 5
U1 1
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-579X
EI 1096-3650
J9 SEMIN CANCER BIOL
JI Semin. Cancer Biol.
PD 2022 DEC
PY 2022
VL 87
BP 214
EP 219
DI 10.1016/j.semcancer.2021.01.004
EA DEC 2022
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 6U0BW
UT WOS:000894037100013
PM 33486077
DA 2024-02-19
ER

PT J
AU Huang, XP
   Zhao, Y
   Wei, M
   Zhuge, RP
   Zheng, XF
AF Huang, Xinping
   Zhao, Yan
   Wei, Min
   Zhuge, Ruipeng
   Zheng, Xiaofeng
TI hCINAP alleviates senescence by regulating MDM2 via p14ARF and the
   HDAC1/CoREST complex
SO JOURNAL OF MOLECULAR CELL BIOLOGY
LA English
DT Article
DE hCINAP; HDAC1/CoREST complex; p14ARF; MDM2; transcription; senescence
ID ADENYLATE KINASE 6; CELLULAR SENESCENCE; PROTEIN; P53; PHOSPHORYLATION;
   LOCUS
AB Cellular senescence is a major process affected by multiple signals and coordinated by a complex signal response network. Identification of novel regulators of cellular senescence and elucidation of their molecular mechanisms will aid in the discovery of new treatment strategies for aging-related diseases. In the present study, we identified human coilin-interacting nuclear ATPase protein (hCINAP) as a negative regulator of aging. Depletion of cCINAP significantly shortened the lifespan of Caenorhabditis elegans and accelerated primary cell aging. Moreover, mCINAP deletion markedly promoted organismal aging and stimulated senescence-associated secretory phenotype in the skeletal muscle and liver from mouse models of radiation-induced senescence. Mechanistically, hCINAP functions through regulating MDM2 status by distinct mechanisms. On the one hand, hCINAP decreases p53 stability by attenuating the interaction between p14ARF and MDM2; on the other hand, hCINAP promotes MDM2 transcription via inhibiting the deacetylation of H3K9ac in the MDM2 promoter by hindering the HDAC1/CoREST complex integrity. Collectively, our data demonstrate that hCINAP is a negative regulator of aging and provide insight into the molecular mechanisms underlying the aging process.
C1 [Huang, Xinping; Zhao, Yan; Wei, Min; Zhuge, Ruipeng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.
   [Huang, Xinping; Zhao, Yan; Wei, Min; Zhuge, Ruipeng; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.
C3 Peking University; Peking University
RP Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.
EM xiaofengz@pku.edu.cn
FU We thank the National Center for Protein Sciences and the Core
   Facilities of Life Sciences at Peking University, particularly Guilan
   Li, Dong Liu, Yinghua Guo, Liying Du, Hongxia Lv, Siying Qin, and Liqin
   Fu, for technical help.
FX We thank the National Center for Protein Sciences and the Core
   Facilities of Life Sciences at Peking University, particularly Guilan
   Li, Dong Liu, Yinghua Guo, Liying Du, Hongxia Lv, Siying Qin, and Liqin
   Fu, for technical help.
CR Bai DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12310
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chibaya L, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2003193118
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Feng X, 2012, PLANT PHYSIOL BIOCH, V61, P180, DOI 10.1016/j.plaphy.2012.10.002
   Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148
   Gannon HS, 2012, CANCER CELL, V21, P668, DOI 10.1016/j.ccr.2012.04.011
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383
   Ji YP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15308
   Kawakami K, 2009, BIOGERONTOLOGY, V10, P415, DOI 10.1007/s10522-008-9176-0
   Ko A, 2016, BMB REP, V49, P598, DOI 10.5483/BMBRep.2016.49.11.120
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lyu GL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04994-z
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511
   Ren H, 2005, P NATL ACAD SCI USA, V102, P303, DOI 10.1073/pnas.0407459102
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026
   Santama N, 2005, J BIOL CHEM, V280, P36429, DOI 10.1074/jbc.M501982200
   Seo J, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10081143
   Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027
   Sturmlechner I, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31239-x
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Takaoka M, 2004, ONCOGENE, V23, P6760, DOI 10.1038/sj.onc.1207923
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991
   Willis-Martinez D, 2010, EXP GERONTOL, V45, P279, DOI 10.1016/j.exger.2009.10.001
   Wu DY, 2018, CELL DEATH DIFFER, V25, P169, DOI 10.1038/cdd.2017.187
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Xu RD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11795-5
   Zhai RT, 2006, FEBS LETT, V580, P3811, DOI 10.1016/j.febslet.2006.05.074
   Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560
   Zhang JF, 2010, CELL MOL LIFE SCI, V67, P1907, DOI 10.1007/s00018-010-0301-2
   Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4
NR 42
TC 1
Z9 1
U1 2
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1674-2788
EI 1759-4685
J9 J MOL CELL BIOL
JI J. Mol. Cell Biol.
PD JUN 13
PY 2023
VL 15
IS 2
AR mjad015
DI 10.1093/jmcb/mjad015
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA Q5NL6
UT WOS:001057988100001
PM 36881716
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Gee, JR
   Ding, QX
   Keller, JN
AF Gee, JR
   Ding, QX
   Keller, JN
TI Modulation of apolipoprotein E and interleukin-1β in the aging liver
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; apolipoprotein E; cytokme; inflammation; interleukin-1 beta;
   liver
ID CULTURED RAT HEPATOCYTES; GENE-EXPRESSION; KUPFFER CELLS; STIMULATED
   GLUCONEOGENESIS; INFLAMMATORY CYTOKINES; E SECRETION; IN-VIVO; A-I; AGE;
   ACTIVATION
AB With aging there is a decline in liver function that includes reductions in hepatic blood flow, metabolite clearance, and impaired tissue repair following injury. An increase in inflammatory signaling is often observed during aging, with inflammation potentially mediating age-related changes in the liver. Apolipoprotein E (ApoE) is primarily produced by the liver and has been shown to possess, anti-inflammatory properties in a variety of paradigms and experimental settings. In the present study, we correlated age-related alterations in ApoE expression with age-related changes in the cytokine interleukin-1 beta (IL-1 beta), in the liver of rats of increasing age. A significant increase in ApoE mRNA, and a significant decrease in IL-1 beta mRNA, was seen with increasing age. At the protein level, ApoE expression increased with aging, although IL-1 beta expression remained constant. No correlation was found between ApoE and IL-1 beta expression at the mRNA or protein level. Taken together, these studies demonstrate that ApoE expression is altered during normal aging, and indicates that there is no correlation between ApoE and IL-1 beta expression in the aging liver. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Kentucky, Sanders Brown Ctr Aging 205, Lexington, KY 40536 USA.
   Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA.
C3 University of Kentucky; University of Kentucky
RP Keller, JN (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging 205, 800 S Limestone, Lexington, KY 40536 USA.
EM Jnkell0@pop.uky.edu
RI Keller, Jeffrey N/N-1975-2017
OI keller, jeffrey/0000-0002-9892-7423
FU NIA NIH HHS [AG000242, AG005119, AG018437] Funding Source: Medline
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   BROUWER A, 1995, CLIN SCI, V88, P211, DOI 10.1042/cs0880211
   CHIBA H, 1990, BIOCHEM MED METAB B, V43, P53, DOI 10.1016/0885-4505(90)90008-O
   de Bont N, 1999, J LIPID RES, V40, P680
   Dinarello C A., 2003, The Cytokine Handbook, VFourth, P643
   Ding QX, 2003, FEBS LETT, V546, P228, DOI 10.1016/S0014-5793(03)00582-9
   GRASEDYCK K, 1980, MECH AGEING DEV, V14, P435, DOI 10.1016/0047-6374(80)90014-7
   Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200
   HARRIS L, 1987, CANCER RES, V47, P3954
   Hilmer SN, 2004, EXP GERONTOL, V39, P53, DOI 10.1016/j.exger.2003.09.016
   Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1
   KMIEC Z, 1983, EXP GERONTOL, V18, P173, DOI 10.1016/0531-5565(83)90030-X
   Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541
   Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507
   Mizuguchi T, 1998, J CELL PHYSIOL, V174, P273, DOI 10.1002/(SICI)1097-4652(199803)174:3<273::AID-JCP1>3.0.CO;2-L
   Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com
   Moors MA, 2000, J LEUKOCYTE BIOL, V68, P131
   Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4
   PANDURO A, 1993, BIOCHIM BIOPHYS ACTA, V1167, P37, DOI 10.1016/0005-2760(93)90214-T
   Patel NV, 2004, NEUROSCI LETT, V371, P199, DOI 10.1016/j.neulet.2004.08.076
   Pie JE, 2002, MOL CELLS, V13, P399
   POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2
   Rensen PCN, 1997, J CLIN INVEST, V99, P2438, DOI 10.1172/JCI119427
   Rikans LE, 1999, MECH AGEING DEV, V108, P173, DOI 10.1016/S0047-6374(99)00012-3
   Roselaar SE, 1998, J LIPID RES, V39, P1740
   Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20
   Sadeghi HM, 1999, EXP GERONTOL, V34, P959, DOI 10.1016/S0531-5565(99)00065-0
   Schiele F, 2000, ATHEROSCLEROSIS, V152, P475, DOI 10.1016/S0021-9150(99)00501-8
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Song H, 1998, CYTOKINE, V10, P275, DOI 10.1006/cyto.1997.0291
   Starck M, 2000, CELL BIOCHEM FUNCT, V18, P9, DOI 10.1002/(SICI)1099-0844(200001/03)18:1<9::AID-CBF841>3.0.CO;2-X
   Stockhaus C, 2002, VET PATHOL, V39, P154, DOI 10.1354/vp.39-1-154
   Sumida KD, 2003, J APPL PHYSIOL, V95, P712, DOI 10.1152/japplphysiol.01125.2002
   Tenger C, 2003, IMMUNOLOGY, V109, P392, DOI 10.1046/j.1365-2567.2003.01665.x
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Vollmar B, 2002, SHOCK, V18, P348, DOI 10.1097/00024382-200210000-00010
   Xie Z, 2003, EXP NEUROL, V182, P135, DOI 10.1016/S0014-4886(03)00057-8
   Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
NR 40
TC 14
Z9 14
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2005
VL 40
IS 5
BP 409
EP 415
DI 10.1016/j.exger.2005.01.010
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 935WN
UT WOS:000229814200009
PM 15919593
DA 2024-02-19
ER

PT J
AU Bloomer, SA
   Wellen, KE
   Henderson, GC
AF Bloomer, Steven A.
   Wellen, Kathryn E.
   Henderson, Gregory C.
TI Sexual dimorphism in the hepatic protein response to a moderate trans
   fat diet in senescence-accelerated mice
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
DE ATP citrate lyase; Fatty acid synthase; MCP-1; Inflammation; Oxidative
   stress
ID SUPEROXIDE-DISMUTASE ACTIVITY; INDUCED LIVER-INJURY; OXIDATIVE STRESS;
   LIPID-METABOLISM; MESSENGER-RNA; ACID SYNTHASE; SAMP8 MICE; EXPRESSION;
   INFLAMMATION; DISEASE
AB Background: Aging is characterized by increases in inflammation and oxidative stress, conditions that are exacerbated by environmental factors such as diet. In this study, we investigated the effects of a trans-fatty acid (TFA) diet on the liver in adult (25 wk) and old (60 wk) senescence-accelerated mice (SAMP8 strain) of both sexes. Our goal was to assess the effects of the diet on protein markers of inflammation and oxidative stress in the liver.
   Methods: Male and female mice were placed on life-long diets containing similar amounts of total fat (17%), with differing amounts of TFA: 2% (moderate TFA group) or 0.2% of total energy from TFA (control diet group). At the indicated ages, livers were harvested and evaluated for markers of inflammation and oxidative stress, as well as for enzymes of fat metabolism via immunoblotting. Relative densities of protein bands were determined and compared via a three-factor ANOVA.
   Results: Compared to males, females demonstrated significantly lower inflammatory protein expression (ICAM-1, MCP-1, COX-2), along with lower expression of the DNA damage marker, Gadd153, and the oxidative stress marker, HO-1. Female mice demonstrated higher expression of antioxidant enzymes (SOD-1, SOD-2, and Ref-1) and lipogenic enzymes (FASN, ACLY) compared to male mice. While HO-1 was elevated in the female mice fed the TFA diet compared to controls, the diet did not affect other markers of oxidative stress or inflammation. However, the diet was associated with significant increases in FASN and ACLY in adult (25 wk) male mice.
   Conclusions: Our results suggest sexually dimorphic protein expression in the liver, with female mice demonstrating lower inflammation and increased oxidative stress defenses. Additionally, considering that FASN and ACLY contribute to hepatic lipogenesis, our results suggest a potential mechanism for the dyslipidemia in adult male mice that is associated with TFA diets.
C1 [Bloomer, Steven A.] Penn State Univ, Abington Coll, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
   [Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.
   [Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.
   [Henderson, Gregory C.] Rutgers State Univ, New Brunswick, NJ USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; University of Pennsylvania; University of
   Pennsylvania; Rutgers University System; Rutgers University New
   Brunswick
RP Bloomer, SA (corresponding author), Penn State Univ, Abington Coll, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
EM sab320@psu.edu
FU Penn State University, Abington College; Division of Life Sciences at
   Rutgers University
FX SAB was supported by a Faculty Development Grant from Penn State
   University, Abington College. The work was also supported by the
   Division of Life Sciences at Rutgers University.
CR Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1
   Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891
   BENHIZIA F, 1994, AM J PHYSIOL-ENDOC M, V267, pE975, DOI 10.1152/ajpendo.1994.267.6.E975
   Bloomer SA, 2016, CELL BIOCHEM FUNCT, V34, P628, DOI 10.1002/cbf.3238
   Bloomer SA, 2015, CELL BIOCHEM FUNCT, V33, P241, DOI 10.1002/cbf.3110
   Bloomer SA, 2014, ARCH GERONTOL GERIAT, V58, P145, DOI 10.1016/j.archger.2013.07.012
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620
   Cassagno N, 2005, BRIT J NUTR, V94, P346, DOI 10.1079/BJN20051512
   Cheng Q, 2013, DIGEST DIS SCI, V58, P2895, DOI 10.1007/s10620-013-2823-6
   Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172
   Cuesta S, 2010, EXP GERONTOL, V45, P950, DOI 10.1016/j.exger.2010.08.016
   Derave W, 2005, EXP GERONTOL, V40, P562, DOI 10.1016/j.exger.2005.05.005
   Dhibi M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-65
   Farhadi A, 2008, LIVER INT, V28, P1026, DOI 10.1111/j.1478-3231.2008.01723.x
   Gong H, 2014, MOL MED REP, V10, P3296, DOI 10.3892/mmr.2014.2648
   Gujral JS, 2004, AM J PHYSIOL-GASTR L, V286, pG499, DOI 10.1152/ajpgi.00318.2003
   Gurusamy N, 2007, FREE RADICAL BIO MED, V43, P397, DOI 10.1016/j.freeradbiomed.2007.04.025
   Haak JL, 2009, AM J PHYSIOL-REG I, V296, pR812, DOI 10.1152/ajpregu.90708.2008
   Ikeyama S, 2003, J BIOL CHEM, V278, P16726, DOI 10.1074/jbc.M300677200
   KATZ N, 1989, EUR J BIOCHEM, V180, P185, DOI 10.1111/j.1432-1033.1989.tb14631.x
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   LIAO F, 1993, J CLIN INVEST, V91, P2572, DOI 10.1172/JCI116495
   Link JC, 2015, ARTERIOSCL THROM VAS, V35, P1778, DOI 10.1161/ATVBAHA.115.305460
   Link JC, 2013, ADIPOCYTE, V2, P74, DOI 10.4161/adip.23320
   Liou J, 2013, LIPIDS, V48, P1135, DOI 10.1007/s11745-013-3831-1
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   Liu YS, 2008, MOL CELL PROTEOMICS, V7, P1737, DOI 10.1074/mcp.M800109-MCP200
   Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009
   Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988
   Lonardo A, 2017, DIGEST LIVER DIS, V49, P471, DOI 10.1016/j.dld.2017.01.147
   Longhi R, 2017, EUR J NUTR, V56, P1003, DOI 10.1007/s00394-015-1148-y
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874
   Micha R, 2009, NAT REV ENDOCRINOL, V5, P335, DOI 10.1038/nrendo.2009.79
   North KE, 2012, EUR J GASTROEN HEPAT, V24, P9, DOI 10.1097/MEG.0b013e32834a94fb
   OBERLEY LW, 1987, ARCH BIOCHEM BIOPHYS, V254, P69, DOI 10.1016/0003-9861(87)90082-8
   Pan QR, 2015, NUTR RES, V35, P576, DOI 10.1016/j.nutres.2015.05.006
   PEARCE J, 1976, HORM METAB RES, V8, P181, DOI 10.1055/s-0028-1093656
   Rehman Hasibur, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P14
   Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036
   Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303
   Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204
   Sekhar KR, 1997, BIOCHEM BIOPH RES CO, V234, P588, DOI 10.1006/bbrc.1997.6697
   Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0
   Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800
   Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074
   Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097
   Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160
   Yesilova Z, 2005, AM J GASTROENTEROL, V100, P850, DOI 10.1111/j.1572-0241.2005.41500.x
   Yuan M, 2005, REPROD FERT DEVELOP, V17, P507, DOI 10.1071/RD04099
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 54
TC 4
Z9 5
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD DEC 13
PY 2017
VL 16
AR 243
DI 10.1186/s12944-017-0639-7
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA FP8FM
UT WOS:000417876300002
PM 29237473
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ding, L
   Zhang, TT
   Che, HX
   Zhang, LY
   Xue, CH
   Chang, YG
   Wang, YM
AF Ding, Lin
   Zhang, Tiantian
   Che, Hongxia
   Zhang, Lingyu
   Xue, Changhu
   Chang, Yaoguang
   Wang, Yuming
TI DHA-Enriched Phosphatidylcholine and DHA-Enriched Phosphatidylserine
   Improve Age-Related Lipid Metabolic Disorder through Different
   Metabolism in the Senescence-Accelerated Mouse
SO EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
LA English
DT Article
DE aging; DHA; Lipid metabolism; phosphatidylcholine; phosphatidylserine
ID POLYUNSATURATED FATTY-ACIDS; FISH-OIL; DOCOSAHEXAENOIC ACID;
   PHOSPHOLIPIDS; EPA; BIOAVAILABILITY; LIPOPROTEINS; FORMULATIONS;
   ABSORPTION; MECHANISMS
AB Aging is an independent risk factor for the development of atherosclerosis, which is characterized by hyperlipemia. The senescence-accelerated mouse (SAMP8) is an animal model used in studies of aging, which is associated with a shift of fatty metabolism toward lipogenesis. This study investigates the effects of docosahexaenoic acid-enriched phosphatidylcholine (DHA-PC) and docosahexaenoic acid-enriched phosphatidylserine (DHA-PS) on age-related lipid metabolic disorder in SAMP8 mice. Main findings and results: Both dietary DHA-PC and DHA-PS significantly decrease serum and hepatic lipid levels. The levels of DHA in hepatic total lipid are significantly increased in both DHA-PC and DHA-PS groups (2.59- and 2.33-fold, respectively). Notably, supplementary DHA-PS remarkably alters the ratio of PE to PC in liver. Mechanistically, DHA-PC and DHA-PS suppresses hepatic SREBP-1c mediates lipogenesis and activates PPAR mediated fatty acid -oxidation in the liver. These data are the first to indicate that DHA-PS has beneficial effects on age-related lipid metabolism.Practical Applications: The results obtained in this work might contribute to the understanding of biological activities of DHA enriched phospholipids and further investigation on its potential application values for food supplements. This study investigates the effects of docosahexaenoic acid-enriched phosphatidylcholine (DHA-PC) and docosahexaenoic acid-enriched phosphatidylserine (DHA-PS) on age-related lipid metabolic disorder in SAMP8 mice. The results shows that DHA-PC and DHA-PS improves age-related lipometabolic disturbance by inhibiting hepatic fatty acid synthesis and enhancing hepatic fatty acid -oxidation, providing a reference for the development of functional ingredients rich in DHA phospholipids.
C1 [Ding, Lin; Zhang, Tiantian; Che, Hongxia; Zhang, Lingyu; Xue, Changhu; Chang, Yaoguang; Wang, Yuming] Ocean Univ China, Coll Food Sci & Engn, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.
   [Xue, Changhu; Wang, Yuming] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Biol Prod, Qingdao 266237, Peoples R China.
C3 Ocean University of China; Laoshan Laboratory
RP Chang, YG; Wang, YM (corresponding author), Ocean Univ China, Coll Food Sci & Engn, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.; Wang, YM (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Biol Prod, Qingdao 266237, Peoples R China.
EM changyg@ouc.edu.cn; wangyuming@ouc.edu.cn
RI lu, yang/IWE-3635-2023; Chang, Yaoguang/E-5875-2014
OI Chang, Yaoguang/0000-0002-8234-7272; Zhang, Lingyu/0000-0002-4501-8445
FU National Natural Science Foundation of China [31371757]; State Key
   Program of National Natural Science of China [31330060]; National
   Natural Science Foundation of China-Shandong Joint Fund for Marine
   Science Research Centers [U1606403]; Fundamental Research Funds for the
   Central Universities [201762028]
FX This work is supported by the National Natural Science Foundation of
   China (No. 31371757), State Key Program of National Natural Science of
   China (Grant No. 31330060), National Natural Science Foundation of
   China-Shandong Joint Fund for Marine Science Research Centers
   (U1606403), and the Fundamental Research Funds for the Central
   Universities (Grant No. 201762028).
CR Amate L, 2001, J NUTR, V131, P1250, DOI 10.1093/jn/131.4.1250
   Arai T, 2009, J ATHEROSCLER THROMB, V16, P283, DOI 10.5551/jat.E463
   Bjorndal B, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-82
   Chizuru K., 2013, CLIN INTERV AGING, V8, P1247
   Davidson MH, 2012, J CLIN LIPIDOL, V6, P573, DOI 10.1016/j.jacl.2012.01.002
   Ding L, 2016, J OLEO SCI, V65, P593, DOI 10.5650/jos.ess16005
   Ding N, 2013, J OLEO SCI, V62, P883, DOI 10.5650/jos.62.883
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fukunaga K, 2016, LIPIDS, V51, P279, DOI 10.1007/s11745-016-4118-0
   Gao Liqian, 2013, Methods Mol Biol, V1002, P233, DOI 10.1007/978-1-62703-360-2_19
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Ikeda I, 2001, J NUTR, V131, P1159, DOI 10.1093/jn/131.4.1159
   IMAIZUMI K, 1983, J NUTR, V113, P2403, DOI 10.1093/jn/113.12.2403
   Kitson AP, 2016, J NUTR BIOCHEM, V33, P91, DOI 10.1016/j.jnutbio.2016.02.009
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Le K. D., 1976, H-S Z PHYSIOL CHEM, V357, P1321
   Lee B, 2010, PROG NEURO-PSYCHOPH, V34, P1085, DOI 10.1016/j.pnpbp.2010.05.031
   Liao WZ, 2016, INT J NANOMED, V11, P1305, DOI 10.2147/IJN.S92257
   Liao WZ, 2016, J AGR FOOD CHEM, V64, P1509, DOI 10.1021/acs.jafc.5b04924
   Liu XF, 2014, EUR J LIPID SCI TECH, V116, P255, DOI 10.1002/ejlt.201300407
   Lou QM, 2012, J FOOD BIOCHEM, V36, P317, DOI 10.1111/j.1745-4514.2011.00544.x
   Mao XZ, 2017, J BIOTECHNOL, V249, P51, DOI 10.1016/j.jbiotec.2017.03.029
   Murota K., 2017, PROSTAGLANDINS LEUKO, V17, P30022
   Ohkubo T, 2010, J OLEO SCI, V59, P247, DOI 10.5650/jos.59.247
   Park HJ, 2013, NUTR NEUROSCI, V16, P47, DOI 10.1179/1476830512Y.0000000029
   Perona JS, 2004, J SEP SCI, V27, P653, DOI 10.1002/jssc.200301723
   Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003
   Rossmeisl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038834
   Schuchardt JP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-145
   Skorve J, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0086-2
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Tillander V, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-20
   Tsushima T, 2014, BIOCATAL AGR BIOTECH, V3, P303, DOI 10.1016/j.bcab.2013.11.013
   Van Noolen L, 2014, PROSTAG LEUKOTR ESS, V91, P111, DOI 10.1016/j.plefa.2014.07.016
   Vigerust NF, 2013, EUR J NUTR, V52, P1315, DOI 10.1007/s00394-012-0441-2
   Wang HL, 2014, J ALZHEIMERS DIS, V39, P841, DOI 10.3233/JAD-131463
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wolf G, 2010, NUTR REV, V68, P316, DOI 10.1111/j.1753-4887.2010.00289.x
   Xiao ZJ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-163
   Yael R., 2010, CLIN INTERV AGING, V5, P313
   Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3
   ZIERENBERG O, 1982, J LIPID RES, V23, P1136
NR 43
TC 22
Z9 23
U1 0
U2 79
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1438-7697
EI 1438-9312
J9 EUR J LIPID SCI TECH
JI Eur. J. Lipid Sci. Technol.
PD JUN
PY 2018
VL 120
IS 6
AR 1700490
DI 10.1002/ejlt.201700490
PG 7
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GI4QD
UT WOS:000434355400010
DA 2024-02-19
ER

PT J
AU Yun, KU
   Oh, SJ
   Oh, JM
   Kang, KW
   Myung, CS
   Song, GY
   Kim, BH
   Kim, SK
AF Yun, Kang Uk
   Oh, Soo Jin
   Oh, Jung Min
   Kang, Keon Wook
   Myung, Chang-Seon
   Song, Gyu Yong
   Kim, Bong-Hee
   Kim, Sang Kyum
TI Age-related changes in hepatic expression and activity of cytochrome
   P450 in male rats
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Drug-metabolizing enzyme; Cytochrome P450; Development and aging;
   Expression and activity; Liver
ID HEPATOCYTE GROWTH-FACTOR; DRUG-METABOLIZING-ENZYMES; LIVER-MICROSOMES;
   DEPENDENT EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; PROTEIN;
   TRANSPORTERS; INDUCIBILITY; INDUCTION
AB Age-related changes in hepatic expression and activity of cytochrome P450 (CYP) were investigated in male rats aged 3 (weanling), 12 (young), 26 (adult), and 104 (old) weeks. Levels of microsomal protein, total CYP, and cytochrome b(5) increased fully after puberty. CYP1A1 was detected only in 3-week-old rats, and CYP1A2, CYP2B1, and CYP2E1 were maximally expressed at 3 weeks but decreased at 12 and 26 weeks. CYP2C11 and CYP3A2 increased markedly after puberty and decreased with aging. Ethoxyresorufin-O-deethylase, methoxyresorufin-O-demethylase, pentoxyresorufin-O-depenthylase, and p-nitrophenol hydroxylase activities were at their highest in 3-week-old rats, and midazolam hydroxylase activity was at a maximum in 12-week-old rats but decreased with aging. The present results show that increasing age caused significant alterations in hepatic expression/activity of CYP isoforms in an isoform-specific manner. These results suggest that age-related changes in hepatic CYP isoforms may be an important factor for deciding the efficacy and safety of xenobiotics.
C1 [Yun, Kang Uk; Oh, Soo Jin; Oh, Jung Min; Myung, Chang-Seon; Song, Gyu Yong; Kim, Bong-Hee; Kim, Sang Kyum] Chungnam Natl Univ, Coll Pharm & RCTCP, Taejon 305764, South Korea.
   [Oh, Soo Jin] KRIBB, Bioevaluat Ctr, Chungbuk, South Korea.
   [Kang, Keon Wook] Chosun Univ, Coll Pharm, Kwangju 501759, South Korea.
C3 Chungnam National University; Korea Research Institute of Bioscience &
   Biotechnology (KRIBB); Chosun University
RP Kim, SK (corresponding author), Chungnam Natl Univ, Coll Pharm & RCTCP, 220 Gung Dong, Taejon 305764, South Korea.
EM sangkim@cnu.ac.kr
OI Song, Gyu Yong/0000-0001-6058-5790; Kim, Sang Kyum/0000-0001-5769-0792;
   Myung, Chang-Seon/0000-0002-6292-2911
FU Engineering Research Center [R11-2002-100-00000-0]; Korea Government
   (MEST) [2009-0093815]
FX This work was supported by Engineering Research Center program (grant
   R11-2002-100-00000-0) and by Priority Research Centers Program
   (2009-0093815) through the Research Foundation of Korea (NRF) grant
   funded by the Korea Government (MEST).
CR BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8
   Chen JJ, 2003, ENVIRON TOXICOL, V18, P115, DOI 10.1002/tox.10107
   Ching KZ, 1996, DRUG METAB DISPOS, V24, P542
   Chovan JP, 2007, XENOBIOTICA, V37, P459, DOI 10.1080/00498250701245250
   Cotreau MM, 2000, J PHARMACOL TOX MET, V43, P41, DOI 10.1016/S1056-8719(00)00086-1
   De Smet K, 2001, BIOCHEM PHARMACOL, V61, P1293, DOI 10.1016/S0006-2952(01)00612-8
   Donato MT, 1998, J PHARMACOL EXP THER, V284, P760
   Estabrook R W, 1978, Methods Enzymol, V52, P212
   Garcia MC, 2001, DRUG METAB DISPOS, V29, P111
   GONZALEZ FJ, 1986, MOL CELL BIOL, V6, P2969, DOI 10.1128/MCB.6.8.2969
   Hirata H, 2008, CANCER-AM CANCER SOC, V112, P1964, DOI 10.1002/cncr.23392
   Iber H, 1998, DRUG METAB DISPOS, V26, P1042
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   Kakizaki S, 2007, LIVER INT, V27, P109, DOI 10.1111/j.1478-3231.2006.01384.x
   Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004
   KITADA M, 1991, JPN J CANCER RES, V82, P426, DOI 10.1111/j.1349-7006.1991.tb01866.x
   Kobayashi K, 2002, BIOCHEM PHARMACOL, V63, P889, DOI 10.1016/S0006-2952(01)00843-7
   KOOP DR, 1986, MOL PHARMACOL, V29, P399
   Liptrott NJ, 2009, BRIT J PHARMACOL, V156, P497, DOI 10.1111/j.1476-5381.2008.00050.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAEDA K, 1984, BIOCHEM PHARMACOL, V33, P509, DOI 10.1016/0006-2952(84)90252-1
   OMIECINSKI CJ, 1990, CANCER RES, V50, P4315
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Pondugula SR, 2009, EXPERT OPIN DRUG MET, V5, P861, DOI 10.1517/17425250903012360
   SCHENKMAN JB, 1989, DRUG METAB REV, V20, P557, DOI 10.3109/03602538909103562
   SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5
   Strobel H W, 1978, Methods Enzymol, V52, P89
   Tani Y, 1999, TOXICOL LETT, V106, P159, DOI 10.1016/S0378-4274(99)00055-7
   Turpeinen M, 2007, XENOBIOTICA, V37, P1367, DOI 10.1080/00498250701658312
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
   WAXMAN DJ, 1984, J BIOL CHEM, V259, P5481
NR 33
TC 46
Z9 52
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD DEC
PY 2010
VL 84
IS 12
BP 939
EP 946
DI 10.1007/s00204-010-0520-1
PG 8
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 684ZQ
UT WOS:000284594200005
PM 20130842
DA 2024-02-19
ER

PT J
AU Jiang, CH
   Chen, HX
   Kang, YQ
   He, XY
   Huang, JY
   Lu, TY
   Sui, X
   Chen, HT
   Xiao, JQ
   Zhang, JB
   Zhang, HW
   Zheng, J
   Yang, Y
   Yao, J
   Cai, JY
   Zhang, YC
AF Jiang, Chenhao
   Chen, Huaxin
   Kang, Yinqian
   He, Xinyi
   Huang, Jianyang
   Lu, Tongyu
   Sui, Xin
   Chen, Haitian
   Xiao, Jiaqi
   Zhang, Jiebin
   Zhang, Hanwen
   Zheng, Jun
   Yang, Yang
   Yao, Jia
   Cai, Jianye
   Zhang, Yingcai
TI Administration of AG490 decreases the senescence of umbilical
   cord-mesenchymal stem cells and promotes the cytotherapeutic effect in
   liver fibrosis
SO CELL DEATH DISCOVERY
LA English
DT Article
ID CELLULAR SENESCENCE; MECHANISMS; THERAPIES; CIRRHOSIS; DISEASE
AB The therapeutic potential of umbilical cord-mesenchymal stem cell (UC-MSC) transplantation in liver fibrosis has been highlighted. However, the fate of transplanted MSCs in the fibrotic microenvironment remains unclear. In this study, we aim to uncover the fate of transplanted MSCs and develop targeting strategies that could enhance the therapeutic efficacy of MSC therapy in liver fibrosis. We used human UC-MSCs as the study object. For in vitro experiments, we stimulated UC-MSCs with several fibrotic-related factors (Liver fibrotic Factors, LF), including TGF & beta;, TNF & alpha; and IFN & gamma; for downstream investigations. We co-cultured LF-treated UC-MSCs with hepatic stellate cell line LX-2 to assess the anti-fibrotic effect. We showed that upon LF stimulation, UC-MSCs exhibited reduced anti-fibrotic activity and underwent rapid senescence. Pathway analysis showed that JAK/STAT3 signaling was highly activated upon LF stimulation, which significantly elevated senescence-associated secretory phenotype (SASP) and senescence in UC-MSCs and could be reversed by a specific JAK inhibitor AG490. Moreover, using both carbon tetrachloride (CCl4) and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induce fibrosis models, we demonstrated that AG490 pretreatment promoted UC-MSCs survival within the fibrotic liver microenvironment and exhibited enhance therapeutic efficacy. Overall, we showed that targeting MSC senescence in vivo through AG490 pretreatment could enhance the anti-fibrotic activities of UC-MSCs.
C1 [Jiang, Chenhao; Lu, Tongyu; Chen, Haitian; Xiao, Jiaqi; Zhang, Jiebin; Zheng, Jun; Yang, Yang; Yao, Jia; Cai, Jianye; Zhang, Yingcai] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou, Peoples R China.
   [Jiang, Chenhao; Lu, Tongyu; Chen, Haitian; Xiao, Jiaqi; Zhang, Jiebin; Zheng, Jun; Yang, Yang; Yao, Jia; Cai, Jianye; Zhang, Yingcai] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou, Peoples R China.
   [Jiang, Chenhao; Lu, Tongyu; Chen, Haitian; Xiao, Jiaqi; Zhang, Jiebin; Zheng, Jun; Yang, Yang; Yao, Jia; Cai, Jianye; Zhang, Yingcai] Guangdong Engn Lab Transplantat, Guangdong Key Lab Liver Dis Res, Guangzhou, Peoples R China.
   [Chen, Huaxin] Sun Yat Sen Univ, Affiliated Hosp 3, Biotherapy Ctr, Guangzhou, Peoples R China.
   [Kang, Yinqian] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.
   [He, Xinyi; Huang, Jianyang] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Peoples R China.
   [Sui, Xin] Sun Yat Sen Univ, Affiliated Hosp 3, Surg ICU, Guangzhou, Peoples R China.
   [Zhang, Hanwen] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30309 USA.
C3 Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University;
   State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen
   University; Sun Yat Sen University; Emory University
RP Yao, J; Cai, JY; Zhang, YC (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou, Peoples R China.; Yao, J; Cai, JY; Zhang, YC (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou, Peoples R China.; Yao, J; Cai, JY; Zhang, YC (corresponding author), Guangdong Engn Lab Transplantat, Guangdong Key Lab Liver Dis Res, Guangzhou, Peoples R China.
EM yaojia6@mail.sysu.edu.cn; caijy23@mail.sysu.edu.cn;
   zhangyc3@mail.sysu.edu.cn
RI liu, peng/JSL-1931-2023; zhang, hanwen/JDX-0906-2023
FU National Natural Science Foundation of China [82170631, 82100663,
   81970567, 82100693, 82270689]; Guangdong Natural Science Foundation
   [2020A1515110687, 2023A1515010160, 2023A1515030052, 2021A1515012136,
   2021A1515010571, 2021A1515111058, 2022A1515012331, 2022A1515012453];
   Sci-tech Research Development Program of Guangdong province
   [2019B020236003]; China Postdoctoral Science Foundation [2021M700174]
FX This work was supported by the grants from the National Natural Science
   Foundation of China (82170631, 82100663, 81970567, 82100693, 82270689),
   Guangdong Natural Science Foundation (2020A1515110687, 2023A1515010160,
   2023A1515030052, 2021A1515012136, 2021A1515010571, 2021A1515111058,
   2022A1515012331, 2022A1515012453), Sci-tech Research Development Program
   of Guangdong province (2019B020236003), China Postdoctoral Science
   Foundation (2021M700174).
CR Alfaifi M, 2018, J HEPATOL, V68, P1272, DOI 10.1016/j.jhep.2018.01.030
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Christ B, 2015, TRENDS MOL MED, V21, P673, DOI 10.1016/j.molmed.2015.09.004
   Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x
   Görg B, 2019, J HEPATOL, V71, P930, DOI 10.1016/j.jhep.2019.06.020
   Haldar D, 2016, FASEB J, V30, P3905, DOI 10.1096/fj.201600433R
   Han YS, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12535
   Hu CX, 2019, J CELL MOL MED, V23, P1657, DOI 10.1111/jcmm.14115
   Hubackova S, 2010, CELL CYCLE, V9, P3085, DOI 10.4161/cc.9.15.12521
   Ji J, 2017, ACTA BIOCH BIOPH SIN, V49, P208, DOI 10.1093/abbs/gmw134
   Kawamura H, 2018, STEM CELL REP, V10, P920, DOI 10.1016/j.stemcr.2018.01.030
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Liu XB, 2009, J CELL BIOCHEM, V106, P903, DOI 10.1002/jcb.22064
   Lu LL, 2006, HAEMATOLOGICA, V91, P1017
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Pourgholaminejad A, 2016, CYTOKINE, V85, P51, DOI 10.1016/j.cyto.2016.06.003
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Salama H, 2014, STEM CELL RES THER, V8, DOI 10.1186/scrt459
   Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182
   Tang WP, 2015, J GASTROEN HEPATOL, V30, P1065, DOI 10.1111/jgh.12893
   Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007
   Vainshtein JM, 2014, INT J RADIAT ONCOL, V89, P786, DOI 10.1016/j.ijrobp.2014.02.017
   Volarevic V, 2014, STEM CELLS, V32, P2818, DOI 10.1002/stem.1818
   Wang HY, 2020, J CELL PHYSIOL, V235, P2722, DOI 10.1002/jcp.29176
   Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21
   Zhang Z, 2013, J HEPATOL, V59, P183, DOI 10.1016/j.jhep.2013.01.018
NR 29
TC 1
Z9 1
U1 2
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2058-7716
J9 CELL DEATH DISCOV
JI Cell Death Discov.
PD JUL 28
PY 2023
VL 9
IS 1
AR 273
DI 10.1038/s41420-023-01546-3
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA N8UO5
UT WOS:001039701000002
PM 37507381
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zs-Nagy, I
   Tanaka, S
   Kitani, K
AF Zs-Nagy, I
   Tanaka, S
   Kitani, K
TI Comparison of the lateral diffusion coefficient of hepatocyte plasma
   membrane proteins in three strains of sensescence accelerated mouse
   (SAM)
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE protein lateral mobility; hepatocyte plasma membrane; smear-FRAP
   technique; peroxide induced fluorescence (PIAF) label; senescence
   accelerated mouse (SAM); aging models
ID FLUORESCENCE PHOTOBLEACHING RECOVERY; NEURO-BLASTOMA CELLS; MURINE
   MODEL; AGE-DEPENDENCE; MUSCLE MEMBRANE; MOBILITY; SENESCENCE; LIPIDS;
   MICE; RATS
AB The lateral diffusion coefficients of proteins (D-p) were measured in hepatocyte plasma membrane in freshly prepared liver smears by means of the fluorescence recovery after photobleaching (FRAP) method. D-p was measured after development of peroxide-induced autofluorescence (PIAF) in a total of 115 senescence accelerated mice (SAM), distributed in three strains. at least five age-groups in each, as follows: (i) SAMR1TA (25 males and 22 females), medium life span (MLS) in months, under specific pathogen free (SPF) conditions, MLSspf 20.1 and 20.01 respectively, while under conventional conditions, MLSDelta pf = 18.9 in average for both sexes; (ii) SAMP6/Ta (18 males and 17 females), MLSspf = 17.1 and 15.3, respectively, and MLScc = 8.1 for both sexes; (iii) SAMP6/Ta (17 males and 16 females), MLSspf = 15.6 and 14.7, respectively, and MLScc = 10.0 for both sexes. A highly significant negative linear age-correlation of D-p (R = 0.975 or higher) was found in each strain, being roughly proportional with the MLScc values. Since the studied mice kept under SPF conditions survived longer, than under conventional conditions, the actual age-dependent decay rates of D-p values did not differ significantly in two pairs of comparisons (female R1/P6 and female R1/P8), whereas they did in all other possible pairs, including also the normal C57BL/6 mice. The main conclusion can be drawn that the D-p of hepatocyte membranes is a good biomarker of aging and survival also in SAM, as in all other inbred and outbred rodents, studied so far. (C) 2001 Elsevier Science ireland Ltd. All rights reserved.
C1 Natl Inst Longev Sci, Obu, Aichi 4748522, Japan.
RP Zs-Nagy, I (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Gerontol, VILEG Hungarian Sect, POB 50, H-4012 Debrecen, Hungary.
EM izsnagy@jaguar.dote.hu
CR AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   Damjanovich S., 1994, MOBILITY PROXIMITY B
   DAWSON RMC, 1969, DATA BIOCH RES, P507
   DELAAT SW, 1979, BIOCHIM BIOPHYS ACTA, V558, P247, DOI 10.1016/0005-2736(79)90064-6
   DELAAT SW, 1980, P NATL ACAD SCI-BIOL, V77, P1526
   DRAGSTEN P, 1979, P NATL ACAD SCI USA, V76, P5163, DOI 10.1073/pnas.76.10.5163
   Fujisawa H, 1999, J GERONTOL A-BIOL, V54, pB276, DOI 10.1093/gerona/54.7.B276
   GEIGER B, 1983, BIOCHIM BIOPHYS ACTA, V737, P305, DOI 10.1016/0304-4157(83)90005-9
   GOLAN DE, 1980, P NATL ACAD SCI-BIOL, V77, P2537, DOI 10.1073/pnas.77.5.2537
   Hosokawa M, 1999, NEUROBIOL AGING, V20, P117, DOI 10.1016/S0197-4580(99)00029-9
   Hosokawa M., 1998, J ANTI-AGING MED, V1, P27, DOI [10.1089/rej.1.1998.1.27, DOI 10.1089/REJ.1.1998.1.27]
   JACOBSON K, 1984, J CELL BIOL, V99, P1624, DOI 10.1083/jcb.99.5.1624
   Kitani K, 1999, MECH AGEING DEV, V107, P299, DOI 10.1016/S0047-6374(98)00139-0
   Kitani K, 1998, ARCH GERONTOL GERIAT, V26, P257, DOI 10.1016/S0167-4943(98)00008-9
   KLEINFELD AM, 1981, BIOCHIM BIOPHYS ACTA, V649, P471, DOI 10.1016/0005-2736(81)90438-7
   Nagy IZ, 1999, EXP BRAIN RES, V124, P233, DOI 10.1007/s002210050618
   NAGY VZ, 1988, TISSUE CELL, V20, P229, DOI 10.1016/0040-8166(88)90044-4
   Nishikawa T, 1998, NEUROSCI LETT, V254, P69, DOI 10.1016/S0304-3940(98)00646-6
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   PETTY HR, 1980, P NATL ACAD SCI-BIOL, V77, P6587, DOI 10.1073/pnas.77.11.6587
   SCHLESSINGER J, 1976, P NATL ACAD SCI USA, V73, P2409, DOI 10.1073/pnas.73.7.2409
   SCHLESSINGER J, 1977, P NATL ACAD SCI USA, V74, P2909, DOI 10.1073/pnas.74.7.2909
   SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0
   SHIMITZKY M, 1994, BIOMEMBRANES, V2
   Snedecor GW, 1980, STAT METHODOL, V7th, P39
   SU YX, 1984, BIOCHIM BIOPHYS ACTA, V776, P92, DOI 10.1016/0005-2736(84)90254-2
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   TAKEDA T, 1994, INT CONGR SER, V1062, P15
   Tanaka S, 2000, ARCH GERONTOL GERIAT, V30, P215, DOI 10.1016/S0167-4943(00)00053-4
   TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207
   WODA BA, 1979, J IMMUNOL, V123, P2161
   WU ES, 1982, P NATL ACAD SCI-BIOL, V79, P4962, DOI 10.1073/pnas.79.16.4962
   Xia C, 1999, MAMM GENOME, V10, P235, DOI 10.1007/s003359900979
   YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7
   Zs-Nagy I, 1998, MECH AGEING DEV, V101, P257, DOI 10.1016/S0047-6374(97)00179-6
   Zs-Nagy I., 1994, MEMBRANE HYPOTHESIS
   ZSNAGY I, 1993, J GERONTOL, V48, pB86, DOI 10.1093/geronj/48.3.B86
   ZSNAGY I, 1989, J GERONTOL, V44, pB83, DOI 10.1093/geronj/44.4.B83
   ZSNAGY I, 1986, EXP GERONTOL, V21, P555, DOI 10.1016/0531-5565(86)90007-0
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZsNagy I, 1996, ARCH GERONTOL GERIAT, V23, P81, DOI 10.1016/0167-4943(96)00710-8
   ZSNAGY I, 2001, IN PRESS MECH AGEING, V107, P299
NR 46
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-APR
PY 2001
VL 32
IS 2
BP 119
EP 137
DI 10.1016/S0167-4943(01)00085-1
PG 19
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 429MK
UT WOS:000168520900005
PM 11313103
DA 2024-02-19
ER

PT J
AU TERAMOTO, S
   FUKUCHI, Y
   UEJIMA, Y
   TERAMOTO, K
   ORIMO, H
AF TERAMOTO, S
   FUKUCHI, Y
   UEJIMA, Y
   TERAMOTO, K
   ORIMO, H
TI INFLUENCES OF CHRONIC TOBACCO-SMOKE INHALATION ON AGING AND OXIDANT
   ANTIOXIDANT BALANCE IN THE SENESCENCE-ACCELERATED MOUSE (SAM)-P/2
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE SENESCENCE-ACCELERATED MOUSE (SAM); GLUTATHIONE (GSH); TOBACCO SMOKE;
   OXYGEN RADICAL; OXIDANT ANTIOXIDANT BALANCE; AGING
ID LIPID PEROXIDE LEVELS; AGE-RELATED-CHANGES; MURINE MODEL; SAM; MEMORY;
   RAT
AB We studied the influences of chronic tobacco exposure on aging and oxidant-antioxidant balance in two different strains of mice, hitherto called SAM (senescence-accelerated mice). One is a senescence-prone strain, ''SAM-P/2,'' and another is a senescence-resistant strain, ''SAM-R/1.'' We used 100 male mice-20 young (12 weeks of age) mice and 30 mature (24 weeks of age) mice from each strain. Half of each series were housed in a Hamburg II machine and exposed to tobacco smoke inhalation for five weeks. The result was that fewer of the mature SAM-P/2 survived compared with the mature SAM-R/1 after chronic tobacco inhalation. The grading of senility in the mature SAM-P/2 was also significantly higher than that in the mature SAM-R/1. The reduction of glutathione contents of blood and liver after tobacco exposure in the mature SAM-P/2 was greater than that in the young SAM-P/2 and the mature SAM-R/1. Moreover, oxygen radical generation of total blood cells stimulated by phorbol-myristate-acetate or opsonized zymosan showed a greater increase in the mature SAM-P/2 compared to the young SAM-P/2 and the mature SAM-R/1. These results indicate that the senescence-prone strain (SAM-P/2) was more susceptible to tobacco smoke exposure than the resistant strain (SAM-R/ 1). The impaired oxidant-antioxidant balance in the SAM-P/2 may therefore contribute to the process of senescence acceleration.
C1 TEIJIN LTD,TEIJIN INST BIOCHEM RES,BIOCHEM LAB,IBARAKI,JAPAN.
C3 Teijin Limited
RP TERAMOTO, S (corresponding author), UNIV TOKYO,FAC MED,DEPT GERIATR,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN.
CR BADWEY JA, 1980, J CELL PHYSIOL, V105, P541, DOI 10.1002/jcp.1041050319
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Dontenwill W., 1967, BEITR TABAKFORSCH, V4, P45
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HOSOKAWA M, 1988, EXP EYE RES, V47, P629, DOI 10.1016/0014-4835(88)90100-5
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   KOMURA S, 1988, J CLIN BIOCHEM NUTR, V5, P255
   MATSUSHITA M, 1986, AM J PATHOL, V125, P276
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   NAGASE T, 1990, BIOCHEM BIOPH RES CO, V168, P485, DOI 10.1016/0006-291X(90)92347-3
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   YAGI K, 1988, J CLIN BIOCHEM NUTR, V5, P21
NR 19
TC 17
Z9 18
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN-FEB
PY 1993
VL 28
IS 1
BP 87
EP 95
DI 10.1016/0531-5565(93)90023-7
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KG131
UT WOS:A1993KG13100008
PM 8436207
DA 2024-02-19
ER

PT J
AU Hu, YQ
   Wang, R
   Wang, SW
   Yuan, CF
   Yuan, Q
   Zhang, YF
   Ren, JX
   He, YM
   Wu, XS
   Dai, WJ
   Wang, WY
   Xie, SJ
AF Hu, Yaqi
   Wang, Rui
   Wang, Shuwen
   Yuan, Chengfu
   Yuan, Qi
   Zhang, Yifan
   Ren, Jianxia
   He, Yumin
   Wu, Xiaoshan
   Dai, Wenjun
   Wang, Wenyong
   Xie, Shijun
TI Selenium-enriched Polysaccharides from <i>Pyracantha fortuneana</i>
   (SePFP) Ameliorated Hepatic Lipid Accumulation through Enhancing
   Mitochondrial Fatty Acid β-Oxidation in Aging Mice
SO JOURNAL OF OLEO SCIENCE
LA English
DT Article; Early Access
DE selenium-enriched polysaccharides from Pyracantha fortuneana (SePFP);
   aging; respiratory quotient; lipid catabolism; mitochondria;
   beta-oxidation
ID LIVER-DISEASE; METABOLISM
AB Selenium-enriched polysaccharides from Pyracantha fortuneana ( SePFP) has many beneficial physiological activities, but how it improves the aging associated abnormal lipid metabolism is still unclear. Therefore, we explored the mechanisms of the regulatory role of SePFP on liver lipid accumulation in aging mice. Methods: 60 naturally aged C57BL/6J male mice were divided into 6 groups: adult group, aging group (21-month-old mice), aging mice treated with low-, medium- and high-doses of SePFP (SePFP-L, SePFP-M, SePFP-H), and aging mice treated with resveratrol (RSV). SePFP and RSV were administrated daily via oral gavage from 16 to 21 months old. The parameters of energy metabolism were measured in all mice before sacrifice, and liver tissues were collected to determine the levels of metabolism-related enzymes by real-time PCR and Western blot. Results: We found that SePFP significantly reduced the body weight, liver to bodyweight ratio, and white fat to body weight ratio in aging mice. SePFP also down-regulated the triglycerides and cholesterol levels in liver and serum, and decreased respiratory quotient in aging mice. The mechanism of SePFP regulating lipid metabolism was mainly through promoting fatty acid transportation to mitochondria and enhancing mitochondrial beta-oxidation and ketone body production. Conclusion: SePFP attenuates liver lipid deposition in aging mice by enhancing hepatic mitochondrial beta-oxidation.
C1 [Hu, Yaqi; Wang, Rui; Wang, Shuwen; Yuan, Chengfu; Zhang, Yifan] China Three Gorges Univ, Coll Basic Med Sci, Yichang 443002, Peoples R China.
   [Yuan, Chengfu; Ren, Jianxia] China Three Gorges Univ, Hubei Prov Clin Res Ctr Precise Prevent & Treatmen, Peoples Hosp 2, Yichang 443002, Peoples R China.
   [Yuan, Qi; He, Yumin] China Three Gorges Univ, Coll Med & Hlth Sci, Yichang 443002, Peoples R China.
   [Wu, Xiaoshan; Dai, Wenjun; Wang, Wenyong] Chongqing Redjoy Hlth Ind Grp Co Ltd, Chongqing 409600, Peoples R China.
   [Xie, Shijun] Second Peoples Hosp Wufeng Tujia Autonomous Cty, Dept Gastroenterol, Yichang 443400, Peoples R China.
C3 China Three Gorges University; China Three Gorges University; China
   Three Gorges University
RP Zhang, YF (corresponding author), China Three Gorges Univ, Coll Basic Med Sci, Yichang 443002, Peoples R China.; Ren, JX (corresponding author), China Three Gorges Univ, Hubei Prov Clin Res Ctr Precise Prevent & Treatmen, Peoples Hosp 2, Yichang 443002, Peoples R China.; He, YM (corresponding author), China Three Gorges Univ, Coll Med & Hlth Sci, Yichang 443002, Peoples R China.
EM specialyifan@yeah.net; 495489045@qq.com; hym0811@163.com
RI LIU, YU/HTR-1607-2023
FU central government guides the special funds for the development of local
   science and technology [2020ZYYD016]; Open Fund Projects of Hubei
   Provincial Clinical Research Center for Precise Prevention and Treatment
   of Elderly Gastrointestinal Cancer amp; The Second People's Hospital of
   China Three Gorges University [2022EGC-01]
FX This work was supported by the grants from central government guides the
   special funds for the development of local science and technology (Grant
   No. 2020ZYYD016 to C.F. Yuan) , and the Open Fund Projects of Hubei
   Provincial Clinical Research Center for Precise Prevention and Treatment
   of Elderly Gastrointestinal Cancer & The Second People's Hospital of
   China Three Gorges University (Grant No. 2022EGC-01 to C.F. Yuan) .
CR Bonzón-Kulichenko E, 2018, J GERONTOL A-BIOL, V73, P1139, DOI 10.1093/gerona/gly081
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042
   Filip R, 2018, CLIN INTERV AGING, V13, P1879, DOI 10.2147/CIA.S170533
   Forni C, 2019, BIOMED RES INT-UK, V2019, DOI 10.1155/2019/8748253
   Frank AP, 2019, J LIPID RES, V60, P1710, DOI 10.1194/jlr.R086975
   Gai HY, 2020, J FOOD SCI, V85, P4050, DOI 10.1111/1750-3841.15482
   GARDNER ID, 1980, REV INFECT DIS, V2, P801
   Gimeno-Mallench L, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109130
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Hänfling B, 2016, MOL ECOL, V25, P3101, DOI 10.1111/mec.13660
   Kim JE, 2012, BIOL TRACE ELEM RES, V150, P360, DOI 10.1007/s12011-012-9519-1
   Longo KA, 2010, AM J PHYSIOL-REG I, V298, pR747, DOI 10.1152/ajpregu.00476.2009
   O'Toole PW, 2018, CELL MOL LIFE SCI, V75, P119, DOI 10.1007/s00018-017-2673-z
   Peng F, 2016, MOLECULES, V21, DOI 10.3390/molecules21121731
   Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9
   Schrauzer GN, 2001, J AM COLL NUTR, V20, P1
   Sun QL, 2016, ONCOTARGET, V7, P28369, DOI 10.18632/oncotarget.8619
   Sun YX, 2009, INT J BIOL MACROMOL, V44, P14, DOI 10.1016/j.ijbiomac.2008.09.010
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774
   Wang SY, 2018, PROG CARDIOVASC DIS, V61, P182, DOI 10.1016/j.pcad.2018.07.011
   Wesselink E, 2019, CLIN NUTR, V38, P982, DOI 10.1016/j.clnu.2018.08.032
   Xie JH, 2016, CRIT REV FOOD SCI, V56, pS60, DOI 10.1080/10408398.2015.1069255
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yao YL, 2020, INT J BIOL MACROMOL, V150, P1162, DOI 10.1016/j.ijbiomac.2019.10.125
   Yuan CF, 2016, NUTR RES, V36, P1243, DOI 10.1016/j.nutres.2016.09.012
   Yuan CF, 2015, MED CHEM, V11, P780, DOI 10.2174/1573406411666150602153357
   Yuan CF, 2015, J SCI FOOD AGR, V95, P3211, DOI 10.1002/jsfa.7287
   Zapletal C, 2008, MICROVASC RES, V76, P104, DOI 10.1016/j.mvr.2008.04.005
NR 30
TC 0
Z9 0
U1 5
U2 5
PU JAPAN OIL CHEMISTS SOC
PI TOKYO
PA YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO,
   103-0027, JAPAN
SN 1345-8957
EI 1347-3352
J9 J OLEO SCI
JI J. Oleo Sci.
PD 2023 
PY 2023
VL 72
IS 10
BP 929
EP 938
DI 10.5650/jos.ess23065
EA SEP 2023
PG 10
WC Chemistry, Applied; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology
GA U0XD7
UT WOS:001071046200001
PM 37704444
OA gold
DA 2024-02-19
ER

PT J
AU Bloomer, SA
   Moyer, ED
   Brown, KE
   Kregel, KC
AF Bloomer, Steven A.
   Moyer, Eric D.
   Brown, Kyle E.
   Kregel, Kevin C.
TI Aging results in accumulation of M1 and M2 hepatic macrophages and a
   differential response to gadolinium chloride
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article; Early Access
DE Fluorescence microscopy; Immunolabelling; iNOS; Kupffer cells; Oxidative
   stress; Inflammation
ID NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; KUPFFER CELLS; OXIDATIVE
   STRESS; IN-VIVO; RAT-LIVER; EXPRESSION; ACTIVATION; PHAGOCYTOSIS;
   PROTEIN
AB Macrophages have vital roles in innate immunity by modulating the inflammatory response via their ability to alter their phenotype from pro-inflammatory (M1) to anti-inflammatory (M2). Aging increases activation of the innate immune system, and macrophage numbers increase in the aged liver. Since macrophages also produce free radical molecules, they are a potential source of age-related oxidative injury in the liver. This study evaluated macrophage phenotype in the aged liver and whether the increase in the number of macrophages with aging is associated with enhanced hepatic oxidative stress. Hepatic macrophage phenotype and oxidative stress were evaluated 2 days after a single intraperitoneal injection of saline or gadolinium chloride (GdCl3, 10 mg/kg) in young (6 months) and aged (24 months) Fischer 344 rats. GdCl3 has been shown to decrease the expression of macrophage-specific markers and impair macrophage phagocytosis in the liver. Saline-treated aged rats demonstrated greater numbers of both M1 (HO-1(+)/iNOS(+)) and M2 (HO-1(+)/CD163(+)) macrophages, without evidence of a phenotypic shift. GdCl3 did not alter levels of dihydroethidium fluorescence or malondialdehyde, suggesting that macrophages are not a major contributor to steady-state levels of oxidative stress. However, GdCl3 decreased M1 and M2 macrophage markers in both age groups, an effect that was attenuated in aged rats. In old animals, GdCl3 decreased iNOS expression to a greater extent than HO-1 or CD163. These results suggest a novel effect of aging on macrophage biology and that GdCl3 shifts hepatic macrophage polarization to the M2 phenotype in aged animals.
C1 [Bloomer, Steven A.; Moyer, Eric D.] Penn State Univ, Abington Coll, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
   [Brown, Kyle E.] Iowa City Vet Adm Med Ctr, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Univ Iowa, Div Gastroenterol Hepatol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.
   [Brown, Kyle E.] Univ Iowa, Program Free Radical & Radiat Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.
   [Kregel, Kevin C.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; University of Iowa; University of Iowa;
   University of Iowa
RP Bloomer, SA (corresponding author), Penn State Univ, Abington Coll, Div Sci & Engn, 1600 Woodland Rd, Abington, PA 19001 USA.
EM sab320@psu.edu
OI Brown, Kyle/0000-0002-8206-036X
FU Penn State Abington; Schreyer Honors College of the Pennsylvania State
   University; Erickson Summer Discovery Grant from the Office of
   Undergraduate Research at Penn State; NIH [AG12350]
FX SAB was supported by a Faculty Development Grant from Penn State
   Abington. EDM was supported by research funds from the Schreyer Honors
   College of the Pennsylvania State University, and an Erickson Summer
   Discovery Grant from the Office of Undergraduate Research at Penn State.
   This work was also supported by NIH grant AG12350 to KCK. No funding
   source had a role in study design, data collection, analysis or
   interpretation of the data, in the writing of the final report, or the
   decision to submit the article for publication.
CR Amanzada A, 2014, LAB INVEST, V94, P235, DOI 10.1038/labinvest.2013.134
   Bauer I, 1998, HEPATOLOGY, V27, P829, DOI 10.1002/hep.510270327
   BIAGI BA, 1990, AM J PHYSIOL, V259, pC515, DOI 10.1152/ajpcell.1990.259.3.C515
   Bloomer SA, 2020, J GERONTOL A-BIOL, V75, P680, DOI 10.1093/gerona/glz055
   Bloomer SA, 2009, J GERONTOL A-BIOL, V64, P419, DOI 10.1093/gerona/gln056
   BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549
   BOSCA L, 1994, J EXP MED, V179, P1119, DOI 10.1084/jem.179.4.1119
   BROUWER A, 1986, ARCH GERONTOL GERIAT, V5, P317, DOI 10.1016/0167-4943(86)90034-8
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Elmore MRP, 2018, AGING CELL, V17, DOI 10.1111/acel.12832
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Fukuda M, 2004, J GASTROEN HEPATOL, V19, P1155, DOI 10.1111/j.1440-1746.2004.03408.x
   Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324
   Haak JL, 2009, AM J PHYSIOL-REG I, V296, pR812, DOI 10.1152/ajpregu.90708.2008
   HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296
   Harrison-Findik DD, 2009, AM J PHYSIOL-GASTR L, V296, pG112, DOI 10.1152/ajpgi.90550.2008
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   HUSZTIK E, 1980, BRIT J EXP PATHOL, V61, P624
   IIMURO Y, 1994, J LEUKOCYTE BIOL, V55, P723, DOI 10.1002/jlb.55.6.723
   Isidro RA, 2015, HISTOCHEM CELL BIOL, V144, P613, DOI 10.1007/s00418-015-1364-9
   Jackaman C, 2013, AGING CELL, V12, P345, DOI 10.1111/acel.12062
   JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Khan HA, 2016, EXP TOXICOL PATHOL, V68, P381, DOI 10.1016/j.etp.2016.05.006
   Klein AD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113599
   KNOOK DL, 1989, IMMUNOL INVEST, V18, P339
   Lee CM, 2004, INT J BIOCHEM CELL B, V36, P481, DOI 10.1016/j.biocel.2003.08.004
   Maeso-Díaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   METZGER Z, 1981, J IMMUNOL, V127, P1109
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   OSWALD IP, 1992, J IMMUNOL, V148, P3578
   Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10
   Pilkington SM, 2019, BRIT J DERMATOL, V180, P849, DOI 10.1111/bjd.17268
   Rai RM, 1996, SHOCK, V6, P243, DOI 10.1097/00024382-199610000-00003
   RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858
   Roland CR, 1996, J LEUKOCYTE BIOL, V60, P487, DOI 10.1002/jlb.60.4.487
   Ruttinger D, 1996, J HEPATOL, V25, P960, DOI 10.1016/S0168-8278(96)80302-3
   Sholomskas Leslee M, 2015, Int J Physiol Pathophysiol Pharmacol, V7, P14
   Smallwood HS, 2011, BIOCHEMISTRY-US, V50, P9911, DOI 10.1021/bi2011866
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Videla LA, 2001, REDOX REP, V6, P155, DOI 10.1179/135100001101536265
   VOMEL T, 1984, Z GERONTOL, V17, P69
   Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   Wong CK, 2017, J IMMUNOL, V199, P1060, DOI 10.4049/jimmunol.1700397
   XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522
   Yan BC, 2010, AM J SURG PATHOL, V34, P1147, DOI 10.1097/PAS.0b013e3181e5dffa
   YU SF, 1990, J LEUKOCYTE BIOL, V48, P412, DOI 10.1002/jlb.48.5.412
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zhong SP, 2012, J BIOL CHEM, V287, P32078, DOI 10.1074/jbc.M112.377358
   Zhu FY, 2015, ONCOL REP, V34, P2643, DOI 10.3892/or.2015.4268
   Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698
NR 56
TC 15
Z9 16
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD 2020 JAN
PY 2020
VL 153
IS 1
BP 37
EP 48
DI 10.1007/s00418-019-01827-y
EA NOV 2019
PG 12
WC Cell Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Microscopy
GA LJ6WG
UT WOS:000494386700001
PM 31691025
DA 2024-02-19
ER

PT J
AU Tammen, SA
   Dolnikowski, GG
   Ausman, LM
   Liu, ZH
   Sauer, J
   Friso, S
   Choi, SW
AF Tammen, Stephanie A.
   Dolnikowski, Gregory G.
   Ausman, Lynne M.
   Liu, Zhenhua
   Sauer, Julia
   Friso, Simonetta
   Choi, Sang-Woon
TI Aging and Alcohol Interact to Alter Hepatic DNA Hydroxymethylation
SO ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE Aging; Alcohol; DNA Hydroxymethylation; Liver; Mouse
ID EPIGENETIC REGULATION; OXIDATIVE STRESS; 5-HYDROXYMETHYLCYTOSINE;
   METHYLATION; ETHANOL; CONSUMPTION; CYP2E1; RAT; 5-METHYLCYTOSINE;
   EXPRESSION
AB Background: Aging and chronic alcohol consumption are both modifiers of DNA methylation, but it is not yet known whether chronic alcohol consumption also alters DNA hydroxymethylation, a newly discovered epigenetic mark produced by oxidation of methylcytosine. Furthermore, it has not been tested whether aging and alcohol interact to modify this epigenetic phenomenon, thereby having an independent effect on gene expression.
   Methods: Old (18 months) and young (4 months) male C57BL/6 mice were pair-fed either a Lieber-DeCarli liquid diet with alcohol (18% of energy) or an isocaloric Lieber-DeCarli control diet for 5 weeks. Global DNA hydroxymethylation and DNA methylation were analyzed from hepatic DNA using a new liquid chromatography-tandem mass spectrometry method. Hepatic mRNA expression of the Tet enzymes were measured via quantitative real-time polymerase chain reaction.
   Results: In young mice, mild chronic alcohol exposure significantly reduced global DNA hydroxymethylation compared with control mice (0.22 +/- 0.01 vs. 0.29 +/- 0.06%, p = 0.004). Alcohol did not significantly alter hydroxymethylcytosine levels in old mice. Old mice fed the control diet showed decreased global DNA hydroxymethylation compared with young mice fed the control diet (0.24 +/- 0.02 vs. 0.29 +/- 0.06%, p = 0.04). This model suggests an interaction between aging and alcohol in determining DNA hydroxymethylation (p(interaction) = 0.009). Expression of Tet2 and Tet3 was decreased in the old mice relative to the young (p < 0.005).
   Conclusions: The observation that alcohol alters DNA hydroxymethylation indicates a new epigenetic effect of alcohol. This is the first study demonstrating the interactive effects of chronic alcohol consumption and aging on DNA hydroxymethylation.
C1 [Tammen, Stephanie A.; Dolnikowski, Gregory G.; Ausman, Lynne M.; Liu, Zhenhua; Sauer, Julia; Choi, Sang-Woon] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Tammen, Stephanie A.; Dolnikowski, Gregory G.; Ausman, Lynne M.; Choi, Sang-Woon] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
   [Liu, Zhenhua; Choi, Sang-Woon] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.
   [Friso, Simonetta] Univ Verona, Sch Med, I-37100 Verona, Italy.
   [Choi, Sang-Woon] CHA Univ, Sch Med, Chaum Life Ctr, Seoul 135948, South Korea.
C3 United States Department of Agriculture (USDA); Tufts University; Tufts
   University; University of Massachusetts System; University of
   Massachusetts Amherst; University of Verona; Pochon Cha University
RP Choi, SW (corresponding author), CHA Univ, Sch Med, Chaum Life Ctr, 442 Dosan Daero, Seoul 135948, South Korea.
EM sang.choi@cha.ac.kr
RI Friso, Simonetta/K-4715-2016; Dolnikowski, G/C-4354-2008
OI Dolnikowski, G/0000-0001-5886-2656
FU U.S. Department of Agriculture [51000-074-01S]; National Institute of
   Health [R21-AA016681, R01 AG025834]
FX This material is based upon work supported by the U.S. Department of
   Agriculture, under agreement No. 51000-074-01S. Any opinions, findings,
   conclusion, or recommendations expressed in this publication are those
   of the author (s) and do not necessarily reflect the view of the U. S.
   Department of Agriculture. This project has been supported in part by
   the National Institute of Health Grants R21-AA016681 and R01 AG025834
   (S-WC).
CR Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496
   Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z
   Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0
   Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975
   Chen H, 2012, RESTOR NEUROL NEUROS, V30, P237, DOI 10.3233/RNN-2012-110223
   Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206
   Choi SW, 1999, J NUTR, V129, P1945, DOI 10.1093/jn/129.11.1945
   Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021
   Cocozza S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023156
   DECARLI LM, 1967, J NUTR, V91, P331, DOI 10.1093/jn/91.3_Suppl.331
   Dzitoyeva S, 2012, NEUROBIOL AGING, V33, P2881, DOI 10.1016/j.neurobiolaging.2012.02.006
   Esfandiari F, 2010, HEPATOLOGY, V51, P932, DOI 10.1002/hep.23382
   Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008
   Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h
   Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367
   Haffner MC, 2011, ONCOTARGET, V2, P627
   Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303
   Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023
   Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223
   Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561
   Jurkowski TP, 2011, CHEMBIOCHEM, V12, P2543, DOI 10.1002/cbic.201100549
   Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x
   Li WW, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870726
   Lieber CS, 2004, HEPATOL RES, V28, P1, DOI 10.1016/j.hepres.2003.08.001
   Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517
   LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417
   Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514
   Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108
   Liu CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062828
   McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270
   Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008
   Münzel M, 2011, ANGEW CHEM INT EDIT, V50, P6460, DOI 10.1002/anie.201101547
   Novak RF, 2000, ARCH PHARM RES, V23, P267, DOI 10.1007/BF02975435
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655
   Sauer J, 2010, BRIT J NUTR, V104, P24, DOI 10.1017/S0007114510000322
   Selhub J, 2002, J Nutr Health Aging, V6, P39
   SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6
   Stickel F, 2000, ALCOHOL CLIN EXP RES, V24, P259, DOI 10.1097/00000374-200003000-00002
   Strauss W M, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0202s42
   Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54
   Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959
   Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   TRIMBLE KC, 1993, HEPATOLOGY, V18, P984, DOI 10.1002/hep.1840180433
   Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739
   Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123
   VANYUSHIN BF, 1973, BIOCHIM BIOPHYS ACTA, V299, P397, DOI 10.1016/0005-2787(73)90264-5
   Wauthier V, 2006, LIFE SCI, V79, P1913, DOI 10.1016/j.lfs.2006.06.046
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011
   Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156
NR 52
TC 20
Z9 22
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2993-7175
J9 ALCOHOL CLIN EXP RES
JI Alcohol Clin. Exp. Res.
PD AUG
PY 2014
VL 38
IS 8
BP 2178
EP 2185
DI 10.1111/acer.12477
PG 8
WC Substance Abuse
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse
GA AO2UQ
UT WOS:000341181900006
PM 25070523
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Dasuri, K
   Nguyen, A
   Zhang, L
   Fernandez-Kim, OS
   Bruce-Keller, AJ
   Blalock, BA
   De Cabo, R
   Keller, JN
AF Dasuri, Kalavathi
   Nguyen, Anhthao
   Zhang, Le
   Fernandez-Kim, Ok Sun
   Bruce-Keller, Annadora J.
   Blalock, Bradford A.
   De Cabo, Rafael
   Keller, Jeffrey N.
TI Comparison of rat liver and brain proteasomes for oxidative
   stress-induced inactivation: Influence of ageing and dietary restriction
SO FREE RADICAL RESEARCH
LA English
DT Article
DE 4-hydroxynonenal; ageing; brain; liver; oxidative stress; proteasome
ID HEPATIC STELLATE CELLS; 26S PROTEASOME; PROTEIN OXIDATION; 20S
   PROTEASOME; MITOCHONDRIAL-FUNCTION; DEGRADATION; INHIBITION; UBIQUITIN;
   RESISTANCE; COMPLEX
AB The present study examined brain and liver derived proteasome complexes to elucidate if there is a differential susceptibility in proteasome complexes from these tissues to undergo inactivation following exposure to oxidative stressors. It then examined the influence of ageing and dietary restriction (DR) on the observed proteasome inactivation. Studies used a filtration based methodology that allows for enrichment of proteasome complexes with less tissue than is required for traditional chromatography procedures. The results indicate that the brain has much lower levels of overall proteasome activity and exhibits increased sensitivity to hydrogen peroxide mediated inactivation as compared to proteasome complexes derived from the liver. Interestingly, the brain proteasome complexes did not appear to have increased susceptibility to 4-hydroxynonenal (HNE)-induced inactivation. Surprisingly, ageing and DR induced minimal effects on oxidative stress mediated proteasome inhibition. These results indicate that the brain not only has lower levels of proteasome activity compared to the liver, but is also more susceptible to inactivation following exposure to some (but certainly not all) oxidative stressors. This data also suggest that ageing and DR may not significantly modulate the resistance of the proteasome to inactivation in some experimental settings.
C1 [Dasuri, Kalavathi; Nguyen, Anhthao; Zhang, Le; Fernandez-Kim, Ok Sun; Bruce-Keller, Annadora J.; Blalock, Bradford A.; Keller, Jeffrey N.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
   [De Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; National Institutes of Health
   (NIH) - USA; NIH National Institute on Aging (NIA)
RP Keller, JN (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM jeffrey.keller@pbrc.edu
RI Keller, Jeffrey N/N-1975-2017; de Cabo, Rafael Carlos/E-7996-2010;
   Bruce-Keller, Annadora/N-1954-2017; DASURI, KALAVATHI/E-7381-2012; de
   Cabo, Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo,
   Rafael/0000-0002-3354-2442; keller, jeffrey/0000-0002-9892-7423
FU National Institute of Aging [AG0257701, AG029885]; NIA
FX This work was supported by grants from the National Institute of Aging
   (AG0257701, AG029885) and supported in part by the intramural program of
   the NIA.
CR Akaishi T, 1996, BIOCHEM MOL BIOL INT, V39, P1017
   Akaishi T, 1996, BRAIN RES, V722, P139, DOI 10.1016/0006-8993(96)00212-0
   Amici M, 2003, FREE RADICAL BIO MED, V34, P987, DOI 10.1016/S0891-5849(02)01369-2
   Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434
   Bonelli MA, 2008, BIOGERONTOLOGY, V9, P1, DOI 10.1007/s10522-007-9111-9
   Bossola M, 2008, BIOGERONTOLOGY, V9, P261, DOI 10.1007/s10522-008-9135-9
   Bowerman B, 2006, DEVELOPMENT, V133, P773, DOI 10.1242/dev.02276
   Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029
   Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V
   Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4
   Cecarini V, 2008, BRAIN RES, V1209, P8, DOI 10.1016/j.brainres.2008.03.003
   Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039
   Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048
   Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200
   Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200
   Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   DAHLMANN B, 1995, BIOCHEM J, V309, P195, DOI 10.1042/bj3090195
   Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185
   Deocaris CC, 2008, BIOGERONTOLOGY, V9, P269, DOI 10.1007/s10522-008-9136-8
   Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637
   Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P130, DOI 10.1089/ars.2006.8.130
   Ding QX, 2003, FEBS LETT, V546, P228, DOI 10.1016/S0014-5793(03)00582-9
   Dubiel W, 1998, ADV MOL CEL, V27, P129, DOI 10.1016/S1569-2558(08)60460-9
   Farout L, 2006, ANTIOXID REDOX SIGN, V8, P205, DOI 10.1089/ars.2006.8.205
   Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003
   Ferrington DA, 2004, FEBS LETT, V578, P217, DOI 10.1016/j.febslet.2004.11.003
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149
   Goto S, 2007, ANN NY ACAD SCI, V1100, P431, DOI 10.1196/annals.1395.048
   Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   Grune Tilman, 2003, Molecular Aspects of Medicine, V24, P195, DOI 10.1016/S0098-2997(03)00014-1
   Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8
   Kapphahn RJ, 2007, EXP EYE RES, V84, P646, DOI 10.1016/j.exer.2006.12.002
   Keller JN, 2006, AGEING RES REV, V5, P1, DOI 10.1016/j.arr.2005.06.002
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X
   Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1
   LEON TI, 2001, LIPIDS, V36, P589
   Li F, 2008, MECH AGEING DEV, V129, P515, DOI 10.1016/j.mad.2008.04.007
   Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845
   Maher JJ, 2001, SEMIN LIVER DIS, V21, P417, DOI 10.1055/s-2001-17555
   NANJI AA, 1993, AM J PATHOL, V142, P367
   Naujokat C, 2002, LAB INVEST, V82, P965, DOI 10.1097/01.LAB.0000022226.23741.37
   Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676
   Poppek D, 2006, ANTIOXID REDOX SIGN, V8, P173, DOI 10.1089/ars.2006.8.173
   Radák Z, 2002, EXP GERONTOL, V37, P1423, DOI 10.1016/S0531-5565(02)00116-X
   Rattan SIS, 2008, BIOL CHEM, V389, P267, DOI 10.1515/BC.2008.030
   Rattan SIS, 2006, FREE RADICAL RES, V40, P1230, DOI 10.1080/10715760600911303
   Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200
   Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200
   TANAHASHI N, 1993, ENZYME PROTEIN, V47, P241, DOI 10.1159/000468683
   Tanaka K, 1997, MOL BIOL REP, V24, P3, DOI 10.1023/A:1006876904158
   Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195
   TORRES C, 2003, J CELL PHYSL, V207, P845
   Torres CA, 2008, FREE RADICAL BIO MED, V44, P403, DOI 10.1016/j.freeradbiomed.2007.10.002
   Tsukamoto H, 1999, ALCOHOL CLIN EXP RES, V23, P911, DOI 10.1111/j.1530-0277.1999.tb04202.x
   Vigouroux S, 2004, MOL NEUROBIOL, V30, P201, DOI 10.1385/MN:30:2:201
   Wachsman JT, 1996, MUTAT RES-FUND MOL M, V350, P25, DOI 10.1016/0027-5107(95)00087-9
   Wang JS, 2006, CELL MOL IMMUNOL, V3, P255
   Widmer R, 2006, FREE RADICAL RES, V40, P1259, DOI 10.1080/10715760600911154
   Xiao BG, 1998, J NEUROL SCI, V157, P1, DOI 10.1016/S0022-510X(98)00049-5
   YOSHIMURA T, 1993, J STRUCT BIOL, V111, P200, DOI 10.1006/jsbi.1993.1050
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 70
TC 25
Z9 26
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PY 2009
VL 43
IS 1
BP 28
EP 36
AR PII 906226821
DI 10.1080/10715760802534812
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 423PZ
UT WOS:000264509500005
PM 19048434
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Aljobaily, N
   Viereckl, MJ
   Hydock, DS
   Aljobaily, H
   Wu, TY
   Busekrus, R
   Jones, B
   Alberson, J
   Han, YY
AF Aljobaily, Nouf
   Viereckl, Michael J.
   Hydock, David S.
   Aljobaily, Hend
   Wu, Tsung-Yen
   Busekrus, Raquel
   Jones, Brandon
   Alberson, Jammie
   Han, Yuyan
TI Creatine Alleviates Doxorubicin-Induced Liver Damage by Inhibiting Liver
   Fibrosis, Inflammation, Oxidative Stress, and Cellular Senescence
SO NUTRIENTS
LA English
DT Article
DE liver damage; doxorubicin; creatine; oxidative stress; senescence; liver
   fibrosis; inflammation
AB Background: Treatment with the chemotherapy drug doxorubicin (DOX) may lead to toxicities that affect non-cancer cells including the liver. Supplementing the diet with creatine (Cr) has been suggested as a potential intervention to minimize DOX-induced side effects, but its effect in alleviating DOX-induced hepatoxicity is currently unknown. Therefore, we aimed to examine the effects of Cr supplementation on DOX-induced liver damage. Methods: Male Sprague-Dawley rats were fed a diet supplemented with 2% Cr for four weeks, 4% Cr for one week followed by 2% Cr for three more weeks, or control diet for four weeks. Animals then received either a bolus i.p. injection of DOX (15 mg/kg) or saline as a placebo. Animals were then sacrificed five days-post injection and markers of hepatoxicity were analyzed using the liver-to-body weight ratio, aspartate transaminase (AST)-to- alanine aminotransferase (ALT) ratio, alkaline phosphatase (ALP), lipemia, and T-Bilirubin. In addition, hematoxylin and eosin (H&E) staining, Picro-Sirius Red staining, and immunofluorescence staining for CD45, 8-OHdG, and beta-galactosidase were performed to evaluate liver morphology, fibrosis, inflammation, oxidative stress, and cellular senescence, respectively. The mRNA levels for biomarkers of liver fibrosis, inflammation, oxidative stress, and senescence-related genes were measured in liver tissues. Chromosomal stability was evaluated using global DNA methylation ELISA. Results: The ALT/AST ratio and liver to body weight ratio tended to increase in the DOX group, and Cr supplementation tended to attenuate this increase. Furthermore, elevated levels of liver fibrosis, inflammation, oxidative stress, and senescence were observed with DOX treatment, and Cr supplementation prior to DOX treatment ameliorated this hepatoxicity. Moreover, DOX treatment resulted in chromosomal instability (i.e., altered DNA methylation profile), and Cr supplementation showed a tendency to restore chromosomal stability with DOX treatment. Conclusion: The data suggest that Cr protected against DOX-induced hepatotoxicity by attenuating fibrosis, inflammation, oxidative stress, and senescence.
C1 [Aljobaily, Nouf; Viereckl, Michael J.; Alberson, Jammie; Han, Yuyan] Univ Northern Colorado, Sch Biol Sci, Greeley, CO 80639 USA.
   [Hydock, David S.; Busekrus, Raquel; Jones, Brandon] Univ Northern Colorado, Sch Sport & Exercise Sci, Greeley, CO 80639 USA.
   [Wu, Tsung-Yen] Univ Washington, Obstet & Gynecol Dept, Seattle, WA 98115 USA.
C3 University of Northern Colorado; University of Northern Colorado;
   University of Washington; University of Washington Seattle
RP Han, YY (corresponding author), Univ Northern Colorado, Sch Biol Sci, Greeley, CO 80639 USA.
EM nouf.aljobaily@unco.edu; michael.viereckl@unco.edu;
   david.hydock@unco.edu; hend.aljobaily@hotmail.com; wuyenyen40@gmail.com;
   raquel.busekrus@unco.edu; brandon.jones@unco.edu;
   Albe4122@bears.unco.edu; yuyan.han@unco.edu
RI han, Yuyan/JPL-8939-2023; Han, Yuyan/A-2291-2014
OI Han, Yuyan/0000-0002-9982-9286
FU University of Northern Colorado; Research, Dissemination and Faculty
   Development Program of University of Northern Colorado; National Science
   Foundation of China [NSF81700507]
FX This research was funded by the University of Northern Colorado Start-up
   funding to Yuyan Han, and the Research, Dissemination and Faculty
   Development Program of University of Northern Colorado and National
   Science Foundation of China (NSF81700507).
CR Alster O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104964
   [Anonymous], 2012, LIVERTOX CLIN RES IN
   Bai J, 2014, CELL PROLIFERAT, V47, P211, DOI 10.1111/cpr.12103
   Bredahl EC, 2020, NUTR CANCER, V72, P939, DOI 10.1080/01635581.2019.1670852
   Bredahl EC, 2017, NUTR CANCER, V69, P607, DOI 10.1080/01635581.2017.1295089
   Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cardinale D, 2015, CIRCULATION, V131, P1981, DOI 10.1161/CIRCULATIONAHA.114.013777
   Clark JF, 1997, J ATHL TRAINING, V32, P45
   DOROSHOW JH, 1986, P NATL ACAD SCI USA, V83, P4514, DOI 10.1073/pnas.83.12.4514
   Ferreira A, 2017, TOXICOLOGY, V390, P63, DOI 10.1016/j.tox.2017.08.011
   Hanna AD, 2014, MOL PHARMACOL, V86, P438, DOI 10.1124/mol.114.093849
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He H, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-018-2456-8
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Ji YJ, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0153-z
   Kawano H, 2014, ANN SURG ONCOL, V21, pS696, DOI 10.1245/s10434-014-3818-z
   Komatsu Y, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-5
   Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164
   Lee WJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060948
   Limdi JK, 2003, POSTGRAD MED J, V79, P307, DOI 10.1136/pmj.79.932.307
   Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Meier RPH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061295
   Nordgren KKS, 2017, TOXICOL SCI, V159, P470, DOI 10.1093/toxsci/kfx150
   Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Persky Adam M., 2007, V46, P275
   Pieniazek A, 2013, ADV MED SCI-POLAND, V58, P104, DOI 10.2478/v10039-012-0063-1
   Rahman AM, 2007, INT J NANOMED, V2, P567
   Rodenak-Kladniew B, 2020, LIFE SCI, V243, DOI 10.1016/j.lfs.2020.117271
   Rogers A.B., 2018, Comparative anatomy and histology, V13, P229, DOI 10.1016/B978-0-12-802900-8.00013-0
   Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213
   Santacruz L, 2015, CARDIOVASC TOXICOL, V15, P180, DOI 10.1007/s12012-014-9283-x
   Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201
   Sauter KAD, 2011, CANCER BIOL THER, V11, P1008, DOI 10.4161/cbt.11.12.15540
   Schipke J, 2017, J APPL PHYSIOL, V122, P1019, DOI 10.1152/japplphysiol.00987.2016
   Silva LA, 2013, J SPORT SCI, V31, P1164, DOI 10.1080/02640414.2013.773403
   Sliwinska MA, 2009, MECH AGEING DEV, V130, P24, DOI 10.1016/j.mad.2008.04.011
   TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249
   Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56
   Torok ZA, 2020, NUTR CANCER, V72, P252, DOI 10.1080/01635581.2019.1623900
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wang LT, 2016, CANCER RES, V76, P6631, DOI 10.1158/0008-5472.CAN-15-3034
   WEISS RB, 1992, SEMIN ONCOL, V19, P670
   Wided K, 2014, PAK J PHARM SCI, V27, P1891
   Wong J, 2014, CANCER BIOL THER, V15, P1395, DOI 10.4161/cbt.29922
   Yao ZQ, 2013, ARCH IMMUNOL THER EX, V61, P193, DOI 10.1007/s00005-013-0219-0
   Yokochi T, 2004, MOL PHARMACOL, V66, P1415, DOI 10.1124/mol.104.002634
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 52
TC 32
Z9 33
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JAN
PY 2021
VL 13
IS 1
AR 41
DI 10.3390/nu13010041
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA PW4RV
UT WOS:000610659100001
PM 33374297
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Jelenik, T
   Kaul, K
   Séquaris, G
   Flögel, U
   Phielix, E
   Kotzka, J
   Knebel, B
   Fahlbusch, P
   Hörbelt, T
   Lehr, S
   Reinbeck, AL
   Müller-Wieland, D
   Esposito, I
   Shulman, GI
   Szendroedi, J
   Roden, M
AF Jelenik, Tomas
   Kaul, Kirti
   Sequaris, Gilles
   Floegel, Ulrich
   Phielix, Esther
   Kotzka, Joerg
   Knebel, Birgit
   Fahlbusch, Pia
   Hoerbelt, Tina
   Lehr, Stefan
   Reinbeck, Anna Lena
   Mueller-Wieland, Dirk
   Esposito, Irene
   Shulman, Gerald I.
   Szendroedi, Julia
   Roden, Michael
TI Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic
   Fatty Liver
SO DIABETES
LA English
DT Article
ID ADIPOSE-TISSUE; HEPATIC STEATOSIS; MITOCHONDRIAL DYSFUNCTION;
   OXIDATIVE-PHOSPHORYLATION; DIABETES-MELLITUS; SMALL BIOPSIES; MICE;
   OBESE; DYSLIPIDEMIA; CONTRIBUTES
AB Nonalcoholic fatty liver disease is associated with hepatic insulin resistance and may result primarily from increased hepatic de novo lipogenesis (PRIM) or secondarily from adipose tissue lipolysis (SEC). We studied mice with hepatocyte- or adipocyte-specific SREBP-1c overexpression as models of PRIM and SEC. PRIM mice featured increased lipogenic gene expression in the liver and adipose tissue. Their selective, liver-specific insulin resistance was associated with increased C18:1-diacylglycerol content and protein kinase C epsilon translocation. SEC mice had decreased lipogenesis mediated by hepatic cholesterol responsive element-binding protein and featured portal/lobular inflammation along with total, whole-body insulin resistance. Hepatic mitochondrial respiration transiently increased and declined with aging along with higher muscle reactive oxygen species production. In conclusion, hepatic insulin resistance originates from lipotoxicity but not from lower mitochondrial capacity, which can even transiently adapt to increased peripheral lipolysis. Peripheral insulin resistance is prevented during increased hepatic lipogenesis only if adipose tissue lipid storage capacity is preserved.
C1 [Jelenik, Tomas; Kaul, Kirti; Sequaris, Gilles; Phielix, Esther; Reinbeck, Anna Lena; Szendroedi, Julia; Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.
   [Jelenik, Tomas; Kaul, Kirti; Sequaris, Gilles; Phielix, Esther; Kotzka, Joerg; Knebel, Birgit; Fahlbusch, Pia; Hoerbelt, Tina; Lehr, Stefan; Szendroedi, Julia; Roden, Michael] German Ctr Diabet Res, Munich, Germany.
   [Floegel, Ulrich] Heinrich Heine Univ Dusseldorf, Fac Med, Dept Mol Cardiol, Dusseldorf, Germany.
   [Kotzka, Joerg; Knebel, Birgit; Fahlbusch, Pia; Hoerbelt, Tina; Lehr, Stefan] German Diabet Ctr, Inst Biochem & Pathobiochem, Dusseldorf, Germany.
   [Mueller-Wieland, Dirk] Univ Hosp Aachen, Dept Internal Med 1, Aachen, Germany.
   [Esposito, Irene] Heinrich Heine Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany.
   [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA.
   [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.
   [Szendroedi, Julia; Roden, Michael] Heinrich Heine Univ Dusseldorf, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany.
C3 Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf;
   Deutsches Diabetes-Zentrum (DDZ); RWTH Aachen University; RWTH Aachen
   University Hospital; Heinrich Heine University Dusseldorf; Howard Hughes
   Medical Institute; Yale University; Yale University; Howard Hughes
   Medical Institute; Heinrich Heine University Dusseldorf
RP Roden, M (corresponding author), German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.; Roden, M (corresponding author), German Ctr Diabet Res, Munich, Germany.; Roden, M (corresponding author), Heinrich Heine Univ Dusseldorf, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany.
EM michael.roden@ddz.uni-duesseldorf.de
RI Roden, Michael/AAD-3843-2019; Esposito, Irene/A-5371-2012; Shulman,
   Gerald I./P-7176-2019; Esposito, Irene/AAQ-2891-2021; Phielix,
   Esther/U-8149-2018
OI Shulman, Gerald I./0000-0003-1529-5668; Esposito,
   Irene/0000-0002-0554-2402; Phielix, Esther/0000-0002-2672-0415; Kotzka,
   Jorg/0000-0003-1173-9372; Muller-Wieland, Dirk/0000-0002-8807-6442;
   Horbelt, Tina/0000-0001-7848-2626; Fahlbusch, Pia/0000-0002-4912-1722
FU Ministry of Science and Research of the State of North Rhine-Westphalia;
   German Federal Ministry of Health; Federal Ministry for Research;
   Helmholtz Alliance to Universities; German Research Foundation [SFB
   1116]; German Diabetes Association; Schmutzler-Stiftung; National
   Institutes of Health/National Institute of Diabetes and Digestive and
   Kidney Diseases [R01-DK-40936, U24-DK-059635, P30-DK-45735]
FX This study was partly supported by the Ministry of Science and Research
   of the State of North Rhine-Westphalia and the German Federal Ministry
   of Health as well as by a grant of the Federal Ministry for Research to
   the German Center for Diabetes Research and by grants from the Helmholtz
   Alliance to Universities, the German Research Foundation (SFB 1116), the
   German Diabetes Association, the Schmutzler-Stiftung, and the National
   Institutes of Health/National Institute of Diabetes and Digestive and
   Kidney Diseases (R01-DK-40936, U24-DK-059635, and P30-DK-45735).
CR Akie TE, 2015, JOVE-J VIS EXP, DOI 10.3791/52982
   Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624
   Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Chan MY, 2008, OBESITY, V16, P972, DOI 10.1038/oby.2008.32
   Ciapaite J, 2007, BBA-MOL BASIS DIS, V1772, P307, DOI 10.1016/j.bbadis.2006.10.018
   Cortés VA, 2014, J LIPID RES, V55, P276, DOI 10.1194/jlr.M045799
   Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y
   Cusi K, 2016, DIABETOLOGIA, V59, P1112, DOI 10.1007/s00125-016-3952-1
   Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621
   Fabbrini E, 2016, GASTROENTEROLOGY, V150, P79, DOI 10.1053/j.gastro.2015.09.003
   Fabbrini E, 2015, J CLIN INVEST, V125, P787, DOI 10.1172/JCI78425
   Fritsch M, 2015, AM J CLIN NUTR, V102, P1051, DOI 10.3945/ajcn.115.107599
   Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116
   Goustin AS, 2013, CELL SIGNAL, V25, P981, DOI 10.1016/j.cellsig.2012.12.011
   Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986
   Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378
   Holmström MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE731, DOI 10.1152/ajpendo.00159.2011
   Hooper AJ, 2011, J LIPID RES, V52, P593, DOI 10.1194/jlr.R008896
   Jelenik T, 2014, DIABETES, V63, P3856, DOI 10.2337/db13-1794
   Jelenik T, 2013, ANTIOXID REDOX SIGN, V19, P258, DOI 10.1089/ars.2012.4910
   Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907
   Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108
   Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658
   Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200
   Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005
   Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400
   Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Saponaro C, 2015, NUTRIENTS, V7, P9453, DOI 10.3390/nu7115475
   Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076
   Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432
   Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182
   Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448
   Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035
   Stagos D, 2015, REDOX REP, V20, P154, DOI 10.1179/1351000214Y.0000000118
   STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x
   Strobel K, 2008, J LIPID RES, V49, P473, DOI 10.1194/jlr.D700024-JLR200
   Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744
   Szczepaniak LS, 2002, MAGN RESON MED, V47, P607, DOI 10.1002/mrm.10086
   Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093
   Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300
   Tucci S, 2011, AM J CLIN NUTR, V94, P439, DOI 10.3945/ajcn.111.012948
   Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
NR 57
TC 103
Z9 107
U1 1
U2 17
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD AUG 1
PY 2017
VL 66
IS 8
BP 2241
EP 2253
DI 10.2337/db16-1147
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA FB3AJ
UT WOS:000406014600021
PM 28490610
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Shrestha, N
   Chaturvedi, P
   Zhu, XY
   Dee, MJ
   George, V
   Janney, C
   Egan, JO
   Liu, B
   Foster, M
   Marsala, L
   Wong, P
   Cubitt, CC
   Foltz, JA
   Tran, J
   Schappe, T
   Hsiao, K
   Leclerc, GM
   You, LJ
   Echeverri, C
   Spanoudis, C
   Carvalho, A
   Kanakaraj, L
   Gilkes, C
   Encalada, N
   Kong, L
   Wang, M
   Fang, B
   Wang, Z
   Jiao, JA
   Muniz, GJ
   Jeng, EK
   Valdivieso, N
   Li, LY
   Deth, R
   Berrien-Elliott, MM
   Fehniger, TA
   Rhode, PR
   Wong, HC
AF Shrestha, Niraj
   Chaturvedi, Pallavi
   Zhu, Xiaoyun
   Dee, Michael J.
   George, Varghese
   Janney, Christopher
   Egan, Jack O.
   Liu, Bai
   Foster, Mark
   Marsala, Lynne
   Wong, Pamela
   Cubitt, Celia C.
   Foltz, Jennifer A.
   Tran, Jennifer
   Schappe, Timothy
   Hsiao, Karin
   Leclerc, Gilles M.
   You, Lijing
   Echeverri, Christian
   Spanoudis, Catherine
   Carvalho, Ana
   Kanakaraj, Leah
   Gilkes, Crystal
   Encalada, Nicole
   Kong, Lin
   Wang, Meng
   Fang, Byron
   Wang, Zheng
   Jiao, Jin-an
   Muniz, Gabriela J.
   Jeng, Emily K.
   Valdivieso, Nicole
   Li, Liying
   Deth, Richard
   Berrien-Elliott, Melissa M.
   Fehniger, Todd A.
   Rhode, Peter R.
   Wong, Hing C.
TI Immunotherapeutic approach to reduce senescent cells and alleviate
   senescence-associated secretory phenotype in mice
SO AGING CELL
LA English
DT Article; Early Access
DE aging; cellular immunology; circadian genes; immunotherapy;
   inflammation; physical performance; senescence; senescent cell
   reduction; senomorphic; type 2 diabetes
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; CELLULAR SENESCENCE;
   VASCULAR-DISEASE; NK CELL; FIBROSIS; INDUCTION; CANCER; SMAD; P53
AB Accumulation of senescent cells (SNCs) with a senescence-associated secretory phenotype (SASP) has been implicated as a major source of chronic sterile inflammation leading to many age-related pathologies. Herein, we provide evidence that a bifunctional immunotherapeutic, HCW9218, with capabilities of neutralizing TGF-b and stimulating immune cells, can be safely administered systemically to reduce SNCs and alleviate SASP in mice. In the diabetic db/db mouse model, subcutaneous administration of HCW9218 reduced senescent islet b cells and SASP resulting in improved glucose tolerance, insulin resistance, and aging index. In naturally aged mice, subcutaneous administration of HCW9218 durably reduced the level of SNCs and SASP, leading to lower expression of pro-inflammatory genes in peripheral organs. HCW9218 treatment also reverted the pattern of key regulatory circadian gene expression in aged mice to levels observed in young mice and impacted genes associated with metabolism and fibrosis in the liver. Single-nucleus RNA Sequencing analysis further revealed that HCW9218 treatment differentially changed the transcriptomic landscape of hepatocyte subtypes involving metabolic, signaling, cell-cycle, and senescence-associated pathways in naturally aged mice. Long-term survival studies also showed that HCW9218 treatment improved physical performance without compromising the health span of naturally aged mice. Thus, HCW9218 represents a novel immunotherapeutic approach and a clinically promising new class of senotherapeutic agents targeting cellular senescence-associated diseases.
C1 [Shrestha, Niraj; Chaturvedi, Pallavi; Zhu, Xiaoyun; Dee, Michael J.; George, Varghese; Janney, Christopher; Egan, Jack O.; Liu, Bai; Leclerc, Gilles M.; You, Lijing; Echeverri, Christian; Spanoudis, Catherine; Carvalho, Ana; Kanakaraj, Leah; Gilkes, Crystal; Encalada, Nicole; Kong, Lin; Wang, Meng; Fang, Byron; Wang, Zheng; Jiao, Jin-an; Muniz, Gabriela J.; Jeng, Emily K.; Valdivieso, Nicole; Li, Liying; Rhode, Peter R.; Wong, Hing C.] HCW Biol Inc, Miramar, FL 33025 USA.
   [Foster, Mark; Marsala, Lynne; Wong, Pamela; Cubitt, Celia C.; Foltz, Jennifer A.; Tran, Jennifer; Schappe, Timothy; Berrien-Elliott, Melissa M.; Fehniger, Todd A.] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA.
   [Hsiao, Karin; Deth, Richard] Nova Southeastern Univ, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA.
C3 Washington University (WUSTL); Nova Southeastern University
RP Wong, HC (corresponding author), HCW Biol Inc, Miramar, FL 33025 USA.
EM hingwong@hcwbiologics.com
OI Janney, Christopher/0000-0003-0714-4843; Leclerc,
   Gilles/0000-0002-3424-9256; Gilkes, Crystal/0009-0008-0984-7132
FU HCW Biologics Inc.; National Institutes of Health (NIH) National Cancer
   Institute [P50CA171963, R01CA205239, P30CA91842]; Siteman Cancer Center
   Immunomonitoring Lab [K12CA1667540]; NIH National Heart, Lung, and Blood
   Institute [T32HL007088]; NIH National Institute of General Medical
   Sciences [T32GM139799]; NIH National Institute of Allergy and Infectious
   Diseases [F30AI161318]; Siteman Cancer Center Investment Program
FX This study was supported by HCW Biologics Inc. Some of the research
   reported in this publication were also supported by grants from the
   National Institutes of Health (NIH) National Cancer Institute
   (P50CA171963 to TAF and MMB-E; R01CA205239 to TAF; P30CA91842 to TAF and
   Siteman Cancer Center Immunomonitoring Lab, and K12CA1667540 to MMB-E),
   NIH National Heart, Lung, and Blood Institute (T32HL007088 to JAF and
   PW), NIH National Institute of General Medical Sciences (T32GM139799 to
   JAF), NIH National Institute of Allergy and Infectious Diseases
   (F30AI161318 to CCC) and the Siteman Cancer Center Investment Program to
   TAF.
CR Acosta-Rodríguez VA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22922-6
   Aguayo-Mazzucato C, 2019, CELL METAB, V30, P129, DOI 10.1016/j.cmet.2019.05.006
   Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Bal SM, 2020, NAT REV IMMUNOL, V20, P552, DOI 10.1038/s41577-020-0282-9
   Bennett MR, 2017, NAT REV CARDIOL, V14, P8, DOI 10.1038/nrcardio.2016.195
   Benomar Y, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00140
   Brighton Paul J, 2017, Elife, V6, DOI 10.7554/eLife.31274
   Budamagunta V, 2021, AGING-US, V13, P19920, DOI 10.18632/aging.203405
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Chandra A, 2022, AGING CELL, V21, DOI 10.1111/acel.13602
   Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005
   Chaturvedi P, 2022, MOL THER, V30, P1171, DOI 10.1016/j.ymthe.2022.01.025
   Clark GT, 2022, PLOS GENET, V18, DOI 10.1371/journal.pgen.1009994
   Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558
   Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950
   de Assis LVM, 2021, CELL MOL LIFE SCI, V78, P4563, DOI 10.1007/s00018-021-03800-2
   Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651
   Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Finger AM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg5174
   Fumagalli V, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abi6112
   Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015
   Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236
   Gasek NS, 2021, NATURE AGING, V1, P870, DOI 10.1038/s43587-021-00121-8
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hiebert P, 2018, DEV CELL, V46, P145, DOI 10.1016/j.devcel.2018.06.012
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Jung J, 2019, NAT CELL BIOL, V21, P85, DOI 10.1038/s41556-018-0217-x
   Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052
   Kale A, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00187-9
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Liang CQ, 2022, NUCLEIC ACIDS RES, V50, P3323, DOI 10.1093/nar/gkac146
   Lin YF, 2021, NEUROBIOL STRESS, V15, DOI 10.1016/j.ynstr.2021.100341
   Liu B, 2021, MOL THER, V29, P2949, DOI 10.1016/j.ymthe.2021.06.001
   Liu H, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2314-6
   Manevski M, 2020, REDOX BIOL, V33, DOI 10.1016/j.redox.2020.101443
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Michelet X, 2018, NAT IMMUNOL, V19, P1330, DOI 10.1038/s41590-018-0251-7
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010
   Moschen AR, 2017, TRENDS ENDOCRIN MET, V28, P388, DOI 10.1016/j.tem.2017.01.003
   Mukherji A, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154337
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nassan M, 2022, NAT REV NEUROL, V18, P7, DOI 10.1038/s41582-021-00577-7
   Nixon BG, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abi8642
   Ogrodnik M, 2021, AGING CELL, V20, DOI 10.1111/acel.13296
   Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149
   Papismadov N, 2021, NAT NEUROSCI, V24, P2, DOI 10.1038/s41593-020-00749-6
   Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199
   Rhode PR, 2016, CANCER IMMUNOL RES, V4, P49, DOI 10.1158/2326-6066.CIR-15-0093-T
   Sedrak MS, 2021, J AM GERIATR SOC, V69, P3077, DOI 10.1111/jgs.17461
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477
   Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shahbazi Jeyran, 2013, Frontiers in Genetics, V4, P80, DOI 10.3389/fgene.2013.00080
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Shi HJ, 2019, NEUROPHARMACOLOGY, V145, P259, DOI 10.1016/j.neuropharm.2018.07.022
   Shi J, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00703
   Singh AK, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140989
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Sturmlechner I, 2021, SCIENCE, V374, DOI 10.1126/science.abb3420
   TAKAHASHI A, 2017, NAT COMMUN, V8, DOI DOI 10.1038/NCOMMS15287
   Tominaga K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205002
   Triana-Martínez F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020346
   Ueda S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01150-4
   van Deursen JM, 2019, SCIENCE, V364, P636, DOI 10.1126/science.aaw1299
   von Kobbe C, 2018, CELL MOL LIFE SCI, V75, P3553, DOI 10.1007/s00018-018-2879-8
   Yin H, 2016, CAN J CARDIOL, V32, P612, DOI 10.1016/j.cjca.2016.02.051
   Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7
   Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155
   Zhang L, 2023, FEBS J, V290, P1362, DOI 10.1111/febs.16350
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 79
TC 2
Z9 2
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 MAY
PY 2023
VL 22
IS 5
AR e13806
DI 10.1111/acel.13806
EA MAR 2023
PG 20
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GX6L0
UT WOS:000958792600001
PM 36967480
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Keshavjee, B
   Lambelet, V
   Coppola, H
   Viertl, D
   Prior, JO
   Kappeler, L
   Armengaud, JB
   Chouraqui, JP
   Chehade, H
   Vanderriele, PE
   Allouche, M
   Balsiger, A
   Sarre, A
   Peyter, AC
   Simeoni, U
   Yzydorczyk, C
AF Keshavjee, Basile
   Lambelet, Valentine
   Coppola, Hanna
   Viertl, David
   Prior, John O.
   Kappeler, Laurent
   Armengaud, Jean-Baptiste
   Chouraqui, Jean-Pierre
   Chehade, Hassib
   Vanderriele, Paul-Emmanuel
   Allouche, Manon
   Balsiger, Anne
   Sarre, Alexandre
   Peyter, Anne-Christine
   Simeoni, Umberto
   Yzydorczyk, Catherine
TI Stress-Induced Premature Senescence Related to Oxidative Stress in the
   Developmental Programming of Nonalcoholic Fatty Liver Disease in a Rat
   Model of Intrauterine Growth Restriction
SO ANTIOXIDANTS
LA English
DT Article
DE intrauterine growth restriction; metabolic syndrome; developmental
   programming; nonalcoholic fatty liver disease; oxidative stress;
   cellular senescence
ID ACTIVATED PROTEIN-KINASE; LOW-BIRTH-WEIGHT; ELEMENT-BINDING PROTEIN-1;
   METABOLIC SYNDROME; HEPATIC STEATOSIS; GENE-EXPRESSION; ENDOTHELIAL
   DYSFUNCTION; TRANSCRIPTION FACTORS; CELLULAR SENESCENCE;
   INSULIN-RESISTANCE
AB Metabolic syndrome (MetS) refers to cardiometabolic risk factors, such as visceral obesity, dyslipidemia, hyperglycemia/insulin resistance, arterial hypertension and non-alcoholic fatty liver disease (NAFLD). Individuals born after intrauterine growth restriction (IUGR) are particularly at risk of developing metabolic/hepatic disorders later in life. Oxidative stress and cellular senescence have been associated with MetS and are observed in infants born following IUGR. However, whether these mechanisms could be particularly associated with the development of NAFLD in these individuals is still unknown. IUGR was induced in rats by a maternal low-protein diet during gestation versus. a control (CTRL) diet. In six-month-old offspring, we observed an increased visceral fat mass, glucose intolerance, and hepatic alterations (increased transaminase levels, triglyceride and neutral lipid deposit) in male rats with induced IUGR compared with the CTRL males; no differences were found in females. In IUGR male livers, we identified some markers of stress-induced premature senescence (SIPS) (lipofuscin deposit, increased protein expression of p21(WAF), p16(INK4a) and Acp53, but decreased pRb/Rb ratio, foxo-1 and sirtuin-1 protein and mRNA expression) associated with oxidative stress (higher superoxide anion levels, DNA damages, decreased Cu/Zn SOD, increased catalase protein expression, increased nfe2 and decreased keap1 mRNA expression). Impaired lipogenesis pathways (decreased pAMPK/AMPK ratio, increased pAKT/AKT ratio, SREBP1 and PPAR gamma protein expression) were also observed in IUGR male livers. At birth, no differences were observed in liver histology, markers of SIPS and oxidative stress between CTRL and IUGR males. These data demonstrate that the livers of IUGR males at adulthood display SIPS and impaired liver structure and function related to oxidative stress and allow the identification of specific therapeutic strategies to limit or prevent adverse consequences of IUGR, particularly metabolic and hepatic disorders.
C1 [Keshavjee, Basile; Lambelet, Valentine; Coppola, Hanna; Armengaud, Jean-Baptiste; Chehade, Hassib; Allouche, Manon; Balsiger, Anne; Sarre, Alexandre; Simeoni, Umberto; Yzydorczyk, Catherine] Univ Lausanne, Dept Woman Mother Child, Div Pediat, DOHaD Lab, CH-1011 Lausanne, Switzerland.
   [Keshavjee, Basile; Lambelet, Valentine; Coppola, Hanna; Viertl, David; Prior, John O.; Armengaud, Jean-Baptiste; Chouraqui, Jean-Pierre; Chehade, Hassib; Allouche, Manon; Balsiger, Anne; Sarre, Alexandre; Peyter, Anne-Christine; Simeoni, Umberto; Yzydorczyk, Catherine] Lausanne Univ Hosp, CH-1011 Lausanne, Switzerland.
   [Viertl, David; Prior, John O.] Univ Lausanne, Dept Nucl Med & Mol Imaging, CH-1011 Lausanne, Switzerland.
   [Kappeler, Laurent] Sorbonne Univ, CRSA, INSERM, F-75000 Paris, France.
   [Kappeler, Laurent] Sorbonne Univ, IHU ICAN Inst Cardiometab & Nutr, F-75000 Paris, France.
   [Chouraqui, Jean-Pierre] Univ Lausanne, Dept Woman Mother Child, Pediat Nutr & Gastroenterol Unit, CH-1011 Lausanne, Switzerland.
   [Vanderriele, Paul-Emmanuel] Univ Lausanne, Natl Ctr Competence Res Kidney, Dept Biomed Sci, CH-1011 Lausanne, Switzerland.
   [Peyter, Anne-Christine] Univ Lausanne, Dept Woman Mother Child, Neonatal Res Lab, Clin Neonatol, CH-1011 Lausanne, Switzerland.
C3 University of Lausanne; University of Lausanne; Centre Hospitalier
   Universitaire Vaudois (CHUV); University of Lausanne; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite;
   Sorbonne Universite; University of Lausanne; University of Lausanne;
   University of Lausanne
RP Yzydorczyk, C (corresponding author), Univ Lausanne, Dept Woman Mother Child, Div Pediat, DOHaD Lab, CH-1011 Lausanne, Switzerland.; Yzydorczyk, C (corresponding author), Lausanne Univ Hosp, CH-1011 Lausanne, Switzerland.
EM catherine.yzydorczyk@chuv.ch
RI Sarre, Alexandre/HNB-4369-2023; Kappeler, Laurent/N-6327-2017; Prior,
   John/I-5364-2017
OI Kappeler, Laurent/0000-0001-7971-0838; Vanderriele, Paul
   Emmanuel/0000-0002-8581-8471; Armengaud,
   Jean-Baptiste/0000-0002-2276-623X; Viertl, David/0000-0001-5203-0939;
   Prior, John/0000-0003-1429-1374; YZYDORCZYK,
   Catherine/0000-0002-0617-7558; Chouraqui,
   Jean-Pierre/0000-0002-6488-922X; Peyter,
   Anne-Christine/0000-0003-2051-1126
FU "Association pour information et la recherche sur les maladies renales
   genetiques" (AIRG-Switzerland)
FX This research was funded by a grant from the "Association pour
   information et la recherche sur les maladies renales genetiques"
   (AIRG-Switzerland).
CR Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489
   Armani A, 2017, FASEB J, V31, P4240, DOI 10.1096/fj.201601125RRR
   Armutcu F, 2008, CLIN CHEM LAB MED, V46, P785, DOI 10.1515/CCLM.2008.166
   Arroyave-Ospina JC, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020174
   Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488
   Biron-Shental T, 2011, EARLY HUM DEV, V87, P73, DOI 10.1016/j.earlhumdev.2010.08.024
   Biron-Shental T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.036
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Carolan-Olah M, 2015, J CLIN NURS, V24, P3716, DOI 10.1111/jocn.12951
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0
   Chen JJ, 2020, INT J BIOL SCI, V16, P2367, DOI 10.7150/ijbs.47143
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Coupé B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893
   Dean RT, 1997, BIOCHEM J, V324, P1
   Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004
   Desai M, 2005, AM J OBSTET GYNECOL, V193, P1224, DOI 10.1016/j.ajog.2005.05.041
   Desai M, 1997, BIOL REV, V72, P329, DOI 10.1017/S0006323196005026
   Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3
   Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010
   Faienza MF, 2013, HORM RES PAEDIAT, V79, P103, DOI 10.1159/000347217
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355
   Fraser A, 2008, J EPIDEMIOL COMMUN H, V62, P48, DOI 10.1136/jech.2006.053181
   Gan Q, 2008, J CELL SCI, V121, P2235, DOI 10.1242/jcs.026633
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Gianfranceschi G, 2016, INT J CARDIOL, V216, P140, DOI 10.1016/j.ijcard.2016.04.155
   Grabowska W, 2017, BIOGERONTOLOGY, V18, P447, DOI 10.1007/s10522-017-9685-9
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Gupta Piyush, 2004, BMC Pediatr, V4, P14, DOI 10.1186/1471-2431-4-14
   Guven ESG, 2013, J MATERN-FETAL NEO M, V26, P576, DOI 10.3109/14767058.2012.745497
   HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019
   Hales CN, 1997, DIABETIC MED, V14, P189
   Han F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07188-9
   Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446
   Hansel B, 2004, J CLIN ENDOCR METAB, V89, P4963, DOI 10.1210/jc.2004-0305
   Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1
   Hong T, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6889533
   Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010
   Intapad S, 2013, HYPERTENSION, V61, P828, DOI 10.1161/HYPERTENSIONAHA.111.00645
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Jensen VS, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0307-8
   Jia YS, 2008, REPROD SCI, V15, P702, DOI 10.1177/1933719108316982
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kakimoto Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40250-0
   Karowicz-Bilinska Agata, 2002, Med Sci Monit, V8, pCR211
   Khandelwal P, 2014, J DEV ORIG HLTH DIS, V5, P189, DOI 10.1017/S2040174414000178
   Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015
   Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386
   Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Lefebvre P, 2021, NAT REV ENDOCRINOL, V17, P662, DOI 10.1038/s41574-021-00538-6
   Lewis CA, 2011, BIOCHEM SOC T, V39, P495, DOI 10.1042/BST0390495
   Li SY, 2011, BIOCHEM BIOPH RES CO, V412, P197, DOI 10.1016/j.bbrc.2011.07.038
   Liang ZX, 2017, ONCOTARGET, V8, P62780, DOI 10.18632/oncotarget.19376
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Ma Y, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11010091
   Maiese K, 2008, TRENDS MOL MED, V14, P219, DOI 10.1016/j.molmed.2008.03.002
   Maiese K, 2007, CURR NEUROVASC RES, V4, P295, DOI 10.2174/156720207782446306
   Marazita MC, 2016, REDOX BIOL, V7, P78, DOI 10.1016/j.redox.2015.11.011
   Martin-Ruiz C, 2004, J BIOL CHEM, V279, P17826, DOI 10.1074/jbc.M311980200
   McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003
   Mitchell BM, 2007, AM J HYPERTENS, V20, P1297, DOI 10.1016/j.amjhyper.2007.08.007
   Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]
   Nobili V, 2007, DIABETES CARE, V30, P2638, DOI 10.2337/dc07-0281
   Oke SL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136986
   Palmieri VO, 2006, J NUTR, V136, P3022, DOI 10.1093/jn/136.12.3022
   Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Perticone F, 2001, DIABETES, V50, P159, DOI 10.2337/diabetes.50.1.159
   Peyter AC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136667
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Ping F, 2017, J DIABETES INVEST, V8, P174, DOI 10.1111/jdi.12555
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Quan HY, 2013, BIOCHEM PHARMACOL, V85, P1330, DOI 10.1016/j.bcp.2013.02.007
   Ramadhani MK, 2006, ATHEROSCLEROSIS, V184, P21, DOI 10.1016/j.atherosclerosis.2005.03.022
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344
   Saget S, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101083
   Saker M, 2008, EUR J OBSTET GYN R B, V141, P95, DOI 10.1016/j.ejogrb.2008.07.013
   Samson SL, 2014, ENDOCRIN METAB CLIN, V43, P1, DOI 10.1016/j.ecl.2013.09.009
   Sandboge S, 2013, ANN MED, V45, P430, DOI 10.3109/07853890.2013.801275
   Sasser TA, 2012, JOVE-J VIS EXP, DOI 10.3791/3680
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006
   Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832
   Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248
   Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279
   Simoncini S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221810159
   Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930
   Stefan N, 2019, LANCET DIABETES ENDO, V7, P313, DOI 10.1016/S2213-8587(18)30154-2
   Suomela E, 2016, J HEPATOL, V65, P784, DOI 10.1016/j.jhep.2016.05.020
   Swanlund JM, 2008, AUTOPHAGY, V4, P936, DOI 10.4161/auto.6768
   Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320
   Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202
   Vassallo PF, 2014, BLOOD, V123, P2116, DOI 10.1182/blood-2013-02-484956
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x
   Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215
   Wang SJ, 2017, HEPATOL RES, V47, P683, DOI 10.1111/hepr.12788
   Weinsaft J W, 2001, Am J Geriatr Cardiol, V10, P348, DOI 10.1111/j.1076-7460.2001.00833.x
   Xie H, 2013, P NATL ACAD SCI USA, V110, P7904, DOI 10.1073/pnas.1217938110
   Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667
   Xu XJ, 2012, J LIPID RES, V53, P792, DOI 10.1194/jlr.P022905
   Yamazaki S, 2014, ENDOCRINOLOGY, V155, P3288, DOI 10.1210/en.2013-2157
   Yzydorczyk C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112796
   Yzydorczyk C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11756-2
   Zarrati M, 2013, ANN NUTR METAB, V63, P69, DOI 10.1159/000351869
   Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974
NR 117
TC 4
Z9 5
U1 1
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD SEP
PY 2022
VL 11
IS 9
AR 1695
DI 10.3390/antiox11091695
PG 26
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 4Q5ZS
UT WOS:000856161600001
PM 36139771
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fujita, T
   Inoue, H
   Kitamura, T
   Sato, N
   Shimosawa, T
   Maruyama, N
AF Fujita, T
   Inoue, H
   Kitamura, T
   Sato, N
   Shimosawa, T
   Maruyama, N
TI Senescence marker protein-30 (SMP30) rescues cell death by enhancing
   plasma membrane Ca<SUP>2+</SUP>-pumping activity in Hep G2 cells
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE aging; apoptosis; Ca2+-binding protein; Ca2+ homeostasis; cell death;
   hepatocyte; Hep G2; plasma membrane Ca2+-pumping ATPase (PMCA); SMP30;
   senescence marker protein-30
ID RAT-LIVER; INTRACELLULAR CALCIUM; IMMATURE THYMOCYTES; GENE-EXPRESSION;
   MUSCLE-CELLS; PUMP; PURIFICATION; REGUCALCIN; APOPTOSIS; ATPASE
AB Senescence marker protein-30 (SMP30) has been reported to decrease with aging in the rat Liver. SMP30 has been also suggested to play a role as a Ca2+-binding protein localized in cytosol of hepatocytes. To elucidate the functional significance of SMP30, we have generated Hep G2 cell lines that stably express large amounts of SMP30 by transfection with human SMP30 cDNA. Using these cell lines, in view of the intracellular Ca2+ homeostasis, we then investigated cytosolic free Ca2+ concentration ([Ca2+](i)) and Na+-independent Ca2+ efflux from the cells after extracellular ATP stimulation. Although stimulation of cells with ATP caused transient [Ca2+], increase in both SMP30 and mock transfectants, rate of decrease after peak in [Ca2+](i) was enhanced S-fold by transfection of SMP30. Correspondingly, Ca2+ efflux was significantly increased in SMP30 transfectants compared with mock transfectants. In addition, more SMP30 transfectants survived than mock transfectants when cell death was induced by Ca2+ ionophore treatment. These results suggest that SMP30 regulates [Ca2+](i) by modulating plasma membrane Ca2+-pumping activity, and thus down-regulation of SMP30 during aging may contribute to deterioration of cellular functions. (C) 1998 Academic Press.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 173, Japan.
   Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 113, Japan.
   Kyorin Univ, Sch Med, Dept Internal Med 1, Mitaka, Tokyo 181, Japan.
   Univ Tokyo, Sch Med, Dept Internal Med 4, Bunkyo Ku, Tokyo 112, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Juntendo University; Kyorin
   University; University of Tokyo
RP Fujita, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 173, Japan.
EM tofujita@center.tmig.or.jp
RI Kitamura, Toshio/AAA-2071-2021; Shimosawa, Tatsuo/A-2920-2015
OI Shimosawa, Tatsuo/0000-0002-8742-5129
CR AW TY, 1990, ARCH BIOCHEM BIOPHYS, V283, P46, DOI 10.1016/0003-9861(90)90610-B
   Azmi S, 1996, CANCER LETT, V107, P97, DOI 10.1016/0304-3835(96)04349-2
   BAKER PF, 1984, CURR TOP MEMBR TRANS, V22, P195
   BARRY WH, 1986, J GEN PHYSIOL, V88, P393, DOI 10.1085/jgp.88.3.393
   Bian XP, 1997, AM J PHYSIOL-CELL PH, V272, pC1241, DOI 10.1152/ajpcell.1997.272.4.C1241
   CARAFOLI E, 1992, J BIOL CHEM, V267, P2115
   CHAREST R, 1985, J BIOL CHEM, V260, P5789
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   DOWD DR, 1992, MOL ENDOCRINOL, V6, P1843, DOI 10.1210/me.6.11.1843
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   FURUKAWA KI, 1988, J BIOL CHEM, V263, P8058
   GAIDO ML, 1991, J BIOL CHEM, V266, P18580
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5
   HOWARD A, 1994, BIOCHEM J, V303, P275, DOI 10.1042/bj3030275
   IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078
   IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0
   Irie H, 1998, J GEN VIROL, V79, P1225, DOI 10.1099/0022-1317-79-5-1225
   JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121
   KAISER N, 1977, P NATL ACAD SCI USA, V74, P638, DOI 10.1073/pnas.74.2.638
   KESSLER F, 1990, J BIOL CHEM, V265, P16012
   KITAMURA T, 1991, HEPATOLOGY, V14, P640, DOI 10.1016/0270-9139(91)90051-V
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOTERSZTAJN S, 1981, J BIOL CHEM, V256, P1209
   MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801
   MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923
   MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7
   MONTEITH GR, 1995, CELL CALCIUM, V18, P459, DOI 10.1016/0143-4160(95)90009-8
   NICOTERA P, 1994, CELL CALCIUM, V16, P279, DOI 10.1016/0143-4160(94)90091-4
   REUTER H, 1968, J PHYSIOL-LONDON, V195, P451, DOI 10.1113/jphysiol.1968.sp008467
   SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225
   SEAMUS MJ, 1990, J IMMUNOL, V145, P1859
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SMITH JB, 1984, P NATL ACAD SCI-BIOL, V81, P7812, DOI 10.1073/pnas.81.24.7812
   TAKAHASHI H, 1994, MOL CELL BIOCHEM, V136, P71, DOI 10.1007/BF00931607
   TAKAHASHI H, 1993, MOL CELL BIOCHEM, V124, P169, DOI 10.1007/BF00929209
   TIMMERMANS JAH, 1995, INT C PROGR BON MIN, pS1981
   VARGHESE S, 1988, J BIOL CHEM, V263, P9776
   Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G
NR 44
TC 87
Z9 99
U1 0
U2 1
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 18
PY 1998
VL 250
IS 2
BP 374
EP 380
DI 10.1006/bbrc.1998.9327
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 122TR
UT WOS:000076088000033
PM 9753637
DA 2024-02-19
ER

PT J
AU Morsiani, C
   Bacalini, MG
   Santoro, A
   Garagnani, P
   Collura, S
   D'Errico, A
   de Eguileor, M
   Grazi, GL
   Cescon, M
   Franceschi, C
   Capri, M
AF Morsiani, Cristina
   Bacalini, Maria Giulia
   Santoro, Aurelia
   Garagnani, Paolo
   Collura, Salvatore
   D'Errico, Antonia
   de Eguileor, Magda
   Grazi, Gian Luca
   Cescon, Matteo
   Franceschi, Claudio
   Capri, Miriam
TI The peculiar aging of human liver: A geroscience perspective within
   transplant context
SO AGEING RESEARCH REVIEWS
LA English
DT Article
DE Liver aging; Hepatitis; Inflammaging; Transplant; Telocytes; Marginal
   donors
ID GUT MICROBIOTA; KUPFFER CELLS; HEPATOCELLULAR-CARCINOMA; METABOLIC
   ZONATION; TELOMERE LENGTH; DONORS OLDER; LIFE-STYLE; AGE; TELOCYTES;
   IDENTIFICATION
AB An appraisal of recent data highlighting aspects inspired by the new Geroscience perspective are here discussed. The main findings are summarized as follows: i) liver has to be considered an immunological organ, and new studies suggest a role for the recently described cells named telocytes; ii) the liver-gut axis represents a crucial connection with environment and life style habits and may influence liver diseases onset; iii) the physiological aging of liver shows relatively modest alterations. Nevertheless, several molecular changes appear to be relevant: a) an increase of microRNA-31-5p;-141-3p;-200c-3p expressions after 60 years of age; b) a remodeling of genome-wide DNA methylation profile evident until 60 years of age and then plateauing; c) changes in transcriptome including the metabolic zones of hepatocyte lobules; d) liver undergoes an accelerated aging in presence of chronic inflammation/liver diseases in a sort of continuum, largely as a consequence of unhealthy life styles and exposure to environmental noxious agents. We argue that chronic liver inflammation has all the major characteristics of "inflammaging" and likely sustains the onset and progression of liver diseases. Finally, we propose to use a combination of parameters, mostly obtained by omics such as transcriptomics and epigenomics, to evaluate in deep both the biological age of liver (in comparison with the chronological age) and the effects of donor-recipient age-mismatches in the context of liver transplant.
C1 [Morsiani, Cristina; Santoro, Aurelia; Garagnani, Paolo; Collura, Salvatore; Franceschi, Claudio; Capri, Miriam] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
   [Bacalini, Maria Giulia] IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.
   [Santoro, Aurelia; Garagnani, Paolo; Capri, Miriam] Univ Bologna, CIG Interdept Ctr Galvani, Bologna, Italy.
   [Garagnani, Paolo] Karolinska Inst, Huddinge Univ Hosp, Clin Chem Dept Lab Med, Stockholm, Sweden.
   [Garagnani, Paolo] Rizzoli Orthopaed Inst, Lab Cell Biol, Bologna, Italy.
   [Garagnani, Paolo] CNR, Inst Mol Genet, Unit Bologna, Bologna, Italy.
   [Garagnani, Paolo] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res CRBA, Bologna, Italy.
   [D'Errico, Antonia] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med DIMES, Pathol Unit, I-40138 Bologna, Italy.
   [de Eguileor, Magda] Univ Insubria, DBSV, Varese, Italy.
   [Grazi, Gian Luca] IRCCS, Regina Elena Natl Canc Inst, Rome, Italy.
   [Cescon, Matteo] St Orsola Marcello Malpighi Hosp, DIMEC Dept Med & Surg Sci, Bologna, Italy.
   [Franceschi, Claudio] Natl Res Lobachevsky State Univ Nizhny Novgorod, Inst ITMM, Dept Appl Math, Nizhnii Novgorod, Russia.
   [Capri, Miriam] Univ Bologna, CSR Ctr Studio Ric Invecchiamento, Bologna, Italy.
C3 University of Bologna; IRCCS Istituto delle Scienze Neurologiche di
   Bologna (ISNB); University of Bologna; Karolinska Institutet; IRCCS
   Istituto Ortopedico Rizzoli; Consiglio Nazionale delle Ricerche (CNR);
   Istituto di Genetica Molecolare (IGM-CNR); IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; IRCCS Azienda
   Ospedaliero-Universitaria di Bologna; University of Bologna; University
   of Insubria; IRCCS Azienda Ospedaliero-Universitaria di Bologna;
   Lobachevsky State University of Nizhni Novgorod; University of Bologna
RP Morsiani, C (corresponding author), Univ Bologna, Alma Mater Studiorum, DIMES Dept Expt Diagnost & Specialty Med, Via San Giacomo 12, I-40126 Bologna, Italy.
EM cristina.morsiani2@unibo.it
RI D'ERRICO, ANTONIETTA/HGU-1912-2022; Bacalini, Maria Giulia/K-4931-2016;
   Grazi, Gian Luca/J-7215-2018
OI D'ERRICO, ANTONIETTA/0000-0003-2747-3732; Bacalini, Maria
   Giulia/0000-0003-1618-2673; Grazi, Gian Luca/0000-0002-3279-0313;
   Garagnani, Paolo/0000-0002-4161-3626; Santoro,
   Aurelia/0000-0002-7187-1116; Cescon, Matteo/0000-0003-1715-3794
FU European Union (EU)'s H2020 Project "Propag-ageing" [634821]; EU JPND
   "Adage"; EU FP7 "HUMAN": Health and the understanding of Metabolism,
   Aging and Nutrition [602757]; University of Bologna FARB linea 2 Project
   2014 [RFBO120790]; CARIPLO (Fondazione Cassa di Risparmio delle Province
   Lombarde)-Ricerca malattie invecchiamento 2016 [2016-0835]; Ministry of
   Education and science of the Russian federation [074-02-2018-330]
FX This work has been partially supported by the European Union (EU)'s
   H2020 Project "Propag-ageing" (grant agreement no. 634821) to CF and PG;
   EU JPND "Adage" to CF; EU FP7 "HUMAN": Health and the understanding of
   Metabolism, Aging and Nutrition (grant agreement no. 602757) to CF;
   University of Bologna FARB linea 2 Project 2014 no. RFBO120790 to MC;
   and CARIPLO (Fondazione Cassa di Risparmio delle Province
   Lombarde)-2016-0835 Ricerca malattie invecchiamento 2016 to ME. Ministry
   of Education and science of the Russian federation(grant agreement no.
   074-02-2018-330) to CF.
CR Adolph TE, 2018, TRENDS IMMUNOL, V39, P712, DOI 10.1016/j.it.2018.05.002
   Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010
   Allaire JM, 2018, TRENDS IMMUNOL, V39, P677, DOI 10.1016/j.it.2018.04.002
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bacalini M. G., 2018, J GERONTOL A-BIOL, DOI [10.1093/gerona/g1y048, DOI 10.1093/GERONA/G1Y048]
   Bei YH, 2015, J CELL MOL MED, V19, P1441, DOI 10.1111/jcmm.12594
   Bei YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115991
   Bellavista E, 2014, MECH AGEING DEV, V141, P26, DOI 10.1016/j.mad.2014.09.003
   Bertuzzo VR, 2017, ANN SURG, V265, P388, DOI 10.1097/SLA.0000000000001681
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Bogdanos DP, 2013, COMPR PHYSIOL, V3, P567, DOI 10.1002/cphy.c120011
   Boteon Yuri L, 2018, Curr Transplant Rep, V5, P113, DOI 10.1007/s40472-018-0188-7
   Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033
   Bruno S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8468549
   Calder PC, 2017, AGEING RES REV, V40, P95, DOI 10.1016/j.arr.2017.09.001
   Capri M, 2018, AGING-US, V10, P156, DOI 10.18632/aging.101378
   Capri M, 2017, AGING CELL, V16, P262, DOI 10.1111/acel.12549
   Castellani GC, 2016, BRIEF BIOINFORM, V17, P527, DOI 10.1093/bib/bbv062
   Catera M, 2016, ONCOTARGET, V7, P7455, DOI 10.18632/oncotarget.7059
   Cavalcanti de A Martins Antonio, 2013, HPB (Oxford), V15, P322
   Ceafalan LC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/957014
   Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123
   Cescon M, 2003, LIVER TRANSPLANT, V9, P1174, DOI 10.1053/jlts.2003.50234
   Cescon M, 2008, LIVER TRANSPLANT, V14, P672, DOI 10.1002/lt.21433
   Cevenini E, 2014, AGE, V36, P949, DOI 10.1007/s11357-013-9604-1
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Corbitt N, 2013, AM J PATHOL, V182, P180, DOI 10.1016/j.ajpath.2012.09.010
   Cretoiu D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081322
   Czigany Z, 2019, LIVER INT, V39, P228, DOI 10.1111/liv.13946
   Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743
   Dasari BVM, 2017, BEST PRACT RES CL GA, V31, P211, DOI 10.1016/j.bpg.2017.03.002
   Dawidowicz J, 2015, J CELL MOL MED, V19, P2500, DOI 10.1111/jcmm.12665
   Dayoub JC, 2018, EXP GERONTOL, V110, P230, DOI 10.1016/j.exger.2018.06.019
   de Oliveira RM, 2018, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00328
   De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034
   Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026
   Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856
   Durand F., 2018, J HEPATOL, DOI [10.1016/j.jhep.2018.12, DOI 10.1016/J.JHEP.2018.12]
   Dyson JK, 2018, LANCET, V391, P2547, DOI 10.1016/S0140-6736(18)30300-3
   Edelstein L., 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00041, DOI 10.3389/FNMO1.2014.00041]
   Edelstein L, 2016, SEMIN CELL DEV BIOL, V55, P9, DOI 10.1016/j.semcdb.2016.03.010
   Enciu AM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/316495
   Engin A, 2017, ADV EXP MED BIOL, V960, P443, DOI 10.1007/978-3-319-48382-5_19
   Federico A, 2017, MINERVA GASTROENTERO, V63, P337, DOI 10.23736/S1121-421X.17.02376-5
   Flores A, 2017, LIVER TRANSPLANT, V23, P1216, DOI 10.1002/lt.24799
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Franceschi C, 2018, ANNU REV NUTR, V38, P329, DOI 10.1146/annurev-nutr-082117-051637
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Franceschi C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00982
   Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005
   Freitas-Lopes MA, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6040048
   Fu SY, 2015, J CELL MOL MED, V19, P676, DOI 10.1111/jcmm.12542
   GALE RP, 1987, THYMUS, V10, P45
   Gao QM, 2019, ANN SURG, V270, P333, DOI 10.1097/SLA.0000000000002876
   GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Grant CR, 2017, CLIN RES HEPATOL GAS, V41, P6, DOI 10.1016/j.clinre.2016.06.003
   Greuter T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95354
   Grizzi F, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-9
   Hamoud AR, 2018, TRENDS ENDOCRIN MET, V29, P140, DOI 10.1016/j.tem.2018.01.002
   Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094
   Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007
   Hofmann JW, 2014, AGE, V36, P1033, DOI 10.1007/s11357-014-9618-3
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Ibba-Manneschi L, 2016, SEMIN CELL DEV BIOL, V55, P62, DOI 10.1016/j.semcdb.2016.01.022
   Ji C, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/513787
   Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x
   Jones R, 2012, BRIT J GEN PRACT, V62, P319, DOI 10.3399/bjgp12X649241
   Luesma MJ, 2013, J CELL MOL MED, V17, P1016, DOI 10.1111/jcmm.12111
   Kamiyama T, 2013, HEPATOLOGY, V57, P2314, DOI 10.1002/hep.26262
   Kanwal F., 2011, GASTROENTEROLOGY, V140, DOI [10.1053/j.gastro.2010.12.032.1182-1188.el, DOI 10.1053/J.GASTRO.2010.12.032.1182-1188.EL]
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kholodenko IV, 2017, BIOMED RES INT-UK, V2017, DOI 10.1155/2017/8910821
   Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012
   Kooman JP, 2017, AM J PHYSIOL-RENAL, V313, pF938, DOI 10.1152/ajprenal.00256.2017
   Kusminski CM, 2018, P NATL ACAD SCI USA, V115, P4308, DOI 10.1073/pnas.1804203115
   Kwekel JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-675
   Lau A, 2019, J CLIN INVEST, V129, P4, DOI 10.1172/JCI123946
   Lebeaupin C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.248
   Lee SJ, 2014, WORLD J HEPATOL, V6, P207, DOI 10.4254/wjh.v6.i4.207
   Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368
   Li PZ, 2017, MOL IMMUNOL, V85, P222, DOI 10.1016/j.molimm.2017.02.018
   Liang X, 2017, J BIOL RHYTHM, V32, P505, DOI 10.1177/0748730417729066
   Nguyen L, 2018, EXP MOL PATHOL, V104, P45, DOI 10.1016/j.yexmp.2017.12.007
   Lué A, 2016, WORLD J GASTROENTERO, V22, P4966, DOI 10.3748/wjg.v22.i21.4966
   Ma JL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101124
   MacRae SL, 2015, AGING-US, V7, P1171, DOI 10.18632/aging.100866
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Malaguarnera G, 2014, WORLD J GASTROENTERO, V20, P16639, DOI 10.3748/wjg.v20.i44.16639
   Masouminia M, 2016, EXP MOL PATHOL, V101, P201, DOI 10.1016/j.yexmp.2016.08.002
   Mendoza AS, 2015, EXP MOL PATHOL, V98, P65, DOI 10.1016/j.yexmp.2014.12.003
   Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988
   Milosevic I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020395
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   POPPER H, 1985, SEMIN LIVER DIS, V5, P221, DOI 10.1055/s-2008-1040619
   Pulze L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13202-9
   Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060
   Rashid HO, 2017, J GASTROEN HEPATOL, V32, P981, DOI 10.1111/jgh.13619
   Rashidi H, 2018, ARCH TOXICOL, V92, P3117, DOI 10.1007/s00204-018-2280-2
   Reccia I, 2017, METABOLISM, V72, P94, DOI 10.1016/j.metabol.2017.04.011
   Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3
   Rutkowski DT, 2019, FEBS J, V286, P356, DOI 10.1111/febs.14389
   Saito Y, 2017, HEPATOL RES, V47, P505, DOI 10.1111/hepr.12872
   Salizzoni M, 2017, TRANSPLANTATION, V101, pe292, DOI 10.1097/TP.0000000000001835
   Santoro A, 2018, CELL MOL LIFE SCI, V75, P129, DOI 10.1007/s00018-017-2674-y
   Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Selwyn FP, 2015, TOXICOL SCI, V147, P84, DOI 10.1093/toxsci/kfv110
   Serra M, 2018, CELL TRANSPLANT, V27, P23, DOI 10.1177/0963689717727541
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sheng JW, 2014, J CELL MOL MED, V18, P355, DOI 10.1111/jcmm.12240
   Shenvi SV, 2012, AGING CELL, V11, P297, DOI 10.1111/j.1474-9726.2011.00788.x
   Song JL, 2015, CELL SIGNAL, V27, P1380, DOI 10.1016/j.cellsig.2015.03.018
   Soraas A, 2019, AGING CELL, V18, DOI 10.1111/acel.12897
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003
   Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048
   Thorsen T, 2015, TRANSPLANTATION, V99, P2534, DOI 10.1097/TP.0000000000000728
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006
   Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556
   Verma S, 2012, HEPATOLOGY, V56, P1510, DOI 10.1002/hep.25787
   Vermehren J, 2018, J HEPATOL, V69, P1178, DOI 10.1016/j.jhep.2018.07.002
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   VINK CLJ, 1959, CLIN CHIM ACTA, V4, P674
   Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607
   Wang F, 2015, CELL PHYSIOL BIOCHEM, V36, P250, DOI 10.1159/000374068
   Wang MJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.167
   Wei WQ, 2018, J CELL PHYSIOL, V233, P9121, DOI 10.1002/jcp.26956
   White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020
   Xiao JJ, 2013, J CELL MOL MED, V17, P1537, DOI 10.1111/jcmm.12195
   Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034
   Yu SZ, 2017, CANCER LETT, V411, P82, DOI 10.1016/j.canlet.2017.09.049
   Yu YS, 2019, J CLIN INVEST, V129, P546, DOI 10.1172/JCI121842
   Zheng YH, 2014, J CELL MOL MED, V18, P568, DOI 10.1111/jcmm.12290
NR 142
TC 29
Z9 30
U1 3
U2 17
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD MAY
PY 2019
VL 51
BP 24
EP 34
DI 10.1016/j.arr.2019.02.002
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HS2KO
UT WOS:000463689700003
PM 30772626
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Falade-Nwulia, O
   Thio, CL
AF Falade-Nwulia, Oluwaseun
   Thio, Chloe L.
TI Liver disease, HIV and aging
SO SEXUAL HEALTH
LA English
DT Article
DE cirrhosis; hepatitis; highly active antiretroviral therapy
ID HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ALPHA-2A PLUS
   RIBAVIRIN; B-VIRUS; HEPATOCELLULAR-CARCINOMA; INFECTED PATIENTS;
   UNITED-STATES; NATURAL-HISTORY; FIBROSIS PROGRESSION; DIABETES-MELLITUS
AB The life expectancy of HIV-infected patients has increased due to the efficacy of highly active antiretroviral therapy (HAART) in controlling HIV replication; thus, the population living with HIV infection is steadily aging. Liver-related morbidity and mortality has emerged as a leading problem in HIV-infected patients. Since aging, HIV infection and HAART all affect the liver, understanding the impact of the combination of these factors on liver disease is crucial for optimisation of care in the aging HIV-infected population. This review will focus on the current understanding of liver disease in older (>50 years old) HIV-negative individuals and in HIV-infected individuals. Areas for future research in the area of HIV, liver disease and aging will also be discussed.
C1 [Falade-Nwulia, Oluwaseun; Thio, Chloe L.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21231 USA.
   [Falade-Nwulia, Oluwaseun] NIH, Crit Care Med Dept, Bethesda, MD 20892 USA.
C3 Johns Hopkins University; National Institutes of Health (NIH) - USA
RP Falade-Nwulia, O (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 855 N Wolfe St,Suite 520, Baltimore, MD 21231 USA.
EM faladeoo@cc.nih.gov
OI Falade-Nwulia, Oluwaseun/0000-0003-2321-2295
FU NIH [AI060449, AI017820]
FX CLT is supported by NIH grants AI060449 and AI017820.
CR ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702
   Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604
   Arenas-Pinto A, 2007, AIDS, V21, P2455, DOI 10.1097/QAD.0b013e3282f08cdc
   Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691
   Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x
   Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004
   Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525
   Bhattacharya D, 2010, JAIDS-J ACQ IMM DEF, V55, P170, DOI 10.1097/QAI.0b013e3181e36420
   BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138
   Borroni G, 2010, HEPATOLOGY, V52, p809A
   Bräu N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289
   Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839
   CHIARAMONTE M, 1987, BIOMED PHARMACOTHER, V41, P121
   Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653
   CLEVELAND JL, 1994, J DENT RES, V73, P1029, DOI 10.1177/00220345940730050301
   Clifford GM, 2008, AIDS, V22, P2135, DOI 10.1097/QAD.0b013e32831103ad
   Crum-Cianflone N, 2009, JAIDS-J ACQ IMM DEF, V50, P464, DOI 10.1097/QAI.0b013e318198a88a
   Culberson JW, 2006, GERIATRICS-US, V61, P23
   Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c
   Dore GJ, 1999, J INFECT DIS, V180, P607, DOI 10.1086/314942
   Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150
   FLOREANI A, 1983, ARCH INTERN MED, V143, P1829, DOI 10.1001/archinte.143.9.1829
   Floreani A, 2009, BEST PRACT RES CL GA, V23, P909, DOI 10.1016/j.bpg.2009.10.005
   Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781
   Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116
   Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Fung J, 2011, J HEPATOL, V54, P159
   Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179
   Gebo KA, 2006, DRUG AGING, V23, P897, DOI 10.2165/00002512-200623110-00005
   Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
   Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811
   Guaraldi G, 2008, CLIN INFECT DIS, V47, P250, DOI 10.1086/589294
   Guaraldi G, 2010, JAIDS-J ACQ IMM DEF, V53, P278, DOI 10.1097/QAI.0b013e3181c990ed
   Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010
   HAYASHI PH, 1991, J MED VIROL, V33, P177, DOI 10.1002/jmv.1890330307
   Howard AA, 2003, CLIN INFECT DIS, V36, P1318, DOI 10.1086/374838
   Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x
   Junaidi O, 2007, CLIN GERIATR MED, V23, P889, DOI 10.1016/j.cger.2007.06.006
   Kawaoka T, 2007, J GASTROENTEROL, V42, P395, DOI 10.1007/s00535-007-2015-2
   Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe
   Kramer JR, 2005, AM J GASTROENTEROL, V100, P56, DOI 10.1111/j.1572-0241.2005.40670.x
   Landrum ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008687
   Mai AL, 1996, J CLIN GASTROENTEROL, V22, P299, DOI 10.1097/00004836-199606000-00012
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Marcus EL, 2005, CLIN INFECT DIS, V41, P1606, DOI 10.1086/497597
   Marzolini C, 2010, ANTIVIR THER, V15, P413, DOI 10.3851/IMP1540
   Mason AL, 1999, HEPATOLOGY, V29, P328, DOI 10.1002/hep.510290235
   Matthews GV, 2007, AIDS, V21, P2112, DOI 10.1097/QAD.0b013e3282ef3873
   Matthews GV, 2006, AIDS, V20, P863, DOI 10.1097/01.aids.0000218550.85081.59
   McGovern BH, 2006, CLIN INFECT DIS, V43, P365, DOI 10.1086/505495
   Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   Moyle G, 2000, CLIN THER, V22, P911, DOI 10.1016/S0149-2918(00)80064-8
   Nkhoma E, 2010, 1 INT WORKSH HIV AG
   Nudo CG, 2006, CAN J GASTROENTEROL, V20, P589, DOI 10.1155/2006/357259
   Núñez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002
   O'Connor S, 2010, JAMA-J AM MED ASSOC, V303, P2349
   Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005
   POTTER JF, 1987, GERONTOLOGY, V33, P380, DOI 10.1159/000212907
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024
   Puoti M, 2004, AIDS, V18, P2285, DOI 10.1097/00002030-200411190-00009
   RUMI MG, 1990, ANN INTERN MED, V112, P379, DOI 10.7326/0003-4819-112-5-379
   Salmon-Ceron D, 2009, J HEPATOL, V50, P736, DOI 10.1016/j.jhep.2008.11.018
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   SHERMAN KE, 1991, J INFECT DIS, V163, P414, DOI 10.1093/infdis/163.2.414
   Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   Spradling PR, 2010, J VIRAL HEPATITIS, V17, P879, DOI 10.1111/j.1365-2893.2009.01249.x
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Thio CL, 2007, AIDS REV, V9, P40
   Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1
   Thomas DL, 2002, HEPATOLOGY, V36, pS201, DOI 10.1053/jhep.2002.36380
   Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450
   TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202
   Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842
   TSENG A, 2010, 1 INT WORKSH HIV AG
   Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631
   van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5
   Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038
NR 89
TC 13
Z9 16
U1 0
U2 0
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1448-5028
EI 1449-8987
J9 SEX HEALTH
JI Sex Health
PY 2011
VL 8
IS 4
SI SI
BP 512
EP 520
DI 10.1071/SH10163
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 844UM
UT WOS:000296774000010
PM 22127037
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Porukala, M
   Vinod, PK
AF Porukala, Manisri
   Vinod, P. K.
TI Network-level analysis of ageing and its relationship with diseases and
   tissue regeneration in the mouse liver
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ONE-CARBON METABOLISM; HIGH-FAT DIET; NF-KAPPA-B; GENE-EXPRESSION;
   PERILIPIN 2; PROTEIN; INFLAMMATION; RELEVANCE; BINDING; MODELS
AB The liver plays a vital role in maintaining whole-body metabolic homeostasis, compound detoxification and has the unique ability to regenerate itself post-injury. Ageing leads to functional impairment of the liver and predisposes the liver to non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC). Mapping the molecular changes of the liver with ageing may help to understand the crosstalk of ageing with different liver diseases. A systems-level analysis of the ageing-induced liver changes and its crosstalk with liver-associated conditions is lacking. In the present study, we performed network-level analyses of the ageing liver using mouse transcriptomic data and a protein-protein interaction (PPI) network. A sample-wise analysis using network entropy measure was performed, which showed an increasing trend with ageing and helped to identify ageing genes based on local entropy changes. To gain further insights, we also integrated the differentially expressed genes (DEGs) between young and different age groups with the PPI network and identified core modules and nodes associated with ageing. Finally, we computed the network proximity of the ageing network with different networks of liver diseases and regeneration to quantify the effect of ageing. Our analysis revealed the complex interplay of immune, cancer signalling, and metabolic genes in the ageing liver. We found significant network proximities between ageing and NAFLD, HCC, liver damage conditions, and the early phase of liver regeneration with common nodes including NLRP12, TRP53, GSK3B, CTNNB1, MAT1 and FASN. Overall, our study maps the network-level changes of ageing and their interconnections with the physiology and pathology of the liver.
C1 [Porukala, Manisri; Vinod, P. K.] IIIT, Ctr Computat Nat Sci & Bioinformat, Hyderabad 500032, India.
C3 International Institute of Information Technology Hyderabad
RP Vinod, PK (corresponding author), IIIT, Ctr Computat Nat Sci & Bioinformat, Hyderabad 500032, India.
EM vinod.pk@iiit.ac.in
OI Vinod, P K/0000-0003-2968-498X
FU Department of Biotechnology [BT/PR31936/BID/7/861/2019]; IHub-Data, IIIT
   Hyderabad
FX <STRONG>& nbsp;</STRONG>PKV acknowledges financial support from the
   Department of Biotechnology (BT/PR31936/BID/7/861/2019) and IHub-Data,
   IIIT Hyderabad.
CR Arteel GE, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100115
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Bergamini E, 2004, INT J BIOCHEM CELL B, V36, P2392, DOI 10.1016/j.biocel.2004.05.007
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11
   Clemens Z, 2021, ELIFE, V10, DOI 10.7554/eLife.61138
   Collin de l'Hortet A, 2014, ENDOCRINOLOGY, V155, P2545, DOI 10.1210/en.2014-1010
   Conte M, 2016, TRENDS ENDOCRIN MET, V27, P893, DOI 10.1016/j.tem.2016.09.001
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   da Silva RP, 2020, J NUTR, V150, P994, DOI 10.1093/jn/nxaa032
   de Jong S, 2021, PROG RETIN EYE RES, V84, DOI 10.1016/j.preteyeres.2021.100952
   DeAngelis RA, 2005, HEPATOLOGY, V42, P1148, DOI 10.1002/hep.20879
   Emma MR, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118743
   Ericksen RE, 2019, CELL METAB, V29, P1151, DOI 10.1016/j.cmet.2018.12.020
   Fabian DK, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00232-1
   Fafián-Labora J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1550-0
   Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114
   Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang JS, 2014, AM J PATHOL, V184, P309, DOI 10.1016/j.ajpath.2013.04.034
   Iimuro Y, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/598109
   Jacenik D, 2020, CLIN CHIM ACTA, V504, P146, DOI 10.1016/j.cca.2020.02.008
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Kampf C, 2014, FASEB J, V28, P2901, DOI 10.1096/fj.14-250555
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18571-9
   Libby AE, 2016, J BIOL CHEM, V291, P24231, DOI 10.1074/jbc.M116.759795
   Lionaki E, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11020214
   Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Menichetti G, 2015, MOL BIOSYST, V11, P1824, DOI 10.1039/c5mb00143a
   Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015
   Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39182
   Perugorria MJ, 2019, NAT REV GASTRO HEPAT, V16, P121, DOI 10.1038/s41575-018-0075-9
   Pibiri M, 2015, AGE, V37, DOI 10.1007/s11357-015-9796-7
   Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415
   Radziejewska A, 2020, LIFESTYLE GENOM, V13, P53, DOI 10.1159/000504602
   Rib L, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0222-0
   Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744
   Rosenzweig A, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00090
   Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126
   Sorgdrager FJH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02565
   Srivastava A, 2020, GENOM PROTEOM BIOINF, V18, P430, DOI 10.1016/j.gpb.2020.12.001
   Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013
   Suh E, 2016, MOLEC NUTRITION, P513, DOI 10.1016/B978-0-12-801816-3.00036-4
   Teschendorff AE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-104
   Tian J, 2016, P NATL ACAD SCI USA, V113, P8182, DOI 10.1073/pnas.1608987113
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Wanders RJA, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00083
   Wang HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19445
   West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Wilson CH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.567
   Wink L, 2022, IMMUN AGEING, V19, DOI 10.1186/s12979-022-00264-1
   Wu DY, 2018, CELL DEATH DIFFER, V25, P169, DOI 10.1038/cdd.2017.187
   Xu SF, 2018, REDOX REP, V23, P213, DOI 10.1080/13510002.2018.1546985
   Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
   Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059
   Zhang LL, 2022, CELL MOL GASTROENTER, V14, P1311, DOI 10.1016/j.jcmgh.2022.07.011
   Zheng RZ, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23158689
   Zhou Y., 2021, ALZHEIMERS RES THER, V13, P1
NR 77
TC 3
Z9 3
U1 1
U2 1
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 21
PY 2023
VL 13
IS 1
AR 4632
DI 10.1038/s41598-023-31315-2
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA L5US8
UT WOS:001023921200065
PM 36944690
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Sulyok, M
   Ferenci, T
   Makara, M
   Horváth, G
   Szlávik, J
   Rupnik, Z
   Kormos, L
   Gerlei, Z
   Sulyok, Z
   Vályi-Nagy, I
AF Sulyok, Mihaly
   Ferenci, Tamas
   Makara, Mihaly
   Horvath, Gabor
   Szlavik, Janos
   Rupnik, Zsofia
   Kormos, Luca
   Gerlei, Zsuzsanna
   Sulyok, Zita
   Valyi-Nagy, Istvan
TI Hepatic fibrosis and factors associated with liver stiffness in HIV
   mono-infected individuals
SO PEERJ
LA English
DT Article
DE HIV; Liver fibrosis; Antiretroviral therapy; Elasticity imaging
   techniques; Bayesian model averaging; Ageing; Lipodystrophy
ID CONTROLLED ATTENUATION PARAMETER; VIRUS-COINFECTED INDIVIDUALS;
   ANTIRETROVIRAL THERAPY; TRANSIENT ELASTOGRAPHY; VIRAL-HEPATITIS;
   RISK-FACTORS; MONOINFECTED PATIENTS; PROGRESSION; BIOPSY;
   IMMUNODEFICIENCY
AB Background. Liver disease has become an important cause of morbidity and mortality even in those HIV-infected individuals who are devoid of hepatitis virus co-infection. The aim of this study was to evaluate the degree of hepatic fibrosis and the role of associated factors using liver stiffness measurement in HIV mono-infected patients without significant alcohol intake.
   Methods. We performed a cross-sectional study of 101 HIV mono-infected patients recruited prospectively from March 1, 2014 to October 30, 2014 at the Center for HIV, St Istvan and St Laszlo Hospital, Budapest, Hungary. To determine hepatic fibrosis, liver stiffness was measured with transient elastography. Demographic, immunologic and other clinical parameters were collected to establish a multivariate model. Bayesian Model Averaging (BMA) was performed to identify predictors of liver stiffness.
   Results. Liver stiffness ranged from 3.0 - 34.3 kPa, with a median value of 5.1 kPa (IQR 1.7). BMA provided a very high support for age (Posterior Effect Probability-PEP: 84.5%), moderate for BMI (PEP: 49.3%), CD4/8 ratio (PEP: 44.2%) and lipodystrophy (PEP: 44.0%). For all remaining variables, the model rather provides evidence against their effect. These results overall suggest that age and BMI have a positive association with LS, while CD4/8 ratio and lipodystrophy are negatively associated.
   Discussion. Our findings shed light on the possible importance of ageing, overweight and HIV-induced immune dysregulation in the development of liver fibrosis in the HIV-infected population. Nonetheless, further controlled studies are warranted to clarify causal relations.
C1 [Sulyok, Mihaly] Semmelweis Univ, Doctoral Sch Clin Med, Budapest, Hungary.
   [Sulyok, Mihaly; Sulyok, Zita] Eberhard Karls Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Ferenci, Tamas] Obuda Univ, John von Neumann Fac Informat, Physiol Controls Grp, Budapest, Hungary.
   [Makara, Mihaly; Valyi-Nagy, Istvan] St Istvan & St Laszlo Hosp, Ctr Hepatol, Budapest, Hungary.
   [Makara, Mihaly; Horvath, Gabor] Hepatol Ctr Buda, Budapest, Hungary.
   [Szlavik, Janos; Rupnik, Zsofia; Kormos, Luca; Valyi-Nagy, Istvan] St Istvan & St Laszlo Hosp, Ctr HIV, Budapest, Hungary.
   [Gerlei, Zsuzsanna] Semmelweis Univ, Transplantat & Surg Clin, Budapest, Hungary.
C3 Semmelweis University; Eberhard Karls University of Tubingen; Obuda
   University; Semmelweis University
RP Sulyok, M (corresponding author), Semmelweis Univ, Doctoral Sch Clin Med, Budapest, Hungary.; Sulyok, M (corresponding author), Eberhard Karls Univ Tubingen, Inst Trop Med, Tubingen, Germany.
EM mihaly.sulyok@uni-tuebingen.de
RI Ferenci, Tamás/H-4682-2012
OI Ferenci, Tamás/0000-0001-6791-3080; Sulyok, Mihaly/0000-0002-6960-5126;
   Valyi-Nagy, Istvan/0000-0003-3581-113X
FU New National Excellence Program of the Ministry of Human Capacities,
   Hungary [UNKP-16-4/III]
FX Tamas Ferenci was supported by the New National Excellence Program of
   the Ministry of Human Capacities, Hungary (UNKP-16-4/III). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Akhtar MA, 2008, EUR J GASTROEN HEPAT, V20, P1194, DOI 10.1097/MEG.0b013e328305b9e0
   [Anonymous], 2016, REGRESSION MODELING
   Audsley J, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw035
   Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x
   Brunet L, 2016, CLIN INFECT DIS, V62, P242, DOI 10.1093/cid/civ838
   Chan AW, 2016, CURR HIV-AIDS REP, V13, P309, DOI 10.1007/s11904-016-0332-x
   Costiniuk CT, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw050
   DallaPiazza M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-116
   Feuth T, 2014, EUR J CLIN MICROBIOL, V33, P1113, DOI 10.1007/s10096-014-2053-7
   Gonzalez FA, 2015, HIV MED, V16, P211, DOI 10.1111/hiv.12197
   Guilabert MIG, 2010, GASTROENT HEPAT-BARC, V33, P425, DOI 10.1016/j.gastrohep.2010.02.005
   Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811
   Han SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052720
   Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519
   Ioannou GN, 2015, EUR J GASTROEN HEPAT, V27, P577, DOI 10.1097/MEG.0000000000000290
   Kliemann DA, 2016, ANN HEPATOL, V15, P27, DOI 10.5604/16652681.1184197
   Konerman MA, 2014, HEPATOLOGY, V59, P767, DOI 10.1002/hep.26741
   Kooij KW, 2016, AIDS, V30, P1771, DOI 10.1097/QAD.0000000000001119
   Lui G, 2016, ALIMENT PHARM THER, V44, P411, DOI 10.1111/apt.13702
   Macías J, 2016, HIV MED, V17, P766, DOI 10.1111/hiv.12384
   Macías J, 2014, AIDS, V28, P1279, DOI 10.1097/QAD.0000000000000248
   Macías J, 2013, CLIN INFECT DIS, V57, P1401, DOI 10.1093/cid/cit537
   Macías J, 2013, AIDS, V27, P2541, DOI 10.1097/QAD.0b013e32836381f3
   Merchante N, 2010, ANTIVIR THER, V15, P753, DOI 10.3851/IMP1612
   Njei B, 2016, J GASTROEN HEPATOL, V31, P1684, DOI 10.1111/jgh.13337
   Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D
   Raftery A., 2015, R PACKAGE VERSION 3
   Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063
   Redd AD, 2013, AIDS RES HUM RETROV, V29, P1026, DOI [10.1089/aid.2013.0004, 10.1089/AID.2013.0004]
   Rivero-Juárez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068953
   Rockstroh JK, 2014, CURR OPIN HIV AIDS, V9, P365, DOI 10.1097/COH.0000000000000064
   Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001
   Sanmartin R, 2014, HIV MED, V15, P203, DOI 10.1111/hiv.12105
   Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078
   Shur NF, 2016, AIDS CARE, V28, P1522, DOI 10.1080/09540121.2016.1191603
   Sulyok M, 2015, EUR J GASTROEN HEPAT, V27, P679, DOI 10.1097/MEG.0000000000000339
   Vecchi VL, 2013, ANN HEPATOL, V12, P740, DOI 10.1016/S1665-2681(19)31315-8
   Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857
   Fernández-Montero JV, 2013, AIDS, V27, P1129, DOI 10.1097/QAD.0b013e32835e063f
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
NR 40
TC 3
Z9 3
U1 0
U2 3
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JAN 11
PY 2017
VL 5
AR e2867
DI 10.7717/peerj.2867
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EL5YK
UT WOS:000394697300003
PM 28097068
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ramirez, T
   Li, YM
   Yin, S
   Xu, MJ
   Feng, DC
   Zhou, Z
   Zang, MW
   Mukhopadhyay, P
   Varga, ZV
   Pacher, P
   Gao, B
   Wang, H
AF Ramirez, Teresa
   Li, Yong-Mei
   Yin, Shi
   Xu, Ming-Jiang
   Feng, Dechun
   Zhou, Zhou
   Zang, Mengwei
   Mukhopadhyay, Partha
   Varga, Zoltan V.
   Pacher, Pal
   Gao, Bin
   Wang, Hua
TI Aging aggravates alcoholic liver injury and fibrosis in mice by
   downregulating sirtuin 1 expression
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Fatty liver; Steatohepatitis; Ethanol; PDGFR-alpha; Middle-age; Hepatic
   stellate cells (HSCs)
ID KILLER T-CELLS; HIGH-FAT DIET; NATURAL-KILLER; MITOCHONDRIAL-FUNCTION;
   HEPATIC STEATOSIS; MOUSE MODEL; IN-VITRO; DISEASE; PROMOTES; INHIBITION
AB Background & Aims: Aging is known to exacerbate the progression of alcoholic liver disease (ALD), but the underlying mechanisms remain obscure. The aim of this study was to use a chronic plus binge ethanol feeding model in mice to evaluate the effects of aging on alcohol-induced liver injury.
   Methods: C57BL/6 mice were subjected to short-term (10 days) ethanol plus one binge or long-term (8 weeks) ethanol plus multiple binges of ethanol. Liver injury and fibrosis were determined. Hepatic stellate cells (HSCs) were isolated and used in in vitro studies.
   Results: Middle-aged (12-14 months) and old-aged (>16 months) mice were more susceptible to liver injury, inflammation, and oxidative stress induced by short-term plus one binge or long-term plus multiple binges of ethanol feeding when compared to young (8-12 weeks) mice. Long-term plus multiple binges of ethanol feeding induced greater liver fibrosis in middle-aged mice than that in young mice. Hepatic expression of sirtuin 1 (SIRT1) protein was downregulated in the middle-aged mice compared to young mice. Restoration of SIRT1 expression via the administration of adenovirus-SIRT1 vector ameliorated short-term plus binge ethanol induced liver injury and fibrosis in middle-aged mice. HSCs isolated from middle-aged mice expressed lower levels of SIRT1 protein and were more susceptible to spontaneous activation in in vitro culture than those from young mice. Overexpression of SIRT1 reduced activation of HSCs from middle-aged mice in vitro with downregulation of PDGFR-alpha and c-Myc, while deletion of SIRT1 activated HSCs isolated from young mice in vitro. Finally, HSC-specific SIRT1 knockout mice were more susceptible to long-term chronic-plus-multiple binges of ethanol-induced liver fibrosis with upregulation of PDGFR-alpha expression.
   Conclusions: Aging exacerbates ALD in mice through the down regulation of SIRT1 in hepatocytes and HSCs. Activation of SIRT1 may serve as a novel target for the treatment of ALD.
   Lay summary: Aged mice are more susceptible to alcohol-induced liver injury and fibrosis, which is, at least in part, due to lower levels of sirtuin 1 protein in hepatocytes and hepatic stellate cells. Our findings suggest that sirtuin 1 activators may have beneficial effects for the treatment of alcoholic liver disease in aged patients. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
C1 [Ramirez, Teresa; Li, Yong-Mei; Yin, Shi; Xu, Ming-Jiang; Feng, Dechun; Zhou, Zhou; Gao, Bin; Wang, Hua] NIAAA, Lab Liver Dis, NIH, Bethesda, MD 20892 USA.
   [Wang, Hua] Anhui Med Univ, Inst Liver Dis, Affiliated Hosp 1, Dept Oncol, 218 Jixi Rd, Hefei 230032, Peoples R China.
   [Yin, Shi] Anhui Med Univ, Affiliated Prov Hosp, Dept Geriatr, Hefei 230032, Peoples R China.
   [Zang, Mengwei] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Mol Med, San Antonio, TX 78229 USA.
   [Mukhopadhyay, Partha; Varga, Zoltan V.; Pacher, Pal] NIAAA, Lab Cardiovasc Physiol & Tissue Injury, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); Anhui Medical University; Anhui
   Medical University; University of Texas System; University of Texas
   Health Science Center at San Antonio; National Institutes of Health
   (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism
   (NIAAA)
RP Gao, B; Wang, H (corresponding author), NIAAA, Lab Liver Dis, NIH, Bethesda, MD 20892 USA.; Gao, B; Wang, H (corresponding author), Anhui Med Univ, Inst Liver Dis, Affiliated Hosp 1, Dept Oncol, 218 Jixi Rd, Hefei 230032, Peoples R China.
EM bgao@mail.nih.gov; wanghua@ahmu.edu.cn
RI Yin, Shi/GPX-3723-2022; Feng, Dechun/Q-5962-2016; Pacher,
   Pal/B-6378-2008; Zhou, Zhou/R-7788-2016; Varga, Zoltan V/J-9264-2017;
   li, yong/HDN-3885-2022
OI Pacher, Pal/0000-0001-7036-8108; Varga, Zoltan V/0000-0002-2758-0784;
   Wang, Hua/0000-0002-2605-5697
FU intramural program of NIAAA, NIH, United States; National Natural
   Science Foundation of China [81522009/H0317, 81470879/H0318]; NIH,
   United States [R01 DK100603, R21AA021181]
FX This work was supported by the intramural program of NIAAA, NIH, United
   States (BG), National Natural Science Foundation of China (No.
   81522009/H0317 to HW, 81470879/H0318 to SY), the NIH, United States
   Grants (R01 DK100603 and R21AA021181 to MZ). No conflicts of interest
   exist for any of the authors.
CR Abdelmegeed MA, 2016, FREE RADICAL BIO MED, V91, P188, DOI 10.1016/j.freeradbiomed.2015.12.016
   Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134
   Arteaga M, 2016, AM J PHYSIOL-GASTR L, V310, pG1155, DOI 10.1152/ajpgi.00271.2015
   Bataller R, 2015, SEMIN LIVER DIS, V35, P146, DOI 10.1055/s-0035-1550054
   Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738
   Bergheim I, 2005, DIGEST DIS, V23, P275, DOI 10.1159/000090175
   Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032
   Cao YN, 2013, J HEPATOL, V59, P1299, DOI 10.1016/j.jhep.2013.07.011
   Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289
   Chung J, 2012, J NUTR, V142, P405, DOI 10.3945/jn.111.150052
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Cui KL, 2015, J HEPATOL, V62, P1311, DOI 10.1016/j.jhep.2014.12.027
   Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010
   Dowds CM, 2015, CLIN IMMUNOL, V159, P128, DOI 10.1016/j.clim.2015.05.008
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]
   Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kirpich IA, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010001
   Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059
   Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014
   Liu XJ, 2015, J HEPATOL, V63, P713, DOI 10.1016/j.jhep.2015.05.018
   Maricic I, 2015, HEPATOLOGY, V61, P1357, DOI 10.1002/hep.27632
   Mathews S, 2016, CELL MOL IMMUNOL, V13, P206, DOI 10.1038/cmi.2015.06
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258
   Pazienza V, 2014, AGING-US, V6, P35, DOI 10.18632/aging.100632
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   SEITZ HK, 1992, RES EXP MED, V192, P205, DOI 10.1007/BF02576276
   Warren Alessandra, 2011, Curr Gerontol Geriatr Res, V2011, P439835, DOI 10.1155/2011/439835
   Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028
   Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009
   Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008
   You M, 2015, HEPATOBIL SURG NUTR, V4, P88, DOI 10.3978/j.issn.2304-3881.2014.12.06
   Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003
NR 41
TC 105
Z9 117
U1 4
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD MAR
PY 2017
VL 66
IS 3
BP 601
EP 609
DI 10.1016/j.jhep.2016.11.004
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA EM3MB
UT WOS:000395218200019
PM 27871879
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Nakajima, T
   Nakashima, T
   Okada, Y
   Jo, M
   Nishikawa, T
   Mitsumoto, Y
   Katagishi, T
   Kimura, H
   Itoh, Y
   Kagawa, K
   Yoshikawa, T
AF Nakajima, Tomoki
   Nakashima, Toshiaki
   Okada, Yoshihisa
   Jo, Masayasu
   Nishikawa, Taichiro
   Mitsumoto, Yasuhide
   Katagishi, Tatsuo
   Kimura, Hiroyuki
   Itoh, Yoshito
   Kagawa, Keizo
   Yoshikawa, Toshikazu
TI Nuclear size measurement is a simple method for the assessment of
   hepatocellular aging in non-alcoholic fatty liver disease: Comparison
   with telomere-specific quantitative FISH and p21 immunohistochemistry
SO PATHOLOGY INTERNATIONAL
LA English
DT Article
DE non-alcoholic fatty liver disease; nuclear enlargement; p21 protein;
   quantitative fluorescent in situ hybridization; senescence; telomere
ID IN-SITU HYBRIDIZATION; CELLULAR SENESCENCE; HUMAN HEPATOCYTES; OXIDATIVE
   STRESS; LENGTH; STEATOHEPATITIS; AGE
AB Telomere-specific quantitative fluorescent in situ hybridization (Q-FISH) accurately evaluates hepatocellular aging on histological sections, but it requires appropriate tissue processing. To establish a more simple method for the assessment of hepatocellular aging, the usefulness of nuclear size measurement was clarified using biopsy liver samples from 64 patients with non-alcoholic fatty liver disease (NAFLD), a model for oxidative stress-associated hepatocellular aging, and 11 control individuals. Relative telomere intensity (RTI) was measured on Q-FISH, and the relative nuclear size (RNS) was calculated as the average nuclear size of the hepatocytes divided by that of lymphocytes. In normal individuals and NAFLD patients, the RTI and RNS were negatively correlated. The degree of nuclear enlargement in NAFLD patients was larger than that in normal individuals with the same telomere length, possibly reflecting telomere-independent senescence. In NAFLD patients with RNS > 2.0, the regenerative responses, indicated by the ratio of Ki-67-positive index to serum alanine aminotransferase level, were significantly reduced. The RNS positively correlated with the p21 expression, another marker of senescence. This all indicates that nuclear enlargement progresses in parallel with reduced regenerative responses, telomere shortening, and p21 upregulation. Nuclear size measurement is an effective method for estimation of hepatocellular aging.
C1 [Nakajima, Tomoki; Nakashima, Toshiaki] Saiseikai Kyoto Hosp, Dept Med, Nagaoka Kyo, Kyoto 6170814, Japan.
   [Okada, Yoshihisa; Jo, Masayasu; Nishikawa, Taichiro; Mitsumoto, Yasuhide; Katagishi, Tatsuo; Kimura, Hiroyuki; Itoh, Yoshito; Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan.
   [Kagawa, Keizo] Fukuchiyama City Hosp, Kyoto, Japan.
C3 Kyoto Prefectural University of Medicine
RP Nakajima, T (corresponding author), Saiseikai Kyoto Hosp, Dept Med, 8 Minamihirao, Nagaoka Kyo, Kyoto 6170814, Japan.
EM tomnaka@silver.ocn.ne.jp
CR Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Ferlicot S, 2003, J PATHOL, V200, P661, DOI 10.1002/path.1392
   Gorla GR, 2001, J CELL SCI, V114, P2943
   Hepperger C, 2007, CHROMOSOMA, V116, P117, DOI 10.1007/s00412-006-0084-2
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200
   Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711
   Kapoor Veena, 2004, Methods Mol Biol, V263, P385
   Kim H, 2009, HEPATOLOGY, V50, P752, DOI 10.1002/hep.23072
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097
   Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026
   Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9
   Mocali A, 2005, J GERONTOL A-BIOL, V60, P695, DOI 10.1093/gerona/60.6.695
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2004, BIOCHEM BIOPH RES CO, V325, P1131, DOI 10.1016/j.bbrc.2004.10.152
   Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   Ohshima S, 2008, CYTOM PART A, V73A, P808, DOI 10.1002/cyto.a.20604
   Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552
   Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Toussaint O, 2002, INT J BIOCHEM CELL B, V34, P1415, DOI 10.1016/S1357-2725(02)00034-1
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   WATANABE T, 1978, VIRCHOWS ARCH B, V27, P307
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
NR 30
TC 42
Z9 44
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1320-5463
EI 1440-1827
J9 PATHOL INT
JI Pathol. Int.
PD MAR
PY 2010
VL 60
IS 3
BP 175
EP 183
DI 10.1111/j.1440-1827.2009.02504.x
PG 9
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 560MM
UT WOS:000274906800004
PM 20403043
DA 2024-02-19
ER

PT J
AU Aravinthan, A
   Mells, G
   Allison, M
   Leathart, J
   Kotronen, A
   Yki-Jarvinen, H
   Daly, AK
   Day, CP
   Anstee, QM
   Alexander, G
AF Aravinthan, Aloysious
   Mells, George
   Allison, Michael
   Leathart, Julian
   Kotronen, Anna
   Yki-Jarvinen, Hannele
   Daly, Ann K.
   Day, Christopher P.
   Anstee, Quentin M.
   Alexander, Graeme
TI Gene polymorphisms of cellular senescence marker p21 and disease
   progression in non-alcohol-related fatty liver disease
SO CELL CYCLE
LA English
DT Article
DE senescence; cell cycle inhibitor p21; polymorphism; chronic liver
   disease; liver fibrosis
ID NONALCOHOLIC STEATOHEPATITIS; FIBROSIS; ASSOCIATION; REGENERATION;
   PREDICTORS; HEPATITIS; SEVERITY; CANCER; DAMAGE
AB Non-alcohol-related fatty liver disease (NAFLD) encompasses a wide spectrum, ranging from steatosis alone to steatohepatitis and fibrosis. Presence of steatohepatitis and fibrosis are key hallmarks of disease progression. Previous studies have demonstrated an association between hepatocyte p21 expression and fibrosis stage in NAFLD. The aim of this study is to investigate the association between the variants of CDKN1A, which encodes p21, and disease progression in NAFLD. To this end, the relation between CDKN1A polymorphism and liver fibrosis was studied in 2 cohorts of biopsyproven NAFLD patients from UK (n = 323) and Finland (n = 123). Genotyping was performed using DNA isolated from lymphocytes collected at the time of liver biopsy. The findings of the UK cohort were tested in the Finnish cohort. Both the UK and Finnish cohorts were significantly different from each other in basic demographics. In the UK cohort, rs762623, of the 6 SNPs across CDKN1A tested, was significantly associated with disease progression in NAFLD. This association was confirmed in the Finnish cohort. Despite the influence on fibrosis development, SNPs across CDKN1A did not affect the progression of liver fibrosis. In conclusion, CDKN1A variant rs762623 is associated with the development but not the propagation of progressive liver disease in NAFLD.
C1 [Aravinthan, Aloysious; Mells, George; Allison, Michael; Alexander, Graeme] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.
   [Leathart, Julian; Daly, Ann K.; Day, Christopher P.; Anstee, Quentin M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Kotronen, Anna; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Helsinki, Finland.
C3 University of Cambridge; Newcastle University - UK; University of
   Helsinki
RP Alexander, G (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.
EM quentin.anstee@newcastle.ac.uk; gja1000@doctors.org.uk
RI Daly, Ann/H-3144-2011; Day, Christopher/Z-3305-2019; Anstee, Quentin
   M./L-2981-2013; Aravinthan, Aloysious D/I-2557-2019
OI Anstee, Quentin M./0000-0002-9518-0088; Aravinthan, Aloysious
   D/0000-0003-0527-5137; Allison, Michael/0000-0003-3677-3294; Daly,
   Ann/0000-0002-7321-0629
CR Al-Serri A, 2012, J HEPATOL, V56, P448, DOI 10.1016/j.jhep.2011.05.029
   Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604
   Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Anstee QM, 2011, SEMIN LIVER DIS, V31, P128, DOI 10.1055/s-0031-1276643
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Daly AK, 1996, PHARMACOGENETICS, V6, P319, DOI 10.1097/00008571-199608000-00005
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009
   Dixon JB, 2003, J HEPATOL, V39, P967, DOI 10.1016/S0168-8278(03)00459-8
   Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540
   Dongiovanni P, 2010, GUT, V59, P267, DOI 10.1136/gut.2009.190801
   Klein S, 2012, LAB INVEST, V92, P1440, DOI 10.1038/labinvest.2012.106
   Kong EKP, 2007, RHEUMATOLOGY, V46, P220, DOI 10.1093/rheumatology/kel210
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Korthagen NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030442
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978
   Ma HX, 2011, LUNG CANCER, V73, P32, DOI 10.1016/j.lungcan.2010.11.001
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Miele L, 2008, GASTROENTEROLOGY, V135, P282, DOI 10.1053/j.gastro.2008.04.004
   Nakajima T, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2005.01178.x
   Nakajima T, 2010, PATHOL INT, V60, P175, DOI 10.1111/j.1440-1827.2009.02504.x
   Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013
   Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622
   Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655
   Yoneda M, 2009, LIVER INT, V29, P1078, DOI 10.1111/j.1478-3231.2009.01988.x
NR 39
TC 49
Z9 53
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD MAY 1
PY 2014
VL 13
IS 9
BP 1489
EP 1494
DI 10.4161/cc.28471
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA AI2BC
UT WOS:000336660700021
PM 24626178
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Fujisawa, K
   Terai, S
   Matsumoto, T
   Takami, T
   Yamamoto, N
   Nishina, H
   Furutani-Seiki, M
   Sakaida, I
AF Fujisawa, Koichi
   Terai, Shuji
   Matsumoto, Toshihiko
   Takami, Taro
   Yamamoto, Naoki
   Nishina, Hiroshi
   Furutani-Seiki, Makoto
   Sakaida, Isao
TI Evidence for a Role of the Transcriptional Regulator Maid in
   Tumorigenesis and Aging
SO PLOS ONE
LA English
DT Article
ID INTERACTING PROTEIN; LIVER-REGENERATION; JAPANESE MEDAKA; MARKER
   PROTEIN; HUMAN HOMOLOG; GCIP; EXPRESSION; ZEBRAFISH; GROWTH;
   HEPATOCARCINOGENESIS
AB Maid is a helix-loop-helix protein that is involved in cell proliferation. In order to further elucidate its physiological functions, we studied Maid activity in two small fish model systems. We found that Maid expression was greatest in zebrafish liver and that it increased following partial hepatectomy. Maid levels were also high in hepatic preneoplastic foci induced by treatment of zebrafish with diethylnitrosamine (DEN), but low in hepatocellular carcinomas (HCC), mixed tumors, and cholangiocarcinomas developing in these animals. In DEN-treated transgenic medaka overexpressing Maid, hepatic BrdU uptake and proliferation were reduced. After successive breedings, Maid transgenic medaka exhibited decreased movement and a higher incidence of abnormal spine curvature, possibly due to the senescence of spinal cord cells. Taken together, our results suggest that Maid levels can influence the progression of liver cancer. In conclusion, we found that Maid is important regulator of hepatocarconogenesis and aging.
C1 [Fujisawa, Koichi; Sakaida, Isao] Yamaguchi Univ, Ctr Reparat Med, Sch Med, Ube, Yamaguchi 7558505, Japan.
   [Fujisawa, Koichi; Terai, Shuji; Matsumoto, Toshihiko; Takami, Taro; Yamamoto, Naoki; Sakaida, Isao] Yamaguchi Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Ube, Yamaguchi 7558505, Japan.
   [Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Chuo Ku, Niigata 9518510, Japan.
   [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo 1138510, Japan.
   [Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
C3 Yamaguchi University; Yamaguchi University; Niigata University; Tokyo
   Medical & Dental University (TMDU); University of Bath
RP Terai, S (corresponding author), Yamaguchi Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.
EM terais@med.niigata-u.ac.jp
RI fujisawa, koichi/AAC-1392-2022
OI Terai, Shuji/0000-0002-5439-635X
FU Japan Society for the Promotion of Science [22390150, 22659148,
   23659398, 25670370]; Ministry of Health, Labour and Welfare; Japan
   Science and Technology Agency (JST); Grants-in-Aid for Scientific
   Research [22659148, 22390150, 25670370, 23659398] Funding Source: KAKEN
FX This study was supported by a Grant-in-Aid for Scientific Research
   (22390150), and Grants-in-Aid for Challenging Exploratory Research
   (22659148, 23659398, 25670370) from the Japan Society for the Promotion
   of Science. This study was supported by Grants-in-Aid for scientific
   research from the Ministry of Health, Labour and Welfare, health and
   labour sciences research grants and Japan Science and Technology Agency
   (JST), the project of realization of regenerative medicine and highway.
CR Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728
   Amatruda T, 2002, GENETIC TESTING HERE
   Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005
   BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539
   Brennan LM, 2001, TOXICOL PATHOL, V29, P387, DOI 10.1080/019262301316905354
   Chang MS, 2000, BIOCHEM BIOPH RES CO, V279, P732, DOI 10.1006/bbrc.2000.3992
   Chang TW, 2008, ONCOGENE, V27, P332, DOI 10.1038/sj.onc.1210651
   Chellas-Géry B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x
   Chen WC, 2008, HISTOPATHOLOGY, V53, P554, DOI 10.1111/j.1365-2559.2008.03154.x
   Fujisawa K, 2011, BIOCHEM BIOPH RES CO, V414, P331, DOI 10.1016/j.bbrc.2011.09.067
   Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006
   Goessling W, 2007, J CLIN ONCOL, V25, P2473, DOI 10.1200/JCO.2006.08.9821
   Hwang SY, 1997, DEV DYNAM, V209, P217, DOI 10.1002/(SICI)1097-0177(199706)209:2<217::AID-AJA7>3.0.CO;2-L
   Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218
   Lee I, 2010, CANCER RES, V70, P4357, DOI 10.1158/0008-5472.CAN-09-3791
   Ma W, 2006, ONCOGENE, V25, P4207, DOI 10.1038/sj.onc.1209450
   Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736
   Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951
   Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104
   Sonnenberg-Riethmacher E, 2007, HEPATOLOGY, V45, P404, DOI 10.1002/hep.21461
   Takami T, 2005, GASTROENTEROLOGY, V128, P1369, DOI 10.1053/j.gastro.2005.03.014
   Terai S, 2000, HEPATOLOGY, V32, P357, DOI 10.1053/jhep.2000.9092
   Xia CZ, 2000, J BIOL CHEM, V275, P20942, DOI 10.1074/jbc.M002598200
   Yao Y, 2000, EXP CELL RES, V257, P22, DOI 10.1006/excr.2000.4884
NR 24
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 24
PY 2015
VL 10
IS 6
AR e0129950
DI 10.1371/journal.pone.0129950
PG 17
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CL4OM
UT WOS:000356932500073
PM 26107180
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Faggioli, F
   Palagano, E
   Di Tommaso, L
   Donadon, M
   Marrella, V
   Recordati, C
   Mantero, S
   Villa, A
   Vezzoni, P
   Cassani, B
AF Faggioli, Francesca
   Palagano, Eleonora
   Di Tommaso, Luca
   Donadon, Matteo
   Marrella, Veronica
   Recordati, Camilla
   Mantero, Stefano
   Villa, Anna
   Vezzoni, Paolo
   Cassani, Barbara
TI B lymphocytes limit senescence-driven fibrosis resolution and favor
   hepatocarcinogenesis in mouse liver injury
SO HEPATOLOGY
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; SCLEROSING CHOLANGITIS; MATRICELLULAR PROTEIN;
   CELLULAR SENESCENCE; HEPATITIS-C; CANCER; CELLS; MICE; CHEMOTHERAPY;
   HEPATOCYTES
AB Hepatocellular carcinoma (HCC) is a frequent neoplasia and a leading cause of inflammation-related cancer mortality. Despite that most HCCs arise from persistent inflammatory conditions, pathways linking chronic inflammation to cancer development are still incompletely elucidated. We dissected the role of adaptive immunity in the Mdr2 knockout (Mdr2(-/-)) mouse, a model of inflammation-associated cancer, in which ablation of adaptive immunity has been induced genetically (Rag2(-/-)Mdr2(-/-) and Mt-Mdr2(-/-) mice) or with in vivo treatments using lymphocyte-specific depleting antibodies (anti-CD20 or anti-CD4/CD8). We found that activated B and T lymphocytes, secreting fibrogenic tumor necrosis factor alpha (TNF) and other proinflammatory cytokines, infiltrated liver of the Mdr2(-/-) mice during chronic fibrosing cholangitis. Lymphocyte ablation, in the Rag2(-/-)Mdr2(-/-) and Mt-Mdr2(-/-) mice, strongly suppressed hepatic stellate cell (HSC) activation and extracellular matrix deposition, enhancing HSC transition to cellular senescence. Moreover, lack of lymphocytes changed the intrahepatic metabolic/oxidative state, resulting in skewed macrophage polarization toward an anti-inflammatory M2 phenotype. Remarkably, hepatocarcinogenesis was significantly suppressed in the Rag2(-/-)Mdr2(-/-) mice, correlating with reduced TNF/NF-B (nuclear factor kappa B) pathway activation. Ablation of CD20(+) B cells, but not of CD4(+)/CD8(+) T cells, in Mdr2(-/-) mice, promoted senescence-mediated fibrosis resolution and inhibited the protumorigenic TNF/NF-B pathway. Interestingly, presence of infiltrating B cells correlated with increased tumor aggressiveness and reduced disease-free survival in human HCC. Conclusion: Adaptive immunity sustains liver fibrosis (LF) and favors HCC growth in chronic injury, by modulating innate components of inflammation and limiting the extent of HSC senescence. Therapies designed for B-cell targeting may be an effective strategy in LF. (Hepatology 2018;67:1970-1985).
C1 [Faggioli, Francesca; Marrella, Veronica; Mantero, Stefano; Villa, Anna; Vezzoni, Paolo; Cassani, Barbara] CNR, Ist Ric Genet & Biomed, Milan Unit, Milan, Italy.
   [Faggioli, Francesca; Palagano, Eleonora; Marrella, Veronica; Mantero, Stefano; Villa, Anna; Vezzoni, Paolo; Cassani, Barbara] Humanitas Clin & Res Ctr, Rozzano, Italy.
   [Palagano, Eleonora] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.
   [Di Tommaso, Luca] Humanitas Clin & Res Ctr, Pathol Unit, Rozzano, Italy.
   [Donadon, Matteo] Humanitas Clin & Res Ctr, Dept Hepatobiliary & Gen Surg, Rozzano, Italy.
   [Di Tommaso, Luca; Donadon, Matteo] Humanitas Univ, Dept Biomed Sci, Rozzano, Italy.
   [Recordati, Camilla] Fdn Filarete, Mouse & Anim Pathol Lab, Milan, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e
   Biomedica (IRGB-CNR); IRCCS Humanitas Research Hospital; University of
   Milan; IRCCS Humanitas Research Hospital; IRCCS Humanitas Research
   Hospital; IRCCS Humanitas Research Hospital; Humanitas University
RP Faggioli, F; Cassani, B (corresponding author), Natl Res Council CNR, Ist Ric Genet & Biomed, Milan Unit, Via Manzoni 113, I-20089 Rozzano, Italy.
EM francesca.faggioli@humanitasresearch.it;
   barbara.cassani@humanitasresearch.it
RI Cassani, Barbara/K-3871-2016; Palagano, Eleonora/X-3805-2018; Donadon,
   Matteo/K-5440-2016; Vezzoni, Paolo/R-3416-2019; Vezzoni,
   Paolo/K-3197-2018; Faggioli, Francesca/K-1592-2016; Recordati,
   Camilla/GLR-1552-2022; Di Tommaso, Luca/ACI-7061-2022; Mantero,
   Stefano/AAE-5515-2021; Marrella, Veronica/K-5591-2016
OI Cassani, Barbara/0000-0002-4115-8109; Donadon,
   Matteo/0000-0003-0296-7648; Faggioli, Francesca/0000-0001-8030-3674; Di
   Tommaso, Luca/0000-0002-9013-4728; Vezzoni, Paolo/0000-0002-6382-3923;
   Marrella, Veronica/0000-0003-4035-8106; Recordati,
   Camilla/0000-0002-7172-9662; Mantero, Stefano/0000-0003-0608-2724
FU MIUR-FIR [RBFR12I3UB, RBAP11H2R9-004]; AMANDA Project (Regione
   Lombardia/CNR); CNR-DSB Aging Project [0059711]
FX Supported by grants MIUR-FIR RBFR12I3UB (to B.C.), MIUR-FIRB
   RBAP11H2R9-004 (to P.V.), AMANDA Project (Regione Lombardia/CNR) to
   P.V., and CNR-DSB Aging Project (to P.V) and Prot. No. 0059711 (to
   F.F.).
CR Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026
   Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019
   Barasli H, 2008, HEPATOLOGY, V48, P1232, DOI 10.1002/hep.22394
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014
   Endig J, 2016, CANCER CELL, V30, P308, DOI 10.1016/j.ccell.2016.06.009
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Fan YN, 2017, HEPATOLOGY, V66, P1644, DOI 10.1002/hep.29304
   Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009
   Fickert P, 2014, J HEPATOL, V60, P1290, DOI 10.1016/j.jhep.2014.02.006
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062
   Grant AJ, 2001, HEPATOLOGY, V33, P1065, DOI 10.1053/jhep.2001.24231
   Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021
   Jang MK, 2014, CURR PHARM DESIGN, V20, P2799, DOI 10.2174/13816128113199990587
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kumar A, 2016, J CLIN ONCOL, V34, pE90, DOI 10.1200/JCO.2013.51.4067
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969
   Marhenke S, 2014, GUT, V63, P1501, DOI 10.1136/gutjnl-2013-304829
   MAUAD TH, 1994, AM J PATHOL, V145, P1237
   Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x
   Murakami J, 1999, HEPATOLOGY, V30, P143, DOI 10.1002/hep.510300107
   Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071
   Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700
   Prieto J, 2015, NAT REV GASTRO HEPAT, V12, P681, DOI 10.1038/nrgastro.2015.173
   Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532
   Sato S, 2003, J INVEST DERMATOL, V120, P542, DOI 10.1046/j.1523-1747.2003.12097.x
   Schneider C, 2012, GUT, V61, P1733, DOI 10.1136/gutjnl-2011-301116
   Schrem H, 2013, LIVER TRANSPLANT, V19, P1252, DOI 10.1002/lt.23722
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395
   SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C
   Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754
   Stechmiller Joyce K, 2005, Nutr Clin Pract, V20, P52, DOI 10.1177/011542650502000152
   Tarao K, 1999, CANCER, V86, P589, DOI 10.1002/(SICI)1097-0142(19990815)86:4<589::AID-CNCR7>3.0.CO;2-K
   Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 45
TC 59
Z9 63
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD MAY
PY 2018
VL 67
IS 5
BP 1970
EP 1985
DI 10.1002/hep.29636
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GD3FF
UT WOS:000430388500029
PM 29105104
OA Bronze
DA 2024-02-19
ER

PT J
AU Liu, AD
   Dong, W
   Peng, J
   Dirsch, O
   Dahmen, U
   Fang, HS
   Zhang, CT
   Sun, J
AF Liu, Anding
   Dong, Wei
   Peng, Jing
   Dirsch, Olaf
   Dahmen, Uta
   Fang, Haoshu
   Zhang, Cuntai
   Sun, Jian
TI Growth differentiation factor 11 worsens hepatocellular injury and liver
   regeneration after liver ischemia reperfusion injury
SO FASEB JOURNAL
LA English
DT Article
DE aging; hepatocyte; cell cycle
ID CELL-CYCLE CONTROL; ISCHEMIA/REPERFUSION INJURY; PARTIAL-HEPATECTOMY;
   PROLIFERATIVE RESPONSE; SKELETAL-MUSCLE; GDF11; AGE; DISEASE; RATS;
   NEUROGENESIS
AB Growth differentiation factor 11 (GDF11) has been implicated in a variety of aging conditions and the regulation of organ regeneration after injury; however, the role of GDF11 in liver ischemia reperfusion injury (IRI) is unknown. The aim of the current study was to investigate the possible role of GDF11 in liver IRI. We investigated the effects of GDF11 in liver IRI in both young (3 mo) and old (22 mo) mice in vivo, and in primary young and old mouse hepatocytes in vitro. Both serum and hepatic GDF11 protein expression levels increased with age and after IRI. Treatment with recombinant GDF11 significantly increased IRI-induced elevations of serum aminotransferase levels, worsened the histologic status of livers, and impaired liver regeneration. In contrast, inhibition of GDF11 activity with neutralizing Abs significantly decreased liver injury and improved liver regeneration after IRI. In vitro, treatment with recombinant GDF11 significantly delayed cell proliferation in cultured hepatocytes that were subjected to hypoxia/reoxygenation insult. Moreover, suppression of cell-cycle progression may be a key mechanism by which GDF11 inhibited hepatocyte regeneration. Collectively, rather than acting as a rejuvenating agent, GDF11 worsens hepatocellular injury and impairs liver regeneration after IRI.Liu, A., Dong, W., Peng, J., Dirsch, O., Dahmen, U., Fang, H., Zhang, C., Sun, J. Growth differentiation factor 11 worsens hepatocellular injury and liver regeneration after liver ischemia reperfusion injury.
C1 [Liu, Anding] Huazhong Univ Sci & Technol, Ctr Med Expt, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.
   [Dong, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Hubei, Peoples R China.
   [Peng, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Clin Lab, Wuhan, Hubei, Peoples R China.
   [Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China.
   [Dirsch, Olaf] Klinikum Chemnitz, Inst Pathol, Chemnitz, Germany.
   [Dahmen, Uta] Friedrich Schiller Univ Jena, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany.
   [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China.
   [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yanjiang, Guangzhou, Guangdong, Peoples R China.
   [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Huazhong University of Science & Technology;
   Huazhong University of Science & Technology; Chemnitz Clinic; Friedrich
   Schiller University of Jena; Anhui Medical University; Sun Yat Sen
   University; Sun Yat Sen University
RP Sun, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yanjiang, Guangzhou, Guangdong, Peoples R China.
EM sjmed02@outlook.com
RI Yang, Yifan/JTV-1487-2023; Liu, Anding/AAU-2477-2020; PENG,
   JING/JNT-2157-2023
FU National Natural Science Fund of China [81300343, 81770680]
FX This work was supported by National Natural Science Fund of China Grants
   81300343 and 81770680. The authors declare no conflicts of interest.
CR Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752
   Brun CE, 2015, CELL METAB, V22, P54, DOI 10.1016/j.cmet.2015.05.009
   Chen L, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-18
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Deneme MA, 2006, J SURG RES, V136, P280, DOI 10.1016/j.jss.2006.08.020
   Do N, 2012, AM J PHYSIOL-GASTR L, V303, pG1220, DOI 10.1152/ajpgi.00105.2012
   Du GQ, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-016-0593-y
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Elliott BT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13343
   Glass DJ, 2016, CELL METAB, V24, P7, DOI 10.1016/j.cmet.2016.06.017
   Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x
   Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231
   Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535
   Harper SC, 2016, CIRC RES, V118, P1143, DOI 10.1161/CIRCRESAHA.116.306206
   Hinken AC, 2016, AGING CELL, V15, P582, DOI 10.1111/acel.12475
   Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006
   Karkampouna S, 2016, ARCH TOXICOL, V90, P347, DOI 10.1007/s00204-014-1436-y
   Karkampouna S, 2012, CURR PHARM DESIGN, V18, P4103, DOI 10.2174/138161212802430521
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Liu AD, 2016, ONCOTARGET, V7, P78372, DOI 10.18632/oncotarget.13281
   Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042
   Liu AD, 2015, INT IMMUNOPHARMACOL, V24, P72, DOI 10.1016/j.intimp.2014.11.014
   Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659
   Liu WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12794
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320
   Nakamura T, 2004, J HEPATOL, V41, P974, DOI 10.1016/j.jhep.2004.08.015
   Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802
   Olson KA, 2015, EUR HEART J, V36, P3426, DOI 10.1093/eurheartj/ehv385
   Onodera K, 2017, THORAX, V72, P893, DOI 10.1136/thoraxjnl-2016-209352
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Rodgers BD, 2015, ENDOCRINOLOGY, V156, P3885, DOI 10.1210/en.2015-1628
   Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475
   RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126
   Schafer MJ, 2016, CELL METAB, V23, P1207, DOI 10.1016/j.cmet.2016.05.023
   Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5
   Shi YT, 2011, J NEUROSCI, V31, P883, DOI 10.1523/JNEUROSCI.2394-10.2011
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527
   Stein GS, 2006, J CELL PHYSIOL, V209, P706, DOI 10.1002/jcp.20843
   Sun J, 2017, LIVER TRANSPLANT, V23, P510, DOI 10.1002/lt.24733
   Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391
   Williams G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078478
   Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8
   Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34624
   Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9
NR 48
TC 18
Z9 19
U1 0
U2 18
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD SEP
PY 2018
VL 32
IS 9
BP 5186
EP 5198
DI 10.1096/fj.201800195R
PG 13
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GS6OR
UT WOS:000443817700045
PM 29913561
OA Bronze
DA 2024-02-19
ER

PT S
AU Mori, A
   Utsumi, K
   Liu, JK
   Hosokawa, M
AF Mori, A
   Utsumi, K
   Liu, JK
   Hosokawa, M
BE Harman, D
   Holliday, R
   Meydani, M
TI Oxidative damage in the senescence-accelerated mouse
SO TOWARDS PROLONGATION OF THE HEALTHY LIFE SPAN: PRACTICAL APPROACHES TO
   INTERVENTION
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on Towards Prolongation of the Healthy Life Span - Practical
   Approaches to Intervention
CY AUG 15-18, 1997
CL ADELAIDE, AUSTRALIA
SP 7th Congress Int Assoc Biomed Gerontol
ID SUPEROXIDE-DISMUTASE ACTIVITY; REPERFUSED RAT-HEART;
   ISCHEMIA-REPERFUSION; PEROMYSCUS-LEUCOPUS; PROTECTIVE ACTIVITY;
   CYTOCHROME-C; LIFE-SPAN; BRAIN; AGE; ANTIOXIDANT
AB The senescence-accelerated mouse (SAM) exhibited a shortened life span (about 18 months) and early manifestation of various signs of senescence, including changes in physical activity, skin, and spinal curvature, The mechanism of senescence acceleration in SAM is thought to be related to free radical damage, Oxidative phosphorylation was estimated in liver mitochondria from SAMPS and the senescence-resistant subtrain, SAMR1, The respiratory control ratio decreased during aging, and the ATP/O, an index of ATP synthesis, was depressed at 18 months of age in SAMPS. DNP-dependent uncoupled respiration in liver mitochondria was markedly decreased, and active uptake of calcium was markedly dysfunctional with aging, These findings suggest that the functional disorders in mitochondria may be closely related to the shorter life span of SAMPS. White-footed (WF) mice can live at least to 5.5 years, when some animals are still capable of reproducing and their external body condition remains healthy, The mitochondrial functions were examined in the same way as in the SAM experiments, However, no particular finding responsible for their longevity was observed in WF mice at 3 and 12 months old, More comprehensive examinations on more aged WF mice are needed for explanation of their greater longevity.
C1 Okayama Univ, Sch Med, Inst Mol & Cellular Med, Dept Neurosci, Okayama 7000914, Japan.
   Ctr Adult Dis, Inst Med Sci, Kurashiki, Okayama 7100824, Japan.
   Kyoto Univ, Chest Dis Res Inst, Kyoto 6068397, Japan.
C3 Okayama University; Kyoto University
RP Mori, A (corresponding author), Okayama Univ, Sch Med, Inst Mol & Cellular Med, Dept Neurosci, Okayama 7000914, Japan.
RI Liu, Jiankang/A-1610-2011
CR BOLLI R, 1990, FREE RADICAL RES COM, V9, P169, DOI 10.3109/10715769009145674
   BOLLI R, 1990, AM J PHYSIOL, V259, pH1901, DOI 10.1152/ajpheart.1990.259.6.H1901
   BRADAMANTE S, 1992, J MOL CELL CARDIOL, V24, P375, DOI 10.1016/0022-2828(92)93192-M
   BURGER J, 1992, GROWTH DEVELOP AGING, V56, P17
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   DAVIES MJ, 1989, FREE RADICAL RES COM, V7, P275, DOI 10.3109/10715768909087952
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   GARLICK PB, 1987, CIRC RES, V61, P757, DOI 10.1161/01.RES.61.5.757
   GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653
   GUO ZY, 1993, GROWTH DEVELOP AGING, V57, P85
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   HAMBURGER SA, 1989, CIRC SHOCK, V29, P329
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HIRAMATSU M, 1992, J NEUROCHEM, V58, P1160, DOI 10.1111/j.1471-4159.1992.tb09375.x
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   HOGEBOOM GH, 1955, METHOD ENZYMOL, V1, P16, DOI 10.1016/0076-6879(55)01007-0
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   HOSOKAWA M, 1984, EXP EYE RES, V38, P105, DOI 10.1016/0014-4835(84)90095-2
   JOTTI A, 1992, PHARMACOL RES, V26, P143, DOI 10.1016/S1043-6618(05)80127-6
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KOMURA S, 1994, SAM MODEL SENESCENCE, P141
   KRAJEWSKI S, 1994, CANCER RES, V54, P5501
   Krippner A, 1996, J BIOL CHEM, V271, P21629, DOI 10.1074/jbc.271.35.21629
   Kumari MVR, 1997, BIOCHEM MOL BIOL INT, V41, P1005
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   MAVELLI I, 1978, J NEUROCHEM, V31, P363, DOI 10.1111/j.1471-4159.1978.tb12472.x
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MODLEUS P, 1983, FUNCTIONS GLUTATHION, P99
   Mori A., 1992, FREE RADICALS BRAIN, P109
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   NAKAMOTO H, 1994, INT CONGR SER, V1062, P137
   Novelli G. P., 1985, FREE RADICAL RES COM, V1, P321
   Packer Lester, 1996, P9, DOI 10.1201/9781439832059.ch2
   PINEMAIL J, 1990, FREE RADICAL RES COM, V9, P181
   ROOT RK, 1975, J CLIN INVEST, V55, P945, DOI 10.1172/JCI108024
   Sacher G A, 1978, Birth Defects Orig Artic Ser, V14, P71
   SAKAMOTO A, 1991, FREE RADICAL BIO MED, V11, P385, DOI 10.1016/0891-5849(91)90155-V
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOCCI DJ, 1995, BRAIN RES, V693, P88, DOI 10.1016/0006-8993(95)00707-W
   SOHAL RS, 1993, BIOCHEM BIOPH RES CO, V196, P7, DOI 10.1006/bbrc.1993.2208
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1994, INT CONGR SER, V1062, P15
   TOBITA M, 1994, INT CONGR SER, V1062, P125
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   YAGI K, 1988, J CLIN BIOCHEM NUTR, V5, P21
   YOSHINO K, 1994, SAM MODEL SENESCENCE, P145
NR 53
TC 36
Z9 39
U1 2
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-109-X; 1-57331-108-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1998
VL 854
BP 239
EP 250
DI 10.1111/j.1749-6632.1998.tb09906.x
PG 12
WC Geriatrics & Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics
GA BM29P
UT WOS:000078303400022
PM 9928434
DA 2024-02-19
ER

PT J
AU Jin, JL
   Wang, GL
   Timchenko, L
   Timchenko, NA
AF Jin, Jingling
   Wang, Guo-Li
   Timchenko, Lubov
   Timchenko, Nikolai A.
TI GSK3β and aging liver
SO AGING-US
LA English
DT Article
DE Aging; cyclin D3; C/EBP; GSK3; liver; proliferation
ID GLYCOGEN-SYNTHASE KINASE-3; RABBIT SKELETAL-MUSCLE; BINDING
   PROTEIN-BETA; C/EBP-ALPHA; INCREASES TRANSLATION; PHOSPHORYLASE-KINASE;
   REGENERATING LIVER; CELL-SURVIVAL; RAT-LIVER; PROLIFERATION
AB The loss of regenerative capacity of tissues is one of the major characteristics of aging. Liver represents a powerful system for investigations of mechanisms by which aging reduces regenerative capacity of tissues. The studies within last five years revealed critical role of epigenetic silencing in the inhibition of liver proliferation in old mice. These studies have shown that a number of cell cycle proteins are silenced in livers of old mice by C/EBP alpha-HDAC1-Brm complex and that old liver fails to reduce the complex and activate these genes in response to proliferative stimulus such as partial hepatectomy. The complex modifies histone H3 on the promoters of c-myc and FoxM1B in the manner which prevents expression of these genes. Despite this progress, little is known about mechanisms by which aging causes this epigenetic silencing. We have recently discovered signal transduction pathways which operate upstream of the C/EBP alpha-HDAC1-Brm complex. These pathways involve communications of growth hormone, GSK3 beta and cyclin D3 [1]. In addition to the liver, GH-GSK3 beta-cyclin D3 pathway is also changed with age in lung, brain and adipose tissues. We suggest that other age associated alterations in these tissues might be mediated by the reduced levels of GSK3 beta and by elevation of cyclin D3. In this review, we summarize these new data and discuss the role of such alterations in the development of aging phenotype in the liver and in other tissues.
C1 [Jin, Jingling; Wang, Guo-Li; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   [Jin, Jingling; Wang, Guo-Li; Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   [Timchenko, Lubov; Timchenko, Nikolai A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine
RP Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.
EM nikolait@bcm.tmc.edu
OI Jin, Jingling/0000-0002-4365-1837
FU National Institutes of Health [AR052791, NS063298, GM55188, CA100070,
   AG025477]
FX This work was supported by National Institutes of Health Grants
   AR052791, NS063298 (to LTT), and GM55188, CA100070, AG025477 (to NAT).
CR BUCHER NLR, 1964, CANCER RES, V24, P509
   Chen H, 2007, J CELL BIOCHEM, V102, P1281, DOI 10.1002/jcb.21358
   Cheong JW, 2003, LEUKEMIA RES, V27, P1159, DOI 10.1016/S0145-2126(03)00102-4
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384
   Eldar-Finkelman H, 2003, EXPERT OPIN INV DRUG, V12, P1511, DOI 10.1517/13543784.12.9.1511
   EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x
   Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574
   Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   JIN J, 2009, MOL CELL BI IN PRESS
   JIN J, 2009, CELL CYCLE IN PRESS
   Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   RYLATT DB, 1980, EUR J BIOCHEM, V107, P529
   Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x
   Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041
   Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x
   Takashima A, 2006, J ALZHEIMERS DIS, V9, P309
   Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   WANG GL, 2008, J BIOL CHEM, V283, P26196
   Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x
   Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983
NR 32
TC 23
Z9 25
U1 0
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUN
PY 2009
VL 1
IS 6
BP 582
EP 585
DI 10.18632/aging.100060
PG 4
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 579UP
UT WOS:000276401300009
PM 20157540
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Le, TD
   Nakahara, Y
   Ueda, M
   Okumura, K
   Hirai, J
   Sato, Y
   Takemoto, D
   Tomimori, N
   Ono, Y
   Nakai, M
   Shibata, H
   Inoue, YH
AF Le, T. D.
   Nakahara, Y.
   Ueda, M.
   Okumura, K.
   Hirai, J.
   Sato, Y.
   Takemoto, D.
   Tomimori, N.
   Ono, Y.
   Nakai, M.
   Shibata, H.
   Inoue, Y. H.
TI Sesamin suppresses aging phenotypes in adult muscular and nervous
   systems and intestines in a <i>Drosophila</i> senescence-accelerated
   model
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE Sesamin; Anti-aging; Drosophila; Muscle; Intestine
ID OXIDATIVE STRESS; RAT-LIVER; FUNCTIONAL LIGNAN; GENE-EXPRESSION;
   LIFE-SPAN; CELLS; CYTOCHROME-P450; ACCUMULATION; MELANOGASTER;
   DYSFUNCTION
AB OBJECTIVE: Sesamin is a major lignan constituent of sesame and possesses various health-promoting effects. Previous studies have demonstrated that sesamin extends the lifespan of Drosophila and Caenorhabditis elegans and corrects oxidative damage-related tissue dysfunction in mammals. To understand its anti-aging effects, we aimed to determine whether sesamin restores tissue function hampered by oxidative damage and suppresses several aging-related phenotypes using Drosophila senescence-accelerated models.
   MATERIALS AND METHODS: We elucidated the anti-aging effects of sesamin on several aging-related phenotypes in the muscle, brain and midgut using the senescence-accelerated models (Sod(n1) mutant and Sod1-depleted flies) by immunostaining experiments. We determined the expression levels of several anti-oxidative and DNA repair genes using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). We also identified the metabolite of sesamin in Drosophila by LC-MS/MS.
   RESULTS: We confirmed that sesamin (0.35 and 2 mg/ml) extended the lifespan of the fly models. As observed in mammals, it can be absorbed and metabolized by Drosophila adults. The sesamin feeding suppressed the age-dependent impairment of locomotor activity and inhibited the accumulation of reactive oxygen species (ROS) in their bodies. Sesamin delayed the age-dependent accumulation of damaged proteins in the muscle, partially suppressed the loss of dopaminergic neurons in adult brains displaying ROS accumulation, and suppressed the accumulation of DNA damage and hyperproliferation of intestinal stem cells. Four antioxidative genes and two DNA repair genes were simultaneously upregulated in sesamin-fed adults.
   CONCLUSIONS: These observations represent the first direct evidence of the anti-aging effects of sesamin at the individual level. We propose that sesamin exerts anti-aging effects in the muscles, brain and midgut by inducing antioxidative and DNA repair genes, resulting in extended lifespan in flies.
C1 [Le, T. D.; Nakahara, Y.; Ueda, M.; Okumura, K.; Hirai, J.; Inoue, Y. H.] Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto, Japan.
   [Sato, Y.; Takemoto, D.; Tomimori, N.; Ono, Y.; Nakai, M.; Shibata, H.] Suntory Wellness Ltd, Inst Hlth Care Sci, Kyoto, Japan.
C3 Kyoto Institute of Technology; Suntory Holdings Ltd
RP Inoue, YH (corresponding author), Kyoto Inst Technol, Insect Biomed Res Ctr, Sakyo Ku, Kyoto, Japan.
EM yhinoue@kit.ac.jp
FU Suntory Wellness Ltd; Joint Research Program of Advanced Insect Research
   Promotion Centre in Kyoto Institute of Technology [2017008]
FX LTD, NY, UM, OK, HJ, and IYH received research grants from Suntory
   Wellness Ltd and Joint Research Program of Advanced Insect Research
   Promotion Centre in Kyoto Institute of Technology (2017008). SY, TD, TN,
   OY, NM and SH are employees of Suntory Wellness Ltd., which is a
   manufacturer of foods that contain sesamin.
CR Alexandrova A, 2008, J BIOCHEM MOL TOXIC, V22, P354, DOI 10.1002/jbt.20248
   Baluchnejadmojarad T, 2017, BIOMED PHARMACOTHER, V88, P754, DOI 10.1016/j.biopha.2017.01.123
   Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bournival J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/921941
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Choi YJ, 2008, BBA-GEN SUBJECTS, V1780, P1093, DOI 10.1016/j.bbagen.2008.06.008
   Das R, 2007, FREE RADICAL BIO MED, V42, P541, DOI 10.1016/j.freeradbiomed.2006.11.020
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954
   Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083
   Fujikawa T, 2005, BIOL PHARM BULL, V28, P169, DOI 10.1248/bpb.28.169
   Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x
   Gladstone M, 2011, J GENET GENOMICS, V38, P497, DOI 10.1016/j.jgg.2011.09.003
   Good RT, 2014, GENOME BIOL EVOL, V6, P1118, DOI 10.1093/gbe/evu083
   Hamada N, 2011, BIOORGAN MED CHEM, V19, P1959, DOI 10.1016/j.bmc.2011.01.059
   HIROSE N, 1992, ANTICANCER RES, V12, P1259
   Ikeda T, 2003, INT J SPORTS MED, V24, P530
   JAFARI M, 2011, FLY, V4, P253
   Jimenez-Del-Rio M, 2008, NEUROSCI RES, V61, P404, DOI 10.1016/j.neures.2008.04.011
   Jones RM, 2012, CURR MED CHEM, V19, P1519
   Kiso Y, 2004, BIOFACTORS, V21, P191, DOI 10.1002/biof.552210139
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101
   Lee WJ, 2009, J AGR FOOD CHEM, V57, P11406, DOI 10.1021/jf902876p
   Lei H, 2013, J SCI FOOD AGR, V93, P1833, DOI 10.1002/jsfa.5974
   Ma JQ, 2014, FOOD CHEM TOXICOL, V64, P41, DOI 10.1016/j.fct.2013.11.017
   Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896
   Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807
   Martinez VG, 2007, DEV NEUROBIOL, V67, P778, DOI 10.1002/dneu.20388
   Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421
   Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371
   Miyahara Y, 2000, INT J MOL MED, V6, P43
   Miyawaki T, 2009, J NUTR SCI VITAMINOL, V55, P87, DOI 10.3177/jnsv.55.87
   Na HJ, 2013, MECH AGEING DEV, V134, P381, DOI 10.1016/j.mad.2013.07.003
   Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961
   Nakano D, 2003, BIOL PHARM BULL, V26, P1701, DOI 10.1248/bpb.26.1701
   Nakano D, 2008, CLIN EXP PHARMACOL P, V35, P324, DOI 10.1111/j.1440-1681.2007.04817.x
   Nakatani Y, 2018, EUR J NUTR, V57, P1137, DOI 10.1007/s00394-017-1396-0
   Namiki M, 2007, CRIT REV FOOD SCI, V47, P651, DOI 10.1080/10408390600919114
   Noguchi Takanori, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS24, DOI 10.1111/j.1440-1681.2004.04103.x
   Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333
   Oka S, 2015, BIOGERONTOLOGY, V16, P485, DOI 10.1007/s10522-015-9570-3
   PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761
   Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002
   Takada S, 2015, EXP PHYSIOL, V100, P1319, DOI 10.1113/EP085251
   Takemoto Daisuke, 2015, Glob J Health Sci, V7, P1, DOI 10.5539/gjhs.v7n6p1
   Tanabe H, 2011, INT J ONCOL, V39, P33, DOI 10.3892/ijo.2011.1011
   Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3
   Tomimori N, 2012, BIOL PHARM BULL, V35, P709, DOI 10.1248/bpb.35.709
   Tsuruoka N, 2005, BIOSCI BIOTECH BIOCH, V69, P179, DOI 10.1271/bbb.69.179
   Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030
   White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205
   Yaguchi Y, 2014, EUR J NUTR, V53, P1659, DOI 10.1007/s00394-014-0671-6
   Yasuda K, 2010, DRUG METAB DISPOS, V38, P2117, DOI 10.1124/dmd.110.035659
   Yasukawa T, 2015, GENES GENET SYST, V90, P11, DOI 10.1266/ggs.90.11
   Zuo YY, 2013, BIOGERONTOLOGY, V14, P107, DOI 10.1007/s10522-012-9413-4
NR 57
TC 20
Z9 21
U1 0
U2 19
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD FEB
PY 2019
VL 23
IS 4
BP 1826
EP 1839
PG 14
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA HO1GJ
UT WOS:000460653200055
PM 30840309
DA 2024-02-19
ER

PT J
AU Fujita, T
   Shirasawa, T
   Maruyama, N
AF Fujita, T
   Shirasawa, T
   Maruyama, N
TI Senescence marker protein-30 (SMP30) and its gerontological significance
SO CURRENT SCIENCE
LA English
DT Article
ID RAT-LIVER; GENE-EXPRESSION; AGE; ELECTROPHORESIS
AB We have isolated and characterized a novel protein designated as senescence marker protein-30 (SMP30). The amount of SMP30 decreases in an androgen-independent manner with increasing age in the rat liver. SMP30 turned out to be identical to a calcium-binding protein called regucalcin. In this review; we give an overview of the structure, expression and possible physiological role(s) of SMP30. We also discuss the hypothetical role of SMP30 in aging and calcium homeostasis.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 173, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Neurophysiol, Itabashi Ku, Tokyo 173, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan
   Institute of Gerontology
RP Fujita, T (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakaecho, Tokyo 173, Japan.
CR DOWD DR, 1992, MOL ENDOCRINOL, V6, P1843, DOI 10.1210/me.6.11.1843
   FUJITA T, 1991, BIOCHEM BIOPH RES CO, V178, P1485, DOI 10.1016/0006-291X(91)91061-G
   FUJITA T, 1986, ANAL BIOCHEM, V159, P8, DOI 10.1016/0003-2697(86)90299-X
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   IACOPINO AM, 1990, P NATL ACAD SCI USA, V87, P4078, DOI 10.1073/pnas.87.11.4078
   KANUNGO MS, 1994, GENES AGING, P173
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Papaconstantinou John, 1996, P150
   RICHARDSON A, 1987, REV BIOL RES AGING, V3, P467
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   TODA T, 1984, ELECTROPHORESIS, V5, P42, DOI 10.1002/elps.1150050108
   TODA T, 1982, ANAL BIOCHEM, V119, P167, DOI 10.1016/0003-2697(82)90682-0
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VARGHESE S, 1988, J BIOL CHEM, V263, P9776
   Yamaguchi M. A., 1992, CALCIUM INHIBITION, P19
NR 20
TC 0
Z9 0
U1 0
U2 0
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD MAY 25
PY 1998
VL 74
IS 10
BP 872
EP 877
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA ZT143
UT WOS:000074053300013
DA 2024-02-19
ER

PT J
AU Widjaja, AA
   Singh, BK
   Adami, E
   Viswanathan, S
   Dong, JR
   D'Agostino, GA
   Ng, B
   Lim, WW
   Tan, J
   Paleja, BS
   Tripathi, M
   Lim, SY
   Shekeran, SG
   Chothani, SP
   Rabes, A
   Sombetzki, M
   Bruinstroop, E
   Min, LP
   Sinha, RA
   Albani, S
   Yen, PM
   Schafer, S
   Cook, SA
AF Widjaja, Anissa A.
   Singh, Brijesh K.
   Adami, Eleonora
   Viswanathan, Sivakumar
   Dong, Jinrui
   D'Agostino, Giuseppe A.
   Ng, Benjamin
   Lim, Wei Wen
   Tan, Jessie
   Paleja, Bhairav S.
   Tripathi, Madhulika
   Lim, Sze Yun
   Shekeran, Shamini Guna
   Chothani, Sonia P.
   Rabes, Anne
   Sombetzki, Martina
   Bruinstroop, Eveline
   Min, Lio Pei
   Sinha, Rohit A.
   Albani, Salvatore
   Yen, Paul M.
   Schafer, Sebastian
   Cook, Stuart A.
TI Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver
   Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic
   Steatohepatitis
SO GASTROENTEROLOGY
LA English
DT Article
DE Fatty Liver; Collagen; Acta2; Alanine Aminotransferase
ID HEPATIC STELLATE CELLS; FATTY LIVER; DISEASE CURRENT; MICE;
   MYOFIBROBLASTS; MECHANISMS; SENESCENCE; EXPRESSION
AB BACKGROUND & AIMS: We studied the role of interleukin 11 (IL11) signaling in the pathogenesis of nonalcoholic steatohepatitis (NASH) using hepatic stellate cells (HSCs), hepatocytes, and mouse models of NASH. METHODS: We stimulated mouse and human fibroblasts, HSCs, or hepatocytes with IL11 and other cytokines and analyzed them by imaging, immunoblot, and functional assays and enzyme-linked immunosorbent assays. Mice were given injections of IL11. Mice with disruption of the interleukin 11 receptor subunit alpha1 gene (Il11ra1(-/-)) mice and Il11ra1(+/+) mice were fed a high-fat methionine-and choline-deficient diet (HFMCD) or a Western diet with liquid fructose (WDF) to induce steatohepatitis; control mice were fed normal chow. db/db mice were fed with methionine-and choline-deficient diet for 12 weeks and C57BL/6 NTac were fed with HFMCD for 10 weeks or WDF for 16 weeks. Some mice were given intraperitoneal injections of anti-IL11 (X203), anti-IL11RA (X209), or a control antibody at different timepoints on the diets. Livers and blood were collected; blood samples were analyzed by biochemistry and liver tissues were analyzed by histology, RNA sequencing, immunoblots, immunohistochemistry, hydroxyproline, and mass cytometry time of flight assays. RESULTS: HSCs incubated with cytokines produced IL11, resulting in activation (phosphorylation) of ERK and expression of markers of fibrosis. Livers of mice given injections of IL11 became damaged, with increased markers of fibrosis, hepatocyte cell death and inflammation. Following the HFMCD or WDF, livers from Il11ra1(-/-) mice had reduced steatosis, fibrosis, expression of markers of inflammation and steatohepatitis, compared to and Il11ra1(+/+) mice on the same diets. Depending on the time of administration of anti-IL11 or anti-IL11RA antibodies to wild-type mice on the HFMCD or WDF, or to db/db mice on the methionine and choline-deficient diet, the antibodies prevented, stopped, or reversed development of fibrosis and steatosis. Blood samples from Il11ra1(+/+) mice fed the WDF and given injections of anti-IL11 or anti-IL11RA, as well as from Il11ra1(-/-) mice fed WDF, had lower serum levels of lipids and glucose than mice not injected with antibody or with disruption of Il11ra1. CONCLUSIONS: Neutralizing antibodies that block IL11 signaling reduce fibrosis, steatosis, hepatocyte death, inflammation and hyperglycemia in mice with diet-induced steatohepatitis. These antibodies also improve the cardiometabolic profile of mice and might be developed for the treatment of NASH.
C1 [Widjaja, Anissa A.; Singh, Brijesh K.; Adami, Eleonora; Viswanathan, Sivakumar; Dong, Jinrui; D'Agostino, Giuseppe A.; Ng, Benjamin; Lim, Wei Wen; Tan, Jessie; Tripathi, Madhulika; Shekeran, Shamini Guna; Chothani, Sonia P.; Bruinstroop, Eveline; Yen, Paul M.; Schafer, Sebastian; Cook, Stuart A.] Duke Natl Univ Singapore, Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore.
   [Ng, Benjamin; Lim, Wei Wen; Tan, Jessie; Lim, Sze Yun; Min, Lio Pei; Schafer, Sebastian; Cook, Stuart A.] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore.
   [Paleja, Bhairav S.; Albani, Salvatore] Duke NUS Acad Med Ctr, SingHlth, Translat Immunol Inst, Singapore, Singapore.
   [Rabes, Anne; Sombetzki, Martina] Univ Med Ctr, Dept Trop Med & Infect Dis, Rostock, Germany.
   [Sinha, Rohit A.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow, Uttar Pradesh, India.
   [Cook, Stuart A.] Imperial Coll London, Natl Heart & Lung Inst, London, England.
   [Cook, Stuart A.] Hammersmith Hosp Campus, MRC London Inst Med Sci, London, England.
C3 National University of Singapore; National Heart Centre Singapore;
   University of Rostock; Sanjay Gandhi Postgraduate Institute of Medical
   Sciences; Imperial College London
RP Cook, SA (corresponding author), Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore.
EM stuart.cook@duke-nus.edu.sg
RI P, Bhairav/HRC-8858-2023; Sinha, Rohit/GXV-2427-2022; Lim,
   Wei-Wen/AAC-7457-2019; Yen, Paul M/V-9857-2019; Ng,
   Benjamin/IZE-4541-2023; Singh, Brijesh Kumar/C-1093-2009
OI Lim, Wei-Wen/0000-0003-0311-943X; Widjaja, Anissa/0000-0001-9404-7608;
   Singh, Brijesh Kumar/0000-0003-4615-3988; Rabes,
   Anne/0000-0003-0495-5931; Paleja, Bhairav/0000-0003-3726-0167;
   D'Agostino, Giuseppe Alessandro/0000-0001-8315-7406; Adami,
   Eleonora/0000-0002-1813-6681
FU National Medical Research Council (NMRC) Singapore STaR awards
   [NMRC/STaR/0029/2017]; NMRC Central Grant; Goh Foundation; Tanoto
   Foundation; Fondation Leducq; NMRC YIRG [NMRC/OFYIRG/0053/2017,
   NMRC/OFYIRG/0002/2016]; NMRC [NMRC/STaR/020/2013, NMRC/MOHIAFCAT2/2/08,
   TCR15Jun006, NMRC/CIRG/1460/2016, NMRC/CG/M003/2017]; Duke-NUS; BMRC
   [SPF2014/005]; SingHealth;  [NMRC/CSA/0054/2013]; 
   [NMRC/CIRG/1457/2016]; MRC [MC_U120085815] Funding Source: UKRI
FX The research was supported by the National Medical Research Council
   (NMRC) Singapore STaR awards to S.A.C. (NMRC/STaR/0029/2017), the NMRC
   Central Grant to the NHCS, Goh Foundation, Tanoto Foundation, and a
   grant from the Fondation Leducq. A.A.W. is supported by the NMRC YIRG
   (NMRC/OFYIRG/0053/2017). B.K.S. is supported by the NMRC YIRG
   (NMRC/OFYIRG/0002/2016). P.M.Y. is supported by NMRC/CSA/0054/2013 and
   NMRC/CIRG/1457/2016. S.A is supported by the NMRC (NMRC/STaR/020/2013,
   NMRC/MOHIAFCAT2/2/08, TCR15Jun006, NMRC/CIRG/1460/2016, and
   NMRC/CG/M003/2017), by Duke-NUS, BMRC (SPF2014/005), and by Duke-NUS and
   SingHealth core funding.
CR Baena M, 2017, J NUTR BIOCHEM, V40, P105, DOI 10.1016/j.jnutbio.2016.10.015
   Banini BA, 2017, CURR OPIN GASTROEN, V33, P134, DOI 10.1097/MOG.0000000000000356
   Brischoux-Boucher E, 2018, CLIN GENET, V94, P373, DOI 10.1111/cge.13409
   Chew V, 2017, P NATL ACAD SCI USA, V114, pE5900, DOI 10.1073/pnas.1706559114
   Dou CW, 2018, GASTROENTEROLOGY, V154, P2209, DOI 10.1053/j.gastro.2018.02.015
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020
   Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5
   Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111
   Kim BM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25699-9
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lau JKC, 2017, J PATHOL, V241, P36, DOI 10.1002/path.4829
   Lawan A, 2017, TRENDS ENDOCRIN MET, V28, P868, DOI 10.1016/j.tem.2017.10.007
   Lawitz EJ, 2004, AM J GASTROENTEROL, V99, P2359, DOI 10.1111/j.1572-0241.2004.40047.x
   Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991
   MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Nandurkar HH, 1997, BLOOD, V90, P2148
   Ng B, 2018, BIORXIV, DOI [10.1101/336537, DOI 10.1101/336537]
   Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200
   Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016
   Simon TG, 2017, OBESITY, V25, P1313, DOI 10.1002/oby.21879
   Stephenson Kristen, 2018, Gene Expression-The Journal of Liver Research, V18, P5, DOI 10.3727/105221617X15093707969658
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Wortham M, 2008, DIGEST DIS SCI, V53, P2761, DOI 10.1007/s10620-007-0193-7
   Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012
   Yasui K, 2011, METABOLISM, V60, P735, DOI 10.1016/j.metabol.2010.07.022
   Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067
   Yu JJ, 2016, CLIN RES HEPATOL GAS, V40, P562, DOI 10.1016/j.clinre.2015.11.009
   Zhu MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140176
NR 40
TC 146
Z9 168
U1 15
U2 70
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD SEP
PY 2019
VL 157
IS 3
BP 777
EP +
DI 10.1053/j.gastro.2019.05.002
PG 30
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA IR7IZ
UT WOS:000481615500031
PM 31078624
OA Green Submitted, hybrid
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Ataabadi, EA
   Golshiri, K
   Jüttner, AA
   de Vries, R
   Van den Berg-Garrelds, I
   Nagtzaam, NMA
   Khan, HN
   Leijten, FPJ
   Brandt, RMC
   Dik, WA
   van der Pluijm, I
   Danser, AHJ
   Sandner, P
   Roks, AJM
AF Ataabadi, Ehsan Ataei
   Golshiri, Keivan
   Juettner, Annika A.
   de Vries, Rene
   Van den Berg-Garrelds, Ingrid
   Nagtzaam, Nicole M. A.
   Khan, Hina N.
   Leijten, Frank P. J.
   Brandt, Renata M. C.
   Dik, Willem A.
   van der Pluijm, Ingrid
   Danser, A. H. Jan
   Sandner, Peter
   Roks, Anton J. M.
TI Soluble guanylate cyclase activator BAY 54-6544 improves vasomotor
   function and survival in an accelerated ageing mouse model
SO AGING CELL
LA English
DT Article; Early Access
DE NO-sGC-cGMP pathway; oxidative stress; senescence; sGC activation;
   survival; vascular ageing
ID DNA-REPAIR; BLOOD-PRESSURE; NUCLEAR ABNORMALITIES; CELLULAR SENESCENCE;
   DYSFUNCTION; LIVER; STIMULATORS; DEFICIENCY; OXIDATION; DISEASE
AB DNA damage is a causative factor in ageing of the vasculature and other organs. One of the most important vascular ageing features is reduced nitric oxide (NO)soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) signaling. We hypothesized that the restoration of NO-sGC-cGMP signaling with an sGC activator (BAY 54-6544) may have beneficial effects on vascular ageing and premature death in DNA repair-defective mice undergoing accelerated ageing. Eight weeks of treatment with a non-pressor dosage of BAY 54-6544 restored the decreased in vivo microvascular cutaneous perfusion in progeroid Ercc1( increment /-) mice to the level of wild-type mice. In addition, BAY 54-6544 increased survival of Ercc1( increment /-) mice. In isolated Ercc1( increment /-) aorta, the decreased endothelium-independent vasodilation was restored after chronic BAY 54-6544 treatment. Senescence markers p16 and p21, and markers of inflammation, including Ccl2, Il6 in aorta and liver, and circulating IL-6 and TNF-alpha were increased in Ercc1( increment /-), which was lowered by the treatment. Expression of antioxidant genes, including Cyb5r3 and Nqo1, was favorably changed by chronic BAY 54-6544 treatment. In summary, BAY 54-6544 treatment improved the vascular function and survival rates in mice with accelerated ageing, which may have implication in prolonging health span in progeria and normal ageing.
C1 [Ataabadi, Ehsan Ataei; Golshiri, Keivan; Juettner, Annika A.; de Vries, Rene; Van den Berg-Garrelds, Ingrid; Leijten, Frank P. J.; Danser, A. H. Jan; Roks, Anton J. M.] Erasmus MC, Div Pharmacol & Vasc Med, Dept Internal Med, Rotterdam, Netherlands.
   [Nagtzaam, Nicole M. A.; Dik, Willem A.] Erasmus MC, Lab Med Immunol, Dept Immunol, Rotterdam, Netherlands.
   [Khan, Hina N.; Brandt, Renata M. C.; van der Pluijm, Ingrid] Erasmus MC, Dept Mol Genet, Rotterdam, Netherlands.
   [van der Pluijm, Ingrid] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands.
   [Sandner, Peter] Bayer AG, Pharma Res Ctr Wuppertal, Pharmaceut R&D, Wuppertal, Germany.
   [Sandner, Peter] Hannover Med Sch, Inst Pharmacol, Hannover, Germany.
C3 Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam;
   Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University
   Rotterdam; Erasmus MC; Bayer AG; Hannover Medical School
RP Roks, AJM (corresponding author), Erasmus MC, Div Pharmacol & Vasc Med, Dept Internal Med, Rotterdam, Netherlands.
EM a.roks@erasmusmc.nl
RI van der Pluijm, Ingrid/HKO-1880-2023
OI garrelds, ingrid/0000-0003-2061-6737; Brandt, Renata M.
   C./0000-0003-0514-5623; Ataei Ataabadi, Ehsan/0000-0002-9797-3890
FU "Stichting Lijf & Leven", the Netherlands [60]
FX A.J.M.R, E.A.A., and K.G., were supported by grant #60 from "Stichting
   Lijf & Leven", the Netherlands.
CR Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101
   Ataabadi EA, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/2308317
   Ataabadi EA, 2020, HYPERTENSION, V76, P1055, DOI 10.1161/HYPERTENSIONAHA.120.15856
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bautista-Niño PK, 2020, CLIN SCI, V134, P727, DOI 10.1042/CS20190124
   Beuve A, 2017, ANTIOXID REDOX SIGN, V26, P137, DOI 10.1089/ars.2015.6591
   Birkisdóttir MB, 2021, AGING CELL, V20, DOI 10.1111/acel.13302
   Breitenstein S, 2017, HANDB EXP PHARMACOL, V243, P225, DOI 10.1007/164_2016_100
   Bridges LE, 2011, JOVE-J VIS EXP, DOI 10.3791/3119
   Burgoyne JR, 2012, HYPERTENSION, V60, P1301, DOI 10.1161/HYPERTENSIONAHA.112.198754
   Calmasini FB, 2016, UROLOGY, V94, P312, DOI 10.1016/j.urology.2016.04.023
   Calvo-Rubio M, 2016, AGING CELL, V15, P477, DOI 10.1111/acel.12451
   de Cabo R, 2010, AGING-US, V2, P63
   del Campo L, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030656
   Diaz-Ruiz A, 2018, AGING CELL, V17, DOI 10.1111/acel.12767
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Durgin BG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129183
   Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380
   Feelisch M, 2020, CARDIOVASC RES, V116, P51, DOI 10.1093/cvr/cvz202
   Flores-Costa R, 2020, P NATL ACAD SCI USA, V117, P28263, DOI 10.1073/pnas.2000466117
   Golshiri K, 2022, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.818355
   Golshiri K, 2021, J PHARMACOL EXP THER, V378, P173, DOI 10.1124/jpet.121.000628
   Golshiri K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134667
   Golshiri K, 2020, BASIC CLIN PHARMACOL, V127, P67, DOI 10.1111/bcpt.13319
   Goto K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153737
   Hahn MG, 2021, J MED CHEM, V64, P5323, DOI 10.1021/acs.jmedchem.0c02154
   Hirth-Dietrich C., 2005, BMC PHARM S1, V5, pP24, DOI [10.1186/1471-2210-5-s1-p24, DOI 10.1186/1471-2210-5-S1-P24]
   Hoffmann LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145048
   Hoffmann LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8235
   Hyun DH, 2006, AGEING RES REV, V5, P209, DOI 10.1016/j.arr.2006.03.005
   Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005
   Juttner Annika A, 2022, Adv Pharmacol, V94, P57, DOI 10.1016/bs.apha.2022.01.001
   Kolijn D, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00345
   Kovacic JC, 2011, CIRCULATION, V123, P1900, DOI 10.1161/CIRCULATIONAHA.110.009118
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217
   Nino PKB, 2015, CLIN SCI, V129, P1061, DOI 10.1042/CS20140753
   Rahaman MM, 2017, CIRC RES, V121, P137, DOI 10.1161/CIRCRESAHA.117.310705
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
   Sandner P, 2021, HANDB EXP PHARMACOL, V264, P355, DOI 10.1007/164_2018_197
   Sandner P, 2017, GERONTOLOGY, V63, P216, DOI 10.1159/000450946
   Sandner P, 2017, RESP MED, V122, pS1, DOI 10.1016/j.rmed.2016.08.022
   Sanyal A, 2017, CELL REP, V18, P225, DOI 10.1016/j.celrep.2016.12.028
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541
   Shah RC, 2018, NITRIC OXIDE-BIOL CH, V76, P97, DOI 10.1016/j.niox.2018.03.013
   Sheehe JL, 2018, J BIOL CHEM, V293, P16791, DOI 10.1074/jbc.RA118.004363
   Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Wu HY, 2017, CLIN SCI, V131, P1941, DOI 10.1042/CS20170026
   Yousefzadeh M, 2021, ELIFE, V10, DOI 10.7554/eLife.62852
   Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
NR 57
TC 5
Z9 5
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 SEP
PY 2022
VL 21
IS 9
AR e13683
DI 10.1111/acel.13683
EA AUG 2022
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 4M3UP
UT WOS:000846457000001
PM 36029161
OA Green Published
DA 2024-02-19
ER

PT J
AU Hosokawa, M
   Fujisawa, H
   Ax, S
   Zahn-Daimler, G
   Zahn, RK
AF Hosokawa, M
   Fujisawa, H
   Ax, S
   Zahn-Daimler, G
   Zahn, RK
TI Age-associated DNA damage is accelerated in the senescence-accelerated
   mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; DNA single strand breaks; alkaline filter elution; SAM mice;
   senescence acceleration; organ specific DNA damage
ID FIBROBLAST-LIKE CELLS; MOUSE SAM; MURINE MODEL; IN-VITRO; STRAINS;
   BRAIN; MECHANISM; ELUTION; TISSUE
AB We investigated how the DNA status correlates with the aging process in organisms, in different organs and in tissues using two inbred strains of mice, which are genetically related but have different senescence patterns. The SAMP1 mice belong to an accelerated senescence-prone and short lived strain, the other, SAMR1 mice are from an accelerated senescence-resistant and long lived strain. Using the alkaline filter elution technique, pieces of tissues from six organs: lung, intestine, liver, brain, muscle, and heart have been examined for DNA damage, mainly DNA single strand breaks. It was shown that in newborns the DNA damage is minimal, and it was increased significantly with calendric age in all organs in both strains. Although the correlation of DNA damage with aging differed in the different six organs, damage was significantly higher in SAMP1 mice than SAMR1 mice at later life in all organs. This is another remarkable example for the strong correlation of DNA damage and aging process, especially with senescence acceleration. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
C1 Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
   Nara Womens Univ, Fac Sci, Dept Biol, Div Human Environm Sci,Grad Sch Human Culture, Nara 6308506, Japan.
   Johannes Gutenberg Univ Mainz, Acad Sci & Literature Bldg Res & Dev, Commiss Aging Res, D-55101 Mainz, Germany.
   Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55101 Mainz, Germany.
C3 Kyoto University; Nara Womens University; Johannes Gutenberg University
   of Mainz; Johannes Gutenberg University of Mainz
RP Hosokawa, M (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
EM hosokawa@frontier.kyoto-u.ac.jp
CR EFFERTH T, 1993, TUMORDIAGN THER, V14, P238
   Fujibayashi Y, 1998, NEUROSCI LETT, V254, P109, DOI 10.1016/S0304-3940(98)00667-3
   Fujisawa H, 1998, J GERONTOL A-BIOL, V53, pB11, DOI 10.1093/gerona/53A.1.B11
   Fujisawa H, 1999, J GERONTOL A-BIOL, V54, pB276, DOI 10.1093/gerona/54.7.B276
   HE PM, 1994, MECH AGEING DEV, V76, P43, DOI 10.1016/0047-6374(94)90006-X
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   Hosokawa M., 1998, J ANTI-AGING MED, V1, P27, DOI [10.1089/rej.1.1998.1.27, DOI 10.1089/REJ.1.1998.1.27]
   KURELEC B, 1992, CRIT REV TOXICOL, V22, P23, DOI 10.3109/10408449209145320
   Nishikawa T, 1998, NEUROSCI LETT, V254, P69, DOI 10.1016/S0304-3940(98)00646-6
   NISITANI S, 1990, MUTAT RES, V237, P221, DOI 10.1016/0921-8734(90)90003-A
   Odagiri Y, 1998, NAT GENET, V19, P116, DOI 10.1038/468
   Payao SLM, 1998, MECH AGEING DEV, V105, P265, DOI 10.1016/S0047-6374(98)00095-5
   STOUT DL, 1982, ANAL BIOCHEM, V127, P302, DOI 10.1016/0003-2697(82)90177-4
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.1093/biomet/34.1-2.28
   Xia C, 1999, MAMM GENOME, V10, P235, DOI 10.1007/s003359900979
   Zahn RK, 1999, MECH AGEING DEV, V108, P99, DOI 10.1016/S0047-6374(98)00151-1
   ZAHN RK, 1987, MECH AGEING DEV, V41, P73, DOI 10.1016/0047-6374(87)90055-8
   Zahn RK, 1996, MECH AGEING DEV, V89, P79, DOI 10.1016/0047-6374(96)01738-1
NR 20
TC 30
Z9 33
U1 1
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP 1
PY 2000
VL 118
IS 1-2
BP 61
EP 70
DI 10.1016/S0047-6374(00)00158-5
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 357RC
UT WOS:000089513800006
PM 10989125
DA 2024-02-19
ER

PT J
AU Uemura, T
   Matsunaga, M
   Yokota, Y
   Takao, K
   Furuchi, T
AF Uemura, Takeshi
   Matsunaga, Miki
   Yokota, Yuka
   Takao, Koichi
   Furuchi, Takemitsu
TI Inhibition of Polyamine Catabolism Reduces Cellular Senescence
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE aging; senescence; spermine oxidase; polyamine metabolism; acrolein
ID ACROLEIN TOXICITY; EXPRESSION; SPERMIDINE; MEMORY; CYTOTOXICITY;
   PERFORMANCE; MECHANISMS; OXIDASE; GROWTH; P21
AB The aging of the global population has necessitated the identification of effective anti-aging technologies based on scientific evidence. Polyamines (putrescine, spermidine, and spermine) are essential for cell growth and function. Age-related reductions in polyamine levels have been shown to be associated with reduced cognitive and physical functions. We have previously found that the expression of spermine oxidase (SMOX) increases with age; however, the relationship between SMOX expression and cellular senescence remains unclear. Therefore, we investigated the relationship between increased SMOX expression and cellular senescence using human-liver-derived HepG2 cells. Intracellular spermine levels decreased and spermidine levels increased with the serial passaging of cells (aged cells), and aged cells showed increased expression of SMOX. The levels of acrolein-conjugated protein, which is produced during spermine degradation, also increases. Senescence-associated & beta;-gal activity was increased in aged cells, and the increase was suppressed by MDL72527, an inhibitor of acetylpolyamine oxidase (AcPAO) and SMOX, both of which are enzymes that catalyze polyamine degradation. DNA damage accumulated in aged cells and MDL72527 reduced DNA damage. These results suggest that the SMOX-mediated degradation of spermine plays an important role in cellular senescence. Our results demonstrate that cellular senescence can be controlled by inhibiting spermine degradation using a polyamine-catabolizing enzyme inhibitor.
C1 [Uemura, Takeshi; Matsunaga, Miki; Yokota, Yuka; Takao, Koichi; Furuchi, Takemitsu] Josai Univ, Fac Pharm & Pharmaceut Sci, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.
C3 Josai University
RP Uemura, T (corresponding author), Josai Univ, Fac Pharm & Pharmaceut Sci, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.
EM t_uemura@josai.ac.jp; ktakao@josai.ac.jp; tfuruchi@josai.ac.jp
OI Uemura, Takeshi/0000-0002-5227-4519
FU Japan Society for the Promotion of Science [22K11860]
FX This study was funded by a grant-in-aid for scientific research (C),
   Japan Society for the Promotion of Science, to T.U. Grant No. 22K11860.
CR Al-Habsi M, 2022, SCIENCE, V378, P370, DOI 10.1126/science.abj3510
   Bachrach U, 2010, PLANT PHYSIOL BIOCH, V48, P490, DOI 10.1016/j.plaphy.2010.02.003
   Bauer MA, 2013, CELL CYCLE, V12, P346, DOI 10.4161/cc.23199
   Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919
   Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598
   Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z
   Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538
   Gil L, 2021, NEUROSCI LETT, V749, DOI 10.1016/j.neulet.2021.135741
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Hofer SJ, 2021, AUTOPHAGY, V17, P2037, DOI 10.1080/15548627.2021.1933299
   Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020
   Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601
   Igarashi K, 2018, AMINO ACIDS, V50, P217, DOI 10.1007/s00726-017-2527-x
   Johnson W, 2016, B WORLD HEALTH ORGAN, V94, P634, DOI 10.2471/BLT.16.181636
   Liang YT, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108941
   Ma J, 2020, AGING-US, V12, P13529, DOI 10.18632/aging.103461
   Maldonado E, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12030651
   Masuko T, 2018, NEUROSCI LETT, V672, P118, DOI 10.1016/j.neulet.2018.01.054
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361
   Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233
   Moskalev A, 2022, TRENDS ENDOCRIN MET, V33, P266, DOI 10.1016/j.tem.2022.01.007
   Nakamura M, 2013, BIOCHEM BIOPH RES CO, V430, P1265, DOI 10.1016/j.bbrc.2012.12.057
   Nakanishi Shima, 2021, Med Sci (Basel), V9, DOI 10.3390/medsci9020028
   Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003
   Ocana PD, 2021, EUR J APPL PHYSIOL, V121, P3447, DOI 10.1007/s00421-021-04803-4
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661
   Qu N, 2003, BIOCHEM J, V375, P465, DOI 10.1042/BJ20030382
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Sakamoto A, 2020, J BIOL CHEM, V295, P8736, DOI 10.1074/jbc.RA120.013833
   Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569
   Sigrist SJ, 2014, AUTOPHAGY, V10, P178, DOI 10.4161/auto.26918
   Soda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064357
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Stites SD, 2018, ALZ DIS ASSOC DIS, V32, P276, DOI 10.1097/WAD.0000000000000262
   Sun TY, 2022, EXP GERONTOL, V163, DOI 10.1016/j.exger.2022.111800
   Tanel A, 2005, BBA-MOL CELL RES, V1743, P255, DOI 10.1016/j.bbamcr.2004.11.007
   Uemura T, 2020, CYTOSKELETON, V77, P414, DOI 10.1002/cm.21638
   Uemura T, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05031
   Uemura T, 2019, INT J BIOCHEM CELL B, V113, P58, DOI 10.1016/j.biocel.2019.05.016
   Uemura T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14929-1
   Uemura T, 2013, TOXICOLOGY, V310, P1, DOI 10.1016/j.tox.2013.05.008
   Vidal-Carou MC, 2003, J CHROMATOGR A, V998, P235, DOI 10.1016/S0021-9673(03)00610-1
   Wickham H., 2016, GGPLOT2: Elegant Graphics for Data Analysis, DOI [10.1007/978-3-319-24277-4, 10.1007/978-0-387-98141-3, DOI 10.1007/978-0-387-98141-3]
   Wirth M, 2018, CORTEX, V109, P181, DOI 10.1016/j.cortex.2018.09.014
   Wu D, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.6.52
   Zhang HL, 2020, AUTOPHAGY, V16, P181, DOI 10.1080/15548627.2019.1687967
NR 55
TC 0
Z9 0
U1 6
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2023
VL 24
IS 17
AR 13397
DI 10.3390/ijms241713397
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA R0HS6
UT WOS:001061241900001
PM 37686212
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Du, K
   Maeso-Díaz, R
   Oh, SH
   Wang, E
   Chen, TY
   Pan, CSP
   Xiang, K
   Dutta, RK
   Wang, XF
   Chi, JT
   Diehl, AM
AF Du, Kuo
   Maeso-Diaz, Raquel
   Oh, Seh Hoon
   Wang, Ergang
   Chen, Tianyi
   Pan, Christopher
   Xiang, Kun
   Dutta, Rajesh Kumar
   Wang, Xiao-Fan
   Chi, Jen-Tsan
   Diehl, Anna Mae
TI Targeting YAP-mediated HSC death susceptibility and senescence for
   treatment of liver fibrosis
SO HEPATOLOGY
LA English
DT Article
ID HIPPO PATHWAY; CANCER; CELLS; FERROPTOSIS; APOPTOSIS
AB Background and Aims: Liver fibrosis results from the accumulation of myofibroblasts (MFs) derived from quiescent HSCs, and yes-associated protein (YAP) controls this state transition. Although fibrosis is also influenced by HSC death and senescence, whether YAP regulates these processes and whether this could be leveraged to treat liver fibrosis are unknown. Approach and Results: YAP activity was manipulated in MF-HSCs to determine how YAP impacts susceptibility to pro-apoptotic senolytic agents or ferroptosis. Effects of senescence on YAP activity and susceptibility to apoptosis versus ferroptosis were also examined. CCl4-treated mice were treated with a ferroptosis inducer or pro-apoptotic senolytic to determine the effects on liver fibrosis. YAP was conditionally disrupted in MFs to determine how YAP activity in MF-HSC affects liver fibrosis in mouse models. Silencing YAP in cultured MF-HSCs induced HSC senescence and vulnerability to senolytics, and promoted ferroptosis resistance. Conversely, inducing HSC senescence suppressed YAP activity, increased sensitivity to senolytics, and decreased sensitivity to ferroptosis. Single-cell analysis of HSCs from fibrotic livers revealed heterogeneous sensitivity to ferroptosis, apoptosis, and senescence. In mice with chronic liver injury, neither the ferroptosis inducer nor senolytic improved fibrosis. However, selectively depleting YAP in MF-HSCs induced senescence and decreased liver injury and fibrosis. Conclusion: YAP determines whether MF-HSCs remain activated or become senescent. By regulating this state transition, Yap controls both HSC fibrogenic activity and susceptibility to distinctmechanisms for cell death. MF-HSC-specific YAP depletion induces senescence and protects injured livers from fibrosis. Clarifying determinants of HSC YAP activity may facilitate the development of novel anti-fibrotic therapies.
C1 [Du, Kuo; Maeso-Diaz, Raquel; Oh, Seh Hoon; Chen, Tianyi; Dutta, Rajesh Kumar; Diehl, Anna Mae] Duke Univ, Dept Med, Durham, NC USA.
   [Wang, Ergang; Pan, Christopher; Xiang, Kun; Wang, Xiao-Fan] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA.
   [Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA.
   [Chi, Jen-Tsan] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA.
C3 Duke University; Duke University; Duke University; Duke University
RP Diehl, AM (corresponding author), Duke Univ, Div Gastroenterol, Snyderman Bldg,Suite 1073, Durham, NC 27710 USA.
EM kuo.du@duke.edu; raquel.maeso.diaz@duke.edu; seh.hoon.oh@duke.edu;
   ergang.wang@duke.edu; tc206@duke.edu; chris.pan@duke.edu;
   kun.xiang@duke.edu; rajesh.dutta@duke.edu; xiao.fan.wang@duke.edu;
   jentsan.chi@duke.edu; annamae.diehl@duke.edu
RI Dutta, Rajesh Kumar/J-7790-2019; Maeso Diaz, Raquel/K-4766-2015
OI Dutta, Rajesh Kumar/0000-0002-1394-0961; DU, KUO/0000-0002-1446-4653;
   Chi, Jen-Tsan/0000-0003-3433-903X; Maeso Diaz,
   Raquel/0000-0002-2448-0251; Xiang, Kun/0000-0001-7793-4352; Wang,
   Ergang/0000-0003-2550-3686
FU 2021 AASLD Pinnacle Award; National Institutes of Health [R37 AA010154,
   R01 DK077794, R56 DK106633, 1R01GM124062]
FX This work was supported by the 2021 AASLD Pinnacle Award to Kuo Du,
   National Institutes of Health grantsR37 AA010154, R01 DK077794, R56
   DK106633awarded to Anna Mae Diehl, and 1R01GM124062 toJen-Tsan Chi.
CR Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Badgley MA, 2020, SCIENCE, V368, P85, DOI 10.1126/science.aaw9872
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Dasari VR, 2017, ONCOTARGET, V8, P28628, DOI 10.18632/oncotarget.15614
   Du K, 2021, LIVER INT, V41, P2214, DOI 10.1111/liv.14945
   El Taghdouini A, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0031-z
   Filliol A, 2022, NATURE, V610, P356, DOI 10.1038/s41586-022-05289-6
   Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126
   Kamm DR, 2022, J PHYSIOL-LONDON, V600, P1825, DOI 10.1113/JP281061
   Kong DL, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3729-8
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Leu JIJ, 2019, P NATL ACAD SCI USA, V116, P8390, DOI 10.1073/pnas.1821277116
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Magesh S, 2022, TRENDS CELL BIOL, V32, P729, DOI 10.1016/j.tcb.2022.05.005
   Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011
   Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904
   Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059
   Saini H, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-020-01720-y
   Siegmund SV, 2005, HEPATOLOGY, V41, P1085, DOI 10.1002/hep.20667
   Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Venkatesh D, 2020, AGING-US, V12, P17800, DOI 10.18632/aging.103961
   Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664
   Wendling O, 2009, GENESIS, V47, P14, DOI 10.1002/dvg.20448
   Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010
   Yang W, 2021, HEPATOLOGY, V74, P2774, DOI 10.1002/hep.31987
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907
   Zhu CY, 2021, NAT REV GASTRO HEPAT, V18, P131, DOI 10.1038/s41575-020-00365-6
NR 30
TC 7
Z9 7
U1 7
U2 22
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 2023
VL 77
IS 6
BP 1998
EP 2015
DI 10.1097/HEP.0000000000000326
PG 18
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA H5SK2
UT WOS:000996557500027
PM 36815382
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Jiao, L
   Gan-Schreier, H
   Zhu, XY
   Wei, W
   Tuma-Kellner, S
   Liebisch, G
   Stremmel, W
   Chamulitrat, W
AF Jiao, Li
   Gan-Schreier, Hongying
   Zhu, Xingya
   Wei, Wang
   Tuma-Kellner, Sabine
   Liebisch, Gerhard
   Stremmel, Wolfgang
   Chamulitrat, Walee
TI Ageing sensitized by iPLA<sub>2</sub>β deficiency induces liver fibrosis
   and intestinal atrophy involving suppression of homeostatic genes and
   alteration of intestinal lipids and bile acids
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article
DE P1a2G6; Ageing; Intestinal homeostasis; XBP1; Lipidomics; FXR
ID INDEPENDENT PHOSPHOLIPASE A(2); ENDOPLASMIC-RETICULUM STRESS; UNFOLDED
   PROTEIN RESPONSE; NUCLEAR HORMONE-RECEPTORS; FACTOR 1-ALPHA HNF1-ALPHA;
   OXIDATIVE STRESS; ER STRESS; HEPATIC STEATOSIS; APOPTOTIC CELLS; MICE
AB Ageing is a major risk factor for various forms of liver and gastrointestinal (GI) disease and genetic background may contribute to the pathogenesis of these diseases. Group VIA phospholipase A2 or iPLA(2)beta is a homeostatic PLA2 by playing a role in phospholipid metabolism and remodeling. Global iPLA(2)beta(-/-) mice exhibit aged-dependent phenotypes with body weight loss and abnormalities in the bone and brain. We have previously reported the abnormalities in these mutant mice showing susceptibility for chemical-induced liver injury and colitis. We hypothesize that iPLA(2)beta deficiency may sensitize with ageing for an induction of GI injury. Male wild-type and iPLA(2)beta(-/-) mice at 4 and 20-22 months of age were studied. Aged, but not young, iPLA(2)beta(-/-) mice showed increased hepatic fibrosis and biliary ductular expansion as well as severe intestinal atrophy associated with increased apoptosis, pro-inflammation, disrupted tight junction, and reduced number of mucin-containing globlet cells. This damage was associated with decreased expression of intestinal endoplasmic stress XBP1 and its regulator HNF1 alpha, FATP4, ACSL5, bile-acid transport genes as well as nuclear receptors LXR alpha and FXR. By LC/MS-MS profiling, iPLA(2)beta deficiency in aged mice caused an increase of intestinal arachidonate-containing phospholipids concomitant with a decrease in ceramides. By the suppression of intestinal FXR/FGF-15 signaling, hepatic bile-acid synthesis gene expression was increased leading to an elevation of secondary and hydrophobic bile acids in liver, bile, and intestine. In conclusions, ageing sensitized by iPLA(2)beta deficiency caused a decline of key intestinal homeostatic genes resulting in the development of GI disease in a gut-to-liver manner.
C1 [Jiao, Li; Gan-Schreier, Hongying; Zhu, Xingya; Wei, Wang; Tuma-Kellner, Sabine; Stremmel, Wolfgang; Chamulitrat, Walee] Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Germany.
   [Liebisch, Gerhard] Univ Regensburg, Inst Clin Chem & Lab Med, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
   [Jiao, Li] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Yunnan, Peoples R China.
   [Jiao, Li] Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China.
C3 Ruprecht Karls University Heidelberg; University of Regensburg; Chinese
   Academy of Medical Sciences - Peking Union Medical College; Institute of
   Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking
   Union Medical College; Peking Union Medical College
RP Chamulitrat, W (corresponding author), Neuenheimer Feld 345 EG, D-69120 Heidelberg, Germany.
EM Walee.Chamulitrat@med.uni-heidelberg.de
RI zhang, wb/JGM-5316-2023; Liebisch, Gerhard/G-6130-2010
OI Liebisch, Gerhard/0000-0003-4886-0811; Stremmel,
   Wolfgang/0000-0002-8545-1753; Jiao, Li/0000-0002-1996-004X
FU Deutsche Forschungsgemeinschaft (DFG) [CH288/6-2]; Wuhan-Heidelberg
   scholarship (HGMF); China scholarship council [201508320262]
FX This study was supported by Deutsche Forschungsgemeinschaft (DFG
   CH288/6-2 to W.C.), Wuhan-Heidelberg scholarship (HGMF WW 2011-2012 to
   W.W.), and China scholarship council (201508320262 to X.Z.). We thank
   Dr. John Turk for providing us with iPLA<INF>2</INF>beta-null mice and
   Weihong Xu for providing initial data.
CR Akiyama TE, 2000, J BIOL CHEM, V275, P27117
   Alemany R, 2007, BBA-BIOMEMBRANES, V1768, P964, DOI 10.1016/j.bbamem.2006.09.024
   Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018
   Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400
   Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002
   BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527
   Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200
   Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186
   Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635
   Bhutto A, 2008, CURR OPIN CLIN NUTR, V11, P651, DOI 10.1097/MCO.0b013e32830b5d37
   Blanchard H, 2014, NEUROCHEM RES, V39, P1522, DOI 10.1007/s11064-014-1342-y
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   BOSMAN GJCGM, 1991, GERONTOLOGY, V37, P95
   Bueno-Hernández N, 2011, INFLAMM BOWEL DIS, V17, pE155, DOI 10.1002/ibd.21856
   Chapman IM, 2002, BIOGERONTOLOGY, V3, P67, DOI 10.1023/A:1015211530695
   Cheon Y, 2012, BBA-MOL CELL BIOL L, V1821, P1278, DOI 10.1016/j.bbalip.2012.02.003
   Coskun M, 2014, DAN MED J, V61
   Deng XL, 2016, BBA-MOL CELL BIOL L, V1861, P449, DOI 10.1016/j.bbalip.2016.02.004
   Duncan SH, 2013, MATURITAS, V75, P44, DOI 10.1016/j.maturitas.2013.02.004
   Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Foster DB, 2000, INFECT IMMUN, V68, P3108, DOI 10.1128/IAI.68.6.3108-3115.2000
   Frakes AE, 2017, MOL CELL, V66, P761, DOI 10.1016/j.molcel.2017.05.031
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Goh GYS, 2014, AGING CELL, V13, P70, DOI 10.1111/acel.12154
   Goldacre MJ, 2009, BEST PRACT RES CL GA, V23, P793, DOI 10.1016/j.bpg.2009.10.008
   Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595
   Heude B, 2003, AM J CLIN NUTR, V77, P803, DOI 10.1093/ajcn/77.4.803
   Hoffmann JM, 2015, CRIT REV BIOCHEM MOL, V50, P380, DOI 10.3109/10409238.2015.1067186
   Hou NS, 2014, P NATL ACAD SCI USA, V111, pE2271, DOI 10.1073/pnas.1318262111
   Inhoffen J, 2015, CANCERS, V7, P2427, DOI 10.3390/cancers7040901
   Jiao L, 2015, DIGEST DIS SCI, V60, P3590, DOI 10.1007/s10620-015-3807-5
   Jiao L, 2015, BBA-MOL BASIS DIS, V1852, P1646, DOI 10.1016/j.bbadis.2015.04.025
   Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021
   Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x
   Kazgan N, 2014, GASTROENTEROLOGY, V146, P1006, DOI 10.1053/j.gastro.2013.12.029
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kinghorn KJ, 2015, BRAIN, V138, P1801, DOI 10.1093/brain/awv132
   Kirkpatrick CL, 2011, J BIOL CHEM, V286, P32300, DOI 10.1074/jbc.M111.247866
   Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018
   Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7
   LEDERLE FA, 1995, DRUG AGING, V6, P465, DOI 10.2165/00002512-199506060-00006
   Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z
   Lenz LS, 2011, J BIOL CHEM, V286, P35578, DOI 10.1074/jbc.M111.226530
   Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384
   Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506
   Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009
   Maher JM, 2006, BIOCHEM PHARMACOL, V72, P512, DOI 10.1016/j.bcp.2006.03.016
   Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823
   Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857
   McMillin M, 2015, MOL ENDOCRINOL, V29, P1720, DOI 10.1210/me.2015-1087
   Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243
   Mooijaart SP, 2007, J GERONTOL A-BIOL, V62, P343, DOI 10.1093/gerona/62.4.343
   Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006
   Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756
   Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104
   Rao RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092142
   Renga B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054472
   Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018
   San Roman AK, 2015, J BIOL CHEM, V290, P1850, DOI 10.1074/jbc.M114.620211
   Schmucker Douglas L, 2003, Clin Dev Immunol, V10, P167, DOI 10.1080/10446670310001642168
   Shang J, 2011, METHOD ENZYMOL, V491, P293, DOI 10.1016/B978-0-12-385928-0.00016-X
   Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026
   Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012
   VANDERWERF SDJ, 1981, EUR J CLIN INVEST, V11, P425, DOI 10.1111/j.1365-2362.1981.tb02009.x
   Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Xu W., 2012, INT LIVER CONGRESSTM
   Yang R, 2016, BBA-GENE REGUL MECH, V1859, P591, DOI 10.1016/j.bbagrm.2016.02.005
   Yoshida H, 2006, CELL STRUCT FUNCT, V31, P117, DOI 10.1247/csf.06016
   Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x
   Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834
NR 75
TC 14
Z9 14
U1 0
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 1879-2618
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD DEC
PY 2017
VL 1862
IS 12
BP 1520
EP 1533
DI 10.1016/j.bbalip.2017.09.001
PG 14
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA FM2LC
UT WOS:000414815300006
PM 28888832
DA 2024-02-19
ER

EF